PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Slomski, A				Slomski, Anita			Online Mindfulness Therapy Improves Residual Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1124	1124		10.1001/jama.2020.2813	http://dx.doi.org/10.1001/jama.2020.2813			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207792				2022-12-28	WOS:000530807000003
J	Slomski, A				Slomski, Anita			Leading HIV Vaccine Trial Stopped for Ineffectiveness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1124	1124		10.1001/jama.2020.2811	http://dx.doi.org/10.1001/jama.2020.2811			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207792				2022-12-28	WOS:000530807000006
J	Slomski, A				Slomski, Anita			Hotspotting Doesn't Prevent Hospital Readmissions in Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1124	1124		10.1001/jama.2020.2814	http://dx.doi.org/10.1001/jama.2020.2814			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207793				2022-12-28	WOS:000530807000004
J	Slomski, A				Slomski, Anita			Despite Law, Most Clinical Trial Results Still Not Posted	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1124	1124		10.1001/jama.2020.2812	http://dx.doi.org/10.1001/jama.2020.2812			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207793				2022-12-28	WOS:000530807000007
J	Oehler, RL; Gompf, SG				Oehler, Richard L.; Gompf, Sandra G.			Shortcomings in the US Pharmaceutical Supply Chain Potential Risks Associated With International Manufacturing and Trade-Related Tariffs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses vulnerabilities in the US drug supply chain given a shift in manufacturing of pharmaceutical ingredients to other countries and calls for a system to identify high-value medications, forecast supplies and shortages, and incentivize domestic production.	[Oehler, Richard L.; Gompf, Sandra G.] Univ S Florida, James A Haley Vet Hosp, Div Infect Dis & Int Med, Morsani Coll Med, Mailstop 111J,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	Oehler, RL (corresponding author), Univ S Florida, James A Haley Vet Hosp, Div Infect Dis & Int Med, Morsani Coll Med, Mailstop 111J,13000 Bruce B Downs Blvd, Tampa, FL 33612 USA.	richard.oehler@va.gov	Gompf, Sandra/A-8882-2013	Gompf, Sandra/0000-0001-6533-7577				[Anonymous], CHINA DAILY; Cogan D., 2018, SHORTAGES STOCKOUTS; CY, 2018, CY 2018 ANN REP INSP; Denigan-Macauley M., 2019, DRUG SAFETY PRELIMIN; Eschoo AF, 2019, WASHINGTON POST; Gibson R., 2018, CHINA RX EXPOSING RI; Gross AE, 2017, CLIN INFECT DIS, V65, P613, DOI 10.1093/cid/cix379; Hunag Y, 2019, US DEPENDENCE PHARM; Stephan LS, 2017, JMIR MHEALTH UHEALTH, V5, DOI 10.2196/mhealth.6510; U.S. Food and Drug Administration, 2020, CURR RES DRUG SHORT	10	5	5	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2020	324	2					143	144		10.1001/jama.2020.1634	http://dx.doi.org/10.1001/jama.2020.1634			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ8RW	32176256				2022-12-28	WOS:000553161000014
J	Zhang, H; Shao, FM; Gu, JQ; Li, L; Wang, YM				Zhang, Hui; Shao, Fengmin; Gu, Jianqin; Li, Li; Wang, Yuming			Ethics Committee Reviews of Applications for Research Studies at 1 Hospital in China During the 2019 Novel Coronavirus Epidemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study reviews research ethics committee applications for COVID-19-related research at a Chinese hospital in February 2020 to characterize study type, approval rate and review time, reason for revision or denial, and issues with informed consent.	[Zhang, Hui; Li, Li] Zhengzhou Univ, Dept Sci Res & Discipline Construct, Henan Prov Peoples Hosp, Zhengzhou, Peoples R China; [Zhang, Hui; Shao, Fengmin; Gu, Jianqin; Li, Li; Wang, Yuming] Zhengzhou Univ, Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China; [Shao, Fengmin] Zhengzhou Univ, Dept Nephrol, Henan Prov Peoples Hosp, Zhengzhou, Peoples R China; [Gu, Jianqin] Zhengzhou Univ, Dept Gen Med, Henan Prov Peoples Hosp, Zhengzhou, Peoples R China; [Wang, Yuming] Zhengzhou Univ, Clin Res Guidance Ctr, Henan Prov Peoples Hosp, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University	Wang, YM (corresponding author), Zhengzhou Univ, Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China.; Wang, YM (corresponding author), Zhengzhou Univ, Henan Prov Peoples Hosp, 7 Weiwu Rd, Zhengzhou 450003, Henan, Peoples R China.	henanyuming@sina.com		Zhang, Hui/0000-0001-8875-5392; Wang, Yuming/0000-0003-0497-055X				Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Schopper D, 2017, PUBLIC HEALTH ETH-UK, V10, P49, DOI 10.1093/phe/phw039; World Health Organization, 2016, GUID MAN ETH ISS INF	3	29	30	2	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1844	1846		10.1001/jama.2020.4362	http://dx.doi.org/10.1001/jama.2020.4362			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32202608	Bronze, Green Published			2022-12-28	WOS:000536221500026
J	Piccirillo, JF; Rodebaugh, TL; Lenze, EJ				Piccirillo, Jay F.; Rodebaugh, Thomas L.; Lenze, Eric J.			Tinnitus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							THERAPY	This JAMA Clinical Insights article reviews the diagnosis and treatment of chronic tinnitus based on current understanding of symptom mechanisms and emphasizes the importance of behavioral therapies (tinnitus retraining) and personalized treatment whenever possible.	[Piccirillo, Jay F.] Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 660 S Euclid Ave,Campus Box 8115, St Louis, MO 63110 USA; [Rodebaugh, Thomas L.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Lenze, Eric J.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Piccirillo, JF (corresponding author), Washington Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 660 S Euclid Ave,Campus Box 8115, St Louis, MO 63110 USA.	piccirii@wustl.edu	Lenze, Eric J/AAW-8652-2021; Amedee, Ronald/A-5480-2011	Lenze, Eric/0000-0002-0471-9368	National Institutes of Health [ROIDC009095]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors receive funding from grant ROIDC009095 from the National Institutes of Health to conduct research to identify factors related to tinnitus.	Beukes EW, 2018, JAMA OTOLARYNGOL, V144, P1126, DOI 10.1001/jamaoto.2018.2238; Bhatt JM, 2016, JAMA OTOLARYNGOL, V142, P959, DOI 10.1001/jamaoto.2016.1700; Hesser H, 2011, CLIN PSYCHOL REV, V31, P545, DOI 10.1016/j.cpr.2010.12.006; Husain FT, 2014, HEARING RES, V307, P153, DOI 10.1016/j.heares.2013.07.010; Masterson EA, 2016, AM J IND MED, V59, P290, DOI 10.1002/ajim.22565; Philippot P, 2012, CLIN PSYCHOL PSYCHOT, V19, P411, DOI 10.1002/cpp.756; Roberts LE, 2013, NEUROSCI BIOBEHAV R, V37, P1754, DOI 10.1016/j.neubiorev.2013.07.007; Scherer RW, 2019, JAMA OTOLARYNGOL, V145, P597, DOI 10.1001/jamaoto.2019.0821; Veterans Benefits Administration, 2018, ANN BEN REP FISC YEA; Westin VZ, 2011, BEHAV RES THER, V49, P737, DOI 10.1016/j.brat.2011.08.001	10	14	16	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1497	1498		10.1001/jama.2020.0697	http://dx.doi.org/10.1001/jama.2020.0697			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LJ1ZH	32176246				2022-12-28	WOS:000529969700021
J	Richard, D; Liu, Z; Cao, JX; Kiapour, AM; Willen, J; Yarlagadda, S; Jagoda, E; Kolachalama, VB; Sieker, JT; Chang, GH; Muthuirulan, P; Young, M; Masson, A; Konrad, J; Hosseinzadeh, S; Maridas, DE; Rosen, V; Krawetz, R; Roach, N; Capellini, TD				Richard, Daniel; Liu, Zun; Cao, Jiaxue; Kiapour, Ata M.; Willen, Jessica; Yarlagadda, Siddharth; Jagoda, Evelyn; Kolachalama, Vijaya B.; Sieker, Jakob T.; Chang, Gary H.; Muthuirulan, Pushpanathan; Young, Mariel; Masson, Anand; Konrad, Johannes; Hosseinzadeh, Shayan; Maridas, David E.; Rosen, Vicki; Krawetz, Roman; Roach, Neil; Capellini, Terence D.			Evolutionary Selection and Constraint on Human Knee Chondrocyte Regulation Impacts Osteoarthritis Risk	CELL			English	Article							GENOME-WIDE ASSOCIATION; ARTICULAR-CARTILAGE; TGF-BETA; R/BIOCONDUCTOR PACKAGE; TRANSCRIPTION FACTOR; EXPRESSION PATTERNS; ANCIENT SELECTION; COMMON VARIANTS; GENE-EXPRESSION; DNA ELEMENTS	During human evolution, the knee adapted to the biomechanical demands of bipedalism by altering chondrocyte developmental programs. This adaptive process was likely not without deleterious consequences to health. Today, osteoarthritis occurs in 250 million people, with risk variants enriched in non-coding sequences near chondrocyte genes, loci that likely became optimized during knee evolution. We explore this relationship by epigenetically profiling joint chondrocytes, revealing ancient selection and recent constraint and drift on knee regulatory elements, which also overlap osteoarthritis variants that contribute to disease heritability by tending to modify constrained functional sequence. We propose a model whereby genetic violations to regulatory constraint, tolerated during knee development, lead to adult pathology. In support, we discover a causal enhancer variant (rs6060369) present in billions of people at a risk locus (GDF5-UQCC1), showing how it impacts mouse knee-shape and osteoarthritis. Overall, our methods link an evolutionarily novel aspect of human anatomy to its pathogenesis.	[Richard, Daniel; Liu, Zun; Cao, Jiaxue; Willen, Jessica; Yarlagadda, Siddharth; Jagoda, Evelyn; Muthuirulan, Pushpanathan; Young, Mariel; Roach, Neil; Capellini, Terence D.] Harvard Univ, Human Evolutionary Biol, Cambridge, MA 02138 USA; [Cao, Jiaxue] Sichuan Agr Univ, Farm Anim Genet Resources Explorat & Innovat Key, Chengdu 611130, Peoples R China; [Kiapour, Ata M.; Sieker, Jakob T.; Konrad, Johannes; Hosseinzadeh, Shayan] Harvard Med Sch, Boston Childrens Hosp, Orthopaed Surg, Boston, MA 02115 USA; [Kolachalama, Vijaya B.; Chang, Gary H.] Boston Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Kolachalama, Vijaya B.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02115 USA; [Kolachalama, Vijaya B.] Boston Univ, Hariri Inst Comp & Computat Sci & Engn, Boston, MA 02115 USA; [Sieker, Jakob T.] Tufts Med Ctr, Pathol & Lab Med, Boston, MA 02111 USA; [Masson, Anand; Krawetz, Roman] Univ Calgary, McCaig Inst Bone & Joint Hlth, Calgary, AB T2N 1N4, Canada; [Maridas, David E.; Rosen, Vicki] Harvard Sch Dent Med, Dev Biol, Boston, MA 02115 USA; [Capellini, Terence D.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Sichuan Agricultural University; Harvard University; Boston Children's Hospital; Harvard Medical School; Boston University; Boston University; Boston University; Tufts Medical Center; University of Calgary; Harvard University; Harvard School of Dental Medicine; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Capellini, TD (corresponding author), Harvard Univ, Human Evolutionary Biol, Cambridge, MA 02138 USA.; Capellini, TD (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	tcapellini@fas.harvard.edu	Maridas, David/ABA-8941-2021; Kolachalama, Vijaya B./AAH-3528-2020	Maridas, David/0000-0001-6680-6005; Kolachalama, Vijaya B./0000-0002-5312-8644; Richard, Daniel/0000-0001-8568-9473; Pushpanathan, Muthuirulan/0000-0001-6240-3073	NIH/NIAMS [1R01AR070139, R01AR065462]; Orthopaedic Foundation at Boston Children's Hospital; NIH/NCATS BU-CTSI [1UL1TR001430]; American Heart Association Scientist Development Grant [17SDG33670323]; Hariri Institute for Computing and Computational Science and Engineering at Boston University; NIH [5U01AG-018820]; HU PRISE; NSF [BCS1518596]; HU; Center for Skeletal Research (Massachusetts General Hospital) [NIH P30 AR066261]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Orthopaedic Foundation at Boston Children's Hospital; NIH/NCATS BU-CTSI; American Heart Association Scientist Development Grant(American Heart Association); Hariri Institute for Computing and Computational Science and Engineering at Boston University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HU PRISE; NSF(National Science Foundation (NSF)); HU; Center for Skeletal Research (Massachusetts General Hospital)	The authors thank Drs. Bruce, Brooks, and Bouxsein for mCT from the Center for Skeletal Research (NIH P30 AR066261) (Massachusetts General Hospital); EpigenDx for ASE; Applied StemCell for mice; Drs. Sabeti (Harvard University [HU]), Zeng (Tufts University), and Goldring (The Hospital for Special Surgery) for cell lines; the HUGMF for targeting; the HUBCF for sequencing; Tufts Medical Center and Boston Children's Hospital for histology; Dr. Worthington (HU) for statistics guidance; Drs. Price (Harvard T.H. Chan School of Public Health), Tabin (Harvard Medical School), Doxey (University of Waterloo), Lowe (Duke University), Bowes (iMorphics), Yau (Marcus Institute for Aging Research), Felson (Boston University), Pregizer (Boston Children's Hospital), and Pilbeam (HU) and the Capellini lab members for insight and manuscript review; three reviewers for their insight into this work. This work was supported by NIH/NIAMS (1R01AR070139 to T.D.C. and R01AR065462 to A.M.K.); the Orthopaedic Foundation at Boston Children's Hospital (to A.M.K.); NIH/NCATS BU-CTSI (1UL1TR001430 to V.B.K. and G.H.C.); an American Heart Association Scientist Development Grant (17SDG33670323 to V.B.K. and G.H.C.); the Hariri Institute for Computing and Computational Science and Engineering at Boston University (Hariri Research Award to V.B.K. and G.H.C.); NIH (5U01AG-018820 to V.B.K. and G.H.C.); HU PRISE (to S.Y.); NSF (BCS1518596 to T.D.C. and N.R.) for mouse research; and HU Dean's Competitive Fund and Milton Fund for Human Research (to T.D.C.).	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; ANDERSEN H, 1961, ACTA ANAT, V46, P279; Barr AJ, 2016, RHEUMATOLOGY, V55, P1585, DOI 10.1093/rheumatology/kew191; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Basit S, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-102; Bauge C, 2014, AGING DIS, V5, P394, DOI 10.14336/AD.2014.0500394; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berenbaum F, 2018, NAT REV RHEUMATOL, V14, P674, DOI 10.1038/s41584-018-0073-x; Betancourt MCC, 2012, P NATL ACAD SCI USA, V109, P8218, DOI 10.1073/pnas.1119899109; Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Blake JA, 2017, NUCLEIC ACIDS RES, V45, pD723, DOI 10.1093/nar/gkw1040; Borges PD, 2014, OSTEOARTHR CARTILAGE, V22, P1419, DOI 10.1016/j.joca.2014.07.014; Boyd JL, 2015, CURR BIOL, V25, P772, DOI 10.1016/j.cub.2015.01.041; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Browning BL, 2018, AM J HUM GENET, V103, P338, DOI 10.1016/j.ajhg.2018.07.015; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Bush EC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-17; Butterfield N.C., 2019, ACCELERATING FUNCTIO, DOI [10.1101/836221., DOI 10.1101/836221]; Capellini TD, 2006, DEVELOPMENT, V133, P2263, DOI 10.1242/dev.02395; Capellini TD, 2017, NAT GENET, V49, P1202, DOI 10.1038/ng.3911; Capra JA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0025; CARNES BA, 1993, POPUL DEV REV, V19, P793, DOI 10.2307/2938414; Casalone E, 2018, ANN RHEUM DIS, V77, P620, DOI 10.1136/annrheumdis-2017-211848; Castano-Betancourt MC, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006260; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Charles MD, 2013, AM J SPORT MED, V41, P374, DOI 10.1177/0363546512472441; Chen H, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006454; Chokalingam K, 2009, TISSUE ENG PT A, V15, P2807, DOI 10.1089/ten.TEA.2008.0560; Coetzee SG, 2015, BIOINFORMATICS, V31, P3847, DOI 10.1093/bioinformatics/btv470; Cotney J, 2013, CELL, V154, P185, DOI 10.1016/j.cell.2013.05.056; Cupit LD, 2004, MAMM GENOME, V15, P618, DOI 10.1007/s00335-004-2370-8; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Darwin C., 1888, DESCENT MAN SELECTIO; Davis CA, 2018, NUCLEIC ACIDS RES, V46, pD794, DOI 10.1093/nar/gkx1081; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Day-Williams AG, 2011, AM J HUM GENET, V89, P446, DOI 10.1016/j.ajhg.2011.08.001; Decker RS, 2014, MATRIX BIOL, V39, P5, DOI 10.1016/j.matbio.2014.08.006; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; DeMare LE, 2013, GENOME RES, V23, P1224, DOI 10.1101/gr.156570.113; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Diez-Roux G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000582; DiLeone RJ, 1998, GENETICS, V148, P401; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, P974, DOI 10.1016/j.joca.2006.03.005; Evangelou E, 2014, ANN RHEUM DIS, V73, P2130, DOI 10.1136/annrheumdis-2012-203114; Evangelou E, 2011, ANN RHEUM DIS, V70, P349, DOI 10.1136/ard.2010.132787; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Ferrer-Admetlla A, 2014, MOL BIOL EVOL, V31, P1275, DOI 10.1093/molbev/msu077; Finger F, 2003, ARTHRITIS RHEUM-US, V48, P3395, DOI 10.1002/art.11341; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Folkesson J, 2007, IEEE T MED IMAGING, V26, P106, DOI 10.1109/TMI.2006.886808; Fox J., 2019, R COMPANION APPL REG, VThird; Frelat MA, 2017, J HUM EVOL, V108, P147, DOI 10.1016/j.jhevol.2017.03.006; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gamer LW, 2018, J BONE MINER RES, V33, P1708, DOI 10.1002/jbmr.3441; GARDNER E, 1968, J ANAT, V102, P289; Gazal S, 2017, NAT GENET, V49, P1421, DOI 10.1038/ng.3954; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Gillis J, 2013, BIOINFORMATICS, V29, P476, DOI 10.1093/bioinformatics/bts727; Gittelman RM, 2015, GENOME RES, V25, P1245, DOI 10.1101/gr.192591.115; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; GOKHMAN David, 2017, BIORXIV, DOI DOI 10.1101/106955; GRAY DJ, 1950, AM J ANAT, V86, P235, DOI 10.1002/aja.1000860204; Grossman SR, 2013, CELL, V152, P703, DOI 10.1016/j.cell.2013.01.035; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Guenther C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000308; Guo M, 2017, ELIFE, V6, DOI 10.7554/eLife.29329; Hashemi J, 2008, J BONE JOINT SURG AM, V90A, P2724, DOI 10.2106/JBJS.G.01358; He YQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-575; Hedman AC, 2015, EMBO REP, V16, P427, DOI 10.15252/embr.201439834; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hijazi A, 2018, OSTEOARTHR CARTILAGE, V26, pS154, DOI 10.1016/j.joca.2018.02.332; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hormozdiari F, 2018, NAT GENET, V50, P1041, DOI 10.1038/s41588-018-0148-2; Houard X, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0375-6; Howell SM, 2010, J BONE JOINT SURG AM, V92A, P98, DOI 10.2106/JBJS.H.01566; Hubisz MJ, 2011, BRIEF BIOINFORM, V12, P41, DOI 10.1093/bib/bbq072; Hume MA, 2015, NUCLEIC ACIDS RES, V43, pD117, DOI 10.1093/nar/gku1045; Hunter D, 2016, ANN RHEUM DIS, V75, P1607, DOI 10.1136/annrheumdis-2015-207602; Hunter DJ, 2019, LANCET, V393, P1745, DOI 10.1016/S0140-6736(19)30417-9; Indjeian VB, 2016, CELL, V164, P45, DOI 10.1016/j.cell.2015.12.007; Infante CR, 2013, DEV BIOL, V374, P234, DOI 10.1016/j.ydbio.2012.11.017; Jackman S., 2017, PSCL CLASSES METHODS; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; Kannu P, 2009, ARTHRITIS RHEUM-US, V60, P325, DOI 10.1002/art.24251; Kanton S, 2019, NATURE, V574, P418, DOI 10.1038/s41586-019-1654-9; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Karolchik D, 2014, NUCLEIC ACIDS RES, V42, pD764, DOI 10.1093/nar/gkt1168; Kassambara A., 2017, FACTOEXTRA EXTRACT V; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kerkhof HJM, 2010, ARTHRITIS RHEUM-US, V62, P499, DOI 10.1002/art.27184; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Klein JC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10439-y; Kokenyesi R, 2000, ARCH BIOCHEM BIOPHYS, V383, P79, DOI 10.1006/abbi.2000.2044; Kosicki M, 2018, NAT BIOTECHNOL, V36, P765, DOI 10.1038/nbt.4192; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, BIOINFORMATICS, V27, P718, DOI 10.1093/bioinformatics/btq671; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liu CF, 2017, SEMIN CELL DEV BIOL, V62, P34, DOI 10.1016/j.semcdb.2016.10.004; Liu YF, 2017, J RHEUMATOL, V44, P1652, DOI 10.3899/jrheum.161488; Loughlin J, 2015, CURR OPIN RHEUMATOL, V27, P284, DOI 10.1097/BOR.0000000000000171; Lovejoy CO, 2007, GAIT POSTURE, V25, P325, DOI 10.1016/j.gaitpost.2006.05.001; Lowenstine LJ, 2016, VET PATHOL, V53, P250, DOI 10.1177/0300985815612154; Lyons KM, 2019, CURR TOP DEV BIOL, V133, P153, DOI 10.1016/bs.ctdb.2019.02.001; Maas SA, 2005, DEV DYNAM, V232, P345, DOI 10.1002/dvdy.20254; Macrini TE, 2013, OSTEOARTHR CARTILAGE, V21, P839, DOI 10.1016/j.joca.2013.03.003; Maechler M., 2018, CLUSTER CLUSTER ANAL; Mathelier A, 2016, NUCLEIC ACIDS RES, V2016, P44; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; MeridaVelasco JA, 1997, ANAT REC, V248, P269, DOI 10.1002/(SICI)1097-0185(199706)248:2<269::AID-AR14>3.0.CO;2-N; Meyer MB, 2014, J BIOL CHEM, V289, P16016, DOI 10.1074/jbc.M114.552216; Miyamoto Y, 2008, NAT GENET, V40, P994, DOI 10.1038/ng.176; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3; Mun J, 2008, ADV ANAL MODELS 800; Nakajima M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009723; Nemec S, 2017, DEVELOPMENT, V144, P3325, DOI 10.1242/dev.154864; Neogi T, 2016, NAT REV RHEUMATOL, V12, pP503, DOI 10.1038/nrrheum.2016.113; Neogi T, 2013, ARTHRITIS RHEUM-US, V65, P2048, DOI 10.1002/art.37987; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; ORAHILLY R, 1951, J ANAT, V85, P166; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Panoutsopoulou K, 2011, ANN RHEUM DIS, V70, P864, DOI 10.1136/ard.2010.141473; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Picard C, 2007, CLIN ORTHOP RELAT R, P59, DOI 10.1097/BLO0b013e3180d09d9c; Polk JD, 2009, AM J PHYS ANTHROPOL, V140, P359, DOI 10.1002/ajpa.21083; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Pregizer SK, 2018, ANN RHEUM DIS, V77, P450, DOI 10.1136/annrheumdis-2017-212475; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Racimo F, 2016, GENETICS, V202, P733, DOI 10.1534/genetics.115.178095; Ramos YFM, 2014, J MED GENET, V51, P596, DOI 10.1136/jmedgenet-2014-102478; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rasmussen MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004342; Reyes C, 2016, ARTHRITIS RHEUMATOL, V68, P1869, DOI 10.1002/art.39707; Richette P, 2011, ANN RHEUM DIS, V70, P139, DOI 10.1136/ard.2010.134015; Rosen V, 2009, CYTOKINE GROWTH F R, V20, P475, DOI 10.1016/j.cytogfr.2009.10.018; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; SCHWARTZ HJ, 1989, J OCCUP ENVIRON MED, V31, P112; Selleri L, 2001, DEVELOPMENT, V128, P3543; Sen M, 2004, ARTHRITIS RHEUM-US, V50, P488, DOI 10.1002/art.20005; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; Shannon P., 2014, MOTIFDB ANNOTATED CO; Shinoda Y, 2008, J BIOL CHEM, V283, P24682, DOI 10.1074/jbc.M709857200; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Sonnery-Cottet B, 2011, J BONE JOINT SURG BR, V93B, P1475, DOI 10.1302/0301-620X.93B11.26905; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Styrkarsdottir U, 2018, NAT GENET, V50, P1681, DOI 10.1038/s41588-018-0247-0; Styrkarsdottir U, 2017, NAT GENET, V49, P801, DOI 10.1038/ng.3816; Styrkarsdottir U, 2014, NAT GENET, V46, P498, DOI 10.1038/ng.2957; Tachmazidou I, 2019, NAT GENET, V51, P230, DOI 10.1038/s41588-018-0327-1; TAJIMA F, 1989, GENETICS, V123, P585; Tardieu C, 1999, AM J PHYS ANTHROPOL, V110, P365, DOI 10.1002/(SICI)1096-8644(199911)110:3<365::AID-AJPA8>3.0.CO;2-T; Tardieu C, 2010, EVOL ANTHROPOL, V19, P174, DOI 10.1002/evan.20276; Team RC., 2022, LANG ENV STAT COMP; Valdes AM, 2006, ARTHRITIS RHEUM-US, V54, P533, DOI 10.1002/art.21621; Valdes AM, 2011, ANN RHEUM DIS, V70, P873, DOI 10.1136/ard.2010.134155; Varki A, 2005, GENOME RES, V15, P1746, DOI 10.1101/gr.3737405; Visel A, 2004, NUCLEIC ACIDS RES, V32, pD552, DOI 10.1093/nar/gkh029; Vitti JJ, 2013, ANNU REV GENET, V47, P97, DOI 10.1146/annurev-genet-111212-133526; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang JLS, 2018, DEV BIOL, V434, P186, DOI 10.1016/j.ydbio.2017.12.013; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Wittkopp PJ, 2012, NAT REV GENET, V13, P59, DOI 10.1038/nrg3095; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Xu SQ, 2018, P NATL ACAD SCI USA, V115, P8799, DOI 10.1073/pnas.1721820115; Ye WD, 2016, DEVELOPMENT, V143, P2548, DOI 10.1242/dev.138750; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zeggini E, 2012, LANCET, V380, P815, DOI 10.1016/S0140-6736(12)60681-3; Zehra R, 2018, GENOME BIOL EVOL, V10, P956, DOI 10.1093/gbe/evy052; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zengini E, 2018, NAT GENET, V50, P549, DOI 10.1038/s41588-018-0079-y; Zhai G, 2009, J MED GENET, V46, P614, DOI 10.1136/jmg.2009.067314; Zhai GJ, 2015, RHEUMATOL INT, V35, P1283, DOI 10.1007/s00296-015-3251-z; Zhang F, 2015, HUM MOL GENET, V24, pR102, DOI 10.1093/hmg/ddv259; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao HX, 2015, DEV BIOL, V398, P242, DOI 10.1016/j.ydbio.2014.12.007; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Zheng J, 2017, BIOINFORMATICS, V33, P272, DOI 10.1093/bioinformatics/btw613	190	30	30	6	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2020	181	2					362	+		10.1016/j.cell.2020.02.057	http://dx.doi.org/10.1016/j.cell.2020.02.057			48	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	LD7BL	32220312	Green Accepted, Bronze			2022-12-28	WOS:000526184900017
J	Hofman, MS; Lawrentschuk, N; Francis, RJ; Tang, C; Vela, I; Thomas, P; Rutherford, N; Martin, JM; Frydenberg, M; Shakher, R; Wong, LM; Taubman, K; Lee, ST; Hsiao, E; Roach, P; Nottage, M; Kirkwood, I; Hayne, D; Link, E; Marusic, P; Matera, A; Herschtal, A; Iravani, A; Hicks, RJ; Williams, S; Murphy, DG				Hofman, Michael S.; Lawrentschuk, Nathan; Francis, Roslyn J.; Tang, Colin; Vela, Ian; Thomas, Paul; Rutherford, Natalie; Martin, Jarad M.; Frydenberg, Mark; Shakher, Ramdave; Wong, Lih-Ming; Taubman, Kim; Lee, Sze Ting; Hsiao, Edward; Roach, Paul; Nottage, Michelle; Kirkwood, Ian; Hayne, Dickon; Link, Emma; Marusic, Petra; Matera, Anetta; Herschtal, Alan; Iravani, Amir; Hicks, Rodney J.; Williams, Scott; Murphy, Declan G.		ProPSMA Study Grp Collaborators	Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study	LANCET			English	Article							TOMOGRAPHY; DIAGNOSIS; MEN	Background Conventional imaging using CT and bone scan has insufficient sensitivity when staging men with high-risk localised prostate cancer. We aimed to investigate whether novel imaging using prostate-specific membrane antigen (PSMA) PET-CT might improve accuracy and affect management. Methods In this multicentre, two-arm, randomised study, we recruited men with biopsy-proven prostate cancer and high-risk features at ten hospitals in Australia. Patients were randomly assigned to conventional imaging with CT and bone scanning or gallium-68 PSMA-11 PET-CT. First-line imaging was done within 21 days following randomisation. Patients crossed over unless three or more distant metastases were identified. The primary outcome was accuracy of first-line imaging for identifying either pelvic nodal or distant-metastatic disease defined by the receiver-operating curve using a predefined reference-standard including histopathology, imaging, and biochemistry at 6-month follow-up. This trial is registered with the Australian New Zealand Clinical Trials Registry, ANZCTR12617000005358. Findings From March 22, 2017, to Nov 2, 2018, 339 men were assessed for eligibility and 302 men were randomly assigned. 152 (50%) men were randomly assigned to conventional imaging and 150 (50%) to PSMA PET-CT. Of 295 (98%) men with follow-up, 87 (30%) had pelvic nodal or distant metastatic disease. PSMA PET-CT had a 27% (95% CI 23-31) greater accuracy than that of conventional imaging (92% [88-95] vs 65% [60-69]; p<0.0001). We found a lower sensitivity (38% [24-52] vs 85% [74-96]) and specificity (91% [85-97] vs 98% [95-100]) for conventional imaging compared with PSMA PET-CT. Subgroup analyses also showed the superiority of PSMA PET-CT (area under the curve of the receiver operating characteristic curve 91% vs 59% [32% absolute difference; 28-35] for patients with pelvic nodal metastases, and 95% vs 74% [22% absolute difference; 18-26] for patients with distant metastases). First-line conventional imaging conferred management change less frequently (23 [15%] men [10-22] vs 41 [28%] men [21-36]; p=0.008) and had more equivocal findings (23% [17-31] vs 7% [4-13]) than PSMA PET-CT did. Radiation exposure was 10.9 mSv (95% CI 9.8-12.0) higher for conventional imaging than for PSMA PET-CT (19.2 mSv vs 8.4 mSv; p<0.001). We found high reporter agreement for PSMA PET-CT (kappa=0.87 for nodal and kappa=0.88 for distant metastases). In patients who underwent second-line image, management change occurred in seven (5%) of 136 patients following conventional imaging, and in 39 (27%) of 146 following PSMA PET-CT. Interpretation PSMA PET-CT is a suitable replacement for conventional imaging, providing superior accuracy, to the combined findings of CT and bone scanning. Copyright (c) 2020 Elsevier Ltd. All rights reserved.	[Hofman, Michael S.; Marusic, Petra; Iravani, Amir; Hicks, Rodney J.] Peter MacCallum Canc Ctr, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic 3000, Australia; [Link, Emma; Matera, Anetta; Herschtal, Alan] Peter MacCallum Canc Ctr, Ctr Biostat & Clin Trials, Melbourne, Vic, Australia; [Williams, Scott] Peter MacCallum Canc Ctr, Div Radiat Oncol, Melbourne, Vic, Australia; [Murphy, Declan G.] Peter MacCallum Canc Ctr, Div Canc Surg, Melbourne, Vic, Australia; [Hofman, Michael S.; Lawrentschuk, Nathan; Link, Emma; Iravani, Amir; Hicks, Rodney J.; Williams, Scott; Murphy, Declan G.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Wong, Lih-Ming] Univ Melbourne, St Vincents Hlth Melbourne, Dept Urol & Surg, Melbourne, Vic, Australia; [Lawrentschuk, Nathan] Austin Hlth, Dept Surg, Melbourne, Vic, Australia; [Lawrentschuk, Nathan] Urol Soc Australia & New Zealand, Edgecliff, NSW, Australia; [Francis, Roslyn J.] Sir Charles Gairdner Hosp, Dept Nucl Med, Perth, WA, Australia; [Francis, Roslyn J.] Univ Western Australia, Fac Hlth & Med Sci, Perth, WA, Australia; [Francis, Roslyn J.] ARTnet, Balmain, NSW, Australia; [Tang, Colin] Sir Charles Gairdner Hosp, Dept Radiat Oncol, Perth, WA, Australia; [Vela, Ian] Queensland Univ Technol, Australian Prostate Canc Res Ctr Queensland, Translat Res Inst, Princess Alexandra Hosp,Dept Urol, Brisbane, Qld, Australia; [Thomas, Paul] Royal Brisbane & Womens Hosp, Dept Nucl Med, Brisbane, Qld, Australia; [Thomas, Paul] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Rutherford, Natalie] Hunter New England Hlth, Dept Nucl Med, Newcastle, NSW, Australia; [Martin, Jarad M.] Univ Newcastle, Sch Med & Publ Hlth, Newcastle, NSW, Australia; [Frydenberg, Mark] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Frydenberg, Mark] Cabrini Hlth, Cabrini Inst, Melbourne, Vic, Australia; [Shakher, Ramdave] Monash Hlth, Monash Hlth Imaging, Melbourne, Vic, Australia; [Taubman, Kim] St Vincents Hlth, Dept Med Imaging PET CT & St Vincents Private Rad, Melbourne, Vic, Australia; [Lee, Sze Ting] Austin Hlth, Dept Mol Imaging & Therapy, Melbourne, Vic, Australia; [Hsiao, Edward; Roach, Paul] Univ Sydney, Dept Nucl Med & PET, Royal North Shore Hosp, Sydney, NSW, Australia; [Nottage, Michelle] South Australian Hlth & Med Res Inst, Clin & Res Imaging Ctr, Adelaide, SA, Australia; [Nottage, Michelle] Dr Jones & Partners Med Imaging, Adelaide, SA, Australia; [Kirkwood, Ian] Royal Adelaide Hosp, Dept Nucl Med & PET, Adelaide, SA, Australia; [Kirkwood, Ian] Univ Adelaide, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Hayne, Dickon] Univ Western Australia, UWA Med Sch, Perth, WA, Australia; [Williams, Scott] Australian & New Zealand Urogenital & Prostate Ca, Camperdown, NSW, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Western Australia; University of Western Australia; University of Western Australia; Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital; University of Queensland; University of Newcastle; Monash University; Cabrini Health; Florey Institute of Neuroscience & Mental Health; Royal North Shore Hospital; University of Sydney; South Australian Health & Medical Research Institute (SAHMRI); Royal Adelaide Hospital; University of Adelaide; University of Western Australia	Hofman, MS (corresponding author), Peter MacCallum Canc Ctr, Mol Imaging & Therapeut Nucl Med, Melbourne, Vic 3000, Australia.	michael.hofman@petermac.org	Iravani, Amir/AAH-5355-2019; Lawrentschuk, Nathan/AAL-8610-2021; Thomas, Paul A/K-7463-2012; Hofman, Michael/H-3121-2019	Iravani, Amir/0000-0002-1273-5835; Lawrentschuk, Nathan/0000-0001-8553-5618; Thomas, Paul A/0000-0002-2420-0950; Hofman, Michael/0000-0001-8622-159X; Tang, Colin/0000-0002-4643-0466; Francis, Roslyn/0000-0002-6256-1351; Hayne, Dickon/0000-0002-4094-401X; Marusic, Petra/0000-0001-7717-8227	Movember; Prostate Cancer Foundation of Australia	Movember; Prostate Cancer Foundation of Australia	Movember and Prostate Cancer Foundation of Australia.	Abuzallouf S, 2004, J UROLOGY, V171, P2122, DOI 10.1097/01.ju.0000123981.03084.06; Afshar-Oromieh A, 2017, EUR J NUCL MED MOL I, V44, P1258, DOI 10.1007/s00259-017-3711-7; Bailey DL, 2018, J NUCL MED, V59, P636, DOI 10.2967/jnumed.117.202861; Briganti A, 2012, EUR UROL, V61, P1132, DOI 10.1016/j.eururo.2011.11.008; Briganti A, 2009, EUR UROL, V55, P261, DOI 10.1016/j.eururo.2008.09.043; Buyyounouski MK, 2017, CA-CANCER J CLIN, V67, P246, DOI 10.3322/caac.21391; Calais J, 2019, LANCET ONCOL, V20, P1286, DOI 10.1016/S1470-2045(19)30415-2; Calais J, 2018, J NUCL MED, V59, P1714, DOI 10.2967/jnumed.118.209387; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Fendler WP, 2019, JAMA ONCOL, V5, P856, DOI 10.1001/jamaoncol.2019.0096; Ferraro DA, 2020, EUR J NUCL MED MOL I, V47, P652, DOI 10.1007/s00259-019-04568-1; Herlemann A, 2016, EUR UROL, V70, P553, DOI 10.1016/j.eururo.2015.12.051; Hofman MS, 2018, BJU INT, V122, P783, DOI 10.1111/bju.14374; Maurer T, 2019, EUR UROL, V75, P659, DOI 10.1016/j.eururo.2018.03.013; Maurer T, 2016, J UROLOGY, V195, P1436, DOI 10.1016/j.juro.2015.12.025; Mohler JL, 2019, J NATL COMPR CANC NE, V17, P479, DOI 10.6004/jnccn.2019.0023; Motter N, EAU GUIDELINES PROST; Ost P, 2018, J CLIN ONCOL, V36, P446, DOI 10.1200/JCO.2017.75.4853; Parker CC, 2018, LANCET, V392, P2353, DOI 10.1016/S0140-6736(18)32486-3; Perera M, 2020, EUR UROL, V77, P403, DOI 10.1016/j.eururo.2019.01.049; Rider JR, 2013, EUR UROL, V63, P88, DOI 10.1016/j.eururo.2012.08.001; Roach PJ, 2018, J NUCL MED, V59, P82, DOI 10.2967/jnumed.117.197160; Schiller K, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-0977-2; Siva S, 2018, EUR UROL, V74, P455, DOI 10.1016/j.eururo.2018.06.004; Touijer KA, 2018, EUR UROL, V73, P890, DOI 10.1016/j.eururo.2017.09.027; van Kalmthout LWM, 2020, J UROLOGY, V203, P537, DOI 10.1097/JU.0000000000000531; van Leeuwen PJ, 2017, BJU INT, V119, P209, DOI 10.1111/bju.13540; Yaxley JW, 2019, BJU INT, V124, P401, DOI 10.1111/bju.14828; Zumsteg ZS, 2015, EUR UROL, V67, P1009, DOI 10.1016/j.eururo.2014.09.028	30	619	629	7	57	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2020	395	10231					1208	1216		10.1016/S0140-6736(20)30314-7	http://dx.doi.org/10.1016/S0140-6736(20)30314-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE6DW	32209449				2022-12-28	WOS:000526814200030
J	Ghinai, I; McPherson, TD; Hunter, JC; Kirking, HL; Christiansen, D; Joshi, K; Rubin, R; Morales-Estrada, S; Black, SR; Pacilli, M; Fricchione, MJ; Chugh, RK; Walblay, KA; Ahmed, NS; Stoecker, WC; Hasan, NF; Burdsall, DP; Reese, HE; Wallace, M; Wang, C; Moeller, D; Korpics, J; Novosad, SA; Benowitz, I; Jacobs, MW; Dasari, VS; Patel, MT; Kauerauf, J; Charles, EM; Ezike, NO; Chu, V; Midgley, CM; Rolfes, MA; Gerber, SI; Lu, XY; Lindstrom, S; Verani, JR; Layden, JE				Ghinai, Isaac; McPherson, Tristan D.; Hunter, Jennifer C.; Kirking, Hannah L.; Christiansen, Demian; Joshi, Kiran; Rubin, Rachel; Morales-Estrada, Shirley; Black, Stephanie R.; Pacilli, Massimo; Fricchione, Marielle J.; Chugh, Rashmi K.; Walblay, Kelly A.; Ahmed, N. Seema; Stoecker, William C.; Hasan, Nausheen F.; Burdsall, Deborah P.; Reese, Heather E.; Wallace, Megan; Wang, Chen; Moeller, Darcie; Korpics, Jacqueline; Novosad, Shannon A.; Benowitz, Isaac; Jacobs, Max W.; Dasari, Vishal S.; Patel, Megan T.; Kauerauf, Judy; Charles, E. Matt; Ezike, Ngozi O.; Chu, Victoria; Midgley, Claire M.; Rolfes, Melissa A.; Gerber, Susan I.; Lu, Xiaoyan; Lindstrom, Stephen; Verani, Jennifer R.; Layden, Jennifer E.		Illinois COVID-19 Investigation	First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA	LANCET			English	Article								Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. In January, 2020, state, local, and federal public health agencies investigated the first case of COVID-19 in Illinois, USA. Methods Patients with confirmed COVID-19 were defined as those with a positive SARS-CoV-2 test. Contacts were people with exposure to a patient with COVID-19 on or after the patient's symptom onset date. Contacts underwent active symptom monitoring for 14 days following their last exposure. Contacts who developed fever, cough, or shortness of breath became persons under investigation and were tested for SARS-CoV-2. A convenience sample of 32 asymptomatic health-care personnel contacts were also tested. Findings Patient 1-a woman in her 60s-returned from China in mid-January, 2020. 1 week later, she was hospitalised with pneumonia and tested positive for SARS-CoV- 2. Her husband (Patient 2) did not travel but had frequent close contact with his wife. He was admitted 8 days later and tested positive for SARS-CoV-2. Overall, 372 contacts of both cases were identified; 347 underwent active symptom monitoring, including 152 community contacts and 195 health-care personnel. Of monitored contacts, 43 became persons under investigation, in addition to Patient 2. These 43 persons under investigation and all 32 asymptomatic health-care personnel tested negative for SARS-CoV-2. Interpretation Person-to-person transmission of SARS-CoV-2 occurred between two people with prolonged, unprotected exposure while Patient 1 was symptomatic. Despite active symptom monitoring and testing of symptomatic and some asymptomatic contacts, no further transmission was detected.	[Ghinai, Isaac; McPherson, Tristan D.; Reese, Heather E.; Wallace, Megan; Chu, Victoria] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [Hunter, Jennifer C.; Novosad, Shannon A.; Benowitz, Isaac] Ctr Dis Control & Prevent, Div Healthcare Qual Promot, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Kirking, Hannah L.; Wallace, Megan; Chu, Victoria; Midgley, Claire M.; Gerber, Susan I.; Lu, Xiaoyan; Lindstrom, Stephen] Ctr Dis Control & Prevent, Div Viral Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Reese, Heather E.; Verani, Jennifer R.] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Jacobs, Max W.; Rolfes, Melissa A.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Dasari, Vishal S.] Ctr Dis Control & Prevent, One Hlth Off, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Ghinai, Isaac; Burdsall, Deborah P.; Patel, Megan T.; Kauerauf, Judy; Charles, E. Matt; Ezike, Ngozi O.] Illinois Dept Publ Hlth, Springfield, IL 62761 USA; [McPherson, Tristan D.; Black, Stephanie R.; Pacilli, Massimo; Fricchione, Marielle J.; Walblay, Kelly A.; Layden, Jennifer E.] Chicago Dept Publ Hlth, Chicago, IL USA; [Christiansen, Demian; Joshi, Kiran; Rubin, Rachel; Morales-Estrada, Shirley] Cook Cty Dept Publ Hlth, Oak Forest, IL USA; [Chugh, Rashmi K.] DuPage Cty Hlth Dept, Wheaton, IL USA; [Ahmed, N. Seema; Stoecker, William C.] Metro Infect Dis Consultants, Burr Ridge, IL USA; [Hasan, Nausheen F.] Premier Primary Care Phys, Carol Stream, IL USA; [Wang, Chen; Moeller, Darcie; Korpics, Jacqueline] Cook Cty Hlth, Chicago, IL USA; [Wang, Chen; Moeller, Darcie; Korpics, Jacqueline] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Jacobs, Max W.] Lake Erie Coll Osteopath Med, Erie, PA USA; [Dasari, Vishal S.] Wright State Univ, Boonshoft Sch Med, Dayton, OH 45435 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Chicago Department of Public Health; Northwestern University; Feinberg School of Medicine; University System of Ohio; Wright State University Dayton	McPherson, TD (corresponding author), Chicago Dept Publ Hlth, Chicago, IL 60612 USA.; Layden, JE (corresponding author), Chicago Dept Publ Hlth, Chicago, IL 60604 USA.	oko9@cdc.gov; jennifer.layden@cityofchicago.org	Ahmed, Naseer/C-8119-2019; Ghinai, Isaac/AAI-7985-2021	Ahmed, Naseer/0000-0002-0960-1123; Wang, Chen Y./0000-0002-9330-8009; /0000-0003-1039-8780; Rolfes, Melissa/0000-0002-0483-9941; Ghinai, Isaac/0000-0003-1322-1331; Wallace, Megan/0000-0003-4331-5785; Reese, Heather/0000-0002-5571-1614				[Anonymous], 2005, STAT 2 M INT HLTH RE; CDC, 2020, INT GUID PREV SPREAD; CDC, 2020, INT US GUID RISK ASS; CDC, 2020, HLTH AL NETW UPD INT; CDC, 2020, EV REP PERS INV PUI; CDC, 2016, INFECT CONTROL BASIC; CDC, 2019, INF CONTR HEALTHC PE; CDC, 2020, RES USE ONLY REAL TI; CDC, 2020, GLOB MAP; Centers for Disease Control and Prevention, 2020, INT GUID COLL HANDL; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chowell G, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0450-0; Cowling BJ, 2015, EUROSURVEILLANCE, V20, P21175; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Li Q., 2020, NEW ENGL J MED, V382, P1199; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Park SW., 2020, RECONCILING EARLY OU, DOI [10.1101/2020.01.30.20019877, DOI 10.1101/2020.01.30.20019877]; Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272; Shen Z, 2004, EMERG INFECT DIS, V10, P256, DOI 10.3201/eid1002.030732; WHO, 2020, COR DIS COVID 19 OUT	21	301	313	3	42	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2020	395	10230					1137	1144		10.1016/S0140-6736(20)30607-3	http://dx.doi.org/10.1016/S0140-6736(20)30607-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KZ9LJ	32178768	Green Published, Bronze			2022-12-28	WOS:000523580400026
J	Horton, R				Horton, Richard			Offline: COVID-19 and the NHS-"a national scandal"	LANCET			English	Editorial Material												richard.horton@lancet.com							0	96	100	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1022	1022						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY5YW	32222186	Green Published, Bronze			2022-12-28	WOS:000522650100016
J	Weiss, P; Murdoch, DR				Weiss, Paul; Murdoch, David R.			Clinical course and mortality risk of severe COVID-19	LANCET			English	Editorial Material							CORONAVIRUS		[Weiss, Paul] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA; [Murdoch, David R.] Univ Otago, Christchurch 8140, New Zealand	Emory University; Rollins School Public Health; University of Otago	Murdoch, DR (corresponding author), Univ Otago, Christchurch 8140, New Zealand.	david.murdoch@otago.ac.nz	Murdoch, David/A-2012-2009					Ahnert P, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2316-x; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cheng PKC, 2004, LANCET, V363, P1699, DOI 10.1016/S0140-6736(04)16255-7; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Oh MD, 2016, NEW ENGL J MED, V375, P1303, DOI 10.1056/NEJMc1511695; Snijders D, 2012, EUR J INTERN MED, V23, P436, DOI 10.1016/j.ejim.2011.10.019; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang X, 2020, LANCET RESP MED, DOI [10.1016/S2213-2600(20)30079-5., DOI 10.1016/S2213-2600(20)30079-5, 10.1016/S2213-2600(20)30079-5, 10.1016/S2213-2600(20)30079]; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	12	409	422	1	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1014	1015		10.1016/S0140-6736(20)30633-4	http://dx.doi.org/10.1016/S0140-6736(20)30633-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY5YW	32197108	Green Published, Bronze			2022-12-28	WOS:000522650100012
J	de Jager, VR; Dawson, R; van Niekerk, C; Hutchings, J; Kim, J; Vanker, N; van der Merwe, L; Choi, J; Nam, K; Diacon, AH				de Jager, Veronique R.; Dawson, Rodney; van Niekerk, Christo; Hutchings, Jane; Kim, Jeongjun; Vanker, Naadira; van der Merwe, Lize; Choi, Jinho; Nam, Kiyean; Diacon, Andreas H.			Telacebec (Q203), a New Antituberculosis Agent	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							EARLY BACTERICIDAL ACTIVITY; PULMONARY TUBERCULOSIS	Telacebec (Q203) is a novel drug that targets Mycobacterium tuberculosis cellular energy production through inhibition of the mycobacterial cytochrome bc1 complex. This proof-of-concept study evaluated the bactericidal activity of telacebec over a period of 14 days in patients with newly diagnosed, drug-susceptible pulmonary tuberculosis.	[de Jager, Veronique R.; van der Merwe, Lize] TASK Appl Sci, Cape Town, South Africa; [Dawson, Rodney] Univ Cape Town, Lung Inst, Cape Town, South Africa; [van Niekerk, Christo; Hutchings, Jane; Kim, Jeongjun; Choi, Jinho; Nam, Kiyean] Qurient, Seongnam, South Korea; [Vanker, Naadira] TASK Lab, Cape Town, South Africa; [Diacon, Andreas H.] Stellenbosch Univ, Cape Town, South Africa	University of Cape Town; Stellenbosch University	de Jager, VR (corresponding author), TASK Appl Sci, Cape Town, South Africa.	dr.veronique@task.org.za			Korea Drug Development Fund	Korea Drug Development Fund(Korea Drug Development Fund (KDDF))	Supported by a grant from the Korea Drug Development Fund.	Diacon AH, 2011, INT J TUBERC LUNG D, V15, P949, DOI 10.5588/ijtld.10.0616; Fox W, 1999, INT J TUBERC LUNG D, V3, pS231; FOX W, 1979, CHEST, V76, P785, DOI 10.1378/chest.76.6.785; Pethe K, 2013, NAT MED, V19, P1157, DOI 10.1038/nm.3262; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07	5	45	45	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1280	1281		10.1056/NEJMc1913327	http://dx.doi.org/10.1056/NEJMc1913327			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY1UO	32212527	Bronze			2022-12-28	WOS:000522357300018
J	Sayburn, A				Sayburn, Anna			Covid-19: trials of four potential treatments to generate "robust data" of what works	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		INSERM, 2020, LAUNCH EUR CLIN TRIA; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; World Health Organization, 2020, R D BLUEPR COVID 1 I	3	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1206	10.1136/bmj.m1206	http://dx.doi.org/10.1136/bmj.m1206			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209549	Bronze			2022-12-28	WOS:000523764200014
J	Otto, KJ; Schmidt, CE				Otto, Kevin J.; Schmidt, Christine E.			Neuron-targeted electrical modulation	SCIENCE			English	Editorial Material							CONDUCTING POLYMERS		[Otto, Kevin J.; Schmidt, Christine E.] Univ Florida, Herbert Wertheim Coll Engn, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Otto, KJ (corresponding author), Univ Florida, Herbert Wertheim Coll Engn, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.	kevin.otto@bme.ufl.edu; schmidt@bme.ufl.edu	Otto, Kevin/R-6657-2018	Otto, Kevin/0000-0002-2317-6194	National Institutes of Health; National Science Foundation; Defense Advanced Research Projects Agency	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	The authors are supported by National Institutes of Health, National Science Foundation,and Defense Advanced Research Projects Agency. We thank M. Urdaneta, B. Ibarra, E. W. Dirr, and J. Murbach for helpful discussions.	Bettinger Christopher J, 2018, Bioelectron Med, V4, P6, DOI 10.1186/s42234-018-0007-6; Birmingham K, 2014, NAT REV DRUG DISCOV, V13, P399, DOI 10.1038/nrd4351; Famm K, 2013, NATURE, V496, P159, DOI 10.1038/496159a; Graczyk EL, 2018, J NEURAL ENG, V15, DOI 10.1088/1741-2552/aab790; Graczyk EL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5187; Green RA, 2008, BIOMATERIALS, V29, P3393, DOI 10.1016/j.biomaterials.2008.04.047; Guimard NK, 2007, PROG POLYM SCI, V32, P876, DOI 10.1016/j.progpolymsci.2007.05.012; Guo BL, 2018, BIOMACROMOLECULES, V19, P1764, DOI 10.1021/acs.biomac.8b00276; Liu J, 2020, SCIENCE, V367, P1372, DOI 10.1126/science.aay4866; Ouyang LQ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026005; PENRY JK, 1990, EPILEPSIA, V31, pS40, DOI 10.1111/j.1528-1157.1990.tb05848.x; Tracey KJ, 2014, BIOELECTRON MED, V1, P1, DOI DOI 10.15424/bioelectronmed.2014.00001; Trevathan JK, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201900892; Wendelken S, 2017, J NEUROENG REHABIL, V14, DOI 10.1186/s12984-017-0320-4; Wilks SJ, 2011, IEEE ENG MED BIO, P5412, DOI 10.1109/IEMBS.2011.6091338	15	13	13	5	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1303	1304		10.1126/science.abb0216	http://dx.doi.org/10.1126/science.abb0216			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193309				2022-12-28	WOS:000522167400028
J	Scheele, BC; Pasmans, F; Skerratt, LF; Berger, L; Martel, A; Beukema, W; Acevedo, AA; Burrowes, PA; Carvalho, T; Catenazzi, A; De la Riva, I; Fisher, MC; Flechas, SV; Foster, CN; Frias-Alvarez, P; Garner, TWJ; Gratwicke, B; Guayasamin, JM; Hirschfeld, M; Kolby, JE; Kosch, TA; La Marca, E; Lindenmayer, DB; Lips, KR; Longo, AV; Maneyro, R; McDonald, CA; Mendelson, J; Palacios-Rodriguez, P; Parra-Olea, G; Richards-Zawacki, CL; Rodel, MO; Rovito, SM; Soto-Azat, C; Toledo, LF; Voyles, J; Weldon, C; Whitfield, SM; Wilkinson, M; Zamudio, KR; Canessa, S				Scheele, Ben C.; Pasmans, Frank; Skerratt, Lee F.; Berger, Lee; Martel, An; Beukema, Wouter; Acevedo, Aldemar A.; Burrowes, Patricia A.; Carvalho, Tamilie; Catenazzi, Alessandro; De la Riva, Ignacio; Fisher, Matthew C.; Flechas, Sandra V.; Foster, Claire N.; Frias-Alvarez, Patricia; Garner, Trenton W. J.; Gratwicke, Brian; Guayasamin, Juan M.; Hirschfeld, Mareike; Kolby, Jonathan E.; Kosch, Tiffany A.; La Marca, Enrique; Lindenmayer, David B.; Lips, Karen R.; Longo, Ana V.; Maneyro, Raul; McDonald, Cait A.; Mendelson, Joseph, III; Palacios-Rodriguez, Pablo; Parra-Olea, Gabriela; Richards-Zawacki, Corinne L.; Roedel, Mark-Oliver; Rovito, Sean M.; Soto-Azat, Claudio; Toledo, Luis Felipe; Voyles, Jamie; Weldon, Che; Whitfield, Steven M.; Wilkinson, Mark; Zamudio, Kelly R.; Canessa, Stefano			Response to Comment on "Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity"	SCIENCE			English	Editorial Material							CHYTRIDIOMYCOSIS; ABUNDANCE; DECLINE	Lambert et al. question our retrospective and holistic epidemiological assessment of the role of chytridiomycosis in amphibian declines. Their alternative assessment is narrow and provides an incomplete evaluation of evidence. Adopting this approach limits understanding of infectious disease impacts and hampers conservation efforts. We reaffirm that our study provides unambiguous evidence that chytridiomycosis has affected at least 501 amphibian species.	[Scheele, Ben C.; Foster, Claire N.; Lindenmayer, David B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 2601, Australia; [Scheele, Ben C.; Lindenmayer, David B.] Threatened Species Recovery Hub, Natl Environm Sci Programme, Canberra, ACT 2601, Australia; [Scheele, Ben C.; Skerratt, Lee F.; Berger, Lee; Frias-Alvarez, Patricia; Kolby, Jonathan E.; Kosch, Tiffany A.] Univ Melbourne, Melbourne Vet Sch, One Hlth Res Grp, Werribee, Vic 3030, Australia; [Pasmans, Frank; Martel, An; Beukema, Wouter; Canessa, Stefano] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Wildlife Hlth Ghent, B-9820 Merelbeke, Belgium; [Acevedo, Aldemar A.] Pontificia Univ Catolica Chile, Lab Biol Evolut, Programa Doctorado Ciencias Biol, Santiago, Chile; [Acevedo, Aldemar A.] Univ Pamplona, Grp Invest Ecol & Biogeog, Barrio El Buque, Pamplona, Colombia; [Burrowes, Patricia A.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Carvalho, Tamilie; Toledo, Luis Felipe] Univ Estadual Campinas, Inst Biol, Dept Biol Anim, Lab Hist Nat Anfibios Brasileiros, Campinas, Brazil; [Catenazzi, Alessandro] Florida Int Univ, Dept Biol Sci, Miami, FL 33199 USA; [De la Riva, Ignacio] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain; [Fisher, Matthew C.] Imperial Coll London, Sch Publ Hlth, MRC Ctr Global Infect Dis Anal, London W2 1PG, England; [Flechas, Sandra V.; Palacios-Rodriguez, Pablo] Univ Los Andes, Dept Biol Sci, Bogota, Colombia; [Flechas, Sandra V.] Sede Venado de Oro, Inst Invest Recursos Biol Alexander von Humboldt, Bogota, Colombia; [Garner, Trenton W. J.] Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England; [Garner, Trenton W. J.; Weldon, Che] North West Univ, Unit Environm Sci & Management, ZA-2520 Potchefstroom, South Africa; [Gratwicke, Brian] Smithsonian Natl Zool Pk, Washington, DC 20008 USA; [Gratwicke, Brian] Conservat Biol Inst, Washington, DC 20008 USA; [Guayasamin, Juan M.] USFQ, Colegio Ciencias Biol & Ambientales COCIBA, Inst Invest Biol & Ambientales BIOSFERA, Lab Biol Evolut, Campus Cumbaya, Quito, Ecuador; [Guayasamin, Juan M.] Univ Tecnol Indoamer, Fac Medio Ambiente, Ingn Biodiversidad & Cambio Climat, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Calle Machala & Sabanilla, Quito, Ecuador; [Guayasamin, Juan M.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Hirschfeld, Mareike; Roedel, Mark-Oliver] Leibniz Inst Evolut & Biodivers Sci, Museum Nat Kunde, D-10115 Berlin, Germany; [Kolby, Jonathan E.] Lancetilla Bot Garden & Res Ctr, Honduras Amphibian Rescue & Conservat Ctr, Tela, Honduras; [Kolby, Jonathan E.] Conservat Agcy, Jamestown, RI 02835 USA; [Kosch, Tiffany A.] Massey Univ, AL Rae Ctr Genet & Breeding, Palmerston North 4442, New Zealand; [La Marca, Enrique] Univ Los Andes, Fac Forestry Engn & Environm Sci, Sch Geog, Merida, Venezuela; [Lips, Karen R.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Longo, Ana V.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Maneyro, Raul] Univ Republica, Fac Ciencias, Lab Sistemat & Hist Nat Vertebrados, CP 11400, Montevideo, Uruguay; [McDonald, Cait A.; Zamudio, Kelly R.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Mendelson, Joseph, III] Zoo Atlanta, Atlanta, GA 30315 USA; [Mendelson, Joseph, III] Georgia Inst Technol, Sch Biol Sci, Atlanta, GA 30332 USA; [Parra-Olea, Gabriela] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City, DF, Mexico; [Richards-Zawacki, Corinne L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Rovito, Sean M.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Genom Avanzada Langebio, Guanajuato 36824, Mexico; [Soto-Azat, Claudio] Univ Andres Bello, Fac Ciencias Vida, Ctr Invest Sustentabilidad, Santiago 8370251, Chile; [Voyles, Jamie] Univ Nevada, Dept Biol, Reno, NV 89557 USA; [Whitfield, Steven M.] Zoo Miami, Conservat & Res Dept, Miami, FL 33177 USA; [Whitfield, Steven M.; Wilkinson, Mark] Florida Int Univ, Sch Earth Environm & Soc, Miami, FL 33199 USA; [Wilkinson, Mark] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England	Australian National University; University of Melbourne; Ghent University; Pontificia Universidad Catolica de Chile; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; Universidade de Sao Paulo; Universidade Estadual de Campinas; State University System of Florida; Florida International University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Imperial College London; Universidad de los Andes (Colombia); Alliance; International Center for Tropical Agriculture - CIAT; Zoological Society of London; North West University - South Africa; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Colorado State University; Leibniz Institut fur Evolutions und Biodiversitatsforschung; Massey University; University of Los Andes Venezuela; University System of Maryland; University of Maryland College Park; State University System of Florida; University of Florida; Universidad de la Republica, Uruguay; Cornell University; University System of Georgia; Georgia Institute of Technology; Universidad Nacional Autonoma de Mexico; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Universidad Andres Bello; Nevada System of Higher Education (NSHE); University of Nevada Reno; State University System of Florida; Florida International University; Natural History Museum London	Scheele, BC (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT 2601, Australia.; Scheele, BC (corresponding author), Threatened Species Recovery Hub, Natl Environm Sci Programme, Canberra, ACT 2601, Australia.; Scheele, BC (corresponding author), Univ Melbourne, Melbourne Vet Sch, One Hlth Res Grp, Werribee, Vic 3030, Australia.	ben.scheele@anu.edu.au	Fisher, Matthew/B-9094-2011; Kolby, Jonathan/GWZ-3092-2022; Beukema, Wouter/D-6365-2014; Pasmans, Frank/D-3667-2014; Whitfield, Steven/AAT-4992-2021; Carvalho, Tamilie/AAT-1575-2020; Catenazzi, Alessandro/C-8615-2009; Kolby, Jonathan/GWV-5557-2022; Kosch, Tiffany/D-2452-2016; Canessa, Stefano/J-2069-2014; Toledo, Luis Felipe/I-4017-2012	Fisher, Matthew/0000-0002-1862-6402; Beukema, Wouter/0000-0002-5839-7683; Whitfield, Steven/0000-0003-3026-9791; Carvalho, Tamilie/0000-0001-7300-2777; Catenazzi, Alessandro/0000-0002-3650-4783; Petersen, Mareike/0000-0001-8666-1931; Burrowes, Patricia/0000-0002-3085-6681; Weldon, Che/0000-0001-6716-0787; Acevedo, Aldemar/0000-0002-4729-2093; Scheele, Benjamin/0000-0001-7284-629X; Kosch, Tiffany/0000-0001-5158-5748; Gratwicke, Brian/0000-0002-7332-4060; Zamudio, Kelly/0000-0001-5107-6206; Canessa, Stefano/0000-0002-0932-826X; McDonald, Coby/0000-0001-8291-6087; Berger, Lee/0000-0001-9227-5439; Toledo, Luis Felipe/0000-0002-4929-9598; Skerratt, Lee/0000-0003-3471-7512	MRC [MR/R015600/1] Funding Source: UKRI; NERC [NE/S000844/1, NE/K014455/1] Funding Source: UKRI; Medical Research Council [MR/R015600/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Christie A. P., BIORXIV; Crawford AJ, 2010, P NATL ACAD SCI USA, V107, P13777, DOI 10.1073/pnas.0914115107; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Johnson CN, 2017, SCIENCE, V356, P270, DOI 10.1126/science.aam9317; Lambert M. R., 2019, SCIENCE; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; Morrison SA, 2017, TRENDS ECOL EVOL, V32, P578, DOI 10.1016/j.tree.2017.05.006; O'Hanlon SJ, 2018, SCIENCE, V360, P621, DOI 10.1126/science.aar1965; OSBORNE WS, 1989, AUST WILDLIFE RES, V16, P537; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Scheele BC, 2017, CONSERV BIOL, V31, P592, DOI 10.1111/cobi.12830; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Sutherland WJ, 2015, NATURE, V526, P317, DOI 10.1038/526317a; Wilson KA, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002413	15	10	10	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI				aay2905	10.1126/science.aay2905	http://dx.doi.org/10.1126/science.aay2905			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193294	Green Submitted			2022-12-28	WOS:000522167400002
J	Ho, FK; Gray, SR; Welsh, P; Petermann-Rocha, F; Foster, H; Waddell, H; Anderson, J; Lyall, D; Sattar, N; Gill, JMR; Mathers, JC; Pell, JP; Celis-Morales, C				Ho, Frederick K.; Gray, Stuart R.; Welsh, Paul; Petermann-Rocha, Fanny; Foster, Hamish; Waddell, Heather; Anderson, Jana; Lyall, Donald; Sattar, Naveed; Gill, Jason M. R.; Mathers, John C.; Pell, Jill P.; Celis-Morales, Carlos			Associations of fat and carbohydrate intake with cardiovascular disease and mortality: prospective cohort study of UK Biobank participants	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; SATURATED FAT; DIETARY-FAT; WEIGHT-LOSS; RISK; COUNTRIES; ADJUSTMENT; HUMANS; ENERGY; ADULTS	Objective - To investigate the association of macronutrient intake with all cause mortality and cardiovascular disease (CVD), and the implications for dietary advice. Design - Prospective population based study. Setting - UK Biobank. Participants - 195 658 of the 502 536 participants in UK Biobank completed at least one dietary questionnaire and were included in the analyses. Diet was assessed using Oxford WebQ, a web based 24 hour recall questionnaire, and nutrient intakes were estimated using standard methodology. Cox proportional models with penalised cubic splines were used to study non-linear associations. Main outcome measures - All cause mortality and incidence of CVD. Results - 4780 (2.4%) participants died over a mean 10.6 (range 9.4-13.9) years of follow-up, and 948 (0.5%) and 9776 (5.0%) experienced fatal and non-fatal CVD events, respectively, over a mean 9.7 (range 8.5-13.0) years of follow-up. Non-linear associations were found for many macronutrients. Carbohydrate intake showed a non-linear association with mortality; no association at 20-50% of total energy intake but a positive association at 50-70% of energy intake (3.14 v 2.75 per 1000 person years, average hazard ratio 1.14, 95% confidence interval 1.03 to 1.28 (60-70% v 50% of energy)). A similar pattern was observed for sugar but not for starch or fibre. A higher intake of monounsaturated fat (2.94 v 3.50 per 1000 person years, average hazard ratio 0.58, 0.51 to 0.66 (20-25% v 5% of energy)) and lower intake of polyunsaturated fat (2.66 v 3.04 per 1000 person years, 0.78, 0.75 to 0.81 (5-7% v 12% of energy)) and saturated fat (2.66 v 3.59 per 1000 person years, 0.67, 0.62 to 0.73 (5-10% v 20% of energy)) were associated with a lower risk of mortality. A dietary risk matrix was developed to illustrate how dietary advice can be given based on current intake. Conclusion - Many associations between macronutrient intake and health outcomes are non-linear. Thus dietary advice could be tailored to current intake. Dietary guidelines on macronutrients (eg, carbohydrate) should also take account of differential associations of its components (eg, sugar and starch).	[Ho, Frederick K.; Petermann-Rocha, Fanny; Foster, Hamish; Anderson, Jana; Lyall, Donald; Pell, Jill P.; Celis-Morales, Carlos] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Gray, Stuart R.; Welsh, Paul; Petermann-Rocha, Fanny; Waddell, Heather; Sattar, Naveed; Gill, Jason M. R.; Celis-Morales, Carlos] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Mathers, John C.] Newcastle Univ, Populat Hlth Sci Inst, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Celis-Morales, Carlos] Univ Mayor, Ctr Exercise Physiol Res CIFE, Santiago, Chile; [Celis-Morales, Carlos] Univ Catolica Maule, Res Grp Educ Phys Act & Hlth GEEAFyS, Talca, Chile	University of Glasgow; University of Glasgow; Newcastle University - UK; Universidad Mayor; Universidad Catolica del Maule	Celis-Morales, C (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland.	carlos.celis@glasgow.ac.uk	Petermann-Rocha, Fanny/AAK-1230-2021; Welsh, Paul/H-5249-2019; Ho, Frederick/AAS-2647-2021; Foster, Hamish/AAX-7703-2021; Gray, Stuart/L-2489-2017	Welsh, Paul/0000-0002-7970-3643; Ho, Frederick/0000-0001-7190-9025; Gray, Stuart/0000-0001-8969-9636; Sattar, Naveed/0000-0002-1604-2593; , Donald/0000-0002-4565-9656; Lyall, Donald/0000-0003-3850-1487; Gill, Jason/0000-0003-3615-0986; Petermann Rocha, Fanny/0000-0002-4384-4962; Waddell, Heather/0000-0001-5845-4804	Welsh assembly government; British Heart Foundation	Welsh assembly government; British Heart Foundation(British Heart Foundation)	UK Biobank was established by the Wellcome Trust, Medical Research Council, Department of Health, Scottish government, and Northwest Regional Development Agency. It has also had funding from the Welsh assembly government and the British Heart Foundation.	Bazzano LA, 2014, ANN INTERN MED, V161, P309, DOI 10.7326/M14-0180; Bell S, 2019, GENERALISABILITY RES; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Celis-Morales C, 2015, GENES NUTR, V10, DOI 10.1007/s12263-014-0450-2; Clifton PM, 2009, NUTR METAB CARDIOVAS, V19, P548, DOI 10.1016/j.numecd.2008.10.006; Collins R, 2012, LANCET, V379, P1173, DOI 10.1016/S0140-6736(12)60404-8; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; de Souza RJ, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3978; Dehghan M, 2017, LANCET, V390, P2050, DOI [10.1016/s0140-6736(17)32252-3, 10.1016/S0140-6736(17)32252-3]; Englyst HN, J ASS OFF ANAL CHEM; FAO, 2018, FOOD BAS DIET GUID; Gardner CD, 2018, JAMA-J AM MED ASSOC, V319, P667, DOI 10.1001/jama.2018.0245; Govindarajulu US, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1104; Henry CJK, 2005, PUBLIC HEALTH NUTR, V8, P1133, DOI 10.1079/PHN2005801; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Jakobsen MU, 2004, AM J EPIDEMIOL, V160, P141, DOI 10.1093/aje/kwh193; Johnston BC, JAMA; Li YP, 2015, J AM COLL CARDIOL, V66, P1538, DOI 10.1016/j.jacc.2015.07.055; Liu B, 2011, PUBLIC HEALTH NUTR, V14, P1998, DOI 10.1017/S1368980011000942; McCance R., 2002, MCCANCE WIDD COMP FO; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; NHS, 2016, TREATM OB; NIH, 2006, YOUR GUID LOW YOUR B; Otto MCD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000506; Otto MCD, 2012, AM J CLIN NUTR, V96, P397, DOI 10.3945/ajcn.112.037770; Poslusna K, 2009, BRIT J NUTR, V101, pS73, DOI 10.1017/S0007114509990602; REISER S, 1979, AM J CLIN NUTR, V32, P1659, DOI 10.1093/ajcn/32.8.1659; SACN (Scientific Advisory Committee on Nutrition), 2015, CARB HLTH; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Scientific Advisory Committee on Nutrition (SACN), 2019, SAT FATS HLTH; Seidelmann SB, 2018, LANCET PUBLIC HEALTH, V3, pE419, DOI 10.1016/S2468-2667(18)30135-X; Siri-Tarino PW, 2010, AM J CLIN NUTR, V91, P535, DOI 10.3945/ajcn.2009.27725; Song MY, 2016, JAMA INTERN MED, V176, P1453, DOI 10.1001/jamainternmed.2016.4182; Stern L, 2004, ANN INTERN MED, V140, P778, DOI 10.7326/0003-4819-140-10-200405180-00007; Townsend PP., 1988, HLTH DEPRIVATION INE; Ueda P, 2017, LANCET DIABETES ENDO, V5, P196, DOI 10.1016/S2213-8587(17)30015-3; Virtanen HEK, 2019, AM J CLIN NUTR, V109, P1462, DOI 10.1093/ajcn/nqz025; WHO, 2018, DRAFT WHO GUID SAT F; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	39	45	47	4	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m688	10.1136/bmj.m688	http://dx.doi.org/10.1136/bmj.m688			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188587	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000523763100004
J	Morgan, M				Morgan, Matt			Matt Morgan: When the problem is urgent and important	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Univ Hosp Wales, Cardiff, Wales	Cardiff University	Morgan, M (corresponding author), Univ Hosp Wales, Cardiff, Wales.	mmorgan@bmj.com		Morgan, Matt/0000-0002-2357-7190					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1062	10.1136/bmj.m1062	http://dx.doi.org/10.1136/bmj.m1062			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184226	Bronze			2022-12-28	WOS:000523762400005
J	Rimmer, A				Rimmer, Abi			Covid-19: BMA calls for rapid testing and appropriate protective equipment for doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Rimmer A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1088	1	2	2	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1099	10.1136/bmj.m1099	http://dx.doi.org/10.1136/bmj.m1099			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184208	Bronze			2022-12-28	WOS:000523762400015
J	Voelker, R				Voelker, Rebecca			Prescription Drugs Switched to OTC	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1034	1034		10.1001/jama.2020.2548	http://dx.doi.org/10.1001/jama.2020.2548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181836				2022-12-28	WOS:000521968800008
J	[Anonymous]				[Anonymous]			The Physiologic Significance of a Record Aeroplane Flight (Reprinted from vol 74, pg 805-806, 1920)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		[Anonymous], 1919, JAMA-J AM MED ASSOC, V72, P496; [Anonymous], 1919, JAMA-J AM MED ASSOC, V73, P1444; [Anonymous], 1919, JAMA-J AM MED ASSOC, V72, P1368; 1920, JAMA, V74, P805	4	0	0	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1101	1101		10.1001/jama.2019.13356	http://dx.doi.org/10.1001/jama.2019.13356			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181839				2022-12-28	WOS:000521968800029
J	Poore, GD; Kopylova, E; Zhu, QY; Carpenter, C; Fraraccio, S; Wandro, S; Kosciolek, T; Janssen, S; Metcalf, J; Song, SJ; Kanbar, J; Miller-Montgomery, S; Heaton, R; Mckay, R; Patel, SP; Swafford, AD; Knight, R				Poore, Gregory D.; Kopylova, Evguenia; Zhu, Qiyun; Carpenter, Carolina; Fraraccio, Serena; Wandro, Stephen; Kosciolek, Tomasz; Janssen, Stefan; Metcalf, Jessica; Song, Se Jin; Kanbar, Jad; Miller-Montgomery, Sandrine; Heaton, Robert; Mckay, Rana; Patel, Sandip Pravin; Swafford, Austin D.; Knight, Rob			Microbiome analyses of blood and tissues suggest cancer diagnostic approach	NATURE			English	Article							READ ALIGNMENT; HALLMARKS; PLATFORM; ORIGIN	Microbial nucleic acids are detected in samples of tissues and blood from more than 10,000 patients with cancer, and machine learning is used to show that these can be used to discriminate between and among different types of cancer, suggesting a new microbiome-based diagnostic approach. Systematic characterization of the cancer microbiome provides the opportunity to develop techniques that exploit non-human, microorganism-derived molecules in the diagnosis of a major human disease. Following recent demonstrations that some types of cancer show substantial microbial contributions(1-10), we re-examined whole-genome and whole-transcriptome sequencing studies in The Cancer Genome Atlas(11) (TCGA) of 33 types of cancer from treatment-naive patients (a total of 18,116 samples) for microbial reads, and found unique microbial signatures in tissue and blood within and between most major types of cancer. These TCGA blood signatures remained predictive when applied to patients with stage Ia-IIc cancer and cancers lacking any genomic alterations currently measured on two commercial-grade cell-free tumour DNA platforms, despite the use of very stringent decontamination analyses that discarded up to 92.3% of total sequence data. In addition, we could discriminate among samples from healthy, cancer-free individuals (n = 69) and those from patients with multiple types of cancer (prostate, lung, and melanoma; 100 samples in total) solely using plasma-derived, cell-free microbial nucleic acids. This potential microbiome-based oncology diagnostic tool warrants further exploration.	[Poore, Gregory D.; Miller-Montgomery, Sandrine; Knight, Rob] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Kopylova, Evguenia; Zhu, Qiyun; Kosciolek, Tomasz; Janssen, Stefan; Knight, Rob] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Carpenter, Carolina; Fraraccio, Serena; Wandro, Stephen; Song, Se Jin; Miller-Montgomery, Sandrine; Patel, Sandip Pravin; Swafford, Austin D.; Knight, Rob] Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA; [Metcalf, Jessica] Colorado State Univ, Dept Anim Sci, Ft Collins, CO 80523 USA; [Kanbar, Jad] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Heaton, Robert] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Mckay, Rana; Patel, Sandip Pravin] Univ Calif San Diego Hlth, Moores Canc Ctr, La Jolla, CA USA; [Knight, Rob] Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA; [Kopylova, Evguenia] Clar Genom, Beerse, Belgium; [Kosciolek, Tomasz] Jagiellonian Univ Krakow, Malopolska Ctr Biotechnol, Krakow, Poland; [Janssen, Stefan] Justus Liebig Univ Giessen, Dept Biol & Chem, Algorithm Bioinformat, Giessen, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Colorado State University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Jagiellonian University; Justus Liebig University Giessen	Knight, R (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.; Knight, R (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.; Knight, R (corresponding author), Univ Calif San Diego, Ctr Microbiome Innovat, La Jolla, CA 92093 USA.; Knight, R (corresponding author), Univ Calif San Diego, Dept Comp Sci & Engn, La Jolla, CA 92093 USA.	robknight@ucsd.edu	Song, Se Jin/ABE-1367-2021; Zhu, Qiyun/ABH-8959-2020; Kosciolek, Tomasz/Y-2805-2019	Song, Se Jin/0000-0003-0750-5709; Kosciolek, Tomasz/0000-0002-9915-7387; Swafford, Austin/0000-0001-5655-8300; Carpenter, Carolina/0000-0002-5716-3068; Zhu, Qiyun/0000-0002-3568-6271; Janssen, Stefan/0000-0003-0955-0589; Knight, Rob/0000-0002-0975-9019	National Institutes of Health [5T32GM007198-42, 5T32GM007198-43]; Merck KGaA; Center for Microbiome Innovation at UC San Diego; Federal funds from the National Cancer Institute, National Institutes of Health [HHSN261201400008C]; ID/IQ Agreement [17X146, HHSN261201500003I]; Chancellor's Initiative in the Microbiome and Microbial Sciences; Illumina, Inc.;  [R00 AA020235];  [R01 DA026334];  [P30 MH062513];  [P01 DA012065];  [P50 DA026306]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck KGaA; Center for Microbiome Innovation at UC San Diego; Federal funds from the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ID/IQ Agreement; Chancellor's Initiative in the Microbiome and Microbial Sciences; Illumina, Inc.; ; ; ; ; 	We acknowledge conversations with C. Sepich, C. Martino, R. Bejar, and H. Carter. G.D.P. has been supported by training grants from the National Institutes of Health during the course of this work (5T32GM007198-42; 5T32GM007198-43). S.F. is partially funded through trainee support from Merck KGaA in partnership with the Center for Microbiome Innovation at UC San Diego. Samples acquired for the validation cohort were collected under the following grants: R00 AA020235, R01 DA026334, P30 MH062513, P01 DA012065, and P50 DA026306. The Seven Bridges Cancer Genomics Cloud was used during the course of this work and has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, Contract No. HHSN261201400008C, and ID/IQ Agreement No. 17X146 under Contract No. HHSN261201500003I. This work was supported in part by the Chancellor's Initiative in the Microbiome and Microbial Sciences (R.K., A.D.S., S.M.-M.) and by Illumina, Inc. through reagent donation in partnership with the Center for Microbiome Innovation at UC San Diego. We thank G. Humphrey and K. Sanders for sample processing, and G. Ackermann, A. Gonzalez, and J. DeReus for assistance with metadata curation and data handling.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Banerjee S, 2017, ONCOTARGET, V8, P36225, DOI 10.18632/oncotarget.16717; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Blauwkamp TA, 2019, NAT MICROBIOL, V4, P663, DOI 10.1038/s41564-018-0349-6; Boedigheimer MJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-285; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240; Burk RD, 2017, NATURE, V543, P378, DOI 10.1038/nature21386; Burnham P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04745-0; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chiu KP, 2019, PEERJ, V7, DOI 10.7717/peerj.7426; Choi JH, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1627-7; Clark TA, 2018, J MOL DIAGN, V20, P686, DOI 10.1016/j.jmoldx.2018.05.004; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Didion JP, 2017, PEERJ, V5, DOI 10.7717/peerj.3720; Eisenhofer R, 2019, TRENDS MICROBIOL, V27, P105, DOI 10.1016/j.tim.2018.11.003; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Glassing A, 2016, GUT PATHOG, V8, DOI 10.1186/s13099-016-0103-7; Gonzalez A, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00050-16; Gonzalez A, 2018, NAT METHODS, V15, P796, DOI 10.1038/s41592-018-0141-9; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Grau J, 2015, BIOINFORMATICS, V31, P2595, DOI 10.1093/bioinformatics/btv153; Greathouse KL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1501-6; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hillmann B, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00069-18; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Hong DK, 2018, DIAGN MICR INFEC DIS, V92, P210, DOI 10.1016/j.diagmicrobio.2018.06.009; Hsieh YY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18596-0; Huang S, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00630-19; Huang YF, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0329-y; Jervis-Bardy J, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0083-8; Jin CC, 2019, CELL, V176, P998, DOI 10.1016/j.cell.2018.12.040; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Kwong TNY, 2018, GASTROENTEROLOGY, V155, P383, DOI 10.1053/j.gastro.2018.04.028; Land ML, 2014, STAND GENOMIC SCI, V9, DOI 10.1186/1944-3277-9-20; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau JW, 2017, CANCER RES, V77, pE3, DOI 10.1158/0008-5472.CAN-17-0387; Lauss M, 2013, CANCER INFORM, V12, P193, DOI 10.4137/CIN.S12862; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Matranga CB, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0519-7; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; McDonald D, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-7; Mecham BH, 2010, BIOINFORMATICS, V26, P1308, DOI 10.1093/bioinformatics/btq118; Meisel M, 2018, NATURE, V557, P580, DOI 10.1038/s41586-018-0125-z; Minich JJ, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00218-17; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Reynolds SM, 2017, CANCER RES, V77, pE7, DOI 10.1158/0008-5472.CAN-17-0617; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson KM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0224-8; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanders JG, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1834-9; SCHERER A., 2009, BATCH EFFECTS NOISE; Shanmughapriya S, 2012, EUR J CLIN MICROBIOL, V31, P2311, DOI 10.1007/s10096-012-1570-5; Svircev Z, 2010, J ENVIRON SCI HEAL C, V28, P39, DOI 10.1080/10590500903585382; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yamamura K, 2016, CLIN CANCER RES, V22, P5574, DOI 10.1158/1078-0432.CCR-16-1786; Ye HB, 2018, CANCER CELL, V34, P659, DOI 10.1016/j.ccell.2018.08.016; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069; Zhu QY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13443-4	79	315	321	43	267	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					567	+		10.1038/s41586-020-2095-1	http://dx.doi.org/10.1038/s41586-020-2095-1		MAR 2020	30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214244	Green Accepted			2022-12-28	WOS:000519162500008
J	Nikoo, MS; Jafari, A; Perera, N; Zhu, MH; Santoruvo, G; Matioli, E				Nikoo, Mohammad Samizadeh; Jafari, Armin; Perera, Nirmana; Zhu, Minghua; Santoruvo, Giovanni; Matioli, Elison			Nanoplasma-enabled picosecond switches for ultrafast electronics	NATURE			English	Article							DC-DC CONVERTER; GAAS IMPATT DIODES; INP GUNN DEVICES; POWER-AMPLIFIER; GHZ OSCILLATOR; CW OSCILLATION; BUCK CONVERTER; PULSE; MW; HEMT	The broad applications of ultrawide-band signals and terahertz waves in quantum measurements(1,2), imaging and sensing techniques(3,4), advanced biological treatments(5), and very-high-data-rate communications(6) have drawn extensive attention to ultrafast electronics. In such applications, high-speed operation of electronic switches is challenging, especially when high-amplitude output signals are required(7). For instance, although field-effect and bipolar junction devices have good controllability and robust performance, their relatively large output capacitance with respect to their ON-state current substantially limits their switching speed(8). Here we demonstrate a novel on-chip, all-electronic device based on a nanoscale plasma (nanoplasma) that enables picosecond switching of electric signals with a wide range of power levels. The very high electric field in the small volume of the nanoplasma leads to ultrafast electron transfer, resulting in extremely short time responses. We achieved an ultrafast switching speed, higher than 10 volts per picosecond, which is about two orders of magnitude larger than that of field-effect transistors and more than ten times faster than that of conventional electronic switches. We measured extremely short rise times down to five picoseconds, which were limited by the employed measurement set-up. By integrating these devices with dipole antennas, high-power terahertz signals with a power-frequency trade-off of 600 milliwatts terahertz squared were emitted, much greater than that achieved by the state of the art in compact solid-state electronics. The ease of integration and the compactness of the nanoplasma switches could enable their implementation in several fields, such as imaging, sensing, communications and biomedical applications.	[Nikoo, Mohammad Samizadeh; Jafari, Armin; Perera, Nirmana; Zhu, Minghua; Santoruvo, Giovanni; Matioli, Elison] Ecole Polytech Fed Lausanne EPFL, Inst Elect Engn, Power & Wide Band Gap Elect Res Lab POWERlab, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Matioli, E (corresponding author), Ecole Polytech Fed Lausanne EPFL, Inst Elect Engn, Power & Wide Band Gap Elect Res Lab POWERlab, Lausanne, Switzerland.	elison.matioli@epfl.ch	Polvani, Lorenzo M/E-5949-2011	Matioli, Elison/0000-0001-6475-001X; Samizadeh Nikoo, Mohammad/0000-0003-3890-7356; Jafari, Armin/0000-0001-6095-2650; Zhu, Minghua/0000-0003-4268-727X				ADLERSTEIN MG, 1984, IEEE ELECTR DEVICE L, V5, P97, DOI 10.1109/EDL.1984.25844; Afshari E, 2005, IEEE J SOLID-ST CIRC, V40, P744, DOI 10.1109/JSSC.2005.843639; Aklimi E, 2017, IEEE J SOLID-ST CIRC, V52, P1618, DOI 10.1109/JSSC.2017.2672986; ALLEN KR, 1959, NATURE, V183, P174, DOI 10.1038/183174a0; [Anonymous], 2019, SIGN GEN EXT MOD; Baliga B., 2019, FUNDAMENTALS POWER S; Bathily M, 2012, IEEE T POWER ELECTR, V27, P610, DOI 10.1109/TPEL.2011.2119380; BAYRAKTAROGLU B, 1983, IEEE ELECTR DEVICE L, V4, P393, DOI 10.1109/EDL.1983.25777; Benea-Chelmus IC, 2019, NATURE, V568, P202, DOI 10.1038/s41586-019-1083-9; Bergveld Henk Jan, 2009, Proceedings of the 2009 IEEE Energy Conversion Congress and Exposition. ECCE 2009, P3698, DOI 10.1109/ECCE.2009.5316334; Bobreshov AM, 2017, IEEE MICROW WIREL CO, V27, P1013, DOI 10.1109/LMWC.2017.2750085; CHANG K, 1981, IEEE T MICROW THEORY, V29, P1278, DOI 10.1109/TMTT.1981.1130553; Chen PY, 2016, IEEE T MICROW THEORY, V64, P4685, DOI 10.1109/TMTT.2016.2623700; Chen YP, 2019, IEEE MICROW WIREL CO, V29, P225, DOI 10.1109/LMWC.2019.2891893; Choi GW, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3523342; Choi JiHyeon, 2015, P IEEE WIR POW TRANS, P1, DOI [DOI 10.1109/WPT.2015.7140167, 10.1109/AVSS.2015.7301763, DOI 10.1109/AVSS.2015.7301763]; Cocker TL, 2016, NATURE, V539, P263, DOI 10.1038/nature19816; De Angelis A, 2011, IEEE T INSTRUM MEAS, V60, P310, DOI 10.1109/TIM.2010.2047591; Deal WR, 2008, IEEE MTT S INT MICR, P398, DOI 10.1109/MWSYM.2008.4633187; Deal WR, 2007, IEEE T MICROW THEORY, V55, P2719, DOI 10.1109/TMTT.2007.910012; del Alamo JA, 2011, NATURE, V479, P317, DOI 10.1038/nature10677; Dusmez S, 2015, IEEE T IND ELECTRON, V62, P3152, DOI 10.1109/TIE.2015.2404825; Eisele H, 2007, ELECTRON LETT, V43, P636, DOI 10.1049/el:20070936; Eisele H, 2006, ELECTRON LETT, V42, P358, DOI 10.1049/el:20060218; Eisele H, 2005, ELECTRON LETT, V41, P329, DOI 10.1049/el:20058165; EISELE H, 1989, SOLID STATE ELECTRON, V32, P253, DOI 10.1016/0038-1101(89)90100-7; Eisele H, 2010, ELECTRON LETT, V46, P422, DOI 10.1049/el.2010.3362; EISELE H, 1986, ELECTRON LETT, V22, P224, DOI 10.1049/el:19860156; Eisele H, 2006, IEEE MICROW WIREL CO, V16, P284, DOI 10.1109/LMWC.2006.873498; Eisele H, 2009, IEEE MICROW WIREL CO, V19, P416, DOI 10.1109/LMWC.2009.2020044; Gao QG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07135-8; Gaspar M, 2016, IEEE T NUCL SCI, V63, P699, DOI 10.1109/TNS.2015.2477603; Gaspar M, 2011, NUCL INSTRUM METH A, V637, P18, DOI 10.1016/j.nima.2011.02.057; Gaye M, 2000, ISCAS 2000: IEEE INTERNATIONAL SYMPOSIUM ON CIRCUITS AND SYSTEMS - PROCEEDINGS, VOL I, P264, DOI 10.1109/ISCAS.2000.857078; Glaser JS, 2010, APPL POWER ELECT CO, P654, DOI 10.1109/APEC.2010.5433602; Griffith Z, 2015, IEEE MICROW WIREL CO, V25, P597, DOI 10.1109/LMWC.2015.2451360; Gurevich V, 2019, PROTECTING ELECT EQU; Hacker J, 2008, IEEE MTT S INT MICR, P402; Han J, 2006, IEEE T MICROW THEORY, V54, P285, DOI 10.1109/TMTT.2005.860299; Hayashi Y, 2013, APPL POWER ELECT CO, P1601, DOI 10.1109/APEC.2013.6520511; Hazucha P, 2005, IEEE J SOLID-ST CIRC, V40, P838, DOI 10.1109/JSSC.2004.842837; Herrick KJ, 2005, IEEE MTT S INT MICR, P843, DOI 10.1109/MWSYM.2005.1516748; HO PS, 1989, REP PROG PHYS, V52, P301, DOI 10.1088/0034-4885/52/3/002; Huang P, 2006, IEEE MTT S INT MICR, P806, DOI 10.1109/MWSYM.2006.249795; IMPATT terahertz sources, 2019, IMPATT TER SOURC; Ingram DL, 1999, IEEE RAD FREQ INTEGR, P95, DOI 10.1109/RFIC.1999.805247; INO M, 1976, ELECTRON LETT, V12, P148, DOI 10.1049/el:19760115; ISHIBASHI T, 1976, IEEE T MICROW THEORY, V24, P858, DOI 10.1109/TMTT.1976.1128974; Jelic V, 2017, NAT PHYS, V13, P591, DOI [10.1038/nphys4047, 10.1038/NPHYS4047]; Johnson E., 1965, 1958 IRE INT CONVENT, VVolume 13, P27, DOI [10.1109/IRECON.1965.1147520, DOI 10.1109/IRECON.1965.1147520]; Kallfass I, 2009, IEEE MICROW WIREL CO, V19, P410, DOI 10.1109/LMWC.2009.2020042; Kanto K, 2008, IEEE RADIO WIRELESS, P77; Katayama Y, 2000, IEEE POWER ELECTRON, P1485, DOI 10.1109/PESC.2000.880526; Kim H, 2015, 2015 9TH INTERNATIONAL CONFERENCE ON POWER ELECTRONICS AND ECCE ASIA (ICPE-ECCE ASIA), P1772, DOI 10.1109/ICPE.2015.7168018; Kim W, 2012, IEEE J SOLID-ST CIRC, V47, P206, DOI 10.1109/JSSC.2011.2169309; Koenig S, 2013, NAT PHOTONICS, V7, P977, DOI [10.1038/NPHOTON.2013.275, 10.1038/nphoton.2013.275]; Kroll J, 2007, NATURE, V449, P698, DOI 10.1038/nature06208; Lee DS, 2011, IEEE ELECTR DEVICE L, V32, P755, DOI 10.1109/LED.2011.2132751; Lee JS, 2001, ELECTRON LETT, V37, P504, DOI 10.1049/el:20010350; LEE TP, 1968, IEEE T ELECTRON DEV, VED15, P741, DOI 10.1109/T-ED.1968.16508; Lee W, 2015, 2015 9TH INTERNATIONAL CONFERENCE ON POWER ELECTRONICS AND ECCE ASIA (ICPE-ECCE ASIA), P233, DOI 10.1109/ICPE.2015.7167792; Leong KMKH, 2015, IEEE MICROW WIREL CO, V25, P397, DOI 10.1109/LMWC.2015.2421336; Lin SY, 2011, 2011 INTERNATIONAL SYMPOSIUM ON VLSI DESIGN, AUTOMATION AND TEST (VLSI-DAT), P320; Liu M, 2016, IEEE T POWER ELECTR, V31, P4280, DOI 10.1109/TPEL.2015.2472565; Loveless AM, 2016, APPL PHYS LETT, V108, DOI 10.1063/1.4953202; Mahfouz MR, 2008, IEEE T MICROW THEORY, V56, P1316, DOI 10.1109/TMTT.2008.923351; Marchand P, 2007, PHYS REV SPEC TOP-AC, V10, DOI 10.1103/PhysRevSTAB.10.112001; Masuda S, 2009, 2009 EUROPEAN MICROWAVE INTEGRATED CIRCUITS CONFERENCE (EUMIC 2009), P443; Mei XB, 2015, IEEE ELECTR DEVICE L, V36, P327, DOI 10.1109/LED.2015.2407193; Mertens KLR, 2002, IEEE J SOLID-ST CIRC, V37, P137, DOI 10.1109/4.982419; Mesyats G.A., 2005, PULSED POWER; Miao M, 2003, MICROW OPT TECHN LET, V39, P470, DOI 10.1002/mop.11250; Micovic M, 2010, IEEE MTT S INT MICR, P237, DOI 10.1109/MWSYM.2010.5516911; Micovic M, 2008, COMP SEMICOND INTEGR, P8; Micovic M, 2010, 2010 IEEE LEST E C H; MOLL JL, 1969, P IEEE, V57, P1250, DOI 10.1109/PROC.1969.7229; Morgan M, 2009, IEEE MTT S INT MICR, P541, DOI 10.1109/MWSYM.2009.5165753; Nguyen C., 2014, TIME DOMAIN ULTRAWID, P27; Onizuka K, 2007, IEEE J SOLID-ST CIRC, V42, P2404, DOI 10.1109/JSSC.2007.906204; Orlenko O. A., 2012, 2012 6th International Conference on Ultrawideband and Ultrashort Impulse Signals (UWBUSIS 2012), P75, DOI 10.1109/UWBUSIS.2012.6379737; Pinon Vincent, 2008, 2008 IEEE International Solid-State Circuits Conference - Digest of Technical Papers, P564, DOI 10.1109/ISSCC.2008.4523308; Power amplifiers, 2019, POW AMPL; PRAGER HJ, 1967, PR INST ELECTR ELECT, V55, P586, DOI 10.1109/PROC.1967.5609; Radisic V, 2012, IEEE T MICROW THEORY, V60, P724, DOI 10.1109/TMTT.2011.2176503; Radisic V, 2010, IEEE MTT S INT MICR, P45, DOI 10.1109/MWSYM.2010.5515248; Radisic V, 2010, IEEE T MICROW THEORY, V58, P1903, DOI 10.1109/TMTT.2010.2050105; Redl R., 1986, IEEE Transactions on Power Electronics, VPE-1, P111, DOI 10.1109/TPEL.1986.4766289; Reed T. B, 2011, IEEE COMP SEM INT CI, P1, DOI DOI 10.1109/CSICS.2011.6062480; Rieh JS, 2014, 2014 12TH IEEE INTERNATIONAL CONFERENCE ON SOLID-STATE AND INTEGRATED CIRCUIT TECHNOLOGY (ICSICT); Rivas J. M., 2006, THESIS; Rossi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36527-5; Ruengwaree A, 2006, EUROP RADAR CONF, P354, DOI 10.1109/EURAD.2006.280348; Samoska L, 2005, IEEE MTT S INT MICR, P1583, DOI 10.1109/MWSYM.2005.1517003; Samoska L, 2004, IEEE MICROW WIREL CO, V14, P56, DOI 10.1109/LMWC.2003.822575; Samoska L, 2001, IEEE MTT S INT MICR, P1805, DOI 10.1109/MWSYM.2001.967257; Schrom G, 2004, IEEE POWER ELECTRON, P4702; Sen B, 2011, ISTANB UNIV J FAC PO, P1; Sengupta K, 2018, NAT ELECTRON, V1, P622, DOI 10.1038/s41928-018-0173-2; SHINGUBARA S, 1991, APPL PHYS LETT, V58, P42, DOI 10.1063/1.104431; Song MK, 2015, ISSCC DIG TECH PAP I, V58, P302, DOI 10.1109/ISSCC.2015.7063046; Sun J, 2009, IEEE T VLSI SYST, V17, P447, DOI 10.1109/TVLSI.2008.2005312; Tessmann A, 2005, IEEE MTT S INT MICR, P1579, DOI 10.1109/MWSYM.2005.1517002; Tkachov S, 2016, APPL POWER ELECT CO, P350, DOI 10.1109/APEC.2016.7467896; Tonouchi M, 2007, NAT PHOTONICS, V1, P97, DOI 10.1038/nphoton.2007.3; TSCHERNITZ M, 1995, ELECTRON LETT, V31, P582, DOI 10.1049/el:19950390; Uhm HS, 2003, J KOREAN PHYS SOC, V42, pS989; Vetury R, 2001, IEEE T ELECTRON DEV, V48, P560, DOI 10.1109/16.906451; Walraven JA, 2000, PROC SPIE, V4180, P30, DOI 10.1117/12.395703; Wang H, 2001, IEEE T MICROW THEORY, V49, P9, DOI 10.1109/22.899956; WELLER KP, 1976, IEEE T MICROW THEORY, V24, P738, DOI 10.1109/TMTT.1976.1128954; Wibben J, 2008, IEEE J SOLID-ST CIRC, V43, P844, DOI 10.1109/JSSC.2008.917321; Wollitzer M, 1996, ELECTRON LETT, V32, P122, DOI 10.1049/el:19960088; Wong SL, 1996, ISSCC DIG TECH PAP I, V39, P52, DOI 10.1109/ISSCC.1996.488510; Wu X, 2017, IEEE J SOLID-ST CIRC, V52, P389, DOI 10.1109/JSSC.2016.2616349; Yang Q, 2012, IEEE SYS MAN CYBERN, P1, DOI 10.1109/ICSMC.2012.6377667; You F, 2008, IEEE T MICROW THEORY, V56, P2190, DOI 10.1109/TMTT.2008.2003530; YOUNG KK, 1989, IEEE T ELECTRON DEV, V36, P399, DOI 10.1109/16.19942; Zhang X, 2019, NATURE, V566, P368, DOI 10.1038/s41586-019-0892-1; Zhen XT, 2018, IEEE T NEUR NET LEAR, V29, P1575, DOI 10.1109/TNNLS.2017.2651068; Zhou J, 2006, PLOS ONE, V11, pe0149645; Zhou JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136287; Zou LF, 2017, IEEE MICROW WIREL CO, V27, P467, DOI 10.1109/LMWC.2017.2690880	123	27	27	19	55	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					534	539		10.1038/s41586-020-2118-y	http://dx.doi.org/10.1038/s41586-020-2118-y			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214267	Green Submitted			2022-12-28	WOS:000521825500022
J	McDermott, MM; Newman, AB				McDermott, Mary M.; Newman, Anne B.			Preserving Clinical Trial Integrity During the Coronavirus Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses ways the coronavirus pandemic is threatening clinical trial conduct and enrollment, and suggests ways to adapt, including changes to how outcomes data are collected and how interventions are delivered and monitored, to minimize trial disruption, maximize trial benefit, and ensure patient health and safety during the pandemic.	[McDermott, Mary M.] Northwestern Univ, Feinberg Sch Med, Dept Med, 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA; [Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA 15260 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McDermott, MM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 750 N Lake Shore Dr,10th Floor, Chicago, IL 60611 USA.	mdm608@northwestern.edu						ClinicalTrials, TRENDS CHARTS MAPS; Pahor M, 2014, JAMA-J AM MED ASSOC, V311, P2387, DOI 10.1001/jama.2014.5616; US Food and Drug Administration, 2020, FDA GUID COND CLIN T	3	118	119	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	2020	323	21					2135	2136		10.1001/jama.2020.4689	http://dx.doi.org/10.1001/jama.2020.4689			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LY8YS	32211830	Bronze			2022-12-28	WOS:000540816000012
J	Truog, RD; Mitchell, C; Daley, GQ				Truog, Robert D.; Mitchell, Christine; Daley, George Q.			The Toughest Triage - Allocating Ventilators in a Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Of all the medical care that will have to be rationed during the Covid-19 pandemic, the most problematic will be mechanical ventilation. One strategy for avoiding debilitating distress over these decisions is to use a triage committee to buffer bedside clinicians.	[Truog, Robert D.; Mitchell, Christine] Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA; [Truog, Robert D.; Mitchell, Christine] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Daley, George Q.] Harvard Med Sch, Off Dean, Fac Med, Boston, MA 02115 USA; [Truog, Robert D.] Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Truog, RD (corresponding author), Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA.; Truog, RD (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Truog, RD (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Crit Care & Pain Med, Boston, MA 02115 USA.			Truog, Robert/0000-0001-5384-8281				[Anonymous], CLIN ETH REC ALL INT; [Anonymous], 2020, CORONAVIRUS CAUTIONA; Johns Hopkins Bloomberg School of Public Health, 2020, VENTILATOR STOCKPILI; Kliff S, 2020, NY TIMES; New York State Department of Health-New York State Task Force on Life and the Law, 2015, VENT ALL GUID	5	380	388	2	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					1973	1975		10.1056/NEJMp2005689	http://dx.doi.org/10.1056/NEJMp2005689			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LT1TD	32202721	Bronze			2022-12-28	WOS:000536856000010
J	Zeng, H; Xu, C; Fan, JL; Tang, YT; Deng, QL; Zhang, W; Long, XH				Zeng, Hui; Xu, Chen; Fan, Junli; Tang, Yueting; Deng, Qiaoling; Zhang, Wei; Long, Xinghua			Antibodies in Infants Born to Mothers With COVID-19 Pneumonia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study describes results of IgM and IgG antibody testing from throat swabs of newborns born to mothers with COVID-19 pneumonia.	[Zeng, Hui; Xu, Chen; Fan, Junli; Tang, Yueting; Deng, Qiaoling; Long, Xinghua] Wuhan Univ, Zhongnan Hosp, Dept Lab Med, Wuhan, Peoples R China; [Zhang, Wei] Wuhan Univ, Zhongnan Hosp, Dept Obstet & Gynaecol, Wuhan, Peoples R China	Wuhan University; Wuhan University	Zhang, W; Long, XH (corresponding author), Wuhan Univ, Zhongnan Hosp, 169 Donghu Rd, Wuhan, Peoples R China.	zw6676@163.com; zhoulongxinghua@qq.com			National Natural Science Foundation of China [81272372]; Zhongnan Hospital of Wuhan University Science, Technology, and Innovation Seed Fund [znpy2016033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhongnan Hospital of Wuhan University Science, Technology, and Innovation Seed Fund	This study was supported by grants 81272372 from the National Natural Science Foundation of China and znpy2016033 from Zhongnan Hospital of Wuhan University Science, Technology, and Innovation Seed Fund.	Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; China NHC, 2020, NEW COR PNEUM PREV C; KOHLER PF, 1966, NATURE, V210, P1070, DOI 10.1038/2101070a0; Ng WF, 2006, PATHOLOGY, V38, P210, DOI 10.1080/00313020600696280; World Health Organization (WHO), LAB TEST 2019 NOV CO	5	495	522	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1848	1849		10.1001/jama.2020.4861	http://dx.doi.org/10.1001/jama.2020.4861			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32215589	Bronze, Green Published			2022-12-28	WOS:000536221500028
J	Zhang, YZ; Holmes, EC				Zhang, Yong-Zhen; Holmes, Edward C.			A Genomic Perspective on the Origin and Emergence of SARS-CoV-2	CELL			English	Editorial Material							CORONAVIRUS; VIRUS	The ongoing pandemic of a new human coronavirus, SARS-CoV-2, has generated enormous global concern. We and others in China were involved in the initial genome sequencing of the virus. Herein, we describe what genomic data reveal about the emergence SARS-CoV-2 and discuss the gaps in our understanding of its origins.	[Zhang, Yong-Zhen; Holmes, Edward C.] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Zhang, Yong-Zhen; Holmes, Edward C.] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China; [Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia	Fudan University; Fudan University; University of Sydney; University of Sydney	Holmes, EC (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.; Holmes, EC (corresponding author), Fudan Univ, Sch Life Sci, Shanghai, Peoples R China.; Holmes, EC (corresponding author), Univ Sydney, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.; Holmes, EC (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW, Australia.	edward.holmes@sydney.edu.au	Holmes, Edward/GVR-9499-2022	Holmes, Edward/0000-0001-9596-3552	National Natural Science Foundation of China [81861138003, 31930001]; Special National Project on investigation of basic resources of China [2019FY101500]; Australian Research Council [FL170100022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special National Project on investigation of basic resources of China; Australian Research Council(Australian Research Council)	This work was funded by the National Natural Science Foundation of China (grants 81861138003 and 31930001), the Special National Project on investigation of basic resources of China (grant 2019FY101500), and the Australian Research Council (grant FL170100022).	Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Grubaugh ND, 2020, NAT MICROBIOL, V5, P529, DOI 10.1038/s41564-020-0690-4; Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2; Holmes EC, 2016, NATURE, V538, P193, DOI 10.1038/nature19790; Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698; Hu Y, 2020, SER MATER SCI ENG, P3; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Labroussaa F, 2020, NATURE, V582, P561, DOI [DOI 10.1038/S41586-020-2294-9, 10.1038/s41586-020-2294-9, DOI 10.1101/2020.02.21.959817]; Lam TT-Y., 2020, IDENTIFICATION 2019; Lin XD, 2017, VIROLOGY, V507, P1, DOI 10.1016/j.virol.2017.03.019; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Minskaia E, 2006, P NATL ACAD SCI USA, V103, P5108, DOI 10.1073/pnas.0508200103; Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang XL, 2016, J VIROL, V90, P3253, DOI 10.1128/JVI.02582-15; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	21	426	445	5	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2020	181	2					223	227		10.1016/j.cell.2020.03.035	http://dx.doi.org/10.1016/j.cell.2020.03.035			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LD7BL	32220310	Green Published, Bronze			2022-12-28	WOS:000526184900005
J	Wang, JG; Xu, CC; Wong, YK; He, YK; Adegnika, AA; Kremsner, PG; Agnandji, ST; Sall, AA; Liang, Z; Qiu, C; Liao, FL; Jiang, TL; Krishna, S; Tu, YY				Wang, Jigang; Xu, Chengchao; Wong, Yin Kwan; He, Yingke; Adegnika, Ayola A.; Kremsner, Peter G.; Agnandji, Selidji T.; Sall, Amadou A.; Liang, Zhen; Qiu, Chen; Liao, Fu Long; Jiang, Tingliang; Krishna, Sanjeev; Tu, Youyou			Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic	LANCET			English	Editorial Material									[Wang, Jigang; Xu, Chengchao; Liang, Zhen; Qiu, Chen] ShenZhen Peoples Hosp, Shenzhen, Peoples R China; [Wang, Jigang; Xu, Chengchao; Wong, Yin Kwan; Liao, Fu Long; Jiang, Tingliang; Tu, Youyou] China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing, Peoples R China; [Wang, Jigang; Xu, Chengchao; Wong, Yin Kwan; Liao, Fu Long; Jiang, Tingliang; Tu, Youyou] China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China; [Wang, Jigang] Cent Peoples Hosp Zhanjiang, Zhanjiang, Guangdong, Peoples R China; [Wong, Yin Kwan; He, Yingke] Singapore Gen Hosp, Dept Anaesthesiol, Singapore, Singapore; [Adegnika, Ayola A.; Kremsner, Peter G.; Agnandji, Selidji T.; Krishna, Sanjeev] Univ Klinikum Tubingen, Inst Tropenmed, Tubingen, Germany; [Adegnika, Ayola A.; Kremsner, Peter G.; Agnandji, Selidji T.; Krishna, Sanjeev] Ctr Rech Med Lambarene, Lambarene, Gabon; [Sall, Amadou A.] Inst Pasteur, Dakar, Senegal; [Krishna, Sanjeev] St Georges Univ London, Inst Infect Immun, Ctr Diagnost & Antimicrobial Resistance, London, England; [Krishna, Sanjeev] St Georges Univ Hosp NHS Fdn Trust, London, England	Jinan University; China Academy of Chinese Medical Sciences; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Singapore General Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; St Georges University London	Tu, YY (corresponding author), China Acad Chinese Med Sci, Artemisinin Res Ctr, Beijing, Peoples R China.; Tu, YY (corresponding author), China Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing, Peoples R China.	yytu@icmm.ac.cn	Qiu, Chen/AAB-6698-2021	Qiu, Chen/0000-0002-1668-8773				[Anonymous], 2020, 52 WHO; [Anonymous], MAL CONTR CAMP LAUNC; Aregawi M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1493-1; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Hoehl S, 2020, NEW ENGL J MED, V382, P1278, DOI 10.1056/NEJMc2001899; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Parpia AS, 2016, EMERG INFECT DIS, V22, P433, DOI 10.3201/eid2203.150977; Plucinski MM, 2015, LANCET INFECT DIS, V15, P1017, DOI 10.1016/S1473-3099(15)00061-4; Walker PGT, 2015, LANCET INFECT DIS, V15, P825, DOI 10.1016/S1473-3099(15)70124-6; WHO, 2020, WHO CHINA JT MISSION; WHO, 2015, WORLD MAL REP 2015; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	12	41	43	3	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2020	395	10230					1094	1096		10.1016/S0140-6736(20)30561-4	http://dx.doi.org/10.1016/S0140-6736(20)30561-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KZ9LJ	32192582	Green Published, Bronze			2022-12-28	WOS:000523580400008
J	Powell, K; Mondino, A; Nemhauser, J; Salas, RC; Gunawardane, R; Di Nicolantonio, F				Powell, Kendall; Mondino, Anna; Nemhauser, Jennifer; Salas, Rafael Carazo; Gunawardane, Ru; Di Nicolantonio, Federica			SCIENCE-ING FROM HOME IN THE CORONAVIRUS ERA	NATURE			English	Editorial Material						Careers; Research management; Lab life		In the first of two articles about laboratory closures triggered by COVID-19, scientists affected by the shutdowns outline the tools they are using to run their research groups remotely. In the first of two articles about laboratory closures triggered by COVID-19, scientists affected by the shutdowns outline the tools they are using to run their research groups remotely.	[Mondino, Anna] Ist Sci San Raffaele, Milan, Italy; [Nemhauser, Jennifer] Univ Washington, Seattle, WA 98195 USA; [Salas, Rafael Carazo] Univ Bristol, Bristol, Avon, England; [Gunawardane, Ru] Allen Inst Cell Sci, Stem Cells & Gene Editing Grp, Seattle, WA USA; [Di Nicolantonio, Federica] Univ Turin, Epigenet Colorectal Canc & Mesothelioma, Turin, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Washington; University of Washington Seattle; University of Bristol; University of Turin	Mondino, A (corresponding author), Ist Sci San Raffaele, Milan, Italy.		Di Nicolantonio, Federica/A-2503-2011	Di Nicolantonio, Federica/0000-0001-9618-2010					0	6	6	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR	2020	580	7803					419	421		10.1038/d41586-020-00935-3	http://dx.doi.org/10.1038/d41586-020-00935-3			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LB8JX	32218550				2022-12-28	WOS:000524877800002
J	Galaasen, EV; Ninnemann, US; Kessler, A; Irvali, N; Rosenthal, Y; Tjiputra, J; Bouttes, N; Roche, DM; Kleiven, HF; Hodell, DA				Galaasen, Eirik Vinje; Ninnemann, Ulysses S.; Kessler, Augustin; Irvali, Nil; Rosenthal, Yair; Tjiputra, Jerry; Bouttes, Nathaelle; Roche, Didier M.; Kleiven, Helga (Kikki) F.; Hodell, David A.			Interglacial instability of North Atlantic Deep Water ventilation	SCIENCE			English	Article							GREENLAND ICE-SHEET; SOUTHERN GREENLAND; ISOTOPE STRATIGRAPHY; CLIMATE VARIABILITY; OCEAN CIRCULATION; LABRADOR SEA; SURFACE; CARBONATE; PLEISTOCENE; STABILITY	Disrupting North Atlantic Deep Water (NADW) ventilation is a key concern in climate projections. We use (sub)centennially resolved bottom water delta C-13 records that span the interglacials of the last 0.5 million years to assess the frequency of and the climatic backgrounds capable of triggering large NADW reductions. Episodes of reduced NADW in the deep Atlantic, similar in magnitude to glacial events, have been relatively common and occasionally long-lasting features of interglacials. NADW reductions were triggered across the range of recent interglacial climate backgrounds, which demonstrates that catastrophic freshwater outburst floods were not a prerequisite for large perturbations. Our results argue that large NADW disruptions are more easily achieved than previously appreciated and that they occurred in past climate conditions similar to those we may soon face.	[Galaasen, Eirik Vinje; Ninnemann, Ulysses S.; Irvali, Nil; Kleiven, Helga (Kikki) F.] Univ Bergen, Dept Earth Sci, Bergen, Norway; [Galaasen, Eirik Vinje; Ninnemann, Ulysses S.; Irvali, Nil; Kleiven, Helga (Kikki) F.] Univ Bergen, Bjerknes Ctr Climate Res, Bergen, Norway; [Kessler, Augustin; Tjiputra, Jerry] Bjerknes Ctr Climate Res, NORCE Norwegian Res Ctr, Bergen, Norway; [Rosenthal, Yair] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ USA; [Rosenthal, Yair] Rutgers State Univ, Dept Earth & Planetary Sci, New Brunswick, NJ USA; [Bouttes, Nathaelle; Roche, Didier M.] Univ Paris Saclay, LSCE, IPSL, CEA,CNRS,UVSQ, Gif Sur Yvette, France; [Roche, Didier M.] Vrije Univ Amsterdam, Dept Earth Sci, Earth & Climate Cluster, Amsterdam, Netherlands; [Hodell, David A.] Univ Cambridge, Dept Earth Sci, Godwin Lab Paleoclimate Res, Cambridge, England	University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; Bjerknes Centre for Climate Research; Norwegian Research Centre (NORCE); Rutgers State University New Brunswick; Rutgers State University New Brunswick; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Vrije Universiteit Amsterdam; University of Cambridge	Galaasen, EV (corresponding author), Univ Bergen, Dept Earth Sci, Bergen, Norway.; Galaasen, EV (corresponding author), Univ Bergen, Bjerknes Ctr Climate Res, Bergen, Norway.	eirik.galaasen@uib.no	Roche, Didier M./C-9875-2010; Tjiputra, Jerry/AAB-5896-2022; Irvalı, Nil/ABC-2468-2021	Roche, Didier M./0000-0001-6272-9428; Irvalı, Nil/0000-0001-5723-5781; Kleiven, Kikki/0000-0002-4956-6182; Galaasen, Eirik Vinje/0000-0002-6851-9066; Tjiputra, Jerry/0000-0002-4600-2453; Kessler, Augustin/0000-0002-1496-843X	Research Council of Norway (RCN) [254964, 245907]	Research Council of Norway (RCN)(Research Council of Norway)	This work was funded by grants from the Research Council of Norway (RCN) through the project THRESHOLDS (RCN grant 254964) and data generation at FARLAB (RCN grant 245907).	Adkins JF, 1997, NATURE, V390, P154, DOI 10.1038/36540; Barker S, 2015, NATURE, V520, P333, DOI 10.1038/nature14330; Berger A, 2016, REV GEOPHYS, V54, P162, DOI 10.1002/2015RG000482; Bouttes N, 2015, GEOSCI MODEL DEV, V8, P1563, DOI 10.5194/gmd-8-1563-2015; Buckley MW, 2016, REV GEOPHYS, V54, P5, DOI 10.1002/2015RG000493; Carlson A, 2008, GEOLOGY, V36, P359, DOI 10.1130/G24519A.1; Channell J. E. T., 2006, P INTEGRATED OCEAN D, V303/306; Colville EJ, 2011, SCIENCE, V333, P620, DOI 10.1126/science.1204673; Corliss BH, 2006, DEEP-SEA RES PT I, V53, P740, DOI 10.1016/j.dsr.2006.01.006; de Vernal A, 2008, SCIENCE, V320, P1622, DOI 10.1126/science.1153929; Eide M, 2017, GLOBAL BIOGEOCHEM CY, V31, P515, DOI [10.1002/2016GB005473, 10.1002/2016GB005472]; Ellison CRW, 2006, SCIENCE, V312, P1929, DOI 10.1126/science.1127213; Evans HF, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001720; Ferrari R, 2014, P NATL ACAD SCI USA, V111, P8753, DOI 10.1073/pnas.1323922111; Fronval T, 1998, QUATERNARY SCI REV, V17, P963, DOI 10.1016/S0277-3791(98)00038-9; Galaasen EV, 2014, SCIENCE, V343, P1129, DOI 10.1126/science.1248667; Goosse H, 2010, GEOSCI MODEL DEV, V3, P603, DOI 10.5194/gmd-3-603-2010; Hatfield RG, 2016, EARTH PLANET SC LETT, V454, P225, DOI 10.1016/j.epsl.2016.09.014; Henry LG, 2016, SCIENCE, V353, P470, DOI 10.1126/science.aaf5529; Hillaire-Marcel C, 2011, MAR GEOL, V279, P188, DOI 10.1016/j.margeo.2010.11.001; HILLAIREMARCEL C, 1994, CAN J EARTH SCI, V31, P63, DOI 10.1139/e94-007; Hodell DA, 2009, EARTH PLANET SC LETT, V288, P10, DOI 10.1016/j.epsl.2009.08.040; Hodell DA, 2008, MAR GEOL, V256, P30, DOI 10.1016/j.margeo.2008.09.010; Hofmann M, 2009, P NATL ACAD SCI USA, V106, P20584, DOI 10.1073/pnas.0909146106; IPCC, 2013, CLIMATE CHANGE 2022; Irvali N, 2020, P NATL ACAD SCI USA, V117, P190, DOI 10.1073/pnas.1911902116; Irvali N, 2012, PALEOCEANOGRAPHY, V27, DOI 10.1029/2011PA002244; Kleiven HF, 2008, SCIENCE, V319, P60, DOI 10.1126/science.1148924; Kohfeld KE, 1996, PALEOCEANOGRAPHY, V11, P679, DOI 10.1029/96PA02617; Laj C., 2004, OCE200402; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lisiecki LE, 2010, CLIM PAST, V6, P305, DOI 10.5194/cp-6-305-2010; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Lisiecki LE, 2008, NATURE, V456, P85, DOI 10.1038/nature07425; Lozier MS, 2019, SCIENCE, V363, P516, DOI 10.1126/science.aau6592; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; McManus JF, 1999, SCIENCE, V283, P971, DOI 10.1126/science.283.5404.971; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MILLERO FJ, 1995, GEOCHIM COSMOCHIM AC, V59, P661, DOI 10.1016/0016-7037(94)00354-O; Nicholl JAL, 2012, NAT GEOSCI, V5, P901, DOI [10.1038/ngeo1622, 10.1038/NGEO1622]; Oppo DW, 1998, SCIENCE, V279, P1335, DOI 10.1126/science.279.5355.1335; Raymo ME, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000921; Reyes AV, 2014, NATURE, V510, P525, DOI 10.1038/nature13456; Rosenthal Y, 1999, ANAL CHEM, V71, P3248, DOI 10.1021/ac981410x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Schmittner A, 2017, PALEOCEANOGRAPHY, V32, P512, DOI 10.1002/2016PA003072; Skinner LC, 2006, QUATERNARY SCI REV, V25, P3312, DOI 10.1016/j.quascirev.2006.07.005; Srokosz MA, 2015, SCIENCE, V348, DOI 10.1126/science.1255575; STOCKER TF, 1991, NATURE, V351, P729, DOI 10.1038/351729a0; Stocker TF, 1997, NATURE, V388, P862, DOI 10.1038/42224; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Stoner JS, 1996, PALEOCEANOGRAPHY, V11, P309, DOI 10.1029/96PA00583; Vettoretti G, 2018, J CLIMATE, V31, P3423, DOI 10.1175/JCLI-D-17-0559.1; Xuan C, 2016, QUATERNARY SCI REV, V142, P74, DOI 10.1016/j.quascirev.2016.04.010; Yu JM, 2008, EARTH PLANET SC LETT, V271, P209, DOI 10.1016/j.epsl.2008.04.010; Yu JM, 2007, EARTH PLANET SC LETT, V258, P73, DOI 10.1016/j.epsl.2007.03.025	57	18	18	2	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1485	+		10.1126/science.aay6381	http://dx.doi.org/10.1126/science.aay6381			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217728	Green Submitted, Green Published			2022-12-28	WOS:000523251600039
J	Kamerow, D; Graham, R				Kamerow, Douglas; Graham, Robert			YANKEE DOODLING Covid-19: Don't forget the impact on US family physicians	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kamerow, Douglas] Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA; [Graham, Robert] Georgetown Univ, Family Med, Washington, DC 20057 USA	Georgetown University; Georgetown University	Kamerow, D (corresponding author), Georgetown Univ, Robert Graham Ctr Policy Studies Primary Care, Washington, DC 20057 USA.	dkamerow@aafp.org						Adamy J., 2020, WALL STREET J; American Board of Medical Specialties, 2019, ABMS BOARD CERT REP; Dalton C., 2020, GUARDIAN	3	30	30	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1260	10.1136/bmj.m1260	http://dx.doi.org/10.1136/bmj.m1260			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217547	Bronze			2022-12-28	WOS:000523764800024
J	Gerada, C				Gerada, Clare			Clare Gerada: Doctors on the covid-19 front line also need to protect themselves and their colleagues	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Gerada, Clare] Hurley Grp, London, England		Gerada, C (corresponding author), Hurley Grp, London, England.	clare.gerada@nhs.net							0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1121	10.1136/bmj.m1121	http://dx.doi.org/10.1136/bmj.m1121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209539	Bronze			2022-12-28	WOS:000523764200001
J	Rubin, R				Rubin, Rita			New Resource for Managing Patients Receiving Long-term Opioid Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1123	1123		10.1001/jama.2020.3017	http://dx.doi.org/10.1001/jama.2020.3017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD1JR	32207783				2022-12-28	WOS:000543732100003
J	Song, A				Song, Anne			The Other Side	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medical essay, a medicine resident describes her father's vegetative state following a cardiac arrest and finds herself identifying with families who don't want limitations on medical care for their loved ones in conflict with her identity as an internist.	[Song, Anne] Hosp Univ Penn, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA	University of Pennsylvania	Song, A (corresponding author), Hosp Univ Penn, Dept Med, Internal Med Residency Program, 3400 Spruce St,100 Centrex, Philadelphia, PA 19104 USA.	anne.song@pennmedicine.upenn.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1135	1136		10.1001/jama.2020.2054	http://dx.doi.org/10.1001/jama.2020.2054			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207802				2022-12-28	WOS:000530807000014
J	Lambert, MR; Womack, MC; Byrne, AQ; Hernandez-Gomez, O; Noss, CF; Rothstein, AP; Blackburn, DC; Collins, JP; Crump, ML; Koo, MS; Nanjappa, P; Rollins-Smith, L; Vredenburg, VT; Rosenblum, EB				Lambert, Max R.; Womack, Molly C.; Byrne, Allison Q.; Hernandez-Gomez, Obed; Noss, Clay F.; Rothstein, Andrew P.; Blackburn, David C.; Collins, James P.; Crump, Martha L.; Koo, Michelle S.; Nanjappa, Priya; Rollins-Smith, Louise; Vredenburg, Vance T.; Rosenblum, Erica B.			Comment on "Amphibian fungal panzootic causes catastrophic and ongoing loss of biodiversity"	SCIENCE			English	Editorial Material								Scheele et al. (Reports, 29 March 2019, p. 1459) bring needed attention to the effects of amphibian infectious disease. However, the data and methods implicating the disease chytridiomycosis in 501 amphibian species declines are deficient. Which species are affected, and how many, remains a critical unanswered question. Amphibians are imperiled; protective actions require public support and robust science.	[Lambert, Max R.; Womack, Molly C.; Byrne, Allison Q.; Hernandez-Gomez, Obed; Noss, Clay F.; Rothstein, Andrew P.; Rosenblum, Erica B.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Womack, Molly C.] Smithsonian Inst, Natl Museum Nat Hist, Washington, DC 20560 USA; [Byrne, Allison Q.; Noss, Clay F.; Rothstein, Andrew P.; Koo, Michelle S.; Vredenburg, Vance T.; Rosenblum, Erica B.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Blackburn, David C.] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Collins, James P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Crump, Martha L.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Crump, Martha L.] Utah State Univ, Ecol Ctr, Logan, UT 84322 USA; [Crump, Martha L.] No Arizona Univ, Dept Biol Sci, Box 5640d, Flagstaff, AZ 86011 USA; [Nanjappa, Priya] Conservat Sci Partners, Ft Collins, CO 80524 USA; [Rollins-Smith, Louise] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37232 USA; [Rollins-Smith, Louise] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA; [Rollins-Smith, Louise] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA; [Rollins-Smith, Louise] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA	University of California System; University of California Berkeley; Smithsonian Institution; Smithsonian National Museum of Natural History; University of California System; University of California Berkeley; State University System of Florida; University of Florida; Arizona State University; Arizona State University-Tempe; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Northern Arizona University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; California State University System; San Francisco State University	Lambert, MR (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	lambert.mrm@gmail.com	Hernandez-Gomez, Obed/AAV-4203-2020; Blackburn, David/L-3812-2019; Hernández-Gómez, Obed/H-9480-2019; Lambert, Max/B-3840-2015	Blackburn, David/0000-0002-1810-9886; Hernández-Gómez, Obed/0000-0003-1226-1534; Collins, James/0000-0003-1022-9952; Koo, Michelle/0000-0003-0410-722X; Lambert, Max/0000-0003-2318-6445; Byrne, Allison/0000-0002-5366-0673				Collins J.P., 2009, EXTINCTION OUR TIMES; Drescher M, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00415.1; Fournier AMV, 2019, CONSERV BIOL, V33, P1370, DOI 10.1111/cobi.13371; Gauchat G, 2012, AM SOCIOL REV, V77, P167, DOI 10.1177/0003122412438225; Gratwicke B, 2016, ANIM CONSERV, V19, P324, DOI 10.1111/acv.12249; Martin TG, 2012, CONSERV BIOL, V26, P29, DOI 10.1111/j.1523-1739.2011.01806.x; Pew Research Center, 2015, PUBLIC SCI VIEWS SCI; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Weiss R, 2017, SCIENCE, V358, P427, DOI 10.1126/science.aar2683	10	24	25	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI				aay1838	10.1126/science.aay1838	http://dx.doi.org/10.1126/science.aay1838			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193293				2022-12-28	WOS:000522167400001
J	Busse, PJ; Christiansen, SC				Busse, Paula J.; Christiansen, Sandra C.			Hereditary Angioedema	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MOLECULAR-WEIGHT KININOGEN; C1 INHIBITOR; ANGIONEUROTIC EDEMA; NORMAL C1-INH; ATTACKS; GENE; SAFETY; MUTATIONS; EFFICACY; PLASMA		[Busse, Paula J.] Icahn Sch Med Mt Sinai, Div Clin Immunol & Allergy, New York, NY 10029 USA; [Christiansen, Sandra C.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California San Diego	Busse, PJ (corresponding author), Icahn Sch Med Mt Sinai, Div Clin Immunol & Allergy, New York, NY 10029 USA.	paula.busse@mssm.edu						Aygoren-Pursun E, 2019, PEDIAT ALLERG IMM-UK, V30, P553, DOI 10.1111/pai.13060; Bafunno V, 2018, J ALLERGY CLIN IMMUN, V141, P1009, DOI 10.1016/j.jaci.2017.05.020; Bafunno V, 2013, J ALLERGY CLIN IMMUN, V132, P748, DOI 10.1016/j.jaci.2013.04.006; Banerji A, 2018, JAMA-J AM MED ASSOC, V320, P2108, DOI 10.1001/jama.2018.16773; Bernstein JA, 2014, J ALLER CL IMM-PRACT, V2, P77, DOI 10.1016/j.jaip.2013.09.008; Binkley KE, 2000, J ALLERGY CLIN IMMUN, V106, P546; Bjorkqvist J, 2015, J CLIN INVEST, V125, P3132, DOI 10.1172/JCI77139; Blanch A, 2006, J ALLERGY CLIN IMMUN, V118, P1330, DOI 10.1016/j.jaci.2006.07.035; Bork K, 2000, LANCET, V356, P213, DOI 10.1016/S0140-6736(00)02483-1; Bork K, 2018, ALLERGY, V73, P442, DOI 10.1111/all.13270; Bork K, 2017, ALLERGY, V72, P320, DOI 10.1111/all.13076; Bork K, 2015, ALLERGY, V70, P1004, DOI 10.1111/all.12648; Bork K, 2019, ALLERGY, V74, P2479, DOI 10.1111/all.13869; Bork K, 2012, J ALLERGY CLIN IMMUN, V130, P692, DOI 10.1016/j.jaci.2012.05.055; Bork K, 2011, ORAL SURG ORAL MED O, V112, P58, DOI 10.1016/j.tripleo.2011.02.034; Bork K, 2009, J ALLERGY CLIN IMMUN, V124, P129, DOI 10.1016/j.jaci.2009.03.038; Bossi F, 2009, J ALLERGY CLIN IMMUN, V124, P1303, DOI 10.1016/j.jaci.2009.08.007; Busse P, 2015, J ALLER CL IMM-PRACT, V3, P213, DOI 10.1016/j.jaip.2014.08.014; Caccia S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-16667-w; Christiansen SC, 2016, CLIN PEDIATR, V55, P935, DOI 10.1177/0009922815616886; Christiansen SC, 2015, ALLERGY ASTHMA PROC, V36, P145, DOI 10.2500/aap.2015.36.3831; Cicardi M, 1996, NEW ENGL J MED, V334, P1666, DOI 10.1056/NEJM199606203342510; Cicardi M, 2010, NEW ENGL J MED, V363, P532, DOI 10.1056/NEJMoa0906393; Cicardi M, 2010, NEW ENGL J MED, V363, P523, DOI 10.1056/NEJMoa0905079; Craig TJ, 2009, J ALLERGY CLIN IMMUN, V124, P801, DOI 10.1016/j.jaci.2009.07.017; Csuka D, 2014, J ALLERGY CLIN IMMUN, V134, P1388, DOI 10.1016/j.jaci.2014.05.030; CURD JG, 1980, J EXP MED, V152, P742, DOI 10.1084/jem.152.3.742; DAVIS AE, 1992, NAT GENET, V1, P354, DOI 10.1038/ng0892-354; de Maat S, 2016, J ALLERGY CLIN IMMUN, V138, P1414, DOI 10.1016/j.jaci.2016.02.021; DONALDSON VH, 1963, AM J MED, V35, P37, DOI 10.1016/0002-9343(63)90162-1; Drouet C, 2008, J ALLERGY CLIN IMMUN, V121, P429, DOI 10.1016/j.jaci.2007.10.048; Ebo DG, 2018, J ALLERGY CLIN IMMUN, V6, P277; Farkas H, 2017, ALLERGY, V72, P300, DOI 10.1111/all.13001; FIELDS T, 1983, J ALLERGY CLIN IMMUN, V72, P54, DOI 10.1016/0091-6749(83)90052-0; Garcia JFB, 2018, J ALLER CL IMM-PRACT, V6, P1406, DOI 10.1016/j.jaip.2017.12.022; Gosswein T, 2008, CYTOGENET GENOME RES, V121, P181, DOI 10.1159/000138883; Hansen CB, 2015, J IMMUNOL, V195, P3596, DOI 10.4049/jimmunol.1402838; Haslund D, 2019, J CLIN INVEST, V129, P388, DOI 10.1172/JCI98869; Joseph K, 2010, ANN ALLERG ASTHMA IM, V104, P50, DOI 10.1016/j.anai.2009.11.014; Kajdacsi E, 2016, J CLIN IMMUNOL, V36, P160, DOI 10.1007/s10875-016-0239-8; Kalmar L, 2005, HUM MUTAT, V25, P1, DOI 10.1002/humu.20112; Kaplan AP, 2017, IMMUNOL ALLERGY CLIN, V37, P513, DOI 10.1016/j.iac.2017.04.001; Kusuma A, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.12.016; Lara-Marquez ML, 2018, CLIN EXP ALLERGY, V48, P1429, DOI 10.1111/cea.13219; Li HH, 2015, J ALLER CL IMM-PRACT, V3, P200, DOI 10.1016/j.jaip.2014.08.002; Longhurst H, 2017, NEW ENGL J MED, V376, P1131, DOI 10.1056/NEJMoa1613627; Lopez-Lera A, 2010, J ALLERGY CLIN IMMUN, V126, P1307, DOI 10.1016/j.jaci.2010.07.037; Lumry WR, 2013, ALLERGY ASTHMA PROC, V34, P155, DOI 10.2500/aap.2013.34.3653; Lumry WR, 2018, J ALLERGY CLIN IMMUN, V6, P1733; Malbran A, 2014, CLIN EXP IMMUNOL, V177, P544, DOI 10.1111/cei.12358; MANDLE RJ, 1976, P NATL ACAD SCI USA, V73, P4179, DOI 10.1073/pnas.73.11.4179; Pappalardo E, 2008, MOL IMMUNOL, V45, P3536, DOI 10.1016/j.molimm.2008.05.007; Pedrosa M, 2016, J CLIN IMMUNOL, V36, P16, DOI 10.1007/s10875-015-0222-9; Rasmussen ER, 2016, ACTA DERM-VENEREOL, V96, P373, DOI 10.2340/00015555-2233; Reshef A, 2015, ALLERGY, V70, P506, DOI 10.1111/all.12587; Reshef A, 2016, CLIN REV ALLERG IMMU, V51, P121, DOI 10.1007/s12016-016-8553-8; Riedl MA, 2017, LANCET, V390, P1595, DOI 10.1016/S0140-6736(17)31963-3; Riedl MA, 2016, J ALLER CL IMM-PRACT, V4, P963, DOI 10.1016/j.jaip.2016.04.018; Riedl MA, 2013, ANN ALLERG ASTHMA IM, V110, P295, DOI 10.1016/j.anai.2013.02.007; Roche O, 2005, HUM MUTAT, V26, P135, DOI 10.1002/humu.20197; ROSEN FS, 1965, SCIENCE, V148, P957, DOI 10.1126/science.148.3672.957; Suffritti C, 2014, CLIN EXP ALLERGY, V44, P1503, DOI 10.1111/cea.12293; Tourangeau LM, 2012, INT ARCH ALLERGY IMM, V157, P417, DOI 10.1159/000329635; Wu MA, 2016, CLIN REV ALLERG IMMU, V51, P162, DOI 10.1007/s12016-016-8541-z; ZAHEDI R, 1995, J CLIN INVEST, V95, P1299, DOI 10.1172/JCI117780; Zahedi R, 1996, J BIOL CHEM, V271, P24307, DOI 10.1074/jbc.271.39.24307; Zanichelli A, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-29; Zotter Z, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-44; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977; Zuraw BL, 2016, CLIN REV ALLERG IMMU, V51, P216, DOI 10.1007/s12016-016-8561-8; Zuraw BL, 2013, J ALLER CL IMM-PRACT, V1, P458, DOI 10.1016/j.jaip.2013.07.002; Zuraw BL, 2012, ALLERGY ASTHMA PROC, V33, pS145, DOI 10.2500/aap.2012.33.3627; Zuraw BL, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2012.02.020; Zuraw BL, 2010, NEW ENGL J MED, V363, P513, DOI 10.1056/NEJMoa0805538	74	119	120	3	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1136	1148		10.1056/NEJMra1808012	http://dx.doi.org/10.1056/NEJMra1808012			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW7AJ	32187470				2022-12-28	WOS:000521333700013
J	Zhao, S; Jang, C; Liu, J; Uehara, K; Gilbert, M; Izzo, L; Zeng, XF; Trefely, S; Fernandez, S; Carrer, A; Miller, KD; Schug, ZT; Snyder, NW; Gade, TP; Titchenell, PM; Rabinowitz, JD; Wellen, KE				Zhao, Steven; Jang, Cholsoon; Liu, Joyce; Uehara, Kahealani; Gilbert, Michael; Izzo, Luke; Zeng, Xianfeng; Trefely, Sophie; Fernandez, Sully; Carrer, Alessandro; Miller, Katelyn D.; Schug, Zachary T.; Snyder, Nathaniel W.; Gade, Terence P.; Titchenell, Paul M.; Rabinowitz, Joshua D.; Wellen, Kathryn E.			Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate	NATURE			English	Article							ATP-CITRATE-LYASE; ACETYL-COA SYNTHETASE; DE-NOVO LIPOGENESIS; FATTY LIVER; HISTONE ACETYLATION; BINDING-SITES; GLUCOSE; CHREBP; GENE; DEFICIENCY	A genetic mouse model is used to reveal a two-pronged mechanism of fructose-induced de novo lipogenesis in the liver, in which fructose catabolism in hepatocytes provides a signal to promote lipogenesis, whereas fructose metabolism by the gut microbiota provides acetate as a substrate to feed lipogenesis. Consumption of fructose has risen markedly in recent decades owing to the use of sucrose and high-fructose corn syrup in beverages and processed foods(1), and this has contributed to increasing rates of obesity and non-alcoholic fatty liver disease(2-4). Fructose intake triggers de novo lipogenesis in the liver(4-6), in which carbon precursors of acetyl-CoA are converted into fatty acids. The ATP citrate lyase (ACLY) enzyme cleaves cytosolic citrate to generate acetyl-CoA, and is upregulated after consumption of carbohydrates(7). Clinical trials are currently pursuing the inhibition of ACLY as a treatment for metabolic diseases(8). However, the route from dietary fructose to hepatic acetyl-CoA and lipids remains unknown. Here, using in vivo isotope tracing, we show that liver-specific deletion of Acly in mice is unable to suppress fructose-induced lipogenesis. Dietary fructose is converted to acetate by the gut microbiota(9), and this supplies lipogenic acetyl-CoA independently of ACLY(10). Depletion of the microbiota or silencing of hepatic ACSS2, which generates acetyl-CoA from acetate, potently suppresses the conversion of bolus fructose into hepatic acetyl-CoA and fatty acids. When fructose is consumed more gradually to facilitate its absorption in the small intestine, both citrate cleavage in hepatocytes and microorganism-derived acetate contribute to lipogenesis. By contrast, the lipogenic transcriptional program is activated in response to fructose in a manner that is independent of acetyl-CoA metabolism. These data reveal a two-pronged mechanism that regulates hepatic lipogenesis, in which fructolysis within hepatocytes provides a signal to promote the expression of lipogenic genes, and the generation of microbial acetate feeds lipogenic pools of acetyl-CoA.	[Zhao, Steven; Liu, Joyce; Gilbert, Michael; Izzo, Luke; Trefely, Sophie; Fernandez, Sully; Carrer, Alessandro; Gade, Terence P.; Wellen, Kathryn E.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Zhao, Steven; Liu, Joyce; Gilbert, Michael; Izzo, Luke; Trefely, Sophie; Fernandez, Sully; Carrer, Alessandro; Wellen, Kathryn E.] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Zhao, Steven; Izzo, Luke] Univ Penn, Cell & Mol Biol Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jang, Cholsoon; Zeng, Xianfeng; Rabinowitz, Joshua D.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Jang, Cholsoon; Zeng, Xianfeng; Rabinowitz, Joshua D.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Liu, Joyce; Uehara, Kahealani; Gilbert, Michael] Univ Penn, Biochem & Mol Biophys Grad Grp, Perelman Sch Med, Philadelphia, PA 19104 USA; [Uehara, Kahealani; Titchenell, Paul M.] Univ Penn, Dept Physiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Uehara, Kahealani; Titchenell, Paul M.; Wellen, Kathryn E.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Trefely, Sophie; Snyder, Nathaniel W.] Temple Univ, Ctr Metab Dis Res, Dept Microbiol & Immunol, Lewis Katz Sch Med, Philadelphia, PA 19122 USA; [Miller, Katelyn D.; Schug, Zachary T.] Wistar Inst Anat & Biol, Mol & Cellular Oncogenesis, 3601 Spruce St, Philadelphia, PA 19104 USA; [Gade, Terence P.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Carrer, Alessandro] VIMM, Padua, Italy	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Princeton University; Princeton University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; The Wistar Institute; University of Pennsylvania; Pennsylvania Medicine; Veneto Institute Molecular Medicine	Wellen, KE (corresponding author), Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA.; Wellen, KE (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.; Wellen, KE (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.	wellenk@upenn.edu	Zhao, Steven/AAM-6258-2020; Trefely, Sophie/AAL-9434-2020; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Uehara, Kahealani/0000-0003-1142-3466; Schug, Zachary/0000-0003-4197-8227; Izzo, Luke/0000-0002-6217-9240; , Steven/0000-0002-8102-8368; Titchenell, Paul/0000-0002-9941-5649; Gilbert, Michael/0000-0002-6574-9069; Carrer, Alessandro/0000-0002-9300-6879; Jang, Cholsoon/0000-0001-6651-4213	American Diabetes Association through post-doctoral fellowship [1-17-PDF-076]; NIAMS training grant [T32AR053461, T32GM07229]; American Diabetes Association [1-18-PDF-144]; Penn-PORT IRACDA grant [K12 GM081259]; NIH [R03HD092630, R01GM132261]; NIH Pioneer Award [1DP1DK113643]; Diabetes Research Center [P30 DK019525];  [R01CA174761];  [R01CA228339];  [R01DK116005];  [F99CA222741];  [K01DK111715]	American Diabetes Association through post-doctoral fellowship; NIAMS training grant; American Diabetes Association(American Diabetes Association); Penn-PORT IRACDA grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research Center; ; ; ; ; 	This work was supported by grants R01CA174761, R01CA228339 and R01DK116005 to K.E.W. S.Z. is supported by pre-doctoral fellowship F99CA222741. C.J. is supported by the American Diabetes Association through post-doctoral fellowship 1-17-PDF-076. K.U. is supported by NIAMS training grant T32AR053461. L.I. is supported by NIGMS training grant T32GM07229. S.T. is supported by the American Diabetes Association through post-doctoral fellowship 1-18-PDF-144. S.F. is supported through the Penn-PORT IRACDA grant K12 GM081259. P.M.T. is supported by K01DK111715. N.W.S. is supported by the NIH grant R03HD092630 and R01GM132261. J.D.R. is supported by the NIH Pioneer Award 1DP1DK113643 and Diabetes Research Center P30 DK019525. We thank S. Berger and P. Mews for providing the AAV.U6.shAcss2.CMV.eGFP.SV40 vector. We thank G. Wu and Y. Saimon for discussions on the microbiome.	Beigneux AP, 2004, J BIOL CHEM, V279, P9557, DOI 10.1074/jbc.M310512200; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Bray GA, 2004, AM J CLIN NUTR, V79, P537; Bulusu V, 2017, CELL REP, V18, P647, DOI 10.1016/j.celrep.2016.12.055; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; den Besten G, 2013, AM J PHYSIOL-GASTR L, V305, pG900, DOI 10.1152/ajpgi.00265.2013; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Frey AJ, 2016, ANAL BIOANAL CHEM, V408, P3651, DOI 10.1007/s00216-016-9448-5; FUKUDA H, 1992, EUR J BIOCHEM, V209, P217, DOI 10.1111/j.1432-1033.1992.tb17279.x; Guan DY, 2018, CELL, V174, P831, DOI 10.1016/j.cell.2018.06.031; Guo L, 2019, J BIOL CHEM, V294, P11805, DOI 10.1074/jbc.RA119.008708; Hannou SA, 2018, J CLIN INVEST, V128, P545, DOI 10.1172/JCI96702; Herman MA, 2016, TRENDS ENDOCRIN MET, V27, P719, DOI 10.1016/j.tem.2016.06.005; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Iizuka K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020181; Ikeda Y, 2001, J BIOL CHEM, V276, P34259, DOI 10.1074/jbc.M103848200; Iroz A, 2017, CELL REP, V21, P403, DOI 10.1016/j.celrep.2017.09.065; Ishimoto T, 2012, P NATL ACAD SCI USA, V109, P4320, DOI 10.1073/pnas.1119908109; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Jensen T, 2018, J HEPATOL, V68, P1063, DOI 10.1016/j.jhep.2018.01.019; Kaden-Volynets V, 2019, EUR J NUTR, V58, P1933, DOI 10.1007/s00394-018-1748-4; Lambert JE, 2014, GASTROENTEROLOGY, V146, P726, DOI 10.1053/j.gastro.2013.11.049; Lanaspa MA, 2018, J CLIN INVEST, V128, P2226, DOI 10.1172/JCI94427; Lee JV, 2018, GENE DEV, V32, P497, DOI 10.1101/gad.311027.117; Li MV, 2010, BIOCHEM BIOPH RES CO, V395, P395, DOI 10.1016/j.bbrc.2010.04.028; Liu XJ, 2018, CELL, V175, P502, DOI 10.1016/j.cell.2018.08.040; Lu M, 2019, CELL METAB, V29, P886, DOI 10.1016/j.cmet.2018.12.019; Lu WY, 2010, ANAL CHEM, V82, P3212, DOI 10.1021/ac902837x; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Mews P, 2017, NATURE, V546, P381, DOI 10.1038/nature22405; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Neinast MD, 2019, CELL METAB, V29, P417, DOI 10.1016/j.cmet.2018.10.013; Parks EJ, 2008, J NUTR, V138, P1039, DOI 10.1093/jn/138.6.1039; Pinkosky SL, 2017, TRENDS MOL MED, V23, P1047, DOI 10.1016/j.molmed.2017.09.001; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; Softic S, 2017, J CLIN INVEST, V127, P4059, DOI 10.1172/JCI94585; Softic S, 2016, DIGEST DIS SCI, V61, P1282, DOI 10.1007/s10620-016-4054-0; Su XY, 2017, ANAL CHEM, V89, P5941, DOI 10.1021/acs.analchem.7b00396; ter Horst KW, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090981; Titchenell PM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8078; Trefely S, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1360-7; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Wang QO, 2010, J LIPID RES, V51, P2516, DOI 10.1194/jlr.M003335; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Zagelbaum NK, 2019, CARDIOL REV, V27, P49, DOI 10.1097/CRD.0000000000000218; Zhao S, 2016, CELL REP, V17, P1037, DOI 10.1016/j.celrep.2016.09.069	48	166	168	19	216	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					586	+		10.1038/s41586-020-2101-7	http://dx.doi.org/10.1038/s41586-020-2101-7		MAR 2020	20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214246	Green Accepted, Green Submitted			2022-12-28	WOS:000520406700003
J	Goss, AL				Goss, Adeline L.			How Becoming a Doctor Made Me a Worse Listener	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								In this narrative medicine essay, a former National Public Radio reporter turned neurologist regrets time and attention she once had to show interest in and learn about people and tells how she's adapted to retain a small measure of that reporter's curiosity in her interactions with patients.	[Goss, Adeline L.] Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Goss, AL (corresponding author), Univ Calif San Francisco, Dept Neurol, 505 Parnassus Ave,Box 0114, San Francisco, CA 94143 USA.	adeline.goss@ucsf.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1041	1042		10.1001/jama.2020.2051	http://dx.doi.org/10.1001/jama.2020.2051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181851				2022-12-28	WOS:000521968800012
J	Karan, A				Karan, Abraar			To control the covid-19 outbreak, young, healthy patients should avoid the emergency department	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Karan, Abraar] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Karan, Abraar] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Karan, A (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.; Karan, A (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	abk655@mail.harvard.edu	Karan, Abraar/AAD-7967-2022						0	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1040	10.1136/bmj.m1040	http://dx.doi.org/10.1136/bmj.m1040			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184232	Bronze			2022-12-28	WOS:000523762400004
J	Mathur, MB; VanderWeele, TJ				Mathur, Maya B.; VanderWeele, Tyler J.			Evidence Relating Health Care Provider Burnout and Quality of Care	ANNALS OF INTERNAL MEDICINE			English	Letter							EXPLORATORY TEST; EXCESS; BIAS		[Mathur, Maya B.] Stanford Univ, Palo Alto, CA 94304 USA; [VanderWeele, Tyler J.] Harvard Univ, Boston, MA 02115 USA	Stanford University; Harvard University	Mathur, MB (corresponding author), Stanford Univ, Palo Alto, CA 94304 USA.			Ioannidis, John P./0000-0003-3118-6859; Tawfik, Daniel/0000-0003-2901-2737	NCI NIH HHS [R01 CA222147] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2011, ARCH GEN PSYCHIAT, V68, P773, DOI 10.1001/archgenpsychiatry.2011.28; Jin ZC, 2015, STAT MED, V34, P343, DOI 10.1002/sim.6342; Johnson V, 2007, CLIN TRIALS, V4, P254, DOI 10.1177/1740774507079437; Tawfik DS, 2019, ANN INTERN MED, V171, P555, DOI 10.7326/M19-1152	5	3	3	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					437	438		10.7326/L19-0826	http://dx.doi.org/10.7326/L19-0826			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176906	Green Accepted			2022-12-28	WOS:000520170800034
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: What might we learn from the covid-19 pandemic?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1087	10.1136/bmj.m1087	http://dx.doi.org/10.1136/bmj.m1087			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184276	Bronze			2022-12-28	WOS:000523762400008
J	Kanarek, N; Petrova, B; Sabatini, DM				Kanarek, Naama; Petrova, Boryana; Sabatini, David M.			Dietary modifications for enhanced cancer therapy	NATURE			English	Review							ONE-CARBON METABOLISM; FATTY-ACID OXIDATION; GLUTAMINE-METABOLISM; METHIONINE RESTRICTION; SERINE BIOSYNTHESIS; CALORIE RESTRICTION; CELL-PROLIFERATION; TRANSFORMED-CELLS; KETOGENIC DIET; HIGH-FRUCTOSE	Tumours depend on nutrients supplied by the host for their growth and survival. Modifications to the host's diet can change nutrient availability in the tumour microenvironment, which might represent a promising strategy for inhibiting tumour growth. Dietary modifications can limit tumour-specific nutritional requirements, alter certain nutrients that target the metabolic vulnerabilities of the tumour, or enhance the cytotoxicity of anti-cancer drugs. Recent reports have suggested that modification of several nutrients in the diet can alter the efficacy of cancer therapies, and some of the newest developments in this quickly expanding field are reviewed here. The results discussed indicate that the dietary habits and nutritional state of a patient must be taken into account during cancer research and therapy.	[Kanarek, Naama; Petrova, Boryana] Boston Childrens Hosp, Dept Pathol, Boston, MA USA; [Kanarek, Naama] Harvard Med Sch, Boston, MA 02115 USA; [Kanarek, Naama; Sabatini, David M.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA USA; [Sabatini, David M.] Koch Inst Integrat Canc Res, Cambridge, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kanarek, N (corresponding author), Boston Childrens Hosp, Dept Pathol, Boston, MA USA.; Kanarek, N (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kanarek, N (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	naama.kanarek@childrens.harvard.edu	Kanarek, Naama/GQB-4951-2022	Kanarek, Naama/0000-0002-2068-3908; /0000-0002-1446-7256; Petrova, Boryana/0000-0001-9996-9353				Ables GP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051357; ADIBI SA, 1973, AM J PHYSIOL, V225, P408, DOI 10.1152/ajplegacy.1973.225.2.408; Allen BG, 2014, REDOX BIOL, V2, P963, DOI 10.1016/j.redox.2014.08.002; Belhocine T, 2006, INT J ONCOL, V28, P1249; Berrigan D, 2002, CARCINOGENESIS, V23, P817, DOI 10.1093/carcin/23.5.817; Beyaz S, 2016, NATURE, V531, P53, DOI 10.1038/nature17173; Biancur DE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15965; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brandhorst S, 2016, RECENT RESULTS CANC, V207, P241, DOI 10.1007/978-3-319-42118-6_12; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Camarda R, 2016, NAT MED, V22, P427, DOI 10.1038/nm.4055; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Caro P, 2012, CANCER CELL, V22, P547, DOI 10.1016/j.ccr.2012.08.014; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Carracedo A, 2012, J CLIN INVEST, V122, P3088, DOI 10.1172/JCI62129; Chakrabarti G, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0137-1; Champ CE, 2014, J NEURO-ONCOL, V117, P125, DOI 10.1007/s11060-014-1362-0; Chan WK, 2014, BLOOD, V123, P3596, DOI 10.1182/blood-2013-10-535112; Cluntun AA, 2017, TRENDS CANCER, V3, P169, DOI 10.1016/j.trecan.2017.01.005; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Courtney KD, 2018, CELL METAB, V28, P793, DOI 10.1016/j.cmet.2018.07.020; Cramer SL, 2017, NAT MED, V23, P120, DOI 10.1038/nm.4232; Curry NL, 2013, CANCER DISCOV, V3, P908, DOI 10.1158/2159-8290.CD-12-0507; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeNicola GM, 2015, NAT GENET, V47, P1475, DOI 10.1038/ng.3421; Descamps O, 2005, MECH AGEING DEV, V126, P1185, DOI 10.1016/j.mad.2005.06.007; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Di Francesco A, 2018, SCIENCE, V362, P770, DOI 10.1126/science.aau2095; Dillon BJ, 2004, CANCER-AM CANCER SOC, V100, P826, DOI 10.1002/cncr.20057; Douard V, 2013, J PHYSIOL-LONDON, V591, P401, DOI 10.1113/jphysiol.2011.215731; Ensor CM, 2002, CANCER RES, V62, P5443; Erickson N, 2017, MED ONCOL, V34, DOI 10.1007/s12032-017-0930-5; Eriksson S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7479; FARBER S, 1947, SCIENCE, V106, P619, DOI 10.1126/science.106.2764.619; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; Faubert B, 2017, CELL, V171, P358, DOI 10.1016/j.cell.2017.09.019; Field MS, 2018, CURR DEV NUTR, V2, DOI 10.1093/cdn/nzy013; Fine EJ, 2012, NUTRITION, V28, P1028, DOI 10.1016/j.nut.2012.05.001; Fontana L, 2004, P NATL ACAD SCI USA, V101, P6659, DOI 10.1073/pnas.0308291101; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Gao X, 2019, NATURE, V572, P397, DOI 10.1038/s41586-019-1437-3; Gao X, 2018, CELL REP, V22, P3507, DOI 10.1016/j.celrep.2018.03.017; Garcia-Bermudez J, 2018, NAT CELL BIOL, V20, P775, DOI 10.1038/s41556-018-0118-z; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Goncalves MD, 2019, SCIENCE, V363, P1345, DOI 10.1126/science.aat8515; Gonzalez PS, 2018, NATURE, V563, P719, DOI 10.1038/s41586-018-0729-3; Gravel SP, 2014, CANCER RES, V74, P7521, DOI 10.1158/0008-5472.CAN-14-2643-T; Gu X, 2017, SCIENCE, V358, P813, DOI 10.1126/science.aao3265; GUO HY, 1993, CANCER RES, V53, P5676; Hannou SA, 2018, J CLIN INVEST, V128, P545, DOI 10.1172/JCI96702; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hens JR, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2367-1; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Hijiya N, 2016, LEUKEMIA LYMPHOMA, V57, P748, DOI 10.3109/10428194.2015.1101098; HOFFMAN RM, 1976, P NATL ACAD SCI USA, V73, P1523, DOI 10.1073/pnas.73.5.1523; Hopkins BD, 2018, NATURE, V560, P499, DOI 10.1038/s41586-018-0343-4; Hosios AM, 2016, DEV CELL, V36, P540, DOI 10.1016/j.devcel.2016.02.012; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; Hui S, 2017, NATURE, V551, P115, DOI 10.1038/nature24057; Izzo F, 2004, J CLIN ONCOL, V22, P1815, DOI 10.1200/JCO.2004.11.120; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Jansen N, 2016, ONCOL LETT, V11, P584, DOI 10.3892/ol.2015.3923; Jeon H, 2016, ONCOTARGET, V7, P67223, DOI 10.18632/oncotarget.11615; Jeon SM, 2012, NATURE, V485, P661, DOI 10.1038/nature11066; Jin CP, 2019, ONCOTARGETS THER, V12, P5425, DOI 10.2147/OTT.S205522; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Kamata S, 2014, MOL NUTR FOOD RES, V58, P1309, DOI 10.1002/mnfr.201300758; Kanarek N, 2018, NATURE, V559, P632, DOI 10.1038/s41586-018-0316-7; Knott SRV, 2018, NATURE, V554, P378, DOI 10.1038/nature25465; Komninou D, 2006, NUTR CANCER, V54, P202, DOI 10.1207/s15327914nc5402_6; Krall AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11457; Kremer JC, 2017, CELL REP, V18, P991, DOI 10.1016/j.celrep.2016.12.077; Labuschagne CF, 2014, CELL REP, V7, P1248, DOI 10.1016/j.celrep.2014.04.045; LACEY JM, 1990, NUTR REV, V48, P297, DOI 10.1111/j.1753-4887.1990.tb02967.x; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Lind DS, 2004, J NUTR, V134, p2837S, DOI 10.1093/jn/134.10.2837S; Liu H, 2015, TOXICOL LETT, V232, P349, DOI 10.1016/j.toxlet.2014.11.011; Locasale JW, 2012, TRENDS ENDOCRIN MET, V23, P545, DOI 10.1016/j.tem.2012.07.005; Longchamp A, 2018, CELL, V173, P117, DOI 10.1016/j.cell.2018.03.001; Lussier DM, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2337-7; Maddocks ODK, 2017, NATURE, V544, P372, DOI 10.1038/nature22056; Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743; Mai BH, 2019, DIABETES METAB SYNDR, V12, P821, DOI 10.2147/DMSO.S198968; Makarem N, 2018, ANNU REV NUTR, V38, P17, DOI 10.1146/annurev-nutr-082117-051805; Malloy VL, 2006, AGING CELL, V5, P305, DOI 10.1111/j.1474-9726.2006.00220.x; Martuscello RT, 2016, CLIN CANCER RES, V22, P2482, DOI 10.1158/1078-0432.CCR-15-0916; Mattaini KR, 2016, J CELL BIOL, V214, P248, DOI 10.1083/jcb.201604085; Mentch SJ, 2015, CELL METAB, V22, P861, DOI 10.1016/j.cmet.2015.08.024; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Miousse IR, 2018, CARCINOGENESIS, V39, P1117, DOI 10.1093/carcin/bgy085; Moloney JN, 2018, SEMIN CELL DEV BIOL, V80, P50, DOI 10.1016/j.semcdb.2017.05.023; Momcilovic M, 2018, CANCER CELL, V33, P905, DOI 10.1016/j.ccell.2018.04.002; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Nencioni A, 2018, NAT REV CANCER, V18, P707, DOI 10.1038/s41568-018-0061-0; Newman AC, 2017, BRIT J CANCER, V116, P1499, DOI 10.1038/bjc.2017.118; NEWMAN EM, 1983, CANCER RES, V43, P4703; Niklison-Chirou MV, 2017, GENE DEV, V31, P1738, DOI 10.1101/gad.302349.117; OHSHIMA H, 1994, MUTAT RES, V305, P253, DOI 10.1016/0027-5107(94)90245-3; ORENTREICH N, 1993, J NUTR, V123, P269; Pacold ME, 2016, NAT CHEM BIOL, V12, P452, DOI [10.1038/NCHEMBIO.2070, 10.1038/nchembio.2070]; PALMER RMJ, 1988, NATURE, V333, P664, DOI 10.1038/333664a0; Pavlova NN, 2018, CELL METAB, V27, P428, DOI 10.1016/j.cmet.2017.12.006; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; Poillet-Perez L, 2018, NATURE, V563, P569, DOI 10.1038/s41586-018-0697-7; PoirsonBichat F, 1997, LIFE SCI, V60, P919, DOI 10.1016/S0024-3205(96)00672-8; PoirsonBichat F, 1997, BRIT J CANCER, V75, P1605, DOI 10.1038/bjc.1997.274; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Poursaitidis I, 2017, CELL REP, V18, P2547, DOI 10.1016/j.celrep.2017.02.054; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Rajagopalan KN, 2011, J NUCL MED, V52, P1005, DOI 10.2967/jnumed.110.084244; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sayin VI, 2017, ELIFE, V6, DOI 10.7554/eLife.28083; Schafer ZT, 2009, NATURE, V461, P109, DOI 10.1038/nature08268; Seyfried TN, 2003, BRIT J CANCER, V89, P1375, DOI 10.1038/sj.bjc.6601269; Shuvalov O, 2017, ONCOTARGET, V8, P23955, DOI 10.18632/oncotarget.15053; Sinha R, 2014, PROSTATE, V74, P1663, DOI 10.1002/pros.22884; Softic S, 2016, DIGEST DIS SCI, V61, P1282, DOI 10.1007/s10620-016-4054-0; Soldati L, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1448-0; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Strekalova E, 2015, CLIN CANCER RES, V21, P2780, DOI 10.1158/1078-0432.CCR-14-2792; Su CH, 2018, BIOCHEM BIOPH RES CO, V500, P462, DOI 10.1016/j.bbrc.2018.04.103; Sullivan LB, 2018, NAT CELL BIOL, V20, P782, DOI 10.1038/s41556-018-0125-0; Sullivan MR, 2019, ELIFE, V8, DOI 10.7554/eLife.44235; Sullivan MR, 2019, CELL METAB, V29, P1410, DOI 10.1016/j.cmet.2019.02.015; Tajan M, 2018, CELL METAB, V28, P721, DOI 10.1016/j.cmet.2018.07.005; Tardito S, 2015, NAT CELL BIOL, V17, P1556, DOI 10.1038/ncb3272; Torrence ME, 2018, ANNU REV CANC BIOL, V2, P251, DOI 10.1146/annurev-cancerbio-030617-050329; Tucci J, 2018, CANCER METAB, V6, DOI 10.1186/s40170-018-0189-0; Vieytes CAM, 2019, CURR NUTR REP, V8, P230, DOI 10.1007/s13668-019-0264-3; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weber DD, 2018, AGING-US, V10, P164, DOI 10.18632/aging.101382; Weng YY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0630-x; Wilson PM, 2014, NAT REV CLIN ONCOL, V11, P282, DOI 10.1038/nrclinonc.2014.51; Yang CD, 2009, CANCER RES, V69, P7986, DOI 10.1158/0008-5472.CAN-09-2266; Yang LF, 2016, CELL METAB, V24, P685, DOI 10.1016/j.cmet.2016.10.011; Yu DY, 2018, FASEB J, V32, P3471, DOI 10.1096/fj.201701211R; Zaugg K, 2011, GENE DEV, V25, P1041, DOI 10.1101/gad.1987211; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018; Zitvogel L, 2017, NAT IMMUNOL, V18, P843, DOI 10.1038/ni.3754	147	115	115	25	190	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					507	517		10.1038/s41586-020-2124-0	http://dx.doi.org/10.1038/s41586-020-2124-0			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214253				2022-12-28	WOS:000521825500018
J	Walton, RT; Christie, KA; Whittaker, MN; Kleinstiver, BP				Walton, Russell T.; Christie, Kathleen A.; Whittaker, Madelynn N.; Kleinstiver, Benjamin P.			Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants	SCIENCE			English	Article							RNA-GUIDED ENDONUCLEASE; OF-FUNCTION MUTATIONS; STRUCTURAL BASIS; DUAL-RNA; DNA; CAS9; NUCLEASES; RECOGNITION; CPF1; BASE	Manipulation of DNA by CRISPR-Cas enzymes requires the recognition of a protospacer-adjacent motif (PAM), limiting target site recognition to a subset of sequences. To remove this constraint, we engineered variants of Streptococcus pyogenes Cas9 (SpCas9) to eliminate the NGG PAM requirement. We developed a variant named SpG that is capable of targeting an expanded set of NGN PAMs, and we further optimized this enzyme to develop a near-PAMless SpCas9 variant named SpRY (NRN and to a lesser extent NYN PAMs). SpRY nuclease and base-editor variants can target almost all PAMs, exhibiting robust activities on a wide range of sites with NRN PAMs in human cells and lower but substantial activity on those with NYN PAMs. Using SpG and SpRY, we generated previously inaccessible disease-relevant genetic variants, supporting the utility of high-resolution targeting across genome editing applications.	[Walton, Russell T.; Christie, Kathleen A.; Whittaker, Madelynn N.; Kleinstiver, Benjamin P.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Walton, Russell T.; Christie, Kathleen A.; Whittaker, Madelynn N.; Kleinstiver, Benjamin P.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Christie, Kathleen A.; Kleinstiver, Benjamin P.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA; [Walton, Russell T.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Walton, Russell T.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Kleinstiver, BP (corresponding author), Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA.; Kleinstiver, BP (corresponding author), Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.; Kleinstiver, BP (corresponding author), Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA.	bkleinstiver@mgh.harvard.edu	Kleinstiver, Benjamin/K-4498-2014	Kleinstiver, Benjamin/0000-0002-5469-0655; Walton, Russell/0000-0002-0546-474X; Christie, Kathleen/0000-0002-8272-6264; Whittaker, Madelynn/0000-0002-3382-1134	Margaret Q. Landenberger Research Foundation; NIH [R00-CA218870, P01-HL142494]; American Society of Gene Cell Therapy	Margaret Q. Landenberger Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Gene Cell Therapy	Research in the Kleinstiver lab was supported by NIH R00-CA218870, NIH P01-HL142494, a Career Development Award from the American Society of Gene & Cell Therapy, and the Margaret Q. Landenberger Research Foundation.	Anders C, 2016, MOL CELL, V61, P895, DOI 10.1016/j.molcel.2016.02.020; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; [Anonymous], 2014, NEW ENGL J MED, V371, P2072, DOI DOI 10.1056/NEJMOA1405386; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Clement K, 2019, NAT BIOTECHNOL, V37, P224, DOI 10.1038/s41587-019-0032-3; Cox JJ, 2010, HUM MUTAT, V31, pE1670, DOI 10.1002/humu.21325; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Esvelt KM, 2013, NAT METHODS, V10, P1116, DOI [10.1038/NMETH.2681, 10.1038/nmeth.2681]; Findlay GM, 2014, NATURE, V513, P120, DOI 10.1038/nature13695; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; Fonfara I, 2014, NUCLEIC ACIDS RES, V42, P2577, DOI 10.1093/nar/gkt1074; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Guo MH, 2019, CELL RES, V29, P183, DOI 10.1038/s41422-018-0131-6; Harper AR, 2015, NAT REV GENET, V16, P689, DOI 10.1038/nrg4017; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hirano S, 2016, MOL CELL, V61, P886, DOI 10.1016/j.molcel.2016.02.018; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kan YN, 2017, GENOME RES, V27, P1099, DOI 10.1101/gr.214775.116; Karvelis T, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0818-7; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NAT BIOTECHNOL, V33, P1293, DOI 10.1038/nbt.3404; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Koblan LW, 2018, NAT BIOTECHNOL, V36, P843, DOI 10.1038/nbt.4172; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Nishimasu H, 2018, SCIENCE, V361, P1259, DOI 10.1126/science.aas9129; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shi JW, 2015, NAT BIOTECHNOL, V33, P661, DOI 10.1038/nbt.3235; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Suzuki K, 2016, NATURE, V540, P144, DOI 10.1038/nature20565; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Walton R., 2020, ZENODO, DOI [10.5281/zenodo.3710516, DOI 10.5281/ZENODO.3710516]; Wu YX, 2019, NAT MED, V25, P776, DOI 10.1038/s41591-019-0401-y; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038	45	337	359	50	373	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2020	368	6488			SI		290	+		10.1126/science.aba8853	http://dx.doi.org/10.1126/science.aba8853			49	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LE2AL	32217751	Green Accepted			2022-12-28	WOS:000526525400047
J	Hunter, DJ				Hunter, David J.			Covid-19 and the Stiff Upper Lip - The Pandemic Response in the United Kingdom	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hunter, David J.] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England	University of Oxford	Hunter, DJ (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England.				Cancer Research UK [29186] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Ferguson N., 2020, IMPERIAL COLL LONDON; Hanage W., 2020, GUARDIAN; Organisation for Economic Co-operation and Development, 2020, OECD DAT HOSP BEDS; Yates T., 2020, GUARDIAN	4	81	81	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2020	382	16								10.1056/NEJMp2005755	http://dx.doi.org/10.1056/NEJMp2005755			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LF9LC	32197002	Bronze			2022-12-28	WOS:000527733300001
J	Khan, SU; Osman, M; Khan, MU; Khan, MS; Zhao, D; Mamas, MA; Savji, N; Al-Abdouh, A; Hasan, RK; Michos, ED				Khan, Safi U.; Osman, Mohammed; Khan, Muhammad U.; Khan, Muhammad Shahzeb; Zhao, Di; Mamas, Mamas A.; Savji, Nazir; Al-Abdouh, Ahmad; Hasan, Rani K.; Michos, Erin D.			Dual Versus Triple Therapy for Atrial Fibrillation After Percutaneous Coronary Intervention A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							ANTITHROMBOTIC THERAPY; ANTIPLATELET THERAPY; ORAL ANTICOAGULANTS; SAFETY; PCI; CLOPIDOGREL; MANAGEMENT; EFFICACY; WARFARIN; ASPIRIN	Background: The safety and effectiveness of dual therapy (direct oral anticoagulant [DOAC] plus P2Y12 inhibitor) versus triple therapy (vitamin K antagonist plus aspirin and P2Y12 inhibitor) in patients with nonvalvular atrial fibrillation (AF) after percutaneous coronary intervention (PCI) is unclear. Purpose: To examine the effects of dual versus triple therapy on bleeding and ischemic outcomes in adults with AF after PCI. Data Sources: Searches of PubMed, EMBASE, and the Cochrane Library (inception to 31 December 2019) and ClinicalTrials.gov (7 January 2020) without language restrictions; journal Web sites; and reference lists. Study Selection: Randomized controlled trials that compared the effects of dual versus triple therapy on bleeding, mortality, and ischemic events in adults with AF after PCI. Data Extraction: Two independent investigators abstracted data, assessed the quality of evidence, and rated the certainty of evidence. Data Synthesis: Four trials encompassing 7953 patients were selected. At the median follow-up of 1 year, high-certainty evidence showed that dual therapy was associated with reduced risk for major bleeding compared with triple therapy (risk difference [RD], -0.013 [95% CI, -0.025 to -0.002]). Low-certainty evidence showed inconclusive effects of dual versus triple therapy on risks for all-cause mortality (RD, 0.004 [CI, -0.010 to 0.017]), cardiovascular mortality (RD, 0.001 [CI, -0.011 to 0.013]), myocardial infarction (RD, 0.003 [CI, -0.010 to 0.017]), stent thrombosis (RD, 0.003 [CI, -0.005 to 0.010]), and stroke (RD, -0.003 [CI, -0.010 to 0.005]). The upper bounds of the CIs for these effects were compatible with possible increased risks with dual therapy. Limitation: Heterogeneity of study designs, dosages of DOACs, and types of P2Y12 inhibitors. Conclusion: In adults with AF after PCI, dual therapy reduces risk for bleeding compared with triple therapy, whereas its effects on risks for death and ischemic end points are still unclear.	[Khan, Safi U.; Khan, Muhammad U.] West Virginia Univ, Dept Med, 1 Med Ctr Dr, Morgantown, WV 26508 USA; [Osman, Mohammed] West Virginia Univ, Dept Cardiovasc Med, 1 Med Ctr Dr, Morgantown, WV 26508 USA; [Khan, Muhammad Shahzeb] John H Stroger Jr Hosp Cook Cty, Chicago, IL USA; [Zhao, Di; Michos, Erin D.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Mamas, Mamas A.] Keele Univ, Keele Cardiovasc Res Grp, Guy Hilton Res Ctr, Thornburrow Dr, Stoke On Trent ST4 7QB, Staffs, England; [Mamas, Mamas A.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Savji, Nazir; Hasan, Rani K.; Michos, Erin D.] Johns Hopkins Sch Med, Baltimore, MD USA; [Al-Abdouh, Ahmad] St Agnes Hosp, Dept Med, 900 South Caton Ave, Baltimore, MD 21229 USA; [Zhao, Di] Welch Ctr, Suite 2600,2024 East Monument St, Baltimore, MD 21205 USA; [Savji, Nazir; Hasan, Rani K.] Johns Hopkins Univ Hosp, Div Cardiol, Sheikh Zayed Tower,Suite 7122,1800 Orleans St, Baltimore, MD 21287 USA; [Michos, Erin D.] Johns Hopkins Univ Hosp, Div Cardiol, Blalock 524-B,600 North Wolfe St, Baltimore, MD 21287 USA	West Virginia University; West Virginia University; John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Keele University; Jefferson University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Khan, SU (corresponding author), West Virginia Univ, Dept Med, 1 Med Ctr Dr, Morgantown, WV 26508 USA.	safinmc@gmail.com	Khan, Shahzeb/AAN-1515-2020; Al-Abdouh, Ahmad/GLR-4657-2022; Mamas, Mamas Andreas/A-2549-2019	Mamas, Mamas Andreas/0000-0001-9241-8890	Blumenthal Scholars Fund in Preventive Cardiology at Johns Hopkins University	Blumenthal Scholars Fund in Preventive Cardiology at Johns Hopkins University	Drs. Michos and Zhao are funded by the Blumenthal Scholars Fund in Preventive Cardiology at Johns Hopkins University.	Adam SS, 2012, ANN INTERN MED, V157, P796, DOI 10.7326/0003-4819-157-10-201211200-00532; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Capodanno D, 2019, J AM COLL CARDIOL, V74, P83, DOI 10.1016/j.jacc.2019.05.016; Capodanno D, 2018, NAT REV CARDIOL, V15, P480, DOI 10.1038/s41569-018-0049-1; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Gargiulo G, 2019, EUR HEART J, V40, P3757, DOI 10.1093/eurheartj/ehz732; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Golwala HB, 2018, EUR HEART J, V39, P1726, DOI 10.1093/eurheartj/ehy162; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.06.004, 10.1016/j.jclinepi.2011.03.017]; Gwyn JCV, 2017, EUR HEART J-CARD PHA, V3, P157, DOI 10.1093/ehjcvp/pvx002; Hahn JY, 2019, JAMA-J AM MED ASSOC, V321, P2428, DOI 10.1001/jama.2019.8146; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hoshi T, 2017, J CARDIOL, V69, P648, DOI 10.1016/j.jjcc.2016.06.007; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Khan SU, 2018, AM J CARDIOL, V121, P1200, DOI 10.1016/j.amjcard.2018.01.036; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Lopes RD, 2019, JAMA CARDIOL, V4, P747, DOI 10.1001/jamacardio.2019.1880; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Mehran R, 2019, NEW ENGL J MED, V381, P2032, DOI 10.1056/NEJMoa1908419; MILLER VT, 1993, NEUROLOGY, V43, P32, DOI 10.1212/WNL.43.1_Part_1.32; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Neumann FJ, 2019, EUR HEART J, V40, P87, DOI 10.1093/eurheartj/ehy394; Perez-Gomez F, 2004, J AM COLL CARDIOL, V44, P1557, DOI 10.1016/j.jacc.2004.05.084; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Turner RM, 2012, INT J EPIDEMIOL, V41, P818, DOI 10.1093/ije/dys041; van Tulder M, 2003, SPINE, V28, P1290, DOI 10.1097/01.BRS.0000065484.95996.AF; Veroniki AA, 2016, RES SYNTH METHODS, V7, P55, DOI 10.1002/jrsm.1164; Vranckx P, 2019, LANCET, V394, P1335, DOI 10.1016/S0140-6736(19)31872-0; Vranckx P, 2018, LANCET, V392, P940, DOI 10.1016/S0140-6736(18)31858-0; Wang TH, 2007, ANAL BIOCHEM, V366, P99, DOI 10.1016/j.ab.2007.04.003; Watanabe H, 2019, JAMA-J AM MED ASSOC, V321, P2414, DOI 10.1001/jama.2019.8145; Yusuf S, 2001, NEW ENGL J MED, V345, P494	33	22	23	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2020	172	7					474	+		10.7326/M19-3763	http://dx.doi.org/10.7326/M19-3763			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA6DM	32176890	Green Accepted			2022-12-28	WOS:000524036500006
J	Deodhar, A; Helliwell, PS; Boehncke, WH; Kollmeier, AP; Hsia, EC; Subramanian, RA; Xu, XL; Sheng, SH; Agarwal, P; Zhou, B; Zhuang, YL; Ritchlin, CT				Deodhar, Atul; Helliwell, Philip S.; Boehncke, Wolf-Henning; Kollmeier, Alexa P.; Hsia, Elizabeth C.; Subramanian, Ramanand A.; Xu, Xie L.; Sheng, Shihong; Agarwal, Prasheen; Zhou, Bei; Zhuang, Yanli; Ritchlin, Christopher T.		DISCOVER-1 Study Grp	Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNF alpha inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial	LANCET			English	Article							SAFETY; ADALIMUMAB; EFFICACY; AXIS	Background Many patients with psoriatic arthritis have an inadequate response to tumour necrosis factor (TNF) inhibitors. Guselkumab, a specific inhibitor of interleukin-23 (IL-23) via IL-23 p19 subunit binding, significantly improved psoriatic arthritis signs and symptoms with an acceptable safety profile in a phase 2 trial. Methods This multicentre, double-blind, randomised, placebo-controlled, phase 3 trial was done at 86 sites in 13 countries across Asia, Australasia, Europe, and North America and enrolled adults with active psoriatic arthritis (at least three swollen and three tender joints; and C-reactive protein =0.3 mg/dL) despite standard therapies. Eligibility criteria included inadequate response to or intolerance of standard treatment, including at least 4 months of apremilast, at least 3 months of non-biologic disease-modifying antirheumatic drugs (DMARDs), or at least 4 weeks of non-steroidal anti-inflammatory drugs for psoriatic arthritis. About 30% of study participants could have previously received one or two TNF inhibitors. Patients were randomly assigned (1:1:1, computer-generated permuted blocks; stratified by baseline DMARD and previous TNF inhibitor use) to subcutaneous guselkumab 100 mg every 4 weeks; guselkumab 100 mg at weeks 0, 4, then every 8 weeks; or matching placebo. The primary endpoint was American College of Rheumatology 20% improvement (ACR20) at week 24 in all patients per assigned treatment group using non-responder imputation. Safety was assessed in all patients per treatment received. This trial is registered at ClinicalTrials.gov, NCT03162796 (active, not recruiting). Findings From Aug 28, 2017, to Aug 17, 2018, we screened 624 patients, of whom 381 were randomly assigned and treated with guselkumab every 4 weeks (n=128), guselkumab every 8 weeks (n=127), or placebo (n=126). 362 patients continued study treatment up to week 24. The primary endpoint was met: ACR20 at week 24 was achieved by significantly greater proportions of patients in the guselkumab every 4 weeks group (76 [59%] of 128 [95% CI 50-68]) and every 8 weeks group (66 [52%] of 127 [43-61]) than in the placebo group (28 [22%] of 126 [15-30]), with percentage differences versus placebo of 37% (95% CI 26-48) for the every 4 weeks group and 30% (19-41) for the every 8 weeks group (both p<0.0001). Serious adverse events up to week 24 occurred in no patients receiving guselkumab every 4 weeks, four (3%) patients receiving guselkumab every 8 weeks, and five (4%) patients receiving placebo. Up to week 24, one patient in the placebo group died from cardiac failure and two had serious infections; no guselkumab-treated patient died or had serious infections. Interpretation Guselkumab demonstrated a favourable benefit-risk profile and might be an effective treatment option for patients with active psoriatic arthritis.	[Deodhar, Atul] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97239 USA; [Helliwell, Philip S.] Univ Leeds, Leeds Inst Rheumat & Musculoskeletal Med, Leeds, W Yorkshire, England; [Helliwell, Philip S.] Leeds Musculoskeletal Biomed Res Ctr, Natl Inst Hlth Res, Leeds, W Yorkshire, England; [Boehncke, Wolf-Henning] Geneva Univ Hosp, Div Dermatol & Venerol, Geneva, Switzerland; [Kollmeier, Alexa P.; Xu, Xie L.] Janssen Res & Dev, Immunol, San Diego, CA USA; [Hsia, Elizabeth C.; Subramanian, Ramanand A.] Janssen Res & Dev, Immunol, Spring House, PA USA; [Zhuang, Yanli] Janssen Res & Dev, Clin Pharmacol & Pharmacometr, Spring House, PA USA; [Sheng, Shihong; Agarwal, Prasheen; Zhou, Bei] Janssen Res & Dev, Clin Biostat, Spring House, PA USA; [Hsia, Elizabeth C.] Univ Penn, Med Ctr, Philadelphia, PA 19104 USA; [Ritchlin, Christopher T.] Univ Rochester, Med Ctr, Allergy Immunol & Rheumatol, Rochester, NY 14642 USA	Oregon Health & Science University; University of Leeds; University of Geneva; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; University of Pennsylvania; University of Rochester	Deodhar, A (corresponding author), Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97239 USA.	deodhara@ohsu.edu			Janssen Research and Development	Janssen Research and Development	Janssen Research and Development.	[Anonymous], HIGHL PRESCR INF; [Anonymous], HIGHL PRESCR INF; [Anonymous], SKIN; [Anonymous], HIGHL PRESCR INF; [Anonymous], HIGHL PRESCR INF; [Anonymous], HIGHL PRESCR INF; Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041; Brembilla NC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01682; Coates LC, 2018, ARTHRITIS RHEUMATOL, V70, P345, DOI 10.1002/art.40391; Costa L, 2017, DRUGS R&D, V17, P509, DOI 10.1007/s40268-017-0215-7; Deodhar A, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-1882-2; Deodhar A, 2018, LANCET, V391, P2213, DOI 10.1016/S0140-6736(18)30952-8; Fagerli KM, 2013, ANN RHEUM DIS, V72, P1840, DOI 10.1136/annrheumdis-2012-203018; Girolomoni G, 2017, J EUR ACAD DERMATOL, V31, P1616, DOI 10.1111/jdv.14433; Girolomoni G, 2012, IMMUNOPHARM IMMUNOT, V34, P548, DOI 10.3109/08923973.2011.653646; Husni ME, 2017, SEMIN ARTHRITIS RHEU, V47, P351, DOI 10.1016/j.semarthrit.2017.05.010; Kulig P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13466; Mease PJ, 2019, ARTHRITIS RHEUMATOL, V71, P1112, DOI 10.1002/art.40851; Merola JF, 2017, SEMIN ARTHRITIS RHEU, V47, P29, DOI 10.1016/j.semarthrit.2017.02.001; Nash P, 2017, LANCET, V389, P2317, DOI 10.1016/S0140-6736(17)31429-0; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Reich K, 2019, BRIT J DERMATOL, V180, P1039, DOI 10.1111/bjd.17454; Reich K, 2017, J AM ACAD DERMATOL, V76, P418, DOI 10.1016/j.jaad.2016.11.042; Ritchlin CT, 2017, NEW ENGL J MED, V376, P957, DOI 10.1056/NEJMra1505557; Siebert S, 2019, ANN RHEUM DIS, V78, P293, DOI 10.1136/annrheumdis-2019-eular.479; Smolen JS, 2018, ANN RHEUM DIS, V77, P472, DOI [10.1136/annrheumdis-2017-211734corr1, 10.1136/annrheumdis-2017-211734]; Suzuki E, 2014, AUTOIMMUN REV, V13, P496, DOI 10.1016/j.autrev.2014.01.050; Tato CM, 2008, IMMUNOL REV, V226, P103, DOI 10.1111/j.1600-065X.2008.00715.x; Uttarkar S, 2019, J ALLERGY CLIN IMMUN, V143, P1302, DOI 10.1016/j.jaci.2018.12.1011; van Kuijk AWR, 2010, ANN RHEUM DIS, V69, P624, DOI 10.1136/ard.2009.108787	30	152	156	2	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2020	395	10230					1115	1125		10.1016/S0140-6736(20)30265-8	http://dx.doi.org/10.1016/S0140-6736(20)30265-8			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KZ9LJ	32178765	Green Accepted			2022-12-28	WOS:000523580400024
J	Mayor, S				Mayor, Susan			Covid-19: Researchers launch app to track spread of symptoms in the UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	13	13	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1263	10.1136/bmj.m1263	http://dx.doi.org/10.1136/bmj.m1263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220898	Bronze			2022-12-28	WOS:000523765200007
J	Palladino, M				Palladino, Michael			Stepping up to leadership	SCIENCE			English	Editorial Material									[Palladino, Michael] Monmouth Univ, Grad Studies, West Long Branch, NJ USA; [Palladino, Michael] Bloomfield Coll, Acad Affairs, Bloomfield, NJ 07003 USA; [Palladino, Michael] Bloomfield Coll, Bloomfield, NJ 07003 USA	Monmouth University	Palladino, M (corresponding author), Bloomfield Coll, Acad Affairs, Bloomfield, NJ 07003 USA.; Palladino, M (corresponding author), Bloomfield Coll, Bloomfield, NJ 07003 USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1494	1494		10.1126/science.367.6485.1494	http://dx.doi.org/10.1126/science.367.6485.1494			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217729				2022-12-28	WOS:000523251600040
J	Naci, H; Salcher-Konrad, M; Kesselheim, AS; Wieseler, B; Rochaix, L; Redberg, RF; Salanti, G; Jackson, E; Garner, S; Stroup, TS; Cipriani, A				Naci, Huseyin; Salcher-Konrad, Maximilian; Kesselheim, Aaron S.; Wieseler, Beate; Rochaix, Lise; Redberg, Rita F.; Salanti, Georgia; Jackson, Emily; Garner, Sarah; Stroup, T. Scott; Cipriani, Andrea			Generating comparative evidence on new drugs and devices before approval	LANCET			English	Review							SURROGATE END-POINTS; CONDITIONAL MARKETING AUTHORIZATION; SUPPORTING FDA APPROVAL; US FOOD; ACCELERATED APPROVAL; CLINICAL-TRIALS; MEDICAL DEVICES; PATIENTS EXPECTATIONS; NETWORK METAANALYSIS; COMPARATIVE EFFICACY	Fewer than half of new drugs have data on their comparative benefits and harms against existing treatment options at the time of regulatory approval in Europe and the USA. Even when active-comparator trials exist, they might not produce meaningful data to inform decisions in clinical practice and health policy. The uncertainty associated with the paucity of well designed active-comparator trials has been compounded by legal and regulatory changes in Europe and the USA that have created a complex mix of expedited programmes aimed at facilitating faster access to new drugs. Comparative evidence generation is even sparser for medical devices. Some have argued that the current process for regulatory approval needs to generate more evidence that is useful for patients, clinicians, and payers in health-care systems. We propose a set of five key principles relevant to the European Medicines Agency, European medical device regulatory agencies, US Food and Drug Administration, as well as payers, that we believe will provide the necessary incentives for pharmaceutical and device companies to generate comparative data on drugs and devices and assure timely availability of evidence that is useful for decision making. First, labelling should routinely inform patients and clinicians whether comparative data exist on new products. Second, regulators should be more selective in their use of programmes that facilitate drug and device approvals on the basis of incomplete benefit and harm data. Third, regulators should encourage the conduct of randomised trials with active comparators. Fourth, regulators should use prospectively designed network meta-analyses based on existing and future randomised trials. Last, payers should use their policy levers and negotiating power to incentivise the generation of comparative evidence on new and existing drugs and devices, for example, by explicitly considering proven added benefit in pricing and payment decisions.	[Naci, Huseyin; Salcher-Konrad, Maximilian] London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England; [Jackson, Emily] London Sch Econ & Polit Sci, Dept Law, London, England; [Kesselheim, Aaron S.] Harvard Med Sch, Program Regulat Therapeut & Law, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Brigham & Womens Hosp, Boston, MA 02115 USA; [Wieseler, Beate] Inst Qual & Efficiency Hlth Care, Cologne, Germany; [Rochaix, Lise] Paris Sch Econ, Hospinn, Paris, France; [Redberg, Rita F.] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Salanti, Georgia] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Garner, Sarah] Univ Manchester, Sch Hlth Sci, Manchester, Lancs, England; [Stroup, T. Scott] Columbia Univ, Dept Psychiat, Vagelos Coll Phys & Surg, New York, NY USA; [Stroup, T. Scott] New York State Psychiat Inst & Hosp, New York, NY 10032 USA; [Cipriani, Andrea] Univ Oxford, Dept Psychiat, Oxford, England; [Cipriani, Andrea] Oxford Hlth NHS Fdn Trust, Warneford Hosp, Oxford, England	University of London; London School Economics & Political Science; University of London; London School Economics & Political Science; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Paris School of Economics; University of California System; University of California San Francisco; University of Bern; University of Manchester; Columbia University; New York State Psychiatry Institute; University of Oxford	Naci, H (corresponding author), London Sch Econ & Polit Sci, Dept Hlth Policy, London WC2A 2AE, England.	h.naci@lse.ac.uk	Stroup, Thomas/AAB-7780-2019; Salcher-Konrad, Maximilian/CAC-0005-2022; Cipriani, Andrea/P-6944-2015	Stroup, Thomas/0000-0002-3123-0672; Salcher-Konrad, Maximilian/0000-0002-5628-5266; Wieseler, Beate/0000-0002-3519-754X; Cipriani, Andrea/0000-0001-5179-8321	National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre [BRC-1215-20005]; Commonwealth Fund; Arnold Ventures; European Union's Horizon 2020 research and innovation programme [825162]	National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre(National Institute for Health Research (NIHR)); Commonwealth Fund; Arnold Ventures; European Union's Horizon 2020 research and innovation programme	The authors thank the participants of the London School of Economics and Political Science's Policy Roundtable (Optimising Existing Evidence to Determine the Comparative Benefits and Harms of New Medicines), held in London, UK, in May, 2017, for their valuable insights about the current policy environment surrounding medicines. This study was funded by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC-1215-20005). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health. HN was funded by the Commonwealth Fund as a Harkness Fellow in Health Care Policy and Practice. ASK's work is funded by Arnold Ventures. GS's work is funded from the European Union's Horizon 2020 research and innovation programme under grant agreement No 825162 (HTx project).	Anderson M, 2019, J CLIN EPIDEMIOL, V105, P50, DOI 10.1016/j.jclinepi.2018.09.003; [Anonymous], MDCG 2019 9 SUMM SAF; Banzi R, 2015, EUR J INTERN MED, V26, P572, DOI 10.1016/j.ejim.2015.08.008; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Beaver JA, 2018, JAMA ONCOL, V4, P849, DOI 10.1001/jamaoncol.2017.5618; Bloem LT, 2019, CLIN PHARMACOL THER, V105, P426, DOI 10.1002/cpt.1169; Budish E, 2015, AM ECON REV, V105, P2044, DOI 10.1257/aer.20131176; Chalkidou K, 2009, MILBANK Q, V87, P339, DOI 10.1111/j.1468-0009.2009.00560.x; Chen C., 2018, FDA REPAYS IND RUSHI; Chen CE, 2012, JAMA-J AM MED ASSOC, V308, P1740, DOI 10.1001/jama.2012.14491; Chen EY, 2019, JAMA INTERN MED, V179, P915, DOI 10.1001/jamainternmed.2019.0583; Chen EY, 2019, JAMA INTERN MED, V179, P642, DOI 10.1001/jamainternmed.2018.8351; Ciani O, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f457; Cipriani A, 2018, LANCET, V391, P1357, DOI 10.1016/S0140-6736(17)32802-7; Cipriani A, 2013, ANN INTERN MED, V159, P130, DOI 10.7326/0003-4819-159-2-201307160-00008; Cohen D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4848; Darrow JJ, 2017, HLTH AFF, DOI DOI 10.1377/HBLOG20171021.268271/FULL/; Darrow JJ, 2018, NEW ENGL J MED, V378, P1444, DOI 10.1056/NEJMhpr1713338; Davis C, 2015, SOC SCI MED, V131, P207, DOI 10.1016/j.socscimed.2014.12.007; Del Fiol G, 2014, JAMA INTERN MED, V174, P710, DOI 10.1001/jamainternmed.2014.368; Del Paggio JC, 2017, LANCET ONCOL, V18, P887, DOI 10.1016/S1470-2045(17)30415-1; Dhruva SS, 2015, NEW ENGL J MED, V373, DOI 10.1056/NEJMp1510514; Dhruva SS, 2009, JAMA-J AM MED ASSOC, V302, P2679, DOI 10.1001/jama.2009.1899; Dias S, 2013, MED DECIS MAKING, V33, P607, DOI 10.1177/0272989X12458724; Downing NS, 2017, JAMA-J AM MED ASSOC, V317, P1854, DOI 10.1001/jama.2017.5150; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Eichler HG, 2008, NAT REV DRUG DISCOV, V7, P818, DOI 10.1038/nrd2664; Eichler HG, 2010, NAT REV DRUG DISCOV, V9, P277, DOI 10.1038/nrd3079; European Medicines Agency, 2018, EMA869282018; European Medicines Agency, 2018, EMA5569232018; European Medicines Agency (EMA), 2006, COND MARK AUTH; Fishman J, 2010, ARCH INTERN MED, V170, P515, DOI 10.1001/archinternmed.2010.11; Fleming TR, 2005, HEALTH AFFAIR, V24, P67, DOI 10.1377/hlthaff.24.1.67; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Fraser AG, 2018, LANCET, V392, P521, DOI 10.1016/S0140-6736(18)31270-4; Gaddipati H, 2012, CLIN CANCER RES, V18, P5172, DOI 10.1158/1078-0432.CCR-12-1135; Goldberg NH, 2011, JAMA-J AM MED ASSOC, V305, P1786, DOI 10.1001/jama.2011.539; Goozner M, 2011, J NATL CANCER I, V103, P455, DOI 10.1093/jnci/djr087; Goring S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024895; Gyawali B, 2019, JAMA INTERN MED, V179, P906, DOI 10.1001/jamainternmed.2019.0462; Gyawali B, 2019, JAMA ONCOL, V5, P607, DOI 10.1001/jamaoncol.2019.0093; Hazlewood GS, 2016, COCHRANE DB SYST REV, V8; Hee SW, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0597-1; Heneghan C, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5515; Herder M, 2019, MILBANK Q, V97, P820, DOI 10.1111/1468-0009.12413; Hilal T, 2019, JAMA ONCOL, V5, P887, DOI 10.1001/jamaoncol.2019.0167; Hoekman J, 2015, CLIN PHARMACOL THER, V98, P534, DOI 10.1002/cpt.174; Hoekman J, 2019, SOC SCI MED, V222, P76, DOI 10.1016/j.socscimed.2018.12.025; Hoekman J, 2016, BRIT J CLIN PHARMACO, V82, P213, DOI 10.1111/bcp.12940; Horn H, 2014, HEALTH POLICY, V116, P147, DOI 10.1016/j.healthpol.2013.12.008; Hofer MP, 2015, NAT REV DRUG DISCOV, V14, P302, DOI 10.1038/nrd4621; Hoffmann TC, 2017, JAMA INTERN MED, V177, P407, DOI 10.1001/jamainternmed.2016.8254; Hoffmann TC, 2015, JAMA INTERN MED, V175, P274, DOI 10.1001/jamainternmed.2014.6016; Hwang TJ, 2018, J CLIN ONCOL, V36, P1805, DOI 10.1200/JCO.2017.77.1592; Hwang TJ, 2017, JAMA-J AM MED ASSOC, V318, P2137, DOI 10.1001/jama.2017.14896; Ioannidis JPA, 2013, NAT REV RHEUMATOL, V9, P665, DOI 10.1038/nrrheum.2013.134; Jabbour E, 2016, AM J HEMATOL, V91, P59, DOI 10.1002/ajh.24249; Jansen JP, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-159; Johnson JR, 2011, J NATL CANCER I, V103, P636, DOI 10.1093/jnci/djr062; Jones DS, 2015, LANCET, V385, P1502, DOI 10.1016/S0140-6736(15)60742-5; Kazandjian D, 2016, SEMIN ONCOL, V43, P682, DOI 10.1053/j.seminoncol.2016.10.008; Kesselheim AS, 2019, JAMA INTERN MED, V179, P707, DOI 10.1001/jamainternmed.2018.8121; Kesselheim AS, 2016, JAMA-J AM MED ASSOC, V315, P1516, DOI 10.1001/jama.2015.16984; Kesselheim AS, 2016, ANN INTERN MED, V164, P500, DOI 10.7326/M15-1906; Kesselheim AS, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4633; Kesselheim AS, 2013, NAT REV DRUG DISCOV, V12, P425, DOI 10.1038/nrd3977; Kim C, 2016, MAYO CLIN PROC, V91, P713, DOI 10.1016/j.mayocp.2016.02.012; Kim J, 2019, NEW ENGL J MED, V381, P1, DOI 10.1056/NEJMp1903305; Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918; Krishnamurti T, 2015, JAMA INTERN MED, V175, P1856, DOI 10.1001/jamainternmed.2015.5355; Kromp M, 2018, COCHR C ED UK SEPT 1; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Lau EMT, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2017.84; Lauenroth VD, 2017, VALUE HEALTH, V20, P927, DOI 10.1016/j.jval.2017.04.006; Lauer MS, 2013, NEW ENGL J MED, V369, P1579, DOI 10.1056/NEJMp1310102; Lesko LJ, 2001, ANNU REV PHARMACOL, V41, P347, DOI 10.1146/annurev.pharmtox.41.1.347; Liu S, 2019, CLIN PHARMACOL THER, V105, P795, DOI 10.1002/cpt.1365; Longo DL, 2017, NEW ENGL J MED, V376, P982, DOI 10.1056/NEJMe1700833; Manns MP, 2013, LANCET INFECT DIS, V13, P378, DOI 10.1016/S1473-3099(13)70074-4; Mostaghim SR, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3837; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; Naci H, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l266; Naci H, 2017, JAMA-J AM MED ASSOC, V318, P626, DOI 10.1001/jama.2017.9415; Naci H, 2013, CIRC-CARDIOVASC QUAL, V6, P390, DOI 10.1161/CIRCOUTCOMES.111.000071; Naci H, 2013, J CLIN EPIDEMIOL, V66, P812, DOI 10.1016/j.jclinepi.2013.04.002; Neez E, 2020, CLIN PHARMACOL THER, V107, P541, DOI 10.1002/cpt.1669; Nikolakopoulou A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k585; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; O'Connor AB, 2010, JAMA-J AM MED ASSOC, V303, P979, DOI 10.1001/jama.2010.257; Pace J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j4494; Palmer SC, 2016, JAMA-J AM MED ASSOC, V316, P313, DOI 10.1001/jama.2016.9400; Pearson SD, 2010, HEALTH AFFAIR, V29, P1796, DOI 10.1377/hlthaff.2010.0623; Pease AM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1680; Puthumana J, 2018, JAMA-J AM MED ASSOC, V320, P301, DOI 10.1001/jama.2018.7619; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Razavi M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11111; Reinhardt U, 2015, JAMA-J AM MED ASSOC, V314, P981, DOI 10.1001/jama.2015.9593; Reith C, 2013, NEW ENGL J MED, V369, P1061, DOI 10.1056/NEJMsb1300760; Reynolds IS, 2014, JAMA INTERN MED, V174, P1773, DOI 10.1001/jamainternmed.2014.4194; Salanti G, 2008, STAT METHODS MED RES, V17, P279, DOI 10.1177/0962280207080643; Salanti G, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2740-2; Saluja R, 2018, J ONCOL PRACT, V14, P316, DOI 10.1200/JOP.17.00058; Sarpatwari A, 2018, HEALTH AFFAIR, V37, P732, DOI 10.1377/hlthaff.2017.1179; Schwartz LM, 2013, P NATL ACAD SCI USA, V110, P14069, DOI 10.1073/pnas.1214646110; Schwartz LM, 2011, ARCH INTERN MED, V171, P1463, DOI 10.1001/archinternmed.2011.396; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Sherman RE, 2017, NAT REV DRUG DISCOV, V16, P297, DOI 10.1038/nrd.2017.25; Siontis GCM, 2015, LANCET, V386, P655, DOI 10.1016/S0140-6736(15)60657-2; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; Temple R, 2000, ANN INTERN MED, V133, P455, DOI 10.7326/0003-4819-133-6-200009190-00014; Tramacere I, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011381.pub2; Treweek S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0776-0; van Luijn JCF, 2007, BRIT J CLIN PHARMACO, V63, P159, DOI 10.1111/j.1365-2125.2006.02812.x; Van Rossum Alison, 2016, Hosp Pharm, V51, P553, DOI 10.1310/hpj5107-553; Vivot A, 2017, ANN ONCOL, V28, P1111, DOI 10.1093/annonc/mdx053; Wallach JD, 2019, J GEN INTERN MED, V34, P492, DOI 10.1007/s11606-018-4779-x; Wallach JD, 2018, CLIN TRIALS, V15, P219, DOI 10.1177/1740774518770648; Wallach JD, 2018, CLIN TRIALS, V15, P243, DOI 10.1177/1740774518770657; Wallach JD, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1023-9; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; WIESELER B, 2019, BMJ-BRIT MED J, V366, P73610, DOI DOI 10.1136/BMJ.L4340; Woloshin S, 2017, NEW ENGL J MED, V377, P1114, DOI 10.1056/NEJMp1705800; Woloshin S, 2014, JAMA-J AM MED ASSOC, V312, P2163, DOI 10.1001/jama.2014.13329; Woodcock J, 2010, NEW ENGL J MED, V363, P1489, DOI 10.1056/NEJMp1010788; Zarin W, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0764-6; Zhang AD, 2019, PREPRINT, DOI [10.1101/19007047, DOI 10.1101/19007047]	127	31	30	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					986	997						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199486	Green Submitted, Green Accepted			2022-12-28	WOS:000521744600030
J	Hall, KD				Hall, Kevin D.			Challenges of human nutrition research	SCIENCE			English	Editorial Material							LONG-TERM		[Hall, Kevin D.] NIDDK, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hall, KD (corresponding author), NIDDK, Bethesda, MD 20892 USA.	kevinh@niddk.nih.gov	Hall, Kevin/F-2383-2010	Hall, Kevin/0000-0003-4062-3133	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Thanks to N. K. Fukagawa, M. B. Katan, K.C. Klatt,P. Ohukainen, M. L. Reitman,and E.J.Weiss for insightful comments. Supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.	Afshin A, 2019, LANCET, V393, P1958, DOI 10.1016/S0140-6736(19)30041-8; Cainzos-Achirica M, 2018, CURR CARDIOVASC RISK, V12, DOI 10.1007/s12170-018-0567-8; Das SK, 2007, AM J CLIN NUTR, V85, P1023, DOI 10.1093/ajcn/85.4.1023; Hall KD, 2019, INT J OBESITY, V43, P2350, DOI 10.1038/s41366-019-0456-3; Interagency Committee on Human Nutrition Research, 2016, NAT NUTR RES ROADM 2; Ioannidis JPA, 2018, JAMA-J AM MED ASSOC, V320, P969, DOI 10.1001/jama.2018.11025; Ioannidis JPA, 2016, AM J CLIN NUTR, V103, P1385, DOI 10.3945/ajcn.116.136085; Ioannidis JPA, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6698; Katz DL, 2014, ANNU REV PUBL HEALTH, V35, P83, DOI 10.1146/annurev-publhealth-032013-182351; Keys A, 1950, BIOL HUMAN STARVATIO; Mozaffarian D, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k822; Nissen SE, 2016, ANN INTERN MED, V164, P558, DOI 10.7326/M16-0035; Satija A, 2015, ADV NUTR, V6, P5, DOI 10.3945/an.114.007492; Toole A.A., 2015, IMPROVING HEALTHTHRO; Vella A, 2016, DIABETES, V65, P2821, DOI 10.2337/db16-0923	15	16	18	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1298	1300		10.1126/science.aba3807	http://dx.doi.org/10.1126/science.aba3807			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193306				2022-12-28	WOS:000522167400025
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: UK government calls on industry to help boost testing capacity to 25 000 people a day	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	1	1	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2020	368								m1118	10.1136/bmj.m1118	http://dx.doi.org/10.1136/bmj.m1118			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DM	32193352	Bronze			2022-12-28	WOS:000523763400005
J	Waked, I; Esmat, G; Elsharkawy, A; El-Serafy, M; Abdel-Razek, W; Ghalab, R; Elshishiney, G; Salah, A; Megid, SA; Kabil, K; El-Sayed, MH; Dabbous, H; El Shazly, Y; Sliman, MA; Abou Hashem, K; Gawad, SA; El Nahas, N; El Sobky, A; El Sonbaty, S; El Tabakh, H; Emad, E; Gemeah, H; Hashem, A; Hassany, M; Hefnawy, N; Hemida, AN; Khadary, A; Labib, K; Mahmoud, F; Mamoun, S; Marei, T; Mekky, S; Meshref, A; Othman, A; Ragab, O; Ramadan, E; Rehan, A; Saad, T; Saeed, R; Sharshar, M; Shawky, H; Shawky, M; Shehata, W; Soror, H; Taha, M; Talha, M; Tealaab, A; Zein, M; Hashish, A; Cordie, A; Omar, Y; Kamal, E; Ammar, I; AbdAlla, M; El Akel, W; Doss, W; Zaid, H				Waked, Imam; Esmat, Gamal; Elsharkawy, Aisha; El-Serafy, Magdy; Abdel-Razek, Wael; Ghalab, Reham; Elshishiney, Galal; Salah, Aysam; Megid, Soad; Kabil, Khaled; El-Sayed, Manal H.; Dabbous, Hany; El Shazly, Yehia; Sliman, Mohamed; Abou Hashem, Khalid; Gawad, Sayed; El Nahas, Nevine; El Sobky, Ahmed; El Sonbaty, Sahar; El Tabakh, Hamdy; Emad, Ehab; Gemeah, Hany; Hashem, Amal; Hassany, Mohamed; Hefnawy, Naseif; Hemida, Abdel N.; Khadary, Ayman; Labib, Kamal; Mahmoud, Faisal; Mamoun, Said; Marei, Tamer; Mekky, Saad; Meshref, Alsayeda; Othman, Alaa; Ragab, Omnia; Ramadan, Elhag; Rehan, Ahmed; Saad, Tarek; Saeed, Ramy; Sharshar, Mohamed; Shawky, Hesham; Shawky, Mohamed; Shehata, Wael; Soror, Hanaa; Taha, Mohsen; Talha, Mahmoud; Tealaab, Adel; Zein, Mohamed; Hashish, Alaa; Cordie, Ahmed; Omar, Yasser; Kamal, Ehab; Ammar, Islam; AbdAlla, Mohamed; El Akel, Wafaa; Doss, Wahid; Zaid, Hala			Screening and Treatment Program to Eliminate Hepatitis C in Egypt	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS-INFECTION; RISK-FACTORS; DISEASE; PREVALENCE; BURDEN; IMPACT	In 2018, the Egyptian government initiated a massive hepatitis C screening and treatment program. The Ministry of Health set the goal of screening all adults (target population, 62.5 million) within 1 year and provided treatment paid for by the government. Nearly 50 million people participated in screening, and approximately 1 million patients were treated for HCV infection.	[Waked, Imam; Abdel-Razek, Wael] Menoufia Univ, Natl Liver Inst, Hepatol Dept, Yassin Abdel Ghaffar St, Shibin Al Kawm 32511, Egypt; [Esmat, Gamal; Elsharkawy, Aisha; El-Serafy, Magdy; Cordie, Ahmed; El Akel, Wafaa; Doss, Wahid] Cairo Univ, Fac Med, Endem Med Dept, Cairo, Egypt; [Ghalab, Reham; Elshishiney, Galal; Salah, Aysam; Megid, Soad; Sliman, Mohamed; Abou Hashem, Khalid; Gawad, Sayed; El Nahas, Nevine; El Sobky, Ahmed; El Sonbaty, Sahar; El Tabakh, Hamdy; Emad, Ehab; Gemeah, Hany; Hashem, Amal; Hefnawy, Naseif; Hemida, Abdel N.; Khadary, Ayman; Labib, Kamal; Mahmoud, Faisal; Mamoun, Said; Marei, Tamer; Mekky, Saad; Meshref, Alsayeda; Othman, Alaa; Ragab, Omnia; Ramadan, Elhag; Rehan, Ahmed; Saad, Tarek; Saeed, Ramy; Sharshar, Mohamed; Shawky, Hesham; Shawky, Mohamed; Shehata, Wael; Soror, Hanaa; Taha, Mohsen; Talha, Mahmoud; Tealaab, Adel; Zein, Mohamed; Zaid, Hala] Ain Shams Univ, Minist Hlth & Populat, Cairo, Egypt; [Kabil, Khaled] Ain Shams Univ, Natl Comm Control Viral Hepatitis, Cairo, Egypt; [El-Sayed, Manal H.] Ain Shams Univ, Pediat Dept, Cairo, Egypt; [Dabbous, Hany] Ain Shams Univ, Hepatol & Trop Med Dept, Cairo, Egypt; [El Shazly, Yehia; Omar, Yasser] Ain Shams Univ, Dept Med, Cairo, Egypt; [Hassany, Mohamed] Al Azhar Univ, Hepatol Dept, Natl Hepatol & Trop Med Res Inst, Cairo, Egypt; [Hashish, Alaa] Al Azhar Univ, World Hlth Org, Communicable Dis Control Cluster, Cairo, Egypt; [Kamal, Ehab; AbdAlla, Mohamed] Al Azhar Univ, Med Res Div, Natl Res Ctr, Cairo, Egypt; [Ammar, Islam] Al Azhar Univ, Trop Med Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Menofia University; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Ain Shams University; Ministry of Health & Population - Egypt; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Ain Shams University; National Hepatology & Tropical Medicine Research Institute (NHTMRI); Egyptian Knowledge Bank (EKB); Ain Shams University; Egyptian Knowledge Bank (EKB); Al Azhar University; National Hepatology & Tropical Medicine Research Institute (NHTMRI); Egyptian Knowledge Bank (EKB); Al Azhar University; World Health Organization Egypt; World Health Organization; Egyptian Knowledge Bank (EKB); Al Azhar University; National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Al Azhar University	Waked, I (corresponding author), Menoufia Univ, Natl Liver Inst, Hepatol Dept, Yassin Abdel Ghaffar St, Shibin Al Kawm 32511, Egypt.	iwaked@liver.g.org	Hassany, Mohamed/ABF-6208-2020; AbdAllah, Mohamed/AAZ-1850-2020; Elakel, Wafaa/ABB-8008-2020; Abdel-Razek, Wael/ABD-9956-2021; Waked, Imam/V-1221-2018	Hassany, Mohamed/0000-0002-6001-8793; AbdAllah, Mohamed/0000-0003-4358-6219; Abdel-Razek, Wael/0000-0003-0114-798X; Hashish, Alaa/0000-0003-0743-6408; Dabbous, Hany/0000-0001-5648-7733; El-Akel, Wafaa/0000-0002-0055-2230; El-Sayed, Manal/0000-0002-6613-0276; Waked, Imam/0000-0002-9857-8972; Elshishiney, Galal/0000-0002-3132-2876	Egyptian government through the Ministry of Health	Egyptian government through the Ministry of Health	The screening and treatment program was funded by the Egyptian government through the Ministry of Health.	[Anonymous], 2018, EG FIG 2018; [Anonymous], 2017, EGYPTIAN POPULATION; [Anonymous], 2019, EGYPT TODAY     0619; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Cooke GS, 2019, LANCET GASTROENTEROL, V4, P135, DOI 10.1016/S2468-1253(18)30270-X; Djibouti Ports and Free Zones Authority (DPFZA), 2019, RAPP STAT ANN 2018; El-Zanaty and Associates, 2015, EG HLTH ISS SURV 201; Elsharkawy A, 2018, J HEPATOL, V68, P691, DOI 10.1016/j.jhep.2017.11.034; Estes C, 2015, ALIMENT PHARM THER, V42, P696, DOI 10.1111/apt.13316; Frank C, 2000, LANCET, V355, P887, DOI 10.1016/S0140-6736(99)06527-7; Gomaa A, 2017, HEPATIC MED-EVID RES, V9, P17, DOI 10.2147/HMER.S113681; Habib M, 2001, HEPATOLOGY, V33, P248, DOI 10.1053/jhep.2001.20797; Kouyoumjian SP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17936-4; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Mohlman MK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2369-y; Omland Lars Haukali, 2013, Clin Epidemiol, V5, P163, DOI 10.2147/CLEP.S43926; Strickland GT, 2006, HEPATOLOGY, V43, P915, DOI 10.1002/hep.21173; Thomas DL, 2019, NEW ENGL J MED, V380, P2041, DOI 10.1056/NEJMra1810477; US Preventive Services Task Force, JAMA; Waked I, 2014, ARAB J GASTROENTEROL, V15, P45, DOI 10.1016/j.ajg.2014.04.003; World Health Organization, 2016, COMB HEP B C REACH E; World Health Organization, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2017, 1 WHO PREQ HEP C RAP; Younossi ZM, 2016, J HEPATOL, V65, pS109, DOI 10.1016/j.jhep.2016.07.005	24	92	95	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1166	1174		10.1056/NEJMsr1912628	http://dx.doi.org/10.1056/NEJMsr1912628			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW7AJ	32187475	Bronze			2022-12-28	WOS:000521333700019
J	Stanbrook, MB				Stanbrook, Matthew B.			In uncontrolled asthma, adding a LAMA to ICS plus LABA improved lung function at 6 mo and reduced exacerbations at 1 y	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stanbrook, Matthew B.] Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto	Stanbrook, MB (corresponding author), Univ Toronto, Toronto Western Hosp, Toronto, ON, Canada.							Asthma GIf, 2022, GLOB STRAT ASTHM MAN; Kerstjens HAM, 2012, NEW ENGL J MED, V367, P1198, DOI 10.1056/NEJMoa1208606	2	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC28	JC28		10.7326/ACPJ202003170-028	http://dx.doi.org/10.7326/ACPJ202003170-028			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176894				2022-12-28	WOS:000520170800009
J	Devi, S				Devi, Sharmila			Health care in the Syrian conflict: 9 years on	LANCET			English	Editorial Material																			0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					855	856						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32171397				2022-12-28	WOS:000520024900017
J	Arentz, M; Yim, E; Klaff, L; Lokhandwala, S; Riedo, FX; Chong, M; Lee, M				Arentz, Matt; Yim, Eric; Klaff, Lindy; Lokhandwala, Sharukh; Riedo, Francis X.; Chong, Maria; Lee, Melissa			Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This case series describes the clinical presentation, characteristics, and outcomes of patients with coronavirus disease 2019 (COVID-19) admitted to the intensive care unit at a public hospital in Washington State in February 2020, including initial reports of cardiomyopathy in one-third of the patients.	[Arentz, Matt] Univ Washington, Dept Global Hlth, 325 Ninth Ave, Seattle, WA 98104 USA; [Yim, Eric; Klaff, Lindy; Lokhandwala, Sharukh; Riedo, Francis X.; Lee, Melissa] Evergreen Healthcare, Kirkland, WA USA; [Chong, Maria] Radia Inc, Lynnwood, WA USA	University of Washington; University of Washington Seattle	Arentz, M (corresponding author), Univ Washington, Dept Global Hlth, 325 Ninth Ave, Seattle, WA 98104 USA.	marentz@uw.edu	Arentz, Matt/GVU-4315-2022	Arentz, Matthew/0000-0002-1107-7754; Lokhandwala, Sharukh/0000-0002-2573-388X				Mullen B, 2020, COVID 19 CLIN GUIDAN; WHO, 2020, WEEKLY EPIDEMIOLOGIC; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Zheng YY, 2020, NAT REV CARDIOL, V17, P259, DOI 10.1038/s41569-020-0360-5	5	1405	1443	5	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2020	323	16					1612	1614		10.1001/jama.2020.4326	http://dx.doi.org/10.1001/jama.2020.4326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LL2GR	32191259	Green Published, Bronze			2022-12-28	WOS:000531373700028
J	Macklin, GR; O'Reilly, KM; Grassly, NC; Edmunds, WJ; Mach, O; Krishnan, RSG; Voorman, A; Vertefeuille, JF; Abdelwahab, J; Gumede, N; Goel, A; Sosler, S; Sever, J; Bandyopadhyay, AS; Pallansch, MA; Nandy, R; Mkanda, P; Diop, OM; Sutter, RW				Macklin, G. R.; O'Reilly, K. M.; Grassly, N. C.; Edmunds, W. J.; Mach, O.; Krishnan, R. Santhana Gopala; Voorman, A.; Vertefeuille, J. F.; Abdelwahab, J.; Gumede, N.; Goel, A.; Sosler, S.; Sever, J.; Bandyopadhyay, A. S.; Pallansch, M. A.; Nandy, R.; Mkanda, P.; Diop, O. M.; Sutter, R. W.			Evolving epidemiology of poliovirus serotype 2 following withdrawal of the serotype 2 oral poliovirus vaccine	SCIENCE			English	Article							OUTBREAK; POLIOMYELITIS	Although there have been no cases of serotype 2 wild poliovirus for more than 20 years, transmission of serotype 2 vaccine-derived poliovirus (VDPV2) and associated paralytic cases in several continents represent a threat to eradication. The withdrawal of the serotype 2 component of oral poliovirus vaccine (OPV2) was implemented in April 2016 to stop VDPV2 emergence and secure eradication of all serotype 2 poliovirus. Globally, children born after this date have limited immunity to prevent transmission. Using a statistical model, we estimated the emergence date and source of VDPV2s detected between May 2016 and November 2019. Outbreak response campaigns with monovalent OPV2 are the only available method to induce immunity to prevent transmission. Yet our analysis shows that using monovalent OPV2 is generating more paralytic VDPV2 outbreaks with the potential for establishing endemic transmission. A novel OPV2, for which two candidates are currently in clinical trials, is urgently required, together with a contingency strategy if this vaccine does not materialize or perform as anticipated.	[Macklin, G. R.; O'Reilly, K. M.; Edmunds, W. J.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England; [Macklin, G. R.; Mach, O.; Krishnan, R. Santhana Gopala; Goel, A.; Diop, O. M.; Sutter, R. W.] WHO, Polio Eradicat, Geneva, Switzerland; [Grassly, N. C.] Imperial Coll London, Dept Infect Dis Epidemiol, London, England; [Voorman, A.; Bandyopadhyay, A. S.] Bill & Melinda Gates Fdn, Seattle, WA USA; [Vertefeuille, J. F.; Pallansch, M. A.; Sutter, R. W.] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Abdelwahab, J.; Nandy, R.] United Nations Childrens Fund UNICEF, New York, NY USA; [Gumede, N.; Mkanda, P.] WHO, Reg Off Africa, Brazzaville, Rep Congo; [Sosler, S.] Gavi Vaccine Alliance, Geneva, Switzerland; [Sever, J.] Rotary Int, Evanston, IL USA	University of London; London School of Hygiene & Tropical Medicine; World Health Organization; Imperial College London; Bill & Melinda Gates Foundation; Centers for Disease Control & Prevention - USA; UNICEF; World Health Organization	Macklin, GR (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.; Macklin, GR (corresponding author), WHO, Polio Eradicat, Geneva, Switzerland.	mackling@who.int	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Bandyopadhyay, Ananda/0000-0002-8395-2001; Voorman, Arend/0000-0001-6242-7796; Macklin, Grace/0000-0002-3014-7447; O'Reilly, Kathleen/0000-0002-4892-8022	UK Medical Research Council; Bill and Melinda Gates Foundation [OPP1191821]; WHO; Department for International Development; MRC [MR/R015600/1] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); WHO(World Health Organization); Department for International Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by a Ph.D. scholarship from the UK Medical Research Council and funding from the Bill and Melinda Gates Foundation (OPP1191821) and WHO. N.C.G. acknowledges joint Centre funding from the UK Medical Research Council and Department for International Development.	[Anonymous], 2013, Wkly Epidemiol Rec, V88, P1; Blake IM, 2018, NEW ENGL J MED, V379, P834, DOI 10.1056/NEJMoa1716677; Burns CC, 2013, J VIROL, V87, P4907, DOI 10.1128/JVI.02954-12; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P222; Fine PEM, 2004, B WORLD HEALTH ORGAN, V82, P47; Global Polio Eradication Initiative, 2018, POL POST STRAT; Global Polio Eradication Initiative, 2018, POL POST CERT STRAT; Global Polio Eradication Initiative, 2019, STAND OP PROC RESP P; Global Polio Eradication Initiative, 2016, CLASS REP VACC DER P; Global Polio Eradication Initiative, 2015, POL ENV SURV EXP PLA; Global Polio Eradication Initiative, 2019, STAND OP PROC RESP P; Global Polio Eradication Initiative, 2016, CLASS REP VACC DER P; Hampton LM, 2016, MMWR-MORBID MORTAL W, V65, P934, DOI 10.15585/mmwr.mm6535a3; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Macklin G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01103; Macklin GR, 2019, LANCET INFECT DIS, V19, P1121, DOI 10.1016/S1473-3099(19)30301-9; Mbaeyi C, 2018, MMWR-MORBID MORTAL W, V67, P690, DOI 10.15585/mmwr.mm6724a5; McCarthy KA, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0937-y; Mosser JF, 2019, LANCET, V393, P1843, DOI 10.1016/S0140-6736(19)30226-0; Nathanson N, 2010, AM J EPIDEMIOL, V172, P1213, DOI 10.1093/aje/kwq320; Pons-Salort M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005728; Tebbens RJD, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1465-7; Thompson KM, 2014, J INFECT DIS, V210, pS475, DOI 10.1093/infdis/jit845; WHO, 2020, EM US LIST PROC VERS; World Health Organization, 2004, POL LAB MAN, V4th; Zarocostas J, 2018, LANCET, V392, P2425, DOI 10.1016/S0140-6736(18)33115-5; Zipursky S., J INFECT DIS S1, V216, pS15; Zipursky S, 2017, J INFECT DIS, V216, pS15, DOI 10.1093/infdis/jix185	30	46	49	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2020	368	6489					401	+		10.1126/science.aba1238	http://dx.doi.org/10.1126/science.aba1238			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LH0XH	32193361	Green Accepted, Green Submitted			2022-12-28	WOS:000528513300039
J	Ray, KK; Wright, RS; Kallend, D; Koenig, W; Leiter, LA; Raal, FJ; Bisch, JA; Richardson, T; Jaros, M; Wijngaard, PLJ; Kastelein, JJP				Ray, Kausik K.; Wright, R. Scott; Kallend, David; Koenig, Wolfgang; Leiter, Lawrence A.; Raal, Frederick J.; Bisch, Jenna A.; Richardson, Tara; Jaros, Mark; Wijngaard, Peter L. J.; Kastelein, John J. P.		ORION-10 Investigator; ORION-11 Investigator	Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADHERENCE	Inclisiran, a small interfering RNA therapeutic, reduces hepatic synthesis of PCSK9. In two separate randomized trials, subcutaneous injections of inclisiran on day 1, day 90, and then every 6 months reduced LDL cholesterol levels by approximately 50% at month 17, with a modest excess of injection-site adverse events. Background Inclisiran inhibits hepatic synthesis of proprotein convertase subtilisin-kexin type 9. Previous studies suggest that inclisiran might provide sustained reductions in low-density lipoprotein (LDL) cholesterol levels with infrequent dosing. Methods We enrolled patients with atherosclerotic cardiovascular disease (ORION-10 trial) and patients with atherosclerotic cardiovascular disease or an atherosclerotic cardiovascular disease risk equivalent (ORION-11 trial) who had elevated LDL cholesterol levels despite receiving statin therapy at the maximum tolerated dose. Patients were randomly assigned in a 1:1 ratio to receive either inclisiran (284 mg) or placebo, administered by subcutaneous injection on day 1, day 90, and every 6 months thereafter over a period of 540 days. The coprimary end points in each trial were the placebo-corrected percentage change in LDL cholesterol level from baseline to day 510 and the time-adjusted percentage change in LDL cholesterol level from baseline after day 90 and up to day 540. Results A total of 1561 and 1617 patients underwent randomization in the ORION-10 and ORION-11 trials, respectively. Mean (+/- SD) LDL cholesterol levels at baseline were 104.7 +/- 38.3 mg per deciliter (2.71 +/- 0.99 mmol per liter) and 105.5 +/- 39.1 mg per deciliter (2.73 +/- 1.01 mmol per liter), respectively. At day 510, inclisiran reduced LDL cholesterol levels by 52.3% (95% confidence interval [CI], 48.8 to 55.7) in the ORION-10 trial and by 49.9% (95% CI, 46.6 to 53.1) in the ORION-11 trial, with corresponding time-adjusted reductions of 53.8% (95% CI, 51.3 to 56.2) and 49.2% (95% CI, 46.8 to 51.6) (P<0.001 for all comparisons vs. placebo). Adverse events were generally similar in the inclisiran and placebo groups in each trial, although injection-site adverse events were more frequent with inclisiran than with placebo (2.6% vs. 0.9% in the ORION-10 trial and 4.7% vs. 0.5% in the ORION-11 trial); such reactions were generally mild, and none were severe or persistent. Conclusions Reductions in LDL cholesterol levels of approximately 50% were obtained with inclisiran, administered subcutaneously every 6 months. More injection-site adverse events occurred with inclisiran than with placebo. (Funded by the Medicines Company; ORION-10 and ORION-11 ClinicalTrials.gov numbers, NCT03399370 and NCT03400800.) )	[Ray, Kausik K.] Imperial Coll London, Imperial Ctr Cardiovasc Dis Prevent, Dept Primary Care & Publ Hlth, Reynolds Bldg,St Dunstans Rd, London W6 8RP, England; [Wright, R. Scott] Mayo Clin, Dept Cardiol, Rochester, MN USA; [Kallend, David] Medicines Co, Zurich, Switzerland; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Koenig, Wolfgang] Partner Site Munich Heart Alliance, Deutsch Zentrum Herz Kreislauf Forsch, German Ctr Cardiovasc Res, Munich, Germany; [Koenig, Wolfgang] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Leiter, Lawrence A.] Univ Toronto, Li Ka Shing Knowledge Inst, St Michaels Hosp, Toronto, ON, Canada; [Raal, Frederick J.] Univ Witwatersrand, Dept Med, Fac Hlth Sci, Johannesburg, South Africa; [Bisch, Jenna A.; Richardson, Tara; Wijngaard, Peter L. J.] Medicines Co, Parsippany, NJ USA; [Jaros, Mark] Summit Analyt, Denver, CO USA; [Kastelein, John J. P.] Univ Amsterdam, Dept Vasc Med, Acad Med Ctr, Amsterdam, Netherlands	Imperial College London; Mayo Clinic; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Witwatersrand; University of Amsterdam; Academic Medical Center Amsterdam	Ray, KK (corresponding author), Imperial Coll London, Imperial Ctr Cardiovasc Dis Prevent, Dept Primary Care & Publ Hlth, Reynolds Bldg,St Dunstans Rd, London W6 8RP, England.	k.ray@imperial.ac.uk	Raal, FJ/ABD-5111-2021	Raal, FJ/0000-0002-9170-7938; Ray, Kausik/0000-0003-0508-0954; Koenig, Wolfgang/0000-0002-2064-9603	the Medicines Company; National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; NIHR Applied Research Collaboration Northwest London	the Medicines Company; National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; NIHR Applied Research Collaboration Northwest London	Supported by the Medicines Company. Dr. Ray receives support from the National Institute for Health Research (NIHR) Imperial Biomedical Research Centre; his institution (Imperial College London) receives support from the NIHR Applied Research Collaboration Northwest London.	Adams D, 2018, NEW ENGL J MED, V379, P11, DOI 10.1056/NEJMoa1716153; [Anonymous], 2018, VOX             0919; Brookhart MA, 2007, ARCH INTERN MED, V167, P847, DOI 10.1001/archinte.167.8.847; CATAPANO AL, 2016, ATHEROSCLEROSIS, V253, P281, DOI [DOI 10.1016/J.ATHER0SCLER0SIS.2016.08.018, 10.1093/eurheartj/ehw272]; Choudhry NK, 2011, ARCH INTERN MED, V171, P814, DOI 10.1001/archinternmed.2010.495; European Medicines Agency, 2017, GUID IMM ASS THER PR; Grundy SM, 2019, J AM COLL CARDIOL, V73, pE285, DOI 10.1016/j.jacc.2018.11.003; Khvorova A, 2017, NEW ENGL J MED, V376, P4, DOI 10.1056/NEJMp1614154; Levin AA, 2017, NEW ENGL J MED, V376, P86, DOI 10.1056/NEJMcibr1613559; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.1093/eurheartj/ehz455, 10.15829/1560-4071-2020-3826]; Ray KK, 2019, LANCET, V394, P697, DOI 10.1016/S0140-6736(19)31950-6; Ray KK, 2017, NEW ENGL J MED, V376, P1430, DOI 10.1056/NEJMoa1615758; Ray KK, 2019, JAMA CARDIOL; Rodriguez F, 2019, JAMA CARDIOL, V4, P206, DOI 10.1001/jamacardio.2018.4936; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sardh E, 2019, NEW ENGL J MED, V380, P549, DOI 10.1056/NEJMoa1807838; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Stoekenbroek RM, 2018, FUTUR CARDIOL, V14, P433, DOI 10.2217/fca-2018-0067; US Food and Drug Administration, 2019, IMM TEST THER PROT P; 2016, CANC DISCOV, V6, pE0118	20	349	361	12	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2020	382	16					1507	1519		10.1056/NEJMoa1912387	http://dx.doi.org/10.1056/NEJMoa1912387			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF9LC	32187462	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000527733300009
J	Zhou, F; Yu, T; Du, RH; Fan, GH; Liu, Y; Liu, ZB; Xiang, J; Wang, YM; Song, B; Gu, XY; Guan, LL; Wei, Y; Li, H; Wu, XD; Xu, JY; Tu, SJ; Zhang, Y; Chen, H; Cao, B				Zhou, Fei; Yu, Ting; Du, Ronghui; Fan, Guohui; Liu, Ying; Liu, Zhibo; Xiang, Jie; Wang, Yeming; Song, Bin; Gu, Xiaoying; Guan, Lulu; Wei, Yuan; Li, Hui; Wu, Xudong; Xu, Jiuyang; Tu, Shengjin; Zhang, Yi; Chen, Hua; Cao, Bin			Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study	LANCET			English	Article							ACUTE RESPIRATORY SYNDROME; MYOCARDIAL-INFARCTION; PNEUMONIA; OUTCOMES; ASSOCIATION; PREDICTORS; INFECTION; ADMISSION; SEPSIS; STROKE	Background Since December, 2019, Wuhan, China, has experienced an outbreak of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Epidemiological and clinical characteristics of patients with COVID-19 have been reported but risk factors for mortality and a detailed clinical course of illness, including viral shedding, have not been well described. Methods In this retrospective, multicentre cohort study, we included all adult inpatients (>= 18 years old) with laboratory-confirmed COVID-19 from Jinyintan Hospital and Wuhan Pulmonary Hospital (Wuhan, China) who had been discharged or had died by Jan 31, 2020. Demographic, clinical, treatment, and laboratory data, including serial samples for viral RNA detection, were extracted from electronic medical records and compared between survivors and non-survivors. We used univariable and multivariable logistic regression methods to explore the risk factors associated with in-hospital death. Findings 191 patients (135 from Jinyintan Hospital and 56 from Wuhan Pulmonary Hospital) were included in this study, of whom 137 were discharged and 54 died in hospital. 91 (48%) patients had a comorbidity, with hypertension being the most common (58 [30%] patients), followed by diabetes (36 [19%] patients) and coronary heart disease (15 [8%] patients). Multivariable regression showed increasing odds of in-hospital death associated with older age (odds ratio 1.10, 95% CI 1.03-1.17, per year increase; p=0.0043), higher Sequential Organ Failure Assessment (SOFA) score (5.65, 2.61-12.23; p<0.0001), and d-dimer greater than 1 mu g/mL (18.42, 2.64-128.55; p=0.0033) on admission. Median duration of viral shedding was 20.0 days (IQR 17.0-24.0) in survivors, but SARS-CoV-2 was detectable until death in non-survivors. The longest observed duration of viral shedding in survivors was 37 days. Interpretation The potential risk factors of older age, high SOFA score, and d-dimer greater than 1 mu g/mL could help clinicians to identify patients with poor prognosis at an early stage. Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Zhou, Fei; Fan, Guohui; Liu, Zhibo; Wang, Yeming; Gu, Xiaoying; Li, Hui; Zhang, Yi; Cao, Bin] Chinese Acad Med Sci, Peking Union Med Coll, Dept Pulm & Crit Care Med, Inst Resp Med,Natl Clin Res Ctr Resp Dis,Ctr Resp, Beijing, Peoples R China; [Yu, Ting; Liu, Ying; Song, Bin; Wei, Yuan; Tu, Shengjin; Chen, Hua] Jinyintan Hosp, Dept TB & Resp Dis, Wuhan 430023, Peoples R China; [Xiang, Jie] Jinyintan Hosp, Dept Clin Lab, Wuhan, Peoples R China; [Wu, Xudong] Jinyintan Hosp, GCP Ctr, Wuhan, Peoples R China; [Du, Ronghui; Guan, Lulu] Wuhan Pulm Hosp, Dept Pulm & Crit Care Med, Wuhan, Peoples R China; [Cao, Bin] China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China; [Fan, Guohui; Gu, Xiaoying] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China; [Wang, Yeming; Cao, Bin] Capital Med Univ, Dept Resp Med, Beijing, Peoples R China; [Xu, Jiuyang; Cao, Bin] Tsinghua Univ, Sch Med, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wuhan Jinyintan Hospital; Wuhan Jinyintan Hospital; Wuhan Jinyintan Hospital; China-Japan Friendship Hospital; China-Japan Friendship Hospital; Capital Medical University; Tsinghua University	Chen, H (corresponding author), Jinyintan Hosp, Dept TB & Resp Dis, Wuhan 430023, Peoples R China.; Cao, B (corresponding author), China Japan Friendship Hosp, Dept Pulm & Crit Care Med, Beijing 100029, Peoples R China.	2716637947@qq.com; caobin_ben@163.com	QS, Y/AFW-2577-2022	Xu, Jiuyang/0000-0002-1906-5918	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences [CIFMS 2018-I2M-1-003]; National Science Grant for Distinguished Young Scholars [81425001/H0104]; National Key Research and Development Program of China [2018YFC1200100, 2018YFC1200102]; Beijing Science and Technology Project [Z19110700660000]; Major Projects of National Science and Technology on New Drug Creation and Development [2020ZX09201001]	Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences; National Science Grant for Distinguished Young Scholars; National Key Research and Development Program of China; Beijing Science and Technology Project; Major Projects of National Science and Technology on New Drug Creation and Development	This study received the following funding: Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (CIFMS 2018-I2M-1-003); National Science Grant for Distinguished Young Scholars (81425001/H0104); National Key Research and Development Program of China (2018YFC1200100, 2018YFC1200102); The Beijing Science and Technology Project (Z19110700660000); Major Projects of National Science and Technology on New Drug Creation and Development (2020ZX09201001). We acknowledge all health-care workers involved in the diagnosis and treatment of patients in Wuhan; and we thank Chen Wang (Peking Union Medical College, Beijing, China), Peter W Horby (University of Oxford, Oxford, UK), and Frederick G Hayden (University of Virginia School of Medicine, Charlottesville, VA, USA) for guidance in study design and interpretation of results, and review of the manuscript.	Arabi YM, 2017, NEW ENGL J MED, V376, P584, DOI 10.1056/NEJMsr1408795; Blackburn R, 2018, CLIN INFECT DIS, V67, P8, DOI 10.1093/cid/cix1144; Chan JWM, 2003, THORAX, V58, P686, DOI 10.1136/thorax.58.8.686; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005; Corman VM, 2016, CLIN INFECT DIS, V62, P477, DOI 10.1093/cid/civ951; Corrales-Medina VF, 2013, LANCET, V381, P496, DOI 10.1016/S0140-6736(12)61266-5; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Davidson JA, 2019, EXPERT REV ANTI-INFE, V17, P939, DOI 10.1080/14787210.2019.1689817; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hong KH, 2018, THORAX, V73, P286, DOI 10.1136/thoraxjnl-2016-209313; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kalil AC, 2016, CLIN INFECT DIS, V63, P575, DOI 10.1093/cid/ciw504; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Li Q., 2020, NEW ENGL J MED, V382, P1199; Marrie TJ, 2007, MEDICINE, V86, P103, DOI 10.1097/MD.0b013e3180421c16; Mendoza-Torres Evelyn, 2015, Ther Adv Cardiovasc Dis, V9, P217, DOI 10.1177/1753944715597623; Milbrandt EB, 2009, MOL MED, V15, P438, DOI 10.2119/molmed.2009.00091; National Health Commission of the People's Republic of China, 2020, CHIN MAN GUID COVID; Oh MD, 2016, NEW ENGL J MED, V375, P1303, DOI 10.1056/NEJMc1511695; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rodelo JR, 2012, AM J EMERG MED, V30, P1991, DOI 10.1016/j.ajem.2012.04.033; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smits SL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000756; Udell JA, 2013, JAMA-J AM MED ASSOC, V310, P1711, DOI 10.1001/jama.2013.279206; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; Wang YM, 2018, J INFECT DIS, V217, P1708, DOI 10.1093/infdis/jiy115; Xu D, 2005, EUR J CLIN MICROBIOL, V24, P165, DOI 10.1007/s10096-005-1299-5; Xu Z, 2020, LANCET RESP MED, DOI [10.1016/S1473-3099(20)30111-0, DOI 10.1016/S1473-3099(20)30111-0]; Yang X, 2020, LANCET RESP MED, DOI [10.1016/S2213-2600(20)30079-5., DOI 10.1016/S2213-2600(20)30079-5, 10.1016/S2213-2600(20)30079-5, 10.1016/S2213-2600(20)30079]; Zhou F, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.02406-2018; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	37	14293	14944	503	3485	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1054	1062		10.1016/S0140-6736(20)30566-3	http://dx.doi.org/10.1016/S0140-6736(20)30566-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY5YW	32171076	Green Published, Bronze			2022-12-28	WOS:000522650100033
J	Ma, N; Jeffrey, SS				Ma, Ning; Jeffrey, Stefanie S.			Deciphering cancer clues from blood	SCIENCE			English	Editorial Material							BREAST-TUMOR CELLS; HETEROGENEITY		[Ma, Ning; Jeffrey, Stefanie S.] Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA	Stanford University	Jeffrey, SS (corresponding author), Stanford Univ, Dept Surg, Sch Med, Stanford, CA 94305 USA.	ssj@stanford.edu		Jeffrey, Stefanie/0000-0003-4478-2764	Marva Warnock Research Fund; Stanford Catalyst for Collaborative Solutions	Marva Warnock Research Fund; Stanford Catalyst for Collaborative Solutions	N.M. is supported by theJohn and Marva Warnock Research Fund. S.S.J. is supported in part by the Stanford Catalyst for Collaborative Solutions. S.S.J. serves as an expert adviser for Ravel Biotechnology.	Bleijs M, 2019, EMBO J, V38, DOI 10.15252/embj.2019101654; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Ebright RY, 2020, SCIENCE, V367, P1468, DOI 10.1126/science.aay0939; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jeffrey SS, 2019, LAB CHIP, V19, P548, DOI 10.1039/c8lc90117a; Keller L, 2019, NAT REV CANCER, V19, P553, DOI 10.1038/s41568-019-0180-2; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Lallo A, 2017, TRANSL LUNG CANCER R, V6, P397, DOI 10.21037/tlcr.2017.08.01; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; Pantel K, 2019, NAT REV CLIN ONCOL, V16, P409, DOI 10.1038/s41571-019-0187-3; Powell AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033788; Ramalingam N, 2018, CANCER J, V24, P104, DOI 10.1097/PPO.0000000000000308; Soler A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34365-z; Yu M, 2014, SCIENCE, V345, P216, DOI 10.1126/science.1253533; Yu M, 2013, SCIENCE, V339, P580, DOI 10.1126/science.1228522	15	12	12	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1424	1425		10.1126/science.abb0736	http://dx.doi.org/10.1126/science.abb0736			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217712				2022-12-28	WOS:000523251600014
J	Al-Mudares, F; Fernandes, CJ				Al-Mudares, Faeq; Fernandes, Caraciolo J.			"Coat Hanger" Appearance of the Ribs	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Respiratory distress developed in a male neonate with a giant omphalocele who had been born at 28 weeks of gestation. A "coat hanger" appearance of the ribs was seen on chest radiography.	[Al-Mudares, Faeq] Texas Childrens Hosp, Houston, TX 77030 USA; [Fernandes, Caraciolo J.] Baylor Coll Med, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Al-Mudares, F (corresponding author), Texas Childrens Hosp, Houston, TX 77030 USA.	faeq.al-mudares@bcm.edu	Fernandes, Caraciolo/ABB-7984-2020	Al-Mudares, Faeq/0000-0002-2127-4081; Fernandes, Caraciolo/0000-0001-5744-3409					0	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1257	1257		10.1056/NEJMicm1910897	http://dx.doi.org/10.1056/NEJMicm1910897			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY1UO	32212521				2022-12-28	WOS:000522357300012
J	Grandi, V; De Francesco, I				Grandi, Vieri; De Francesco, Irene			Penile Kaposi's Sarcoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Grandi, Vieri; De Francesco, Irene] Guys & St Thomas Hosp NHS Trust, London, England		Grandi, V (corresponding author), Guys & St Thomas Hosp NHS Trust, London, England.	vieri.grandi@gstt.nhs.uk		Grandi, Vieri/0000-0001-8201-346X					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					E20	E20		10.1056/NEJMicm1908438	http://dx.doi.org/10.1056/NEJMicm1908438			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KW7AJ	32187472				2022-12-28	WOS:000521333700001
J	Tawfik, DS; Ioannidis, JPA				Tawfik, Daniel S.; Ioannidis, John P. A.			Evidence Relating Health Care Provider Burnout and Quality of Care RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							EXCESS		[Tawfik, Daniel S.; Ioannidis, John P. A.] Stanford Univ, Stanford, CA 94305 USA	Stanford University	Tawfik, DS (corresponding author), Stanford Univ, Stanford, CA 94305 USA.		Ioannidis, John P. A./G-9836-2011	Tawfik, Daniel/0000-0003-2901-2737				Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2013, J MATH PSYCHOL, V57, P184, DOI 10.1016/j.jmp.2013.03.002; Mathur MB, 2019, SENSITIVITY ANAL PUB, DOI [10.31219/osf.io/s9dp6, DOI 10.31219/OSF.IO/S9DP6]; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Terrin N, 2003, STAT MED, V22, P2113, DOI 10.1002/sim.1461	5	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					438	439		10.7326/L19-0827	http://dx.doi.org/10.7326/L19-0827			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176907				2022-12-28	WOS:000520170800035
J	Field, DJ; Benito, J; Chen, AB; Jagt, JWM; Ksepka, DT				Field, Daniel J.; Benito, Juan; Chen, Albert; Jagt, John W. M.; Ksepka, Daniel T.			Late Cretaceous neornithine from Europe illuminates the origins of crown birds	NATURE			English	Article							GALLINULOIDES-WYOMINGENSIS; PHYLOGENETIC AFFINITIES; EARLY PALEOCENE; FOSSIL EVIDENCE; DIVERSIFICATION; EXTINCTION; MORPHOLOGY; EVOLUTION; AVES; LIFE	Our understanding of the earliest stages of crown bird evolution is hindered by an exceedingly sparse avian fossil record from the Mesozoic era. The most ancient phylogenetic divergences among crown birds are known to have occurred in the Cretaceous period(1-3), but stem-lineage representatives of the deepest subclades of crown birds-Palaeognathae (ostriches and kin), Galloanserae (landfowl and waterfowl) and Neoaves (all other extant birds)-are unknown from the Mesozoic era. As a result, key questions related to the ecology(4,5), biogeography(3,6,7) and divergence times(1,8-10) of ancestral crown birds remain unanswered. Here we report a new Mesozoic fossil that occupies a position close to the last common ancestor of Galloanserae and fills a key phylogenetic gap in the early evolutionary history of crown birds(10,11). Asteriornis maastrichtensis, gen. et sp. nov., from the Maastrichtian age of Belgium (66.8-66.7 million years ago), is represented by a nearly complete, three-dimensionally preserved skull and associated postcranial elements. The fossil represents one of the only well-supported crown birds from the Mesozoic era(12), and is the first Mesozoic crown bird with well-represented cranial remains. Asteriornis maastrichtensis exhibits a previously undocumented combination of galliform (landfowl)-like and anseriform (waterfowl)-like features, and its presence alongside a previously reported Ichthyornis-like taxon from the same locality(13) provides direct evidence of the co-occurrence of crown birds and avialan stem birds. Its occurrence in the Northern Hemisphere challenges biogeographical hypotheses of a Gondwanan origin of crown birds(3), and its relatively small size and possible littoral ecology may corroborate proposed ecological filters(4,5,9) that influenced the persistence of crown birds through the end-Cretaceous mass extinction. A newly discovered fossil from the Cretaceous of Belgium is the oldest modern bird ever found, showing a unique combination of features and suggesting attributes shared by avian survivors of the end-Cretaceous extinction.	[Field, Daniel J.; Benito, Juan; Chen, Albert] Univ Cambridge, Dept Earth Sci, Cambridge, England; [Benito, Juan; Chen, Albert] Univ Bath, Milner Ctr Evolut, Dept Biol & Biochem, Bath, Avon, England; [Jagt, John W. M.] Nat Hist Museum Maastricht, Maastricht, Netherlands; [Ksepka, Daniel T.] Bruce Museum, Greenwich, CT USA	University of Cambridge; University of Bath	Field, DJ (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge, England.	djf70@cam.ac.uk		Benito Moreno, Juan/0000-0003-4497-2058; Field, Daniel/0000-0002-1786-0352; Chen, Albert/0000-0002-2671-9190	UK Research and Innovation Future Leaders Fellowship [MR/S032177/1]; Royal Society [RGS/R2/192390]; Systematics Association Research Grant; Isaac Newton Trust; Hesse Award from the American Ornithological Society; Jurassic Foundation; Geological Association; NSF [DEB 1655736]; Paleontological Society; UKRI [MR/S032177/1] Funding Source: UKRI	UK Research and Innovation Future Leaders Fellowship(UK Research & Innovation (UKRI)); Royal Society(Royal Society of London); Systematics Association Research Grant; Isaac Newton Trust; Hesse Award from the American Ornithological Society; Jurassic Foundation; Geological Association; NSF(National Science Foundation (NSF)); Paleontological Society; UKRI	We thank M. van Dinther for collecting and donating the specimen; J. Vellekoop for advice on geochronology; K. Smithson, T. Thompson and V. Fernandez for scanning support; M. Brooke, M. Lowe, M. Clementz, L. Vietti, J. Cooper, J. White, C. Levitt, R. Irmis, K. MacKenzie and J. Sertich for collections assistance; B. Creisler for etymological information; and T. Worthy and J. Watanabe for anatomical advice. We are grateful to L. Witmer and F. Degrange for sharing three-dimensional models of Presbyornis and Conflicto, respectively, and to P. Krzeminski for his artwork. D.J.F. acknowledges support from the UK Research and Innovation Future Leaders Fellowship MR/S032177/1, the Royal Society Research Grant RGS/R2/192390, a Systematics Association Research Grant and the Isaac Newton Trust; J.B. acknowledges the Hesse Award from the American Ornithological Society and grants from the Jurassic Foundation, Geological Association and Paleontological Society; and D.T.K. acknowledges support from the NSF award DEB 1655736.	Agnolin FL, 2017, SCI NAT-HEIDELBERG, V104, DOI 10.1007/s00114-017-1508-y; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; Berv JS, 2018, SYST BIOL, V67, P1, DOI 10.1093/sysbio/syx064; Bi SD, 2018, NATURE, V558, P390, DOI 10.1038/s41586-018-0210-3; Bourdon E, 2005, NATURWISSENSCHAFTEN, V92, P586, DOI 10.1007/s00114-005-0047-0; Bright JA, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1432-1; Budd GE, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz1626; Claramunt S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501005; Clarke J, 2004, B AM MUS NAT HIST, P1; Clarke JA, 2005, NATURE, V433, P305, DOI 10.1038/nature03150; Clarke JA, 2016, NATURE, V538, P502, DOI 10.1038/nature19852; Clyde WC, 2016, EARTH PLANET SC LETT, V452, P272, DOI 10.1016/j.epsl.2016.07.041; Cooney CR, 2017, NATURE, V542, P344, DOI 10.1038/nature21074; Cracraft J., 1988, Systematics Association Special Volume Series, P339; Cracraft J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P143; Donsker D, 2020, IOC WORLD BIRD LIST; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Dyke GJ, 2002, NATURWISSENSCHAFTEN, V89, P408, DOI 10.1007/s00114-002-0352-9; Elzanowski A, 2010, J MORPHOL, V271, P305, DOI 10.1002/jmor.10799; Ericson PGP, 2006, BIOL LETTERS, V2, P543, DOI 10.1098/rsbl.2006.0523; Ericson PGP, 1997, ZOOL J LINN SOC-LOND, V121, P429; Evers SW, 2019, PEERJ, V7, DOI 10.7717/peerj.6811; FEDUCCIA A, 1995, SCIENCE, V267, P637, DOI 10.1126/science.267.5198.637; Felice RN, 2018, P NATL ACAD SCI USA, V115, P555, DOI 10.1073/pnas.1716437115; Field DJ, 2018, BMC EVOL BIOL, V18, DOI 10.1186/s12862-018-1212-3; Field DJ, 2018, CURR BIOL, V28, P1825, DOI 10.1016/j.cub.2018.04.062; Field DJ, 2018, NATURE, V557, P96, DOI 10.1038/s41586-018-0053-y; Field DJ, 2018, P NATL ACAD SCI USA, V115, P448, DOI 10.1073/pnas.1721208115; Field DJ, 2015, PALAEONTOLOGY, V58, P401, DOI 10.1111/pala.12165; Field DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082000; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; He HY, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020792; Heath TA, 2014, P NATL ACAD SCI USA, V111, pE2957, DOI 10.1073/pnas.1319091111; Hope Sylvia, 2002, P339; Huxley Thomas H., 1867, Proceedings of the Zoological Society, P415; Jarvis ED, 2014, SCIENCE, V346, P1320, DOI 10.1126/science.1253451; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Kealy S, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1090-0; Keutgen N, 2018, NETH J GEOSCI, V97, P229, DOI 10.1017/njg.2018.15; Kimball RT, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11070109; Ksepka DT, 2017, P NATL ACAD SCI USA, V114, P8047, DOI 10.1073/pnas.1700188114; Ksepka DT, 2015, ANN MO BOT GARD, V100, P300, DOI 10.3417/2014032; Ksepka DT, 2009, CLADISTICS, V25, P173, DOI 10.1111/j.1096-0031.2009.00250.x; Larson DW, 2016, CURR BIOL, V26, P1325, DOI 10.1016/j.cub.2016.03.039; Lee MSY, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1071; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Livezey BC, 1997, ZOOL J LINN SOC-LOND, V121, P361, DOI 10.1111/j.1096-3642.1997.tb01285.x; Longrich NR, 2011, P NATL ACAD SCI USA, V108, P15253, DOI 10.1073/pnas.1110395108; Mayr G, 2004, ACTA PALAEONTOL POL, V49, P211; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Mayr G, 2016, AVIAN EVOLUTION; Mayr G, 2021, PAP PALAEONTOL, V7, P217, DOI 10.1002/spp2.1284; Mayr G, 2018, CRETACEOUS RES, V86, P178, DOI 10.1016/j.cretres.2018.02.013; Mayr G, 2017, J BIOGEOGR, V44, P956, DOI 10.1111/jbi.12943; Mayr Gerald, 2011, Palaeobiodiversity Palaeoenvironments, V91, P325, DOI 10.1007/s12549-011-0062-4; Mayr G, 2011, ZOOL SCR, V40, P448, DOI 10.1111/j.1463-6409.2011.00484.x; Mayr G, 2010, J VERTEBR PALEONTOL, V30, P1313, DOI 10.1080/02724634.2010.501465; Miller S, 2010, IEEE INT WORKS GENET, P45, DOI 10.1109/GEFS.2010.5454158; Mourer-Chauvire C., 1982, Geobios Memoire Special (Lyon), P413; Musser G, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11070102; O'Connor JK, 2020, PALAEONTOLOGY, V63, P13, DOI 10.1111/pala.12453; O'Connor JK., 2011, LIVING DINOSAURS EVO, P39, DOI [10.1002/9781119990475.ch3, DOI 10.1002/9781119990475.CH3]; Olson S.L., 1980, Smithsonian Contributions to Zoology, P1; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Phillips MJ, 2016, SYST BIOL, V65, P546, DOI 10.1093/sysbio/syv115; Polly PD, 2015, PALAEONTOL ELECTRON, V18; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Puschel HP, 2020, PALAEONTOLOGY, V63, P67, DOI 10.1111/pala.12443; Reddy S, 2017, SYST BIOL, V66, P857, DOI 10.1093/sysbio/syx041; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Saupe EE, 2019, P NATL ACAD SCI USA, V116, P12895, DOI 10.1073/pnas.1903866116; Simoes TR, 2018, NATURE, V557, P706, DOI 10.1038/s41586-018-0093-3; Tambussi CP, 2019, ZOOL J LINN SOC-LOND, V186, P673, DOI 10.1093/zoolinnean/zly085; Vinther J, 2017, NATURE, V542, P471, DOI 10.1038/nature21055; Waardenberg AJ, 2019, PEERJ, V7, DOI 10.7717/peerj.8206; Wang X, 2018, SCI REP, V8; Worthy TH, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170975; Worthy TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150871; Xing LD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26848-w; Zhang C, 2016, SYST BIOL, V65, P228, DOI 10.1093/sysbio/syv080	82	38	39	5	46	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					397	+		10.1038/s41586-020-2096-0	http://dx.doi.org/10.1038/s41586-020-2096-0			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188952	Green Submitted			2022-12-28	WOS:000520778000018
J	Lane, R				Lane, Richard			Mary Herbert: solving the puzzles of reproductive biology	LANCET			English	Biographical-Item																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1315	1315		10.1016/S0140-6736(19)32271-8	http://dx.doi.org/10.1016/S0140-6736(19)32271-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9RJ	32171433				2022-12-28	WOS:000489613700013
J	Emanuel, EJ; Persad, G; Upshur, R; Thome, B; Parker, M; Glickman, A; Zhang, C; Boyle, C; Smith, M; Phillips, JP				Emanuel, Ezekiel J.; Persad, Govind; Upshur, Ross; Thome, Beatriz; Parker, Michael; Glickman, Aaron; Zhang, Cathy; Boyle, Connor; Smith, Maxwell; Phillips, James P.			Fair Allocation of Scarce Medical Resources in the Time of Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH	The Covid-19 pandemic has already stressed health care systems throughout the world, requiring rationing of medical equipment and care. The authors discuss the ethical values relevant to health care rationing and provide six recommendations to guide fair allocation of scarce medical resources during the pandemic.	[Emanuel, Ezekiel J.; Glickman, Aaron; Zhang, Cathy; Boyle, Connor] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Persad, Govind] Univ Denver, Sturm Coll Law, Denver, CO USA; [Upshur, Ross] Univ Toronto, Div Clin Publ Hlth, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Smith, Maxwell] Western Univ, Sch Hlth Studies, London, ON, Canada; [Thome, Beatriz] Univ Fed Sao Paulo, Prevent Med Dept, Sao Paulo, SP, Brazil; [Parker, Michael] Univ Oxford, Wellcome Ctr Eth & Humanities, Ethox Ctr, Oxford, England; [Phillips, James P.] George Washington Univ Hosp, Dept Emergency, Washington, DC USA	University of Pennsylvania; Pennsylvania Medicine; University of Denver; University of Toronto; Western University (University of Western Ontario); Universidade Federal de Sao Paulo (UNIFESP); University of Oxford; George Washington University	Emanuel, EJ (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA.		; thome, beatriz/B-7337-2018	Persad, Govind/0000-0002-9436-9209; thome, beatriz/0000-0002-3941-3756				American Hospital Association, 2018, AHA ANN SURV; [Anonymous], 2014, CHEST, V146, p484A; [Anonymous], 2017, PAND INFL PLAN 2017; [Anonymous], 2007, RESP PAND INFL ETH F; [Anonymous], 2010, INFL PAND PROV CRIT; [Anonymous], 2020, COVID 19 SENT SURV; [Anonymous], 2014, CHEST, V146, p484A; Biesecker M, 2020, CELEBRITIES GET VIRU; Campbell, 2020, THE GUARDIAN; Casadevall A, 2020, J CLIN INVEST; Centers for Disease Control and Prevention, 2020, STRAT OPT SUPPL N95; Centers for Disease Control and Prevention, 2020, UPD GUID EV TEST PER; Centers for Disease Control and Prevention, 2018, INT UPD PLANN GUID A; Cohn J., 2020, HUFFINGTON POST; Craxi L, 2020, ASIAN BIOETHICS REV, V12, P325, DOI 10.1007/s41649-020-00127-1; Devlin H., 2020, GUARDIAN; Emanuel EJ, 2006, SCIENCE, V312, P854, DOI 10.1126/science.1125347; Ferguson N., 2020, IMPERIAL COLL LONDON; Gold J, 2020, KAISER HLTH NEWS; Harrison C, 2020, NAT BIOTECHNOL; Hick JL, 2020, NAM PERSPECTIVES; Irvin CB, 2008, PREHOSP DISASTER MED, V23, P328, DOI 10.1017/S1049023X00005963; Jacobs A, 2020, NY TIMES; Kerstein SJ, 2017, J APPL PHILOS, V34, P635, DOI 10.1111/japp.12158; Kuhn A., 2020, S KOREAN CITY IS CHA; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Livingston E, 2020, JAMA; Mounk Y, 2020, EXTRAORDINARY DECISI; Persad G, 2009, LANCET, V373, P423, DOI 10.1016/S0140-6736(09)60137-9; Reske JJ, 2020, EPIGENET CHROMATIN, V13, DOI 10.1186/s13072-020-00342-y; Rosenbaum Sara J, 2011, ETHICAL CONSIDERATIO; Rubinson L, 2010, DISASTER MED PUBLIC, V4, P199, DOI 10.1001/dmp.2010.18; Sanger-Katz M, 2020, NY TIMES; Society of Critical Care Medicine, CRIT CAR STAT; Toner E., 2020, WHAT US HOSP SHOULD; Whoriskey P., 2020, WASHINGTON POST; Wu Z, 2020, JAMA; Zimmer C., 2020, NY TIMES; Zucker HA., 2015, VENTILATOR ALLOCATIO	39	1537	1586	30	136	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					2049	2055		10.1056/NEJMsb2005114	http://dx.doi.org/10.1056/NEJMsb2005114			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LT1TD	32202722	Bronze, Green Published			2022-12-28	WOS:000536856000022
J	Willett, FR; Deo, DR; Avansino, DT; Rezaii, P; Hochberg, LR; Henderson, JM; Shenoy, KV				Willett, Francis R.; Deo, Darrel R.; Avansino, Donald T.; Rezaii, Paymon; Hochberg, Leigh R.; Henderson, Jaimie M.; Shenoy, Krishna V.			Hand Knob Area of Premotor Cortex Represents the Whole Body in a Compositional Way	CELL			English	Article							PRIMARY MOTOR CORTEX; ELECTROCORTICOGRAPHIC SPECTRAL-ANALYSIS; HUMAN SENSORIMOTOR CORTEX; ARM MOVEMENTS; CORTICAL REPRESENTATION; ORGANIZATION; SYSTEM; COORDINATION; TETRAPLEGIA; FMRI	Decades after the motor homunculus was first proposed, it is still unknown how different body parts are intermixed and interrelated in human motor cortical areas at single-neuron resolution. Using multi-unit recordings, we studied how face, head, arm, and leg movements are represented in the hand knob area of premotor cortex (precentral gyrus) in people with tetraplegia. Contrary to traditional expectations, we found strong representation of all movements and a partially "compositional'' neural code that linked together all four limbs. The code consisted of (1) a limb-coding component representing the limb to be moved and (2) a movement-coding component where analogous movements from each limb (e.g., hand grasp and toe curl) were represented similarly. Compositional coding might facilitate skill transfer across limbs, and it provides a useful framework for thinking about how the motor system constructs movement. Finally, we leveraged these results to create a whole-body intracortical brain-computer interface that spreads targets across all limbs.	[Willett, Francis R.; Deo, Darrel R.; Avansino, Donald T.; Rezaii, Paymon; Henderson, Jaimie M.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Willett, Francis R.; Deo, Darrel R.; Shenoy, Krishna V.] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA; [Deo, Darrel R.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Hochberg, Leigh R.] Providence VA Med Ctr, Rehabil R&D Serv, VA RR&D Ctr Neurorestorat & Neurotechnol, Providence, RI USA; [Hochberg, Leigh R.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.] Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Hochberg, Leigh R.] Massachusetts Gen Hosp, Dept Neurol, Ctr Neurotechnol & Neurorecovery, Boston, MA 02114 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA; [Willett, Francis R.; Shenoy, Krishna V.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shenoy, Krishna V.] Stanford Univ, Wu Tsai Neurosci Inst, BioX Program, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; Brown University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Willett, FR (corresponding author), Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA.; Willett, FR (corresponding author), Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.; Willett, FR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	fwillett@stanford.edu		Rezaii, Paymon/0000-0002-4803-0853; Henderson, Jaimie/0000-0002-3276-2267; Deo, Darrel/0000-0002-1929-8383	Office of Research and Development, Rehabilitation R and D Service; Department of Veterans Affairs [N9288C, N2864C, A2295R, B6453R]; Executive Committee on Research of Massachusetts General Hospital; NIDCD [R01DC009899, R01DC014034]; NINDS [U01NS098968]; Simons Foundation Collaboration on the Global Brain [543045]; Office of Naval Research [W911NF-14-20013]; Howard Hughes Medical Institute; Wu Tsai Neuroscience Institute at Stanford	Office of Research and Development, Rehabilitation R and D Service; Department of Veterans Affairs(US Department of Veterans Affairs); Executive Committee on Research of Massachusetts General Hospital; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Simons Foundation Collaboration on the Global Brain; Office of Naval Research(Office of Naval Research); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wu Tsai Neuroscience Institute at Stanford	We thank participants T5 and T7 and their caregivers for their dedicated contributions to this research; N. Lam, E. Siauciunas, and B. Davis for administrative support; and J. Simeral and B. Sorice for data collection with T7. This work was supported by the Office of Research and Development, Rehabilitation R and D Service, and Department of Veterans Affairs N9288C, N2864C, A2295R, and B6453R (to L.R.H.); the Executive Committee on Research of Massachusetts General Hospital (to L.R.H.); NIDCD R01DC009899 (to L.R.H.); NINDS U01NS098968 (to L.R.H.); Larry and Pamela Garlick, Samuel and Betsy Reeves, the Wu Tsai Neuroscience Institute at Stanford, and NIDCD R01DC014034 (to J.M.H. and K.V.S.); the Simons Foundation Collaboration on the Global Brain 543045 (K.V.S.); the Office of Naval Research W911NF-14-20013 (K.V.S.); and the Howard Hughes Medical Institute (to K.V.S.). The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.	Abadi M., 2016, ARXIV PREPRINT; Aflalo T, 2015, SCIENCE, V348, P906, DOI 10.1126/science.aaa5417; Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; Allefeld C, 2014, NEUROIMAGE, V89, P345, DOI 10.1016/j.neuroimage.2013.11.043; Bishop C.M., 2006, PATTERN RECOGN; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Brodmann K, 1909, VERGLEICHENDE LOKALI; Bundy DT, 2018, J NEUROSCI, V38, P10042, DOI 10.1523/JNEUROSCI.0015-18.2018; Christou EA, 2008, J MOTOR BEHAV, V40, P186, DOI 10.3200/JMBR.40.3.186-189; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Criscimagna-Hemminger SE, 2003, J NEUROPHYSIOL, V89, P168, DOI 10.1152/jn.00622.2002; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Diedrichsen J, 2013, CEREB CORTEX, V23, P1362, DOI 10.1093/cercor/bhs120; Diedrichsen J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005508; Fagg AH, 1997, IEEE INT CONF ROBOT, P2638, DOI 10.1109/ROBOT.1997.619359; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; Fujiwara Y, 2017, NEUROIMAGE, V147, P302, DOI 10.1016/j.neuroimage.2016.11.058; Ganguly K, 2009, J NEUROSCI, V29, P12948, DOI 10.1523/JNEUROSCI.2471-09.2009; Genon S, 2018, NEUROIMAGE, V170, P400, DOI 10.1016/j.neuroimage.2017.02.034; Genon S, 2017, CEREB CORTEX, V27, P2095, DOI 10.1093/cercor/bhw065; GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Geyer S, 2000, ANAT EMBRYOL, V202, P443, DOI 10.1007/s004290000127; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Geyer S., 2004, MICROSTRUCTURAL BORD; Heming EA, 2019, ELIFE, V8, DOI 10.7554/eLife.48190; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Hoy KE, 2004, BRAIN RES REV, V46, P315, DOI 10.1016/j.brainresrev.2004.07.013; Ifft PJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006159; Jarosiewicz B, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac7328; Jin YL, 2016, IEEE ENG MED BIO, P1544, DOI 10.1109/EMBC.2016.7591005; Kelso JAS, 2002, J EXP PSYCHOL HUMAN, V28, P776, DOI 10.1037//0096-1523.28.4.776; Kingma D.P., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1412.6980; Kobak D, 2016, ELIFE, V5, DOI 10.7554/eLife.10989; KURATA K, 1989, EXP BRAIN RES, V77, P245, DOI 10.1007/BF00274982; Latash ML, 1999, J MOTOR BEHAV, V31, P107, DOI 10.1080/00222899909600981; Leyton ASF, 1917, Q J EXP PHYSIOL, V11, P135, DOI 10.1113/expphysiol.1917.sp000240; Lotze M, 2000, NEUROIMAGE, V11, P473, DOI 10.1006/nimg.2000.0556; Meier JD, 2008, J NEUROPHYSIOL, V100, P1800, DOI 10.1152/jn.90531.2008; MILAN L, 1995, APPL STAT-J ROY ST C, V44, P31, DOI 10.2307/2986193; Miller KJ, 2007, J NEUROSCI, V27, P2424, DOI 10.1523/JNEUROSCI.3886-06.2007; Morris T, 2009, EXP BRAIN RES, V192, P33, DOI 10.1007/s00221-008-1547-x; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nozaki D, 2006, NAT NEUROSCI, V9, P1364, DOI 10.1038/nn1785; Nuyujukian P, 2015, IEEE T BIO-MED ENG, V62, P21, DOI 10.1109/TBME.2014.2354697; Pandarinath C, 2017, ELIFE, V6, DOI 10.7554/eLife.18554; Penfield W, 1937, BRAIN, V60, P389, DOI 10.1093/brain/60.4.389; Penfield W., 1950, CEREBRAL CORTEX MAN; Qi HX, 2000, J NEUROPHYSIOL, V84, P2133, DOI 10.1152/jn.2000.84.4.2133; Rademacher J, 2001, BRAIN, V124, P2232, DOI 10.1093/brain/124.11.2232; RADEMACHER J, 1993, CEREB CORTEX, V3, P313, DOI 10.1093/cercor/3.4.313; Ramsey S, 2019, JMIR RES PROTOC, V8, DOI 10.2196/15356; Reverberi C, 2012, CEREB CORTEX, V22, P1237, DOI 10.1093/cercor/bhr200; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; Rokni U, 2003, J NEUROSCI, V23, P11577; Ruescher J, 2013, NEUROIMAGE, V81, P164, DOI 10.1016/j.neuroimage.2013.04.102; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Savin DN, 2008, EXP BRAIN RES, V186, P175, DOI 10.1007/s00221-007-1220-9; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Severiano A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019539; Shea CH, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00052; Soska KC, 2012, DEV PSYCHOBIOL, V54, P372, DOI 10.1002/dev.20595; Trautmann EM, 2019, NEURON, V103, P292, DOI 10.1016/j.neuron.2019.05.003; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; White LE, 1997, CEREB CORTEX, V7, P18, DOI 10.1093/cercor/7.1.18; Wiestler T, 2014, J NEUROSCI, V34, P5054, DOI 10.1523/JNEUROSCI.5363-13.2014; Yang GR, 2019, NAT NEUROSCI, V22, P297, DOI 10.1038/s41593-018-0310-2; Yokoi A, 2017, J NEUROPHYSIOL, V117, P1043, DOI 10.1152/jn.00387.2016; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141; Zhang CY, 2017, NEURON, V95, P697, DOI 10.1016/j.neuron.2017.06.040; Zilles K, 1995, J ANAT, V187, P515	73	35	36	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2020	181	2					396	+		10.1016/j.cell.2020.02.043	http://dx.doi.org/10.1016/j.cell.2020.02.043			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LD7BL	32220308	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000526184900019
J	Lie, AK; Greene, JA				Lie, Anne Kveim; Greene, Jeremy A.			From Ariadne's Thread to the Labyrinth Itself - Nosology and the Infrastructure of Modern Medicine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DIAGNOSIS	As medicine begins adopting the 11th revision of the International Classification of Diseases, tracing the history of disease classification in medical practice since 1700 reveals substantive changes in the infrastructure supporting medical knowledge and practice.	[Lie, Anne Kveim] Univ Oslo, Dept Community Med & Global Hlth, Oslo, Norway; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Dept Hist Med, Baltimore, MD USA; [Greene, Jeremy A.] Johns Hopkins Univ, Sch Med, Ctr Med Humanities & Social Med, Baltimore, MD USA	University of Oslo; Johns Hopkins University; Johns Hopkins University	Lie, AK (corresponding author), Univ Oslo, Dept Community Med & Global Hlth, Oslo, Norway.				NLM NIH HHS [G13 LM012988] Funding Source: Medline	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Armstrong D, 2011, SOC SCI MED, V73, P801, DOI 10.1016/j.socscimed.2011.05.017; Beemer JK, 2009, SOC SCI HIST, V33, P307, DOI 10.1215/01455532-2009-003; Berg F, 1957, LINNES SYSTEMA MORBO; BLAXTER M, 1978, SOC SCI MED, V12, P9, DOI 10.1016/0271-7123(78)90017-2; Bowker G. C., 1999, SORTING THINGS OUT C; Burke MC, 2011, ADV MED SOCIOL, V12, P183, DOI 10.1108/S1057-6290(2011)0000012013; Cullen W, 1769, SYNOPSIS NOSOLOGI ME; de Sauvages FrancoisBoissier., 1763, NOSOLOGIA METHODICA; DeLacy M, 1999, J HIST MED ALL SCI, V54, P261, DOI 10.1093/jhmas/54.2.261; Diepgen P, 1941, SUDHOFFS ARCH GESCH, V34, P61; Faber K, 1923, NOSOGRAPHY MODERN IN; Farr W, 1839, LONDON J STAT SOC LO, P63; Fischer-Homberger E, 1970, Med Hist, V14, P397; Foucault M., 1994, BIRTH CLIN; Greene J, CULTURAL HIST MED MO; Hess V, 1998, THEOR MED BIOETH, V19, P203, DOI 10.1023/A:1009957730860; Hess V, 2014, EARLY SCI MED, V19, P471, DOI 10.1163/15733823-00195p05; Johnson LMR, 2018, ICD 11 HURRY WAIT; King L S, 1966, Bull Hist Med, V40, P43; Kveim Lie A, 2008, RADESYKENS TILBLIVEL; Lie AK, 2018, TIDSSKR NOR LAEGEFOR, V138, P138; Lie AK, 2016, ARV NORDIC YB FOLKLO, V72, P61; Lopez Pinero JM, 1961, ASCLEPIO, V13, P1961; Moriyama IM, 2011, HIST STAT CLASSIFICA; Pomata G, 2010, EARLY SCI MED, V15, P193, DOI 10.1163/157338210X493932; Reed GM, 2016, WORLD PSYCHIATRY, V15, P205, DOI 10.1002/wps.20354; Rosenberg CE, 2002, MILBANK Q, V80, P237, DOI 10.1111/1468-0009.t01-1-00003; Temkin Owsei, 1977, DOUBLE FACE JANUS OT, P441; World Health Organization, 2019, ICD 11 IMPL TRANS GU, V1, P1; World Health Organization, 2018, ICD 11 CLASS DIS MAP	30	8	8	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1273	1277		10.1056/NEJMms1913140	http://dx.doi.org/10.1056/NEJMms1913140			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY1UO	32212526	Green Accepted			2022-12-28	WOS:000522357300016
J	Vince, G				Vince, Gaia			The world's largest refugee camp prepares for covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												gaiavince@wanderinggaia.com						Dong Y, 2020, EPIDEMIOLOGY COVID 1; Vince G., 2019, SURVIVE WORLDS BIGGE	2	24	24	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1205	10.1136/bmj.m1205	http://dx.doi.org/10.1136/bmj.m1205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217520	Bronze			2022-12-28	WOS:000523764800011
J	Zondervan, KT; Becker, CM; Missmer, SA				Zondervan, Krina T.; Becker, Christian M.; Missmer, Stacey A.			Endometriosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							QUALITY-OF-LIFE; CANCER-ASSOCIATED MUTATIONS; ESTROGEN-RECEPTOR-BETA; WOMEN; PAIN; RISK; PATHOGENESIS; DISEASE; MENSTRUATION; MANAGEMENT	About 10% of reproductive-age women have endometriosis. Symptoms can include severe pain, dysmenorrhea, dyspareunia, dysuria, infertility, and fatigue. The pathogenesis is unclear. Hormonal therapy controls symptoms in some women; others require surgery, which may not be effective.	[Zondervan, Krina T.; Becker, Christian M.] Univ Oxford, Endometriosis Care & Res CaRe Ctr, Nuffield Dept Womens & Reprod Hlth, John Radcliffe Hosp, Oxford, England; [Zondervan, Krina T.] Univ Oxford, John Radcliffe Hosp, Wellcome Ctr Human Genet, Oxford, England; [Missmer, Stacey A.] Boston Childrens Hosp, Div Adolescent & Young Adult Med, Dept Med, Boston, MA USA; [Missmer, Stacey A.] Harvard Med Sch, Boston Ctr Endometriosis, Boston Childrens Hosp, Boston, MA 02115 USA; [Missmer, Stacey A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Missmer, Stacey A.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Missmer, Stacey A.] Michigan State Univ, Coll Human Med, Dept Obstet Gynecol & Reprod Biol, Grand Rapids, MI USA	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Michigan State University; Michigan State University College of Human Medicine	Zondervan, KT (corresponding author), Univ Oxford, Nuffield Dept Womens & Reprod Hlth, Womens Ctr, John Radcliffe Hosp, Level 3, Oxford OX3 9DU, England.	krina.zondervan@whr.ox.ac.uk	Zondervan, Krina/M-1143-2013	Zondervan, Krina/0000-0002-0275-9905				Anglesio MS, 2017, NEW ENGL J MED, V376, P1835, DOI 10.1056/NEJMoa1614814; [Anonymous], 2016, PREV CHRONIC DIS, V13, pE40; [Anonymous], 2014, ALZHEIMERS DEMENT J, V10, pe47; As-Sanie S, 2016, J PAIN, V17, P1, DOI 10.1016/j.jpain.2015.09.008; Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Ballard K, 2006, FERTIL STERIL, V86, P1296, DOI 10.1016/j.fertnstert.2006.04.054; Becker CM, 2017, FERTIL STERIL, V108, P125, DOI 10.1016/j.fertnstert.2017.05.004; Berkley KJ, 2005, SCIENCE, V308, P1587, DOI 10.1126/science.1111445; Beste MT, 2014, SCI TRANSL MED, V6; Brandsborg B, 2018, CURR OPIN ANESTHESIO, V31, P268, DOI 10.1097/ACO.0000000000000586; Bulun SE, 2012, SEMIN REPROD MED, V30, P39, DOI 10.1055/s-0031-1299596; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Carey ET, 2017, DRUGS, V77, P285, DOI 10.1007/s40265-016-0687-8; Casper RF, 2014, FERTIL STERIL, V102, DOI 10.1016/j.fertnstert.2014.07.1211; Caumo W, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00357; Dunselman GAJ, 2014, HUM REPROD, V29, P400, DOI 10.1093/humrep/det457; Esserman LJ, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0035-5; Evers JLH, 2013, HUM REPROD, V28, P2023, DOI 10.1093/humrep/det298; Ferrero S, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-89; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Forster R, 2019, FASEB J, V33, P11210, DOI 10.1096/fj.201900797R; Gallagher JS, 2018, J ADOLESCENT HEALTH, V63, P766, DOI 10.1016/j.jadohealth.2018.06.027; Gargett CE, 2014, MOL HUM REPROD, V20, P591, DOI 10.1093/molehr/gau025; Greaves E, 2015, AM J PATHOL, V185, P2286, DOI 10.1016/j.ajpath.2015.04.012; HALME J, 1984, OBSTET GYNECOL, V64, P151; Han SJ, 2015, CELL, V163, P960, DOI 10.1016/j.cell.2015.10.034; Holt VL, 2000, EPIDEMIOLOGY, V11, P654, DOI 10.1097/00001648-200011000-00007; Horne AW, 2019, BJOG-INT J OBSTET GY, V126, P1414, DOI 10.1111/1471-0528.15894; International Association for the Study of Pain, 2018, IASP STAT OP; Jerman LF, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124313; Johnson NP, 2017, HUM REPROD, V32, P315, DOI 10.1093/humrep/dew293; Kang YJ, 2014, HUM REPROD, V29, P2176, DOI 10.1093/humrep/deu172; Khera AV, 2018, NAT GENET, V50, P1219, DOI 10.1038/s41588-018-0183-z; Klemmt PAB, 2007, HUM REPROD, V22, P3139, DOI 10.1093/humrep/dem262; Knapp VJ, 1999, FERTIL STERIL, V72, P10; Kvaskoff M, 2015, HUM REPROD UPDATE, V21, P500, DOI 10.1093/humupd/dmv013; Lac V, 2019, J PATHOL, V249, P173, DOI 10.1002/path.5314; Laschke MW, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.02.036; Laufer M R, 1997, J Pediatr Adolesc Gynecol, V10, P199; Laux-Biehlmann A, 2015, TRENDS PHARMACOL SCI, V36, P270, DOI 10.1016/j.tips.2015.03.004; Lee SH, 2013, HUM MOL GENET, V22, P832, DOI 10.1093/hmg/dds491; Mahajan A, 2018, NAT GENET, V50, P1505, DOI 10.1038/s41588-018-0241-6; Michailidou K, 2015, NAT GENET, V47, P373, DOI 10.1038/ng.3242; Mu F, 2018, AM J EPIDEMIOL, V187, P515, DOI 10.1093/aje/kwx272; Nisenblat V, 2016, COCHRANE DB SYST REV, V5, P12179; Nisenblat V, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009591.pub2; Nnoaham KE, 2012, FERTIL STERIL, V98; Nnoaham KE, 2011, FERTIL STERIL, V96, P366, DOI 10.1016/j.fertnstert.2011.05.090; Powell JE, 2016, HUM MOL GENET, V25, P5046, DOI 10.1093/hmg/ddw320; Practice Comm Amer Soc Reprod Med, 2012, FERTIL STERIL, V98, P591, DOI 10.1016/j.fertnstert.2012.05.031; Prescott J, 2016, HUM REPROD, V31, P1475, DOI 10.1093/humrep/dew085; Rahmioglu N, 2018, LARGE SCALE GENOME W, DOI 10.1101/406967v1; Reich S, 2019, MACROMOL CHEM PHYS, V220, DOI 10.1002/macp.201900007; Reis FM, 2013, HUM REPROD UPDATE, V19, P406, DOI 10.1093/humupd/dmt010; Rush G, 2019, HEALTH QUAL LIFE OUT, V17, DOI 10.1186/s12955-019-1185-y; Saha R, 2015, FERTIL STERIL, V104, P947, DOI 10.1016/j.fertnstert.2015.06.035; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Santamaria X, 2018, HUM REPROD UPDATE, V24, P673, DOI 10.1093/humupd/dmy028; Sapkota Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15539; Schliep KC, 2015, HUM REPROD, V30, P2427, DOI 10.1093/humrep/dev147; Shafrir AL, 2018, BEST PRACT RES CL OB, V51, P1, DOI 10.1016/j.bpobgyn.2018.06.001; Shah DK, 2010, ACTA OBSTET GYN SCAN, V89, P646, DOI 10.3109/00016341003657900; Shigesi N, 2019, HUM REPROD UPDATE, V25, P486, DOI 10.1093/humupd/dmz014; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Suda K, 2018, CELL REP, V24, P1777, DOI 10.1016/j.celrep.2018.07.037; SUGINAMI H, 1991, AM J OBSTET GYNECOL, V165, P214, DOI 10.1016/0002-9378(91)90254-O; Symons LK, 2018, TRENDS MOL MED, V24, P748, DOI 10.1016/j.molmed.2018.07.004; Taylor HS, 2017, NEW ENGL J MED, V377, P28, DOI 10.1056/NEJMoa1700089; The World Bank, 2017, POP AG 15 64 POP; Treloar SA, 2005, AM J HUM GENET, V77, P365, DOI 10.1086/432960; Vercellini P, 2016, FERTIL STERIL, V106, P1552, DOI 10.1016/j.fertnstert.2016.10.022; Vercellini P, 2014, NAT REV ENDOCRINOL, V10, P261, DOI 10.1038/nrendo.2013.255; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; Whiteman MK, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.039; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Zondervan KT, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0008-5; 2016, CANC DISCOV, V6, pE0139	78	370	398	31	169	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1244	1256		10.1056/NEJMra1810764	http://dx.doi.org/10.1056/NEJMra1810764			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY1UO	32212520				2022-12-28	WOS:000522357300011
J	O'Dowd, A				O'Dowd, Adrian			Role model: Alex Ball	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m915	10.1136/bmj.m915	http://dx.doi.org/10.1136/bmj.m915			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205363	Bronze			2022-12-28	WOS:000523764100003
J	Burki, T				Burki, Talha			What now for DFID?	LANCET			English	Editorial Material																			0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					938	938						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199480				2022-12-28	WOS:000521744600013
J	Holland, DM; Nicholls, KW; Basinski, A				Holland, David M.; Nicholls, Keith W.; Basinski, Aurora			The Southern Ocean and its interaction with the Antarctic Ice Sheet	SCIENCE			English	Review							ANNULAR MODE; VARIABILITY; SHELVES; TRENDS; DRIVEN	The Southern Ocean exerts a major influence on the mass balance of the Antarctic Ice Sheet, either indirectly, by its influence on air temperatures and winds, or directly, mostly through its effects on ice shelves. How much melting the ocean causes depends on the temperature of the water, which in turn is controlled by the combination of the thermal structure of the surrounding ocean and local ocean circulation, which in turn is determined largely by winds and bathymetry. As climate warms and atmospheric circulation changes, there will be follow-on changes in the ocean circulation and temperature. These consequences will affect the pace of mass loss of the Antarctic Ice Sheet.	[Holland, David M.; Basinski, Aurora] NYU, Dept Math, 550 1st Ave, New York, NY 10012 USA; [Holland, David M.; Basinski, Aurora] New York Univ Abu Dhabi Inst, Abu Dhabi, U Arab Emirates; [Nicholls, Keith W.] British Antarctic Survey, Cambridge CB3 0ET, England	New York University; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Holland, DM (corresponding author), NYU, Dept Math, 550 1st Ave, New York, NY 10012 USA.; Holland, DM (corresponding author), New York Univ Abu Dhabi Inst, Abu Dhabi, U Arab Emirates.	david.holland@nyu.edu			NSF [PLR-1739003]; NYU Abu Dhabi grant [G1204]; NERC [NE/S006656/1]	NSF(National Science Foundation (NSF)); NYU Abu Dhabi grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	D.M.H. and A.B. were supported by NSF grant PLR-1739003 and NYU Abu Dhabi grant no. G1204. K.W.N. is supported by NERC grant NE/S006656/1.	Alley RB, 2015, ANNU REV EARTH PL SC, V43, P207, DOI 10.1146/annurev-earth-060614-105344; Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Arthern RJ, 2017, GEOPHYS RES LETT, V44, P2352, DOI 10.1002/2017GL072514; Bell RE, 2020, SCIENCE, V367, P1321, DOI 10.1126/science.aaz5489; Broecker WS, 1987, GLOBAL BIOGEOCHEM CY, V1, P251, DOI 10.1029/GB001i003p00251; Broecker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07; Ding QH, 2011, NAT GEOSCI, V4, P398, DOI [10.1038/ngeo1129, 10.1038/NGEO1129]; Ding QH, 2012, J CLIMATE, V25, P6330, DOI 10.1175/JCLI-D-11-00523.1; Dinniman MS, 2003, DEEP-SEA RES PT II, V50, P3103, DOI 10.1016/j.dsr2.2003.07.011; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Fogt RL, 2006, J CLIMATE, V19, P979, DOI 10.1175/JCLI3671.1; Fogt RL, 2009, J CLIMATE, V22, P5346, DOI 10.1175/2009JCLI2786.1; Gudmundsson GH, 2019, GEOPHYS RES LETT, V46, P13903, DOI 10.1029/2019GL085027; Hellmer HH, 2012, NATURE, V485, P225, DOI 10.1038/nature11064; Holland PR, 2019, NAT GEOSCI, V12, P718, DOI 10.1038/s41561-019-0420-9; Iudicone D, 2008, J PHYS OCEANOGR, V38, P1401, DOI 10.1175/2007JPO3525.1; Jacobs SS, 1996, GEOPHYS RES LETT, V23, P957, DOI 10.1029/96GL00723; Jacobs S, 2006, PHILOS T R SOC A, V364, P1657, DOI 10.1098/rsta.2006.1794; Jenkins A, 2018, NAT GEOSCI, V11, P733, DOI 10.1038/s41561-018-0207-4; Jenkins A, 2016, OCEANOGRAPHY, V29, P106, DOI 10.5670/oceanog.2016.103; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Khazendar A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13243; L'Heureux ML, 2006, J CLIMATE, V19, P276, DOI 10.1175/JCLI3617.1; Lachlan-Cope T, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006386; LEWIS EL, 1986, J GEOPHYS RES-OCEANS, V91, P1756, DOI 10.1029/JC091iC10p11756; Li XC, 2014, NATURE, V505, P538, DOI 10.1038/nature12945; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Medley B, 2019, NAT CLIM CHANGE, V9, P34, DOI 10.1038/s41558-018-0356-x; Morlighem M, 2020, NAT GEOSCI, V13, P132, DOI 10.1038/s41561-019-0510-8; Nitsche FO, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001694; Paolo FS, 2018, NAT GEOSCI, V11, P121, DOI 10.1038/s41561-017-0033-0; Pattyn F, 2020, SCIENCE, V367, P1331, DOI 10.1126/science.aaz5487; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Raphael MN, 2016, B AM METEOROL SOC, V97, P111, DOI 10.1175/BAMS-D-14-00018.1; Rignot E, 2002, SCIENCE, V296, P2020, DOI 10.1126/science.1070942; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; SCAR, 2013, SO OC OBS SYST SOOS; Schneider DP, 2008, P NATL ACAD SCI USA, V105, P12154, DOI 10.1073/pnas.0803627105; Smith JA, 2017, NATURE, V541, P77, DOI 10.1038/nature20136; ten Brink U. S., 1992, 6 INT S ANT EARTH SC, P763; Thoma M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034939; Thomas R, 2004, SCIENCE, V306, P255, DOI 10.1126/science.1099650; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	44	17	18	15	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1326	1330		10.1126/science.aaz5491	http://dx.doi.org/10.1126/science.aaz5491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193320				2022-12-28	WOS:000522167400041
J	Son, K; Scharer, OD				Son, Kook; Scharer, Orlando D.			Repair, Removal, and Shutdown: It All Hinges on RNA Polymerase II Ubiquitylation	CELL			English	Editorial Material							COUPLED DNA-REPAIR	Two papers, by Nakazawa and Vidakovic, show how ubiquitylation of a single lysine residue in RNA polymerase II serves as a master switch to regulate transcription, RNA polymerase II degradation, and transcription-coupled nucleotide excision repair in response to DNA damage.	[Son, Kook; Scharer, Orlando D.] Inst Basic Sci, Ctr Genom Integr, Ulsan 44919, South Korea; [Scharer, Orlando D.] Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan 44919, South Korea	Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Scharer, OD (corresponding author), Inst Basic Sci, Ctr Genom Integr, Ulsan 44919, South Korea.; Scharer, OD (corresponding author), Ulsan Natl Inst Sci & Technol, Sch Life Sci, Ulsan 44919, South Korea.	orlando.scharer@ibs.re.kr	Schärer, Orlando D./AAF-8613-2021					Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Gregersen LH, 2018, TRENDS BIOCHEM SCI, V43, P327, DOI 10.1016/j.tibs.2018.02.010; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Lans H, 2019, NAT REV MOL CELL BIO, V20, P766, DOI 10.1038/s41580-019-0169-4; Li SS, 2002, EMBO J, V21, P5921, DOI 10.1093/emboj/cdf589; Nakazawa Y, 2020, CELL, V180, P1228, DOI 10.1016/j.cell.2020.02.010; Scharer OD, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012609; van der Weegen Y., 2019, BIORXIV, DOI [10. 1101/707216, DOI 10.1101/707216]; Vidakovic A.T., 2020, CELL, V180, P1245	9	5	5	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1039	1041		10.1016/j.cell.2020.02.053	http://dx.doi.org/10.1016/j.cell.2020.02.053			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32200798	Bronze			2022-12-28	WOS:000520925300004
J	Lesser, L				Lesser, Lenard			Any of 4 screening options suggested for screen-naive adults 59 to 70 y with >= 3% 15-y risk for colorectal cancer Comment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Lesser, Lenard] One Med, San Francisco, CA 94111 USA		Lesser, L (corresponding author), One Med, San Francisco, CA 94111 USA.							Hassan C, 2012, ALIMENT PHARM THER, V36, P929, DOI 10.1111/apt.12071; Ran T, 2019, CLIN GASTROENTEROL H, V17, P1969, DOI 10.1016/j.cgh.2019.01.014	2	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC26	JC26		10.7326/ACPJ202003170-026	http://dx.doi.org/10.7326/ACPJ202003170-026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176892				2022-12-28	WOS:000520170800005
J	Gallego, LD; Schneider, M; Mittal, C; Romanauska, A; Carrillo, RGM; Schubert, T; Pugh, BF; Kohler, A				Gallego, Laura D.; Schneider, Maren; Mittal, Chitvan; Romanauska, Anete; Carrillo, Ricardo M. Gudino; Schubert, Tobias; Pugh, B. Franklin; Koehler, Alwin			Phase separation directs ubiquitination of gene-body nucleosomes	NATURE			English	Article							H2B UBIQUITYLATION; HISTONE H2B; MONOUBIQUITINATION; BRE1	The yeast E3 ligase Bre1 forms a core-shell condensate with the scaffold protein Lge1, implicating liquid-liquid phase separation as a mechanism in the ubiquitination of histone H2B along gene bodies. The conserved yeast E3 ubiquitin ligase Bre1 and its partner, the E2 ubiquitin-conjugating enzyme Rad6, monoubiquitinate histone H2B across gene bodies during the transcription cycle(1). Although processive ubiquitination might-in principle-arise from Bre1 and Rad6 travelling with RNA polymerase II2, the mechanism of H2B ubiquitination across genic nucleosomes remains unclear. Here we implicate liquid-liquid phase separation(3) as the underlying mechanism. Biochemical reconstitution shows that Bre1 binds the scaffold protein Lge1, which possesses an intrinsically disordered region that phase-separates via multivalent interactions. The resulting condensates comprise a core of Lge1 encapsulated by an outer catalytic shell of Bre1. This layered liquid recruits Rad6 and the nucleosomal substrate, which accelerates the ubiquitination of H2B. In vivo, the condensate-forming region of Lge1 is required to ubiquitinate H2B in gene bodies beyond the +1 nucleosome. Our data suggest that layered condensates of histone-modifying enzymes generate chromatin-associated 'reaction chambers', with augmented catalytic activity along gene bodies. Equivalent processes may occur in human cells, and cause neurological disease when impaired.	[Gallego, Laura D.; Schneider, Maren; Romanauska, Anete; Carrillo, Ricardo M. Gudino; Schubert, Tobias; Koehler, Alwin] Med Univ Vienna, Max Perutz Labs, VBC, Vienna, Austria; [Mittal, Chitvan; Pugh, B. Franklin] Penn State Univ, Ctr Eukaryot Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kohler, A (corresponding author), Med Univ Vienna, Max Perutz Labs, VBC, Vienna, Austria.	alwin.koehler@mfpl.ac.at	Mittal, Chitvan/GSN-2531-2022	Gallego, Laura D./0000-0001-8481-8747	NOMIS Pioneering Research Grant; L'Oreal-UNESCO-OeAW Austria Fellowship; OeAW DOC Fellowship; National Institutes of Health [HG004160]	NOMIS Pioneering Research Grant; L'Oreal-UNESCO-OeAW Austria Fellowship(L'Oreal Group); OeAW DOC Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Zagrovic and A. Polyansky for critical insights into the multivalency of Lge1 LLPS, and Lge1 and WAC sequence analyses; O. R. Abdi for technical support; and G. Warren and D. Gerlich for discussions. A.K. was funded in part by a NOMIS Pioneering Research Grant, L.D.G. by a L'Oreal-UNESCO-OeAW Austria Fellowship and A.R. by an OeAW DOC Fellowship. B.F.P. and C.M. were funded by the National Institutes of Health grant HG004160.	Alberti S, 2017, CURR BIOL, V27, pR1097, DOI 10.1016/j.cub.2017.08.069; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Bartonek L, 2019, NUCLEIC ACIDS RES, V47, pW632, DOI 10.1093/nar/gkz407; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Cucinotta CE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005420; DeSanto C, 2015, J MED GENET, V52, P754, DOI 10.1136/jmedgenet-2015-103069; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Fuchs G, 2014, BBA-GENE REGUL MECH, V1839, P694, DOI 10.1016/j.bbagrm.2014.01.002; Gallego LD, 2016, P NATL ACAD SCI USA, V113, P10553, DOI 10.1073/pnas.1606863113; Gibson BA, 2019, CELL, V179, P470, DOI 10.1016/j.cell.2019.08.037; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Lai WKM, 2017, NAT REV MOL CELL BIO, V18, P548, DOI 10.1038/nrm.2017.47; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Li H., 2013, ARXIV13033997 Q BIO; Reja R, 2015, GENE DEV, V29, P1942, DOI 10.1101/gad.268896.115; Rossi MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05265-7; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Turco E, 2015, J BIOL CHEM, V290, P5298, DOI 10.1074/jbc.M114.626788; Van Oss SB, 2016, MOL CELL, V64, P815, DOI 10.1016/j.molcel.2016.10.008; Vinayachandran V, 2018, GENOME RES, V28, P357, DOI 10.1101/gr.226761.117; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Wei MT, 2017, NAT CHEM, V9, P1118, DOI [10.1038/NCHEM.2803, 10.1038/nchem.2803]; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Zhang F, 2011, MOL CELL, V41, P384, DOI 10.1016/j.molcel.2011.01.024	33	55	56	8	67	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					592	+		10.1038/s41586-020-2097-z	http://dx.doi.org/10.1038/s41586-020-2097-z		MAR 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214243	Green Accepted			2022-12-28	WOS:000519162500009
J	Zhou, ZS; Torres, M; Sha, HB; Halbrook, CJ; Van den Bergh, F; Reinert, RB; Yamada, T; Wang, SW; Luo, YY; Hunter, AH; Wang, CQ; Sanderson, TH; Liu, ML; Taylor, A; Sesaki, H; Lyssiotis, CA; Wu, J; Kersten, S; Beard, DA; Qi, L				Zhou, Zhangsen; Torres, Mauricio; Sha, Haibo; Halbrook, Christopher J.; Van den Bergh, Francoise; Reinert, Rachel B.; Yamada, Tatsuya; Wang, Siwen; Luo, Yingying; Hunter, Allen H.; Wang, Chunqing; Sanderson, Thomas H.; Liu, Meilian; Taylor, Aaron; Sesaki, Hiromi; Lyssiotis, Costas A.; Wu, Jun; Kersten, Sander; Beard, Daniel A.; Qi, Ling			Endoplasmic reticulum-associated degradation regulates mitochondrial dynamics in brown adipocytes	SCIENCE			English	Article							ER-ASSOCIATED DEGRADATION; SCANNING-ELECTRON-MICROSCOPY; COMPLEX; SEL1L; HRD1; DYSFUNCTION; PROTEASOME; INSIGHTS; NETWORKS; CONTACTS	The endoplasmic reticulum (ER) engages mitochondria at specialized ER domains known as mitochondria-associated membranes (MAMs). Here, we used three-dimensional high-resolution imaging to investigate the formation of pleomorphic "megamitochondria" with altered MAMs in brown adipocytes lacking the Sel1L-Hrd1 protein complex of ER-associated protein degradation (ERAD). Mice with ERAD deficiency in brown adipocytes were cold sensitive and exhibited mitochondrial dysfunction. ERAD deficiency affected ER-mitochondria contacts and mitochondrial dynamics, at least in part, by regulating the turnover of the MAM protein, sigma receptor 1 (SigmaR1). Thus, our study provides molecular insights into ER-mitochondrial cross-talk and expands our understanding of the physiological importance of Sel1L-Hrd1 ERAD.	[Zhou, Zhangsen; Torres, Mauricio; Halbrook, Christopher J.; Van den Bergh, Francoise; Wang, Siwen; Luo, Yingying; Sanderson, Thomas H.; Lyssiotis, Costas A.; Wu, Jun; Beard, Daniel A.; Qi, Ling] Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA; [Sha, Haibo] Cornell Univ, Div Nutr Sci, Ithaca, NY 14850 USA; [Reinert, Rachel B.; Qi, Ling] Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Med Sch, Ann Arbor, MI 48105 USA; [Yamada, Tatsuya; Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Hunter, Allen H.] Univ Michigan, Coll Engn, Ann Arbor, MI 48109 USA; [Hunter, Allen H.] Univ Michigan, Michigan Ctr Mat Characterizat, Ann Arbor, MI 48109 USA; [Wang, Chunqing; Liu, Meilian] Univ New Mexico, Dept Biochem & Mol Biol & Autophagy, Inflammat & Metab Ctr Biomed Res Excellence, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Sanderson, Thomas H.] Univ Michigan, Dept Emergency Med, Med Sch, Ann Arbor, MI 48105 USA; [Taylor, Aaron] Univ Michigan, Biomed Res Core Facil, Ann Arbor, MI 48109 USA; [Lyssiotis, Costas A.] Univ Michigan, Div Gastroenterol & Hepatol, Dept Internal Med, Med Sch, Ann Arbor, MI 48109 USA; [Lyssiotis, Costas A.] Univ Michigan, Rogel Canc Ctr, Med Sch, Ann Arbor, MI 48109 USA; [Wu, Jun] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Kersten, Sander] Wageningen Univ, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Sha, Haibo] Novartis Inst BioMed Res Inc, In Vivo Pharmacol Cardiovasc & Metab Dis, Cambridge, MA 02139 USA	University of Michigan System; University of Michigan; Cornell University; University of Michigan System; University of Michigan; Johns Hopkins University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of New Mexico; University of New Mexico's Health Sciences Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Wageningen University & Research; Novartis	Qi, L (corresponding author), Univ Michigan, Med Sch, Dept Mol & Integrat Physiol, Ann Arbor, MI 48105 USA.; Qi, L (corresponding author), Univ Michigan, Dept Internal Med, Div Metab Endocrinol & Diabet, Med Sch, Ann Arbor, MI 48105 USA.	lingq@med.umich.edu	Lyssiotis, Costas A/AAI-1923-2019; Kersten, Sander/A-1116-2011; Sanderson, Thomas/K-6656-2012	Lyssiotis, Costas A/0000-0001-9309-6141; Kersten, Sander/0000-0003-4488-7734; Van den Bergh, Francoise/0000-0003-4025-6863; Sanderson, Thomas/0000-0003-0112-8164; Zhou, Zhangsen/0000-0001-7333-4624; Reinert, Rachel/0000-0001-7778-4219; Qi, Ling/0000-0001-8229-0184; Torres-Gutierrez, Mauricio Andres/0000-0002-5081-9044	Training Program in Endocrinology and Metabolism [5T32DK007245]; 2017 AACR NextGen Grant for Transformative Cancer Research [17-20-01-LYSS]; ACS Research Scholar Grant [RSG-18-186-01]; ADA Postdoctoral Fellowship [1-19-PDF-093]; Pew Latin American Postdoctoral Fellowship; NIH [DK097153];  [1R01GM123266];  [R01GM130695];  [HL144657];  [1R01DK107583];  [R01DK110439];  [P20GM121176];  [R01NS086819];  [R01NS091242];  [UL1TR000433];  [F32CA228328];  [P30DK034933];  [1R01GM113188];  [1R01DK105393];  [1R01DK120047];  [1R35GM130292]	Training Program in Endocrinology and Metabolism; 2017 AACR NextGen Grant for Transformative Cancer Research; ACS Research Scholar Grant; ADA Postdoctoral Fellowship; Pew Latin American Postdoctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; ; ; ; ; ; ; ; ; ; ; 	This work is supported by 1R01GM123266 and R01GM130695 (H.Se.); HL144657 (D. A.B.); 1R01DK107583 (J.W.); R01DK110439 and P20GM121176 (M.L.); R01NS086819 and R01NS091242 (T.H.S.); UL1TR000433, F32CA228328, and P30DK034933 (C.J.H.); and 1R01GM113188, 1R01DK105393, 1R01DK120047, and 1R35GM130292 (L.Q.). Metabolomics studies performed at the University of Michigan were supported by NIH grant DK097153. Z.Z. is supported by ADA Postdoctoral Fellowship (1-19-PDF-093). M.T. was supported in part by the Pew Latin American Postdoctoral Fellowship. R.B.R. is supported by the Training Program in Endocrinology and Metabolism (5T32DK007245). C.A.L. was supported by a 2017 AACR NextGen Grant for Transformative Cancer Research (17-20-01-LYSS) and an ACS Research Scholar Grant (RSG-18-186-01).	Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Balsa E, 2019, MOL CELL, V74, P877, DOI 10.1016/j.molcel.2019.03.031; Bernard-Marissal N, 2015, BRAIN, V138, P875, DOI 10.1093/brain/awv008; Bhattacharya A, 2019, J CELL SCI, V132, DOI 10.1242/jcs.232850; Bhattacharya A, 2018, EMBO J, V37, DOI 10.15252/embj.201899277; Bleazard W, 1999, NAT CELL BIOL, V1, P298, DOI 10.1038/13014; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gregianin E, 2016, HUM MOL GENET, V25, P3741, DOI 10.1093/hmg/ddw220; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hwang JW, 2018, TRENDS BIOCHEM SCI, V43, P593, DOI 10.1016/j.tibs.2018.06.005; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Ji WK, 2017, J CELL BIOL, V216, P4123, DOI 10.1083/jcb.201610057; Ji YW, 2016, CELL REP, V16, P2630, DOI 10.1016/j.celrep.2016.08.003; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim GH, 2018, J CLIN INVEST, V128, P1125, DOI 10.1172/JCI96420; Kim H, 2015, SEMIN CANCER BIOL, V33, P25, DOI 10.1016/j.semcancer.2015.02.003; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Kyostila K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002759; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055; Lee KS, 2018, P NATL ACAD SCI USA, V115, pE8844, DOI 10.1073/pnas.1721136115; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; McLelland GL, 2018, ELIFE, V7, DOI 10.7554/eLife.32866; Mellai M, 2015, ONCOTARGET, V6, P12452, DOI 10.18632/oncotarget.3611; Montibeller L, 2018, CELL STRESS CHAPERON, V23, P897, DOI 10.1007/s12192-018-0897-y; Mori T, 2012, J PHARMACOL EXP THER, V341, P663, DOI 10.1124/jpet.111.190868; Murley A, 2013, ELIFE, V2, DOI 10.7554/eLife.00422; Paillusson S, 2016, TRENDS NEUROSCI, V39, P146, DOI 10.1016/j.tins.2016.01.008; Pike JA, 2017, METHODS, V115, P42, DOI 10.1016/j.ymeth.2017.01.005; Prause J, 2013, HUM MOL GENET, V22, P1581, DOI 10.1093/hmg/ddt008; Qi L, 2017, TRENDS CELL BIOL, V27, P430, DOI 10.1016/j.tcb.2016.12.002; Rowland AA, 2012, NAT REV MOL CELL BIO, V13, P607, DOI 10.1038/nrm3440; Salvador-Gallego R, 2017, CELL, V171, P1224, DOI 10.1016/j.cell.2017.11.005; Schoebel S, 2017, NATURE, V548, P352, DOI 10.1038/nature23314; Schulz J, 2017, J CELL SCI, V130, P3322, DOI 10.1242/jcs.206847; Sha HB, 2014, CELL METAB, V20, P458, DOI 10.1016/j.cmet.2014.06.015; Shi GJ, 2017, J CLIN INVEST, V127, P3897, DOI 10.1172/JCI94771; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Steffen J, 2017, MOL BIOL CELL, V28, P600, DOI 10.1091/mbc.E16-07-0545; Sugiura A, 2013, MOL CELL, V51, P20, DOI 10.1016/j.molcel.2013.04.023; Sun SY, 2016, MOL BIOL CELL, V27, P483, DOI 10.1091/mbc.E15-10-0724; Sun SY, 2014, P NATL ACAD SCI USA, V111, pE582, DOI 10.1073/pnas.1318114111; Sun SY, 2012, DIABETES, V61, P1471, DOI 10.2337/db11-1389; Twig G, 2006, AM J PHYSIOL-CELL PH, V291, pC176, DOI 10.1152/ajpcell.00348.2005; Vashistha N, 2016, P NATL ACAD SCI USA, V113, P5934, DOI 10.1073/pnas.1603079113; Wei JC, 2018, EMBO J, V37, DOI 10.15252/embj.201898942; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu HX, 2018, SCIENCE, V361, pCP15, DOI 10.1126/science.aan5835; Wu TD, 2014, GENE DEV, V28, P708, DOI 10.1101/gad.238246.114; Wu XD, 2018, CURR OPIN CELL BIOL, V53, P22, DOI 10.1016/j.ceb.2018.04.004; Yamada T, 2018, CELL METAB, V28, P588, DOI 10.1016/j.cmet.2018.06.014; Yang Y, 2018, J BIOL CHEM, V293, P12934, DOI 10.1074/jbc.RA117.001267; Zhou H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00755	64	52	55	9	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2020	368	6486					54	+		10.1126/science.aay2494	http://dx.doi.org/10.1126/science.aay2494			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4UP	32193362	Green Accepted			2022-12-28	WOS:000523259700057
J	Lewis, K				Lewis, Kim			The Science of Antibiotic Discovery	CELL			English	Review							BETA-LACTAMASE INHIBITOR; MYCOBACTERIUM-TUBERCULOSIS; PERSISTER CELLS; ESSENTIAL GENES; DRUG DISCOVERY; IN-VITRO; RESISTANCE; VANCOMYCIN; EFFICACY; SPECTRUM	We are experiencing an antimicrobial resistance (AMR) crisis, brought on by the drying up of the antibiotic discovery pipeline and the resulting unchecked spread of resistant pathogens. Traditional methods of screening environmental isolates or compound libraries have not produced a new drug in over 30 years. Antibiotic discovery is uniquely difficult due to a highly restrictive penetration barrier and other mechanisms that allow bacteria to survive in the presence of toxic compounds. In this Perspective, we analyze the challenges facing discovery and discuss an emerging new platform for antibiotic discovery. The penetration barrier makes screening conventional synthetic compound libraries largely impractical, and actinomycetes, the main source of natural product compounds, have been overmined. The emerging platform is based on understanding the rules that guide the permeation of molecules into bacteria and on advances in microbiology, which enable us to identify and access attractive groups of secondary metabolite producers. Establishing this platform will enable reliable production of lead compounds to combat AMR.	[Lewis, Kim] Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA	Northeastern University	Lewis, K (corresponding author), Northeastern Univ, Dept Biol, Antimicrobial Discovery Ctr, Boston, MA 02115 USA.	k.lewis@neu.edu			NIH [PO1 AI118687, R01 AI141966]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The author is grateful to Olga Lomovskaya and to members of the Antimicrobial Discovery Center for helpful suggestions. Recent work from the Author's lab desribed in this paper was supported by grants PO1 AI118687 and R01 AI141966 from the NIH.	AHARONOWITZ Y, 1992, ANNU REV MICROBIOL, V46, P461, DOI 10.1146/annurev.mi.46.100192.002333; Alekshun MN, 2007, CELL, V128, P1037, DOI 10.1016/j.cell.2007.03.004; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Ardal C, 2020, NAT REV MICROBIOL, V18, P267, DOI 10.1038/s41579-019-0293-3; Baltz R. H., 2005, SIM NEWS, V55, P186; Baltz RH., 2007, MICROBE, V2, P125; Bergval IL, 2009, J ANTIMICROB CHEMOTH, V64, P515, DOI 10.1093/jac/dkp237; Blizzard TA, 2014, BIOORG MED CHEM LETT, V24, P780, DOI 10.1016/j.bmcl.2013.12.101; Brotz-Oesterhelt H, 2005, NAT MED, V11, P1082, DOI 10.1038/nm1306; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Conlon BP, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.51, 10.1038/nmicrobiol.2016.51]; Crawford JM, 2011, CHEM COMMUN, V47, P7559, DOI 10.1039/c1cc11574j; Crits-Christoph A, 2018, NATURE, V558, P440, DOI 10.1038/s41586-018-0207-y; Cross KL, 2019, NAT BIOTECHNOL, V37, P1314, DOI 10.1038/s41587-019-0260-6; D'Onofrio A, 2010, CHEM BIOL, V17, P254, DOI 10.1016/j.chembiol.2010.02.010; DAVIS BD, 1986, P NATL ACAD SCI USA, V83, P6164, DOI 10.1073/pnas.83.16.6164; Davis J.A., 2004, GATHERING BIOL WARFA; Durand-Reville TF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.104; EMERSON RL, 1946, J BACTERIOL, V52, P357, DOI 10.1128/JB.52.3.357-366.1946; Fenn K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0380-5; Gavrish E, 2014, CHEM BIOL, V21, P509, DOI 10.1016/j.chembiol.2014.01.014; Gottig S, 2014, J ANTIMICROB CHEMOTH, V69, P2578, DOI 10.1093/jac/dku170; Grazziotin AL, 2015, FEBS J, V282, P3395, DOI 10.1111/febs.13350; Griffith EC, 2019, ACS INFECT DIS, V5, P1915, DOI 10.1021/acsinfecdis.9b00245; Hart EM, 2019, P NATL ACAD SCI USA, V116, P21748, DOI 10.1073/pnas.1912345116; Hecker SJ, 2015, J MED CHEM, V58, P3682, DOI 10.1021/acs.jmedchem.5b00127; Homma T, 2016, ANTIMICROB AGENTS CH, V60, P6510, DOI 10.1128/AAC.01050-16; Imai Y, 2019, NATURE, V576, P459, DOI 10.1038/s41586-019-1791-1; Jangra M, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/aac.00338-19, 10.1128/AAC.00338-19]; Johnson EO, 2019, NATURE, V571, P72, DOI 10.1038/s41586-019-1315-z; Juhas M, 2011, TRENDS CELL BIOL, V21, P562, DOI 10.1016/j.tcb.2011.07.005; Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Kim W, 2018, NATURE, V556, P103, DOI 10.1038/nature26157; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; Kobylka J, 2020, ANN NY ACAD SCI, V1459, P38, DOI 10.1111/nyas.14239; Kollef MH, 2007, CLIN INFECT DIS, V45, pS191, DOI 10.1086/519470; Konovalova A, 2017, ANNU REV MICROBIOL, V71, P539, DOI 10.1146/annurev-micro-090816-093754; LECLERCQ R, 1988, NEW ENGL J MED, V319, P157, DOI 10.1056/NEJM198807213190307; Levasseur P, 2014, ANTIMICROB AGENTS CH, V58, P6490, DOI 10.1128/AAC.03579-14; Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191; Lewis K, 2019, PERSISTER CELLS AND INFECTIOUS DISEASE, P1, DOI 10.1007/978-3-030-25241-0; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lewis K, 2012, NATURE, V485, P439, DOI 10.1038/485439a; Li XZ, 2015, CLIN MICROBIOL REV, V28, P337, DOI 10.1128/CMR.00117-14; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Liu B, 2020, J MED CHEM, V63, P2789, DOI 10.1021/acs.jmedchem.9b01518; Liu F, 2016, CURR OPIN CHEM BIOL, V32, P48, DOI 10.1016/j.cbpa.2016.03.011; Liu JF, 2020, SCIENCE, V367, P200, DOI 10.1126/science.aay3041; Liu J, 2013, BIOORG MED CHEM LETT, V23, P5654, DOI 10.1016/j.bmcl.2013.08.026; Lloyd KG, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00055-18; LOMOVSKAYA O, 1992, P NATL ACAD SCI USA, V89, P8938, DOI 10.1073/pnas.89.19.8938; Luther A, 2019, NATURE, V576, P452, DOI 10.1038/s41586-019-1665-6; Marshall CG, 1997, P NATL ACAD SCI USA, V94, P6480, DOI 10.1073/pnas.94.12.6480; Melchers MJ, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01699-18; Mourtada R, 2019, NAT BIOTECHNOL, V37, P1186, DOI 10.1038/s41587-019-0222-z; Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103; Muller A, 2016, P NATL ACAD SCI USA, V113, pE7077, DOI 10.1073/pnas.1611173113; Mulcahy LR, 2010, J BACTERIOL, V192, P6191, DOI 10.1128/JB.01651-09; Nagai Junya, 2004, Drug Metab Pharmacokinet, V19, P159, DOI 10.2133/dmpk.19.159; Nichols D, 2010, APPL ENVIRON MICROB, V76, P2445, DOI 10.1128/AEM.01754-09; O'Rourke A, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01207-19; O'Shea R, 2008, J MED CHEM, V51, P2871, DOI 10.1021/jm700967e; Pantel L, 2018, MOL CELL, V70, P83, DOI 10.1016/j.molcel.2018.03.001; Parker EN, 2020, NAT MICROBIOL, V5, P67, DOI 10.1038/s41564-019-0604-5; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pew, 2016, SCI ROADMAP ANTIBIOT; Phillips JW, 2011, CHEM BIOL, V18, P955, DOI 10.1016/j.chembiol.2011.06.011; POINAR GO, 1993, FUND APPL NEMATOL, V16, P333; Raheem N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02866; Rajamuthiah R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089189; Ramos-Castaneda JA, 2018, J INFECTION, V76, P438, DOI 10.1016/j.jinf.2018.02.007; Richter MF, 2017, NATURE, V545, P299, DOI 10.1038/nature22308; Rutledge PJ, 2015, NAT REV MICROBIOL, V13, P509, DOI 10.1038/nrmicro3496; Sakoulas G, 2004, J CLIN MICROBIOL, V42, P2398, DOI 10.1128/JCM.42.6.2398-2402.2004; Scangarella-Oman NE, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01302-19; Schatz A, 1944, P SOC EXP BIOL MED, V55, P66, DOI 10.3181/00379727-55-14461; Schumacher MA, 2015, NATURE, V524, P59, DOI 10.1038/nature14662; Scott RW, 2017, CURR TOP MED CHEM, V17, P576, DOI 10.2174/1568026616666160713130452; Shan Y, 2017, MBIO, V8, DOI 10.1128/mBio.02267-16; Shima J, 1996, J BACTERIOL, V178, P7276, DOI 10.1128/jb.178.24.7276-7284.1996; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Smith PA, 2018, NATURE, V561, P189, DOI 10.1038/s41586-018-0483-6; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Storek KM, 2018, P NATL ACAD SCI USA, V115, P3692, DOI 10.1073/pnas.1800043115; Suring W, 2017, MOL ECOL, V26, P3217, DOI 10.1111/mec.14109; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]; Tambong JT, 2013, CURR MICROBIOL, V66, P138, DOI 10.1007/s00284-012-0250-0; Taylor SN, 2018, NEW ENGL J MED, V379, P1835, DOI 10.1056/NEJMoa1706988; Tobias NJ, 2017, NAT MICROBIOL, V2, P1676, DOI 10.1038/s41564-017-0039-9; Tobias NJ, 2018, TRENDS MICROBIOL, V26, P833, DOI 10.1016/j.tim.2018.04.007; Tommasi R, 2015, NAT REV DRUG DISCOV, V14, P529, DOI 10.1038/nrd4572; Torrey HL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155127; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Vilcheze C, 2007, ANNU REV MICROBIOL, V61, P35, DOI 10.1146/annurev.micro.61.111606.122346; Wang J, 2006, NATURE, V441, P358, DOI 10.1038/nature04784; WHO, 2019, GLOB TUB REP; Winterberg H, 1898, Z HYG, V29, P75, DOI DOI 10.1007/BF02217377; Xu LF, 2017, ANN CLIN MICROB ANTI, V16, DOI 10.1186/s12941-017-0191-3; Zalis EA, 2019, MBIO, V10, DOI 10.1128/mBio.01930-19; Zhao M, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01067-18, 10.1128/aac.01067-18]	106	173	177	60	298	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2020	181	1					29	45		10.1016/j.cell.2020.02.056	http://dx.doi.org/10.1016/j.cell.2020.02.056			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KZ5RI	32197064	Bronze			2022-12-28	WOS:000523319000011
J	Jacobsen, KH				Jacobsen, Kathryn H.			Will COVID-19 generate global preparedness?	LANCET			English	Editorial Material							HEALTH		[Jacobsen, Kathryn H.] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA	George Mason University	Jacobsen, KH (corresponding author), George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA.	kjacobse@gmu.edu	Jacobsen, Kathryn H./B-5857-2008	Jacobsen, Kathryn H./0000-0002-4198-6246				Aitsi-Selmi A, 2016, PREHOSP DISASTER MED, V31, P74, DOI 10.1017/S1049023X15005531; Center for Health Security, 2019, GLOB HLTH SEC IND BU; Center for Health Security, 2019, PREP HIGH IMP RESP P; Global Health Security Index; A World At Risk, 2019, WORLD RISK ANN REP G; Jacobsen KH, 2016, ECOHEALTH, V13, P200, DOI 10.1007/s10393-016-1100-5; Kandel N, 2019, WKLY EPIDEMIOL REC, V94, piii; Kandel N, 2020, LANCET, V395, P1047, DOI 10.1016/S0140-6736(20)30553-5; Kelly TR, 2017, PREV VET MED, V137, P112, DOI 10.1016/j.prevetmed.2016.11.023; Lee VJ, 2020, LANCET INFECT DIS, V20, P17, DOI 10.1016/S1473-3099(19)30674-7; World Health Organization, 2019, ROAD MAP ACC MED VAC; Zumla A, 2016, INT J INFECT DIS, V47, P5, DOI 10.1016/j.ijid.2016.06.012	11	60	62	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1013	1014		10.1016/S0140-6736(20)30559-6	http://dx.doi.org/10.1016/S0140-6736(20)30559-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY5YW	32199074	Green Published, Bronze			2022-12-28	WOS:000522650100011
J	Sheka, AC; Adeyi, O; Thompson, J; Hameed, B; Crawford, PA; Ikramuddin, S				Sheka, Adam C.; Adeyi, Oyedele; Thompson, Julie; Hameed, Bilal; Crawford, Peter A.; Ikramuddin, Sayeed			Nonalcoholic Steatohepatitis: A Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FATTY LIVER-DISEASE; BARIATRIC SURGERY; ADVANCED FIBROSIS; INSULIN-RESISTANCE; REDUCES FEATURES; VITAMIN-E; AMINOTRANSFERASE; MORTALITY; NAFLD; RISK	IMPORTANCE Nonalcoholic steatohepatitis (NASH) is the inflammatory subtype of nonalcoholic fatty liver disease (NAFLD) and is associated with disease progression, development of cirrhosis, and need for liver transplant. Despite its importance, NASH is underrecognized in clinical practice. OBSERVATIONS NASH affects an estimated 3% to 6% of the US population and the prevalence is increasing. NASH is strongly associated with obesity, dyslipidemia, type 2 diabetes, and metabolic syndrome. Although a number of noninvasive tests and scoring systems exist to characterize NAFLD and NASH, liver biopsy is the only accepted method for diagnosis of NASH. Currently, no NASH-specific therapies are approved by the US Food and Drug Administration. Lifestyle modification is the mainstay of treatment, including dietary changes and exercise, with the primary goal being weight loss. Substantial improvement in histologic outcomes, including fibrosis, is directly correlated with increasing weight loss. In some cases, bariatric surgery may be indicated to achieve and maintain the necessary degree of weight loss required for therapeutic effect. An estimated 20% of patients with NASH will develop cirrhosis, and NASH is predicted to become the leading indication for liver transplants in the US. The mortality rate among patients with NASH is substantially higher than the general population or patients without this inflammatory subtype of NAFLD, with annual all-cause mortality rate of 25.56 per 1000 person-years and a liver-specific mortality rate of 11.77 per 1000 person-years. CONCLUSIONS AND RELEVANCE Nonalcoholic steatohepatitis affects 3% to 6% of the US population, is more prevalent in patients with metabolic disease and obesity, progresses to cirrhosis in approximately 20% of cases, and is associated with increased rates of liver-specific and overall mortality. Early identification and targeted treatment of patients with nonalcoholic steatohepatitis are needed to improve patient outcomes, including directing patients toward intensive lifestyle modification to promote weight loss and referral for bariatric surgery as indicated for management of obesity and metabolic disease.	[Sheka, Adam C.; Ikramuddin, Sayeed] Univ Minnesota, Dept Surg, 420 Delaware St SE,MMC 195, Minneapolis, MN 55455 USA; [Adeyi, Oyedele] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Thompson, Julie] Univ Minnesota, Dept Med, Div Gastroenterol Hepatol & Nutr, Box 736 UMHC, Minneapolis, MN 55455 USA; [Hameed, Bilal] Univ Calif San Francisco, Dept Med, Div Gastroenterol, San Francisco, CA 94143 USA; [Crawford, Peter A.] Univ Minnesota, Dept Med, Div Mol Med, Box 736 UMHC, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities	Ikramuddin, S (corresponding author), Univ Minnesota, Dept Surg, 420 Delaware St SE,MMC 195, Minneapolis, MN 55455 USA.	ikram001@umn.edu		Crawford, Peter/0000-0001-8597-4426	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH) [R21 DK122832]	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Drs Ikramuddin and Crawford are supported by grant R21 DK122832 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health (NIH).	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abner Erin L, 2011, Curr Aging Sci, V4, P158; Ajmera V, 2018, CLIN GASTROENTEROL H, V16, P341, DOI [10.1016/j.cgh.2017.11.040, 10.1016/j.cgh.2018.01.026]; Aminian A, 2019, JAMA-J AM MED ASSOC, V322, P1271, DOI 10.1001/jama.2019.14231; Angulo P, 2007, HEPATOLOGY, V45, P846, DOI 10.1002/hep.21496; Angulo P, 2015, GASTROENTEROLOGY, V149, P389, DOI 10.1053/j.gastro.2015.04.043; Angulo P, 2015, SEMIN LIVER DIS, V35, P132, DOI 10.1055/s-0035-1550065; Angulo P, 2010, HEPATOLOGY, V51, P373, DOI 10.1002/hep.23521; [Anonymous], 1992, AM J CLIN NUTR, V55, p487S; Armstrong MJ, 2016, LANCET, V387, P679, DOI 10.1016/S0140-6736(15)00803-X; Arnett DK, 2019, J AM COLL CARDIOL, V74, pE177, DOI 10.1016/j.jacc.2019.03.010; Ballon-Landa E, 2018, CURR OPIN UROL, V28, P55, DOI 10.1097/MOU.0000000000000460; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bower G, 2015, OBES SURG, V25, P2280, DOI 10.1007/s11695-015-1691-x; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Carroll Margaret, 2015, NCHS Data Brief, P198; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; Dongiovanni P, 2015, J HEPATOL, V63, P705, DOI 10.1016/j.jhep.2015.05.006; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Ekstedt M, 2015, HEPATOLOGY, V61, P1547, DOI 10.1002/hep.27368; Estes C, 2018, J HEPATOL, V69, P896, DOI 10.1016/j.jhep.2018.05.036; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fryar Cheryl D, 2017, NCHS Data Brief, P1; Hales Craig M, 2017, NCHS Data Brief, P1; Hernaez R, 2011, HEPATOLOGY, V54, P1082, DOI 10.1002/hep.24452; Idilman IS, 2016, ACTA RADIOL, V57, P271, DOI 10.1177/0284185115580488; Ikramuddin S, 2018, JAMA-J AM MED ASSOC, V319, P266, DOI 10.1001/jama.2017.20813; Jan A, 2015, OBES SURG, V25, P1518, DOI 10.1007/s11695-015-1727-2; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kleiner DE, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.12565; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lassailly G, 2015, GASTROENTEROLOGY, V149, P379, DOI 10.1053/j.gastro.2015.04.014; Loomba R, 2014, HEPATOLOGY, V60, P1920, DOI 10.1002/hep.27362; LUDWIG J, 1980, MAYO CLIN PROC, V55, P434; Machado MV, 2013, J HEPATOL, V58, P1007, DOI 10.1016/j.jhep.2012.11.021; Mathurin P, 2009, GASTROENTEROLOGY, V137, P532, DOI 10.1053/j.gastro.2009.04.052; Matteoni CA, 1999, GASTROENTEROLOGY, V116, P1413, DOI 10.1016/S0016-5085(99)70506-8; Maximos M, 2015, HEPATOLOGY, V61, P153, DOI 10.1002/hep.27395; Mendola Nicholas D, 2018, NCHS Data Brief, P1; Mikolasevic I, 2018, WORLD J GASTROENTERO, V24, P1491, DOI 10.3748/wjg.v24.i14.1491; Minervini MI, 2009, J HEPATOL, V50, P501, DOI 10.1016/j.jhep.2008.10.030; Mofrad P, 2003, HEPATOLOGY, V37, P1286, DOI 10.1053/jhep.2003.50229; Musso G, 2012, DIABETOLOGIA, V55, P885, DOI 10.1007/s00125-011-2446-4; Musso G, 2011, ANN MED, V43, P617, DOI 10.3109/07853890.2010.518623; Nalbantoglu I, 2014, WORLD J GASTROENTERO, V20, P9026, DOI 10.3748/wjg.v20.i27.9026; Noureddin M, 2018, AM J GASTROENTEROL, V113, P1649, DOI 10.1038/s41395-018-0088-6; Ong JP, 2008, J HEPATOL, V49, P608, DOI 10.1016/j.jhep.2008.06.018; Ong JP, 2005, OBES SURG, V15, P310, DOI 10.1381/0960892053576820; Pai RK, 2019, ALIMENT PHARM THER, V50, P1100, DOI 10.1111/apt.15503; Pan JJ, 2014, WORLD J HEPATOL, V6, P274, DOI 10.4254/wjh.v6.i5.274; Pastori D, 2015, DIGEST LIVER DIS, V47, P4, DOI 10.1016/j.dld.2014.07.170; Patel NS, 2015, CLIN GASTROENTEROL H, V13, P561, DOI 10.1016/j.cgh.2014.08.039; Sanyal Arun J, 2011, Hepatology, V54, P344, DOI 10.1002/hep.24376; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; SCHURKS M, 2010, BMJ-BRIT MED J, V341, DOI DOI 10.1136/BMJ.C5702; Shah AG, 2009, CLIN GASTROENTEROL H, V7, P1104, DOI 10.1016/j.cgh.2009.05.033; Shin D, 2018, INT J CARDIOL, V259, P216, DOI 10.1016/j.ijcard.2018.01.139; Sorbi D, 1999, AM J GASTROENTEROL, V94, P1018; Stine JG, 2018, ALIMENT PHARM THER, V48, P696, DOI 10.1111/apt.14937; Tran TT, 2006, J GASTROEN HEPATOL, V21, P381, DOI 10.1111/j.1440-1746.2005.03968.x; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; van der Windt Dirk J., 2018, Gene Expression, V18, P89, DOI 10.3727/105221617X15124844266408; Verma S, 2013, LIVER INT, V33, P1398, DOI 10.1111/liv.12226; Vilar-Gomez E, 2015, GASTROENTEROLOGY, V149, P367, DOI 10.1053/j.gastro.2015.04.005; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Younossi ZM, 2019, HEPATOLOGY, V69, P564, DOI 10.1002/hep.30254; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	70	371	390	50	155	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1175	1183		10.1001/jama.2020.2298	http://dx.doi.org/10.1001/jama.2020.2298			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207804				2022-12-28	WOS:000530807000020
J	Rimmer, A				Rimmer, Abi			Covid-19: give NHS staff rest spaces and free parking not thank yous, says doctor	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		RIMMER A, 2019, BMJ-BRIT MED J, V365, DOI DOI 10.1136/BMJ.L2233	1	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1171	10.1136/bmj.m1171	http://dx.doi.org/10.1136/bmj.m1171			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205317	Bronze			2022-12-28	WOS:000523764100015
J	Kumbhari, V; Cheskin, LJ				Kumbhari, Vivek; Cheskin, Lawrence J.			In reflux-related heartburn unresponsive to PPIs, surgery increased treatment success vs active medical treatment Comment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Kumbhari, Vivek] Johns Hopkins Med Inst, Baltimore, MD 21205 USA; [Cheskin, Lawrence J.] George Mason Univ, Coll Hlth & Human Serv, Fairfax, VA 22030 USA	Johns Hopkins University; Johns Hopkins Medicine; George Mason University	Kumbhari, V (corresponding author), Johns Hopkins Med Inst, Baltimore, MD 21205 USA.		Cheskin, Lawrence/AAM-1094-2021	Cheskin, Lawrence/0000-0003-0262-1030				Campos GMR, 1999, J GASTROINTEST SURG, V3, P292	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC32	JC32		10.7326/ACPJ202003170-032	http://dx.doi.org/10.7326/ACPJ202003170-032			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176898				2022-12-28	WOS:000520170800017
J	Voelker, R				Voelker, Rebecca			Cardiac Ultrasound Uses Artificial Intelligence to Produce Images	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	3	3	3	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1034	1034		10.1001/jama.2020.2547	http://dx.doi.org/10.1001/jama.2020.2547			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181835				2022-12-28	WOS:000521968800006
J	Kalil, AC				Kalil, Andre C.			Treating COVID-19-Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORTICOSTEROID TREATMENT	This Viewpoint uses the absence of known effective treatment for Ebola virus disease to emphasize the costs of off-label and compassionate drug use during an infectious disease outbreak and the importance of establishing the efficacy and safety of promising drug leads in randomized trials to inform their clinical use.	[Kalil, Andre C.] Univ Nebraska, Med Ctr, Dept Internal Med, Div Infect Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Kalil, AC (corresponding author), Univ Nebraska, Med Ctr, Dept Internal Med, 95400 Nebraska Med Ctr, Omaha, NE 68135 USA.	akalil@unmc.edu						[Anonymous], 2020, JAMA; [Anonymous], 2019, ACT TOC PRESCR INF; Arabi YM, 2018, AM J RESP CRIT CARE, V197, P757, DOI 10.1164/rccm.201706-1172OC; Burton TM, 2015, WALL STREET J; ClinicalTrials.gov, 2020, AD COVID 19 TREATM T; Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330; Kalil AC, 2011, INTENS CARE MED, V37, P420, DOI 10.1007/s00134-010-2121-0; Lee N, 2004, J CLIN VIROL, V31, P304, DOI 10.1016/j.jcv.2004.07.006; Russell CD, 2020, LANCET, V395, P473, DOI 10.1016/S0140-6736(20)30317-2; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	10	293	307	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1897	1898		10.1001/jama.2020.4742	http://dx.doi.org/10.1001/jama.2020.4742			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32208486	Bronze			2022-12-28	WOS:000536934300008
J	Gostin, LO; Hodge, JG; Wiley, LF				Gostin, Lawrence O.; Hodge, James G., Jr.; Wiley, Lindsay F.			Presidential Powers and Response to COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint reviews legal powers the US president and state governors have to implement travel and other restrictions to control the spread of coronavirus, and discusses the need to balance rights to privacy and liberty with public health in ways that do not disadvantage already vulnerable populations.	[Gostin, Lawrence O.] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Phoenix, AZ USA; [Wiley, Lindsay F.] Amer Univ, Washington Coll Law, Washington, DC 20016 USA	Georgetown University; Arizona State University; Arizona State University-Downtown Phoenix; American University	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Wiley, Lindsay/0000-0001-7918-329X				Emanuel Z, 2020, STATE LOCAL GOVT MUS; Fink S., 2020, NEW YORK TIMES	2	44	44	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2020	323	16					1547	1548		10.1001/jama.2020.4335	http://dx.doi.org/10.1001/jama.2020.4335			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LL2GR	32186661	Green Published, Bronze			2022-12-28	WOS:000531373700013
J	Ray, KK; Nicholls, SJ; Buhr, KA; Ginsberg, HN; Johansson, JO; Kalantar-Zadeh, K; Kulikowski, E; Toth, PP; Wong, N; Sweeney, M; Schwartz, GG				Ray, Kausik K.; Nicholls, Stephen J.; Buhr, Kevin A.; Ginsberg, Henry N.; Johansson, Jan O.; Kalantar-Zadeh, Kamyar; Kulikowski, Ewelina; Toth, Peter P.; Wong, Norman; Sweeney, Michael; Schwartz, Gregory G.		BETonMACE Investigators Committees	Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HISTONE ACETYLTRANSFERASE; INHIBITOR; RVX-208; DISEASE; BROMODOMAIN; OUTCOMES; BRD4	Importance Bromodomain and extraterminal proteins are epigenetic regulators of gene transcription. Apabetalone is a selective bromodomain and extraterminal protein inhibitor targeting bromodomain 2 and is hypothesized to have potentially favorable effects on pathways related to atherothrombosis. Pooled phase 2 data suggest favorable effects on clinical outcomes. Objective To test whether apabetalone significantly reduces major adverse cardiovascular events. Design, Setting, and Participants A randomized, double-blind, placebo-controlled trial, conducted at 190 sites in 13 countries. Patients with an acute coronary syndrome in the preceding 7 to 90 days, type 2 diabetes, and low high-density lipoprotein cholesterol levels were eligible for enrollment, which started November 11, 2015, and ended July 4, 2018, with end of follow-up on July 3, 2019. Interventions Patients were randomized (1:1) to receive apabetalone, 100 mg orally twice daily (n = 1215), or matching placebo (n = 1210) in addition to standard care. Main Outcomes and Measures The primary outcome was a composite of time to the first occurrence of cardiovascular death, nonfatal myocardial infarction, or stroke. Results Among 2425 patients who were randomized (mean age, 62 years; 618 women [25.6%]), 2320 (95.7%) had full ascertainment of the primary outcome. During a median follow-up of 26.5 months, 274 primary end points occurred: 125 (10.3%) in apabetalone-treated patients and 149 (12.4%) in placebo-treated patients (hazard ratio, 0.82 [95% CI, 0.65-1.04]; P = .11). More patients allocated to apabetalone than placebo discontinued study drug (114 [9.4%] vs 69 [5.7%]) for reasons including elevations of liver enzyme levels (35 [2.9%] vs 11 [0.9%]). Conclusions and Relevance Among patients with recent acute coronary syndrome, type 2 diabetes, and low high-density lipoprotein cholesterol levels, the selective bromodomain and extraterminal protein inhibitor apabetalone added to standard therapy did not significantly reduce the risk of major adverse cardiovascular events.	[Ray, Kausik K.] Imperial Coll London, Imperial Ctr Cardiovasc Dis Preven, London, England; [Nicholls, Stephen J.] Monash Univ, Monash Cardiovasc Res Ctr, Melbourne, Vic, Australia; [Buhr, Kevin A.] Univ Wisconsin, Stat Data Anal Ctr, Madison, WI USA; [Ginsberg, Henry N.] Columbia Univ, Irving Inst Clin & Translat Res, New York, NY USA; [Johansson, Jan O.; Kulikowski, Ewelina; Wong, Norman; Sweeney, Michael] Resverlogix Corp, Calgary, AB, Canada; [Kalantar-Zadeh, Kamyar] Univ Calif Irvine, Div Nephrol & Hypertens, Irvine, CA USA; [Toth, Peter P.] CGH Med Ctr, Sterling, IL USA; [Toth, Peter P.] Johns Hopkins Univ, Sch Med, Cicarrone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA; [Schwartz, Gregory G.] Univ Colorado, Sch Med, Div Cardiol, Aurora, CO USA	Imperial College London; Monash University; University of Wisconsin System; University of Wisconsin Madison; Columbia University; University of California System; University of California Irvine; Johns Hopkins University; University of Colorado System; University of Colorado Anschutz Medical Campus	Ray, KK (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, Imperial Ctr Cardiovasc Dis Prevent, St Dunstans Rd, London W6 8RP, England.	k.ray@imperial.ac.uk	Kalantar-Zadeh, Kamyar/Q-4734-2018	Kalantar-Zadeh, Kamyar/0000-0002-8666-0725; Johansson, Jan/0000-0002-3576-2748	Resverlogix Corporation; NIHR Imperial Biomedical Research Centre	Resverlogix Corporation; NIHR Imperial Biomedical Research Centre	Funded by Resverlogix Corporation. Supported by the NIHR Imperial Biomedical Research Centre (Dr Ray).	Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bhatt DL, 2019, NEW ENGL J MED, V380, P11, DOI 10.1056/NEJMoa1812792; Brown JD, 2014, MOL CELL, V56, P219, DOI 10.1016/j.molcel.2014.08.024; Devaiah BN, 2016, NAT STRUCT MOL BIOL, V23, P540, DOI 10.1038/nsmb.3228; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fanaroff AC, 2019, CIRCULATION, V139, P863, DOI 10.1161/CIRCULATIONAHA.118.037202; Gilham D, 2016, ATHEROSCLEROSIS, V247, P48, DOI 10.1016/j.atherosclerosis.2016.01.036; Hajmirza A, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010016; Jahagirdar R, 2014, ATHEROSCLEROSIS, V236, P91, DOI 10.1016/j.atherosclerosis.2014.06.008; Kanno T, 2014, NAT STRUCT MOL BIOL, V21, P1047, DOI 10.1038/nsmb.2912; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Mathias H, 2019, ATHEROSCLEROSIS, V290, P59, DOI 10.1016/j.atherosclerosis.2019.09.002; Nicholls SJ, 2018, AM J CARDIOVASC DRUG, V18, P109, DOI 10.1007/s40256-017-0250-3; Nicholls SJ, 2016, AM J CARDIOVASC DRUG, V16, P55, DOI 10.1007/s40256-015-0146-z; Nicholls SJ, 2011, J AM COLL CARDIOL, V57, P1111, DOI 10.1016/j.jacc.2010.11.015; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Ray KK, 2019, AM HEART J, V217, P72, DOI 10.1016/j.ahj.2019.08.001; Ray KK, 2019, LANCET DIABETES ENDO, V7, P618, DOI 10.1016/S2213-8587(19)30158-5; Ridker PM, 2017, CIRC RES, V120, P617, DOI 10.1161/CIRCRESAHA.116.310527; Robles-Diaz M, 2014, GASTROENTEROLOGY, V147, P109, DOI 10.1053/j.gastro.2014.03.050; Shishikura D, 2019, AM J CARDIOVASC DRUG, V19, P49, DOI 10.1007/s40256-018-0298-8; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Tsujikawa LM, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0696-z; Wasiak S, 2017, J CARDIOVASC TRANSL, V10, P337, DOI 10.1007/s12265-017-9755-z; Wasiak S, 2016, DATA BRIEF, V8, P1280, DOI 10.1016/j.dib.2016.07.047; Zeng L, 2002, FEBS LETT, V513, P124, DOI 10.1016/S0014-5793(01)03309-9; Zinman B, 2016, NEW ENGL J MED, V374, P1094, DOI 10.1056/NEJMc1600827	27	58	60	1	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2020	323	16					1565	1573		10.1001/jama.2020.3308	http://dx.doi.org/10.1001/jama.2020.3308			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LL2GR	32219359	Bronze, Green Published			2022-12-28	WOS:000531373700022
J	Gilan, O; Rioja, I; Knezevic, K; Bell, MJ; Yeung, MM; Harker, NR; Lam, EYN; Chung, CW; Bamborough, P; Petretich, M; Urh, M; Atkinson, SJ; Bassil, AK; Roberts, EJ; Vassiliadis, D; Burr, ML; Preston, AGS; Wellaway, C; Werner, T; Gray, JR; Michon, AM; Gobbetti, T; Kumar, V; Soden, PE; Haynes, A; Vappiani, J; Tough, DF; Taylor, S; Dawson, SJ; Bantscheff, M; Lindon, M; Drewes, G; Demont, EH; Daniels, DL; Grandi, P; Prinjha, RK; Dawson, MA				Gilan, Omer; Rioja, Inmaculada; Knezevic, Kathy; Bell, Matthew J.; Yeung, Miriam M.; Harker, Nicola R.; Lam, Enid Y. N.; Chung, Chun-wa; Bamborough, Paul; Petretich, Massimo; Urh, Marjeta; Atkinson, Stephen J.; Bassil, Anna K.; Roberts, Emma J.; Vassiliadis, Dane; Burr, Marian L.; Preston, Alex G. S.; Wellaway, Christopher; Werner, Thilo; Gray, James R.; Michon, Anne-Marie; Gobbetti, Thomas; Kumar, Vinod; Soden, Peter E.; Haynes, Andrea; Vappiani, Johanna; Tough, David F.; Taylor, Simon; Dawson, Sarah-Jane; Bantscheff, Marcus; Lindon, Matthew; Drewes, Gerard; Demont, Emmanuel H.; Daniels, Danette L.; Grandi, Paola; Prinjha, Rab K.; Dawson, Mark A.			Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation	SCIENCE			English	Article							BROMODOMAIN INHIBITOR OTX015; SKIN INFLAMMATION; DOSE-ESCALATION; ACUTE-LEUKEMIA; RECOGNITION; RESISTANCE; CHROMATIN; BINDING; PROFILE; BRD4	The two tandem bromodomains of the BET (bromodomain and extraterminal domain) proteins enable chromatin binding to facilitate transcription. Drugs that inhibit both bromodomains equally have shown efficacy in certain malignant and inflammatory conditions. To explore the individual functional contributions of the first (BD1) and second (BD2) bromodomains in biology and therapy, we developed selective BD1 and BD2 inhibitors. We found that steady- state gene expression primarily requires BD1, whereas the rapid increase of gene expression induced by inflammatory stimuli requires both BD1 and BD2 of all BET proteins. BD1 inhibitors phenocopied the effects of pan-BET inhibitors in cancer models, whereas BD2 inhibitors were predominantly effective in models of inflammatory and autoimmune disease. These insights into the differential requirement of BD1 and BD2 for the maintenance and induction of gene expression may guide future BET-targeted therapies.	[Gilan, Omer; Knezevic, Kathy; Yeung, Miriam M.; Lam, Enid Y. N.; Vassiliadis, Dane; Burr, Marian L.; Dawson, Sarah-Jane; Dawson, Mark A.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Gilan, Omer; Lam, Enid Y. N.; Vassiliadis, Dane; Burr, Marian L.; Dawson, Sarah-Jane; Dawson, Mark A.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Rioja, Inmaculada; Bell, Matthew J.; Harker, Nicola R.; Chung, Chun-wa; Bamborough, Paul; Atkinson, Stephen J.; Bassil, Anna K.; Roberts, Emma J.; Preston, Alex G. S.; Wellaway, Christopher; Gray, James R.; Gobbetti, Thomas; Soden, Peter E.; Haynes, Andrea; Tough, David F.; Taylor, Simon; Lindon, Matthew; Demont, Emmanuel H.; Prinjha, Rab K.] GlaxoSmithKline Med Res Ctr, Epigenet RU, Stevenage, Herts, England; [Petretich, Massimo; Werner, Thilo; Michon, Anne-Marie; Vappiani, Johanna; Bantscheff, Marcus; Drewes, Gerard; Grandi, Paola] GlaxoSmithKline, Funct Genom R&D, Cellzome GmbH, Heidelberg, Germany; [Urh, Marjeta; Daniels, Danette L.] Promega Corp, Madison, WI USA; [Kumar, Vinod] GlaxoSmithKline, Computat Biol, Collegeville, PA USA; [Dawson, Sarah-Jane; Dawson, Mark A.] Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; University of Melbourne; GlaxoSmithKline; GlaxoSmithKline; Cellzome GmbH; Promega Corporation; GlaxoSmithKline; University of Melbourne	Dawson, MA (corresponding author), Peter MacCallum Canc Ctr, Melbourne, Vic, Australia.; Dawson, MA (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.; Prinjha, RK (corresponding author), GlaxoSmithKline Med Res Ctr, Epigenet RU, Stevenage, Herts, England.; Dawson, MA (corresponding author), Univ Melbourne, Ctr Canc Res, Melbourne, Vic, Australia.	rabinder.prinjha@gsk.com; mark.dawson@petermac.org	Bantscheff, Marcus/AAQ-2903-2021; Dawson, Mark A/B-9317-2017	Bantscheff, Marcus/0000-0002-8343-8977; Dawson, Mark A/0000-0002-5464-5029; Petretich, Massimo/0000-0001-7486-8222; Knezevic, Kathy/0000-0002-3940-3363; Lam, Enid Yi Ni/0000-0001-5843-7836; Harker, Nicola/0000-0003-3612-4366; Gilan, Omer/0000-0003-4156-2619; Vassiliadis, Dane/0000-0002-7814-4851; Yeung, Miriam/0000-0002-9455-1887; Burr, Marian/0000-0002-8995-3398	CCV Dunlop fellowship; HHMI international research scholarship; Victoria Cancer Agency fellowship; CRUK; NHMRC [1106444, 1144649, 1146192]; University of Melbourne; Peter MacCallum Foundation; CSL Centenary fellowship	CCV Dunlop fellowship(Canadian Institutes of Health Research (CIHR)); HHMI international research scholarship; Victoria Cancer Agency fellowship; CRUK(Cancer Research UK); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); University of Melbourne(University of Melbourne); Peter MacCallum Foundation; CSL Centenary fellowship	We thank the following funders for fellowship and grant support: a CCV Dunlop fellowship and an HHMI international research scholarship to M.A.D.; a Victoria Cancer Agency fellowship to O.G. and E.Y. N.L.; CRUK to M.L.B.; and a CSL Centenary fellowship to S.J.D. Work from the Dawson laboratory is supported by grant funding from the NHMRC (1106444, 1144649, 1146192), the University of Melbourne, and the Peter MacCallum Foundation.	Amorim S, 2016, LANCET HAEMATOL, V3, pE196, DOI 10.1016/S2352-3026(16)00021-1; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; Becher I, 2016, NAT CHEM BIOL, V12, P908, DOI [10.1038/NCHEMBIO.2185, 10.1038/nchembio.2185]; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Berthon C, 2016, LANCET HAEMATOL, V3, pE186, DOI 10.1016/S2352-3026(15)00247-1; Burr ML, 2019, CANCER CELL, V36, P385, DOI 10.1016/j.ccell.2019.08.008; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; Dawson M, 2017, BLOOD, V130; Dawson MA, 2017, SCIENCE, V355, P1147, DOI 10.1126/science.aam7304; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Duan QM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5084; Faivre EJ, 2020, NATURE, V578, P306, DOI 10.1038/s41586-020-1930-8; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong CY, 2015, NATURE, V525, P538, DOI 10.1038/nature14888; Gamsjaeger R, 2011, MOL CELL BIOL, V31, P2632, DOI 10.1128/MCB.05413-11; Hatemi G, 2015, NEW ENGL J MED, V372, P1510, DOI 10.1056/NEJMoa1408684; KELSO A, 1994, INT IMMUNOL, V6, P1515, DOI 10.1093/intimm/6.10.1515; Klein K, 2016, ANN RHEUM DIS, V75, P422, DOI 10.1136/annrheumdis-2014-205809; Lewin J, 2018, J CLIN ONCOL, V36, P3007, DOI 10.1200/JCO.2018.78.2292; Matzuk MM, 2012, CELL, V150, P673, DOI 10.1016/j.cell.2012.06.045; McLure KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083190; Middleton SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35653-4; Miller TCR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13855; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muhar M, 2018, SCIENCE, V360, P800, DOI 10.1126/science.aao2793; Nadeem A, 2015, PHARMACOL RES, V99, P248, DOI 10.1016/j.phrs.2015.06.001; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Riching KM, 2018, ACS CHEM BIOL, V13, P2758, DOI 10.1021/acschembio.8b00692; Seal J, 2012, BIOORG MED CHEM LETT, V22, P2968, DOI 10.1016/j.bmcl.2012.02.041; Shang EY, 2007, DEVELOPMENT, V134, P3507, DOI 10.1242/dev.004481; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Sun LP, 2018, AM J PHYSIOL-RENAL, V315, pF469, DOI 10.1152/ajprenal.00527.2017; Tough DF, 2016, NAT REV DRUG DISCOV, V15, P835, DOI 10.1038/nrd.2016.185; Tsherniak A, 2017, CELL, V170, P564, DOI 10.1016/j.cell.2017.06.010; Tyler DS, 2017, SCIENCE, V356, P1397, DOI 10.1126/science.aal2066; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	44	171	174	11	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2020	368	6489					387	+		10.1126/science.aaz8455	http://dx.doi.org/10.1126/science.aaz8455			128	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LH0XH	32193360	Green Accepted			2022-12-28	WOS:000528513300037
J	Johnson, PDR				Johnson, Paul D. R.			Buruli ulcer: cured by 8 weeks of oral antibiotics?	LANCET			English	Editorial Material							MYCOBACTERIUM-ULCERANS; STREPTOMYCIN; COMBINATION; INFECTION; EFFICACY		[Johnson, Paul D. R.] Austin Hlth, Infect Dis Dept, Heidelberg, Vic 3084, Australia; [Johnson, Paul D. R.] Univ Melbourne, Heidelberg, Vic 3084, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Johnson, PDR (corresponding author), Austin Hlth, Infect Dis Dept, Heidelberg, Vic 3084, Australia.; Johnson, PDR (corresponding author), Univ Melbourne, Heidelberg, Vic 3084, Australia.	paul.johnson@austin.org.au						Chauty A, 2007, ANTIMICROB AGENTS CH, V51, P4029, DOI 10.1128/AAC.00175-07; Chauty A, 2011, CLIN INFECT DIS, V52, P94, DOI 10.1093/cid/ciq072; Converse PJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00426-19, 10.1128/aac.00426-19]; Espey David K., 2002, International Journal of Infectious Diseases, V6, P60, DOI 10.1016/S1201-9712(02)90138-4; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; Friedman ND, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002315; Gordon CL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000770; Jenkin GA, 2002, MED J AUSTRALIA, V176, P180; Nienhuis WA, 2012, CLIN INFECT DIS, V54, P519, DOI 10.1093/cid/cir856; O'Brien DP, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001473; O'Brien DP, 2009, MED J AUSTRALIA, V191, P564, DOI 10.5694/j.1326-5377.2009.tb03313.x; Omansen TF, 2019, EMERG INFECT DIS, V25, P2183, DOI 10.3201/eid2512.190427; Phillips RO, 2020, LANCET, V395, P1259, DOI 10.1016/S0140-6736(20)30047-7; Wadagni AC, 2018, LANCET INFECT DIS, V18, P650, DOI 10.1016/S1473-3099(18)30160-9; WHO, 2004, ROL SPEC ANT MYC ULC; World Health Organisation, 2001, BUR ULC MAN MYC ULC	16	5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2020	395	10232					1231	1232		10.1016/S0140-6736(20)30478-5	http://dx.doi.org/10.1016/S0140-6736(20)30478-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LE6FH	32171421	hybrid, Green Published			2022-12-28	WOS:000526818800004
J	Appleton, RE				Appleton, Richard E.			Second-line anticonvulsants for paediatric convulsive status epilepticus	LANCET			English	Editorial Material							LEVETIRACETAM; PHENYTOIN; CHILDHOOD		[Appleton, Richard E.] Alder Hey Childrens Hlth Pk, Roald Dahl Neurophysiol Dept, Liverpool L12 2AP, Merseyside, England	Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital	Appleton, RE (corresponding author), Alder Hey Childrens Hlth Pk, Roald Dahl Neurophysiol Dept, Liverpool L12 2AP, Merseyside, England.	richardappleton55@hotmail.co.uk						[Anonymous], LEVETIRACETAM VERSUS; [Anonymous], ADV PAEDIAT LIFE SUP; Chamberlain JM, 2020, LANCET, V395, P1217, DOI 10.1016/S0140-6736(20)30611-5; Chin RFM, 2006, LANCET, V368, P222, DOI 10.1016/S0140-6736(06)69043-0; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Kapur J, 2019, NEW ENGL J MED, V381, P2103, DOI 10.1056/NEJMoa1905795; Lyttle MD, 2019, LANCET, V393, P2125, DOI 10.1016/S0140-6736(19)30724-X; McTague A, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001905.pub3; Senthil Kumar CS, 2018, INT J PEDIAT RES, V5, P237, DOI DOI 10.17511/ijpr.2018.i04.13; Singh K, 2018, J PEDIATR NEUROSCI, V13, P158, DOI 10.4103/jpn.JPN_126_17	10	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2020	395	10231					1172	1173		10.1016/S0140-6736(20)30674-7	http://dx.doi.org/10.1016/S0140-6736(20)30674-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LE6DW	32203690				2022-12-28	WOS:000526814200009
J	Leavitt, BR; Tabrizi, SJ				Leavitt, Blair R.; Tabrizi, Sarah J.			Antisense oligonucleotides for neurodegeneration	SCIENCE			English	Editorial Material							REDUCTION; DISEASE		[Leavitt, Blair R.] Univ British Columbia, Ctr Mol Med & Therapeut, UBC Hosp, Dept Med Genet, Vancouver, BC, Canada; [Leavitt, Blair R.] Univ British Columbia, Ctr Huntingtons Dis, UBC Hosp, Dept Med Genet, Vancouver, BC, Canada; [Leavitt, Blair R.] Univ British Columbia, Div Neurol, Dept Med, Vancouver, BC, Canada; [Leavitt, Blair R.] BC Childrens Hosp, Vancouver, BC, Canada; [Tabrizi, Sarah J.] UCL, Huntingtons Dis Ctr, Dept Neurodegenerat Dis, London, England; [Tabrizi, Sarah J.] UCL, UK Dementia Res Inst, UCL Queen Sq Inst Neurol, London, England	University of British Columbia; University of British Columbia; University of British Columbia; BC Childrens Hospital; University of British Columbia; University of London; University College London; University of London; University College London	Leavitt, BR (corresponding author), Univ British Columbia, Ctr Mol Med & Therapeut, UBC Hosp, Dept Med Genet, Vancouver, BC, Canada.; Leavitt, BR (corresponding author), Univ British Columbia, Ctr Huntingtons Dis, UBC Hosp, Dept Med Genet, Vancouver, BC, Canada.; Leavitt, BR (corresponding author), Univ British Columbia, Div Neurol, Dept Med, Vancouver, BC, Canada.; Leavitt, BR (corresponding author), BC Childrens Hosp, Vancouver, BC, Canada.	bleavitt@cmmt.ubc.ca; s.tabrizi@ucl.ac.uk		Tabrizi, Sarah/0000-0003-2716-2045; leavitt, Blair/0000-0002-4532-766X	MRC [UKDRI-1008/2] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bates GP, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.5; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; Gonzalez-Alegre P, 2019, HUM MOL GENET, V28, pR80, DOI 10.1093/hmg/ddz138; Iwamoto N, 2017, NAT BIOTECHNOL, V35, P845, DOI 10.1038/nbt.3948; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Raymond GJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131175; Rinaldi C, 2018, NAT REV NEUROL, V14, P9, DOI 10.1038/nrneurol.2017.148; Skotte NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107434; Southwell AL, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3959; Tabrizi SJ, 2019, NEURON, V102, P899, DOI 10.1016/j.neuron.2019.05.001; Tabrizi SJ, 2019, NEW ENGL J MED, V380, P2307, DOI 10.1056/NEJMoa1900907; Zhao HT, 2017, MOL THER-NUCL ACIDS, V8, P508, DOI 10.1016/j.omtn.2017.08.002	15	38	38	4	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1428	1429		10.1126/science.aba4624	http://dx.doi.org/10.1126/science.aba4624			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217715	Green Submitted			2022-12-28	WOS:000523251600017
J	Rimmer, A				Rimmer, Abi			Covid-19: what do trainees need to know?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		BMA, 2019, FAT FAC CHART; NHS Employers, 2016, TERMS COND SERV NHS	2	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1276	10.1136/bmj.m1276	http://dx.doi.org/10.1136/bmj.m1276			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220829	Bronze			2022-12-28	WOS:000523765200013
J	Lam, TTY; Jia, N; Zhang, YW; Shum, MHH; Jiang, JF; Zhu, HC; Tong, YG; Shi, YX; Ni, XB; Liao, YS; Li, WJ; Jiang, BG; Wei, W; Yuan, TT; Zheng, K; Cui, XM; Li, J; Pei, GQ; Qiang, X; Cheung, WYM; Li, LF; Sun, FF; Qin, S; Huang, JC; Leung, GM; Holmes, EC; Hu, YL; Guan, Y; Cao, WC				Lam, Tommy Tsan-Yuk; Jia, Na; Zhang, Ya-Wei; Shum, Marcus Ho-Hin; Jiang, Jia-Fu; Zhu, Hua-Chen; Tong, Yi-Gang; Shi, Yong-Xia; Ni, Xue-Bing; Liao, Yun-Shi; Li, Wen-Juan; Jiang, Bao-Gui; Wei, Wei; Yuan, Ting-Ting; Zheng, Kui; Cui, Xiao-Ming; Li, Jie; Pei, Guang-Qian; Qiang, Xin; Cheung, William Yiu-Man; Li, Lian-Feng; Sun, Fang-Fang; Qin, Si; Huang, Ji-Cheng; Leung, Gabriel M.; Holmes, Edward C.; Hu, Yan-Ling; Guan, Yi; Cao, Wu-Chun			Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins	NATURE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; GENOMIC CHARACTERIZATION; BATS; ORIGIN; BETACORONAVIRUSES; DIVERSITY; CHINA; ALPHACORONAVIRUSES; IDENTIFICATION	The ongoing outbreak of viral pneumonia in China and across the world is associated with a new coronavirus, SARS-CoV-2(1). This outbreak has been tentatively associated with a seafood market in Wuhan, China, where the sale of wild animals may be the source of zoonotic infection(2).Although bats are probable reservoir hosts for SARS-CoV-2, the identity of any intermediate host that may have facilitated transfer to humans is unknown. Here we report the identification of SARS-CoV-2-related coronaviruses in Malayan pangolins (Manisjavanica) seized in anti-smuggling operations in southern China. Metagenomic sequencing identified pangolin-associated coronaviruses that belong to two sub-lineages of SARS-CoV-2-related coronaviruses, including one that exhibits strong similarity in the receptor-binding domain to SARS-CoV-2. The discovery of multiple lineages of pangolin coronavirus and their similarity to SARS-CoV-2 suggests that pangolins should be considered as possible hosts in the emergence of new coronaviruses and should be removed from wet markets to prevent zoonotic transmission.	[Lam, Tommy Tsan-Yuk; Zhu, Hua-Chen; Guan, Yi] Shantou Univ, Guangdong Hongkong Joint Lab Emerging Infect Dis, Joint Inst Virol Shantou Univ & Univ Hong Kong, Shantou, Peoples R China; [Lam, Tommy Tsan-Yuk; Shum, Marcus Ho-Hin; Zhu, Hua-Chen; Ni, Xue-Bing; Liao, Yun-Shi; Cheung, William Yiu-Man; Leung, Gabriel M.; Guan, Yi] Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China; [Jia, Na; Zhang, Ya-Wei; Jiang, Jia-Fu; Jiang, Bao-Gui; Yuan, Ting-Ting; Cui, Xiao-Ming; Li, Jie; Pei, Guang-Qian; Qiang, Xin; Qin, Si; Cao, Wu-Chun] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Tong, Yi-Gang; Li, Wen-Juan] Beijing Univ Chem Technol, Coll Life Sci & Technol, Beijing Adv Innovat Ctr Soft Matter Sci & Engn BA, Beijing, Peoples R China; [Shi, Yong-Xia; Zheng, Kui; Sun, Fang-Fang; Huang, Ji-Cheng] Guangzhou Customs Technol Ctr, Guangzhou, Peoples R China; [Wei, Wei; Hu, Yan-Ling] Guangxi Med Univ, Inst Life Sci, Nanning, Peoples R China; [Li, Lian-Feng] Guangxi Med Univ, Sch Informat & Management, Nanning, Peoples R China; [Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci & Sch Med Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia; [Hu, Yan-Ling] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Peoples R China	Shantou University; University of Hong Kong; Beijing Institute of Microbiology & Epidemiology; Beijing University of Chemical Technology; Guangxi Medical University; Guangxi Medical University; University of Sydney; Guangxi Medical University	Guan, Y (corresponding author), Shantou Univ, Guangdong Hongkong Joint Lab Emerging Infect Dis, Joint Inst Virol Shantou Univ & Univ Hong Kong, Shantou, Peoples R China.; Guan, Y (corresponding author), Univ Hong Kong, Sch Publ Hlth, State Key Lab Emerging Infect Dis, Hong Kong, Peoples R China.; Cao, WC (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Hu, YL (corresponding author), Guangxi Med Univ, Inst Life Sci, Nanning, Peoples R China.; Hu, YL (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Peoples R China.	huyanling@gxmu.edu.cn; yguan@hku.hk; caowc@bmi.ac.cn	Zhu, Huachen/A-8252-2017; Lam, Tommy Tsan-Yuk/D-4837-2012; Jiang, Baogui/ABE-5439-2021; Holmes, Edward/GVR-9499-2022; Cheung, Yiu Man/T-2708-2019	Zhu, Huachen/0000-0003-2711-0501; Leung, Gabriel/0000-0002-2503-6283; Holmes, Edward/0000-0001-9596-3552; Guan, Yi/0000-0001-6057-9243	Natural Science Foundation of China (NSFC) [81621005]; State Key Research Development Program of China [2019YFC1200401]; NSFC Excellent Young Scientists Fund (Hong Kong and Macau) [31922087]; National Key Plan for Scientific Research and Development of China [2016YFD0500302, 2017YFE0190800]; Li Ka Shing Foundation; National Institutes of Health [HHSN272201400006C]; Guangxi Scientific and Technological Research [2020AB39264]; Guangxi Medical University Training Program for Distinguished Young Scholars; Australian Research Council [FL170100022];  [2019B121205009]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); State Key Research Development Program of China(State Key Development Program for Basic Research of China); NSFC Excellent Young Scientists Fund (Hong Kong and Macau); National Key Plan for Scientific Research and Development of China; Li Ka Shing Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guangxi Scientific and Technological Research; Guangxi Medical University Training Program for Distinguished Young Scholars; Australian Research Council(Australian Research Council); 	We thank the staff of the Guangxi and Guangdong Custom Bureau for their laborious anti-smuggling operations and all of the scientists who shared their genomic sequences of the coronaviruses used in this study. The computations were performed using research computing facilities offered by Information Technology Services, the University of Hong Kong. This work was supported by research grants from The Natural Science Foundation of China (NSFC; 81621005), the State Key Research Development Program of China (2019YFC1200401), NSFC Excellent Young Scientists Fund (Hong Kong and Macau) (31922087), National Key Plan for Scientific Research and Development of China (2016YFD0500302 and 2017YFE0190800), funding for Guangdong-Hongkong-Macau Joint Laboratory (2019B121205009), Li Ka Shing Foundation, National Institutes of Health (HHSN272201400006C), Guangxi Scientific and Technological Research (2020AB39264) and Guangxi Medical University Training Program for Distinguished Young Scholars, and the Australian Research Council (FL170100022).	Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104; Cohen J., 2020, SCIENCE; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; Drexler JF, 2010, J VIROL, V84, P11336, DOI 10.1128/JVI.00650-10; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Guan Y, 2003, SCIENCE, V302, P276, DOI 10.1126/science.1087139; Han YL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01900; He BA, 2014, J VIROL, V88, P7070, DOI 10.1128/JVI.00631-14; He RT, 2004, BIOCHEM BIOPH RES CO, V316, P476, DOI 10.1016/j.bbrc.2004.02.074; Heinrich S, 2017, GLOBAL TRAFFICKING P; Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07; Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698; Hu D, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0155-5; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Liu P, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11110979; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Marra MA, 2003, SCIENCE, V300, P1399, DOI 10.1126/science.1085953; Rozewicki J, 2019, NUCLEIC ACIDS RES, V47, pW5, DOI 10.1093/nar/gkz342; Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tang XC, 2006, J VIROL, V80, P7481, DOI 10.1128/JVI.00697-06; Tao Y, 2019, MICROBIOL RESOUR ANN, V8, DOI [10.1128/MRA.00548-19, 10.1128/mra.00548-19]; Vega VB, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-32; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang M, 2005, EMERG INFECT DIS, V11, P1860, DOI 10.3201/eid1112.041293; Wang W, 2017, J VIROL, V91, DOI [10.1128/jvi.00764-17, 10.1128/JVI.00764-17]; World Health Organization, COR DIS 2019 COVID 1; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu ZG, 2016, J INFECT DIS, V213, P579, DOI 10.1093/infdis/jiv476; Wu ZQ, 2016, ISME J, V10, P609, DOI 10.1038/ismej.2015.138; Xu L, 2016, VIROL SIN, V31, P69, DOI 10.1007/s12250-016-3727-3; Yang L, 2013, EMERG INFECT DIS, V19, P989, DOI 10.3201/eid1906.121648; Yeh SH, 2004, P NATL ACAD SCI USA, V101, P2542, DOI 10.1073/pnas.0307904100; Yuan JF, 2010, J GEN VIROL, V91, P1058, DOI 10.1099/vir.0.016378-0; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	39	897	923	25	194	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 9	2020	583	7815					282	+		10.1038/s41586-020-2169-0	http://dx.doi.org/10.1038/s41586-020-2169-0		MAR 2020	15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MH5KF	32218527	Green Submitted, Bronze			2022-12-28	WOS:000541035500001
J	Safiri, S; Kolahi, AA; Hoy, D; Buchbinder, R; Mansournia, MA; Bettampadi, D; Ashrafi-Asgarabad, A; Almasi-Hashiani, A; Smith, E; Sepidarkish, M; Cross, M; Qorbani, M; Moradi-Lakeh, M; Woolf, AD; March, L; Collins, G; Ferreira, ML				Safiri, Saeid; Kolahi, Ali-Asghar; Hoy, Damian; Buchbinder, Rachelle; Mansournia, Mohammad Ali; Bettampadi, Deepti; Ashrafi-Asgarabad, Ahad; Almasi-Hashiani, Amir; Smith, Emma; Sepidarkish, Mahdi; Cross, Marita; Qorbani, Mostafa; Moradi-Lakeh, Maziar; Woolf, Anthony D.; March, Lyn; Collins, Gary; Ferreira, Manuela L.			Global, regional, and national burden of neck pain in the general population, 1990-2017: systematic analysis of the Global Burden of Disease Study 2017	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TASK-FORCE; EPIDEMIOLOGY; BONE	OBJECTIVE To use data from the Global Burden of Disease Study between 1990 and 2017 to report the rates and trends of point prevalence, annual incidence, and years lived with disability for neck pain in the general population of 195 countries. DESIGN Systematic analysis. DATA SOURCE Global Burden of Diseases, Injuries, and Risk Factors Study 2017. MAIN OUTCOME MEASURES Numbers and age standardised rates per 100 000 population of neck pain point prevalence, annual incidence, and years lived with disability were compared across regions and countries by age, sex, and sociodemographic index. Estimates were reported with uncertainty intervals. RESULTS Globally in 2017 the age standardised rates for point prevalence of neck pain per 100 000 population was 3551.1 (95% uncertainty interval 3139.5 to 3977.9), for incidence of neck pain per 100 000 population was 806.6 (713.7 to 912.5), and for years lived with disability from neck pain per 100 000 population was 352.0 (245.6 to 493.3). These estimates did not change significantly between 1990 and 2017. The global point prevalence of neck pain in 2017 was higher in females compared with males, although this was not significant at the 0.05 level. Prevalence increased with age up to 70-74 years and then decreased. Norway (6151.2 (95% uncertainty interval 5382.3 to 6959.8)), Finland (5750.3 (5058.4 to 6518.3)), and Denmark (5316 (4674 to 6030.1)) had the three highest age standardised point prevalence estimates in 2017. The largest increases in age standardised point prevalence estimates from 1990 to 2017 were in the United Kingdom (14.6% (10.6% to 18.8%)), Sweden (10.4% (6.0% to 15.4%)), and Kuwait (2.6% (2.0% to 3.2%)). In general, positive associations, but with fluctuations, were found between age standardised years lived with disability for neck pain and sociodemographic index at the global level and for all Global Burden of Disease regions, suggesting the burden is higher at higher sociodemographic indices. CONCLUSIONS Neck pain is a serious public health problem in the general population, with the highest burden in Norway, Finland, and Denmark. Increasing population awareness about risk factors and preventive strategies for neck pain is warranted to reduce the future burden of this condition.	[Safiri, Saeid] Tabriz Univ Med Sci, Aging Res Inst, Phys Med & Rehabil Res Ctr, Tabriz, Iran; [Safiri, Saeid] Univ Tehran Med Sci, Neurosci Inst, Sports Med Res Ctr, Tehran, Iran; [Safiri, Saeid] Tabriz Univ Med Sci, Sch Med, Dept Community Med, Social Determinants Hlth Res Ctr, Tabriz, Iran; [Kolahi, Ali-Asghar] Shahid Beheshti Univ Med Sci, Social Determinants Hlth Res Ctr, Tehran, Iran; [Hoy, Damian; March, Lyn] Global Alliance Musculoskeletal Hlth, Tehran, Iran; [Hoy, Damian; Smith, Emma; Cross, Marita; March, Lyn; Ferreira, Manuela L.] Univ Sydney, Inst Bone & Joint Res, Kolling Inst, Fac Med & Hlth, Sydney, NSW, Australia; [Buchbinder, Rachelle] Cabrini Inst, Monash Dept Clin Epidemiol, Melbourne, Vic, Australia; [Buchbinder, Rachelle] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Bettampadi, Deepti] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Ashrafi-Asgarabad, Ahad] Bam Univ Med Sci, Sch Hlth, Dept Epidemiol, Bam, Iran; [Almasi-Hashiani, Amir] Arak Univ Med Sci, Sch Hlth, Dept Epidemiol, Arak, Iran; [Smith, Emma] Univ Sydney, Pain Management Res Inst, Fac Med & Hlth, Sydney, NSW, Australia; [Sepidarkish, Mahdi] Babol Univ Med Sci, Sch Publ Hlth, Dept Biostat & Epidemiol, Babol Sar, Iran; [Qorbani, Mostafa] Alborz Univ Med Sci, Noncommunicable Dis Res Ctr, Karaj, Iran; [Moradi-Lakeh, Maziar] Iran Univ Med Sci, Prevent Med & Publ Hlth Res Ctr, Tehran, Iran; [Woolf, Anthony D.] Royal Cornwall Hosp, Truro, England; [Woolf, Anthony D.] Univ Exeter, Med Sch, Truro, England; [Collins, Gary] Univ Oxford, Botnar Res Ctr, Ctr Stat Med, NDORMS, Oxford, England	Tabriz University of Medical Science; Tehran University of Medical Sciences; Tabriz University of Medical Science; Shahid Beheshti University Medical Sciences; University of Sydney; Kolling Institute of Medical Research; Cabrini Health; Monash University; Monash University; Tehran University of Medical Sciences; University of Michigan System; University of Michigan; University of Sydney; Babol University of Medical Sciences; Iran University of Medical Sciences; Royal Cornwall Hospital; University of Exeter; University of Oxford	Ferreira, ML (corresponding author), Royal North Shore Hosp, Level 10,Kolling Bldg, St Leonards, NSW 2065, Australia.	manuela.ferreira@sydney.edu.au	Collins, Gary Stephen/A-2258-2014; Bettampadi, Deepti/W-5804-2019; sepidarkish/N-6176-2019; Moradi-Lakeh, Maziar/ABC-9793-2021; Kolahi, Ali-Asghar/F-1981-2010; Ferreira, Manuela/AAQ-5446-2020; Qorbani, Mostafa/M-8171-2017; Almasi-Hashiani, Amir/P-3356-2018; Buchbinder, Rachelle/G-2952-2011	Collins, Gary Stephen/0000-0002-2772-2316; Bettampadi, Deepti/0000-0002-4331-1568; Moradi-Lakeh, Maziar/0000-0001-7381-5305; Kolahi, Ali-Asghar/0000-0003-0178-3732; Ferreira, Manuela/0000-0002-3479-0683; Almasi-Hashiani, Amir/0000-0003-4434-561X; Buchbinder, Rachelle/0000-0002-0597-0933; Smith, Emma/0000-0001-6510-2583	Bill and Melinda Gates Foundation; Shahid Beheshti University of Medical Sciences, Tehran, Iran [20732-4-7]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Shahid Beheshti University of Medical Sciences, Tehran, Iran	The Global Burden of Disease Study is funded by the Bill and Melinda Gates Foundation. The funder was not involved in the preparation of this manuscript. The present report was also supported by Shahid Beheshti University of Medical Sciences, Tehran, Iran (grant No 20732-4-7). MLF holds a National Health and Medical Research Council of Australia research fellowship.	Cohen SP, 2015, MAYO CLIN PROC, V90, P284, DOI 10.1016/j.mayocp.2014.09.008; Fejer R, 2006, EUR SPINE J, V15, P834, DOI 10.1007/s00586-004-0864-4; Guzman J, 2009, J MANIP PHYSIOL THER, V32, pS17, DOI 10.1016/j.jmpt.2008.11.007; Haldeman S, 2010, J OCCUP ENVIRON MED, V52, P424, DOI 10.1097/JOM.0b013e3181d44f3b; Henschke N, 2015, MAYO CLIN PROC, V90, P139, DOI 10.1016/j.mayocp.2014.09.010; Hogg-Johnson S, 2008, SPINE, V33, pS39, DOI 10.1097/BRS.0b013e31816454c8; Hoy DG, 2010, BEST PRACT RES CL RH, V24, P783, DOI 10.1016/j.berh.2011.01.019; Hoy D, 2014, ANN RHEUM DIS, V73, P1309, DOI 10.1136/annrheumdis-2013-204431; Hoy DG, 2014, ANN RHEUM DIS, V73, P982, DOI 10.1136/annrheumdis-2013-204344; James SL, 2018, LANCET, V392, P1789, DOI 10.1016/s0140-6736(18)32279-7; Kyu HH, 2018, LANCET, V392, P1859, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3]; Manchikanti L, 2009, PAIN PHYSICIAN, V12, P35; Moradi-Lakeh M, 2017, ANN RHEUM DIS, V76, P1365, DOI 10.1136/annrheumdis-2016-210146; Roth GA, 2018, LANCET, V392, P1736, DOI 10.1016/s0140-6736(18)32203-7; Salomon JA, 2012, LANCET, V380, P2129, DOI 10.1016/S0140-6736(12)61680-8; Sebbag E, 2019, ANN RHEUM DIS, V78, P844, DOI 10.1136/annrheumdis-2019-215142; Stanaway JD, 2018, LANCET, V392, P1923, DOI [10.1016/S0140-6736(18)32225-6, 10.1016/s0140-6736(18)32225-6]; Stevens GA, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002056, 10.1371/journal.pmed.1002116]; Wang Y., 2011, SMOOTHING SPLINES ME, DOI [10.1201/b10954, DOI 10.1201/B10954]	19	119	123	8	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m791	10.1136/bmj.m791	http://dx.doi.org/10.1136/bmj.m791			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217608	Green Published, hybrid			2022-12-28	WOS:000523764800002
J	Cook, R; Davidson, P; Martin, R				Cook, Rob; Davidson, Peter; Martin, Rosie		NIHR Dissemination Ctr	NIHR SIGNALS Computerised speech and language therapy can help people with aphasia find words following a stroke	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cook, Rob; Martin, Rosie] Bazian Economist Intelligence Unit Healthcare, London, England; [Davidson, Peter] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com						Cozzan C, 2016, AIP ADV, V6, DOI 10.1063/1.4964925; National Institute for Health and Care Excellence, 2013, STROK REH AD CG162; NHS, APHASIA; Royal College of Speech and Language Therapists, 2014, RCSLT RES MAN COMM P	4	0	1	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m520	10.1136/bmj.m520	http://dx.doi.org/10.1136/bmj.m520			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213484				2022-12-28	WOS:000523764500001
J	Dyer, C				Dyer, Clare			Irish Supreme Court upholds win for woman whose cervical cancer was missed	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2018, BMJ-BRIT MED J, V362, DOI DOI 10.1136/BMJ.K3912; DYER C, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2062	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1196	10.1136/bmj.m1196	http://dx.doi.org/10.1136/bmj.m1196			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209545				2022-12-28	WOS:000523764200009
J	Rubin, R				Rubin, Rita			White Blood Cells Might Provide Clues to Breast Cancer Risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1123	1123		10.1001/jama.2020.2457	http://dx.doi.org/10.1001/jama.2020.2457			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD1JR	32207781				2022-12-28	WOS:000543732100001
J	Lane, R				Lane, Richard			Sean Wasserman: rising star in TB-HIV research and medicine	LANCET			English	Biographical-Item																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					941	941						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX2XG	32199483				2022-12-28	WOS:000521744600016
J	Sahu, S; Ditiu, L; Lawson, L; Ntoumi, F; Arakaki, D; Zumla, A				Sahu, Suvanand; Ditiu, Lucica; Lawson, Lovett; Ntoumi, Francine; Arakaki, Denise; Zumla, Alimuddin			UN General Assembly tuberculosis targets: are we on track?	LANCET			English	Editorial Material									[Sahu, Suvanand; Ditiu, Lucica] Global Hlth Campus, Stop TB Partnership Secretariat, Geneva, Switzerland; [Lawson, Lovett] Zankli Med Serv, Abuja, Nigeria; [Ntoumi, Francine] Marien Nguabi Univ, Brazzaville, Rep Congo; [Ntoumi, Francine] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Arakaki, Denise] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil; [Arakaki, Denise] Minist Hlth, Natl TB Control Program, Brasilia, DF, Brazil; [Zumla, Alimuddin] UCL, Ctr Clin Microbiol, Div Infect & Immun, London, England; [Zumla, Alimuddin] Univ Coll London Hosp NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London EC1V 2PD, England	Eberhard Karls University of Tubingen; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Zumla, A (corresponding author), UCL, Ctr Clin Microbiol, Div Infect & Immun, London, England.; Zumla, A (corresponding author), Univ Coll London Hosp NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London EC1V 2PD, England.	a.zumla@ucl.ac.uk	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735				[Anonymous], 2019, LANCET, V394, P1482, DOI 10.1016/S0140-6736(19)32459-6; Banerjee S., 2020, RAPID SIMULTANEOUS T; Nadda JP, 2019, LANCET, V393, P1270, DOI 10.1016/S0140-6736(19)30487-8; Reid MJA, 2019, LANCET, V393, P1331, DOI 10.1016/S0140-6736(19)30024-8; Sahu S, 2019, LANCET GLOB HEALTH, V7, pE558, DOI 10.1016/S2214-109X(19)30068-3; Stop TB Partnership, 2019, GLOB PLAN END TB 201; Stop TB Partnership, 2019, DECL RIGHTS PEOPL AF; Stop TB Partnership, 2019, GLOB DRUG FAC PED DR; Stop TB Partnership, 2019, STOP TB PARTN BOARD; Stop TB Partnership, COMM HUM RIGHTS GEND; The Global Fund, 2020, TECHN BRIEF TUB GEND; WHO, 2019, RAPID COMMUNICATION; WHO, 2019, GLOB TU REP 2019	13	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					928	930						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199477	Green Submitted			2022-12-28	WOS:000521744600009
J	Bell, RE; Seroussi, H				Bell, Robin E.; Seroussi, Helene			History, mass loss, structure, and dynamic behavior of the Antarctic Ice Sheet	SCIENCE			English	Review							WEST ANTARCTICA; PINE ISLAND; SHELF; CLIMATE; GLACIERS; SURFACE; LARSEN; WATER; SENSITIVITY; WIDESPREAD	Antarctica contains most of Earth's fresh water stored in two large ice sheets. The more stable East Antarctic Ice Sheet is larger and older, rests on higher topography, and hides entire mountain ranges and ancient lakes. The less stable West Antarctic Ice Sheet is smaller and younger and was formed on what was once a shallow sea. Recent observations made with several independent satellite measurements demonstrate that several regions of Antarctica are losing mass, flowing faster, and retreating where ice is exposed to warm ocean waters. The Antarctic contribution to sea level rise has reached similar to 8 millimeters since 1992. In the future, if warming ocean waters and increased surface meltwater trigger faster ice flow, sea level rise will accelerate.	[Bell, Robin E.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Seroussi, Helene] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr MS 300-323, Pasadena, CA 91109 USA	Columbia University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Bell, RE (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	robinb@ldeo.columbia.edu	Seroussi, Helene/AAX-5342-2021	Seroussi, Helene/0000-0001-9201-1644	National Aeronautics and Space Administration; Lamont Doherty Earth Observatory of Columbia University; Old York Foundation	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Lamont Doherty Earth Observatory of Columbia University; Old York Foundation	A portion of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. GRACE data comes from (50), accessed 28 January 2020. Antarctic velocity data comes from (51), accessed 28 January 2020. Ice front positions for Larsen A and B comes from (6, 52). Cryo portal Enveo snow, glaciers, and ice sheet products and services dataset was accessed 6 February 2020. The radar data in Fig. 3 is from Gamburtsev Mountains-International Polar Year AGAP project Line 560; http://podds.ldeo.columbia.edu:1986/legacyData/AGAP/DataLevel_1/RADAR/DecimatedSAR_images/L560_WholeLineEchogram.jpg; Lake Vostok NASA Icebridge Flight 20131127, data available at https://data.cresis.ku.edu/data/rds; and CRESIS data 20091224_frames 24, 25, and 26. Data are available at the same web server. B. Honisch provided guidance on the paleoclimate data in Fig. 1. I. Cordero and C. Dieck Locke assisted with the figure production. K. Tinto, R. Constantino, B. Keisling, and C. Siddoway provided important feedback on the manuscript. Funding from Lamont Doherty Earth Observatory of Columbia University and the Old York Foundation supported this work.	ALLEY RB, 1986, NATURE, V322, P57, DOI 10.1038/322057a0; Banwell AF, 2013, GEOPHYS RES LETT, V40, P5872, DOI 10.1002/2013GL057694; Barletta VR, 2018, SCIENCE, V360, P1335, DOI 10.1126/science.aao1447; Bell RE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025207; Bell RE, 2017, NATURE, V544, P344, DOI 10.1038/nature22048; Boening C, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053055; Buizert C, 2015, NATURE, V520, P661, DOI 10.1038/nature14401; Creyts TT, 2014, GEOPHYS RES LETT, V41, P8114, DOI 10.1002/2014GL061491; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Escutia C, 2019, OCEANOGRAPHY, V32, P32, DOI 10.5670/oceanog.2019.117; Feldmann J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4132; Foster GL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14845; Francis J. E., 2008, ANTARCTICA KEYSTONE, P19, DOI [10.3133/of2007-1047, DOI 10.3133/OF2007-1047]; Fretwell P, 2013, CRYOSPHERE, V7, P375, DOI 10.5194/tc-7-375-2013; Fricker HA, 2007, SCIENCE, V315, P1544, DOI 10.1126/science.1136897; Frieler K, 2016, EARTH SYST DYNAM, V7, P203, DOI 10.5194/esd-7-203-2016; Gurses O, 2019, CRYOSPHERE, V13, P2317, DOI 10.5194/tc-13-2317-2019; Hansen J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0294; Jacobs SS, 2011, NAT GEOSCI, V4, P519, DOI [10.1038/NGEO1188, 10.1038/ngeo1188]; Jordan TA, 2020, NAT REV EARTH ENV, V1, P117, DOI 10.1038/s43017-019-0013-6; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kapitsa AP, 1996, NATURE, V381, P684, DOI 10.1038/381684a0; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kingslake J, 2017, NATURE, V544, P349, DOI 10.1038/nature22049; Levy RH, 2019, NAT GEOSCI, V12, P132, DOI 10.1038/s41561-018-0284-4; Livermore R, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2005GC001224; Morlighem M, 2020, NAT GEOSCI, V13, P132, DOI 10.1038/s41561-019-0510-8; Mouginot J, 2019, P NATL ACAD SCI USA, V116, P9239, DOI 10.1073/pnas.1904242116; Mouginot J, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9040364; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2014, GEOPHYS RES LETT, V41, P3502, DOI 10.1002/2014GL060140; Rignot E, 2013, SCIENCE, V341, P266, DOI 10.1126/science.1235798; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046583; Robel AA, 2019, GEOPHYS RES LETT, V46, P12092, DOI 10.1029/2019GL084397; Rott H, 2011, CRYOSPHERE, V5, P125, DOI 10.5194/tc-5-125-2011; Rott H, 2018, CRYOSPHERE, V12, P1273, DOI 10.5194/tc-12-1273-2018; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Seroussi H, 2017, GEOPHYS RES LETT, V44, P6191, DOI 10.1002/2017GL072910; Seroussi H., 2020, CRYOSPHERE, V2020, P1; Shepherd A, 2018, NATURE, V558, P219, DOI 10.1038/s41586-018-0179-y; Smith JA, 2017, NATURE, V541, P77, DOI 10.1038/nature20136; Tinto KJ, 2019, NAT GEOSCI, V12, P441, DOI 10.1038/s41561-019-0370-2; Trusel LD, 2015, NAT GEOSCI, V8, P927, DOI [10.1038/ngeo2563, 10.1038/NGEO2563]; Turner J, 2016, NATURE, V535, P411, DOI 10.1038/nature18645; Watkins MM, 2015, J GEOPHYS RES-SOL EA, V120, P2648, DOI 10.1002/2014JB011547; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]; Wiese D. N., 2017, ANTARCTICA MASS VARI; Wolovick MJ, 2018, CRYOSPHERE, V12, P2955, DOI 10.5194/tc-12-2955-2018; Wuite J, 2015, CRYOSPHERE, V9, P957, DOI 10.5194/tc-9-957-2015	53	16	16	8	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1321	1325		10.1126/science.aaz5489	http://dx.doi.org/10.1126/science.aaz5489			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193319				2022-12-28	WOS:000522167400040
J	Hirsch, C				Hirsch, Calvin			In dementia with aggression and agitation, several interventions help vs usual care	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CITALOPRAM		[Hirsch, Calvin] UC Davis Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), UC Davis Med Ctr, Sacramento, CA 95817 USA.							Chun A, 2014, J AM GERIATR SOC, V62, P950, DOI 10.1111/jgs.12770; Leonpacher AK, 2016, AM J PSYCHIAT, V173, P473, DOI 10.1176/appi.ajp.2016.15020248; Schneider LS, 2016, AM J PSYCHIAT, V173, P465, DOI 10.1176/appi.ajp.2015.15050648; Smeets CHW, 2018, J CLIN EPIDEMIOL, V101, P17, DOI 10.1016/j.jclinepi.2018.05.004	4	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC31	JC31		10.7326/ACPJ202003170-031	http://dx.doi.org/10.7326/ACPJ202003170-031			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176897				2022-12-28	WOS:000520170800015
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: medical schools are urged to fast-track final year students	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Medical Schools Council, 2020, ADV MED SCH COUNC UK	1	25	28	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m1064	10.1136/bmj.m1064	http://dx.doi.org/10.1136/bmj.m1064			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2CT	32179533	Bronze			2022-12-28	WOS:000523761500005
J	Mahase, E				Mahase, Elisabeth			Covid-19: outbreak could last until spring 2021 and see 7.9 million hospitalised in the UK	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Change.org, TEST FRONTL NHS STAF; MAHASE E, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M918	2	13	13	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m1071	10.1136/bmj.m1071	http://dx.doi.org/10.1136/bmj.m1071			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2CT	32179567	Bronze			2022-12-28	WOS:000523761500008
J	Hendershot, JN; Smith, JR; Anderson, CB; Letten, AD; Frishkoff, LO; Zook, JR; Fukami, T; Daily, GC				Hendershot, J. Nicholas; Smith, Jeffrey R.; Anderson, Christopher B.; Letten, Andrew D.; Frishkoff, Luke O.; Zook, Jim R.; Fukami, Tadashi; Daily, Gretchen C.			Intensive farming drives long-term shifts in avian community composition	NATURE			English	Article							SUSTAINING BIODIVERSITY; EXTINCTION DEBT; EXPANSION; DYNAMICS; RECORDS	Variation in vegetation and climate affects the long-term changes in bird communities in intensive-agriculture habitats, but not in diversified-agriculture or natural-forest habitats, by changing the local colonization and extinction rates. Agricultural practices constitute both the greatest cause of biodiversity loss and the greatest opportunity for conservation(1,2), given the shrinking scope of protected areas in many regions. Recent studies have documented the high levels of biodiversity-across many taxa and biomes-that agricultural landscapes can support over the short term(1,3,4). However, little is known about the long-term effects of alternative agricultural practices on ecological communities(4,5) Here we document changes in bird communities in intensive-agriculture, diversified-agriculture and natural-forest habitats in 4 regions of Costa Rica over a period of 18 years. Long-term directional shifts in bird communities were evident in intensive- and diversified-agricultural habitats, but were strongest in intensive-agricultural habitats, where the number of endemic and International Union for Conservation of Nature (IUCN) Red List species fell over time. All major guilds, including those involved in pest control, pollination and seed dispersal, were affected. Bird communities in intensive-agricultural habitats proved more susceptible to changes in climate, with hotter and drier periods associated with greater changes in community composition in these settings. These findings demonstrate that diversified agriculture can help to alleviate the long-term loss of biodiversity outside natural protected areas(1).	[Hendershot, J. Nicholas; Smith, Jeffrey R.; Anderson, Christopher B.; Letten, Andrew D.; Fukami, Tadashi; Daily, Gretchen C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Hendershot, J. Nicholas; Smith, Jeffrey R.; Anderson, Christopher B.; Daily, Gretchen C.] Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA; [Letten, Andrew D.] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland; [Letten, Andrew D.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Frishkoff, Luke O.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Zook, Jim R.] Union Ornitologos Costa Rica, Naranjo De Alajuela, Alajuela, Costa Rica; [Daily, Gretchen C.] Stanford Univ, Woods Inst Environm, Stanford, CA 94305 USA; [Daily, Gretchen C.] Stanford Univ, Nat Capital Project, Stanford, CA 94305 USA	Stanford University; Stanford University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Queensland; University of Texas System; University of Texas Arlington; Stanford University; Stanford University	Hendershot, JN (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Hendershot, JN (corresponding author), Stanford Univ, Ctr Conservat Biol, Stanford, CA 94305 USA.	jhende@stanford.edu	Hendershot, J Nicholas/AAO-9686-2021; Smith, Jeffrey/B-1925-2015	Hendershot, J Nicholas/0000-0001-9570-8447; Anderson, Christopher/0000-0001-7392-4368; Letten, Andrew/0000-0001-6436-7942; Smith, Jeffrey/0000-0001-5768-216X	Gerhard Casper and John P. Morgridge Fellowship; Stanford Graduate Fellowship; NSF GRFP [DGE-1656518]; Ward Wilson Woods Jr Environmental Studies Fund; LuEsther T. Mertz Charitable Trust; Moore Family Foundation; Winslow Foundation	Gerhard Casper and John P. Morgridge Fellowship; Stanford Graduate Fellowship(Stanford University); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Ward Wilson Woods Jr Environmental Studies Fund; LuEsther T. Mertz Charitable Trust; Moore Family Foundation; Winslow Foundation	We thank the landowners, the Organization for Tropical Studies and the Los Cusingos Bird Sanctuary for making the collection of these data possible; P.-J. Ke, E. Mordecai and members of the Fukami and Daily laboratories at Stanford University for feedback; and J. Barlow and T. Tscharntke for comments. Financial support for J.N.H. was provided by the Gerhard Casper and John P. Morgridge Fellowship and the Stanford Graduate Fellowship. J.R.S. was supported by the NSF GRFP DGE-1656518 and the Ward Wilson Woods Jr Environmental Studies Fund. Funding for data collection over all years was through support to G.C.D. from the LuEsther T. Mertz Charitable Trust, the Moore Family Foundation and the Winslow Foundation.	Anderson CB, 2018, ECOL LETT, V21, P1572, DOI 10.1111/ele.13106; [Anonymous], 2021, LANG ENV STAT COMP; Bar-On YM, 2018, P NATL ACAD SCI USA, V115, P6506, DOI 10.1073/pnas.1711842115; Bell G, 2011, SCIENCE, V332, P1327, DOI 10.1126/science.1203105; Brawn JD, 2017, NAT CLIM CHANGE, V7, P133, DOI [10.1038/nclimate3183, 10.1038/NCLIMATE3183]; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; de Camino R., 2000, EVALUATION COUNTRY C; De Palma A, 2018, ADV ECOL RES, V58, P163, DOI 10.1016/bs.aecr.2017.12.004; Essl F, 2015, TRENDS ECOL EVOL, V30, P375, DOI 10.1016/j.tree.2015.05.002; Essl F, 2015, DIVERS DISTRIB, V21, P534, DOI 10.1111/ddi.12312; Frishkoff LO, 2016, ECOL LETT, V19, P1081, DOI 10.1111/ele.12645; Frishkoff LO, 2014, SCIENCE, V345, P1343, DOI 10.1126/science.1254610; Fukami T, 2005, P ROY SOC B-BIOL SCI, V272, P2105, DOI 10.1098/rspb.2005.3277; Fukami T, 2015, ANNU REV ECOL EVOL S, V46, P1, DOI 10.1146/annurev-ecolsys-110411-160340; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Gilbert B, 2013, P NATL ACAD SCI USA, V110, P1744, DOI 10.1073/pnas.1212375110; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hastings A, 2018, SCIENCE, V361, P990, DOI 10.1126/science.aat6412; Jackson ST, 2010, TRENDS ECOL EVOL, V25, P153, DOI 10.1016/j.tree.2009.10.001; Justice CO, 1998, IEEE T GEOSCI REMOTE, V36, P1228, DOI 10.1109/36.701075; Karp DS, 2013, ECOL LETT, V16, P1339, DOI 10.1111/ele.12173; Karp DS, 2011, P NATL ACAD SCI USA, V108, P21134, DOI 10.1073/pnas.1118276108; Kehoe L, 2017, NAT ECOL EVOL, V1, P1129, DOI 10.1038/s41559-017-0234-3; Kremen C, 2018, SCIENCE, V362, DOI 10.1126/science.aau6020; Kremen C, 2015, ANN NY ACAD SCI, V1355, P52, DOI 10.1111/nyas.12845; Larson H, 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2019-2.RLTS.T196326A89803716.en, DOI 10.2305/IUCN.UK.2019-3.RLTS.T5143A17944705.EN]; Lobo J., 2005, HIST NATURAL GOLFI C; MacLean SA, 2018, GLOBAL CHANGE BIOL, V24, P5882, DOI 10.1111/gcb.14458; Mendenhall CD, 2016, P NATL ACAD SCI USA, V113, P14544, DOI 10.1073/pnas.1604981113; Myneni R. B., 2015, MCD15A3H V006 MODIS, DOI DOI 10.5067/MODIS/MCD15A3H.006; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Northrup JM, 2019, GLOBAL CHANGE BIOL, V25, P1561, DOI 10.1111/gcb.14571; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Oksanen J., 2017, R PACKAGE VERSION 2; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Ranganathan J, 2008, P NATL ACAD SCI USA, V105, P17852, DOI 10.1073/pnas.0808874105; Rosero-Bixby L, 2002, REV BIOL TROP, V50, P585; Royle J. A., 2008, HIERARCHICAL MODELIN; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Sanchez Julio E., 1998, Ornitologia Neotropical, V9, P99; Sandoval Luis, 2018, Check List, V14, P141; Sandoval Luis, 2010, BULLETIN OF THE BRITISH ORNITHOLOGISTS CLUB, V130, P237; Simpson D, 2017, STAT SCI, V32, P1, DOI 10.1214/16-STS576; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Springmann M, 2018, NATURE, V562, P519, DOI 10.1038/s41586-018-0594-0; Stiles F.G., 1989, GUIDE BIRDS COSTA RI; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Tulloch VJD, 2015, FRONT ECOL ENVIRON, V13, P91, DOI 10.1890/140022; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Wan Z., 2015, MOD11A1 V006 MODIS T, DOI DOI 10.5067/MODIS/MOD11A1.006; Wilson AM, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002415; Zuur AF, 2016, METHODS ECOL EVOL, V7, P636, DOI 10.1111/2041-210X.12577	53	47	50	20	120	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					393	+		10.1038/s41586-020-2090-6	http://dx.doi.org/10.1038/s41586-020-2090-6			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188954				2022-12-28	WOS:000520778000017
J	Raal, FJ; Kallend, D; Ray, KK; Turner, T; Koenig, W; Wright, RS; Wijngaard, PLJ; Curcio, D; Jaros, MJ; Leiter, LA; Kastelein, JJP				Raal, Frederick J.; Kallend, David; Ray, Kausik K.; Turner, Traci; Koenig, Wolfgang; Wright, R. Scott; Wijngaard, Peter L. J.; Curcio, Danielle; Jaros, Mark J.; Leiter, Lawrence A.; Kastelein, John J. P.		ORION-9 Investigators	Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR RISK; DOUBLE-BLIND; PLACEBO; PCSK9; CHOLESTEROL; INHIBITION; EVOLOCUMAB; GUIDELINES; CLINICIAN; VARIANTS	Background Familial hypercholesterolemia is characterized by an elevated level of low-density lipoprotein (LDL) cholesterol and an increased risk of premature atherosclerotic cardiovascular disease. Monoclonal antibodies directed against proprotein convertase subtilisin-kexin type 9 (PCSK9) have been shown to reduce LDL cholesterol levels by more than 50% but require administration every 2 to 4 weeks. In a phase 2 trial, a twice-yearly injection of inclisiran, a small interfering RNA, was shown to inhibit hepatic synthesis of PCSK9 in adults with heterozygous familial hypercholesterolemia. Methods In this phase 3, double-blind trial, we randomly assigned, in a 1:1 ratio, 482 adults who had heterozygous familial hypercholesterolemia to receive subcutaneous injections of inclisiran sodium (at a dose of 300 mg) or matching placebo on days 1, 90, 270, and 450. The two primary end points were the percent change from baseline in the LDL cholesterol level on day 510 and the time-adjusted percent change from baseline in the LDL cholesterol level between day 90 and day 540. Results The median age of the patients was 56 years, and 47% were men; the mean baseline level of LDL cholesterol was 153 mg per deciliter. At day 510, the percent change in the LDL cholesterol level was a reduction of 39.7% (95% confidence interval [CI], -43.7 to -35.7) in the inclisiran group and an increase of 8.2% (95% CI, 4.3 to 12.2) in the placebo group, for a between-group difference of -47.9 percentage points (95% CI, -53.5 to -42.3; P<0.001). The time-averaged percent change in the LDL cholesterol level between day 90 and day 540 was a reduction of 38.1% (95% CI, -41.1 to -35.1) in the inclisiran group and an increase of 6.2% (95% CI, 3.3 to 9.2) in the placebo group, for a between-group difference of -44.3 percentage points (95% CI, -48.5 to -40.1; P<0.001). There were robust reductions in LDL cholesterol levels in all genotypes of familial hypercholesterolemia. Adverse events and serious adverse events were similar in the two groups. Conclusions Among adults with heterozygous familial hypercholesterolemia, those who received inclisiran had significantly lower levels of LDL cholesterol than those who received placebo, with an infrequent dosing regimen and an acceptable safety profile. (Funded by the Medicines Company; ORION-9 ClinicalTrials.gov number, NCT03397121.).) This phase 3 trial evaluated the safety and efficacy of inclisiran, a small interfering RNA that inhibits hepatic PCSK9 synthesis, in 482 adults with heterozygous familial hypercholesterolemia, who received subcutaneous injections of inclisiran or placebo on days 1, 90, 270, and 450. Changes in cholesterol were assessed up to day 540.	[Raal, Frederick J.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Kallend, David] Medicines Co, Zurich, Switzerland; [Ray, Kausik K.] Imperial Coll London, Imperial Ctr Cardiovasc Dis Prevent, Dept Primary Care & Publ Hlth, London, England; [Turner, Traci] Medpace Reference Labs, Cincinnati, OH USA; [Koenig, Wolfgang] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Koenig, Wolfgang] Munich Heart Alliance, German Ctr Cardiovasc Res, Munich, Germany; [Koenig, Wolfgang] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Wright, R. Scott] Mayo Clin, Div Prevent Cardiol, Rochester, MN USA; [Wright, R. Scott] Mayo Clin, Dept Cardiol, Rochester, MN USA; [Wijngaard, Peter L. J.; Curcio, Danielle] Medicines Co, Parsippany, NJ USA; [Jaros, Mark J.] Summit Analyt, Denver, CO USA; [Leiter, Lawrence A.] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Kastelein, John J. P.] Univ Amsterdam, Dept Vasc Med, Acad Med Ctr, Amsterdam, Netherlands	University of Witwatersrand; Imperial College London; German Heart Centre Munich; Technical University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance; Ulm University; Mayo Clinic; Mayo Clinic; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Amsterdam; Academic Medical Center Amsterdam	Raal, FJ (corresponding author), Univ Witwatersrand, Div Endocrinol & Metab, Fac Hlth Sci, 7 York Rd, ZA-2193 Johannesburg, South Africa.	frederick.raal@wits.ac.za	Raal, FJ/ABD-5111-2021; MASANA, LUIS/M-7002-2019; Diaz Diaz, Jose luis/Q-2523-2015	Raal, FJ/0000-0002-9170-7938; MASANA, LUIS/0000-0002-0789-4954; Hove, Jens/0000-0002-5600-5623; Bottcher, Morten/0000-0002-2116-2370; Diaz Diaz, Jose luis/0000-0002-9194-495X; Ray, Kausik/0000-0003-0508-0954; Koenig, Wolfgang/0000-0002-2064-9603	Medicines Company	Medicines Company	Supported by the Medicines Company.	Amor-Salamanca A, 2017, J AM COLL CARDIOL, V70, P1732, DOI 10.1016/j.jacc.2017.08.009; Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Berberich AJ, 2019, NAT REV CARDIOL, V16, P9, DOI 10.1038/s41569-018-0052-6; BROWN MS, 1981, NEW ENGL J MED, V305, P515, DOI 10.1056/NEJM198108273050909; Chora JR, 2018, GENET MED, V20, P591, DOI 10.1038/gim.2017.151; Cuchel M, 2014, EUR HEART J, V35, P2146, DOI 10.1093/eurheartj/ehu274; Defesche JC, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.93; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; Iacocca MA, 2018, HUM MUTAT, V39, P1631, DOI 10.1002/humu.23634; Iacocca MA, 2017, J LIPID RES, V58, P2202, DOI 10.1194/jlr.D079301; Iacocca MA, 2017, EXPERT REV MOL DIAGN, V17, P641, DOI 10.1080/14737159.2017.1332997; Kastelein JJP, 2017, J CLIN LIPIDOL, V11, P195, DOI 10.1016/j.jacl.2016.12.004; Nair JK, 2014, J AM CHEM SOC, V136, P16958, DOI 10.1021/ja505986a; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Raal FJ, 2016, ATHEROSCLEROSIS, V248, P238, DOI 10.1016/j.atherosclerosis.2016.03.009; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; Raal FJ, 2015, LANCET, V385, P341, DOI 10.1016/S0140-6736(14)61374-X; Ray KK, 2017, NEW ENGL J MED, V376, P1430, DOI 10.1056/NEJMoa1615758; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Sjouke B, 2016, J CLIN LIPIDOL, V10, P1462, DOI 10.1016/j.jacl.2016.09.003; Talmud PJ, 2013, LANCET, V381, P1293, DOI 10.1016/S0140-6736(12)62127-8	23	231	239	9	38	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 16	2020	382	16					1520	1530		10.1056/NEJMoa1913805	http://dx.doi.org/10.1056/NEJMoa1913805			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF9LC	32197277	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000527733300010
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: "Illogical" lack of testing is causing healthy staff to self-isolate, BMA chief warns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Newman M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1257	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1277	10.1136/bmj.m1277	http://dx.doi.org/10.1136/bmj.m1277			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220877	Bronze			2022-12-28	WOS:000523765200014
J	Greenberg, N; Docherty, M; Gnanapragasam, S; Wessely, S				Greenberg, Neil; Docherty, Mary; Gnanapragasam, Sam; Wessely, Simon			Managing mental health challenges faced by healthcare workers during covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							UK ARMED-FORCES; DISORDER		[Greenberg, Neil; Wessely, Simon] Kings Coll London, NIHR Hlth Protect Res Unit Emergency Preparednes, London, England; [Docherty, Mary; Gnanapragasam, Sam] South London & Maudsley NHS Trust, London, England	University of London; King's College London; South London & Maudsley NHS Trust	Greenberg, N (corresponding author), Kings Coll London, NIHR Hlth Protect Res Unit Emergency Preparednes, London, England.	neil.greenberg@kcl.ac.uk	Gnanarpagasam, Sam/AAM-9416-2020	Gnanarpagasam, Sam/0000-0001-9495-6879; greenberg, neil/0000-0003-4550-2971; Wessely, Simon Charles/0000-0002-6743-9929				Brooks S, 2020, BMJ MILITARY HEALTH, V166, P52, DOI 10.1136/jramc-2017-000876; Brooks SK, 2019, BRIT MED BULL, V129, P25, DOI 10.1093/bmb/ldy040; Flanagan E, 2020, J INTERPROF CARE, V34, P140, DOI 10.1080/13561820.2019.1636008; Greenberg N., 2003, J MENTAL HLTH, V12, P565, DOI [10.1080/09638230310001627928, DOI 10.1080/09638230310001627928]; Iversen AC, 2008, PSYCHOL MED, V38, P511, DOI 10.1017/S0033291708002778; Jones N, 2012, PSYCHIATRY, V75, P49, DOI 10.1521/psyc.2012.75.1.49; Litz BT, 2009, CLIN PSYCHOL REV, V29, P695, DOI 10.1016/j.cpr.2009.07.003; Murray E, 2018, EMERG MED J, V35, P590, DOI 10.1136/emermed-2017-207216; National Institute for Health and Care Excellence, 2018, POSTTRAUMATIC STRESS; Salkovskis PM, 1999, BEHAV RES THER, V37, P559, DOI 10.1016/S0005-7967(98)00153-3; Williamson V, 2018, BRIT J PSYCHIAT, V212, P339, DOI 10.1192/bjp.2018.55	11	912	935	7	73	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1211	10.1136/bmj.m1211	http://dx.doi.org/10.1136/bmj.m1211			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LA2EA	32217624	Bronze			2022-12-28	WOS:000523764800013
J	Cook, R; Davidson, P; White, A				Cook, Rob; Davidson, Peter; White, Alicia		NIHR Dissemination Ctr	Online patient feedback is positive, but not used effectively	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material								The study Powell J, Atherton H, Williams V, et al. Using online patient feedback to improve NHS services: the INQUIRE multimethod study. Health Serv Deliv Res 2019;7:38. This project was funded by the NIHR Health Services and Delivery Research programme (project number HS&DR 14/04/48). To read the full NIHR Signal, go to: https://discover.dc.nihr.ac.uk/content/signal-000861/online-patient-feedback-is-mostly-positive-but-is-not-being-used-effectively	[Cook, Rob; White, Alicia] Bazian, Economist Intelligence Unit Healthcare, London, England; [Davidson, Peter] Univ Southampton, Wessex Inst, Southampton, Hants, England	University of Southampton	Cook, R (corresponding author), Bazian, Economist Intelligence Unit Healthcare, London, England.	rob.cook@bazian.com							0	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m517	10.1136/bmj.m517	http://dx.doi.org/10.1136/bmj.m517			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205307				2022-12-28	WOS:000523764100001
J	Cipriani, A; Ioannidis, JPA; Rothwell, PM; Glasziou, P; Li, TJ; Hernandez, AF; Tomlinson, A; Simes, J; Naci, H				Cipriani, Andrea; Ioannidis, John P. A.; Rothwell, Peter M.; Glasziou, Paul; Li, Tianjing; Hernandez, Adrian F.; Tomlinson, Anneka; Simes, John; Naci, Huseyin			Generating comparative evidence on new drugs and devices after approval	LANCET			English	Review							SURROGATE END-POINTS; TRANSIENT ISCHEMIC ATTACK; RANDOMIZED CONTROLLED-TRIALS; EARLY RECURRENT STROKE; US FOOD; CLINICAL-TRIALS; CARDIOVASCULAR EVENTS; ACCELERATED APPROVAL; THERAPEUTIC AGENTS; MASTER PROTOCOLS	Certain limitations of evidence available on drugs and devices at the time of market approval often persist in the post-marketing period. Often, post-marketing research landscape is fragmented. When regulatory agencies require pharmaceutical and device manufacturers to conduct studies in the post-marketing period, these studies might remain incomplete many years after approval. Even when completed, many post-marketing studies lack meaningful active comparators, have observational designs, and might not collect patient-relevant outcomes. Regulators, in collaboration with the industry and patients, ought to ensure that the key questions unanswered at the time of drug and device approval are resolved in a timely fashion during the post-marketing phase. We propose a set of seven key guiding principles that we believe will provide the necessary incentives for pharmaceutical and device manufacturers to generate comparative data in the post-marketing period. First, regulators (for drugs and devices), notified bodies (for devices in Europe), health technology assessment organisations, and payers should develop customised evidence generation plans, ensuring that future post-approval studies address any limitations of the data available at the time of market entry impacting the benefit-risk profiles of drugs and devices. Second, post-marketing studies should be designed hierarchically: priority should be given to efforts aimed at evaluating a product's net clinical benefit in randomised trials compared with current known effective therapy, whenever possible, to address common decisional dilemmas. Third, post-marketing studies should incorporate active comparators as appropriate. Fourth, use of non-randomised studies for the evaluation of clinical benefit in the post-marketing period should be limited to instances when the magnitude of effect is deemed to be large or when it is possible to reasonably infer the comparative benefits or risks in settings, in which doing a randomised trial is not feasible. Fifth, efficiency of randomised trials should be improved by streamlining patient recruitment and data collection through innovative design elements. Sixth, governments should directly support and facilitate the production of comparative post-marketing data by investing in the development of collaborative research networks and data systems that reduce the complexity, cost, and waste of rigorous post-marketing research efforts. Last, financial incentives and penalties should be developed or more actively reinforced.	[Cipriani, Andrea; Tomlinson, Anneka] Univ Oxford, Dept Psychiat, Oxford, England; [Cipriani, Andrea; Tomlinson, Anneka] Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford, England; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Biomed Data Sci, Palo Alto, CA 94304 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Palo Alto, CA 94304 USA; [Rothwell, Peter M.] Univ Oxford, Ctr Prevent Stroke & Dementia, Oxford, England; [Glasziou, Paul] Univ Bond, Ctr Res Evidence Based Practice, Gold Coast, Qld, Australia; [Li, Tianjing] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Hernandez, Adrian F.] Duke Univ, Sch Med, Duke Clin Res Inst, Durham, NC USA; [Simes, John] Univ Sydney, Clin Trials Ctr, Natl Hlth & Med Res Council, Sydney, NSW, Australia; [Naci, Huseyin] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England	University of Oxford; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Duke University; University of Sydney; University of London; London School Economics & Political Science	Cipriani, A (corresponding author), Univ Oxford, Warneford Hosp, Dept Psychiat, Oxford OX3 7JX, England.	andrea.cipriani@psych.ox.ac.uk	Rothwell, Peter/ABE-5913-2020; Ioannidis, John P. A./G-9836-2011; Glasziou, Paul/A-7832-2008; Cipriani, Andrea/P-6944-2015	Rothwell, Peter/0000-0001-9739-9211; Glasziou, Paul/0000-0001-7564-073X; Tomlinson, Anneka/0000-0002-4721-2006; Ioannidis, John P./0000-0003-3118-6859; Li, Tianjing/0000-0001-5371-4558; Cipriani, Andrea/0000-0001-5179-8321	National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre [BRC-1215-20005]; Commonwealth Fund; MRC [MC_PC_17215] Funding Source: UKRI	National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre(National Institute for Health Research (NIHR)); Commonwealth Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC-1215-20005). The views expressed are those of the authors and not necessarily those of the UK National Health Service, the NIHR, or the UK Department of Health. HN was funded by the Commonwealth Fund as a Harkness Fellow in Health Care Policy and Practice.	Angus DC, 2019, NAT REV DRUG DISCOV, V18, P797, DOI 10.1038/s41573-019-0034-3; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 2019, BMJ; [Anonymous], BMJ; [Anonymous], MDCG 2019 9 SUMM SAF; [Anonymous], EVID BASED MENT HLTH; [Anonymous], CLIN TRIAL EVIDENCE; Antoniou M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149803; Avorn J, 2015, NEW ENGL J MED, V372, P2473, DOI 10.1056/NEJMp1506964; Banzi R, 2015, EUR J INTERN MED, V26, P572, DOI 10.1016/j.ejim.2015.08.008; Beaver JA, 2018, JAMA ONCOL, V4, P849, DOI 10.1001/jamaoncol.2017.5618; Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Bhatt DL, 2016, NEW ENGL J MED, V375, P65, DOI 10.1056/NEJMra1510061; Bitterman DS, 2020, JNCI-J NATL CANCER I, V112, P229, DOI 10.1093/jnci/djz167; Bloem LT, 2019, CLIN PHARMACOL THER, V105, P426, DOI 10.1002/cpt.1169; Boden WE, 2011, NEW ENGL J MED, V365, P2255, DOI 10.1056/NEJMoa1107579; Bourgeois FT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028820, 10.1371/journal.pone.0050906]; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; Carpenter D, 2010, PRINC STUD AM POLIT, P1; Chace MJ, 2012, J CLIN PSYCHIAT, V73, P1388, DOI 10.4088/JCP.12m07794; Chen EY, 2019, JAMA INTERN MED, V179, P915, DOI 10.1001/jamainternmed.2019.0583; Chen EY, 2019, JAMA INTERN MED, V179, P642, DOI 10.1001/jamainternmed.2018.8351; Ciani O, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f457; Cipriani A, 2018, LANCET, V391, P1357, DOI 10.1016/S0140-6736(17)32802-7; Corrigan-Curay J, 2018, JAMA-J AM MED ASSOC, V320, P867, DOI 10.1001/jama.2018.10136; Dias S, 2010, J CLIN EPIDEMIOL, V63, P587, DOI 10.1016/j.jclinepi.2010.01.005; DiMasi JA, 2013, CLIN THER, V35, P808, DOI 10.1016/j.clinthera.2013.04.004; Djulbegovic B, 2018, J CLIN EPIDEMIOL, V98, P24, DOI 10.1016/j.jclinepi.2018.01.011; Donoghue M, 2012, CLIN CANCER RES, V18, P1496, DOI 10.1158/1078-0432.CCR-11-2149; Downing NS, 2014, JAMA-J AM MED ASSOC, V311, P368, DOI 10.1001/jama.2013.282034; Dreyer NA, 2010, HEALTH AFFAIR, V29, P1818, DOI 10.1377/hlthaff.2010.0666; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; Eichler HG, 2012, CLIN PHARMACOL THER, V91, P426, DOI 10.1038/clpt.2011.345; Fabbri A, 2018, AM J PUBLIC HEALTH, V108, pE9, DOI 10.2105/AJPH.2018.304677; Federico CA, 2019, JAMA INTERN MED, V179, P90, DOI 10.1001/jamainternmed.2018.5705; Ference BA, 2017, EUR HEART J, V38, P2459, DOI 10.1093/eurheartj/ehx144; Fitzpatrick T, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6019; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Fleurence RL, 2019, CLIN PHARMACOL THER, V106, P30, DOI 10.1002/cpt.1380; Fleurence RL, 2019, JAMA CARDIOL, V4, P197, DOI 10.1001/jamacardio.2018.4933; Fleurence RL, 2014, J AM MED INFORM ASSN, V21, P578, DOI 10.1136/amiajnl-2014-002747; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Franklin JM, 2019, CLIN PHARMACOL THER, V105, P867, DOI 10.1002/cpt.1351; Fraser AG, 2018, LANCET, V392, P521, DOI 10.1016/S0140-6736(18)31270-4; Garattini S, 2016, EUR J INTERN MED, V32, P13, DOI 10.1016/j.ejim.2016.03.020; Glasziou P, 2007, BMJ-BRIT MED J, V334, P349, DOI 10.1136/bmj.39070.527986.68; Guyatt G., 2015, CUREUS J MED SCIENCE, V3rd ed., DOI DOI 10.7759/CUR; Gyawali B, 2019, JAMA INTERN MED, V179, P906, DOI 10.1001/jamainternmed.2019.0462; Haslam A, 2019, EUR J CANCER, V106, P196, DOI 10.1016/j.ejca.2018.11.012; Herder M, 2019, MILBANK Q, V97, P820, DOI 10.1111/1468-0009.12413; Hernandez AF, 2015, ANN INTERN MED, V163, P635, DOI 10.7326/M15-1460; Hochman M, 2010, JAMA-J AM MED ASSOC, V303, P951, DOI 10.1001/jama.2010.240; Horton R, 2004, LANCET, V364, P1995, DOI 10.1016/S0140-6736(04)17523-5; Hwang TJ, 2017, CLIN PHARMACOL THER, V102, P290, DOI 10.1002/cpt.705; Hwang TJ, 2019, INT J CANCER, V144, P1746, DOI 10.1002/ijc.31957; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; James S, 2015, NAT REV CARDIOL, V12, P312, DOI 10.1038/nrcardio.2015.33; Janiaud P, 2019, CANCER TREAT REV, V73, P20, DOI 10.1016/j.ctrv.2018.12.003; Johnston A, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0749-2; Juni P, 2004, LANCET, V364, P2021, DOI 10.1016/S0140-6736(04)17514-4; Kesselheim AS, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4633; Kesselheim AS, 2011, HEALTH AFFAIR, V30, P2318, DOI 10.1377/hlthaff.2011.0370; Kesselheim AS, 2010, NEW ENGL J MED, V363, P1855, DOI 10.1056/NEJMhle1002961; Kleijnen S, 2012, VALUE HEALTH, V15, P954, DOI 10.1016/j.jval.2012.04.010; Kmietowicz Z, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b217; Kovic B, 2018, JAMA INTERN MED, V178, P1586, DOI 10.1001/jamainternmed.2018.4710; Kramer DB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001276; Kramer DB, 2012, NEW ENGL J MED, V366, P848, DOI 10.1056/NEJMhle1113918; Kumar S, 2019, LANCET, V394, P281, DOI 10.1016/S0140-6736(19)31711-8; Kurz X, 2018, PHARMACOEPIDEM DR S, V27, P245, DOI 10.1002/pds.4381; Lathyris DN, 2010, EUR J CLIN INVEST, V40, P172, DOI 10.1111/j.1365-2362.2009.02240.x; Li GW, 2016, J CLIN EPIDEMIOL, V80, P16, DOI 10.1016/j.jclinepi.2016.08.003; Li LX, 2017, LANCET, V390, P490, DOI 10.1016/S0140-6736(17)30770-5; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Lincoff AM, 2017, NEW ENGL J MED, V376, P1933, DOI 10.1056/NEJMoa1609581; Mello MM, 2012, NEW ENGL J MED, V367, P959, DOI 10.1056/NEJMhle1207160; Melvin T, 2019, EFORT OPEN REV, V4, P351, DOI 10.1302/2058-5241.4.180061; Menon V, 2014, CIRCULATION, V129, P2705, DOI 10.1161/CIRCULATIONAHA.113.008221; Moore TJ, 2018, JAMA INTERN MED, V178, P1451, DOI 10.1001/jamainternmed.2018.3931; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Naci H, 2019, BRIT J SPORT MED, V53, P859, DOI 10.1136/bjsports-2018-099921; Naci H, 2017, JAMA-J AM MED ASSOC, V318, P626, DOI 10.1001/jama.2017.9415; Naci H, 2017, MILBANK Q, V95, P261, DOI 10.1111/1468-0009.12261; Naci H, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5741; Naci H, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5577; Nyberg K, 2019, UPSALA J MED SCI, V124, P33, DOI 10.1080/03009734.2018.1550453; Pease AM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1680; Peden CJ, 2019, LANCET, V393, P2213, DOI 10.1016/S0140-6736(18)32521-2; Platt R, 2018, NEW ENGL J MED, V379, P2091, DOI 10.1056/NEJMp1809643; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P2491, DOI 10.1001/jama.2012.5545; Rathi VK, 2015, JAMA-J AM MED ASSOC, V314, P604, DOI 10.1001/jama.2015.8761; Rawlins M, 2008, LANCET, V372, P2152, DOI 10.1016/S0140-6736(08)61930-3; Razavi M, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.11111; Reith C, 2013, NEW ENGL J MED, V369, P1061, DOI 10.1056/NEJMsb1300760; Renfro LA, 2017, ANN ONCOL, V28, P34, DOI 10.1093/annonc/mdw413; Reynolds IS, 2014, JAMA INTERN MED, V174, P1773, DOI 10.1001/jamainternmed.2014.4194; Ridley DB, 2006, HEALTH AFFAIR, V25, P429, DOI 10.1377/hlthaff.25.2.429; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2016, LANCET, V388, P365, DOI 10.1016/S0140-6736(16)30468-8; Rothwell PM, 2011, LANCET, V377, P1681, DOI 10.1016/S0140-6736(11)60516-3; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; Salanti G, 2008, ANN INTERN MED, V148, P544, DOI 10.7326/0003-4819-148-7-200804010-00011; Salanti G, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2740-2; Shuren J, 2016, JAMA-J AM MED ASSOC, V316, P1153, DOI 10.1001/jama.2016.8708; Skydel JJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3410; Speich B, 2018, J CLIN EPIDEMIOL, V96, P1, DOI 10.1016/j.jclinepi.2017.12.018; Sturmer T, 2006, J CLIN EPIDEMIOL, V59, P437, DOI 10.1016/j.jclinepi.2005.07.004; Tap WD, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.18_suppl.LBA3; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Topol EJ, 2004, NEW ENGL J MED, V351, P1707, DOI 10.1056/NEJMp048286; US Food and Drug Administration, 2018, MAST PROT EFF CLIN T; Vandenbroucke JP, 2004, LANCET, V363, P1728, DOI 10.1016/S0140-6736(04)16261-2; Walker S, 2012, VALUE HEALTH, V15, P570, DOI 10.1016/j.jval.2011.12.013; Wallach JD, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1344-3; Wallach JD, 2019, J GEN INTERN MED, V34, P492, DOI 10.1007/s11606-018-4779-x; Wallach JD, 2018, CLIN TRIALS, V15, P219, DOI 10.1177/1740774518770648; Wallach JD, 2018, CLIN TRIALS, V15, P243, DOI 10.1177/1740774518770657; Wallach JD, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2031; Wang B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4679; Woloshin S, 2017, NEW ENGL J MED, V377, P1114, DOI 10.1056/NEJMp1705800; Woodcock J, 2017, NEW ENGL J MED, V377, P62, DOI 10.1056/NEJMra1510062; Yndigegn T, 2018, HEART, V104, P1562, DOI 10.1136/heartjnl-2017-312322; Zeitoun JD, 2018, CLIN PHARMACOL THER, V104, P1000, DOI 10.1002/cpt.1038	125	25	25	1	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					998	1010						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199487	Green Submitted, Green Accepted			2022-12-28	WOS:000521744600031
J	Nagashima, S; Tabara, LC; Tilokani, L; Paupe, V; Anand, H; Pogson, JH; Zunino, R; McBride, HM; Prudent, J				Nagashima, Shun; Tabara, Luis-Carlos; Tilokani, Lisa; Paupe, Vincent; Anand, Hanish; Pogson, Joe H.; Zunino, Rodolfo; McBride, Heidi M.; Prudent, Julien			Golgi-derived PI(4)P-containing vesicles drive late steps of mitochondrial division	SCIENCE			English	Article							FISSION; ACTIN; PROTEINS; DRP1; PEROXISOMES; MORPHOLOGY; DYNAMICS; PLATFORM; MAPL; BETA	Mitochondrial plasticity is a key regulator of cell fate decisions. Mitochondrial division involves Dynamin-related protein-1 (Drp1) oligomerization, which constricts membranes at endoplasmic reticulum (ER) contact sites. The mechanisms driving the final steps of mitochondrial division are still unclear. Here, we found that microdomains of phosphatidylinositol 4-phosphate [PI(4)P] on trans-Golgi network (TGN) vesicles were recruited to mitochondria-ER contact sites and could drive mitochondrial division downstream of Drp1. The loss of the small guanosine triphosphatase ADP-ribosylation factor 1 (Arf1) or its effector, phosphatidylinositol 4-kinase III beta [PI(4)KIII beta], in different mammalian cell lines prevented PI(4)P generation and led to a hyperfused and branched mitochondrial network marked with extended mitochondrial constriction sites. Thus, recruitment of TGN-PI(4)P-containing vesicles at mitochondria-ER contact sites may trigger final events leading to mitochondrial scission.	[Nagashima, Shun; Tabara, Luis-Carlos; Tilokani, Lisa; Paupe, Vincent; Anand, Hanish; Prudent, Julien] Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0XY, England; [Pogson, Joe H.; Zunino, Rodolfo; McBride, Heidi M.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3B 2B4, Canada	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Cambridge; McGill University	Prudent, J (corresponding author), Univ Cambridge, Med Res Council Mitochondrial Biol Unit, Cambridge Biomed Campus, Cambridge CB2 0XY, England.; McBride, HM (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3B 2B4, Canada.	heidi.mcbride@mcgill.ca; julien.prudent@mrc-mbu.cam.ac.uk	McBride, Heidi M./ABD-5774-2021; McBride, Heidi M/C-1162-2008; Tabara, Luis Carlos/AAI-3989-2021	McBride, Heidi M./0000-0003-4666-2280; McBride, Heidi M/0000-0003-4666-2280; Prudent, Julien/0000-0003-3821-6088; Zunino, Rodolfo/0000-0002-0986-2550; , Hanish/0000-0002-3850-9641; Nagashima, Shun/0000-0001-8042-0897; Tabara Rodriguez, Luis Carlos/0000-0001-7684-3811	Canadian Institutes of Health Research Operating Grants Program (CIHR) [68833]; Medical Research Council (MRC) [MC_UU_00015/7, RG89175]; Isaac Newton Trust [RG89529]; Wellcome Trust Institutional Strategic Support Fund [RG89305]; Daiichi Sankyo Foundation of Life Science; Ramon Areces postdoctoral fellowships; MRC; European Union's Horizon 2020 research and innovation program [MITODYN-749926]; MRC [MC_UU_00015/7] Funding Source: UKRI	Canadian Institutes of Health Research Operating Grants Program (CIHR)(Canadian Institutes of Health Research (CIHR)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Isaac Newton Trust; Wellcome Trust Institutional Strategic Support Fund(Wellcome Trust); Daiichi Sankyo Foundation of Life Science; Ramon Areces postdoctoral fellowships; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union's Horizon 2020 research and innovation program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Canadian Institutes of Health Research Operating Grants Program (CIHR grant 68833 to H.M.M.), the Medical Research Council (MRC grants MC_UU_00015/7 and RG89175 to J.P.), the Isaac Newton Trust (grant RG89529 to J.P.), and the Wellcome Trust Institutional Strategic Support Fund (grant RG89305 to J.P.). H.M.M. is a Canada Research Chair. S.N. and L.-C.T. are recipients of Daiichi Sankyo Foundation of Life Science and Ramon Areces postdoctoral fellowships, respectively. L. T. was supported by an MRC-funded graduate student fellowship. V. P was supported by the European Union's Horizon 2020 research and innovation program (MITODYN-749926).	Ackema KB, 2014, EMBO J, V33, P2659, DOI 10.15252/embj.201489039; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Bindels DS, 2017, NAT METHODS, V14, P53, DOI [10.1038/NMETH.4074, 10.1038/nmeth.4074]; Braschi E, 2010, CURR BIOL, V20, P1310, DOI 10.1016/j.cub.2010.05.066; Braschi E, 2009, EMBO REP, V10, P748, DOI 10.1038/embor.2009.86; Chun J, 2008, MOL BIOL CELL, V19, P3488, DOI 10.1091/mbc.E08-04-0373; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Dowler S, 2000, BIOCHEM J, V351, P19, DOI 10.1042/0264-6021:3510019; Fonseca TB, 2019, NATURE, V570, pE34, DOI 10.1038/s41586-019-1296-y; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hong NH, 2015, J CELL BIOL, V210, P753, DOI 10.1083/jcb.201412127; Kamerkar SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07543-w; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555; Li SA, 2015, J CELL BIOL, V208, P109, DOI 10.1083/jcb.201404050; Li XL, 2003, J BIOL CHEM, V278, P17012, DOI 10.1074/jbc.M212031200; Lochmuller H, 1999, EXP CELL RES, V248, P186, DOI 10.1006/excr.1999.4407; Mesmin B, 2013, CELL, V155, P830, DOI 10.1016/j.cell.2013.09.056; Moore AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12886; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pogson JH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004815; Prudent J, 2015, MOL CELL, V59, P941, DOI 10.1016/j.molcel.2015.08.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Sugiura A, 2017, NATURE, V542, P251, DOI 10.1038/nature21375; Tilokani L, 2018, ESSAYS BIOCHEM, V62, P341, DOI 10.1042/EBC20170104; Tondera D, 2009, EMBO J, V28, P1589, DOI 10.1038/emboj.2009.89; von Filseck JM, 2015, SCIENCE, V349, P432, DOI 10.1126/science.aab1346; von Filseck JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7671; Williamson Chad D, 2015, Curr Protoc Cell Biol, V68, DOI 10.1002/0471143030.cb0327s68; Wong YC, 2018, NATURE, V554, P382, DOI 10.1038/nature25486; Zhao XH, 2000, J BIOL CHEM, V275, P14642, DOI 10.1074/jbc.275.19.14642; Zunino R, 2007, J CELL SCI, V120, P1178, DOI 10.1242/jcs.03418	39	67	70	6	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1366	+		10.1126/science.aax6089	http://dx.doi.org/10.1126/science.aax6089			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193326				2022-12-28	WOS:000522167400050
J	Zuk, M				Zuk, Marlene			Shallow ponds prompt fitness-favorable species interbreeding	SCIENCE			English	Editorial Material							PREFERENCE		[Zuk, Marlene] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Zuk, M (corresponding author), Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA.	mzuk@umn.edu						Chen C, 2020, SCIENCE, V367, P1377, DOI 10.1126/science.aaz5109; GWYNNE DT, 1983, J AUST ENTOMOL SOC, V22, P79; Mayr E, 1942, SYSTEMATICS ORIGIN S; McDermott A, 2019, P NATL ACAD SCI USA, V116, P12116, DOI 10.1073/pnas.1907565116; Mendelson TC, 2012, TRENDS ECOL EVOL, V27, P421, DOI 10.1016/j.tree.2012.04.001; Peterson MA, 2005, EVOLUTION, V59, P2639; RYAN MJ, 1993, EVOLUTION, V47, P647, DOI 10.1111/j.1558-5646.1993.tb02118.x; Taylor SA, 2019, NAT ECOL EVOL, V3, P170, DOI 10.1038/s41559-018-0777-y; THOMPSON JN, 1988, ENTOMOL EXP APPL, V47, P3, DOI 10.1007/BF00186709; Zuk M., 2018, SEXUAL SELECTION VER	10	1	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1304	1305		10.1126/science.abb2398	http://dx.doi.org/10.1126/science.abb2398			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193310				2022-12-28	WOS:000522167400029
J	Yamamoto, S; Okamoto, K				Yamamoto, Shinya; Okamoto, Koh			Blood Culture Results Before and After Antimicrobial Administration	ANNALS OF INTERNAL MEDICINE			English	Letter									[Yamamoto, Shinya; Okamoto, Koh] Univ Tokyo Hosp, Tokyo, Japan	University of Tokyo	Yamamoto, S (corresponding author), Univ Tokyo Hosp, Tokyo, Japan.			Yamamoto, Shinya/0000-0003-2890-7256; Okamoto, Koh/0000-0002-4072-9096				Baron EJ, 2005, CUMITECH C; Cheng MP, 2019, ANN INTERN MED, V171, P547, DOI 10.7326/M19-1696; Miller JM, 2018, CLIN INFECT DIS, V67, pE1, DOI 10.1093/cid/ciy381	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					440	440		10.7326/L19-0793	http://dx.doi.org/10.7326/L19-0793			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176902				2022-12-28	WOS:000520170800038
J	Rimmer, A				Rimmer, Abi			Covid-19: Medical conferences around the world are cancelled after US cases are linked to Massachusetts meeting	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Baker C, 2020, NO 591 DECLARATION S; Commonwealth of Massachusetts, 2020, COV 19 CAS QUAR MON; Massachusetts Department of Public Health, 2020, 15 NEW PRES POS CAS	3	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m1054	10.1136/bmj.m1054	http://dx.doi.org/10.1136/bmj.m1054			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32169834	Bronze			2022-12-28	WOS:000520014600007
J	McMichael, TM; Currie, DW; Clark, S; Pogosjans, S; Kay, M; Schwartz, NG; Lewis, J; Baer, A; Kawakami, V; Lukoff, MD; Ferro, J; Brostrom-Smith, C; Rea, TD; Sayre, MR; Riedo, FX; Russell, D; Hiatt, B; Montgomery, P; Rao, AK; Chow, EJ; Tobolowsky, F; Hughes, MJ; Bardossy, AC; Oakley, LP; Jacobs, JR; Stone, ND; Reddy, SC; Jernigan, JA; Honein, MA; Clark, TA; Duchin, JS				McMichael, Temet M.; Currie, Dustin W.; Clark, Shauna; Pogosjans, Sargis; Kay, Meagan; Schwartz, Noah G.; Lewis, James; Baer, Atar; Kawakami, Vance; Lukoff, Margaret D.; Ferro, Jessica; Brostrom-Smith, Claire; Rea, Thomas D.; Sayre, Michael R.; Riedo, Francis X.; Russell, Denny; Hiatt, Brian; Montgomery, Patricia; Rao, Agam K.; Chow, Eric J.; Tobolowsky, Farrell; Hughes, Michael J.; Bardossy, Ana C.; Oakley, Lisa P.; Jacobs, Jesica R.; Stone, Nimalie D.; Reddy, Sujan C.; Jernigan, John A.; Honein, Margaret A.; Clark, Thomas A.; Duchin, Jeffrey S.		Public Hlth Seattle King; CDC COVID 19 Invest Team	Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONAVIRUS	Background Long-term care facilities are high-risk settings for severe outcomes from outbreaks of Covid-19, owing to both the advanced age and frequent chronic underlying health conditions of the residents and the movement of health care personnel among facilities in a region. Methods After identification on February 28, 2020, of a confirmed case of Covid-19 in a skilled nursing facility in King County, Washington, Public Health-Seattle and King County, aided by the Centers for Disease Control and Prevention, launched a case investigation, contact tracing, quarantine of exposed persons, isolation of confirmed and suspected cases, and on-site enhancement of infection prevention and control. Results As of March 18, a total of 167 confirmed cases of Covid-19 affecting 101 residents, 50 health care personnel, and 16 visitors were found to be epidemiologically linked to the facility. Most cases among residents included respiratory illness consistent with Covid-19; however, in 7 residents no symptoms were documented. Hospitalization rates for facility residents, visitors, and staff were 54.5%, 50.0%, and 6.0%, respectively. The case fatality rate for residents was 33.7% (34 of 101). As of March 18, a total of 30 long-term care facilities with at least one confirmed case of Covid-19 had been identified in King County. Conclusions In the context of rapidly escalating Covid-19 outbreaks, proactive steps by long-term care facilities to identify and exclude potentially infected staff and visitors, actively monitor for potentially infected patients, and implement appropriate infection prevention and control measures are needed to prevent the introduction of Covid-19. On February 28, 2020, public health officials in the Seattle area were informed of a Covid-19 infection at a long-term care facility. An investigation identified 167 infected persons associated with the facility, including residents, health care personnel, and visitors; more than a third of the 101 residents identified died.	[McMichael, Temet M.; Clark, Shauna; Pogosjans, Sargis; Kay, Meagan; Lewis, James; Baer, Atar; Kawakami, Vance; Lukoff, Margaret D.; Ferro, Jessica; Brostrom-Smith, Claire; Duchin, Jeffrey S.] Publ Hlth Seattle & King Cty, Seattle, WA USA; [Rea, Thomas D.; Sayre, Michael R.; Duchin, Jeffrey S.] Univ Washington, Seattle, WA 98195 USA; [Riedo, Francis X.] EvergreenHealth, Kirkland, WA USA; [Russell, Denny; Hiatt, Brian] Washington State Publ Hlth Lab, Shoreline, WA USA; [Montgomery, Patricia] Washington State Dept Hlth, Tumwater, WA USA; [McMichael, Temet M.; Currie, Dustin W.; Schwartz, Noah G.; Chow, Eric J.; Tobolowsky, Farrell; Bardossy, Ana C.; Oakley, Lisa P.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA; [McMichael, Temet M.; Currie, Dustin W.; Schwartz, Noah G.; Rao, Agam K.; Chow, Eric J.; Tobolowsky, Farrell; Hughes, Michael J.; Bardossy, Ana C.; Oakley, Lisa P.; Jacobs, Jesica R.; Stone, Nimalie D.; Reddy, Sujan C.; Jernigan, John A.; Honein, Margaret A.; Clark, Thomas A.] Ctr Dis Control & Prevent, COVID 19 Emergency Response, Atlanta, GA USA; [Jacobs, Jesica R.] Ctr Dis Control & Prevent, Lab Leadership Serv, Atlanta, GA USA	University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Honein, MA (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Hwy NE,Mailstop S-106-3, Atlanta, GA 30341 USA.	mhonein@cdc.gov	Chow, Eric J./T-6061-2019; Tobolowsky, Farrell/AAS-5908-2020; Taylor, Joanne/GOK-2244-2022; Sayre, Michael/E-8383-2017	Chow, Eric J./0000-0003-3349-9330; Taylor, Joanne/0000-0001-7458-2865; Schwartz, Noah/0000-0002-2252-1646; Jernigan, John/0000-0001-8163-925X; Currie, Dustin/0000-0003-2061-2672; Sayre, Michael/0000-0003-0322-3181; Oakley, Lisa/0000-0002-9299-7922; Jacobs, Jesica/0000-0002-8316-5884				CDC, 2020, INT CLIN GUID MAN PA, DOI DOI 10.1016/J.CELL.2020.02.052; Centers for Disease Control and Prevention, 2020, INT GUID LAB 2019 NC; Centers for Disease Control and Prevention, INT INF PREV CONTR R; Centers for Disease Control and Prevention, 2020, UPD INT GUID OUTBR C; Centers for Disease Control and Prevention, 2020, PREP COVID 19 LONG T; Centers for Disease Control and Prevention, 2020, SYMPT COR DIS 2019 C; Centers for Disease Control and Prevention, 2020, REAL TIM RT PCR PAN; Centers for Disease Control and Prevention, 2020, REAL TIM RT PCR PAN; Centers for Disease Control and Prevention, 2020, INTERIM GUIDELINES C; Centers for Disease Control and Prevention, 2020, EV TEST PERS CONR DI; Hand J, 2018, EMERG INFECT DIS, V24, P1964, DOI 10.3201/eid2410.180862; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Kimball A, 2020, MMWR MORB MORTAL WKL; Lansbury LE, 2017, INFLUENZA OTHER RESP, V11, P356, DOI 10.1111/irv.12464; McMichael TM, 2020, MMWR-MORBID MORTAL W, V69, P339, DOI 10.15585/mmwr.mm6912e1; Public Health-Seattle & King County, COR DIS 2019 COVID 1; Public Health-Seattle & King County, 2020, LOC HLTH OFF ANN NEW; Washington Governor Jay Inslee, PROCLAMATIONS RE COV; Washington State Department of Health, 2020, HEALTHC PROV RES REC; Washington State Department of Health, 2020, REC LONG TERM CAR FA; WHO, 2020, WEEKLY EPIDEMIOLOGIC; WHO, 2020, ROLLING UPDATES CORO; World Health Organization, 2020, PNEUM UNKN CAUS CHIN; World Health Organization, 2020, MENT HLTH PSYCH CONS; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	26	776	793	19	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					2005	2011		10.1056/NEJMoa2005412	http://dx.doi.org/10.1056/NEJMoa2005412			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT1TD	32220208	Green Published, Bronze			2022-12-28	WOS:000536856000015
J	Curtis, JR; Kross, EK; Stapleton, RD				Curtis, J. Randall; Kross, Erin K.; Stapleton, Renee D.			The Importance of Addressing Advance Care Planning and Decisions About Do-Not-Resuscitate Orders During Novel Coronavirus 2019 (COVID-19)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint emphasizes the importance of advanced care planning and goals-of-care discussions with older patients and those with chronic disease during the spread of coronavirus disease (COVID-19), given the likelihood these patients could become critically ill and require resuscitation and advanced life support if they became infected with SARS-CoV-2.	[Curtis, J. Randall; Kross, Erin K.] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [Curtis, J. Randall; Kross, Erin K.] Univ Washington, Cambia Palliat Care Ctr Excellence, 325 Ninth Ave,POB 359762, Seattle, WA 98104 USA; [Stapleton, Renee D.] Univ Vermont, Larner Coll Med, Div Pulm & Crit Care Med, Burlington, VT USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Vermont	Curtis, JR (corresponding author), Univ Washington, Cambia Palliat Care Ctr Excellence, 325 Ninth Ave,POB 359762, Seattle, WA 98104 USA.	jrc@u.washington.edu		Curtis, J. Randall/0000-0001-9529-845X				Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Back AL., 2020, COVID READY COMMUNIC; Bosslet GT, 2016, INTENS CARE MED, V42, P422, DOI 10.1007/s00134-015-4192-4; Cwrtis JR, 2007, CHEST, V132, P748, DOI 10.1378/chest.07-0745; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Goodman E, 2020, CONVERSATION PROJECT; Ornstein KA, 2017, J PAIN SYMPTOM MANAG, V53, P178, DOI 10.1016/j.jpainsymman.2016.08.023; Rubenfeld G., 2020, GLOBE MAIL; Sudore RL, 2018, JAMA INTERN MED, V178, P1616, DOI 10.1001/jamainternmed.2018.4657; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994	10	221	223	2	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1771	1772		10.1001/jama.2020.4894	http://dx.doi.org/10.1001/jama.2020.4894			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32219360	Bronze			2022-12-28	WOS:000536221500009
J	McCloskey, B; Zumla, A; Ippolito, G; Blumberg, L; Arbon, P; Cicero, A; Endericks, T; Lim, PL; Borodina, M				McCloskey, Brian; Zumla, Alimuddin; Ippolito, Giuseppe; Blumberg, Lucille; Arbon, Paul; Cicero, Anita; Endericks, Tina; Lim, Poh Lian; Borodina, Maya		WHO Novel Coronavirus-19 Mass Gath	Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma	LANCET			English	Editorial Material							SURVEILLANCE; VIRUS		[McCloskey, Brian] Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London SW1Y 4LE, England; [Zumla, Alimuddin] UCL, Div Infect & Immun, Ctr Clin Microbiol, London, England; [Zumla, Alimuddin] UCL Hosp NHS Fdn Trust, NIHR Biomed Res Ctr, London, England; [Ippolito, Giuseppe] Natl Inst Infect Dis Lazzaro Spallanzani IRCCS, Rome, Italy; [Blumberg, Lucille] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Arbon, Paul] Flinders Univ S Australia, Adelaide, SA, Australia; [Cicero, Anita] Johns Hopkins Ctr Hlth Secur, Baltimore, MD USA; [Endericks, Tina] Publ Hlth England, London, England; [Lim, Poh Lian] Natl Ctr Infect Dis, Singapore, Singapore; [Lim, Poh Lian] TanTock Seng Hosp, Singapore, Singapore; [Borodina, Maya] Fed Med Biol Agcy Russia, Acad Postgrad Educ, Moscow, Russia	University of London; University College London; University of London; University College London; IRCCS Lazzaro Spallanzani; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Flinders University South Australia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Public Health England; National Centre for Infectious Diseases Singapore; Tan Tock Seng Hospital	McCloskey, B (corresponding author), Royal Inst Int Affairs, Ctr Global Hlth Secur, Chatham House, London SW1Y 4LE, England.	bmccloskey@chathamhouse.org	ZUMLA, Alimuddin/ABA-8208-2020	ZUMLA, Alimuddin/0000-0002-5111-5735	Italian Ministry of Health; Pan-African Network on Emerging and Re-Emerging Infections (PANDORA-ID-NET); European and Developing Countries Clinical Trials Partnership; UK National Institutes of Health Research Senior Investigator Award; Centre on Global Health Security, Chatham House, Royal Institute of International Affairs, London [SW1Y 4LE]; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London,UK; NIHR Biomedical Research Centre, UCL Hospitals NHS FoundationTrust, London,UK; National Institute for Communicable Diseases; Johns Hopkins Center for Health Security, Baltimore, MD, USA; Public Health England, London, UK	Italian Ministry of Health(Ministry of Health, Italy); Pan-African Network on Emerging and Re-Emerging Infections (PANDORA-ID-NET); European and Developing Countries Clinical Trials Partnership; UK National Institutes of Health Research Senior Investigator Award; Centre on Global Health Security, Chatham House, Royal Institute of International Affairs, London; Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London,UK; NIHR Biomedical Research Centre, UCL Hospitals NHS FoundationTrust, London,UK; National Institute for Communicable Diseases; Johns Hopkins Center for Health Security, Baltimore, MD, USA; Public Health England, London, UK	All authors have a special interest in mass gatherings health and are members of the WHO Novel Coronavirus-19 Mass Gatherings Expert Group. GI is supported by the Italian Ministry of Health (Ricerca Corrente Linea 1). AZ and GI are co-principal investigators of the Pan-African Network on Emerging and Re-Emerging Infections (PANDORA-ID-NET) and thank the European and Developing Countries Clinical Trials Partnership for support. AZ is in receipt of a UK National Institutes of Health Research Senior Investigator Award. We thank members of the WHO Novel Coronavirus-19 Mass Gatherings Expert Group: Maurizio Barbeschi, Robert Vitillo, Bonnie Henry, Richard Budgett, Andrew Massey, Michael Hopmeier, Amaia Artazcoz Glaria, Lucia Mullen, Crystal Watson, Christian Haggenmiller, and Rick Nunes-Vaz, among others.; Centre on Global Health Security, Chatham House, Royal Institute of International Affairs, London SW1Y 4LE, UK (BM); Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, London,UK (AZ); NIHR Biomedical Research Centre, UCL Hospitals NHS FoundationTrust, London,UK (AZ); National Institute for Infectious Diseases-Lazzaro Spallanzani-IRCCS, Rome, Italy (GI); National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa (LB); Flinders University, Adelaide, SA, Australia (PA); Johns Hopkins Center for Health Security, Baltimore, MD, USA (AC); Public Health England, London, UK (TE); National Centre for Infectious Diseases and TanTock Seng Hospital, Singapore (PLL); and Academy of Postgraduate Education, Federal Medical Biological Agency of Russia, Moscow, Russia (MB)	Blumberg L, 2016, INT J INFECT DIS, V47, P38, DOI 10.1016/j.ijid.2016.06.011; Ebrahim SH, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa029; Ippolito G, 2020, LANCET RESP MED, V8, P230, DOI 10.1016/S2213-2600(20)30070-9; McCloskey B, 2014, LANCET, V383, P2083, DOI 10.1016/S0140-6736(13)62342-9; Memish ZA, 2019, LANCET, V393, P2073, DOI 10.1016/S0140-6736(19)30501-X; Memish ZA, 2014, LANCET, V383, P2030, DOI 10.1016/S0140-6736(14)60225-7; Memish ZA, 2014, LANCET, V383, P2073, DOI 10.1016/S0140-6736(14)60381-0; Petersen E, 2020, CURR OPIN PULM MED, V26, P197, DOI 10.1097/MCP.0000000000000675; Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001; Smallwood CAH, 2014, LANCET, V383, P2090, DOI 10.1016/S0140-6736(13)62384-3; WHO, 2020, COUNTR TECHN GUID CO; WHO, 2020, COR DIS COVID 19 OUT; World Health Organization, 2020, KEY PLANN REC MASS G; World Health Organization, 2011, GLOB MASS GATH IMPL; World Health Organization, 2015, PUBL HLTH MASS GATH; World Health Organization, 2020, COR DIS COVID 19 ADV	16	185	187	3	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2020	395	10230					1096	1099		10.1016/S0140-6736(20)30681-4	http://dx.doi.org/10.1016/S0140-6736(20)30681-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KZ9LJ	32203693	Green Published, Bronze			2022-12-28	WOS:000523580400009
J	Mease, PJ; Rahman, P; Gottlieb, AB; Kollmeier, AP; Hsia, EC; Xu, XL; Sheng, SH; Agarwal, P; Zhou, B; Zhuang, YL; van der Heijde, D; McInnes, IB				Mease, Philip J.; Rahman, Proton; Gottlieb, Alice B.; Kollmeier, Alexa P.; Hsia, Elizabeth C.; Xu, Xie L.; Sheng, Shihong; Agarwal, Prasheen; Zhou, Bei; Zhuang, Yanli; van der Heijde, Desiree; McInnes, Iain B.		Discover-2 Study Grp	Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial	LANCET			English	Article							IL-23; CYTOKINE; INFLAMMATION; USTEKINUMAB; ADALIMUMAB; EFFICACY; MODERATE; SAFETY; BURDEN; DRIVES	Background The interleukin-23 (IL-23)/T-helper 17 cell pathway is implicated in psoriatic arthritis pathogenesis. Guselkumab, an IL-23 inhibitor that specifically binds the IL-23 p19 subunit, significantly and safely improved psoriatic arthritis in a phase 2 study. DISCOVER-2 was a phase 3 trial to assess guselkumab in biologic-naive patients with psoriatic arthritis. Methods This phase 3, double-blind, placebo-controlled study was done at 118 sites in 13 countries across Asia, Europe, and North America. We enrolled biologic-naive patients with active psoriatic arthritis (at least five swollen joints, at least five tender joints, and C-reactive protein =0.6 mg/dL) despite standard therapies. Patients were randomly assigned (1:1:1, computer-generated permuted blocks; stratified by baseline disease-modifying antirheumatic drug use and C-reactive protein concentration) to subcutaneous injections of guselkumab 100 mg every 4 weeks; guselkumab 100 mg at weeks 0, 4, then every 8 weeks; or placebo. The primary endpoint was American College of Rheumatology 20% improvement (ACR20) response at week 24 in all patients per assigned treatment group. Safety was assessed in all patients per treatment received. This trial is registered at ClinicalTrials.gov, NCT03158285 (active, not recruiting). Findings From July 13, 2017, to Aug 3, 2018, 1153 patients were screened, of whom 741 were randomly assigned to receive guselkumab every 4 weeks (n=246), every 8 weeks (n=248), or placebo (n=247). One patient in the every 4 weeks group and one in the placebo group did not start treatment, and the remaining 739 patients started treatment; 716 patients continued treatment up to week 24. Significantly greater proportions of patients in the guselkumab every 4 weeks group (156 [64%] of 245 [95% CI 57-70]) and every 8 weeks group (159 [64%] of 248 [58-70]) than in the placebo group ( 81 [33%] of 246 [27-39]) achieved an ACR20 response at week 24 (percentage differences vs placebo 31% [95% CI 22-39] for the every 4 weeks group and 31% [23-40] for the every 8 weeks group; both p<0.0001). Up to week 24, serious adverse events occurred in eight (3%) of 245 patients receiving guselkumab every 4 weeks (three serious infections), three (1%) of 248 receiving guselkumab every 8 weeks (one serious infection), and seven (3%) of 246 receiving placebo (one serious infection). No deaths occurred. Interpretation Guselkumab, a human monoclonal antibody that specifically inhibits IL-23 by binding the cytokine's p19 subunit, was efficacious and demonstrated an acceptable benefit-risk profile in patients with active psoriatic arthritis who were naive to treatment with biologics. These data support the use of selective inhibition of IL-23 to treat psoriatic arthritis.	[Mease, Philip J.] Providence St Joseph Hlth, Dept Rheumatol, Swedish Med Ctr, Seattle, WA 98122 USA; [Mease, Philip J.] Univ Washington, Seattle, WA 98122 USA; [Rahman, Proton] Mem Univ Newfoundland, Dept Rheumatol, St John, NF, Canada; [Gottlieb, Alice B.] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY 10029 USA; [Hsia, Elizabeth C.] Janssen Res & Dev, Immunol, Spring House, PA USA; [Zhuang, Yanli] Janssen Res & Dev, Clin Pharmacol & Pharmacometr, Spring House, PA USA; [Sheng, Shihong; Agarwal, Prasheen; Zhou, Bei] Janssen Res & Dev, Clin Biostat, Spring House, PA USA; [Kollmeier, Alexa P.; Xu, Xie L.] Janssen Res & Dev, Immunol, San Diego, CA USA; [van der Heijde, Desiree] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands; [McInnes, Iain B.] Univ Glasgow, Div Immunol, Glasgow, Lanark, Scotland	Swedish Medical Center; University of Washington; University of Washington Seattle; Memorial University Newfoundland; Icahn School of Medicine at Mount Sinai; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Glasgow	Mease, PJ (corresponding author), Providence St Joseph Hlth, Dept Rheumatol, Swedish Med Ctr, Seattle, WA 98122 USA.; Mease, PJ (corresponding author), Univ Washington, Seattle, WA 98122 USA.	pmease@philipmease.com	van der Heijde, Désirée/I-6774-2019	van der Heijde, Désirée/0000-0002-5781-158X	Janssen Research and Development	Janssen Research and Development	Janssen Research and Development.	[Anonymous], SKIN; Blauvelt A, 2017, J AM ACAD DERMATOL, V76, P405, DOI 10.1016/j.jaad.2016.11.041; Coates LC, 2017, RMD OPEN, V3, DOI 10.1136/rmdopen-2017-000567; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Deodhar A, 2020, LANCET, V395, P1115, DOI 10.1016/S0140-6736(20)30265-8; Deodhar A, 2018, LANCET, V391, P2213, DOI 10.1016/S0140-6736(18)30952-8; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Gottlieb A, 2020, J DERMATOL TREAT, V31, P662, DOI 10.1080/09546634.2019.1605142; Husni ME, 2017, SEMIN ARTHRITIS RHEU, V47, P351, DOI 10.1016/j.semarthrit.2017.05.010; Kopp T, 2003, J IMMUNOL, V170, P5438, DOI 10.4049/jimmunol.170.11.5438; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee Seina, 2010, P T, V35, P680; Lee Y, 2013, BMB REP, V46, P479, DOI 10.5483/BMBRep.2013.46.10.141; Lubrano E, 2016, DRUGS, V76, P663, DOI 10.1007/s40265-016-0557-4; Mease P, 2017, NEW ENGL J MED, V377, P1537, DOI 10.1056/NEJMoa1615975; Mease PJ, 2018, SEMIN ARTHRITIS RHEU, V47, P786, DOI 10.1016/j.semarthrit.2017.10.021; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Papp KA, 2017, NEW ENGL J MED, V376, P1551, DOI 10.1056/NEJMoa1607017; Reich K, 2019, BRIT J DERMATOL, V180, P1039, DOI 10.1111/bjd.17454; Reich K, 2019, LANCET, V394, P831, DOI 10.1016/S0140-6736(19)31773-8; Reich K, 2017, J AM ACAD DERMATOL, V76, P418, DOI 10.1016/j.jaad.2016.11.042; Schurich A, 2018, RHEUMATOLOGY, V57, P246, DOI 10.1093/rheumatology/kex186; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Siebert S, 2019, ANN RHEUM DIS, V78, P293, DOI 10.1136/annrheumdis-2019-eular.479; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; van der Heijde D, 2005, ANN RHEUM DIS, V64, P61, DOI 10.1136/ard.2004.030809; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	28	156	162	2	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2020	395	10230					1126	1136		10.1016/S0140-6736(20)30263-4	http://dx.doi.org/10.1016/S0140-6736(20)30263-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KZ9LJ	32178766	Green Published, Green Accepted			2022-12-28	WOS:000523580400025
J	Nunn, N				Nunn, Nathan			The historical roots of economic development	SCIENCE			English	Review							COLONIAL ORIGINS; SLAVE-TRADE; INSTITUTIONS; CONSEQUENCES; MISSIONARIES; EVOLUTION; EDUCATION; LEGACY; STATE	This article reviews an emerging area of research within economics that seeks to better understand contemporary economic outcomes by taking a historical perspective. The field has established that many of the contemporary differences in comparative economic development have their roots in the distant past. The insights gained from this literature are not only of academic importance but also useful for thinking about policies that help to address global development moving forward. I provide examples of recent studies that have begun to take on this important next step in the literature by using insights gleaned from historical analyses to better understand policy and its optimal design.	[Nunn, Nathan] Harvard Univ, 1805 Cambridge St, Cambridge, MA 02139 USA; [Nunn, Nathan] Canadian Inst Adv Res CIFAR, 1805 Cambridge St, Cambridge, MA 02139 USA	Harvard University	Nunn, N (corresponding author), Harvard Univ, 1805 Cambridge St, Cambridge, MA 02139 USA.; Nunn, N (corresponding author), Canadian Inst Adv Res CIFAR, 1805 Cambridge St, Cambridge, MA 02139 USA.	nnunn@fas.harvard.edu		Nunn, Nathan/0000-0002-5101-9866				Acemoglu D, 2001, AM ECON REV, V91, P1369, DOI 10.1257/aer.91.5.1369; Acemoglu D, 2005, AM ECON REV, V95, P546, DOI 10.1257/0002828054201305; Albouy DY, 2012, AM ECON REV, V102, P3059, DOI 10.1257/aer.102.6.3059; Alesina A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190510; Alesina A, 2013, Q J ECON, V128, P469, DOI 10.1093/qje/qjt005; Alsan M., 2018, DOES DIVERSITY MATTE; Alsan M, 2018, Q J ECON, V133, P407, DOI 10.1093/qje/qjx029; Alsan M, 2015, AM ECON REV, V105, P382, DOI 10.1257/aer.20130604; [Anonymous], 2018, WORKING PAPER; [Anonymous], 2017, WORKING PAPER; Archarya A, 2018, DEEP ROOTS SLAVERY S; Ashraf N, 2020, J POLIT ECON, V128, P591, DOI 10.1086/704572; Ater Itai, 2019, WORKING PAPER; Banerjee A, 2005, AM ECON REV, V95, P1190, DOI 10.1257/0002828054825574; Banerjee AV, 2014, ANNU REV ECON, V6, P951, DOI 10.1146/annurev-economics-080213-041110; Bau N., 2019, WORKING PAPER; Bauer M, 2016, J ECON PERSPECT, V30, P249, DOI 10.1257/jep.30.3.249; Becker SO, 2016, ECON J, V126, P40, DOI 10.1111/ecoj.12220; Bergeron A., 2019, WORKING PAPER; Bertocchi G, 2014, EUR ECON REV, V70, P197, DOI 10.1016/j.euroecorev.2014.04.007; Boyd R., 1985, CULTURE EVOLUTIONARY; Caicedo FV, 2019, Q J ECON, V134, P507, DOI 10.1093/qje/qjy024; Campa P, 2019, REV ECON STAT, V101, P233, DOI 10.1162/rest_a_00772; Castello-Climent A, 2018, ECON J, V128, P3039, DOI 10.1111/ecoj.12551; Colella F., 2019, 12584 IZA; CONRAD AH, 1958, J POLIT ECON, V66, P95, DOI 10.1086/258020; Darity W., 2018, WORKING PAPER; Dell M, 2020, REV ECON STUD, V87, P164, DOI 10.1093/restud/rdz017; Dell M, 2018, ECONOMETRICA, V86, P2083, DOI 10.3982/ECTA15122; Dell M, 2010, ECONOMETRICA, V78, P1863, DOI 10.3982/ECTA8121; Domar ED, 1946, ECONOMETRICA, V14, P137, DOI 10.2307/1905364; Eltis D, 2000, J ECON HIST, V60, P123; Engerman S., 1997, LATIN AM FELL ESSAYS, P260; Enke B, 2019, Q J ECON, V134, P953, DOI 10.1093/qje/qjz001; Fogel R.W., 1964, RAILROADS AM EC GROW; Fogel Robert W., 1974, TIME CROSS; Gennaioli N, 2007, J ECON GROWTH, V12, P185, DOI 10.1007/s10887-007-9017-z; Giuliano P., 2018, WORKING PAPER; Giuliano P, 2014, REV ECON STUD, V81, P787, DOI 10.1093/restud/rdt040; Grosjean P, 2019, REV ECON STUD, V86, P723, DOI 10.1093/restud/rdy025; Grosjean P, 2014, J EUR ECON ASSOC, V12, P1285, DOI 10.1111/jeea.12096; Guiso L, 2016, J EUR ECON ASSOC, V14, P1401, DOI 10.1111/jeea.12177; Harrod RF, 1939, ECON J, V49, P14, DOI 10.2307/2225181; Henrich J, 2019, NAT HUM BEHAV, V3, P129, DOI 10.1038/s41562-018-0512-3; Inikori, 2002, AFRICANS IND REVOLUT; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jha S, 2013, AM POLIT SCI REV, V107, P806, DOI 10.1017/S0003055413000464; Jia RX, 2014, REV ECON STAT, V96, P596, DOI 10.1162/REST_a_00458; Jia RX, 2014, ECON J, V124, P92, DOI 10.1111/ecoj.12037; Jones E., 1988, GROWTH RECURRING EC; Jung Y., 2019, WORKING PAPER; Kelly M., 2019, WORKING PAPER; Klemp M., 2019, WORKING PAPER; La Porta R, 1998, J POLIT ECON, V106, P1113, DOI 10.1086/250042; La Porta R, 2008, J ECON LIT, V46, P285, DOI 10.1257/jel.46.2.285; LaPorta R, 1997, J FINANC, V52, P1131, DOI 10.1111/j.1540-6261.1997.tb02727.x; Lewis W.A., 1954, MANCHESTER SCH EC SO, V22, P139, DOI DOI 10.1111/J.1467-9957.1954.TB00021.X; Loper J., 2019, WORKING PAPER; Maddison A., 2003, WORLD EC HIST STAT; Madestam A, 2013, Q J ECON, V128, P1633, DOI 10.1093/qje/qjt021; Michalopoulos S, 2013, ECONOMETRICA, V81, P113, DOI 10.3982/ECTA9613; Mokyr Joel, 1990, LEVER RICHES TECHNOL; Montgomery M, 2017, POLIT SOC, V45, P225, DOI 10.1177/0032329217704432; Moscona J., 2018, WORKING PAPER; Nisbett Richard E., 1996, CULTURE HONOR PSYCHO; Nunn N., 2008, I EC PERFORMANCE, P148; Nunn N, 2008, Q J ECON, V123, P139, DOI 10.1162/qjec.2008.123.1.139; Nunn N, 2011, AM ECON REV, V101, P3221, DOI 10.1257/aer.101.7.3221; Nunn N, 2010, J ECON PERSPECT, V24, P163, DOI 10.1257/jep.24.2.163; Okoye D., 2017, SEA CHANGES TRANSATL; Pascali L, 2017, AM ECON REV, V107, P2821, DOI 10.1257/aer.20140832; Pomeranz K., 2000, GREAT DIVERGENCE CHI; Richards A. J., 1950, AFRICAN SYSTEMS KINS, P207; Rodney W., 1972, EUROPE UNDERDEVELOPE; Schneider D. M., 1961, MATRILINEAL KINSHIP; SCHNEIDER J, 1971, ETHNOLOGY, V10, P1, DOI 10.2307/3772796; Schulz JF, 2019, SCIENCE, V366, P707, DOI 10.1126/science.aau5141; SOLOW RM, 1956, Q J ECON, V70, P65, DOI 10.2307/1884513; Teso E, 2019, J EUR ECON ASSOC, V17, P497, DOI 10.1093/jeea/jvy010; Waldinger M, 2017, J DEV ECON, V127, P355, DOI 10.1016/j.jdeveco.2016.12.010; Wantchekon L, 2015, Q J ECON, V130, P703, DOI 10.1093/qje/qjv004	81	35	35	5	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1441	+	eaaz9986	10.1126/science.aaz9986	http://dx.doi.org/10.1126/science.aaz9986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217703				2022-12-28	WOS:000523251600026
J	Berwick, DM; Shine, K				Berwick, Donald M.; Shine, Kenneth			Enhancing Private Sector Health System Preparedness for 21st-Century Health Threats: Foundational Principles From a National Academies Initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint summarizes recommendations made by National Academies of Sciences, Engineering, and Medicine (NASEM) experts to address the US health system's preparedness for major threats, highlighting 5 principles to help regions prepare for specific threats as a prelude to partnerships that would facilitate more comprehensive national preparedness.	[Berwick, Donald M.] Inst Healthcare Improvement IHI, 53 State St,19th Floor, Boston, MA 02109 USA; [Shine, Kenneth] Univ Texas Austin, Dept Internal Med, Austin, TX 78712 USA	Institute for Healthcare Improvement; University of Texas System; University of Texas Austin	Berwick, DM (corresponding author), Inst Healthcare Improvement IHI, 53 State St,19th Floor, Boston, MA 02109 USA.	donberwick@gmail.com						[Anonymous], 2019, CONT PROSP CLIENTS; Courtney B, 2009, BIOSECUR BIOTERROR, V7, P153, DOI 10.1089/bsp.2009.0020; Emergency Response/WATrac, NW HEALTHC RESP NETW; Hospital Preparedness Program, 2019, HOSP PREP PROGR; Kadlec R, 2018, ASPRS NEW VISION REG; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; Regional Healthcare Coordination Center, NO VIRG HOSP ALL; Ventola C Lee, 2011, P T, V36, P740	8	14	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1133	1134		10.1001/jama.2020.1310	http://dx.doi.org/10.1001/jama.2020.1310			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207806	Bronze			2022-12-28	WOS:000530807000013
J	Mahase, E				Mahase, Elisabeth			Uterine fibroid drug is recalled after case of liver failure requiring transplant prompts EU review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		European Medicines Agency, 2020, UL AC 5MG MED PROD; Medicines and Healthcare Products Regulatory Agency, 2020, EU1127500015 MED HEA	2	5	5	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m1112	10.1136/bmj.m1112	http://dx.doi.org/10.1136/bmj.m1112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188589				2022-12-28	WOS:000523763100014
J	Niederkrotenthaler, T; Braun, M; Pirkis, J; Till, B; Stack, S; Sinyor, M; Tran, US; Voracek, M; Cheng, QJ; Arendt, F; Scherr, S; Yip, PSF; Spittal, MJ				Niederkrotenthaler, Thomas; Braun, Marlies; Pirkis, Jane; Till, Benedikt; Stack, Steven; Sinyor, Mark; Tran, Ulrich S.; Voracek, Martin; Cheng, Qijin; Arendt, Florian; Scherr, Sebastian; Yip, Paul S. F.; Spittal, Matthew J.			Association between suicide reporting in the media and suicide: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CELEBRITY SUICIDE; COVERAGE; IDEATION; BIAS	Objective - To examine the association between reporting on suicides, especially deaths of celebrities by suicide, and subsequent suicides in the general population. Design - Systematic review and meta-analysis. Data sources - PubMed/Medline, PsychInfo, Scopus, Web of Science, Embase, and Google Scholar, searched up to September 2019. Review methods - Studies were included if they compared at least one time point before and one time point after media reports on suicide; follow-up was two months or less; the outcome was death by suicide; and the media reports were about non-fictional suicides. Data from studies adopting an interrupted time series design, or single or multiple arm before and after comparisons, were reviewed. Results - 31 studies were identified and analysed, and 20 studies at moderate risk of bias were included in the main analyses. The risk of suicide increased by 13% in the period after the media reported a death of a celebrity by suicide (rate ratio 1.13, 95% confidence interval 1.08 to 1.18; 14 studies; median follow-up 28 days, range 7-60 days). When the suicide method used by the celebrity was reported, there was an associated 30% increase in deaths by the same method (rate ratio 1.30, 95% confidence interval 1.18 to 1.44; 11 studies; median follow-up 28 days, range 14-60 days). For general reporting of suicide, the rate ratio was 1.002 (0.997 to 1.008; five studies; median follow-up 1 day, range 1-8 days) for a one article increase in the number of reports on suicide. Heterogeneity was large and partially explained by celebrity and methodological factors. Enhanced funnel plots suggested some publication bias in the literature. Conclusions - Reporting of deaths of celebrities by suicide appears to have made a meaningful impact on total suicides in the general population. The effect was larger for increases by the same method as used by the celebrity. General reporting of suicide did not appear to be associated with suicide although associations for certain types of reporting cannot be excluded. The best available intervention at the population level to deal with the harmful effects of media reports is guidelines for responsible reporting. These guidelines should be more widely implemented and promoted, especially when reporting on deaths of celebrities by suicide. Systematic review registration - PROSPERO CRD42019086559.	[Niederkrotenthaler, Thomas; Braun, Marlies; Till, Benedikt] Med Univ Vienna, Unit Suicide Res & Mental Hlth Promot, Dept Social & Prevent Med, Ctr Publ Hlth, Kinderspitalgasse 15, A-1090 Vienna, Austria; [Niederkrotenthaler, Thomas; Braun, Marlies; Till, Benedikt; Tran, Ulrich S.; Voracek, Martin; Arendt, Florian] Wiener Werkstaette Suicide Res, Vienna, Austria; [Pirkis, Jane; Spittal, Matthew J.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Mental Hlth, Melbourne, Vic, Australia; [Stack, Steven] Wayne State Univ, Dept Criminol, Detroit, MI USA; [Stack, Steven] Wayne State Univ, Dept Psychiat, Detroit, MI USA; [Sinyor, Mark] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Toronto, ON, Canada; [Sinyor, Mark] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Tran, Ulrich S.; Voracek, Martin] Univ Vienna, Sch Psychol, Dept Basic Psychol Res & Res Methods, Vienna, Austria; [Cheng, Qijin] Chinese Univ Hong Kong, Dept Social Work, Hong Kong, Peoples R China; [Arendt, Florian] Univ Vienna, Dept Commun, Vienna, Austria; [Scherr, Sebastian] Katholieke Univ Leuven, Sch Mass Commun Res, Leuven, Belgium; [Yip, Paul S. F.] Univ Hong Kong, Ctr Suicide Res & Prevent, Hong Kong, Peoples R China; [Yip, Paul S. F.] Univ Hong Kong, Dept Social Work & Social Adm, Hong Kong, Peoples R China	Medical University of Vienna; University of Melbourne; Wayne State University; Wayne State University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Vienna; Chinese University of Hong Kong; University of Vienna; KU Leuven; University of Hong Kong; University of Hong Kong	Niederkrotenthaler, T (corresponding author), Med Univ Vienna, Unit Suicide Res & Mental Hlth Promot, Dept Social & Prevent Med, Ctr Publ Hlth, Kinderspitalgasse 15, A-1090 Vienna, Austria.; Niederkrotenthaler, T (corresponding author), Wiener Werkstaette Suicide Res, Vienna, Austria.	thomas.niederkrotenthaler@meduniwien.ac.at	Sinyor, Mark/AAM-5403-2020; Scherr, Sebastian/ABE-5525-2020	Sinyor, Mark/0000-0002-7756-2584; Scherr, Sebastian/0000-0003-4730-1575; Braun, Marlies/0000-0002-6573-2195; Tran, Ulrich/0000-0002-6589-3167; Arendt, Florian/0000-0003-1107-8682; Niederkrotenthaler, Thomas/0000-0001-9550-628X; Cheng, Qijin/0000-0002-6223-5345	Austrian Science Fund (FWF) [KLI627-B30]; Australian Research Council Future Fellowship [FT180100075]; Australian Government	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Australian Research Council Future Fellowship(Australian Research Council); Australian Government(Australian GovernmentCGIAR)	No specific funding for this study. MB is funded by the Austrian Science Fund (FWF), grant No KLI627-B30. MJS is a recipient of an Australian Research Council Future Fellowship (project No FT180100075) funded by the Australian Government. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	BARON JN, 1985, AM SOCIOL REV, V50, P347, DOI 10.2307/2095544; Carmichael V, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216543; Cheng QJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175580; Choi YJ, 2016, J MEDIA ECON, V29, P92, DOI 10.1080/08997764.2016.1170020; Creed M, 2017, CAN J PSYCHIAT, V62, P313, DOI 10.1177/0706743715621255; Dyer Richard, 1998, STARS; Egger M, 1998, BRIT MED J, V316, P140; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falagas ME, 2008, FASEB J, V22, P338, DOI 10.1096/fj.07-9492LSF; Fu KW, 2007, J EPIDEMIOL COMMUN H, V61, P540, DOI 10.1136/jech.2005.045005; Gould MS, 2014, LANCET PSYCHIAT, V1, P34, DOI 10.1016/S2215-0366(14)70225-1; Hagihara A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-321; Handley MA, 2018, ANNU REV PUBL HEALTH, V39, P5, DOI 10.1146/annurev-publhealth-040617-014128; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Knapp G, 2003, STAT MED, V22, P2693, DOI 10.1002/sim.1482; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Lee AR, 2014, PSYCHIAT RES, V219, P518, DOI 10.1016/j.psychres.2014.06.037; Lipari R, 2015, NSDUH DATA REV SUICI; Nguyen VM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132557; Niederkrotenthaler T, 2017, MEDIA SUICIDE INT PE; Niederkrotenthaler T, 2009, SOC SCI MED, V69, P1085, DOI 10.1016/j.socscimed.2009.07.041; Niederkrotenthaler T, 2020, BRIT J PSYCHIAT, V217, P693, DOI 10.1192/bjp.2019.259; Niederkrotenthaler T, 2014, AM J PREV MED, V47, pS235, DOI 10.1016/j.amepre.2014.06.010; Niederkrotenthaler T, 2012, J EPIDEMIOL COMMUN H, V66, P1037, DOI 10.1136/jech-2011-200707; Niederkrotenthaler T, 2010, BRIT J PSYCHIAT, V197, P234, DOI 10.1192/bjp.bp.109.074633; Nock MK, 2008, BRIT J PSYCHIAT, V192, P98, DOI 10.1192/bjp.bp.107.040113; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; Pirkis J, 2001, Crisis, V22, P146, DOI 10.1027//0227-5910.22.4.146; Pirkis J, 2020, AUST NZ J PSYCHIAT, V54, P99, DOI 10.1177/0004867419888297; Pirkis J, 2009, CRISIS, V30, P25, DOI 10.1027/0227-5910.30.1.25; Pouliot L, 2011, J AFFECT DISORDERS, V134, P488, DOI 10.1016/j.jad.2011.04.050; Schmidt WP, 2017, EMERG THEMES EPIDEMI, V14, DOI 10.1186/s12982-017-0063-5; Sinyor M, 2018, CAN MED ASSOC J, V190, pE900, DOI 10.1503/cmaj.170698; Sinyor M, 2017, CURR OPIN PSYCHIATR, V30, P1, DOI 10.1097/YCO.0000000000000296; Sinyor M, 2016, CAN J PUBLIC HEALTH, V107, pE330, DOI [10.17269/cjph.107.5437, 10.17269/CJPH.107.5437]; Stack S, 2005, SUICIDE LIFE-THREAT, V35, P121, DOI 10.1521/suli.35.2.121.62877; Stack S., 1991, LIFE SPAN PERSPECTIV, P187, DOI [10.1007/978-1-4899-0724-0_14, DOI 10.1007/9781-48990724-0_14]; Sterne JA., 2019, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604.CH25; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Sterne JAC, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4002; Sudak HS, 2005, ACAD PSYCHIATR, V29, P495, DOI 10.1176/appi.ap.29.5.495; Thiese MS, 2014, BIOCHEM MEDICA, V24, P199, DOI 10.11613/BM.2014.022; Thomson H, 2018, SYST REV-LONDON, V7, DOI 10.1186/s13643-017-0659-4; Till B, 2019, J CLIN PSYCHIAT, V80, DOI 10.4088/JCP.17m11975; Till B, 2015, BRIT J PSYCHIAT, V207, P72, DOI 10.1192/bjp.bp.114.152827; Till B, 2014, J CLIN PSYCHIAT, V75, P886, DOI 10.4088/JCP.13m08861; Till B, 2013, DEATH STUD, V37, P383, DOI 10.1080/07481187.2012.673531; World Health Organization, 2017, PREV SUIC RES MED PR; World Health Organization, 2014, PREV SUIC PREV SUIC	50	112	112	8	39	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m575	10.1136/bmj.m575	http://dx.doi.org/10.1136/bmj.m575			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LA2DJ	32188637	Green Published, hybrid			2022-12-28	WOS:000523763100003
J	Glasziou, P; Doust, J				Glasziou, Paul; Doust, Jenny			In patients with hypertension, taking all BP-lowering drugs at bedtime vs in the morning reduced CV events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Glasziou, Paul; Doust, Jenny] Bond Univ, Gold Coast, Qld, Australia	Bond University	Glasziou, P (corresponding author), Bond Univ, Gold Coast, Qld, Australia.		Doust, Jenny/AGI-8773-2022; Glasziou, Paul/A-7832-2008	Doust, Jenny/0000-0002-4024-9308; Glasziou, Paul/0000-0001-7564-073X				Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Hermida RC, 2010, CHRONOBIOL INT, V27, P1629, DOI 10.3109/07420528.2010.510230; Rorie DA, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2318-4	3	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC29	JC29		10.7326/ACPJ202003170-029	http://dx.doi.org/10.7326/ACPJ202003170-029			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176895				2022-12-28	WOS:000520170800011
J	Major, J; Pusztai, P; Igaz, P				Major, Judit; Pusztai, Peter; Igaz, Peter			A short ring finger points to a diagnosis of Turner syndrome again	LANCET			English	Editorial Material									[Major, Judit; Pusztai, Peter; Igaz, Peter] Semmelweis Univ, Fac Med, Dept Internal Med 2, H-1088 Budapest, Hungary	Semmelweis University	Igaz, P (corresponding author), Semmelweis Univ, Fac Med, Dept Internal Med 2, H-1088 Budapest, Hungary.	igaz.peter@med.semmelweis-univ.hu	Igaz, Peter/D-3081-2014	Igaz, Peter/0000-0003-2192-554X					0	0	0	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					E51	E51						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32171415				2022-12-28	WOS:000520024900005
J	Helmrich, S; Arias, A; Lochead, G; Wintermantel, TM; Buchhold, M; Diehl, S; Whitlock, S				Helmrich, S.; Arias, A.; Lochead, G.; Wintermantel, T. M.; Buchhold, M.; Diehl, S.; Whitlock, S.			Signatures of self-organized criticality in an ultracold atomic gas (vol 577, pg 481, 2020)	NATURE			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				whitlock@unistra.fr						Helmrich S, 2020, NATURE, V577, P481, DOI 10.1038/s41586-019-1908-6	1	1	1	1	22	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					E13	E13		10.1038/s41586-020-2091-5	http://dx.doi.org/10.1038/s41586-020-2091-5		MAR 2020	1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214242	Bronze			2022-12-28	WOS:000518884500001
J	Bachireddy, C; Chen, C; Dar, M				Bachireddy, Chethan; Chen, Christopher; Dar, Mohammad			Securing the Safety Net and Protecting Public Health During a Pandemic Medicaid's Response to COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint reviews options legally available to state Medicaid programs to respond to the COVID-19 pandemic, including increasing coverage of the uninsured, expanding telehealth capabilities, removing financial barriers to testing and treatment, and easing limits on drug prescriptions.	[Bachireddy, Chethan] Virginia Dept Med Assistance Serv, Richmond, VA USA; [Chen, Christopher] Washington Hlth Care Author, Olympia, WA USA; [Dar, Mohammad] Massachusetts Medicaid MassHlth, One Ashburton Pl, Boston, MA 02108 USA		Dar, M (corresponding author), Massachusetts Medicaid MassHlth, One Ashburton Pl, Boston, MA 02108 USA.	Mohammad.Dar1@massmail.state.ma.us		Dar, Mohammad/0000-0002-5013-7801; Chen, Christopher/0000-0003-4800-0352; Bachireddy, Chethan/0000-0002-8855-5769				[Anonymous], 2020, MEDICAID CORONAVIRUS; Burak EW, 2019, ARE STATES USING MED; Center for Connected Health Policy, 2019, NAT POL TEL MED STAT; Centers for Medicare Medicaid Services, COVID 19 FREQ ASK QU; Healy Jack, 2020, NY TIMES	5	21	21	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2009	2010		10.1001/jama.2020.4272	http://dx.doi.org/10.1001/jama.2020.4272			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32191260	Bronze			2022-12-28	WOS:000538023900024
J	Bauchner, H; Fontanarosa, PB; Livingston, EH				Bauchner, Howard; Fontanarosa, Phil B.; Livingston, Edward H.			Conserving Supply of Personal Protective Equipment-A Call for Ideas	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												howard.bauchner@jamanetwork.org							0	92	94	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1911	1911		10.1001/jama.2020.4770	http://dx.doi.org/10.1001/jama.2020.4770			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32196543	Bronze			2022-12-28	WOS:000536934300016
J	Hick, JL; Biddinger, PD				Hick, John L.; Biddinger, Paul D.			Novel Coronavirus and Old Lessons - Preparing the Health System for the Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hick, John L.] Univ Minnesota, Dept Emergency Med, Minneapolis, MN 55455 USA; [Hick, John L.] Hennepin Healthcare, Minneapolis, MN 55415 USA; [Biddinger, Paul D.] Harvard Med Sch, Dept Emergency Med, Boston, MA 02115 USA; [Biddinger, Paul D.] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Hick, JL (corresponding author), Univ Minnesota, Dept Emergency Med, Minneapolis, MN 55455 USA.; Hick, JL (corresponding author), Hennepin Healthcare, Minneapolis, MN 55415 USA.							[Anonymous], 2019, PAT CAR STRAT SCAR R; Christian MD, 2014, CHEST, V146, pE61S, DOI 10.1378/chest.14-0736; Einav S, 2014, CHEST, V146, pE17S, DOI 10.1378/chest.14-0734; Hick JL, 2020, NAM PERSPECTIVES; Institute of Medicine, 2012, CRIS STAND CAR SYST, V1	5	84	87	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2020	382	20								10.1056/NEJMp2005118	http://dx.doi.org/10.1056/NEJMp2005118			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LR8KG	32212515	Bronze			2022-12-28	WOS:000535944700002
J	White, DB; Lo, B				White, Douglas B.; Lo, Bernard			A Framework for Rationing Ventilators and Critical Care Beds During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALLOCATION; DISASTERS	This Viewpoint describes a framework for rationing ventilators during the COVID-19 pandemic should intensive care units find themselves with more patients than they can care for, using a score-based system that incorporates patients' likelihood of surviving to hospital discharge and beyond and their role in the public health response to the outbreak.	[White, Douglas B.] Univ Pittsburgh, Sch Med, Program Ethics & Decis Making Crit Illness, CRISMA Ctr,Dept Crit Care Med, Pittsburgh, PA USA; [Lo, Bernard] Greenwall Fdn, New York, NY USA; [Lo, Bernard] Univ Calif San Francisco, San Francisco, CA 94143 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Francisco	White, DB (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Program Eth & Decis Making Crit Illness, 3550 Terrace St,Scaife Hall,Room 608, Pittsburgh, PA 15261 USA.	douglas.white@pitt.edu			National Institutes of Health-National Heart, Lung, and Blood Institute [K24HL148314]	National Institutes of Health-National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health-National Heart, Lung, and Blood Institute grant K24HL148314 (Dr White).	Biddison ELD, 2018, CHEST, V153, P187, DOI 10.1016/j.chest.2017.08.001; Christian MD, 2014, CHEST, V146, pE61S, DOI 10.1378/chest.14-0736; Colorado Department of Public Health and Environment, 2018, CDPHE ALL HAZ INT EM; Egan TM, 2006, AM J TRANSPLANT, V6, P1212, DOI 10.1111/j.1600-6143.2006.01276.x; Gostin L, 2006, JAMA-J AM MED ASSOC, V295, P1700, DOI 10.1001/jama.295.14.1700; White DB, 2020, MODEL HOSP POLICY AL; White DB, 2009, ANN INTERN MED, V150, P132, DOI 10.7326/0003-4819-150-2-200901200-00011; Williams A, 1997, HEALTH ECON, V6, P117, DOI 10.1002/(SICI)1099-1050(199703)6:2<117::AID-HEC256>3.0.CO;2-B	8	425	431	3	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1773	1774		10.1001/jama.2020.5046	http://dx.doi.org/10.1001/jama.2020.5046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32219367	Bronze			2022-12-28	WOS:000536221500010
J	Angelucci, E; Li, JM; Greenberg, P; Wu, DP; Hou, M; Figueroa, EHM; Rodriguez, MG; Dong, XW; Ghosh, J; Izquierdo, M; Garcia-Manero, G				Angelucci, Emanuele; Li, Junmin; Greenberg, Peter; Wu, Depei; Hou, Ming; Montano Figueroa, Efreen Horacio; Guadalupe Rodriguez, Maria; Dong, Xunwei; Ghosh, Jagannath; Izquierdo, Miguel; Garcia-Manero, Guillermo		TELESTO Study	Iron Chelation in Transfusion-Dependent Patients With Low- to Intermediate-1-Risk Myelodysplastic Syndromes A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							PROGNOSTIC-FACTORS; SCORING SYSTEM; MDS PATIENTS; RISK MDS; THERAPY; OVERLOAD; SURVIVAL; DEFERASIROX; CRITERIA; ANEMIA	Background: Iron chelation therapy (ICT) in patients with lower-risk myelodysplastic syndromes (MDS) has not been evaluated in randomized studies. Objective: To evaluate event-free survival (EFS) and safety of ICT in iron-overloaded patients with low- or intermediate-1-risk MDS. Design: Multicenter, randomized, double-blind, placebo-controlled trial (TELESTO). (ClinicalTrials.gov: NCT00940602) Setting: 60 centers in 16 countries. Participants: 225 patients with serum ferritin levels greater than 2247 pmol/L; prior receipt of 15 to 75 packed red blood cell units; and no severe cardiac, liver, or renal abnormalities. Intervention: Deferasirox dispersible tablets (10 to 40 mg/kg per day) (n = 149) or matching placebo (n = 76). Measurements: The primary end point was EFS, defined as time from date of randomization to first documented nonfatal event (related to cardiac or liver dysfunction and transformation to acute myeloid leukemia) or death, whichever occurred first. Results: Median time on treatment was 1.6 years (interquartile range [IQR], 0.5 to 3.1 years) in the deferasirox group and 1.0 year (IQR, 0.6 to 2.0 years) in the placebo group. Median EFS was prolonged by approximately 1 year with deferasirox versus placebo (3.9 years [95% CI, 3.2 to 4.3 years] vs. 3.0 years [CI, 2.2 to 3.7 years], respectively; hazard ratio, 0.64 [CI, 0.42 to 0.96]). Adverse events occurred in 97.3% of deferasirox recipients and 90.8% of placebo recipients. Exposure-adjusted incidence rates of adverse events (>= 15 events per 100 patient treatment-years) in deferasirox versus placebo recipients, respectively, were 24.7 versus 23.9 for diarrhea, 21.8 versus 18.7 for pyrexia, 16.7 versus 22.7 for upper respiratory tract infection, and 15.9 versus 0.9 for increased serum creatinine concentration. Limitations: The protocol was amended from a phase 3 to a phase 2 study, with a reduced target sample size from 630 to 210 participants. There was differential follow-up between treatment groups. Conclusion: The findings support ICT in iron-overloaded patients with low- to intermediate-1-risk MDS, with longer EFS compared with placebo and a clinically manageable safety profile. Therefore, ICT may be considered in these patients. Primary Funding Source: Novartis Pharma AG.	[Angelucci, Emanuele] IRCCS Osped Policlin San Martino, Hematol & Transplant Ctr, Largo Rosanna Benzi 10, I-16132 Genoa, Italy; [Li, Junmin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Shanghai, Peoples R China; [Greenberg, Peter] Stanford Univ, Med Ctr, 875 Blake Wilbur Dr,Room 2335, Stanford, CA 94305 USA; [Wu, Depei] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Shizi St 188, Suzhou 215006, Peoples R China; [Hou, Ming] Shandong Univ, Qilu Hosp, Dept Hematol, 107 Wenhua West Rd, Jinan, Peoples R China; [Montano Figueroa, Efreen Horacio] Hosp Gen Mexico City, Dept Hematol, Dr Balmis 148, Mexico City 06720, DF, Mexico; [Guadalupe Rodriguez, Maria] Hosp Especialidades Ctr Med La Raza, Dept Hematol, Ctr Med Nacl Raza, IMSS, Seris & Zaachila S-N, Mexico City 02990, DF, Mexico; [Dong, Xunwei; Ghosh, Jagannath] Novartis Pharmaceut, One Hlth Plaza, E Hanover, NJ 07936 USA; [Izquierdo, Miguel] Novartis Pharma AG, Novartis Campus, CH-4056 Basel, Switzerland; [Garcia-Manero, Guillermo] Univ Texas Houston, MD Anderson Canc Ctr, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Garcia-Manero, Guillermo] Univ Texas Houston, MD Anderson Canc Ctr, Div Canc Med, Dept Leukemia,Sect Myelodysplast Syndromes, 1515 Holcombe Blvd,Unit 428, Houston, TX 77030 USA	Shanghai Jiao Tong University; Stanford University; Soochow University - China; Shandong University; Hospital General de Mexico; Instituto Mexicano del Seguro Social; Novartis; Novartis; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Angelucci, E (corresponding author), IRCCS Osped Policlin San Martino, Hematol & Transplant Ctr, Largo Rosanna Benzi 10, I-16132 Genoa, Italy.	emanuele.angelucci@hsanmartino.it	Angelucci, Emanuele/AAC-1855-2021; Symeonidis, Argiris/K-2287-2019	Symeonidis, Argiris/0000-0002-3685-3473; SANTINI, VALERIA/0000-0002-5439-2172; Colita, Andrei/0000-0002-6531-7717; Cascavilla, Nicola/0000-0002-8901-2379; Li, Junmin/0000-0003-1338-8764; KAPSALI, ELENI/0000-0002-5304-7553	Novartis Pharma AG; Novartis Pharmaceuticals Corporation	Novartis Pharma AG; Novartis Pharmaceuticals Corporation(Novartis)	By Novartis Pharma AG. Financial support for medical writing assistance was provided by Novartis Pharmaceuticals Corporation.	Bollig C, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007476.pub3; Castelli R, 2018, MED ONCOL, V35, DOI 10.1007/s12032-018-1135-2; Cheson BD, 2006, BLOOD, V108, P419, DOI 10.1182/blood-2005-10-4149; De Swart L, 2011, BLOOD, V118, P1195; Delforge M, 2014, LEUKEMIA RES, V38, P557, DOI 10.1016/j.leukres.2014.02.003; Gattermann N, 2018, INT J HEMATOL, V107, P55, DOI 10.1007/s12185-017-2367-1; Gattermann N, 2010, LEUKEMIA RES, V34, P1143, DOI 10.1016/j.leukres.2010.03.009; Germing U, 2004, HAEMATOLOGICA, V89, P905; Germing U, 2012, LEUKEMIA, V26, P1286, DOI 10.1038/leu.2011.391; Goldberg SL, 2010, J CLIN ONCOL, V28, P2847, DOI 10.1200/JCO.2009.25.2395; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg Peter L, 2002, Hematology Am Soc Hematol Educ Program, P136; Imran F, 2017, EXPERT REV HEMATOL, V10, P53, DOI 10.1080/17474086.2017.1268910; Killick SB, 2017, BRIT J HAEMATOL, V177, P375, DOI 10.1111/bjh.14602; Langemeijer S, 2016, BLOOD, V128, DOI 10.1182/blood.V128.22.3186.3186; Leitch HA, 2018, LEUKEMIA RES, V74, P21, DOI 10.1016/j.leukres.2018.09.005; Leitch HA, 2017, BRIT J HAEMATOL, V179, P83, DOI 10.1111/bjh.14825; Lyons RM, 2017, LEUKEMIA RES, V56, P88, DOI 10.1016/j.leukres.2017.01.033; Mainous AG, 2014, BRIT J HAEMATOL, V167, P720, DOI 10.1111/bjh.13053; Malcovati L, 2005, J CLIN ONCOL, V23, P7594, DOI 10.1200/JCO.2005.01.7038; Malcovati L, 2011, HAEMATOL-HEMATOL J, V96, P1433, DOI 10.3324/haematol.2011.044602; Meerpohl JJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007461.pub3; Montalban-Bravo G, 2018, AM J HEMATOL, V93, P129, DOI 10.1002/ajh.24930; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Neukirchen J, 2012, LEUKEMIA RES, V36, P1067, DOI 10.1016/j.leukres.2012.04.006; Nolte F, 2015, LEUKEMIA RES, V39, P1028, DOI 10.1016/j.leukres.2015.06.008; Novartis Pharmaceuticals, EXJADE DEF US PRESCR; Platzbecker U, 2017, LEUKEMIA, V31, P1944, DOI 10.1038/leu.2017.192; Remacha AF, 2015, ANN HEMATOL, V94, P779, DOI 10.1007/s00277-014-2274-y; Rose C, 2010, LEUKEMIA RES, V34, P864, DOI 10.1016/j.leukres.2009.12.004; SCHAFER AI, 1981, NEW ENGL J MED, V304, P319, DOI 10.1056/NEJM198102053040603; Steensma DP, 2013, BEST PRACT RES CL HA, V26, P431, DOI 10.1016/j.beha.2013.09.009; Taher AT, 2012, BLOOD, V120, P970, DOI 10.1182/blood-2012-02-412692; Tefferi A, 2009, NEW ENGL J MED, V361, P1872, DOI 10.1056/NEJMra0902908; Zeidan AM, 2019, ANN HEMATOL, V98, P339, DOI 10.1007/s00277-018-3539-7; Zeidan AM, 2018, BLOOD REV, V32, P368, DOI 10.1016/j.blre.2018.03.002; Zeidan AM, 2015, J COMP EFFECT RES, V4, P327, DOI [10.2217/CER.15.20, 10.2217/cer.15.20]	37	49	50	2	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2020	172	8					513	+		10.7326/M19-0916	http://dx.doi.org/10.7326/M19-0916			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF9LH	32203980				2022-12-28	WOS:000527733800012
J	Kuehn, BM				Kuehn, Bridget M.			Boosting the Ranks of American Indian and Alaska Native Physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item								This Medical News article discusses programs that enable more American Indian/Alaska Native students to enter medical school.											0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2020	323	14					1330	1332		10.1001/jama.2020.2349	http://dx.doi.org/10.1001/jama.2020.2349			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH1YB	32211823				2022-12-28	WOS:000528583600001
J	Kerschbaumer, A; Aletaha, D				Kerschbaumer, Andreas; Aletaha, Daniel			Targeting p19 in psoriatic arthritis: more than just another therapeutic approach?	LANCET			English	Editorial Material									[Kerschbaumer, Andreas; Aletaha, Daniel] Med Univ Vienna, Div Rheumatol, Dept Med 3, A-1090 Vienna, Austria	Medical University of Vienna	Kerschbaumer, A (corresponding author), Med Univ Vienna, Div Rheumatol, Dept Med 3, A-1090 Vienna, Austria.	andreas.kerschbaumer@meduniwien.ac.at						[Anonymous], CLIN INV MED PROD TR; Deodhar A, 2020, LANCET, V395, P1115, DOI 10.1016/S0140-6736(20)30265-8; FELSON DT, 1995, ARTHRITIS RHEUM, V38, P727, DOI 10.1002/art.1780380602; Kerschbaumer A, 2018, BEST PRACT RES CL RH, V32, P401, DOI 10.1016/j.berh.2018.08.004; Lubrano E, 2020, J RHEUMATOL, V47, P1490, DOI 10.3899/jrheum.190679; Mease PJ, 2020, LANCET, V395, P1126, DOI 10.1016/S0140-6736(20)30263-4; Mease PJ, 2020, ANN RHEUM DIS, V79, P123, DOI 10.1136/annrheumdis-2019-215386; Oelke KR, 2019, J COMP EFFECT RES, V8, P607, DOI 10.2217/cer-2019-0023; Smolen JS, 2018, ANN RHEUM DIS, V77, P472, DOI [10.1136/annrheumdis-2017-211734corr1, 10.1136/annrheumdis-2017-211734]	9	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 4	2020	395	10230					1091	1093		10.1016/S0140-6736(20)30525-0	http://dx.doi.org/10.1016/S0140-6736(20)30525-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KZ9LJ	32178770				2022-12-28	WOS:000523580400006
J	Liu, JX; Rehm, CD; Onopa, J; Mozaffarian, D				Liu, Junxiu; Rehm, Colin D.; Onopa, Jennifer; Mozaffarian, Dariush			Trends in Diet Quality Among Youth in the United States, 1999-2016	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTHY EATING INDEX; US CHILDREN; CONSUMPTION; DISEASE; ASSOCIATIONS; ADULTS; INCOME; FAT; AGE	IMPORTANCE Prior studies of dietary trends among US youth have evaluated major macronutrients or only a few foods or have used older data. OBJECTIVE To characterize trends in diet quality among US youth. DESIGN, SETTING, AND PARTICIPANTS Serial cross-sectional investigation using 24-hour dietary recalls from youth aged 2 to 19 years from 9 National Health and Nutrition Examination Survey (NHANES) cycles (1999-2016). EXPOSURES Calendar year and population sociodemographic characteristics. MAIN OUTCOMES AND MEASURES The primary outcomes were the survey-weighted, energy-adjusted mean consumption of dietary components and proportion meeting targets of the American Heart Association (AHA) 2020 continuous diet score (range, 0-50; based on total fruits and vegetables, whole grains, fish and shellfish, sugar-sweetened beverages, and sodium). Additional outcomes were the AHA secondary score (range, 0-80; adding nuts, seeds, and legumes; processed meat; and saturated fat) and Healthy Eating Index (HEI) 2015 score (range, 0-100). Poor diet was defined as less than 40% adherence (scores, <20 for primary and <32 for secondary AHA scores); intermediate as 40% to 79.9% adherence (scores, 20-39.9 and 32-63.9, respectively); and ideal, as at least 80% adherence (scores, >= 40 and >= 64, respectively). Higher diet scores indicate better diet quality; a minimal clinically important difference has not been quantified. RESULTS Of 31 420 youth aged 2 to 19 years included, the mean age was 10.6 years; 49.1% were female. From 1999 to 2016, the estimated AHA primary diet score significantly increased from 14.8 (95% CI, 14.1-15.4) to 18.8 (95% CI, 18.1-19.6) (27.0% improvement), the estimated AHA secondary diet score from 29.2 (95% CI, 28.1-30.4) to 33.0 (95% CI, 32.0-33.9) (13.0% improvement), and the estimated HEI-2015 score from 44.6 (95% CI, 43.5-45.8) to 49.6 (95% CI, 48.5-50.8) (11.2% improvement) (P <.001 for trend for each). Based on the AHA primary diet score, the estimated proportion of youth with poor diets significantly declined from 76.8%(95% CI, 72.9%-80.2%) to 56.1%(95% CI, 51.4%-60.7%) and with intermediate diets significantly increased from 23.2%(95% CI, 19.8%-26.9%) to 43.7%(95% CI, 39.1%-48.3%) (P <.001 for trend for each). The estimated proportion meeting ideal quality significantly increased but remained low, from 0.07%(95% CI, 0.01%-0.49%) to 0.25%(95% CI, 0.10%-0.62%) (P =.03 for trend). Persistent dietary variations were identified across multiple sociodemographic groups. The estimated proportion of youth with a poor diet in 2015-2016 was 39.8%(95% CI, 35.1%-44.5%) for ages 2 to 5 years (unweighted n = 666), 52.5%(95% CI, 46.4%-58.5%) for ages 6 to 11 years (unweighted n = 1040), and 66.6%(95% CI, 61.4%-71.4%) for ages 12 to 19 years (unweighted n = 1195), with persistent differences across levels of parental education, household income, and household food security status. CONCLUSIONS AND RELEVANCE Based on serial NHANES surveys from 1999 to 2016, the estimated overall diet quality of US youth showed modest improvement, but more than half of youth still had poor-quality diets.	[Liu, Junxiu; Onopa, Jennifer; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA; [Rehm, Colin D.] Montefiore Med Ctr, Off Community & Populat Hlth, 111 E 210th St, Bronx, NY 10467 USA; [Rehm, Colin D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA	Tufts University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Liu, JX (corresponding author), Tufts Univ, Friedman Sch Nutr Sci & Policy, 150 Harrison Ave, Boston, MA 02111 USA.	junxiu.liu@tufts.edu	Mozaffarian, Dariush/ABC-2822-2020	REHM, COLIN/0000-0002-7644-0040	National Institutes of Health (NHLBI) [R01 HL 130735, 17POST33670808]; American Heart Association	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association)	This research was supported by the National Institutes of Health (NHLBI grant R01 HL 130735) and a postdoctoral fellowship award to Dr Liu (17POST33670808) from the American Heart Association.	[Anonymous], FORTUNE; [Anonymous], LETS MOV AM MOV RAIS; Bleich SN, 2018, OBESITY, V26, P432, DOI 10.1002/oby.22056; Bleich SN, 2015, OBESITY, V23, P1039, DOI 10.1002/oby.21050; Centers for Disease Control and Prevention, NHANES SURV METH AN; Costa CS, 2018, PUBLIC HEALTH NUTR, V21, P148, DOI 10.1017/S1368980017001331; Dunford EK, 2018, PEDIATR OBES, V13, P247, DOI 10.1111/ijpo.12220; Gidding Samuel S, 2005, Circulation, V112, P2061, DOI 10.1161/CIRCULATIONAHA.105.169251; Gu X, 2017, AM J CLIN NUTR, V105, P194, DOI 10.3945/ajcn.116.135095; Hales CM, 2018, JAMA-J AM MED ASSOC, V319, P1723, DOI 10.1001/jama.2018.3060; Hiza HAB, 2013, DIET QUALITY CHILDRE; Hiza HAB, 2013, J ACAD NUTR DIET, V113, P297, DOI 10.1016/j.jand.2012.08.011; Kraak VI., 2006, FOOD MARK CHILDR YOU; Krebs-Smith SM, 2018, J ACAD NUTR DIET, V118, P1591, DOI 10.1016/j.jand.2018.05.021; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947; Mozaffarian D, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2426; Mozaffarian D, 2016, CIRCULATION, V133, P187, DOI 10.1161/CIRCULATIONAHA.115.018585; National Academies of Sciences E and Medicine., 2019, DIETARY REFERENCE IN, DOI [10.17226/25353, DOI 10.17226/25353]; National Cancer Institute, HLTH EAT IND; Paarlberg R, 2018, SOCIETY, V55, P308, DOI 10.1007/s12115-018-0260-z; Powell LM, 2014, HEALTH PLACE, V29, P124, DOI 10.1016/j.healthplace.2014.06.006; Rehm CD, 2016, NUTRIENTS, V8, DOI 10.3390/nu8120804; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Savage JS, 2007, J LAW MED ETHICS, V35, P22, DOI 10.1111/j.1748-720X.2007.00111.x; Scaglioni S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060706; Schwingshackl L, 2018, J ACAD NUTR DIET, V118, P74, DOI 10.1016/j.jand.2017.08.024; Shan ZL, 2019, JAMA-J AM MED ASSOC, V322, P1178, DOI 10.1001/jama.2019.13771; Slining MM, 2013, PEDIATR OBES, V8, P307, DOI 10.1111/j.2047-6310.2013.00156.x; Thomson JL, 2019, AM J CLIN NUTR, V109, P127, DOI 10.1093/ajcn/nqy284; Tuttle, 2018, AM EATING HABITS FOO, V196; *US DEP HHS, DIET GUID AM; Whole Grains Council, SUCC AW WHOL GRAIN S	34	76	79	2	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1161	1174		10.1001/jama.2020.0878	http://dx.doi.org/10.1001/jama.2020.0878			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LK4BZ	32207798	Bronze, Green Published			2022-12-28	WOS:000530807000019
J	Dyer, O				Dyer, Owen			Covid-19: US testing ramps up as early response draws harsh criticism	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, NPR PBS NEWSHOU 0317; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Ferguson N., 2020, IMPERIAL COLL LONDON; Leonhardt D., 2020, NY TIMES	4	11	11	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1167	10.1136/bmj.m1167	http://dx.doi.org/10.1136/bmj.m1167			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205342	Bronze			2022-12-28	WOS:000523764100011
J	Thornton, J				Thornton, Jacqui			Clinical trials suspended in UK to prioritise covid-19 studies and free up staff	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cancer Research UK, TRIAL LOOK 2 NEW TES; MHRA, 2020, MAN CLIN TRIALS COR; National Institute for Health Research, DHSC ISS GUID IMP CO	3	20	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1172	10.1136/bmj.m1172	http://dx.doi.org/10.1136/bmj.m1172			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205354	Bronze			2022-12-28	WOS:000523764100016
J	Coombes, R				Coombes, Rebecca			Covid-19: experts question the evidence behind closing London Underground and city metros during the pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item												rcoombes@bmj.com						Adler AJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-232	1	0	0	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2020	368								m1154	10.1136/bmj.m1154	http://dx.doi.org/10.1136/bmj.m1154			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DO	32198178	Bronze			2022-12-28	WOS:000523763600011
J	Westbrook, A; van den Bosch, R; Maatta, JI; Hofmans, L; Papadopetraki, D; Cools, R; Frank, MJ				Westbrook, A.; van den Bosch, R.; Maatta, J. I.; Hofmans, L.; Papadopetraki, D.; Cools, R.; Frank, M. J.			Dopamine promotes cognitive effort by biasing the benefits versus costs of cognitive work	SCIENCE			English	Article							DECISION-MAKING; STRIATAL DOPAMINE; PREFRONTAL CORTEX; REWARD; AVOIDANCE; RELEASE; SIGNALS	Stimulants such as methylphenidate are increasingly used for cognitive enhancement but precise mechanisms are unknown. We found that methylphenidate boosts willingness to expend cognitive effort by altering the benefit-to-cost ratio of cognitive work. Willingness to expend effort was greater for participants with higher striatal dopamine synthesis capacity, whereas methylphenidate and sulpiride, a selective D2 receptor antagonist, increased cognitive motivation more for participants with lower synthesis capacity. A sequential sampling model informed by momentary gaze revealed that decisions to expend effort are related to amplification of benefit-versus-cost information attended early in the decision process, whereas the effect of benefits is strengthened with higher synthesis capacity and by methylphenidate. These findings demonstrate that methylphenidate boosts the perceived benefits versus costs of cognitive effort by modulating striatal dopamine signaling.	[Westbrook, A.; Frank, M. J.] Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA; [Westbrook, A.; van den Bosch, R.; Maatta, J. I.; Hofmans, L.; Papadopetraki, D.; Cools, R.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, Nijmegen, Netherlands; [Westbrook, A.; van den Bosch, R.; Maatta, J. I.; Hofmans, L.; Papadopetraki, D.; Cools, R.] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Nijmegen, Netherlands; [Frank, M. J.] Brown Univ, Carney Inst Brain Sci, Providence, RI 02912 USA	Brown University; Radboud University Nijmegen; Radboud University Nijmegen; Brown University	Westbrook, A (corresponding author), Brown Univ, Dept Cognit Linguist & Psychol Sci, Providence, RI 02912 USA.; Westbrook, A (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Ctr Cognit Neuroimaging, Nijmegen, Netherlands.; Westbrook, A (corresponding author), Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Nijmegen, Netherlands.	andrew.westbrook@brown.edu	Cools, Roshan/D-1905-2010; van den Bosch, Ruben/O-4528-2018	Hofmans, Lieke/0000-0001-7259-6243; Maatta, Jessica Ida Maria/0000-0002-1130-0557; Papadopetraki, Danae/0000-0001-8278-3886; Cools, Roshan/0000-0001-8994-5534; Westbrook, Andrew/0000-0002-7956-2609; van den Bosch, Ruben/0000-0002-3994-8291; Frank, Michael/0000-0001-8451-0523	NWO VICI grant [453-14-005 (2015/01379/VI)]; NIH [F32MH115600-01A1, R01MH080066]	NWO VICI grant(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NWO VICI grant 453-14-005 (2015/01379/VI) to R.C., NIH grant F32MH115600-01A1 to A.W., and NIH grant R01MH080066 to M.J.F.	Aarts E, 2014, NEUROPSYCHOLOGIA, V62, P390, DOI 10.1016/j.neuropsychologia.2014.05.023; Aarts E, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00163; Apps MAJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep16880; Cavanagh JF, 2014, J EXP PSYCHOL GEN, V143, P1476, DOI 10.1037/a0035813; Cocker PJ, 2012, NEUROPSYCHOPHARMACOL, V37, P1825, DOI 10.1038/npp.2012.30; Collins AGE, 2014, PSYCHOL REV, V121, P337, DOI 10.1037/a0037015; Cools R, 2015, CURR OPIN BEHAV SCI, V4, P152, DOI 10.1016/j.cobeha.2015.05.007; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Eisenegger C, 2014, NEUROPSYCHOPHARMACOL, V39, P2366, DOI 10.1038/npp.2014.84; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frobose MI, 2018, J EXP PSYCHOL GEN, V147, P1763, DOI 10.1037/xge0000523; Hosking JG, 2015, NEUROPSYCHOPHARMACOL, V40, P1005, DOI 10.1038/npp.2014.285; Jocham G, 2011, J NEUROSCI, V31, P1606, DOI 10.1523/JNEUROSCI.3904-10.2011; Kool W, 2010, J EXP PSYCHOL GEN, V139, P665, DOI 10.1037/a0020198; Krajbich I, 2010, NAT NEUROSCI, V13, P1292, DOI 10.1038/nn.2635; Manohar SG, 2015, CURR BIOL, V25, P1707, DOI 10.1016/j.cub.2015.05.038; McGuigan S, 2019, BRAIN, V142, P719, DOI 10.1093/brain/awy341; MOGHADDAM B, 1990, J NEUROCHEM, V54, P1755, DOI 10.1111/j.1471-4159.1990.tb01230.x; Muhammed K, 2020, CORTEX, V122, P198, DOI 10.1016/j.cortex.2018.12.001; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; Pauli WM, 2016, P NATL ACAD SCI USA, V113, P1907, DOI 10.1073/pnas.1507610113; Piray P, 2017, CEREB CORTEX, V27, P485, DOI 10.1093/cercor/bhv243; Salarnone JD, 2016, BEHAV PROCESS, V127, P3, DOI 10.1016/j.beproc.2016.02.008; Schmidt L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001266; Spencer RC, 2015, BIOL PSYCHIAT, V77, P940, DOI 10.1016/j.biopsych.2014.09.013; Swanson JM, 2003, NEUROSCI BIOBEHAV R, V27, P615, DOI 10.1016/j.neubiorev.2003.08.013; Timmer MHM, 2018, EUR J NEUROSCI, V48, P2374, DOI 10.1111/ejn.14137; van der Schaaf ME, 2014, CEREB CORTEX, V24, P633, DOI 10.1093/cercor/bhs344; Volkow ND, 2011, MOL PSYCHIATR, V16, P1147, DOI 10.1038/mp.2010.97; Volkow N D, 2001, J Neurosci, V21, pRC121; Volkow ND, 1998, AM J PSYCHIAT, V155, P1325, DOI 10.1176/ajp.155.10.1325; Westbrook A, 2016, NEURON, V89, P695, DOI [10.1016/j.neuron.2015.12.029, 10.1016/j.neuron.2016.07.020]; Westbrook A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068210; Wiecki TV, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00014; WIESEL FA, 1982, PSYCHOPHARMACOLOGY, V76, P44, DOI 10.1007/BF00430753; Wu Q, 2002, J NEUROSCI, V22, P6272	36	92	93	15	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1362	+		10.1126/science.aaz5891	http://dx.doi.org/10.1126/science.aaz5891			39	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193325	Green Submitted, Green Accepted			2022-12-28	WOS:000522167400049
J	Wise, J				Wise, Jacqui			The BMJ Awards 2020: Mental health team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2020	368								m962	10.1136/bmj.m962	http://dx.doi.org/10.1136/bmj.m962			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LA2DM	32193255				2022-12-28	WOS:000523763400002
J	Kuehn, BM				Kuehn, Bridget M.			Hong Kong Unrest Contributes to Increased Mental Health Care Burden	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1033	1033		10.1001/jama.2020.1987	http://dx.doi.org/10.1001/jama.2020.1987			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX6DC	32181853				2022-12-28	WOS:000521968800003
J	Treasure, J; Duarte, TA; Schmidt, U				Treasure, Janet; Duarte, Tiago Antunes; Schmidt, Ulrike			Eating disorders	LANCET			English	Review							RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; GENOME-WIDE ASSOCIATION; FAMILY-BASED TREATMENT; GUIDED SELF-HELP; 2-YEAR FOLLOW-UP; ANOREXIA-NERVOSA; BULIMIA-NERVOSA; INPATIENT TREATMENT; PSYCHOLOGICAL TREATMENTS	Eating disorders are disabling, deadly, and costly mental disorders that considerably impair physical health and disrupt psychosocial functioning. Disturbed attitudes towards weight, body shape, and eating play a key role in the origin and maintenance of eating disorders. Eating disorders have been increasing over the past 50 years and changes in the food environment have been implicated. All health-care providers should routinely enquire about eating habits as a component of overall health assessment. Six main feeding and eating disorders are now recognised in diagnostic systems: anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant-restrictive food intake disorder, pica, and rumination disorder. The presentation form of eating disorders might vary for men versus women, for example. As eating disorders are under-researched, there is a great deal of uncertainty as to their pathophysiology, treatment, and management. Future challenges, emerging treatments, and outstanding research questions are addressed.	[Treasure, Janet; Duarte, Tiago Antunes; Schmidt, Ulrike] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England; [Schmidt, Ulrike] South London & Maudsley NHS Fdn Trust, London, England; [Duarte, Tiago Antunes] Hosp Santa Maria, Ctr Hosp Univ Lisboa Norte, Serv Psiquiatria & Saude Mental, Lisbon, Portugal	University of London; King's College London; South London & Maudsley NHS Trust; Universidade de Lisboa; Hospital Santa Maria	Treasure, J (corresponding author), Kings Coll London, Dept Psychol Med, Inst Psychiat Psychol & Neurosci, London SE5 8AZ, England.	janet.treasure@kcl.ac.uk			National Institute of Health Research Senior Investigator Award	National Institute of Health Research Senior Investigator Award	US is supported by a National Institute of Health Research Senior Investigator Award. US and JT receive salary support from the National Institute of Health Research Mental Health Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and King's College London.	Afifi TO, 2017, INT J EAT DISORDER, V50, P1281, DOI 10.1002/eat.22783; [Anonymous], MQ LANDSC AN; [Anonymous], UK MED RES COUNC REC; [Anonymous], 2013, DIAGNOSTIC STAT MANU, DOI [10.1176/appi.books.9780890425596, DOI 10.1176/APPI.BOOKS.9780890425596]; [Anonymous], AD EAT DIS COMM INP; Attia E, 2019, AM J PSYCHIAT, V176, P449, DOI 10.1176/appi.ajp.2018.18101125; Barona M, 2019, NEUROSCI BIOBEHAV R, V100, P285, DOI 10.1016/j.neubiorev.2019.03.002; Bartholdy S, 2019, BIOL PSYCHIAT, V85, P956, DOI 10.1016/j.biopsych.2019.01.027; Birmingham C. L., 2019, MED MANAGEMENT EATIN; Blanchet C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020278; Breithaupt L, 2018, CURR NEUROPHARMACOL, V16, P1102, DOI 10.2174/1570159X16666180222163450; Brewerton TD, 2017, J CHILD ADOL PSYCHOP, V27, P920, DOI 10.1089/cap.2017.0133; Brewerton TD, 2017, EAT WEIGHT DISORD-ST, V22, P241, DOI 10.1007/s40519-016-0355-8; Brockmeyer T, 2019, INT J EAT DISORDER, V52, P520, DOI 10.1002/eat.23024; Brown A, 2018, EARLY INTERV PSYCHIA, V12, P250, DOI 10.1111/eip.12382; Bulik CM, 2019, PSYCHIAT CLIN NEUROS, V73, P518, DOI 10.1111/pcn.12857; Byrne S, 2017, PSYCHOL MED, V47, P2823, DOI 10.1017/S0033291717001349; Cagar-Nazai HP, 2014, NEUROSCI BIOBEHAV R, V42, P55, DOI 10.1016/j.neubiorev.2013.12.002; Cardi V, 2020, PSYCHOL MED, V50, P2610, DOI 10.1017/S0033291719002824; Cardi V, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00012; Cardi V, 2014, INT J EAT DISORDER, V47, P543, DOI 10.1002/eat.22261; Clus D, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.7898; Dahlgren CL, 2018, NORD PSYCHOL, V70, P209, DOI 10.1080/19012276.2017.1410071; Dalton A, 2019, GUT MICROBES, V10, P555, DOI 10.1080/19490976.2018.1562268; Dalton B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021531; Dalton B, 2018, CURR NEUROPHARMACOL, V16, P1174, DOI 10.2174/1570159X16666180108111532; Dalton B, 2017, CURR OPIN PSYCHIATR, V30, P458, DOI 10.1097/YCO.0000000000000361; Davies H, 2012, EUR EAT DISORD REV, V20, P211, DOI 10.1002/erv.2170; de Jonge P, 2014, DIABETOLOGIA, V57, P699, DOI 10.1007/s00125-013-3157-9; De Paoli T, 2018, EAT DISORD, V26, P343, DOI 10.1080/10640266.2017.1405651; de Zwaan M, 2017, JAMA PSYCHIAT, V74, P987, DOI 10.1001/jamapsychiatry.2017.2150; Delaney CB, 2015, INT J EAT DISORDER, V48, P238, DOI 10.1002/eat.22279; Dobrescu SR, 2020, BRIT J PSYCHIAT, V216, P97, DOI [10.1192/bjp.2019.113, 10.1192/bjp.2019.113[Opens]; Donnelly B, 2018, J EAT DISORD, V6, DOI 10.1186/s40337-018-0187-1; Dumont E, 2019, INT J EAT DISORDER, V52, P447, DOI 10.1002/eat.23053; Duncan L, 2017, AM J PSYCHIAT, V174, P850, DOI 10.1176/appi.ajp.2017.16121402; Eddy KT, 2019, INT J EAT DISORDER, V52, P361, DOI 10.1002/eat.23042; Eddy KT, 2017, J CLIN PSYCHIAT, V78, P184, DOI 10.4088/JCP.15m10393; Eichen DM, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0813-7; Eisler I, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1129-6; Elzakkers IFFM, 2016, BJPSYCH OPEN, V2, P147, DOI 10.1192/bjpo.bp.115.002485; Fairburn CG, 2015, INT J EAT DISORDER, V48, P1038, DOI 10.1002/eat.22398; Ferrer-Garcia M, 2019, CYBERPSYCH BEH SOC N, V22, P60, DOI 10.1089/cyber.2017.0675; Ferrer-Garcia M, 2017, EUR EAT DISORD REV, V25, P479, DOI 10.1002/erv.2538; Fichter MM, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-23; Fisher CA, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004780.pub4; Foerde K, 2015, NAT NEUROSCI, V18, P1571, DOI 10.1038/nn.4136; Foldi CJ, 2017, NEUROPSYCHOPHARMACOL, V42, P2292, DOI 10.1038/npp.2017.63; Fornaro M, 2016, NEUROPSYCH DIS TREAT, V12, P1827, DOI 10.2147/NDT.S109637; Garber AK, 2016, INT J EAT DISORDER, V49, P293, DOI 10.1002/eat.22482; Gaudio S, 2016, NEUROSCI BIOBEHAV R, V71, P578, DOI 10.1016/j.neubiorev.2016.09.032; Ghaderi A, 2018, PEERJ, V6, DOI 10.7717/peerj.5113; Gibson D, 2019, PSYCHIAT CLIN N AM, V42, P263, DOI 10.1016/j.psc.2019.01.009; Giel KE, 2017, EAT WEIGHT DISORD-ST, V22, P345, DOI 10.1007/s40519-017-0371-3; Glenny EM, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0797-3; Godart N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028249; Goodman JH, 2014, J CLIN PSYCHIAT, V75, pE1153, DOI 10.4088/JCP.14r09035; Gray E, 2018, J AM ACAD CHILD PSY, V57, P288, DOI 10.1016/j.jaac.2018.01.011; Gregertsen EC, 2019, PSYCHIAT RES, V271, P484, DOI 10.1016/j.psychres.2018.11.068; Gutierrez E, 2013, INT J EAT DISORDER, V46, P289, DOI 10.1002/eat.22095; Hale MD, 2019, EAT WEIGHT DISORD-ST, V24, P179, DOI 10.1007/s40519-018-0572-4; Harrison A, 2014, PSYCHIAT RES, V218, P187, DOI 10.1016/j.psychres.2014.04.007; Harrison ME, 2019, APPETITE, V137, P62, DOI 10.1016/j.appet.2019.02.012; Hartmann AS, 2020, EAT WEIGHT DISORD-ST, V25, P811, DOI 10.1007/s40519-019-00693-w; Hartmann AS, 2018, EUR CHILD ADOLES PSY, V27, P1509, DOI 10.1007/s00787-018-1179-z; Hay P, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0056-0; Hay PJ, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010827.pub2; Hedman A, 2019, J CHILD PSYCHOL PSYC, V60, P803, DOI 10.1111/jcpp.12958; Herpertz-Dahlmann B, 2017, EUR CHILD ADOLES PSY, V26, P1031, DOI 10.1007/s00787-017-0945-7; Herpertz-Dahlmann B, 2014, LANCET, V383, P1222, DOI 10.1016/S0140-6736(13)62411-3; Hibbs R, 2015, BJPSYCH OPEN, V1, P56, DOI 10.1192/bjpo.bp.115.000273; Hilbert A, 2019, PSYCHIAT CLIN N AM, V42, P33, DOI 10.1016/j.psc.2018.10.011; Hilbert A, 2019, J CONSULT CLIN PSYCH, V87, P91, DOI 10.1037/ccp0000358; Hilbert A, 2017, CURR OPIN PSYCHIATR, V30, P423, DOI 10.1097/YCO.0000000000000360; Himmerich H, 2019, SOC PSYCH PSYCH EPID, V54, P813, DOI 10.1007/s00127-019-01667-0; Hodel MA, 2019, PALLIAT SUPPORT CARE, V17, P621, DOI 10.1017/S1478951519000233; Hodsoll J, 2017, EUR EAT DISORD REV, V25, P551, DOI 10.1002/erv.2540; Holland G, 2016, BODY IMAGE, V17, P100, DOI 10.1016/j.bodyim.2016.02.008; Hubel C, 2019, MOL PSYCHIATR, V24, P901, DOI 10.1038/s41380-018-0254-7; Ilyas A, 2019, MOL CELL ENDOCRINOL, V497, DOI 10.1016/j.mce.2018.10.005; Javaras KN, 2015, INT J EAT DISORDER, V48, P1070, DOI 10.1002/eat.22467; Jewell T, 2016, INT J EAT DISORDER, V49, P354, DOI 10.1002/eat.22473; Kastner D, 2019, INT J EAT DISORDER, V52, P101, DOI 10.1002/eat.22975; Kerr-Gaffney J, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00102; Keski-Rahkonen A, 2016, CURR OPIN PSYCHIATR, V29, P340, DOI 10.1097/YCO.0000000000000278; Kessler RC, 2013, BIOL PSYCHIAT, V73, P904, DOI 10.1016/j.biopsych.2012.11.020; Kim EJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00461; Konig HH, 2018, INT J EAT DISORDER, V51, P155, DOI 10.1002/eat.22822; Kothari R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00208; Larsen JT, 2017, INT J EAT DISORDER, V50, P1404, DOI 10.1002/eat.22798; Le Grange D, 2016, J AM ACAD CHILD PSY, V55, P683, DOI 10.1016/j.jaac.2016.05.007; Levinson CA, 2015, INT J EAT DISORDER, V48, P271, DOI 10.1002/eat.22344; Limburg K, 2017, J CLIN PSYCHOL, V73, P1301, DOI 10.1002/jclp.22435; Linardon J, 2017, CLIN PSYCHOL REV, V58, P125, DOI 10.1016/j.cpr.2017.10.005; Lipsman N, 2017, LANCET PSYCHIAT, V4, P285, DOI 10.1016/S2215-0366(17)30076-7; Litmanen J, 2017, NORD J PSYCHIAT, V71, P61, DOI 10.1080/08039488.2016.1224272; Liu W, 2018, NEUROSURGERY, V83, P86, DOI 10.1093/neuros/nyx366; Llewellyn C, 2015, PHYSIOL BEHAV, V152, P494, DOI 10.1016/j.physbeh.2015.07.006; Lock J, 2019, INT J EAT DISORDER, V52, P746, DOI 10.1002/eat.23077; Lock J, 2018, EUR EAT DISORD REV, V26, P62, DOI 10.1002/erv.2571; Lutter M, 2017, NEUROTHERAPEUTICS, V14, P614, DOI 10.1007/s13311-017-0535-x; Macdonald P., 2009, CLIN GUIDE COLLABORA; Madden S, 2015, PSYCHOL MED, V45, P415, DOI 10.1017/S0033291714001573; Madra M, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.35; Magill N, 2016, EUR EAT DISORD REV, V24, P122, DOI 10.1002/erv.2422; Marcus MD, 2009, INT J EAT DISORDER, V42, P739, DOI 10.1002/eat.20725; McClelland J, 2018, EUR EAT DISORD REV, V26, P129, DOI 10.1002/erv.2579; McClelland J, 2016, NEUROSCI BIOBEHAV R, V71, P506, DOI 10.1016/j.neubiorev.2016.09.024; Micali N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002646; Mitchison D, 2020, PSYCHOL MED, V50, P981, DOI 10.1017/S0033291719000898; National Institute for Health and Care Excellence, 2017, EATING DISORDERS REC; Nazar BP, 2014, COMPR PSYCHIAT, V55, P572, DOI 10.1016/j.comppsych.2013.09.015; Oldershaw A, 2012, EUR EAT DISORD REV, V20, P502, DOI 10.1002/erv.2153; Olivo G, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081907; Park RJ, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00044; Paslakis G, 2017, INT J EAT DISORDER, V50, P1243, DOI 10.1002/eat.22768; Phillipou A, 2018, AUST NZ J PSYCHIAT, V52, P13, DOI 10.1177/0004867417722640; Pugh J, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00523; Rizzo SM, 2019, NUTR CLIN PRACT, V34, P359, DOI 10.1002/ncp.10187; Robinson L, 2016, OSTEOPOROSIS INT, V27, P1953, DOI 10.1007/s00198-015-3468-4; Robinson P., 2018, BJPSYCH ADV, V24, P20, DOI DOI 10.1192/BJA.2017.2; Rocks T, 2014, J ACAD NUTR DIET, V114, P897, DOI 10.1016/j.jand.2013.11.022; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Schag K, 2019, PSYCHOTHER PSYCHOSOM, V88, P141, DOI 10.1159/000499696; Schalla MA, 2019, EUR EAT DISORD REV, V27, P447, DOI 10.1002/erv.2679; Schaumberg K, 2017, EUR EAT DISORD REV, V25, P432, DOI 10.1002/erv.2553; Schmidt U, 2007, AM J PSYCHIAT, V164, P591, DOI 10.1176/appi.ajp.164.4.591; Schmidt U, 2016, INT J EAT DISORDER, V49, P793, DOI 10.1002/eat.22523; Schmidt U, 2016, LANCET PSYCHIAT, V3, P313, DOI 10.1016/S2215-0366(16)00081-X; Schmidt U, 2015, J CONSULT CLIN PSYCH, V83, P796, DOI 10.1037/ccp0000019; Schwensen HF, 2018, EAT WEIGHT DISORD-ST, V23, P399, DOI 10.1007/s40519-018-0499-9; Seed T, 2016, CLIN PSYCHOL PSYCHOT, V23, P352, DOI 10.1002/cpp.1963; Seitz J, 2019, PSYCHIAT CLIN N AM, V42, P93, DOI 10.1016/j.psc.2018.10.004; Singleton C, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00209; Slade E, 2018, PSYCHOL MED, V48, P2629, DOI 10.1017/S0033291718001071; Smink FRE, 2016, PSYCHOL MED, V46, P1189, DOI 10.1017/S003329171500272X; Smink FRE, 2013, CURR OPIN PSYCHIATR, V26, P543, DOI 10.1097/YCO.0b013e328365a24f; Smith KE, 2018, INT J EAT DISORDER, V51, P798, DOI 10.1002/eat.22929; Smith KE, 2018, CLIN PSYCHOL REV, V61, P9, DOI 10.1016/j.cpr.2018.03.004; Solmi F, 2016, SOC PSYCH PSYCH EPID, V51, P369, DOI 10.1007/s00127-015-1146-7; Sonneville KR, 2015, PSYCHOL MED, V45, P2511, DOI 10.1017/S0033291715000148; Staite E, 2018, DIABETIC MED, V35, P1329, DOI 10.1111/dme.13700; Steinglass JE, 2019, PSYCHIAT CLIN N AM, V42, P75, DOI 10.1016/j.psc.2018.10.008; Steinglass JE, 2014, INT J EAT DISORDER, V47, P174, DOI 10.1002/eat.22214; Steinhausen HC, 2015, INT J EAT DISORDER, V48, P845, DOI 10.1002/eat.22402; Stice E, 2019, J CONSULT CLIN PSYCH, V87, P79, DOI 10.1037/ccp0000365; Stice E, 2018, BEHAV RES THER, V105, P52, DOI 10.1016/j.brat.2018.03.005; Stice E, 2017, J ABNORM PSYCHOL, V126, P38, DOI 10.1037/abn0000219; Stoving RK, 2019, EUR J ENDOCRINOL, V180, pR9, DOI 10.1530/EJE-18-0596; Strand M, 2019, INT J EAT DISORDER, V52, P331, DOI 10.1002/eat.22962; Su XJ, 2016, EUR CHILD ADOLES PSY, V25, P1245, DOI 10.1007/s00787-016-0848-z; Sun X, 2017, EUR PSYCHIAT, V45, P139, DOI 10.1016/j.eurpsy.2017.05.029; Tchanturia K, 2015, COGNITIVE REMEDIATION THERAPY (CRT) FOR EATING AND WEIGHT DISORDERS, P1; Thienpont L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007454; Trachsel M, 2019, BMC PSYCHIATRY, V19, DOI 10.1186/s12888-019-2091-x; Treasure J, 2015, DIABETIC MED, V32, P1541, DOI 10.1111/dme.12839; Treasure J, 2018, EUR EAT DISORD REV, V26, P83, DOI 10.1002/erv.2578; Treasure J, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.74; Treasure J, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-015-0652-3; Treasure J, 2015, EARLY INTERV PSYCHIA, V9, P173, DOI 10.1111/eip.12170; Turton R, 2018, EUR EAT DISORD REV, V26, P11, DOI 10.1002/erv.2566; Udo T, 2019, INT J EAT DISORDER, V52, P42, DOI 10.1002/eat.23004; van den Berg E, 2019, EUR EAT DISORD REV, V27, P331, DOI 10.1002/erv.2683; van Furth EF, 2016, LANCET PSYCHIAT, V3, P706, DOI 10.1016/S2215-0366(16)30147-X; Wade TD, 2019, PSYCHIAT CLIN N AM, V42, P21, DOI 10.1016/j.psc.2018.10.002; Watson HJ, 2019, NAT GENET, V51, P1207, DOI 10.1038/s41588-019-0439-2; Watson HJ, 2019, INT J EAT DISORDER, V52, P643, DOI 10.1002/eat.23073; Werthmann J, 2019, INT J EAT DISORDER, V52, P681, DOI 10.1002/eat.23064; Whitney J, 2012, EUR EAT DISORD REV, V20, P142, DOI 10.1002/erv.1076; Wierenga CE, 2018, INT J EAT DISORDER, V51, P863, DOI 10.1002/eat.22876; Wiss DA, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00545; Wisting L, 2019, J EAT DISORD, V7, DOI 10.1186/s40337-018-0232-0; Wolpert M, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1079-6; Wonderlich SA, 2014, PSYCHOL MED, V44, P543, DOI 10.1017/S0033291713001098; World Health Organization (WHO), 2019, INT CLASS DIS ICD 11; Yim SH, 2019, PSYCHIAT CLIN N AM, V42, P231, DOI 10.1016/j.psc.2019.01.006; Zeeck A, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00158; Zipfel S, 2015, LANCET PSYCHIAT, V2, P1099, DOI 10.1016/S2215-0366(15)00356-9; Zipfel S, 2014, LANCET, V383, P127, DOI 10.1016/S0140-6736(13)61746-8; Zrinzo L, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00326	180	191	196	39	158	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					899	911						13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32171414				2022-12-28	WOS:000520024900038
J	Jiao, L; Howard, S; Ran, S; Wang, ZY; Rodriguez, JO; Sigrist, M; Wang, ZQ; Butch, NP; Madhavan, V				Jiao, Lin; Howard, Sean; Ran, Sheng; Wang, Zhenyu; Rodriguez, Jorge Olivares; Sigrist, Manfred; Wang, Ziqiang; Butch, Nicholas P.; Madhavan, Vidya			Chiral superconductivity in heavy-fermion metal UTe2	NATURE			English	Article							HIDDEN ORDER; FERROMAGNETISM; COEXISTENCE; SR2RUO4; LATTICE; STATES	Scanning tunnelling microscopy and spectroscopy measurements show chiral edge states inside the superconducting gap of the heavy-fermion superconductor UTe2, indicating the presence of chiral spin-triplet superconductivity. Spin-triplet superconductors are condensates of electron pairs with spin 1 and an odd-parity wavefunction(1). An interesting manifestation of triplet pairing is the chiral p-wave state, which is topologically non-trivial and provides a natural platform for realizing Majorana edge modes(2,3). However, triplet pairing is rare in solid-state systems and has not been unambiguously identified in any bulk compound so far. Given that pairing is usually mediated by ferromagnetic spin fluctuations, uranium-based heavy-fermion systems containing f-electron elements, which can harbour both strong correlations and magnetism, are considered ideal candidates for realizing spin-triplet superconductivity(4). Here we present scanning tunnelling microscopy studies of the recently discovered heavy-fermion superconductor UTe2, which has a superconducting transition temperature of 1.6 kelvin(5). We find signatures of coexisting Kondo effect and superconductivity that show competing spatial modulations within one unit cell. Scanning tunnelling spectroscopy at step edges reveals signatures of chiral in-gap states, which have been predicted to exist at the boundaries of topological superconductors. Combined with existing data that indicate triplet pairing in UTe2, the presence of chiral states suggests that UTe2 is a strong candidate for chiral-triplet topological superconductivity.	[Jiao, Lin; Howard, Sean; Wang, Zhenyu; Rodriguez, Jorge Olivares; Madhavan, Vidya] Univ Illinois, Dept Phys, Urbana, IL USA; [Jiao, Lin; Howard, Sean; Wang, Zhenyu; Rodriguez, Jorge Olivares; Madhavan, Vidya] Univ Illinois, Mat Res Lab, Urbana, IL USA; [Ran, Sheng; Butch, Nicholas P.] Natl Inst Stand & Technol, NIST Ctr Neutron Res, Gaithersburg, MD 20899 USA; [Ran, Sheng; Butch, Nicholas P.] Univ Maryland, Dept Phys, Ctr Nanophys & Adv Mat, College Pk, MD 20742 USA; [Sigrist, Manfred] Swiss Fed Inst Technol, Inst Theoret Phys, Zurich, Switzerland; [Wang, Ziqiang] Boston Coll, Dept Phys, Chestnut Hill, MA 02167 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park; Swiss Federal Institutes of Technology Domain; ETH Zurich; Boston College	Madhavan, V (corresponding author), Univ Illinois, Dept Phys, Urbana, IL USA.; Madhavan, V (corresponding author), Univ Illinois, Mat Res Lab, Urbana, IL USA.	vm1@illinois.edu		Howard, Sean/0000-0002-6132-4688; Jiao, Lin/0000-0002-8343-0190; Ran, Sheng/0000-0003-1557-267X; Wang, Zhenyu/0000-0002-4857-7234; Butch, Nicholas/0000-0002-6083-8388				Aoki D, 2001, NATURE, V413, P613, DOI 10.1038/35098048; Aoki D, 2019, J PHYS SOC JPN, V88, DOI 10.7566/JPSJ.88.043702; Aynajian P, 2010, P NATL ACAD SCI USA, V107, P10383, DOI 10.1073/pnas.1005892107; DYNES RC, 1978, PHYS REV LETT, V41, P1509, DOI 10.1103/PhysRevLett.41.1509; Ernst S, 2011, NATURE, V474, P362, DOI 10.1038/nature10148; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Gyenis A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02841-9; Hamidian MH, 2016, NATURE, V532, P343, DOI 10.1038/nature17411; Haule K, 2009, NAT PHYS, V5, P796, DOI 10.1038/NPHYS1392; Hillier AD, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.097001; Honerkamp C, 1998, J LOW TEMP PHYS, V111, P895, DOI 10.1023/A:1022281409397; Huy NT, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.067006; Ishida K, 1998, NATURE, V396, P658, DOI 10.1038/25315; Jiao L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13762; Kallin C, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/4/042501; Kashiwaya S, 2000, REP PROG PHYS, V63, P1641, DOI 10.1088/0034-4885/63/10/202; Kashiwaya S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.077003; Knebel G, 2019, J PHYS SOC JPN, V88, DOI 10.7566/JPSJ.88.063707; Kobayashi S, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.214514; Kozii V, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601835; LEGGETT AJ, 1975, REV MOD PHYS, V47, P331, DOI 10.1103/RevModPhys.47.331; Mackenzie AP, 2003, REV MOD PHYS, V75, P657, DOI 10.1103/RevModPhys.75.657; Madhavan V, 1998, SCIENCE, V280, P567, DOI 10.1126/science.280.5363.567; Maltseva M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.206402; Metz T, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.220504; Miyake A, 2019, J PHYS SOC JPN, V88, DOI 10.7566/JPSJ.88.063706; Pustogow A, 2019, NATURE, V574, P72, DOI 10.1038/s41586-019-1596-2; Ran S, 2019, NAT PHYS, V15, P1250, DOI 10.1038/s41567-019-0670-x; Ran S, 2019, SCIENCE, V365, P684, DOI 10.1126/science.aav8645; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Sato M, 2017, REP PROG PHYS, V80, DOI 10.1088/1361-6633/aa6ac7; Saxena SS, 2000, NATURE, V406, P587, DOI 10.1038/35020500; Schmidt AR, 2010, NATURE, V465, P570, DOI 10.1038/nature09073; Singh UR, 2013, REV SCI INSTRUM, V84, DOI 10.1063/1.4788941; STEWART GR, 1984, PHYS REV LETT, V52, P679, DOI 10.1103/PhysRevLett.52.679; Sundar S, 2019, PHYS REV B, V100, DOI [10.1103/physrevb.100.140502, 10.1103/PhysRevB.100.140502]; Tamura S, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.104511; Tokunaga Y, 2019, J PHYS SOC JPN, V88, DOI 10.7566/JPSJ.88.073701; TRANQUADA JM, 1995, NATURE, V375, P561, DOI 10.1038/375561a0; Yamashiro M, 1997, PHYS REV B, V56, P7847, DOI 10.1103/PhysRevB.56.7847	41	106	106	25	200	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					523	527		10.1038/s41586-020-2122-2	http://dx.doi.org/10.1038/s41586-020-2122-2			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214254	Green Submitted			2022-12-28	WOS:000521825500020
J	Rosenbaum, L				Rosenbaum, Lisa			Facing Covid-19 in Italy - Ethics, Logistics, and Therapeutics on the Epidemic's Front Line	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Physicians in northern Italy have learned some painful lessons about rationing care during an epidemic. As health care systems work out ethical allocation principles, it seems clear that only with transparency and inclusivity can public trust and cooperation be achieved.										Biddison ELD, 2019, CHEST, V155, P848, DOI 10.1016/j.chest.2018.09.025; Horowitz J, 2020, NEW YORK TIMES	2	518	537	3	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2020	382	20					1873	1875		10.1056/NEJMp2005492	http://dx.doi.org/10.1056/NEJMp2005492			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LR8KG	32187459	Bronze			2022-12-28	WOS:000535944700013
J	Kloecker, DE; Davies, MJ; Khunti, K; Zaccardi, F				Kloecker, David E.; Davies, Melanie J.; Khunti, Kamlesh; Zaccardi, Francesco			Uses and Limitations of the Restricted Mean Survival Time: Illustrative Examples From Cardiovascular Outcomes and Mortality Trials in Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE GLUCOSE CONTROL; STRUCTURED PERSONAL CARE; FOLLOW-UP; MULTIFACTORIAL INTERVENTION; CLINICAL-TRIAL; TO-EVENT; MACROVASCULAR EVENTS; GLYCEMIC CONTROL; LIFE EXPECTANCY; BLOOD-PRESSURE	The restricted mean survival time (RMST) has been advocated as an alternative or a supplement to the hazard ratio for reporting the effect of an intervention in a randomized clinical trial. The RMST difference allows quantification of the postponement of an outcome during a specified (restricted) interval and corresponds to the difference between the areas under the 2 survival curves for the intervention and control groups. This article presents examples of the use of the RMST in a research and a clinical context. First, the authors demonstrate how the RMST difference can answer research questions about the efficacy of different treatments. Estimates are presented for the effects of pharmacologic or strategy-driven glucose-lowering interventions for adults with type 2 diabetes from 36 trials and 9 follow-up studies reporting cardiovascular outcomes and mortality. The authors show how these measures may be used to mitigate uncertainty about the efficacy of intensive glucose control. Second, the authors demonstrate how the RMST difference may be used in the setting of a clinical consultation to guide the decision to start or discontinue a treatment. They then discuss the advantages of the RMST over the absolute risk difference, the number needed to treat, and the median survival time difference. They argue that the RMST difference is both easy to interpret and flexible in its application to different settings. Finally, they highlight the major limitations of the RMST, including difficulties in comparing studies of heterogeneous designs and in inferring the long-term effects of treatments using trials of short duration, and summarize the available statistical software for calculating the RMST.	[Kloecker, David E.; Khunti, Kamlesh; Zaccardi, Francesco] Leicester Gen Hosp, Leicester Diabet Ctr, Leicester Real World Evidence Unit, Gwendolen Rd, Leicester LE5 4PW, Leics, England; [Kloecker, David E.; Davies, Melanie J.; Khunti, Kamlesh; Zaccardi, Francesco] Leicester Gen Hosp, Leicester Diabet Ctr, Diabet Res Ctr, Leicester, Leics, England; [Davies, Melanie J.; Khunti, Kamlesh; Zaccardi, Francesco] Leicester Gen Hosp, Leicester Diabet Ctr, Gwendolen Rd, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University Hospitals of Leicester NHS Trust; Leicester General Hospital; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Kloecker, DE (corresponding author), Leicester Gen Hosp, Leicester Diabet Ctr, Leicester Real World Evidence Unit, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	dek9@student.le.ac.uk	/ABC-9527-2021	Khunti, Kamlesh/0000-0003-2343-7099; Davies, Melanie/0000-0002-9987-9371	NIHR Applied Research Collaborations East Midlands; NIHR Leicester Biomedical Research Centre	NIHR Applied Research Collaborations East Midlands; NIHR Leicester Biomedical Research Centre	From NIHR Applied Research Collaborations East Midlands and NIHR Leicester Biomedical Research Centre. The funding bodies had no role in the design, conduct, or analysis of the study or in the decision to submit the manuscript for publication.	A'Hern RP, 2016, J CLIN ONCOL, V34, P3474, DOI 10.1200/JCO.2016.67.8045; Altman DG, 1999, BRIT MED J, V319, P1492, DOI 10.1136/bmj.319.7223.1492; Austin PC, 2017, STAT MED, V36, P1203, DOI 10.1002/sim.7215; Carstensen B., 2019, DO STATINS ONLY POST; Cefalu WT, 2018, DIABETES CARE, V41, P14, DOI 10.2337/dci17-0057; Claggett B, 2018, CIRCULATION, V138, P1599, DOI 10.1161/CIRCULATIONAHA.118.033810; Cronin A, 2016, STATA J, V16, P702, DOI 10.1177/1536867X1601600310; Davies MJ, 2018, DIABETOLOGIA, V61, P2461, DOI 10.1007/s00125-018-4729-5; Dehbi HM, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2250; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Erdmann E, 2016, DIABETES OBES METAB, V18, P266, DOI 10.1111/dom.12608; Frye RL, 2009, NEW ENGL J MED, V360, P2503, DOI [DOI 10.1056/NEJMOA0805796, 10.1056/NEJMoa0805796]; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gantz I, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0593-8; Gde P, 2016, DIABETOLOGIA, V59, P2298, DOI 10.1007/s00125-016-4065-6; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2019, LANCET, V394, P121, DOI 10.1016/S0140-6736(19)31149-3; Gerstein HC, 2016, DIABETES CARE, V39, P701, DOI 10.2337/dc15-2283; Gerstein HC, 2012, NEW ENGL J MED, V367, P319, DOI 10.1056/NEJMoa1203858; Ghosh AK, 2004, LANCET, V364, P1108, DOI 10.1016/S0140-6736(04)17119-5; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; Hansen LJ, 2013, DIABETOLOGIA, V56, P1243, DOI 10.1007/s00125-013-2893-1; Harrell F., PROBLEMS NNT; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Hernan MA, 2010, EPIDEMIOLOGY, V21, P13, DOI 10.1097/EDE.0b013e3181c1ea43; Hernandez AF, 2018, LANCET, V392, P1519, DOI 10.1016/S0140-6736(18)32261-X; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2017, NEW ENGL J MED, V377, P1228, DOI 10.1056/NEJMoa1612917; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Horiguchi M, PACKAGE SURVRM2ADAPT; Husain M, 2019, NEW ENGL J MED, V381, P841, DOI 10.1056/NEJMoa1901118; Kaneko M, 2019, CLIN DRUG INVEST, V39, P469, DOI 10.1007/s40261-019-00770-z; Kaneko M, 2019, CLIN DRUG INVEST, V39, P179, DOI 10.1007/s40261-018-0731-4; Kaneko M, 2018, ANN PHARMACOTHER, V52, P632, DOI 10.1177/1060028018757407; Kaneko M, 2017, ANN PHARMACOTHER, V51, P570, DOI 10.1177/1060028017698496; Keene ON, 2002, STAT MED, V21, P3687, DOI 10.1002/sim.1312; Kent DM, 2020, ANN INTERN MED, V172, pW1, DOI 10.7326/M18-3668; Kent DM, 2020, ANN INTERN MED, V172, P35, DOI 10.7326/M18-3667; Kent DM, 2016, INT J EPIDEMIOL, V45, P2075, DOI 10.1093/ije/dyw118; Kim DH, 2017, JAMA CARDIOL, V2, P1179, DOI 10.1001/jamacardio.2017.2922; Kooy A, 2009, ARCH INTERN MED, V169, P616, DOI 10.1001/archinternmed.2009.20; Kristensen ML, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007118; Lambert PC., STANDSURV; Lincoff AM, 2014, JAMA-J AM MED ASSOC, V311, P1515, DOI 10.1001/jama.2014.3321; Marso Steven P, 2017, N Engl J Med, V377, P723, DOI 10.1056/NEJMoa1615692; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Mendes D, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0875-8; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Overgaard M, 2015, STATA J, V15, P809, DOI 10.1177/1536867X1501500313; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Punthakee Z, 2016, DIABETES CARE, V39, P709, DOI 10.2337/dc15-1676; Raz I, 2009, DIABETES CARE, V32, P381, DOI 10.2337/dc08-1671; Reaven PD, 2019, NEW ENGL J MED, V380, P2215, DOI 10.1056/NEJMoa1806802; Rosenstock J, 2019, JAMA-J AM MED ASSOC, V321, P69, DOI 10.1001/jama.2018.18269; Royston P, 2015, STATA J, V15, P1098, DOI 10.1177/1536867X1501500409; Saad ED, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx179; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Seidu S, 2019, DIABETES OBES METAB, V21, P1668, DOI 10.1111/dom.13724; Spiegelhalter D, 2017, ANNU REV STAT APPL, V4, P31, DOI 10.1146/annurev-statistics-010814-020148; Stensrud MJ, 2019, EUR HEART J, V40, P1378, DOI 10.1093/eurheartj/ehy770; Sussman JB, 2015, JAMA INTERN MED, V175, P1942, DOI 10.1001/jamainternmed.2015.5110; Trinquart L, 2016, J CLIN ONCOL, V34, P1813, DOI 10.1200/JCO.2015.64.2488; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ueki K, 2017, LANCET DIABETES ENDO, V5, P951, DOI 10.1016/S2213-8587(17)30327-3; Uno H, PACKAGE SURVRM2; Uno H, 2015, ANN INTERN MED, V163, P127, DOI 10.7326/M14-1741; Uno H, 2014, J CLIN ONCOL, V32, P2380, DOI 10.1200/JCO.2014.55.2208; Vaccaro O, 2017, LANCET DIABETES ENDO, V5, P887, DOI 10.1016/S2213-8587(17)30317-0; Wei YH, 2017, STATA J, V17, P786, DOI 10.1177/1536867X1701700402; White WB, 2013, NEW ENGL J MED, V369, P1327, DOI 10.1056/NEJMoa1305889; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Yeh RW, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k5094; Yoshii H, 2014, J ATHEROSCLER THROMB, V21, P563; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720; Zipkin DA, 2014, ANN INTERN MED, V161, P270, DOI 10.7326/M14-0295; Zoungas S, 2014, NEW ENGL J MED, V371, P1392, DOI 10.1056/NEJMoa1407963	86	33	33	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2020	172	8					541	+		10.7326/M19-3286	http://dx.doi.org/10.7326/M19-3286			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF9LH	32203984	Green Submitted			2022-12-28	WOS:000527733800015
J	Sun, XC; Bernstein, MJ; Meng, MZ; Rao, SY; Sorensen, AT; Yao, L; Zhang, XH; Anikeeva, PO; Lin, YX				Sun, Xiaochen; Bernstein, Max J.; Meng, Meizhen; Rao, Siyuan; Sorensen, Andreas T.; Yao, Li; Zhang, Xiaohui; Anikeeva, Polina O.; Lin, Yingxi			Functionally Distinct Neuronal Ensembles within the Memory Engram	CELL			English	Article							PERFORANT PATH INPUTS; DENTATE GYRUS; PATTERN SEPARATION; GRANULE CELLS; FEAR GENERALIZATION; ENTORHINAL CORTEX; MOSSY CELLS; TERM-MEMORY; C-FOS; CONTEXT	Memories are believed to be encoded by sparse ensembles of neurons in the brain. However, it remains unclear whether there is functional heterogeneity within individual memory engrams, i.e., if separate neuronal subpopulations encode distinct aspects of thememory and drivememory expression differently. Here, we show that contextual fear memory engrams in the mouse dentate gyrus contain functionally distinct neuronal ensembles, genetically defined by the Fos- or Npas4-dependent transcriptional pathways. The Fos-dependent ensemble promotes memory generalization and receives enhanced excitatory synaptic inputs from the medial entorhinal cortex, which we find itself also mediates generalization. The Npas4-dependent ensemble promotes memory discrimination and receives enhanced inhibitory drive from local cholecystokinin-expressing interneurons, the activity of which is required for discrimination. Our study provides causal evidence for functional heterogeneity within the memory engram and reveals synaptic and circuit mechanisms used by each ensemble to regulate the memory discrimination-generalization balance.	[Sun, Xiaochen; Bernstein, Max J.; Meng, Meizhen; Rao, Siyuan; Sorensen, Andreas T.; Anikeeva, Polina O.; Lin, Yingxi] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sun, Xiaochen; Lin, Yingxi] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Sun, Xiaochen] MIT, Mol & Cellular Neurosci Grad Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Rao, Siyuan; Anikeeva, Polina O.] MIT, Res Lab Elect, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Yao, Li; Zhang, Xiaohui] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Yao, Li; Zhang, Xiaohui] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing 100875, Peoples R China; [Anikeeva, Polina O.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Meng, Meizhen] SUNY Upstate Med Univ, Neurosci Grad Program, Syracuse, NY 13210 USA; [Sorensen, Andreas T.] Univ Copenhagen, Dept Neurosci, Copenhagen, Denmark; [Lin, Yingxi] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Beijing Normal University; Beijing Normal University; Massachusetts Institute of Technology (MIT); State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Copenhagen; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Lin, YX (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lin, YX (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Lin, YX (corresponding author), SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA.	linyi@upstate.edu	Sun, Xiaochen/GLR-2510-2022; Sørensen, Andreas Toft/P-4745-2018	Sun, Xiaochen/0000-0002-1266-7510; Sørensen, Andreas Toft/0000-0001-5887-9247; /0000-0002-7002-1275	Henry E. Singleton Fellowship; Leventhal Graduate Student Fellowship; Hugo Shong Fellowship; Simons Postdoctoral Fellowship; Beijing Municipal Science & Technology Commission, China [Z181100001518001]; MIT Great China Fund for Innovation; NIH BRAIN Initiative [1R01MH111872]; Solomon BuchsbaumResearch Foundation Award; NIH [MH091220, NS088421, MH116673, DC014701]	Henry E. Singleton Fellowship; Leventhal Graduate Student Fellowship; Hugo Shong Fellowship; Simons Postdoctoral Fellowship; Beijing Municipal Science & Technology Commission, China(Beijing Municipal Science & Technology Commission); MIT Great China Fund for Innovation; NIH BRAIN Initiative; Solomon BuchsbaumResearch Foundation Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	WethankC.M. Fletcher and J. Radulovic for critical reading of themanuscript; M. Xu for providing Fosflx/flx mice; G. Fishell for sharing Dlx5/6 constructs; L. Paul, Y. Zhang, J. Xue, T.D. Yelhekar, and F.-J. Weng for technical assistance; andW. Xu, D.S. Roy, P.E. Castillo, G. Vargish, E.L.Q. Lee, J. Guo, and the entire Lin laboratory for helpful suggestions. This work was funded by a Henry E. Singleton Fellowship, Leventhal Graduate Student Fellowship, and Hugo Shong Fellowship (X.S.); Simons Postdoctoral Fellowship (S.R.); Beijing Municipal Science & Technology Commission, China (Z181100001518001; X.Z.); MIT Great China Fund for Innovation (Y.L. and X.Z.); NIH BRAIN Initiative 1R01MH111872 (P.O.A.); and Solomon BuchsbaumResearch Foundation Award and NIH grants MH091220, NS088421, MH116673, and DC014701 (Y.L.).	AMARAL DG, 1989, NEUROSCIENCE, V31, P571, DOI 10.1016/0306-4522(89)90424-7; Barth AL, 2004, J NEUROSCI, V24, P6466, DOI 10.1523/JNEUROSCI.4737-03.2004; Barth AL, 2007, CURR OPIN NEUROBIOL, V17, P567, DOI 10.1016/j.conb.2007.10.003; Bartos M, 2012, J PHYSIOL-LONDON, V590, P669, DOI 10.1113/jphysiol.2011.226175; Bernier BE, 2017, J NEUROSCI, V37, P6359, DOI 10.1523/JNEUROSCI.3029-16.2017; Cai DJ, 2016, NATURE, V534, P115, DOI 10.1038/nature17955; Castillo PE, 2012, NEURON, V76, P70, DOI 10.1016/j.neuron.2012.09.020; Chelaru MI, 2008, P NATL ACAD SCI USA, V105, P16344, DOI 10.1073/pnas.0807744105; Choi JH, 2018, SCIENCE, V360, P430, DOI 10.1126/science.aas9204; Danielson NB, 2017, NEURON, V93, P552, DOI 10.1016/j.neuron.2016.12.019; Deng W, 2013, ELIFE, V2, DOI 10.7554/eLife.00312; Denny CA, 2014, NEURON, V83, P189, DOI 10.1016/j.neuron.2014.05.018; Diehl GW, 2017, NEURON, V94, P83, DOI 10.1016/j.neuron.2017.03.004; Dimidschstein J, 2016, NAT NEUROSCI, V19, P1743, DOI 10.1038/nn.4430; Dunsmoor JE, 2015, BIOL PSYCHIAT, V78, P336, DOI 10.1016/j.biopsych.2015.04.010; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fyhn M, 2007, NATURE, V446, P190, DOI 10.1038/nature05601; Garner AR, 2012, SCIENCE, V335, P1513, DOI 10.1126/science.1214985; Ghandour K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10683-2; GoodSmith D, 2017, NEURON, V93, P677, DOI 10.1016/j.neuron.2016.12.026; Grewe BF, 2017, NATURE, V543, P670, DOI 10.1038/nature21682; Grosmark AD, 2016, SCIENCE, V351, P1440, DOI 10.1126/science.aad1935; Grosso A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03682-2; Guenthner CJ, 2013, NEURON, V78, P773, DOI 10.1016/j.neuron.2013.03.025; Guo NN, 2018, NAT MED, V24, P438, DOI 10.1038/nm.4491; Guzowski JF, 2005, CURR OPIN NEUROBIOL, V15, P599, DOI 10.1016/j.conb.2005.08.018; Hainmueller T, 2018, NATURE, V558, P292, DOI 10.1038/s41586-018-0191-2; Hales JB, 2014, CELL REP, V9, P893, DOI 10.1016/j.celrep.2014.10.009; Han JH, 2009, SCIENCE, V323, P1492, DOI 10.1126/science.1164139; Hartzell AL, 2018, ELIFE, V7, DOI 10.7554/eLife.35927; Hashimotodani Y, 2017, NEURON, V95, P928, DOI 10.1016/j.neuron.2017.07.028; Hefft S, 2005, NAT NEUROSCI, V8, P1319, DOI 10.1038/nn1542; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Huckleberry KA, 2016, LEARN MEMORY, V23, P703, DOI 10.1101/lm.042374.116; Jinde S, 2012, NEURON, V76, P1189, DOI 10.1016/j.neuron.2012.10.036; Josselyn SA, 2015, NAT REV NEUROSCI, V16, P521, DOI 10.1038/nrn4000; Jun JK, 2010, J NEUROSCI, V30, P916, DOI 10.1523/JNEUROSCI.2062-09.2010; Kanter BR, 2017, NEURON, V93, P1480, DOI 10.1016/j.neuron.2017.03.001; Kawashima T, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00037; Kawashima T, 2013, NAT METHODS, V10, P889, DOI [10.1038/NMETH.2559, 10.1038/nmeth.2559]; Kheirbek MA, 2013, NEURON, V77, P955, DOI 10.1016/j.neuron.2012.12.038; Kheirbek MA, 2012, NAT NEUROSCI, V15, P1613, DOI 10.1038/nn.3262; Kitamura T, 2015, NEURON, V87, P1317, DOI 10.1016/j.neuron.2015.08.036; Knierim JJ, 2016, NEUROBIOL LEARN MEM, V129, P38, DOI 10.1016/j.nlm.2015.10.008; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lacagnina AF, 2019, NAT NEUROSCI, V22, P753, DOI 10.1038/s41593-019-0361-z; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Lonergan ME, 2010, NEURAL PLAST, V2010, P1, DOI 10.1155/2010/139891; Macek TA, 1996, J NEUROPHYSIOL, V76, P3798, DOI 10.1152/jn.1996.76.6.3798; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Mallory CS, 2018, CURR OPIN NEUROBIOL, V49, P158, DOI 10.1016/j.conb.2018.02.014; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Miao CL, 2015, NEURON, V88, P590, DOI 10.1016/j.neuron.2015.09.051; Mongiat LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005320; Nakashiba T, 2012, CELL, V149, P188, DOI 10.1016/j.cell.2012.01.046; Nakayama D, 2015, J NEUROSCI, V35, P819, DOI 10.1523/JNEUROSCI.2525-14.2015; Osborne LC, 2008, J NEUROSCI, V28, P13522, DOI 10.1523/JNEUROSCI.4390-08.2008; Park S, 2016, NEUROPSYCHOPHARMACOL, V41, P2987, DOI 10.1038/npp.2016.73; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Petersen RP, 2013, NEUROSCIENCE, V252, P154, DOI 10.1016/j.neuroscience.2013.07.063; Pignatelli M, 2019, NEURON, V101, P274, DOI 10.1016/j.neuron.2018.11.029; Ramamoorthi K, 2011, SCIENCE, V334, P1669, DOI 10.1126/science.1208049; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Richter K, 2016, PHYS REV APPL, V5, DOI 10.1103/PhysRevApplied.5.024007; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Rozeske RR, 2018, NEURON, V97, P898, DOI 10.1016/j.neuron.2017.12.044; Ryan TJ, 2015, SCIENCE, V348, P1007, DOI 10.1126/science.aaa5542; Scharfman HE, 2013, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00106; Senzai Y, 2017, NEURON, V93, P691, DOI 10.1016/j.neuron.2016.12.011; Sorensen AT, 2016, ELIFE, V5, DOI 10.7554/eLife.13918; Sun XC, 2016, TRENDS NEUROSCI, V39, P264, DOI 10.1016/j.tins.2016.02.003; Tanaka KZ, 2018, J EXP NEUROSCI, V12, DOI 10.1177/1179069518815942; Tanaka KZ, 2018, SCIENCE, V361, P392, DOI 10.1126/science.aat5397; Tanaka KZ, 2014, NEURON, V84, P347, DOI 10.1016/j.neuron.2014.09.037; Taniguchi H, 2011, NEURON, V71, P995, DOI 10.1016/j.neuron.2011.07.026; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; Tonegawa S, 2015, NEURON, V87, P918, DOI 10.1016/j.neuron.2015.08.002; TREVES A, 1994, HIPPOCAMPUS, V4, P374, DOI 10.1002/hipo.450040319; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; van Dijk MT, 2018, NEURON, V98, P832, DOI 10.1016/j.neuron.2018.04.018; Weng FJ, 2018, NEURON, V97, P1137, DOI 10.1016/j.neuron.2018.01.026; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907; Witter MP, 2007, PROG BRAIN RES, V163, P43, DOI 10.1016/S0079-6123(07)63003-9; Xu W, 2013, SCIENCE, V339, P1290, DOI 10.1126/science.1229534; Yap EL, 2018, NEURON, V100, P330, DOI 10.1016/j.neuron.2018.10.013; Yiu AP, 2014, NEURON, V83, P722, DOI 10.1016/j.neuron.2014.07.017; Yokose J, 2017, SCIENCE, V355, P398, DOI 10.1126/science.aal2690; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859; Zhao R, 2016, CELL REP, V16, P793, DOI 10.1016/j.celrep.2016.06.032; Zhou Y, 2009, NAT NEUROSCI, V12, P1438, DOI 10.1038/nn.2405	98	69	70	8	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2020	181	2					410	+		10.1016/j.cell.2020.02.055	http://dx.doi.org/10.1016/j.cell.2020.02.055			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	LD7BL	32187527	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000526184900020
J	Chamberlain, JM; Kapur, J; Shinnar, S; Elm, J; Holsti, M; Babcock, L; Rogers, A; Barsan, W; Cloyd, J; Lowenstein, D; Bleck, TP; Conwit, R; Meinzer, C; Cock, H; Fountain, NB; Underwood, E; Connor, JT; Silbergleit, R				Chamberlain, James M.; Kapur, Jaideep; Shinnar, Shlomo; Elm, Jordan; Holsti, Maija; Babcock, Lynn; Rogers, Alex; Barsan, William; Cloyd, James; Lowenstein, Daniel; Bleck, Thomas P.; Conwit, Robin; Meinzer, Caitlyn; Cock, Hannah; Fountain, Nathan B.; Underwood, Ellen; Connor, Jason T.; Silbergleit, Robert		Neurological Emergencies Treatment; Pediat Emergency Care Appl Res Net	Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial	LANCET			English	Article							CONVULSIVE STATUS EPILEPTICUS; 2ND-LINE TREATMENT; OPEN-LABEL; EPIDEMIOLOGY; MULTICENTER; PHENYTOIN; OUTCOMES; CHILDREN	Background Benzodiazepine-refractory, or established, status epilepticus is thought to be of similar pathophysiology in children and adults, but differences in underlying aetiology and pharmacodynamics might differentially affect response to therapy. In the Established Status Epilepticus Treatment Trial (ESETT) we compared the efficacy and safety of levetiracetam, fosphenytoin, and valproate in established status epilepticus, and here we describe our results after extending enrolment in children to compare outcomes in three age groups. Methods In this multicentre, double-blind, response-adaptive, randomised controlled trial, we recruited patients from 58 hospital emergency departments across the USA. Patients were eligible for inclusion if they were aged 2 years or older, had been treated for a generalised convulsive seizure of longer than 5 min duration with adequate doses of benzodiazepines, and continued to have persistent or recurrent convulsions in the emergency department for at least 5 min and no more than 30 min after the last dose of benzodiazepine. Patients were randomly assigned in a response-adaptive manner, using Bayesian methods and stratified by age group (<18 years, 18-65 years, and >65 years), to levetiracetam, fosphenytoin, or valproate. All patients, investigators, study staff, and pharmacists were masked to treatment allocation. The primary outcome was absence of clinically apparent seizures with improved consciousness and without additional antiseizure medication at 1 h from start of drug infusion. The primary safety outcome was life-threatening hypotension or cardiac arrhythmia. The efficacy and safety outcomes were analysed by intention to treat. This study is registered in ClinicalTrials.gov, NCT01960075. Findings Between Nov 3, 2015, and Dec 29, 2018, we enrolled 478 patients and 462 unique patients were included: 225 children (aged <18 years), 186 adults (18-65 years), and 51 older adults (>65 years). 175 (38%) patients were randomly assigned to levetiracetam, 142 (31%) to fosphenyltoin, and 145 (31%) were to valproate. Baseline characteristics were balanced across treatments within age groups. The primary efficacy outcome was met in those treated with levetiracetam for 52% (95% credible interval 41-62) of children, 44% (33-55) of adults, and 37% (19-59) of older adults; with fosphenytoin in 49% (38-61) of children, 46% (34-59) of adults, and 35% (17-59) of older adults; and with valproate in 52% (41-63) of children, 46% (34-58) of adults, and 47% (25-70) of older adults. No differences were detected in efficacy or primary safety outcome by drug within each age group. With the exception of endotracheal intubation in children, secondary safety outcomes did not significantly differ by drug within each age group. Interpretation Children, adults, and older adults with established status epilepticus respond similarly to levetiracetam, fosphenytoin, and valproate, with treatment success in approximately half of patients. Any of the three drugs can be considered as a potential first-choice, second-line drug for benzodiazepine-refractory status epilepticus. Copyright (c) 2020 Elsevier Ltd. All rights reserved.	[Chamberlain, James M.] Childrens Natl Hosp, Div Emergency Med, Washington, DC USA; [Kapur, Jaideep; Fountain, Nathan B.] Univ Virginia, Hlth Sci Ctr, Dept Neurol, Charlottesville, VA 22908 USA; [Shinnar, Shlomo] Montefiore Med Ctr, Albert Einstein Coll Med, Neurol Pediat & Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Elm, Jordan; Meinzer, Caitlyn; Underwood, Ellen] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Holsti, Maija] Univ Utah, Div Pediat Emergency Med, Salt Lake City, UT USA; [Babcock, Lynn] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Pediat Emergency Med, Cincinnati, OH USA; [Rogers, Alex] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Rogers, Alex] Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; [Barsan, William; Silbergleit, Robert] Univ Michigan, Dept Emergency Med, Neuro Emergencies Res, Ann Arbor, MI 48109 USA; [Cloyd, James] Univ Minnesota, Coll Pharm, Ctr Orphan Drug Res, Minneapolis, MN 55455 USA; [Lowenstein, Daniel] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Bleck, Thomas P.] Northwestern Univ, Feinberg Sch Med, Div Stroke & Neurocrit Care, Chicago, IL 60611 USA; [Conwit, Robin] NINDS, NIH, Neurosci Ctr, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Cock, Hannah] St Georges Univ London, Inst Mol & Clin Sci, London, England; [Connor, Jason T.] ConfluenceStat LLC, Cooper City, FL USA; [Connor, Jason T.] Univ Cent Florida, Coll Med, Cooper City, FL USA	Children's National Health System; University of Virginia; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Medical University of South Carolina; Utah System of Higher Education; University of Utah; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); St Georges University London; State University System of Florida; University of Central Florida	Silbergleit, R (corresponding author), Univ Michigan, Neuro Emergencies, Ann Arbor, MI 48106 USA.	robert.silbergleit@umich.edu	Hendrickson, Marissa/ABA-7225-2021; Resource Center, NINDS Human Genetics/AGF-2474-2022; Cock, Hannah/ABB-1573-2021; Sander-Effron, Samuel/AAX-2231-2020; Rosenthal, Eric/A-2085-2017	Isenberg, Derek/0000-0002-4452-5939; Trinka, Eugen/0000-0002-5950-2692; Thomas, Danny/0000-0002-7470-9835; Miller, Kathleen/0000-0001-9130-578X; Jaton, Eric/0000-0002-2337-5820; Quinn, James/0000-0002-3694-2118; Kapur, Jaideep/0000-0002-8608-1352; Rosenthal, Eric/0000-0003-3900-356X	National Institute of Neurological Disorders and Stroke, National Institutes of Health	National Institute of Neurological Disorders and Stroke, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institute of Neurological Disorders and Stroke, National Institutes of Health.	Betjemann JP, 2015, LANCET NEUROL, V14, P615, DOI 10.1016/S1474-4422(15)00042-3; Connor JT, 2013, J CLIN EPIDEMIOL, V66, pS130, DOI 10.1016/j.jclinepi.2013.02.015; Dalziel SR, 2019, LANCET, V393, P2135, DOI 10.1016/S0140-6736(19)30722-6; DELORENZO RJ, 1995, J CLIN NEUROPHYSIOL, V12, P316; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; Gainza-Lein M, 2018, JAMA NEUROL, V75, P410, DOI 10.1001/jamaneurol.2017.4382; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Kapur J, 2019, NEW ENGL J MED, V381, P2103, DOI 10.1056/NEJMoa1905795; Lyttle MD, 2019, LANCET, V393, P2125, DOI 10.1016/S0140-6736(19)30724-X; Shinnar S, 1997, EPILEPSIA, V38, P907, DOI 10.1111/j.1528-1157.1997.tb01256.x; Towne AR, 2007, INT REV NEUROBIOL, V81, P111, DOI 10.1016/S0074-7742(06)81007-X; Trinka E, 2017, SEIZURE-EUR J EPILEP, V44, P65, DOI 10.1016/j.seizure.2016.11.001; Trinka E, 2016, EXPERT OPIN PHARMACO, V17, P513, DOI 10.1517/14656566.2016.1127354	13	80	83	1	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2020	395	10231					1217	1224		10.1016/S0140-6736(20)30611-5	http://dx.doi.org/10.1016/S0140-6736(20)30611-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE6DW	32203691	Green Accepted, Bronze			2022-12-28	WOS:000526814200031
J	Casswell, S; Rehm, J				Casswell, Sally; Rehm, Juergen			Reduction in global alcohol-attributable harm unlikely after setback at WHO Executive Board	LANCET			English	Editorial Material							DISEASE		[Casswell, Sally] Massey Univ, Coll Hlth, Auckland 1141, New Zealand; [Rehm, Juergen] CAMH, Inst Mental Hlth Policy Res, Toronto, ON, Canada; [Rehm, Juergen] CAMH, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Rehm, Juergen] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Rehm, Juergen] Tech Univ Dresden, Epidemiol Res Unit, Klin Psychol & Psychotherapie, Dresden, Germany; [Rehm, Juergen] IM Sechenov First Moscow State Med Univ, Inst Leadership & Hlth Management, Dept Int Hlth Projects, Moscow, Russia	Massey University; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; Technische Universitat Dresden; Sechenov First Moscow State Medical University	Casswell, S (corresponding author), Massey Univ, Coll Hlth, Auckland 1141, New Zealand.	s.casswell@massey.ac.nz		Casswell, Sally/0000-0002-2211-7096				Bennett JE, 2018, LANCET, V392, P1072, DOI 10.1016/S0140-6736(18)31992-5; Carah N, 2018, CRIT PUBLIC HEALTH, V28, P70, DOI 10.1080/09581596.2017.1282154; Carah N, 2017, ADDICTION, V112, P370, DOI 10.1111/add.13599; Casswell S, 2019, LANCET, V394, P1396, DOI 10.1016/S0140-6736(19)31883-5; Casswell S, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.020305; Chisholm D, 2018, J STUD ALCOHOL DRUGS, V79, P514, DOI 10.15288/jsad.2018.79.514; Craig L, 2019, TOB CONTROL, V28, pS129, DOI 10.1136/tobaccocontrol-2019-054940; Engaging America's Global Leadership (EAGL), 2020, WE NEED COLL SOL CUR; Manthey J, 2019, LANCET, V393, P2493, DOI 10.1016/S0140-6736(18)32744-2; Marten R, 2020, LANCET GLOB HEALTH, V8, pE329, DOI 10.1016/S2214-109X(20)30008-5; McNeill D, 2017, J WORLD TRADE, V51, P159; Movendi International, 2020, WHO COUNTR REQ ACC A; NCD Alliance, 2020, ACC ACT RED HARMF US; Probst C, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1080-0; Shield K, 2020, LANCET PUBLIC HEALTH, V5, pE51, DOI 10.1016/S2468-2667(19)30231-2; Tangcharoensathien V, 2019, INT J HEALTH POLICY, V8, P256, DOI 10.15171/ijhpm.2019.02; World Health Organization, 2020, ACC ACT RED HARMF US; Zuboff S., 2019, AGE SURVEILLANCE CAP	18	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1020	1021						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY5YW	32222185	Bronze			2022-12-28	WOS:000522650100015
J	Will, M				Will, Manuel			Neanderthal surf and turf	SCIENCE			English	Editorial Material							CAVE; EXPLOITATION; AFRICA		[Will, Manuel] Univ Tubingen, Dept Early Prehist & Quaternary Ecol, D-72070 Tubingen, Germany	Eberhard Karls University of Tubingen	Will, M (corresponding author), Univ Tubingen, Dept Early Prehist & Quaternary Ecol, D-72070 Tubingen, Germany.	manuel.will@uni-tuebingen.de		Will, Manuel/0000-0001-8116-2543				Bailey G., 2017, SEA ARCHAEOLOGY PALA; Boivin N, 2013, QUATERN INT, V300, P32, DOI 10.1016/j.quaint.2013.01.008; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; Cunnane S., 2010, HUMAN BRAIN EVOLUTIO; Fa DA, 2016, QUATERN INT, V407, P16, DOI 10.1016/j.quaint.2015.11.148; Garrod DAE, 1928, J R ANTHROPOL INST G, V58, P33; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Hoffmann DL, 2018, SCIENCE, V359, P912, DOI 10.1126/science.aap7778; Marean CW, 2007, NATURE, V449, P905, DOI 10.1038/nature06204; Marean CW, 2014, J HUM EVOL, V77, P17, DOI 10.1016/j.jhevol.2014.02.025; Stiner M.C., 1994, HONOR THIEVES ZOOARC; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; Will M, 2019, J WORLD PREHIST, V32, P33, DOI 10.1007/s10963-018-09127-4; Zilhao J., 2019, SCIENCE, V367	15	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1422	1423		10.1126/science.abb3568	http://dx.doi.org/10.1126/science.abb3568			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217711				2022-12-28	WOS:000523251600013
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on . . . anosmia	BMJ-BRITISH MEDICAL JOURNAL			English	News Item															AHRC [AH/N50452X/1] Funding Source: UKRI	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		Hopkins C, LOSS SENSE SMELL MAR; World Health Organization, COR	2	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1202	10.1136/bmj.m1202	http://dx.doi.org/10.1136/bmj.m1202			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209546	Bronze			2022-12-28	WOS:000523764200012
J	Swerdlow, DL; Finelli, L				Swerdlow, David L.; Finelli, Lyn			Preparation for Possible Sustained Transmission of 2019 Novel Coronavirus: Lessons From Previous Epidemics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Swerdlow, David L.] Pfizer Vaccines, Collegeville, PA USA; [Finelli, Lyn] Merck & Co Inc, Ctr Observat & Real World Evidence, Kenilworth, NJ USA	Pfizer; Merck & Company	Swerdlow, DL (corresponding author), Pfizer Vaccines, Med Dev & Sci Clin Affairs, 500 Arcola Rd, Collegeville, PA 19426 USA.	david.swerdlow@pfizer.com						[Anonymous], CLIN INFECT DIS S; [Anonymous], NEW ENGL J MED; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Chowell G, 2004, EMERG INFECT DIS, V10, P1258, DOI 10.3201/eid1007.030647; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Killerby ME, 2020, EMERG INFECT DIS, V26, P191, DOI 10.3201/eid2602.190697; Rasmussen SA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0020-2016; Swerdlow DL, 2011, CLIN INFECT DIS, V52, pS1, DOI 10.1093/cid/ciq005; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; World Health Organization, NOV COR 2019 NCOV SI	10	59	61	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1129	1130		10.1001/jama.2020.1960	http://dx.doi.org/10.1001/jama.2020.1960			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207807	Bronze			2022-12-28	WOS:000530807000011
J	Liu, K				Liu, Kai			How I faced my coronavirus anxiety	SCIENCE			English	Editorial Material								In early February, I was working from home when I received a message informing me-and all the other professors at my university in China-that courses would be taught online because of the novel coronavirus. I was already feeling anxious about the mounting epidemic, and my university had locked its doors a few days earlier. Then, when I realized I'd have to teach students online, my anxiety level grew. I didn't have any experience with online teaching platforms. I was also skeptical about how effective they'd be. "How will I gauge the students' reactions to my lectures through a computer screen?" I wondered. "Will they learn anything?"	[Liu, Kai] Jiangsu Normal Univ, Xuzhou, Jiangsu, Peoples R China	Jiangsu Normal University	Liu, K (corresponding author), Jiangsu Normal Univ, Xuzhou, Jiangsu, Peoples R China.								0	12	15	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1398	1398		10.1126/science.367.6484.1398	http://dx.doi.org/10.1126/science.367.6484.1398			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193330				2022-12-28	WOS:000522167400056
J	Smith, J				Smith, Jesse			THE FROZEN CONTENT	SCIENCE			English	Editorial Material																			0	0	0	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1316	1317		10.1126/science.abb5660	http://dx.doi.org/10.1126/science.abb5660			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193317				2022-12-28	WOS:000522167400038
J	Haseltine, WA				Haseltine, William A.			Universal Disease Screening and Treatment - The Egyptian Example	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Haseltine, William A.] ACCESS Hlth Int, New York, NY 10017 USA; [Haseltine, William A.] Haseltine Fdn Sci & Arts, New York, NY USA		Haseltine, WA (corresponding author), ACCESS Hlth Int, New York, NY 10017 USA.; Haseltine, WA (corresponding author), Haseltine Fdn Sci & Arts, New York, NY USA.							Elgharably A, 2017, INT J GEN MED, V10, P1, DOI 10.2147/IJGM.S119301; Haseltine WA, 2019, COMMUNICATION	2	5	5	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1081	1083		10.1056/NEJMp1915818	http://dx.doi.org/10.1056/NEJMp1915818			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KW7AJ	32187465				2022-12-28	WOS:000521333700005
J	Kischka, U				Kischka, Udo			Stroke: the doctor as patient	LANCET			English	Editorial Material									[Kischka, Udo] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England	University of Oxford	Kischka, U (corresponding author), Univ Oxford, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England.	kischka@btinternet.com							0	0	0	2	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2019	394	10213					1984	1985		10.1016/S0140-6736(19)32642-X	http://dx.doi.org/10.1016/S0140-6736(19)32642-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JT4GR	32171417				2022-12-28	WOS:000500950200014
J	Bonaca, MP; Bauersachs, RM; Anand, SS; Debus, ES; Nehler, MR; Patel, MR; Fanelli, F; Capell, WH; Diao, LH; Jaeger, N; Hess, CN; Pap, AF; Kittelson, JM; Gudz, I; Matyas, L; Krievins, DK; Diaz, R; Brodmann, M; Muehlhofer, E; Haskell, LP; Berkowitz, SD; Hiatt, WR				Bonaca, Marc P.; Bauersachs, Rupert M.; Anand, Sonia S.; Debus, E. Sebastian; Nehler, Mark R.; Patel, Manesh R.; Fanelli, Fabrizio; Capell, Warren H.; Diao, Lihong; Jaeger, Nicole; Hess, Connie N.; Pap, Akos F.; Kittelson, John M.; Gudz, Ivan; Matyas, Lajos; Krievins, Dainis K.; Diaz, Rafael; Brodmann, Marianne; Muehlhofer, Eva; Haskell, Lloyd P.; Berkowitz, Scott D.; Hiatt, William R.			Rivaroxaban in Peripheral Artery Disease after Revascularization	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE CORONARY SYNDROMES; ADVERSE LIMB EVENTS; OUTCOMES; CLOPIDOGREL; TICAGRELOR; ASPIRIN; VORAPAXAR; PRASUGREL; ISCHEMIA	Patients with peripheral artery disease who underwent revascularization were randomly assigned to receive rivaroxaban (2.5 mg twice daily) or placebo. All patients received aspirin. The primary outcome of acute limb ischemia, major amputation for vascular causes, MI, ischemic stroke, or cardiovascular death occurred less frequently with rivaroxaban. Background Patients with peripheral artery disease who have undergone lower-extremity revascularization are at high risk for major adverse limb and cardiovascular events. The efficacy and safety of rivaroxaban in this context are uncertain. Methods In a double-blind trial, patients with peripheral artery disease who had undergone revascularization were randomly assigned to receive rivaroxaban (2.5 mg twice daily) plus aspirin or placebo plus aspirin. The primary efficacy outcome was a composite of acute limb ischemia, major amputation for vascular causes, myocardial infarction, ischemic stroke, or death from cardiovascular causes. The principal safety outcome was major bleeding, defined according to the Thrombolysis in Myocardial Infarction (TIMI) classification; major bleeding as defined by the International Society on Thrombosis and Haemostasis (ISTH) was a secondary safety outcome. Results A total of 6564 patients underwent randomization; 3286 were assigned to the rivaroxaban group, and 3278 were assigned to the placebo group. The primary efficacy outcome occurred in 508 patients in the rivaroxaban group and in 584 in the placebo group; the Kaplan-Meier estimates of the incidence at 3 years were 17.3% and 19.9%, respectively (hazard ratio, 0.85, 95% confidence interval [CI], 0.76 to 0.96; P=0.009). TIMI major bleeding occurred in 62 patients in the rivaroxaban group and in 44 patients in the placebo group (2.65% and 1.87%; hazard ratio, 1.43; 95% CI, 0.97 to 2.10; P=0.07). ISTH major bleeding occurred in 140 patients in the rivaroxaban group, as compared with 100 patients in the placebo group (5.94% and 4.06%; hazard ratio, 1.42; 95% CI, 1.10 to 1.84; P=0.007). Conclusions In patients with peripheral artery disease who had undergone lower-extremity revascularization, rivaroxaban at a dose of 2.5 mg twice daily plus aspirin was associated with a significantly lower incidence of the composite outcome of acute limb ischemia, major amputation for vascular causes, myocardial infarction, ischemic stroke, or death from cardiovascular causes than aspirin alone. The incidence of TIMI major bleeding did not differ significantly between the groups. The incidence of ISTH major bleeding was significantly higher with rivaroxaban and aspirin than with aspirin alone.	[Bonaca, Marc P.; Bauersachs, Rupert M.; Capell, Warren H.; Diao, Lihong; Jaeger, Nicole; Hess, Connie N.; Hiatt, William R.] Univ Colorado, Colorado Prevent Ctr CPC Clin Res, Anschutz Med Campus, Aurora, CO USA; [Bonaca, Marc P.; Hess, Connie N.; Hiatt, William R.] Univ Colorado, Dept Med, Div Cardiovasc Med, Anschutz Med Campus, Aurora, CO USA; [Nehler, Mark R.] Univ Colorado, Dept Surg, Div Vasc Surg, Anschutz Med Campus, Aurora, CO USA; [Capell, Warren H.] Univ Colorado, Dept Med, Div Endocrinol, Anschutz Med Campus, Aurora, CO USA; [Kittelson, John M.] Univ Colorado, Colorado Sch Publ Hlth, Dept Biostat & Informat, Anschutz Med Campus, Aurora, CO USA; [Bauersachs, Rupert M.] Klinikum Darmstadt, Dept Vasc Med, Darmstadt, Germany; [Bauersachs, Rupert M.] Johannes Gutenberg Univ Mainz, Ctr Thrombosis & Hemostasis, Mainz, Germany; [Debus, E. Sebastian] Univ Hamburg Eppendorf, Dept Vasc Med Vasc Surge Angiol Endovasc Therapy, Hamburg, Germany; [Pap, Akos F.; Muehlhofer, Eva] Bayer, Wuppertal, Germany; [Anand, Sonia S.] Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON, Canada; [Anand, Sonia S.] McMaster Univ, Hamilton, ON, Canada; [Patel, Manesh R.] Duke Univ, Div Cardiol, Clin Res Inst, Durham, NC USA; [Fanelli, Fabrizio] Univ Florence, Careggi Univ Hosp, Vasc & Intervent Radiol Dept, Florence, Italy; [Gudz, Ivan] Ivano Frankivsk Natl Med Univ, Ivano Frankivsk, Ukraine; [Matyas, Lajos] BAZ Cty Univ, Teaching Hosp, Miskolc, Hungary; [Krievins, Dainis K.] Univ Latvia, Pauls Stradins Univ Hosp, Riga, Latvia; [Diaz, Rafael] ICR Inst Cardiovasc Rosario, ECLA Estudios Clin Latino Amer, Rosario, Argentina; [Brodmann, Marianne] Med Univ Graz, Div Angiol, Graz, Austria; [Haskell, Lloyd P.] Janssen Res & Dev, Raritan, NJ USA; [Berkowitz, Scott D.] Bayer US, Clin Dev, Whippany, NJ USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Klinikum Darmstadt; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; McMaster University; Population Health Research Institute; McMaster University; Duke University; University of Florence; Azienda Ospedaliero Universitaria Careggi; Ivano-Frankivsk National Medical University; Pauls Stradins Clinical University Hospital; University of Latvia; Medical University of Graz; Johnson & Johnson; Janssen Pharmaceuticals	Bonaca, MP (corresponding author), Univ Colorado, Anschutz Sch Med, CPC Clin Res, 13199 E Montview Blvd,Suite 200, Aurora, CO 80045 USA.	marc.bonaca@cpcmed.org	Patel, Manesh/AAC-5385-2019; Gudz, Ivan/ABH-5884-2020; Bonaca, Marc/AAJ-2397-2021; Berkowitz, Scott Darrell/AAS-9397-2021; Maslovskyi, Valentyn/V-3896-2019; Karpenko, Andrei/AAH-1725-2020; Maslovskyi, Valentyn/GQO-9125-2022	Bonaca, Marc/0000-0002-9860-3584; Berkowitz, Scott Darrell/0000-0002-9428-4408; Maslovskyi, Valentyn/0000-0001-5184-1799; Maslovskyi, Valentyn/0000-0001-5184-1799	Bayer Pharmaceutical; Janssen Pharmaceutical; American Heart Association Strategically Focused Research Network in Vascular Disease [18SFRN3390085, 18SFRN33960262]	Bayer Pharmaceutical; Janssen Pharmaceutical; American Heart Association Strategically Focused Research Network in Vascular Disease	Supported by a grant from Bayer and Janssen Pharmaceuticals. Dr. Bonaca was supported by awards (18SFRN3390085 [BWH-DH SFRN Center] and 18SFRN33960262 [BWH-DH Clinical Project]) from the American Heart Association Strategically Focused Research Network in Vascular Disease.	Aboyans V, 2018, EUR HEART J, V39, P763, DOI 10.1093/eurheartj/ehx095; Agarwal S, 2016, J AM COLL CARDIOL, V67, P1901, DOI 10.1016/j.jacc.2016.02.040; Anand SS, 2018, LANCET, V391, P219, DOI 10.1016/S0140-6736(17)32409-1; Belch JJF, 2010, J VASC SURG, V52, P825, DOI 10.1016/j.jvs.2010.04.027; Bonaca MP, 2016, J AM COLL CARDIOL, V67, P2719, DOI 10.1016/j.jacc.2016.03.524; Bonaca MP, 2016, CIRCULATION, V133, P997, DOI 10.1161/CIRCULATIONAHA.115.019355; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Bonaca MP, 2013, CIRCULATION, V127, P1522, DOI 10.1161/CIRCULATIONAHA.112.000679; Capell WH, 2018, AM HEART J, V199, P83, DOI 10.1016/j.ahj.2018.01.011; Eikelboom JW, 2017, NEW ENGL J MED, V377, P1319, DOI 10.1056/NEJMoa1709118; Fowkes FGR, 2017, NAT REV CARDIOL, V14, DOI 10.1038/nrcardio.2016.179; Gerhard-Herman MD, 2017, CIRCULATION, V135, pE726, DOI 10.1161/CIR.0000000000000471; HERTZER NR, 1984, ANN SURG, V199, P223, DOI 10.1097/00000658-198402000-00016; Hess CN, 2020, J AM COLL CARDIOL, V75, P498, DOI 10.1016/j.jacc.2019.11.050; Hess CN, 2019, CIRCULATION, V140, P556, DOI 10.1161/CIRCULATIONAHA.119.039773; Hess CN, 2018, J AM COLL CARDIOL, V72, P999, DOI 10.1016/j.jacc.2018.06.041; Hiatt WR, 2017, NEW ENGL J MED, V376, P32, DOI 10.1056/NEJMoa1611688; Jones WS, 2017, CIRCULATION, V135, P241, DOI 10.1161/CIRCULATIONAHA.116.025880; Kumbhani DJ, 2014, EUR HEART J, V35, P2864, DOI 10.1093/eurheartj/ehu080; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mehta SR, 2018, J AM COLL CARDIOL, V71, P303, DOI [10.1016/j.jacc.2017.12.001, 10.1016/j.jacc.2018.03.008]; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Steg PG, 2019, NEW ENGL J MED, V381, P1309, DOI 10.1056/NEJMoa1908077; Tangelder MJD, 2000, LANCET, V355, P346; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yusuf S, 2001, NEW ENGL J MED, V345, P494	29	309	321	3	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21					1994	2004		10.1056/NEJMoa2000052	http://dx.doi.org/10.1056/NEJMoa2000052			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT1TD	32222135	Bronze			2022-12-28	WOS:000536856000014
J	Poston, JT; Patel, BK; Davis, AM				Poston, Jason T.; Patel, Bhakti K.; Davis, Andrew M.			Management of Critically Ill Adults With COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This JAMA Clinical Guidelines Synopsis summarizes the 2020 Surviving Sepsis Campaign guidelines on the treatment of critically ill adults with coronavirus disease 2019 (COVID-19).	[Poston, Jason T.; Patel, Bhakti K.] Univ Chicago, Pulm & Crit Care, Chicago, IL 60637 USA; [Davis, Andrew M.] Univ Chicago, Gen Internal Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Poston, JT (corresponding author), Univ Chicago, 850 E 58th St, Chicago, IL 60615 USA.	Jason.Poston@uchospitals.edu						Bednarczyk JM, 2017, CRIT CARE MED, V45, P1538, DOI 10.1097/CCM.0000000000002554; Bentzer P, 2016, JAMA-J AM MED ASSOC, V316, P1298, DOI 10.1001/jama.2016.12310; Frat JP, 2015, NEW ENGL J MED, V372, P2185, DOI 10.1056/NEJMoa1503326; Lansbury L., 2019, Cochrane Database of Systematic Reviews, pCD010406; Patel BK, 2016, JAMA-J AM MED ASSOC, V315, P2435, DOI 10.1001/jama.2016.6338; Radonovich LJ, 2019, JAMA-J AM MED ASSOC, V322, P824, DOI 10.1001/jama.2019.11645; SIAARTI, 2020, CLIN ETH REC ALL INT; Surviving Sepsis Campaign, 2020, COVID 19 GUID; Wang Y., 2020, MEDRXIV, DOI 10.1101/2020.03.06.20032342; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	10	210	211	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1839	1841		10.1001/jama.2020.4914	http://dx.doi.org/10.1001/jama.2020.4914			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32215647	Bronze			2022-12-28	WOS:000536221500024
J	Biswal, S; Borja-Tabora, C; Vargas, LM; Velasquez, H; Alera, MT; Sierra, V; Rodriguez-Arenales, EJ; Yu, D; Wickramasinghe, P; Moreira, ED; Fernando, AD; Gunasekera, D; Kosalaraksa, P; Espinoza, F; Lopez-Medina, E; Bravo, L; Tuboi, S; Hutagalung, Y; Garbes, P; Escudero, I; Rauscher, M; Bizjajeva, S; LeFevre, I; Borkowski, A; Saez-Llorens, X; Wallace, D				Biswal, Shibadas; Borja-Tabora, Charissa; Martinez Vargas, Luis; Velasquez, Hector; Theresa Alera, Maria; Sierra, Victor; Johana Rodriguez-Arenales, Edith; Yu, Delia; Wickramasinghe, Pujitha; Moreira, Edson Duarte, Jr.; Fernando, Asvini D.; Gunasekera, Dulanie; Kosalaraksa, Pope; Espinoza, Felix; Lopez-Medina, Eduardo; Bravo, Lulu; Tuboi, Suely; Hutagalung, Yanee; Garbes, Pedro; Escudero, Ian; Rauscher, Martina; Bizjajeva, Svetlana; LeFevre, Inge; Borkowski, Astrid; Saez-Llorens, Xavier; Wallace, Derek		TIDES Study Grp	Efficacy of a tetravalent dengue vaccine in healthy children aged 4-16 years: a randomised, placebo-controlled, phase 3 trial	LANCET			English	Article							SAFETY; IMMUNOGENICITY; CANDIDATE; ADULTS; RECOMBINANT; VIRUS; DENVAX; PDK-53; ASIA	Background A substantial unmet need remains for safe and effective vaccines against dengue virus disease, particularly for individuals who are dengue-naive and those younger than 9 years. We aimed to assess the efficacy, safety, and immunogenicity of a live attenuated tetravalent dengue vaccine (TAK-003) in healthy children aged 4-16 years. Methods We present data up to 18 months post-vaccination from an ongoing phase 3, randomised, double-blind trial of TAK-003 in endemic regions of Asia and Latin America (26 medical and research centres across Brazil, Colombia, Dominican Republic, Nicaragua, Panama, Philippines, Sri Lanka, and Thailand). Healthy children aged 4-16 years were randomly assigned 2:1 (stratified by age and region) to receive two doses of TAK-003 or two doses of placebo, 3 months apart. Investigators, participants and their parents or guardians, and sponsor representatives advising on trial conduct were masked to trial group assignments. Participants presenting with febrile illness were tested for virologically confirmed dengue (VCD) by serotype-specific RT-PCR. In timeframes beginning 30 days post-second dose, the primary endpoint (overall vaccine efficacy) was assessed in the first 11 months, and the secondary endpoints (efficacy by baseline serostatus, serotype, hospitalised dengue, and severe dengue) in the first 17 months. This study is registered with ClinicalTrials.gov, NCT02747927. Findings 20 099 participants were randomly assigned and vaccinated between Sept 7, 2016, and Aug 18, 2017; 19 021 (94.6%) were included in the per protocol analysis, and 20 071 (99.9%) in the safety set. The primary endpoint was achieved with an overall vaccine efficacy of 80.2% (95% CI 73.3 to 85.3; 61 cases of VCD in the TAK-003 group vs 149 cases of VCD in the placebo group). In the secondary endpoint assessment timeframe, an overall vaccine efficacy of 73.3% (95% CI 66.5 to 78.8) was observed. Analysis of secondary endpoints showed efficacies of 76.1% (95% CI 68.5 to 81.9) in individuals who were seropositive at baseline, 66.2% (49.1 to 77.5) in individuals who were seronegative at baseline, 90.4% (82.6 to 94.7) against hospitalised dengue, and 85.9% (31.9 to 97.1) against dengue haemorrhagic fever. Efficacy varied by individual serotypes (DENV 1, 69.8% [95% CI 54.8 to 79.9]; DENV 2, 95.1% [89.9 to 97.6]; DENV 3, 48.9% [27.2 to 64.1]; DENV 4, 51.0% [-69.4 to 85.8]). Cumulative rates of serious adverse events were similar in TAK-003 (4.0%) and placebo (4.8%) recipients, and were consistent with expected medical disorders in the study population. Infection was the most frequent reason leading to serious adverse events. 20 participants (<0.1% of the safety set) were withdrawn from the trial due to 21 adverse events by the end of part two; 14 of these participants received TAK-003 and six received placebo. Interpretation TAK-003 was well tolerated and efficacious against symptomatic dengue in children regardless of serostatus before immunisation. Vaccine efficacy varied by serotype, warranting continued follow-up to assess longer-term vaccine performance.	[Biswal, Shibadas; Garbes, Pedro; Wallace, Derek] Takeda Vaccines, Boston, MA 02139 USA; [Borja-Tabora, Charissa] Res Inst Trop Med, Muntinlupa, Philippines; [Martinez Vargas, Luis] Ctr Atenc & Invest Med, Santo Domingo, Dominican Rep; [Velasquez, Hector] Ctr Atenc & Invest Med, Acacias, Colombia; [Theresa Alera, Maria] Philippines Armed Forces Res Inst Med Sci, Virol Res Unit, Cebu, Philippines; [Sierra, Victor] Ctr Atenc & Invest Med, Yopal, Colombia; [Johana Rodriguez-Arenales, Edith] Ctr Atenc & Invest Med, Aguazul, Colombia; [Yu, Delia] De La Salle Med & Hlth Sci Inst, Dasmarinas, Philippines; [Wickramasinghe, Pujitha] Univ Colombo, Colombo, Sri Lanka; [Moreira, Edson Duarte, Jr.] Assoc Obras Sociais Irma Dulce Hosp Santo Antonio, Salvador, BA, Brazil; [Moreira, Edson Duarte, Jr.] Fundacao Oswaldo Cruz, Salvador, BA, Brazil; [Fernando, Asvini D.] Univ Kelaniya, Fac Med, Kelaniya, Sri Lanka; [Gunasekera, Dulanie] Univ Sri Jayawardenenpura, Fac Med Sci, Gangodawila, Sri Lanka; [Kosalaraksa, Pope] Khon Kaen Univ, Fac Med, Khon Kaen, Thailand; [Espinoza, Felix] Natl Autonomous Univ Nicaragua, Leon, Nicaragua; [Lopez-Medina, Eduardo] Univ Valle, Ctr Estudios Infectol Pediat, Cali, Colombia; [Lopez-Medina, Eduardo] Ctr Med Imbanaco, Cali, Colombia; [Bravo, Lulu] Univ Philippines Manila, Ermita, Philippines; [Tuboi, Suely] Takeda Pharmaceut, Sao Paulo, Brazil; [Hutagalung, Yanee; Escudero, Ian] Takeda Vaccines, Singapore, Singapore; [Rauscher, Martina; Bizjajeva, Svetlana; LeFevre, Inge; Borkowski, Astrid] Takeda Pharmaceut Int, Zurich, Switzerland; [Saez-Llorens, Xavier] Ctr Vacunac Int Cevaxin, Sistema Nacl Invest Secretaria Nacl Ciencia & Tec, Hosp Nino Dr Jose Renan Esquivel, Panama City, Panama	Research Institute for Tropical Medicine - Philippines; De La Salle Medical & Health Sciences Institute (DLSMHSI); University of Colombo; Fundacao Oswaldo Cruz; University Kelaniya; University Sri Jayewardenepura; Khon Kaen University; Universidad del Valle; University of the Philippines System; University of the Philippines Manila; Secretaria Nacional de Ciencia, Tecnologia e Innovacin (SENACYT)	Biswal, S (corresponding author), Takeda Vaccines, Boston, MA 02139 USA.	shibadas.biswal@takeda.com	Tricou, Vianney/S-6101-2019; Moreira, Edson D/J-1758-2012; Moreira Jr, Edson Duarte/GRF-5620-2022	Tricou, Vianney/0000-0002-5465-8647; Moreira, Edson D/0000-0002-7081-8348; Moreira Jr, Edson Duarte/0000-0002-7081-8348; Dietze, Reynaldo/0000-0002-6995-8001	Takeda Vaccines	Takeda Vaccines	Takeda Vaccines.	Alvarado-Castro V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4290-z; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Biswal S, 2019, NEW ENGL J MED, V381, P2009, DOI 10.1056/NEJMoa1903869; Bos S, 2018, PATHOG GLOB HEALTH, V112, P294, DOI 10.1080/20477724.2018.1514136; Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000; Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6; George SL, 2015, J INFECT DIS, V212, P1032, DOI 10.1093/infdis/jiv179; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; Huang CYH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002243; Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003; Osorio JE, 2016, EXPERT REV VACCINES, V15, P497, DOI 10.1586/14760584.2016.1128328; Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4; Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020; Rupp R, 2015, VACCINE, V33, P6351, DOI 10.1016/j.vaccine.2015.09.008; Saez-Llorens X, 2018, LANCET INFECT DIS, V18, P162, DOI 10.1016/S1473-3099(17)30632-1; Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4; Sharma M, 2020, J INFECT DIS, V221, P867, DOI 10.1093/infdis/jiz081; Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265; Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; Tricou V, 2020, LANCET, V395, P1434, DOI 10.1016/S0140-6736(20)30556-0; Villar LA, 2013, PEDIATR INFECT DIS J, V32, P1102, DOI 10.1097/INF.0b013e31829b8022; Waickman AT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01778; WHO, 1997, DENG HAEM FEV DIAGN; WHO, 2019, EM TOP 10 THREATS GL; WHO, 2019, FACT SHEETS DENG SEV; Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1; World Health Organization, 2018, Weekly Epidemiological Record, V93, P457; World Health Organization, 2009, DENGUE GUIDELINES DI; Yoksan S, 1986, ARBOVIRUS RES AUSTR, P358	32	68	69	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2020	395	10234					1423	1433		10.1016/S0140-6736(20)30414-1	http://dx.doi.org/10.1016/S0140-6736(20)30414-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LO3LS	32197105				2022-12-28	WOS:000533530700019
J	Dyer, C				Dyer, Clare			Offering Avastin for wet AMD is legal, says appeal court	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		COHEN D, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5021; Cohen D, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k4035	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1273	10.1136/bmj.m1273	http://dx.doi.org/10.1136/bmj.m1273			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220923				2022-12-28	WOS:000523765200010
J	Pulla, P				Pulla, Priyanka			Covid-19: India imposes lockdown for 21 days and cases rise	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Barnagarwala T., 2020, MSN NEWS        0321; Mandal S, 2020, INDIAN J MED RES, V151, P190, DOI 10.4103/ijmr.IJMR_504_20	2	79	85	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1251	10.1136/bmj.m1251	http://dx.doi.org/10.1136/bmj.m1251			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217534	Bronze			2022-12-28	WOS:000523764800017
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: FDA approves use of convalescent plasma to treat critically ill patients	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		FDA, INV COV 19 CONV PLAS; Hixenbaugh M., 2020, NBC NEWS; Palca J., 2020, NATL PUBLIC RAD 0324	3	96	100	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1256	10.1136/bmj.m1256	http://dx.doi.org/10.1136/bmj.m1256			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217555	Bronze			2022-12-28	WOS:000523764800021
J	Lee, YJ; Oh, BL				Lee, Yunjeong; Oh, Baek-Lok			Retinal Detachment in X-Linked Retinoschisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Yunjeong; Oh, Baek-Lok] Seoul Natl Univ Hosp, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital	Oh, BL (corresponding author), Seoul Natl Univ Hosp, Seoul, South Korea.	baeklok@snu.ac.kr		Oh, Baek-Lok/0000-0001-6007-5176					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1149	1149		10.1056/NEJMicm1904890	http://dx.doi.org/10.1056/NEJMicm1904890			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KW7AJ	32187471				2022-12-28	WOS:000521333700014
J	Zhang, T; Yin, CR; Boyd, DF; Quarato, G; Ingram, JP; Shubina, M; Ragan, KB; Ishizuka, T; Crawford, JC; Tummers, B; Rodriguez, DA; Xue, J; Peri, S; Kaiser, WJ; Lopez, CB; Xu, Y; Upton, JW; Thomas, PG; Green, DR; Balachandran, S				Zhang, Ting; Yin, Chaoran; Boyd, David F.; Quarato, Giovanni; Ingram, Justin P.; Shubina, Maria; Ragan, Katherine B.; Ishizuka, Takumi; Crawford, Jeremy Chase; Tummers, Bart; Rodriguez, Diego A.; Xue, Jia; Peri, Suraj; Kaiser, William J.; Lopez, Carolina B.; Xu, Yan; Upton, Jason W.; Thomas, Paul G.; Green, Douglas R.; Balachandran, Siddharth			Influenza Virus Z-RNAs Induce ZBP1-Mediated Necroptosis	CELL			English	Article							DOUBLE-STRANDED-RNA; Z-ALPHA DOMAIN; CELL-DEATH; Z-DNA; MLKL; INNATE; IMMUNE; RECOGNITION; INFECTION; APOPTOSIS	Influenza A virus (IAV) is a lytic RNA virus that triggers receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-mediated pathways of apoptosis and mixed lineage kinase domain-like pseudokinase (MLKL)-dependent necroptosis in infected cells. ZBP1 initiates RIPK3-driven cell death by sensing IAV RNA and activating RIPK3. Here, we show that replicating IAV generates Z-RNAs, which activate ZBP1 in the nucleus of infected cells. ZBP1 then initiates RIPK3-mediated MLKL activation in the nucleus, resulting in nuclear envelope disruption, leakage of DNA into the cytosol, and eventual necroptosis. Cell death induced by nuclear MLKL was a potent activator of neutrophils, a cell type known to drive inflammatory pathology in virulent IAV disease. Consequently, MLKL-deficient mice manifest reduced nuclear disruption of lung epithelia, decreased neutrophil recruitment into infected lungs, and increased survival following a lethal dose of IAV. These results implicate Z-RNA as a new pathogenassociated molecular pattern and describe a ZBP1-initiated nucleus-to-plasma membrane "inside-out" death pathway with potentially pathogenic consequences in severe cases of influenza.	[Zhang, Ting; Yin, Chaoran; Ingram, Justin P.; Shubina, Maria; Peri, Suraj; Balachandran, Siddharth] Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Boyd, David F.; Quarato, Giovanni; Crawford, Jeremy Chase; Tummers, Bart; Rodriguez, Diego A.; Thomas, Paul G.; Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Ragan, Katherine B.; Upton, Jason W.] Univ Texas Austin, LaMontagne Ctr Infect Dis, Dept Mol Biosci, Austin, TX 78712 USA; [Ishizuka, Takumi; Xu, Yan] Univ Miyazaki, Fac Med, Dept Med Sci, Div Chem, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan; [Xue, Jia; Lopez, Carolina B.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Kaiser, William J.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA	Fox Chase Cancer Center; St Jude Children's Research Hospital; University of Texas System; University of Texas Austin; University of Miyazaki; University of Pennsylvania; University of Texas System; University of Texas Health San Antonio	Balachandran, S (corresponding author), Fox Chase Canc Ctr, Blood Cell Dev & Funct Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	siddharth.balachandran@fccc.edu	Lopez, Carolina/A-8887-2008; Ishizuka, Takumi/E-9491-2012; Crawford, Jeremy Chase/G-5711-2013; Thomas, Paul G./H-1063-2018; Quarato, Giovanni/F-8272-2016	Lopez, Carolina/0000-0002-7669-6572; Ishizuka, Takumi/0000-0003-0956-784X; Crawford, Jeremy Chase/0000-0003-4096-6048; Yin, Chaoran/0000-0002-4193-7022; Rodriguez, Diego/0000-0003-4771-0221; Thomas, Paul G./0000-0001-7955-0256; Quarato, Giovanni/0000-0003-1167-3422; Xu, Yan/0000-0003-0379-8866; Zhang, Ting/0000-0002-8645-581X; Upton, Jason/0000-0002-4218-4026	NIH [AI121832, CA168621, CA190542, AI135025, AI144400, P30CA006927, AI44828, CA231620, AI134862, AI137062, AI135709]; St. Jude Center of Excellence for Influenza Research and Surveillance (SJCEIRS) NIAID [HHSN272201400006C]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); St. Jude Center of Excellence for Influenza Research and Surveillance (SJCEIRS) NIAID	We are grateful to Charles Hardin and David Stollar for advice on Z-RNA studies and to Glenn Rall for comments on the manuscript. This work was supported by NIH (CA168621, CA190542, AI135025, AI144400, and P30CA006927 to S.B.; AI44828 and CA231620 to D.R. G.; AI134862 and AI137062 to C.B.L.; and AI135709 to J.W.U.). P.G.T. was supported by NIH (AI121832) and the St. Jude Center of Excellence for Influenza Research and Surveillance (SJCEIRS) NIAID (HHSN272201400006C).	Athanasiadis A, 2012, SEMIN CELL DEV BIOL, V23, P275, DOI 10.1016/j.semcdb.2011.11.001; Balasubramaniyam T, 2018, MOLECULES, V23, DOI 10.3390/molecules23102572; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Brown BA, 2000, P NATL ACAD SCI USA, V97, P13532, DOI 10.1073/pnas.240464097; Camp JV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00550; Chen PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061446; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Dondelinger Y, 2014, CELL REP, V7, P971, DOI 10.1016/j.celrep.2014.04.026; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; HARDIN CC, 1988, BIOCHEMISTRY-US, V27, P4169, DOI 10.1021/bi00411a040; HARDIN CC, 1987, BIOCHEMISTRY-US, V26, P5191, DOI 10.1021/bi00390a044; Isermann P, 2017, NUCLEUS-PHILA, V8, P268, DOI 10.1080/19491034.2017.1292191; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Kang TB, 2008, J IMMUNOL, V181, P2522, DOI 10.4049/jimmunol.181.4.2522; Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; KLEINIG H, 1970, J CELL BIOL, V46, P396, DOI 10.1083/jcb.46.2.396; Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791; Kuriakose T, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag2045; Mandal P, 2014, MOL CELL, V56, P481, DOI 10.1016/j.molcel.2014.10.021; Mauad T, 2010, AM J RESP CRIT CARE, V181, P72, DOI 10.1164/rccm.200909-1420OC; Mocarski ES, 2014, J IMMUNOL, V192, P2019, DOI 10.4049/jimmunol.1302426; Murai S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06985-6; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; NAYAK DP, 1985, CURR TOP MICROBIOL, V114, P103; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; Nogusa S, 2016, CELL HOST MICROBE, V20, P13, DOI 10.1016/j.chom.2016.05.011; Philip NH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005910; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Quarato G, 2016, MOL CELL, V61, P589, DOI 10.1016/j.molcel.2016.01.011; Rich A, 2003, NAT REV GENET, V4, P566, DOI 10.1038/nrg1115; Rodrigue-Gervais IG, 2014, CELL HOST MICROBE, V15, P23, DOI 10.1016/j.chom.2013.12.003; Rodriguez DA, 2016, CELL DEATH DIFFER, V23, P76, DOI 10.1038/cdd.2015.70; Roh JS, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e27; Rosenberger CM, 2014, J GEN VIROL, V95, P350, DOI 10.1099/vir.0.058438-0; Samuel CE, 2011, VIROLOGY, V411, P180, DOI 10.1016/j.virol.2010.12.004; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Sanders CJ, 2011, CELL TISSUE RES, V343, P13, DOI 10.1007/s00441-010-1043-z; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Szczesny B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19216-1; Thapa RJ, 2016, CELL HOST MICROBE, V20, P674, DOI 10.1016/j.chom.2016.09.014; Upton JW, 2017, IMMUNOL REV, V277, P90, DOI 10.1111/imr.12539; Vietri M, 2016, CURR OPIN CELL BIOL, V40, P90, DOI 10.1016/j.ceb.2016.03.001; Wang HY, 2014, MOL CELL, V54, P133, DOI 10.1016/j.molcel.2014.03.003; Weber K, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0007-1; WITTIG B, 1991, P NATL ACAD SCI USA, V88, P2259, DOI 10.1073/pnas.88.6.2259; Xue J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00326; Yatim N, 2017, NAT REV IMMUNOL, V17, P262, DOI 10.1038/nri.2017.9; Yoon S, 2016, CELL DEATH DIFFER, V23, P253, DOI 10.1038/cdd.2015.92; ZARLING DA, 1987, P NATL ACAD SCI USA, V84, P6117, DOI 10.1073/pnas.84.17.6117; ZARLING DA, 1990, J MOL BIOL, V211, P147, DOI 10.1016/0022-2836(90)90017-G; Zhao Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07314-7	55	142	144	15	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1115	+		10.1016/j.cell.2020.02.050	http://dx.doi.org/10.1016/j.cell.2020.02.050			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32200799	Green Accepted, Bronze			2022-12-28	WOS:000520925300010
J	Peng, RC; Xu, X; Jing, JM; Wang, M; Peng, Q; Liu, S; Wu, Y; Bao, XC; Wang, PY; Qi, JX; Gao, GF; Shi, Y				Peng, Ruchao; Xu, Xin; Jing, Jiamei; Wang, Min; Peng, Qi; Liu, Sheng; Wu, Ying; Bao, Xichen; Wang, Peiyi; Qi, Jianxun; Gao, George F.; Shi, Yi			Structural insight into arenavirus replication machinery	NATURE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS; L PROTEIN; NONTEMPLATED BASES; POLYMERASE; VIRUS; TERMINUS; SYSTEM; DOMAIN; RNAS	The authors provide high-resolution structures of two arenavirus polymerases, revealing that the active site of arenavirus polymerase is inherently switched on, without the requirement for allosteric activation by 5 '-viral RNA, and that dimerization facilitates polymerase activity. Arenaviruses can cause severe haemorrhagic fever and neurological diseases in humans and other animals, exemplified by Lassa mammarenavirus, Machupo mammarenavirus and lymphocytic choriomeningitis virus, posing great threats to public health(1-4). These viruses encode a large multi-domain RNA-dependent RNA polymerase for transcription and replication of the viral genome(5). Viral polymerases are one of the leading antiviral therapeutic targets. However, the structure of arenavirus polymerase is not yet known. Here we report the near-atomic resolution structures of Lassa and Machupo virus polymerases in both apo and promoter-bound forms. These structures display a similar overall architecture to influenza virus and bunyavirus polymerases but possess unique local features, including an arenavirus-specific insertion domain that regulates the polymerase activity. Notably, the ordered active site of arenavirus polymerase is inherently switched on, without the requirement for allosteric activation by 5 '-viral RNA, which is a necessity for both influenza virus and bunyavirus polymerases(6,7). Moreover, dimerization could facilitate the polymerase activity. These findings advance our understanding of the mechanism of arenavirus replication and provide an important basis for developing antiviral therapeutics.	[Peng, Ruchao; Jing, Jiamei; Wang, Min; Peng, Qi; Liu, Sheng; Qi, Jianxun; Gao, George F.; Shi, Yi] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Peng, Ruchao; Xu, Xin; Jing, Jiamei; Wang, Min; Peng, Qi; Qi, Jianxun; Gao, George F.; Shi, Yi] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China; [Peng, Qi; Wu, Ying; Gao, George F.; Shi, Yi] Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China; [Peng, Qi; Gao, George F.; Shi, Yi] Chinese Acad Sci, CEEID, Ctr Influenza Res & Early Warning CASCIRE, CAS TWAS, Beijing, Peoples R China; [Wu, Ying] Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China; [Bao, Xichen] Chinese Acad Sci, Guangzhou Inst Biomed & Hearth, Key Lab Regenerat Biol, Guangzhou, Peoples R China; [Wang, Peiyi; Gao, George F.] Southern Univ Sci & Technol, Dept Biol, Shenzhen, Peoples R China; [Gao, George F.] Chinese Ctr Dis Control & Prevent China Cdc, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China; [Shi, Yi] Univ Chinese Acad Sci, Chongqing Gen Hosp, Chongqing Key Lab Neurodegenerat Dis, Chongqing, Peoples R China; [Shi, Yi] Jilin Univ, Coll Basic Med, Changchun, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan University; Chinese Academy of Sciences; Southern University of Science & Technology; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Jilin University	Gao, GF; Shi, Y (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.; Gao, GF; Shi, Y (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Gao, GF; Shi, Y (corresponding author), Shenzhen Third Peoples Hosp, Shenzhen Key Lab Pathogen & Immun, Shenzhen, Peoples R China.; Gao, GF; Shi, Y (corresponding author), Chinese Acad Sci, CEEID, Ctr Influenza Res & Early Warning CASCIRE, CAS TWAS, Beijing, Peoples R China.; Gao, GF (corresponding author), Southern Univ Sci & Technol, Dept Biol, Shenzhen, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China Cdc, Natl Inst Viral Dis Control & Prevent, Beijing, Peoples R China.; Shi, Y (corresponding author), Univ Chinese Acad Sci, Chongqing Gen Hosp, Chongqing Key Lab Neurodegenerat Dis, Chongqing, Peoples R China.; Shi, Y (corresponding author), Jilin Univ, Coll Basic Med, Changchun, Peoples R China.	gaof@im.ac.cn; shiyi@im.ac.cn	Qi, Jianxun/ABF-1646-2021; Gao, George Fu/ABD-5229-2021; Peng, Ruchao/AAU-2083-2021	Peng, Ruchao/0000-0002-2741-6212; Bao, Xichen/0000-0003-0389-4233	Strategic Priority Research Program of CAS [XDB29010000]; National Science and Technology Major Project [2018ZX10101004, 2018ZX09711003]; External Cooperation Program of CAS [153211KYSB20160001]; Advanced Customer Cultivation Project of Wuhan National Biosafety Laboratory, CAS [2018ACCP-MS11]; National Natural Science Foundation of China (NSFC) [81871658]; Young Elite Scientist Sponsorship Program (YESS) by China Association for Science and Technology (CAST) [2018QNRC001]; NSFC Innovative Research Group [81621091]; Excellent Young Scientist Program; NSFC [81622031]; Youth Innovation Promotion Association of CAS [2015078]	Strategic Priority Research Program of CAS; National Science and Technology Major Project; External Cooperation Program of CAS; Advanced Customer Cultivation Project of Wuhan National Biosafety Laboratory, CAS; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Young Elite Scientist Sponsorship Program (YESS) by China Association for Science and Technology (CAST); NSFC Innovative Research Group; Excellent Young Scientist Program; NSFC(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of CAS	We thank all staff members at the Center of Biological Imaging (CBI), Institute of Biophysics (IBP), Chinese Academy of Sciences (CAS), the Cryo-EM Center of Southern University of Science and Technology (SUST), and the Cryo-EM department of the National Center for Protein Science Shanghai (NCPSS), CAS, for assistance with data collection; are grateful to G. Wang (The Core Facilities at School of Life Sciences, Peking University), T. Yang and staff members in the EM department of the State Key Laboratory of Membrane Biology, Institute of Zoology (IOZ), CAS, Beijing, for technical support in electron microscope operation; and appreciate the assistance of H. Song and F. Zhao (the Research Facility Center at Beijing Institutes of Life Science, CAS) in the ForteBio Octet experiment. This study was supported by the Strategic Priority Research Program of CAS (XDB29010000), the National Science and Technology Major Project (2018ZX10101004), the External Cooperation Program of CAS (153211KYSB20160001), the Advanced Customer Cultivation Project of Wuhan National Biosafety Laboratory, CAS (no. 2018ACCP-MS11) and the National Natural Science Foundation of China (NSFC) (81871658). M.W. is supported by the National Science and Technology Major Project (2018ZX09711003). R.P. is supported by the Young Elite Scientist Sponsorship Program (YESS) by China Association for Science and Technology (CAST) (2018QNRC001). G.F.G. is supported partly as a leading principal investigator of the NSFC Innovative Research Group (81621091). Y.S. is supported by the Excellent Young Scientist Program, the NSFC (81622031) and the Youth Innovation Promotion Association of CAS (2015078).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brunotte L, 2011, J VIROL, V85, P324, DOI 10.1128/JVI.00721-10; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Charrel RN, 2003, ANTIVIR RES, V57, P89, DOI 10.1016/S0166-3542(02)00202-4; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CHILDS JE, 1991, AM J TROP MED HYG, V44, P117, DOI 10.4269/ajtmh.1991.44.117; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fan HT, 2019, NATURE, V573, P287, DOI 10.1038/s41586-019-1530-7; Gao GF, 2018, CELL, V172, P1157, DOI 10.1016/j.cell.2018.02.025; Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006; Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; Hengrung N, 2015, NATURE, V527, P114, DOI 10.1038/nature15525; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lehmann M, 2014, J VIROL, V88, P8713, DOI 10.1128/JVI.00652-14; Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; MEYER BJ, 1993, J VIROL, V67, P2621, DOI 10.1128/JVI.67.5.2621-2627.1993; Morin B, 2013, CURR OPIN VIROL, V3, P103, DOI 10.1016/j.coviro.2013.03.008; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Peng Q, 2019, NAT MICROBIOL, V4, P1750, DOI 10.1038/s41564-019-0487-5; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; POLYAK SJ, 1995, J VIROL, V69, P3211, DOI 10.1128/JVI.69.5.3211-3215.1995; Pyle JD, 2019, P NATL ACAD SCI USA, V116, P10518, DOI 10.1073/pnas.1900790116; RAJU R, 1990, VIROLOGY, V174, P53, DOI 10.1016/0042-6822(90)90053-T; Reguera J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005636; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Rosenthal M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006400; Sanchez AB, 2005, J VIROL, V79, P7262, DOI 10.1128/JVI.79.11.7262-7268.2005; Sehnal D, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-39; Te Velthuis A.J.W., 2017, J VIROL, V92, DOI DOI 10.1128/JVI.01775-17; Thierry E, 2016, MOL CELL, V61, P125, DOI 10.1016/j.molcel.2015.11.016; Vogel D, 2019, J BIOL CHEM, V294, P8088, DOI 10.1074/jbc.RA118.006973; Wilda M, 2008, J VIROL, V82, P11454, DOI 10.1128/JVI.01533-08; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	43	20	20	3	53	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					615	+		10.1038/s41586-020-2114-2	http://dx.doi.org/10.1038/s41586-020-2114-2		MAR 2020	21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214249				2022-12-28	WOS:000520406700004
J	Riley, RD; Ensor, J; Snell, KIE; Harrell, FE; Martin, GP; Reitsma, JB; Moons, KGM; Collins, G; van Smeden, M				Riley, Richard D.; Ensor, Joie; Snell, Kym I. E.; Harrell, Frank E., Jr.; Martin, Glen P.; Reitsma, Johannes B.; Moons, Karel G. M.; Collins, Gary; van Smeden, Maarten			Calculating the sample size required for developing a clinical prediction model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EXTERNAL VALIDATION; STATISTICAL POWER; REGRESSION-MODELS; PROGNOSTIC MODEL; EVENTS; RISK; NUMBER; SELECTION; ACCURACY; APPLICABILITY	Clinical prediction models aim to predict outcomes in individuals, to inform diagnosis or prognosis in healthcare. Hundreds of prediction models are published in the medical literature each year, yet many are developed using a dataset that is too small for the total number of participants or outcome events. This leads to inaccurate predictions and consequently incorrect healthcare decisions for some individuals. In this article, the authors provide guidance on how to calculate the sample size required to develop a clinical prediction model.	[Riley, Richard D.; Ensor, Joie; Snell, Kym I. E.] Keele Univ, Sch Primary Community & Social Care, Ctr Prognosis Res, Keele ST5 5BG, Staffs, England; [Harrell, Frank E., Jr.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Martin, Glen P.] Univ Manchester, Fac Biol Med & Hlth, Div Informat Imaging & Data Sci, Manchester, Lancs, England; [Reitsma, Johannes B.; Moons, Karel G. M.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci, Utrecht, Netherlands; [Collins, Gary; van Smeden, Maarten] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Ctr Stat Med, Oxford, England; [van Smeden, Maarten] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands	Keele University; Vanderbilt University; University of Manchester; Utrecht University; Utrecht University Medical Center; University of Oxford; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Riley, RD (corresponding author), Keele Univ, Sch Primary Community & Social Care, Ctr Prognosis Res, Keele ST5 5BG, Staffs, England.	r.riley@keele.ac.uk	Riley, Richard David/ABE-5877-2020; Collins, Gary Stephen/A-2258-2014; Ensor, Joie/AAE-9109-2019; Snell, Kym/L-1918-2015; van Smeden, Maarten/Y-7034-2019	Riley, Richard David/0000-0001-8699-0735; Collins, Gary Stephen/0000-0002-2772-2316; Ensor, Joie/0000-0001-7481-0282; Snell, Kym/0000-0001-9373-6591; van Smeden, Maarten/0000-0002-5529-1541; Reitsma, Johannes/0000-0003-4026-4345	Netherlands Organisation for Scientific Research [9120.8004, 918.10.615]; CTSA award from the National Center for Advancing Translational Sciences [UL1 TR002243]; National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford; NIHR School for Primary Care Research; NIHR	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); CTSA award from the National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NIHR School for Primary Care Research; NIHR(National Institute for Health Research (NIHR))	KGMM receives funding from the Netherlands Organisation for Scientific Research (project 9120.8004 and 918.10.615). For his work on this paper, FEH was supported by CTSA award No UL1 TR002243 from the National Center for Advancing Translational Sciences. Its contents are solely the responsibility of the authors and do not necessarily represent official views of the National Center for Advancing Translational Sciences or the US National Institutes of Health. GC is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford. KIES is funded by the NIHR School for Primary Care Research. This (publication/paper/report) presents independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the National Health Service, NIHR, or Department of Health and Social Care.	ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Austin PC, 2017, STAT METHODS MED RES, V26, P796, DOI 10.1177/0962280214558972; Austin PC, 2015, J CLIN EPIDEMIOL, V68, P627, DOI 10.1016/j.jclinepi.2014.12.014; Collins GS, 2016, STAT MED, V35, P214, DOI 10.1002/sim.6787; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Concato J, 1995, J CLIN EPIDEMIOL, V48, P1495, DOI 10.1016/0895-4356(95)00510-2; Copas J B, 1997, Stat Methods Med Res, V6, P167, DOI 10.1191/096228097667367976; COPAS JB, 1983, J R STAT SOC B, V45, P311; Courvoisier DS, 2011, J CLIN EPIDEMIOL, V64, P993, DOI 10.1016/j.jclinepi.2010.11.012; Cox DR., 1989, ANAL BINARY DATA; de Jong VMT, 2019, STAT MED, V38, P1601, DOI 10.1002/sim.8063; Debray TPA, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6460; Debray TPA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001886; Debray TPA, 2014, STAT MED, V33, P2341, DOI 10.1002/sim.6080; Debray TPA, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-121; Debray TPA, 2012, STAT MED, V31, P2697, DOI 10.1002/sim.5412; Ensor J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011190; Ensor J, 2016, HEALTH TECHNOL ASSES, V20, P1, DOI 10.3310/hta20120; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Greenland S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1981; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Harrell Frank, REGRESSION MODELING; Hastie T, 2009, ELEMENTS STAT LEARNI, P33, DOI 10.1007/978-0-387-84858-7; HAYBITTLE JL, 1982, BRIT J CANCER, V45, P361, DOI 10.1038/bjc.1982.62; Heinze G, 2018, BIOMETRICAL J, V60, P431, DOI 10.1002/bimj.201700067; Hippisley-Cox J, 2017, BMJ-BRIT MED J, V357, P2099, DOI DOI 10.1136/BMJ.J2099; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; Hsieh FY, 2003, EVAL HEALTH PROF, V26, P239, DOI 10.1177/0163278703255230; Hsieh FY, 2000, CONTROL CLIN TRIALS, V21, P552, DOI 10.1016/S0197-2456(00)00104-5; Hudda MT, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l4293; Jinks RC, 2015, BMC MED RES METHODOL, V15, DOI 10.1186/s12874-015-0078-y; Kelley K, 2003, PSYCHOL METHODS, V8, P305, DOI 10.1037/1082-989X.8.3.305; Kelley K, 2007, BEHAV RES METHODS, V39, P755, DOI 10.3758/BF03192966; Maxwell SE, 2008, ANNU REV PSYCHOL, V59, P537, DOI 10.1146/annurev.psych.59.103006.093735; McClelland GH, 2000, AM PSYCHOL, V55, P963, DOI 10.1037/0003-066X.55.8.963; McFadden D., 1974, CONDITIONAL LOGIT AN, P105, DOI DOI 10.1108/EB028592; Moons KGM, 2019, ANN INTERN MED, V170, pW1, DOI 10.7326/M18-1377; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; North RA, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1875; O'Quigley J, 2005, STAT MED, V24, P479, DOI 10.1002/sim.1946; Ogundimu Emmanuel O, 2016, J Clin Epidemiol, V76, P175, DOI 10.1016/j.jclinepi.2016.02.031; Pavlou M, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3868; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Riley RD, 2019, PROGNOSIS RES HEALTH; Riley RD, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k4597; Riley RD, 2019, STAT MED, V38, P1276, DOI 10.1002/sim.7992; Riley RD, 2019, STAT MED, V38, P1262, DOI 10.1002/sim.7993; Riley RD, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3140; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2003, STAT MED, V22, P639, DOI 10.1002/sim.1310; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; SAUERBREI W, 1992, STAT MED, V11, P2093, DOI 10.1002/sim.4780111607; Sauerbrei W, 2011, J BIOPHARM STAT, V21, P1206, DOI 10.1080/10543406.2011.629890; Schmoor C, 2000, STAT MED, V19, P441, DOI 10.1002/(SICI)1097-0258(20000229)19:4<441::AID-SIM349>3.0.CO;2-N; Steyerberg EW, 2004, STAT MED, V23, P2567, DOI 10.1002/sim.1844; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Steyerberg EW, 2009, CLIN PREDICTION MODE, DOI 10.1007/978-0-387-77244-8; Steyerberg EW, 2016, J CLIN EPIDEMIOL, V69, P245, DOI 10.1016/j.jclinepi.2015.04.005; Steyerberg EW, 2014, BIOMETRICAL J, V56, P601, DOI 10.1002/bimj.201300297; Steyerberg EW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001381; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Van Calster B, 2016, J CLIN EPIDEMIOL, V74, P167, DOI 10.1016/j.jclinepi.2015.12.005; van der Ploeg T, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-137; van Houwelingen JC, 2001, STAT NEERL, V55, P17, DOI 10.1111/1467-9574.00154; van Smeden M, 2019, STAT METHODS MED RES, V28, P2455, DOI 10.1177/0962280218784726; van Smeden M, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0267-3; VANHOUWELINGEN JC, 1990, STAT MED, V9, P1303, DOI 10.1002/sim.4780091109; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Vergouwe Y, 2017, STAT MED, V36, P4529, DOI 10.1002/sim.7179; Vittinghoff E, 2007, AM J EPIDEMIOL, V165, P710, DOI 10.1093/aje/kwk052; Wells PS, 1997, LANCET, V350, P1795, DOI 10.1016/S0140-6736(97)08140-3; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Wessler Benjamin S, 2017, Diagn Progn Res, V1, P20, DOI 10.1186/s41512-017-0021-2; Whittle Rebecca, 2017, Diagn Progn Res, V1, P1, DOI 10.1186/s41512-016-0006-6; Wolff RF, 2019, ANN INTERN MED, V170, P51, DOI 10.7326/M18-1376; Wynants L, 2015, J CLIN EPIDEMIOL, V68, P1406, DOI 10.1016/j.jclinepi.2015.02.002; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	78	326	334	31	86	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m441	10.1136/bmj.m441	http://dx.doi.org/10.1136/bmj.m441			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LA2DJ	32188600	Bronze, Green Published, Green Accepted			2022-12-28	WOS:000523763100002
J	Cheng, MP; Stenstrom, R; Paquette, K; Yansouni, C; Sweet, D				Cheng, Matthew P.; Stenstrom, Robert; Paquette, Katryn; Yansouni, Cedric; Sweet, David			Blood Culture Results Before and After Antimicrobial Administration RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Cheng, Matthew P.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Stenstrom, Robert] Univ British Columbia, St Pauls Hosp, Vancouver, BC, Canada; [Stenstrom, Robert] Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada; [Paquette, Katryn] McGill Univ, Montreal Childrens Hosp, Montreal, PQ, Canada; [Yansouni, Cedric] McGill Univ, Hlth Ctr, Montreal, PQ, Canada; [Sweet, David] Univ British Columbia, Vancouver, BC, Canada; [Sweet, David] Vancouver Gen Hosp, Vancouver, BC, Canada	Harvard University; Brigham & Women's Hospital; Harvard Medical School; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; McGill University; McGill University; University of British Columbia; University of British Columbia	Cheng, MP (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA.		Cheng, Matthew P./AAO-7051-2020	Okamoto, Koh/0000-0002-4072-9096; /0000-0002-4765-3469				Clinical and Laboratory Standards Institute, 2016, DEV IN VITR SUSC TES, V4th; Garnacho-Montero J, 2014, INTENS CARE MED, V40, P32, DOI 10.1007/s00134-013-3077-7; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058	3	2	2	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					440	441		10.7326/L19-0796	http://dx.doi.org/10.7326/L19-0796			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176905				2022-12-28	WOS:000520170800039
J	Rose, C				Rose, Christian			Am I Part of the Cure or Am I Part of the Disease? Keeping Coronavirus Out When a Doctor Comes Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A front-line physician wonders how he can protect a vulnerable member of his household from the pathogens he's exposed to in the ED - especially in a rapidly spreading pandemic of a novel virus and amid so many uncertainties.	[Rose, Christian] Stanford Univ, Ctr Hlth Policy, Freeman Spogli Inst Int Studies, Sch Med, Stanford, CA 94305 USA; [Rose, Christian] Stanford Univ, Ctr Primary Care & Outcomes Res, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Rose, C (corresponding author), Stanford Univ, Ctr Hlth Policy, Freeman Spogli Inst Int Studies, Sch Med, Stanford, CA 94305 USA.; Rose, C (corresponding author), Stanford Univ, Ctr Primary Care & Outcomes Res, Sch Med, Stanford, CA 94305 USA.		Rose, Christian/AAP-2569-2021	Rose, Christian/0000-0002-5115-649X				[Anonymous], 2020, COR DIS 2019 COVID 1; Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7; Wu Z, 2020, JAMA	3	39	40	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2020	382	18					1684	1685		10.1056/NEJMp2004768	http://dx.doi.org/10.1056/NEJMp2004768			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LL1YQ	32187461	Bronze			2022-12-28	WOS:000531351300011
J	Weidemann, S; Kremer, M; Helbig, T; Hofmann, T; Stegmaier, A; Greiter, M; Thomale, R; Szameit, A				Weidemann, Sebastian; Kremer, Mark; Helbig, Tobias; Hofmann, Tobias; Stegmaier, Alexander; Greiter, Martin; Thomale, Ronny; Szameit, Alexander			Topological funneling of light	SCIENCE			English	Article							PARITY-TIME SYMMETRY	Dissipation is a general feature of non-Hermitian systems. But rather than being an unavoidable nuisance, non-Hermiticity can be precisely controlled and hence used for sophisticated applications, such as optical sensors with enhanced sensitivity. In our work, we implement a non-Hermitian photonic mesh lattice by tailoring the anisotropy of the nearest-neighbor coupling. The appearance of an interface results in a complete collapse of the entire eigenmode spectrum, leading to an exponential localization of all modes at the interface. As a consequence, any light field within the lattice travels toward this interface, irrespective of its shape and input position. On the basis of this topological phenomenon, called the "non-Hermitian skin effect," we demonstrate a highly efficient funnel for light.	[Weidemann, Sebastian; Kremer, Mark; Szameit, Alexander] Univ Rostock, Inst Phys, D-18059 Rostock, Germany; [Helbig, Tobias; Hofmann, Tobias; Stegmaier, Alexander; Greiter, Martin; Thomale, Ronny] Julius Maximilians Univ Wurzburg, Dept Phys & Astron, D-97074 Wurzburg, Germany	University of Rostock; University of Wurzburg	Szameit, A (corresponding author), Univ Rostock, Inst Phys, D-18059 Rostock, Germany.	alexander.szameit@uni-rostock.de	Szameit, Alexander/AGK-5446-2022	Szameit, Alexander/0000-0003-0071-6941; Thomale, Ronny/0000-0002-3979-8836; Stegmaier, Alexander/0000-0002-8864-5182; Kremer, Mark/0000-0003-2597-7259; Weidemann, Sebastian/0000-0002-0090-1760; Hofmann, Tobias/0000-0002-1888-9464; Helbig, Tobias/0000-0003-1894-0183	Deutsche Forschungsgemeinschaft [BL 574/13-1, SZ 276/19-1, SZ 276/20-1, SZ 276/9-2, 258499086-SFB 1170]; WurzburgDresden Cluster of Excellence on Complexity and Topology in Quantum Matter ct.qmat [39085490-EXC 2147]; Alfried Krupp von Bohlen und Halbach Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); WurzburgDresden Cluster of Excellence on Complexity and Topology in Quantum Matter ct.qmat; Alfried Krupp von Bohlen und Halbach Foundation	The authors acknowledge funding from the Deutsche Forschungsgemeinschaft (BL 574/13-1, SZ 276/19-1, SZ 276/20-1, SZ 276/9-2, and 258499086-SFB 1170), the WurzburgDresden Cluster of Excellence on Complexity and Topology in Quantum Matter ct.qmat (39085490-EXC 2147), and the Alfried Krupp von Bohlen und Halbach Foundation.	ANDERSON PW, 1958, PHYS REV, V109, P1492, DOI 10.1103/PhysRev.109.1492; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Eichelkraut T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3533; El-Ganainy R, 2007, OPT LETT, V32, P2632, DOI 10.1364/OL.32.002632; El-Ganainy R, 2018, NAT PHYS, V14, P11, DOI 10.1038/NPHYS4323; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Ghatak A., 2019, OBSERVATION NONHERMI; Ghatak A., 2019, ARXIV190711619CONDMA; Ghatak A, 2019, J PHYS-CONDENS MAT, V31, DOI [10.1088/1361-648X/ab11b3, 10.1088/1361-648x/ab11b3]; Gong ZP, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.031079; Guo A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.093902; Hatano N, 1996, PHYS REV LETT, V77, P570, DOI 10.1103/PhysRevLett.77.570; Helbig T., 2019, OBSERVATION BULK BOU; Helbig T., 2019, ARXIV190711562CONDMA; Hodaei H, 2017, NATURE, V548, P187, DOI 10.1038/nature23280; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Klauck F, 2019, NAT PHOTONICS, V13, P883, DOI 10.1038/s41566-019-0517-0; Kremer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08104-x; Lee CH, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.201103; Lee TE, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.133903; Miri MA, 2019, SCIENCE, V363, P42, DOI 10.1126/science.aar7709; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Schreiber A, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.180403; Schreiber A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.050502; SU WP, 1979, PHYS REV LETT, V42, P1698, DOI 10.1103/PhysRevLett.42.1698; Weidemann S., 2020, DATA SET TOPOLOGICAL, DOI [10.18453/rosdok_id00002571, DOI 10.18453/ROSDOK_ID00002571]; Wimmer M, 2015, SCI REP-UK, V5, DOI 10.1038/srep17760; Xiao L, 2017, NAT PHYS, V13, P1117, DOI 10.1038/NPHYS4204; Xiao L., 2019, OBSERVATION NONHERMI; Xiao L, 2020, NAT PHYS, V16, P761, DOI 10.1038/s41567-020-0836-6; Xiong Y, 2018, J PHYS COMMUN, V2, DOI 10.1088/2399-6528/aab64a; Yao SY, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.086803	33	216	219	16	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 17	2020	368	6488			SI		311	+		10.1126/science.aaz8727	http://dx.doi.org/10.1126/science.aaz8727			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LE2AL	32217752	Green Submitted, Bronze			2022-12-28	WOS:000526525400051
J	Newman, M				Newman, Melanie			Covid-19: doctors' leaders warn that staff could quit and may die over lack of protective equipment	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hua MJ, 2020, ROUTINE INFECT PREVE; Public Health England, US SURG FAC MASK FFP; RIMMER A, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M978; WHO, 2020, RAT US PERS PROT EQ	4	24	23	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1257	10.1136/bmj.m1257	http://dx.doi.org/10.1136/bmj.m1257			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217522	Bronze			2022-12-28	WOS:000523764800022
J	Han, XP; Zhou, ZM; Fei, LJ; Sun, HY; Wang, RY; Chen, Y; Chen, HD; Wang, JJ; Tang, HN; Ge, WH; Zhou, YC; Ye, F; Jiang, MM; Wu, JQ; Xiao, YY; Jia, XN; Zhang, TY; Ma, XJ; Zhang, Q; Bai, XL; Lai, SJ; Yu, CX; Zhu, LJ; Lin, R; Gao, YC; Wang, M; Wu, YQ; Zhang, JM; Zhan, RY; Zhu, SY; Hu, HL; Wang, CC; Chen, M; Huang, H; Liang, TB; Chen, JH; Wang, WL; Zhang, D; Guo, GJ				Han, Xiaoping; Zhou, Ziming; Fei, Lijiang; Sun, Huiyu; Wang, Renying; Chen, Yao; Chen, Haide; Wang, Jingjing; Tang, Huanna; Ge, Wenhao; Zhou, Yincong; Ye, Fang; Jiang, Mengmeng; Wu, Junqing; Xiao, Yanyu; Jia, Xiaoning; Zhang, Tingyue; Ma, Xiaojie; Zhang, Qi; Bai, Xueli; Lai, Shujing; Yu, Chengxuan; Zhu, Lijun; Lin, Rui; Gao, Yuchi; Wang, Min; Wu, Yiqing; Zhang, Jianming; Zhan, Renya; Zhu, Saiyong; Hu, Hailan; Wang, Changchun; Chen, Ming; Huang, He; Liang, Tingbo; Chen, Jianghua; Wang, Weilin; Zhang, Dan; Guo, Guoji			Construction of a human cell landscape at single-cell level	NATURE			English	Article							MESSENGER-RNA-SEQ; REVEALS; MOUSE; EXPRESSION; IDENTITY; RECONSTRUCTION; DIVERSITY; ATLAS	Single-cell analysis is a valuable tool for dissecting cellular heterogeneity in complex systems(1). However, a comprehensive single-cell atlas has not been achieved for humans. Here we use single-cell mRNA sequencing to determine the cell-type composition of all major human organs and construct a scheme for the human cell landscape (HCL). We have uncovered a single-cell hierarchy for many tissues that have not been well characterized. We established a 'single-cell HCL analysis' pipeline that helps to define human cell identity. Finally, we performed a single-cell comparative analysis of landscapes from human and mouse to identify conserved genetic networks. We found that stem and progenitor cells exhibit strong transcriptomic stochasticity, whereas differentiated cells are more distinct. Our results provide a useful resource for the study of human biology. Single-cell RNA sequencing is used to generate a dataset covering all major human organs in both adult and fetal stages, enabling comparison with similar datasets for mouse tissues.	[Han, Xiaoping; Zhou, Ziming; Fei, Lijiang; Sun, Huiyu; Wang, Renying; Chen, Haide; Wang, Jingjing; Ye, Fang; Jiang, Mengmeng; Wu, Junqing; Xiao, Yanyu; Zhang, Tingyue; Lai, Shujing; Yu, Chengxuan; Guo, Guoji] Zhejiang Univ, Ctr Stem Cell & Regenerat Med, Sch Med, Hangzhou, Peoples R China; [Han, Xiaoping; Huang, He; Guo, Guoji] Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China; [Chen, Yao; Wu, Yiqing; Zhang, Dan] Zhejiang Univ, Womens Hosp, Sch Med, Dept Reprod Endocrinol, Hangzhou, Peoples R China; [Chen, Haide; Wang, Jingjing; Guo, Guoji] Dr Li Dak Sum & Yip Yio Chin Ctr Stem Cell & Rege, Zhejiang Prov Key Lab Tissue Engn & Regenerat Med, Hangzhou, Peoples R China; [Tang, Huanna; Chen, Jianghua] Zhejiang Univ, Affiliated Hosp 1, Kidney Dis Ctr, Sch Med, Hangzhou, Peoples R China; [Ge, Wenhao; Zhu, Lijun; Wang, Weilin] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China; [Zhou, Yincong; Chen, Ming] Zhejiang Univ, Coll Life Sci, Hangzhou, Peoples R China; [Jia, Xiaoning; Hu, Hailan] Zhejiang Univ, Ctr Neurosci, Sch Med, Hangzhou, Peoples R China; [Ma, Xiaojie; Zhu, Saiyong] Zhejiang Univ, Life Sci Inst, Hangzhou, Peoples R China; [Zhang, Qi; Bai, Xueli; Liang, Tingbo] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Hepatobiliary & Pancreat Surg, Hangzhou, Peoples R China; [Lin, Rui] Hangzhou Repugene Technol, Hangzhou, Peoples R China; [Gao, Yuchi] Annoroad Gene Technol, Beijing, Peoples R China; [Wang, Min] Veritas Genet Asia, Hangzhou, Peoples R China; [Zhang, Jianming] Zhejiang Univ, Affiliated Hosp 2, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China; [Zhan, Renya] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Neurosurg, Hangzhou, Peoples R China; [Wang, Changchun] Univ Chinese Acad Sci, Inst Canc Res & Basic Med Sci, Zhejiang Canc Hosp, Chinese Acad Sci,Canc Hosp, Hangzhou, Peoples R China; [Huang, He; Guo, Guoji] Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China; [Huang, He; Guo, Guoji] Zhejiang Univ, Stem Cell Inst, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Cancer Hospital; Zhejiang University; Zhejiang University	Han, XP; Guo, GJ (corresponding author), Zhejiang Univ, Ctr Stem Cell & Regenerat Med, Sch Med, Hangzhou, Peoples R China.; Han, XP; Guo, GJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Sch Med, Hangzhou, Peoples R China.; Guo, GJ (corresponding author), Dr Li Dak Sum & Yip Yio Chin Ctr Stem Cell & Rege, Zhejiang Prov Key Lab Tissue Engn & Regenerat Med, Hangzhou, Peoples R China.; Guo, GJ (corresponding author), Zhejiang Univ, Inst Hematol, Hangzhou, Peoples R China.; Guo, GJ (corresponding author), Zhejiang Univ, Stem Cell Inst, Hangzhou, Peoples R China.	xhan@zju.edu.cn; ggj@zju.edu.cn	Zhou, yixin/HGE-2329-2022	Chen, Yao/0000-0001-6722-8788; Guo, Guoji/0000-0002-1716-4621; Lin, Rui/0000-0002-1859-7904; Chen, Ming/0000-0002-9677-1699	National Natural Science Foundation of China [91842301, 81770188, 31722027, 31922049, 31701290, 31871473]; National Key Research and Development Program [2018YFA0107804, 2018YFA0107801, 2018YFA0800503, 2018YFC1005003]; Zhejiang Provincial Natural Science Foundation of China [R17H080001]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	We thank G-BIO (Hangzhou), Sidansai Biotechnology (Shanghai), BGI (Shenzhen) and CNGB (Shenzhen) for supporting this project; Vazyme for supplying the customized enzymes in the study; the Core Facilities of Zhejiang University School of Medicine for technical support; the Center of Cryo-Electron Microscopy at Zhejiang University for computational support; and Y. Zhu, J. Zhu, L. Huang, L. Shao, Z. Wang, H. Huang, X. Wu, W. Lin, M. Bai, Q. Sun, X. Wu, M. Yao, F. Zhu, Z. Li, L. Huang, L. Shao, Z. Wang and X. Chen for help with sample collection. This publication is part of the Human Cell Atlas: www.humancellatlas.org/publications/. G.G. is a participant of the Human Cell Atlas Project (International), the Alliance for Atlas of Blood Cells (China), and the Cell Atlas Project (Zhejiang University Stem Cell Institute). This work was supported by the National Natural Science Foundation of China (grants 91842301, 81770188, 31722027, 31922049, 31701290, and 31871473), the National Key Research and Development Program (grants 2018YFA0107804, 2018YFA0107801, 2018YFA0800503, and 2018YFC1005003), the Zhejiang Provincial Natural Science Foundation of China (grant R17H080001), and the Fundamental Research Funds for the Central Universities (G.G.).	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; [Anonymous], 2018, NATURE, V562, P367, DOI DOI 10.1038/S41586-018-0590-4; Baron M, 2016, CELL SYST, V3, P346, DOI 10.1016/j.cels.2016.08.011; Bass JIF, 2013, NAT METHODS, V10, P1169, DOI [10.1038/NMETH.2728, 10.1038/nmeth.2728]; Blakeley P, 2015, DEVELOPMENT, V142, P3151, DOI 10.1242/dev.123547; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chu LF, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1033-x; Crow M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03282-0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Fincher CT, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1736; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; Gao S, 2018, NAT CELL BIOL, V20, DOI 10.1038/s41556-018-0105-4; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guo JT, 2018, CELL RES, V28, P1141, DOI 10.1038/s41422-018-0099-2; Guo JT, 2017, CELL STEM CELL, V21, P533, DOI 10.1016/j.stem.2017.09.003; Guo MZ, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1278; Han XP, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1426-0; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Karamitros D, 2018, NAT IMMUNOL, V19, P85, DOI 10.1038/s41590-017-0001-2; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; Lake BB, 2018, NAT BIOTECHNOL, V36, P70, DOI 10.1038/nbt.4038; Li L, 2017, CELL STEM CELL, V20, P858, DOI 10.1016/j.stem.2017.03.007; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Nguyen QH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04334-1; Pijuan-Sala B, 2019, NATURE, V566, P490, DOI 10.1038/s41586-019-0933-9; Plass M, 2018, SCIENCE, V360, DOI 10.1126/science.aaq1723; Plasschaert LW, 2018, NATURE, V560, P377, DOI 10.1038/s41586-018-0394-6; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Roerink SF, 2018, NATURE, V556, P457, DOI 10.1038/s41586-018-0024-3; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sebe-Pedros A, 2018, CELL, V173, P1520, DOI 10.1016/j.cell.2018.05.019; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spanjaard B, 2018, NAT BIOTECHNOL, V36, P469, DOI 10.1038/nbt.4124; Suo SB, 2018, CELL REP, V25, P1436, DOI 10.1016/j.celrep.2018.10.045; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tosches MA, 2018, SCIENCE, V360, P881, DOI 10.1126/science.aar4237; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Tsang JCH, 2017, P NATL ACAD SCI USA, V114, pE7786, DOI 10.1073/pnas.1710470114; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; Wagner DE, 2018, SCIENCE, V360, P981, DOI 10.1126/science.aar4362; Wang M, 2018, CELL STEM CELL, V23, P599, DOI 10.1016/j.stem.2018.08.007; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Young MD, 2018, SCIENCE, V361, P594, DOI 10.1126/science.aat1699; Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980	65	320	330	62	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY	2020	581	7808					303	+		10.1038/s41586-020-2157-4	http://dx.doi.org/10.1038/s41586-020-2157-4		MAR 2020	28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LQ2CZ	32214235				2022-12-28	WOS:000532687800001
J	Janes, AC				Janes, Amy C.			Is it worth the effort?	SCIENCE			English	Editorial Material							DOPAMINE; BRAIN; STRIATUM; CUES		[Janes, Amy C.] Harvard Med Sch, McLean Hosp, Dept Psychiat, Funct Integrat Addict Res Lab, Belmont, MA 02478 USA	Harvard University; McLean Hospital	Janes, AC (corresponding author), Harvard Med Sch, McLean Hosp, Dept Psychiat, Funct Integrat Addict Res Lab, Belmont, MA 02478 USA.	ajanes@mclean.harvard.edu	Janes, Amy/A-5322-2013	Janes, Amy/0000-0002-3749-5006	NIDA [K02 DA042987]	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))	A.C.J. is supported by NIDA grant K02 DA042987. She provides consulting services for Axial Biotherapeutics.	Addicott MA, 2019, PHARMACOL BIOCHEM BE, V183, P14, DOI 10.1016/j.pbb.2019.06.008; Chong TTJ, 2015, CORTEX, V69, P40, DOI 10.1016/j.cortex.2015.04.003; Floresco SB, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00062; Franklin TR, 2009, NEUROPSYCHOPHARMACOL, V34, P717, DOI 10.1038/npp.2008.124; Haber SN, 2016, DIALOGUES CLIN NEURO, V18, P7; Janes AC, 2010, BIOL PSYCHIAT, V67, P722, DOI 10.1016/j.biopsych.2009.12.034; Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4; Pierce RC, 2006, NEUROSCI BIOBEHAV R, V30, P215, DOI 10.1016/j.neubiorev.2005.04.016; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; Tricomi EM, 2004, NEURON, V41, P281, DOI 10.1016/S0896-6273(03)00848-1; Volkow ND, 2005, BIOL PSYCHIAT, V57, P1410, DOI 10.1016/j.biopsych.2004.11.006; Volkow ND, 2008, NEUROIMAGE, V39, P1266, DOI 10.1016/j.neuroimage.2007.09.059; Volkow ND, 2006, J NEUROSCI, V26, P6583, DOI 10.1523/JNEUROSCI.1544-06.2006; Westbrook A, 2020, SCIENCE, V367, P1362, DOI 10.1126/science.aaz5891	14	0	0	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1300	1301		10.1126/science.abb0265	http://dx.doi.org/10.1126/science.abb0265			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193307	Green Accepted			2022-12-28	WOS:000522167400026
J	Barnett, ML				Barnett, Michael L.			Opioid Prescribing in the Midst of Crisis - Myths and Realities	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							BACK-PAIN	With the opioid-prescribing debate remaining hopelessly polarized - opioids are either industrially sponsored weapons of mass addiction or a misunderstood last hope for alleviating suffering - persistent myths contribute to overprescribing or underprescribing.	[Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Barnett, Michael L.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	Barnett, ML (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.; Barnett, ML (corresponding author), Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.		Barnett, Michael/ABA-4159-2021; Barnett, Michael/AAF-4017-2019	Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609				Busse JW, 2018, JAMA-J AM MED ASSOC, V320, P2448, DOI 10.1001/jama.2018.18472; Friedman BW, 2015, JAMA-J AM MED ASSOC, V314, P1572, DOI 10.1001/jama.2015.13043; Human Rights Watch, 2018, NOT ALL BE COMP CHRO; Krebs EE, 2018, JAMA-J AM MED ASSOC, V319, P872, DOI 10.1001/jama.2018.0899; National Academies of Sciences Engineering and Medicine, 2019, FRAM OP PRESCR GUID, DOI 10.17226/25555	5	16	16	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1086	1088		10.1056/NEJMp1914257	http://dx.doi.org/10.1056/NEJMp1914257			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KW7AJ	32187467				2022-12-28	WOS:000521333700007
J	Devalaraja, S; To, TKJ; Folkert, IW; Natesan, R; Alam, MZ; Li, MH; Tada, Y; Budagyan, K; Dang, MT; Zhai, L; Lobel, GP; Ciotti, GE; Eisinger-Mathason, TSK; Asangani, IA; Weber, K; Simon, MC; Haldar, M				Devalaraja, Samir; To, Tsun Ki Jerrick; Folkert, Ian W.; Natesan, Ramakrishnan; Alam, Md Zahidul; Li, Minghong; Tada, Yuma; Budagyan, Konstantin; Dang, Mai T.; Zhai, Li; Lobel, Graham P.; Ciotti, Gabrielle E.; Eisinger-Mathason, T. S. Karin; Asangani, Irfan A.; Weber, Kristy; Simon, M. Celeste; Haldar, Malay			Tumor-Derived Retinoic Acid Regulates Intratumoral Monocyte Differentiation to Promote Immune Suppression	CELL			English	Article							DENDRITIC CELLS; BREAST-CANCER; IL-13 RECEPTORS; MOUSE MODEL; EXPRESSION; MACROPHAGES; HOMEOSTASIS; HETEROGENEITY; PROGRESSION; PREDICTOR	The immunosuppressive tumor microenvironment (TME) is a major barrier to immunotherapy. Within solid tumors, why monocytes preferentially differentiate into immunosuppressive tumor-associated macrophages (TAMs) rather than immunostimulatory dendritic cells (DCs) remains unclear. Using multiple murine sarcoma models, we find that the TME induces tumor cells to produce retinoic acid (RA), which polarizes intratumoral monocyte differentiation toward TAMs and away from DCs via suppression of DC-promoting transcription factor Irf4. Genetic inhibition of RA production in tumor cells or pharmacologic inhibition of RA signaling within TME increases stimulat monocyte-derived cells, enhances T cell-dependent anti-tumor immunity, and synergizes with immune checkpoint blockade. Furthermore, an RA-responsive gene signature in human monocytes correlates with an immunosuppressive TME in multiple human tumors. RA has been considered as an anti-cancer agent, whereas our work demonstrates its tumorigenic capability via iediated immune suppression and provide proof of concept for targeting this pathway for tumor immunotherapy.	[Devalaraja, Samir; To, Tsun Ki Jerrick; Alam, Md Zahidul; Li, Minghong; Tada, Yuma; Zhai, Li; Lobel, Graham P.; Ciotti, Gabrielle E.; Eisinger-Mathason, T. S. Karin; Haldar, Malay] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19014 USA; [Devalaraja, Samir; To, Tsun Ki Jerrick; Folkert, Ian W.; Natesan, Ramakrishnan; Lobel, Graham P.; Ciotti, Gabrielle E.; Eisinger-Mathason, T. S. Karin; Asangani, Irfan A.; Simon, M. Celeste; Haldar, Malay] Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Devalaraja, Samir; To, Tsun Ki Jerrick; Folkert, Ian W.; Haldar, Malay] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Folkert, Ian W.] Univ Penn, Perelman Sch Med, Dept Surg, Philadelphia, PA 19104 USA; [Budagyan, Konstantin] Drexel Univ, Coll Med, Dept Biochem & Mol Biol, Philadelphia, PA 19104 USA; [Natesan, Ramakrishnan; Asangani, Irfan A.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Dang, Mai T.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Asangani, Irfan A.] Univ Penn, Perelman Sch Med, Penn Epigenet Inst, Philadelphia, PA 19104 USA; [Weber, Kristy] Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Simon, M. Celeste] Univ Penn, Perelman Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Drexel University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Haldar, M (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19014 USA.; Haldar, M (corresponding author), Univ Penn, Perelman Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.; Haldar, M (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.	mhaldar@pennmedicine.upenn.edu	Simon, Celeste/AAG-3941-2021; Natesan, Ramakrishnan/AAM-6473-2021	Natesan, Ramakrishnan/0000-0002-7888-9255; Lobel, Graham/0000-0002-9166-2979	Burroughs Wellcome CAMS; Concern Foundation; Slay Sarcoma Research Initiative; Sarcoma Program at UPenn; NIH [F30CA236464];  [NCI-R37CA234027]	Burroughs Wellcome CAMS(Burroughs Wellcome Fund); Concern Foundation; Slay Sarcoma Research Initiative; Sarcoma Program at UPenn; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	We thank Drs. Brian Keith and Ivan Maillard for their scientific input and Dr. Michael Gonzalez for help with scRNA-seq. We thank Y. Daikhin, O. Horyn, and Ilanna Nissim for performing the ATRA measurements in the Metabolomics Core Facility, The Children's Hospital of Philadelphia (CHOP). We also thank FCM cores at UPenn and CHOP, CAG Core at CHOP, and HIC core at UPenn. Thisworkwas supportedby the NCI-R37CA234027 (M.H.), Burroughs Wellcome CAMS (M.H.), the Concern Foundation (M.H.), the Slay Sarcoma Research Initiative (M.H.), the Sarcoma Program at UPenn (M.H.), and NIH F30CA236464 (S.D.).	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Barrott JJ, 2015, ONCOTARGET, V6, P22758, DOI 10.18632/oncotarget.4283; Bhatt S, 2014, J IMMUNOL, V192, P5098, DOI 10.4049/jimmunol.1303073; Bhattacharya N, 2016, IMMUNITY, V45, P641, DOI 10.1016/j.immuni.2016.08.008; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Broz ML, 2015, CANCER IMMUNOL RES, V3, P313, DOI 10.1158/2326-6066.CIR-15-0041; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chiba T, 2016, J AM SOC NEPHROL, V27, P495, DOI 10.1681/ASN.2014111108; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Duester G, 2017, SCIENCE, V358, P1394, DOI 10.1126/science.aar6752; Ehnman M, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00248; Erkelens MN, 2017, TRENDS IMMUNOL, V38, P168, DOI 10.1016/j.it.2016.12.006; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Gubin MM, 2018, CELL, V175, P1014, DOI 10.1016/j.cell.2018.09.030; Gundra UM, 2017, NAT IMMUNOL, V18, P642, DOI 10.1038/ni.3734; Haldar M, 2007, CANCER CELL, V11, P375, DOI 10.1016/j.ccr.2007.01.016; Haldar M, 2014, IMMUNOL REV, V262, P25, DOI 10.1111/imr.12215; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Jin CJ, 2010, LEUKEMIA RES, V34, P513, DOI 10.1016/j.leukres.2009.10.006; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Khoury T, 2012, MODERN PATHOL, V25, P388, DOI 10.1038/modpathol.2011.172; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Klebanoff CA, 2013, J EXP MED, V210, P1961, DOI 10.1084/jem.20122508; Kumar S, 2012, BBA-MOL CELL BIOL L, V1821, P198, DOI 10.1016/j.bbalip.2011.04.004; Laoui D, 2011, IMMUNOBIOLOGY, V216, P1192, DOI 10.1016/j.imbio.2011.06.007; Lehtonen A, 2005, J IMMUNOL, V175, P6570, DOI 10.4049/jimmunol.175.10.6570; Li T, 2010, LAB INVEST, V90, P234, DOI 10.1038/labinvest.2009.127; Li XS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-705; Marcato P, 2015, MOL ONCOL, V9, P17, DOI 10.1016/j.molonc.2014.07.010; McCormick SM, 2015, CYTOKINE, V75, P38, DOI 10.1016/j.cyto.2015.05.023; Menezes S, 2016, IMMUNITY, V45, P1205, DOI 10.1016/j.immuni.2016.12.001; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Mohty M, 2003, BRIT J HAEMATOL, V122, P829, DOI 10.1046/j.1365-2141.2003.04489.x; Nefedova Y, 2007, CANCER RES, V67, P11021, DOI 10.1158/0008-5472.CAN-07-2593; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Olingy CE, 2019, J LEUKOCYTE BIOL, V106, P309, DOI 10.1002/JLB.4RI0818-311R; Richards DM, 2013, CANCER MICROENVIRON, V6, P179, DOI 10.1007/s12307-012-0123-x; Salmon H, 2019, NAT REV CANCER, V19, P215, DOI 10.1038/s41568-019-0125-9; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schreiber TH, 2009, BRIT J CANCER, V101, P381, DOI 10.1038/sj.bjc.6605198; Suzuki A, 2015, CYTOKINE, V75, P79, DOI 10.1016/j.cyto.2015.05.026; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; Veglia F, 2017, CURR OPIN IMMUNOL, V45, P43, DOI 10.1016/j.coi.2017.01.002; Vellozo NS, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01560; Wei D, 2015, HEART LUNG CIRC, V24, P780, DOI 10.1016/j.hlc.2015.03.021; Zhang W, 2013, CANCER LETT, V328, P120, DOI 10.1016/j.canlet.2012.08.033; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	58	81	83	10	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1098	+		10.1016/j.cell.2020.02.042	http://dx.doi.org/10.1016/j.cell.2020.02.042			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32169218	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000520925300009
J	Rimmer, A				Rimmer, Abi			Trainees and covid-19: your questions answered	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, JOINT POLICY STATEME; Health Education England, 2020, SUPP COV 19 RESP; Membership of the Royal Colleges of Physicians of the United Kingdom, EX CANC DUE COV 19; Royal College of Anaethetists, 2020, COV 19 RCOAS PREP; Royal College of Pathologists, 2020, ROYAL COLL PATH ROYA; Royal College of Psychiatrists, 2020, UPD MRCPSYCH EX COV; Royal College of Psychiatrists, EX CANC HONG KONG SI; Royal College of Radiologists, RCR POS COR COV 19 A	8	12	12	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m1059	10.1136/bmj.m1059	http://dx.doi.org/10.1136/bmj.m1059			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32170027	Bronze			2022-12-28	WOS:000520014600010
J	Chatterjee, S; Guidi, M; Seeberger, PH; Gilmore, K				Chatterjee, Sourav; Guidi, Mara; Seeberger, Peter H.; Gilmore, Kerry			Automated radial synthesis of organic molecules	NATURE			English	Article							FLOW PLATFORM; CHEMISTRY	An automated synthesis instrument comprising a series of continuous flow modules that are radially arranged around a central switching station can achieve both linear and convergent syntheses. Automated synthesis platforms accelerate and simplify the preparation of molecules by removing the physical barriers to organic synthesis. This provides unrestricted access to biopolymers and small molecules via reproducible and directly comparable chemical processes. Current automated multistep syntheses rely on either iterative(1-4) or linear processes(5-9), and require compromises in terms of versatility and the use of equipment. Here we report an approach towards the automated synthesis of small molecules, based on a series of continuous flow modules that are radially arranged around a central switching station. Using this approach, concise volumes can be exposed to any reaction conditions required for a desired transformation. Sequential, non-simultaneous reactions can be combined to perform multistep processes, enabling the use of variable flow rates, reuse of reactors under different conditions, and the storage of intermediates. This fully automated instrument is capable of both linear and convergent syntheses and does not require manual reconfiguration between different processes. The capabilities of this approach are demonstrated by performing optimizations and multistep syntheses of targets, varying concentrations via inline dilutions, exploring several strategies for the multistep synthesis of the anticonvulsant drug rufinamide(10), synthesizing eighteen compounds of two derivative libraries that are prepared using different reaction pathways and chemistries, and using the same reagents to perform metallaphotoredox carbon-nitrogen cross-couplings(11) in a photochemical module-all without instrument reconfiguration.	[Chatterjee, Sourav; Guidi, Mara; Seeberger, Peter H.; Gilmore, Kerry] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany; [Guidi, Mara; Seeberger, Peter H.] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany	Max Planck Society; Free University of Berlin	Gilmore, K (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany.	kerry.gilmore@mpikg.mpg.de		Guidi, Mara/0000-0002-0453-9519; Chatterjee, Sourav/0000-0002-5449-9818; Gilmore, Kerry/0000-0001-9897-6017	Max-Planck Society; Army Research Office [W911NF-16-1-0557]; DFG InCHeM [FOR 2177]	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Army Research Office; DFG InCHeM(German Research Foundation (DFG))	We acknowledge financial support from the Max-Planck Society, the Army Research Office under contract W911NF-16-1-0557, and the DFG InCHeM (FOR 2177). We thank B. Pieber, J. Malik, S. Moon and F. Hentschel for suggestions and support; J. von Szada-Borryszkowski and J. Petersen for construction of the instrument housing; and Vapourtec for software support with the incorporation of their equipment.	Adamo A, 2016, SCIENCE, V352, P61, DOI 10.1126/science.aaf1337; Bedard AC, 2018, SCIENCE, V361, P1220, DOI 10.1126/science.aat0650; Britton J, 2017, ANGEW CHEM INT EDIT, V56, P8823, DOI 10.1002/anie.201704529; Britton J, 2017, CHEM SOC REV, V46, P1250, DOI 10.1039/c6cs00830e; CARUTHERS MH, 1985, SCIENCE, V230, P281, DOI 10.1126/science.3863253; Corcoran EB, 2016, SCIENCE, V353, P279, DOI 10.1126/science.aag0209; Fitzpatrick DE, 2018, ANGEW CHEM INT EDIT, V57, P15128, DOI 10.1002/anie.201809080; Gerardy R, 2018, EUR J ORG CHEM, V2018, P2301, DOI 10.1002/ejoc.201800149; Ghislieri D, 2015, ANGEW CHEM INT EDIT, V54, P678, DOI 10.1002/anie.201409765; Gutmann B, 2015, ANGEW CHEM INT EDIT, V54, P6688, DOI 10.1002/anie.201409318; HEPLER LG, 1981, THERMOCHIM ACTA, V50, P69, DOI 10.1016/0040-6031(81)85044-7; Hwang YJ, 2017, CHEM COMMUN, V53, P6649, DOI 10.1039/c7cc03584e; Li JQ, 2015, SCIENCE, V347, P1221, DOI 10.1126/science.aaa5414; Malet-Sanz L, 2012, J MED CHEM, V55, P4062, DOI 10.1021/jm2006029; MERRIFIELD RB, 1965, SCIENCE, V150, P178, DOI 10.1126/science.150.3693.178; Milligan JA, 2019, ANGEW CHEM INT EDIT, V58, P6152, DOI 10.1002/anie.201809431; Padmaja RD, 2018, ORG PROCESS RES DEV, V22, P457, DOI 10.1021/acs.oprd.7b00373; Pastre JC, 2013, CHEM SOC REV, V42, P8849, DOI 10.1039/c3cs60246j; Plante OJ, 2001, SCIENCE, V291, P1523, DOI 10.1126/science.1057324; Plutschack MB, 2017, CHEM REV, V117, P11796, DOI 10.1021/acs.chemrev.7b00183; Schotten C, 2018, REACT CHEM ENG, V3, P210, DOI 10.1039/c8re00010g; Steiner S, 2019, SCIENCE, V363, P144, DOI 10.1126/science.aav2211; Twilton J, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0052; Zhang P, 2018, CHEM-EUR J, V24, P2776, DOI 10.1002/chem.201706004	24	75	74	11	102	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					379	+		10.1038/s41586-020-2083-5	http://dx.doi.org/10.1038/s41586-020-2083-5			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188949				2022-12-28	WOS:000520778000015
J	Regan, EC; Wang, DQ; Jin, CH; Utama, MI; Gao, BN; Wei, X; Zhao, SH; Zhao, WY; Zhang, ZC; Yumigeta, K; Blei, M; Carlstrom, JD; Watanabe, K; Taniguchi, T; Tongay, S; Crommie, M; Zettl, A; Wang, F				Regan, Emma C.; Wang, Danqing; Jin, Chenhao; Utama, M. Iqbal; Gao, Beini; Wei, Xin; Zhao, Sihan; Zhao, Wenyu; Zhang, Zuocheng; Yumigeta, Kentaro; Blei, Mark; Carlstrom, Johan D.; Watanabe, Kenji; Taniguchi, Takashi; Tongay, Sefaattin; Crommie, Michael; Zettl, Alex; Wang, Feng			Mott and generalized Wigner crystal states in WSe2/WS2 moire superlattices	NATURE			English	Article							INSULATOR; ELECTRONS; MOS2	Strongly correlated insulating Mott and generalized Wigner phases are detected in WSe2/WS2 moire superlattices, and their electrical properties and excited spin states are studied using an optical technique. Moire superlattices can be used to engineer strongly correlated electronic states in two-dimensional van der Waals heterostructures, as recently demonstrated in the correlated insulating and superconducting states observed in magic-angle twisted-bilayer graphene and ABC trilayer graphene/boron nitride moire superlattices(1-4). Transition metal dichalcogenide moire heterostructures provide another model system for the study of correlated quantum phenomena(5) because of their strong light-matter interactions and large spin-orbit coupling. However, experimental observation of correlated insulating states in this system is challenging with traditional transport techniques. Here we report the optical detection of strongly correlated phases in semiconducting WSe2/WS2 moire superlattices. We use a sensitive optical detection technique and reveal a Mott insulator state at one hole per superlattice site and surprising insulating phases at 1/3 and 2/3 filling of the superlattice, which we assign to generalized Wigner crystallization on the underlying lattice(6-11). Furthermore, the spin-valley optical selection rules(12-14) of transition metal dichalcogenide heterostructures allow us to optically create and investigate low-energy excited spin states in the Mott insulator. We measure a very long spin relaxation lifetime of many microseconds in the Mott insulating state, orders of magnitude longer than that of charge excitations. Our studies highlight the value of using moire superlattices beyond graphene to explore correlated physics.	[Regan, Emma C.; Wang, Danqing; Jin, Chenhao; Utama, M. Iqbal; Gao, Beini; Wei, Xin; Zhao, Sihan; Zhao, Wenyu; Zhang, Zuocheng; Carlstrom, Johan D.; Crommie, Michael; Zettl, Alex; Wang, Feng] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Regan, Emma C.; Wang, Danqing] Univ Calif Berkeley, Grad Grp Appl Sci & Technol, Berkeley, CA 94720 USA; [Regan, Emma C.; Wang, Danqing; Utama, M. Iqbal; Crommie, Michael; Zettl, Alex; Wang, Feng] Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA; [Jin, Chenhao] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY USA; [Utama, M. Iqbal] Univ Calif Berkeley, Dept Mat Sci & Engn, Berkeley, CA 94720 USA; [Gao, Beini] Huazhong Univ Sci & Technol, Dept Phys, Wuhan, Peoples R China; [Wei, Xin] Univ Chinese Acad Sci, Sch Phys, Beijing, Peoples R China; [Yumigeta, Kentaro; Blei, Mark; Tongay, Sefaattin] Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ USA; [Carlstrom, Johan D.] Lund Univ, Dept Phys, Lund, Sweden; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Crommie, Michael; Zettl, Alex; Wang, Feng] Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA; [Crommie, Michael; Zettl, Alex; Wang, Feng] Lawrence Berkeley Natl Lab, Berkeley, CA USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Huazhong University of Science & Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Arizona State University; Arizona State University-Tempe; Lund University; National Institute for Materials Science; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Wang, F (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.; Wang, F (corresponding author), Lawrence Berkeley Natl Lab, Mat Sci Div, Berkeley, CA 94720 USA.; Wang, F (corresponding author), Univ Calif Berkeley, Kavli Energy NanoSci Inst, Berkeley, CA 94720 USA.; Wang, F (corresponding author), Lawrence Berkeley Natl Lab, Berkeley, CA USA.	fengwang76@berkeley.edu	Tongay, Sefaattin/E-6388-2011; JIN, CHENHAO/GYV-5734-2022; Utama, Iqbal Bakti/AAM-4849-2020; wang, Feng/I-5727-2015; Tongay, Sefaattin/ACQ-5306-2022; Zhao, Sihan/AAL-3313-2021	Utama, Iqbal Bakti/0000-0002-4454-8348; wang, Feng/0000-0001-8369-6194; Tongay, Sefaattin/0000-0001-8294-984X; Zhao, Sihan/0000-0003-2162-734X; Wei, Xin/0000-0003-2383-4297; Gao, Beini/0000-0002-4544-4962	US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division [DE-AC02-05-CH11231, KCWF16]; US Army Research Office under MURI [W911NF-17-1-0312]; Department of Defense through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Kavli Postdoctoral Fellowship; NSF [DMR-1552220, 1838443]	US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); US Army Research Office under MURI(MURI); Department of Defense through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program; Kavli Postdoctoral Fellowship; NSF(National Science Foundation (NSF))	We thank S. Li for discussions, S. Wang for help with device fabrication, and C. Stansbury and C. Wang for assistance with figure design. This work was supported primarily by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, Materials Sciences and Engineering Division under contract number DE-AC02-05-CH11231 (van der Waals heterostructures programme, KCWF16). The device fabrication was also supported by the US Army Research Office under MURI award W911NF-17-1-0312. E.C.R. acknowledges support from the Department of Defense through the National Defense Science & Engineering Graduate Fellowship (NDSEG) Program. C.J. acknowledges support from a Kavli Postdoctoral Fellowship. S.T. acknowledges support from NSF DMR-1552220 and 1838443.	Allain A, 2015, NAT MATER, V14, P1195, DOI 10.1038/nmat4452; Back P, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.237404; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen G, 2019, TUNABLE CORRELATED C; Chen GR, 2019, NATURE, V572, P215, DOI 10.1038/s41586-019-1393-y; Chen GR, 2019, NAT PHYS, V15, P237, DOI 10.1038/s41567-018-0387-2; Fallahazad B, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.086601; Giannetti C, 2016, ADV PHYS, V65, P58, DOI 10.1080/00018732.2016.1194044; Grover T, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245121; Hiraki K, 1998, PHYS REV LETT, V80, P4737, DOI 10.1103/PhysRevLett.80.4737; HUBBARD J, 1978, PHYS REV B, V17, P494, DOI 10.1103/PhysRevB.17.494; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Jin CH, 2019, NATURE, V567, P76, DOI 10.1038/s41586-019-0976-y; Jin CH, 2018, SCIENCE, V360, P893, DOI 10.1126/science.aao3503; Kadantsev ES, 2012, SOLID STATE COMMUN, V152, P909, DOI 10.1016/j.ssc.2012.02.005; Kim J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700518; Kumar N, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.161403; Law KT, 2017, P NATL ACAD SCI USA, V114, P6996, DOI 10.1073/pnas.1706769114; Lenarcic Z, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.016401; Li YL, 2013, NANO LETT, V13, P3329, DOI 10.1021/nl401561r; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; MOTT NF, 1949, P PHYS SOC LOND A, V62, P416, DOI 10.1088/0370-1298/62/7/303; Okamoto H, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.125102; Padhi B, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.205141; Padhi B, 2018, NANO LETT, V18, P6175, DOI 10.1021/acs.nanolett.8b02033; Roch JG, 2019, NAT NANOTECHNOL, V14, P432, DOI 10.1038/s41565-019-0397-y; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wigner E, 1934, PHYS REV, V46, P1002, DOI 10.1103/PhysRev.46.1002; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Zhang Y., 2019, MOIRE QUANTUM CHEM	36	287	290	44	414	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					359	+		10.1038/s41586-020-2092-4	http://dx.doi.org/10.1038/s41586-020-2092-4			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188951	Green Submitted			2022-12-28	WOS:000520778000011
J	Tricou, V; Saez-Llorens, X; Yu, D; Rivera, L; Jimeno, J; Villarreal, AC; Dato, E; de Suman, OS; Montenegro, N; DeAntonio, R; Mazara, S; Vargas, M; Mendoza, D; Rauscher, M; Brose, M; Lefevre, I; Tuboi, S; Borkowski, A; Wallace, D				Tricou, Vianney; Saez-Llorens, Xavier; Yu, Delia; Rivera, Luis; Jimeno, Jose; Villarreal, Ana Cecilia; Dato, Epiphany; de Suman, Onix Saldana; Montenegro, Nathali; DeAntonio, Rodrigo; Mazara, Sonia; Vargas, Maria; Mendoza, Debbie; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Tuboi, Suely; Borkowski, Astrid; Wallace, Derek			Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2-17 years: a randomised, placebo-controlled, phase 2 trial	LANCET			English	Article							HEALTHY-CHILDREN; ADULTS; CANDIDATE; RECOMBINANT; DENVAX; ASIA	Background An unmet clinical need remains for an effective tetravalent dengue vaccine suitable for all age groups, regardless of serostatus. We assessed the immunogenicity and safety of three different dose schedules of a tetravalent dengue vaccine (TAK-003) over a 48-month period in children living in dengue-endemic countries. Methods We did a large, phase 2, double-blind, placebo-controlled trial at three sites in the Dominican Republic, Panama, and the Philippines. Healthy participants aged 2-17 years were randomly assigned 1:2:5:1 using an interactive web response system with stratification by age to receive either a two-dose primary series (days 1 and 91), one primary dose (day 1), one primary dose plus booster (days 1 and 365), or placebo. Participants and relevant study personnel were masked to the random assignment until completion of the study at month 48. To maintain masking, TAK-003 recipients were administered placebo doses when appropriate. The primary objective was assessment of neutralising geometric mean titres for each serotype to month 48 assessed in the per-protocol immunogenicity subset. Secondary safety endpoints included proportions of participants with serious adverse events and symptomatic virologically confirmed dengue. This study is registered with ClinicalTrials.gov, NCT02302066. Findings Between Dec 5, 2014, and Feb 13, 2015, 1800 children were randomly assigned to the following groups: two-dose primary series (n=201), one primary dose (n=398), one primary dose plus 1-year booster (n=1002), and placebo (n=199). Of them, 1479 (82%) participants completed the 48-month study. Immunogenicity endpoints were assessed in 562 participants enrolled in the immunogenicity subset, of whom 509 were included in the per-protocol subset. At month 48, antibody titres remained elevated in all TAK-003 groups compared with placebo, irrespective of baseline serostatus. At month 48, geometric mean titres were 378 (95% CI 226-632) in two-dose, 421 (285-622) in one-dose, 719 (538-960) in one-dose plus 1-year booster, and 100 (50-201) in placebo recipients against DENV 1; 1052 (732-1511), 1319 (970-1794), 1200 (927-1553), and 208 (99-437) against DENV 2; 183 (113-298), 201 (135-298), 288 (211-392), and 71 (37-139) against DENV 3; and 152 (97-239), 164 (114-236), 219 (165-290), and 46 (26-82) against DENV 4; and tetravalent seropositivity rate was 89% (79-96), 86% (80-92), 97% (93-99), and 60% (47-72), respectively. Virologically confirmed dengue was recorded in 37 (2%) TAK-003 and 13 (7%) placebo participants, with a relative risk of 0.35 (0.19-0.65). No vaccine-related serious adverse events or severe dengue virus disease were reported. Interpretation TAK-003 elicited antibody responses against all four serotypes, which persisted to 48 months post-vaccination, regardless of baseline serostatus. No important safety risks were identified. We observed a long-term reduction in risk of symptomatic dengue virus disease in vaccinees. Results from this study provide a long-term safety database and support assessment of the vaccine in the ongoing phase 3 efficacy study.	[Tricou, Vianney; Rauscher, Martina; Brose, Manja; Lefevre, Inge; Borkowski, Astrid] Takeda Pharmaceut Int, CH-8152 Zurich, Switzerland; [Saez-Llorens, Xavier] Hosp Nino Dr Jose Renan Esquivel, Panama City, Panama; [Saez-Llorens, Xavier; DeAntonio, Rodrigo] Secretaria Nacl Ciencia Tecnol & Innovac, Sistema Nacl Invest, Panama City, Panama; [Yu, Delia; Dato, Epiphany] De La Salle Hlth Sci Inst, Cavite, Philippines; [Rivera, Luis; Mazara, Sonia; Vargas, Maria] Hosp Univ Maternidad Nuestra Senora Altagracia, Santo Domingo, Dominican Rep; [Jimeno, Jose; Villarreal, Ana Cecilia; de Suman, Onix Saldana; Montenegro, Nathali; DeAntonio, Rodrigo] Ctr Vacunac Int Cevaxin, Panama City, Panama; [Mendoza, Debbie] Takeda Vaccines, Singapore, Singapore; [Tuboi, Suely] Takeda Pharmaceut, Rio De Janeiro, Brazil; [Wallace, Derek] Takeda Vaccines, Cambridge, MA USA	Secretaria Nacional de Ciencia, Tecnologia e Innovacin (SENACYT); De La Salle University; De La Salle University Dasmarinas	Tricou, V (corresponding author), Takeda Pharmaceut Int, CH-8152 Zurich, Switzerland.	vianney.tricou@takeda.com	DeAntonio, Rodrigo/AAM-2032-2021; Tricou, Vianney/S-6101-2019	DeAntonio, Rodrigo/0000-0003-2586-4115; Tricou, Vianney/0000-0002-5465-8647	Takeda Vaccines	Takeda Vaccines	Takeda Vaccines.	Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Biswal S, 2020, LANCET; Biswal S, 2019, NEW ENGL J MED, V381, P2009, DOI 10.1056/NEJMoa1903869; Chu HY, 2015, J INFECT DIS, V212, P1618, DOI 10.1093/infdis/jiv258; George SL, 2015, J INFECT DIS, V212, P1032, DOI 10.1093/infdis/jiv179; Halstead S, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz062; Huang CYH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002243; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Osorio JE, 2016, EXPERT REV VACCINES, V15, P497, DOI 10.1586/14760584.2016.1128328; Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4; Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020; Pan American Health Organization, 2020, REP CAS DENG FEV AM; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; Rupp R, 2015, VACCINE, V33, P6351, DOI 10.1016/j.vaccine.2015.09.008; Saez-Llorens X, 2018, LANCET INFECT DIS, V18, P162, DOI 10.1016/S1473-3099(17)30632-1; Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4; Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; Tricou V, 2020, VACCINE, V38, P1513, DOI 10.1016/j.vaccine.2019.11.061; van der Schaar HM, 2009, IMMUNOBIOLOGY, V214, P613, DOI 10.1016/j.imbio.2008.11.008; Vigne C, 2017, HUM VACC IMMUNOTHER, V13, P2004, DOI 10.1080/21645515.2017.1333211; World Health Organization, 2018, REV SAGE REC US DENG; World Health Organization, 2019, DENG SEV DENG FACT S; Yoksan S, 1986, ARBOVIRUS RES AUSTR, P358; 2012, PROM ACC MED TECHN, P1	25	30	30	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2020	395	10234					1434	1443		10.1016/S0140-6736(20)30556-0	http://dx.doi.org/10.1016/S0140-6736(20)30556-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LO3LS	32197107				2022-12-28	WOS:000533530700020
J	Moore, C				Moore, Caroline			Prostate-specific membrane antigen PET-CT before radical treatment	LANCET			English	Editorial Material							CANCER		[Moore, Caroline] UCL, Urol Dept, London WC1E 6BT, England	University of London; University College London	Moore, C (corresponding author), UCL, Urol Dept, London WC1E 6BT, England.	caroline.moore@ucl.ac.uk	Moore, Caroline/T-2391-2017	Moore, Caroline/0000-0003-0202-7912				Boeve LMS, 2019, EUR UROL; Burdett S, 2019, EUR UROL, V76, P115, DOI 10.1016/j.eururo.2019.02.003; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Hofman MS, 2020, LANCET, V395, P1208, DOI 10.1016/S0140-6736(20)30314-7; Parker CC, 2018, LANCET, V392, P2353, DOI 10.1016/S0140-6736(18)32486-3; Preisser F, 2020, J UROLOGY, V203, P338, DOI 10.1097/JU.0000000000000504; Sooriakumaran P, 2017, BJU INT, V120, pE8, DOI 10.1111/bju.13925; van Leeuwen FWB, 2019, NAT REV UROL, V16, P159, DOI 10.1038/s41585-018-0140-8; Zumsteg ZS, 2015, EUR UROL, V67, P1009, DOI 10.1016/j.eururo.2014.09.028	9	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2020	395	10231					1170	1172		10.1016/S0140-6736(20)30527-4	http://dx.doi.org/10.1016/S0140-6736(20)30527-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LE6DW	32209450				2022-12-28	WOS:000526814200008
J	Kim, D; Jung, HJ; Park, IJ; Larson, BW; Dunfield, SP; Xiao, CX; Kim, J; Tong, JH; Boonmongkolras, P; Ji, SG; Zhang, F; Pae, SR; Kim, M; Kang, SB; Dravid, V; Berry, JJ; Kim, JY; Zhu, K; Kim, DH; Shin, B				Kim, Daehan; Jung, Hee Joon; Park, Ik Jae; Larson, Bryon W.; Dunfield, Sean P.; Xiao, Chuanxiao; Kim, Jekyung; Tong, Jinhui; Boonmongkolras, Passarut; Ji, Su Geun; Zhang, Fei; Pae, Seong Ryul; Kim, Minkyu; Kang, Seok Beom; Dravid, Vinayak; Berry, Joseph J.; Kim, Jin Young; Zhu, Kai; Kim, Dong Hoe; Shin, Byungha			Efficient, stable silicon tandem cells enabled by anion-engineered wide-bandgap perovskites	SCIENCE			English	Article							SOLAR-CELLS; GAP PEROVSKITES	Maximizing the power conversion efficiency (PCE) of perovskite/silicon tandem solar cells that can exceed the Shockley-Queisser single-cell limit requires a high-performing, stable perovskite top cell with a wide bandgap. We developed a stable perovskite solar cell with a bandgap of similar to 1.7 electron volts that retained more than 80% of its initial PCE of 20.7% after 1000 hours of continuous illumination. Anion engineering of phenethylammonium-based two-dimensional (2D) additives was critical for controlling the structural and electrical properties of the 2D passivation layers based on a lead iodide framework. The high PCE of 26.7% of a monolithic two-terminal wide-bandgap perovskite/silicon tandem solar cell was made possible by the ideal combination of spectral responses of the top and bottom cells.	[Kim, Daehan; Kim, Jekyung; Boonmongkolras, Passarut; Pae, Seong Ryul; Kim, Minkyu; Shin, Byungha] Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Daejeon 34141, South Korea; [Jung, Hee Joon; Dravid, Vinayak] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Park, Ik Jae; Ji, Su Geun; Kim, Jin Young] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 08826, South Korea; [Larson, Bryon W.; Dunfield, Sean P.; Xiao, Chuanxiao; Tong, Jinhui; Zhang, Fei; Berry, Joseph J.; Zhu, Kai; Kim, Dong Hoe] Natl Renewable Energy Lab, Golden, CO 80401 USA; [Dunfield, Sean P.] Univ Colorado Boulder, Mat Sci & Engn Program, Boulder, CO 80309 USA; [Kang, Seok Beom; Kim, Dong Hoe] Sejong Univ, Dept Nanotechnol & Adv Mat Engn, Seoul 05006, South Korea; [Berry, Joseph J.] Univ Colorado Boulder, Dept Phys, Boulder, CO 80309 USA; [Berry, Joseph J.] Univ Colorado Boulder, Renewable & Sustainable Energy Inst, Boulder, CO 80309 USA	Korea Advanced Institute of Science & Technology (KAIST); Northwestern University; Seoul National University (SNU); United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Colorado System; University of Colorado Boulder; Sejong University; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Shin, B (corresponding author), Korea Adv Inst Sci & Technol, Dept Mat Sci & Engn, Daejeon 34141, South Korea.; Kim, JY (corresponding author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 08826, South Korea.; Zhu, K; Kim, DH (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.; Kim, DH (corresponding author), Sejong Univ, Dept Nanotechnol & Adv Mat Engn, Seoul 05006, South Korea.	jykim.mse@snu.ac.kr; kai.zhu@nrel.gov; donghoe.k@sejong.ac.kr; byungha@kaist.ac.kr	Kang, Seok Beom/HGA-0547-2022; Jung, Hee Joon/AAA-9421-2019; ZHANG, FEI/L-3977-2019; Kim, Jin Young/B-7077-2012; Zhu, Kai/AAF-1940-2019; Kim, Jin Young/AAB-6510-2020; Dravid, Vinayak/B-6688-2009; Al-Betar, Mohammed Azmi/E-9758-2017	Jung, Hee Joon/0000-0001-7963-0897; ZHANG, FEI/0000-0002-3774-9520; Kim, Jin Young/0000-0001-7728-3182; Kim, Jin Young/0000-0001-7746-9972; berry, joseph/0000-0003-3874-3582; Al-Betar, Mohammed Azmi/0000-0003-1980-1791; Boonmongkolras, Passarut/0000-0002-5081-7794; Kim, Daehan/0000-0003-2359-1862; Kim, Jekyung/0000-0002-8250-5736; Park, Ik Jae/0000-0002-3377-6249; Dunfield, Sean/0000-0002-2855-4457	National Research Foundation of Korea (NRF) - Korean government's Ministry of Science and ICT (MSIT) [NRF-2018R1A5A1025594, 2017R1A2B3010474, 2020R1A2C3008111]; Korea Institute of Energy Technology Evaluation and Planning (KETEP); Ministry of Trade, Industry and Energy (MOTIE) of the Republic of Korea [20183010014470, 20193091010310]; Nano-Material Technology Development Program (Green Nano Technology Development Program) through the NRF - Ministry of Education, Science and Technology [2018M3A7B4065662, 2019M3D1A2104109]; Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office, U.S. Department of Energy (DOE) [DE-AC36-08GO28308]; Alliance for Sustainable Energy, Limited Liability Company (LLC); National Renewable Energy Laboratory; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF) [ECCS-1542205]; MRSEC IRG2 program [NSF DMR-1720139]; International Institute for Nanotechnology (IIN); Keck Foundation; State of Illinois, through the IIN	National Research Foundation of Korea (NRF) - Korean government's Ministry of Science and ICT (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea); Korea Institute of Energy Technology Evaluation and Planning (KETEP)(Korea Institute of Energy Technology Evaluation & Planning (KETEP)); Ministry of Trade, Industry and Energy (MOTIE) of the Republic of Korea(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Nano-Material Technology Development Program (Green Nano Technology Development Program) through the NRF - Ministry of Education, Science and Technology(National Research Foundation of Korea); Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office, U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Alliance for Sustainable Energy, Limited Liability Company (LLC); National Renewable Energy Laboratory(United States Department of Energy (DOE)); Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF); MRSEC IRG2 program; International Institute for Nanotechnology (IIN); Keck Foundation(W.M. Keck Foundation); State of Illinois, through the IIN	This work was supported by the National Research Foundation of Korea (NRF) funded by the Korean government's Ministry of Science and ICT (MSIT) (nos. NRF-2018R1A5A1025594, 2017R1A2B3010474, and 2020R1A2C3008111); the Korea Institute of Energy Technology Evaluation and Planning (KETEP) and the Ministry of Trade, Industry and Energy (MOTIE) of the Republic of Korea (nos. 20183010014470 and 20193091010310); and the Nano-Material Technology Development Program (Green Nano Technology Development Program) through the NRF funded by the Ministry of Education, Science and Technology (nos. 2018M3A7B4065662 and 2019M3D1A2104109). The work at the National Renewable Energy Laboratory was supported by De-risking Halide Perovskite Solar Cells program of the National Center for Photovoltaics, funded by Office of Energy Efficiency and Renewable Energy, Solar Energy Technologies Office, U.S. Department of Energy (DOE) under contract no. DE-AC36-08GO28308 with Alliance for Sustainable Energy, Limited Liability Company (LLC), the Manager and Operator of the National Renewable Energy Laboratory. The views expressed in the article do not necessarily represent the views of the DOE or the U.S. government. The U.S. government retains and the publisher, by accepting the article for publication, acknowledges that the U.S. government retains a nonexclusive, paid-up, irrevocable, worldwide license to publish or reproduce the published form of this work, or allow others to do so, for U.S. government purposes. This work made use of the EPIC facility of Northwestern University's NUANCE Center, which has received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF ECCS-1542205); the MRSEC IRG2 program (NSF DMR-1720139) at the Materials Research Center; the International Institute for Nanotechnology (IIN); the Keck Foundation; and the State of Illinois, through the IIN.	Barthel J, 2018, ULTRAMICROSCOPY, V193, P1, DOI 10.1016/j.ultramic.2018.06.003; Bush KA, 2018, ACS ENERGY LETT, V3, P2173, DOI 10.1021/acsenergylett.8b01201; Bush KA, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.9; Chen B, 2019, JOULE, V3, P177, DOI 10.1016/j.joule.2018.10.003; Christians JA, 2018, NAT ENERGY, V3, P68, DOI 10.1038/s41560-017-0067-y; Croll A, 2017, J CRYST GROWTH, V466, P16, DOI 10.1016/j.jcrysgro.2017.03.006; Fassl P, 2018, ENERG ENVIRON SCI, V11, P3380, DOI 10.1039/c8ee01136b; Gunawan O, 2019, NATURE, V575, P151, DOI 10.1038/s41586-019-1632-2; Hoke ET, 2015, CHEM SCI, V6, P613, DOI 10.1039/c4sc03141e; Ishikawa R, 2011, NAT MATER, V10, P278, DOI 10.1038/NMAT2957; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Jost M, 2018, ENERG ENVIRON SCI, V11, P3511, DOI 10.1039/c8ee02469c; Jung HJ, 2018, ADV MATER, V30, DOI 10.1002/adma.201802769; Jung M, 2018, ENERG ENVIRON SCI, V11, P2188, DOI 10.1039/c8ee00995c; Kim D, 2016, J PHYS CHEM C, V120, P21330, DOI 10.1021/acs.jpcc.6b08744; Kim DH, 2019, JOULE, V3, P1734, DOI 10.1016/j.joule.2019.04.012; Kim DH, 2017, ADV MATER, V29, DOI 10.1002/adma.201606831; Kim YC, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201502104; Kim YM, 2012, NAT MATER, V11, P888, DOI [10.1038/NMAT3393, 10.1038/nmat3393]; Lee JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02432-0; Leijtens T, 2018, NAT ENERGY, V3, P828, DOI 10.1038/s41560-018-0190-4; Liu YH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw2543; Mailoa JP, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4914179; Mazzarella L, 2019, ADV ENERGY MATER, V9, DOI 10.1002/aenm.201803241; Pae SR, 2018, ACS APPL MATER INTER, V10, P534, DOI 10.1021/acsami.7b14499; Park IJ, 2019, JOULE, V3, P807, DOI 10.1016/j.joule.2018.11.017; Reid OG, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa9559; Rong YG, 2018, SCIENCE, V361, DOI 10.1126/science.aat8235; Sahli F, 2018, NAT MATER, V17, P820, DOI 10.1038/s41563-018-0115-4; Sahli F, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201701609; Shen HP, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau9711; Shen JX, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201801027; Tong JH, 2019, SCIENCE, V364, P475, DOI 10.1126/science.aav7911; Wang ZP, 2017, NAT ENERGY, V2, DOI 10.1038/nenergy.2017.135; Werner J, 2016, J PHYS CHEM LETT, V7, P161, DOI 10.1021/acs.jpclett.5b02686; Xu JX, 2020, SCIENCE, V367, P1097, DOI 10.1126/science.aaz5074; Zheng JH, 2018, ENERG ENVIRON SCI, V11, P2432, DOI 10.1039/c8ee00689j	37	213	216	48	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2020	368	6487					155	+		10.1126/science.aba3433	http://dx.doi.org/10.1126/science.aba3433			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LB9YI	32217753	Bronze			2022-12-28	WOS:000524986900039
J	Kandel, N; Chungong, S; Omaar, A; Xing, J				Kandel, Nirmal; Chungong, Stella; Omaar, Abbas; Xing, Jun			Health security capacities in the context of COVID-19 outbreak: an analysis of International Health Regulations annual report data from 182 countries	LANCET			English	Article								Background Public health measures to prevent, detect, and respond to events are essential to control public health risks, including infectious disease outbreaks, as highlighted in the International Health Regulations (IHR). In light of the outbreak of 2019 novel coronavirus disease (COVID-19), we aimed to review existing health security capacities against public health risks and events. Methods We used 18 indicators from the IHR State Party Annual Reporting (SPAR) tool and associated data from national SPAR reports to develop five indices: (1) prevent, (2) detect, (3) respond, (4) enabling function, and (5) operational readiness. We used SPAR 2018 data for all of the indicators and categorised countries into five levels across the indices, in which level 1 indicated the lowest level of national capacity and level 5 the highest. We also analysed data at the regional level (using the six geographical WHO regions). Findings Of 182 countries, 52 (28%) had prevent capacities at levels 1 or 2, and 60 (33%) had response capacities at levels 1 or 2. 81 (45%) countries had prevent capacities and 78 (43%) had response capacities at levels 4 or 5, indicating that these countries were operationally ready. 138 (76%) countries scored more highly in the detect index than in the other indices. 44 (24%) countries did not have an effective enabling function for public health risks and events, including infectious disease outbreaks (7 [4%] at level 1 and 37 [ 20%] at level 2). 102 (56%) countries had level 4 or level 5 enabling function capacities in place. 32 (18%) countries had low readiness (2 [1%] at level 1 and 30 [17%] at level 2), and 104 (57%) countries were operationally ready to prevent, detect, and control an outbreak of a novel infectious disease (66 [36%] at level 4 and 38 [21%] at level 5). Interpretation Countries vary widely in terms of their capacity to prevent, detect, and respond to outbreaks. Half of all countries analysed have strong operational readiness capacities in place, which suggests that an effective response to potential health emergencies could be enabled, including to COVID-19. Findings from local risk assessments are needed to fully understand national readiness capacities in relation to COVID-19. Capacity building and collaboration between countries are needed to strengthen global readiness for outbreak control. Copyright (C) 2020. World Health Organization. Published by Elsevier Ltd. All rights reserved.	[Kandel, Nirmal; Chungong, Stella; Omaar, Abbas; Xing, Jun] WHO, WHO Hlth Emergency Program, CH-1211 Geneva, Switzerland	World Health Organization	Kandel, N (corresponding author), WHO, WHO Hlth Emergency Program, CH-1211 Geneva, Switzerland.	kandeln@who.int						[Anonymous], 2020, RISK COMM COMM ENG R; Benecke Olivia, 2019, Glob Pediatr Health, V6, p2333794X19862949, DOI 10.1177/2333794X19862949; Biezen R, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6729-x; Faas AJ, 2015, HUM ORGAN, V74, P287, DOI 10.17730/0018-7259-74.4.287; Gesesew HA, 2016, ETHIOP J HEALTH SCI, V26, P331, DOI 10.4314/ejhs.v26i4.5; Ghulam A, 2021, BIOSCI RES, V18, P47; Global Preparedness Monitoring Board, 2019, ANN REP GLOB PREP HL; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kandel N, 2019, WEEKLY EPIDEMIOLOGIC; Kandel N, 2017, LANCET GLOB HEALTH, V5, pE857, DOI 10.1016/S2214-109X(17)30264-4; Kandel Nirmal, 2015, J Bus Contin Emer Plan, V8, P295; Lim SS, 2018, LANCET, V392, P1217, DOI 10.1016/S0140-6736(18)31941-X; Montgomery JM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6769-2; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Richman D. D., 2016, CLIN VIROLOGY; Semenza JC, 2019, TRANSBOUND EMERG DIS, V66, P1855, DOI 10.1111/tbed.13211; Talisuna A, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001312; Tam T, 2018, Can Commun Dis Rep, V44, P98; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; The World Bank, 2017, WORLD BANK WHO HALF; United Nations Office for Disaster Risk Reduction, KEY CONC DET PROB RI; WHO, 2020, LAB DIAGN NOV COR; WHO, IHR COUNTR CAP ASS M; WHO, 2019, GLOB HLTH OBS INT HL; WHO, 2020, RESP COMM SPREAD COV, DOI DOI 10.1017/DMP.2020.166; WHO, 2019, THEM PAP STAT COUNTR; WHO, 2019, IHR STAT PART SELF A; Who.int. WHO, 2016, INT HLTH REG 2005; World Health Organisation, 2019, MAN EP KEY FACTS MAJ; World Health Organization, 2020, WHO; World Health Organization, 2020, 36 WHO; World Health Organization, 2018, IHR MON EV FRAM; World Health Organization, 2018, PRIOR DIS RES DEV EM; World Health Organization, 2019, WHO BENCHM INT HLTH; World Health Organization (WHO), 2018, STAT PART SELF ASS A; World Health Organization [WHO], 2017, STRAT FRAM EM PREP; World Health Organization (WHO), 2020, 2019 NOVEL CORONAVIR; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	38	229	239	11	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1047	1053		10.1016/S0140-6736(20)30553-5	http://dx.doi.org/10.1016/S0140-6736(20)30553-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY5YW	32199075	Green Published, Bronze			2022-12-28	WOS:000522650100032
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: UK lockdown is "crucial" to saving lives, say doctors and scientists	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	39	39	1	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1204	10.1136/bmj.m1204	http://dx.doi.org/10.1136/bmj.m1204			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209548	Bronze			2022-12-28	WOS:000523764200013
J	Day, M				Day, Michael			Covid-19: European drugs agency to review safety of ibuprofen	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086; European Medicines Agency, 2020, EMA GIV ADV US NONST; Park S, MANAGING FEVER ADULT	3	44	47	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1168	10.1136/bmj.m1168	http://dx.doi.org/10.1136/bmj.m1168			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205306	Bronze			2022-12-28	WOS:000523764100012
J	Salles, A; Choo, EK				Salles, Arghavan; Choo, Esther K.			Queen Bee phenomenon: a consequence of the hive	LANCET			English	Editorial Material									[Salles, Arghavan] Stanford Univ, Sch Med, Palo Alto, CA 94304 USA; [Choo, Esther K.] Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Portland, OR 97239 USA	Stanford University; Oregon Health & Science University	Choo, EK (corresponding author), Oregon Hlth & Sci Univ, Ctr Policy & Res Emergency Med, Portland, OR 97239 USA.	chooe@ohsu.edu@choo_ek		Choo, Esther/0000-0001-8847-5745					0	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					940	940						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199482				2022-12-28	WOS:000521744600015
J	Qiao, AN; Han, S; Li, XM; Li, ZX; Zhao, PS; Dai, AT; Chang, R; Tai, LH; Tan, QX; Chu, XJ; Ma, LM; Thorsen, TS; Reedtz-Runge, S; Yang, DH; Wang, MW; Sexton, PM; Wootten, D; Sun, F; Zhao, Q; Wu, BL				Qiao, Anna; Han, Shuo; Li, Xinmei; Li, Zhixin; Zhao, Peishen; Dai, Antao; Chang, Rulve; Tai, Linhua; Tan, Qiuxiang; Chu, Xiaojing; Ma, Limin; Thorsen, Thor Seneca; Reedtz-Runge, Steffen; Yang, Dehua; Wang, Ming-Wei; Sexton, Patrick M.; Wootten, Denise; Sun, Fei; Zhao, Qiang; Wu, Beili			Structural basis of G(s) and G(i) recognition by the human glucagon receptor	SCIENCE			English	Article							CRYO-EM STRUCTURE; GLP-1 RECEPTOR; SPECIFICITY; ACTIVATION; COMPLEX; CELLS; CA2+	Class B G protein-coupled receptors, an important class of therapeutic targets, signal mainly through the G(s) class of heterotrimeric G proteins, although they do display some promiscuity in G protein binding. Using cryo-electron microscopy, we determined the structures of the human glucagon receptor (GCGR) bound to glucagon and distinct classes of heterotrimeric G proteins, G(s) or G(i1). These two structures adopt a similar open binding cavity to accommodate G(s) and G(i1). The G(s) binding selectivity of GCGR is explained by a larger interaction interface, but there are specific interactions that affect G(i) more than G(s) binding. Conformational differences in the receptor intracellular loops were found to be key selectivity determinants. These distinctions in transducer engagement were supported by mutagenesis and functional studies.	[Qiao, Anna; Han, Shuo; Dai, Antao; Tan, Qiuxiang; Chu, Xiaojing; Ma, Limin; Yang, Dehua; Wang, Ming-Wei; Wu, Beili] Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China; [Qiao, Anna; Han, Shuo; Tan, Qiuxiang; Chu, Xiaojing; Ma, Limin; Zhao, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Qiao, Anna; Li, Xinmei; Tai, Linhua; Wang, Ming-Wei; Sun, Fei; Zhao, Qiang; Wu, Beili] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Li, Xinmei; Tai, Linhua; Sun, Fei] Chinese Acad Sci, Natl Lab Biomacromol, Natl Ctr Prot Sci Beijing, CAS Ctr Excellence Biomacromol,Inst Biophys, Beijing 100101, Peoples R China; [Li, Zhixin; Chang, Rulve; Wang, Ming-Wei; Sexton, Patrick M.; Wootten, Denise] Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China; [Zhao, Peishen; Sexton, Patrick M.; Wootten, Denise] Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Zhao, Peishen; Sexton, Patrick M.; Wootten, Denise] Monash Univ, Dept Pharmacol, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Dai, Antao; Yang, Dehua; Wang, Ming-Wei] Chinese Acad Sci, Natl Ctr Drug Screening, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Thorsen, Thor Seneca; Reedtz-Runge, Steffen] Novo Nordisk AS, DK-2760 Malov, Denmark; [Wang, Ming-Wei; Wu, Beili] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China; [Sun, Fei] Chinese Acad Sci, Ctr Biol Imaging, Inst Biophys, Beijing 100101, Peoples R China; [Zhao, Qiang; Wu, Beili] Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Fudan University; Monash University; Monash University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Novo Nordisk; ShanghaiTech University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences	Wu, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, CAS Key Lab Receptor Res, Shanghai 201203, Peoples R China.; Zhao, Q (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China.; Sun, F; Zhao, Q; Wu, BL (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Sun, F (corresponding author), Chinese Acad Sci, Natl Lab Biomacromol, Natl Ctr Prot Sci Beijing, CAS Ctr Excellence Biomacromol,Inst Biophys, Beijing 100101, Peoples R China.; Wootten, D (corresponding author), Fudan Univ, Sch Pharm, Shanghai 201203, Peoples R China.; Wootten, D (corresponding author), Monash Univ, Drug Discovery Biol, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.; Wootten, D (corresponding author), Monash Univ, Dept Pharmacol, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia.; Wu, BL (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China.; Sun, F (corresponding author), Chinese Acad Sci, Ctr Biol Imaging, Inst Biophys, Beijing 100101, Peoples R China.; Zhao, Q; Wu, BL (corresponding author), Chinese Acad Sci, CAS Ctr Excellence Biomacromol, Beijing 100101, Peoples R China.	denise.wootten@monash.edu; feisun@ibp.ac.cn; zhaoq@simm.ac.cn; beiliwu@simm.ac.cn	Wootten, Denise/ABD-5703-2021; Yang, Dehua/M-5789-2019; Zhao, Peishen/AFQ-6840-2022	Wootten, Denise/0000-0003-4563-1642; Tan, Qiuxiang/0000-0001-5006-7148; Zhao, Peishen/0000-0003-0185-0595; Li, Xinmei/0000-0002-6202-218X; han, shuo/0000-0003-0760-0183; li, zhixin/0000-0002-4288-5025; Tai, Linhua/0000-0001-8435-9683	National Key R&D Program of China [2018YFA0507000, 2017YFA0504703]; National Science Foundation of China [31825010, 81525024, 31830020, 81872915, 81773792]; CAS Strategic Priority Research Program [XDB37000000]; Shanghai Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee [18XD1404800]; National Science & Technology Major Project-Key New Drug Creation and Manufacturing Program, China [2018ZX09711002]; Shanghai Science and Technology Development Fund [16ZR1407100]; Australian National Health and Medical Research Council (NHMRC) [1126857, 1150083]; National Mega R&D Program for Drug Discovery [2018ZX09735-001]	National Key R&D Program of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS Strategic Priority Research Program; Shanghai Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee; National Science & Technology Major Project-Key New Drug Creation and Manufacturing Program, China; Shanghai Science and Technology Development Fund; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); National Mega R&D Program for Drug Discovery	Supported by the National Key R&D Program of China 2018YFA0507000 (B.W., Q.Z., and M.-W.W.) and 2017YFA0504703 (F.S.); National Science Foundation of China grants 31825010 (B.W.), 81525024 (Q.Z.), 31830020 (F.S.), 81872915 (M.-W.W.), and 81773792 (D.Y.); CAS Strategic Priority Research Program XDB37000000 (B.W.); Shanghai Outstanding Academic Leaders Plan of Shanghai Municipal Science and Technology Committee 18XD1404800 (Q.Z. and S.H.); the National Science & Technology Major Project-Key New Drug Creation and Manufacturing Program, China grant 2018ZX09711002 (L.M., D.Y., and M.-W.W.); the National Mega R&D Program for Drug Discovery grant 2018ZX09735-001 (M.-W.W.); Shanghai Science and Technology Development Fund 16ZR1407100 (A.D.); and Australian National Health and Medical Research Council (NHMRC) grants 1126857 (D.W.) and 1150083 (P.M.S.). D.W. is an NHMRC Senior Research Fellow and P.M.S. is a Senior Principal Research Fellow.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aromataris EC, 2006, J PHYSIOL-LONDON, V573, P611, DOI 10.1113/jphysiol.2006.109819; Bagger JI, 2011, DIABETES OBES METAB, V13, P965, DOI 10.1111/j.1463-1326.2011.01427.x; Blank T, 2003, J NEUROSCI, V23, P700, DOI 10.1523/JNEUROSCI.23-02-00700.2003; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Culhane KJ, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00264; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Draper-Joyce CJ, 2018, NATURE, V558, P559, DOI 10.1038/s41586-018-0236-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Garcia-Nafria J, 2019, MOL CELL ENDOCRINOL, V488, P1, DOI 10.1016/j.mce.2019.02.006; Garcia-Nafria J, 2018, NATURE, V558, P620, DOI 10.1038/s41586-018-0241-9; GRADY T, 1987, J BIOL CHEM, V262, P15514; Grammatopoulos DK, 2001, J NEUROCHEM, V76, P509, DOI 10.1046/j.1471-4159.2001.00067.x; Habegger KM, 2010, NAT REV ENDOCRINOL, V6, P689, DOI 10.1038/nrendo.2010.187; Hansen LH, 1998, AM J PHYSIOL-CELL PH, V274, pC1552, DOI 10.1152/ajpcell.1998.274.6.C1552; HANSEN LH, 1998, AM J PHYSIOL, V274, pC155; Kang YY, 2018, NATURE, V558, P553, DOI 10.1038/s41586-018-0215-y; Kato HE, 2019, NATURE, V572, P80, DOI 10.1038/s41586-019-1337-6; Kilts JD, 2000, CIRC RES, V87, P705, DOI 10.1161/01.RES.87.8.705; Koehl A, 2018, NATURE, V558, P547, DOI 10.1038/s41586-018-0219-7; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kumar KK, 2019, CELL, V176, P448, DOI 10.1016/j.cell.2018.11.040; Liang YL, 2018, NATURE, V561, P492, DOI 10.1038/s41586-018-0535-y; Liang YL, 2018, NATURE, V555, P121, DOI 10.1038/nature25773; Liang YL, 2017, NATURE, V546, P118, DOI 10.1038/nature22327; Maeda S, 2019, SCIENCE, V364, P552, DOI 10.1126/science.aaw5188; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Monnier C, 2011, EMBO J, V30, P32, DOI 10.1038/emboj.2010.270; Okashah N, 2019, P NATL ACAD SCI USA, V116, P12054, DOI 10.1073/pnas.1905993116; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rose AS, 2014, J AM CHEM SOC, V136, P11244, DOI 10.1021/ja5055109; Rossi M, 2018, J CLIN INVEST, V128, P746, DOI 10.1172/JCI94505; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; UNSON CG, 1987, P NATL ACAD SCI USA, V84, P4083, DOI 10.1073/pnas.84.12.4083; VanRampelbergh J, 1997, BBA-MOL CELL RES, V1357, P249, DOI 10.1016/S0167-4889(97)00028-1; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wootten D, 2017, CHEM REV, V117, P111, DOI 10.1021/acs.chemrev.6b00049; Wootten D, 2016, BIOCHEM PHARMACOL, V118, P68, DOI 10.1016/j.bcp.2016.08.015; Wootten D, 2016, CELL, V165, P1632, DOI 10.1016/j.cell.2016.05.023; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Xu YZ, 2009, J RECEPT SIG TRANSD, V29, P318, DOI 10.3109/10799890903295150; Zhang HN, 2018, NATURE, V553, P106, DOI 10.1038/nature25153; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang Y, 2017, NATURE, V546, P248, DOI 10.1038/nature22394; Zhao LH, 2019, SCIENCE, V364, P148, DOI 10.1126/science.aav7942; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	53	59	60	9	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1346	+		10.1126/science.aaz5346	http://dx.doi.org/10.1126/science.aaz5346			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193322				2022-12-28	WOS:000522167400046
J	Rimmer, A				Rimmer, Abi			Covid-19: GPs can stop health checks for over 75s and routine medicine reviews	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Care Quality Commission, 2020, CQC STOP ROUT INSP F; General Medical Council, 2020, TWITTER; Kanani N, 2020, COMMUNICATION   0319	3	11	11	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2020	368								m1157	10.1136/bmj.m1157	http://dx.doi.org/10.1136/bmj.m1157			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DO	32198147	Bronze			2022-12-28	WOS:000523763600014
J	Starke, J; Ehlers, TA; Schaller, M				Starke, J.; Ehlers, T. A.; Schaller, M.			Latitudinal effect of vegetation on erosion rates identified along western South America	SCIENCE			English	Article							COSMOGENIC NUCLIDES; DENUDATION RATES; BE-10 CONCENTRATIONS; LANDSCAPE RESPONSE; HYPERARID ATACAMA; SCALING FACTORS; HALF-LIFE; CLIMATE; NORTHERN; ANDES	Vegetation influences erosion by stabilizing hillslopes and accelerating weathering, thereby providing a link between the biosphere and Earth's surface. Previous studies investigating vegetation effects on erosion have proved challenging owing to poorly understood interactions between vegetation and other factors, such as precipitation and surface processes. We address these complexities along 3500 kilometers of the extreme climate and vegetation gradient of the Andean Western Cordillera (6 degrees S to 36 degrees S latitude) using 86 cosmogenic radionuclide-derived, millennial time scale erosion rates and multivariate statistics. We identify a bidirectional response to vegetation's influence on erosion whereby correlations between vegetation cover and erosion range from negative (dry, sparsely vegetated settings) to positive (wetter, more vegetated settings). These observations result from competing interactions between precipitation and vegetation on erosion in each setting.	[Starke, J.; Ehlers, T. A.; Schaller, M.] Univ Tubingen, Dept Geosci, D-72074 Tubingen, Germany	Eberhard Karls University of Tubingen	Ehlers, TA (corresponding author), Univ Tubingen, Dept Geosci, D-72074 Tubingen, Germany.	todd.ehlers@uni-tuebingen.de		Schaller, Mirjam/0000-0003-4638-0873; Ehlers, Todd/0000-0001-9436-0303	European Research Council (ERC) [CoG 615703]; German Science Foundation (DFG) priority research program EarthShape [EH329/17-2]	European Research Council (ERC)(European Research Council (ERC)European Commission); German Science Foundation (DFG) priority research program EarthShape(German Research Foundation (DFG))	This study was funded by a European Research Council (ERC) consolidator grant (CoG 615703) and the German Science Foundation (DFG) priority research program EarthShape (EH329/17-2) to T.A.E.	Abbuhl LM, 2011, EARTH SURF PROC LAND, V36, P1464, DOI 10.1002/esp.2164; Abbuhl LM, 2010, GEOMORPHOLOGY, V123, P257, DOI 10.1016/j.geomorph.2010.07.017; Acosta VT, 2015, LITHOSPHERE-US, V7, P408, DOI 10.1130/L402.1; Aguilar G, 2014, QUAT GEOCHRONOL, V19, P163, DOI 10.1016/j.quageo.2013.01.011; Alward RD, 1999, SCIENCE, V283, P229, DOI 10.1126/science.283.5399.229; Audin L, 2003, J QUATERNARY SCI, V18, P681, DOI 10.1002/jqs.787; Balco G, 2013, QUAT GEOCHRONOL, V18, P149, DOI 10.1016/j.quageo.2013.02.002; Berner RA, 1997, SCIENCE, V276, P544, DOI 10.1126/science.276.5312.544; Bookhagen B., 2013, HIGH RESOLUTION SPAT; Braucher R, 2011, EARTH PLANET SC LETT, V309, P1, DOI 10.1016/j.epsl.2011.06.036; Broxton PD, 2014, J APPL METEOROL CLIM, V53, P1996, DOI 10.1175/JAMC-D-13-0356.1; Buitenwerf R, 2015, NAT CLIM CHANGE, V5, P364, DOI 10.1038/nclimate2533; Carretier S, 2015, GEOL SOC SPEC PUBL, V399, P401, DOI 10.1144/SP399.16; Carretier S, 2013, GEOLOGY, V41, P195, DOI 10.1130/G33735.1; Carretier S, 2015, EARTH SURF PROC LAND, V40, P1719, DOI 10.1002/esp.3748; Chmeleff J, 2010, NUCL INSTRUM METH B, V268, P192, DOI 10.1016/j.nimb.2009.09.012; Cooper FJ, 2016, GEOLOGY, V44, P675, DOI 10.1130/G38254.1; Derry LA, 2006, SCIENCE, V311, P1386, DOI 10.1126/science.1124183; Dietrich WE, 2006, NATURE, V439, P411, DOI 10.1038/nature04452; Dunai TJ, 2000, EARTH PLANET SC LETT, V176, P157, DOI 10.1016/S0012-821X(99)00310-6; Dunne J, 1999, GEOMORPHOLOGY, V27, P3, DOI 10.1016/S0169-555X(98)00086-5; Farias M., 2008, 7 INT S AND GEOD ISA; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Ganopolski A, 1998, SCIENCE, V280, P1916, DOI 10.1126/science.280.5371.1916; Garcin Y, 2017, EARTH PLANET SC LETT, V459, P58, DOI 10.1016/j.epsl.2016.11.017; Granger DE, 2014, ELEMENTS, V10, P369, DOI 10.2113/gselements.10.5.369; Hartmann J, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004370; Hartmann K, 2009, QUATERN INT, V194, P28, DOI 10.1016/j.quaint.2007.06.037; Hoke GD, 2007, TECTONICS, V26, DOI 10.1029/2006TC002082; Jordan TE, 2010, TECTONICS, V29, DOI 10.1029/2010TC002661; Jungers MC, 2013, EARTH PLANET SC LETT, V371, P125, DOI 10.1016/j.epsl.2013.04.005; Jvreskog, 1996, APPL FACTOR ANAL NAT; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Knott M., 1999, LATENT VARIABLE MODE; Kober F, 2009, EARTH SURF PROC LAND, V34, P398, DOI 10.1002/esp.1748; Kober F, 2006, GEOL SOC AM SPEC PAP, V398, P75, DOI 10.1130/2006.2398(05); Korschinek G, 2010, NUCL INSTRUM METH B, V268, P187, DOI 10.1016/j.nimb.2009.09.020; LANGBEIN W. B., 1958, TRANS AMER GEOPHYS UNION, V39, P1076; Mahadevan S., 1996, RELIABILITY BASED ME; McPhillips D, 2013, J GEOPHYS RES-EARTH, V118, P2488, DOI 10.1002/2013JF002837; Mishra AK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211325; Mutz SG, 2018, EARTH SURF DYNAM, V6, P271, DOI 10.5194/esurf-6-271-2018; Nishiizumi K, 2005, EARTH PLANET SC LETT, V237, P499, DOI 10.1016/j.epsl.2005.05.032; Norton KP, 2009, EARTH SURF PROC LAND, V34, P145, DOI 10.1002/esp.1700; Olen SM, 2016, EARTH PLANET SC LETT, V445, P57, DOI 10.1016/j.epsl.2016.03.047; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Perron JT, 2017, ANNU REV EARTH PL SC, V45, P561, DOI 10.1146/annurev-earth-060614-105405; Phillips FM, 2016, QUAT GEOCHRONOL, V31, P220, DOI 10.1016/j.quageo.2015.10.005; Placzek CJ, 2010, EARTH PLANET SC LETT, V295, P12, DOI 10.1016/j.epsl.2010.03.006; Reber R, 2017, TERRA NOVA, V29, P282, DOI 10.1111/ter.12274; RENARD KG, 1994, J HYDROL, V157, P287, DOI 10.1016/0022-1694(94)90110-4; Retallack GJ, 1997, SCIENCE, V276, P583, DOI 10.1126/science.276.5312.583; Riebe CS, 2001, GEOLOGY, V29, P447, DOI 10.1130/0091-7613(2001)029<0447:MCCOER>2.0.CO;2; Rivas-Martinez S, 2011, INT J GEOBOT RES, V1, P21, DOI [10.5616/ijgr110002, DOI 10.5616/IJGR110002]; Schaller M, 2018, EARTH PLANET SC LETT, V489, P111, DOI 10.1016/j.epsl.2018.02.026; Schlunegger F, 2006, TERRA NOVA, V18, P217, DOI 10.1111/j.1365-3121.2006.00682.x; Schmid M, 2018, EARTH SURF DYNAM, V6, P859, DOI 10.5194/esurf-6-859-2018; Schwanghart W, 2014, EARTH SURF DYNAM, V2, P1, DOI 10.5194/esurf-2-1-2014; SCHWARTZMAN DW, 1989, NATURE, V340, P457, DOI 10.1038/340457a0; Starke J, 2017, J GEOPHYS RES-EARTH, V122, P1949, DOI 10.1002/2016JF004153; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; von Blanckenburg F, 2014, ELEMENTS, V10, P341, DOI 10.2113/gselements.10.5.341; Worner G, 2000, REV GEOL CHILE, V27, P205; Zeng N, 2002, J CLIMATE, V15, P3474, DOI 10.1175/1520-0442(2002)015&lt;3474:NDIACV&gt;2.0.CO;2	66	26	27	10	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1358	+		10.1126/science.aaz0840	http://dx.doi.org/10.1126/science.aaz0840			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193324				2022-12-28	WOS:000522167400048
J	Bailey, CS; Rasoulinejad, P; Taylor, D; Sequeira, K; Miller, T; Watson, J; Rosedale, R; Bailey, SI; Gurr, KR; Siddiqi, F; Glennie, A; Urquhart, JC				Bailey, Chris S.; Rasoulinejad, Parham; Taylor, David; Sequeira, Keith; Miller, Thomas; Watson, Jim; Rosedale, Richard; Bailey, Stewart I.; Gurr, Kevin R.; Siddiqi, Fawaz; Glennie, Andrew; Urquhart, Jennifer C.			Surgery versus Conservative Care for Persistent Sciatica Lasting 4 to 12 Months	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUMBAR DISC HERNIATION; NONOPERATIVE TREATMENT; WORKERS-COMPENSATION; OUTCOMES; TRIAL; DURATION; PAIN; DISKECTOMY; GUIDELINE; DIAGNOSIS	In a single-center, randomized trial involving 128 patients with sciatica lasting 4 to 12 months and lumbar disk herniation, diskectomy was superior to conservative care in reducing leg-pain intensity at 6 months after enrollment. Among the patients assigned to conservative care, 34% crossed over to undergo surgery. Background The treatment of chronic sciatica caused by herniation of a lumbar disk has not been well studied in comparison with acute disk herniation. Data are needed on whether diskectomy or a conservative approach is better for sciatica that has persisted for several months. Methods In a single-center trial, we randomly assigned patients with sciatica that had lasted for 4 to 12 months and lumbar disk herniation at the L4-L5 or L5-S1 level in a 1:1 ratio to undergo microdiskectomy or to receive 6 months of standardized nonoperative care followed by surgery if needed. Surgery was performed by spine surgeons who used conventional microdiskectomy techniques. The primary outcome was the intensity of leg pain on a visual analogue scale (ranging from 0 to 10, with higher scores indicating more severe pain) at 6 months after enrollment. Secondary outcomes were the score on the Oswestry Disability Index, back and leg pain, and quality-of-life scores at 6 weeks, 3 months, 6 months, and 1 year. Results From 2010 through 2016, a total of 790 patients were screened; of those patients, 128 were enrolled, with 64 in each group. Among the patients assigned to undergo surgery, the median time from randomization to surgery was 3.1 weeks; of the 64 patients in the nonsurgical group, 22 (34%) crossed over to undergo surgery at a median of 11 months after enrollment. At baseline, the mean score for leg-pain intensity was 7.7 in the surgical group and 8.0 in the nonsurgical group. The primary outcome of the leg-pain intensity score at 6 months was 2.8 in the surgical group and 5.2 in the nonsurgical group (adjusted mean difference, 2.4; 95% confidence interval, 1.4 to 3.4; P<0.001). Secondary outcomes including the score on the Owestry Disability Index and pain at 12 months were in the same direction as the primary outcome. Nine patients had adverse events associated with surgery, and one patient underwent repeat surgery for recurrent disk herniation. Conclusions In this single-center trial involving patients with sciatica lasting more than 4 months and caused by lumbar disk herniation, microdiskectomy was superior to nonsurgical care with respect to pain intensity at 6 months of follow-up. (Funded by Physicians' Services Incorporated Foundation; ClinicalTrials.gov number, NCT01335646.).)	[Bailey, Chris S.; Rasoulinejad, Parham; Taylor, David; Bailey, Stewart I.; Gurr, Kevin R.; Siddiqi, Fawaz; Glennie, Andrew; Urquhart, Jennifer C.] Western Univ, Schulich Sch Med & Dent, London Hlth Sci Ctr, Dept Surg, London, ON, Canada; [Rasoulinejad, Parham] Western Univ, Schulich Sch Med & Dent, London Hlth Sci Ctr, Occupat Hlth & Safety, London, ON, Canada; [Bailey, Chris S.; Rasoulinejad, Parham; Taylor, David; Bailey, Stewart I.; Gurr, Kevin R.; Siddiqi, Fawaz; Glennie, Andrew] St Josephs Hosp, Lawson Hlth Res Inst, London, ON, Canada; [Sequeira, Keith] St Josephs Hosp, Parkwood Inst, Reg Rehabil & Spinal Cord Injury Outpatients Park, London, ON, Canada; [Miller, Thomas] St Josephs Hosp, Dept Phys Med & Rehabil, London, ON, Canada; [Watson, Jim] St Josephs Hosp, Dept Anesthesia & Perioperat Med, London, ON, Canada	London Health Sciences Centre; Western University (University of Western Ontario); London Health Sciences Centre; Western University (University of Western Ontario); McGill University; Western University (University of Western Ontario); McGill University; Western University (University of Western Ontario); McGill University; Western University (University of Western Ontario); McGill University; Western University (University of Western Ontario)	Bailey, CS (corresponding author), London Hlth Sci Ctr, E1-317,800 Commissioners Rd, London, ON N6A 4G5, Canada.	chris.-bailey@-lhsc.-on.-ca	Urquhart, Jennifer/Q-7604-2016; Bailey, Christopher/L-7522-2015	Urquhart, Jennifer/0000-0002-9393-814X; Bailey, Christopher/0000-0001-5508-8415; Glennie, R. Andrew/0000-0002-7548-1334	Physicians' Services Incorporated Foundation	Physicians' Services Incorporated Foundation	Supported by a grant from the Physicians' Services Incorporated Foundation.	Atlas SJ, 2007, SPINE, V32, P2019, DOI 10.1097/BRS.0b013e318133d69b; Atlas SJ, 2010, SPINE, V35, P89, DOI 10.1097/BRS.0b013e3181c68047; Bendo JA, 2006, ORTHOPAEDIC KNOWLEDG, P289; Buttermann GR, 2004, J BONE JOINT SURG AM, V86A, P670, DOI 10.2106/00004623-200404000-00002; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Fairbank JCT, 2000, SPINE, V25, P2940, DOI 10.1097/00007632-200011150-00017; Grevitt M, 1997, J BONE JOINT SURG BR, V79B, P48, DOI 10.1302/0301-620X.79B1.1269; Hopman WM, 2000, CAN MED ASSOC J, V163, P265; Kreiner DS, 2014, SPINE J, V14, P180, DOI 10.1016/j.spinee.2013.08.003; Lurie JD, 2008, SPINE, V33, P2663, DOI 10.1097/BRS.0b013e31818cb0db; Ng LCL, 2004, J BONE JOINT SURG BR, V86B, P546, DOI 10.1302/0301-620X.86B4.14419; Nygaard OP, 2000, J NEUROSURG, V92, P131, DOI 10.3171/spi.2000.92.2.0131; Osterman H, 2006, SPINE, V31, P2409; Peul WC, 2008, BRIT MED J, V336, P1355, DOI 10.1136/bmj.a143; Peul WC, 2007, NEW ENGL J MED, V356, P2245, DOI 10.1056/NEJMoa064039; Poitras S, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-54; Quon JA, 2013, SPINE J, V13, P1736, DOI 10.1016/j.spinee.2013.05.038; Rihn JA, 2011, J BONE JOINT SURG AM, V93A, P1906, DOI 10.2106/JBJS.J.00878; Weinstein JN, 2006, JAMA-J AM MED ASSOC, V296, P2441, DOI 10.1001/jama.296.20.2441; Weinstein JN, 2008, SPINE, V33, P2789, DOI 10.1097/BRS.0b013e31818ed8f4	20	63	64	4	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1093	1102		10.1056/NEJMoa1912658	http://dx.doi.org/10.1056/NEJMoa1912658			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW7AJ	32187469	Bronze			2022-12-28	WOS:000521333700009
J	Eaton, L				Eaton, Lynn			No reduction in stillbirths, deaths, and injuries in babies for three years, finds review	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2020	368								m1120	10.1136/bmj.m1120	http://dx.doi.org/10.1136/bmj.m1120			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DM	32193283				2022-12-28	WOS:000523763400006
J	Wise, J				Wise, Jacqui			The BMJ Awards 2020: Innovation in quality improvement	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2020	368								m961	10.1136/bmj.m961	http://dx.doi.org/10.1136/bmj.m961			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DM	32193280				2022-12-28	WOS:000523763400001
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: all non-urgent elective surgery is suspended for at least three months in England	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		NHS England and NHS Improvement, 2020, COMMUNICATION   0317	1	172	176	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m1106	10.1136/bmj.m1106	http://dx.doi.org/10.1136/bmj.m1106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188602	Bronze			2022-12-28	WOS:000523763100013
J	Okike, K; Chan, PH; Prentice, HA; Paxton, EW; Burri, RA				Okike, Kanu; Chan, Priscilla H.; Prentice, Heather A.; Paxton, Elizabeth W.; Burri, Robert A.			Association Between Uncemented vs Cemented Hemiarthroplasty and Revision Surgery Among Patients With Hip Fracture	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FEMORAL-NECK FRACTURES; ARTHROPLASTY; FIXATION; TRIAL	Importance Consensus guidelines and systematic reviews have suggested that cemented fixation is more effective than uncemented fixation in hemiarthroplasty for displaced femoral neck fractures. Given that these recommendations are based on research performed outside the United States, it is uncertain whether these findings also reflect the US experience. Objective To compare the outcomes associated with cemented vs uncemented hemiarthroplasty in a large US integrated health care system. Design, Setting, and Participants Retrospective cohort study of 12 491 patients aged 60 years and older who underwent hemiarthroplasty treatment of a hip fracture between 2009 and 2017 at 1 of the 36 hospitals owned by Kaiser Permanente, a large US health maintenance organization. Patients were followed up until membership termination, death, or the study end date of December 31, 2017. Exposures Hemiarthroplasty (prosthetic replacement of the femoral head) fixation via bony growth into a porous-coated implant (uncemented) or with cement. Main Outcomes and Measures The primary outcome measure was aseptic revision, defined as any reoperation performed after the index procedure involving exchange of the existing implant for reasons other than infection. Secondary outcomes were mortality (in-hospital, postdischarge, and overall), 90-day medical complications, 90-day emergency department visits, and 90-day unplanned readmissions. Results Among 12 491 patients in the study cohort who underwent hemiarthroplasty for hip fracture (median age, 83 years; 8660 women [69.3%]), 6042 (48.4%) had undergone uncemented fixation and 6449 (51.6%) had undergone cemented fixation, and the median length of follow-up was 3.8 years. In the multivariable regression analysis controlling for confounders, uncemented fixation was associated with a significantly higher risk of aseptic revision (cumulative incidence at 1 year after operation, 3.0% vs 1.3%; absolute difference, 1.7% [95% CI, 1.1%-2.2%]; hazard ratio [HR], 1.77 [95% CI, 1.43-2.19]; P < .001). Of the 6 prespecified secondary end points, none showed a statistically significant difference between groups, including in-hospital mortality (1.7% for uncemented fixation vs 2.0% for cemented fixation; HR, 0.94 [95% CI, 0.73-1.21]; P = .61) and overall mortality (cumulative incidence at 1 year after operation: 20.0% for uncemented fixation vs 22.8% for cemented fixation; HR, 0.95 [95% CI, 0.90-1.01]; P = .08). Conclusions and Relevance Among patients with hip fracture treated with hemiarthroplasty in a large US integrated health care system, uncemented fixation, compared with cemented fixation, was associated with a statistically significantly higher risk of aseptic revision. These findings suggest that US surgeons should consider cemented fixation in the hemiarthroplasty treatment of displaced femoral neck fractures in the absence of contraindications.	[Okike, Kanu] Kaiser Permanente, Hawaii Permanente Med Grp, 3288 Moanalua Rd, Honolulu, HI 96819 USA; [Chan, Priscilla H.; Prentice, Heather A.; Paxton, Elizabeth W.] Kaiser Permanente, Surg Outcomes & Anal Dept, San Diego, CA USA; [Burri, Robert A.] Kaiser Permanente, Permanente Med Grp, San Rafael, CA USA	Kaiser Permanente; Permanente Medical Groups; Kaiser Permanente; Kaiser Permanente; Permanente Medical Groups	Okike, K (corresponding author), Kaiser Permanente, Hawaii Permanente Med Grp, 3288 Moanalua Rd, Honolulu, HI 96819 USA.	okike@post.harvard.edu	Paxton, Elizabeth/GXH-9981-2022	Prentice, Heather/0000-0002-2200-6564; Paxton, Elizabeth/0000-0003-1941-8186				Abdulkarim A, 2013, ORTHOP REV, V5, P34, DOI 10.4081/or.2013.e8; Agency for Healthcare Research and Quality, AHRQ QUAL IND; American Academy of Orthopaedic Surgeons, 2014, MAN HIP FRACT ELD EV; American Joint Replacement Registry, ANN REP 2018; American Society of Anesthesiologists, ASA PHYS STAT CLASS; Austin PC, 2016, CIRCULATION, V133, P601, DOI 10.1161/CIRCULATIONAHA.115.017719; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Baig Muhammad Nouman, 2017, BMJ Case Rep, V2017, DOI 10.1136/bcr-2017-220158; Bhandari M, 2003, J BONE JOINT SURG AM, V85A, P1673, DOI 10.2106/00004623-200309000-00004; Bhandari M, 2019, NEW ENGL J MED, V381, P2199, DOI 10.1056/NEJMoa1906190; DeAngelis JP, 2012, J ORTHOP TRAUMA, V26, P135, DOI 10.1097/BOT.0b013e318238b7a5; Donaldson AJ, 2009, BRIT J ANAESTH, V102, P12, DOI 10.1093/bja/aen328; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ertefaie A, 2017, PHARMACOEPIDEM DR S, V26, P357, DOI 10.1002/pds.4158; Frenken M R M, 2018, Eur J Orthop Surg Traumatol, V28, P1305, DOI 10.1007/s00590-018-2202-2; Huang HH, 2019, CLIN ORTHOP RELAT R, V477, P1750, DOI 10.1097/CORR.0000000000000729; Inacio Maria C S, 2015, Perm J, V19, P29, DOI 10.7812/TPP/14-231; Inngul C, 2015, BONE JOINT J, V97B, P1475, DOI 10.1302/0301-620X.97B11.36248; Ju DG, 2017, J BONE JOINT SURG AM, V99, P1932, DOI 10.2106/JBJS.16.01247; Karrholm J, NZ JOINT REGISTRY 18; Maciejewski ML, 2019, JAMA-J AM MED ASSOC, V321, P2124, DOI 10.1001/jama.2019.5646; Murray DW, 2013, BONE JOINT J, V95B, P51, DOI 10.1302/0301-620X.95B11.32976; National Joint Registry, 15 ANN REP 2018; Okike K, 2017, J BONE JOINT SURG AM, V99, P1547, DOI 10.2106/JBJS.16.01133; Parker MI, 2010, J BONE JOINT SURG BR, V92B, P116, DOI 10.1302/0301-620X.92B1.22753; Parker MJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001706.pub4; Paxton EW, 2017, J SHOULDER ELB SURG, V26, pE137, DOI 10.1016/j.jse.2017.02.003; Rosen H., CLIN MANIFESTATIONS; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Swedish Hip Arthroplasty Register, 2017, SWED HIP ARTHR REG A; Taylor F, 2012, J BONE JOINT SURG AM, V94A, P577, DOI 10.2106/JBJS.K.00006; Vertullo CJ, 2019, J BONE JOINT SURG AM, V101, P1261, DOI 10.2106/JBJS.18.01350; White IR, 2009, STAT MED, V28, P1982, DOI 10.1002/sim.3618	34	25	26	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1077	1084		10.1001/jama.2020.1067	http://dx.doi.org/10.1001/jama.2020.1067			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181848	Bronze, Green Published			2022-12-28	WOS:000521968800020
J	Prochazka, AV				Prochazka, Allan V.			Review: Automated mobile phone text messaging increases smoking cessation (moderate evidence) Comment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Prochazka, Allan V.] Univ Colorado, Sch Med, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Boulder	Prochazka, AV (corresponding author), Univ Colorado, Sch Med, Boulder, CO 80309 USA.							Akbar S, 2020, J AM MED INFORM ASSN, V27, P330, DOI 10.1093/jamia/ocz175; Cole-Lewis H, 2017, TOB CONTROL, V26, P683, DOI 10.1136/tobaccocontrol-2016-052945; Siu AL, 2015, ANN INTERN MED, V163, P622, DOI 10.7326/M15-2023	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC33	JC33		10.7326/ACPJ202003170-033	http://dx.doi.org/10.7326/ACPJ202003170-033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176899				2022-12-28	WOS:000520170800019
J	Zhang, ZB; Zhang, Y; Xia, SY; Kong, Q; Li, SY; Liu, X; Junqueira, C; Meza-Sosa, KF; Mok, TMY; Ansara, J; Sengupta, S; Yao, YD; Wu, H; Lieberman, J				Zhang, Zhibin; Zhang, Ying; Xia, Shiyu; Kong, Qing; Li, Shunying; Liu, Xing; Junqueira, Caroline; Meza-Sosa, Karla F.; Mok, Temy Mo Yin; Ansara, James; Sengupta, Satyaki; Yao, Yandan; Wu, Hao; Lieberman, Judy			Gasdermin E suppresses tumour growth by activating anti-tumour immunity	NATURE			English	Article							CANCER; DEATH; PYROPTOSIS; APOPTOSIS	Cleavage of the gasdermin proteins to produce pore-forming amino-terminal fragments causes inflammatory cell death (pyroptosis)(1). Gasdermin E (GSDME, also known as DFNA5)-mutated in familial ageing-related hearing loss(2)-can be cleaved by caspase 3, thereby converting noninflammatory apoptosis to pyroptosis in GSDME-expressing cells(3-5). GSDME expression is suppressed in many cancers, and reduced GSDME levels are associated with decreased survival as a result of breast cancer(2,6), suggesting that GSDME might be a tumour suppressor. Here we show that 20 of 22 tested cancer-associated GSDME mutations reduce GSDME function. In mice, knocking out Gsdme in GSDME-expressing tumours enhances, whereas ectopic expression in Gsdme-repressed tumours inhibits, tumour growth. This tumour suppression is mediated by killer cytotoxic lymphocytes: it is abrogated in perforin-deficient mice or mice depleted of killer lymphocytes. GSDME expression enhances the phagocytosis of tumour cells by tumour-associated macrophages, as well as the number and functions of tumour-infiltrating natural-killer and CD8(+) T lymphocytes. Killer-cell granzyme B also activates caspase-independent pyroptosis in target cells by directly cleaving GSDME at the same site as caspase 3. Uncleavable or pore-defective GSDME proteins are not tumour suppressive. Thus, tumour GSDME acts as a tumour suppressor by activating pyroptosis, enhancing anti-tumour immunity. The gasdermin E protein is shown to act as a tumour suppressor: it is cleaved by caspase 3 and granzyme B and leads to pyroptosis of cancer cells, provoking an immune response to the tumour.	[Zhang, Zhibin; Zhang, Ying; Xia, Shiyu; Liu, Xing; Junqueira, Caroline; Meza-Sosa, Karla F.; Mok, Temy Mo Yin; Ansara, James; Wu, Hao; Lieberman, Judy] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Zhang, Zhibin; Zhang, Ying; Liu, Xing; Junqueira, Caroline; Meza-Sosa, Karla F.; Mok, Temy Mo Yin; Ansara, James; Sengupta, Satyaki; Lieberman, Judy] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Xia, Shiyu; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Kong, Qing] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Kong, Qing] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Li, Shunying; Yao, Yandan] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Breast Tumor Ctr, Guangzhou, Peoples R China; [Liu, Xing] Chinese Acad Sci, Inst Pasteur Shanghai, Ctr Microbes Dev & Hlth, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Junqueira, Caroline] Fundacao Oswaldo Cruz, Rene Rachou Inst, Belo Horizonte, MG, Brazil; [Meza-Sosa, Karla F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Lab Neuroimmunobiol, Dept Med Mol & Bioproc, Cuernavaca, Morelos, Mexico; [Mok, Temy Mo Yin] City Univ Hong Kong, Dept Biomed Sci, Hong Kong, Peoples R China; [Sengupta, Satyaki] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Sun Yat Sen University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Fundacao Oswaldo Cruz; Universidad Nacional Autonoma de Mexico; City University of Hong Kong; Harvard University; Dana-Farber Cancer Institute	Zhang, ZB; Lieberman, J (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Zhang, ZB; Lieberman, J (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	zhibin.zhang@childrens.harvard.edu; judy.lieberman@childrens.harvard.edu	Junqueira, Caroline/GVR-8109-2022; Meza-Sosa, Karla F/V-1439-2017; Sengupta, Satyaki/AAD-6065-2022; /C-4369-2009	Meza-Sosa, Karla F/0000-0002-0095-2357; /0000-0003-4898-2114; Junqueira, Caroline/0000-0003-0545-0986; Zhang, Zhibin/0000-0003-1349-2713; Zhang, Ying/0000-0002-1116-2182	NIH [R01 AI139914]; Charles A. King Trust Fellowship; Department of Defense Breast Cancer Breakthrough Fellowship Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust Fellowship; Department of Defense Breast Cancer Breakthrough Fellowship Award(United States Department of Defense)	We thank the US National Institutes of Health (NIH) Tetramer Core Facility for providing the eGFP tetramer. This work was supported by NIH grant R01 AI139914 (to H.W. and J.L.), a Charles A. King Trust Fellowship (to Z.Z.) and a Department of Defense Breast Cancer Breakthrough Fellowship Award (to Y.Z.). The mutations in GSDME primary tumours and primary human breast cancer and colorectal cancer expression analyses in this study are based upon data generated by The Cancer Genome Atlas (TCGA) Research Network (https://www.cancer.gov/tcga).	Aaes TL, 2016, CELL REP, V15, P274, DOI 10.1016/j.celrep.2016.03.037; Chowdhury D, 2008, ANNU REV IMMUNOL, V26, P389, DOI 10.1146/annurev.immunol.26.021607.090404; de Beeck KO, 2012, ANN OTO RHINOL LARYN, V121, P197; Dotiwala F, 2015, JOVE-J VIS EXP, DOI 10.3791/52911; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Goldman M., 2019, PREPRINT, DOI [10.1101/326470v6, 10.1101/326470v6:326470]; Kambara H, 2018, CELL REP, V22, P2924, DOI 10.1016/j.celrep.2018.02.067; Liu X, 2017, ADV IMMUNOL, V135, P81, DOI 10.1016/bs.ai.2017.02.002; Nagata S, 2018, ANNU REV IMMUNOL, V36, P489, DOI 10.1146/annurev-immunol-042617-053010; Palchaudhuri R, 2015, CELL REP, V13, P2027, DOI 10.1016/j.celrep.2015.10.042; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Rogers C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09397-2; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sollberger G, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar6689; Teng X, 2005, BIOORG MED CHEM LETT, V15, P5039, DOI 10.1016/j.bmcl.2005.07.077; Thiery Jerome, 2010, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0337s47; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wenzel SE, 2017, CELL, V171, P628, DOI 10.1016/j.cell.2017.09.044; Werfel TA, 2018, SEMIN IMMUNOPATHOL, V40, P545, DOI 10.1007/s00281-018-0698-5; Xia XJ, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1883-8	24	454	476	58	383	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					415	+		10.1038/s41586-020-2071-9	http://dx.doi.org/10.1038/s41586-020-2071-9		MAR 2020	22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188940	Green Accepted			2022-12-28	WOS:000519162500006
J	Brown, J; Makker, HK				Brown, James; Makker, Himender K.			An approach to excessive daytime sleepiness in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CLINICAL-PRACTICE GUIDELINE; AMERICAN-COLLEGE; BARIATRIC SURGERY; INSOMNIA DISORDER; STILL NEED; APNEA; PREVALENCE; WAKEFULNESS; MANAGEMENT		[Brown, James] Royal Free Hosp, London, England; [Makker, Himender K.] Univ Coll London Hosp, Dept Thorac Med, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London	Makker, HK (corresponding author), Univ Coll London Hosp, Dept Thorac Med, London, England.	himender.makker@nhs.net						Alajmi M, 2007, LUNG, V185, P67, DOI 10.1007/s00408-006-0117-x; American Academy of Sleep Medicine, 2014, DIAGNOSTIC CODING MA, V3rd; Ashrafian H, 2015, OBES SURG, V25, P1239, DOI 10.1007/s11695-014-1533-2; Billiard M, 2016, SLEEP MED REV, V29, P23, DOI 10.1016/j.smrv.2015.08.007; Brasure M, 2016, ANN INTERN MED, V165, P113, DOI 10.7326/M15-1782; British Lung Foundation, 2015, OBSTR SLEEP APN TOOL; British Thoracic Society, 2018, POS STAT DRIV OBSTR; Chapman JL, 2016, EUR RESPIR J, V47, P1420, DOI 10.1183/13993003.01509-2015; Chapman JL, 2014, THORAX, V69, P274, DOI 10.1136/thoraxjnl-2013-203796; Chattu VK, 2018, SLEEP SCI, V11, P56, DOI 10.5935/1984-0063.20180013; Chung F, 2016, CHEST, V149, P631, DOI 10.1378/chest.15-0903; Douglas NJ, 1998, THORAX, V53, P414, DOI 10.1136/thx.53.5.414; Driver and Vehicle Licensing Agency, 2016, ASS FITN DRIV GUID M; Faraco J, 2011, SLEEP MED RES, V2, P39, DOI [10.17241/smr.2011.2.2.39, DOI 10.17241/SMR.2011.2.2.39]; Ford ES, 2014, SLEEP, V37, P1283, DOI 10.5665/sleep.3914; Giles TL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001106.pub2; HORNE JA, 1995, BRIT MED J, V310, P565, DOI 10.1136/bmj.310.6979.565; Horvath CM, 2018, OBES SURG, V28, P2720, DOI 10.1007/s11695-018-3222-z; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kornum BR, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2016.100; LeBlanc M, 2009, SLEEP, V32, P1027, DOI 10.1093/sleep/32.8.1027; Leu-Semenescu S, 2014, SLEEP MED, V15, P681, DOI 10.1016/j.sleep.2014.01.021; National Institute for Health and Care Excellence, 2015, OBSTR SLEEP APN SYND; National Institute for Health and Care Excellence, 2017, NARC CAT AD PIT; Ohayon MM, 2012, ARCH GEN PSYCHIAT, V69, P71, DOI 10.1001/archgenpsychiatry.2011.1240; Ohayon MM, 2008, SLEEP MED REV, V12, P129, DOI 10.1016/j.smrv.2008.01.001; Ohayon MM, 2002, SLEEP MED REV, V6, P97, DOI 10.1053/smrv.2002.0186; Peppard PE, 2013, AM J EPIDEMIOL, V177, P1006, DOI 10.1093/aje/kws342; Qaseem A, 2016, ANN INTERN MED, V165, P125, DOI 10.7326/M15-2175; Qaseem A, 2013, ANN INTERN MED, V159, P471, DOI 10.7326/00030003-4819-159-7-201310010-00704; Shochat T, 1999, SLEEP, V22, pS359; Steier J, 2014, THORAX, V69, P390, DOI 10.1136/thoraxjnl-2013-203887; Sullivan SS, 2008, CHEST, V134, P854, DOI 10.1378/chest.08-0822; Sullivan SS, 2015, EXPERT OPIN EMERG DR, V20, P571, DOI 10.1517/14728214.2015.1115480; Szentkiralyi A, 2018, SLEEP BASEL, DOI [10.1093/sleep/zsy237.30551198, DOI 10.1093/SLEEP/ZSY237.30551198]; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705	36	1	1	1	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1047	10.1136/bmj.m1047	http://dx.doi.org/10.1136/bmj.m1047			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220833				2022-12-28	WOS:000523765200001
J	Hotchkiss, RS; Opal, SM				Hotchkiss, Richard S.; Opal, Steven M.			Activating Immunity to Fight a Foe - A New Path	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Could the immunomodulatory drugs that have produced impressive outcomes in cancer be used to boost immunity to counter infection in the context of sepsis? Recent findings in animal models provide some support for this strategy.	[Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Opal, Steven M.] Brown Univ, Dept Med, Alpert Med Sch, Providence, RI 02912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brown University	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.; Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA.				NIGMS NIH HHS [R35 GM126928] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Francois B, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98960; Hotchkiss RS, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.45; Opal SM, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1549-1; Vesely MCA, 2019, CELL, V178, P1176, DOI 10.1016/j.cell.2019.07.032; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009	5	28	29	2	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1270	1272		10.1056/NEJMcibr1917242	http://dx.doi.org/10.1056/NEJMcibr1917242			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY1UO	32212525	Green Published, Green Accepted			2022-12-28	WOS:000522357300015
J	Xu, SB; Yu, LL; Luo, X; Wang, MH; Chen, GH; Zhang, Q; Liu, WH; Zhou, ZY; Song, JH; Jing, HT; Huang, GY; Liang, FX; Wang, H; Wang, W				Xu, Shabei; Yu, Lingling; Luo, Xiang; Wang, Minghuan; Chen, Guohua; Zhang, Qing; Liu, Wenhua; Zhou, Zhongyu; Song, Jinhui; Jing, Huitao; Huang, Guangying; Liang, Fengxia; Wang, Hua; Wang, Wei			Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PLACEBO; ELECTROACUPUNCTURE; HEADACHE; PAIN; VALIDATION; DEPRESSION; INVENTORY; MECHANISM; EFFICACY; DISEASE	Objective - To assess the efficacy of manual acupuncture as prophylactic treatment for acupuncture naive patients with episodic migraine without aura. Design - Multicentre, randomised, controlled clinical trial with blinded participants, outcome assessment, and statistician. Setting - Seven hospitals in China, 5 June 2016 to 15 November 2018. Participants - 150 acupuncture naive patients with episodic migraine without aura. Interventions - 20 sessions of manual acupuncture at true acupuncture points plus usual care, 20 sessions of non-penetrating sham acupuncture at heterosegmental non-acupuncture points plus usual care, or usual care alone over 8 weeks. Main outcome measures - Change in migraine days and migraine attacks per four weeks during weeks 1-20 after randomisation compared with baseline (four weeks before randomisation). Results - Among 150 randomised patients (mean age 36.5 (SD 11.4) years; 123 (82%) women), 147 were included in the full analysis set. Compared with sham acupuncture, manual acupuncture resulted in a significantly greater reduction in migraine days at weeks 13 to 20 and a significantly greater reduction in migraine attacks at weeks 17 to 20. The reduction in mean number of migraine days was 3.5 (SD 2.5) for manual versus 2.4 (3.4) for sham (adjusted difference -1.4, 95% confidence interval -2.4 to -0.3; P=0.005) at weeks 13 to 16 and 3.9 (3.0) for manual versus 2.2 (3.2) for sham (adjusted difference -2.1, -2.9 to -1.2; P<0.001) at weeks 17 to 20. At weeks 17 to 20, the reduction in mean number of attacks was 2.3 (1.7) for manual versus 1.6 (2.5) for sham (adjusted difference -1.0, -1.5 to -0.5; P<0.001). No severe adverse events were reported. No significant difference was seen in the proportion of patients perceiving needle penetration between manual acupuncture and sham acupuncture (79% v 75%; P=0.891). Conclusions - Twenty sessions of manual acupuncture was superior to sham acupuncture and usual care for the prophylaxis of episodic migraine without aura. These results support the use of manual acupuncture in patients who are reluctant to use prophylactic drugs or when prophylactic drugs are ineffective, and it should be considered in future guidelines.	[Xu, Shabei; Yu, Lingling; Luo, Xiang; Wang, Minghuan; Wang, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Hubei, Peoples R China; [Chen, Guohua] Wuhan Hosp Tradit Chinese & Western Med, Wuhan Hosp 1, Dept Neurol, Wuhan, Hubei, Peoples R China; [Zhang, Qing; Huang, Guangying] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Integrated Tradit Chinese & Western Me, Wuhan, Hubei, Peoples R China; [Liu, Wenhua] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Sci Res Management, Wuhan, Hubei, Peoples R China; [Zhou, Zhongyu] Hubei Prov Hosp Tradit Chinese Med, Dept Acupuncture, Wuhan, Hubei, Peoples R China; [Song, Jinhui] Hubei Univ Med, Xiangyang Peoples Hosp 1, Dept Neurol, Xiangyang, Hubei, Peoples R China; [Jing, Huitao] Second Hosp Huangshi, Dept Rehabil Med, Huangshi, Hubei, Peoples R China; [Liang, Fengxia; Wang, Hua] Hubei Univ Chinese Med, Coll Acupuncture & Orthoped, Hubei Prov Collaborat Innovat Ctr Prevent Treatme, Wuhan 430065, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Hubei University of Medicine; Hubei University of Chinese Medicine	Wang, W (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Neurol, Wuhan 430030, Hubei, Peoples R China.	wwang@vip.126.com	Liang, Feng/GZK-4305-2022; Liang, Fenghua/HHM-3798-2022		National Natural Science Foundation of China [61327902]; Hubei University of Chinese Medicine/Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibustion	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei University of Chinese Medicine/Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibustion	This study was supported by a grant from the National Natural Science Foundation of China (61327902), and a project grant from Hubei University of Chinese Medicine/Hubei Provincial Collaborative Innovation Center of Preventive Treatment by Acupuncture and Moxibustion. Study sponsors were not involved in study design, data interpretation, writing the article, or the decision to submit the article for publication.	Allais G, 2002, HEADACHE, V42, P855, DOI 10.1046/j.1526-4610.2002.02203.x; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Birch S, 2006, J ALTERN COMPLEM MED, V12, P303, DOI 10.1089/acm.2006.12.303; Buysse D J, 1989, Psychiatry Res, V28, P193; CADDEN SW, 1983, BRAIN RES, V275, P1, DOI 10.1016/0006-8993(83)90412-2; Cole JC, 2007, QUAL LIFE RES, V16, P1231, DOI 10.1007/s11136-007-9217-1; Diener HC, 2006, LANCET NEUROL, V5, P310, DOI 10.1016/S1474-4422(06)70382-9; Dodick DW, 2018, JAMA-J AM MED ASSOC, V319, P1999, DOI 10.1001/jama.2018.4853; Facco E, 2008, HEADACHE, V48, P398, DOI 10.1111/j.1526-4610.2007.00916.x; Geisser ME, 1997, CLIN J PAIN, V13, P163, DOI 10.1097/00002508-199706000-00011; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; Hay SI, 2017, LANCET, V389, pE1; He W, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1580-z; Hocum JD, 2016, SCI REP-UK, V6, DOI 10.1038/srep36610; Kaptchuk TJ, 2011, PHILOS T R SOC B, V366, P1849, DOI 10.1098/rstb.2010.0385; Kim BH, 2017, BMC COMPLEM ALTERN M, V17, DOI 10.1186/s12906-017-1589-3; Kim SK, 2006, J PHYSIOL SCI, V56, P259, DOI 10.2170/physiolsci.SC002706; Le Bars D, 1992, Patol Fiziol Eksp Ter, P55; Leyfer OT, 2006, J ANXIETY DISORD, V20, P444, DOI 10.1016/j.janxdis.2005.05.004; Li Y, 2012, CAN MED ASSOC J, V184, P401, DOI 10.1503/cmaj.110551; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Linde K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-75; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; LIU X, 1986, PAIN, V24, P383, DOI 10.1016/0304-3959(86)90124-7; Lund Irene, 2006, Acupunct Med, V24, P13; Lundeberg Thomas, 2007, Acupunct Med, V25, P100; MacPherson H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093739; Makary MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18870-1; Mao JJ, 2007, EXPLORE-NY, V3, P372, DOI 10.1016/j.explore.2006.12.003; Massiou H, 2005, REV NEUROL-FRANCE, V161, P681; Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; Plaster R, 2014, ACUPUNCT MED, V32, P236, DOI 10.1136/acupmed-2013-010489; Pringsheim T, 2012, CAN J NEUROL SCI, V39, pS1; Puledda F, 2018, NEUROTHERAPEUTICS, V15, P336, DOI 10.1007/s13311-018-0623-6; Santoro A, 2017, NEUROL SCI, V38, P1779, DOI 10.1007/s10072-017-3054-y; Schliessbach J, 2011, PAIN MED, V12, P268, DOI 10.1111/j.1526-4637.2010.01051.x; Schulte LH, 2015, LANCET NEUROL, V14, P6, DOI 10.1016/S1474-4422(14)70295-9; Skljarevski V, 2018, JAMA NEUROL, V75, P187, DOI 10.1001/jamaneurol.2017.3859; Spaeth RB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/204259; Steiner TJ, 2018, J HEADACHE PAIN, V19, DOI 10.1186/s10194-018-0846-2; Stovner LJ, 2018, LANCET NEUROL, V17, P954, DOI 10.1016/S1474-4422(18)30499-X; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Thiese MS, 2016, J THORAC DIS, V8, pE928, DOI 10.21037/jtd.2016.08.16; Tsui P, 2002, ACUPUNCTURE ELECTRO, V27, P107, DOI 10.3727/036012902816026040; Wallasch TM, 2012, J ALTERN COMPLEM MED, V18, P777, DOI 10.1089/acm.2011.0308; Wang KL, 2010, COMPLEMENT THER MED, V18, P249, DOI 10.1016/j.ctim.2010.09.005; Wang LP, 2011, PAIN, V152, P1864, DOI 10.1016/j.pain.2011.04.006; Wang YY, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/920353; Zhao L, 2017, JAMA INTERN MED, V177, P508, DOI 10.1001/jamainternmed.2016.9378; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004	52	52	61	15	56	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m697	10.1136/bmj.m697	http://dx.doi.org/10.1136/bmj.m697			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213509	Green Published, hybrid			2022-12-28	WOS:000523764500003
J	Kahn, PA; Daggula, KR; Teng, W; Hintz, RC; Berland, G				Kahn, Peter A.; Daggula, Krishna R.; Teng, Wei; Hintz, Richard C.; Berland, Gretchen			Medical Exemption From Disconnection of Utilities in Connecticut	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HEALTH	This study uses data from the Connecticut Public Utilities Regulatory Authority to describe trends in medical exemptions from utility disconnection and characteristics and health care use of adults applying for such exemptions at a Yale New Haven Hospital care practice between 2011 and 2017.	[Kahn, Peter A.] Yale Sch Med, Dept Internal Med, New Haven, CT USA; [Daggula, Krishna R.; Teng, Wei; Hintz, Richard C.] Yale New Haven Hlth Syst, Joint Data Analyt Team, New Haven, CT USA; [Berland, Gretchen] Yale Sch Med, Dept Gen Internal Med, New Haven, CT USA	Yale University; Yale University; Yale University	Kahn, PA (corresponding author), Yale Univ, Sch Med, 20 York St,Tompkins 209, New Haven, CT 06504 USA.	peter.kahn@yale.edu			NCATS NIH HHS [UL1 TR001863] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		[Anonymous], 2017, 2017 2 REL LIHEAP BL; [Anonymous], 2017, MED PROV GUID UT LAW; Cook JT, 2008, PEDIATRICS, V122, pE867, DOI 10.1542/peds.2008-0286; Frank DA, 2006, PEDIATRICS, V118, pE1293, DOI 10.1542/peds.2005-2943; Hernandez D, 2015, ENVIRON JUSTICE, V8, P151, DOI 10.1089/env.2015.0015	5	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1189	1190		10.1001/jama.2020.0542	http://dx.doi.org/10.1001/jama.2020.0542			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207786	Bronze, Green Published			2022-12-28	WOS:000530807000023
J	Kmietowicz, Z				Kmietowicz, Zosia			Covid-19: Highest risk patients are asked to stay at home for 12 weeks	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1089; Public Health England, 2020, COVID 19 GUID SHIELD	2	16	16	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1170	10.1136/bmj.m1170	http://dx.doi.org/10.1136/bmj.m1170			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205309	Bronze			2022-12-28	WOS:000523764100014
J	Ouyang, M; Li, XY; Zhang, J; Feng, PQ; Pu, H; Kong, LX; Bai, ZC; Rong, LW; Xu, XM; Chi, W; Wang, Q; Chen, F; Lu, CM; Shen, JR; Zhang, LX				Ouyang, Min; Li, Xiaoyi; Zhang, Jing; Feng, Peiqiang; Pu, Hua; Kong, Lingxi; Bai, Zechen; Rong, Liwei; Xu, Xiumei; Chi, Wei; Wang, Qiang; Chen, Fan; Lu, Congming; Shen, Jianren; Zhang, Lixin			Liquid-Liquid Phase Transition Drives Intra-chloroplast Cargo Sorting	CELL			English	Article							SIGNAL RECOGNITION PARTICLE; PROTEIN-TRANSPORT; PRECURSOR PROTEINS; PEPTIDE-BINDING; ANKYRIN REPEAT; TRANSLOCATION; SEPARATION; IMPORT; PLASTIDS; FEATURES	In eukaryotic cells, organelle biogenesis is pivotal for cellular function and cell survival. Chloroplasts are unique organelles with a complex internal membrane network. The mechanisms of the migration of imported nuclear-encoded chloroplast proteins across the crowded stroma to thylakoid membranes are less understood. Here, we identified two Arabidopsis ankyrin-repeat proteins, STT1 and STT2, that specifically mediate sorting of chloroplast twin arginine translocation (cpTat) pathway proteins to thylakoid membranes. STT1 and STT2 form a unique heterodimer through interaction of their C-terminal ankyrin domains. Binding of cpTat substrate by N-terminal intrinsically disordered regions of STT complex induces liquid-liquid phase separation. The multivalent nature of STT oligomer is critical for phase separation. STT-Hcf106 interactions reverse phase separation and facilitate cargo targeting and translocation across thylakoid membranes. Thus, the formation of phase-separated droplets emerges as a novel mechanism of intra-chloroplast cargo sorting. Our findings highlight a conserved mechanism of phase separation in regulating organelle biogenesis.	[Ouyang, Min; Li, Xiaoyi; Zhang, Jing; Feng, Peiqiang; Pu, Hua; Kong, Lingxi; Bai, Zechen; Rong, Liwei; Chi, Wei; Shen, Jianren; Zhang, Lixin] Chinese Acad Sci, Photosynth Res Ctr, Inst Bot, Key Lab Photobiol, Beijing 100093, Peoples R China; [Xu, Xiumei; Wang, Qiang; Zhang, Lixin] Henan Univ, Sch Life Sci, State Key Lab Crop Stress Adaptat & Improvement, 85 Minglun St, Kaifeng 475001, Peoples R China; [Ouyang, Min] Hubei Univ, Sch Life Sci, State Key Lab Biocatalysis & Enzyme Engn, Wuhan 430062, Peoples R China; [Shen, Jianren] Okayama Univ, Res Inst Interdisciplinary Sci, Okayama 7008530, Japan; [Shen, Jianren] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Chen, Fan] Chinese Acad Sci, State Key Lab Mol Dev Biol, Beijing 100086, Peoples R China; [Lu, Congming] Shandong Agr Univ, Coll Life Sci, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China; [Zhang, Jing; Kong, Lingxi; Bai, Zechen; Rong, Liwei; Chi, Wei] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Henan University; Hubei University; Okayama University; Okayama University; Chinese Academy of Sciences; Shandong Agricultural University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, LX (corresponding author), Chinese Acad Sci, Photosynth Res Ctr, Inst Bot, Key Lab Photobiol, Beijing 100093, Peoples R China.; Zhang, LX (corresponding author), Henan Univ, Sch Life Sci, State Key Lab Crop Stress Adaptat & Improvement, 85 Minglun St, Kaifeng 475001, Peoples R China.	zhanglixin@henu.edu.cn	Zhang, Jing/HII-4294-2022; Xu, Xiumei/GLS-9586-2022	Chen, Fan/0000-0003-4482-3116; Zhang, Lixin/0000-0003-0268-6774	National Natural Science Foundation of China [31471267, 31130059]; State Key Basic Research and Development Plan of China [2015CB150100]; National Key Research and Development Program of China [2017YFA0503700]; Outstanding Talents Fund of Henan University, China; State Key Laboratory of Biocatalysis and Enzyme Engineering of Hubei University, China; Youth Innovation Promotion Association CAS, China [2013059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Basic Research and Development Plan of China(National Basic Research Program of China); National Key Research and Development Program of China; Outstanding Talents Fund of Henan University, China; State Key Laboratory of Biocatalysis and Enzyme Engineering of Hubei University, China; Youth Innovation Promotion Association CAS, China	We thank Professor Jean-David Rochaix and Professor Lei Wang for assisting in writing and discussion. We thank Professor Tom Rapoport for giving us valuable suggestions. We thank the Shanghai Synchrotron Radiation Facility (SSRF) BL17U. We thank Engineer Jingquan Li for technical assistance. This study was supported by the National Natural Science Foundation of China (31471267 and 31130059), the State Key Basic Research and Development Plan of China (2015CB150100), the National Key Research and Development Program of China (2017YFA0503700), the Outstanding Talents Fund of Henan University, China, the State Key Laboratory of Biocatalysis and Enzyme Engineering of Hubei University, China, and the Youth Innovation Promotion Association CAS, China (2013059).	Albert S, 1999, PLANT J, V17, P169, DOI 10.1046/j.1365-313X.1999.00361.x; Bae W, 2008, NAT CELL BIOL, V10, P220, DOI 10.1038/ncb1683; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Barros-Barbosa A, 2019, FEBS J, V286, P24, DOI 10.1111/febs.14704; Berks BC, 2015, ANNU REV BIOCHEM, V84, P843, DOI 10.1146/annurev-biochem-060614-034251; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; Celedon JM, 2012, J CELL BIOL, V197, P523, DOI 10.1083/jcb.201201096; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YL, 2018, NATURE, V564, P125, DOI 10.1038/s41586-018-0713-y; Chi W, 2013, ANNU REV PLANT BIOL, V64, P559, DOI 10.1146/annurev-arplant-050312-120147; Chiu CC, 2008, PLANT J, V56, P793, DOI 10.1111/j.1365-313X.2008.03638.x; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cross BCS, 2009, NAT REV MOL CELL BIO, V10, P255, DOI 10.1038/nrm2657; DeLille J, 2000, P NATL ACAD SCI USA, V97, P1926, DOI 10.1073/pnas.030395197; Dow JM, 2013, BIOCHEM J, V452, P57, DOI 10.1042/BJ20121832; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frielingsdorf S, 2008, J BIOL CHEM, V283, P33838, DOI 10.1074/jbc.M806334200; Garcion C, 2006, PLANT J, V48, P895, DOI 10.1111/j.1365-313X.2006.02922.x; Gonzalez KL, 2018, P NATL ACAD SCI USA, V115, pE3163, DOI 10.1073/pnas.1721279115; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Holzl G, 2019, ANNU REV PLANT BIOL, V70, P51, DOI 10.1146/annurev-arplant-050718-100202; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Jarvis P, 2013, NAT REV MOL CELL BIO, V14, P787, DOI 10.1038/nrm3702; Jiang JJ, 2019, PLANT CELL, V31, P1308, DOI 10.1105/tpc.18.00946; Kikuchi S, 2013, SCIENCE, V339, P571, DOI 10.1126/science.1229262; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lee DW, 2017, CURR OPIN PLANT BIOL, V40, P1, DOI [10.1016/j.pbI.2017.06.011, 10.1016/j.pbi.2017.06.011]; Li HM, 2010, ANNU REV PLANT BIOL, V61, P157, DOI 10.1146/annurev-arplant-042809-112222; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Ma XY, 2013, PLANT CELL, V25, P999, DOI 10.1105/tpc.112.107409; Ma XY, 2010, EMBO J, V29, P1477, DOI 10.1038/emboj.2010.44; Maillard J, 2007, P NATL ACAD SCI USA, V104, P15641, DOI 10.1073/pnas.0703967104; Mayer MP, 2019, J BIOL CHEM, V294, P2085, DOI 10.1074/jbc.REV118.002810; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Milovanovic D, 2018, SCIENCE, V361, P604, DOI 10.1126/science.aat5671; Mitrea DM, 2016, CELL COMMUN SIGNAL, V14, DOI 10.1186/s12964-015-0125-7; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Motohashi R, 2001, P NATL ACAD SCI USA, V98, P10499, DOI 10.1073/pnas.181304598; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouyang M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1278; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rolland N, 2012, ANNU REV GENET, V46, P233, DOI 10.1146/annurev-genet-110410-132544; Rosenzweig ESF, 2017, CELL, V171, P148, DOI 10.1016/j.cell.2017.08.008; Schleiff E, 2011, NAT REV MOL CELL BIO, V12, P48, DOI 10.1038/nrm3027; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2004, CURR GENET, V44, P295, DOI 10.1007/s00294-003-0450-z; Settles AM, 1997, SCIENCE, V278, P1467, DOI 10.1126/science.278.5342.1467; Skalitzky CA, 2011, PLANT PHYSIOL, V155, P354, DOI 10.1104/pp.110.166546; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Ulfig A, 2017, J BIOL CHEM, V292, P10865, DOI 10.1074/jbc.M117.788950; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Viana AAB, 2010, J BIOL CHEM, V285, P12948, DOI 10.1074/jbc.M110.109744; Winstone TML, 2015, BIOCHEMISTRY-US, V54, P2040, DOI 10.1021/bi500891d; YUAN JG, 1994, SCIENCE, V266, P796, DOI 10.1126/science.7973633	61	35	38	6	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1144	+		10.1016/j.cell.2020.02.045	http://dx.doi.org/10.1016/j.cell.2020.02.045			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32169217	Bronze			2022-12-28	WOS:000520925300012
J	Kuehn, BM				Kuehn, Bridget M.			International Measles Vaccination Campaign to Reach Millions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1033	1033		10.1001/jama.2020.2493	http://dx.doi.org/10.1001/jama.2020.2493			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181854				2022-12-28	WOS:000521968800004
J	Voelker, R				Voelker, Rebecca			FDA Takes on Agricultural Biotech	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1034	1034		10.1001/jama.2020.2449	http://dx.doi.org/10.1001/jama.2020.2449			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181834				2022-12-28	WOS:000521968800007
J	Okada, T; Fukuhara, T; Tanaka, S; Taguchi, M; Arai, T; Senshu, H; Sakatani, N; Shimaki, Y; Demura, H; Ogawa, Y; Suko, K; Sekiguchi, T; Kouyama, T; Takita, J; Matsunaga, T; Imamura, T; Wada, T; Hasegawa, S; Helbert, J; Muller, TG; Hagermann, A; Biele, J; Grott, M; Hamm, M; Delbo, M; Hirata, N; Hirata, N; Yamamoto, Y; Sugita, S; Namiki, N; Kitazato, K; Arakawa, M; Tachibana, S; Ikeda, H; Ishiguro, M; Wada, K; Honda, C; Honda, R; Ishihara, Y; Matsumoto, K; Matsuoka, M; Michikami, T; Miura, A; Morota, T; Noda, H; Noguchi, R; Ogawa, K; Shirai, K; Tatsumi, E; Yabuta, H; Yokota, Y; Yamada, M; Abe, M; Hayakawa, M; Iwata, T; Ozaki, M; Yano, H; Hosoda, S; Mori, O; Sawada, H; Shimada, T; Takeuchi, H; Tsukizaki, R; Fujii, A; Hirose, C; Kikuchi, S; Mimasu, Y; Ogawa, N; Ono, G; Takahashi, T; Takei, Y; Yamaguchi, T; Yoshikawa, K; Terui, F; Saiki, T; Nakazawa, S; Yoshikawa, M; Watanabe, S; Tsuda, Y				Okada, Tatsuaki; Fukuhara, Tetsuya; Tanaka, Satoshi; Taguchi, Makoto; Arai, Takehiko; Senshu, Hiroki; Sakatani, Naoya; Shimaki, Yuri; Demura, Hirohide; Ogawa, Yoshiko; Suko, Kentaro; Sekiguchi, Tomohiko; Kouyama, Toru; Takita, Jun; Matsunaga, Tsuneo; Imamura, Takeshi; Wada, Takehiko; Hasegawa, Sunao; Helbert, Joern; Mueller, Thomas G.; Hagermann, Axel; Biele, Jens; Grott, Matthias; Hamm, Maximilian; Delbo, Marco; Hirata, Naru; Hirata, Naoyuki; Yamamoto, Yukio; Sugita, Seiji; Namiki, Noriyuki; Kitazato, Kohei; Arakawa, Masahiko; Tachibana, Shogo; Ikeda, Hitoshi; Ishiguro, Masateru; Wada, Koji; Honda, Chikatoshi; Honda, Rie; Ishihara, Yoshiaki; Matsumoto, Koji; Matsuoka, Moe; Michikami, Tatsuhiro; Miura, Akira; Morota, Tomokatsu; Noda, Hirotomo; Noguchi, Rina; Ogawa, Kazunori; Shirai, Kei; Tatsumi, Eri; Yabuta, Hikaru; Yokota, Yasuhiro; Yamada, Manabu; Abe, Masanao; Hayakawa, Masahiko; Iwata, Takahiro; Ozaki, Masanobu; Yano, Hajime; Hosoda, Satoshi; Mori, Osamu; Sawada, Hirotaka; Shimada, Takanobu; Takeuchi, Hiroshi; Tsukizaki, Ryudo; Fujii, Atsushi; Hirose, Chikako; Kikuchi, Shota; Mimasu, Yuya; Ogawa, Naoko; Ono, Go; Takahashi, Tadateru; Takei, Yuto; Yamaguchi, Tomohiro; Yoshikawa, Kent; Terui, Fuyuto; Saiki, Takanao; Nakazawa, Satoru; Yoshikawa, Makoto; Watanabe, Seiichiro; Tsuda, Yuichi			Highly porous nature of a primitive asteroid revealed by thermal imaging	NATURE			English	Article							162173 RYUGU; SURFACE; MISSION; ONBOARD; SAMPLE; RETURN	Carbonaceous (C-type) asteroids(1) are relics of the early Solar System that have preserved primitive materials since their formation approximately 4.6 billion years ago. They are probably analogues of carbonaceous chondrites(2,3) and are essential for understanding planetary formation processes. However, their physical properties remain poorly known because carbonaceous chondrite meteoroids tend not to survive entry to Earth's atmosphere. Here we report on global one-rotation thermographic images of the C-type asteroid 162173 Ryugu, taken by the thermal infrared imager (TIR)(4) onboard the spacecraft Hayabusa2(5), indicating that the asteroid's boulders and their surroundings have similar temperatures, with a derived thermal inertia of about 300 J m(-2) s(-0.5) K-1 (300 tiu). Contrary to predictions that the surface consists of regolith and dense boulders, this low thermal inertia suggests that the boulders are more porous than typical carbonaceous chondrites(6) and that their surroundings are covered with porous fragments more than 10 centimetres in diameter. Close-up thermal images confirm the presence of such porous fragments and the flat diurnal temperature profiles suggest a strong surface roughness effect(7,8). We also observed in the close-up thermal images boulders that are colder during the day, with thermal inertia exceeding 600 tiu, corresponding to dense boulders similar to typical carbonaceous chondrites(6). These results constrain the formation history of Ryugu: the asteroid must be a rubble pile formed from impact fragments of a parent body with microporosity(9) of approximately 30 to 50 per cent that experienced a low degree of consolidation. The dense boulders might have originated from the consolidated innermost region or they may have an exogenic origin. This high-porosity asteroid may link cosmic fluffy dust to dense celestial bodies(10). Thermal imaging data obtained from the spacecraft Hayabusa2 reveal that the carbonaceous asteroid 162173 Ryugu is an object of unusually high porosity.	[Okada, Tatsuaki; Tanaka, Satoshi; Sakatani, Naoya; Shimaki, Yuri; Wada, Takehiko; Hasegawa, Sunao; Yamamoto, Yukio; Tachibana, Shogo; Matsuoka, Moe; Miura, Akira; Noguchi, Rina; Yokota, Yasuhiro; Abe, Masanao; Hayakawa, Masahiko; Iwata, Takahiro; Ozaki, Masanobu; Yano, Hajime; Hosoda, Satoshi; Mori, Osamu; Sawada, Hirotaka; Shimada, Takanobu; Takeuchi, Hiroshi; Tsukizaki, Ryudo; Fujii, Atsushi; Kikuchi, Shota; Mimasu, Yuya; Ogawa, Naoko; Takahashi, Tadateru; Takei, Yuto; Yamaguchi, Tomohiro; Terui, Fuyuto; Saiki, Takanao; Nakazawa, Satoru; Yoshikawa, Makoto; Watanabe, Seiichiro; Tsuda, Yuichi] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa, Japan; [Okada, Tatsuaki; Sugita, Seiji; Tachibana, Shogo; Morota, Tomokatsu; Tatsumi, Eri] Univ Tokyo, Tokyo, Japan; [Fukuhara, Tetsuya; Taguchi, Makoto] Rikkyo Univ, Tokyo, Japan; [Tanaka, Satoshi; Yamamoto, Yukio; Namiki, Noriyuki; Matsumoto, Koji; Abe, Masanao; Iwata, Takahiro; Ozaki, Masanobu; Yano, Hajime; Takeuchi, Hiroshi; Yoshikawa, Makoto; Tsuda, Yuichi] Grad Univ Adv Studies, SOKENDAI, Hayama, Kanagawa, Japan; [Tanaka, Satoshi; Imamura, Takeshi] Univ Tokyo, Kashiwa, Chiba, Japan; [Arai, Takehiko] Ashikaga Univ, Ashikaga, Japan; [Senshu, Hiroki; Sugita, Seiji; Wada, Koji; Yamada, Manabu] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba, Japan; [Demura, Hirohide; Ogawa, Yoshiko; Suko, Kentaro; Hirata, Naru; Kitazato, Kohei; Honda, Chikatoshi] Univ Aizu, Aizu Wakamatsu, Japan; [Sekiguchi, Tomohiko] Hokkaido Univ, Asahikawa, Hokkaido, Japan; [Kouyama, Toru] Natl Inst Adv Ind Sci & Technol, Tokyo, Japan; [Takita, Jun] Hokkaido Kitami Hokuto High Sch, Kitami, Hokkaido, Japan; [Matsunaga, Tsuneo; Ishihara, Yoshiaki] Natl Inst Environm Studies NIES, Tsukuba, Ibaraki, Japan; [Helbert, Joern; Grott, Matthias; Hamm, Maximilian] German Aerosp Ctr DLR, Berlin, Germany; [Mueller, Thomas G.] Max Planck Inst Extraterr Phys, Garching, Germany; [Hagermann, Axel] Univ Stirling, Stirling, Scotland; [Biele, Jens] German Aerosp Ctr DLR, Cologne, Germany; [Hamm, Maximilian] Univ Potsdam, Potsdam, Germany; [Delbo, Marco] Univ Cote Azur, CNRS, Lab Lagrange, Observ Cote Azur, Nice, France; [Hirata, Naoyuki; Arakawa, Masahiko; Ogawa, Kazunori; Shirai, Kei] Kobe Univ, Kobe, Hyogo, Japan; [Namiki, Noriyuki; Matsumoto, Koji; Noda, Hirotomo] NAOJ, Mitaka, Tokyo, Japan; [Ikeda, Hitoshi; Hirose, Chikako; Ono, Go; Yoshikawa, Kent] JAXA, Res & Dev Directorate, Sagamihara, Kanagawa, Japan; [Ishiguro, Masateru] Seoul Natl Univ, Seoul, South Korea; [Honda, Rie] Kochi Univ, Kochi, Japan; [Michikami, Tatsuhiro] Kindai Univ, Higashihiroshima, Japan; [Ogawa, Kazunori; Ogawa, Naoko] Japan Aerosp Explorat Agcy JAXA, Space Explorat Ctr, Sagamihara, Kanagawa, Japan; [Tatsumi, Eri] Univ La Laguna, Inst Astrofis Canarias, Tenerife, Spain; [Yabuta, Hikaru] Hiroshima Univ, Higashihiroshima, Japan; [Watanabe, Seiichiro] Nagoya Univ, Nagoya, Aichi, Japan; [Takahashi, Tadateru] NEC Corp Ltd, Fuchu, Tokyo, Japan; [Yamaguchi, Tomohiro] Mitsubishi Electr Corp, Kamakura, Kanagawa, Japan	Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; Rikkyo University; Graduate University for Advanced Studies - Japan; University of Tokyo; Chiba Institute of Technology; University of Aizu; Hokkaido University; National Institute of Advanced Industrial Science & Technology (AIST); National Institute for Environmental Studies - Japan; Helmholtz Association; German Aerospace Centre (DLR); Max Planck Society; University of Stirling; Helmholtz Association; German Aerospace Centre (DLR); University of Potsdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Kobe University; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Japan Aerospace Exploration Agency (JAXA); Seoul National University (SNU); Kochi University; Kindai University (Kinki University); Japan Aerospace Exploration Agency (JAXA); Instituto de Astrofisica de Canarias; Universidad de la Laguna; Hiroshima University; Nagoya University; NEC Corporation; Mitsubishi Electric Corporation	Okada, T (corresponding author), Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa, Japan.; Okada, T (corresponding author), Univ Tokyo, Tokyo, Japan.	okada@planeta.sci.isas.jaxa.jp	Sugita, Seiji/GQI-1142-2022; Matsumoto, Koji/AAF-7825-2021; Mueller, Thomas/AAB-7126-2019; Noguchi, Rina/HCH-0362-2022; Wada, Takehiko/ACR-9959-2022; Biele, Jens/ABI-1218-2020; Matsunaga, Tsuneo/H-3040-2018; Okada, Tatsuaki/O-6614-2014; Kouyama, Toru/B-1155-2017; Hasegawa, Sunao/R-4768-2017	Sugita, Seiji/0000-0001-6076-3614; Matsumoto, Koji/0000-0003-4319-1970; Mueller, Thomas/0000-0003-1343-5719; Noguchi, Rina/0000-0001-8281-2448; Biele, Jens/0000-0002-7414-829X; Matsunaga, Tsuneo/0000-0002-3380-5230; Tatsumi, Eri/0000-0002-6142-9842; Yamamoto, Yukio/0000-0001-7172-1911; Hamm, Maximilian/0000-0002-7476-0892; Okada, Tatsuaki/0000-0001-6381-8107; Takeuchi, Hiroshi/0000-0001-5863-4653; Hirata, Naru/0000-0002-2435-604X; Kouyama, Toru/0000-0002-1060-3986; Hagermann, Axel/0000-0002-1818-9396; Shimaki, Yuri/0000-0001-8966-7650; Hasegawa, Sunao/0000-0001-6366-2608; Helbert, Jorn/0000-0001-5346-9505; Matsuoka, Moe/0000-0003-1091-3041; Arai, Takehiko/0000-0002-5711-7731; Sakatani, Naoya/0000-0003-4791-5227	JSPS KAKENHI [JP26287108, JP17H06459, JP17K05639, JP19H01951, JP19K03958]; JSPS Core-to-Core programme "International Network of Planetary Sciences"; French space agency CNES; European Union's Horizon 2020 Research and Innovation Programme, project "Small Bodies Near and Far" (SBNAF) [687378]; STFC [ST/S001271/1]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS Core-to-Core programme "International Network of Planetary Sciences"; French space agency CNES(Centre National D'etudes Spatiales); European Union's Horizon 2020 Research and Innovation Programme, project "Small Bodies Near and Far" (SBNAF); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank all the members of the Hayabusa2 Project and supporting staff for their technical assistance and scientific discussions, and especially S. Matsuura of Kwansei Gakuin University the use of the cavity blackbody and collimator to calibrate TIR. This research is supported in part by the JSPS KAKENHI (numbers JP26287108, JP17H06459, JP17K05639, JP19H01951 and JP19K03958), and the JSPS Core-to-Core programme "International Network of Planetary Sciences". M.D. acknowledges support from the French space agency CNES. T.G.M. received funding from the European Union's Horizon 2020 Research and Innovation Programme, under grant agreement number 687378, as part of the project "Small Bodies Near and Far" (SBNAF). A.H. was supported by STFC grant ST/S001271/1.	Arai T, 2017, SPACE SCI REV, V208, P239, DOI 10.1007/s11214-017-0353-9; Arakawa S, 2017, ASTRON ASTROPHYS, V608, DOI 10.1051/0004-6361/201732182; Bardyn A, 2017, MON NOT R ASTRON SOC, V469, pS712, DOI 10.1093/mnras/stx2640; Biele J, 2019, PROG EARTH PLANET SC, V6, DOI 10.1186/s40645-019-0291-0; Britt D. T., 2002, ASTEROIDS 3, VIII, P485; CHASE SC, 1976, ICARUS, V28, P565, DOI 10.1016/0019-1035(76)90130-5; Christensen PR, 2001, J GEOPHYS RES-PLANET, V106, P23873, DOI 10.1029/2000JE001415; Delbo M., 2015, ASTEROIDS, VIV, P107, DOI DOI 10.2458/AZU_UAPRESS_9780816530595-CH006; DellaGiustina DN, 2019, NAT ASTRON, V3, P341, DOI 10.1038/s41550-019-0731-1; DeMeo F.E., 2015, ASTEROIDS, VIV, P13, DOI [10.2458/azuuapress9780816532131-ch002, DOI 10.2458/AZUUAPRESS9780816532131-CH002, 10.2458/azu_uapress_9780816532131-ch002, DOI 10.2458/AZU_UAPRESS_9780816532131-CH002]; Flynn GJ, 2018, CHEM ERDE-GEOCHEM, V78, P269, DOI 10.1016/j.chemer.2017.04.002; Fujiwara A, 2006, SCIENCE, V312, P1330, DOI 10.1126/science.1125841; Fukuhara T, 2017, EARTH PLANETS SPACE, V69, DOI 10.1186/s40623-017-0727-y; Fukuhara T, 2011, EARTH PLANETS SPACE, V63, P1009, DOI 10.5047/eps.2011.06.019; Grott M, 2019, NAT ASTRON, V3, P971, DOI 10.1038/s41550-019-0832-x; Groussin O, 2013, ICARUS, V222, P580, DOI 10.1016/j.icarus.2012.10.003; Ho TM, 2017, SPACE SCI REV, V208, P339, DOI 10.1007/s11214-016-0251-6; Housen KR, 2011, ICARUS, V211, P856, DOI 10.1016/j.icarus.2010.09.017; Jaumann R, 2019, SCIENCE, V365, P817, DOI 10.1126/science.aaw8627; Kawaguchi J, 2003, ACTA ASTRONAUT, V52, P117, DOI 10.1016/S0094-5765(02)00146-7; Kieffer H. H., 1977, Journal of Geophysical Research, V82, P4249, DOI 10.1029/JS082i028p04249; KIEFFER HH, 1973, J GEOPHYS RES, V78, P4291, DOI 10.1029/JB078i020p04291; Kitazato K, 2019, SCIENCE, V364, P272, DOI 10.1126/science.aav7432; Matthews M. S., 1989, ASTEROIDS, VII; Muller TG, 2017, ASTRON ASTROPHYS, V598, DOI 10.1051/0004-6361/201629584; Okada T, 2017, SPACE SCI REV, V208, P255, DOI 10.1007/s11214-016-0286-8; Paige DA, 2010, SPACE SCI REV, V150, P125, DOI 10.1007/s11214-009-9529-2; Rivkin A.S., 2015, ASTEROIDS, P65, DOI DOI 10.2458/AZU_UAPRESS_9780816532131-CH004; Rozitis B, 2011, MON NOT R ASTRON SOC, V415, P2042, DOI 10.1111/j.1365-2966.2011.18718.x; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Saunders P, 2013, AIP CONF PROC, V1552, P619, DOI 10.1063/1.4819613; Shimaki Y, 2019, LUNAR PLANET SCI C, V50, P1724; Sj CPO, 2012, METEORIT PLANET SCI, V47, P319, DOI 10.1111/j.1945-5100.2012.01331.x; Sugita S, 2019, SCIENCE, V364, P252, DOI 10.1126/science.aaw0422; Takita J, 2017, SPACE SCI REV, V208, P287, DOI 10.1007/s11214-017-0336-x; Tsuda Y, 2016, ACTA ASTRONAUT, V127, P702, DOI 10.1016/j.actaastro.2016.01.027; Veverka J, 1999, ICARUS, V140, P3, DOI 10.1006/icar.1999.6120; Watanabe S, 2019, SCIENCE, V364, P268, DOI 10.1126/science.aav8032; Yoshimitsu T., 2015, 11 LOW COST PLAN MIS	40	67	69	5	46	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					518	522		10.1038/s41586-020-2102-6	http://dx.doi.org/10.1038/s41586-020-2102-6		MAR 2020	5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214245	Green Published, Green Accepted			2022-12-28	WOS:000519841400001
J	Horton, R				Horton, Richard			Offline: A dangerous virus, but not the one you think	LANCET			English	Editorial Material												richard.horton@lancet.com							0	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					854	854						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32171396	Green Published, Bronze			2022-12-28	WOS:000520024900016
J	Jones, H				Jones, Helen			How to become a doctor in the Royal Navy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m640	10.1136/bmj.m640	http://dx.doi.org/10.1136/bmj.m640			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32169896	Bronze			2022-12-28	WOS:000520014600002
J	Wagner, FR; Dienemann, C; Wang, HB; Stutzer, A; Tegunov, D; Urlaub, H; Cramer, P				Wagner, Felix R.; Dienemann, Christian; Wang, Haibo; Stuetzer, Alexandra; Tegunov, Dimitry; Urlaub, Henning; Cramer, Patrick			Structure of SWI/SNF chromatin remodeller RSC bound to a nucleosome	NATURE			English	Article							RECOMBINANT HISTONES; STRUCTURE PREDICTION; DNA TRANSLOCATION; PROTEIN; COMPLEX; SEQUENCE; DOMAIN; YEAST; VISUALIZATION; TRANSCRIPTION	The cryo-electron microscopy structure of the 16-subunit yeast SWI/SNF complex RSC in complex with a nucleosome substrate provides insights into the chromatin-remodelling function of this family of protein complexes. Chromatin-remodelling complexes of the SWI/SNF family function in the formation of nucleosome-depleted, transcriptionally active promoter regions (NDRs)(1,2). In the yeast Saccharomyces cerevisiae, the essential SWI/SNF complex RSC3 contains 16 subunits, including the ATP-dependent DNA translocase Sth1(4,5). RSC removes nucleosomes from promoter regions(6,7) and positions the specialized +1 and -1 nucleosomes that flank NDRs(8,9). Here we present the cryo-electron microscopy structure of RSC in complex with a nucleosome substrate. The structure reveals that RSC forms five protein modules and suggests key features of the remodelling mechanism. The body module serves as a scaffold for the four flexible modules that we call DNA-interacting, ATPase, arm and actin-related protein (ARP) modules. The DNA-interacting module binds extra-nucleosomal DNA and is involved in the recognition of promoter DNA elements(8,10,11) that influence RSC functionality(12). The ATPase and arm modules sandwich the nucleosome disc with the Snf2 ATP-coupling (SnAC) domain and the finger helix, respectively. The translocase motor of the ATPase module engages with the edge of the nucleosome at superhelical location +2. The mobile ARP module may modulate translocase-nucleosome interactions to regulate RSC activity(5). The RSC-nucleosome structure provides a basis for understanding NDR formation and the structure and function of human SWI/SNF complexes that are frequently mutated in cancer(13).	[Wagner, Felix R.; Dienemann, Christian; Wang, Haibo; Tegunov, Dimitry; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany; [Stuetzer, Alexandra; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry, Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de	; Tegunov, Dimitry/D-7834-2015	Dienemann, Christian/0000-0002-2172-5110; Wang, Haibo/0000-0003-2416-9153; Tegunov, Dimitry/0000-0001-7019-3221	Boehringer Ingelheim Fonds PhD fellowship; Deutsche Forschungsgemeinschaft [SFB860, SPP1935, EXC 2067/1-390729940]; European Research Council [693023]; Volkswagen Foundation	Boehringer Ingelheim Fonds PhD fellowship(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Volkswagen Foundation(Volkswagen)	We thank current and former members of the Cramer Laboratory, including S. Osman, G. Kokic, P. Seweryn, S. Schilbach, S. Neyer and H. Hillen. F.R.W. was supported by a Boehringer Ingelheim Fonds PhD fellowship. H.U. was supported by the Deutsche Forschungsgemeinschaft (SFB860). P.C. was supported by the Deutsche Forschungsgemeinschaft (SFB860, SPP1935, EXC 2067/1-390729940), the European Research Council Advanced Investigator Grant TRANSREGULON (grant agreement no. 693023), and the Volkswagen Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angus-Hill ML, 2001, MOL CELL, V7, P741, DOI 10.1016/S1097-2765(01)00219-2; Asturias FJ, 2002, P NATL ACAD SCI USA, V99, P13477, DOI 10.1073/pnas.162504299; Ayala R, 2018, NATURE, V556, P391, DOI 10.1038/s41586-018-0021-6; Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Brahma S, 2019, MOL CELL, V73, P238, DOI 10.1016/j.molcel.2018.10.046; Brogaard K, 2012, NATURE, V486, P496, DOI 10.1038/nature11142; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Cairns BR, 1999, MOL CELL, V4, P715, DOI 10.1016/S1097-2765(00)80382-2; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Cakiroglu A, 2019, GENOME RES, V29, P988, DOI 10.1101/gr.243139.118; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chaban Y, 2008, NAT STRUCT MOL BIOL, V15, P1272, DOI 10.1038/nsmb.1524; Chambers AL, 2013, NUCLEIC ACIDS RES, V41, P9168, DOI 10.1093/nar/gkt662; Charlop-Powers Z, 2010, CELL RES, V20, P529, DOI 10.1038/cr.2010.43; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Clapier CR, 2016, MOL CELL, V62, P453, DOI 10.1016/j.molcel.2016.03.032; Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Dechassa ML, 2010, MOL CELL, V38, P590, DOI 10.1016/j.molcel.2010.02.040; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eustermann S, 2018, NATURE, V556, P386, DOI 10.1038/s41586-018-0029-y; Farnung L, 2017, NATURE, V550, P539, DOI 10.1038/nature24046; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grimm M, 2015, NUCLEIC ACIDS RES, V43, pW362, DOI 10.1093/nar/gkv463; Han Y., 2019, CRYO ELECT MICROSCOP, DOI [10.1101/805184v1, DOI 10.1101/805184V1]; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kasten M, 2004, EMBO J, V23, P1348, DOI 10.1038/sj.emboj.7600143; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kidmose RT, 2019, IUCRJ, V6, P526, DOI 10.1107/S2052252519007619; Klein-Brill A, 2019, CELL REP, V26, P279, DOI 10.1016/j.celrep.2018.12.020; Krietenstein N, 2016, CELL, V167, P709, DOI 10.1016/j.cell.2016.09.045; Kubik S, 2018, MOL CELL, V71, P89, DOI 10.1016/j.molcel.2018.05.030; Kubik S, 2015, MOL CELL, V60, P422, DOI 10.1016/j.molcel.2015.10.002; Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087; Leschziner AE, 2007, P NATL ACAD SCI USA, V104, P4913, DOI 10.1073/pnas.0700706104; Li MJ, 2019, NATURE, V567, P409, DOI 10.1038/s41586-019-1029-2; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Lorch Y, 2004, METHOD ENZYMOL, V377, P316; Lorch Y, 2018, MOL CELL, V72, P594, DOI 10.1016/j.molcel.2018.09.030; Lorch Y, 2017, Q REV BIOPHYS, V50, DOI 10.1017/S003358351700004X; Lorch Y, 2014, GENE DEV, V28, P2492, DOI 10.1101/gad.250704.114; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METH MOL B, V119, P1; Maskell DP, 2015, NATURE, V523, P366, DOI 10.1038/nature14495; Materne P, 2016, ELIFE, V5, DOI 10.7554/eLife.13500; Nicolas RH, 1996, GENE, V175, P233, DOI 10.1016/0378-1119(96)82845-9; Patel AB, 2019, ELIFE, V8, DOI 10.7554/eLife.54449; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pulice JL, 2016, COLD SH Q B, V81, P53, DOI 10.1101/sqb.2016.81.031021; Ramachandran S, 2015, GENOME RES, V25, P381, DOI 10.1101/gr.182618.114; Raman S, 2009, PROTEINS, V77, P89, DOI 10.1002/prot.22540; Reichen C, 2016, ACTA CRYSTALLOGR D, V72, P168, DOI 10.1107/S2059798315023116; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saha A, 2005, NAT STRUCT MOL BIOL, V12, P747, DOI 10.1038/nsmb973; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Sandhya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205267; Satterwhite E, 2001, BLOOD, V98, P3413, DOI 10.1182/blood.V98.12.3413; Schrodinger L.L.C.,, 2015, PYMOL MOL GRAPHICS S; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; Sen P, 2013, MOL CELL BIOL, V33, P360, DOI 10.1128/MCB.00922-12; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Sundaramoorthy R, 2018, ELIFE, V7, DOI 10.7554/eLife.35720; Suto RK, 2000, NAT STRUCT BIOL, V7, P1121; Szerlong H, 2008, NAT STRUCT MOL BIOL, V15, P469, DOI 10.1038/nsmb.1403; Taneda T, 2004, MOL GENET GENOMICS, V271, P479, DOI 10.1007/s00438-004-0999-3; Treich I, 1998, NUCLEIC ACIDS RES, V26, P3739, DOI 10.1093/nar/26.16.3739; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Wang WD, 1998, P NATL ACAD SCI USA, V95, P492, DOI 10.1073/pnas.95.2.492; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Willhoft O, 2018, SCIENCE, V362, P199, DOI 10.1126/science.aat7716; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Worden EJ, 2019, CELL, V176, P1490, DOI 10.1016/j.cell.2019.02.002; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yan LJ, 2019, NAT STRUCT MOL BIOL, V26, P258, DOI 10.1038/s41594-019-0199-9; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Ye YP, 2019, SCIENCE, V366, P838, DOI 10.1126/science.aay0033; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	88	56	56	3	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					448	+		10.1038/s41586-020-2088-0	http://dx.doi.org/10.1038/s41586-020-2088-0		MAR 2020	19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188943	Green Submitted, Green Accepted			2022-12-28	WOS:000519162500003
J	Tang, YH; Li, LZ; Li, TX; Xu, Y; Liu, S; Barmak, K; Watanabe, K; Taniguchi, T; MacDonald, AH; Shan, J; Mak, KF				Tang, Yanhao; Li, Lizhong; Li, Tingxin; Xu, Yang; Liu, Song; Barmak, Katayun; Watanabe, Kenji; Taniguchi, Takashi; MacDonald, Allan H.; Shan, Jie; Mak, Kin Fai			Simulation of Hubbard model physics in WSe2/WS2 moire superlattices	NATURE			English	Article							INSULATOR	Study of WSe2/WS2 moire superlattices reveals the phase diagram of the triangular-lattice Hubbard model, including a Mott insulating state at half-filling and a possible magnetic quantum phase transition near 0.6 filling. The Hubbard model, formulated by physicist John Hubbard in the 1960s(1), is a simple theoretical model of interacting quantum particles in a lattice. The model is thought to capture the essential physics of high-temperature superconductors, magnetic insulators and other complex quantum many-body ground states(2,3). Although the Hubbard model provides a greatly simplified representation of most real materials, it is nevertheless difficult to solve accurately except in the one-dimensional case(2,3). Therefore, the physical realization of the Hubbard model in two or three dimensions, which can act as an analogue quantum simulator (that is, it can mimic the model and simulate its phase diagram and dynamics(4,5)), has a vital role in solving the strong-correlation puzzle, namely, revealing the physics of a large number of strongly interacting quantum particles. Here we obtain the phase diagram of the two-dimensional triangular-lattice Hubbard model by studying angle-aligned WSe2/WS2 bilayers, which form moire superlattices(6) because of the difference between the lattice constants of the two materials. We probe the charge and magnetic properties of the system by measuring the dependence of its optical response on an out-of-plane magnetic field and on the gate-tuned carrier density. At half-filling of the first hole moire superlattice band, we observe a Mott insulating state with antiferromagnetic Curie-Weiss behaviour, as expected for a Hubbard model in the strong-interaction regime(2,3,7-9). Above half-filling, our experiment suggests a possible quantum phase transition from an antiferromagnetic to a weak ferromagnetic state at filling factors near 0.6. Our results establish a new solid-state platform based on moire superlattices that can be used to simulate problems in strong-correlation physics that are described by triangular-lattice Hubbard models.	[Tang, Yanhao; Li, Lizhong; Li, Tingxin; Xu, Yang; Shan, Jie; Mak, Kin Fai] Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA; [Liu, Song] Columbia Univ, Dept Mech Engn, New York, NY 10027 USA; [Barmak, Katayun] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Watanabe, Kenji; Taniguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [MacDonald, Allan H.] Univ Texas Austin, Dept Phys, Austin, TX 78712 USA; [Shan, Jie; Mak, Kin Fai] Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA; [Shan, Jie; Mak, Kin Fai] Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA	Cornell University; Columbia University; Columbia University; National Institute for Materials Science; University of Texas System; University of Texas Austin; Cornell University	Shan, J; Mak, KF (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.; Shan, J; Mak, KF (corresponding author), Cornell Univ, Lab Atom & Solid State Phys, Ithaca, NY 14853 USA.; Shan, J; Mak, KF (corresponding author), Kavli Inst Cornell Nanoscale Sci, Ithaca, NY 14853 USA.	jie.shan@cornell.edu; kinfai.mak@cornell.edu	Barmak, Katayun/A-9804-2008; Xu, Yang/CAF-7633-2022; Tang, Yanhao/AAM-3808-2021; MacDonald, Allan/M-9883-2019; MacDonald, Allan/GPF-8212-2022; Mak, Kin Fai/E-9004-2015; Barmak, Katayun/AFU-8454-2022; Watanabe, Kenji/ABB-2135-2021; Liu, Song/Z-1870-2018	Barmak, Katayun/0000-0003-0070-158X; Xu, Yang/0000-0003-4223-8677; MacDonald, Allan/0000-0003-3561-3379; Mak, Kin Fai/0000-0002-5768-199X; Barmak, Katayun/0000-0003-0070-158X; Watanabe, Kenji/0000-0003-3701-8119; Liu, Song/0000-0002-3046-3335; Li, Tingxin/0000-0002-3572-4530	US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0019481, DE-SC0013883]; ONR [N00014-18-1-2368]; NSF MRSEC programme through Columbia University, Center for Precision Assembly of Superstratic and Superatomic Solids [DMR-1420634]; David and Lucille Packard Fellowship; Welch Foundation [TBF1473]	US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE)); ONR(Office of Naval Research); NSF MRSEC programme through Columbia University, Center for Precision Assembly of Superstratic and Superatomic Solids; David and Lucille Packard Fellowship(The David & Lucile Packard Foundation); Welch Foundation(The Welch Foundation)	We thank L. Fu for discussions. Research was primarily supported by the US Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES), under award number DE-SC0019481 (optical spectroscopy and theory) and DE-SC0013883 (device fabrication). The transport measurements were supported by ONR N00014-18-1-2368. The growth of WSe<INF>2</INF> crystals was supported by the NSF MRSEC programme through Columbia University, Center for Precision Assembly of Superstratic and Superatomic Solids (DMR-1420634), and the growth of the hBN crystals by the Elemental Strategy Initiative of MEXT, Japan and CREST (JPMJCR15F3), Japan Science and Technology Agency. K.F.M. acknowledges support from a David and Lucille Packard Fellowship. A.H.M. acknowledges support from Welch Foundation grant TBF1473.	Alexeev EM, 2019, NATURE, V567, P81, DOI 10.1038/s41586-019-0986-9; [Anonymous], COMPUTATIONAL STAT P; [Anonymous], TUNABLE CORRELATED C; Back P, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.237404; Bistritzer R, 2011, P NATL ACAD SCI USA, V108, P12233, DOI 10.1073/pnas.1108174108; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen GR, 2019, NATURE, V572, P215, DOI 10.1038/s41586-019-1393-y; Chen GR, 2019, NAT PHYS, V15, P237, DOI 10.1038/s41567-018-0387-2; Georgescu IM, 2014, REV MOD PHYS, V86, P153, DOI 10.1103/RevModPhys.86.153; He K, 2013, NANO LETT, V13, P2931, DOI 10.1021/nl4013166; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Jin CH, 2019, NATURE, V567, P76, DOI 10.1038/s41586-019-0976-y; Tran K, 2019, NATURE, V567, P71, DOI 10.1038/s41586-019-0975-z; Li G, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.161118; Lu XB, 2019, NATURE, V574, P653, DOI 10.1038/s41586-019-1695-0; Mak KF, 2018, NAT PHOTONICS, V12, P451, DOI 10.1038/s41566-018-0204-6; Mak KF, 2016, NAT PHOTONICS, V10, P216, DOI [10.1038/NPHOTON.2015.282, 10.1038/nphoton.2015.282]; Merino J, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.235107; Movva HCP, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.247701; Quintanilla J, 2009, PHYS WORLD, V22, P32; Roch JG, 2019, NAT NANOTECHNOL, V14, P432, DOI 10.1038/s41565-019-0397-y; Rohringer G, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.025003; SCHUTTE WJ, 1987, J SOLID STATE CHEM, V70, P207, DOI 10.1016/0022-4596(87)90057-0; Serlin M, 2020, SCIENCE, V367, P900, DOI 10.1126/science.aay5533; Seyler KL, 2019, NATURE, V567, P66, DOI 10.1038/s41586-019-0957-1; Sharpe AL, 2019, SCIENCE, V365, P605, DOI 10.1126/science.aaw3780; Sidler M, 2017, NAT PHYS, V13, P255, DOI [10.1038/NPHYS3949, 10.1038/nphys3949]; Tarruell L, 2018, CR PHYS, V19, P365, DOI 10.1016/j.crhy.2018.10.013; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang ZF, 2017, NANO LETT, V17, P740, DOI 10.1021/acs.nanolett.6b03855; WANNIER GH, 1950, PHYS REV, V79, P357, DOI 10.1103/PhysRev.79.357; Wu FC, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.026402; Wu FC, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.147401; Yankowitz M, 2019, SCIENCE, V363, P1059, DOI 10.1126/science.aav1910; Zheng WH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134422	37	277	280	39	267	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					353	+		10.1038/s41586-020-2085-3	http://dx.doi.org/10.1038/s41586-020-2085-3			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188950				2022-12-28	WOS:000520778000010
J	Cao, B; Wang, Y; Wen, D; Liu, W; Wang, JL; Fan, G; Ruan, L; Song, B; Cai, Y; Wei, M; Li, X; Xia, J; Chen, N; Xiang, J; Yu, T; Bai, T; Xie, X; Zhang, L; Li, C; Yuan, Y; Chen, H; Li, HD; Huang, H; Tu, S; Gong, F; Liu, Y; Wei, Y; Dong, C; Zhou, F; Gu, X; Xu, J; Liu, Z; Zhang, Y; Li, H; Shang, L; Wang, K; Li, K; Zhou, X; Dong, X; Qu, Z; Lu, S; Hu, X; Ruan, S; Luo, S; Wu, J; Peng, L; Cheng, F; Pan, L; Zou, J; Jia, C; Wang, J; Liu, X; Wang, S; Wu, X; Ge, Q; He, J; Zhan, H; Qiu, F; Guo, L; Huang, C; Jaki, T; Hayden, FG; Horby, PW; Zhang, D; Wang, C				Cao, B.; Wang, Y.; Wen, D.; Liu, W.; Wang, Jingli; Fan, G.; Ruan, L.; Song, B.; Cai, Y.; Wei, M.; Li, X.; Xia, J.; Chen, N.; Xiang, J.; Yu, T.; Bai, T.; Xie, X.; Zhang, L.; Li, C.; Yuan, Y.; Chen, H.; Li, Huadong; Huang, H.; Tu, S.; Gong, F.; Liu, Y.; Wei, Y.; Dong, C.; Zhou, F.; Gu, X.; Xu, J.; Liu, Z.; Zhang, Y.; Li, Hui; Shang, L.; Wang, K.; Li, K.; Zhou, X.; Dong, X.; Qu, Z.; Lu, S.; Hu, X.; Ruan, S.; Luo, S.; Wu, J.; Peng, L.; Cheng, F.; Pan, L.; Zou, J.; Jia, C.; Wang, Juan; Liu, X.; Wang, S.; Wu, X.; Ge, Q.; He, J.; Zhan, H.; Qiu, F.; Guo, L.; Huang, C.; Jaki, T.; Hayden, F. G.; Horby, P. W.; Zhang, D.; Wang, C.			A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EAST RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS; NEURAMINIDASE INHIBITORS; LOPINAVIR/RITONAVIR; COMBINATION; INFECTION; SARS; REPLICATION	BACKGROUND No therapeutics have yet been proven effective for the treatment of severe illness caused by SARS-CoV-2. METHODS We conducted a randomized, controlled, open-label trial involving hospitalized adult patients with confirmed SARS-CoV-2 infection, which causes the respiratory illness Covid-19, and an oxygen saturation (Sao(2)) of 94% or less while they were breathing ambient air or a ratio of the partial pressure of oxygen (Pao(2)) to the fraction of inspired oxygen (Fio(2)) of less than 300 mm Hg. Patients were randomly assigned in a 1:1 ratio to receive either lopinavir-ritonavir (400 mg and 100 mg, respectively) twice a day for 14 days, in addition to standard care, or standard care alone. The primary end point was the time to clinical improvement, defined as the time from randomization to either an improvement of two points on a seven-category ordinal scale or discharge from the hospital, whichever came first. RESULTS A total of 199 patients with laboratory-confirmed SARS-CoV-2 infection underwent randomization; 99 were assigned to the lopinavir-ritonavir group, and 100 to the standard-care group. Treatment with lopinavir-ritonavir was not associated with a difference from standard care in the time to clinical improvement (hazard ratio for clinical improvement, 1.31; 95% confidence interval [CI], 0.95 to 1.80). Mortality at 28 days was similar in the lopinavir-ritonavir group and the standard-care group (19.2% vs. 25.0%; difference, -5.8 percentage points; 95% CI, -17.3 to 5.7). The percentages of patients with detectable viral RNA at various time points were similar. In a modified intention-to-treat analysis, lopinavir-ritonavir led to a median time to clinical improvement that was shorter by 1 day than that observed with standard care (hazard ratio, 1.39; 95% CI, 1.00 to 1.91). Gastrointestinal adverse events were more common in the lopinavir-ritonavir group, but serious adverse events were more common in the standard-care group. Lopinavir-ritonavir treatment was stopped early in 13 patients (13.8%) because of adverse events. CONCLUSIONS In hospitalized adult patients with severe Covid-19, no benefit was observed with lopinavir-ritonavir treatment beyond standard care. Future trials in patients with severe illness may help to confirm or exclude the possibility of a treatment benefit. (Funded by Major Projects of National Science and Technology on New Drug Creation and Development and others; Chinese Clinical Trial Register number, ChiCTR2000029308.)	[Cao, B.; Wang, Y.; Fan, G.; Zhou, F.; Gu, X.; Liu, Z.; Zhang, Y.; Li, Hui; Shang, L.; Wang, C.] China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China; [Fan, G.; Gu, X.] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China; [Cao, B.; Wang, Y.; Zhou, F.; Liu, Z.; Zhang, Y.; Li, Hui; Wang, C.] Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China; [Li, X.] Capital Med Univ, Beijing Ditan Hosp, Clin & Res Ctr Infect Dis, Beijing, Peoples R China; [Dong, C.] Peking Univ, Hosp 1, Clin Res Inst, Beijing, Peoples R China; [Xu, J.] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Shang, L.] Beijing Univ Chinese Med, Beijing, Peoples R China; [Guo, L.] Chinese Acad Med Sci, NHC Key Lab Syst Biol Pathogens, Inst Pathogen Biol, Beijing, Peoples R China; [Guo, L.] Chinese Acad Med Sci, Christophe Merieux Lab, Inst Pathogen Biol, Beijing, Peoples R China; [Guo, L.; Wang, C.] Peking Union Med Coll, Beijing, Peoples R China; [Wen, D.; Liu, W.; Wang, Jingli; Ruan, L.; Song, B.; Cai, Y.; Wei, M.; Xia, J.; Chen, N.; Xiang, J.; Yu, T.; Bai, T.; Xie, X.; Zhang, L.; Li, C.; Yuan, Y.; Chen, H.; Li, Huadong; Huang, H.; Tu, S.; Gong, F.; Liu, Y.; Wei, Y.; Wang, K.; Li, K.; Zhou, X.; Dong, X.; Qu, Z.; Lu, S.; Hu, X.; Ruan, S.; Luo, S.; Wu, J.; Peng, L.; Cheng, F.; Pan, L.; Zou, J.; Jia, C.; Wang, Juan; Liu, X.; Wang, S.; Wu, X.; Ge, Q.; He, J.; Zhan, H.; Qiu, F.; Huang, C.; Zhang, D.] Jin Yin Tan Hosp, Wuhan, Peoples R China; [Jaki, T.] Univ Lancaster, Lancaster, England; [Horby, P. W.] Univ Oxford, Oxford, England; [Hayden, F. G.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA	China-Japan Friendship Hospital; China-Japan Friendship Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Peking University; Tsinghua University; Beijing University of Chinese Medicine; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Lancaster University; University of Oxford; University of Virginia	Cao, B; Wang, C (corresponding author), China Japan Friendship Hosp, Ctr Resp Med, Dept Pulm & Crit Care Med, Natl Clin Res Ctr Resp Dis, Beijing, Peoples R China.; Cao, B; Wang, C (corresponding author), Chinese Acad Med Sci, Inst Resp Med, Beijing, Peoples R China.; Wang, C (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Zhang, D (corresponding author), Jin Yin Tan Hosp, Wuhan, Peoples R China.	caobin_ben@163.com; 1813886398@qq.com; cyh-birm@263.net	wang, chen/GWM-9481-2022	Xu, Jiuyang/0000-0002-1906-5918; Shang, Lianhan/0000-0001-9483-3529	Major Projects of National Science and Technology on New Drug Creation and Development [2020ZX09201001, 2020ZX09201012]; Chinese Academy of Medical Sciences (CAMS) Emergency Project of Covid-19 [2020HY320001]; National Science Grant for Distinguished Young Scholars [81425001/H0104]; National Institute for Health Research Senior Research Fellowship [2015-08-001]; Wellcome Trust; Bill and Melinda Gates Foundation; United Kingdom Department of Health and Social Care; MRC [MC_PC_19056] Funding Source: UKRI	Major Projects of National Science and Technology on New Drug Creation and Development; Chinese Academy of Medical Sciences (CAMS) Emergency Project of Covid-19; National Science Grant for Distinguished Young Scholars; National Institute for Health Research Senior Research Fellowship; Wellcome Trust(Wellcome Trust); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); United Kingdom Department of Health and Social Care; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from Major Projects of National Science and Technology on New Drug Creation and Development (2020ZX09201001) and (2020ZX09201012); the Chinese Academy of Medical Sciences (CAMS) Emergency Project of Covid-19 (2020HY320001); and a National Science Grant for Distinguished Young Scholars (81425001/H0104). Dr. Jaki is a recipient of a National Institute for Health Research Senior Research Fellowship (2015-08-001). Dr. Horby reports receiving funding from the Wellcome Trust, the Bill and Melinda Gates Foundation, and the United Kingdom Department of Health and Social Care.	[Anonymous], 2017, NATL EARLY WARNING S; [Anonymous], COR DIS COVID 2019 R; Arabi YM, 2018, TRIALS, V19, DOI 10.1186/s13063-017-2427-0; Chan JFW, 2013, J INFECTION, V67, P606, DOI 10.1016/j.jinf.2013.09.029; Chan JFW, 2015, J INFECT DIS, V212, P1904, DOI 10.1093/infdis/jiv392; Chan K. S., 2003, Hong Kong Medical Journal, V9, P399; Chen F, 2004, J CLIN VIROL, V31, P69, DOI 10.1016/j.jcv.2004.03.003; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14; Hart BJ, 2014, J GEN VIROL, V95, P571, DOI 10.1099/vir.0.061911-0; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Katzen J, 2019, CLIN INFECT DIS, V69, P52, DOI 10.1093/cid/ciy860; Kim UJ, 2016, ANTIVIR THER, V21, P455, DOI 10.3851/IMP3002; Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744; Louie JK, 2012, CLIN INFECT DIS, V55, P1198, DOI 10.1093/cid/cis636; Min CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep25359; Muthuri SG, 2014, LANCET RESP MED, V2, P395, DOI 10.1016/S2213-2600(14)70041-4; Spanakis N, 2014, INT J ANTIMICROB AG, V44, P528, DOI 10.1016/j.ijantimicag.2014.07.026; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang YM, 2020, J INFECT DIS, V221, P1688, DOI 10.1093/infdis/jiz656; Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101; Yamamoto N, 2004, BIOCHEM BIOPH RES CO, V318, P719, DOI 10.1016/j.bbrc.2004.04.083; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	24	3097	3265	37	446	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 7	2020	382	19					1787	1799		10.1056/NEJMoa2001282	http://dx.doi.org/10.1056/NEJMoa2001282			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LO1TS	32187464	Green Published, Bronze			2022-12-28	WOS:000533411000010
J	Pung, R; Chiew, CJ; Young, BE; Chin, S; Chen, MIC; Clapham, HE; Cook, AR; Maurer-Stroh, S; Toh, MPHS; Poh, C; Low, M; Lum, J; Koh, VTJ; Mak, TM; Cui, L; Lin, RVTP; Heng, D; Leo, YS; Lye, DC; Lee, VJM				Pung, Rachael; Chiew, Calvin J.; Young, Barnaby E.; Chin, Sarah; Chen, Mark I-C; Clapham, Hannah E.; Cook, Alex R.; Maurer-Stroh, Sebastian; Toh, Matthias P. H. S.; Poh, Cuiqin; Low, Mabel; Lum, Joshua; Koh, Valerie T. J.; Mak, Tze M.; Cui, Lin; Lin, Raymond V. T. P.; Heng, Derrick; Leo, Yee-Sin; Lye, David C.; Lee, Vernon J. M.		Singapore 2019 Novel Coronavirus	Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures	LANCET			English	Article								Background Three clusters of coronavirus disease 2019 (COVID-19) linked to a tour group from China, a company conference, and a church were identified in Singapore in February, 2020. Methods We gathered epidemiological and clinical data from individuals with confirmed COVID-19, via interviews and inpatient medical records, and we did field investigations to assess interactions and possible modes of transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Open source reports were obtained for overseas cases. We reported the median (IQR) incubation period of SARS-CoV-2. Findings As of Feb 15, 2020, 36 cases of COVID-19 were linked epidemiologically to the first three clusters of circumscribed local transmission in Singapore. 425 close contacts were quarantined. Direct or prolonged close contact was reported among affected individuals, although indirect transmission (eg, via fomites and shared food) could not be excluded. The median incubation period of SARS-CoV-2 was 4 days (IQR 3-6). The serial interval between transmission pairs ranged between 3 days and 8 days. Interpretation SARS-CoV-2 is transmissible in community settings, and local clusters of COVID-19 are expected in countries with high travel volume from China before the lockdown of Wuhan and institution of travel restrictions. Enhanced surveillance and contact tracing is essential to minimise the risk of widespread transmission in the community. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Pung, Rachael; Chiew, Calvin J.; Chin, Sarah; Poh, Cuiqin; Low, Mabel; Lum, Joshua; Koh, Valerie T. J.; Heng, Derrick; Lee, Vernon J. M.] Minist Hlth, Singapore, Singapore; [Young, Barnaby E.; Chen, Mark I-C; Leo, Yee-Sin; Lye, David C.] Natl Ctr Infect Dis, Singapore, Singapore; [Young, Barnaby E.; Leo, Yee-Sin; Lye, David C.] Tan Tock Seng Hosp, Singapore, Singapore; [Chen, Mark I-C; Clapham, Hannah E.; Cook, Alex R.; Leo, Yee-Sin; Lee, Vernon J. M.] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Clapham, Hannah E.; Cook, Alex R.] Natl Univ Singapore, Singapore, Singapore; [Clapham, Hannah E.; Cook, Alex R.] Natl Univ Hlth Syst, Singapore, Singapore; [Maurer-Stroh, Sebastian] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Maurer-Stroh, Sebastian] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore; [Maurer-Stroh, Sebastian; Mak, Tze M.; Cui, Lin; Lin, Raymond V. T. P.] Natl Ctr Infect Dis, Natl Publ Hlth Lab, Singapore, Singapore; [Toh, Matthias P. H. S.] Natl Ctr Infect Dis, Natl Publ Hlth & Epidemiol Unit, Singapore, Singapore; [Young, Barnaby E.; Leo, Yee-Sin; Lye, David C.] Lee Kong Chian Sch Med, Singapore, Singapore; [Leo, Yee-Sin; Lye, David C.] Yong Loo Lin Sch Med, Singapore, Singapore	Ministry of Health-Singapore; National Centre for Infectious Diseases Singapore; Tan Tock Seng Hospital; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; National Centre for Infectious Diseases Singapore; National Centre for Infectious Diseases Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Lee, VJM (corresponding author), Minist Hlth, Communicable Dis Div, Singapore 169852, Singapore.	vernon_lee@moh.gov.sg	Chen, Mark/AGC-5338-2022; Maurer-Stroh, Sebastian/Q-9476-2019; Young, Barnaby/GVR-9935-2022; Lye, David/ABF-4402-2021; Cook, Alex/B-5941-2011	Chen, Mark/0000-0001-9369-5830; Maurer-Stroh, Sebastian/0000-0003-0813-9640; Chow, Angela/0000-0002-4063-736X; Lye, David/0000-0003-0324-0205; Young, Barnaby/0000-0003-1010-2230; Wei, Wycliffe/0000-0002-1995-1610; Mak, Tze Minn/0000-0002-8249-8353; Cook, Alex/0000-0002-6271-5832				[Anonymous], 2020, CHANNEL NEWSASI 0205; [Anonymous], 2020, YULIN NEWS      0203; [Anonymous], 2005, STAT 2 M INT HLTH RE; [Anonymous], 2020, 2 NEW CAS PNEUM CONF; [Anonymous], 2003, INF DIS ACT; Backer JA, 2020, EUROSURVEILLANCE, V25, P10, DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; DW.com, 2020, WUH PNEUM VIR CONT S; Lauer SA, 2020, INCUBATION PERIOD 20, DOI [10.1101/2020.02.02.20020016v1, DOI 10.1101/2020.02.02.20020016V1]; Ministry of Health Singapore, 2020, CONF IMP CAS NOV COR; Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227; People's Government of Guangxi Zhuang Autonomous Region, 2020, EM NOT FIND CONT CON; The State Council People's Republic of China, 2020, WUH NOV COR PREV CON; WHO, 2020, 3 WHO; World Health Organization, 2020, COR DIS 2019 COVID 2; Wuhan Municipal Health Commission, 2019, REP CURR PNEUM EP SI	16	366	372	1	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1039	1046		10.1016/S0140-6736(20)30528-6	http://dx.doi.org/10.1016/S0140-6736(20)30528-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY5YW	32192580	Green Published, Bronze			2022-12-28	WOS:000522650100031
J	Starr, D				Starr, Douglas			THE BIAS DETECTIVE	SCIENCE			English	Editorial Material																			0	0	0	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1418	1421		10.1126/science.367.6485.1418	http://dx.doi.org/10.1126/science.367.6485.1418			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217710				2022-12-28	WOS:000523251600012
J	Vaitiekenas, S; Winkler, GW; van Heck, B; Karzig, T; Deng, MT; Flensberg, K; Glazman, LI; Nayak, C; Krogstrup, P; Lutchyn, RM; Marcus, CM				Vaitiekenas, S.; Winkler, G. W.; van Heck, B.; Karzig, T.; Deng, M. -T.; Flensberg, K.; Glazman, L. I.; Nayak, C.; Krogstrup, P.; Lutchyn, R. M.; Marcus, C. M.			Flux-induced topological superconductivity in full-shell nanowires (Publication with Expression of Concern. See vol. 373, pg. 500, 2021)	SCIENCE			English	Article; Publication with Expression of Concern							COULOMB-BLOCKADE; CHARGE-TRANSPORT; QUANTUM; STATES; PHASE; DIMENSIONS; TRANSITION; BREAKING; FERMIONS; PARITY	Hybrid semiconductor-superconductor nanowires have emerged as a promising platform for realizing topological superconductivity (TSC). Here, we present a route to TSC using magnetic flux applied to a full superconducting shell surrounding a semiconducting nanowire core. Tunneling into the core reveals a hard induced gap near zero applied flux, corresponding to zero phase winding, and a gapped region with a discrete zero-energy state around one applied flux quantum, corresponding to 2p phase winding. Theoretical analysis indicates that the winding of the superconducting phase can induce a transition to a topological phase supporting Majorana zero modes. Measured Coulomb blockade peak spacing around one flux quantum shows a length dependence that is consistent with the existence of Majorana modes at the ends of the nanowire.	[Vaitiekenas, S.; Deng, M. -T.; Flensberg, K.; Krogstrup, P.; Marcus, C. M.] Univ Copenhagen, Niels Bohr Inst, Ctr Quantum Devices, DK-2100 Copenhagen, Denmark; [Vaitiekenas, S.; Deng, M. -T.; Flensberg, K.; Krogstrup, P.; Marcus, C. M.] Univ Copenhagen, Niels Bohr Inst, Microsoft Quantum Lab Copenhagen, DK-2100 Copenhagen, Denmark; [Winkler, G. W.; van Heck, B.; Karzig, T.; Nayak, C.; Lutchyn, R. M.] Univ Calif Santa Barbara, Microsoft Quantum, Microsoft Stn Q, Santa Barbara, CA 93106 USA; [Glazman, L. I.] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Glazman, L. I.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	University of Copenhagen; Niels Bohr Institute; University of Copenhagen; Niels Bohr Institute; Microsoft; University of California System; University of California Santa Barbara; Yale University; Yale University	Marcus, CM (corresponding author), Univ Copenhagen, Niels Bohr Inst, Ctr Quantum Devices, DK-2100 Copenhagen, Denmark.; Marcus, CM (corresponding author), Univ Copenhagen, Niels Bohr Inst, Microsoft Quantum Lab Copenhagen, DK-2100 Copenhagen, Denmark.; Lutchyn, RM (corresponding author), Univ Calif Santa Barbara, Microsoft Quantum, Microsoft Stn Q, Santa Barbara, CA 93106 USA.	rolutchy@microsoft.com; chmarcus@microsoft.com	van Heck, Bernard/GRX-7503-2022; Flensberg, Karsten/N-4718-2014; Deng, Mingtang/I-2692-2015; Krogstrup, Peter/G-4323-2011	van Heck, Bernard/0000-0001-9119-1911; Flensberg, Karsten/0000-0002-8311-0103; Deng, Mingtang/0000-0003-2809-6158; Winkler, Georg Wolfgang/0000-0003-2677-7267; Vaitiekenas, Saulius/0000-0002-5007-461X; Krogstrup, Peter/0000-0002-1930-8553	Microsoft; Danish National Research Foundation; European Commission; National Science Foundation (NSF) [PHY-1607611]; State Key Laboratory of High Performance Computing, China; NSF Division of Materials Research grant [1603243]	Microsoft(Microsoft); Danish National Research Foundation(Danmarks Grundforskningsfond); European Commission(European CommissionEuropean Commission Joint Research Centre); National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); State Key Laboratory of High Performance Computing, China; NSF Division of Materials Research grant	Research was supported by Microsoft, the Danish National Research Foundation, and the European Commission. This work was performed in part at the Aspen Center for Physics, which is supported by National Science Foundation (NSF) grant PHY-1607611. M.-T.D. acknowledges support from State Key Laboratory of High Performance Computing, China. L.I.G. acknowledges support from NSF Division of Materials Research grant 1603243.	Albrecht SM, 2016, NATURE, V531, P206, DOI 10.1038/nature17162; Alicea J, 2011, NAT PHYS, V7, P412, DOI 10.1038/NPHYS1915; Alicea J, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125318; [Anonymous], 2011, SOLID STATE PHYS; BEENAKKER CWJ, 1991, PHYS REV B, V44, P1646, DOI 10.1103/PhysRevB.44.1646; CAROLI C, 1964, PHYS LETT, V9, P307, DOI 10.1016/0031-9163(64)90375-0; Cheng M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.107001; Chiu CK, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.054504; Chiu CK, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144507; COCHRAN JF, 1958, PHYS REV, V111, P132, DOI 10.1103/PhysRev.111.132; Dao VH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.134524; Das Sarma S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.166802; Das Sarma S, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.220506; de Juan F, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.107003; DEGENNES PG, 1981, CR ACAD SCI II, V292, P279; Deng MT, 2016, SCIENCE, V354, P1557, DOI 10.1126/science.aaf3961; Fu L, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.096407; Fu L, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.056402; GORDON JM, 1984, PHYS REV B, V29, P5232, DOI 10.1103/PhysRevB.29.5232; Groth CW, 2014, NEW J PHYS, V16, DOI 10.1088/1367-2630/16/6/063065; HEKKING FWJ, 1993, PHYS REV LETT, V70, P4138, DOI 10.1103/PhysRevLett.70.4138; Hell M, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.107701; HERGENROTHER JM, 1994, PHYS REV LETT, V72, P1742, DOI 10.1103/PhysRevLett.72.1742; Higginbotham AP, 2015, NAT PHYS, V11, P1017, DOI [10.1038/nphys3461, 10.1038/NPHYS3461]; Hosur P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.097001; Kiendl T, 2019, PHYS REV B, V100, DOI 10.1103/PhysRevB.100.035426; Kitaev AY., 2001, PHYS-USP+, V44, P131, DOI [10.1070/1063-7869/44/10S/S29, DOI 10.1070/1063-7869/44/10S/S29]; Kittel C, 2021, INTRO SOLID STATE PH; Koshnick NC, 2007, SCIENCE, V318, P1440, DOI 10.1126/science.1148758; Kotetes P, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.014514; Krogstrup P, 2015, NAT MATER, V14, P400, DOI [10.1038/nmat4176, 10.1038/NMAT4176]; Lee M, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241402; LITTLE WA, 1962, PHYS REV LETT, V9, P9, DOI 10.1103/PhysRevLett.9.9; Liu CX, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.075161; Liu Y, 2001, SCIENCE, V294, P2332, DOI 10.1126/science.1066144; Lutchyn RM, 2018, NAT REV MATER, V3, P52, DOI 10.1038/s41578-018-0003-1; Lutchyn RM, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214528; Lutchyn RM, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.077001; Mourik V, 2012, SCIENCE, V336, P1003, DOI 10.1126/science.1222360; Nadj-Perge S, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.020407; Nayak C, 2008, REV MOD PHYS, V80, P1083, DOI 10.1103/RevModPhys.80.1083; Nijholt B., 2019, ADAPTIVE PARALLEL AC; Nijholt B, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.235434; O'Farrell ECT, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.256803; Oreg Y, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.177002; Peng Y, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.106801; Pientka F, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021032; Read N, 2000, PHYS REV B, V61, P10267, DOI 10.1103/PhysRevB.61.10267; Romito A, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.020502; Rosdahl TO, 2018, PHYS REV B, V97, DOI 10.1103/PhysRevB.97.045421; Sau JD, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.040502; Schuwalow S., 2019, ARXIV191002735CONDMA; Schwiete G, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.037001; Sharma S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.067801; Shen J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07279-7; Stanescu TD, 2018, BEILSTEIN J NANOTECH, V9, P1512, DOI 10.3762/bjnano.9.142; Stanescu TD, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.144522; Sternfeld I, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.037001; Sticlet D, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.115421; Thijssen JM, 2008, PHYS STATUS SOLIDI B, V245, P1455, DOI 10.1002/pssb.200743470; Tinkham M., 1996, INTRO SUPERCONDUCTIV, V2nd ed.; Vaitiekenas S., 2020, SIMULATION CODE FLUX, DOI [10.5281/zenodo.3636085, DOI 10.5281/ZENODO.3636085]; Vaitiekenas S., 2020, REPLICATION DATA FLU, DOI [10.5281/zenodo.3585690, DOI 10.5281/ZENODO.3585690]; van Heck B, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.155450; Vuik A, 2019, SCIPOST PHYS, V7, DOI 10.21468/SciPostPhys.7.5.061; Vurgaftman I, 2001, J APPL PHYS, V89, P5815, DOI 10.1063/1.1368156; Wang DF, 2018, SCIENCE, V362, P333, DOI 10.1126/science.aao1797; Wang X, 2015, NPJ QUANTUM INFORM, V1, DOI 10.1038/npjqi.2015.3; Wimmer M, 2012, ACM T MATH SOFTWARE, V38, DOI 10.1145/2331130.2331138; Winkler GW, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.245408; Winkler R, 2003, SPRINGER TRACTS MOD, V191, P1, DOI 10.1007/b13586; Woods BD, 2019, PHYS REV B, V99, DOI 10.1103/PhysRevB.99.161118; Xu JP, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.017001; Zhang H, 2018, NATURE, V556, P74, DOI 10.1038/nature26142	82	86	86	5	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1442	+	eaav3392	10.1126/science.aav3392	http://dx.doi.org/10.1126/science.aav3392			54	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217701	Green Submitted			2022-12-28	WOS:000523251600027
J	Greenhalgh, T; Koh, GCH; Car, J				Greenhalgh, Trisha; Koh, Gerald Choon Huat; Car, Josip			10-MINUTE CONSULTATION Covid-19: a remote assessment in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Greenhalgh, Trisha] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Koh, Gerald Choon Huat] Natl Univ Singapore, Yong Loo Lin Sch Med, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Car, Josip] Nanyang Technol Univ, Lee Kong Chian Sch Med, Ctr Populat Hlth Sci, Singapore, Singapore; [Car, Josip] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England	University of Oxford; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London	Greenhalgh, T (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	trish.greenhalgh@phc.ox.ac.uk	Greenhalgh, Trisha/B-1825-2015; Car, Josip/H-6755-2015	Greenhalgh, Trisha/0000-0003-2369-8088; Car, Josip/0000-0001-8969-371X	Wellcome Trust [WT104830MA]; National Institute for Health Research [BRC-1215-20008, HSDR 13/59/26]; Health Foundation; Scottish Government; ESRC [ES/V010069/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); National Institute for Health Research(National Institute for Health Research (NIHR)); Health Foundation; Scottish Government; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	TG thanks the Wellcome Trust (grant number WT104830MA), National Institute for Health Research (grant number BRC-1215-20008 and HS&DR 13/59/26), Health Foundation, and Scottish Government for funding her video consultation research.	[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; de Simone G, 2020, POS STAT ESC COUNC H; Donaghy E, 2019, BRIT J GEN PRACT, V69, pE586, DOI 10.3399/bjgp19X704141; Greenhalgh T, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m998; Gu JY, 2020, GASTROENTEROLOGY, V158, P1518, DOI 10.1053/j.gastro.2020.02.054; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Li JPO, 2020, BRIT J OPHTHALMOL, V104, P297, DOI 10.1136/bjophthalmol-2020-315994; Liang T., 2020, HDB COVID 19 PREVENT; Morrison C., 2020, CORONAVIRUS RESILIEN; National Institute for Health and Clinical Excellence, 2018, CHRON OBSTR PULM DIS; Neighbour R., 2020, BJGP; Pludderman A., 2020, OXFORD COVID 19 EVID; Seuren LM, 2020, J MED INTERNET RES, V22, DOI 10.2196/16694; Shaw S, 2018, NIHR J LIB; UK Government, 2020, COVID 19 GUID HOUS P; UK National Health Service, 2020, CLIN GUID MAN EM DEP; US Centers for Disese Control and Prevention, 2020, COR COVID 19; US Department of Health and Human Services, NOT ENF DISCR TEL RE; van Galen LS, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k1047; Video consultations-for patients, QUICK GUID PAT BARTS; Walzl N, 2019, BMC EMERG MED, V19, DOI 10.1186/s12873-019-0225-6; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	22	295	306	4	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m1182	10.1136/bmj.m1182	http://dx.doi.org/10.1136/bmj.m1182			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213507	Green Published, Bronze			2022-12-28	WOS:000523764500010
J	Rubin, R				Rubin, Rita			Government Cites California for Violating Federal Conscience Laws	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1123	1123		10.1001/jama.2020.3016	http://dx.doi.org/10.1001/jama.2020.3016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD1JR	32207782				2022-12-28	WOS:000543732100002
J	Mahase, E				Mahase, Elisabeth			Covid-19: six million doses of hydroxychloroquine donated to US despite lack of evidence	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	14	14	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1166	10.1136/bmj.m1166	http://dx.doi.org/10.1136/bmj.m1166			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205321	Bronze			2022-12-28	WOS:000523764100010
J	Sim, I; Stebbins, M; Bierer, BE; Butte, AJ; Drazen, J; Dzau, V; Hernandez, AF; Krumholz, HM; Lo, B; Munos, B; Perakslis, E; Rockhold, F; Ross, JS; Terry, SF; Yamamoto, KR; Zarin, DA; Li, R				Sim, Ida; Stebbins, Michael; Bierer, Barbara E.; Butte, Atul J.; Drazen, Jeffrey; Dzau, Victor; Hernandez, Adrian F.; Krumholz, Harlan M.; Lo, Bernard; Munos, Bernard; Perakslis, Eric; Rockhold, Frank; Ross, Joseph S.; Terry, Sharon F.; Yamamoto, Keith R.; Zarin, Deborah A.; Li, Rebecca			Time for NIH to lead on data sharing A draft policy is generally supportive but should start mandating data sharing	SCIENCE			English	Editorial Material									[Sim, Ida; Butte, Atul J.; Yamamoto, Keith R.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Sim, Ida; Li, Rebecca] Vivli, Cambridge, MA 02138 USA; [Bierer, Barbara E.; Zarin, Deborah A.] Brigham & Womens Hosp, Multireg Clin Trials Ctr, Cambridge, MA USA; [Bierer, Barbara E.; Zarin, Deborah A.] Harvard Univ, Cambridge, MA 02138 USA; [Bierer, Barbara E.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Bierer, Barbara E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Drazen, Jeffrey] Brigham & Womens Hosp, Dept Med, Div Pulm, 75 Francis St, Boston, MA 02115 USA; [Drazen, Jeffrey] Brigham & Womens Hosp, Dept Med, Commun Div, 75 Francis St, Boston, MA 02115 USA; [Dzau, Victor] Natl Acad Med, Washington, DC USA; [Hernandez, Adrian F.; Perakslis, Eric; Rockhold, Frank] Duke Univ, Durham, NC USA; [Krumholz, Harlan M.; Ross, Joseph S.] Yale Univ, New Haven, CT USA; [Lo, Bernard] Greenwall Fdn, New York, NY USA; [Munos, Bernard] FasterCures Milken Inst, Washington, DC USA; [Terry, Sharon F.] Genet Alliance, Washington, DC USA; [Li, Rebecca] Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA	University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; National Academies of Sciences, Engineering & Medicine; Duke University; Yale University; Harvard University; Harvard Medical School	Sim, I (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.; Sim, I (corresponding author), Vivli, Cambridge, MA 02138 USA.	ida.sim@ucsf.edu		Ross, Joseph/0000-0002-9218-3320; Perakslis, Eric/0000-0003-2395-810X	Bristol-Myers-Squibb; Arnold Ventures; Doris Duke Charitable Trust; Helmsley Charitable Trust; Johnson and Johnson; National Institute of Allergy and Infectious Diseases	Bristol-Myers-Squibb(Bristol-Myers Squibb); Arnold Ventures; Doris Duke Charitable Trust(Doris Duke Charitable Foundation (DDCF)); Helmsley Charitable Trust; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	I.S,R.L., and B.E.B. are cofounders of Vivli, a nonprofit platform for clinical trial data sharing,and currently serve on the Vivli Board of Directors. R.L. is an employee of Vivli, and I.S. is a paid consultant of Vivli. M.S.serves on the Vivli Board of Directors, and B.L. and J.D. serve on Vivli's External Advisory Committee. F.R. serves as a Vivli Senior Advisor and Principal Investigator of Supporting Open Access for Researchers, Duke Clinical Research Institute's data sharing platform partially funded by Bristol-MyersSquibb. Vivli receives funding support from the Arnold Ventures, Doris Duke Charitable Trust, the Helmsley Charitable Trust, the pharmaceutical industry, and academic institutional partners. J.S.R.and H.M.K. are co-founders of the Yale Open Data Access Project, a Yale University platform for clinical trial sharing, which shares trials forand receives support from Johnson and Johnson. A.J.B. receives research support from the National Institute of Allergy and Infectious Diseases as principal investigator of ImmPort, an open-access data repository, including clinical trials data. Additional author disclosures are provided as supplementary materials.	Banzi R, 2019, TRIALS, V20, DOI 10.1186/s13063-019-3253-3; Bergeris A, 2018, JAMA-J AM MED ASSOC, V319, P406, DOI 10.1001/jama.2017.20581; [(GAO) U.S. GovernmentAccountabilityOffice (GAO)Federal Research], 2019, GAO2081; Holdren JP, 2013, INCREASING ACCESS RE; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Li R., 2018, NAM PERSPECT, DOI [10.31478/201811b, DOI 10.31478/201811B]; Mello MM, 2018, NEW ENGL J MED, V378, P2202, DOI 10.1056/NEJMsa1713258; National Institutes of Health, 2019, FED REGISTER; National Institutes of Health (NIH), 2015, PLAN INCR ACC SCI PU; NIH, 2017, NIH POL DISS NIH FUN; Pierce HH, 2019, NATURE, V570, P30, DOI 10.1038/d41586-019-01715-4; Rockhold F, 2016, NEW ENGL J MED, V375, P1115, DOI 10.1056/NEJMp1608086; Ross JS, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.268; Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18; Zarin DA, 2016, NEW ENGL J MED, V375, P1998, DOI 10.1056/NEJMsr1611785	15	20	20	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1308	+		10.1126/science.aba4456	http://dx.doi.org/10.1126/science.aba4456			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193313				2022-12-28	WOS:000522167400032
J	Iino, Y; Sawada, T; Yamaguchi, K; Tajiri, M; Ishii, S; Kasai, H; Yagishita, S				Iino, Yusuke; Sawada, Takeshi; Yamaguchi, Kenji; Tajiri, Mio; Ishii, Shin; Kasai, Haruo; Yagishita, Sho			Dopamine D2 receptors in discrimination learning and spine enlargement	NATURE			English	Article							STRUCTURAL PLASTICITY; NEURONS; PREDICTION; NUCLEUS; SENSITIZATION; COCAINE; METHAMPHETAMINE; EXTINCTION; ACTIVATION; HYPOTHESIS	Detection of dopamine dips by neurons that express dopamine D2 receptors in the striatum is used to refine generalized reward conditioning mediated by dopamine D1 receptors. Dopamine D2 receptors (D2Rs) are densely expressed in the striatum and have been linked to neuropsychiatric disorders such as schizophrenia(1,2). High-affinity binding of dopamine suggests that D2Rs detect transient reductions in dopamine concentration (the dopamine dip) during punishment learning(3-5). However, the nature and cellular basis of D2R-dependent behaviour are unclear. Here we show that tone reward conditioning induces marked stimulus generalization in a manner that depends on dopamine D1 receptors (D1Rs) in the nucleus accumbens (NAc) of mice, and that discrimination learning refines the conditioning using a dopamine dip. In NAc slices, a narrow dopamine dip (as short as 0.4 s) was detected by D2Rs to disinhibit adenosine A(2A) receptor (A(2A)R)-mediated enlargement of dendritic spines in D2R-expressing spiny projection neurons (D2-SPNs). Plasticity-related signalling by Ca2+/calmodulin-dependent protein kinase II and A(2A)Rs in the NAc was required for discrimination learning. By contrast, extinction learning did not involve dopamine dips or D2-SPNs. Treatment with methamphetamine, which dysregulates dopamine signalling, impaired discrimination learning and spine enlargement, and these impairments were reversed by a D2R antagonist. Our data show that D2Rs refine the generalized reward learning mediated by D1Rs.	[Iino, Yusuke; Sawada, Takeshi; Yamaguchi, Kenji; Tajiri, Mio; Kasai, Haruo; Yagishita, Sho] Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Lab Struct Physiol, Tokyo, Japan; [Iino, Yusuke; Sawada, Takeshi; Yamaguchi, Kenji; Tajiri, Mio; Ishii, Shin; Kasai, Haruo; Yagishita, Sho] Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, Tokyo, Japan; [Ishii, Shin] Kyoto Univ, Grad Sch Informat, Kyoto, Japan	University of Tokyo; University of Tokyo; Kyoto University	Kasai, H; Yagishita, S (corresponding author), Univ Tokyo, Ctr Dis Biol & Integrat Med, Fac Med, Lab Struct Physiol, Tokyo, Japan.; Kasai, H; Yagishita, S (corresponding author), Univ Tokyo, Int Res Ctr Neurointelligence WPI IRCN, Tokyo, Japan.	hkasai@m.u-tokyo.ac.jp; yagishita-tky@umin.ac.jp	Yagishita, Sho/HII-4239-2022; Yagishita, Sho/Y-6908-2019	Yagishita, Sho/0000-0003-2854-773X; Yagishita, Sho/0000-0003-2854-773X; Yamaguchi, Kenji/0000-0003-3071-9035; Ishii, Shin/0000-0001-9385-8230; Sawada, Takeshi/0000-0001-7000-2296	CREST [JPMJCR1652]; JST, SRPBS [JP19dm0107120]; Brain/MINDS [19dm0207069h0001]; AMED from JSPS [26221001, 19K16249, 16H06395, 16H06396, 16K21720]; World Premier International Research Center Initiative (WPI) from MEXT; Takeda Science Foundation; Naito Foundation	CREST(Core Research for Evolutional Science and Technology (CREST)); JST, SRPBS; Brain/MINDS; AMED from JSPS; World Premier International Research Center Initiative (WPI) from MEXT; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	We thank T. Yoshikawa for support of the MAP model, Y. Li for the GRAB<INF>DA1m</INF> plasmid, N. Uchida, J. Johansen, M. Lazarus, H. Urakubo, K. Kasai, S. Koike, and S. Kondo for discussions, and A. Kurabayashi, M. Asaumi, R. Nakazato and A. Nishikawa for technical assistance. This work was supported by CREST (JPMJCR1652 to H.K.) from JST, SRPBS (JP19dm0107120 to H.K.), Brain/MINDS (19dm0207069h0001 to S.Y.) from AMED, Grants-in-Aid (No. 26221001 to H.K.; 19K16249, 16H06395, 16H06396 and 16K21720 to S.Y.) from JSPS, the World Premier International Research Center Initiative (WPI) from MEXT, Takeda Science Foundation (to S.Y.), and The Naito Foundation (to Y.I.). M.T. and T.S. are Research Fellows for Young Scientists of JSPS.	Agid O, 2006, J PSYCHIATR NEUROSCI, V31, P93; Beyeler A, 2016, NEURON, V90, P348, DOI 10.1016/j.neuron.2016.03.004; BORDI F, 1992, J NEUROSCI, V12, P2493; Castro LRV, 2013, J PHYSIOL-LONDON, V591, P3197, DOI 10.1113/jphysiol.2013.252197; Chang CY, 2016, NAT NEUROSCI, V19, P111, DOI 10.1038/nn.4191; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Danjo T, 2014, P NATL ACAD SCI USA, V111, P6455, DOI 10.1073/pnas.1404323111; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; de Jong JW, 2019, NEURON, V101, P133, DOI 10.1016/j.neuron.2018.11.005; Ellis-Davies GCR, 2007, J NEUROSCI, V27, P6601, DOI 10.1523/JNEUROSCI.1519-07.2007; Eshel N, 2015, NATURE, V525, P243, DOI 10.1038/nature14855; Farnia V, 2014, AM J DRUG ALCOHOL AB, V40, P10, DOI 10.3109/00952990.2013.861843; Ferre S, 2004, PARKINSONISM RELAT D, V10, P265, DOI 10.1016/j.parkreldis.2004.02.014; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Gershman SJ, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00164; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Guo QC, 2015, BIOMED OPT EXPRESS, V6, P3919, DOI 10.1364/BOE.6.003919; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Howes OD, 2016, WORLD PSYCHIATRY, V15, P3, DOI 10.1002/wps.20276; Jensen J, 2008, NEUROPSYCHOPHARMACOL, V33, P473, DOI 10.1038/sj.npp.1301437; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; LINDEFORS N, 1989, J PHARMACOL METHOD, V22, P141, DOI 10.1016/0160-5402(89)90011-9; Lobo MK, 2010, SCIENCE, V330, P385, DOI 10.1126/science.1188472; Marcott PF, 2014, NEURON, V84, P164, DOI 10.1016/j.neuron.2014.08.058; Mathis A, 2018, NAT NEUROSCI, V21, P1281, DOI 10.1038/s41593-018-0209-y; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; Menegas W, 2017, ELIFE, V6, DOI 10.7554/eLife.21886; Murakoshi H, 2017, NEURON, V94, P37, DOI 10.1016/j.neuron.2017.02.036; Plotkin JL, 2014, NEURON, V83, P178, DOI 10.1016/j.neuron.2014.05.032; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; Samson RD, 2010, COGN NEURODYNAMICS, V4, P91, DOI 10.1007/s11571-010-9109-x; Saunders A, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00047; Schiffmann SN, 2007, PROG NEUROBIOL, V83, P277, DOI 10.1016/j.pneurobio.2007.05.001; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Seeman P, 2006, EXPERT OPIN THER TAR, V10, P515, DOI 10.1517/14728222.10.4.515; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shimosato K, 2000, PHARMACOL BIOCHEM BE, V66, P285, DOI 10.1016/S0091-3057(00)00185-4; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Steinberg EE, 2013, NAT NEUROSCI, V16, P966, DOI 10.1038/nn.3413; Sun FM, 2018, CELL, V174, P481, DOI 10.1016/j.cell.2018.06.042; Tan KR, 2012, NEURON, V73, P1173, DOI 10.1016/j.neuron.2012.02.015; Tanaka JI, 2008, SCIENCE, V319, P1683, DOI 10.1126/science.1152864; Tervo DGR, 2016, NEURON, V92, P372, DOI 10.1016/j.neuron.2016.09.021; Ujike H, 2004, ANN NY ACAD SCI, V1025, P279, DOI 10.1196/annals.1316.035; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wiecki TV, 2009, PSYCHOPHARMACOLOGY, V204, P265, DOI 10.1007/s00213-008-1457-4; Yagishita S, 2014, SCIENCE, V345, P1616, DOI 10.1126/science.1255514; Yamaguchi K, 2019, MINIMAL BEHAV TIME W, DOI [10.1101/641365v1, DOI 10.1101/641365V1]; Zombeck JA, 2009, PSYCHOPHARMACOLOGY, V201, P589, DOI 10.1007/s00213-008-1327-0	51	56	57	1	36	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					555	+		10.1038/s41586-020-2115-1	http://dx.doi.org/10.1038/s41586-020-2115-1		MAR 2020	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX4BT	32214250				2022-12-28	WOS:000520406700005
J	Dyer, C				Dyer, Clare			TB expert is suspended for 12 months for possessing extreme pornography	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1094	10.1136/bmj.m1094	http://dx.doi.org/10.1136/bmj.m1094			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184298				2022-12-28	WOS:000523762400013
J	Banerjee, A; Fyfe, JC; Polvani, LM; Waugh, D; Chang, KL				Banerjee, Antara; Fyfe, John C.; Polvani, Lorenzo M.; Waugh, Darryn; Chang, Kai-Lan			A pause in Southern Hemisphere circulation trends due to the Montreal Protocol	NATURE			English	Article							STRATOSPHERIC OZONE RECOVERY; ANNULAR MODE; IMPACT; ATTRIBUTION; DEPLETION; FORCINGS; AEROSOL; JET	Observations show robust near-surface trends in Southern Hemisphere tropospheric circulation towards the end of the twentieth century, including a poleward shift in the mid-latitude jet(1,2), a positive trend in the Southern Annular Mode(1,3-6) and an expansion of the Hadley cell(7,8). It has been established that these trends were driven by ozone depletion in the Antarctic stratosphere due to emissions of ozone-depleting substances(9-11). Here we show that these widely reported circulation trends paused, or slightly reversed, around the year 2000. Using a pattern-based detection and attribution analysis of atmospheric zonal wind, we show that the pause in circulation trends is forced by human activities, and has not occurred owing only to internal or natural variability of the climate system. Furthermore, we demonstrate that stratospheric ozone recovery, resulting from the Montreal Protocol, is the key driver of the pause. Because pre-2000 circulation trends have affected precipitation(12-14), and potentially ocean circulation and salinity(15-17), we anticipate that a pause in these trends will have wider impacts on the Earth system. Signatures of the effects of the Montreal Protocol and the associated stratospheric ozone recovery might therefore manifest, or have already manifested, in other aspects of the Earth system.	[Banerjee, Antara; Chang, Kai-Lan] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Banerjee, Antara; Chang, Kai-Lan] NOAA, Chem Sci Div, Earth Syst Res Lab, Boulder, CO 80305 USA; [Fyfe, John C.] Environm & Climate Change Canada, Canadian Ctr Climate Modelling & Anal, Victoria, BC, Canada; [Polvani, Lorenzo M.] Columbia Univ, Dept Appl Phys & Appl Math, New York, NY USA; [Waugh, Darryn] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD USA; [Waugh, Darryn] Univ New South Wales, Sch Math & Stat, Sydney, NSW, Australia	University of Colorado System; University of Colorado Boulder; National Oceanic Atmospheric Admin (NOAA) - USA; Environment & Climate Change Canada; Canadian Centre for Climate Modelling & Analysis (CCCma); Columbia University; Johns Hopkins University; University of New South Wales Sydney	Banerjee, A (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.; Banerjee, A (corresponding author), NOAA, Chem Sci Div, Earth Syst Res Lab, Boulder, CO 80305 USA.	antara.banerjee@noaa.gov	Banerjee, Antara/ABC-1903-2020; Chang, Kai-Lan/AAU-7009-2020; Polvani, Lorenzo M/E-5949-2011; Waugh, Darryn/K-3688-2016	Chang, Kai-Lan/0000-0001-5812-3183; Waugh, Darryn/0000-0001-7692-2798				Arblaster JM, 2006, J CLIMATE, V19, P2896, DOI 10.1175/JCLI3774.1; Barnes EA, 2014, J CLIMATE, V27, P852, DOI 10.1175/JCLI-D-13-00246.1; Barnes EA, 2013, J CLIMATE, V26, P7117, DOI 10.1175/JCLI-D-12-00536.1; Braesicke P., 2018, SCI ASSESSMENT OZONE; Cionni I, 2011, ATMOS CHEM PHYS, V11, P11267, DOI 10.5194/acp-11-11267-2011; Davis SM, 2012, J CLIMATE, V25, P1061, DOI 10.1175/JCLI-D-11-00127.1; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Engel A., 2018, 58 WORLD MET ORG; Engel A, 2018, ATMOS CHEM PHYS, V18, P601, DOI 10.5194/acp-18-601-2018; FARMAN JC, 1985, NATURE, V315, P207, DOI 10.1038/315207a0; Garfinkel CI, 2015, GEOPHYS RES LETT, V42, P10824, DOI 10.1002/2015GL066942; Gelaro R, 2017, J CLIMATE, V30, P5419, DOI 10.1175/JCLI-D-16-0758.1; Gillett NP, 2013, GEOPHYS RES LETT, V40, P1189, DOI 10.1002/grl.50249; Gillett NP, 2013, GEOPHYS RES LETT, V40, P2302, DOI 10.1002/grl.50500; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Holt JI, 2017, J GEOPHYS RES-ATMOS, V122, P6379, DOI 10.1002/2016JD025890; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Karpechko A. Y, 2018, 58 WORLD MET ORG; Kobayashi S, 2015, J METEOROL SOC JPN, V93, P5, DOI 10.2151/jmsj.2015-001; Langematz U, 2018, 58 WORLD MET ORG; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; McLandress C, 2011, J CLIMATE, V24, P1850, DOI 10.1175/2010JCLI3958.1; Monahan AH, 2008, J CLIMATE, V21, P1963, DOI 10.1175/2007JCLI1841.1; Monahan AH, 2006, J CLIMATE, V19, P6409, DOI 10.1175/JCLI3960.1; Morgenstern O, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD013728; Morgenstern O, 2017, GEOSCI MODEL DEV, V10, P639, DOI 10.5194/gmd-10-639-2017; Perlwitz J, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033317; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Polvani LM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046712; Santer BD, 2020, P NATL ACAD SCI USA, V117, P2723, DOI 10.1073/pnas.1922907117; Scheff J, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052910; Schmidt DF, 2017, GEOPHYS RES LETT, V44, P10573, DOI 10.1002/2017GL075380; Solomon A, 2015, GEOPHYS RES LETT, V42, P5547, DOI 10.1002/2015GL064744; Solomon A, 2016, J CLIMATE, V29, P3463, DOI 10.1175/JCLI-D-16-0034.1; SOLOMON S, 1986, NATURE, V321, P755, DOI 10.1038/321755a0; Solomon S, 2016, SCIENCE, V353, P269, DOI 10.1126/science.aae0061; Son SW, 2008, SCIENCE, V320, P1486, DOI 10.1126/science.1155939; Son SW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014271; Sun LT, 2014, J ATMOS SCI, V71, P2335, DOI 10.1175/JAS-D-13-0290.1; Swart NC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052810; Swart NC, 2015, J CLIMATE, V28, P8840, DOI 10.1175/JCLI-D-15-0334.1; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; Waugh DW, 2015, J CLIMATE, V28, P6581, DOI 10.1175/JCLI-D-15-0138.1; Waugh DW, 2013, SCIENCE, V339, P568, DOI 10.1126/science.1225411	45	65	65	5	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					544	548		10.1038/s41586-020-2120-4	http://dx.doi.org/10.1038/s41586-020-2120-4			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LF2ML	32214266				2022-12-28	WOS:000527257200002
J	Koven, S				Koven, Suzanne			The art of medicine	LANCET			English	Editorial Material									[Koven, Suzanne] Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Koven, S (corresponding author), Massachusetts Gen Hosp, Div Gen Internal Med, Boston, MA 02114 USA.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 12	2019	394	10206					1316	1317		10.1016/S0140-6736(19)32272-X	http://dx.doi.org/10.1016/S0140-6736(19)32272-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	JC9RJ	32171434				2022-12-28	WOS:000489613700014
J	Merchant, RM; Lurie, N				Merchant, Raina M.; Lurie, Nicole			Social Media and Emergency Preparedness in Response to Novel Coronavirus	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the ways social media can be used as a critical tool in managing the COVID-19 outbreak, such as by directing users to trusted sources and counteracting misinformation, and how it can transform aspects of preparedness and response for the future.	[Merchant, Raina M.] Univ Penn, Perelman Sch Med, Penn Med Ctr Digital Hlth, Philadelphia, PA 19104 USA; [Merchant, Raina M.] Univ Penn, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Lurie, Nicole] Coalit Epidem Preparedness Innovat, Washington, DC USA; [Lurie, Nicole] Massachusetts Gen Hosp, Boston, MA 02114 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Massachusetts General Hospital	Merchant, RM (corresponding author), Univ Penn, Ctr Hlth Care Innovat, Penn Med Ctr Digital Hlth, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	raina.merchant@pennmedicine.upenn.edu			National Institutes of Health/National Heart, Lung, and Blood Institute [R01HL141844]; National Human Genome Research Institute [R01 HG009655]; Coalition for Epidemic Preparedness Innovation and serving as Assistant Secretary for Preparedness and Response in the US Department of Health and Human Services	National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Coalition for Epidemic Preparedness Innovation and serving as Assistant Secretary for Preparedness and Response in the US Department of Health and Human Services	Dr Merchant reported being funded by grants from the National Institutes of Health/National Heart, Lung, and Blood Institute (R01HL141844) and the National Human Genome Research Institute (R01 HG009655). Dr Lurie reported currently being a compensated strategic advisor for the Coalition for Epidemic Preparedness Innovation and serving as Assistant Secretary for Preparedness and Response in the US Department of Health and Human Services from 2009 to 2017.	[Anonymous], DO I US CRIS RESP AC; Clement J, 2019, NUMBER GLOBAL SOCIAL; Jin K-X, KEEPING PEOPLE SAFE; Josephson A, 2020, BRAND COMMUNICATIONS; Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P411, DOI 10.1001/jama.2019.21084; Merchant RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215476; Paules CI, 2020, JAMA-J AM MED ASSOC, V323, P707, DOI 10.1001/jama.2020.0757; World Health Organization Novel Coronavirus, 2019, 13 WHO	8	178	184	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2011	2012		10.1001/jama.2020.4469	http://dx.doi.org/10.1001/jama.2020.4469			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32202611	Bronze			2022-12-28	WOS:000538023900025
J	Livingston, E; Desai, A; Berkwits, M				Livingston, Edward; Desai, Angel; Berkwits, Michael			Sourcing Personal Protective Equipment During the COVID-19 Pandemic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												edward.livingston@jamanetwork.org						[Anonymous], NAT COVID 19 MED EQ; [Anonymous], 2006, REUS FAC INFL PAND F; Bauchner H, 2020, JAMA-J AM MED ASSOC, V323, P1911, DOI 10.1001/jama.2020.4770; Bowden E., 2020, NEW YORK POST; Center for Disease Control and Prevention, 2020, STRAT OPT SUPPL FAC; Harris AD, 2013, JAMA-J AM MED ASSOC, V310, P1571, DOI 10.1001/jama.2013.277815; Morris C, 2020, FORTUNE; Rubin MA, 2018, JAMA-J AM MED ASSOC, V319, P863, DOI 10.1001/jama.2017.21122; Trexler P, 2020, MSN             0326; Vozzola E, 2018, AM J INFECT CONTROL, V46, P881, DOI 10.1016/j.ajic.2018.02.002	10	223	224	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1912	1914		10.1001/jama.2020.5317	http://dx.doi.org/10.1001/jama.2020.5317			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32221579	Bronze			2022-12-28	WOS:000536934300017
J	Rule, AD; Lieske, JC; Pais, VM				Rule, Andrew D.; Lieske, John C.; Pais, Vernon M., Jr.			Management of Kidney Stones in 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUIDELINE	This JAMA Insights Clinical Update reviews the diagnosis and management of kidney stones and proposes a treatment algorithm based on imaging findings, symptom control, and risk of recurrence.	[Rule, Andrew D.; Lieske, John C.] Mayo Clin, Div Nephrol & Hypertens, 200 First St SW, Rochester, MN 55905 USA; [Rule, Andrew D.] Mayo Clin, Div Epidemiol, Rochester, MN USA; [Lieske, John C.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Pais, Vernon M., Jr.] Geisel Sch Med Dartmouth, Div Urol, Hanover, NH USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Dartmouth College	Rule, AD (corresponding author), Mayo Clin, Div Nephrol & Hypertens, 200 First St SW, Rochester, MN 55905 USA.	rule.andrew@mayo.edu	Lieske, John/ABA-4829-2020					Assimos D, 2016, J UROLOGY, V196, P1161, DOI 10.1016/j.juro.2016.05.091; Cui Y, 2019, J UROLOGY, V201, P950, DOI 10.1097/JU.0000000000000029; D'Costa MR, 2019, J AM SOC NEPHROL, V30, P1251, DOI 10.1681/ASN.2018121241; Dhondup T, 2018, AM J KIDNEY DIS, V72, P790, DOI 10.1053/j.ajkd.2018.06.012; Kittanamongkolchai W, 2018, MAYO CLIN PROC, V93, P291, DOI 10.1016/j.mayocp.2017.11.018; Qaseem A, 2014, ANN INTERN MED, V161, P659, DOI 10.7326/M13-2908; Rule AD, 2014, J AM SOC NEPHROL, V25, P2878, DOI 10.1681/ASN.2013091011; Singh P, 2015, MAYO CLIN PROC, V90, P1356, DOI 10.1016/j.mayocp.2015.07.016; Turk C, 2016, EUR UROL, V69, P468, DOI 10.1016/j.eururo.2015.07.040; Vaughan LE, 2019, MAYO CLIN PROC, V94, P202, DOI 10.1016/j.mayocp.2018.09.016	10	20	21	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 19	2020	323	19					1961	1962		10.1001/jama.2020.0662	http://dx.doi.org/10.1001/jama.2020.0662			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT2XF	32191284				2022-12-28	WOS:000536934300022
J	Onder, G; Rezza, G; Brusaferro, S				Onder, Graziano; Rezza, Giovanni; Brusaferro, Silvio			Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint from physicians with the Italian National Institute of Health confirms a higher case-fatality rate from coronavirus disease 2019 (COVID-19) in Italy compared with China and explains possible reasons, including age, cause of death definitions, and testing strategy.	[Onder, Graziano] Ist Super Sanita, Dept Cardiovasc Endocrine Metab Dis & Aging, Via Giano della Bella 34-0161, Rome, Italy; [Rezza, Giovanni] Ist Super Sanita, Dept Infect Dis, Rome, Italy; [Brusaferro, Silvio] Ist Super Sanita, Off President, Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Onder, G (corresponding author), Ist Super Sanita, Dept Cardiovasc Endocrine Metab Dis & Aging, Via Giano della Bella 34-0161, Rome, Italy.	graziano.onder@iss.it	Onder, Graziano/K-7489-2016	Onder, Graziano/0000-0003-3400-4491				[Anonymous], 2020, CORONAVIRUS DIS 2019; [Anonymous], 2020, REPORT WHO CHINA JOI; Feng ZJ, 2020, CHINA CDC WEEKLY, V2, P113, DOI 10.46234/ccdcw2020.032; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Livingston E, 2020, JAMA	5	2438	2508	8	75	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1775	1776		10.1001/jama.2020.4683	http://dx.doi.org/10.1001/jama.2020.4683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32203977	Bronze			2022-12-28	WOS:000536221500011
J	Chou, CW; Collopy, AL; Kurz, C; Lin, Y; Harding, ME; Plessow, PN; Fortier, T; Diddams, S; Leibfried, D; Leibrandt, DR				Chou, C. W.; Collopy, A. L.; Kurz, C.; Lin, Y.; Harding, M. E.; Plessow, P. N.; Fortier, T.; Diddams, S.; Leibfried, D.; Leibrandt, D. R.			Frequency-comb spectroscopy on pure quantum states of a single molecular ion	SCIENCE			English	Article								Spectroscopy is a powerful tool for studying molecules and is commonly performed on large thermal molecular ensembles that are perturbed by motional shifts and interactions with the environment and one another, resulting in convoluted spectra and limited resolution. Here, we use quantum-logic techniques to prepare a trapped molecular ion in a single quantum state, drive terahertz rotational transitions with an optical frequency comb, and read out the final state nondestructively, leaving the molecule ready for further manipulation. We can resolve rotational transitions to 11 significant digits and derive the rotational constant of (CaH+)-Ca-40 to be B-R = 142 501 777.9(1.7) kilohertz. Our approach is suited for a wide range of molecular ions, including polyatomics and species relevant for tests of fundamental physics, chemistry, and astrophysics.	[Chou, C. W.; Collopy, A. L.; Kurz, C.; Lin, Y.; Fortier, T.; Diddams, S.; Leibfried, D.; Leibrandt, D. R.] NIST, Time & Frequency Div, Boulder, CO 80305 USA; [Lin, Y.] Univ Sci & Technol China, CAS Key Lab Microscale Magnet Resonance, Hefei 230026, Peoples R China; [Lin, Y.] Univ Sci & Technol China, Dept Modern Phys, Hefei 230026, Peoples R China; [Lin, Y.] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Lin, Y.] Univ Sci & Technol China, Synerget Innovat Ctr Quantum Informat & Quantum P, Hefei 230026, Peoples R China; [Harding, M. E.] KIT, Inst Nanotechnol, D-76021 Karlsruhe, Germany; [Plessow, P. N.] KIT, Inst Catalysis Res & Technol, D-76021 Karlsruhe, Germany; [Fortier, T.; Diddams, S.; Leibfried, D.; Leibrandt, D. R.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA	National Institute of Standards & Technology (NIST) - USA; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; University of Colorado System; University of Colorado Boulder	Chou, CW (corresponding author), NIST, Time & Frequency Div, Boulder, CO 80305 USA.	chin-wen.chou@nist.gov	Harding, Michael E/B-3366-2009; Harding, Michael E./K-3800-2019; Diddams, Scott A/L-2819-2013	Harding, Michael E/0000-0002-3633-493X; Diddams, Scott A/0000-0002-2144-0764; Leibrandt, David Ray/0000-0003-1452-4879; Collopy, Alejandra/0000-0002-9209-9516; Chou, Chin-wen/0000-0002-1637-5136	U.S. Army Research Office [W911NF-19-1-0172]; National Research Council postdoctoral fellowship; National Key R&D Program of China [2018YFA0306600]; National Natural Science Foundation of China [11974330]; Anhui Initiative in Quantum Information Technologies [AHY050000]; Alexander von Humboldt foundation; state of Baden-Wurttemberg through bwHPC (bwUnicluster) [RV bw17D01]; state of Baden-Wurttemberg through bwHPC (JUSTUS) [RV bw17D01]	U.S. Army Research Office; National Research Council postdoctoral fellowship; National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Initiative in Quantum Information Technologies; Alexander von Humboldt foundation(Alexander von Humboldt Foundation); state of Baden-Wurttemberg through bwHPC (bwUnicluster); state of Baden-Wurttemberg through bwHPC (JUSTUS)	This work was supported by the U.S. Army Research Office (grant no. W911NF-19-1-0172). A.L.C. is supported by a National Research Council postdoctoral fellowship. Y.L. acknowledges support from the National Key R&D Program of China (grant no. 2018YFA0306600), the National Natural Science Foundation of China (grant no. 11974330), and the Anhui Initiative in Quantum Information Technologies (grant no. AHY050000). C.K. acknowledges support from the Alexander von Humboldt foundation. P.N.P. acknowledges support by the state of Baden-Wurttemberg through bwHPC (bwUnicluster and JUSTUS, RV bw17D01).	Alighanbari S, 2018, NAT PHYS, V14, P555, DOI 10.1038/s41567-018-0074-3; Bartels A, 2004, OPT LETT, V29, P1081, DOI 10.1364/OL.29.001081; Berger R, 2001, ANGEW CHEM INT EDIT, V40, P1667; Blatt R, 2008, NATURE, V453, P1008, DOI 10.1038/nature07125; Cairncross WB, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.153001; Chou C. W., 2020, NIST PUBLIC DATA REP, DOI [10.18434/M32180, DOI 10.18434/M32180]; Chou C. W., 2020, NIST PUBLIC DATA REP; Chou CW, 2017, NATURE, V545, P203, DOI 10.1038/nature22338; Ding S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023028; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Flambaum VV, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.150801; Hayes D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.140501; Kondov SS, 2019, NAT PHYS, V15, P1118, DOI 10.1038/s41567-019-0632-3; Koput J, 2002, J PHYS CHEM A, V106, P9595, DOI 10.1021/jp026283u; KUCHARSKI SA, 1991, THEOR CHIM ACTA, V80, P387, DOI 10.1007/BF01117419; Leibfried D, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023029; McCarron D, 2018, J PHYS B-AT MOL OPT, V51, DOI 10.1088/1361-6455/aadfba; McGuire B. A., 2018, ARXIV180909132V1ASTR; Ni KK, 2008, SCIENCE, V322, P231, DOI 10.1126/science.1163861; OLIPHANT N, 1991, J CHEM PHYS, V95, P6645, DOI 10.1063/1.461534; Phillips WD, 1998, REV MOD PHYS, V70, P721, DOI 10.1103/RevModPhys.70.721; Quack M, 2000, PHYS REV LETT, V84, P3807, DOI 10.1103/PhysRevLett.84.3807; RAGHAVACHARI K, 1989, CHEM PHYS LETT, V157, P479, DOI 10.1016/S0009-2614(89)87395-6; Roos C, 1999, PHYS REV LETT, V83, P4713, DOI 10.1103/PhysRevLett.83.4713; Rungango R., 2015, NEW J PHYS, V17, DOI 10.1080/01442351003643401 16; Schiller S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032505; Schmidt PO, 2005, SCIENCE, V309, P749, DOI 10.1126/science.1114375; Shuman ES, 2010, NATURE, V467, P820, DOI 10.1038/nature09443; Sinhal M, 2020, SCIENCE, V367, P1213, DOI 10.1126/science.aaz9837; Solaro C, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.253601; Wolf F, 2016, NATURE, V530, P457, DOI 10.1038/nature16513	34	28	29	4	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1458	+		10.1126/science.aba3628	http://dx.doi.org/10.1126/science.aba3628			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217722	Green Submitted			2022-12-28	WOS:000523251600032
J	Dyer, O				Dyer, Owen			Covid-19: hospitals brace for disaster as US surpasses China in number of cases	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Pollack R, 2020, COMMUNICATION    MAR	1	4	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1278	10.1136/bmj.m1278	http://dx.doi.org/10.1136/bmj.m1278			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220826	Bronze			2022-12-28	WOS:000523765200015
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Lack of PPE in care homes is risking spread of virus, leaders warn	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	15	15	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1280	10.1136/bmj.m1280	http://dx.doi.org/10.1136/bmj.m1280			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220878	Bronze			2022-12-28	WOS:000523765200016
J	[Anonymous]				[Anonymous]			Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease? (vol 368, m1174, 2020)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Extance A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1174	1	10	12	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1270	10.1136/bmj.m1270	http://dx.doi.org/10.1136/bmj.m1270			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220899	Bronze			2022-12-28	WOS:000523765200009
J	Thornton, J				Thornton, Jacqui			Don't forget chronic lung and immune conditions during covid-19, says WHO	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Thornton J, 2019, LANCET INFECT DIS, V19, P1291, DOI 10.1016/S1473-3099(19)30645-0; WHO, 2019, GLOB TUB REP; WHO, TUBERCULOSIS; WHO, 2018, POL DECL UN GEN ASS	4	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1192	10.1136/bmj.m1192	http://dx.doi.org/10.1136/bmj.m1192			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209542	Bronze			2022-12-28	WOS:000523764200008
J	Mahase, E				Mahase, Elisabeth			Covid-19: medical students to be employed by NHS as part of epidemic response	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1064; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1071	2	17	18	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2020	368								m1156	10.1136/bmj.m1156	http://dx.doi.org/10.1136/bmj.m1156			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DO	32198184	Bronze			2022-12-28	WOS:000523763600013
J	Muendlein, HI; Jetton, D; Connolly, WM; Eidell, KP; Magri, Z; Smirnova, I; Poltorak, A				Muendlein, Hayley I.; Jetton, David; Connolly, Wilson M.; Eidell, Keith P.; Magri, Zoie; Smirnova, Irina; Poltorak, Alexander			cFLIP(L) protects macrophages from LPS-induced pyroptosis via inhibition of complex II formation	SCIENCE			English	Article							GASDERMIN D; CELL-DEATH; APOPTOSIS	Cell death and inflammation are interdependent host responses to infection. During pyroptotic cell death, interleukin-1 beta (IL-1 beta) release occurs through caspase-1 and caspase-11-mediated gasdermin D pore formation. In vivo, responses to lipopolysaccharide (LPS) result in IL-1 beta secretion. In vitro, however, murine macrophages require a second "danger signal" for the inflammasome-driven maturation of IL-1 beta. Recent reports have shown caspase-8-mediated pyroptosis in LPS-activated macrophages but have provided conflicting evidence regarding the release of IL-1 beta under these conditions. Here, to further characterize the mechanism of LPS-induced secretion in vitro, we reveal an important role for cellular FLICE-like inhibitory protein (cFLIP) in the regulation of the inflammatory response. Specifically, we show that deficiency of the long isoform cFLIP(L) promotes complex II formation, driving pyroptosis, and the secretion of IL-1 beta in response to LPS alone.	[Muendlein, Hayley I.] Tufts Grad Sch Biomed Sci, Grad Program Genet, Boston, MA 02111 USA; [Jetton, David; Eidell, Keith P.; Magri, Zoie] Tufts Grad Sch Biomed Sci, Grad Program Immunol, Boston, MA 02111 USA; [Connolly, Wilson M.; Smirnova, Irina; Poltorak, Alexander] Tufts Univ, Dept Immunol, Sch Med, Boston, MA 02111 USA; [Poltorak, Alexander] Petrozavodsk State Univ, Lab Genet Innate Immun, Petrozavodsk 185910, Republic Of Kar, Russia	Tufts University; Petrozavodsk State University	Poltorak, A (corresponding author), Tufts Univ, Dept Immunol, Sch Med, Boston, MA 02111 USA.; Poltorak, A (corresponding author), Petrozavodsk State Univ, Lab Genet Innate Immun, Petrozavodsk 185910, Republic Of Kar, Russia.	alexander.poltorak@tufts.edu		Magri, Zoie/0000-0001-9378-4278; Poltorak, Alexander/0000-0002-5375-6587; Eidell, Keith/0000-0002-5971-218X; Muendlein, Hayley/0000-0003-3006-5780	NIH [AI135369, AI056234]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants AI135369 and AI056234 to A.P.	Aglietti RA, 2016, P NATL ACAD SCI USA, V113, P7858, DOI 10.1073/pnas.1607769113; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Fu TM, 2016, MOL CELL, V64, P236, DOI 10.1016/j.molcel.2016.09.009; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Paquette N, 2012, P NATL ACAD SCI USA, V109, P12710, DOI 10.1073/pnas.1008203109; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Ram DR, 2016, P NATL ACAD SCI USA, V113, P1606, DOI 10.1073/pnas.1517562113; Reddick LE, 2014, MOL CELL, V54, P321, DOI 10.1016/j.molcel.2014.03.010; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Tsuchiya Y, 2015, INT J MOL SCI, V16, P30321, DOI 10.3390/ijms161226232; Vince JE, 2016, CELL MOL LIFE SCI, V73, P2349, DOI 10.1007/s00018-016-2205-2	15	51	54	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1379	+		10.1126/science.aay3878	http://dx.doi.org/10.1126/science.aay3878			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193329	Green Accepted			2022-12-28	WOS:000522167400053
J	Cloutier, R; Clement, AM; Lee, MSY; Noel, R; Bechard, I; Roy, V; Long, JA				Cloutier, Richard; Clement, Alice M.; Lee, Michael S. Y.; Noel, Roxanne; Bechard, Isabelle; Roy, Vincent; Long, John A.			Elpistostege and the origin of the vertebrate hand	NATURE			English	Article							TETRAPOD-LIKE FISH; PHYLOGENETIC NOMENCLATURE; PECTORAL FIN; PANDERICHTHYS; ANATOMY; GIRDLE; ACANTHOSTEGA; EVOLUTION	The pectoral fin of an Elpistostege watsoni specimen from the Upper Devonian period of Canada combines digits and fin rays, blurring the line between the appendages of fish and land vertebrates. The evolution of fishes to tetrapods (four-limbed vertebrates) was one of the most important transformations in vertebrate evolution. Hypotheses of tetrapod origins rely heavily on the anatomy of a few tetrapod-like fish fossils from the Middle and Late Devonian period (393-359 million years ago)(1). These taxa-known as elpistostegalians-include Panderichthys(2), Elpistostege(3,4) and Tiktaalik(1,5), none of which has yet revealed the complete skeletal anatomy of the pectoral fin. Here we report a 1.57-metre-long articulated specimen of Elpistostege watsoni from the Upper Devonian period of Canada, which represents-to our knowledge-the most complete elpistostegalian yet found. High-energy computed tomography reveals that the skeleton of the pectoral fin has four proximodistal rows of radials (two of which include branched carpals) as well as two distal rows that are organized as digits and putative digits. Despite this skeletal pattern (which represents the most tetrapod-like arrangement of bones found in a pectoral fin to date), the fin retains lepidotrichia (fin rays) distal to the radials. We suggest that the vertebrate hand arose primarily from a skeletal pattern buried within the fairly typical aquatic pectoral fin of elpistostegalians. Elpistostege is potentially the sister taxon of all other tetrapods, and its appendages further blur the line between fish and land vertebrates.	[Cloutier, Richard; Noel, Roxanne; Bechard, Isabelle; Roy, Vincent] Univ Quebec Rimouski, Rimouski, PQ, Canada; [Cloutier, Richard; Clement, Alice M.; Lee, Michael S. Y.; Long, John A.] Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia; [Lee, Michael S. Y.] South Australian Museum, Earth Sci Sect, Adelaide, SA, Australia	University of Quebec; Universite du Quebec a Rimouski; Flinders University South Australia; South Australian Museum	Cloutier, R (corresponding author), Univ Quebec Rimouski, Rimouski, PQ, Canada.; Cloutier, R (corresponding author), Flinders Univ S Australia, Coll Sci & Engn, Adelaide, SA, Australia.	richard_cloutier@uqar.ca	Clement, Alice/ABH-2642-2020	Clement, Alice/0000-0003-0380-7347; Cloutier, Richard/0000-0001-5780-3304; Long, John/0000-0001-8012-0114	Research Laboratory in Paleontology and Evolutionary Biology at UQAR (Power Corporation); Chantier 3 grant from Ministry of Education, Leasure, and Sports (Government of Quebec); Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grants; Flinders University international exchange grant; Australian Research Council (ARC) DP grant; Flinders Strategic Professor Fund for travel to Canada in 2014/2016	Research Laboratory in Paleontology and Evolutionary Biology at UQAR (Power Corporation); Chantier 3 grant from Ministry of Education, Leasure, and Sports (Government of Quebec); Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Flinders University international exchange grant; Australian Research Council (ARC) DP grant(Australian Research Council); Flinders Strategic Professor Fund for travel to Canada in 2014/2016	We thank the Parc National de Miguasha-especially O. Matton, J. Kerr and F. Charest-for the loan of the specimen, and the special opportunity to work on this material; J. Willet for the skilful mechanical preparation of the specimen; A. E. Latimer and T. Senden for access to high-resolution micro-computed tomography; M. Coates and T. Grunbaum for comments and suggestions; S. Cumbaa for providing access to a Tiktaalik cast at the Canadian Museum of Nature; E. B. Daeschler and N. H. Shubin for discussions and providing us with casts of the skull, pectoral girdle and fin of Tiktaalik; and the Centre de Developpement et de Recherche en Imagerie Numerique (CDRIN) for providing access to computer facilities The X-ray high-energy tomography was done by M. Colbert and J. A. Maisano. Some images were provided by J. Kerr and C. Rodrigue. This work was funded by a Research Laboratory in Paleontology and Evolutionary Biology at UQAR (Power Corporation), a Chantier 3 grant from Ministry of Education, Leasure, and Sports (Government of Quebec) to R.C. and I.B., Natural Sciences and Engineering Research Council of Canada (NSERC) discovery grants to R.C., and Flinders University international exchange grant to R.C. J.A.L. and M.S.Y.L. acknowledge an Australian Research Council (ARC) DP grant; J.A.L. also acknowledges Flinders Strategic Professor Fund for travel to Canada in 2014/2016.	AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; Ahlberg PE, 2011, SPEC PAP PALAEONTOL, P17, DOI 10.1111/j.1475-4983.2011.01077.x; Anderson JS, 2002, SYST BIOL, V51, P822, DOI 10.1080/10635150290102447; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Bechard I, 2014, PALAEONTOL ELECTRON, V17; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Boisvert CA, 2009, ACTA ZOOL-STOCKHOLM, V90, P297, DOI 10.1111/j.1463-6395.2008.00389.x; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Callier V, 2009, SCIENCE, V324, P364, DOI 10.1126/science.1167542; Carroll Robert L., 2007, P185; Clack J. A., 2012, GAINING GROUND ORIGI; CLACK JA, 1988, PALAEONTOLOGY, V31, P699; Clack JA, 2007, INTEGR COMP BIOL, V47, P510, DOI 10.1093/icb/icm055; Clement G, 2014, PALEONTOL J+, V48, P1082, DOI 10.1134/S0031030114100037; Cloutier R., 2004, RECENT ADV ORIGIN EA, P217; COATES MI, 1994, DEVELOPMENT, P169; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Cope E. D., 1892, Proceedings of the American Philosophical Society, Vxxx, P278; Cuervo R, 2012, P NATL ACAD SCI USA, V109, P3838, DOI 10.1073/pnas.1006619109; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Downs JP, 2008, NATURE, V455, P925, DOI 10.1038/nature07189; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; GODFREY SJ, 1989, PHILOS T ROY SOC B, V323, P75, DOI 10.1098/rstb.1989.0002; Hohn-Schulte B, 2013, HIST BIOL, V25, P167, DOI 10.1080/08912963.2012.755677; Holland T, 2013, J MORPHOL, V274, P147, DOI 10.1002/jmor.20078; Johanson Z, 2007, J EXP ZOOL PART B, V308B, P757, DOI 10.1002/jez.b.21197; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; Lee MSY, 1999, ZOOL SCR, V28, P361, DOI 10.1046/j.1463-6409.1999.00017.x; LONG JA, 1985, ALCHERINGA, V9, P1, DOI 10.1080/03115518508618955; Nakamura T, 2016, NATURE, V537, P225, DOI 10.1038/nature19322; Niedzwiedzki G, 2010, NATURE, V463, P43, DOI 10.1038/nature08623; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P293; Shubin NH, 2014, P NATL ACAD SCI USA, V111, P893, DOI 10.1073/pnas.1322559111; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; Standen EM, 2014, NATURE, V513, P54, DOI 10.1038/nature13708; Stewart TA, 2017, EVODEVO, V8, DOI 10.1186/s13227-017-0084-8; Swartz B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033683; Swofford D.L., 2003, PAUP VERSION 40 B10; Vorobyeva E., 1991, P68; Westoll TS, 1938, NATURE, V141, P127, DOI 10.1038/141127a0; Witzmann F, 2011, ACTA ZOOL-STOCKHOLM, V92, P281, DOI 10.1111/j.1463-6395.2010.00460.x; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773; Zhu M, 2017, NAT ECOL EVOL, V1, P1470, DOI 10.1038/s41559-017-0293-5	50	26	26	16	76	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					549	+		10.1038/s41586-020-2100-8	http://dx.doi.org/10.1038/s41586-020-2100-8		MAR 2020	11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214248				2022-12-28	WOS:000520406700002
J	Howell, JD				Howell, Joel D.			Inpatient Notes: Hospital Wards	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Howell, Joel D.] Univ Michigan, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Howell, JD (corresponding author), Univ Michigan, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	jhowell@umich.edu						Emerson C, 1911, HOSP MANAGE, P18; Howell JD, 1995, TECHNOLOGY HOSP TRAN; Naylor Annmarie, 2008, MED DESIGN ARCHITECT, P7893; Rosenberg Charles E., 1987, CARE STRANGERS RISE; Stevens R., 1999, SICKNESS WEALTH AM H	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					HO2	HO3		10.7326/M20-0268	http://dx.doi.org/10.7326/M20-0268			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176919				2022-12-28	WOS:000520170800001
J	Pincus, D; Jenkinson, R; Paterson, M; Leroux, T; Ravi, B				Pincus, Daniel; Jenkinson, Richard; Paterson, Michael; Leroux, Timothy; Ravi, Bheeshma			Association Between Surgical Approach and Major Surgical Complications in Patients Undergoing Total Hip Arthroplasty	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIRECT ANTERIOR APPROACH; ADMINISTRATIVE DATA; HIGH-RISK; OBESITY; HEALTH; PREVALENCE; ADULTS; INDEX	Importance Controversy exists about the preferred surgical approach for total hip arthroplasty (THA). Objective To determine whether an anterior approach is associated with lower risk of complications than either a lateral or posterior approach. Design, Setting, and Participants Population-based retrospective cohort study of all adults in Ontario, Canada, who had undergone primary THA for osteoarthritis between April 1, 2015, and March 31, 2018. All patients were followed up over a 1-year period (study end date, March 31, 2019). Exposures Surgical approach (anterior vs lateral/posterior) for THA. Main Outcomes and Measures Major surgical complications within 1 year (composite of deep infection requiring surgery, dislocation requiring closed or open reduction, or revision surgery). Outcomes were compared among propensity-score matched groups using Cox proportional hazards regression. Results Of the 30 098 patients (mean [SD] age, 67 years [10.7 years]; 16 079 women [53.4%]) who underwent THA, 2995 (10%) underwent the anterior approach; 21 248 (70%), the lateral approach; and 5855 (20%) the posterior approach performed at 1 of 73 hospitals by 1 of 298 surgeons. All patients were followed up for 1 year. Compared with those undergoing the lateral or posterior approach, patients undergoing an anterior approach were younger (mean age, 65 vs 67 years; standardized difference, 0.17); had lower rates of morbid obesity (4.8% vs 7.6%; standardized difference, 0.12), diabetes (14.2% vs 19.9%; standardized difference, 0.15), and hypertension (53.4% vs 62.9%; standardized difference, 0.19); and were treated by higher-volume surgeons (median range, 111 procedures; interquartile range, 69-172 vs 77 procedures, interquartile range, 50-119 in the prior year; standardized difference, 0.55). Compared with 2993 propensity-score matched patients undergoing a lateral or posterior approach, the 2993 matched patients undergoing anterior approaches had a significantly greater risk of a major surgical complication (61 patients [2%] vs 29 patients [1%]; absolute risk difference, 1.07%; 95% CI, 0.46%-1.69%; hazard ratio, 2.07; 95% CI, 1.48 to 2.88). Conclusions and Relevance Among patients undergoing total hip arthroplasty, an anterior surgical approach compared with a posterior or lateral surgical approach was associated with a small but statistically significant increased risk of major surgical complications. The findings may help inform decisions about surgical approach for hip arthroplasty, although further research is needed to understand pain and functional outcomes.	[Pincus, Daniel; Jenkinson, Richard; Leroux, Timothy; Ravi, Bheeshma] Univ Toronto, Dept Surg, Div Orthopaed Surg, 149 Coll St,Room 508-A, Toronto, ON M5T 1PS, Canada; [Pincus, Daniel; Jenkinson, Richard; Ravi, Bheeshma] Sunnybrook Hlth Sci Ctr, Div Orthopaed Surg, Toronto, ON, Canada; [Pincus, Daniel; Paterson, Michael; Ravi, Bheeshma] ICES, Toronto, ON, Canada; [Leroux, Timothy] Toronto Western Hosp, Div Orthopaed Surg, Toronto, ON, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Pincus, D (corresponding author), Univ Toronto, Dept Surg, Div Orthopaed Surg, 149 Coll St,Room 508-A, Toronto, ON M5T 1PS, Canada.	d.pincus@utoronto.ca			Marvin Tile Chair in Orthopaedic Surgery at Sunnybrook Health Sciences Centre, Toronto; ICES, an independent research institute - Ontario Ministry of Health and Long-Term Care	Marvin Tile Chair in Orthopaedic Surgery at Sunnybrook Health Sciences Centre, Toronto; ICES, an independent research institute - Ontario Ministry of Health and Long-Term Care	This study was supported by the Marvin Tile Chair in Orthopaedic Surgery at Sunnybrook Health Sciences Centre, Toronto, and by ICES, an independent research institute funded by the Ontario Ministry of Health and Long-Term Care.	Abdel MP, 2019, J ARTHROPLASTY, V34, pS24, DOI 10.1016/j.arth.2019.02.006; Abdel MP, 2017, J ARTHROPLASTY, V32, P2744, DOI 10.1016/j.arth.2017.04.005; Aggarwal VK, 2019, BONE JOINT J, V101B, P646, DOI 10.1302/0301-620X.101B6.BJJ-2018-1474.R1; American Joint Replacement Registry, 2019, ANN REP 2019; Anis HK, 2019, J ARTHROPLASTY, V34, pS331, DOI 10.1016/j.arth.2018.11.022; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2009, STAT MED, V28, P3083, DOI 10.1002/sim.3697; BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444; Beard DJ, 2018, LANCET, V391, P329, DOI 10.1016/S0140-6736(17)32457-1; Bohl DD, 2018, J ARTHROPLASTY, V33, P2256, DOI 10.1016/j.arth.2018.02.037; Canadian Institute for Health Information, 2018, ICD 10 CA CCI COD EV; Canadian Institute for Health Information, 2019, HIP KNEE REPL CAN 20; Carli AV, 2018, J ARTHROPLASTY, V33, P3201, DOI 10.1016/j.arth.2018.05.043; Colosia AD, 2013, DIABETES METAB SYNDR, V6, P327, DOI 10.2147/DMSO.S51325; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Ferguson RJ, 2018, LANCET, V392, P1662, DOI 10.1016/S0140-6736(18)31777-X; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Glazier RH, 2000, CAN J PUBLIC HEALTH, V91, P268, DOI 10.1007/BF03404286; Goulding K, 2010, CLIN ORTHOP RELAT R, V468, P2397, DOI 10.1007/s11999-010-1406-5; Hu FB, 2003, LIPIDS, V38, P103, DOI 10.1007/s11745-003-1038-4; Hubbard RE, 2009, J NUTR HEALTH AGING, V13, P468, DOI 10.1007/s12603-009-0085-y; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Ko DT, 2004, JAMA-J AM MED ASSOC, V291, P1864, DOI 10.1001/jama.291.15.1864; Kyriakopoulos G, 2018, EFORT OPEN REV, V3, P574, DOI 10.1302/2058-5241.3.180023; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; Meermans G, 2017, BONE JOINT J, V99B, P732, DOI 10.1302/0301-620X.99B6.38053; Nakata K, 2009, J ARTHROPLASTY, V24, P698, DOI 10.1016/j.arth.2008.04.012; NHS Digital, 2017, PROV Q PAT REP OUTC; O'Donnell DE, 2012, PULM MED, V2012, DOI 10.1155/2012/818925; Pincus D, 2017, JAMA-J AM MED ASSOC, V318, P1994, DOI 10.1001/jama.2017.17606; Ravi B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3284; Restrepo C, 2010, J ARTHROPLASTY, V25, P671, DOI 10.1016/j.arth.2010.02.002; Schultz SE, 2013, CHRON DIS INJ CAN, V33, P160; Shofoluwe AI, 2018, J ARTHROPLASTY, V33, P167, DOI 10.1016/j.arth.2017.08.015; Tu Karen, 2007, Open Med, V1, pe18; Watts CD, 2015, J ARTHROPLASTY, V30, P2296, DOI 10.1016/j.arth.2015.06.016; Weiner JP, 2020, J HOPKINS ACG SYSTEM; Yourex-West H, 2017, GLOBAL NEWS     0919	40	49	53	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1070	1076		10.1001/jama.2020.0785	http://dx.doi.org/10.1001/jama.2020.0785			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX6DC	32181847	Green Published, Bronze			2022-12-28	WOS:000521968800019
J	Schinkel, M; Panday, RN; Nanayakkara, P				Schinkel, Michiel; Panday, Rishi Nannan; Nanayakkara, Prabath			Blood Culture Results Before and After Antimicrobial Administration	ANNALS OF INTERNAL MEDICINE			English	Letter							ANTIBIOTICS		[Schinkel, Michiel] Vrije Univ Amsterdam, Med Ctr, Acad Med Ctr, Ctr Expt & Mol Med,Amsterdam UMC, Amsterdam, Netherlands; [Schinkel, Michiel; Panday, Rishi Nannan; Nanayakkara, Prabath] Vrije Univ Amsterdam, Med Ctr, Amsterdam UMC, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam	Schinkel, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Acad Med Ctr, Ctr Expt & Mol Med,Amsterdam UMC, Amsterdam, Netherlands.; Schinkel, M (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam UMC, Amsterdam, Netherlands.							Alam N, 2018, LANCET RESP MED, V6, P40, DOI 10.1016/S2213-2600(17)30469-1; Cheng MP, 2019, ANN INTERN MED, V171, P547, DOI 10.7326/M19-1696; Ippolito MM, 2017, CLIN INFECT DIS, V65, P486, DOI 10.1093/cid/cix336; Mi MY, 2019, NEW ENGL J MED, V380, P593, DOI 10.1056/NEJMclde1809210; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					439	439		10.7326/L19-0794	http://dx.doi.org/10.7326/L19-0794			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176903				2022-12-28	WOS:000520170800036
J	White, M; Aguirre, E; Finegood, DT; Holmes, C; Sacks, G; Smith, R				White, Martin; Aguirre, Emilie; Finegood, Diane T.; Holmes, Chris; Sacks, Gary; Smith, Richard			What role should the commercial food system play in promoting health through better diet?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ULTRA-PROCESSED FOODS; IMPACT; BEVERAGES; COMPANIES; INDUSTRY; COST; LEVY		[White, Martin] Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Ctr Diet & Act Res, Cambridge, England; [Aguirre, Emilie] Univ Chicago, Sch Law, Chicago, IL 60637 USA; [Aguirre, Emilie] Harvard Sch Business, Boston, MA USA; [Finegood, Diane T.] Simon Fraser Univ, Morris J Wosk Ctr Dialogue, Vancouver, BC, Canada; [Sacks, Gary] Deakin Univ, Global Obes Ctr, Burwood, Vic 3125, Australia; [Smith, Richard] Univ Exeter, Coll Med & Hlth, Exeter, Devon, England	University of Cambridge; University of Chicago; Harvard University; Simon Fraser University; Deakin University; University of Exeter	White, M (corresponding author), Univ Cambridge, Inst Metab Sci, MRC Epidemiol Unit, Ctr Diet & Act Res, Cambridge, England.	martin.white@mrc-epid.cam.ac.uk		Smith, Richard/0000-0003-3837-6559	MRC [MR/K023187/1] Funding Source: UKRI; Medical Research Council [MR/K023187/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aastrup J, 2010, INT REV RETAIL DISTR, V20, P147, DOI 10.1080/09593960903498284; Adams J, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0210-8; Augustin MA, 2016, TRENDS FOOD SCI TECH, V56, P115, DOI 10.1016/j.tifs.2016.08.005; Bandy LK, 2020, BMC MED, V18, DOI 10.1186/s12916-019-1477-4; Battilana J, 2019, HARVARD BUS REV, V97, P124; Beckman J, 2017, GLOBAL LANDSCAPE AGR; Bottemiller Evich H, 2017, POLITICO; Breslin PAS, 2013, CURR BIOL, V23, pR409, DOI 10.1016/j.cub.2013.04.010; Brooks J., 2016, FISH CHIPS COMMERCIA; Bua A, 2018, POLICY DES PRACT, V1, P126, DOI 10.1080/25741292.2018.1469242; Burns C, 2010, NUTR REV, V68, P182, DOI 10.1111/j.1753-4887.2010.00275.x; Cairns G, 2013, APPETITE, V62, P194, DOI 10.1016/j.appet.2012.07.016; Centre for Diet and Activity Research, 2019, FOOD ENV ASS TOOL; Cornelsen L, 2017, J EPIDEMIOL COMMUN H, V71, P1107, DOI 10.1136/jech-2017-209947; Corporate Europe Observatory, RED LIGHT CONS INF F; Crocketta RA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009315.pub2; Cullerton K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221250; Cullerton K, 2019, OBES REV, V20, P1073, DOI 10.1111/obr.12851; Department for Environment Food and Rural Affairs, 2013, FAM FOOD 2012; Department for Environment Food & Rural Affairs, 2019, NAT FOOD STRAT; Department of Health and Social Care, 2018, CHILDH OB PLA ACT; Eccles RG, 2014, MANAGE SCI, V60, P2835, DOI 10.1287/mnsc.2014.1984; Ejlerskov KT, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0684-2; Fiolet T, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k322; Food Foundation Food Climate Research Network, 2019, PLAT UP PROGR 2; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Goffe L, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0429-z; Haddad L, 2018, NATURE, V556, P19, DOI 10.1038/d41586-018-03918-7; He FJ, 2014, J HUM HYPERTENS, V28, P345, DOI 10.1038/jhh.2013.105; Henrichs AC, 2014, SPRINGER THESES-RECO, P1, DOI [10.1155/2014/205184, 10.1007/978-3-319-01487-6]; Hillier-Brown FC, 2017, OBES REV, V18, P227, DOI 10.1111/obr.12479; Hillier-Brown FC, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-3980-2; Hollands GJ, 2015, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009164.pub2, 10.1002/14651858.CD011045.pub2]; Imamura F, 2015, LANCET GLOB HEALTH, V3, pE132, DOI 10.1016/S2214-109X(14)70381-X; Johnston LM, 2015, ANNU REV PUBL HEALTH, V36, P255, DOI 10.1146/annurev-publhealth-031914-122802; Jones P, 2006, BRIT FOOD J, V108, P838, DOI 10.1108/00070700610702091; Kauer I, 2018, GLOBAL INDEX 2018; Knai C, 2015, FOOD POLICY, V54, P1, DOI 10.1016/j.foodpol.2015.04.002; Lang T., 2003, Development Policy Review, V21, P555, DOI 10.1111/j.1467-8659.2003.00223.x; Lang T, 2016, FOOD WARS; Lang T, 2009, J HUNGER ENVIRON NUT, V4, P315, DOI 10.1080/19320240903321227; Lencucha R, 2018, INT J HEALTH POLICY, V7, P485, DOI 10.15171/ijhpm.2018.10; Lobstein T, 2019, ATLAS CHILDHOOD OBES; Malhi L, 2009, J HUNGER ENVIRON NUT, V4, P466, DOI 10.1080/19320240903346448; Mhurchu CN, 2016, PUBLIC HEALTH NUTR, V19, P401, DOI 10.1017/S1368980015000968; Mialon M, 2015, OBES REV, V16, P519, DOI 10.1111/obr.12289; Monteiro CA, 2013, OBES REV, V14, P21, DOI 10.1111/obr.12107; Monteiro CA, 2019, PUBLIC HEALTH NUTR, V22, P936, DOI 10.1017/S1368980018003762; Moodie R, 2013, LANCET, V381, P670, DOI 10.1016/S0140-6736(12)62089-3; Muller M, 2009, J HUNGER ENVIRON NUT, V4, P225, DOI 10.1080/19320240903321193; Nago ES, 2014, CRIT REV FOOD SCI, V54, P1103, DOI 10.1080/10408398.2011.627095; Nelson G, 2018, NAT SUSTAIN, V1, P773, DOI 10.1038/s41893-018-0192-z; Nestle M, 2013, FOOD POLITICS FOOD I, DOI DOI 10.1525/9780520955066/HTML; Nguyen BT, 2014, PUBLIC HEALTH NUTR, V17, P2445, DOI 10.1017/S1368980014001153; Penney TL, 2018, J EPIDEMIOL COMMUN H, V72, pA43, DOI 10.1136/jech-2018-SSMabstracts.88; Porter ME, 2011, HARVARD BUS REV, V89, P62; Remnant J, 2015, APPETITE, V92, P36, DOI 10.1016/j.appet.2015.04.069; Rivlin G, 2016, RIGGED SUPERMARKET S; Roberts SB, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4864; Robinson E, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4982; Rutter H, 2017, LANCET, V390, P2602, DOI 10.1016/S0140-6736(17)31267-9; Sacks G, 2018, CRIT PUBLIC HEALTH, V28, P253, DOI 10.1080/09581596.2017.1371844; Scrinis G, 2018, PUBLIC HEALTH NUTR, V21, P247, DOI 10.1017/S1368980017001392; Secretariat of the WHO Framework Convention on Tobacco Control, 2019, INF NOT CLASS NOV EM; Shrimpton R, 2012, HNP DISCUSSION PAPER; Simon M, 2006, APPETITE PROFIT FOOD; Solomon RC., 2003, BUILDING TRUST BUSIN, DOI [10.1093/0195161114.001.0001, DOI 10.1093/0195161114.001.0001]; Srour B, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1451; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001242, 10.1371/journal.pmed.1001235]; Swinburn B, 2019, INFORMAS INT NETWORK; Swinburn B, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102544; Swinburn BA, 2019, LANCET, V393, P791, DOI 10.1016/S0140-6736(18)32822-8; Tansey G., 1995, FOOD SYSTEM GUIDE; The Food Foundation, 2017, PEAS PLEAS; Vallgarda S, 2015, EUR J CLIN NUTR, V69, P223, DOI 10.1038/ejcn.2014.224; Vandevijvere S, 2019, OBES REV, V20, P10, DOI 10.1111/obr.12860; Welch S., 2016, CRAINS DETROIT BUSIN; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Williams P, 2005, NUTR REV, V63, P256, DOI [10.1301/nr.2005.jul.256-264, 10.1111/j.1753-4887.2005.tb00382.x]; Yau A, 2019, EUR J CLIN NUTR, V73, P997, DOI 10.1038/s41430-018-0347-z; Zlatevska N, 2018, J RETAILING, V94, P89, DOI 10.1016/j.jretai.2017.09.007	81	31	30	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m545	10.1136/bmj.m545	http://dx.doi.org/10.1136/bmj.m545			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LA2DC	32184211	Green Published, hybrid			2022-12-28	WOS:000523762400001
J	Brody, H				Brody, Herb			Cancer diagnosis	NATURE			English	Editorial Material						Cancer; Health care; Medical research		Detecting tumours earlier and more precisely could lead to more effective treatment. Detecting tumours earlier and more precisely could lead to more effective treatment.											0	5	5	3	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					S1	S1		10.1038/d41586-020-00840-9	http://dx.doi.org/10.1038/d41586-020-00840-9			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX4BT	32214258				2022-12-28	WOS:000521825500001
J	Grabowski, DC; Maddox, KEJ				Grabowski, David C.; Joynt Maddox, Karen E.			Postacute Care Preparedness for COVID-19 Thinking Ahead	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses the second surge of COVID-19 patients on postacute care facilities and offers suggestions on how the medical community and policy makers should prepare by ensuring adequate infrastructure, staff training, and protective equipment.	[Grabowski, David C.] Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA; [Joynt Maddox, Karen E.] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, St Louis, MO 63110 USA; [Joynt Maddox, Karen E.] Washington Univ, Inst Publ Hlth, Ctr Hlth Econ & Policy, St Louis, MO 63110 USA	Harvard University; Harvard Medical School; Washington University (WUSTL); Washington University (WUSTL)	Grabowski, DC (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, 180 Longwood Ave, Boston, MA 02115 USA.	grabowski@hcp.med.harvard.edu		Grabowski, David/0000-0003-2915-5770	NHLBI NIH HHS [R01 HL143421] Funding Source: Medline; NIA NIH HHS [P01 AG032952, R01 AG054656, R56 AG062544, R01 AG060935, R01 AG060935] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Buchman TG, 2020, CRIT CARE MED, V48, P289, DOI 10.1097/CCM.0000000000004226; Centers for Medicare & Medicaid Services, 2020, MED TEL HLTH CAR PRO; Geng FL, 2019, HEALTH AFFAIR, V38, P1095, DOI 10.1377/hlthaff.2018.05322; Grabowski DC, 2014, HEALTH AFFAIR, V33, P244, DOI 10.1377/hlthaff.2013.0922; Levine DM, 2019, ANN INTERN MED; Murthy S, 2020, JAMA-J AM MED ASSOC, V323, P1499, DOI 10.1001/jama.2020.3633; Smith M, 2020, NY TIMES	7	85	86	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 26	2020	323	20					2007	2008		10.1001/jama.2020.4686	http://dx.doi.org/10.1001/jama.2020.4686			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU8UM	32211831	Bronze			2022-12-28	WOS:000538023900023
J	Parmet, WE; Sinha, MS				Parmet, Wendy E.; Sinha, Michael S.			Covid-19-The Law and Limits of Quarantine	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Community transmission of the new coronavirus is occurring in several parts of the United States, and travel bans and mandatory quarantines alone cannot end the outbreak. Many public health and legal scholars believe that more constructive tools are needed.	[Parmet, Wendy E.; Sinha, Michael S.] Northeastern Univ, Sch Law, Ctr Hlth Policy & Law, Boston, MA 02115 USA; [Sinha, Michael S.] Harvard MIT Ctr Regulatory Sci, Boston, MA USA; [Sinha, Michael S.] Harvard Med Sch, Boston, MA 02115 USA	Northeastern University; Harvard University; Harvard Medical School	Parmet, WE (corresponding author), Northeastern Univ, Sch Law, Ctr Hlth Policy & Law, Boston, MA 02115 USA.							Aledort JE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-208; American Civil Liberties Union, 2015, FEAR POL EB QUAR HUR; Gostin Jr Lawrence O., 2020, JAMA; Parmet WE, 2018, WAKE FOREST J LAW PO, V9, P1	4	227	240	1	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2020	382	15							e28	10.1056/NEJMp2004211	http://dx.doi.org/10.1056/NEJMp2004211			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LE6DO	32187460	Bronze			2022-12-28	WOS:000526813400002
J	Margolis, DM; Archin, NM; Cohen, MS; Eron, JJ; Ferrari, G; Garcia, V; Gay, CL; Goonetilleke, N; Joseph, SB; Swanstrom, R; Turner, AMW; Wahl, A				Margolis, David M.; Archin, Nancie M.; Cohen, Myron S.; Eron, Joseph J.; Ferrari, Guido; Garcia, Victor; Gay, Cynthia L.; Goonetilleke, Nilu; Joseph, Sarah B.; Swanstrom, Ronald; Turner, Anne-Marie W.; Wahl, Angela			Curing HIV: Seeking to Target and Clear Persistent Infection	CELL			English	Review							CD4(+) T-CELLS; REPLICATION-COMPETENT HIV-1; ANTIRETROVIRAL THERAPY; LATENT RESERVOIR; TISSUE RESERVOIRS; VIRUS; VIREMIA; VIVO; INDIVIDUALS; RESPONSES	y Human immunodeficiency virus type 1 (HIV-1) infection persists despite years of antiretroviral therapy (ART). To remove the stigma and burden of chronic infection, approaches to eradicate or cure HIV infection are desired. Attempts to augment ART with therapies that reverse viral latency, paired with immunotherapies to clear infection, have advanced into the clinic, but the field is still in its infancy. We review foundational studies and highlight new insights in HIV cure research. Together with advances in ART delivery and HIV prevention strategies, future therapies that clear HIV infection may relieve society of the affliction of the HIV pandemic.	[Margolis, David M.; Archin, Nancie M.; Eron, Joseph J.; Gay, Cynthia L.; Goonetilleke, Nilu; Joseph, Sarah B.; Turner, Anne-Marie W.] Univ N Carolina, Sch Med, UNC HIV Cure Ctr, Chapel Hill, NC 27599 USA; [Margolis, David M.; Archin, Nancie M.; Cohen, Myron S.; Eron, Joseph J.; Gay, Cynthia L.; Turner, Anne-Marie W.] Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA; [Margolis, David M.; Goonetilleke, Nilu; Joseph, Sarah B.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Margolis, David M.] Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Cohen, Myron S.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27599 USA; [Ferrari, Guido] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Ferrari, Guido] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Garcia, Victor; Wahl, Angela] Univ N Carolina, Sch Med, Int Ctr Adv Translat Sci, Div Infect Dis,Dept Med, Chapel Hill, NC 27599 USA; [Garcia, Victor; Joseph, Sarah B.; Swanstrom, Ronald; Wahl, Angela] Univ N Carolina, Sch Med, Ctr AIDS Res, Chapel Hill, NC 27599 USA; [Joseph, Sarah B.; Swanstrom, Ronald] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Swanstrom, Ronald] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Margolis, DM (corresponding author), Univ N Carolina, Sch Med, UNC HIV Cure Ctr, Chapel Hill, NC 27599 USA.; Margolis, DM (corresponding author), Univ N Carolina, Sch Med, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA.; Margolis, DM (corresponding author), Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Margolis, DM (corresponding author), Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA.	dmargo@med.unc.edu	Ferrari, Guido/Z-2137-2019	Margolis, David/0000-0001-5714-0002; Gay, Cynthia/0000-0002-3620-3059; Turner, Anne-Marie/0000-0002-7312-4616	National Institutes of Health [UM1-AI126619, UL1TR002489, AI064518, AI50410]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Luisa Ferrari for editorial support and especially for the dedication of the people living with HIV (PLWH) who participate in research towards an HIV cure. This study was supported by National Institutes of Health grants UM1-AI126619 (to D.M.M.), UL1TR002489 (to the UNC TRaCS Institute), AI064518 (to G.F.), and AI50410 (to the UNC Center for AIDS Research).	Abrahams MR, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw5589; Abreu CM, 2019, MBIO, V10, DOI 10.1128/mBio.01659-19; Anderson JL, 2020, J INFECT DIS, V221, P744, DOI 10.1093/infdis/jiz509; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Archin NM, 2017, J CLIN INVEST, V127, P3126, DOI [10.1172/JCI92684, 10.1172/jci92684]; Avalos CR, 2017, MBIO, V8, DOI 10.1128/mBio.01186-17; Badamchi-Zadeh A., 2018, J VIROL; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Bale MJ, 2019, CURR OPIN HIV AIDS, V14, P188, DOI 10.1097/COH.0000000000000535; Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Boehm D, 2017, AIDS RES HUM RETROV, V33, pS8, DOI 10.1089/aid.2017.0180; Boehm D, 2013, VIRUSES-BASEL, V5, P1571, DOI 10.3390/v5061571; Borducchi EN, 2018, NATURE, V563, P360, DOI 10.1038/s41586-018-0600-6; Bradley T, 2018, CELL REP, V25, P107, DOI 10.1016/j.celrep.2018.09.020; Brodin J, 2016, ELIFE, V5, DOI 10.7554/eLife.18889; Bronnimann MP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00020; Bruner KM, 2019, NATURE, V566, P120, DOI 10.1038/s41586-019-0898-8; Bruner KM, 2016, NAT MED, V22, P1043, DOI 10.1038/nm.4156; Bui JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006283; Buzon MJ, 2014, NAT MED, V20, P139, DOI 10.1038/nm.3445; Cabrera C, 2015, CLIN CHEM, V61, P1372, DOI 10.1373/clinchem.2015.243287; Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268; Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411; Chapuis AG, 2011, BLOOD, V117, P5391, DOI 10.1182/blood-2010-11-320226; Cheng L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94366; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Clutton GT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01452; Conrad RJ, 2017, MOL CELL, V67, P1001, DOI 10.1016/j.molcel.2017.07.025; Crooks AM, 2015, J INFECT DIS, V212, P1361, DOI 10.1093/infdis/jiv218; Dash PK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10366-y; Del Prete GQ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127717; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Denton PW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003872; Denton PW, 2012, J VIROL, V86, P630, DOI 10.1128/JVI.06120-11; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Eisinger RW, 2018, EMERG INFECT DIS, V24, P413, DOI 10.3201/eid2403.171797; Estes JD, 2017, NAT MED, V23, P1271, DOI 10.1038/nm.4411; Farber DL, 2014, NAT REV IMMUNOL, V14, P24, DOI 10.1038/nri3567; Ferrari G, 2016, NAT REV DRUG DISCOV, V15, P823, DOI 10.1038/nrd.2016.173; Fidler S, 2020, LANCET, V395, P888, DOI 10.1016/S0140-6736(19)32990-3; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fisher L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02741; Fromentin R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005761; Ganor Y, 2019, NAT MICROBIOL, V4, P633, DOI 10.1038/s41564-018-0335-z; Garcia JV, 2016, J CLIN INVEST, V126, P424, DOI 10.1172/JCI80562; Garrido C, 2018, J VIROL, V92, DOI 10.1128/JVI.00235-18; Gay CL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61878-3; Gay CL, 2017, J INFECT DIS, V215, P1725, DOI 10.1093/infdis/jix191; Goonetilleke N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01966; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Gosselin A, 2017, AIDS, V31, P35, DOI 10.1097/QAD.0000000000001309; Gulick RM, 2019, ANNU REV MED, V70, P137, DOI 10.1146/annurev-med-041217-013717; Gutierrez C, 2016, AIDS, V30, P1385, DOI 10.1097/QAD.0000000000001064; Hamer DH, 2004, CURR HIV RES, V2, P99, DOI 10.2174/1570162043484915; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Haynes BF, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaz2686; Henrich TJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002417; Hiener B, 2017, CELL REP, V21, P813, DOI 10.1016/j.celrep.2017.09.081; Ho YC, 2013, CELL, V155, P540, DOI 10.1016/j.cell.2013.09.020; Honeycutt JB, 2017, NAT MED, V23, P638, DOI 10.1038/nm.4319; Hosmane NN, 2017, J EXP MED, V214, P959, DOI 10.1084/jem.20170193; Houzet L, 2014, J INFECT DIS, V210, pS622, DOI 10.1093/infdis/jiu328; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jiang G, 2019, JCI INSIGHT, V4; Jiang GC, 2018, J CLIN INVEST, V128, P1190, DOI 10.1172/JCI98071; Jiang GC, 2015, AIDS RES HUM RETROV, V31, P4, DOI [10.1089/AID.2014.0199, 10.1089/aid.2014.0199]; Joseph SB, 2018, J LEUKOCYTE BIOL, V103, P421, DOI 10.1002/JLB.2RI0517-200R; JOSEPH SB, 2019, AIDS S2, V33, pS17, DOI DOI 10.1097/QAD.0000000000002253; Katlama C, 2016, AIDS, V30, P221, DOI 10.1097/QAD.0000000000000894; Kim JH, 2015, ANNU REV MED, V66, P423, DOI 10.1146/annurev-med-052912-123749; Lam S, 2013, IMMUNOTHERAPY-UK, V5, P407, DOI [10.2217/imt.13.23, 10.2217/IMT.13.23]; Lamers SL, 2016, J VIROL, V90, P8968, DOI 10.1128/JVI.00674-16; Lehrman G, 2004, JAIDS-J ACQ IMM DEF, V36, P1103, DOI 10.1097/00126334-200408150-00015; Leth S, 2016, LANCET HIV, V3, pE463, DOI 10.1016/S2352-3018(16)30055-8; Lim SY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4521; Luzuriaga K, 2015, NEW ENGL J MED, V372, P786, DOI 10.1056/NEJMc1413931; Lynch RM, 2015, SCI TRANSL MED, V7; Macedo AB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02450; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Marsden MD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006575; Mbonye U, 2014, VIROLOGY, V454, P328, DOI 10.1016/j.virol.2014.02.008; McBrien JB, 2020, NATURE, V578, P154, DOI 10.1038/s41586-020-1946-0; MEIER UC, 1995, SCIENCE, V270, P1360, DOI 10.1126/science.270.5240.1360; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Moog C, 2014, MUCOSAL IMMUNOL, V7, P46, DOI 10.1038/mi.2013.23; Nixon CC, 2020, NATURE, V578, P160, DOI 10.1038/s41586-020-1951-3; Pache L, 2015, CELL HOST MICROBE, V18, P345, DOI 10.1016/j.chom.2015.08.009; Pallikkuth S, 2016, J VIROL, V90, P2718, DOI 10.1128/JVI.02883-15; Pankau MD, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008286; Pardons M, 2019, CELL REP, V29, P2783, DOI 10.1016/j.celrep.2019.10.101; Pegu A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9447; Peterson CW, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006956; Pollara J, 2013, CURR HIV RES, V11, P378, DOI 10.2174/1570162X113116660059; Prins JM, 1999, AIDS, V13, P2405, DOI 10.1097/00002030-199912030-00012; Rasmussen TA, 2014, LANCET HIV, V1, pE13, DOI 10.1016/S2352-3018(14)70014-1; Rasmussen TA, 2018, ADV EXP MED BIOL, V1075, P285, DOI 10.1007/978-981-13-0484-2_12; Razooky BS, 2015, CELL, V160, P990, DOI 10.1016/j.cell.2015.02.009; Rhode PR, 2016, CANCER IMMUNOL RES, V4, P49, DOI 10.1158/2326-6066.CIR-15-0093-T; Riddler SA, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy242; Robinson HL, 2018, CLIN PHARMACOL THER, V104, P1062, DOI 10.1002/cpt.1208; Ruelas DS, 2013, CELL, V155, P519, DOI 10.1016/j.cell.2013.09.044; Sampey GC, 2018, SMAC MIMETIC AZD5582, P312447, DOI [10.1101/312447, DOI 10.1101/312447]; Santra S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005042; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Simonetti FR, 2016, P NATL ACAD SCI USA, V113, P1883, DOI 10.1073/pnas.1522675113; Sneller MC, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax3447; Sneller MC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8848; Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142; Soriano-Sarabia N, 2014, J VIROL, V88, P14070, DOI 10.1128/JVI.01900-14; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; Sung JA, 2018, MOL THER, V26, P2496, DOI 10.1016/j.ymthe.2018.08.015; Sung JA, 2015, J INFECT DIS, V212, P258, DOI 10.1093/infdis/jiv022; Sung JAM, 2015, J CLIN INVEST, V125, P4077, DOI 10.1172/JCI82314; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Thaysen-Andersen M, 2016, GLYCOCONJUGATE J, V33, P417, DOI 10.1007/s10719-015-9627-1; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; Tran TA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003305; Nguyen TV, 2017, IEEE INT ENTERP, P8, DOI 10.1109/EDOCW.2017.11; Turner AMW, 2017, YALE J BIOL MED, V90, P229; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; Varela-Rohena A, 2008, NAT MED, V14, P1390, DOI 10.1038/nm.1779; Vibholm LK, 2019, AIDS, V33, P1315, DOI 10.1097/QAD.0000000000002213; Wagner TA, 2014, SCIENCE, V345, P570, DOI 10.1126/science.1256304; Wahl A, 2019, NAT BIOTECHNOL, V37, P1163, DOI 10.1038/s41587-019-0225-9; Wahl A, 2015, J VIROL, V89, P10868, DOI 10.1128/JVI.01702-15; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Warren JA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00291; Watson DC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006902; Webb GM, 2018, BLOOD ADV, V2, P76, DOI 10.1182/bloodadvances.2017012971; Whitney JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07881-9; Wightman F, 2015, AIDS, V29, P504, DOI 10.1097/QAD.0000000000000562; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; Winckelmann A, 2017, AIDS, V31, P771, DOI 10.1097/QAD.0000000000001400; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wong JK, 2016, CURR OPIN HIV AIDS, V11, P362, DOI 10.1097/COH.0000000000000293; Xu YY, 2019, MOL THER-METH CLIN D, V15, P9, DOI 10.1016/j.omtm.2019.07.008; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308; Zerbato JM, 2019, CLIN INFECT DIS, V69, P1919, DOI 10.1093/cid/ciz108; Zhen A, 2017, J CLIN INVEST, V127, P260, DOI 10.1172/JCI89488; Zhen AJ, 2015, MOL THER, V23, P1358, DOI 10.1038/mt.2015.102	149	61	63	6	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2020	181	1					189	206		10.1016/j.cell.2020.03.005	http://dx.doi.org/10.1016/j.cell.2020.03.005			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KZ5RI	32220311	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000523319000021
J	Bullock, JL				Bullock, Justin L.			Suicide - Rewriting My Story	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								As an intern with a mental illness, I approached the starting line knowing that at some point my vulnerabilities would be exposed and that hitting the wall was inevitable. I didn't know when, but if my history of mental illness was any indicator, my crash would be bad.	[Bullock, Justin L.] Univ Calif San Francisco, Sch Med, Dept Internal Med, San Francisco, CA 94115 USA	University of California System; University of California San Francisco	Bullock, JL (corresponding author), Univ Calif San Francisco, Sch Med, Dept Internal Med, San Francisco, CA 94115 USA.		Bullock, Justin/AAJ-6017-2021	Bullock, Justin/0000-0003-4240-9798					0	2	2	1	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1196	1197		10.1056/NEJMp1917203	http://dx.doi.org/10.1056/NEJMp1917203			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY1UO	32212517				2022-12-28	WOS:000522357300006
J	Gostin, LO; Hodge, JG				Gostin, Lawrence O.; Hodge, James G., Jr.			US Emergency Legal Responses to Novel Coronavirus: Balancing Public Health and Civil Liberties	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence O.] Georgetown Univ, Law Ctr, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Hodge, James G., Jr.] Arizona State Univ, Sandra Day OConnor Coll Law, Ctr Publ Hlth Law & Policy, Phoenix, AZ USA	Georgetown University; Arizona State University; Arizona State University-Downtown Phoenix	Gostin, LO (corresponding author), Georgetown Univ, Law Ctr, 600 New Jersey Ave NW,McDonough 568, Washington, DC 20001 USA.	gostin@law.georgetown.edu						[Anonymous], 2020, PROCL SUSP ENTR IMM; del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1039, DOI 10.1001/jama.2020.1490; Gostin LO, 2017, JAMA-J AM MED ASSOC, V317, P1211, DOI 10.1001/jama.2017.1021; Hanfling D, 2012, JAMA-J AM MED ASSOC, V308, P675, DOI 10.1001/jama.2012.8171; Seck HH, 2020, 4 MORE MILITARY BASE; US Department of Health and Human Services, 2020, DET PUBL HLTH EM EX; US Department of State, 2020, CHIN TRAV ADV	7	57	59	4	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1131	1132		10.1001/jama.2020.2025	http://dx.doi.org/10.1001/jama.2020.2025			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207808	Bronze			2022-12-28	WOS:000530807000012
J	Unadkat, S; Farquhar, M				Unadkat, Shreena; Farquhar, Michael			Doctors' wellbeing: self-care during the covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Unadkat, Shreena; Farquhar, Michael] Evelina London Childrens Hosp, Sleep Med Dept, London, England		Unadkat, S (corresponding author), Evelina London Childrens Hosp, Sleep Med Dept, London, England.	Shreena.Unadkat@gstt.nhs.uk							0	32	33	2	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1150	10.1136/bmj.m1150	http://dx.doi.org/10.1136/bmj.m1150			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209559	Bronze			2022-12-28	WOS:000523764200002
J	Horton, R				Horton, Richard			Offline: COVID-19-a reckoning	LANCET			English	Editorial Material												richard.horton@lancet.com							0	32	33	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					935	935						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199478	Green Published, Bronze			2022-12-28	WOS:000521744600011
J	Pattyn, F; Morlighem, M				Pattyn, Frank; Morlighem, Mathieu			The uncertain future of the Antarctic Ice Sheet	SCIENCE			English	Review							THWAITES GLACIER; SENSITIVITY; RETREAT; STABILITY; GREENLAND; COLLAPSE; SNOWFALL; BASIN	The Antarctic Ice Sheet is losing mass at an accelerating pace, and ice loss will likely continue over the coming decades and centuries. Some regions of the ice sheet may reach a tipping point, potentially leading to rates of sea level rise at least an order of magnitude larger than those observed now, owing to strong positive feedbacks in the ice-climate system. How fast and how much Antarctica will contribute to sea level remains uncertain, but multimeter sea level rise is likely for a mean global temperature increase of around 2 degrees C above preindustrial levels on multicentennial time scales, or sooner for unmitigated scenarios.	[Pattyn, Frank] Univ Libre Bruxelles, Lab Glaciol, Brussels, Belgium; [Morlighem, Mathieu] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA USA	Universite Libre de Bruxelles; University of California System; University of California Irvine	Pattyn, F (corresponding author), Univ Libre Bruxelles, Lab Glaciol, Brussels, Belgium.	fpattyn@ulb.ac.be	Morlighem, Mathieu/O-9942-2014	Morlighem, Mathieu/0000-0001-5219-1310; Pattyn, Frank/0000-0003-4805-5636				Barletta VR, 2018, SCIENCE, V360, P1335, DOI 10.1126/science.aao1447; Bart PJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29911-8; Bassis JN, 2012, P ROY SOC A-MATH PHY, V468, P913, DOI 10.1098/rspa.2011.0422; Brondex J, 2019, CRYOSPHERE, V13, P177, DOI 10.5194/tc-13-177-2019; Bulthuis K, 2019, CRYOSPHERE, V13, P1349, DOI 10.5194/tc-13-1349-2019; Christianson K, 2016, GEOPHYS RES LETT, V43, P10817, DOI 10.1002/2016GL070500; Clerc F, 2019, GEOPHYS RES LETT, V46, P12108, DOI 10.1029/2019GL084183; Cornford SL, 2015, CRYOSPHERE, V9, P1579, DOI 10.5194/tc-9-1579-2015; DeConto RM, 2016, NATURE, V531, P591, DOI 10.1038/nature17145; Dutrieux P, 2014, SCIENCE, V343, P174, DOI 10.1126/science.1244341; Edwards TL, 2019, NATURE, V566, P58, DOI 10.1038/s41586-019-0901-4; Favier L, 2014, NAT CLIM CHANGE, V4, P117, DOI [10.1038/nclimate2094, 10.1038/NCLIMATE2094]; Favier L, 2019, GEOSCI MODEL DEV, V12, P2255, DOI 10.5194/gmd-12-2255-2019; Feldmann J, 2015, P NATL ACAD SCI USA, V112, P14191, DOI 10.1073/pnas.1512482112; Gillet-Chaulet F, 2016, GEOPHYS RES LETT, V43, P10311, DOI 10.1002/2016GL069937; Golledge NR, 2015, NATURE, V526, P421, DOI 10.1038/nature15706; Golledge NR, 2019, NATURE, V566, P65, DOI 10.1038/s41586-019-0889-9; Grant GR, 2019, NATURE, V574, P237, DOI 10.1038/s41586-019-1619-z; Gudmundsson GH, 2019, GEOPHYS RES LETT, V46, P13903, DOI 10.1029/2019GL085027; Hanna E, 2020, EARTH-SCI REV, V201, DOI 10.1016/j.earscirev.2019.102976; Haselof M, 2018, J GLACIOL, V64, P417, DOI 10.1017/jog.2018.30; Joughin I, 2014, SCIENCE, V344, P735, DOI 10.1126/science.1249055; Larour E, 2019, SCIENCE, V364, P969, DOI 10.1126/science.aav7908; Levermann A, 2014, EARTH SYST DYNAM, V5, P271, DOI 10.5194/esd-5-271-2014; Medley B, 2019, NAT CLIM CHANGE, V9, P34, DOI 10.1038/s41558-018-0356-x; Morlighem M, 2020, NAT GEOSCI, V13, P132, DOI 10.1038/s41561-019-0510-8; Nias IJ, 2016, J GLACIOL, V62, P552, DOI 10.1017/jog.2016.40; Nowicki SMJ, 2016, GEOSCI MODEL DEV, V9, P4521, DOI 10.5194/gmd-9-4521-2016; Paolo FS, 2015, SCIENCE, V348, P327, DOI 10.1126/science.aaa0940; Pattyn F, 2018, NAT CLIM CHANGE, V8, P1053, DOI 10.1038/s41558-018-0305-8; Pattyn F, 2013, J GLACIOL, V59, P410, DOI 10.3189/2013JoG12J129; Pollard D, 2015, EARTH PLANET SC LETT, V412, P112, DOI 10.1016/j.epsl.2014.12.035; Pritchard HD, 2009, NATURE, V461, P971, DOI 10.1038/nature08471; Rignot E, 2019, P NATL ACAD SCI USA, V116, P1095, DOI 10.1073/pnas.1812883116; Rintoul SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601610; Ritz C, 2015, NATURE, V528, P115, DOI 10.1038/nature16147; Robel AA, 2019, GEOPHYS RES LETT, V46, P12092, DOI 10.1029/2019GL084397; Schmidtko S, 2014, SCIENCE, V346, P1227, DOI 10.1126/science.1256117; Schoof C, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000664; Sergienko OV, 2019, J GLACIOL, V65, P833, DOI 10.1017/jog.2019.53; Seroussi H, 2017, GEOPHYS RES LETT, V44, P6191, DOI 10.1002/2017GL072910; Seroussi H, 2019, CRYOSPHERE, V13, P1441, DOI 10.5194/tc-13-1441-2019; Shepherd A, 2018, NATURE, V558, P223, DOI 10.1038/s41586-018-0171-6; Sun S, 2017, CRYOSPHERE, V11, P2543, DOI 10.5194/tc-11-2543-2017; Thompson DWJ, 2011, NAT GEOSCI, V4, P741, DOI [10.1038/ngeo1296, 10.1038/NGEO1296]; Turner J, 2019, GEOPHYS RES LETT, V46, P3502, DOI 10.1029/2018GL081517; Weertman J., 1974, J GLACIOL, V13, P3, DOI [DOI 10.3189/S0022143000023327, 10.3189/S0022143000023327]	47	35	37	12	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1331	1335		10.1126/science.aaz5487	http://dx.doi.org/10.1126/science.aaz5487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193321	Green Submitted			2022-12-28	WOS:000522167400042
J	Crinier, A; Narni-Mancinelli, E; Ugolini, S; Vivier, E				Crinier, Adeline; Narni-Mancinelli, Emilie; Ugolini, Sophie; Vivier, Eric			SnapShot: Natural Killer Cells	CELL			English	Editorial Material									[Crinier, Adeline; Narni-Mancinelli, Emilie; Ugolini, Sophie; Vivier, Eric] Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France; [Vivier, Eric] Hop La Timone, AP HM, Immunol, Marseille Immunopole, Marseille, France; [Vivier, Eric] Innate Pharma, Innate Pharma Res Labs, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Crinier, A (corresponding author), Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy, Marseille, France.		Narni-Mancinelli, Emilie/X-1888-2018; Vivier, Eric/F-8939-2010	Narni-Mancinelli, Emilie/0000-0002-7001-1026; Vivier, Eric/0000-0001-7022-8287				Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34; Chiossone L, 2018, NAT REV IMMUNOL, V18, P671, DOI 10.1038/s41577-018-0061-z; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Gauthier L, 2019, CELL, V177, P1701, DOI 10.1016/j.cell.2019.04.041; Liu EL, 2020, NEW ENGL J MED, V382, P545, DOI 10.1056/NEJMoa1910607; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022	10	40	42	3	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1280	1281		10.1016/j.cell.2020.02.029	http://dx.doi.org/10.1016/j.cell.2020.02.029			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32200803	Bronze			2022-12-28	WOS:000520925300021
J	Wang, DS; Wang, JQ; Bai, LY; Pan, H; Feng, H; Clevers, H; Zeng, YA				Wang, Daisong; Wang, Jingqiang; Bai, Lanyue; Pan, Hong; Feng, Hua; Clevers, Hans; Zeng, Yi Arial			Long-Term Expansion of Pancreatic Islet Organoids from Resident Procr(+ )Progenitors	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; ADULT-MOUSE PANCREAS; BETA-CELLS; IN-VITRO; PROGENITOR CELLS; DUCT CELLS; ENDOCRINE; DIFFERENTIATION; LINEAGE; IDENTIFICATION	It has generally proven challenging to produce functional beta cells in vitro. Here, we describe a previously unidentified protein C receptor positive (Procr(+)) cell population in adult mouse pancreas through singlecell RNA sequencing (scRNA-seq). The cells reside in islets, do not express differentiation markers, and feature epithelial-to-mesenchymal transition characteristics. By genetic lineage tracing, Procr(+) islet cells undergo clonal expansion and generate all four endocrine cell types during adult homeostasis. Sorted Procr(+) cells, representing similar to 1% of islet cells, can robustly form islet-like organoids when cultured at clonal density. Exponential expansion can be maintained over long periods by serial passaging, while differentiation can be induced at any time point in culture. beta cells dominate in differentiated islet organoids, while alpha, delta, and PP cells occtat lower frequencies. The organoids are glucose-responsive and insulin-secreting. Upon transplantation in diabetic mice, these organoids reverse disease. These findings demonstrate that the adult mouse pancreatic islet contains a population of Procr(+) endocrine progenitors.	[Wang, Daisong; Wang, Jingqiang; Bai, Lanyue; Pan, Hong; Zeng, Yi Arial] Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol,State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Feng, Hua] Chinese Acad Sci, Biomed Big Data Ctr, CAS MPG Partner Inst Computat Biol, Shanghai Inst Biol Sci,Omics Core, Shanghai 200031, Peoples R China; [Clevers, Hans] Royal Netherlands Acad Arts & Sci KNAW, Hubrecht Inst & Oncode Inst, Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Clevers, Hans] Univ Utrecht, Utrecht, Netherlands; [Clevers, Hans] Princess Maxima Ctr, Utrecht, Netherlands	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Utrecht University; Utrecht University Medical Center; Utrecht University	Zeng, YA (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci, Inst Biochem & Cell Biol,State Key Lab Cell Biol, Shanghai 200031, Peoples R China.	yzeng@sibcb.ac.cn			Chinese Academy of Sciences [XDB19020200, XDA16020200]; National Natural Science Foundation of China [31625020, 31530045, 31830056, 31861163006, 31661143043]; National Key Research and Development Program of China [2019YFA0802001]; Shanghai Municipal Science and Technology Commission [17XD1404000]; CAS-NWO Programme Joint Research Project [153D31KYSB20150100, 40-41405-98-208]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Shanghai Municipal Science and Technology Commission(Science & Technology Commission of Shanghai Municipality (STCSM)); CAS-NWO Programme Joint Research Project	Thanks to Ling Ge and Jun He in Cell Biology Core Facility of SIBCB for helps in electron microscopy experiments; to Dr. Changpeng Xin in Omics Core of BioMed Big Data Center, CAS-MPG Partner Institute for Computational Biology; to Drs. Zhiyong Liu and Chao Li of Institute of Neuroscience, Chinese Academy of Sciences; to Drs. Fuchou Tang, Li Li, and Lin Li of Peking University for help in single-cell sequencing experiments; to Drs. Chengran Xu and Xinxin Yu of Peking University for kindly providing the Ngn3-Cre mice and for help in single-cell sequencing experiments; to Biocytogen Co. for assistance in knockin mouse generation; to Dr. Chi Chung Hui of University of Toronto and Dr. Roel Nusse of Stanford University for helpful comments on the manuscript. This research was supported by grants from the Chinese Academy of Sciences (XDB19020200 and XDA16020200 to Y.A.Z.); National Natural Science Foundation of China (31625020, 31530045, 31830056, 31861163006, and 31661143043 to Y.A.Z.); National Key Research and Development Program of China (2019YFA0802001); Shanghai Municipal Science and Technology Commission (17XD1404000 to Y.A.Z.); and CAS-NWO Programme Joint Research Project (153D31KYSB20150100 to Y.A.Z. and 40-41405-98-208 to H.C.).	Aguayo-Mazzucato C, 2018, CELL METAB, V27, P57, DOI 10.1016/j.cmet.2017.08.007; Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Byrnes LE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06176-3; Cheng X, 2012, CELL STEM CELL, V10, P371, DOI 10.1016/j.stem.2012.02.024; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Gohary Y, 2016, ENDOCRINOLOGY, V157, P166, DOI 10.1210/en.2015-1175; Fares I, 2017, BLOOD, V129, P3344, DOI 10.1182/blood-2016-11-750729; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gao R, 2005, DIABETOLOGIA, V48, P2296, DOI 10.1007/s00125-005-1935-8; Gehart H, 2019, CELL, V176, P1158, DOI 10.1016/j.cell.2018.12.029; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Greggio C, 2013, DEVELOPMENT, V140, P4452, DOI 10.1242/dev.096628; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hardikar AA, 2016, STEM CELLS BIOL REG, P1, DOI 10.1007/978-3-319-45307-1; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Iwasaki H, 2010, BLOOD, V116, P544, DOI 10.1182/blood-2009-08-240903; Jiang FX, 2014, STEM CELLS DEV, V23, P2803, DOI 10.1089/scd.2014.0214; Jin L, 2013, P NATL ACAD SCI USA, V110, P3907, DOI 10.1073/pnas.1301889110; Johnston NR, 2016, CELL METAB, V24, P389, DOI 10.1016/j.cmet.2016.06.020; Kopp JL, 2011, DEVELOPMENT, V138, P653, DOI 10.1242/dev.056499; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee JH, 2014, CELL, V156, P440, DOI 10.1016/j.cell.2013.12.039; Liu YX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010020; Lysy PA, 2013, CURR DIABETES REP, V13, P695, DOI 10.1007/s11892-013-0400-1; Minami K, 2005, P NATL ACAD SCI USA, V102, P15116, DOI 10.1073/pnas.0507567102; Mohammed JS, 2009, LAB CHIP, V9, P97, DOI 10.1039/b809590f; Ouziel-Yahalom L, 2006, BIOCHEM BIOPH RES CO, V341, P291, DOI 10.1016/j.bbrc.2005.12.187; Pagliuca FW, 2014, CELL, V159, P428, DOI 10.1016/j.cell.2014.09.040; Pan FC, 2013, DEVELOPMENT, V140, P751, DOI 10.1242/dev.090159; Pan FC, 2011, DEV DYNAM, V240, P530, DOI 10.1002/dvdy.22584; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ramiya VK, 2000, NAT MED, V6, P278; Rezania A, 2014, NAT BIOTECHNOL, V32, P1121, DOI 10.1038/nbt.3033; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Rukstalis JM, 2007, GENE EXPR PATTERNS, V7, P471, DOI 10.1016/j.modgep.2006.11.001; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Scavuzzo MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05740-1; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Smukler SR, 2011, CELL STEM CELL, V8, P281, DOI 10.1016/j.stem.2011.01.015; Sneddon JB, 2012, NATURE, V491, P765, DOI 10.1038/nature11463; Sugiyama T, 2013, P NATL ACAD SCI USA, V110, P12691, DOI 10.1073/pnas.1304507110; Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; van der Meulen T, 2017, CELL METAB, V25, P911, DOI 10.1016/j.cmet.2017.03.017; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yatoh S, 2007, DIABETES, V56, P1802, DOI 10.2337/db06-1670; Yu QC, 2016, CELL RES, V26, P1079, DOI 10.1038/cr.2016.85; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	54	70	84	18	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1198	+		10.1016/j.cell.2020.02.048	http://dx.doi.org/10.1016/j.cell.2020.02.048			33	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32200801	Bronze			2022-12-28	WOS:000520925300015
J	Wallace, ZS; Miloslavsky, EM				Wallace, Zachary S.; Miloslavsky, Eli M.			STATE OF THE ART REVIEW Management of ANCA associated vasculitis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ANTINEUTROPHIL CYTOPLASMIC ANTIBODY; DAILY ORAL CYCLOPHOSPHAMIDE; LONG-TERM OUTCOMES; WEGENERS-GRANULOMATOSIS; PLASMA-EXCHANGE; MYCOPHENOLATE-MOFETIL; MAINTENANCE THERAPY; RANDOMIZED-TRIAL; RENAL-TRANSPLANTATION; REMISSION-MAINTENANCE	Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a small to medium vessel vasculitis associated with excess morbidity and mortality. This review explores how management of AAV has evolved over the past two decades with pivotal randomized controlled trials shaping the management of induction and maintenance of remission. Contemporary AAV care is characterized by approaches that minimize the cumulative exposure to cyclophosphamide and glucocorticoids, increasingly use rituximab for remission induction and maintenance, and consider therapies with less toxicity (for example, methotrexate, mycophenolate mofetil) for manifestations of AAV that do not threaten organ function or survival. Simultaneously, improvements in outcomes, such as renal and overall survival, have been observed. Additional trials and observational studies evaluating the comparative effectiveness of agents for AAV in various patient subgroups are needed. Prospective studies are necessary to assess the effect of psychosocial interventions on patient reported outcomes in AAV. Despite the expanding array of treatments for AAV, little guidance on how to personalize AAV care is available to physicians.	[Wallace, Zachary S.] Massachusetts Gen Hosp, Dept Med, Mongan Inst, Clin Epidemiol Program,Div Rheumatol Allergy & Im, Boston, MA 02114 USA; [Wallace, Zachary S.; Miloslavsky, Eli M.] Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Rheumatol Unit, Boston, MA 02114 USA; [Wallace, Zachary S.; Miloslavsky, Eli M.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wallace, ZS (corresponding author), Massachusetts Gen Hosp, Dept Med, Mongan Inst, Clin Epidemiol Program,Div Rheumatol Allergy & Im, Boston, MA 02114 USA.; Wallace, ZS (corresponding author), Massachusetts Gen Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Rheumatol Unit, Boston, MA 02114 USA.; Wallace, ZS (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	zswallace@mgh.harvard.edu			NIH/NIAMS [K23AR073334, L30 AR070520]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	ZSW receives funding from NIH/NIAMS (K23AR073334 and L30 AR070520).	Adu D, 1997, QJM-MON J ASSOC PHYS, V90, P401, DOI 10.1093/qjmed/90.6.401; Alba MA, 2017, AUTOIMMUN REV, V16, P722, DOI 10.1016/j.autrev.2017.05.008; Basu N, 2014, ANN RHEUM DIS, V73, P207, DOI 10.1136/annrheumdis-2012-202750; Berti A, 2019, J AUTOIMMUN, V105, DOI 10.1016/j.jaut.2019.07.001; Berti A, 2017, ARTHRITIS RHEUMATOL, V69, P2338, DOI 10.1002/art.40313; BOLTON WK, 1989, AM J NEPHROL, V9, P368; Bosch X, 2007, JAMA-J AM MED ASSOC, V298, P655, DOI 10.1001/jama.298.6.655; Bosch X, 2006, LANCET, V368, P404, DOI 10.1016/S0140-6736(06)69114-9; Brown PM, 2016, NAT REV RHEUMATOL, V12, P731, DOI 10.1038/nrrheum.2016.175; Buckley L, 2017, ARTHRITIS RHEUMATOL, V69, P1521, DOI 10.1002/art.40137; Carpenter DM, 2009, ARTHRIT RHEUM-ARTHR, V61, P259, DOI 10.1002/art.24235; Cartin-Ceba R, 2012, ARTHRITIS RHEUM-US, V64, P3770, DOI 10.1002/art.34584; Charles P, 2018, ANN RHEUM DIS, V77, P1144, DOI 10.1136/annrheumdis-2017-212878; Clowse MEB, 2011, ARTHRIT CARE RES, V63, P1777, DOI 10.1002/acr.20605; Cornec D, 2016, NAT REV RHEUMATOL, V12, P570, DOI 10.1038/nrrheum.2016.123; Cortazar FB, 2018, KIDNEY INT REP, V3, P394, DOI 10.1016/j.ekir.2017.11.004; Cui Z, 2011, MEDICINE, V90, P303, DOI 10.1097/MD.0b013e31822f6f68; CUPPS TR, 1982, J IMMUNOL, V128, P2453; de Groot K, 2005, ARTHRITIS RHEUM-US, V52, P2461, DOI 10.1002/art.21142; De Groot K, 1998, J RHEUMATOL, V25, P492; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; Despujol CPD, 2010, RHEUMATOLOGY, V49, P2181, DOI 10.1093/rheumatology/keq244; Distler O, 2019, NEW ENGL J MED, V380, P2518, DOI 10.1056/NEJMoa1903076; Durel CA, 2019, RHEUMATOLOGY, V58, P1565, DOI 10.1093/rheumatology/kez071; FAUCI AS, 1973, MEDICINE, V52, P535, DOI 10.1097/00005792-197311000-00002; FAUCI AS, 1983, ANN INTERN MED, V98, P76, DOI 10.7326/0003-4819-98-1-76; Finkielman JD, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.08.016; Flossmann O, 2011, ANN RHEUM DIS, V70, P488, DOI 10.1136/ard.2010.137778; Fussner LA, 2016, ARTHRITIS RHEUMATOL, V68, P1700, DOI 10.1002/art.39637; Geetha D, 2015, J AM SOC NEPHROL, V26, P976, DOI 10.1681/ASN.2014010046; Geetha D, 2011, TRANSPLANTATION, V91, P1370, DOI 10.1097/TP.0b013e31821ab9aa; Girard C, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001088; Guillevin L, 1999, ARTHRITIS RHEUM-US, V42, P421, DOI 10.1002/1529-0131(199904)42:3<421::AID-ANR5>3.0.CO;2-6; Guillevin L, 2014, NEW ENGL J MED, V371, P1771, DOI 10.1056/NEJMoa1404231; Guillevin L, 1997, ARTHRITIS RHEUM, V40, P2187, DOI 10.1002/art.1780401213; Han F, 2011, AM J NEPHROL, V33, P185, DOI 10.1159/000324364; Harper L, 2012, ANN RHEUM DIS, V71, P955, DOI 10.1136/annrheumdis-2011-200477; Haubitz M, 1998, ARTHRITIS RHEUM, V41, P1835, DOI 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q; Heijl C, 2011, ANN RHEUM DIS, V70, P1415, DOI 10.1136/ard.2010.145250; Hervier B, 2009, ANN RHEUM DIS, V68, P404, DOI 10.1136/ard.2008.096131; Hiemstra TF, 2010, JAMA-J AM MED ASSOC, V304, P2381, DOI 10.1001/jama.2010.1658; Hilhorst M, 2015, J AM SOC NEPHROL, V26, P2314, DOI 10.1681/ASN.2014090903; Hoang LT, 2008, ARCH OPHTHALMOL-CHIC, V126, P651, DOI 10.1001/archopht.126.5.651; HOFFMAN GS, 1992, ARTHRITIS RHEUM, V35, P1322, DOI 10.1002/art.1780351113; Hoffman GS, 2003, J RHEUMATOL, V30, P1017; HOFFMAN GS, 1992, ANN INTERN MED, V116, P488, DOI 10.7326/0003-4819-116-6-488; Hogan SL, 2005, ANN INTERN MED, V143, P621, DOI 10.7326/0003-4819-143-9-200511010-00005; Holle JU, 2013, RHEUMATOLOGY, V52, P875, DOI 10.1093/rheumatology/kes382; Holle JU, 2011, ARTHRITIS RHEUM-US, V63, P257, DOI 10.1002/art.27763; Homma S, 2004, RESPIROLOGY, V9, P190, DOI 10.1111/j.1440-1843.2004.00581.x; Hosoda C, 2016, RESPIROLOGY, V21, P920, DOI 10.1111/resp.12763; Hozumi H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199659; Hruskova Z, 2015, NEPHROL DIAL TRANSPL, V30, pi159, DOI 10.1093/ndt/gfu328; Hu WH, 2008, NEPHROL DIAL TRANSPL, V23, P1307, DOI 10.1093/ndt/gfm780; Ishizaki J, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1429-3; Jayne D, 2003, NEW ENGL J MED, V349, P36, DOI 10.1056/NEJMoa020286; Jayne D, 2014, RHEUMATOLOGY, V53, P12; Jayne DRW, 2007, J AM SOC NEPHROL, V18, P2180, DOI 10.1681/ASN.2007010090; Jayne DRW, 2017, J AM SOC NEPHROL, V28, P2756, DOI 10.1681/ASN.2016111179; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Jennette JC, 2014, NAT REV RHEUMATOL, V10, P463, DOI 10.1038/nrrheum.2014.103; Jindal KK, 1999, KIDNEY INT, V55, pS33, DOI 10.1046/j.1523-1755.1999.07005.x; Jones RB, 2019, ANN RHEUM DIS, V78, P399, DOI 10.1136/annrheumdis-2018-214245; Jones RB, 2015, ANN RHEUM DIS, V74, P1178, DOI 10.1136/annrheumdis-2014-206404; Jones RB, 2010, NEW ENGL J MED, V363, P211, DOI 10.1056/NEJMoa0909169; Kagiyama N, 2015, BMJ OPEN RESPIR RES, V2, DOI 10.1136/bmjresp-2014-000058; Karras A, 2017, ANN RHEUM DIS, V76, P1662, DOI 10.1136/annrheumdis-2017-211123; Kay J, 2018, ANN RHEUM DIS, V77, P165, DOI 10.1136/annrheumdis-2017-211937; Keller SF, 2016, RHEUM DIS CLIN N AM, V42, P91, DOI 10.1016/j.rdc.2015.08.010; Keogh KA, 2006, AM J RESP CRIT CARE, V173, P180, DOI 10.1164/rccm.200507-1144OC; Keogh KA, 2005, ARTHRITIS RHEUM-US, V52, P262, DOI 10.1002/art.20718; Kessenbrock K, 2009, NAT MED, V15, P623, DOI 10.1038/nm.1959; Keystone E, 2007, ARTHRITIS RHEUM-US, V56, P3896, DOI 10.1002/art.23059; Koutantji M, 2003, ARTHRIT RHEUM-ARTHR, V49, P826, DOI 10.1002/art.11471; Kronbichler A, 2015, NEPHROL DIAL TRANSPL, V30, P1075, DOI 10.1093/ndt/gfv216; Langford CA, 1996, ARTHRITIS RHEUM, V39, P1754, DOI 10.1002/art.1780391020; Langford CA, 2017, ARTHRITIS RHEUMATOL, V69, P837, DOI 10.1002/art.40044; Latimer NR, 2014, PHARMACOECONOMICS, V32, P1171, DOI 10.1007/s40273-014-0189-z; Levy JB, 2001, ANN INTERN MED, V134, P1033, DOI 10.7326/0003-4819-134-11-200106050-00009; Lieberthal JG, 2013, J RHEUMATOL, V40, P674, DOI 10.3899/jrheum.120879; Limper AH, 2011, AM J RESP CRIT CARE, V183, P96, DOI 10.1164/rccm.2008-740ST; Lionaki S, 2009, KIDNEY INT, V76, P644, DOI 10.1038/ki.2009.218; Lionaki S, 2012, ARTHRITIS RHEUM-US, V64, P3452, DOI 10.1002/art.34562; Little MA, 2009, NEPHROL DIAL TRANSPL, V24, P3219, DOI 10.1093/ndt/gfp347; Liu GY, 2019, CHEST, V156, P715, DOI 10.1016/j.chest.2019.05.014; Lyons PA, 2012, NEW ENGL J MED, V367, P214, DOI 10.1056/NEJMoa1108735; Mahr A, 2013, ANN RHEUM DIS, V72, P1003, DOI 10.1136/annrheumdis-2012-201750; Meier-Kriesche HU, 2002, TRANSPLANTATION, V74, P1377, DOI 10.1097/00007890-200211270-00005; Merkel PA, 2016, ARTHRITIS RHEUMA S10, V68; Merkel PA, 2017, ARTHRITIS RHEUMATOL, V69, P1054, DOI 10.1002/art.40034; Miloslavsky EM, 2017, ANN RHEUM DIS, V76, P543, DOI 10.1136/annrheumdis-2016-210002; Miloslaysky EM, 2018, SEMIN ARTHRITIS RHEU, V48, P288, DOI 10.1016/j.semarthrit.2018.01.013; Monach PA, 2013, ANN RHEUM DIS, V72, P1342, DOI 10.1136/annrheumdis-2012-201981; Montante A, 2019, CLIN EXP RHEUMATOL, V37, pS137; Monti S, 2019, ARTHRITIS RHEUMATOL, V71; MOORE PM, 1951, LARYNGOSCOPE, V61, P320; Moran S, 2014, CURR OPIN RHEUMATOL, V26, P37, DOI 10.1097/BOR.0000000000000006; NHS England Specialised Services Clinical Reference Group for Specialised Rheumatology, 2015, CLIN COMM POL RIT TR; Ntatsaki E, 2014, RHEUMATOLOGY, V53, P2306, DOI 10.1093/rheumatology/ket445; O'Reilly VP, 2016, J AM SOC NEPHROL, V27, P2906, DOI 10.1681/ASN.2015050511; Pagnoux C, 2016, ARTHRITIS RHEUMATOL, V68, P2837, DOI 10.1002/art.39860; Pagnoux C, 2008, NEW ENGL J MED, V359, P2790, DOI 10.1056/NEJMoa0802311; Panupattanapong S, 2018, ARTHRITIS RHEUMATOL, V70, P2067, DOI 10.1002/art.40577; Pendergraft WF, 2014, CLIN J AM SOC NEPHRO, V9, P736, DOI 10.2215/CJN.07340713; Pepper RJ, 2019, RHEUMATOLOGY, V58, P260, DOI 10.1093/rheumatology/key288; Popa ER, 1999, J ALLERGY CLIN IMMUN, V103, P885, DOI 10.1016/S0091-6749(99)70434-3; Pryor BD, 1996, ARTHRITIS RHEUM, V39, P1475, DOI 10.1002/art.1780390906; Puechal X, 2016, ARTHRITIS RHEUMATOL, V68, P690, DOI 10.1002/art.39450; Pugnet G, 2016, CLIN EXP RHEUMATOL, V34, pS54; Qiu TT, 2017, AUTOIMMUN REV, V16, P136, DOI 10.1016/j.autrev.2016.12.005; Quinn KA, 2019, RHEUMATOLOGY, V58, P2203, DOI 10.1093/rheumatology/kez217; Rahmattulla C, 2016, ANN RHEUM DIS, V75, P1687, DOI 10.1136/annrheumdis-2015-207601; Rahmattulla C, 2015, ARTHRITIS RHEUMATOL, V67, P3270, DOI 10.1002/art.39317; Rhee RL, 2016, ARTHRITIS RHEUMATOL, V68, P1711, DOI 10.1002/art.39614; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Robson J, 2015, ANN RHEUM DIS, V74, P177, DOI 10.1136/annrheumdis-2013-203927; Robson JC, 2018, ANN RHEUM DIS, V77, P1158, DOI 10.1136/annrheumdis-2017-212713; Rudmik L, 2015, JAMA-J AM MED ASSOC, V314, P926, DOI 10.1001/jama.2015.7544; Seo P, 2008, J RHEUMATOL, V35, P2017; Shen J, 2011, CLIN TRANSPLANT, V25, P380, DOI 10.1111/j.1399-0012.2010.01248.x; Smith R, 2019, ARTHRITIS RHEUMATOL, V71; Smith RM, 2012, ARTHRITIS RHEUM-US, V64, P3760, DOI 10.1002/art.34583; SNELLER MC, 1995, ARTHRITIS RHEUM, V38, P608, DOI 10.1002/art.1780380505; Solans-Laque R, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006083; Specks U, 2001, ARTHRITIS RHEUM, V44, P2836, DOI 10.1002/1529-0131(200112)44:12<2836::AID-ART471>3.0.CO;2-W; Specks U, 2015, NEPHROL DIAL TRANSPL, V30, P1083, DOI 10.1093/ndt/gfv217; Specks U, 2015, J AM SOC NEPHROL, V26, P505, DOI 10.1681/ASN.2014080817; Specks U, 2013, NEW ENGL J MED, V369, P417, DOI 10.1056/NEJMoa1213277; Stahn C, 2008, NAT CLIN PRACT RHEUM, V4, P525, DOI 10.1038/ncprheum0898; Stassen PM, 2007, ANN RHEUM DIS, V66, P798, DOI 10.1136/ard.2006.060301; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; STEVENSON HC, 1980, IMMUNOLOGY, V39, P391; Stone JH, 2005, NEW ENGL J MED, V352, P351; Stone JH, 1999, J RHEUMATOL, V26, P1134; Stone JH, 2001, ARTHRITIS RHEUM, V44, P912, DOI 10.1002/1529-0131(200104)44:4<912::AID-ANR148>3.0.CO;2-5; Stone JH, 2010, NEW ENGL J MED, V363, P221, DOI 10.1056/NEJMoa0909905; Tan JA, 2019, ARTHRIT CARE RES, V71, P155, DOI 10.1002/acr.23587; Tan JA, 2017, ANN RHEUM DIS, V76, P1566, DOI 10.1136/annrheumdis-2016-210942; Terrier B, 2018, ANN RHEUM DIS, V77, P1151, DOI 10.1136/annrheumdis-2017-212768; Tomasson G, 2012, ARTHRIT CARE RES, V64, P273, DOI 10.1002/acr.20649; Tomasson G, 2012, RHEUMATOLOGY, V51, P100, DOI 10.1093/rheumatology/ker280; Unizony S, 2016, ANN RHEUM DIS, V75, P1166, DOI 10.1136/annrheumdis-2015-208073; van Daalen EE, 2017, ANN RHEUM DIS, V76, P1064, DOI 10.1136/annrheumdis-2016-209925; VANDERWOUDE FJ, 1985, LANCET, V1, P425; Wallace ZS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02855; Wallace ZS, 2018, ANN RHEUM DIS, V77, P1333, DOI 10.1136/annrheumdis-2018-213452; Wallace ZS, 2018, ARTHRIT CARE RES, V70, P1495, DOI 10.1002/acr.23521; Wallace ZS, 2017, ARTHRIT CARE RES, V69, P915, DOI 10.1002/acr.22976; Wallace ZS, 2016, SEMIN ARTHRITIS RHEU, V45, P483, DOI 10.1016/j.semarthrit.2015.07.009; Walsh M, 2020, NEW ENGL J MED, V382, P622, DOI 10.1056/NEJMoa1803537; Walsh M, 2013, KIDNEY INT, V84, P397, DOI 10.1038/ki.2013.131; Walsh M, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-73; Walsh M, 2012, ARTHRITIS RHEUM-US, V64, P542, DOI 10.1002/art.33361; Walsh M, 2011, AM J KIDNEY DIS, V57, P566, DOI 10.1053/j.ajkd.2010.10.049; Walsh M, 2010, ARTHRIT CARE RES, V62, P1166, DOI 10.1002/acr.20176; WALTON EW, 1958, BRIT MED J, V2, P265, DOI 10.1136/bmj.2.5091.265; Watanabe H, 2018, ARTHRITIS RHEUMATOL, V70, P1626, DOI 10.1002/art.40538; Watts RA, 2009, ARTHRIT CARE RES, V61, P1412, DOI 10.1002/art.24544; Weinkauf J, 2010, TRANSPL P, V42, P2707, DOI 10.1016/j.transproceed.2010.04.053; Wu EY, 2019, ARTHRITIS RHEUMATOL, V71, P1894, DOI 10.1002/art.41011; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Xie G, 2013, ARTHRITIS RHEUM-US, V65, P2457, DOI 10.1002/art.38036; Yates M, 2016, ANN RHEUM DIS, V75, P1583, DOI 10.1136/annrheumdis-2016-209133; ZHU LP, 1987, J CLIN INVEST, V79, P1082, DOI 10.1172/JCI112922	164	42	44	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m421	10.1136/bmj.m421	http://dx.doi.org/10.1136/bmj.m421			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188597				2022-12-28	WOS:000523763100001
J	Cousins, S				Cousins, Sophie			Rethinking period poverty	LANCET			English	Editorial Material																			0	1	1	4	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					857	858						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32171398				2022-12-28	WOS:000520024900018
J	Meeks, LM; Maraki, I; Singh, S; Curry, RH				Meeks, Lisa M.; Maraki, Ioanna; Singh, Satendra; Curry, Raymond H.			Global commitments to disability inclusion in health professions	LANCET			English	Editorial Material									[Meeks, Lisa M.] Univ Michigan, Med Sch, Dept Family Med, Ann Arbor, MI 48104 USA; [Maraki, Ioanna] Gen Med Council, London, England; [Singh, Satendra] Univ Delhi, Univ Coll Med Sci, Delhi, India; [Singh, Satendra] GTB Hosp, Delhi, India; [Curry, Raymond H.] Univ Illinois, Coll Med, Chicago, IL USA	University of Michigan System; University of Michigan; University of Delhi; University College of Medical Sciences; University of Delhi; University College of Medical Sciences; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Meeks, LM (corresponding author), Univ Michigan, Med Sch, Dept Family Med, Ann Arbor, MI 48104 USA.	meeksli@med.umich.edu	Meeks, Lisa/AAJ-9958-2021; Curry, Raymond H./ABD-2043-2020	Curry, Raymond H./0000-0003-3381-0125; Singh, Satendra/0000-0002-4857-659X				Bristow LR., 2004, NATIONS COMPELLING I; Choo EK, 2019, LANCET, V394, P453, DOI 10.1016/S0140-6736(19)31798-2; General Medical Council, 2019, WELC VAL SUPP DIS LE; Jain NR, 2020, DISABIL SOC, V35, P389, DOI 10.1080/09687599.2019.1647149; Kezar LB, 2019, ACAD MED, V94, P520, DOI 10.1097/ACM.0000000000002517; Lancet Grp, 2019, LANCET, V394, P452, DOI 10.1016/S0140-6736(19)31797-0; McColl MA, 2010, DISABIL SOC, V25, P205, DOI 10.1080/09687590903537406; McKee Michael, 2016, AMA J Ethics, V18, P993, DOI 10.1001/journalofethics.2016.18.10.medu1-1610; Medical Deans Australia and New Zealand, 2017, INH REQ STUD MED AUS; Meeks LM, 2018, ACAD MED, V93, P540, DOI 10.1097/ACM.0000000000002112; Meeks LM., 2018, ACCESSIBILITY INCLUS; Shakespeare T, 2009, LANCET, V374, P1815, DOI 10.1016/S0140-6736(09)62050-X; Silver JK, 2019, HEALTH EQUITY, V3, P360, DOI 10.1089/heq.2019.0040; Singh Satendra, 2019, Indian J Med Ethics, V4, P29, DOI 10.20529/IJME.2018.064; Stergiopoulos E, 2018, ACAD MED, V93, P1550, DOI 10.1097/ACM.0000000000002300; WHO, WORLD REP DIS 2011	16	9	9	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					852	853						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32171395	Bronze			2022-12-28	WOS:000520024900015
J	Rimmer, A				Rimmer, Abi			Covid-19: GPs call for same personal protective equipment as hospital doctors	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Public Health England, COVID 19 INT GUID PR	1	6	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m1055	10.1136/bmj.m1055	http://dx.doi.org/10.1136/bmj.m1055			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32169866	Bronze			2022-12-28	WOS:000520014600008
J	Abram, NJ; Wright, NM; Ellis, B; Dixon, BC; Wurtzel, JB; England, MH; Ummenhofer, CC; Philibosian, B; Cahyarini, SY; Yu, TL; Shen, CC; Cheng, H; Edwards, RL; Heslop, D				Abram, Nerilie J.; Wright, Nicky M.; Ellis, Bethany; Dixon, Bronwyn C.; Wurtzel, Jennifer B.; England, Matthew H.; Ummenhofer, Caroline C.; Philibosian, Belle; Cahyarini, Sri Yudawati; Yu, Tsai-Luen; Shen, Chuan-Chou; Cheng, Hai; Edwards, R. Lawrence; Heslop, David			Coupling of Indo-Pacific climate variability over the last millennium	NATURE			English	Article							INDIAN-OCEAN DIPOLE; INTERTROPICAL CONVERGENCE ZONE; NINO-SOUTHERN OSCILLATION; EL-NINO; EARTHQUAKE SUPERCYCLES; VOLCANIC-ERUPTIONS; HIGH-PRECISION; EVENTS; FREQUENCY; WEST	Coral records indicate that the variability of the Indian Ocean Dipole over the last millennium is strongly coupled to variability in the El Nino/Southern Oscillation and that recent extremes are unusual but not unprecedented. The Indian Ocean Dipole (IOD) affects climate and rainfall across the world, and most severely in nations surrounding the Indian Ocean(1-4). The frequency and intensity of positive IOD events increased during the twentieth century(5) and may continue to intensify in a warming world(6). However, confidence in predictions of future IOD change is limited by known biases in IOD models(7) and the lack of information on natural IOD variability before anthropogenic climate change. Here we use precisely dated and highly resolved coral records from the eastern equatorial Indian Ocean, where the signature of IOD variability is strong and unambiguous, to produce a semi-continuous reconstruction of IOD variability that covers five centuries of the last millennium. Our reconstruction demonstrates that extreme positive IOD events were rare before 1960. However, the most extreme event on record (1997) is not unprecedented, because at least one event that was approximately 27 to 42 per cent larger occurred naturally during the seventeenth century. We further show that a persistent, tight coupling existed between the variability of the IOD and the El Nino/Southern Oscillation during the last millennium. Indo-Pacific coupling was characterized by weak interannual variability before approximately 1590, which probably altered teleconnection patterns, and by anomalously strong variability during the seventeenth century, which was associated with societal upheaval in tropical Asia. A tendency towards clustering of positive IOD events is evident in our reconstruction, which-together with the identification of extreme IOD variability and persistent tropical Indo-Pacific climate coupling-may have implications for improving seasonal and decadal predictions and managing the climate risks of future IOD variability.	[Abram, Nerilie J.; Wright, Nicky M.; Ellis, Bethany; Dixon, Bronwyn C.; Wurtzel, Jennifer B.; Heslop, David] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Abram, Nerilie J.; Wright, Nicky M.] Australian Natl Univ, ARC Ctr Excellence Climate Extremes, Canberra, ACT, Australia; [Ellis, Bethany; Dixon, Bronwyn C.] Australian Natl Univ, ARC Ctr Excellence Climate Syst Sci, Canberra, ACT, Australia; [Dixon, Bronwyn C.] Univ Melbourne, Sch Geog, Melbourne, Vic, Australia; [England, Matthew H.] Univ New South Wales, Climate Change Res Ctr, Sydney, NSW, Australia; [England, Matthew H.; Ummenhofer, Caroline C.] Univ New South Wales, ARC Ctr Excellence Climate Extremes, Sydney, NSW, Australia; [Ummenhofer, Caroline C.] Woods Hole Oceanog Inst, Dept Phys Oceanog, Woods Hole, MA 02543 USA; [Philibosian, Belle] US Geol Survey, Earthquake Sci Ctr, 345 Middlefield Rd, Menlo Pk, CA 94025 USA; [Cahyarini, Sri Yudawati] Indonesian Inst Sci LIPI, Res Ctr Geotechnol, Bandung, Indonesia; [Yu, Tsai-Luen; Shen, Chuan-Chou] Natl Taiwan Univ, Dept Geosci, High Precis Mass Spectrometry & Environm Change L, Taipei, Taiwan; [Yu, Tsai-Luen; Shen, Chuan-Chou] Natl Taiwan Univ, Res Ctr Future Earth, Taipei, Taiwan; [Shen, Chuan-Chou] Natl Taiwan Univ, Global Change Res Ctr, Taipei, Taiwan; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian, Peoples R China; [Cheng, Hai; Edwards, R. Lawrence] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN USA; [Wurtzel, Jennifer B.] New South Wales Dept Primary Ind, Orange, NSW, Australia	Australian National University; Australian National University; ARC Centre of Excellence for Climate System Science; Australian National University; University of Melbourne; University of New South Wales Sydney; University of New South Wales Sydney; Woods Hole Oceanographic Institution; United States Department of the Interior; United States Geological Survey; Indonesian Institute of Sciences; National Taiwan University; National Taiwan University; National Taiwan University; Xi'an Jiaotong University; University of Minnesota System; University of Minnesota Twin Cities; NSW Department of Primary Industries	Abram, NJ (corresponding author), Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia.; Abram, NJ (corresponding author), Australian Natl Univ, ARC Ctr Excellence Climate Extremes, Canberra, ACT, Australia.	nerilie.abram@anu.edu.au	lin, ke/GZM-8300-2022; CHENG, HAI/H-3413-2017; Heslop, David/AGE-1592-2022; Shen, Chuan-Chou/H-9642-2013; Philibosian, Belle/AAB-7987-2019; Abram, Nerilie/AAT-5171-2021; England, Matthew H/A-7539-2011; Cahyarini, Sri Yudawati/T-5725-2018	CHENG, HAI/0000-0002-5305-9458; Heslop, David/0000-0001-8245-0555; Shen, Chuan-Chou/0000-0003-2833-2771; Philibosian, Belle/0000-0003-3138-4716; England, Matthew H/0000-0001-9696-2930; Ellis, Bethany/0000-0002-4662-1115; Wright, Nicky/0000-0002-5600-3193; Wurtzel, Jennifer/0000-0002-5285-4492; Abram, Nerilie/0000-0003-1246-2344; Cahyarini, Sri Yudawati/0000-0001-8378-0716	Australian Research Council QEII Fellowship [DP110101161]; ARC Centre of Excellence for Climate Extremes (CLEX) [CE170100023]; ARC [DP140102059, FT160100029]; Australian Research Training Program scholarship; ARC Centre of Excellence for Climate System Science [CE110001028]; Earth Science and Climate Change Hub of the Australian Government's National Environmental Science Programme (NESP); US National Science Foundation [AGS-1602455]; Science Vanguard Research Program of the Ministry of Science and Technology [108-2119-M-002-012]; Higher Education Sprout Project of the Ministry of Education, Taiwan, China [108L901001]; National Natural Science Foundation of China [NSFC 41888101]; Indonesian Institute of Sciences [2889/II/KS/2001]	Australian Research Council QEII Fellowship(Australian Research Council); ARC Centre of Excellence for Climate Extremes (CLEX); ARC(Australian Research Council); Australian Research Training Program scholarship; ARC Centre of Excellence for Climate System Science(Australian Research Council); Earth Science and Climate Change Hub of the Australian Government's National Environmental Science Programme (NESP); US National Science Foundation(National Science Foundation (NSF)); Science Vanguard Research Program of the Ministry of Science and Technology; Higher Education Sprout Project of the Ministry of Education, Taiwan, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Indonesian Institute of Sciences(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This research was supported by an Australian Research Council QEII Fellowship to N.J.A. (DP110101161; including C.-C.S., H.C. and R.L.E.) and the ARC Centre of Excellence for Climate Extremes (CLEX; CE170100023; to N.J.A., N.M.W., M.H.E. and C.C.U.). Further support to N.J.A. was provided by ARC Discovery Project DP140102059 and Future Fellowship FT160100029. B.E. was supported by an Australian Research Training Program scholarship and B.C.D. received scholarship support from the ARC Centre of Excellence for Climate System Science (CE110001028). M.H.E. is also supported by the Earth Science and Climate Change Hub of the Australian Government's National Environmental Science Programme (NESP). C.C.U. acknowledges support by the US National Science Foundation (AGS-1602455). C.-C.S. thanks the Science Vanguard Research Program of the Ministry of Science and Technology (108-2119-M-002-012) and the Higher Education Sprout Project of the Ministry of Education, Taiwan, China (108L901001) for support. H.C. acknowledges support by the National Natural Science Foundation of China (NSFC 41888101). We gratefully acknowledge the Ministry of Research, Technology and Higher Education, and the Director of Intellectual Property Management as Secretary of the Coordinating Team for Foreign Research Permit (TKPIPA) for the research permit in Indonesia. Fieldwork was carried out in 2001 under research permit 2889/II/KS/2001, supported by W. Hantoro and the Indonesian Institute of Sciences. We thank W. Hantoro, B. Suwargadi, D. Prayudi, I. Suprianto, M. Gagan, K. Glenn, T. Watanabe, H. Scott-Gagan, and K. Sieh for assistance with fieldwork, J. Cowley, J. Cali, D. Becker, A. Kimbrough, S. Wong, B. Plunkett, S. Sosdian, H. Scott-Gagan and C.-H. Hsu for laboratory support, the NCAR CESM1 modelling group for making their last millennium ensemble simulations available, and Australia's National Computational Infrastructure and CLEX Computational Modeling Systems team for data hosting and support. We acknowledge Python Software Foundation (Python version 3.7.2), MathWorks Inc. (MATLAB Release 2014a) and R. Pawlowicz (M_Map mapping package for MATLAB, version 1.4g) for software used in analysis and figure generation. Any use of trade, firm or product names is for descriptive purposes only and does not imply endorsement by the US Government. We thank J. Addison and R. Halley (US Geological Survey) for internal reviews of this manuscript before submission, and S. Eggins for leadership and guidance.	Abram NJ, 2007, NATURE, V445, P299, DOI 10.1038/nature05477; Abram NJ, 2016, NATURE, V536, P411, DOI 10.1038/nature19082; Abram NJ, 2015, PALEOCEANOGRAPHY, V30, P1391, DOI 10.1002/2015PA002810; Abram NJ, 2008, NAT GEOSCI, V1, P849, DOI 10.1038/ngeo357; Abram NJ, 2003, SCIENCE, V301, P952, DOI 10.1126/science.1083841; Adler RF, 2018, ATMOSPHERE-BASEL, V9, DOI 10.3390/atmos9040138; Boomgaard P, 2001, ASIAN POPULATION HIS, P451; Cai W, 2009, GEOPHYS RES LETT, V36, DOI [10.1029/2009GL037604, 10.1029/2009GL039902]; Cai WJ, 2019, SCIENCE, V363, P944, DOI 10.1126/science.aav4236; Cai WJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03789-6; Cai WJ, 2014, NATURE, V510, P254, DOI 10.1038/nature13327; Cai WJ, 2013, NAT GEOSCI, V6, P999, DOI [10.1038/ngeo2009, 10.1038/NGEO2009]; Chan D, 2019, NATURE, V571, P393, DOI 10.1038/s41586-019-1349-2; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Conroy JL, 2017, PALEOCEANOGRAPHY, V32, P484, DOI 10.1002/2016PA003073; Datwyler C, 2019, INT J CLIMATOL, V39, P2711, DOI 10.1002/joc.5983; DeLong KL, 2013, PALAEOGEOGR PALAEOCL, V373, P6, DOI 10.1016/j.palaeo.2012.08.019; Denniston RF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34485; Esper J, 2017, B VOLCANOL, V79, DOI 10.1007/s00445-017-1125-9; Freund MB, 2019, NAT GEOSCI, V12, P450, DOI 10.1038/s41561-019-0353-3; Gagan MK, 2015, EARTH PLANET SC LETT, V432, P461, DOI 10.1016/j.epsl.2015.10.002; Gao CC, 2008, J GEOPHYS RES-ATMOS, V113, DOI [10.1029/2008JD010239, 10.1029/2009JD012133]; Gergis JL, 2009, CLIMATIC CHANGE, V92, P343, DOI 10.1007/s10584-008-9476-z; Goodkin NF, 2019, GEOPHYS RES LETT, V46, P4790, DOI 10.1029/2019GL081939; Grove R, 2018, PALG STUD WORLD ENV, P49, DOI 10.1057/978-1-137-45740-0_3; Grove R, 2018, PALG STUD WORLD ENV, P81, DOI 10.1057/978-1-137-45740-0_4; Guemas V, 2013, J CLIMATE, V26, P726, DOI 10.1175/JCLI-D-12-00049.1; Guillet S, 2017, NAT GEOSCI, V10, P123, DOI [10.1038/NGEO2875, 10.1038/ngeo2875]; Han WQ, 2014, B AM METEOROL SOC, V95, P1679, DOI 10.1175/BAMS-D-13-00028.1; Hashizume M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00269; Henley BJ, 2015, CLIM DYNAM, V45, P3077, DOI 10.1007/s00382-015-2525-1; Holland PR, 2019, NAT GEOSCI, V12, P718, DOI 10.1038/s41561-019-0420-9; Konecky BL, 2019, GEOPHYS RES LETT, V46, P1622, DOI 10.1029/2018GL080188; Lavigne F, 2013, P NATL ACAD SCI USA, V110, P16742, DOI 10.1073/pnas.1307520110; Lim EP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12674-z; Ma TJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24552-3; Maher N, 2015, GEOPHYS RES LETT, V42, P6024, DOI 10.1002/2015GL064751; McGregor HV, 2011, GEOCHIM COSMOCHIM AC, V75, P3930, DOI 10.1016/j.gca.2011.04.017; McGregor HV, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC002093; Meyers G, 2007, J CLIMATE, V20, P2872, DOI 10.1175/JCLI4152.1; Natawidjaja DH, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004025; Natawidjaja DH, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002398; Neukom R, 2019, NAT GEOSCI, V12, P643, DOI 10.1038/s41561-019-0400-0; Otto-Bliesner BL, 2016, B AM METEOROL SOC, V97, P735, DOI 10.1175/BAMS-D-14-00233.1; Philibosian B, 2017, J GEOPHYS RES-SOL EA, V122, P642, DOI 10.1002/2016JB013560; Philibosian B, 2014, J GEOPHYS RES-SOL EA, V119, P7258, DOI 10.1002/2014JB011200; Philibosian B, 2012, J GEOPHYS RES-SOL EA, V117, DOI 10.1029/2011JB009075; Plummer CT, 2012, CLIM PAST, V8, P1929, DOI 10.5194/cp-8-1929-2012; Purich A, 2019, GEOPHYS RES LETT, V46, P6848, DOI 10.1029/2019GL082671; Raupach M, 2009, GEOPHYS RES LETT, V36; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Ren HL, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046031; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Rustic GT, 2015, SCIENCE, V350, P1537, DOI 10.1126/science.aac9937; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Shen CC, 2008, GEOCHIM COSMOCHIM AC, V72, P4201, DOI 10.1016/j.gca.2008.06.011; Shen CC, 2012, GEOCHIM COSMOCHIM AC, V99, P71, DOI 10.1016/j.gca.2012.09.018; Sieh K, 2008, SCIENCE, V322, P1674, DOI 10.1126/science.1163589; Sigl M, 2015, NATURE, V523, P543, DOI 10.1038/nature14565; Smith TM, 2008, J CLIMATE, V21, P2283, DOI 10.1175/2007JCLI2100.1; Stevenson S, 2010, J CLIMATE, V23, P5540, DOI 10.1175/2010JCLI3609.1; Stuecker MF, 2017, GEOPHYS RES LETT, V44, P2481, DOI 10.1002/2016GL072308; Thirumalai K, 2019, PALEOCEANOGR PALEOCL, V34, P1316, DOI 10.1029/2019PA003669; Thompson D. M., 2011, GEOPHYS RES LETT, V38, p[L14706, L19705]; Tierney JE, 2013, NATURE, V493, P389, DOI 10.1038/nature11785; Ummenhofer CC, 2017, J CLIMATE, V30, P1739, DOI 10.1175/JCLI-D-16-0200.1; Ummenhofer CC, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036801; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Weller E, 2013, J CLIMATE, V26, P6649, DOI 10.1175/JCLI-D-12-00807.1; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Yan H, 2015, NAT GEOSCI, V8, P315, DOI 10.1038/NGEO2375; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Zachariasen J, 1999, J GEOPHYS RES-SOL EA, V104, P895, DOI 10.1029/1998JB900050; Zhang LY, 2018, GEOPHYS RES LETT, V45, P1040, DOI 10.1002/2017GL076003; Zhang PZ, 2008, SCIENCE, V322, P940, DOI 10.1126/science.1163965	77	71	77	8	126	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					385	+		10.1038/s41586-020-2084-4	http://dx.doi.org/10.1038/s41586-020-2084-4		MAR 2020	23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188937				2022-12-28	WOS:000518736400001
J	Barrett, E; Lawrence, E; Waldman, D; Brislen, H				Barrett, Eileen; Lawrence, Elizabeth; Waldman, Daniel; Brislen, Heather			Improving How State Medical Boards Ask Physicians About Mental Health Diagnoses: A Case Study From New Mexico	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Barrett, Eileen; Lawrence, Elizabeth; Brislen, Heather] Univ New Mexico, Dept Internal Med, MSC10 5550,1, Albuquerque, NM 87131 USA; [Waldman, Daniel] Univ New Mexico, Family & Community Med, MSC 09 5040,1, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico	Barrett, E (corresponding author), Univ New Mexico, Dept Internal Med, MSC10 5550,1, Albuquerque, NM 87131 USA.	barrett.eileen@gmail.com						Aaronson AL, 2018, ACAD PSYCHIATR, V42, P469, DOI 10.1007/s40596-017-0881-3; American Medical Association, 2016, ACC CONF HLTH SERV M; Candilis PJ, 2019, ANN INTERN MED, V170, P871, DOI 10.7326/M18-3605; Dyrbye LN, 2017, MAYO CLIN PROC, V92, P1486, DOI 10.1016/j.mayocp.2017.06.020; Dyrbye LN, 2015, ACAD MED, V90, P961, DOI 10.1097/ACM.0000000000000655; Federation of State Medical Boards, 2018, PHYS WELLN BURN; Gold KJ, 2017, FAM MED, V49, P464; Gold KJ, 2016, GEN HOSP PSYCHIAT, V43, P51, DOI 10.1016/j.genhosppsych.2016.09.004; Sweeney JM, 2019, KEVINMD         0917	9	4	4	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 5	2020	172	9					617	+		10.7326/M19-3681	http://dx.doi.org/10.7326/M19-3681			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LK7EH	32203976				2022-12-28	WOS:000531024900013
J	Bauchner, H; Golub, RM; Zylke, J				Bauchner, Howard; Golub, Robert M.; Zylke, Jody			Editorial Concern-Possible Reporting of the Same Patients With COVID-19 in Different Reports	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												howard.bauchner@jamanetwork.org						Flanagin A, 2020, AMA MANUAL STYLE GUI, P201	1	91	91	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 7	2020	323	13					1256	1256		10.1001/jama.2020.3980	http://dx.doi.org/10.1001/jama.2020.3980			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE3DZ	32176775	Bronze			2022-12-28	WOS:000526602700014
J	Dee, SG; Cobb, KM; Emile-Geay, J; Ault, TR; Edwards, RL; Cheng, H; Charles, CD				Dee, Sylvia G.; Cobb, Kim M.; Emile-Geay, Julien; Ault, Toby R.; Edwards, R. Lawrence; Cheng, Hai; Charles, Christopher D.			No consistent ENSO response to volcanic forcing over the last millennium	SCIENCE			English	Article							EL-NINO; TROPICAL PACIFIC; PMIP SIMULATIONS; CLIMATE; ERUPTIONS; RECONSTRUCTIONS; OSCILLATION; VARIABILITY; IMPACTS; MODEL	The El Nino-Southern Oscillation (ENSO) shapes global climate patterns yet its sensitivity to external climate forcing remains uncertain. Modeling studies suggest that ENSO is sensitive to sulfate aerosol forcing associated with explosive volcanism but observational support for this effect remains ambiguous. Here, we used absolutely dated fossil corals from the central tropical Pacific to gauge ENSO's response to large volcanic eruptions of the last millennium. Superposed epoch analysis reveals a weak tendency for an El Nino-like response in the year after an eruption, but this response is not statistically significant, nor does it appear after the outsized 1257 Samalas eruption. Our results suggest that those models showing a strong ENSO response to volcanic forcing may overestimate the size of the forced response relative to natural ENSO variability.	[Dee, Sylvia G.] Rice Univ, Dept Earth Environm & Planetary Sci, Houston, TX 77005 USA; [Cobb, Kim M.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Emile-Geay, Julien] Univ Southern Calif, Dept Earth Sci, Los Angeles, CA 90089 USA; [Ault, Toby R.] Cornell Univ, Dept Earth & Atmospher Sci, Ithaca, NY 14853 USA; [Edwards, R. Lawrence; Cheng, Hai] Univ Minnesota, Dept Earth Sci, Minneapolis, MN 55455 USA; [Cheng, Hai] Xi An Jiao Tong Univ, Inst Global Environm Change, Xian 710054, Peoples R China; [Charles, Christopher D.] Scripps Inst Oceanog, San Diego, CA 92037 USA	Rice University; University System of Georgia; Georgia Institute of Technology; University of Southern California; Cornell University; University of Minnesota System; University of Minnesota Twin Cities; Xi'an Jiaotong University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Dee, SG (corresponding author), Rice Univ, Dept Earth Environm & Planetary Sci, Houston, TX 77005 USA.	sylvia.dee@rice.edu		Dee, Sylvia/0000-0002-2140-785X; Cobb, Kim/0000-0002-2125-9164	Peter Voss Postdoctoral Fellowship in the Institute at Brown for Environment and Society; Brown University; University of Texas at Austin, Institute for Geophysics Postdoctoral Fellowship; NSF Marine Geology and Geophysics [0752091, 1502832, 1836645]; NSF OCE award [0752585]; NOAA [NA18OAR4310426]	Peter Voss Postdoctoral Fellowship in the Institute at Brown for Environment and Society; Brown University; University of Texas at Austin, Institute for Geophysics Postdoctoral Fellowship; NSF Marine Geology and Geophysics(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NSF OCE award(National Science Foundation (NSF)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This research was supported by the Peter Voss Postdoctoral Fellowship in the Institute at Brown for Environment and Society, Brown University, as well as the University of Texas at Austin, Institute for Geophysics Postdoctoral Fellowship, both awarded to S.D.; by NSF Marine Geology and Geophysics awards 0752091, 1502832, and 1836645 to K. C.; NSF OCE award 0752585 to C.D. C. and K.C.; and NOAA grant NA18OAR4310426 to J.E.G.	Adams JB, 2003, NATURE, V426, P274, DOI 10.1038/nature02101; Anchukaitis KJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044843; Burke A, 2019, EARTH PLANET SC LETT, V521, P113, DOI 10.1016/j.epsl.2019.06.006; Cai WJ, 2018, NATURE, V564, P201, DOI 10.1038/s41586-018-0776-9; Cai WJ, 2015, NAT CLIM CHANGE, V5, P849, DOI [10.1038/nclimate2743, 10.1038/NCLIMATE2743]; Cheng H, 2013, EARTH PLANET SC LETT, V371, P82, DOI 10.1016/j.epsl.2013.04.006; Cobb KM, 2013, SCIENCE, V339, P67, DOI 10.1126/science.1228246; Cobb KM, 2003, NATURE, V424, P271, DOI 10.1038/nature01779; Cobb KM, 2003, EARTH PLANET SC LETT, V210, P91, DOI 10.1016/S0012-821X(03)00138-9; Cobb KM, 2001, GEOPHYS RES LETT, V28, P2209, DOI 10.1029/2001GL012919; Comboul M, 2014, CLIM PAST, V10, P825, DOI 10.5194/cp-10-825-2014; Crowley T.J., 2008, PAGES NEWS, V16, P22, DOI [DOI 10.1029/2002GL0166335, 10.22498/pages.16.2.22, DOI 10.22498/PAGES.16.2.22]; Dee S, 2015, J ADV MODEL EARTH SY, V7, P1220, DOI 10.1002/2015MS000447; Efron B., 1994, INTRO BOOTSTRAP; Emile-Geay J, 2008, J CLIMATE, V21, P3134, DOI 10.1175/2007JCLI1884.1; Emile-Geay J, 2013, J CLIMATE, V26, P2302, DOI [10.1175/JCLI-D-11-00511.1, 10.1175/JCLI-D-11-00510.1]; Gao C., J GEOPHYS RES ATMOS, V111; Gao CC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006710; Guillet S, 2017, NAT GEOSCI, V10, P123, DOI [10.1038/NGEO2875, 10.1038/ngeo2875]; Khodri M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00755-6; Lavigne F, 2013, P NATL ACAD SCI USA, V110, P16742, DOI 10.1073/pnas.1307520110; LeGrande AN, 2016, NAT GEOSCI, V9, P652, DOI 10.1038/NGEO2771; Lehner F, 2016, GEOPHYS RES LETT, V43, P2851, DOI 10.1002/2016GL067935; Li JB, 2013, NAT CLIM CHANGE, V3, P822, DOI [10.1038/nclimate1936, 10.1038/NCLIMATE1936]; Liu Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15386; Maher N, 2015, GEOPHYS RES LETT, V42, P6024, DOI 10.1002/2015GL064751; Mann ME, 2005, J CLIMATE, V18, P447, DOI 10.1175/JCLI-3276.1; Meyer A, 2016, J CLIMATE, V29, P1325, DOI 10.1175/JCLI-D-15-0034.1; Moses CS, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001196; Otto-Bliesner BL, 2016, B AM METEOROL SOC, V97, P735, DOI 10.1175/BAMS-D-14-00233.1; Pausata FSR, 2016, GEOPHYS RES LETT, V43, P8694, DOI 10.1002/2016GL069575; Pausata FSR, 2015, P NATL ACAD SCI USA, V112, P13784, DOI 10.1073/pnas.1509153112; Plazzotta M, 2018, GEOPHYS RES LETT, V45, P5663, DOI 10.1029/2018GL077583; Rao MP, 2019, DENDROCHRONOLOGIA, V55, P119, DOI 10.1016/j.dendro.2019.05.001; Sayani H., 2019, GEOCHEM GEOPHY GEOSY, V20, P11; Schmidt GA, 2012, GEOSCI MODEL DEV, V5, P185, DOI 10.5194/gmd-5-185-2012; Schmidt GA, 2011, GEOSCI MODEL DEV, V4, P33, DOI 10.5194/gmd-4-33-2011; Sigl M, 2015, NATURE, V523, P543, DOI 10.1038/nature14565; Stevenson S, 2017, P NATL ACAD SCI USA, V114, P1822, DOI 10.1073/pnas.1612505114; Stevenson S, 2016, J CLIMATE, V29, P2907, DOI 10.1175/JCLI-D-15-0239.1; Stoffel M, 2015, NAT GEOSCI, V8, P784, DOI [10.1038/ngeo2526, 10.1038/NGEO2526]; Thompson DM, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048224; Toohey M, 2017, EARTH SYST SCI DATA, V9, P809, DOI 10.5194/essd-9-809-2017; Wittenberg AT, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038710; Zaunbrecher LK, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001788	45	42	42	6	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1477	+		10.1126/science.aax2000	http://dx.doi.org/10.1126/science.aax2000			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217726				2022-12-28	WOS:000523251600037
J	Harvey, A				Harvey, Anna			Covid-19: medical schools given powers to graduate final year students early to help NHS	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, EP UPD MONK MULT OUT; British Medical Association Students, COVID 19 UPD MED STU; General Medical Council, INF MED STUD; Harvey A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1197; Medical Schools Council, STAT EXP MED STUD VO	5	19	20	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1227	10.1136/bmj.m1227	http://dx.doi.org/10.1136/bmj.m1227			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217530	Bronze			2022-12-28	WOS:000523764800016
J	McNamara, DA; Patel, N				McNamara, David A.; Patel, Nimesh			Preexcited Atrial Fibrillation after a Blood Draw	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								A 33-year-old man presented to the emergency department with palpitations. An electrocardiogram showed preexcited atrial fibrillation.	[McNamara, David A.; Patel, Nimesh] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	McNamara, DA (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA.	davidmcnam@gmail.com							0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					E22	E22		10.1056/NEJMicm1901934	http://dx.doi.org/10.1056/NEJMicm1901934			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY1UO	32212522				2022-12-28	WOS:000522357300001
J	Campbell, JR; Bastos, ML				Campbell, Jonathon R.; Bastos, Mayara L.			No time to waste: preventing tuberculosis in children	LANCET			English	Editorial Material									[Campbell, Jonathon R.; Bastos, Mayara L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Campbell, Jonathon R.; Bastos, Mayara L.] McGill Int TB Ctr, Montreal, PQ, Canada; [Bastos, Mayara L.] Univ Estado Rio De Janeiro, Inst Social Med, Dept Epidemiol, Rio De Janeiro, Brazil	McGill University; Universidade do Estado do Rio de Janeiro	Campbell, JR (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada.; Campbell, JR (corresponding author), McGill Int TB Ctr, Montreal, PQ, Canada.	jonathon.campbell@mail.mcgill.ca	Campbell, Jonathon/AAN-4252-2021	Campbell, Jonathon/0000-0003-2341-2166	Fonds de Recherche du Quebec -Sante [258907]; Canadian Institutes of Health Research [FRD331745]	Fonds de Recherche du Quebec -Sante(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	JRC is supported by a postdoctoral fellowship from the Fonds de Recherche du Quebec -Sante (award #258907) and MLB is supported by a grant from the Canadian Institutes of Health Research (FRD331745). We thank Dick Menzies (McGill University, Montreal, QC, Canada) for reviewing an early draft of this Comment. We declare no competing interests.	Diallo T, 2018, NEW ENGL J MED, V379, P454, DOI 10.1056/NEJMoa1714284; Dowdy DW, 2017, J INFECT DIS, V216, pS654, DOI 10.1093/infdis/jix320; Kagujje M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7652-x; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278; Martinez L, 2020, LANCET, V395, P973, DOI 10.1016/S0140-6736(20)30166-5; McIntosh AI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223966; Pedrazzoli D, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01877-2016; THOMPSON NJ, 1982, B WORLD HEALTH ORGAN, V60, P555; Timire C, 2019, INT J TUBERC LUNG D, V23, P1235, DOI 10.5588/ijtld.19.0248; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; WHO, 2019, GLOB TUB REP; World Health Organization, 2018, LAT TUB INF UPD CONS	12	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					924	926						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199475				2022-12-28	WOS:000521744600007
J	Mohandas, P; Lowden, M; Varma, S				Mohandas, Padma; Lowden, Martyn; Varma, Sandeep			Bowen's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SQUAMOUS-CELL CARCINOMA; IN-SITU		[Mohandas, Padma; Varma, Sandeep] Nottingham Univ Hosp NHS Trust, Nottingham NHS Treatment Ctr, Nottingham, England; [Lowden, Martyn] Cropwell Bishop, Cropwell Bishop Hlth Ctr, Nottingham, England; [Varma, Sandeep] Univ Nottingham, Sch Med, Nottingham, England	Nottingham University Hospital NHS Trust; University of Nottingham	Mohandas, P (corresponding author), Nottingham Univ Hosp NHS Trust, Nottingham NHS Treatment Ctr, Nottingham, England.	pmohandas@nhs.net						Bell HK, 1999, CLIN EXP DERMATOL, V24, P338; Eimpunth S, 2017, DERMATOL SURG, V43, P698, DOI 10.1097/DSS.0000000000001028; Hansen JP, 2008, DERMATOL SURG, V34, P878, DOI 10.1111/j.1524-4725.2008.34172.x; Morton C, 2006, ARCH DERMATOL, V142, P729, DOI 10.1001/archderm.142.6.729; Morton CA, 2014, BRIT J DERMATOL, V170, P245, DOI 10.1111/bjd.12766; National Institute for Health and Care Excellence, 2016, QS130 NAT I HLTH CAR; Ramrakha-Jones VS, 2003, BRIT J DERMATOL, V148, P1167, DOI 10.1046/j.1365-2133.2003.54013.x; THESTRUPPEDERSEN K, 1988, ACTA DERM-VENEREOL, V68, P236	8	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2020	368								m813	10.1136/bmj.m813	http://dx.doi.org/10.1136/bmj.m813			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DO	32198148				2022-12-28	WOS:000523763600001
J	Kanellopoulos, AK; Mariano, V; Spinazzi, M; Woo, YJ; McLean, C; Pech, U; Li, KW; Armstrong, JD; Giangrande, A; Callaerts, P; Smit, AB; Abrahams, BS; Fiala, A; Achsel, T; Bagni, C				Kanellopoulos, Alexandros K.; Mariano, Vittoria; Spinazzi, Marco; Woo, Young Jae; McLean, Colin; Pech, Ulrike; Li, Ka Wan; Armstrong, J. Douglas; Giangrande, Angela; Callaerts, Patrick; Smit, August B.; Abrahams, Brett S.; Fiala, Andre; Achsel, Tilmann; Bagni, Claudia			Aralar Sequesters GABA into Hyperactive Mitochondria, Causing Social Behavior Deficits	CELL			English	Article							AUTISM SPECTRUM DISORDER; FRAGILE-X; COMPLEX I; PROTEIN COMPLEXES; GENE-EXPRESSION; DROSOPHILA; DYSFUNCTION; CYFIP1; BRAIN; SCHIZOPHRENIA	Social impairment is frequently associated with mitochondrial dysfunction and altered neurotransmission. Although mitochondrial function is crucial for brain homeostasis, it remains unknown whether mitochondrial disruption contributes to social behavioral deficits. Here, we show that Drosophila mutants in the homolog of the human CYFIP1, a gene linked to autism and schizophrenia, exhibit mitochondrial hyperactivity and altered group behavior. We identify the regulation of GABA availability by mitochondrial activity as a biologically relevant mechanism and demonstrate its contribution to social behavior. Specifically, increased mitochondrial activity causes gamma aminobutyric acid (GABA) sequestration in the mitochondria, reducing GABAergic signaling and resulting in social deficits. Pharmacological and genetic manipulation of mitochondrial activity or GABA signaling corrects the observed abnormalities. We identify Aralar as the mitochondrial transporter that sequesters GABA upon increased mitochondrial activity. This study increases our understanding of how mitochondria modulate neuronal homeostasis and social behavior under physiopathological conditions.	[Kanellopoulos, Alexandros K.; Mariano, Vittoria; Achsel, Tilmann; Bagni, Claudia] Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland; [Mariano, Vittoria; Callaerts, Patrick] Katholieke Univ Leuven, Dept Human Genet, B-3000 Leuven, Belgium; [Spinazzi, Marco] Katholieke Univ Leuven, Dept Human Genet, VIB Ctr Brain & Dis Res Leuven, B-3000 Leuven, Belgium; [Woo, Young Jae; Abrahams, Brett S.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Woo, Young Jae] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [McLean, Colin] Univ Edinburgh, Sch Informat, Edinburgh EH8 9YL, Midlothian, Scotland; [Pech, Ulrike; Fiala, Andre] Univ Gottingen, Dept Mol Neurobiol Behav, D-37073 Gottingen, Germany; [Li, Ka Wan; Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Armstrong, J. Douglas] Univ Edinburgh, Sch Informat, SIDB, Edinburgh EH8 9YL, Midlothian, Scotland; [Armstrong, J. Douglas] Forschungszentrum Julich, Computat Biomed Inst IAS 5 INM 9, D-52428 Julich, Germany; [Giangrande, Angela] Univ Strasbourg, CNRS, INSERM, UMR7104, F-67400 Illkirch Graffenstaden, France; [Abrahams, Brett S.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Bagni, Claudia] Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy; [Spinazzi, Marco] Angers Univ Hosp, Neuromuscular Reference Ctr, Dept Neurol, F-49933 Angers, France	University of Lausanne; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; University of Edinburgh; University of Gottingen; Vrije Universiteit Amsterdam; University of Edinburgh; Helmholtz Association; Research Center Julich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yeshiva University; Albert Einstein College of Medicine; University of Rome Tor Vergata; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Bagni, C (corresponding author), Univ Lausanne, Dept Fundamental Neurosci, CH-1005 Lausanne, Switzerland.; Bagni, C (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, I-00133 Rome, Italy.	claudia.bagni@unil.ch	Fiala, André/AAA-3852-2019; Callaerts, Patrick/I-8118-2013	Fiala, André/0000-0002-9745-5145; Woo, Young/0000-0002-9233-5099; Mariano, Vittoria/0000-0002-9848-0262; li, ka wan/0000-0001-6983-5055; Kanellopoulos, Alexandros/0000-0002-2094-7491; Bagni, Claudia/0000-0002-4419-210X; Callaerts, Patrick/0000-0003-4530-4561	KUL Funds Opening the Future (OTF); Queen Elisabeth Foundation (Belgium); NCCR Synapsy (Switzerland) [51NF40-158776]; Novartis (Switzerland); PRIN [201789LFKB]; EU-FP7 "SynSys" [HEALTH-2009-2.1.2-1]; German Research Foundation [SFB 889/B04]; Bernstein Center for Computational Neuroscience Gottingen [01GQ1005A]; INSERM, CNRS; Autism Speaks Meixner translational postdoctoral fellowship [9728]; Greek State Scholarships Foundation IKY; Fondation Sophie Afenduli; Autism Research Institute (ARI); EMBO [ALTF 648-2013]; VIB; FWO [G065408.N10, G078914N]; SNSF [310030-182651];  [ANR-10-LABX-0030-INRT]	KUL Funds Opening the Future (OTF); Queen Elisabeth Foundation (Belgium); NCCR Synapsy (Switzerland); Novartis (Switzerland); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); EU-FP7 "SynSys"; German Research Foundation(German Research Foundation (DFG)); Bernstein Center for Computational Neuroscience Gottingen; INSERM, CNRS; Autism Speaks Meixner translational postdoctoral fellowship; Greek State Scholarships Foundation IKY; Fondation Sophie Afenduli; Autism Research Institute (ARI); EMBO(European Molecular Biology Organization (EMBO)); VIB; FWO(FWO); SNSF(Swiss National Science Foundation (SNSF)); 	This work was supported by VIB, KUL Funds Opening the Future (OTF), the Queen Elisabeth Foundation (Belgium), SNSF 310030-182651, NCCR Synapsy 51NF40-158776 (Switzerland), Novartis (Switzerland), and PRIN 201789LFKB to C.B. Additional funds were from HEALTH-2009-2.1.2-1 EU-FP7 "SynSys" (to C.B., A.B.S., and J.D.A.), the German Research Foundation (SFB 889/B04), and the Bernstein Center for Computational Neuroscience Gottingen (grant 01GQ1005A) (to U.P. and A.F.) and INSERM, CNRS, and ANR-10-LABX-0030-INRT (to A.G.). A.K.K. was the recipient of the Autism Speaks Meixner translational postdoctoral fellowship (grant 9728) and supported by the Greek State Scholarships Foundation IKY, the Fondation Sophie Afenduli, and Autism Research Institute (ARI). M.S. was the recipient of an EMBO long-term fellowship (ALTF 648-2013) and supported by funding to Bart De Strooper. P.C. was supported by a grant from VIB and FWO (G065408.N10 and G078914N). We thank Efthimios Skoulakis, Ronald Davis, Rob Jackson, Brett H. Graham, Hugo Bellen, and Patrik Verstreken for fly stocks and reagents. We acknowledge the Developmental Hybridoma Studies Bank for antibodies, the Bloomington Drosophila Stock Center and Vienna Drosophila Resource Center for resources, and Flybase for essential information. We thank Annick Crevoisier and Eef Lemmens for administrative assistance. We are grateful to Vassil Altanov, Elisa Cappuyns, and Lysimachos Zografos for preliminary data and Kris Dickson and Richard Benton for critical reading of this manuscript. We thank Ilse Smolders and Ann Van Eeckhaut for help with the initial HPLC analysis. We are particularly grateful to Dr. Julijana Ivanisevic and Dr. Hector Gallart-Ayala at the Metabolomic Unit, University of Lausanne, for excellent advice, support, and analysis of the metabolites and Federico Caicci at the electron microscopy facility of the Department of Biology, University of Padova for the excellent TEM analysis of the mitochondria. The graphical model was made by ServierMedical Art (https://www.servier.com/).This paper is dedicated to the memory of an inspiring mentor and visionary scientist, Fotis C. Kafatos.	Aditi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep31411; Akarsu Suleyman, 2014, J Mol Psychiatry, V2, P6, DOI 10.1186/s40303-014-0006-9; Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Amoedo ND, 2016, BBA-MOL CELL RES, V1863, P2394, DOI 10.1016/j.bbamcr.2016.04.011; Anholt RRH, 2012, ANNU REV GENET, V46, P145, DOI 10.1146/annurev-genet-110711-155514; Anitei M, 2010, NAT CELL BIOL, V12, P330, DOI 10.1038/ncb2034; Anitha A, 2012, MOL AUTISM, V3, DOI 10.1186/2040-2392-3-12; Aoki Y, 2016, MOL NEUROBIOL, V53, P1579, DOI 10.1007/s12035-015-9116-3; Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Bachmann SO, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-018-0338-9; Badal KK, 2019, CELL REP, V26, P507, DOI 10.1016/j.celrep.2018.12.073; Balijepalli S, 1999, NEUROPHARMACOLOGY, V38, P567, DOI 10.1016/S0028-3908(98)00215-9; BASTOCK M, 1956, EVOLUTION, V10, P421, DOI 10.2307/2407002; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Ben-Ari Y, 2017, TRENDS NEUROSCI, V40, P536, DOI 10.1016/j.tins.2017.07.001; Ben-Ari Y, 2012, NEUROSCIENTIST, V18, P467, DOI 10.1177/1073858412438697; Benke D, 2018, NEUROPHARMACOLOGY, V136, P46, DOI 10.1016/j.neuropharm.2017.07.030; Bergman O, 2016, CAN J PSYCHIAT, V61, P457, DOI 10.1177/0706743716648290; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; Boccuto L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-16; Bonnighausen J, 2015, MOL MICROBIOL, V98, P1115, DOI 10.1111/mmi.13203; Bozdagi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042422; Braat S, 2015, NEURON, V86, P1119, DOI 10.1016/j.neuron.2015.03.042; Brambilla P, 2003, MOL PSYCHIATR, V8, P721, DOI 10.1038/sj.mp.4001362; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cafferkey M, 2014, AM J MED GENET A, V164, P1916, DOI 10.1002/ajmg.a.36554; Carillo P, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00100; Castora FJ, 2019, PROG NEURO-PSYCHOPH, V92, P83, DOI 10.1016/j.pnpbp.2018.12.015; Castro JP, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00196; Cellot G, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00070; Chateauvieux S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/479364; Chen N, 2015, BBA-PROTEINS PROTEOM, V1854, P827, DOI 10.1016/j.bbapap.2015.02.008; Chen ZC, 2010, NATURE, V468, P533, DOI 10.1038/nature09623; Coghlan S, 2012, NEUROSCI BIOBEHAV R, V36, P2044, DOI 10.1016/j.neubiorev.2012.07.005; Cox DM, 2015, INT J MOL SCI, V16, P4068, DOI 10.3390/ijms16024068; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Das D K, 2015, Mol Neuropsychiatry, V1, P116; Davenport EC, 2019, CELL REP, V26, P2037, DOI 10.1016/j.celrep.2019.01.092; Davis MI, 2014, J BIOL CHEM, V289, P13717, DOI 10.1074/jbc.M113.511030; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; De Rubeis S, 2013, NEURON, V79, P1169, DOI 10.1016/j.neuron.2013.06.039; De Wolf V, 2013, AM J MED GENET A, V161, P2846, DOI 10.1002/ajmg.a.36209; Depner H, 2014, NAT PROTOC, V9, P2796, DOI 10.1038/nprot.2014.192; Di Marino D, 2015, J CHEM THEORY COMPUT, V11, P3401, DOI 10.1021/ct500431h; Dominguez-Iturza N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11203-y; Edden RAE, 2012, ARCH GEN PSYCHIAT, V69, P750, DOI 10.1001/archgenpsychiatry.2011.2280; Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859; Ejima Aki, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4847; Foss-Feig JH, 2017, BIOL PSYCHIAT, V81, P848, DOI 10.1016/j.biopsych.2017.03.005; Friedman SD, 2003, NEUROLOGY, V60, P100, DOI 10.1212/WNL.60.1.100; Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507; Gallart-Ayala H, 2018, ANAL CHIM ACTA, V1037, P327, DOI 10.1016/j.aca.2018.04.002; Galy A, 2011, DEV BIOL, V359, P37, DOI 10.1016/j.ydbio.2011.08.009; Gandal MJ, 2018, SCIENCE, V359, P693, DOI 10.1126/science.aad6469; Garcia MJ, 2019, J EXP ZOOL PART A, V331, P192, DOI 10.1002/jez.2253; Garcia-Cazorla A, 2018, J INHERIT METAB DIS, V41, P909, DOI 10.1007/s10545-018-00252-y; Genheden M, 2015, J NEUROSCI, V35, P972, DOI 10.1523/JNEUROSCI.2641-14.2015; Ghanizadeh A, 2013, MITOCHONDRION, V13, P515, DOI 10.1016/j.mito.2012.10.001; Goldenthal MJ, 2015, BIOMARK MED, V9, P957, DOI 10.2217/bmm.15.72; Griffiths KK, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4314025; Han S, 2014, NEURON, V81, P1282, DOI 10.1016/j.neuron.2014.01.016; Han S, 2012, NATURE, V489, P385, DOI 10.1038/nature11356; Hollis F, 2017, CURR OPIN NEUROBIOL, V45, P178, DOI 10.1016/j.conb.2017.05.018; Homberg U, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00230; Hsiao K, 2016, J NEUROSCI, V36, P1564, DOI 10.1523/JNEUROSCI.0511-15.2016; Hsu CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20259; Hu YH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-357; Hunt SE, 2018, DATABASE-OXFORD, DOI [10.1093/database/bay119, 10.1186/1471-2164-11-293]; Kanellopoulos AK, 2012, J NEUROSCI, V32, P13111, DOI 10.1523/JNEUROSCI.1347-12.2012; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Khacho M, 2018, DEV DYNAM, V247, P47, DOI 10.1002/dvdy.24538; Koganezawa M, 2016, CURR BIOL, V26, P1395, DOI 10.1016/j.cub.2016.04.017; Kolodziejczyk A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002110; Konradi C, 2017, SCHIZOPHR RES, V187, P1, DOI 10.1016/j.schres.2017.07.007; Kosmidis S, 2011, NEUROBIOL DIS, V43, P213, DOI 10.1016/j.nbd.2011.03.013; Krumschnabel Gerhard, 2015, Methods Mol Biol, V1264, P245, DOI 10.1007/978-1-4939-2257-4_22; Kuo HY, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0076-19.2019; Leblond CS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002521; Lee D, 2003, J NEUROSCI, V23, P4625; Legido A, 2013, SEMIN PEDIATR NEUROL, V20, P163, DOI 10.1016/j.spen.2013.10.008; Lepagnol-Bestel AM, 2008, MOL PSYCHIATR, V13, P385, DOI 10.1038/sj.mp.4002120; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; Maguire SE, 2015, J BIOL CHEM, V290, P20407, DOI 10.1074/jbc.M114.602276; Marland JRK, 2016, J BIOL CHEM, V291, P2080, DOI 10.1074/jbc.M115.686956; Masuda-Nakagawa LM, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00035; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McGuire Sean E, 2004, Sci STKE, V2004, ppl6, DOI 10.1126/stke.2202004pl6; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Michaeli S, 2011, PLANT J, V67, P485, DOI 10.1111/j.1365-313X.2011.04612.x; Midani FS, 2017, ANAL BIOCHEM, V520, P27, DOI 10.1016/j.ab.2016.12.011; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Mukherjee A, 2019, CELL, V178, P1387, DOI 10.1016/j.cell.2019.07.023; Napoli I, 2008, CELL, V134, P1042, DOI 10.1016/j.cell.2008.07.031; Napolioni V, 2011, MOL NEUROBIOL, V44, P83, DOI 10.1007/s12035-011-8192-2; Nebel RA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148039; Nevado J, 2014, GENET MOL BIOL, V37, P210, DOI 10.1590/S1415-47572014000200007; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Oguro-Ando A, 2015, MOL PSYCHIATR, V20, P1069, DOI 10.1038/mp.2014.124; Orefice LL, 2016, CELL, V166, P299, DOI 10.1016/j.cell.2016.05.033; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; Panja D, 2014, CELL REP, V9, P1430, DOI 10.1016/j.celrep.2014.10.016; Pardo Beatriz, 2013, Front Endocrinol (Lausanne), V4, P149, DOI 10.3389/fendo.2013.00149; Pathania M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.16; Patowary A, 2017, AUTISM RES, V10, P1338, DOI 10.1002/aur.1792; Pech U, 2015, CELL REP, V10, P2083, DOI 10.1016/j.celrep.2015.02.065; Perry SW, 2011, BIOTECHNIQUES, V50, P98, DOI 10.2144/000113610; Picard M, 2015, TRENDS NEUROSCI, V38, P468, DOI 10.1016/j.tins.2015.06.001; Raefsky SM, 2017, FREE RADICAL BIO MED, V102, P203, DOI 10.1016/j.freeradbiomed.2016.11.045; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Reynolds MF, 2007, CURR MED CHEM, V14, P2799, DOI 10.2174/092986707782360088; Robinson JE, 2018, CURR OPIN NEUROBIOL, V48, P17, DOI 10.1016/j.conb.2017.08.003; Roci I, 2016, ANAL CHEM, V88, P2707, DOI 10.1021/acs.analchem.5b04071; Rosenfeld M, 2011, BIOL PSYCHIAT, V69, P980, DOI 10.1016/j.biopsych.2011.01.010; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Sakurai T, 2010, BIOL PSYCHIAT, V67, P887, DOI 10.1016/j.biopsych.2009.08.042; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Santini E, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan0665; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Schwede M, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9237-x; Selimbeyoglu A, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6733; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Silva AI, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11119-7; Simon AF, 2012, GENES BRAIN BEHAV, V11, P243, DOI 10.1111/j.1601-183X.2011.00740.x; Sohal VS, 2019, MOL PSYCHIATR, V24, P1248, DOI 10.1038/s41380-019-0426-0; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; Sokolowski MB, 2001, NAT REV GENET, V2, P879, DOI 10.1038/35098592; Son G, 2018, BMB REP, V51, P549, DOI 10.5483/BMBRep.2018.51.11.226; Spinazzi M, 2019, P NATL ACAD SCI USA, V116, P277, DOI 10.1073/pnas.1811938116; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Stathopoulos S., 2018, BIORXIV, DOI [10.1101/310748, DOI 10.1101/310748.]; Stefansson H, 2014, NATURE, V505, P361, DOI 10.1038/nature12818; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Sun J, 2018, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00006; Tam GWC, 2010, BIOCHEM SOC T, V38, P445, DOI 10.1042/BST0380445; Tauber JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027100; Taurines R, 2010, EUR CHILD ADOLES PSY, V19, P441, DOI 10.1007/s00787-009-0074-z; Tochitani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056901; Toker L, 2015, NEUROPSYCH DIS TREAT, V11, P2441, DOI 10.2147/NDT.S70346; Traag VA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036115; Ugur B, 2017, CELL REP, V21, P3794, DOI 10.1016/j.celrep.2017.12.005; Urraca N, 2013, AUTISM RES, V6, P268, DOI 10.1002/aur.1284; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Vanlerberghe C, 2015, EUR J MED GENET, V58, P140, DOI 10.1016/j.ejmg.2015.01.002; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Vos Melissa, 2010, Front Synaptic Neurosci, V2, P139, DOI 10.3389/fnsyn.2010.00139; Wang J, 2015, ANN HUM GENET, V79, P329, DOI 10.1111/ahg.12121; Wang P, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0058-6; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; Williams S.G., 2019, BIORXIV, DOI [10.1101/722504, DOI 10.1101/722504.]; Woo YJ, 2019, BIOL PSYCHIAT, V86, P306, DOI 10.1016/j.biopsych.2019.04.008; Woo YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158036; Wu CL, 2011, CURR BIOL, V21, P848, DOI 10.1016/j.cub.2011.02.041; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Yao CH, 2019, ELIFE, V8, DOI 10.7554/eLife.41351; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yoon KJ, 2014, CELL STEM CELL, V15, P79, DOI 10.1016/j.stem.2014.05.003; Yoon WH, 2017, NEURON, V93, P115, DOI 10.1016/j.neuron.2016.11.038; Yuan Q, 2014, NAT NEUROSCI, V17, P81, DOI 10.1038/nn.3581; Yuen RKC, 2017, NAT NEUROSCI, V20, P602, DOI 10.1038/nn.4524; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhang HG, 2002, GENETICS, V162, P1283; Zhao Q, 2013, SCHIZOPHRENIA BULL, V39, P712, DOI 10.1093/schbul/sbr197; Zoghbi Huda Y, 2012, Cold Spring Harb Perspect Biol, V4, DOI 10.1101/cshperspect.a009886; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009; Zwarts L, 2011, P NATL ACAD SCI USA, V108, P17070, DOI 10.1073/pnas.1113877108	172	30	31	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1178	+		10.1016/j.cell.2020.02.044	http://dx.doi.org/10.1016/j.cell.2020.02.044			40	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32200800	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000520925300014
J	Gornall, J				Gornall, Jonathan			INVESTIGATION Big cannabis in the UK: is industry support for wider patient access motivated by promises of recreational market worth billions?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						All-Party Parliamentary Group for Drug Policy Reform, 2016, ACC MED CANN M PAT N; [Anonymous], PROJ TWENTY21; [Anonymous], 2018, WHAT AR PUBL PERC CA; [Anonymous], 2020, PROJECT TWENTY21 REG; [Anonymous], 2019, CLEAR; [Anonymous], 2019, UK CANN REP; [Anonymous], 2019, EUR CANN REP; Barnes M, 2016, CANNABIS EVIDENCE ME; Busby M, 2018, GUARDIAN; Caldwell C., 2018, VICE; Centre for Medicinal Cannabis, ADV ACC MED CANN UK; Dorbian I., 2019, FORBES; Freeman TP, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1141; McCusker P., 2019, TRICKLE UK CANNABIS; Moore S., 2018, WHATEVER HAPPENED BI; Ricketts A., 2015, 3 SECTOR; SOL Global Investments, US; Travis Alan, 2009, GUARDIAN; Volteface, 7 REAS LEG CANN	19	8	8	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m1002	10.1136/bmj.m1002	http://dx.doi.org/10.1136/bmj.m1002			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188592				2022-12-28	WOS:000523763100007
J	Meester, RGS; Lansdorp-Vogelaar, I; Winawer, SJ; Zauber, AG; Knudsen, AB; Ladabaum, U				Meester, Reinier G. S.; Lansdorp-Vogelaar, Iris; Winawer, Sidney J.; Zauber, Ann G.; Knudsen, Amy B.; Ladabaum, Uri			Intensity of Surveillance for Patients With Colorectal Adenomas RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							POLYPECTOMY; CANCER		[Meester, Reinier G. S.; Lansdorp-Vogelaar, Iris] Erasmus MC, Univ Med Ctr, Rotterdam, Netherlands; [Winawer, Sidney J.; Zauber, Ann G.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Knudsen, Amy B.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Ladabaum, Uri] Stanford Univ, Stanford, CA 94305 USA	Erasmus University Rotterdam; Erasmus MC; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts General Hospital; Stanford University	Meester, RGS (corresponding author), Erasmus MC, Univ Med Ctr, Rotterdam, Netherlands.							Brenner H, 2007, GUT, V56, P1585, DOI 10.1136/gut.2007.122739; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Saini SD, 2010, GASTROENTEROLOGY, V138, P2292, DOI 10.1053/j.gastro.2010.03.004; Zauber AG, 2012, NEW ENGL J MED, V366, P687, DOI 10.1056/NEJMoa1100370; Zhao SB, 2019, GASTROENTEROLOGY, V156, P1661, DOI 10.1053/j.gastro.2019.01.260	5	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					442	+		10.7326/L19-0829	http://dx.doi.org/10.7326/L19-0829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176909	Green Submitted			2022-12-28	WOS:000520170800041
J	Vincent, C; Oikonomou, E; Carthey, J; Macrae, C				Vincent, Charles; Oikonomou, Eirini; Carthey, Jane; Macrae, Carl			Redesigning safety regulation in the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PATIENT SAFETY		[Vincent, Charles; Oikonomou, Eirini] Univ Oxford, Dept Expt Psychol, 49 Walton St,New Radcliffe House, Oxford OX2 6AE, England; [Carthey, Jane] Jane Carthey Consulting, London, England; [Macrae, Carl] Univ Nottingham, Nottingham Univ Business Sch, Jubilee Campus,Wollaton Rd, Nottingham NG8 1BB, England	University of Oxford; University of Nottingham	Vincent, C (corresponding author), Univ Oxford, Dept Expt Psychol, 49 Walton St,New Radcliffe House, Oxford OX2 6AE, England.	vincent@psy.ox.ac.uk		Macrae, Carl/0000-0003-3198-7808; Oikonomou, Eirini/0000-0001-8408-9476	Health Foundation	Health Foundation	We thank the Health Foundation for funding the original research. We thank Gwyn Bevan, Ted Baker, and Paul Simpson for comments on an earlier draft of this paper. The views expressed are those of the authors.	Berwick D, 2013, IMPROVING SAFETY PAT; Dixon-Woods M, 2016, BMJ QUAL SAF, V25, P485, DOI 10.1136/bmjqs-2016-005232; Edwards N, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3414; Hutter BM, 1997, COMPLIANCE REGULATIO; MacRae C., 2010, ANTICIPATING RISKS O, P139, DOI [10.1017/CBO9780511761553.008, DOI 10.1017/CBO9780511761553.008]; Macrae C., 2014, CLOSE CALLS MANAGING, DOI [10.1057/9781137376121, DOI 10.1057/9781137376121]; NHS Providers, 2017, IMP REG SHIFT ENV; NHS Providers, 2015, MAX VAL REG APPR; Oikonomou E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-028663; Professional Standards Authority, 2015, RETH REG; Smithson R, 2018, ROOM IMPROVEMENT; Thorlby R, 2014, FRANCIS REPORT ONE Y; Vincent C, 2014, BMJ QUAL SAF, V23, P670, DOI 10.1136/bmjqs-2013-002757; Walshe K, 2002, BRIT MED J, V324, P967, DOI 10.1136/bmj.324.7343.967; Yeung K, 2010, SOC SCI MED, V71, P502, DOI 10.1016/j.socscimed.2010.04.017	15	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m760	10.1136/bmj.m760	http://dx.doi.org/10.1136/bmj.m760			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2CT	32179534	Green Published			2022-12-28	WOS:000523761500001
J	Hopman, J; Allegranzi, B; Mehtar, S				Hopman, Joost; Allegranzi, Benedetta; Mehtar, Shaheen			Managing COVID-19 in Low- and Middle-Income Countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses challenges to managing a COVID-19 outbreak in low- and middle-income countries (LMICs), reviewing how absence of testing, critical care capacity, climate, war, distrust, and large refugee populations could complicate implementation of proven infection prevention and control measures.	[Hopman, Joost] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Radboudumc Ctr Infect Dis, Grootepl 10,Postbus 9101, NL-6500 HB Nijmegen, Netherlands; [Hopman, Joost] Med Sans Frontieres, Amsterdam, Netherlands; [Allegranzi, Benedetta] WHO, Dept Integrated Hlth Serv, Infect Prevent & Control Tech & Clin Hub, Geneva, Switzerland; [Allegranzi, Benedetta] Univ Geneva, Inst Global Hlth, Geneva, Switzerland; [Mehtar, Shaheen] Infect Control Africa Network, Cape Town, South Africa	Radboud University Nijmegen; Doctors Without Borders; World Health Organization; University of Geneva	Hopman, J (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Radboudumc Ctr Infect Dis, Grootepl 10,Postbus 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hopman@radboudumc.nl						[Anonymous], MIN REQ INF PREV CON; Gates B, 2020, NEW ENGL J MED, V382, P1677, DOI 10.1056/NEJMp2003762; Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1; Kayali M, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0191-3; Nkengasong JN, 2020, LANCET, V395, P841, DOI 10.1016/S0140-6736(20)30464-5; Roberts B, 2012, B WORLD HEALTH ORGAN, V90, P2, DOI 10.2471/BLT.11.098863; Touray S, 2018, J CRIT CARE, V47, P245, DOI 10.1016/j.jcrc.2018.07.022; WHO, 2019, REP WHO CHIN JOINT M; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xie JF, 2020, INTENS CARE MED, V46, P1863, DOI 10.1007/s00134-020-06211-2	10	265	275	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2020	323	16					1549	1550		10.1001/jama.2020.4169	http://dx.doi.org/10.1001/jama.2020.4169			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LL2GR	32176764	Bronze			2022-12-28	WOS:000531373700014
J	Zhang, LL; Lin, DZ; Sun, XYY; Curth, U; Drosten, C; Sauerhering, L; Becker, S; Rox, K; Hilgenfeld, R				Zhang, Linlin; Lin, Daizong; Sun, Xinyuanyuan; Curth, Ute; Drosten, Christian; Sauerhering, Lucie; Becker, Stephan; Rox, Katharina; Hilgenfeld, Rolf			Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors	SCIENCE			English	Article							3C PROTEASE; M-PRO; SARS; CORONAVIRUS; ULTRACENTRIFUGATION; BINDING; DIMER	The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is a global health emergency. An attractive drug target among coronaviruses is the main protease (M-pro, also called 3CL(pro)) because of its essential role in processing the polyproteins that are translated from the viral RNA. We report the x-ray structures of the unliganded SARS-CoV-2 M-pro and its complex with an alpha-ketoamide inhibitor. This was derived from a previously designed inhibitor but with the P3-P2 amide bond incorporated into a pyridone ring to enhance the half-life of the compound in plasma. On the basis of the unliganded structure, we developed the lead compound into a potent inhibitor of the SARS-CoV-2 Mpro. The pharmacokinetic characterization of the optimized inhibitor reveals a pronounced lung tropism and suitability for administration by the inhalative route.	[Zhang, Linlin; Lin, Daizong; Sun, Xinyuanyuan; Hilgenfeld, Rolf] Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, D-23562 Lubeck, Germany; [Zhang, Linlin; Sun, Xinyuanyuan; Hilgenfeld, Rolf] Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, D-23562 Lubeck, Germany; [Lin, Daizong] Changchun Discovery Sci Ltd, 789 Shunda Rd, Changchun 130012, Jilin, Peoples R China; [Curth, Ute] Hannover Med Sch, Inst Biophys Chem, D-30625 Hannover, Germany; [Drosten, Christian] Charite Univ Med Berlin, Inst Virol, D-10117 Berlin, Germany; [Sauerhering, Lucie; Becker, Stephan] Univ Marburg, Inst Virol, D-35043 Marburg, Germany; [Sauerhering, Lucie; Becker, Stephan] Univ Marburg, German Ctr Infect Res DZIF, Marburg Giessen Langen Site, D-35043 Marburg, Germany; [Rox, Katharina] Helmholtz Ctr Infect Res HZI, Dept Chem Biol, D-38124 Braunschweig, Germany; [Rox, Katharina] Helmholtz Ctr Infect Res, German Ctr Infect Res DZIF, Hannover Braunschweig Site, D-38124 Braunschweig, Germany	University of Lubeck; German Center for Infection Research; University of Lubeck; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Philipps University Marburg; German Center for Infection Research; Philipps University Marburg; Helmholtz Association; Helmholtz-Center for Infection Research; German Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research	Hilgenfeld, R (corresponding author), Univ Lubeck, Inst Biochem, Ctr Struct & Cell Biol Med, D-23562 Lubeck, Germany.; Hilgenfeld, R (corresponding author), Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, D-23562 Lubeck, Germany.	rolf.hilgenfeld@uni-luebeck.de		Hilgenfeld, Rolf/0000-0001-8850-2977; Rox, Katharina/0000-0002-8020-1384; Sun, Xinyuanyuan/0000-0002-2761-2862	German Center for Infection Research (DZIF) [TTU01, 8011801806, TTU09, 8004709710]	German Center for Infection Research (DZIF)	We thank the German Center for Infection Research (DZIF) for financial support (projects TTU01, grant 8011801806, and TTU09, grant 8004709710).	Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658; Anand K, 2002, EMBO J, V21, P3213, DOI 10.1093/emboj/cdf327; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Chen H, 2006, J BIOL CHEM, V281, P13894, DOI 10.1074/jbc.M510745200; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dragovich PS, 1999, BIOORGAN MED CHEM, V7, P589, DOI 10.1016/S0968-0896(99)00005-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hilgenfeld R, 2014, FEBS J, V281, P4085, DOI 10.1111/febs.12936; Hsu WC, 2005, J BIOL CHEM, V280, P22741, DOI 10.1074/jbc.M502556200; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kratochwil NA, 2002, BIOCHEM PHARMACOL, V64, P1355, DOI 10.1016/S0006-2952(02)01074-2; Krug M, 2012, J APPL CRYSTALLOGR, V45, P568, DOI 10.1107/S0021889812011715; Kusov Y, 2015, VIROLOGY, V484, P313, DOI 10.1016/j.virol.2015.06.016; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Lim LZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101941; Liu YY, 1999, ANAL BIOCHEM, V267, P331, DOI 10.1006/abio.1998.3014; Mueller U, 2012, J SYNCHROTRON RADIAT, V19, P442, DOI 10.1107/S0909049512006395; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shi JH, 2006, FEBS J, V273, P1035, DOI 10.1111/j.1742-4658.2006.05130.x; Tan JZ, 2013, J VIROL, V87, P4339, DOI 10.1128/JVI.01123-12; Tan JZ, 2005, J MOL BIOL, V354, P25, DOI 10.1016/j.jmb.2005.09.012; Tian QP, 2001, TETRAHEDRON LETT, V42, P6807, DOI 10.1016/S0040-4039(01)01416-2; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Weiss MS, 1997, J APPL CRYSTALLOGR, V30, P203, DOI 10.1107/S0021889897003907; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Xue XY, 2007, J MOL BIOL, V366, P965, DOI 10.1016/j.jmb.2006.11.073; Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100; Zhang L, 2020, MED CHEM RES, V29, P575, DOI 10.1007/s00044-020-02509-4; Zhang L, 2020, STRUCT CONCRETE, V21, P1612, DOI 10.1002/suco.201900550; Zhang LL, 2020, J MED CHEM, V63, P4562, DOI 10.1021/acs.jmedchem.9b01828; Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu L., 2012, CRYSTAL STRUCTURE SA; Zhu LL, 2011, ANTIVIR RES, V92, P204, DOI 10.1016/j.antiviral.2011.08.001	43	1648	1700	34	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2020	368	6489					409	+		10.1126/science.abb3405	http://dx.doi.org/10.1126/science.abb3405			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LH0XH	32198291	Green Published			2022-12-28	WOS:000528513300041
J	Vincent, JL; Sakr, Y; Singer, M; Martin-Loeches, I; Machado, FR; Marshall, JC; Finfer, S; Pelosi, P; Brazzi, L; Aditianingsih, D; Timsit, JF; Du, B; Wittebole, X; Maca, J; Kannan, S; Gorordo-Delsol, LA; De Waele, JJ; Mehta, Y; Bonten, MJM; Khanna, AK; Kollef, M; Human, M; Angus, DC				Vincent, Jean-Louis; Sakr, Yasser; Singer, Mervyn; Martin-Loeches, Ignacio; Machado, Flavia R.; Marshall, John C.; Finfer, Simon; Pelosi, Paolo; Brazzi, Luca; Aditianingsih, Dita; Timsit, Jean-Francois; Du, Bin; Wittebole, Xavier; Maca, Jan; Kannan, Santhana; Gorordo-Delsol, Luis A.; De Waele, Jan J.; Mehta, Yatin; Bonten, Marc J. M.; Khanna, Ashish K.; Kollef, Marin; Human, Mariesa; Angus, Derek C.			Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEPSIS; DEFINITIONS; MORTALITY; IMPACT; SCORE	Importance Infection is frequent among patients in the intensive care unit (ICU). Contemporary information about the types of infections, causative pathogens, and outcomes can aid the development of policies for prevention, diagnosis, treatment, and resource allocation and may assist in the design of interventional studies. Objective To provide information about the prevalence and outcomes of infection and the available resources in ICUs worldwide. Design, Setting, and Participants Observational 24-hour point prevalence study with longitudinal follow-up at 1150 centers in 88 countries. All adult patients (aged >= 18 years) treated at a participating ICU during a 24-hour period commencing at 08:00 on September 13, 2017, were included. The final follow-up date was November 13, 2017. Exposures Infection diagnosis and receipt of antibiotics. Main Outcomes and Measures Prevalence of infection and antibiotic exposure (cross-sectional design) and all-cause in-hospital mortality (longitudinal design). Results Among 15x202f;202 included patients (mean age, 61.1 years [SD, 17.3 years]; 9181 were men [60.4%]), infection data were available for 15x202f;165 (99.8%); 8135 (54%) had suspected or proven infection, including 1760 (22%) with ICU-acquired infection. A total of 10x202f;640 patients (70%) received at least 1 antibiotic. The proportion of patients with suspected or proven infection ranged from 43% (141/328) in Australasia to 60% (1892/3150) in Asia and the Middle East. Among the 8135 patients with suspected or proven infection, 5259 (65%) had at least 1 positive microbiological culture; gram-negative microorganisms were identified in 67% of these patients (n = 3540), gram-positive microorganisms in 37% (n = 1946), and fungal microorganisms in 16% (n = 864). The in-hospital mortality rate was 30% (2404/7936) in patients with suspected or proven infection. In a multilevel analysis, ICU-acquired infection was independently associated with higher risk of mortality compared with community-acquired infection (odds ratio [OR], 1.32 [95% CI, 1.10-1.60]; P = .003). Among antibiotic-resistant microorganisms, infection with vancomycin-resistant Enterococcus (OR, 2.41 [95% CI, 1.43-4.06]; P = .001), Klebsiella resistant to beta-lactam antibiotics, including third-generation cephalosporins and carbapenems (OR, 1.29 [95% CI, 1.02-1.63]; P = .03), or carbapenem-resistant Acinetobacter species (OR, 1.40 [95% CI, 1.08-1.81]; P = .01) was independently associated with a higher risk of death vs infection with another microorganism. Conclusions and Relevance In a worldwide sample of patients admitted to ICUs in September 2017, the prevalence of suspected or proven infection was high, with a substantial risk of in-hospital mortality. This study characterizes the point prevalence and outcomes of infection among adult patients treated at international intensive care units during a 24-hour period. Question What was the prevalence of infection and the hospital mortality rate in intensive care units (ICUs) worldwide in 2017? Findings In a 24-hour point prevalence study conducted at 1150 centers in 88 countries on September 13, 2017, 54% of patients in the ICU had suspected or proven infection; 70% of all patients were receiving at least 1 antibiotic (prophylactic or therapeutic). Hospital mortality was 30% in patients with proven or suspected infection. Meaning Among a worldwide sample of patients in ICUs in 2017, the prevalence of suspected or proven infection was 54%.	[Vincent, Jean-Louis] Univ Libre Bruxelles, Erasme Univ Hosp, Dept Intens Care, Brussels, Belgium; [Sakr, Yasser] Uniklinikum Jena, Dept Anesthesiol & Intens Care, Jena, Germany; [Singer, Mervyn] UCL, Bloomsbury Inst Intens Care Med, London, England; [Martin-Loeches, Ignacio] St James Hosp, Multidisciplinary Intens Care Res Org, Dept Intens Care Med, Dublin, Ireland; [Martin-Loeches, Ignacio] Univ Barcelona, Hosp Clin, IDIBAPS, CIBERES, Barcelona, Spain; [Machado, Flavia R.] Univ Fed Sao Paulo, Dept Intens Care, Sao Paulo, Brazil; [Marshall, John C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Finfer, Simon] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Pelosi, Paolo] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Pelosi, Paolo] IRCCS Oncol & Neurosci, San Martino Policlin Hosp, Anesthesia & Intens Care, Genoa, Italy; [Brazzi, Luca] Univ Turin, Dept Surg Sci, Univ Hosp Citta Salute & Sci, Turin, Italy; [Aditianingsih, Dita] Univ Indonesia, Cipto Mangunkusumo Hosp, Dept Anesthesia & Intens Care, Fac Med, Jakarta, Indonesia; [Timsit, Jean-Francois] Bichat Claude Bernard Univ Hosp, Med & Infect Dis ICU, AP HP, Paris, France; [Du, Bin] Peking Union Med Coll Hosp, Med ICU, Beijing, Peoples R China; [Wittebole, Xavier] UCL, Clin Univ St Luc, Crit Care Dept, Brussels, Belgium; [Maca, Jan] Univ Hosp Ostrava, Dept Anesthesiol & Intens Care Med, Ostrava, Czech Republic; [Kannan, Santhana] SWBH Trust, Dept Anaesthesia & Crit Care, Birmingham, W Midlands, England; [Gorordo-Delsol, Luis A.] Hosp Juarez Mexico, Unidad Cuidados Intens Adultos, Mexico City, DF, Mexico; [De Waele, Jan J.] Ghent Univ Hosp, Dept Crit Care Med, Ghent, Belgium; [Mehta, Yatin] Medanta, Medanta Inst Crit Care & Anesthesiol, Gurugram, India; [Bonten, Marc J. M.] Univ Utrecht, Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [Khanna, Ashish K.] Wake Forest Univ, Sch Med, Dept Anesthesiol, Sect Crit Care Med,Wake Forest Baptist Med Ctr, Winston Salem, NC 27101 USA; [Khanna, Ashish K.] Outcomes Res Consortium, Cleveland, OH USA; [Kollef, Marin] Washington Univ, Sch Med, Div Pulm & Crit Care Med, St Louis, MO USA; [Human, Mariesa] Netcare Union Clinton Hosp, Level 1 Trauma Ctr, Alberton, South Africa; [Angus, Derek C.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA	Universite Libre de Bruxelles; University of London; University College London; Trinity College Dublin; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universidade Federal de Sao Paulo (UNIFESP); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Genoa; A.O.U. Citta della Salute e della Scienza di Torino; University of Turin; University of Indonesia; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University Hospital Ostrava; Ghent University; Ghent University Hospital; Utrecht University; Utrecht University Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vincent, JL (corresponding author), Erasme Univ Hosp, Dept Intens Care, Route Lennik 808, B-1070 Brussels, Belgium.	jlvincent@intensive.org	Man, May/ABC-4840-2020; Arslantas, Reyhan/AAG-3175-2020; Gorordo, Luis/AAP-7757-2020; De Waele, Jan J/E-2704-2013; Valeanu, Liana/AAM-3543-2020; Brazzi, Luca/AAS-4978-2020; Wittebole, Xavier/ABC-2036-2021; Singer, Mervyn/J-4425-2012; martin-loeches, Prof. Ignacio/Q-6645-2018	Man, May/0000-0001-5832-4786; Arslantas, Reyhan/0000-0001-5597-9242; Gorordo, Luis/0000-0001-7708-5813; De Waele, Jan J/0000-0003-1017-9748; Valeanu, Liana/0000-0001-7530-2781; Brazzi, Luca/0000-0001-7059-0622; Wittebole, Xavier/0000-0002-0621-8727; Rea-Neto, Alvaro/0000-0001-5524-0907; Singer, Mervyn/0000-0002-1042-6350; Finfer, Simon/0000-0002-2785-5864; Casas Rodriguez, Javier/0000-0002-2210-0091; martin-loeches, Prof. Ignacio/0000-0002-5834-4063				Asim Priyendu, 2016, Perspect Clin Res, V7, P28, DOI 10.4103/2229-3485.173778; Baykara N, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2013-1; Calandra T, 2005, CRIT CARE MED, V33, P1538, DOI 10.1097/01.CCM.0000168253.91200.83; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fisman D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0114548, 10.1371/currents.outbreaks.89c0d3783f36958d96ebbae97348d571]; Jang TN, 2009, J HOSP INFECT, V73, P143, DOI 10.1016/j.jhin.2009.06.007; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Rudd KE, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2157-z; Sakr Y, 2015, CRIT CARE MED, V43, P519, DOI 10.1097/CCM.0000000000000754; SepNet Critical Care Trials Grp, 2016, INTENS CARE MED, V42, P1980, DOI 10.1007/s00134-016-4504-3; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sunenshine RH, 2007, EMERG INFECT DIS, V13, P97, DOI 10.3201/eid1301.060716; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]; The World Bank, GNI PER CAP ATL METH; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Zhou JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107181	20	173	178	5	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1478	1487		10.1001/jama.2020.2717	http://dx.doi.org/10.1001/jama.2020.2717			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32207816	Bronze, Green Published			2022-12-28	WOS:000529969700018
J	Russell, OM; Gorman, GS; Lightowlers, RN; Turnbull, DM				Russell, Oliver M.; Gorman, Grainne S.; Lightowlers, Robert N.; Turnbull, Doug M.			Mitochondrial Diseases: Hope for the Future	CELL			English	Review							ACTIVATED PROTEIN-KINASE; GENE-THERAPY; MOUSE MODEL; SELECTIVE ELIMINATION; ALLOTOPIC EXPRESSION; NAD(+) METABOLISM; DNA HETEROPLASMY; MTDNA MUTATION; NUCLEAR; MYOPATHY	Mitochondrial diseases are clinically heterogeneous disorders caused by a wide spectrum of mutations in genes encoded by either the nuclear or the mitochondrial genome. Treatments for mitochondrial diseases are currently focused on symptomatic management rather than improving the biochemical defect caused by a particular mutation. This review focuses on the latest advances in the development of treatments for mitochondrial disease, both small molecules and gene therapies, as well as methods to prevent transmission of mitochondrial disease through the germline.	[Russell, Oliver M.; Gorman, Grainne S.; Lightowlers, Robert N.; Turnbull, Doug M.] Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Russell, Oliver M.; Gorman, Grainne S.; Turnbull, Doug M.] Newcastle Univ, Fac Med Sci, Clin & Translat Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Gorman, Grainne S.] NuTH NHS Fdn Trust, NIHR Newcastle BRC, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Lightowlers, Robert N.] Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; Newcastle University - UK	Lightowlers, RN; Turnbull, DM (corresponding author), Newcastle Univ, Fac Med Sci, Wellcome Ctr Mitochondrial Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Turnbull, DM (corresponding author), Newcastle Univ, Fac Med Sci, Clin & Translat Res Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.; Lightowlers, RN (corresponding author), Newcastle Univ, Fac Med Sci, Biosci Inst, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	robert.lightowlers@newcastle.ac.uk; doug.turnbull@newcastle.ac.uk		Russell, Oliver/0000-0002-9414-9193	Wellcome Centre for Mitochondrial Research [203105/Z/16/Z]; MRC Centre for Ageing and Vitality [MR/L016354/1]; MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort [G0800674]; EU Marie Sklodowska-Curie ITN [721757]; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; Lily Foundation; UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children'' Service; MRC [MR/L016354/1, G0800674] Funding Source: UKRI	Wellcome Centre for Mitochondrial Research; MRC Centre for Ageing and Vitality(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU Marie Sklodowska-Curie ITN; UK NIHR Biomedical Research Centre in Age and Age Related Diseases; Lily Foundation; UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children'' Service; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by Wellcome Centre for Mitochondrial Research (203105/Z/16/Z); MRC Centre for Ageing and Vitality (MR/L016354/1); MRC Centre for Translational Research in Neuromuscular Disease Mitochondrial Disease Patient Cohort (G0800674); the EU Marie Sklodowska-Curie ITN (721757); the UK NIHR Biomedical Research Centre in Age and Age Related Diseases award to the Newcastle upon Tyne Hospitals NHS Foundation Trust; The Lily Foundation; and the UK NHS Specialist Commissioners "Rare Mitochondrial Disorders of Adults and Children'' Service.	Alexeyev MF, 2008, GENE THER, V15, P516, DOI [10.1038/gt.2008.11, 10.1038/sj.gt.2008.11]; Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4; Augustine EF, 2013, J CHILD NEUROL, V28, P1142, DOI 10.1177/0883073813495959; Avula S, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0292-7; Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8; Barrow JJ, 2016, MOL CELL, V64, P163, DOI 10.1016/j.molcel.2016.08.023; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bax BE, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081096; Besouw M, 2013, DRUG DISCOV TODAY, V18, P785, DOI 10.1016/j.drudis.2013.02.003; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Cejudo P, 2005, MUSCLE NERVE, V32, P342, DOI 10.1002/mus.20368; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chatfield KC, 2019, JACC-BASIC TRANSL SC, V4, P147, DOI 10.1016/j.jacbts.2018.12.005; Chinnery PF, 1999, GENE THER, V6, P1919, DOI 10.1038/sj.gt.3301061; Civiletto G, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708799; Colella M, 2018, ACS APPL MATER INTER, V10, P40001, DOI 10.1021/acsami.8b15942; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Desai S, 2018, EXP BIOL MED, V243, P554, DOI 10.1177/1535370217752351; Dillon LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044335; Dillon LM, 2012, HUM MOL GENET, V21, P2288, DOI 10.1093/hmg/dds049; Dinkova-Kostova AT, 2015, FREE RADICAL BIO MED, V88, P179, DOI 10.1016/j.freeradbiomed.2015.04.036; Dominguez-Gonzalez C, 2019, ANN NEUROL, V86, P293, DOI 10.1002/ana.25506; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Ehinger JK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12317; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Ellouze S, 2008, AM J HUM GENET, V83, P373, DOI 10.1016/j.ajhg.2008.08.013; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Ferrari M, 2017, P NATL ACAD SCI USA, V114, pE4241, DOI 10.1073/pnas.1621511114; Field M. J., 2010, RARE DIS ORPHAN PROD; Fightaging, 2019, MOR SER TRIAL FAIL G; Frazier AE, 2019, J BIOL CHEM, V294, P5386, DOI 10.1074/jbc.R117.809194; Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9; Gammage PA, 2018, TRENDS GENET, V34, P101, DOI 10.1016/j.tig.2017.11.001; Garone C, 2018, BIOCHEM SOC T, V46, P1247, DOI 10.1042/BST20180134; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Gerards M, 2011, BRAIN, V134, P210, DOI 10.1093/brain/awq273; Golubitzky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026883; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gorman GS, 2018, LANCET, V392, P1191, DOI 10.1016/S0140-6736(18)31868-3; Gorman GS, 2016, NAT REV DIS PRIMERS, V2, P1, DOI 10.1038/nrdp.2016.80; Gorman GS, 2015, ANN NEUROL, V77, P753, DOI 10.1002/ana.24362; Greenfield A, 2017, NAT BIOTECHNOL, V35, P1059, DOI 10.1038/nbt.3997; Guy J, 2017, OPHTHALMOLOGY, V124, P1621, DOI 10.1016/j.ophtha.2017.05.016; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hashimoto M, 2015, MOL THER, V23, P1592, DOI 10.1038/mt.2015.126; Hellebrekers DMEI, 2012, HUM REPROD UPDATE, V18, P341, DOI 10.1093/humupd/dms008; Hirano M, 2012, BBA-GEN SUBJECTS, V1820, P625, DOI 10.1016/j.bbagen.2012.01.006; Hudry E, 2019, NEURON, V101, P839, DOI 10.1016/j.neuron.2019.02.017; Hyslop LA, 2016, NATURE, V534, P383, DOI [10.1038/nature18303, 10.1038/nature183030]; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jain IH, 2019, CELL METAB, V30, P824, DOI 10.1016/j.cmet.2019.07.006; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Jeppesen TD, 2006, BRAIN, V129, P3402, DOI 10.1093/brain/awl149; Johnson SC, 2016, ONCOTARGET, V7, P44876, DOI 10.18632/oncotarget.10381; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Kandul NP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13100; Katsyuba E, 2018, NATURE, V563, P354, DOI 10.1038/s41586-018-0645-6; Katsyuba E, 2017, EMBO J, V36, P2670, DOI 10.15252/embj.201797135; Kauppila JHK, 2016, CELL REP, V16, P2980, DOI 10.1016/j.celrep.2016.08.037; Khan NA, 2017, CELL METAB, V26, P419, DOI 10.1016/j.cmet.2017.07.007; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Klopstock T, 2013, BRAIN, V136, DOI 10.1093/brain/aws279; Klopstock T, 2011, BRAIN, V134, P2677, DOI 10.1093/brain/awr170; Koene S, 2018, J INHERIT METAB DIS, V41, P1267, DOI 10.1007/s10545-018-0229-5; Lake NJ, 2016, ANN NEUROL, V79, P190, DOI 10.1002/ana.24551; Latorre-Pellicer A, 2016, NATURE, V535, P561, DOI 10.1038/nature18618; Lee CF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39419-4; Lott Marie T, 2013, CURRENT PROTOCOLS BI; Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270; Madsen KL, 2020, NEUROLOGY, V94, pE687, DOI 10.1212/WNL.0000000000008861; MCGRATH J, 1983, J EXP ZOOL, V228, P355, DOI 10.1002/jez.1402280218; McWilliams TG, 2018, CELL METAB, V27, P439, DOI 10.1016/j.cmet.2017.12.008; Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2018, NAT REV DRUG DISCOV, V17, P865, DOI 10.1038/nrd.2018.174; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Newman Jane, 2015, J Neuromuscul Dis, V2, P151; Ng Yi Shiau, 2019, Wellcome Open Res, V4, P201, DOI 10.12688/wellcomeopenres.15599.1; Noe N, 2013, MITOCHONDRION, V13, P417, DOI 10.1016/j.mito.2012.12.003; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Parikh S, 2019, NEUROMUSCULAR DISORD, V29, P895, DOI 10.1016/j.nmd.2019.09.012; Patgiri A, 2020, NAT BIOTECHNOL, V38, P309, DOI 10.1038/s41587-019-0377-7; Perales-Clemente E, 2011, NUCLEIC ACIDS RES, V39, P225, DOI 10.1093/nar/gkq769; Piantadosi CA, 2008, CIRC RES, V103, P1232, DOI 10.1161/01.RES.0000338597.71702.ad; Pickett SJ, 2019, NEW ENGL J MED, V380, P1971, DOI 10.1056/NEJMc1808565; Pickett SJ, 2018, ANN CLIN TRANSL NEUR, V5, P333, DOI 10.1002/acn3.532; Poulton J, 2019, NEUROMUSCULAR DISORD, V29, P725, DOI 10.1016/j.nmd.2019.08.004; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Reddy P, 2015, CELL, V161, P459, DOI 10.1016/j.cell.2015.03.051; Repp BM, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0784-8; Robinson BH, 2006, MOL GENET METAB, V89, P3, DOI 10.1016/j.ymgme.2006.05.015; Robledinos-Anton N, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9372182; Rudolph G, 2013, J NEURO-OPHTHALMOL, V33, P30, DOI 10.1097/WNO.0b013e318272c643; Ryan E, 2006, Ir Med J, V99, P262; Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132; Saada A, 2019, EBIOMEDICINE, V47, P14, DOI 10.1016/j.ebiom.2019.08.005; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schober P, 2018, ANESTH ANALG, V126, P1068, DOI 10.1213/ANE.0000000000002798; Skladal D, 2003, BRAIN, V126, P1905, DOI 10.1093/brain/awg170; Srivastava S, 2001, HUM MOL GENET, V10, P3093, DOI 10.1093/hmg/10.26.3093; Steffann J, 2007, J MED GENET, V44, P664, DOI 10.1136/jmg.2006.048553; Steffann J, 2018, CELL STEM CELL, V22, P481, DOI 10.1016/j.stem.2018.01.004; Stewart JB, 2015, NAT REV GENET, V16, P530, DOI 10.1038/nrg3966; Suen DF, 2010, P NATL ACAD SCI USA, V107, P11835, DOI 10.1073/pnas.0914569107; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Tachibana M, 2013, NATURE, V493, P627, DOI 10.1038/nature11647; Tachibana M, 2009, NATURE, V461, P367, DOI 10.1038/nature08368; Tanaka M, 2002, J BIOMED SCI, V9, P534, DOI 10.1007/BF02254980; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; Taylor RW, 1997, NAT GENET, V15, P212, DOI 10.1038/ng0297-212; Taylor RW, 2001, ADV DRUG DELIVER REV, V49, P121, DOI 10.1016/S0169-409X(01)00130-2; Thompson K, 2020, J INHERIT METAB DIS, V43, P36, DOI 10.1002/jimd.12104; To TL, 2019, CELL, V179, P1222, DOI 10.1016/j.cell.2019.10.032; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valenci I, 2015, MITOCHONDRION, V20, P64, DOI 10.1016/j.mito.2014.11.001; van de Weijer T, 2015, DIABETES, V64, P1193, DOI 10.2337/db14-0667; Viscomi C, 2011, CELL METAB, V14, P80, DOI 10.1016/j.cmet.2011.04.011; Wenz T, 2016, CELL METAB, V24, P889, DOI 10.1016/j.cmet.2016.11.006; Wenz T, 2016, P NATL ACAD SCI USA, V113, pE8502, DOI 10.1073/pnas.1619713114; Whitaker RM, 2016, ANNU REV PHARMACOL, V56, P229, DOI 10.1146/annurev-pharmtox-010715-103155; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wredenberg A, 2002, P NATL ACAD SCI USA, V99, P15066, DOI 10.1073/pnas.232591499; Yang S, 2016, EBIOMEDICINE, V10, P258, DOI 10.1016/j.ebiom.2016.07.002; Yang Y, 2018, PROTEIN CELL, V9, P283, DOI 10.1007/s13238-017-0499-y; Yatsuga S, 2012, HUM MOL GENET, V21, P526, DOI 10.1093/hmg/ddr482; Zhang J, 2017, REPROD BIOMED ONLINE, V34, P361, DOI 10.1016/j.rbmo.2017.01.013; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	131	123	127	14	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2020	181	1					168	188		10.1016/j.cell.2020.02.051	http://dx.doi.org/10.1016/j.cell.2020.02.051			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KZ5RI	32220313	Bronze			2022-12-28	WOS:000523319000020
J	Dyer, C				Dyer, Clare			Shortcomings in cardiac unit at St George's hospital linked to 67 deaths	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		DYER C, 2019, BMJ-BRIT MED J, V364, DOI DOI 10.1136/BMJ.L423; NHS England, 2020, IND MORT REV CARD SU	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1281	10.1136/bmj.m1281	http://dx.doi.org/10.1136/bmj.m1281			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220897				2022-12-28	WOS:000523765200017
J	Harvey, A				Harvey, Anna			Covid-19: medical students should not work outside their competency, says BMA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, COV 19 MED STUD REQ; GMC, INF MED STUD; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1156	3	8	8	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1197	10.1136/bmj.m1197	http://dx.doi.org/10.1136/bmj.m1197			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209588	Bronze			2022-12-28	WOS:000523764200010
J	Kuehn, BM				Kuehn, Bridget M.			Adults Are Making It Easier for Children to Ingest Dangerous Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1125	1125		10.1001/jama.2020.2406	http://dx.doi.org/10.1001/jama.2020.2406			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207809				2022-12-28	WOS:000530807000008
J	Tanne, JH				Tanne, Janice Hopkins			Covid-19: cases grow in US as Trump pushes promise of a malaria drug	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Faturechi R, 2020, PROPUBLICA      0319; Griggs C., 2020, NY TIMES; Johns Hopkins Center for Systems Engineering and Science, 2020, COVID 19 CAS; Liptak K, 2020, TRUMP SAYS FDA WILL; Mak Tim, 2020, NPR             0319; Sanger DE, 2020, NEW YORK TIMES	6	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2020	368								m1155	10.1136/bmj.m1155	http://dx.doi.org/10.1136/bmj.m1155			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DO	32198179	Bronze			2022-12-28	WOS:000523763600012
J	Hurley, R				Hurley, Richard			MEDICAL CANNABIS Industry's plan to accelerate prescribing of medical cannabis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hurley, Richard] BMJ, London, England		Hurley, R (corresponding author), BMJ, London, England.	rhurley@bmj.com						[Anonymous], 2019, EUR CANN REP; Conservative Drug Policy Reform Group, SUPP CO; Couch D., 2019, LEFT SCALE ILLEGAL C	3	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m1063	10.1136/bmj.m1063	http://dx.doi.org/10.1136/bmj.m1063			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188588				2022-12-28	WOS:000523763100009
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Why force GP streaming on NHS emergency departments?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Cooper A, 2019, EMERG MED J, V36, P625, DOI 10.1136/emermed-2018-208305; Cowling TE, 2014, J ROY SOC MED, V107, P432, DOI 10.1177/0141076814542669; Full Fact, 2017, AR PAT GOING A E INS; National Health Executive, 2017, INT STREAM SERV BE I; National Institute for Health and Care Excellence, 2018, MIN INJ UN URG CAR C; NHS Improvement, 7 DAY URG CAR GP CTR; Philip P., 2019, BLOG WHAT DOES LONG; Ramlakhan S, 2016, EMERG MED J, V33, P495, DOI 10.1136/emermed-2015-204900	8	2	2	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m992	10.1136/bmj.m992	http://dx.doi.org/10.1136/bmj.m992			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188596	Bronze			2022-12-28	WOS:000523763100006
J	Martinengo, L; Spinazze, P; Car, J				Martinengo, Laura; Spinazze, Pier; Car, Josip			Mobile messaging with patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TEXT; HEALTH; INTERVENTIONS; REMINDERS; TRIAL		[Martinengo, Laura; Spinazze, Pier; Car, Josip] Nanyang Technol Univ, Lee Kong Chian Sch Med, Ctr Populat Hlth Sci CePHaS, Singapore, Singapore; [Spinazze, Pier] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, Global Digital Hlth Unit, London, England	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Imperial College London	Car, J (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Ctr Populat Hlth Sci CePHaS, Singapore, Singapore.	josip.car@ntu.edu.sg	Martinengo, Laura/AAY-8201-2020; Spinazze, Pier/AAP-6924-2020; Car, Josip/H-6755-2015	Martinengo, Laura/0000-0003-3539-7207; Spinazze, Pier/0000-0002-1416-0174; Car, Josip/0000-0001-8969-371X				Abroms LC, 2014, AM J PREV MED, V47, P242, DOI 10.1016/j.amepre.2014.04.010; Akdeniz Y., 1997, UK GOVT POLICY ENCRY, DOI [10.2139/ssrn.41701, DOI 10.2139/SSRN.41701]; Armanasco AA, 2017, AM J PREV MED, V52, P391, DOI 10.1016/j.amepre.2016.10.042; Cello Health Insight, 2015, DIG HLTH DEB REP DOC; De Grood C, 2016, J MULTIDISCIP HEALTH, V9, DOI 10.2147/JMDH.S103881; Dobson R, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1959; European Commission, 2018, DAT PROT; Free C, 2011, LANCET, V378, P49, DOI 10.1016/S0140-6736(11)60701-0; Gagnon MP, 2016, J AM MED INFORM ASSN, V23, P212, DOI 10.1093/jamia/ocv052; Giardina TD, 2015, PATIENT EDUC COUNS, V98, P788, DOI 10.1016/j.pec.2015.02.011; Ramon EXG, 2017, DILEMAS CONTEMP-EDUC, V5; Gurol-Urganci I, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007458.pub3; Hall AK, 2015, ANNU REV PUBL HEALTH, V36, P393, DOI 10.1146/annurev-publhealth-031914-122855; Haun Jolie N, 2015, J Med Internet Res, V17, pe282, DOI 10.2196/jmir.5152; IBM X-Force Research, 2016, REV YEAR SER DAT BRE; Information Governance Alliance, 2018, GEN DAT PROT REG GUI; International Telecommunications Union (ITU), 2018, ITU REL 2018 GLOB RE; Kang XY, 2016, CLIN GASTROENTEROL H, V14, P429, DOI 10.1016/j.cgh.2015.09.038; Kerrison RS, 2015, BRIT J CANCER, V112, P1005, DOI 10.1038/bjc.2015.36; Leahy D, 2017, BRIT J GEN PRACT, V67, pE744, DOI 10.3399/bjgp17X693065; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Lyles C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001852; Mbuagbaw L, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0654-6; Moghaddasi Hamid, 2016, Open Med Inform J, V10, P4; Newport F., 2014, NEW ERA COMMUNICATIO; Patel Suha J, 2018, Mhealth, V4, P14, DOI 10.21037/mhealth.2018.04.05; Pew Research Center, 2018, DEM MOB DEV OWN AD U; Pillemer F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154743; Poorman E, 2015, MATERN CHILD HLTH J, V19, P969, DOI 10.1007/s10995-014-1595-8; Prater VS, 2014, BIOMEDICAL HLTH INFO; Quinlan D, 2018, Ir Med J, V111, P729; Ramachandran A, 2013, LANCET DIABETES ENDO, V1, P191, DOI 10.1016/S2213-8587(13)70067-6; Robotham D, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012116; Rohman L, 2015, J TELEMED TELECARE, V21, P408, DOI 10.1177/1357633X15583778; Sarkar U, 2010, J HEALTH COMMUN, V15, P183, DOI 10.1080/10810730.2010.499988; Stockwell MS, 2012, JAMA-J AM MED ASSOC, V307, P1702, DOI 10.1001/jama.2012.502; Thakkar J, 2016, JAMA INTERN MED, V176, P340, DOI 10.1001/jamainternmed.2015.7667; US Department of Health & Human Services, 2019, HLTH INF PRIV; West D., 2012, ISSUES TECHNOLOGY IN; Wilson E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002479; Yasmin F, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0286-3; Yusufovna Feruza Sattarova, 2011, [Asia-pacific Journal of Multimedia Services Convergent with Art, Humanities, and Sociology, 예술인문사회 융합 멀티미디어 논문지], V1, P91, DOI 10.14257/AJMAHS.2011.12.06; Zallman L, 2017, INFORM HEALTH SOC CA, V42, P32, DOI 10.3109/17538157.2015.1113177	43	11	11	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m884	10.1136/bmj.m884	http://dx.doi.org/10.1136/bmj.m884			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LA2CT	32179548				2022-12-28	WOS:000523761500002
J	Rimmer, A				Rimmer, Abi			Covid-19: junior doctor calls on colleagues to gather supplies for staff working long hours	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Banfield P, 2020, TWITTER; BMA Scotland, 2019, BMA SCOTL CAR YOU TH; Cheetham J, 2020, TWITTER; Muirhead LJ, 2020, TWITTER; Peel L, 2020, TWITTER; Shircliff E, 2020, TWITTER	6	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m1072	10.1136/bmj.m1072	http://dx.doi.org/10.1136/bmj.m1072			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2CT	32179508	Bronze			2022-12-28	WOS:000523761500009
J	Dyer, C				Dyer, Clare			Cardiologist is awarded 870 pound 000 after he was sacked for raising safety concerns	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dr Kevin Beatt v Croydon Health Services NHS Trust, 2017, EWCA CIV 401	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m1061	10.1136/bmj.m1061	http://dx.doi.org/10.1136/bmj.m1061			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32169838				2022-12-28	WOS:000520014600012
J	Erler, JT; Bennewith, KL; Nicolau, M; Dornhofer, N; Kong, CT; Le, QT; Chi, JTA; Jeffrey, SS; Giaccia, AJ				Erler, Janine T.; Bennewith, Kevin L.; Nicolau, Monica; Dornhofer, Nadja; Kong, Christina; Le, Quynh-Thu; Chi, Jen-Tsan Ashley; Jeffrey, Stefanie S.; Giaccia, Amato J.			RETRACTION: Lysyl oxidase is essential for hypoxia-induced metastasis (Retraction of Vol 440, Pg 1222, 2006)	NATURE			English	Retraction								A Retraction to this paper has been published and can be accessed via a link at the top of the paper.				giaccia@stanford.edu		Le, Quynh Thu/0000-0002-3682-1439				Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695	1	0	0	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					456	456		10.1038/s41586-020-2112-4	http://dx.doi.org/10.1038/s41586-020-2112-4			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188947	Bronze			2022-12-28	WOS:000520778000029
J	Woolston, C				Woolston, Chris			Australian junior scientists report damaging lack of support at work	NATURE			English	News Item																			0	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					457	458		10.1038/d41586-020-00687-0	http://dx.doi.org/10.1038/d41586-020-00687-0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU4SG	32173722				2022-12-28	WOS:000519699800003
J	McWhite, CD; Papoulas, O; Drew, K; Cox, RM; June, V; Dong, OX; Kwon, T; Wan, CH; Salmi, ML; Roux, SJ; Browning, KS; Chen, ZJ; Ronald, PC; Marcotte, EM				McWhite, Claire D.; Papoulas, Ophelia; Drew, Kevin; Cox, Rachael M.; June, Viviana; Dong, Oliver Xiaoou; Kwon, Taejoon; Wan, Cuihong; Salmi, Mari L.; Roux, Stanley J.; Browning, Karen S.; Chen, Z. Jeffrey; Ronald, Pamela C.; Marcotte, Edward M.			A Pan-plant Protein Complex Map Reveals Deep Conservation and Novel Assemblies	CELL			English	Article							SCALE GENE NETWORK; HUMAN INTERACTOME; ANION CHANNEL; GENOME; MULTIPLE; EVOLUTION; SIZE; TRANSCRIPTION; PURIFICATION; ASSOCIATION	Plants are foundational for global ecological and economic systems, but most plant proteins remain uncharacterized. Protein interaction networks often suggest protein functions and open new avenues to characterize genes and proteins. We therefore systematically determined protein complexes from 13 plant species of scientific and agricultural importance, greatly expanding the known repertoire of stable protein complexes in plants. By using co-fractionation mass spectrometry, we recovered known complexes, confirmed complexes predicted to occur in plants, and identified previously unknown interactions conserved over 1.1 billion years of green plant evolution. Several novel complexes are involved in vernalization and pathogen defense, traits critical for agriculture. We also observed plant analogs of animal complexes with distinct molecular assemblies, including a megadalton-scale tRNA multi-synthetase complex. The resulting map offers a cross-species view of conserved, stable protein assemblies shared across plant cells and provides a mechanistic, biochemical framework for interpreting plant genetics and mutant phenotypes.	[McWhite, Claire D.; Papoulas, Ophelia; Drew, Kevin; Cox, Rachael M.; June, Viviana; Wan, Cuihong; Salmi, Mari L.; Roux, Stanley J.; Browning, Karen S.; Chen, Z. Jeffrey; Marcotte, Edward M.] Univ Texas Austin, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Dong, Oliver Xiaoou; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Dong, Oliver Xiaoou; Ronald, Pamela C.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Dong, Oliver Xiaoou; Ronald, Pamela C.] Joint Bioenergy Inst, Emeryville, CA 94608 USA; [Kwon, Taejoon] UNIST, Sch Life Sci, Dept Biomed Engn, 50 UNIST Gil, Ulsan 44919, South Korea; [Wan, Cuihong] Cent China Normal Univ, Sch Life Sci, Hubei Key Lab Genet Regulat & Integrat Biol, 152 Luoyu Rd, Wuhan 430079, Peoples R China	University of Texas System; University of Texas Austin; University of California System; University of California Davis; University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Ulsan National Institute of Science & Technology (UNIST); Central China Normal University	Marcotte, EM (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu	Kwon, Taejoon/AAR-9814-2020; Kwon, Taejoon/S-3835-2016; Ronald, Pamela/AAK-7664-2020	Kwon, Taejoon/0000-0002-9794-6112; Drew, Kevin/0000-0002-1260-4413; June, Viviana/0000-0001-5519-4971; Marcotte, Edward/0000-0001-8808-180X	Welch Foundation [F-1515]; NSF [1237975]; Army Research Office [W911NF-12-1-0390]; NIH [GM123683, K99 HD092613, R01 GM109076, GM122968, R35 GM122480]; Office of Science, Office of Biological and Environmental Research of the US Department of Energy [DE-AC02-05CH11231]	Welch Foundation(The Welch Foundation); NSF(National Science Foundation (NSF)); Army Research Office; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research of the US Department of Energy(United States Department of Energy (DOE))	The authors thank Angel Syrett for plant illustrations; Ben Liebeskind for fern transcriptome and feature aid; Anna Battenhouse for data deposition aid; Claire Palmer for early orthology calculations; Hong Qiao, Alan Lloyd, and the University of Texas UTEX Culture Collection of Algae for plant and algal samples; Dan Boutz for mass-spectrometry aid; Riddhiman Garge and Momo Sae-Lee for coconut preparation; Andrew Emili for early discussions; and John Wallingford and Dannie Durand for feedback. Research was funded by grants from the Welch Foundation (F-1515 to E.M.M.); NSF (1237975 to P.C.R. and E.M.M.); Army Research Office (W911NF-12-1-0390); and NIH (GM123683 to C.D.M., K99 HD092613 to K.D., R01 GM109076 to Z.J.C., GM122968 to P.C.R., and R35 GM122480 to E.M.M.). The Joint BioEnergy Institute was supported by the Office of Science, Office of Biological and Environmental Research of the US Department of Energy under contract no. DE-AC02-05CH11231 between Lawrence Berkeley National Laboratory and the US Department of Energy.	Abdrakhmanova A, 2005, FEBS LETT, V579, P6781, DOI 10.1016/j.febslet.2005.11.008; Adamiec M, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2445-2; Ahn HK, 2019, J EXP BOT, V70, P2741, DOI 10.1093/jxb/erz099; Armero A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173300; Aryal UK, 2017, J PROTEOMICS, V166, P8, DOI 10.1016/j.jprot.2017.06.004; Babu CV S., 2014, AGILENT APPL NOTE SE; Baker MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14271; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; Bassel GW, 2012, PLANT CELL, V24, P3859, DOI 10.1105/tpc.112.100776; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Braun P, 2011, SCIENCE, V333, P601, DOI 10.1126/science.1203877; Browning K.S., 2006, CURR PROTOC MICROBIO; Browning Karen S, 2015, Arabidopsis Book, V13, pe0176, DOI 10.1199/tab.0176; Cestari I, 2013, MOL CELL BIOL, V33, P4872, DOI 10.1128/MCB.00711-13; CUTTER VM, 1952, SCIENCE, V115, P58, DOI 10.1126/science.115.2977.58; Dhawan R, 2009, PLANT CELL, V21, P1000, DOI 10.1105/tpc.108.062364; Dong SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005704; Drew K, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167490; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Fleurdepine S, 2007, NUCLEIC ACIDS RES, V35, P3306, DOI 10.1093/nar/gkm200; Fraser HB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r252; Gadeyne A, 2014, CELL, V156, P691, DOI 10.1016/j.cell.2014.01.039; Gan XC, 2011, NATURE, V477, P419, DOI 10.1038/nature10414; Gilbert M, 2019, J PROTEOME RES, V18, P107, DOI 10.1021/acs.jproteome.8b00382; Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hirano Y, 2005, NATURE, V437, P1381, DOI 10.1038/nature04106; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Jarvis DE, 2017, NATURE, V542, P307, DOI 10.1038/nature21370; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kan JH, 2018, MOL PLANT PATHOL, V19, P2011, DOI 10.1111/mpp.12677; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kirkwood KJ, 2013, MOL CELL PROTEOMICS, V12, P3851, DOI 10.1074/mcp.M113.032367; Klykov O, 2018, NAT PROTOC, V13, P2964, DOI 10.1038/s41596-018-0074-x; Koornneef M., 1981, ARABID INF SERV, V18, P45; Kriechbaumer V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20840-0; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kumar S, 2017, MOL BIOL EVOL, V34, P1812, DOI 10.1093/molbev/msx116; Kwon T, 2011, J PROTEOME RES, V10, P2949, DOI 10.1021/pr2002116; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Lahmy S, 2004, PLANT J, V39, P809, DOI 10.1111/j.1365-313X.2004.02166.x; Laporte D, 2014, FEBS LETT, V588, P4268, DOI 10.1016/j.febslet.2014.10.007; Lee I, 2011, P NATL ACAD SCI USA, V108, P18548, DOI 10.1073/pnas.1110384108; Lee I, 2010, NAT BIOTECHNOL, V28, P149, DOI 10.1038/nbt.1603; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Lintala M, 2014, MOL PLANT, V7, P45, DOI 10.1093/mp/sst129; Liu J, 2016, PLANT PHYSIOL, V171, P424, DOI 10.1104/pp.15.01335; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Lopez Y, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav117; Majeran W, 2008, MOL CELL PROTEOMICS, V7, P1609, DOI 10.1074/mcp.M800016-MCP200; Malovannaya A, 2011, CELL, V145, P787, DOI 10.1016/j.cell.2011.05.006; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marsh JA, 2015, ANNU REV BIOCHEM, V84, P551, DOI 10.1146/annurev-biochem-060614-034142; MATZKE AJM, 1992, FEBS LETT, V302, P81, DOI 10.1016/0014-5793(92)80290-W; McBride Z, 2019, MOL CELL PROTEOMICS, V18, P1588, DOI 10.1074/mcp.RA119.001400; McGary KL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r258; MONDAL H, 1972, EUR J BIOCHEM, V25, P463, DOI 10.1111/j.1432-1033.1972.tb01716.x; Mukaihara T, 2004, MOL MICROBIOL, V54, P863, DOI 10.1111/j.1365-2958.2004.04328.x; Niehaus TD, 2015, PLANT PHYSIOL, V169, P1436, DOI 10.1104/pp.15.00959; O'Malley RC, 2015, METHODS MOL BIOL, V1284, P323, DOI 10.1007/978-1-4939-2444-8_16; Oellrich A, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0053-y; Oliver S, 2000, NATURE, V403, P601, DOI 10.1038/35001165; Omura Y, 2009, BMB REP, V42, P232, DOI 10.5483/BMBRep.2009.42.4.232; Panchy N, 2014, G3-GENES GENOM GENET, V4, P2461, DOI 10.1534/g3.114.015032; Papatheodorou I, 2018, NUCLEIC ACIDS RES, V46, pD246, DOI 10.1093/nar/gkx1158; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prasad M, 2015, J BIOL CHEM, V290, P2604, DOI 10.1074/jbc.M114.605808; Pulido P, 2018, PLANT PHYSIOL, V177, P1539, DOI 10.1104/pp.18.00602; Rhee SY, 2014, TRENDS PLANT SCI, V19, P212, DOI 10.1016/j.tplants.2013.10.006; Rivosecchi J, 2019, EMBO J, V38, DOI 10.15252/embj.2019101955; Rohila JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006685; Salmi ML, 2008, PLANTA, V229, P151, DOI 10.1007/s00425-008-0817-y; Savary S, 2019, NAT ECOL EVOL, V3, P430, DOI 10.1038/s41559-018-0793-y; Schwikowski B, 2000, NAT BIOTECHNOL, V18, P1257, DOI 10.1038/82360; Shikanai T, 2016, BBA-BIOENERGETICS, V1857, P1015, DOI 10.1016/j.bbabio.2015.10.013; Strasser R, 2016, GLYCOBIOLOGY, V26, P926, DOI 10.1093/glycob/cww023; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Takabayashi A, 2017, PLANT CELL PHYSIOL, V58, DOI 10.1093/pcp/pcw219; Tateda C, 2011, J EXP BOT, V62, P4773, DOI 10.1093/jxb/err113; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; Van Leene J, 2008, TRENDS PLANT SCI, V13, P517, DOI 10.1016/j.tplants.2008.08.002; Van Leene J, 2011, TRENDS PLANT SCI, V16, P141, DOI 10.1016/j.tplants.2010.12.004; Van Leene J, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.53; Veerappa R, 2019, PLANT CELL ENVIRON, V42, P337, DOI 10.1111/pce.13425; Vercruyssen L, 2014, PLANT CELL, V26, P210, DOI 10.1105/tpc.113.115907; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walhout AJM, 2001, NAT REV MOL CELL BIO, V2, P55, DOI 10.1038/35048107; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Weiss M, 2010, PROTEOMICS, V10, P1297, DOI 10.1002/pmic.200900414; Wu Z, 2016, PLANT CELL, V28, P55, DOI 10.1105/tpc.15.00949; Zhang YX, 2010, CURR GENOMICS, V11, P40, DOI 10.2174/138920210790218016	104	74	74	15	104	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 16	2020	181	2					460	+		10.1016/j.cell.2020.02.049	http://dx.doi.org/10.1016/j.cell.2020.02.049			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	LD7BL	32191846	Green Submitted, Bronze, Green Accepted			2022-12-28	WOS:000526184900023
J	Doherty, JU				Doherty, John U.			Combined Antiplatelet and Anticoagulant Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Navigating Between Scylla and Charybdis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANTITHROMBOTIC THERAPY		[Doherty, John U.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Philadelphia, PA 19107 USA	Jefferson University	Doherty, JU (corresponding author), Jefferson Heart Inst, 925 Chestnut St, Philadelphia, PA 19107 USA.	john.doherty@jefferson.edu						Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Gargiulo G, 2019, EUR HEART J, V40, P3757, DOI 10.1093/eurheartj/ehz732; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Hucker WJ, 2019, STROKE PREVENTION AT, P149; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Khan SU, 2020, ANN INTERN MED, V172, P474, DOI 10.7326/M19-3763; Lopes RD, 2019, NEW ENGL J MED, V380, P1509, DOI 10.1056/NEJMoa1817083; Steffel J, 2018, EUR HEART J, V39, P1330, DOI 10.1093/eurheartj/ehy136; Tomaselli GF, 2017, J AM COLL CARDIOL, V70, P3042, DOI 10.1016/j.jacc.2017.09.1085; Vranckx P, 2019, LANCET, V394, P1335, DOI 10.1016/S0140-6736(19)31872-0	10	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2020	172	7					495	496		10.7326/M20-0572	http://dx.doi.org/10.7326/M20-0572			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA6DM	32176888				2022-12-28	WOS:000524036500009
J	Reichardt, S; Piepho, HP; Stintzi, A; Schaller, A				Reichardt, S.; Piepho, H. -P.; Stintzi, A.; Schaller, A.			Peptide signaling for drought-induced tomato flower drop	SCIENCE			English	Article							FLORAL ORGAN ABSCISSION; INFLORESCENCE-DEFICIENT; ARABIDOPSIS; PROTEASE; RECEPTOR; PHYTOSULFOKINE; SUBTILASES; LIBRARIES; EFFICIENT; VERSATILE	The premature abscission of flowers and fruits limits crop yield under environmental stress. Drought-induced flower drop in tomato plants was found to be regulated by phytosulfokine (PSK), a peptide hormone previously known for its growth-promoting and immune-modulating activities. PSK formation in response to drought stress depends on phytaspase 2, a subtilisin-like protease of the phytaspase subtype that generates the peptide hormone by aspartate-specific processing of the PSK precursor in the tomato flower pedicel. The mature peptide acts in the abscission zone where it induces expression of cell wall hydrolases that execute the abscission process. Our results provide insight into the molecular control of abscission as regulated by proteolytic processing to generate a small plant peptide hormone.	[Reichardt, S.; Stintzi, A.; Schaller, A.] Univ Hohenheim, Dept Plant Physiol & Biochem, Stuttgart, Germany; [Piepho, H. -P.] Univ Hohenheim, Inst Crop Sci, Biostat Unit, Stuttgart, Germany	University Hohenheim; University Hohenheim	Stintzi, A; Schaller, A (corresponding author), Univ Hohenheim, Dept Plant Physiol & Biochem, Stuttgart, Germany.	annick.stintzi@uni-hohenheim.de; andreas.schaller@uni-hohenheim.de	Schaller, Andreas/AAC-1940-2020	Schaller, Andreas/0000-0001-6872-9576; Stintzi, Annick/0000-0002-6479-8184; Reichardt, Sven/0000-0001-9779-9610	German Research Foundation (DFG) [SCHA 591/8-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by a grant from the German Research Foundation (DFG) to A.Sc. (SCHA 591/8-1).	Aalen RB, 2013, J EXP BOT, V64, P5253, DOI 10.1093/jxb/ert338; Albert M, 2010, J BIOL CHEM, V285, P19035, DOI 10.1074/jbc.M110.124800; Beloshistov RE, 2018, NEW PHYTOL, V218, P1167, DOI 10.1111/nph.14568; Bosch M, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0257-8; Bosch M, 2014, PLANT PHYSIOL, V166, P396, DOI 10.1104/pp.114.237388; Brukhin V, 2003, SEX PLANT REPROD, V15, P311, DOI 10.1007/s00497-003-0167-7; Butenko MA, 2003, PLANT CELL, V15, P2296, DOI 10.1105/tpc.014365; Cho SK, 2008, P NATL ACAD SCI USA, V105, P15629, DOI 10.1073/pnas.0805539105; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Hander T, 2019, SCIENCE, V363, P1301, DOI 10.1126/science.aar7486; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Ito Y, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00442; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KALAITZIS P, 1995, PLANT MOL BIOL, V28, P647, DOI 10.1007/BF00021190; Kissoudis C, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02009; Ladwig F, 2015, PLANT CELL, V27, P1718, DOI 10.1105/tpc.15.00306; LANAHAN MB, 1994, PLANT CELL, V6, P521, DOI 10.1105/tpc.6.4.521; LIZADA MCC, 1979, ANAL BIOCHEM, V100, P140, DOI 10.1016/0003-2697(79)90123-4; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Matsubayashi Y, 1996, P NATL ACAD SCI USA, V93, P7623, DOI 10.1073/pnas.93.15.7623; Meir S, 2010, PLANT PHYSIOL, V154, P1929, DOI 10.1104/pp.110.160697; Meng XZ, 2016, CELL REP, V14, P1330, DOI 10.1016/j.celrep.2016.01.023; Meyer M, 2016, J BIOL CHEM, V291, P19449, DOI 10.1074/jbc.M116.744151; Meyer M, 2016, J EXP BOT, V67, P4325, DOI 10.1093/jxb/erw220; Niederhuth CE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-37; PANDEY RK, 1984, AGRON J, V76, P549, DOI 10.2134/agronj1984.00021962007600040009x; Patharkar OR, 2018, J EXP BOT, V69, P733, DOI 10.1093/jxb/erx256; Patharkar OR, 2016, PLANT PHYSIOL, V172, P510, DOI 10.1104/pp.16.01004; Patterson SE, 2004, PLANT PHYSIOL, V134, P194, DOI 10.1104/pp.103.028027; PEARCE G, 1991, SCIENCE, V253, P895, DOI 10.1126/science.253.5022.895; Peet MM, 1997, J EXP BOT, V48, P101, DOI 10.1093/jxb/48.1.101; Reichardt S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28769-0; Sade N., 2015, BIO-PROTOCOL, V5, pE1451, DOI [10.21769/BioProtoc.1451, DOI 10.21769/BIOPROTOC.1451]; Santiago J, 2016, ELIFE, V5, DOI 10.7554/eLife.15075; Sauter M, 2015, J EXP BOT, V66, P5160, DOI 10.1093/jxb/erv071; Sawicki M, 2015, J EXP BOT, V66, P1707, DOI 10.1093/jxb/eru533; Schaller A, 2018, NEW PHYTOL, V218, P901, DOI 10.1111/nph.14582; Schardon K, 2016, SCIENCE, V354, P1594, DOI 10.1126/science.aai8550; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Schilling O, 2011, BIOL CHEM, V392, P1031, DOI 10.1515/BC.2011.158; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Stenvik GE, 2008, PLANT CELL, V20, P1805, DOI 10.1105/tpc.108.059139; Stroup W. W., 2003, GEN LINEAR MIXED MOD; Sundaresan S, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01258; Taylor A, 2017, MOL PLANT MICROBE IN, V30, P489, DOI [10.1094/MPMI-10-16-0218-R, 10.1094/mpmi-10-16-0218-r]; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wilkinson JQ, 1997, NAT BIOTECHNOL, V15, P444, DOI 10.1038/nbt0597-444; Xu Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48664-6	49	46	47	29	171	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1482	+		10.1126/science.aaz5641	http://dx.doi.org/10.1126/science.aaz5641			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217727				2022-12-28	WOS:000523251600038
J	Stocker, TF				Stocker, Thomas F.			Surprises for climate stability	SCIENCE			English	Editorial Material							NORTH-ATLANTIC; INSTABILITY; EVENTS		[Stocker, Thomas F.] Univ Bern, Climate & Environm Phys, CH-3012 Bern, Switzerland; [Stocker, Thomas F.] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland	University of Bern; University of Bern	Stocker, TF (corresponding author), Univ Bern, Climate & Environm Phys, CH-3012 Bern, Switzerland.; Stocker, TF (corresponding author), Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland.	stocker@climate.unibe.ch						Bakker P, 2016, GEOPHYS RES LETT, V43, P12252, DOI 10.1002/2016GL070457; BROECKER WS, 1985, NATURE, V315, P21, DOI 10.1038/315021a0; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Dansgaard W., 1984, GEOPHYS MONOGR SER, P288, DOI DOI 10.1029/GM029P0288; Frajka-Williams E, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00260; Galaasen EV, 2020, SCIENCE, V367, P1485, DOI 10.1126/science.aay6381; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; LORENZ EN, 1963, J ATMOS SCI, V20, P130, DOI 10.1175/1520-0469(1963)020<0130:DNF>2.0.CO;2; Martrat B, 2007, SCIENCE, V317, P502, DOI 10.1126/science.1139994; OESCHGER H, 1984, CLIMATE PROCESSES CL, P299, DOI DOI 10.1029/GM029P0299; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Vettoretti G, 2016, GEOPHYS RES LETT, V43, P5336, DOI 10.1002/2016GL068891	13	2	2	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1425	1426		10.1126/science.abb3569	http://dx.doi.org/10.1126/science.abb3569			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217713				2022-12-28	WOS:000523251600015
J	Devi, S				Devi, Sharmila			Building bridges in Yemen	LANCET			English	Editorial Material																			0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					939	939						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199481	Green Published, Bronze			2022-12-28	WOS:000521744600014
J	Gupta, S; Lieberman, D				Gupta, Samir; Lieberman, David			Intensity of Surveillance for Patients With Colorectal Adenomas	ANNALS OF INTERNAL MEDICINE			English	Letter									[Gupta, Samir] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Gupta, Samir] Univ Calif San Diego, San Diego, CA 92103 USA; [Lieberman, David] Oregon Hlth & Sci Univ, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Oregon Health & Science University	Gupta, S (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.; Gupta, S (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.							Click B, 2018, JAMA-J AM MED ASSOC, V319, P2021, DOI 10.1001/jama.2018.5809; He XS, 2020, GASTROENTEROLOGY, V158, P852, DOI 10.1053/j.gastro.2019.06.039; Meester RGS, 2019, ANN INTERN MED, V171, P612, DOI 10.7326/M18-3633	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					441	442		10.7326/L19-0828	http://dx.doi.org/10.7326/L19-0828			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176908				2022-12-28	WOS:000520170800040
J	Carlson, RR				Carlson, Rachel Ragnhild			IN PURSUIT OF CREATIVE LIBERTY	NATURE			English	Editorial Material									[Carlson, Rachel Ragnhild] Stanford Univ, Stanford, CA 94305 USA; [Carlson, Rachel Ragnhild] Arizona State Univ, Tempe, AZ 85287 USA	Stanford University; Arizona State University; Arizona State University-Tempe	Carlson, RR (corresponding author), Stanford Univ, Stanford, CA 94305 USA.; Carlson, RR (corresponding author), Arizona State Univ, Tempe, AZ 85287 USA.								0	0	0	0	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					458	458		10.1038/d41586-020-00642-z	http://dx.doi.org/10.1038/d41586-020-00642-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KU4SG	32173721	Bronze			2022-12-28	WOS:000519699800004
J	Patel, AB; Verma, A				Patel, Ankit B.; Verma, Ashish			COVID-19 and Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers What Is the Evidence?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CORONAVIRUS; ACE2	This Viewpoint reviews the pathophysiological and observational basis for speculating that angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) might worsen clinical outcomes for patients with COVID-19, and summarizes guidance from specialty societies to continue the drugs in patients who need them pending more definitive evidence of harm.	[Patel, Ankit B.; Verma, Ashish] Brigham & Womens Hosp, Renal Div, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Patel, AB (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	apatel38@bwh.harvard.edu	Verma, Ashish/AAF-1268-2020	Verma, Ashish/0000-0001-9497-6327; Patel, Ankit/0000-0001-6812-1464				American Heart Association, HFSA ACC AHA STAT AD; de Simone G, 2020, POS STAT ESC COUNC H; Khan A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1823-x; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Rice GI, 2004, BIOCHEM J, V383, P45, DOI 10.1042/BJ20040634; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	9	279	285	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1769	1770		10.1001/jama.2020.4812	http://dx.doi.org/10.1001/jama.2020.4812			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32208485	Bronze			2022-12-28	WOS:000536221500008
J	Bedford, J; Enria, D; Giesecke, J; Heymann, DL; Ihekweazu, C; Kobinger, G; Lane, HC; Memish, Z; Oh, MD; Sall, AA; Schuchat, A; Ungchusak, K; Wieler, LH				Bedford, Juliet; Enria, Delia; Giesecke, Johan; Heymann, David L.; Ihekweazu, Chikwe; Kobinger, Gary; Lane, H. Clifford; Memish, Ziad; Oh, Myoung-don; Sall, Amadou Alpha; Schuchat, Anne; Ungchusak, Kumnuan; Wieler, Lothar H.		WHO Strategic Tech Advisory Grp	COVID-19: towards controlling of a pandemic	LANCET			English	Editorial Material									[Enria, Delia] Inst Nacl Enfermedades Virales Humanas INEVH Juli, Buenos Aires, DF, Argentina; [Enria, Delia] CCWHOOPS Viral Haemorrhag Fevers & Arboviruses, Buenos Aires, DF, Argentina; [Giesecke, Johan] Karolinska Inst, Stockholm, Sweden; [Heymann, David L.] London Sch Hyg Trop Med, Infect Dis Epidemiol, London WC1E 7HT, England; [Ihekweazu, Chikwe] Nigeria Ctr Dis Control, Abuja, Nigeria; [Kobinger, Gary] Univ Laval, Fac Med, Infect Dis Res Ctr, Quebec City, PQ, Canada; [Lane, H. Clifford] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Memish, Ziad] Minist Hlth, Res & Innovat Ctr, Riyadh, Saudi Arabia; [Oh, Myoung-don] Seoul Natl Univ Hosp, SNU Coll Med, Dept Internal Med, JW Lee Ctr Global Med, Seoul, South Korea; [Sall, Amadou Alpha] Inst Pasteur, Dakar, Senegal; [Schuchat, Anne] Ctr Dis Control & Prevent, Atlanta, GA USA; [Ungchusak, Kumnuan] Minist Hlth, Dept Dis Control, Bangkok, Thailand; [Wieler, Lothar H.] Robert Koch Inst, Berlin, Germany	Karolinska Institutet; University of London; London School of Hygiene & Tropical Medicine; Laval University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Ministry of Health - Saudi Arabia; Seoul National University (SNU); Seoul National University Hospital; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand; Robert Koch Institute	Heymann, DL (corresponding author), London Sch Hyg Trop Med, Infect Dis Epidemiol, London WC1E 7HT, England.	david.heymann@lshtm.ac.uk	Memish, Ziad Ahmed/AEJ-9424-2022	Memish, Ziad Ahmed/0000-0002-5099-0714				[Anonymous], UPD INCR KING COUNT; Kim JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e86; National Institute of Infection Diseases, 2020, FIELD BRIEF DIAM PRI; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; WHO, 2020, COORD GLOB RES ROADM; WHO, 2020, 55 WHO; WHO-China Joint Mission Members, 2020, REP WHO CHIN JOINT M; World Health Organization, 2020, CRIT PREP READ RESP; World Health Organization (WHO), 2020, 2019 NOVEL CORONAVIR; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	11	696	727	4	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1015	1018		10.1016/S0140-6736(20)30673-5	http://dx.doi.org/10.1016/S0140-6736(20)30673-5			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY5YW	32197103	Green Published, Bronze, Green Submitted			2022-12-28	WOS:000522650100013
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: diabetes clinicians set up social media account to help alleviate patients' fears	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	8	8	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1262	10.1136/bmj.m1262	http://dx.doi.org/10.1136/bmj.m1262			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220832	Bronze			2022-12-28	WOS:000523765200006
J	Kuehn, BM				Kuehn, Bridget M.			Hundreds of Health Care Workers Exposed to Rabies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1125	1125		10.1001/jama.2020.2851	http://dx.doi.org/10.1001/jama.2020.2851			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207810				2022-12-28	WOS:000530807000009
J	Rimmer, A				Rimmer, Abi			Covid-19: doctors in final trimester of pregnancy should avoid direct patient contact	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Royal College of Obstetricians and Gynaecologists, 2020, COR COVID 19 INF PRE	1	6	6	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1173	10.1136/bmj.m1173	http://dx.doi.org/10.1136/bmj.m1173			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205356	Bronze			2022-12-28	WOS:000523764100017
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: Doctors warn of humanitarian catastrophe at Europe's largest refugee camp	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	8	8	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1097	10.1136/bmj.m1097	http://dx.doi.org/10.1136/bmj.m1097			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184206	Bronze			2022-12-28	WOS:000523762400014
J	Wang, QY; Wang, YP; Ding, JJ; Wang, CH; Zhou, XH; Gao, WQ; Huang, HW; Shao, F; Liu, ZB				Wang, Qinyang; Wang, Yupeng; Ding, Jingjin; Wang, Chunhong; Zhou, Xuehan; Gao, Wenqing; Huang, Huanwei; Shao, Feng; Liu, Zhibo			A bioorthogonal system reveals antitumour immune function of pyroptosis	NATURE			English	Article							DRUG; PRINCIPLES; ORGANOTRIFLUOROBORATE; NANOPARTICLES; CLEAVAGE; DESIGN	Bioorthogonal chemistry capable of operating in live animals is needed to investigate biological processes such as cell death and immunity. Recent studies have identified a gasdermin family of pore-forming proteins that executes inflammasome-dependent and -independent pyroptosis(1-5). Pyroptosis is proinflammatory, but its effect on antitumour immunity is unknown. Here we establish a bioorthogonal chemical system, in which a cancer-imaging probe phenylalanine trifluoroborate (Phe-BF3) that can enter cells desilylates and 'cleaves' a designed linker that contains a silyl ether. This system enabled the controlled release of a drug from an antibody-drug conjugate in mice. When combined with nanoparticle-mediated delivery, desilylation catalysed by Phe-BF3 could release a client protein-including an active gasdermin-from a nanoparticle conjugate, selectively into tumour cells in mice. We applied this bioorthogonal system to gasdermin, which revealed that pyroptosis of less than 15% of tumour cells was sufficient to clear the entire 4T1 mammary tumour graft. The tumour regression was absent in immune-deficient mice or upon T cell depletion, and was correlated with augmented antitumour immune responses. The injection of a reduced, ineffective dose of nanoparticle-conjugated gasdermin along with Phe-BF3 sensitized 4T1 tumours to anti-PD1 therapy. Our bioorthogonal system based on Phe-BF3 desilylation is therefore a powerful tool for chemical biology; our application of this system suggests that pyroptosis-induced inflammation triggers robust antitumour immunity and can synergize with checkpoint blockade. In mouse models of cancer, a biorthogonal chemical system based on desilylation catalysed by phenylalanine trifluoroborate enables the controlled release of gasdermin to induce pyroptosis selectively in tumour cells	[Wang, Qinyang; Wang, Chunhong; Zhou, Xuehan; Liu, Zhibo] Peking Univ, Coll Chem & Mol Engn, Beijing Natl Lab Mol Sci Radiochem & Radiat Chem, Key Lab Fundamental Sci, Beijing, Peoples R China; [Wang, Yupeng; Shao, Feng] Chinese Acad Med Sci, Res Unit Pyroptosis & Immun, Beijing, Peoples R China; [Wang, Yupeng; Ding, Jingjin; Gao, Wenqing; Huang, Huanwei; Shao, Feng] Natl Inst Biol Sci, Beijing, Peoples R China; [Ding, Jingjin] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing, Peoples R China; [Shao, Feng] Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing, Peoples R China; [Liu, Zhibo] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Tsinghua University; Peking University	Liu, ZB (corresponding author), Peking Univ, Coll Chem & Mol Engn, Beijing Natl Lab Mol Sci Radiochem & Radiat Chem, Key Lab Fundamental Sci, Beijing, Peoples R China.; Shao, F (corresponding author), Chinese Acad Med Sci, Res Unit Pyroptosis & Immun, Beijing, Peoples R China.; Shao, F (corresponding author), Natl Inst Biol Sci, Beijing, Peoples R China.; Shao, F (corresponding author), Tsinghua Univ, Tsinghua Inst Multidisciplinary Biomed Res, Beijing, Peoples R China.; Liu, ZB (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing, Peoples R China.	shaofeng@nibs.ac.cn; zbliu@pku.edu.cn		Zhou, Xuehan/0000-0002-7366-9915; Shao, Feng/0000-0002-9562-7791; Ding, Jingjin/0000-0001-9941-7997	NSFC [U1867209, 21778003, 81788104]; National Key Research and Development Program of China [2017YFA0505900, 2016YFA0501500]; Chinese Academy of Medical Sciences Initiative for Innovative Medicine [2019-I2M-5-084]	NSFC(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Chinese Academy of Medical Sciences Initiative for Innovative Medicine	We thank J. Sui, Z. Shen, F. Zheng and P. Xu for reagents; J. Chen, F. Wang, X. Jia, Z. Jiang and W. He for technical assistance; M. Shi for the cartoon illustration; and X. Liu, P.R. Chen, T. Luo and W. Wei for advice. The work was supported by NSFC grants U1867209 and 21778003 to Z.L., NSFC Basic Science Center Project (81788104), the National Key Research and Development Program of China (2017YFA0505900 and 2016YFA0501500), Chinese Academy of Medical Sciences Initiative for Innovative Medicine (2019-I2M-5-084) to F.S.	Blanco E, 2015, NAT BIOTECHNOL, V33, P941, DOI 10.1038/nbt.3330; Broz P, 2020, NAT REV IMMUNOL, V20, P143, DOI 10.1038/s41577-019-0228-2; Casares N, 2005, J EXP MED, V202, P1691, DOI 10.1084/jem.20050915; Chau CH, 2019, LANCET, V394, P793, DOI 10.1016/S0140-6736(19)31774-X; Cheng Y, 2008, J AM CHEM SOC, V130, P10643, DOI 10.1021/ja801631c; Crouch RD, 2004, TETRAHEDRON, V60, P5833, DOI 10.1016/j.tet.2004.04.042; De M, 2009, NAT CHEM, V1, P461, DOI [10.1038/NCHEM.334, 10.1038/nchem.334]; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Duncan B, 2010, J CONTROL RELEASE, V148, P122, DOI 10.1016/j.jconrel.2010.06.004; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Handy CJ, 2000, J ORG CHEM, V65, P3542, DOI 10.1021/jo991771s; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Lee PH, 2019, J EXP MED, V216, P2619, DOI 10.1084/jem.20181218; Liu ZB, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500694; Liu ZB, 2015, NAT PROTOC, V10, P1423, DOI 10.1038/nprot.2015.090; Liu ZB, 2015, CHEM-EUR J, V21, P3924, DOI 10.1002/chem.201405829; Liu ZB, 2014, ANGEW CHEM INT EDIT, V53, P11876, DOI 10.1002/anie.201406258; Liu ZB, 2014, J NUCL MED, V55, P1499, DOI 10.2967/jnumed.114.137836; Lyon RP, 2015, NAT BIOTECHNOL, V33, P733, DOI 10.1038/nbt.3212; Nelson TD, 1996, SYNTHESIS-STUTTGART, P1031; Papasani MR, 2012, NANOMED-NANOTECHNOL, V8, P804, DOI 10.1016/j.nano.2012.01.008; Perrin DM, 2016, ACCOUNTS CHEM RES, V49, P1333, DOI 10.1021/acs.accounts.5b00398; Rana S, 2010, CURR OPIN CHEM BIOL, V14, P828, DOI 10.1016/j.cbpa.2010.10.001; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Rossin R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03880-y; Ruan JB, 2018, NATURE, V557, P62, DOI 10.1038/s41586-018-0058-6; SCHWARTZ HS, 1973, CANCER RES, V33, P1837; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Swierczewska M, 2011, PHYS CHEM CHEM PHYS, V13, P9929, DOI 10.1039/c0cp02967j; Tu JL, 2018, J AM CHEM SOC, V140, P8410, DOI 10.1021/jacs.8b05093; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wilhelm S, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.14; Zheng YQ, 2018, NAT CHEM, V10, P787, DOI 10.1038/s41557-018-0055-2; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	36	305	316	111	585	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					421	+		10.1038/s41586-020-2079-1	http://dx.doi.org/10.1038/s41586-020-2079-1		MAR 2020	24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188939				2022-12-28	WOS:000519162500004
J	Kanazawa, K; Sano, TG; Cairoli, A; Baule, A				Kanazawa, Kiyoshi; Sano, Tomohiko G.; Cairoli, Andrea; Baule, Adrian			Loopy Levy flights enhance tracer diffusion in active suspensions	NATURE			English	Article							BACTERIAL; SUCCESS; ALGAE	A theoretical framework describing the hydrodynamic interactions between a passive particle and an active medium in out-of-equilibrium systems predicts long-range Levy flights for the diffusing particle driven by the density of the active component. Brownian motion is widely used as a model of diffusion in equilibrium media throughout the physical, chemical and biological sciences. However, many real-world systems are intrinsically out of equilibrium owing to energy-dissipating active processes underlying their mechanical and dynamical features(1). The diffusion process followed by a passive tracer in prototypical active media, such as suspensions of active colloids or swimming microorganisms(2), differs considerably from Brownian motion, as revealed by a greatly enhanced diffusion coefficient(3-10) and non-Gaussian statistics of the tracer displacements(6,9,10). Although these characteristic features have been extensively observed experimentally, there is so far no comprehensive theory explaining how they emerge from the microscopic dynamics of the system. Here we develop a theoretical framework to model the hydrodynamic interactions between the tracer and the active swimmers, which shows that the tracer follows a non-Markovian coloured Poisson process that accounts for all empirical observations. The theory predicts a long-lived Levy flight regime(11) of the loopy tracer motion with a non-monotonic crossover between two different power-law exponents. The duration of this regime can be tuned by the swimmer density, suggesting that the optimal foraging strategy of swimming microorganisms might depend crucially on their density in order to exploit the Levy flights of nutrients(12). Our framework can be applied to address important theoretical questions, such as the thermodynamics of active systems(13), and practical ones, such as the interaction of swimming microorganisms with nutrients and other small particles(14) (for example, degraded plastic) and the design of artificial nanoscale machines(15).	[Kanazawa, Kiyoshi] Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan; [Kanazawa, Kiyoshi] Tokyo Inst Technol, Inst Innovat Res, Yokohama, Kanagawa, Japan; [Sano, Tomohiko G.] Ritsumeikan Univ, Dept Phys Sci, Shiga, Japan; [Sano, Tomohiko G.] Ecole Polytech Fed Lausanne, Inst Engn Mech, Flexible Struct Lab, Lausanne, Switzerland; [Cairoli, Andrea] Imperial Coll London, Dept Bioengn, London, England; [Cairoli, Andrea; Baule, Adrian] Queen Mary Univ London, Sch Math Sci, London, England; [Cairoli, Andrea] Francis Crick Inst, London, England	University of Tsukuba; Tokyo Institute of Technology; Ritsumeikan University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Imperial College London; University of London; Queen Mary University London; Francis Crick Institute	Kanazawa, K (corresponding author), Univ Tsukuba, Fac Engn Informat & Syst, Tsukuba, Ibaraki, Japan.; Kanazawa, K (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Yokohama, Kanagawa, Japan.	kiyoshi@sk.tsukuba.ac.jp	Kanazawa, Kiyoshi/GCK-2054-2022; Cairoli, Andrea/GVS-7145-2022	Kanazawa, Kiyoshi/0000-0002-6531-1438; 	JSPS KAKENHI [16K16016, 18K13519]; Royal Commission for the Exhibition of 1851; Yukawa Institute for Theoretical Physics, Kyoto University;  [16J05315]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Royal Commission for the Exhibition of 1851; Yukawa Institute for Theoretical Physics, Kyoto University; 	We thank D. Mizuno, H. Takayasu, M. Takayasu, H. Hayakawa and F. van Wijland for discussions. This work was supported by a Grant-in-Aid for JSPS Fellows (grant number 16J05315), JSPS KAKENHI (grant numbers 16K16016 and 18K13519) and a Research Fellowship granted by the Royal Commission for the Exhibition of 1851. A.C. acknowledges the hospitality of the Yukawa Institute for Theoretical Physics, Kyoto University as well as financial support. Simulations and numerical calculations were carried out using the Cray XC40 supercomputer at Yukawa Institute for Theoretical Physics in Kyoto University.	Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; Bechinger C, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.045006; Benichou O, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.81; Campbell N, 1910, P CAMB PHILOS SOC, V15, P117; Chechkin AV, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.021002; Coffey W.T., 2004, LANGEVIN EQUATION, V2nd; Drescher K, 2011, P NATL ACAD SCI USA, V108, P10940, DOI 10.1073/pnas.1019079108; Drescher K, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168101; Dunkel J, 2010, SOFT MATTER, V6, P4268, DOI 10.1039/c0sm00164c; Gardiner C, 2009, STOCHASTIC METHODS H; Goldstein RE, 2015, ANNU REV FLUID MECH, V47, P343, DOI 10.1146/annurev-fluid-010313-141426; Holtsmark J, 1919, ANN PHYS-BERLIN, V58, P577; HUGHES BD, 1981, P NATL ACAD SCI USA, V78, P3287, DOI 10.1073/pnas.78.6.3287; Humphries NE, 2012, P NATL ACAD SCI USA, V109, P7169, DOI 10.1073/pnas.1121201109; Jepson A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.041002; Kanazawa K, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.090601; Koch DL, 2011, ANNU REV FLUID MECH, V43, P637, DOI 10.1146/annurev-fluid-121108-145434; Kurihara T, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.030601; Kurtuldu H, 2011, P NATL ACAD SCI USA, V108, P10391, DOI 10.1073/pnas.1107046108; Lauga E, 2009, REP PROG PHYS, V72, DOI 10.1088/0034-4885/72/9/096601; Leptos KC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198103; Lin Z, 2011, J FLUID MECH, V669, P167, DOI 10.1017/S002211201000563X; MANTEGNA RN, 1994, PHYS REV LETT, V73, P2946, DOI 10.1103/PhysRevLett.73.2946; Mino GL, 2013, J FLUID MECH, V729, P423, DOI 10.1017/jfm.2013.304; Mino G, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.048102; Morozov A, 2014, SOFT MATTER, V10, P2748, DOI 10.1039/c3sm52201f; Needleman D, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2017.48; Pushkin DO, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.188101; Thiffeault JL, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.023023; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Wang B, 2012, NAT MATER, V11, P481, DOI 10.1038/nmat3308; Wu XL, 2000, PHYS REV LETT, V84, P3017, DOI 10.1103/PhysRevLett.84.3017; Zaid I, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.030602; Zaid IM, 2011, J R SOC INTERFACE, V8, P1314, DOI 10.1098/rsif.2010.0545	35	31	31	1	26	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					364	+		10.1038/s41586-020-2086-2	http://dx.doi.org/10.1038/s41586-020-2086-2			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188948	Green Submitted			2022-12-28	WOS:000520778000012
J	Meiners, T; Frolov, T; Rudd, RE; Dehm, G; Liebscher, CH				Meiners, Thorsten; Frolov, Timofey; Rudd, Robert E.; Dehm, Gerhard; Liebscher, Christian H.			Observations of grain-boundary phase transformations in an elemental metal	NATURE			English	Article							FREE-ENERGY; CU; SUPERSTRUCTURES; EMBRITTLEMENT; TRANSITIONS; COMPLEXIONS; ALGORITHM; COPPER	Atomic-resolution observations combined with simulations show that grain boundaries within elemental copper undergo temperature-induced solid-state phase transformation to different structures; grain boundary phases can also coexist and are kinetically trapped structures. The theory of grain boundary (the interface between crystallites, GB) structure has a long history(1) and the concept of GBs undergoing phase transformations was proposed 50 years ago(2,3). The underlying assumption was that multiple stable and metastable states exist for different GB orientations(4-6). The terminology 'complexion' was recently proposed to distinguish between interfacial states that differ in any equilibrium thermodynamic property(7). Different types of complexion and transitions between complexions have been characterized, mostly in binary or multicomponent systems(8-19). Simulations have provided insight into the phase behaviour of interfaces and shown that GB transitions can occur in many material systems(20-24). However, the direct experimental observation and transformation kinetics of GBs in an elemental metal have remained elusive. Here we demonstrate atomic-scale GB phase coexistence and transformations at symmetric and asymmetric [111 over bar ] tilt GBs in elemental copper. Atomic-resolution imaging reveals the coexistence of two different structures at sigma 19b GBs (where sigma 19 is the density of coincident sites and b is a GB variant), in agreement with evolutionary GB structure search and clustering analysis(21,25,26). We also use finite-temperature molecular dynamics simulations to explore the coexistence and transformation kinetics of these GB phases. Our results demonstrate how GB phases can be kinetically trapped, enabling atomic-scale room-temperature observations. Our work paves the way for atomic-scale in situ studies of metallic GB phase transformations, which were previously detected only indirectly(9,15,27-29), through their influence on abnormal grain growth, non-Arrhenius-type diffusion or liquid metal embrittlement.	[Meiners, Thorsten; Dehm, Gerhard; Liebscher, Christian H.] Max Planck Inst Eisenforsch GmbH, Dusseldorf, Germany; [Frolov, Timofey; Rudd, Robert E.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	Max Planck Society; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Dehm, G; Liebscher, CH (corresponding author), Max Planck Inst Eisenforsch GmbH, Dusseldorf, Germany.; Frolov, T (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	frolov2@llnl.gov; dehm@mpie.de; liebscher@mpie.de	Dehm, Gerhard/C-8919-2014	Dehm, Gerhard/0000-0003-1601-8267; Frolov, Timofey/0000-0001-8985-6187; Rudd, Robert/0000-0002-6632-2681; Liebscher, Christian/0000-0001-8620-4597	European Research Council [787446 GB-CORRELATE]; US Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Laboratory Directed Research and Development Program at Lawrence Livermore National Laboratory [19-ERD-026]	European Research Council(European Research Council (ERC)European Commission); US Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program at Lawrence Livermore National Laboratory	We thank G. Richter and his team from the Max Planck Institute for Intelligent Systems for producing the Cu thin films by molecular beam epitaxy. T.F. is grateful to R. Freitas for the help with the free energy calculations. G.D. and T.M. acknowledge financial support from the European Research Council through grant number 787446 GB-CORRELATE. Support for T.F. and R.E.R. was provided under the auspices of the US Department of Energy by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. T.F. and R.E.R. were funded by the Laboratory Directed Research and Development Program at Lawrence Livermore National Laboratory under Project Tracking Code number 19-ERD-026.	Aramfard M, 2018, ACTA MATER, V146, P304, DOI 10.1016/j.actamat.2017.12.062; CAHN JW, 1982, J PHYS-PARIS, V43, P199, DOI 10.1051/jphyscol:1982619; Cantwell PR, 2014, ACTA MATER, V62, P1, DOI 10.1016/j.actamat.2013.07.037; CARRION F, 1983, SCRIPTA METALL MATER, V17, P915, DOI 10.1016/0036-9748(83)90261-2; Chua ALS, 2010, NAT MATER, V9, P418, DOI [10.1038/nmat2712, 10.1038/NMAT2712]; Dehm G, 2005, Z METALLKD, V96, P249, DOI 10.3139/146.101027; Dehm G, 2003, MICROELECTRON ENG, V70, P412, DOI 10.1016/S0167-9317(03)00395-2; Dillon SJ, 2007, ACTA MATER, V55, P6208, DOI 10.1016/j.actamat.2007.07.029; Dillon SJ, 2009, JOM-US, V61, P38, DOI 10.1007/s11837-009-0179-3; Divinski SV, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.144104; Duscher G, 2004, NAT MATER, V3, P621, DOI 10.1038/nmat1191; FOILES SM, 1994, PHYS REV B, V49, P14930, DOI 10.1103/PhysRevB.49.14930; Freitas R, 2018, PHYS REV MATER, V2, DOI 10.1103/PhysRevMaterials.2.093603; Freitas R, 2016, COMP MATER SCI, V112, P333, DOI 10.1016/j.commatsci.2015.10.050; Frolov T, 2018, NANOSCALE, V10, P8253, DOI [10.1039/c8nr00271a, 10.1039/C8NR00271A]; Frolov T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.224107; Frolov T, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.224106; Frolov T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2919; Gibbs J, 1928, COLLECTED WORK JW GI; Han J, 2016, ACTA MATER, V104, P259, DOI 10.1016/j.actamat.2015.11.035; Hart E. W, 1972, NATURE BEHAV GRAIN B, P155; HART EW, 1968, SCRIPTA METALL MATER, V2, P179, DOI 10.1016/0036-9748(68)90222-6; Khalajhedayati A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10802; Luo J, 2011, SCIENCE, V333, P1730, DOI 10.1126/science.1208774; Lyakhov AO, 2013, COMPUT PHYS COMMUN, V184, P1172, DOI 10.1016/j.cpc.2012.12.009; MAKSIMOVA EL, 1988, ACTA METALL MATER, V36, P1573, DOI 10.1016/0001-6160(88)90225-8; Oganov AR, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2210932; Ophus C, 2017, ADV STRUCT CHEM IMAG, V3, DOI 10.1186/s40679-017-0046-1; Peter NJ, 2018, PHYS REV LETT, V121, DOI 10.1103/PhysRevLett.121.255502; Phillips MA, 2004, MICROELECTRON ENG, V75, P117, DOI 10.1016/j.mee.2003.12.053; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Pryor A, 2017, ADV STRUCT CHEM IMAG, V3, DOI 10.1186/s40679-017-0048-z; Rabkin E, 1999, PHIL MAG LETT, V79, P409, DOI 10.1080/095008399177020; Rohrer GS, 2016, CURR OPIN SOLID ST M, V20, P231, DOI 10.1016/j.cossms.2016.03.001; ROTTMAN C, 1988, J PHYS-PARIS, V49, P313, DOI 10.1051/jphyscol:1988538; Schweinfest R, 2004, NATURE, V432, P1008, DOI 10.1038/nature03198; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Sutton A. P., 1995, INTERFACES CRYSTALLI; Tang M, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.024102; Tang M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.075502; Udler D, 1996, PHYS REV LETT, V77, P3379, DOI 10.1103/PhysRevLett.77.3379; Wang ZC, 2011, NATURE, V479, P380, DOI 10.1038/nature10593; Yu ZY, 2017, SCIENCE, V358, P97, DOI 10.1126/science.aam8256; Zhou NX, 2016, CURR OPIN SOLID ST M, V20, P268, DOI 10.1016/j.cossms.2016.05.001; Zhu Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02937-2	45	76	78	23	193	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					375	+		10.1038/s41586-020-2082-6	http://dx.doi.org/10.1038/s41586-020-2082-6			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188953	Green Accepted, Green Submitted			2022-12-28	WOS:000520778000014
J	Armstrong, PW; Pieske, B; Anstrom, KJ; Ezekowitz, J; Hernandez, AF; Butler, J; Lam, CSP; Ponikowski, P; Voors, AA; Jia, G; McNulty, SE; Patel, MJ; Roessig, L; Koglin, J; O'Connor, CM				Armstrong, Paul W.; Pieske, Burkert; Anstrom, Kevin J.; Ezekowitz, Justin; Hernandez, Adrian F.; Butler, Javed; Lam, Carolyn S. P.; Ponikowski, Piotr; Voors, Adriaan A.; Jia, Gang; McNulty, Steven E.; Patel, Mahesh J.; Roessig, Lothar; Koglin, Joerg; O'Connor, Christopher M.		VICTORIA Study Grp	Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOLUBLE GUANYLATE-CYCLASE; STIMULATOR; IMPACT; TRIAL	BackgroundThe effect of vericiguat, a novel oral soluble guanylate cyclase stimulator, in patients with heart failure and reduced ejection fraction who had recently been hospitalized or had received intravenous diuretic therapy is unclear. MethodsIn this phase 3, randomized, double-blind, placebo-controlled trial, we assigned 5050 patients with chronic heart failure (New York Heart Association class II, III, or IV) and an ejection fraction of less than 45% to receive vericiguat (target dose, 10 mg once daily) or placebo, in addition to guideline-based medical therapy. The primary outcome was a composite of death from cardiovascular causes or first hospitalization for heart failure. ResultsOver a median of 10.8 months, a primary-outcome event occurred in 897 of 2526 patients (35.5%) in the vericiguat group and in 972 of 2524 patients (38.5%) in the placebo group (hazard ratio, 0.90; 95% confidence interval [CI], 0.82 to 0.98; P=0.02). A total of 691 patients (27.4%) in the vericiguat group and 747 patients (29.6%) in the placebo group were hospitalized for heart failure (hazard ratio, 0.90; 95% CI, 0.81 to 1.00). Death from cardiovascular causes occurred in 414 patients (16.4%) in the vericiguat group and in 441 patients (17.5%) in the placebo group (hazard ratio, 0.93; 95% CI, 0.81 to 1.06). The composite of death from any cause or hospitalization for heart failure occurred in 957 patients (37.9%) in the vericiguat group and in 1032 patients (40.9%) in the placebo group (hazard ratio, 0.90; 95% CI, 0.83 to 0.98; P=0.02). Symptomatic hypotension occurred in 9.1% of the patients in the vericiguat group and in 7.9% of the patients in the placebo group (P=0.12), and syncope occurred in 4.0% of the patients in the vericiguat group and in 3.5% of the patients in the placebo group (P=0.30). ConclusionsAmong patients with high-risk heart failure, the incidence of death from cardiovascular causes or hospitalization for heart failure was lower among those who received vericiguat than among those who received placebo. (Funded by Merck Sharp & Dohme [a subsidiary of Merck] and Bayer; VICTORIA ClinicalTrials.gov number, NCT02861534.) Patients with chronic heart failure and a reduced ejection fraction were randomly assigned to the soluble guanylate cyclase stimulator vericiguat or placebo, in addition to guideline-based medical therapy. The incidence of death from cardiovascular causes or first hospitalization for heart failure was lower among patients who received vericiguat.	[Armstrong, Paul W.; Ezekowitz, Justin] Univ Alberta, Canadian VIGOUR Ctr, Edmonton, AB, Canada; [Pieske, Burkert] Charite, Berlin, Germany; [Pieske, Burkert] German Heart Ctr, Berlin, Germany; [Roessig, Lothar] Bayer, Wuppertal, Germany; [Anstrom, Kevin J.; Hernandez, Adrian F.; McNulty, Steven E.; O'Connor, Christopher M.] Duke Univ, Duke Clin Res Inst, Durham, NC USA; [Butler, Javed] Univ Mississippi, Med Ctr, Jackson, MS 39216 USA; [Lam, Carolyn S. P.] Natl Heart Ctr Singapore, Singapore, Singapore; [Lam, Carolyn S. P.] Duke Natl Univ Singapore, Singapore, Singapore; [Ponikowski, Piotr] Wroclaw Med Univ, Cardiol Dept, Wroclaw, Poland; [Voors, Adriaan A.] Univ Groningen, Groningen, Netherlands; [Jia, Gang; Patel, Mahesh J.; Koglin, Joerg] Merck, Kenilworth, NJ USA; [O'Connor, Christopher M.] Inova Heart & Vasc Inst, Falls Church, VA USA	University of Alberta; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; Duke University; University of Mississippi; University of Mississippi Medical Center; National Heart Centre Singapore; National University of Singapore; Wroclaw Medical University; University of Groningen; Merck & Company; Inova Fairfax Hospital	Armstrong, PW (corresponding author), Univ Alberta, Katz Grp Ctr Pharm & Hlth Res 4 120, 8613 114 St NW, Edmonton, AB T6G 2E1, Canada.	paul.armstrong@ualberta.ca	celik, Ahmet/AAA-6615-2021; Naka, Katerina K./O-1431-2019; YILMAZ, Mehmet Birhan/Y-1372-2019; Stork, Stefan/AAR-4182-2020; Nielsen, Olav Wendelboe/S-4390-2016; Boldueva, Svetlana/AAH-3862-2019; Lam, Carolyn SP/ABD-6810-2021; Prozesky, Hans Walter/ABE-6956-2020; Voors, Adriaan/ABE-6784-2020; Pieske, Burkert/M-8089-2016	celik, Ahmet/0000-0002-9417-7610; Naka, Katerina K./0000-0002-9900-9659; YILMAZ, Mehmet Birhan/0000-0002-8169-8628; Stork, Stefan/0000-0002-1771-7249; Nielsen, Olav Wendelboe/0000-0003-3532-9431; Boldueva, Svetlana/0000-0002-1898-084X; Lam, Carolyn SP/0000-0003-1903-0018; Prozesky, Hans Walter/0000-0001-9715-3449; GALINIER, Michel/0000-0003-1735-3390; Kulbachuk, Oleksandr/0000-0003-0646-6701; Pouleur, Anne-Catherine/0000-0002-2395-1787; Vojacek, Jan F/0000-0001-7724-9734; Chalikias, George/0000-0003-4331-730X; Girerd, Nicolas/0000-0002-3278-2057; Ycaza Zurita, Maria Gabriela/0000-0003-4602-6153; Gomez-Bueno, Manuel/0000-0002-9764-7518; Mahon, Niall/0000-0002-2872-2297; Kasprzak, Jaroslaw D/0000-0002-5850-8187; Lanas, Fernando/0000-0003-3595-9759; Villegas Lara, Beatriz/0000-0002-7397-9550; Pieske, Burkert/0000-0002-6466-5306	Merck Sharp Dohme; Bayer	Merck Sharp Dohme(Merck & Company); Bayer(Bayer AG)	Funded by Merck Sharp & Dohme [a subsidiary of Merck] and Bayer; VICTORIA ClinicalTrials.gov number, NCT02861534.	ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; [Anonymous], 2013, ADEMPAS PRESCRIBING; Armstrong PW, 2018, JACC-HEART FAIL, V6, P96, DOI 10.1016/j.jchf.2017.08.013; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Butler J, 2019, J AM COLL CARDIOL, V73, P935, DOI 10.1016/j.jacc.2018.11.049; Follmann M, 2017, J MED CHEM, V60, P5146, DOI 10.1021/acs.jmedchem.7b00449; Gheorghiade M, 2015, JAMA-J AM MED ASSOC, V314, P2251, DOI 10.1001/jama.2015.15734; Heidenreich PA, 2013, CIRC-HEART FAIL, V6, P606, DOI 10.1161/HHF.0b013e318291329a; McAlister FA, 2019, EUR J HEART FAIL, V21, P1510, DOI 10.1002/ejhf.1655; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray JJ, EUR HEART J; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; McMurray JJV, 2014, EUR J HEART FAIL, V16, P817, DOI 10.1002/ejhf.115; Pieske B, 2019, EUR J HEART FAIL, V21, P1596, DOI 10.1002/ejhf.1664; Ruppar TM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002606; Sangaralingham LR, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004302; Srivastava PK, 2018, JAMA CARDIOL, V3, P1226, DOI 10.1001/jamacardio.2018.3957; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738	18	391	410	3	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2020	382	20					1883	1893		10.1056/NEJMoa1915928	http://dx.doi.org/10.1056/NEJMoa1915928			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LR8KG	32222134	Green Published, Bronze			2022-12-28	WOS:000535944700017
J	Sindelar, JL				Sindelar, Jody L.			Regulating Vaping - Policies, Possibilities, and Perils	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sindelar, Jody L.] Yale Sch Publ Hlth, New Haven, CT 06510 USA	Yale University	Sindelar, JL (corresponding author), Yale Sch Publ Hlth, New Haven, CT 06510 USA.							Buckell J, 2018, TOB CONTROL; Buckell J, 2019, ADDICTION, V114, P1427, DOI 10.1111/add.14610; Centers for Disease Control and Prevention, 2020, OUTBR LUNG INJ ASS U; Cullen KA, 2019, JAMA-J AM MED ASSOC, V322, P2095, DOI 10.1001/jama.2019.18387; National Academies of Sciences Engineering and Medicine, 2018, PUBL HLTH CONS E CIG	5	21	21	2	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 14	2020	382	20								10.1056/NEJMp1917065	http://dx.doi.org/10.1056/NEJMp1917065			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LR8KG	32212514	Bronze			2022-12-28	WOS:000535944700001
J	Rosenthal, PJ				Rosenthal, Philip J.			Are three drugs for malaria better than two?	LANCET			English	Editorial Material							FALCIPARUM-MALARIA; RESISTANCE		[Rosenthal, Philip J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Rosenthal, PJ (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	philip.rosenthal@ucsf.edu						Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Conrad MD, 2019, LANCET INFECT DIS, V19, pE338, DOI 10.1016/S1473-3099(19)30261-0; Krishna S, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2976-7; Phyo AP, 2016, CLIN INFECT DIS, V63, P784, DOI 10.1093/cid/ciw388; van der Pluijm RW, 2020, LANCET, V395, P1345, DOI 10.1016/S0140-6736(20)30552-3; van der Pluijm RW, 2019, LANCET INFECT DIS, V19, P952, DOI 10.1016/S1473-3099(19)30391-3; van Huijsduijnen RH, 2018, CURR OPIN PHARMACOL, V42, P1, DOI 10.1016/j.coph.2018.05.006; White NJ, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2955-z; WHO, 2019, WORLD MALARIA REPORT	11	8	8	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2020	395	10233					1316	1317		10.1016/S0140-6736(20)30560-2	http://dx.doi.org/10.1016/S0140-6736(20)30560-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MP7SQ	32171077	hybrid			2022-12-28	WOS:000552401700010
J	Kang, G; Taguchi, AT; Stubbe, J; Drennan, CL				Kang, Gyunghoon; Taguchi, Alexander T.; Stubbe, JoAnne; Drennan, Catherine L.			Structure of a trapped radical transfer pathway within a ribonucleotide reductase holocomplex	SCIENCE			English	Article							COUPLED ELECTRON-TRANSFER; HYDROGEN-BOND NETWORK; ESCHERICHIA-COLI; DISTANCE MEASUREMENTS; SUBUNIT INTERFACE; PROTEIN; MODEL; SPECTROSCOPY; MECHANISM; UNMASKS	Ribonucleotide reductases (RNRs) are a diverse family of enzymes that are alone capable of generating 2'-deoxynucleotides de novo and are thus critical in DNA biosynthesis and repair. The nucleotide reduction reaction in all RNRs requires the generation of a transient active site thiyl radical, and in class I RNRs, this process involves a long-range radical transfer between two subunits, alpha and beta. Because of the transient subunit association, an atomic resolution structure of an active alpha 2 beta 2 RNR complex has been elusive. We used a doubly substituted beta 2, E52Q/(2,3,5)-trifluorotyrosine122-beta 2, to trap wild-type alpha 2 in a long-lived alpha 2 beta 2 complex. We report the structure of this complex by means of cryo-electron microscopy to 3.6-angstrom resolution, allowing for structural visualization of a 32-angstrom-long radical transfer pathway that affords RNR activity.	[Kang, Gyunghoon; Drennan, Catherine L.] MIT, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Kang, Gyunghoon; Stubbe, JoAnne; Drennan, Catherine L.] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Taguchi, Alexander T.; Stubbe, JoAnne; Drennan, Catherine L.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Taguchi, Alexander T.] RubrYc Therapeut, San Carlos, CA USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Drennan, CL (corresponding author), MIT, Howard Hughes Med Inst, Cambridge, MA 02138 USA.; Stubbe, J; Drennan, CL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Stubbe, J; Drennan, CL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	stubbe@mit.edu; cdrennan@mit.edu		Drennan, Catherine/0000-0001-5486-2755; Stubbe, JoAnne/0000-0001-8076-4489	National Institutes of Health [R35 GM126982, R01 GM29595, F32 GM123596]; David H. Koch Graduate Fellowship	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); David H. Koch Graduate Fellowship	This work was supported by the National Institutes of Health grants R35 GM126982 (to C.L.D), R01 GM29595 (to J.S.), and F32 GM123596 (A.T.T.) and by a David H. Koch Graduate Fellowship to G.K.; C.L.D. is a Howard Hughes Medical Institute investigator.	Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551; Ando N, 2011, P NATL ACAD SCI USA, V108, P21046, DOI 10.1073/pnas.1112715108; Argirevic T, 2012, J AM CHEM SOC, V134, P17661, DOI 10.1021/ja3071682; Artin E, 2009, BIOCHEMISTRY-US, V48, P11622, DOI 10.1021/bi901590q; Aye Y, 2015, ONCOGENE, V34, P2011, DOI 10.1038/onc.2014.155; Bennati M, 2005, J AM CHEM SOC, V127, P15014, DOI 10.1021/ja054991y; Bepler T, 2018, LECT N BIOINFORMAT, V10812, P245; BOLLINGER JM, 1994, J AM CHEM SOC, V116, P8024, DOI 10.1021/ja00097a009; BROWN NC, 1969, J MOL BIOL, V46, P39, DOI 10.1016/0022-2836(69)90056-4; CLIMENT I, 1992, BIOCHEMISTRY-US, V31, P4801, DOI 10.1021/bi00135a009; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eriksson M, 1997, STRUCTURE, V5, P1077, DOI 10.1016/S0969-2126(97)00259-1; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Greene BL, 2018, J AM CHEM SOC, V140, P15744, DOI 10.1021/jacs.8b07902; Greene BL, 2017, J AM CHEM SOC, V139, P16657, DOI 10.1021/jacs.7b08192; Kasanmascheff M, 2016, CHEM SCI, V7, P2170, DOI 10.1039/c5sc03460d; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Licht S, 1996, SCIENCE, V271, P477, DOI 10.1126/science.271.5248.477; Lin QH, 2017, J BIOL CHEM, V292, P9229, DOI 10.1074/jbc.M117.783092; MAO SS, 1992, BIOCHEMISTRY-US, V31, P9733, DOI 10.1021/bi00155a029; Minnihan EC, 2013, ACCOUNTS CHEM RES, V46, P2524, DOI 10.1021/ar4000407; Minnihan EC, 2013, P NATL ACAD SCI USA, V110, P3835, DOI 10.1073/pnas.1220691110; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Moriya T, 2017, JOVE-J VIS EXP, DOI 10.3791/55448; Nick TU, 2017, BIOCHEMISTRY-US, V56, P3647, DOI 10.1021/acs.biochem.7b00462; Nick TU, 2015, J AM CHEM SOC, V137, P289, DOI 10.1021/ja510513z; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Oyala PH, 2016, J AM CHEM SOC, V138, P7951, DOI 10.1021/jacs.6b03605; Penczek PA, 2014, ULTRAMICROSCOPY, V140, P9, DOI 10.1016/j.ultramic.2014.01.009; Ravichandran K, 2017, BIOCHEMISTRY-US, V56, P856, DOI 10.1021/acs.biochem.6b01145; Ravichandran KR, 2015, J AM CHEM SOC, V137, P14387, DOI 10.1021/jacs.5b09189; Reece SY, 2009, ANNU REV BIOCHEM, V78, P673, DOI 10.1146/annurev.biochem.78.080207.092132; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; SALOWE SP, 1987, BIOCHEMISTRY-US, V26, P3408, DOI 10.1021/bi00386a024; Seyedsayamdost MR, 2007, J AM CHEM SOC, V129, P15748, DOI 10.1021/ja076459b; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Thomas WC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10568-4; UHLIN U, 1994, NATURE, V370, P533, DOI 10.1038/370533a0; Uppsten M, 2006, J MOL BIOL, V359, P365, DOI 10.1016/j.jmb.2006.03.035; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Worsdorfer B, 2013, J AM CHEM SOC, V135, P8585, DOI 10.1021/ja401342s; Yokoyama K, 2010, J AM CHEM SOC, V132, P15368, DOI 10.1021/ja1069344; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zimanyi CM, 2016, ELIFE, V5, DOI 10.7554/eLife.07141; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	47	51	51	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 24	2020	368	6489					424	+		10.1126/science.aba6794	http://dx.doi.org/10.1126/science.aba6794			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LH0XH	32217749	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000528513300045
J	Phillips, RO; Robert, J; Abass, KM; Thompson, W; Sarfo, FS; Wilson, T; Sarpong, G; Gateau, T; Chauty, A; Omollo, R; Otieno, MO; Egondi, TW; Ampadu, EO; Agossadou, D; Marion, E; Ganlonon, L; Wansbrough-Jones, M; Grosset, J; Macdonald, JM; Treadwell, T; Saunderson, P; Paintsil, A; Lehman, L; Frimpong, M; Sarpong, NF; Saizonou, R; Tiendrebeogo, A; Ohene, SA; Stienstra, Y; Asiedu, KB; van der Werf, TS				Phillips, Richard O.; Robert, Jerome; Abass, Kabiru Mohamed; Thompson, William; Sarfo, Fred Stephen; Wilson, Tuah; Sarpong, Godfred; Gateau, Thierry; Chauty, Annick; Omollo, Raymond; Otieno, Michael Ochieng; Egondi, Thaddaeus W.; Ampadu, Edwin O.; Agossadou, Didier; Marion, Estelle; Ganlonon, Line; Wansbrough-Jones, Mark; Grosset, Jacques; Macdonald, John M.; Treadwell, Terry; Saunderson, Paul; Paintsil, Albert; Lehman, Linda; Frimpong, Michael; Sarpong, Nanaa Francisca; Saizonou, Raoul; Tiendrebeogo, Alexandre; Ohene, Sally-Ann; Stienstra, Ymkje; Asiedu, Kingsley B.; van der Werf, Tjip S.		Study Team	Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial	LANCET			English	Article							MYCOBACTERIUM-ULCERANS; COMBINATION; EFFICACY; EPIDEMIOLOGY; INFECTION; DISEASE	Background Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifampicin 10 mg/kg plus intramuscular streptomycin 15 mg/kg once daily for 8 weeks (RS8) is highly effective, but streptomycin injections are painful and potentially harmful. We aimed to compare the efficacy and tolerability of fully oral rifampicin 10 mg/kg plus clarithromycin 15 mg/kg extended release once daily for 8 weeks (RC8) with that of RS8 for treatment of early Buruli ulcer lesions. Methods We did an open-label, non-inferiority, randomised (1:1 with blocks of six), multicentre, phase 3 clinical trial comparing fully oral RC8 with RS8 in patients with early, limited Buruli ulcer lesions. There were four trial sites in hospitals in Ghana (Agogo, Tepa, Nkawie, Dunkwa) and one in Benin (Pobe). Participants were included if they were aged 5 years or older and had typical Buruli ulcer with no more than one lesion (caterories I and II) no larger than 10 cm in diameter. The trial was open label, and neither the investigators who took measurements of the lesions nor the attending doctors were masked to treatment assignment. The primary clinical endpoint was lesion healing (ie, full epithelialisation or stable scar) without recurrence at 52 weeks after start of antimicrobial therapy. The primary endpoint and safety were assessed in the intention-to-treat population. A sample size of 332 participants was calculated to detect inferiority of RC8 by a margin of 12%. This study was registered with ClinicalTrials.gov, NCT01659437. Findings Between Jan 1, 2013, and Dec 31, 2017, participants were recruited to the trial. We stopped recruitment after 310 participants. Median age of participants was 14 years (IQR 10-29) and 153 (52%) were female. 297 patients had PCR-confirmed Buruli ulcer; 151 (51%) were assigned to RS8 treatment, and 146 (49%) received oral RC8 treatment. In the RS8 group, lesions healed in 144 (95%, 95% CI 91 to 98) of 151 patients, whereas lesions healed in 140 (96%, 91 to 99) of 146 patients in the RC8 group. The difference in proportion, -0.5% (-5.2 to 4.2), was not significantly greater than zero (p=0.59), showing that RC8 treatment is non-inferior to RS8 treatment for lesion healing at 52 weeks. Treatment-related adverse events were recorded in 20 (13%) patients receiving RS8 and in nine (7%) patients receiving RC8. Most adverse events were grade 1-2, but one (1%) patient receiving RS8 developed serious ototoxicity and ended treatment after 6 weeks. No patients needed surgical resection. Four patients (two in each study group) had skin grafts. Interpretation Fully oral RC8 regimen was non-inferior to RS8 for treatment of early, limited Buruli ulcer and was associated with fewer adverse events. Therefore, we propose that fully oral RC8 should be the preferred therapy for early, limited lesions of Buruli ulcer. Copyright (C) 2020 World Health Organization; licensee Elsevier.	[Phillips, Richard O.; Sarfo, Fred Stephen; Frimpong, Michael; Sarpong, Nanaa Francisca] Kwame Nkrumah Univ Sci & Technol, Komfo Anokye Teaching Hosp, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Robert, Jerome] Sorbonne Univ, AP HP, Ctr Natl Reference Mycobacteries, INSERM,Ctr Immunol & Malad Infect, Bacteriol Site Pitie, Paris, France; [Abass, Kabiru Mohamed; Thompson, William] Agogo Presbyterian Hosp, Agogo, Ghana; [Wilson, Tuah] Nkawie Toaso Govt Hosp, Nkawie Panyin, Ghana; [Sarpong, Godfred] Dunkwa Govt Hosp, Dunkwa On Offin, Ghana; [Gateau, Thierry; Chauty, Annick; Ganlonon, Line] Ctr Diagnost & Traitement Lepre & Ulcere Buruli M, Oueme Plateau, Pobe, Benin; [Omollo, Raymond; Otieno, Michael Ochieng; Egondi, Thaddaeus W.] Africa Reg Off, Drugs Neglected Dis Initiat, Nairobi, Kenya; [Ampadu, Edwin O.] Ghana Hlth Serv, Natl Buruli Ulcer Control Programme, Accra, Ghana; [Agossadou, Didier] Programme Natl Lutte Lepre & Ulcere Buruli, Cotonou, Benin; [Marion, Estelle] Univ Angers, French Natl Inst Hlth & Med Res, Ctr Rech Cancerol & Immunol Nantes Angers, Angers, France; [Wansbrough-Jones, Mark] St Georges Univ London, Inst Infect & Immun, London, England; [Grosset, Jacques] Johns Hopkins Univ, Dept Med, Ctr TB Res, Baltimore, MD USA; [Macdonald, John M.] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA; [Macdonald, John M.] Hosp Bernard Meys Project Medishare, Port Au Prince, Haiti; [Treadwell, Terry] Inst Adv Wound Care, Montgomery, AL USA; [Saunderson, Paul; Lehman, Linda] Amer Leprosy Miss, Greenville, SC USA; [Paintsil, Albert] Korle BU Teaching Hosp, Reconstruct & Plast Surg Unit, Accra, Ghana; [Saizonou, Raoul] WHO, Country Off Benin, Cotonou, Benin; [Tiendrebeogo, Alexandre] WHO, Reg Off Africa, Brazzaville, Rep Congo; [Ohene, Sally-Ann] WHO, Country Off Ghana, Accra, Ghana; [Stienstra, Ymkje; van der Werf, Tjip S.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Infect Dis, NL-9713 GZ Groningen, Netherlands; [Asiedu, Kingsley B.] WHO, Dept Neglected Trop Dis, Geneva, Switzerland	Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ghana Health Service; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; St Georges University London; Johns Hopkins University; University of Miami; World Health Organization; World Health Organization; World Health Organization; University of Groningen; World Health Organization	van der Werf, TS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Infect Dis, NL-9713 GZ Groningen, Netherlands.	t.s.van.der.werf@umcg.nl	ROBERT, Jérôme/C-3993-2011; Phillips, Richard Odame/ABD-5394-2021; Frimpong, Michael/ABF-3631-2020; Saunderson, Paul/AAH-8770-2021; Marion, Estelle/G-3437-2016	ROBERT, Jérôme/0000-0002-9380-0570; Phillips, Richard Odame/0000-0001-8992-0222; Frimpong, Michael/0000-0003-1901-6793; KIKI, Gbetogo Maxime/0000-0002-4368-1817; Loglo, Aloysius/0000-0002-7179-8799; Marion, Estelle/0000-0003-4917-9665; Agbavor, Bernadette/0000-0002-2856-265X	WHO; MAP International; American Leprosy Missions; Fondation Raoul Follereau France; Buruli ulcer Groningen Foundation; Sanofi-Pasteur; BuruliVac; MRC [MR/J01477X/1] Funding Source: UKRI	WHO(World Health Organization); MAP International; American Leprosy Missions; Fondation Raoul Follereau France; Buruli ulcer Groningen Foundation; Sanofi-Pasteur; BuruliVac; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	WHO with additional support from MAP International, American Leprosy Missions, Fondation Raoul Follereau France, Buruli ulcer Groningen Foundation, Sanofi-Pasteur, and BuruliVac.	Abass KM, 2015, AM J TROP MED HYG, V92, P115, DOI 10.4269/ajtmh.14-0405; Alffenaar JWC, 2010, ANTIMICROB AGENTS CH, V54, P3878, DOI 10.1128/AAC.00099-10; Almeida D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000933; Ampah KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004603; Anagonou EG, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3845-2; [Anonymous], 2017, 4 WHO REP NEGL TROP; Barogui YT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003200; Beeres DT, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007273; Chauty A, 2011, CLIN INFECT DIS, V52, P94, DOI 10.1093/cid/ciq072; Converse PJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00426-19, 10.1128/aac.00426-19]; Converse PJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006728; Eddyani M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089407; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; Friedman ND, 2016, ANTIMICROB AGENTS CH, V60, P2692, DOI 10.1128/AAC.02853-15; Herbinger KH, 2009, CLIN INFECT DIS, V48, P1055, DOI 10.1086/597398; Jansson M, 2014, J CLIN MICROBIOL, V52, P1246, DOI 10.1128/JCM.03119-13; Ji BH, 2007, ANTIMICROB AGENTS CH, V51, P3737, DOI 10.1128/AAC.00730-07; Johnson PDR, 2019, LANCET GLOB HEALTH, V7, pE821, DOI 10.1016/S2214-109X(19)30233-5; Klis S, 2016, TROP MED INT HEALTH, V21, P1191, DOI 10.1111/tmi.12745; Klis S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002739; Loftus MJ, 2018, EMERG INFECT DIS, V24, P1988, DOI 10.3201/eid2411.171593; Marsollier L, 2003, ANTIMICROB AGENTS CH, V47, P1228, DOI 10.1128/AAC.47.4.1228-1232.2003; Nienhuis WA, 2012, CLIN INFECT DIS, V54, P519, DOI 10.1093/cid/cir856; Nienhuis WA, 2010, LANCET, V375, P664, DOI 10.1016/S0140-6736(09)61962-0; O'Brien DP, 2017, INTERN MED J, V47, P1011, DOI 10.1111/imj.13511; OBrien DP, 2019, CLIN INFECT DIS; Phillips RO, 2014, ANTIMICROB AGENTS CH, V58, P1161, DOI 10.1128/AAC.02165-13; Sarfo FS, 2010, ANTIMICROB AGENTS CH, V54, P3678, DOI 10.1128/AAC.00299-10; Scherr N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07804-8; Schulz KF, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000251; Simpson H, 2019, LANCET GLOB HEALTH, V7, pE912, DOI 10.1016/S2214-109X(19)30171-8; Stienstra Y, 2005, TROP MED INT HEALTH, V10, P1251, DOI 10.1111/j.1365-3156.2005.01519.x; Stienstra Y, 2002, AM J TROP MED HYG, V67, P207, DOI 10.4269/ajtmh.2002.67.207; Tai AYC, 2018, EMERG INFECT DIS, V24, P58, DOI 10.3201/eid2401.171070; Velink A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005261; Vincent QB, 2014, LANCET GLOB HEALTH, V2, pE422, DOI 10.1016/S2214-109X(14)70223-2; Wadagni AC, 2018, LANCET INFECT DIS, V18, P650, DOI 10.1016/S1473-3099(18)30160-9; WHO, 2012, FACT INV BUR ULC CLI; World Health Organization, 2020, NEGLECTED TROPICAL D; Yeboah-Manu D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006560	40	34	34	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 18	2020	395	10232					1259	1267		10.1016/S0140-6736(20)30047-7	http://dx.doi.org/10.1016/S0140-6736(20)30047-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE6FH	32171422	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-28	WOS:000526818800025
J	Haines, A; de Barros, EF; Berlin, A; Heymann, DL; Harris, MJ				Haines, Andy; de Barros, Enrique Falceto; Berlin, Anita; Heymann, David L.; Harris, Matthew J.			National UK programme of community health workers for COVID-19 response	LANCET			English	Editorial Material							CARE		[Haines, Andy] London Sch Hyg & Trop Med, Ctr Climate Change & Planetary Hlth, London, England; [de Barros, Enrique Falceto] Univ Caxias do Sul, Caxias Do Sul, RS, Brazil; [Berlin, Anita] Queen Mary Univ London, Barts & London Sch Med & Dent, Primary Care Educ & Community Based Med Educ, London, England; [Heymann, David L.] London Sch Hyg & Trop Med, Infect Dis Epidemiol, London, England; [Harris, Matthew J.] Imperial Coll London, Dept Primary Care & Publ Hlth, London W6 8RP, England	University of London; London School of Hygiene & Tropical Medicine; Universidade de Caxias do Sul; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Harris, MJ (corresponding author), Imperial Coll London, Dept Primary Care & Publ Hlth, London W6 8RP, England.	m.harris@imperial.ac.uk		Haines, Andy/0000-0002-8053-4605; Harris, Matthew/0000-0002-0005-9710				[Anonymous], ON MILL COMM HLTH WO; [Anonymous], J ROY SOC MED; [Anonymous], 2020, BUDG 2020 WHAT YOU N; [Anonymous], GRAND CONVERGENCE CH; Fine PEM, 2013, LANCET, V381, P1249, DOI 10.1016/S0140-6736(13)60766-7; Gillam S, 2016, J PUBLIC HEALTH-UK, V38, P522, DOI 10.1093/pubmed/fdv069; Hayhoe B, 2018, J ROY SOC MED, V111, P453, DOI 10.1177/0141076818803443; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; Skopec M, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l6205; WHO, 2019, REP WHO CHIN JOINT M	11	39	44	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2020	395	10231					1173	1175		10.1016/S0140-6736(20)30735-2	http://dx.doi.org/10.1016/S0140-6736(20)30735-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LE6DW	32220277	Green Published, Green Submitted, Bronze			2022-12-28	WOS:000526814200010
J	Remuzzi, A; Remuzzi, G				Remuzzi, Andrea; Remuzzi, Giuseppe			COVID-19 and Italy: what next?	LANCET			English	Article								The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has already taken on pandemic proportions, affecting over 100 countries in a matter of weeks. A global response to prepare health systems worldwide is imperative. Although containment measures in China have reduced new cases by more than 90%, this reduction is not the case elsewhere, and Italy has been particularly affected. There is now grave concern regarding the Italian national health system's capacity to effectively respond to the needs of patients who are infected and require intensive care for SARS-CoV-2 pneumonia. The percentage of patients in intensive care reported daily in Italy between March 1 and March 11, 2020, has consistently been between 9% and 11% of patients who are actively infected. The number of patients infected since Feb 21 in Italy closely follows an exponential trend. If this trend continues for 1 more week, there will be 30 000 infected patients. Intensive care units will then be at maximum capacity; up to 4000 hospital beds will be needed by mid-April, 2020. Our analysis might help political leaders and health authorities to allocate enough resources, including personnel, beds, and intensive care facilities, to manage the situation in the next few days and weeks. If the Italian outbreak follows a similar trend as in Hubei province, China, the number of newly infected patients could start to decrease within 3-4 days, departing from the exponential trend. However, this cannot currently be predicted because of differences between social distancing measures and the capacity to quickly build dedicated facilities in China.	[Remuzzi, Andrea] Univ Bergamo, Dept Management Informat & Prod Engn, I-24044 Dalmine, Italy; [Remuzzi, Giuseppe] IRCCS, Ist Ric Farmacol Mario Negri, Rome, Italy	University of Bergamo; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Remuzzi, A (corresponding author), Univ Bergamo, Dept Management Informat & Prod Engn, I-24044 Dalmine, Italy.	andrea.remuzzi@unibg.it						[Anonymous], 2020, THE ECONOMIST; Callaway E., 2020, NATURE, V2020, P579, DOI DOI 10.1038/d41586-020-00551-1; Johns Hopkins Center for Systems Science and Engineering, 2020, COR COVID 19 GLOB CA; Joint Mission, 2020, REP WHO CHIN JOINT M; Leung G., 2020, REAL TIME NOWCAST FO; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316	6	1706	1760	28	146	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 11	2020	395	10231					1225	1228		10.1016/S0140-6736(20)30627-9	http://dx.doi.org/10.1016/S0140-6736(20)30627-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE6DW	32178769	Green Published, Bronze			2022-12-28	WOS:000526814200032
J	Stack, CB; Meibohm, AR; Liao, JM; Guallar, E				Stack, Catharine B.; Meibohm, Anne R.; Liao, Joshua M.; Guallar, Eliseo			Studies Using Randomized Trial Data to Compare Nonrandomized Exposures	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stack, Catharine B.; Meibohm, Anne R.] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Liao, Joshua M.] Univ Washington, Sch Med, 1959 NE Pacific St, Seattle, WA 98115 USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Room 2-645, Baltimore, MD 21205 USA; [Guallar, Eliseo] Johns Hopkins Sch Med, Baltimore, MD USA; [Stack, Catharine B.] Jazz Pharmaceut, 2005 Market St,Suite 2100, Philadelphia, PA 19103 USA	American College of Physicians; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Jazz Pharmaceuticals	Meibohm, AR (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	ameibohm@acponline.org						Ananth CV, 2016, BJOG-INT J OBSTET GY, V123, P1056, DOI 10.1111/1471-0528.13732; Hernan MA, 2013, ANN INTERN MED, V159, P560, DOI 10.7326/0003-4819-159-8-201310150-00709; Howard G, 2012, PROG CARDIOVASC DIS, V54, P367, DOI 10.1016/j.pcad.2011.08.003; Porta M., 2014, DICT EPIDEMIOLOGY, V6th ed; Rigotti NA, 2018, ANN INTERN MED, V168, P613, DOI 10.7326/M17-2048; Rigotti NA, 2016, AM J PREV MED, V51, P597, DOI 10.1016/j.amepre.2016.04.005; Rubin DB, 2006, STAT SCI, V21, P206, DOI 10.1214/088342306000000259; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607	9	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 7	2020	172	7					492	+		10.7326/M20-0071	http://dx.doi.org/10.7326/M20-0071			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA6DM	32176887				2022-12-28	WOS:000524036500008
J	Dessert, C; Rodd, NL; Safdi, BR				Dessert, Christopher; Rodd, Nicholas L.; Safdi, Benjamin R.			The dark matter interpretation of the 3.5-keV line is inconsistent with blank-sky observations	SCIENCE			English	Article							PHOTON IMAGING CAMERA; XMM-NEWTON; STERILE NEUTRINOS; GALACTIC-CENTER; EMISSION	Observations of nearby galaxies and galaxy clusters have reported an unexpected x-ray emission line around 3.5 kilo-electron volts (keV). Proposals to explain this line include decaying dark matter -in particular, that the decay of sterile neutrinos with a mass around 7 keV could match the available data. If this interpretation is correct, the 3.5- keV line should also be emitted by dark matter in the halo of the Milky Way. We used more than 30 megaseconds of XMM-Newton (X-ray Multi-Mirror Mission) blank-sky observations to test this hypothesis, finding no evidence of the 3.5-keV line emission from the Milky Way halo. We set an upper limit on the decay rate of dark matter in this mass range, which is inconsistent with the possibility that the 3.5-keV line originates from dark matter decay.	[Dessert, Christopher; Safdi, Benjamin R.] Univ Michigan, Dept Phys, Leinweber Ctr Theoret Phys, Ann Arbor, MI 48109 USA; [Rodd, Nicholas L.] Univ Calif Berkeley, Berkeley Ctr Theoret Phys, Berkeley, CA 94720 USA; [Rodd, Nicholas L.] Lawrence Berkeley Natl Lab, Theoret Phys Grp, Berkeley, CA 94720 USA	University of Michigan System; University of Michigan; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Safdi, BR (corresponding author), Univ Michigan, Dept Phys, Leinweber Ctr Theoret Phys, Ann Arbor, MI 48109 USA.	bsafdi@umich.edu		Rodd, Nicholas/0000-0003-3472-7606; Dessert, Christopher/0000-0003-1994-088X	Department of Energy Early Career Grant [DE-SC0019225]; Miller Institute for Basic Research in Science at the University of California, Berkeley	Department of Energy Early Career Grant(United States Department of Energy (DOE)); Miller Institute for Basic Research in Science at the University of California, Berkeley(University of California System)	C.D. and B.R.S. were supported by the Department of Energy Early Career Grant DE-SC0019225. N.L.R. is supported by the Miller Institute for Basic Research in Science at the University of California, Berkeley. Computational resources and services were provided by Advanced Research Computing at the University of Michigan, Ann Arbor.	Abdalla H, 2018, ASTRON ASTROPHYS, V610, DOI [10.1051/0004-6361/201833052, 10.1051/0004-6361/201732426]; Aharonian FA, 2017, ASTROPHYS J LETT, V837, DOI 10.3847/2041-8213/aa61fa; Anderson ME, 2015, MON NOT R ASTRON SOC, V452, P3905, DOI 10.1093/mnras/stv1559; Boyarsky A, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.161301; Boyarsky A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.251301; Boyarsky A., 2018, ARXIV181210488ASTROP; Bulbul E, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/13; Burkert A, 1996, IAU SYMP, P175, DOI 10.1017/S0074180900232324; Cappelluti N, 2018, ASTROPHYS J, V854, DOI 10.3847/1538-4357/aaaa68; Catena R, 2010, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2010/08/004; Cicoli M, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.023540; Conlon JP, 2014, J COSMOL ASTROPART P, DOI 10.1088/1475-7516/2014/11/033; Cowan G, 2011, ARXIV11053166PHYSICS; Cowan G, 2011, EUR PHYS J C, V71, DOI 10.1140/epjc/s10052-011-1554-0; Gu L, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201527634; Hopkins PF, 2018, MON NOT R ASTRON SOC, V480, P800, DOI 10.1093/mnras/sty1690; JAMES F, 1975, COMPUT PHYS COMMUN, V10, P343, DOI 10.1016/0010-4655(75)90039-9; Jeltema T, 2015, MON NOT R ASTRON SOC, V450, P2143, DOI 10.1093/mnras/stv768; Kuntz KD, 2008, ASTRON ASTROPHYS, V478, P575, DOI 10.1051/0004-6361:20077912; Kusenko A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.241301; Lumb DH, 2002, ASTRON ASTROPHYS, V389, P93, DOI 10.1051/0004-6361:20020531; Malyshev D, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.103506; Moretti A, 2009, AIP CONF PROC, V1126, P223, DOI 10.1063/1.3149419; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Navarro JF, 1996, ASTROPHYS J, V462, P563, DOI 10.1086/177173; PAL PB, 1982, PHYS REV D, V25, P766, DOI 10.1103/PhysRevD.25.766; Rodd N., 2020, ZENODO, DOI [10.5281/zenodo.3669387, DOI 10.5281/ZENODO.3669387]; Rolke WA, 2005, NUCL INSTRUM METH A, V551, P493, DOI 10.1016/j.nima.2005.05.068; Ruchayskiy O, 2016, MON NOT R ASTRON SOC, V460, P1390, DOI 10.1093/mnras/stw1026; Salucci P, 2000, ASTROPHYS J, V537, pL9, DOI 10.1086/312747; Shah C, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/1/52; Shi XD, 1999, PHYS REV LETT, V82, P2832, DOI 10.1103/PhysRevLett.82.2832; Struder L, 2001, ASTRON ASTROPHYS, V365, pL18, DOI 10.1051/0004-6361:20000066; Struder L, 2003, NUCL INSTRUM METH A, V512, P386, DOI 10.1016/S0168-9002(03)01917-X; Turner MJL, 2001, ASTRON ASTROPHYS, V365, pL27, DOI 10.1051/0004-6361:20000087; Urban O, 2015, MON NOT R ASTRON SOC, V451, P2447, DOI 10.1093/mnras/stv1142; XMM-Newton Science Operations Centre Team, 2018, US GUID XMM NEWT SCI	42	30	30	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1465	+		10.1126/science.aaw3772	http://dx.doi.org/10.1126/science.aaw3772			53	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217724	Green Submitted			2022-12-28	WOS:000523251600034
J	Madsen, RSK; Qiao, A; Sen, JN; Hung, I; Chen, KZ; Gan, ZH; Sen, S; Yue, YZ				Madsen, Rasmus S. K.; Qiao, Ang; Sen, Jishnu; Hung, Ivan; Chen, Kuizhi; Gan, Zhehong; Sen, Sabyasachi; Yue, Yuanzheng			Ultrahigh-field Zn-67 NMR reveals short-range disorder in zeolitic imidazolate framework glasses	SCIENCE			English	Article							SOLID-STATE NMR; QUADRUPOLAR NUCLEI; SPECTROSCOPY; LIQUIDS	The structure of melt-quenched zeolitic imidazole framework (ZIF) glasses can provide insights into their glass-formation mechanism. We directly detected short-range disorder in ZIF glasses using ultrahigh-field zinc-67 solid-state nuclear magnetic resonance spectroscopy. Two distinct Zn sites characteristic of the parent crystals transformed upon melting into a single tetrahedral site with a broad distribution of structural parameters. Moreover, the ligand chemistry in ZIFs appeared to have no controlling effect on the short-range disorder, although the former affected their phase-transition behavior. These findings reveal structure-property relations and could help design metal-organic framework glasses.	[Madsen, Rasmus S. K.; Qiao, Ang; Yue, Yuanzheng] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Sen, Jishnu; Sen, Sabyasachi] Univ Calif Davis, Dept Mat Sci & Engn, Davis, CA 95616 USA; [Hung, Ivan; Chen, Kuizhi; Gan, Zhehong] Natl High Magnet Field Lab, 1800 E Paul Dirac Dr, Tallahassee, FL 32310 USA; [Yue, Yuanzheng] Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan 430070, Peoples R China; [Yue, Yuanzheng] Qilu Univ Technol, Sch Mat Sci & Engn, Jinan 250353, Peoples R China	Aalborg University; University of California System; University of California Davis; State University System of Florida; Florida State University; Wuhan University of Technology; Qilu University of Technology	Yue, YZ (corresponding author), Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark.; Sen, S (corresponding author), Univ Calif Davis, Dept Mat Sci & Engn, Davis, CA 95616 USA.; Yue, YZ (corresponding author), Wuhan Univ Technol, State Key Lab Silicate Mat Architectures, Wuhan 430070, Peoples R China.; Yue, YZ (corresponding author), Qilu Univ Technol, Sch Mat Sci & Engn, Jinan 250353, Peoples R China.	sbsen@ucdavis.edu; yy@bio.aau.dk	Hung, Ivan/D-8301-2018; Gan, Zhehong/C-2400-2011; Yue, Yuanzheng/H-1313-2011	Hung, Ivan/0000-0001-8916-739X; Gan, Zhehong/0000-0002-9855-5113; Yue, Yuanzheng/0000-0002-6048-5236; Chen, Kuizhi/0000-0002-9853-7070; Madsen, Rasmus Skov Klitgaard/0000-0002-7072-7091; Qiao, Ang/0000-0003-2195-464X	VILLUM FONDEN [13253]; NSFC, China [51802263]; National Science Foundation grant [NSF-DMR 1855176]; National Science Foundation [NSF/DMR-1644779]; state of Florida; NSF [DMR-1039938, DMR-0603042]; NIH [BTRR 1P41 GM122698]	VILLUM FONDEN(Villum Fonden); NSFC, China(National Natural Science Foundation of China (NSFC)); National Science Foundation grant(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); state of Florida; NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank the VILLUM FONDEN (13253) and the NSFC (51802263), China, for financial support. S.S. acknowledges support from the National Science Foundation grant NSF-DMR 1855176. The National High Magnetic Field Laboratory (NHMFL) is supported by the National Science Foundation through NSF/DMR-1644779 and the state of Florida. Development of the 36-T series connected hybrid magnet and NMR instrumentation was supported by NSF (DMR-1039938 and DMR-0603042) and NIH (BTRR 1P41 GM122698).	Ali MA, 2019, ACS OMEGA, V4, P12081, DOI 10.1021/acsomega.9b01559; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Banerjee R, 2008, SCIENCE, V319, P939, DOI 10.1126/science.1152516; Bastow TJ, 1996, J PHYS-CONDENS MAT, V8, P11309, DOI 10.1088/0953-8984/8/50/051; Bennett TD, 2016, J AM CHEM SOC, V138, P3484, DOI 10.1021/jacs.5b13220; Bennett TD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9079; Clupper DC, 2003, J NON-CRYST SOLIDS, V318, P43, DOI 10.1016/S0022-3093(02)01857-4; d'Espinose de la Caillerie JB, 2008, J MAGN RESON, V192, P244, DOI 10.1016/j.jmr.2008.03.001; Frentzel-Beyme L, 2019, J AM CHEM SOC, V141, P12362, DOI 10.1021/jacs.9b05558; Frentzel-Beyme L, 2019, J MATER CHEM A, V7, P985, DOI 10.1039/c8ta08016j; Gaillac R, 2018, J PHYS CHEM C, V122, P6730, DOI 10.1021/acs.jpcc.8b00385; Gaillac R, 2017, NAT MATER, V16, P1149, DOI [10.1038/NMAT4998, 10.1038/nmat4998]; Gan ZH, 2017, J MAGN RESON, V284, P125, DOI 10.1016/j.jmr.2017.08.007; Greaves GN, 2007, ADV PHYS, V56, P1, DOI 10.1080/00018730601147426; Harris RK, 2001, PURE APPL CHEM, V73, P1795, DOI 10.1351/pac200173111795; Kentgens APM, 1997, GEODERMA, V80, P271, DOI 10.1016/S0016-7061(97)00056-6; KUPCE E, 1995, J MAGN RESON SER A, V115, P273, DOI 10.1006/jmra.1995.1179; Larsen FH, 1999, J AM CHEM SOC, V121, P3783, DOI 10.1021/ja9839623; Lipton AS, 2004, J AM CHEM SOC, V126, P4735, DOI 10.1021/ja0305609; Massiot D, 2002, MAGN RESON CHEM, V40, P70, DOI 10.1002/mrc.984; Moghadam PZ, 2017, CHEM MATER, V29, P2618, DOI 10.1021/acs.chemmater.7b00441; Mroue KH, 2010, J PHYS CHEM A, V114, P324, DOI 10.1021/jp908325n; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Qiao A, 2019, OPT LETT, V44, P1623, DOI 10.1364/OL.44.001623; Qiao A, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao6827; Siegel R, 2007, J MAGN RESON, V184, P85, DOI 10.1016/j.jmr.2006.09.007; SPEARING DR, 1994, COMPUT GEOSCI, V20, P615, DOI 10.1016/0098-3004(94)90083-3; Sutrisno A, 2012, CHEM-EUR J, V18, P12251, DOI 10.1002/chem.201201563; Umeyama D, 2015, CHEM COMMUN, V51, P12728, DOI 10.1039/c5cc04626b; Umeyama D, 2015, J AM CHEM SOC, V137, P864, DOI 10.1021/ja511019u; WU G, 1995, INORG CHEM, V34, P1595, DOI 10.1021/ic00110a043; Zhang JY, 2019, CHEM COMMUN, V55, P2521, DOI 10.1039/c8cc09574d; Zhao YB, 2016, J AM CHEM SOC, V138, P10818, DOI 10.1021/jacs.6b07078; Zhou C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07532-z	34	65	65	23	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1473	+		10.1126/science.aaz0251	http://dx.doi.org/10.1126/science.aaz0251			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217725	Green Submitted, Green Accepted			2022-12-28	WOS:000523251600036
J	Wilson, JM; Malvania, N; Le, Y; Zhang, YC; Rigol, M; Weiss, DS				Wilson, Joshua M.; Malvania, Neel; Le, Yuan; Zhang, Yicheng; Rigol, Marcos; Weiss, David S.			Observation of dynamical fermionization	SCIENCE			English	Article							IMPENETRABLE BOSONS; GAS; SYSTEMS	The wave function of a Tonks-Girardeau (T-G) gas of strongly interacting bosons in one dimension maps onto the absolute value of the wave function of a noninteracting Fermi gas. Although this fermionization makes many aspects of the two gases identical, their equilibrium momentum distributions are quite different. We observed dynamical fermionization, where the momentum distribution of a T-G gas evolves from bosonic to fermionic after its axial confinement is removed. The asymptotic momentum distribution after expansion in one dimension is the distribution of rapidities, which are the conserved quantities associated with many-body integrable systems. Our measurements agree well with T-G gas theory. We also studied momentum evolution after the trap depth is suddenly changed to a new nonzero value, and we observed the theoretically predicted bosonic-fermionic oscillations.	[Wilson, Joshua M.; Malvania, Neel; Le, Yuan; Zhang, Yicheng; Rigol, Marcos; Weiss, David S.] Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Weiss, DS (corresponding author), Penn State Univ, Dept Phys, 104 Davey Lab, University Pk, PA 16802 USA.	dsweiss@psu.edu	Wilson, Joshua M/H-2177-2015; Weiss, David S/B-7886-2010; Rigol, Marcos/B-3505-2008	Wilson, Joshua M/0000-0002-1422-633X; Rigol, Marcos/0000-0002-5806-5873; Le, Yuan/0000-0002-0261-5135; Malvania, Neel/0000-0003-4220-6579; Zhang, Yicheng/0000-0002-4480-4508	NSF [PHY-1707482, PHY-1707576]; U.S. Army Research Office [W911NF-16-0031-P00005]	NSF(National Science Foundation (NSF)); U.S. Army Research Office	Supported by NSF grants PHY-1707482 (Y.Z. and M.R.) and PHY-1707576 (D.S.W., J.M.W., N.M., and Y.L.) and by U.S. Army Research Office grant W911NF-16-0031-P00005 (D.S.W., J.M.W., N.M., and Y.L.). The computations were carried out at the Institute for CyberScience at Penn State.	Bertini B, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.207201; Bethe H, 1931, Z PHYS, V71, P205, DOI 10.1007/BF01341708; Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; Bolech CJ, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.110602; Calabrese P, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/06/064001; Calabrese P, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/06/064003; Campbell AS, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.125302; Castro-Alvaredo OA, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041065; Caux JS, 2019, SCIPOST PHYS, V6, DOI 10.21468/SciPostPhys.6.6.070; Cazalilla MA, 2011, REV MOD PHYS, V83, P1405, DOI 10.1103/RevModPhys.83.1405; Fang B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.035301; GIRARDEAU M, 1960, J MATH PHYS, V1, P516, DOI 10.1063/1.1703687; Guan XW, 2013, REV MOD PHYS, V85, P1633, DOI 10.1103/RevModPhys.85.1633; Kinoshita T, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.190406; Kinoshita T, 2006, NATURE, V440, P900, DOI 10.1038/nature04693; Kinoshita T, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011602; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; LIEB EH, 1963, PHYS REV, V130, P1605, DOI 10.1103/PhysRev.130.1605; Mei ZT, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.021607; Menotti C, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043610; Minguzzi A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.240404; Moritz H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.250402; Olshanii M, 1998, PHYS REV LETT, V81, P938, DOI 10.1103/PhysRevLett.81.938; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Rigol M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.013604; Rigol M, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.031603; Rigol M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.230404; Rigol M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.240403; Rigol M, 2005, MOD PHYS LETT B, V19, P861, DOI 10.1142/S0217984905008876; Rigol M, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.063607; Schemmer M, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.090601; Segal SR, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.053601; Sutherland B, 1998, PHYS REV LETT, V80, P3678, DOI 10.1103/PhysRevLett.80.3678; Sutherland B., 2004, BEAUTIFUL MODELS; Tang YJ, 2018, PHYS REV X, V8, DOI 10.1103/PhysRevX.8.021030; Tolra BL, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.190401; Vidmar L, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.175301; Weiss D. S., HARVARD DATAVERSE, DOI [10.7910/DVN/7H7GRO, DOI 10.7910/DVN/7H7GRO]	40	33	33	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1461	+		10.1126/science.aaz0242	http://dx.doi.org/10.1126/science.aaz0242			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217723	Green Submitted			2022-12-28	WOS:000523251600033
J	Kozal, M; Aberg, J; Pialoux, G; Cahn, P; Thompson, M; Molina, JM; Grinsztejn, B; Diaz, R; Castagna, A; Kumar, P; Latiff, G; DeJesus, E; Gummel, M; Gartland, M; Pierce, A; Ackerman, P; Llamoso, C; Lataillade, M				Kozal, Michael; Aberg, Judith; Pialoux, Gilles; Cahn, Pedro; Thompson, Melanie; Molina, Jean-Michel; Grinsztejn, Beatriz; Diaz, Ricardo; Castagna, Antonella; Kumar, Princy; Latiff, Gulam; DeJesus, Edwin; Gummel, Mark; Gartland, Margaret; Pierce, Amy; Ackerman, Peter; Llamoso, Cyril; Lataillade, Max		BRIGHTE Trial Team	Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATTACHMENT INHIBITOR BMS-626529; PRODRUG BMS-663068; ACTIVE COMPONENT; PHASE 2B; EFFICACY; DOLUTEGRAVIR; AI438011; SAFETY; TRIAL	BackgroundAmong some patients with human immunodeficiency virus type 1 (HIV-1) infection who have undergone multiple antiretroviral therapies and have limited options for treatment, new classes of antiretroviral drugs with novel mechanisms of action are needed. Fostemsavir is the prodrug of temsavir, a first-in-class investigational HIV-1 attachment inhibitor. MethodsIn this ongoing phase 3 trial in 23 countries, we enrolled patients with multidrug-resistant HIV-1 infection in two cohorts, according to their remaining treatment options. In the first cohort, we assigned (in a 3:1 ratio) patients who had the option of using at least one fully active, approved antiretroviral drug in at least one but no more than two antiretroviral classes to add either fostemsavir (at a dose of 600 mg twice daily) or placebo to their failing regimen for 8 days, followed by open-label fostemsavir plus optimized background therapy (randomized cohort). In the second cohort, patients who had no remaining antiretroviral options were started on open-label fostemsavir plus optimized background therapy on day 1 (nonrandomized cohort). The primary end point was the mean change in the HIV-1 RNA level from day 1 through day 8 in the randomized cohort. ResultsA total of 371 patients were treated, including 272 in the randomized cohort and 99 in the nonrandomized cohort. At day 8, the mean decrease in the HIV-1 RNA level was 0.79 log(10) copies per milliliter in the fostemsavir group and 0.17 log(10) copies in the placebo group (P<0.001). At week 48, a virologic response (HIV-1 RNA level, <40 copies per milliliter) had occurred in 54% of the patients in the randomized cohort and in 38% of those in the nonrandomized cohort; the mean increase in the CD4+ T-cell count was 139 cells per cubic millimeter and 64 cells per cubic millimeter, respectively. Adverse events led to the discontinuation of fostemsavir in 7% of the patients. In the randomized cohort, glycoprotein 120 (gp120) substitutions were found in 20 of 47 patients (43%) with virologic failure. ConclusionsIn patients with multidrug-resistant HIV-1 infection with limited therapy options, those who received fostemsavir had a significantly greater decrease in the HIV-1 RNA level than those who received placebo during the first 8 days. Efficacy was sustained through 48 weeks. (Funded by Bristol-Myers Squibb and GSK/ViiV Healthcare; BRIGHTE ClinicalTrials.gov number, NCT02362503.) In this international trial involving 371 patients with highly drug-resistant HIV-1 infection, fostemsavir reduced the HIV-1 RNA level by 0.79 log(10) copies per milliliter during the first 8 days of treatment. At week 48, more than half the patients treated with fostemsavir and an optimized background regimen had a virologic response.	[Kozal, Michael] Yale Univ, Sch Med, New Haven, CT USA; [Kozal, Michael] Vet Affairs Connecticut Healthcare Syst, New Haven, CT USA; [Ackerman, Peter; Llamoso, Cyril; Lataillade, Max] ViiV Healthcare, 36 E Ind Rd, Branford, CT 06405 USA; [Aberg, Judith] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Pialoux, Gilles] Hop Tenon, AP HP, Paris, France; [Molina, Jean-Michel] Hop St Louis, AP HP, Paris, France; [Molina, Jean-Michel] Univ Paris Diderot Paris 7, Paris, France; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Thompson, Melanie] AIDS Res Consortium Atlanta, Atlanta, GA USA; [Grinsztejn, Beatriz] Fundacao Oswald Cruz, Inst Pesquisa Clin Evandro Chagas, Rio De Janeiro, Brazil; [Diaz, Ricardo] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Castagna, Antonella] Ist Sci San Raffaele, Milan, Italy; [Kumar, Princy] Georgetown Univ Hosp, Washington, DC 20007 USA; [Latiff, Gulam] Maxwell Ctr, Durban, South Africa; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Gummel, Mark] GlaxoSmithKline, Upper Providence, PA USA; [Gartland, Margaret; Pierce, Amy] ViiV Healthcare, Res Triangle Pk, NC USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Icahn School of Medicine at Mount Sinai; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Georgetown University; Orlando Immunology Center; GlaxoSmithKline; GlaxoSmithKline	Lataillade, M (corresponding author), ViiV Healthcare, 36 E Ind Rd, Branford, CT 06405 USA.	max.x.lataillade@viivhealthcare.com	Castagna, Antonella/K-3280-2018; Belaunzaran-Zamudio, Pablo F./T-4218-2019; Streinu-Cercel, Adrian/M-5835-2017	Castagna, Antonella/0000-0002-8338-9714; Belaunzaran-Zamudio, Pablo F./0000-0003-4775-4734; Streinu-Cercel, Adrian/0000-0001-6382-5067; Mallon, Patrick/0000-0002-4337-6222; , Michael/0000-0002-7719-7396; Walmsley, Sharon/0000-0002-3959-5692; Orofino, Giancarlo/0000-0003-3115-9674	Bristol-Myers Squibb; GSK/ViiV Healthcare	Bristol-Myers Squibb(Bristol-Myers Squibb); GSK/ViiV Healthcare	Funded by Bristol-Myers Squibb and GSK/ViiV Healthcare; BRIGHTE ClinicalTrials.gov number, NCT02362503.	Akil B, 2015, ANTIVIR THER, V20, P343, DOI 10.3851/IMP2878; Brown J, 2013, J PHARM SCI-US, V102, P1742, DOI 10.1002/jps.23476; Castagna A, 2014, J INFECT DIS, V210, P354, DOI 10.1093/infdis/jiu051; Emu B, 2018, NEW ENGL J MED, V379, P645, DOI 10.1056/NEJMoa1711460; Food Drug Administration Center for Drugs Evaluation Research, 2015, HUM IMM VIR 1 INF DE; Hruska M, 2013, 14 INT WORKSH CLIN P; Hsu R, 2018, 22 INT AIDS C AMST J; Lalezari JP, 2015, LANCET HIV, V2, pE427, DOI 10.1016/S2352-3018(15)00177-0; Langley DR, 2015, PROTEINS, V83, P331, DOI 10.1002/prot.24726; Lataillade M, 2017, 16 EUR AIDS C MIL OC; Lataillade M, 2018, JAIDS-J ACQ IMM DEF, V77, P299, DOI [10.1097/QAI.0000000000001602, 10.1097/qai.0000000000001602]; Li ZF, 2013, ANTIMICROB AGENTS CH, V57, P4172, DOI 10.1128/AAC.00513-13; Mani N, 2012, AIDS, V26, P899, DOI 10.1097/QAD.0b013e3283519371; Murray JS, 1999, AIDS, V13, P797, DOI 10.1097/00002030-199905070-00008; Nowicka-Sans B, 2012, ANTIMICROB AGENTS CH, V56, P3498, DOI 10.1128/AAC.00426-12; Pancera M, 2017, NAT CHEM BIOL, V13, P1115, DOI [10.1038/NCHEMBIO.2460, 10.1038/nchembio.2460]; Ray N, 2013, JAIDS-J ACQ IMM DEF, V64, P7, DOI 10.1097/QAI.0b013e31829726f3; Stolbach A, 2015, J MED TOXICOL, V11, P326, DOI 10.1007/s13181-015-0465-0; Thompson M, 2017, ANTIVIR THER, V22, P215, DOI 10.3851/IMP3112; Thompson S, 2019, INT J EVID BASED COA, P4, DOI 10.24384/86ee-ps25; Wensing AM, 2017, TOP ANTIVIR MED, V24, P132; Zhou NN, 2014, J ANTIMICROB CHEMOTH, V69, P573, DOI 10.1093/jac/dkt412; Zhu L, 2015, ANTIMICROB AGENTS CH, V59, P3816, DOI 10.1128/AAC.04914-14	23	59	61	3	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1232	1243		10.1056/NEJMoa1902493	http://dx.doi.org/10.1056/NEJMoa1902493			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY1UO	32212519	Bronze			2022-12-28	WOS:000522357300010
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Covid-19-recriminations and political point scoring must wait	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com							0	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m1153	10.1136/bmj.m1153	http://dx.doi.org/10.1136/bmj.m1153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213508	Bronze			2022-12-28	WOS:000523764500005
J	Mahase, E				Mahase, Elisabeth			Covid-19: most patients require mechanical ventilation in first 24 hours of critical care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, REP 196 PAT CRIT ILL	1	41	46	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1201	10.1136/bmj.m1201	http://dx.doi.org/10.1136/bmj.m1201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209544	Bronze			2022-12-28	WOS:000523764200011
J	Salisbury, H				Salisbury, Helen			Helen Salisbury: Coronavirus diaries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												helen.salisbury@phc.ox.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1178	10.1136/bmj.m1178	http://dx.doi.org/10.1136/bmj.m1178			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209552	Bronze			2022-12-28	WOS:000523764200005
J	Rimmer, A				Rimmer, Abi			Sixty seconds on ... covid kindness	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1169	10.1136/bmj.m1169	http://dx.doi.org/10.1136/bmj.m1169			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205322	Bronze			2022-12-28	WOS:000523764100013
J	Boujan, N; Geraud, C				Boujan, Nolwenn; Geraud, Cyrill			Neuropsychiatric symptoms, skin disease, and weight loss: necrolytic migratory erythema and a glucagonoma	LANCET			English	Editorial Material									[Boujan, Nolwenn] Heidelberg Univ, Dept Dermatol Venereol & Allergol, Univ Med Ctr, DE-68167 Mannheim, Germany; [Boujan, Nolwenn] Heidelberg Univ, Med Fac Mannheim, DE-68167 Mannheim, Germany; [Geraud, Cyrill] Heidelberg Univ, Sect Clin & Mol Dermatol, Med Fac Mannheim, Mannheim, Germany; [Geraud, Cyrill] Heidelberg Univ, European Ctr Angiosci, Mannheim, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Boujan, N (corresponding author), Heidelberg Univ, Dept Dermatol Venereol & Allergol, Univ Med Ctr, DE-68167 Mannheim, Germany.; Boujan, N (corresponding author), Heidelberg Univ, Med Fac Mannheim, DE-68167 Mannheim, Germany.	nolwenn.boujan@umm.de		Geraud, Cyrill/0000-0001-9432-6869					0	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					985	985						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199485				2022-12-28	WOS:000521744600029
J	Kintisch, E				Kintisch, Eli			THE LOST COLONY Some 900,000 king penguins vanished without a trace. Why?	SCIENCE			English	Editorial Material																			0	1	1	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1318	1320		10.1126/science.367.6484.1318	http://dx.doi.org/10.1126/science.367.6484.1318			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193318				2022-12-28	WOS:000522167400039
J	Thornton, J				Thornton, Jacqui			Ethnic minority patients receive worse mental healthcare than white patients, review finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Adams A, 2014, SOC SCI MED, V116, P161, DOI 10.1016/j.socscimed.2014.07.004; Bignall T., 2019, RACIAL DISPARITIES M; Department of Health and Social Care, 2018, MOD MENT HLTH ACT FI; Race Equality Foundation, 2019, RAC DISP MENT HLTH E	4	0	0	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m1058	10.1136/bmj.m1058	http://dx.doi.org/10.1136/bmj.m1058			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LA2CT	32179575				2022-12-28	WOS:000523761500004
J	Iacobucci, G				Iacobucci, Gareth			Sixty seconds on ... AA	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ferri M, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005032.pub2; Kelly JF, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012880.pub2	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m1056	10.1136/bmj.m1056	http://dx.doi.org/10.1136/bmj.m1056			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32169952				2022-12-28	WOS:000520014600009
J	Whitty, CJM; Watt, FM				Whitty, Christopher J. M.; Watt, Fiona M.			Map clusters of diseases to tackle multimorbidity	NATURE			English	Editorial Material						Health care; Medical research; Public health		Many people now have two or more diseases at once. It is time to rethink funding, research, publishing, training and treatment for this growing problem. Many people now have two or more diseases at once. It is time to rethink funding, research, publishing, training and treatment for this growing problem.	[Whitty, Christopher J. M.] Dept Hlth & Social Care, London, England; [Watt, Fiona M.] MRC, London, England; [Watt, Fiona M.] Kings Coll London, London, England	University of London; King's College London	Whitty, CJM (corresponding author), Dept Hlth & Social Care, London, England.	chris.whitty@dhsc.gov.uk; watt@mrc.ukri.org	Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154				Afshar S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2008-7; Allerton LA, 2011, J INTELLECT DISABILI, V15, P269, DOI 10.1177/1744629511430772; [Anonymous], 2018, MULT PRIOR GLOB HLTH; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Centers for Disease Control (CDC), 1981, MMWR Morb Mortal Wkly Rep, V30, P305; Chang AY, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001386; da Silva SN, 2017, INT J PAEDIATR DENT, V27, P388, DOI 10.1111/ipd.12274; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Dunbar P, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.7613; Firth J, 2019, LANCET PSYCHIAT, V6, P675, DOI 10.1016/S2215-0366(19)30132-4; Foreman KJ, 2018, LANCET, V392, P2052, DOI [10.1016/S0140-6736(18)31694-5, 10.1016/s0140-6736(18)31694-5]; Jani BD, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1305-x; Kingston A, 2018, AGE AGEING, V47, P374, DOI 10.1093/ageing/afx201; Lis K, 2014, ARCH MED SCI, V10, P1175, DOI 10.5114/aoms.2014.47827; Miller M, 2014, BEHAV BRAIN RES, V269, P95, DOI 10.1016/j.bbr.2014.04.011; Nicholson K, 2019, BRIT J GEN PRACT, V69, pE647, DOI 10.3399/bjgp19X704657; Pan HH, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004428; Regev A, 2017, ELIFE, V6, DOI 10.7554/eLife.27041; Rijken M., 2013, Eurohealth, V19, P29; Schiotz ML, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4314-8; Zhang R, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024268	21	22	22	4	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					494	496		10.1038/d41586-020-00837-4	http://dx.doi.org/10.1038/d41586-020-00837-4			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KW9QD	32210388				2022-12-28	WOS:000521517300005
J	Localio, AR; Meibohm, AR; Guallar, E				Localio, A. Russell; Meibohm, Anne R.; Guallar, Eliseo			Finding the Pathway: Mediation Analyses in Randomized Controlled Trials	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SENSITIVITY-ANALYSIS; CAUSAL; SIZE		[Localio, A. Russell] Univ Penn, Philadelphia, PA 19104 USA; [Meibohm, Anne R.] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Localio, A. Russell] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Div Biostat, 617 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 2024 East Monument St,Room 2-645, Baltimore, MD 21205 USA; [Guallar, Eliseo] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Med, 2024 East Monument St,Room 2-645, Baltimore, MD 21205 USA	University of Pennsylvania; American College of Physicians; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Localio, AR (corresponding author), Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Div Biostat, 617 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	rlocalio@pennmedicine.upenn.edu						Daniel RM, 2011, STATA J, V11, P479, DOI 10.1177/1536867X1101100401; Ding P, 2016, BIOMETRIKA, V103, P483, DOI 10.1093/biomet/asw012; Ding P, 2016, EPIDEMIOLOGY, V27, P368, DOI 10.1097/EDE.0000000000000457; Emsley R., 2013, PARAMED STATA MODULE; Hicks R, 2011, STATA J, V11, P605, DOI 10.1177/1536867X1101100407; Imai K, 2010, PSYCHOL METHODS, V15, P309, DOI 10.1037/a0020761; Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321; Kenny DA, 2016, POWMEDR; Lange T, 2011, EPIDEMIOLOGY, V22, P575, DOI 10.1097/EDE.0b013e31821c680c; SAS Institute, 2018, CAUSALMED SAS STAT 1; Stapleton LM, 2015, J EXP EDUC, V83, P547, DOI 10.1080/00220973.2014.919569; Steen J, 2020, FLEXIBLE MEDIATION A; Talloen W, 2016, J EDUC BEHAV STAT, V41, P359, DOI 10.3102/1076998616636855; Tchetgen EJT, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1351; Have TR, 2007, BIOMETRICS, V63, P926, DOI 10.1111/j.1541-0420.2007.00766.x; Tingley D., 2015, MEDIATION R PACKAGE; Tingley D, 2014, J STAT SOFTW, V59; Valeri L, COMPUTATIONAL TOOLS; Valeri L, 2013, PSYCHOL METHODS, V18, P137, DOI 10.1037/a0031034; Vallurupalli M, 2020, ANN INTERN MED, V172, P523, DOI 10.7326/M19-2945; VanderWeele T J, 2014, Epidemiol Methods, V2, P95; VanderWeele TJ, 2015, EXPLANATION CAUSAL I; VanderWeele TJ, 2017, J R STAT SOC B, V79, P917, DOI 10.1111/rssb.12194; VanderWeele TJ, 2016, ANNU REV PUBL HEALTH, V37, P17, DOI 10.1146/annurev-publhealth-032315-021402; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P749, DOI 10.1097/EDE.0000000000000121; Vanderweele TJ, 2013, J AM STAT ASSOC, V108, P469, DOI 10.1080/01621459.2013.779832; VanderWeele TJ, 2011, EPIDEMIOLOGY, V22, P582, DOI 10.1097/EDE.0b013e31821db37e; Vittinghoff E, 2015, PREV SCI, V16, P1128, DOI 10.1007/s11121-014-0528-5; Wang W, 2017, J R STAT SOC C-APPL, V66, P741, DOI 10.1111/rssc.12188	29	1	1	3	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2020	172	8					553	+		10.7326/M20-0887	http://dx.doi.org/10.7326/M20-0887			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LF9LH	32203981				2022-12-28	WOS:000527733800016
J	Jain, N; Blauch, LR; Szymanski, MR; Das, R; Tang, SKY; Yin, YW; Fire, AZ				Jain, Nimit; Blauch, Lucas R.; Szymanski, Michal R.; Das, Rhiju; Tang, Sindy K. Y.; Yin, Y. Whitney; Fire, Andrew Z.			Transcription polymerase-catalyzed emergence of novel RNA replicons	SCIENCE			English	Article							ESCHERICHIA-COLI; STRUCTURAL BASIS; MOLECULAR-BASIS; MESSENGER-RNA; DNA; REPLICATION; INITIATION; SEQUENCE; REVEALS; SEARCH	Transcription polymerases can exhibit an unusual mode of regenerating certain RNA templates from RNA, yielding systems that can replicate and evolve with RNA as the information carrier. Two classes of pathogenic RNAs (hepatitis delta virus in animals and viroids in plants) are copied by host transcription polymerases. Using in vitro RNA replication by the transcription polymerase of T7 bacteriophage as an experimental model, we identify hundreds of new replicating RNAs, define three mechanistic hallmarks of replication (subterminal de novo initiation, RNA shape-shifting, and interrupted rolling-circle synthesis), and describe emergence from DNA seeds as a mechanism for the origin of novel RNA replicons. These results inform models for the origins and replication of naturally occurring RNA genetic elements and suggest a means by which diverse RNA populations could be propagated as hereditary material in cellular contexts.	[Jain, Nimit; Fire, Andrew Z.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Jain, Nimit; Fire, Andrew Z.] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Jain, Nimit] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Blauch, Lucas R.; Tang, Sindy K. Y.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Szymanski, Michal R.; Yin, Y. Whitney] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Szymanski, Michal R.; Yin, Y. Whitney] Univ Texas Med Branch, Sealy Ctr Struct Biol, Galveston, TX 77555 USA; [Szymanski, Michal R.] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80307 Gdansk, Poland; [Szymanski, Michal R.] Med Univ Gdansk, PL-80307 Gdansk, Poland; [Das, Rhiju] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk; Stanford University	Fire, AZ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.; Fire, AZ (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	afire@stanford.edu	Jain, Nimit/HIK-2809-2022	, Nimit/0000-0001-8759-2456; Fire, Andrew/0000-0001-6217-8312; Das, Rhiju/0000-0001-7497-0972; Tang, Sindy/0000-0003-1465-2432; Szymanski, Michal/0000-0001-9452-8508	NIH [R01GM37706, R35GM130366, R01AI134611, R35GM122579, T32GM008412]; Stanford Graduate Fellowship; NSF Center for Cellular Construction [DBI-1548297]; National Science Centre, Poland [UMO-2016/21/P/NZ1/01085]; Jane B. Kempner Postdoctoral Fellowship; National Science Foundation [ECCS-1542152]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); NSF Center for Cellular Construction; National Science Centre, Poland(National Science Centre, Poland); Jane B. Kempner Postdoctoral Fellowship; National Science Foundation(National Science Foundation (NSF))	This work was supported by NIH grants R01GM37706 (A.Z.F.), R35GM130366 (A.Z.F.), R01AI134611 (Y.W.Y.), R35GM122579 (R.D.), and T32GM008412 (L.R.B.); a Stanford Graduate Fellowship (N.J.); NSF DBI-1548297 Center for Cellular Construction (L.R.B. and S.K.Y.T.); National Science Centre, Poland grant UMO-2016/21/P/NZ1/01085 (M.R.S.); and a Jane B. Kempner Postdoctoral Fellowship (M.R.S). Part of this work was performed at the Stanford Nano Shared Facilities (SNSF), supported by the National Science Foundation under award ECCS-1542152.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; [Anonymous], **DATA OBJECT**, DOI DOI 10.0.HTTPS://CRAN.R-PR0JECT.0RG/PACKAGE=TABLE0NE; Arribere JA, 2016, NATURE, V534, P719, DOI 10.1038/nature18308; Bartel D.P, 1999, RNA WORLD 2 NAT MOD, V37, P143; BIEBRICH.CK, 1973, P NATL ACAD SCI USA, V70, P934, DOI 10.1073/pnas.70.3.934; Biebricher CK, 1996, EMBO J, V15, P3458, DOI 10.1002/j.1460-2075.1996.tb00712.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brazas R, 1996, SCIENCE, V274, P90, DOI 10.1126/science.274.5284.90; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; Delgado S, 2005, J VIROL, V79, P12934, DOI 10.1128/JVI.79.20.12934-12943.2005; Diener TO, 2016, BIOL DIRECT, V11, DOI 10.1186/s13062-016-0116-7; DOMINGO E, 1978, CELL, V13, P735, DOI 10.1016/0092-8674(78)90223-4; ENGLAND TE, 1978, NATURE, V275, P560, DOI 10.1038/275560a0; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FIRE A, 1995, P NATL ACAD SCI USA, V92, P4641, DOI 10.1073/pnas.92.10.4641; Flores R, 2009, VIRUSES-BASEL, V1, P317, DOI 10.3390/v1020317; Furrows SJ, 2001, CLIN MICROBIOL INFEC, V7, P227, DOI 10.1046/j.1469-0691.2001.00248.x; Gholamalipour Y, 2018, NUCLEIC ACIDS RES, V46, P9253, DOI 10.1093/nar/gky796; Gildehaus N, 2007, NUCLEIC ACIDS RES, V35, P1885, DOI 10.1093/nar/gkm085; Ginzburg Carlo, 1976, FORMAGGIO VERMI COSM; GRODBERG J, 1988, J BACTERIOL, V170, P1245, DOI 10.1128/jb.170.3.1245-1253.1988; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Kakimoto Y, 2015, AIP CONF PROC, V1649, P113, DOI 10.1063/1.4913554; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; KONARSKA MM, 1989, CELL, V57, P423, DOI 10.1016/0092-8674(89)90917-3; KONARSKA MM, 1990, CELL, V63, P609, DOI 10.1016/0092-8674(90)90456-O; KRUPP G, 1989, NUCLEIC ACIDS RES, V17, P3023, DOI 10.1093/nar/17.8.3023; Lai MMC, 2005, J VIROL, V79, P7951, DOI 10.1128/JVI.79.13.7951-7958.2005; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Matsumura S, 2016, SCIENCE, V354, P1293, DOI 10.1126/science.aag1582; MILLS DR, 1988, J MOL BIOL, V200, P489, DOI 10.1016/0022-2836(88)90538-4; Mindich L, 1999, ADV VIRUS RES, V53, P341, DOI 10.1016/S0065-3527(08)60355-3; MOODY MD, 1994, BIOCHEMISTRY-US, V33, P13836, DOI 10.1021/bi00250a038; MURCHIE AIH, 1987, NUCLEIC ACIDS RES, V15, P9641, DOI 10.1093/nar/15.23.9641; Navarro JA, 2000, EMBO J, V19, P2662, DOI 10.1093/emboj/19.11.2662; Navarro JA, 2000, VIROLOGY, V268, P218, DOI 10.1006/viro.1999.0161; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; PRIANO C, 1987, COLD SPRING HARB SYM, V52, P321, DOI 10.1101/SQB.1987.052.01.037; Pruitt K., 2012, NCBI HDB; Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308; Sanders R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075296; Sarcar SN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32231-6; Seidl CI, 2013, NUCLEIC ACIDS RES, V41, P2552, DOI 10.1093/nar/gks1334; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Steitz TA, 2004, CURR OPIN STRUC BIOL, V14, P4, DOI 10.1016/j.sbi.2004.01.006; SUMPER M, 1975, P NATL ACAD SCI USA, V72, P162, DOI 10.1073/pnas.72.1.162; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Takeshita D, 2012, NAT STRUCT MOL BIOL, V19, P229, DOI 10.1038/nsmb.2204; Urabe H, 2010, BIOCHEMISTRY-US, V49, P1809, DOI 10.1021/bi901805u; Wagner SD, 2013, EMBO J, V32, P781, DOI 10.1038/emboj.2013.18; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Wettich A, 2001, BIOCHEMISTRY-US, V40, P3308, DOI 10.1021/bi002756g; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300; ZHENG GX, 1988, J BIOL CHEM, V263, P5356; ZHOU W, 1995, CELL, V82, P577, DOI 10.1016/0092-8674(95)90030-6; Zyrina NV, 2014, FEMS MICROBIOL LETT, V351, P1, DOI 10.1111/1574-6968.12326	65	10	10	7	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 10	2020	368	6487					153	+	eaay0688	10.1126/science.aay0688	http://dx.doi.org/10.1126/science.aay0688			66	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LB9YI	32217750	Green Accepted, Bronze			2022-12-28	WOS:000524986900037
J	Limb, M				Limb, Matthew			The BMJ Awards 2020: Respiratory team of the year	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1098	10.1136/bmj.m1098	http://dx.doi.org/10.1136/bmj.m1098			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217528				2022-12-28	WOS:000523764800005
J	Sykes, DB; Zhang, EW; Leaf, RSK; Nardi, V; Turbett, SE				Sykes, David B.; Zhang, Eric W.; Leaf, Rebecca S. Karp; Nardi, Valentina; Turbett, Sarah E.			Case 10-2020: An 83-Year-Old Man with Pancytopenia and Acute Renal Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN GRANULOCYTIC ANAPLASMOSIS; INFECTIOUS-DISEASES SOCIETY; DIAGNOSIS; LEUKEMIA	An 83-year-old man presented with pancytopenia and acute renal failure. The haptoglobin level was normal, but levels of d-dimer and lactate dehydrogenase were markedly elevated. Tretinoin was administered, and diagnostic test results were received.	[Sykes, David B.; Leaf, Rebecca S. Karp; Turbett, Sarah E.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Zhang, Eric W.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Nardi, Valentina; Turbett, Sarah E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sykes, David B.; Leaf, Rebecca S. Karp; Turbett, Sarah E.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Zhang, Eric W.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [Nardi, Valentina; Turbett, Sarah E.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Sykes, DB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Sykes, DB (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.							[Anonymous], 2011, NEW ENGL J MED, V364, P759; [Anonymous], 2018, NEW ENGL J MED, V378, P2023; Bakken JS, 2006, ANN NY ACAD SCI, V1078, P236, DOI 10.1196/annals.1374.042; Bakken JS, 2015, INFECT DIS CLIN N AM, V29, P341, DOI 10.1016/j.idc.2015.02.007; Baron EJ, 2013, CLIN INFECT DIS, V57, pE22, DOI 10.1093/cid/cit278; Centers for Disease Control and Prevention, 2019, AN EP STAT; Dhand A, 2007, CLIN INFECT DIS, V45, P589, DOI 10.1086/520659; Dzik WH, 2003, VOX SANG, V85, P40, DOI 10.1046/j.1423-0410.2003.00313.x; Ganz T, 2019, NEW ENGL J MED, V381, P1148, DOI 10.1056/NEJMra1804281; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669; Lehmann S, 2017, LEUKEMIA, V31, P1457, DOI 10.1038/leu.2017.71; Lo-Coco F, 2013, NEW ENGL J MED, V369, P111, DOI 10.1056/NEJMoa1300874; Lo-Coco F, 2016, NEW ENGL J MED, V374, P1197, DOI 10.1056/NEJMc1513710; Mead P, 2019, MMWR-MORBID MORTAL W, V68, P703, DOI 10.15585/mmwr.mm6832a4; Tallman MS, 2019, J NATL COMPR CANC NE, V17, P721, DOI 10.6004/jnccn.2019.0028; Turbett SE, 2020, CLIN INFECT DIS, V70, P1215, DOI 10.1093/cid/ciz346; Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667; Zarychanski R, 2017, HEMATOL-AM SOC HEMAT, P660, DOI 10.1182/asheducation-2017.1.660	19	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1258	1266		10.1056/NEJMcpc1916250	http://dx.doi.org/10.1056/NEJMcpc1916250			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY1UO	32212524				2022-12-28	WOS:000522357300013
J	Dyer, O				Dyer, Owen			Covid-19: Trump declares intention to "re-open economy" within weeks against experts' advice	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Cohen J., 2020, SCIENCE, V22, DOI [10.1126/science.abb8295, DOI 10.1126/SCIENCE.ABB8295]; Ferguson N., 2020, IMPERIAL COLL LONDON	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m1217	10.1136/bmj.m1217	http://dx.doi.org/10.1136/bmj.m1217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213487	Bronze			2022-12-28	WOS:000523764500014
J	Harpavat, S; Garcia-Prats, JA; Anaya, C; Brandt, ML; Lupo, PJ; Finegold, MJ; Obuobi, A; ElHennawy, AA; Jarriel, WS; Shneider, BL				Harpavat, Sanjiv; Garcia-Prats, Joseph A.; Anaya, Carlos; Brandt, Mary L.; Lupo, Philip J.; Finegold, Milton J.; Obuobi, Alice; ElHennawy, Adel A.; Jarriel, William S.; Shneider, Benjamin L.			Diagnostic Yield of Newborn Screening for Biliary Atresia Using Direct or Conjugated Bilirubin Measurements	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEPATOPORTOENTEROSTOMY; JAUNDICE; OUTCOMES; OPERATION; INFANTS; COHORT; AGE	IMPORTANCE Treating biliary atresia in newborns earlier can delay or prevent the need for liver transplant; however, treatment typically occurs later because biliary atresia is difficult to detect during its early stages. OBJECTIVE To determine the diagnostic yield of newborn screening for biliary atresia with direct or conjugated bilirubin measurements and to evaluate the association of screening implementation with clinical outcomes. DESIGN, SETTING, AND PARTICIPANTS A cross-sectional screening study of 124 385 infants born at 14 Texas hospitals between January 2015 and June 2018; and a pre-post study of 43 infants who underwent the Kasai portoenterostomy as treatment for biliary atresia at the region's largest pediatric hepatology center before (January 2008-June 2011) or after (January 2015-June 2018) screening implementation. Final follow-up occurred on July 15, 2019. EXPOSURES Two-stage screening with direct or conjugated bilirubin measurements. In stage 1, all newborns were tested within the first 60 hours of life, with a positive screening result defined as bilirubin levels exceeding derived 95th percentile reference intervals. In stage 2, infants who had a positive screening result in stage 1 were retested at or before the 2-week well-child visit, with a positive screening result defined as bilirubin levels greater than the stage 1 result or greater than 1mg/dL. MAIN OUTCOMES AND MEASURES The primary outcomes of the screening study were sensitivity, specificity, positive predictive value, and negative predictive value based on infants testing positive in both stages. The reference standard was biliary atresia diagnosed at the region's pediatric hepatology centers. The primary outcome of the pre-post study was the age infants underwent the Kasai portoenterostomy for treatment of biliary atresia. RESULTS Of 124 385 newborns in the screening study, 49.2% were female, 87.6% were of term gestational age, 70.0% were white, and 48.1% were Hispanic. Screening identified the 7 known infants with biliary atresia with a sensitivity of 100% (95% CI, 56.1%-100.0%), a specificity of 99.9% (95% CI, 99.9%-99.9%), a positive predictive value of 5.9% (95% CI, 2.6%-12.2%), and a negative predictive value of 100.0%(95% CI, 100.0%-100.0%). In the pre-post study, 24 infants were treated before screening implementation and 19 infants were treated after screening implementation (including 6 of 7 from the screening study, 7 from screening at nonstudy hospitals, and 6 from referrals because of clinical symptoms). The age infants underwent the Kasai portoenterostomy was significantly younger after screening was implemented (mean age, 56 days [SD, 19 days] before screening implementation vs 36 days [SD, 22 days] after screening implementation; between-group difference, 19 days [95% CI, 7-32 days]; P =.004). CONCLUSIONS AND RELEVANCE Newborn screening with direct or conjugated bilirubin measurements detected all known infants with biliary atresia in the study population, although the 95% CI around the sensitivity estimate was wide and the study design did not ensure complete ascertainment of false-negative results. Research is needed in larger populations to obtain more precise estimates of diagnostic yield and to better understand the clinical outcomes and cost-effectiveness of this screening approach.	[Harpavat, Sanjiv; Shneider, Benjamin L.] Baylor Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 6621 Fannin St,MWT 1010, Houston, TX 77030 USA; [Harpavat, Sanjiv; Garcia-Prats, Joseph A.; Brandt, Mary L.; Lupo, Philip J.; Obuobi, Alice; ElHennawy, Adel A.; Shneider, Benjamin L.] Texas Childrens Hosp, 6621 Fannin St,MWT 1010, Houston, TX 77030 USA; [Garcia-Prats, Joseph A.; Obuobi, Alice; ElHennawy, Adel A.] Baylor Coll Med, Dept Pediat, Div Neonatol, Houston, TX 77030 USA; [Anaya, Carlos] Univ Texas Rio Grande Valley, Sch Med, Edinburg, TX USA; [Anaya, Carlos] Doctors Hosp Renaissance, Edinburg, TX USA; [Brandt, Mary L.] Baylor Coll Med, Dept Surg, Houston, TX 77030 USA; [Lupo, Philip J.] Baylor Coll Med, Dept Pediat, Div Hematol Oncol, Houston, TX 77030 USA; [Finegold, Milton J.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Jarriel, William S.] Womans Hosp Texas, Houston, TX USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Rio Grande Valley; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Harpavat, S (corresponding author), Baylor Coll Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, 6621 Fannin St,MWT 1010, Houston, TX 77030 USA.; Harpavat, S (corresponding author), Texas Childrens Hosp, 6621 Fannin St,MWT 1010, Houston, TX 77030 USA.	harpavat@bcm.edu		Lupo, Philip/0000-0003-0978-5863	National Institute of Diabetes and Digestive and Kidney Diseases [1 K23 DK109207]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant 1 K23 DK109207 from the National Institute of Diabetes and Digestive and Kidney Diseases.	Bezerra JA, 2018, HEPATOLOGY, V68, P1163, DOI 10.1002/hep.29905; Bezerra JA, 2014, JAMA-J AM MED ASSOC, V311, P1750, DOI 10.1001/jama.2014.2623; Clinical and Laboratory Standards Institute, 2008, EP28A3C CLIN LAB STA; Davis AR, 2011, J PEDIATR-US, V158, P562, DOI 10.1016/j.jpeds.2010.09.061; DOUMAS BT, 1991, CRIT REV CL LAB SCI, V28, P415, DOI 10.3109/10408369109106872; Fanna M, 2019, J PEDIATR GASTR NUTR, V69, P416, DOI 10.1097/MPG.0000000000002446; Fawaz R, 2017, J PEDIATR GASTR NUTR, V64, P154, DOI 10.1097/MPG.0000000000001334; Gong ZH, 2020, EUR J PEDIATR SURG, V30, P459, DOI 10.1055/s-0039-1698764; Gu YH, 2015, J PEDIATR-US, V166, P897, DOI 10.1016/j.jpeds.2014.12.063; Guthery SL, 2019, HEPATOLOGY, V70, p54A; Harpavat S, 2018, J PEDIATR GASTR NUTR, V66, P850, DOI 10.1097/MPG.0000000000001887; Harpavat S, 2016, NEW ENGL J MED, V375, P605, DOI 10.1056/NEJMc1601230; Harpavat S, 2016, J PEDIATR GASTR NUTR, V62, P799, DOI 10.1097/MPG.0000000000001097; Harpavat S, 2011, PEDIATRICS, V128, pE1428, DOI 10.1542/peds.2011-1869; Jimenez-Rivera C, 2013, J PEDIATR GASTR NUTR, V56, P344, DOI 10.1097/MPG.0b013e318282a913; Kwon C, 2000, ARCH PEDIAT ADOL MED, V154, P714, DOI 10.1001/archpedi.154.7.714; Lin JS, 2015, WORLD J GASTROENTERO, V21, P13080, DOI 10.3748/wjg.v21.i46.13080; Liu GY, 2017, VIROL SIN, V32, P376, DOI 10.1007/s12250-017-4055-y; Maisels MJ, 2004, PEDIATRICS, V114, P297; Masucci L, 2019, J MED SCREEN, V26, P113, DOI 10.1177/0969141319832039; Noorulla F, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.13321; Per H, 2013, NEUROL SCI, V34, P51, DOI 10.1007/s10072-012-0965-5; Schreiber RA, 2007, J PEDIATR-US, V151, P659, DOI 10.1016/j.jpeds.2007.05.051; Schreiber RA, 2014, J MED SCREEN, V21, P126, DOI 10.1177/0969141314542115; Serinet MO, 2009, PEDIATRICS, V123, P1280, DOI 10.1542/peds.2008-1949; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Shneider BL, 2016, J PEDIATR-US, V170, P211, DOI 10.1016/j.jpeds.2015.11.058; Sokol RJ, 2007, HEPATOLOGY, V46, P566, DOI 10.1002/hep.21790; Superina R, 2011, ANN SURG, V254, P577, DOI 10.1097/SLA.0b013e3182300950; van Hasselt PM, 2009, ARCH DIS CHILD-FETAL, V94, pF456, DOI 10.1136/adc.2008.148239; Wadhwani SI, 2008, PEDIATRICS, V121, pE1438, DOI 10.1542/peds.2007-2709; Wang KS, 2015, PEDIATRICS, V136, pE1663, DOI 10.1542/peds.2015-3570; Wu JF, 2018, HEPATOLOGY, V68, P616, DOI 10.1002/hep.29856	33	39	42	2	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1141	1150		10.1001/jama.2020.0837	http://dx.doi.org/10.1001/jama.2020.0837			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207797	Bronze, Green Published			2022-12-28	WOS:000530807000017
J	Singh, I; Naci, H; Miller, J; Caplan, A; Cipriani, A				Singh, Ilina; Naci, Huseyin; Miller, Jennifer; Caplan, Arthur; Cipriani, Andrea			Ethical implications of poor comparative effectiveness evidence: obligations in industry-research partnerships	LANCET			English	Editorial Material									[Singh, Ilina; Cipriani, Andrea] Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England; [Singh, Ilina] Univ Oxford, Big Data Inst, Wellcome Ctr Eth & Humanities, Oxford, England; [Naci, Huseyin] London Sch Econ & Polit Sci, Dept Hlth Policy, London, England; [Miller, Jennifer] Yale Univ, Yale Sch Med, New Haven, CT USA; [Caplan, Arthur] NYU, Grossman Sch Med, Div Med Eth, New York, NY USA; [Cipriani, Andrea] Warneford Hosp, Oxford Hlth NHS Fdn Trust, Oxford, England	University of Oxford; University of Oxford; University of London; London School Economics & Political Science; Yale University; New York University	Singh, I (corresponding author), Univ Oxford, Dept Psychiat, Oxford OX3 7JX, England.; Singh, I (corresponding author), Univ Oxford, Big Data Inst, Wellcome Ctr Eth & Humanities, Oxford, England.	ilina.singh@psych.ox.ac.uk	Cipriani, Andrea/P-6944-2015	Cipriani, Andrea/0000-0001-5179-8321; Caplan, Art/0000-0002-4061-8011; Miller, Jennifer/0000-0002-3591-369X; Singh, Ilina/0000-0003-4497-3587	Wellcome Trust [104825/Z/14/Z, 203132/Z/16/Z] Funding Source: Medline; Department of Health [RP-2017-08-ST2-006] Funding Source: Medline	Wellcome Trust(Wellcome Trust); Department of Health		[Anonymous], 2019, BMJ; Cipriani A, 2020, LANCET, V395, P998, DOI 10.1016/S0140-6736(19)33177-0; Goldman E, 2008, INFORM SCI KNOWL MAN, V14, P121; Greenhalgh T, 2019, HEALTH EXPECT, V22, P785, DOI 10.1111/hex.12888; Henshall C, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1406-z; Herder M, 2019, MILBANK Q, V97, P820, DOI 10.1111/1468-0009.12413; Kroenke K, 2015, JAMA INTERN MED, V175, P1770, DOI 10.1001/jamainternmed.2015.5243; Kumar S, 2019, LANCET, V394, P281, DOI 10.1016/S0140-6736(19)31711-8; Mittelstadt BD, 2016, BIG DATA SOC, V3, P1, DOI 10.1177/2053951716679679; Montgomery Jonathan., 2013, NOVEL NEUROTECHNOLOG; Naci H, 2020, LANCET, V395, P986, DOI 10.1016/S0140-6736(19)33178-2; Tomlinson A, 2020, EVID-BASED MENT HEAL, V23, P52, DOI 10.1136/ebmental-2019-300118	12	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					926	928						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32199476	Green Accepted, Green Submitted			2022-12-28	WOS:000521744600008
J	Bergstrom, A; McCarthy, SA; Hui, RY; Almarri, MA; Ayub, Q; Danecek, P; Chen, Y; Felkel, S; Hallast, P; Kamm, J; Blanche, H; Deleuze, JF; Cann, H; Mallick, S; Reich, D; Sandhu, MS; Skoglund, P; Scally, A; Xue, YL; Durbin, R; Tyler-Smith, C				Bergstrom, Anders; McCarthy, Shane A.; Hui, Ruoyun; Almarri, Mohamed A.; Ayub, Qasim; Danecek, Petr; Chen, Yuan; Felkel, Sabine; Hallast, Pille; Kamm, Jack; Blanche, Helene; Deleuze, Jean-Francois; Cann, Howard; Mallick, Swapan; Reich, David; Sandhu, Manjinder S.; Skoglund, Pontus; Scally, Aylwyn; Xue, Yali; Durbin, Richard; Tyler-Smith, Chris			Insights into human genetic variation and population history from 929 diverse genomes	SCIENCE			English	Article							SEPARATION HISTORY; NEANDERTHAL; ANCESTRY; SEQUENCE; INFERENCE; GENOTYPE; DNA; COALESCENT; MIGRATION; FRAMEWORK	Genome sequences from diverse human groups are needed to understand the structure of genetic variation in our species and the history of, and relationships between, different populations. We present 929 high-coverage genome sequences from 54 diverse human populations, 26 of which are physically phased using linked-read sequencing. Analyses of these genomes reveal an excess of previously undocumented common genetic variation private to southern Africa, central Africa, Oceania, and the Americas, but an absence of such variants fixed between major geographical regions. We also find deep and gradual population separations within Africa, contrasting population size histories between hunter-gatherer and agriculturalist groups in the past 10,000 years, and a contrast between single Neanderthal but multiple Denisovan source populations contributing to present-day human populations.	[Bergstrom, Anders; McCarthy, Shane A.; Almarri, Mohamed A.; Ayub, Qasim; Danecek, Petr; Chen, Yuan; Felkel, Sabine; Hallast, Pille; Kamm, Jack; Sandhu, Manjinder S.; Xue, Yali; Durbin, Richard; Tyler-Smith, Chris] Wellcome Sanger Inst, Hinxton CB10 1SA, England; [Bergstrom, Anders; Skoglund, Pontus] Francis Crick Inst, London NW1 1AT, England; [McCarthy, Shane A.; Hui, Ruoyun; Kamm, Jack; Scally, Aylwyn; Durbin, Richard] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Hui, Ruoyun] Univ Cambridge, McDonald Inst Archaeol Res, Cambridge CB2 3ER, England; [Ayub, Qasim] Monash Univ, Malaysia Genom Facil, Trop Med & Biol Multidisciplinary Platform, Bandar Sunway 47500, Malaysia; [Ayub, Qasim] Monash Univ Malaysia, Sch Sci, Bandar Sunway 47500, Malaysia; [Felkel, Sabine] Univ Vet Med Vienna, Inst Anim Breeding & Genet, A-1210 Vienna, Austria; [Hallast, Pille] Univ Tartu, Inst Biomed & Translat Med, EE-50411 Tartu, Estonia; [Kamm, Jack] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Blanche, Helene; Deleuze, Jean-Francois; Cann, Howard] Fdn Jean Dausset, Ctr Etud Polymorphisme Humain, F-75010 Paris, France; [Blanche, Helene; Deleuze, Jean-Francois] GENMED Labex, ANR 10 LABX 0013, Paris, France; [Mallick, Swapan; Reich, David] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Mallick, Swapan; Reich, David] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Sandhu, Manjinder S.] Univ Cambridge, Dept Med, Cambridge CB2 0QQ, England	Wellcome Trust Sanger Institute; Francis Crick Institute; University of Cambridge; University of Cambridge; Monash University; Monash University Sunway; Monash University; Monash University Sunway; University of Veterinary Medicine Vienna; University of Tartu; Foundation Jean Dausset-CEPH; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Cambridge	Bergstrom, A; Tyler-Smith, C (corresponding author), Wellcome Sanger Inst, Hinxton CB10 1SA, England.; Bergstrom, A (corresponding author), Francis Crick Inst, London NW1 1AT, England.	ab34@sanger.ac.uk; cts@sanger.ac.uk		Almarri, Mohamed/0000-0003-1255-0918; Hallast, Pille/0000-0002-0588-3987; Bergstrom, Anders/0000-0002-4096-9268; Hui, Ruoyun/0000-0002-5689-7131; Kamm, Jack/0000-0003-2412-756X; Skoglund, Pontus/0000-0002-3021-5913; McCarthy, Shane/0000-0002-2715-4187; Ayub, Qasim/0000-0003-3291-0917	Wellcome [098051, 206194, 207492]; Francis Crick Institute [FC001595]; Cancer Research UK; UK Medical Research Council; Wellcome Trust [217223/Z/19/Z]; European Research Council [852558]; Gates Cambridge scholarship; Estonian Research Council [PUT1036]	Wellcome; Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Gates Cambridge scholarship; Estonian Research Council(Estonian Research Council)	A.B., S.A.M., M.A.A, Q.A., P.D., Y.C., S.F., P.H., J.K, M.S.S., Y.X., R.D., and C.T.-S. were supported by Wellcome grants 098051 and 206194 and S.A.M. and R.D. by Wellcome grant 207492. A.B. and P.S. were supported by the Francis Crick Institute (grant FC001595), which receives its core funding from Cancer Research UK, the UK Medical Research Council, and the Wellcome Trust. P.S. was also supported by the European Research Council (grant 852558) and the Wellcome Trust (grant 217223/Z/19/Z). R.H. was supported by a Gates Cambridge scholarship. P.H. was supported by the Estonian Research Council (grant PUT1036). D.R. is an investigator of the Howard Hughes Medical Institute.	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Bergstrom A, 2017, SCIENCE, V357, P1160, DOI 10.1126/science.aan3842; Browning BL, 2016, AM J HUM GENET, V98, P116, DOI 10.1016/j.ajhg.2015.11.020; Browning SR, 2018, CELL, V173, P53, DOI 10.1016/j.cell.2018.02.031; Browning SR, 2015, AM J HUM GENET, V97, P404, DOI 10.1016/j.ajhg.2015.07.012; Cann HM, 2002, SCIENCE, V296, P261; Delaneau O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4934; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/mss075; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Fenner JN, 2005, AM J PHYS ANTHROPOL, V128, P415, DOI 10.1002/ajpa.20188; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Garrison E, 2018, NAT BIOTECHNOL, V36, P875, DOI 10.1038/nbt.4227; Haak W, 2015, NATURE, V522, P207, DOI 10.1038/nature14317; Handsaker RE, 2015, NAT GENET, V47, P296, DOI 10.1038/ng.3200; Jacobs GS, 2019, CELL, V177, P1010, DOI 10.1016/j.cell.2019.02.035; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jakobsson M, 2013, GENETICS, V193, P515, DOI 10.1534/genetics.112.144758; Jun G, 2012, AM J HUM GENET, V91, P839, DOI 10.1016/j.ajhg.2012.09.004; Kamm J, 2020, J AM STAT ASSOC, V115, P1472, DOI 10.1080/01621459.2019.1635482; Kelleher J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004842; Lazaridis I, 2018, BIORXIV, P1, DOI [10.1101/423079(, DOI 10.1101/423079]; Lazaridis I, 2016, NATURE, V536, P419, DOI 10.1038/nature19310; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lippold Sebastian, 2014, Investig Genet, V5, P13, DOI 10.1186/2041-2223-5-13; Llamas B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501385; Loh PR, 2016, NAT GENET, V48, P811, DOI 10.1038/ng.3571; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Mallick S, 2016, NATURE, V538, P201, DOI 10.1038/nature18964; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Pagani L, 2016, NATURE, V538, P238, DOI 10.1038/nature19792; Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pickrell JK, 2014, P NATL ACAD SCI USA, V111, P2632, DOI 10.1073/pnas.1313787111; Pinotti T, 2019, CURR BIOL, V29, P149, DOI 10.1016/j.cub.2018.11.029; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Poznik GD, 2016, NAT GENET, V48, P593, DOI 10.1038/ng.3559; Poznik GD, 2013, SCIENCE, V341, P562, DOI 10.1126/science.1237619; Prufer K, 2017, SCIENCE, V358, P655, DOI 10.1126/science.aao1887; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Qin PF, 2015, MOL BIOL EVOL, V32, P2665, DOI 10.1093/molbev/msv141; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sankararaman S, 2014, NATURE, V507, P354, DOI 10.1038/nature12961; Scally A, 2016, CURR OPIN GENET DEV, V41, P36, DOI 10.1016/j.gde.2016.07.008; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi WT, 2010, MOL BIOL EVOL, V27, P385, DOI 10.1093/molbev/msp243; Simons J, 2018, ROUT STUD RENAIS LIT, P21; Skoglund P, 2017, CELL, V171, P59, DOI 10.1016/j.cell.2017.08.049; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Song SY, 2017, GENETICS, V205, P385, DOI 10.1534/genetics.116.192963; Staab PR, 2015, BIOINFORMATICS, V31, P1680, DOI 10.1093/bioinformatics/btu861; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Terhorst J, 2017, NAT GENET, V49, P303, DOI 10.1038/ng.3748; Tischler G, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-13; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Vernot B, 2014, SCIENCE, V343, P1017, DOI 10.1126/science.1245938; Zhao H, 2014, BIOINFORMATICS, V30, P1006, DOI 10.1093/bioinformatics/btt730; Zheng GXY, 2016, NAT BIOTECHNOL, V34, P303, DOI 10.1038/nbt.3432	76	187	188	15	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1339	+	eaay5012	10.1126/science.aay5012	http://dx.doi.org/10.1126/science.aay5012			88	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193295	Green Submitted, Green Accepted			2022-12-28	WOS:000522167400043
J	Carpenter, G; Coffey, R				Carpenter, Graham; Coffey, Robert			Stanley Cohen (1922-2020) Award-winning biochemist who shed light on cell growth	SCIENCE			English	Biographical-Item									[Carpenter, Graham] Vanderbilt Univ, Dept Biochem, Nashville, TN 37212 USA; [Coffey, Robert] Vanderbilt Univ, Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Carpenter, G (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37212 USA.	graham.carpenter@vanderbilt.edu						COHEN SF, PUBLICATION LIST	1	1	1	2	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1307	1307		10.1126/science.abb4095	http://dx.doi.org/10.1126/science.abb4095			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193312				2022-12-28	WOS:000522167400031
J	Cohen, J				Cohen, Jon			SICK TIME	SCIENCE			English	Editorial Material																			0	10	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1294	1297		10.1126/science.367.6484.1294	http://dx.doi.org/10.1126/science.367.6484.1294			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193305				2022-12-28	WOS:000522167400024
J	Grasby, KL; Jahanshad, N; Painter, JN; Colodro-Conde, L; Bralten, J; Hibar, DP; Lind, PA; Pizzagalli, F; Ching, CRK; McMahon, MAB; Shatokhina, N; Zsembik, LCP; Thomopoulos, SI; Zhu, AH; Strike, LT; Agartz, I; Alhusaini, S; Almeida, MAA; Alnaes, D; Amlien, IK; Andersson, M; Ard, T; Armstrong, NJ; Ashley-Koch, A; Atkins, JR; Bernard, M; Brouwer, RM; Buimer, EEL; Bulow, R; Burger, C; Cannon, DM; Chakravarty, M; Chen, Q; Cheung, JW; Couvy-Duchesne, B; Dale, AM; Dalvie, S; de Araujo, TK; de Zubicaray, GI; de Zwarte, SMC; den Braber, A; Doan, NT; Dohm, K; Ehrlich, S; Engelbrecht, HR; Erk, S; Fan, CC; Fedko, IO; Foley, SF; Ford, JM; Fukunaga, M; Garrett, ME; Ge, T; Giddaluru, S; Goldman, AL; Green, MJ; Groenewold, NA; Grotegerd, D; Gurholt, TP; Gutman, BA; Hansell, NK; Harris, MA; Harrison, MB; Haswell, CC; Hauser, M; Herms, S; Heslenfeld, DJ; Ho, NF; Hoehn, D; Hoffmann, P; Holleran, L; Hoogman, M; Hottenga, JJ; Ikeda, M; Janowitz, D; Jansen, IE; Jia, T; Jockwitz, C; Kanai, R; Karama, S; Kasperaviciute, D; Kaufmann, T; Kelly, S; Kikuchi, M; Klein, M; Knapp, M; Knodt, AR; Kramer, B; Lam, M; Lancaster, TM; Lee, PH; Lett, TA; Lewis, LB; Lopes-Cendes, I; Luciano, M; Macciardi, F; Marquand, AF; Mathias, SR; Melzer, TR; Milaneschi, Y; Mirza-Schreiber, N; Moreira, JCV; Muhleisen, TW; Muller-Myhsok, B; Najt, P; Nakahara, S; Nho, K; Loohuis, LMO; Orfanos, DP; Pearson, JF; Pitcher, TL; Putz, B; Quide, Y; Ragothaman, A; Rashid, FM; Reay, WR; Redlich, R; Reinbold, CS; Repple, J; Richard, G; Riedel, BC; Risacher, SL; Rocha, CS; Mota, NR; Salminen, L; Saremi, A; Saykin, AJ; Schlag, F; Schmaal, L; Schofield, PR; Secolin, R; Shapland, CY; Shen, L; Shin, J; Shumskaya, E; Sonderby, IE; Sprooten, E; Tansey, KE; Teumer, A; Thalamuthu, A; Tordesillas-Gutierrez, D; Turner, JA; Uhlmann, A; Vallerga, CL; van der Meer, D; van Donkelaar, MMJ; van Eijk, L; van Erp, TGM; van Haren, NEM; van Rooij, D; van Tol, MJ; Veldink, JH; Verhoef, E; Walton, E; Wang, M; Wang, Y; Wardlaw, JM; Wen, W; Westlye, LT; Whelan, CD; Witt, SH; Wittfeld, K; Wolf, C; Wolfers, T; Wu, JQ; Yasuda, CL; Zaremba, D; Zhang, Z; Zwiers, MP; Artiges, E; Assareh, AA; Ayesa-Arriola, R; Belger, A; Brandt, CL; Brown, GG; Cichon, S; Curran, JE; Davies, GE; Degenhardt, F; Dennis, MF; Dietsche, B; Djurovic, S; Doherty, CP; Espiritu, R; Garijo, D; Gil, Y; Gowland, PA; Green, RC; Hausler, AN; Heindel, W; Ho, BC; Hoffmann, WU; Holsboer, F; Homuth, G; Hosten, N; Jack, CR; Jang, M; Jansen, A; Kimbrel, NA; Kolskar, K; Koops, S; Krug, A; Lim, KO; Luykx, JJ; Mathalon, DH; Mather, KA; Mattay, VS; Matthews, S; Van Son, JM; McEwen, SC; Melle, I; Morris, DW; Mueller, BA; Nauck, M; Nordvik, JE; Nothen, MM; O'Leary, DS; Opel, N; Martinot, MLP; Pike, GB; Preda, A; Quinlan, EB; Rasser, PE; Ratnakar, V; Reppermund, S; Steen, VM; Tooney, PA; Torres, FR; Veltman, DJ; Voyvodic, JT; Whelan, R; White, T; Yamamori, H; Adams, HHH; Bis, JC; Debette, S; Decarli, C; Fornage, M; Gudnason, V; Hofer, E; Ikram, MA; Launer, L; Longstreth, WT; Lopez, OL; Mazoyer, B; Mosley, TH; Roshchupkin, GV; Satizabal, CL; Schmidt, R; Seshadri, S; Yang, Q; Alvim, MKM; Ames, D; Anderson, TJ; Andreassen, OA; Arias-Vasquez, A; Bastin, ME; Baune, BT; Beckham, JC; Blangero, J; Boomsma, DI; Brodaty, H; Brunner, HG; Buckner, RL; Buitelaar, JK; Bustillo, JR; Cahn, W; Cairns, MJ; Calhoun, V; Carr, VJ; Caseras, X; Caspers, S; Cavalleri, GL; Cendes, F; Corvin, A; Crespo-Facorro, B; Dalrymple-Alford, JC; Dannlowski, U; de Geus, EJC; Deary, IJ; Delanty, N; Depondt, C; Desrivieres, S; Donohoe, G; Espeseth, T; Fernandez, G; Fisher, SE; Flor, H; Forstner, AJ; Francks, C; Franke, B; Glahn, DC; Gollub, RL; Grabe, HJ; Gruber, O; Haberg, AK; Hariri, AR; Hartman, CA; Hashimoto, R; Heinz, A; Henskens, FA; Hillegers, MHJ; Hoekstra, PJ; Holmes, AJ; Hong, LE; Hopkins, WD; Pol, HEH; Jernigan, TL; Jonsson, EG; Kahn, RS; Kennedy, MA; Kircher, TTJ; Kochunov, P; Kwok, JBJ; Le Hellard, S; Loughland, CM; Martin, NG; Martinot, JL; McDonald, C; McMahon, KL; Meyer-Lindenberg, A; Michie, PT; Morey, RA; Mowry, B; Nyberg, L; Oosterlaan, J; Ophoff, RA; Pantelis, C; Paus, T; Pausova, Z; Penninx, BWJH; Polderman, TJC; Posthuma, D; Rietschel, M; Roffman, JL; Rowland, LM; Sachdev, PS; Samann, PG; Schall, U; Schumann, G; Scott, RJ; Sim, K; Sisodiya, SM; Smoller, JW; Sommer, IE; St Pourcain, B; Stein, DJ; Toga, AW; Trollor, JN; Van der Wee, NJA; van't Ent, D; Volzke, H; Walter, H; Weber, B; Weinberger, DR; Wright, MJ; Zhou, J; Stein, JL; Thompson, PM; Medland, SE				Grasby, Katrina L.; Jahanshad, Neda; Painter, Jodie N.; Colodro-Conde, Lucia; Bralten, Janita; Hibar, Derrek P.; Lind, Penelope A.; Pizzagalli, Fabrizio; Ching, Christopher R. K.; McMahon, Mary Agnes B.; Shatokhina, Natalia; Zsembik, Leo C. P.; Thomopoulos, Sophia I.; Zhu, Alyssa H.; Strike, Lachlan T.; Agartz, Ingrid; Alhusaini, Saud; Almeida, Marcio A. A.; Alnaes, Dag; Amlien, Inge K.; Andersson, Micael; Ard, Tyler; Armstrong, Nicola J.; Ashley-Koch, Allison; Atkins, Joshua R.; Bernard, Manon; Brouwer, Rachel M.; Buimer, Elizabeth E. L.; Bulow, Robin; Burger, Christian; Cannon, Dara M.; Chakravarty, Mallar; Chen, Qiang; Cheung, Joshua W.; Couvy-Duchesne, Baptiste; Dale, Anders M.; Dalvie, Shareefa; de Araujo, Tania K.; de Zubicaray, Greig I.; de Zwarte, Sonja M. C.; den Braber, Anouk; Nhat Trung Doan; Dohm, Katharina; Ehrlich, Stefan; Engelbrecht, Hannah-Ruth; Erk, Susanne; Fan, Chun Chieh; Fedko, Iryna O.; Foley, Sonya F.; Ford, Judith M.; Fukunaga, Masaki; Garrett, Melanie E.; Ge, Tian; Giddaluru, Sudheer; Goldman, Aaron L.; Green, Melissa J.; Groenewold, Nynke A.; Grotegerd, Dominik; Gurholt, Tiril P.; Gutman, Boris A.; Hansell, Narelle K.; Harris, Mathew A.; Harrison, Marc B.; Haswell, Courtney C.; Hauser, Michael; Herms, Stefan; Heslenfeld, Dirk J.; Ho, New Fei; Hoehn, David; Hoffmann, Per; Holleran, Laurena; Hoogman, Martine; Hottenga, Jouke-Jan; Ikeda, Masashi; Janowitz, Deborah; Jansen, Iris E.; Jia, Tianye; Jockwitz, Christiane; Kanai, Ryota; Karama, Sherif; Kasperaviciute, Dalia; Kaufmann, Tobias; Kelly, Sinead; Kikuchi, Masataka; Klein, Marieke; Knapp, Michael; Knodt, Annchen R.; Kramer, Bernd; Lam, Max; Lancaster, Thomas M.; Lee, Phil H.; Lett, Tristram A.; Lewis, Lindsay B.; Lopes-Cendes, Iscia; Luciano, Michelle; Macciardi, Fabio; Marquand, Andre F.; Mathias, Samuel R.; Melzer, Tracy R.; Milaneschi, Yuri; Mirza-Schreiber, Nazanin; Moreira, Jose C. V.; Muhleisen, Thomas W.; Mueller-Myhsok, Bertram; Najt, Pablo; Nakahara, Soichiro; Nho, Kwangsik; Loohuis, Loes M. Olde; Orfanos, Dimitri Papadopoulos; Pearson, John F.; Pitcher, Toni L.; Putz, Benno; Quide, Yann; Ragothaman, Anjanibhargavi; Rashid, Faisal M.; Reay, William R.; Redlich, Ronny; Reinbold, Celine S.; Repple, Jonathan; Richard, Genevieve; Riedel, Brandalyn C.; Risacher, Shannon L.; Rocha, Cristiane S.; Mota, Nina R.; Salminen, Lauren; Saremi, Arvin; Saykin, Andrew J.; Schlag, Fenja; Schmaal, Lianne; Schofield, Peter R.; Secolin, Rodrigo; Shapland, Chin Yang; Shen, Li; Shin, Jean; Shumskaya, Elena; Sonderby, Ida E.; Sprooten, Emma; Tansey, Katherine E.; Teumer, Alexander; Thalamuthu, Anbupalam; Tordesillas-Gutierrez, Diana; Turner, Jessica A.; Uhlmann, Anne; Vallerga, Costanza L.; van der Meer, Dennis; van Donkelaar, Marjolein M. J.; van Eijk, Liza; van Erp, Theo G. M.; van Haren, Neeltje E. M.; van Rooij, Daan; van Tol, Marie-Jose; Veldink, Jan H.; Verhoef, Ellen; Walton, Esther; Wang, Mingyuan; Wang, Yunpeng; Wardlaw, Joanna M.; Wen, Wei; Westlye, Lars T.; Whelan, Christopher D.; Witt, Stephanie H.; Wittfeld, Katharina; Wolf, Christiane; Wolfers, Thomas; Wu, Jing Qin; Yasuda, Clarissa L.; Zaremba, Dario; Zhang, Zuo; Zwiers, Marcel P.; Artiges, Eric; Assareh, Amelia A.; Ayesa-Arriola, Rosa; Belger, Aysenil; Brandt, Christine L.; Brown, Gregory G.; Cichon, Sven; Curran, Joanne E.; Davies, Gareth E.; Degenhardt, Franziska; Dennis, Michelle F.; Dietsche, Bruno; Djurovic, Srdjan; Doherty, Colin P.; Espiritu, Ryan; Garijo, Daniel; Gil, Yolanda; Gowland, Penny A.; Green, Robert C.; Hausler, Alexander N.; Heindel, Walter; Ho, Beng-Choon; Hoffmann, Wolfgang U.; Holsboer, Florian; Homuth, Georg; Hosten, Norbert; Jack, Clifford R., Jr.; Jang, MiHyun; Jansen, Andreas; Kimbrel, Nathan A.; Kolskar, Knut; Koops, Sanne; Krug, Axel; Lim, Kelvin O.; Luykx, Jurjen J.; Mathalon, Daniel H.; Mather, Karen A.; Mattay, Venkata S.; Matthews, Sarah; Van Son, Jaqueline Mayoral; McEwen, Sarah C.; Melle, Ingrid; Morris, Derek W.; Mueller, Bryon A.; Nauck, Matthias; Nordvik, Jan E.; Noethen, Markus M.; O'Leary, Daniel S.; Opel, Nils; Martinot, Marie-Laure Paillere; Pike, G. Bruce; Preda, Adrian; Quinlan, Erin B.; Rasser, Paul E.; Ratnakar, Varun; Reppermund, Simone; Steen, Vidar M.; Tooney, Paul A.; Torres, Fabio R.; Veltman, Dick J.; Voyvodic, James T.; Whelan, Robert; White, Tonya; Yamamori, Hidenaga; Adams, Hieab H. H.; Bis, Joshua C.; Debette, Stephanie; Decarli, Charles; Fornage, Myriam; Gudnason, Vilmundur; Hofer, Edith; Ikram, M. Arfan; Launer, Lenore; Longstreth, W. T.; Lopez, Oscar L.; Mazoyer, Bernard; Mosley, Thomas H.; Roshchupkin, Gennady V.; Satizabal, Claudia L.; Schmidt, Reinhold; Seshadri, Sudha; Yang, Qiong; Alvim, Marina K. M.; Ames, David; Anderson, Tim J.; Andreassen, Ole A.; Arias-Vasquez, Alejandro; Bastin, Mark E.; Baune, Bernhard T.; Beckham, Jean C.; Blangero, John; Boomsma, Dorret I.; Brodaty, Henry; Brunner, Han G.; Buckner, Randy L.; Buitelaar, Jan K.; Bustillo, Juan R.; Cahn, Wiepke; Cairns, Murray J.; Calhoun, Vince; Carr, Vaughan J.; Caseras, Xavier; Caspers, Svenja; Cavalleri, Gianpiero L.; Cendes, Fernando; Corvin, Aiden; Crespo-Facorro, Benedicto; Dalrymple-Alford, John C.; Dannlowski, Udo; de Geus, Eco J. C.; Deary, Ian J.; Delanty, Norman; Depondt, Chantal; Desrivieres, Sylvane; Donohoe, Gary; Espeseth, Thomas; Fernandez, Guillen; Fisher, Simon E.; Flor, Herta; Forstner, Andreas J.; Francks, Clyde; Franke, Barbara; Glahn, David C.; Gollub, Randy L.; Grabe, Hans J.; Gruber, Oliver; Haberg, Asta K.; Hariri, Ahmad R.; Hartman, Catharina A.; Hashimoto, Ryota; Heinz, Andreas; Henskens, Frans A.; Hillegers, Manon H. J.; Hoekstra, Pieter J.; Holmes, Avram J.; Hong, L. Elliot; Hopkins, William D.; Pol, Hilleke E. Hulshoff; Jernigan, Terry L.; Jonsson, Erik G.; Kahn, Rene S.; Kennedy, Martin A.; Kircher, Tilo T. J.; Kochunov, Peter; Kwok, John B. J.; Le Hellard, Stephanie; Loughland, Carmel M.; Martin, Nicholas G.; Martinot, Jean-Luc; McDonald, Colm; McMahon, Katie L.; Meyer-Lindenberg, Andreas; Michie, Patricia T.; Morey, Rajendra A.; Mowry, Bryan; Nyberg, Lars; Oosterlaan, Jaap; Ophoff, Roel A.; Pantelis, Christos; Paus, Tomas; Pausova, Zdenka; Penninx, Brenda W. J. H.; Polderman, Tinca J. C.; Posthuma, Danielle; Rietschel, Marcella; Roffman, Joshua L.; Rowland, Laura M.; Sachdev, Perminder S.; Samann, Philipp G.; Schall, Ulrich; Schumann, Gunter; Scott, Rodney J.; Sim, Kang; Sisodiya, Sanjay M.; Smoller, Jordan W.; Sommer, Iris E.; St Pourcain, Beate; Stein, Dan J.; Toga, Arthur W.; Trollor, Julian N.; Van der Wee, Nic J. A.; van't Ent, Dennis; Volzke, Henry; Walter, Henrik; Weber, Bernd; Weinberger, Daniel R.; Wright, Margaret J.; Zhou, Juan; Stein, Jason L.; Thompson, Paul M.; Medland, Sarah E.		Alzheimer's Dis; CHARGE Consortium; EPIGEN Consortium; IMAGEN Consortium; SYS Consortium; Parkinson's Progression; Enhancing NeuroImaging	The genetic architecture of the human cerebral cortex	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; OBSERVER-INDEPENDENT CHARACTERIZATION; CENTRAL SULCUS; FUNCTIONAL ANNOTATION; COMMON VARIANTS; CORTICAL SULCI; SURFACE-AREA; METAANALYSIS; LOCI; EXPRESSION	The cerebral cortex underlies our complex cognitive capabilities, yet little is known about the specific genetic loci that influence human cortical structure. To identify genetic variants that affect cortical structure, we conducted a genome-wide association meta-analysis of brain magnetic resonance imaging data from 51,665 individuals. We analyzed the surface area and average thickness of the whole cortex and 34 regions with known functional specializations. We identified 199 significant loci and found significant enrichment for loci influencing total surface area within regulatory elements that are active during prenatal cortical development, supporting the radial unit hypothesis. Loci that affect regional surface area cluster near genes in Wnt signaling pathways, which influence progenitor expansion and areal identity. Variation in cortical structure is genetically correlated with cognitive function, Parkinson's disease, insomnia, depression, neuroticism, and attention deficit hyperactivity disorder.	[Grasby, Katrina L.; Painter, Jodie N.; Colodro-Conde, Lucia; Lind, Penelope A.; Medland, Sarah E.] QIMR Berghofer Med Res Inst, Psychiat Genet, Brisbane, Qld, Australia; [Jahanshad, Neda; Hibar, Derrek P.; Pizzagalli, Fabrizio; Ching, Christopher R. K.; McMahon, Mary Agnes B.; Shatokhina, Natalia; Thomopoulos, Sophia I.; Zhu, Alyssa H.; Cheung, Joshua W.; Gutman, Boris A.; Harrison, Marc B.; Ragothaman, Anjanibhargavi; Rashid, Faisal M.; Riedel, Brandalyn C.; Salminen, Lauren; Saremi, Arvin; Whelan, Christopher D.; Thompson, Paul M.] Univ Southern Calif, Keck Sch Med, Imaging Genet Ctr, Mark & Mary Stevens Neuroimaging & Informat Inst, Los Angeles, CA USA; [Colodro-Conde, Lucia; van Eijk, Liza; Medland, Sarah E.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Colodro-Conde, Lucia; Lind, Penelope A.] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Colodro-Conde, Lucia] Univ Murcia, Fac Psychol, Murcia, Spain; [Bralten, Janita; Hoogman, Martine; Klein, Marieke; Mota, Nina R.; Shumskaya, Elena; Wolfers, Thomas; Arias-Vasquez, Alejandro; Brunner, Han G.; Franke, Barbara] Radboud Univ Nijmegen, Dept Human Genet, Med Ctr, Nijmegen, Netherlands; [Bralten, Janita; Hoogman, Martine; Klein, Marieke; Marquand, Andre F.; Mota, Nina R.; Shumskaya, Elena; Sprooten, Emma; van Rooij, Daan; Zwiers, Marcel P.; Arias-Vasquez, Alejandro; Brunner, Han G.; Buitelaar, Jan K.; Fernandez, Guillen; Fisher, Simon E.; Francks, Clyde; Franke, Barbara; St Pourcain, Beate] Radboud Univ Nijmegen, Donders Inst Brain, Cognit & Behaviour, Nijmegen, Netherlands; [Hibar, Derrek P.] Genentech Inc, Personalized Healthcare, San Francisco, CA USA; [Lind, Penelope A.; Medland, Sarah E.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Ching, Christopher R. K.] Univ Calif Los Angeles, Grad Interdepartmental Program Neuroscience, Los Angeles, CA USA; [Zsembik, Leo C. P.; Stein, Jason L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Zsembik, Leo C. P.; Stein, Jason L.] Univ N Carolina, Neuroscience Ctr, Chapel Hill, NC USA; [Strike, Lachlan T.; Couvy-Duchesne, Baptiste; Hansell, Narelle K.; van Eijk, Liza; Mowry, Bryan; Wright, Margaret J.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia; [Agartz, Ingrid; Nhat Trung Doan; Gurholt, Tiril P.; Kaufmann, Tobias; Richard, Genevieve; Sonderby, Ida E.; Wang, Yunpeng; Westlye, Lars T.; Brandt, Christine L.; Kolskar, Knut; Melle, Ingrid; Andreassen, Ole A.; Espeseth, Thomas] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Agartz, Ingrid; Alnaes, Dag; Nhat Trung Doan; Gurholt, Tiril P.; Kaufmann, Tobias; Richard, Genevieve; Sonderby, Ida E.; Wang, Yunpeng; Westlye, Lars T.; Brandt, Christine L.; Kolskar, Knut; Melle, Ingrid; Andreassen, Ole A.; Jonsson, Erik G.] Univ Oslo, Inst Clin Med, NORMENT KG Jebsen Ctr Psychosis Res, Oslo, Norway; [Agartz, Ingrid; Alnaes, Dag; Gurholt, Tiril P.] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Agartz, Ingrid; Jonsson, Erik G.] Karolinska Inst, Dept Clin Neuroscience, Ctr Psychiat Res, Stockholm, Sweden; [Alhusaini, Saud; Whelan, Christopher D.; Delanty, Norman] Royal Coll Surgeons Ireland, Dept Mol & Cellular Therapeut, Dublin, Ireland; [Alhusaini, Saud] Yale Sch Med, Dept Neurol, New Haven, CT USA; [Almeida, Marcio A. A.; Curran, Joanne E.; Blangero, John] Univ Texas Rio Grande Valley, Dept Human Genet, Sch Med, Brownsville, TX USA; [Almeida, Marcio A. A.; Curran, Joanne E.; Blangero, John] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Sch Med, Brownsville, TX USA; [Amlien, Inge K.; Reinbold, Celine S.] Univ Oslo, Dept Psychol, Ctr Lifespan Changes Brain & Cognit, Oslo, Norway; [Andersson, Micael; Nyberg, Lars] Umea Univ, Dept Integrat Med Biol, Umea, Sweden; [Andersson, Micael; Nyberg, Lars] Umea Univ, Umea Ctr Funct Brain Imaging, Umea, Sweden; [Ard, Tyler; Toga, Arthur W.] Univ Southern Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Keck Sch Med, Lab Neuro Imaging, Los Angeles, CA USA; [Armstrong, Nicola J.] Murdoch Univ, Math & Stat, Murdoch, WA, Australia; [Ashley-Koch, Allison; Garrett, Melanie E.; Hauser, Michael] Duke Univ, Duke Mol Physiol Inst, Med Ctr, Durham, NC USA; [Atkins, Joshua R.; Reay, William R.; Wu, Jing Qin; Tooney, Paul A.; Cairns, Murray J.; Scott, Rodney J.] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Atkins, Joshua R.; Reay, William R.; Rasser, Paul E.; Cairns, Murray J.; Schall, Ulrich] Univ Newcastle, Prior Ctr Brain & Mental Hlth Res, Callaghan, NSW, Australia; [Bernard, Manon; Shin, Jean; Pausova, Zdenka] Univ Toronto, Hosp Sick Children, Toronto, ON, Canada; [Brouwer, Rachel M.; Buimer, Elizabeth E. L.; de Zwarte, Sonja M. C.; Klein, Marieke; van Haren, Neeltje E. M.; Koops, Sanne; Luykx, Jurjen J.; Pol, Hilleke E. Hulshoff; Kahn, Rene S.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Psychiat, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Bulow, Robin] Ernst Moritz Arndt Univ Greifswald, Univ Med, Inst Radiol & Neuroradiol, Greifswald, Germany; [Burger, Christian; Dohm, Katharina; Grotegerd, Dominik; Redlich, Ronny; Repple, Jonathan; Zaremba, Dario; Opel, Nils; Baune, Bernhard T.; Dannlowski, Udo] Univ Munster, Dept Psychiat, Munster, Germany; [Cannon, Dara M.; Najt, Pablo; Morris, Derek W.; McDonald, Colm] Natl Univ Ireland Galway, Ctr Neuroimaging & Cognit Genom, Galway, Ireland; [Chakravarty, Mallar; Karama, Sherif] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Chakravarty, Mallar] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Chakravarty, Mallar] McGill Univ, Dept Biol & Biomed Engn, Montreal, PQ, Canada; [Chen, Qiang; Goldman, Aaron L.; Mattay, Venkata S.; Weinberger, Daniel R.] Lieber Inst Brain Dev, Baltimore, MD USA; [Couvy-Duchesne, Baptiste; Vallerga, Costanza L.] Univ Queensland, Inst Mol Bioscience, Brisbane, Qld, Australia; [Couvy-Duchesne, Baptiste] QIMR Berghofer Med Res Inst, Genet Epidemiol, Brisbane, Qld, Australia; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosciences, La Jolla, CA USA; [Dale, Anders M.; Jernigan, Terry L.] Univ Calif San Diego, Dept Radiol, San Diego, CA USA; [Dalvie, Shareefa; Groenewold, Nynke A.; Uhlmann, Anne] Univ Cape Town, Dept Psychiat & Mental Hlth, Cape Town, South Africa; [de Araujo, Tania K.; Lopes-Cendes, Iscia; Rocha, Cristiane S.; Secolin, Rodrigo; Torres, Fabio R.] Univ Estadual Campinas, Sch Med Sci, Dept Med Genet & Genom Med, Campinas, Brazil; [de Araujo, Tania K.; Lopes-Cendes, Iscia; Moreira, Jose C. V.; Rocha, Cristiane S.; Secolin, Rodrigo; Yasuda, Clarissa L.; Torres, Fabio R.; Alvim, Marina K. M.; Cendes, Fernando] BRAINN, Campinas, Brazil; [de Zubicaray, Greig I.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Fac Hlth, Brisbane, Qld, Australia; [den Braber, Anouk; Fedko, Iryna O.; Hottenga, Jouke-Jan; Boomsma, Dorret I.; de Geus, Eco J. C.; van't Ent, Dennis] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [den Braber, Anouk] Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Dept Neurol, Amsterdam Neuroscience,Amsterdam UMC, Amsterdam, Netherlands; [Ehrlich, Stefan] Tech Univ Dresden, Div Psychol & Social Med & Dev Neurosciences, Fac Med, Dresden, Germany; [Engelbrecht, Hannah-Ruth; Martin, Nicholas G.] Univ Cape Town, Inst Infect Dis & Mol Med, Div Human Genet, Cape Town, South Africa; [Erk, Susanne; Lett, Tristram A.; Walter, Henrik] Campus Charite Mitte, Dept Psychiat & Psychotherap, Div Mind & Brain Res, Berlin, Germany; [Erk, Susanne; Lett, Tristram A.; Walter, Henrik] Charite, Freie Univ Berlin, Humboldt Univ Berlin, Berlin, Germany; [Erk, Susanne; Lett, Tristram A.; Walter, Henrik] Berlin Inst Hlth, Berlin, Germany; [Fan, Chun Chieh; Jernigan, Terry L.] Univ Calif San Diego, Dept Cognit Sci, San Diego, CA USA; [Foley, Sonya F.; Lancaster, Thomas M.] Cardiff Univ, Brain Res Imaging Ctr, Cardiff, Wales; [Ford, Judith M.] San Francisco Vet Adm Med Ctr, San Francisco, CA USA; [Fukunaga, Masaki] Natl Inst Physiol Sci, Div Cerebral Integrat, Okazaki, Aichi, Japan; [Ge, Tian; Lee, Phil H.; Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodevelopmental Genet Unit, Ctr Genom Med, Boston, MA USA; [Ge, Tian] Massachusetts Gen Hosp, Athinoula Martinos Ctr Biomed Imaging, Boston, MA USA; [Giddaluru, Sudheer] Univ Bergen, Dept Clin Sci, NORMENT KG Jebsen Ctr Psychosis Res, Bergen, Norway; [Green, Melissa J.; Quide, Yann; Carr, Vaughan J.] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Green, Melissa J.; Quide, Yann; Carr, Vaughan J.] Neuroscience Res Australia, Sydney, NSW, Australia; [Gutman, Boris A.] Illinois Inst Technol, Dept Biomed Engn, Chicago, IL USA; [Harris, Mathew A.; Wardlaw, Joanna M.; Bastin, Mark E.] Univ Edinburgh, Ctr Clin Brain Sci & Edinburgh Imaging, Edinburgh, Midlothian, Scotland; [Harris, Mathew A.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland; [Haswell, Courtney C.; Belger, Aysenil; Voyvodic, James T.; Morey, Rajendra A.] Duke Univ, Duke UNC Brain Imaging & Anal Ctr, Med Ctr, Durham, NC USA; [Haswell, Courtney C.; Dennis, Michelle F.; Kimbrel, Nathan A.; Morey, Rajendra A.] Durham VA Med Ctr, Mental Illness Res Educ & Clin Ctr Post Deploymen, Durham, NC USA; [Herms, Stefan; Hoffmann, Per; Muhleisen, Thomas W.; Reinbold, Celine S.; Cichon, Sven; Forstner, Andreas J.] Univ Basel, Dept Biomedicine, Basel, Switzerland; [Herms, Stefan; Hoffmann, Per; Reinbold, Celine S.; Cichon, Sven; Forstner, Andreas J.] Univ Basel Hosp, Inst Med Genet & Pathol, Basel, Switzerland; [Herms, Stefan] Univ Bonn, Dept Genom, Life & Brain Res Ctr, Bonn, Germany; [Heslenfeld, Dirk J.] Vrije Univ Amsterdam, Dept Cognit & Clin Neuropsychol, Amsterdam, Netherlands; [Ho, New Fei; Lam, Max; Wang, Mingyuan] Inst Mental Hlth, Div Res, Singapore, Singapore; [Hoehn, David; Mirza-Schreiber, Nazanin; Mueller-Myhsok, Bertram; Putz, Benno; Holsboer, Florian; Samann, Philipp G.] Max Planck Inst Psychiat, Munich, Germany; [Hoffmann, Per; Degenhardt, Franziska; Noethen, Markus M.; Forstner, Andreas J.] Univ Bonn, Inst Human Genet, Sch Med, Bonn, Germany; [Hoffmann, Per; Degenhardt, Franziska; Noethen, Markus M.; Forstner, Andreas J.] Univ Hosp, Bonn, Germany; [Holleran, Laurena; Donohoe, Gary] Natl Univ Galway Ireland, Sch Psychol, Ctr Neuroimaging & Cognit Genom, Galway, Ireland; [Ikeda, Masashi] Fujita Hlth Univ, Dept Psychiat, Sch Med, Toyoake, Aichi, Japan; [Janowitz, Deborah; Wittfeld, Katharina; Grabe, Hans J.] Univ Med Greifswald, Dept Psychiat & Psychotherapy, Greifswald, Germany; [Jansen, Iris E.; Polderman, Tinca J. C.; Posthuma, Danielle] Vrije Univ Amsterdam, Ctr Neurogen & Cognit Res, Complex Trait Genet, Amsterdam, Netherlands; [Jansen, Iris E.] Vrije Univ Amsterdam, Alzheimer Ctr, Vrije Univ Med Ctr, Dept Neurol,Amsterdam Neuroscience, Amsterdam, Netherlands; [Jia, Tianye; Schumann, Gunter] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Shanghai, Peoples R China; [Jia, Tianye] Fudan Univ, Key Lab Computat Neuroscience & Brain Inspired In, Minist Educ, Shanghai, Peoples R China; [Jia, Tianye; Desrivieres, Sylvane; Schumann, Gunter] Kings Coll London, Inst Psychiat Psychol & Neuroscience, Ctr Populat Neuroscience & Precis Med PONS, London, England; [Jockwitz, Christiane; Muhleisen, Thomas W.; Cichon, Sven; Caspers, Svenja] Res Ctr Julich, INM 1, Julich, Germany; [Jockwitz, Christiane] Rhein Westfal TH Aachen, Fac Med, Dept Psychiat Psychotherapy & Psychosomat, Aachen, Germany; [Jockwitz, Christiane; Caspers, Svenja] Julich Aachen Res Alliance, JARA BRAIN, Julich, Germany; [Kanai, Ryota] Araya Inc, Dept Neuroinformat, Tokyo, Japan; [Kanai, Ryota] Univ Sussex, Sch Psychol, Sackler Ctr Consciousness Sci, Falmer, England; [Kanai, Ryota] Tokyo Inst Technol, Earth Life Sci Inst, Tokyo, Japan; [Karama, Sherif] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Karama, Sherif] Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada; [Kasperaviciute, Dalia; Sisodiya, Sanjay M.] UCL Queen Sq Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Kasperaviciute, Dalia] Queen Mary Univ London, Genom England, London, England; [Kelly, Sinead] Harvard Med Sch, Publ Psychiat Div, Massachusetts Mental Hlth Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Kelly, Sinead] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Psychiat Neuroimaging Lab, Boston, MA USA; [Kikuchi, Masataka] Osaka Univ, Grad Sch Med, Dept Genome Informat, Suita, Osaka, Japan; [Knapp, Michael] Univ Hosp Bonn, Dept Med Biometry Informat & Epidemiol, Bonn, Germany; [Knodt, Annchen R.; Hariri, Ahmad R.] Duke Univ, Dept Psychol & Neuroscience, Durham, NC USA; [Kramer, Bernd; Gruber, Oliver] Univ Heidelberg Hosp, Sect Expt Psychopathol & Neuroimaging, Dept Gen Psychiat, Heidelberg, Germany; [Kramer, Bernd] Univ Med Ctr Gottingen, Dept Psychiat & Psychotherapy, Ctr Translat Res Syst Neuroscience & Psychiat, Gottingen, Germany; [Lam, Max] Genome Inst Singapore, Human Genet, Singapore, Singapore; [Lancaster, Thomas M.; Tansey, Katherine E.; Caseras, Xavier] Cardiff Univ, MRC Ctr Neuropsychiatr Genet & Genom, Cardiff, Wales; [Lee, Phil H.; Gollub, Randy L.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Lewis, Lindsay B.] McGill Univ, McGill Ctr Integrat Neuroscience, Montreal, PQ, Canada; [Luciano, Michelle; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Luciano, Michelle; Wardlaw, Joanna M.; Bastin, Mark E.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Macciardi, Fabio; Nakahara, Soichiro; van Erp, Theo G. M.] Univ Calif Irvine, Dept Psychiat & Human Behav, Sch Med, Irvine, CA USA; [Marquand, Andre F.; van Rooij, Daan; Zwiers, Marcel P.; Buitelaar, Jan K.] Radboud Univ Nijmegen, Dept Cognit Neuroscience, Med Ctr, Nijmegen, Netherlands; [Mathias, Samuel R.] Yale Univ, Dept Psychiat, Sch Med, New Haven, CT USA; [Mathias, Samuel R.; Glahn, David C.] Hartford Hosp, Inst Living, Olin Neuropsychiatr Res Ctr, Hartford, CT USA; [Melzer, Tracy R.; Pitcher, Toni L.; Anderson, Tim J.] Univ Otago, Dept Med, Christchurch, New Zealand; [Melzer, Tracy R.; Pitcher, Toni L.; Anderson, Tim J.; Dalrymple-Alford, John C.] New Zealand Brain Res Inst, Christchurch, New Zealand; [Melzer, Tracy R.; Pitcher, Toni L.; Anderson, Tim J.; Dalrymple-Alford, John C.] Brain Res New Zealand Rangahau Roro Aotearoa, Christchurch, New Zealand; [Milaneschi, Yuri; Veltman, Dick J.; Penninx, Brenda W. J. H.] Vrije Univ, Amsterdam Publ Hlth & Amsterdam Neuroscience, Amsterdam UMC, Dept Psychiat, Amsterdam, Netherlands; [Milaneschi, Yuri; Veltman, Dick J.; Penninx, Brenda W. J. H.] GGZ inGeest, Amsterdam, Netherlands; [Mirza-Schreiber, Nazanin] Helmholtz Zentrum Munchen, Inst Neurogen, German Res Ctr Environm Hlth, Neuherberg, Germany; [Moreira, Jose C. V.] IC Inst Comp, Campinas, Brazil; [Muhleisen, Thomas W.] Heinrich Heine Univ, Cecile & Oskar Vogt Inst Brain Res, Fac Med, Dusseldorf, Germany; [Mueller-Myhsok, Bertram] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Mueller-Myhsok, Bertram] Inst Translat Med, Liverpool, Merseyside, England; [Nakahara, Soichiro] Astellas Pharmaceut, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan; [Nho, Kwangsik; Riedel, Brandalyn C.; Risacher, Shannon L.; Saykin, Andrew J.] Indiana Univ, Dept Radiol & Imaging Sci, Sch Med, Indianapolis, IN USA; [Loohuis, Loes M. Olde; Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehavioral Genet, Los Angeles, CA USA; [Orfanos, Dimitri Papadopoulos] Univ Paris Saclay, NeuroSpin, CEA, Gif Sur Yvette, France; [Pearson, John F.] Univ Otago, Biostatist & Computat Biol Unit, Christchurch, New Zealand; [Pearson, John F.; Kennedy, Martin A.] Univ Otago, Dept Pathol & Biomed Sci, Christchurch, New Zealand; [Richard, Genevieve; Westlye, Lars T.; Kolskar, Knut; Espeseth, Thomas] Univ Oslo, Dept Psychol, Oslo, Norway; [Richard, Genevieve; Kolskar, Knut; Nordvik, Jan E.] Sunnaas Rehabil Hosp HT, Nesodden, Norway; [Mota, Nina R.; Arias-Vasquez, Alejandro; Franke, Barbara] Radboud Univ Nijmegen, Dept Psychiat, Med Ctr, Nijmegen, Netherlands; [Saykin, Andrew J.] Indiana Univ, Dept Med & Mol Genet, Sch Med, Indianapolis, IN USA; [Schlag, Fenja; Shapland, Chin Yang; Verhoef, Ellen; Fisher, Simon E.; Francks, Clyde; St Pourcain, Beate] Max Planck Inst Psycholinguist, Language & Genet Dept, Nijmegen, Netherlands; [Schmaal, Lianne] Natl Ctr Excellence Youth Mental Hlth, Orygen, Melbourne, Vic, Australia; [Schmaal, Lianne] Univ Melbourne, Ctr Youth Mental Hlth, Melbourne, Vic, Australia; [Schmaal, Lianne] Vrije Univ Univ, Vrije Univ Amsterdam, Dept Psychiat, Med Ctr, Amsterdam, Netherlands; [Schofield, Peter R.; Mather, Karen A.; Kwok, John B. J.] Neuroscience Res Australia, Sydney, NSW, Australia; [Schofield, Peter R.; Kwok, John B. J.] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Shen, Li] Univ Pennsylvania, Dept Biostatist Epidemiol & Informat, Philadelphia, PA USA; [Shin, Jean] Univ Toronto, Bloorview Res Inst, Populat Neuroscience & Dev Neuroimaging, East York, ON, Canada; [Shumskaya, Elena; Zwiers, Marcel P.] Radboud Univ Nijmegen, Donders Ctr Cognit Neuroimaging, Nijmegen, Netherlands; [Teumer, Alexander; Hoffmann, Wolfgang U.; Volzke, Henry] Univ Med Greifswald, Inst Community Med, Greifswald, Germany; [Thalamuthu, Anbupalam; Wen, Wei; Assareh, Amelia A.; Mather, Karen A.; Reppermund, Simone; Brodaty, Henry; Sachdev, Perminder S.; Trollor, Julian N.] Univ New South Wales, Ctr Healthy Brain Ageing, Sydney, NSW, Australia; [Tordesillas-Gutierrez, Diana] Valdecilla Biomed Res Inst IDIVAL, Neuroimaging Unit, Technol Facil, Santander, Spain; [Tordesillas-Gutierrez, Diana; Walton, Esther; Ayesa-Arriola, Rosa; Van Son, Jaqueline Mayoral; Crespo-Facorro, Benedicto] Centro Investigac Biomed Red Salud Mental, Santander, Spain; [Turner, Jessica A.] Georgia State Univ, Dept Psychol, Atlanta, GA USA; [Turner, Jessica A.] Mind Res Network, Albuquerque, NM USA; [Uhlmann, Anne] Univ Vermont, Dept Psychiat, Burlington, VT USA; [van der Meer, Dennis] Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT, Oslo, Norway; [van der Meer, Dennis] Univ Oslo, Inst Clin Med, Oslo, Norway; [van der Meer, Dennis] Maastricht Univ, Sch Mental Hlth & Neuroscience, Fac Hlth Med & Life Sci, Maastricht, Netherlands; [van Donkelaar, Marjolein M. J.] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [van Haren, Neeltje E. M.; White, Tonya; Hillegers, Manon H. J.] Erasmus Med Ctr Sophia Childrens Hosp, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [van Tol, Marie-Jose; Sommer, Iris E.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, Cognit Neuroscience Ctr, Groningen, Netherlands; [Veldink, Jan H.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Walton, Esther; Matthews, Sarah; St Pourcain, Beate] Univ Bristol Sch Med, Dept Populat Hlth Sci, MRC Integrat Epidemiol Unit, Bristol, Avon, England; [Walton, Esther] Univ Bath, Dept Psychol, Bath, Avon, England; [Wardlaw, Joanna M.] Univ Edinburgh, UK Dementia Res Inst, Edinburgh, Midlothian, Scotland; [Witt, Stephanie H.; Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Mannheim, Germany; [Wittfeld, Katharina; Hoffmann, Wolfgang U.; Grabe, Hans J.] German Ctr Neurodegenerat Dis Rostock Greifswald, Greifswald, Germany; [Wolf, Christiane] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Yasuda, Clarissa L.; Alvim, Marina K. M.; Cendes, Fernando] Univ Estadual Campinas, FCM, Dept Neurol, Campinas, Brazil; [Zhang, Zuo; Quinlan, Erin B.; Desrivieres, Sylvane; Schumann, Gunter] Kings Coll London, Social Genet & Dev Psychiat Ctr, Inst Psychiat, London, England; [Artiges, Eric; Martinot, Marie-Laure Paillere; Martinot, Jean-Luc] Univ Paris Saclay, INSERM Unit Neuroimaging Psychiat 1000, Gif Sur Yvette, France; [Ayesa-Arriola, Rosa; Van Son, Jaqueline Mayoral; Crespo-Facorro, Benedicto] Univ Cantabria IDIVAL, Univ Hosp Marques Valdecilla, Sch Med, Dept Psychiat, Santander, Spain; [Belger, Aysenil] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Belger, Aysenil] Univ N Carolina, Frank Porter Graham Child Dev Inst, Chapel Hill, NC USA; [Brown, Gregory G.; Jernigan, Terry L.] Univ Calif San Diego, Dept Psychiat, San Diego, CA USA; [Brown, Gregory G.] VA San Diego Healthcare Syst, San Diego, CA USA; [Davies, Gareth E.] Avera Inst Human Genet, Sioux Falls, SD USA; [Dietsche, Bruno; Jansen, Andreas; Krug, Axel; Kircher, Tilo T. J.] Philipps Univ Marburg, Dept Psychiat & Psychotherapy, Marburg, Germany; [Djurovic, Srdjan] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Djurovic, Srdjan; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Dept Clin Sci, NORMENT, Bergen, Norway; [Doherty, Colin P.] St James Hosp, Dept Neurol, Dublin, Ireland; [Doherty, Colin P.] TBSI, Acad Unit Neurol, Dublin, Ireland; [Doherty, Colin P.; Delanty, Norman] Royal Coll Surgeons Ireland, Future Neuro, Dublin, Ireland; [Espiritu, Ryan; Garijo, Daniel; Gil, Yolanda; Jang, MiHyun; Ratnakar, Varun] Univ Southern Calif, Inst Informat Sci, Los Angeles, CA USA; [Gowland, Penny A.] Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Nottingham, England; [Green, Robert C.] Brigham & Womens Hosp, Boston, MA USA; [Green, Robert C.] Broad Inst, Boston, MA USA; [Green, Robert C.] Harvard Med Sch, Boston, MA USA; [Hausler, Alexander N.; Weber, Bernd] Univ Bonn, Ctr Econ & Neuroscience, Bonn, Germany; [Hausler, Alexander N.; Weber, Bernd] Univ Hosp Bonn, Inst Expt Epileptol & Cognit Res, Bonn, Germany; [Heindel, Walter] Univ Munster, Dept Clin Radiol, Munster, Germany; [Ho, Beng-Choon; O'Leary, Daniel S.] Univ Iowa, Dept Psychiat, Coll Med, Iowa City, IA USA; [Holsboer, Florian] HMNC Holding GmbH, Munich, Germany; [Homuth, Georg] Univ Med Greifswald, Interfaculty Inst Genet & Funct Genom, Dept Funct Genom, Greifswald, Germany; [Hosten, Norbert] Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Jack, Clifford R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA; [Jansen, Andreas] Univ Marburg, Core Unit Brainimaging, Fac Med, Marburg, Germany; [Kimbrel, Nathan A.; Beckham, Jean C.] Duke Univ, Dept Psychiat & Behav Sci, Sch Med, Durham, NC USA; [Lim, Kelvin O.; Mueller, Bryon A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN USA; [Luykx, Jurjen J.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Translat Neuroscience, UMC Utrecht Brain Ctr, Utrecht, Netherlands; [Luykx, Jurjen J.] GGNet Mental Hlth, Apeldoorn, Netherlands; [Mathalon, Daniel H.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Mathalon, Daniel H.] Univ Calif San Francisco, Weill Inst Neurosciences, San Francisco, CA USA; [Mathalon, Daniel H.] Vet Affairs San Francisco Healthcare Syst, Mental Hlth Serv 116d, San Francisco, CA USA; [Mattay, Venkata S.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD USA; [Mattay, Venkata S.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [McEwen, Sarah C.] Pacif Brain Hlth Ctr, Santa Monica, CA USA; [McEwen, Sarah C.] John Wayne Canc Inst, Santa Monica, CA USA; [Nauck, Matthias] Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany; [Nauck, Matthias] German Ctr Cardiovascular Res, Greifswald, Germany; [Martinot, Marie-Laure Paillere] APHP Pitie Salpetriere Hosp, Child & Adolescent Psychiat Dept, Paris, France; [Pike, G. Bruce] Univ Calgary, Hotchkiss Brain Inst, Radiol & Clin Neurosciences, Calgary, AB, Canada; [Preda, Adrian] Univ Calif Irvine, Sch Med, Irvine, CA USA; [Rasser, Paul E.; Henskens, Frans A.; Loughland, Carmel M.] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia; [Rasser, Paul E.] Univ Newcastle, Prior Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Rasser, Paul E.; Tooney, Paul A.; Schall, Ulrich] Hunter Med Res Inst, Newcastle, NSW, Australia; [Reppermund, Simone; Trollor, Julian N.] Univ New South Wales, Dept Dev Disabil Neuropsychiatry, Sydney, NSW, Australia; [Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Dr Einar Martens Res Grp Biol Psychiat, Ctr Med Genet & Mol Med, Bergen, Norway; [Whelan, Robert] Trin Coll Dublin, Sch Psychol, Dublin, Ireland; [White, Tonya] Erasmus Univ, Dept Radiol, Med Ctr, Rotterdam, Netherlands; [Yamamori, Hidenaga; Hashimoto, Ryota] Osaka Univ, Dept Psychiat, Grad Sch Med, Suita, Osaka, Japan; [Adams, Hieab H. H.; Ikram, M. Arfan; Lopez, Oscar L.; Roshchupkin, Gennady V.] Erasmus MC Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Adams, Hieab H. H.; Roshchupkin, Gennady V.] Erasmus MC Med Ctr, Dept Radiol & Nucl Med, Rotterdam, Netherlands; [Adams, Hieab H. H.] Erasmus MC Med Ctr, Dept Clin Genet, Rotterdam, Netherlands; [Bis, Joshua C.] Univ Washington, Dept Med, Cardiovascular Hlth Res Unit, Seattle, WA USA; [Debette, Stephanie] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, INSERM, Team VINTAGE,UMR 1219, Bordeaux, France; [Debette, Stephanie] CHU Bordeaux, Dept Neurol, Bordeaux, France; [Decarli, Charles] Univ Calif, Dept Neurol, Davis, CA USA; [Fornage, Myriam] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX USA; [Gudnason, Vilmundur] Iceland Heart Assoc, Kopavogur, Iceland; [Gudnason, Vilmundur] Univ Iceland, Fac Med, Reykjavik, Iceland; [Hofer, Edith; Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Clin Div Neurogeriatr, Graz, Austria; [Hofer, Edith] Med Univ Graz, Inst Med Informat Stat & Documentat, Graz, Austria; [Launer, Lenore] Natl Inst Aging, Intramural Res Program, Lab Epidemiol & Populat Sci, Bethesda, MD USA; [Longstreth, W. T.] Univ Washington, Dept Neurol & Epidemiol, Seattle, WA USA; [Lopez, Oscar L.; Roshchupkin, Gennady V.] Erasmus MC Med Ctr, Med Informat, Rotterdam, Netherlands; [Mazoyer, Bernard] Univ Bordeaux, CNRS, Neurodegenerat Dis Inst UMR 5293, CEA, Bordeaux, France; [Mosley, Thomas H.] Univ Mississippi, MIND Ctr, Med Ctr, Jackson, MS USA; [Satizabal, Claudia L.; Seshadri, Sudha] Univ Texas Hlth Sci Ctr, Glenn Biggs Inst Alzheimers & Neurodegenerat Dis, San Antonio, TX USA; [Satizabal, Claudia L.] Univ Texas Hlth Sci Ctr, Dept Epidemiol & Biostatist, San Antonio, TX USA; [Satizabal, Claudia L.; Seshadri, Sudha] Boston Univ, Dept Neurol, Sch Med, Boston, MA USA; [Seshadri, Sudha] Boston Univ, Framingham Heart Study, Sch Med, Boston, MA USA; [Seshadri, Sudha] Boston Univ, Dept Neurol, Sch Med, Boston, MA USA; [Yang, Qiong] Boston Univ, Dept Biostatist, Sch Publ Hlth, Boston, MA USA; [Ames, David] Univ Melbourne, Acad Unit Psychiat Old Age, Melbourne, Vic, Australia; [Ames, David] Natl Ageing Res Inst, Melbourne, Vic, Australia; [Anderson, Tim J.] Canterbury Dist Hlth Board, Dept Neurol, Christchurch, New Zealand; [Baune, Bernhard T.; Pantelis, Christos] Univ Melbourne, Melbourne Med Sch, Dept Psychiat, Melbourne, Vic, Australia; [Baune, Bernhard T.; Pantelis, Christos] Univ Melbourne, Florey Inst Neuroscience & Mental Hlth, Parkville, Vic, Australia; [Beckham, Jean C.] VA Mid Atlant Mental Illness Res Educ & Clin Ctr, VA Healthcare Syst, Durham, VA USA; [Brodaty, Henry] Univ New South Wales, Dementia Ctr Res Collaborat, Sydney, NSW, Australia; [Brunner, Han G.] Maastricht Univ, Dept Clin Genet, Med Ctr, Maastricht, Netherlands; [Brunner, Han G.] Maastricht Univ, Sch Oncol & Dev Biol GROW, Med Ctr, Maastricht, Netherlands; [Buckner, Randy L.] Harvard Univ, Dept Psychol, Boston, MA USA; [Buckner, Randy L.] Harvard Univ, Ctr Brain Sci, Boston, MA USA; [Buckner, Randy L.; Gollub, Randy L.; Holmes, Avram J.; Roffman, Joshua L.; Smoller, Jordan W.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA USA; [Buckner, Randy L.; Gollub, Randy L.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Buitelaar, Jan K.] Karakter Child & Adolescent Psychiat Univ Ctr, Nijmegen, Netherlands; [Bustillo, Juan R.] Univ New Mexico, Dept Psychiat, Albuquerque, NM USA; [Cahn, Wiepke] Univ Utrecht, Univ Med Ctr Utrecht, Dept Psychiat, Utrecht, Netherlands; [Cairns, Murray J.] Schizophrenia Res Inst, Randwick, NSW, Australia; [Calhoun, Vince] Emory Univ, Georgia State Univ, Georgia Inst Technol, Tri Inst Ctr Translat Res Neuroimaging & Data Sci, Atlanta, GA USA; [Carr, Vaughan J.] Monash Univ, Dept Psychiat, Clayton, Vic, Australia; [Caspers, Svenja] Heinrich Heine Univ, Inst Anat 1, Fac Med, Dusseldorf, Germany; [Cavalleri, Gianpiero L.] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin, Ireland; [Cavalleri, Gianpiero L.] SFI FutureNeuro Res Ctr, Dublin, Ireland; [Corvin, Aiden] Trin Coll Dublin, Dept Psychiat, Dublin, Ireland; [Crespo-Facorro, Benedicto] Univ Seville, Hosp Univ Virgen Rocio, IBiS, Seville, Spain; [Dalrymple-Alford, John C.] Univ Canterbury, Sch Psychol Speech & Hearing, Christchurch, New Zealand; [Depondt, Chantal] Univ Libre Bruxelles, Dept Neurol, Hop Erasme, Brussels, Belgium; [Flor, Herta] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Cognit & Clin Neuroscience, Mannheim, Germany; [Forstner, Andreas J.] Univ Basel, Dept Psychiat UPK, Basel, Switzerland; [Forstner, Andreas J.] Univ Marburg, Ctr Human Genet, Marburg, Germany; [Glahn, David C.] Boston Childrens Hosp, Tommy Fuss Ctr Neuropsychiatr Dis Res, Boston, MA USA; [Glahn, David C.] Harvard Med Sch, Dept Psychiat, Boston, MA USA; [Haberg, Asta K.] Norwegian Univ Sci & Technol, Dept Neuroscience, Trondheim, Norway; [Haberg, Asta K.] St Olavs Univ Hosp, Dept Radiol & Nucl Med, Trondheim, Norway; [Hartman, Catharina A.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Hashimoto, Ryota] Osaka Univ, United Grad Sch Child Dev, Mol Res Ctr Childrens Mental Dev, Suita, Osaka, Japan; [Hashimoto, Ryota] Natl Inst Mental Hlth, Dept Pathol Mental Dis, Natl Ctr Neurol & Psychiat, Tokyo, Japan; [Heinz, Andreas] Charite, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany; [Henskens, Frans A.] Univ Newcastle, Hlth Behaviour Res Grp, Callaghan, NSW, Australia; [Hillegers, Manon H. J.; Sommer, Iris E.] Univ Utrecht, Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Hoekstra, Pieter J.; Sommer, Iris E.] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands; [Holmes, Avram J.] Yale Univ, Dept Psychol, New Haven, CT USA; [Hong, L. Elliot; Kochunov, Peter; Rowland, Laura M.] Univ Maryland, Dept Psychiat, Maryland Psychiat Res Ctr, Sch Med, Baltimore, MD USA; [Hopkins, William D.] Univ Texas MD Anderson Canc Ctr, Dept Comparat Med, Bastrop, TX USA; [Jernigan, Terry L.] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA USA; [Kahn, Rene S.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY USA; [Kwok, John B. J.] Univ Sydney, Neurogenet & Epigenet Brain & Mind Ctr, Sydney, NSW, Australia; [Loughland, Carmel M.] Hunter New England Mental Hlth Serv, Newcastle, NSW, Australia; [McMahon, Katie L.] Queensland Univ Technol, Sch Clin Sci, Herston Imaging Res Facil, Brisbane, Qld, Australia; [Meyer-Lindenberg, Andreas] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Germany; [Michie, Patricia T.] Univ Newcastle, Sch Psychol, Callaghan, NSW, Australia; [Mowry, Bryan] Univ Queensland, Queensland Ctr Mental Hlth Res, Brisbane, Qld, Australia; [Nyberg, Lars] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Oosterlaan, Jaap] Emma Childrens Hosp Acad Med Ctr, Amsterdam, Netherlands; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Vrije Univ Med Ctr, Dept Pediat, Amsterdam, Netherlands; [Oosterlaan, Jaap] Vrije Univ Amsterdam, Clin Neuropsychol Sect, Amsterdam, Netherlands; [Pantelis, Christos] Sunshine Hosp, Northwestern Mental Hlth, St Albans, Vic, Australia; [Paus, Tomas] Univ Toronto, Bloorview Res Inst, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Paus, Tomas] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Paus, Tomas] Child Mind Inst, Ctr Developing Brain, New York, NY USA; [Pausova, Zdenka] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Posthuma, Danielle] Vrije Univ Amsterdam, Vrije Univ Med Ctr, Dept Clin Genet, Amsterdam, Netherlands; [Sachdev, Perminder S.] Prince Wales Hosp, Neuropsychiatr Inst, Sydney, NSW, Australia; [Schumann, Gunter] Humboldt Univ, Dept Psychiat & Psychotherapie, PONS Res Grp, Charite Campus Mitte, Berlin, Germany; [Schumann, Gunter] Leibniz Inst Neurobiol, Magdeburg, Germany; [Scott, Rodney J.] John Hunter Hosp, Div Mol Med, New Lambton Heights, NSW, Australia; [Sim, Kang] Inst Mental Hlth, Gen Psychiat, Singapore, Singapore; [Sisodiya, Sanjay M.] Chalfont Ctr Epilepsy, Gerrards Cross, England; [Smoller, Jordan W.] Broad Inst, Stanley Ctr Psychiat Res, Boston, MA USA; [Sommer, Iris E.] Univ Bergen, Dept Med & Biol Psychol, Bergen, Norway; [Stein, Dan J.] Univ Cape Town, Dept Psychiat, Cape Town, South Africa; [Stein, Dan J.] Univ Cape Town, Neuroscience Inst, Cape Town, South Africa; [Stein, Dan J.] Univ Cape Town, MRC Unit Risk & Resilience Mental Disorders, Cape Town, South Africa; [Van der Wee, Nic J. A.] Leiden Univ, Dept Psychiat, Med Ctr, Leiden, Netherlands; [Weinberger, Daniel R.] Johns Hopkins Univ, Psychiat, Neurol, Neuroscience,Genetics, Baltimore, MD USA; [Wright, Margaret J.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Zhou, Juan] Duke Nat Univ Singapore Med Sch, Ctr Cognit Neuroscience Neuroscience & Behav Diso, Singapore, Singapore	QIMR Berghofer Medical Research Institute; University of Southern California; University of Queensland; Queensland University of Technology (QUT); University of Murcia; Radboud University Nijmegen; Radboud University Nijmegen; Roche Holding; Genentech; University of Queensland; University of California System; University of California Los Angeles; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Queensland; University of Oslo; University of Oslo; Diakonhjemmet Hospital; Karolinska Institutet; Royal College of Surgeons - Ireland; Yale University; University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Rio Grande Valley; University of Oslo; Umea University; Umea University; University of Southern California; Murdoch University; Duke University; University of Newcastle; University of Newcastle; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Utrecht University; Utrecht University Medical Center; Ernst Moritz Arndt Universitat Greifswald; University of Munster; Ollscoil na Gaillimhe-University of Galway; McGill University; McGill University; McGill University; University of Queensland; QIMR Berghofer Medical Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Cape Town; Universidade Estadual de Campinas; Queensland University of Technology (QUT); Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Technische Universitat Dresden; University of Cape Town; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; University of California System; University of California San Diego; Cardiff University; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Bergen; University of New South Wales Sydney; Neuroscience Research Australia; Illinois Institute of Technology; University of Edinburgh; University of Edinburgh; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; University of Basel; University of Basel; University of Bonn; Vrije Universiteit Amsterdam; Max Planck Society; University of Bonn; University of Bonn; Fujita Health University; Greifswald Medical School; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Fudan University; Fudan University; University of London; King's College London; Helmholtz Association; Research Center Julich; RWTH Aachen University; University of Sussex; Tokyo Institute of Technology; McGill University; McGill University; University of London; University College London; University of London; Queen Mary University London; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Osaka University; University of Bonn; Duke University; Ruprecht Karls University Heidelberg; University of Gottingen; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Cardiff University; Harvard University; Harvard Medical School; McGill University; University of Edinburgh; University of Edinburgh; University of California System; University of California Irvine; Radboud University Nijmegen; Yale University; Hartford Hospital; University of Otago; University of Amsterdam; Vrije Universiteit Amsterdam; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Heinrich Heine University Dusseldorf; University of Munich; University of Liverpool; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California Los Angeles; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Otago; University of Otago; University of Oslo; Radboud University Nijmegen; Indiana University System; Indiana University-Purdue University Indianapolis; Max Planck Society; Orygen, The National Centre of Excellence in Youth Mental Health; Orygen, The National Centre of Excellence in Youth Mental Health; University of Melbourne; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Neuroscience Research Australia; University of New South Wales Sydney; University of Pennsylvania; University of Toronto; Radboud University Nijmegen; Greifswald Medical School; University of New South Wales Sydney; Hospital Universitario Marques de Valdecilla (HUMV); University System of Georgia; Georgia State University; Lovelace Respiratory Research Institute; University of Vermont; University of Oslo; University of Oslo; Maastricht University; Max Planck Society; Erasmus University Rotterdam; Erasmus MC; University of Groningen; Utrecht University; Utrecht University Medical Center; University of Bristol; University of Bath; University of Edinburgh; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Wurzburg; Universidade Estadual de Campinas; University of London; King's College London; UDICE-French Research Universities; Universite Paris Saclay; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Philipps University Marburg; University of Oslo; University of Bergen; Trinity College Dublin; Royal College of Surgeons - Ireland; University of Southern California; University of Nottingham; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Bonn; University of Bonn; University of Munster; University of Iowa; Greifswald Medical School; Mayo Clinic; Philipps University Marburg; Duke University; University of Minnesota System; University of Minnesota Twin Cities; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins University; John Wayne Cancer Institute; Greifswald Medical School; German Centre for Cardiovascular Research; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Calgary; University of California System; University of California Irvine; University of Newcastle; University of Newcastle; Hunter Medical Research Institute; University of Newcastle; University of New South Wales Sydney; University of Bergen; Haukeland University Hospital; Trinity College Dublin; Erasmus University Rotterdam; Erasmus MC; Osaka University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; University of California System; University of California Davis; University of Texas System; University of Texas Health Science Center Houston; Icelandic Heart Association; University of Iceland; Medical University of Graz; Medical University of Graz; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Washington; University of Washington Seattle; Erasmus University Rotterdam; Erasmus MC; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Mississippi; University of Mississippi Medical Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Boston University; Boston University; Framingham Heart Study; Boston University; Boston University; University of Melbourne; National Ageing Research Institute; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of New South Wales Sydney; Maastricht University; Maastricht University; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Radboud University Nijmegen; University of New Mexico; Utrecht University; Utrecht University Medical Center; Emory University; University System of Georgia; Georgia Institute of Technology; Georgia State University; Monash University; Heinrich Heine University Dusseldorf; Royal College of Surgeons - Ireland; Trinity College Dublin; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; University of Canterbury; Universite Libre de Bruxelles; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Basel; Philipps University Marburg; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Groningen; Osaka University; National Center for Neurology & Psychiatry - Japan; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Newcastle; Utrecht University; Utrecht University Medical Center; University of Groningen; Yale University; University System of Maryland; University of Maryland Baltimore; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai; University of Sydney; Queensland University of Technology (QUT); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Newcastle; Queensland Centre for Mental Health Research; University of Queensland; Umea University; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leibniz Institut fur Neurobiologie (LIN); John Hunter Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Bergen; University of Cape Town; University of Cape Town; University of Cape Town; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johns Hopkins University; University of Queensland	Grasby, KL; Jahanshad, N (corresponding author), QIMR Berghofer Med Res Inst, Psychiat Genet, Brisbane, Qld, Australia.	katrina.grasby@qimrberghofer.edu.au; njahansh@usc.edu; jason_stein@med.unc.edu; pthomp@usc.edu; sarah.medland@qimrberghofer.edu.au	Ikram, M. Arfan/AAM-5225-2021; Kennedy, Martin A/A-4942-2008; Donohoe, Gary/J-6481-2013; Ayesa-Arriola, Rosa/AFS-1408-2022; McDonald, Colm/C-1430-2009; Cannon, Dara M/C-1323-2009; Heinz, Andreas/ABB-7736-2020; Buimer, Elizabeth/GXM-6452-2022; Jockwitz, Christiane/GLU-5939-2022; chen, qiang/GWZ-7308-2022; Teumer, Alexander/S-7438-2019; Hansell, Narelle K/A-4553-2016; Secolin, Rodrigo/G-1738-2010; Hulshoff Pol, Hilleke Evertje/B-4795-2014; Mathalon, Daniel H/AEE-5878-2022; Medland, Sarah/AAT-7595-2020; Cendes, Fernando/C-1301-2012; Franke, Barbara/D-4836-2009; de Zubicaray, Greig/ABC-8955-2021; Walter, Henrik/O-2612-2013; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Zwiers, Marcel P/D-2968-2009; Morris, Derek/AAW-8343-2021; Wittfeld, Katharina/AFB-1549-2022; Grasby, Katrina/AAU-9349-2021; Najt, Pablo/AAX-2262-2021; Andreassen, Ole A./AAY-7531-2020; de Araujo, Tânia Kawasaki/D-1889-2015; Pike, Bruce/K-5562-2014; Knol, Maria/AAP-9725-2020; Boomsma, Dorret I/AAX-4470-2020; Mirza-Schreiber, Nazanin/AAD-1558-2022; yasuda, clarissa lin/D-4599-2018; Sachdev, Perminder/ABC-1137-2020; Artiges, Eric/AAT-7219-2021; van Eijk, Liza/AAX-6101-2020; Kochunov, Peter/GQH-9532-2022; Francks, Clyde/E-1384-2012; Lind, Penelope A/ABC-5341-2021; Colodro-Conde, Lucia/L-5515-2014; Kaufmann, Tobias/M-8972-2017; Armstrong, Nicola J./AAF-3045-2021; Desrivières, Sylvane/ABC-4336-2021; Jansen, Andreas/AAL-5264-2020; Turner, Jessica A/H-7282-2015; Francks, Clyde/AGU-8875-2022; DeCarli, Charles/B-5541-2009; Salminen, Lauren/T-1400-2019; Zhang, Zuo/ABB-8762-2020; Stein, Dan/A-1752-2008; Rocha, Cristiane S/B-7671-2012; Pizzagalli, Fabrizio/AAE-4990-2022; Thompson, Paul M/C-4194-2018; Pearson, John F/D-7428-2012; Krug, Axel/ABC-8530-2020; Karama, Sherif/AAT-2683-2021; Wu, Jingqin/V-9319-2019; TOONEY, PAUL ANTHONY/G-7280-2013; Jia, Tianye/AAC-3925-2019; Preda, Adrian/K-8889-2013; Gruber, Oliver/AAY-5563-2020; Mirza-Schreiber, Nazanin/AAD-1563-2022; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; najt, pablo/ABH-6011-2020; Repple, Jonathan/I-4948-2015; Wolfers, Thomas/ABF-1461-2020; Calhoun, Vince D./ACN-9399-2022; Ho, Beng-Choon/D-6959-2011; Fernandez, Guillen/B-3771-2009; Pantelis, Christos/H-7722-2014; chen, qiang/HGU-5418-2022; Dalvie, Shareefa/T-4621-2019; Adams, Hieab/GLN-6421-2022; Hoffmann, Per/A-5149-2010; Hernandez, María/GYU-3543-2022; Fisher, Simon E./E-9130-2012; Walton, Esther/P-9832-2019; Fukunaga, Masaki/F-6441-2013; Wright, Margaret Jane/A-4560-2016; van der Meer, Dennis/H-6663-2019; Lam, Max/AAM-4946-2021; Shen, Li/AAB-6870-2021; Walton, Esther/GSN-8429-2022; Jahanshad, Neda/ABD-5944-2021; van Eijk, Liza/AAO-3531-2021; Blangero, John/ABA-7175-2021; Gowland, Penny A./I-9016-2012; Weber, Bernd/H-5244-2012; Hoogman, Martine/G-8958-2015; Buitelaar, J.K./AAY-7522-2020; Grasby, Katrina/M-7536-2016; Kircher, Tilo/AAT-6480-2020; Strike, Lachlan T/R-3902-2018; Wardlaw, Joanna M/Y-3456-2019; Bralten, Janita/AAB-9566-2019; White, Tonya/AAU-2226-2021; Lind, Penelope A/B-2553-2009; Jack, Clifford R/F-2508-2010; Sprooten, Emma/N-3836-2017; de Geus, Eco/M-9318-2015; Scott, Rodney/B-2827-2013; Caspers, Svenja/H-9346-2013; Mowry, Bryan/G-5046-2010; Gudnason, Vilmundur/K-6885-2015; Tansey, Katherine/B-1033-2013; Quide, Yann/B-6567-2013; Penninx, Brenda WJH/S-7627-2017; debette, stephanie/T-4946-2019	Kennedy, Martin A/0000-0002-6445-8526; Donohoe, Gary/0000-0003-3037-7426; Ayesa-Arriola, Rosa/0000-0003-0570-5352; McDonald, Colm/0000-0003-1661-5192; Cannon, Dara M/0000-0001-7378-3411; Heinz, Andreas/0000-0001-5405-9065; Buimer, Elizabeth/0000-0002-8143-3160; Jockwitz, Christiane/0000-0001-9332-7982; Teumer, Alexander/0000-0002-8309-094X; Hansell, Narelle K/0000-0002-8229-9741; Secolin, Rodrigo/0000-0002-2485-9560; Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; Mathalon, Daniel H/0000-0001-6090-4974; Medland, Sarah/0000-0003-1382-380X; Cendes, Fernando/0000-0001-9336-9568; Franke, Barbara/0000-0003-4375-6572; de Zubicaray, Greig/0000-0003-4506-0579; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Zwiers, Marcel P/0000-0001-5483-2935; Morris, Derek/0000-0002-3413-570X; Wittfeld, Katharina/0000-0003-4383-5043; de Araujo, Tânia Kawasaki/0000-0003-3056-3894; Pike, Bruce/0000-0001-8924-683X; Knol, Maria/0000-0002-3597-1531; yasuda, clarissa lin/0000-0001-9084-7173; Sachdev, Perminder/0000-0002-9595-3220; Artiges, Eric/0000-0003-4461-7646; Francks, Clyde/0000-0002-9098-890X; Lind, Penelope A/0000-0002-3887-2598; Colodro-Conde, Lucia/0000-0002-9004-364X; Kaufmann, Tobias/0000-0002-4003-1018; Armstrong, Nicola J./0000-0002-4477-293X; Desrivières, Sylvane/0000-0002-9120-7060; Jansen, Andreas/0000-0002-3140-8207; Turner, Jessica A/0000-0003-0076-8434; Salminen, Lauren/0000-0002-0684-9991; Zhang, Zuo/0000-0002-6752-3434; Stein, Dan/0000-0001-7218-7810; Rocha, Cristiane S/0000-0001-5678-2070; Thompson, Paul M/0000-0002-4720-8867; Pearson, John F/0000-0001-5607-4517; Krug, Axel/0000-0002-0564-2497; Wu, Jingqin/0000-0002-2052-3875; Jia, Tianye/0000-0001-5399-2953; Preda, Adrian/0000-0003-3373-2438; Mirza-Schreiber, Nazanin/0000-0003-0836-8267; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; najt, pablo/0000-0002-4263-3880; Repple, Jonathan/0000-0003-1379-9491; Wolfers, Thomas/0000-0002-7693-0621; Calhoun, Vince D./0000-0001-9058-0747; Ho, Beng-Choon/0000-0003-3976-1555; Fernandez, Guillen/0000-0002-5522-0604; Pantelis, Christos/0000-0002-9565-0238; Hoffmann, Per/0000-0002-6573-983X; Fisher, Simon E./0000-0002-3132-1996; Walton, Esther/0000-0002-0935-2200; Fukunaga, Masaki/0000-0003-1010-2644; Wright, Margaret Jane/0000-0001-7133-4970; van der Meer, Dennis/0000-0002-0466-386X; van Eijk, Liza/0000-0001-8254-1019; Gowland, Penny A./0000-0002-4900-4817; Weber, Bernd/0000-0002-7811-9605; Hoogman, Martine/0000-0002-1261-7628; Grasby, Katrina/0000-0001-8539-0228; Kircher, Tilo/0000-0002-2514-2625; Strike, Lachlan T/0000-0003-2885-5898; Wardlaw, Joanna M/0000-0002-9812-6642; Bralten, Janita/0000-0003-1440-8675; White, Tonya/0000-0003-0271-1896; Lind, Penelope A/0000-0002-3887-2598; Jack, Clifford R/0000-0001-7916-622X; Sprooten, Emma/0000-0002-1691-9105; Zhou, Juan/0000-0002-0180-8648; Thalamuthu, Anbupalam/0000-0002-7114-1260; Ikram, Mohammad Arfan/0000-0003-0372-8585; Banaschewski, Tobias/0000-0003-4595-1144; Posthuma, Danielle/0000-0001-7582-2365; Foley, Sonya/0000-0002-8390-2709; Dalvie, Shareefa/0000-0003-2333-4823; Curran, Joanne/0000-0002-6898-155X; Tooney, Paul/0000-0003-3745-4367; Luykx, Jurjen/0000-0002-6439-2774; Groenewold, Nynke A./0000-0002-0865-8427; /0000-0003-1391-9481; Mather, Karen Anne/0000-0003-4143-8941; de Geus, Eco/0000-0001-6022-2666; Ghanbari, Mohsen/0000-0002-9476-7143; Scott, Rodney/0000-0001-7724-3404; Blangero, John/0000-0001-6250-5723; Quinlan, Erin Burke/0000-0003-2927-1632; Cavalleri, Gianpiero/0000-0002-9802-0506; Risacher, Shannon/0000-0002-3304-7943; Doherty, Colin/0000-0002-8869-8567; Caspers, Svenja/0000-0001-5083-4669; Whelan, Christopher/0000-0003-0308-5583; O'Leary, Daniel/0000-0003-1959-6521; Erk, Susanne/0000-0003-0961-3543; Vernooij, Meike/0000-0003-4658-2176; Whelan, Robert/0000-0002-2790-7281; Lancaster, Thomas/0000-0003-1322-2449; Polderman, Tinca/0000-0001-5564-301X; Caseras, Xavier/0000-0002-8490-6891; den Braber, A./0000-0002-3377-2627; Mowry, Bryan/0000-0002-4115-5645; Van Duijn, Cornelia/0000-0002-2374-9204; Ehrlich, Stefan/0000-0003-2132-4445; Shenkman, Elizabeth/0000-0003-4903-1804; Mishra, Aniket/0000-0002-8141-1543; Fedko, Iryna/0000-0003-1962-916X; Gurholt, Tiril/0000-0002-1272-7616; Pitcher, Toni/0000-0003-4661-5038; Flor, Herta/0000-0003-4809-5398; Schumann, Gunter/0000-0003-4905-5523; Gudnason, Vilmundur/0000-0001-5696-0084; Painter, Jodie/0000-0002-4992-2458; Seppi, Klaus/0000-0001-6503-1455; Jang, MiHyun/0000-0001-5638-2237; Thomopoulos, Sophia I/0000-0002-0046-4070; Uhlmann, Anne/0000-0002-1753-7811; Nees, Frauke/0000-0002-7796-8234; Tansey, Katherine/0000-0002-9663-3376; Amlien, Inge Kasbohm/0000-0002-8508-9088; Lim, Kelvin/0000-0002-2390-7268; Saba, Yasaman/0000-0002-3549-2493; Ard, Tyler/0000-0002-5123-1226; Sim, Kang/0000-0003-3209-9626; Quide, Yann/0000-0002-8569-7139; Penninx, Brenda WJH/0000-0001-7779-9672; Wen, Wei/0000-0003-2753-3870; Schall, Ulrich/0000-0001-9041-4562; Pizzagalli, Fabrizio/0000-0003-4582-0224; Sommer, Iris/0000-0001-5597-3262; St Pourcain, Beate/0000-0002-4680-3517; debette, stephanie/0000-0001-8675-7968; Jonsson, Erik/0000-0001-8368-6332	National Institutes of Health (NIH) Big Data to Knowledge (BD2K) Initiative, a cross-NIH partnership [U54 EB020403]; Kavli Foundation; National Health and Medical Research Council (NHMRC) [1158127]; NHMRC Senior Research Fellowship [APP1103623, APP1173025]; QIMR Berghofer Fellowship; German Federal Ministry of Education and Science (BMBF) [FKZ 01EG940]; German Research Foundation (DFG) [ER 155/6-1]; BMBF through the Integrated Network IntegraMent under the e:Med Program [01ZX1314A]; Swiss National Science Foundation [156791]; Initiative and Networking Fund of the Helmholtz Association; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (H2020) [720270, 785907]; NIH [U01 AG024904]; Department of Defense ADNI [W81XWH-12-2-0012]; National Institute on Aging (NIA); National Institute of Biomedical Imaging and Bioengineering; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; Fujirebio; Michael J. Fox Foundation (MJFF) [14848]; Heinz Nixdorf Foundation (Germany); AbbVie; Eisai Inc.; BioClinica, Inc.; F. Hoffmann-La Roche, Ltd.; Genentech, Inc.; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research AMP; Development, LLC.; Johnson AMP; Johnson Pharmaceutical Research AMP; Development, LLC; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer, Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; Canadian Institutes of Health Research; NIA [U24 AG21886, R03 AG054936]; NLM [R01 LM012535]; Wellcome [102215/2/13/2]; UK Medical Research Council (MRC) [102215/2/13/2]; 23andMe; Australian NHMRC; Pratt Foundation; Ramsay Health Care; Viertel Charitable Foundation; Schizophrenia Research Institute (Australia); NSW Health; Macquarie Group Foundation; Neurobehavioral Genetics Unit; NHMRC [1067137, 1147644, 1051672, 1121474, 628386, 1105825]; Wallenberg Scholar grant from the Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderbergs Foundation; HelseVest RHF [911554]; Bergen Research Foundation; University of Bergen; Dr Einar Martens Fund; K.G. Jebsen Foundation; Research Council of Norway [177458/V 50, 204966/F 20]; Bayer Healthcare, AG;  [R01 MH116147];  [R01 MH1161671];  [P41 EB015922];  [RF1 AG051710];  [RF1 AG041915];  [R56 AG058854];  [R01 AG059874];  [R01 MH117601];  [R01MH118349];  [R00MH102357];  [R01 MH085772]; BBSRC [BB/F019394/1] Funding Source: UKRI; MRC [G0700704, MR/N027558/1, G1001245, MC_PC_19009, MR/M013111/1, G0701120, MR/R024065/1] Funding Source: UKRI	National Institutes of Health (NIH) Big Data to Knowledge (BD2K) Initiative, a cross-NIH partnership(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kavli Foundation; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); QIMR Berghofer Fellowship; German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); BMBF through the Integrated Network IntegraMent under the e:Med Program(Federal Ministry of Education & Research (BMBF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Initiative and Networking Fund of the Helmholtz Association; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (H2020)(European Research Council (ERC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense ADNI(United States Department of Defense); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Araclon Biotech; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Cogstate(CogState Limited); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; Fujirebio; Michael J. Fox Foundation (MJFF); Heinz Nixdorf Foundation (Germany); AbbVie(AbbVie); Eisai Inc.(Eisai Co Ltd); BioClinica, Inc.; F. Hoffmann-La Roche, Ltd.(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research AMP; Development, LLC.; Johnson AMP; Johnson Pharmaceutical Research AMP; Development, LLC; Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer, Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Wellcome; UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); 23andMe; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Pratt Foundation; Ramsay Health Care; Viertel Charitable Foundation; Schizophrenia Research Institute (Australia); NSW Health; Macquarie Group Foundation; Neurobehavioral Genetics Unit; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Wallenberg Scholar grant from the Knut and Alice Wallenberg Foundation; Torsten and Ragnar Soderbergs Foundation; HelseVest RHF; Bergen Research Foundation; University of Bergen; Dr Einar Martens Fund; K.G. Jebsen Foundation; Research Council of Norway(Research Council of Norway); Bayer Healthcare, AG(Bayer AGBayer Healthcare Pharmaceuticals); ; ; ; ; ; ; ; ; ; ; ; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by U54 EB020403 from the National Institutes of Health (NIH) Big Data to Knowledge (BD2K) Initiative, a cross-NIH partnership. Additional support was provided by R01 MH116147, R01 MH1161671, P41 EB015922, RF1 AG051710, RF1 AG041915, R56 AG058854, R01 AG059874, R01 MH117601, the Michael J. Fox Foundation (MJFF; 14848), the Kavli Foundation, and National Health and Medical Research Council (NHMRC) Project Grant 1158127 (to S.E.M.). S.E.M. was funded by an NHMRC Senior Research Fellowship (APP1103623). K.L.G. was supported by APP1173025. L.C.-C. was supported by a QIMR Berghofer Fellowship. J.L.S. was supported by R01MH118349 and R00MH102357. The 1000BRAINS cohort thanks the Heinz Nixdorf Foundation (Germany) for generous support of the Heinz Nixdorf Recall Study, which is also supported by the German Federal Ministry of Education and Science (BMBF; FKZ 01EG940) and the German Research Foundation (DFG; ER 155/6-1). This work was further supported by the BMBF through the Integrated Network IntegraMent under the e:Med Program (01ZX1314A to S.Ci) and the Swiss National Science Foundation (156791 to S.Ci). The Initiative and Networking Fund of the Helmholtz Association supported S.Ca, the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (H2020) supported S.Ci (Human Brain Project SGA1, 720270) and supported S.Ca and S.Ci (Human Brain Project SGA2, 785907). The Alzheimer's Disease Neuroimaging Initiative (ADNI1 and ADNI2GO) was supported by NIH (U01 AG024904) and Department of Defense ADNI (W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from AbbVie; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche, Ltd., and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development, LLC; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer, Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research provided funds to support ADNI clinical sites in Canada. Private sector contributions were facilitated by the Foundation for the National Institutes of Health (FNIH) (www.fnih.org).The grantee organization is the Northern California Institute for Research and Education, and the study was coordinated by the Alzheimer's Therapeutic Research Institute at the University of Southern California. Samples used in this study were from the National Centralized Repository for Alzheimer's Disease and Related Dementias, which received government support under a cooperative agreement grant (U24 AG21886) awarded by the NIA. Support for data analysis was provided by NLM R01 LM012535 and NIA R03 AG054936 (to K.N.). The UK Medical Research Council (MRC) and Wellcome (102215/2/13/2) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website (www.bristol.ac.uk/alspac/external/documents/grant-acknowledgements.pdf).ALSPAC neuroimaging data were specifically funded by R01 MH085772 (to T.P.; r r ). GWAS data were generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America), with support from 23andMe. Data and sample collection by the Australian Schizophrenia Research Bank (ASRB) were supported by the Australian NHMRC, the Pratt Foundation, Ramsay Health Care, and the Viertel Charitable Foundation. The ASRB was also supported by the Schizophrenia Research Institute (Australia), with infrastructure funding from NSW Health and the Macquarie Group Foundation. DNA analysis was supported by the Neurobehavioral Genetics Unit, with funding from NSW Health and the NHMRC Project Grants (1067137, 1147644, 1051672). M.C. was supported by a NHMRC Senior Research Fellowship (1121474). C.P. was supported by a NHMRC Senior Principal Research Fellowship (628386 and 1105825). BETULA was supported by a Wallenberg Scholar grant from the Knut and Alice Wallenberg Foundation and a grant from Torsten and Ragnar Soderbergs Foundation to L.N., HelseVest RHF (911554 to S.L.H.), grants from the Bergen Research Foundation and the University of Bergen to S.L.H., grants from the Dr Einar Martens Fund and the K.G. Jebsen Foundation to S.L.H. and V.M.S., and the Research Council of Norway (177458/V 50 to T.E. and 204966/F 20 to L.T.W.). Nijmegen's BIG resource is part of Cognomics, a joint initiative by researchers of the Donders Centre for Cognitive Neuroimaging, the Human Genetics and Cognitive Neuroscience departments of the Radboud University Medical Center, and the Max Planck LLC; Neuralstem; Taisho; Heptares; Pfizer; Sound Pharma; Luye Pharma; Takeda; and Regeneron. N.H. is a stockholder of Siemens AG, Erlangen, Germany. R.B. has received travel grants and speaker honoraria from Bayer Healthcare, AG. R.L.B. is a paid consultant for Roche.	Adams HHH, 2016, NAT NEUROSCI, V19, P1569, DOI 10.1038/nn.4398; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anney RJL, 2014, LANCET NEUROL, V13, P893, DOI 10.1016/S1474-4422(14)70171-1; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnold PD, 2018, MOL PSYCHIATR, V23, P1181, DOI 10.1038/mp.2017.154; Aschard H, 2015, AM J HUM GENET, V96, P329, DOI 10.1016/j.ajhg.2014.12.021; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; Bae BI, 2015, DEV CELL, V32, P423, DOI 10.1016/j.devcel.2015.01.035; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bruyn G. W., 1990, CLIN NEUROL NEUROSUR, V93, P93, DOI [10.1016/0303-8467(91)90043-O, DOI 10.1016/0303-8467(91)90043-O]; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Chelala C, 2009, BIOINFORMATICS, V25, P655, DOI 10.1093/bioinformatics/btn653; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Coulon O, 2006, NEUROIMAGE S1, V31, P29; Coulon O, 2011, IEEE ENG MED BIO, P7795, DOI 10.1109/IEMBS.2011.6091921; Cykowski MD, 2008, CEREB CORTEX, V18, P1999, DOI 10.1093/cercor/bhm224; de la Torre-Ubieta L, 2018, CELL, V172, P289, DOI 10.1016/j.cell.2017.12.014; de Leeuw CA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004219; Demontis D, 2019, NAT GENET, V51, P63, DOI 10.1038/s41588-018-0269-7; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DiGiacomo V, 2016, BIOL REV, V91, P288, DOI 10.1111/brv.12170; Duarte RRR, 2016, AM J MED GENET B, V171, P806, DOI 10.1002/ajmg.b.32445; Duncan LE, 2018, MOL PSYCHIATR, V23, P666, DOI 10.1038/mp.2017.77; Duncan L, 2017, AM J PSYCHIAT, V174, P850, DOI 10.1176/appi.ajp.2017.16121402; Elliott LT, 2018, NATURE, V562, P210, DOI 10.1038/s41586-018-0571-7; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Ferrari R, 2014, LANCET NEUROL, V13, P686, DOI 10.1016/S1474-4422(14)70065-1; Finucane HK, 2018, NAT GENET, V50, P621, DOI 10.1038/s41588-018-0081-4; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fromer M, 2016, NAT NEUROSCI, V19, P1442, DOI 10.1038/nn.4399; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gao JJ, 2017, NEUROPSYCHOPHARMACOL, V42, P811, DOI 10.1038/npp.2016.197; Giusti-Rodriguez P. M., 2019, 406330 BIORXIV; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Harrison-Uy SJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008094; Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408; Hibar DP, 2015, NATURE, V520, P224, DOI 10.1038/nature14101; Hofer E, 2019, 409649 BIORXIV, DOI [10.1101/409649, DOI 10.1101/409649]; Hopkins WD, 2010, NEUROSCIENCE, V171, P544, DOI 10.1016/j.neuroscience.2010.07.018; Hopkins WD, 2014, BRAIN BEHAV EVOLUT, V84, P19, DOI 10.1159/000362431; Hormozdiari F, 2014, GENETICS, V198, P497, DOI 10.1534/genetics.114.167908; Howard DM, 2019, NAT NEUROSCI, V22, P343, DOI 10.1038/s41593-018-0326-7; Huang ZY, 2009, DEV BIOL, V327, P132, DOI 10.1016/j.ydbio.2008.12.003; Ikram MA, 2012, NAT GENET, V44, P539, DOI 10.1038/ng.2245; Itoh Yasuhiro, 2016, Neurogenesis (Austin), V3, pe1256854, DOI 10.1080/23262133.2016.1256854; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Jansen P. R., 2019, NAT GENET, V51, P394; Jansen PR, 2019, NAT GENET, V51, P394, DOI 10.1038/s41588-018-0333-3; Jayakumar AR, 2014, J NEUROCHEM, V131, P333, DOI 10.1111/jnc.12810; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lee JJ, 2019, INTELLIGENCE, V75, P48, DOI 10.1016/j.intell.2019.01.011; Lee JJ, 2018, NAT GENET, V50, P1112, DOI 10.1038/s41588-018-0147-3; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; McCarthy S, 2016, NAT GENET, V48, P1279, DOI 10.1038/ng.3643; McDaniel MA, 2005, INTELLIGENCE, V33, P337, DOI 10.1016/j.intell.2004.11.005; Meechan DW, 2011, INT J DEV NEUROSCI, V29, P283, DOI 10.1016/j.ijdevneu.2010.08.005; Munji RN, 2011, J NEUROSCI, V31, P1676, DOI 10.1523/JNEUROSCI.5404-10.2011; Nagel M, 2018, NAT GENET, V50, P920, DOI 10.1038/s41588-018-0151-7; Nalls M. A., 2019, 388165 BIORXIV; Noyce A.J., 2019, EXPANDING PARKINSON, P388165, DOI [10.1101/388165, DOI 10.1101/388165]; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Brien HE, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1567-1; O'Connor LJ, 2018, NAT GENET, V50, P1728, DOI 10.1038/s41588-018-0255-0; Okbay A, 2016, NAT GENET, V48, P624, DOI 10.1038/ng.3552; Okerlund ND, 2010, J NEUROSCI, V30, P4362, DOI 10.1523/JNEUROSCI.0354-10.2010; Otowa T, 2016, MOL PSYCHIATR, V21, P1391, DOI 10.1038/mp.2015.197; Panizzon MS, 2009, CEREB CORTEX, V19, P2728, DOI 10.1093/cercor/bhp026; Pappa I, 2016, AM J MED GENET B, V171, P562, DOI 10.1002/ajmg.b.32333; Pardinas AF, 2018, NAT GENET, V50, P381, DOI 10.1038/s41588-018-0059-2; Perrot M, 2011, MED IMAGE ANAL, V15, P529, DOI 10.1016/j.media.2011.02.008; Pers TH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6890; Polioudakis D, 2019, NEURON, V103, P785, DOI 10.1016/j.neuron.2019.06.011; Porter HF, 2017, SCI REP-UK, V7, DOI 10.1038/srep38837; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Riviere D, 2002, MED IMAGE ANAL, V6, P77, DOI 10.1016/S1361-8415(02)00052-X; Roffe M, 2013, J BIOL CHEM, V288, P10860, DOI 10.1074/jbc.M113.461970; Ronan JL, 2013, NAT REV GENET, V14, P347, DOI 10.1038/nrg3413; Savage JE, 2018, NAT GENET, V50, P912, DOI 10.1038/s41588-018-0152-6; Scrucca L, 2016, R J, V8, P289; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Sniekers S, 2017, NAT GENET, V49, P1107, DOI 10.1038/ng.3869; Solozobova V, 2012, STEM CELL REV REP, V8, P813, DOI 10.1007/s12015-012-9381-8; Stahl EA, 2019, NAT GENET, V51, P793, DOI 10.1038/s41588-019-0397-8; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Strike LT, 2019, CEREB CORTEX, V29, P952, DOI 10.1093/cercor/bhy002; Thompson P., 2019, PSYARXIV, DOI 10.31234/osf.io/qnsh7.; Tielbeek JJ, 2017, JAMA PSYCHIAT, V74, P1242, DOI 10.1001/jamapsychiatry.2017.3069; van der Sluis S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003235; Verbanck M, 2018, NAT GENET, V50, P693, DOI 10.1038/s41588-018-0099-7; Vuoksimaa E, 2015, CEREB CORTEX, V25, P2127, DOI 10.1093/cercor/bhu018; Wang DF, 2018, SCIENCE, V362, P333, DOI 10.1126/science.aao1797; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Watanabe K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01261-5; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	110	183	189	23	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1340	+	eaay6690	10.1126/science.aay6690	http://dx.doi.org/10.1126/science.aay6690			79	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193296	Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000522167400044
J	Kvon, EZ; Zhu, YW; Kelman, G; Novak, CS; Plajzer-Frick, I; Kato, M; Garvin, TH; Pham, Q; Harrington, AN; Hunter, RD; Godoy, J; Meky, EM; Akiyama, JA; Afzal, V; Tran, S; Escande, F; Gilbert-Dussardier, B; Jean-Marcais, N; Hudaiberdiev, S; Ovcharenko, I; Dobbs, MB; Gurnett, CA; Manouvrier-Hanu, S; Petit, F; Visel, A; Dickel, DE; Pennacchio, LA				Kvon, Evgeny Z.; Zhu, Yiwen; Kelman, Guy; Novak, Catherine S.; Plajzer-Frick, Ingrid; Kato, Momoe; Garvin, Tyler H.; Quan Pham; Harrington, Anne N.; Hunter, Riana D.; Godoy, Janeth; Meky, Eman M.; Akiyama, Jennifer A.; Afzal, Veena; Tran, Stella; Escande, Fabienne; Gilbert-Dussardier, Brigitte; Jean-Marcais, Nolwenn; Hudaiberdiev, Sanjarbek; Ovcharenko, Ivan; Dobbs, Matthew B.; Gurnett, Christina A.; Manouvrier-Hanu, Sylvie; Petit, Florence; Visel, Axel; Dickel, Diane E.; Pennacchio, Len A.			Comprehensive In Vivo Interrogation Reveals Phenotypic Impact of Human Enhancer Variants	CELL			English	Article							REGULATORY SEQUENCE ZRS; RANGE SHH ENHANCER; TRIPHALANGEAL THUMB; SONIC HEDGEHOG; TRANSCRIPTIONAL ENHANCERS; INTRAFAMILIAL VARIABILITY; POINT MUTATIONS; EXPRESSION; LIMB; GENE	Establishing causal links between non-coding variants and human phenotypes is an increasing challenge. Here, we introduce a high-throughput mouse reporter assay for assessing the pathogenic potential of human enhancer variants in vivo and examine nearly a thousand variants in an enhancer repeatedly linked to polydactyly. We show that 71% of all rare non-coding variants previously proposed as causal lead to reporter gene expression in a pattern consistent with their pathogenic role. Variants observed to alter enhancer activity were further confirmed to cause polydactyly in knockin mice. We also used combinatorial and single-nucleotide mutagener's to evaluate the in vivo impact of mutations affecting all positions of the enhancer and identified additional functional substitutions, including potentially pathogenic variants hitherto not observed in humans. Our results uncover the functional consequences of hundreds of mutations in a phenotype-associated enhancer and establish a widely applicable strategy for systematic in vivo evaluation of human enhancer variants.	[Kvon, Evgeny Z.; Zhu, Yiwen; Kelman, Guy; Novak, Catherine S.; Plajzer-Frick, Ingrid; Kato, Momoe; Garvin, Tyler H.; Quan Pham; Harrington, Anne N.; Hunter, Riana D.; Godoy, Janeth; Meky, Eman M.; Akiyama, Jennifer A.; Afzal, Veena; Tran, Stella; Visel, Axel; Dickel, Diane E.; Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA; [Escande, Fabienne; Manouvrier-Hanu, Sylvie; Petit, Florence] Univ Lille, CHU Lille, EA7364, F-59000 Lille, France; [Gilbert-Dussardier, Brigitte] Univ Poitiers, CHU Poitiers, EA3808, F-86000 Poitiers, France; [Jean-Marcais, Nolwenn] CHU Dijon Bourgogne, Dept Clin Genet, F-21000 Dijon, France; [Hudaiberdiev, Sanjarbek; Ovcharenko, Ivan] NLM, Computat Biol Branch, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD USA; [Dobbs, Matthew B.] Washington Univ, Sch Med, Dept Orthopaed Surg, St Louis, MO 63110 USA; [Gurnett, Christina A.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Visel, Axel; Pennacchio, Len A.] US DOE, Joint Genome Inst, Berkeley, CA 94720 USA; [Visel, Axel] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Pennacchio, Len A.] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Universite de Lille - ISITE; CHU Lille; Universite de Lille; CHU Poitiers; Universite de Poitiers; CHU Dijon Bourgogne; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Washington University (WUSTL); Washington University (WUSTL); United States Department of Energy (DOE); Joint Genome Institute - JGI; University of California System; University of California Merced; University of California System; University of California Berkeley	Visel, A; Dickel, DE; Pennacchio, LA (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, Berkeley, CA 94720 USA.; Visel, A; Pennacchio, LA (corresponding author), US DOE, Joint Genome Inst, Berkeley, CA 94720 USA.; Visel, A (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.; Pennacchio, LA (corresponding author), Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA.	avisel@lbl.gov; dedickel@lbl.gov; lapennacchio@lbl.gov	Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; Dickel, Diane/0000-0001-5497-6824; Pennacchio, Len/0000-0002-8748-3732; Kelman, Guy/0000-0001-8604-3279; Hunter, Riana/0000-0002-2888-1079	National Institutes of Health [R01HG003988, K99HG009682, R01AR067715]; Helen Hay Whitney Foundation - Howard Hughes Medical Institute; Department of Energy Contract, University of California [DE-AC02-05CH11231]; Intramural Research Program of the National Library of Medicine at the NIH	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney Foundation - Howard Hughes Medical Institute(Howard Hughes Medical Institute); Department of Energy Contract, University of California; Intramural Research Program of the National Library of Medicine at the NIH	The authors would like to acknowledge Muriel Holder-Espinasse (Guy's Hospital, London), Ghislaine Plessis (CHU Caen), Alain Verloes (CHU Paris), Carine Abel (Hopital de la Croix Rousse, Lyon), the French reference centers for developmental anomalies, and ERN-ITHACA for patient recruitment. The authors also thank Valentina Snetkova and Marco Osterwalder for help with enhancer pattern annotation and J. Omar Yanez-Cuna for help with designing mutant enhancer alleles. The authors would also like to thank Jonna Austin for photo permissions. This work was supported by National Institutes of Health grants R01HG003988 (to L.A.P.), K99HG009682 (to E.Z.K.), and R01AR067715 (to C.A.G and M.B.D). E.Z.K. was supported by a postdoctoral fellowship from the Helen Hay Whitney Foundation funded by the Howard Hughes Medical Institute. The research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. I.O. and S.H. were supported by the Intramural Research Program of the National Library of Medicine at the NIH.	Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Al-Qattan MM, 2012, AM J MED GENET A, V158A, P2610, DOI 10.1002/ajmg.a.35584; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Albuisson J, 2011, CLIN GENET, V79, P371, DOI 10.1111/j.1399-0004.2010.01465.x; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Attanasio C, 2013, SCIENCE, V342, DOI 10.1126/science.1241006; Baas M, 2017, AM J MED GENET A, V173, P2898, DOI 10.1002/ajmg.a.38398; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Cai Fengying, 2019, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V36, P890, DOI 10.3760/cma.j.issn.1003-9406.2019.09.009; Cho TJ, 2013, J PEDIATR ORTHOP B, V22, P219, DOI 10.1097/BPB.0b013e32835106b2; Dorshorst B, 2010, J HERED, V101, P339, DOI 10.1093/jhered/esp120; Dunn IC, 2011, DEV DYNAM, V240, P1163, DOI 10.1002/dvdy.22623; Fakhouri WD, 2014, HUM MOL GENET, V23, P2711, DOI 10.1093/hmg/ddt664; Farooq M, 2010, EUR J HUM GENET, V18, P733, DOI 10.1038/ejhg.2009.225; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Furniss D, 2008, HUM MOL GENET, V17, P2417, DOI 10.1093/hmg/ddn141; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Girisha KM, 2014, AM J MED GENET A, V164, P898, DOI 10.1002/ajmg.a.36367; Gurnett CA, 2007, AM J MED GENET A, V143A, P27, DOI 10.1002/ajmg.a.31563; HEUTINK P, 1994, NAT GENET, V6, P287, DOI 10.1038/ng0394-287; Hill RE, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0357; Inoue F, 2015, GENOMICS, V106, P159, DOI 10.1016/j.ygeno.2015.06.005; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Kircher M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11526-w; KNUDSEN TB, 1981, J EMBRYOL EXP MORPH, V65, P289; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kvon EZ, 2016, CELL, V167, P633, DOI 10.1016/j.cell.2016.09.028; Kvon EZ, 2015, GENOMICS, V106, P185, DOI 10.1016/j.ygeno.2015.06.007; Leal F, 2016, CURR BIOL, V26, P2966, DOI 10.1016/j.cub.2016.09.020; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Letelier J, 2018, NAT GENET, V50, P504, DOI 10.1038/s41588-018-0080-5; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Lettice LA, 2008, HUM MOL GENET, V17, P978, DOI 10.1093/hmg/ddm370; Lettice LA, 2014, DEVELOPMENT, V141, P1715, DOI 10.1242/dev.095430; Li X, 2017, NATURE, V550, P239, DOI 10.1038/nature24267; Lodder E., 2009, THESIS; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Masuya H, 2007, GENOMICS, V89, P207, DOI 10.1016/j.ygeno.2006.09.005; May D, 2012, NAT GENET, V44, P89, DOI 10.1038/ng.1006; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Norbnop P, 2014, J HUM GENET, V59, P467, DOI 10.1038/jhg.2014.50; Osterwalder M, 2018, NATURE, V554, P239, DOI 10.1038/nature25461; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sagai T, 2004, MAMM GENOME, V15, P23, DOI 10.1007/s00335-033-2317-5; Semerci CN, 2009, CLIN GENET, V76, P85, DOI 10.1111/j.1399-0004.2009.01192.x; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Smith RP, 2013, NAT GENET, V45, P1021, DOI 10.1038/ng.2713; Tasic B, 2011, P NATL ACAD SCI USA, V108, P7902, DOI 10.1073/pnas.1019507108; Tewhey R, 2016, CELL, V165, P1519, DOI 10.1016/j.cell.2016.04.027; Turner TN, 2017, CELL, V171, P710, DOI 10.1016/j.cell.2017.08.047; van Arensbergen J, 2019, NAT GENET, V51, P1160, DOI 10.1038/s41588-019-0455-2; VanderMeer JE, 2014, HUM MUTAT, V35, P945, DOI 10.1002/humu.22581; VanderMeer JE, 2012, AM J MED GENET A, V158A, P2031, DOI 10.1002/ajmg.a.35473; VanderMeer JE, 2011, DEV DYNAM, V240, P920, DOI 10.1002/dvdy.22535; Vanlerberghe C, 2015, CLIN GENET, V88, P479, DOI 10.1111/cge.12534; Visel A, 2007, NUCLEIC ACIDS RES, V35, pD88, DOI 10.1093/nar/gkl822; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang SF, 2019, ENVIRON ENG SCI, V36, P1061, DOI 10.1089/ees.2018.0540; Wieczorek D, 2010, HUM MUTAT, V31, P81, DOI 10.1002/humu.21142; Wright CF, 2019, AM J HUM GENET, V104, P275, DOI 10.1016/j.ajhg.2018.12.015; Wu PF, 2016, CYTOGENET GENOME RES, V149, P171, DOI 10.1159/000448820; ZAKANY J, 1988, NEURON, V1, P679, DOI 10.1016/0896-6273(88)90167-5; Zguricas J, 1999, J MED GENET, V36, P32; Zhao J, 2009, HUM MOL GENET, V18, P3090, DOI 10.1093/hmg/ddp250	68	36	36	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1262	+		10.1016/j.cell.2020.02.031	http://dx.doi.org/10.1016/j.cell.2020.02.031			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32169219	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000520925300019
J	Mahase, E				Mahase, Elisabeth			Covid-19: schools set to close across UK except for children of health and social care workers	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	5	7	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2020	368								m1140	10.1136/bmj.m1140	http://dx.doi.org/10.1136/bmj.m1140			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DM	32193197	Bronze			2022-12-28	WOS:000523763400007
J	Liakos, A; Liakopoulou, P; Tsapas, A				Liakos, Aris; Liakopoulou, Paraskevi; Tsapas, Apostolos			Cyclical pressurized topical wound oxygen therapy increased healing of refractory diabetic foot ulcers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Liakos, Aris; Liakopoulou, Paraskevi; Tsapas, Apostolos] Aristotle Univ Thessaloniki, Thessaloniki, Greece	Aristotle University of Thessaloniki	Liakos, A (corresponding author), Aristotle Univ Thessaloniki, Thessaloniki, Greece.							American Diabetes Association, 2020, Diabetes Care, V43, pS135, DOI 10.2337/dc20-S011; Pocock SJ, 2005, JAMA-J AM MED ASSOC, V294, P2228, DOI 10.1001/jama.294.17.2228	2	2	2	5	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC27	JC27		10.7326/ACPJ202003170-027	http://dx.doi.org/10.7326/ACPJ202003170-027			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176893				2022-12-28	WOS:000520170800007
J	Paterlini, M				Paterlini, Marta			On the front lines of coronavirus: the Italian response to covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												martapaterlini@gmail.com						[Anonymous], 2020, I SUPERIORE SANIT IN; [Anonymous], 2020, NHK WORLD; [Anonymous], 2020, REUTERS; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; World Health Organization (WHO), 2020, COR DIS COVID 19 TEC	5	68	70	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m1065	10.1136/bmj.m1065	http://dx.doi.org/10.1136/bmj.m1065			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2CT	32179517	Bronze			2022-12-28	WOS:000523761500006
J	Rimmer, A				Rimmer, Abi			Primary care networks: LMC leaders vote to reject revised agreement on directed enhanced services	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		IACOBUCCI G, 2020, BMJ-BRIT MED J, V368, P64633, DOI DOI 10.1136/BMJ.M230; RIMMER A, 2020, BMJ-BRIT MED J, V368, P33962, DOI DOI 10.1136/BMJ.M533	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m1069	10.1136/bmj.m1069	http://dx.doi.org/10.1136/bmj.m1069			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2CT	32179555				2022-12-28	WOS:000523761500007
J	Harvey, A				Harvey, Anna			BMJ STUDENT Medical memes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												aharvey@bmj.com						Dawkins R, 1989, SELFISH GENE; GERADA C, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L6029; Gil P., 2020, WHAT IS MEME WHAT AR; Nunez-Mulder L, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l2223; RIMMER A, 2019, BMJ-BRIT MED J, V365, P82494, DOI DOI 10.1136/BMJ.L4105	5	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m531	10.1136/bmj.m531	http://dx.doi.org/10.1136/bmj.m531			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32169860				2022-12-28	WOS:000520014600001
J	Petrie, MC; Verma, S; Docherty, KF; Inzucchi, SE; Anand, I; Belohlavek, J; Bohm, M; Chiang, CE; Chopra, VK; de Boer, RA; Desai, AS; Diez, M; Drozdz, J; Dukat, A; Ge, JB; Howlett, J; Katova, T; Kitakaze, M; Ljungman, CEA; Merkely, B; Nicolau, JC; O'Meara, E; Vinh, PN; Schou, M; Tereshchenko, S; Kober, L; Kosiborod, MN; Langkilde, AM; Martinez, FA; Ponikowski, P; Sabatine, MS; Sjostrand, M; Solomon, SD; Johanson, P; Greasley, PJ; Boulton, D; Bengtsson, O; Jhund, PS; McMurray, JJV				Petrie, Mark C.; Verma, Subodh; Docherty, Kieran F.; Inzucchi, Silvio E.; Anand, Inder; Belohlavek, Jan; Boehm, Michael; Chiang, Chern-En; Chopra, Vijay K.; de Boer, Rudolf A.; Desai, Akshay S.; Diez, Mirta; Drozdz, Jaroslaw; Dukat, Andre; Ge, Junbo; Howlett, Jonathan; Katova, Tzvetana; Kitakaze, Masafumi; Ljungman, Charlotta E. A.; Merkely, Bela; Nicolau, Jose C.; O'Meara, Eileen; Vinh, Pham Nguyen; Schou, Morten; Tereshchenko, Sergey; Kober, Lars; Kosiborod, Mikhail N.; Langkilde, Anna Maria; Martinez, Felipe A.; Ponikowski, Piotr; Sabatine, Marc S.; Sjostrand, Mikaela; Solomon, Scott D.; Johanson, Per; Greasley, Peter J.; Boulton, David; Bengtsson, Olof; Jhund, Pardeep S.; McMurray, John J. V.			Effect of Dapagliflozin on Worsening Heart Failure and Cardiovascular Death in Patients With Heart Failure With and Without Diabetes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMPA-REG; EMPAGLIFLOZIN; OUTCOMES; SGLT2; INHIBITORS; MORTALITY	Importance Additional treatments are needed for heart failure with reduced ejection fraction (HFrEF). Sodium-glucose cotransporter 2 (SGLT2) inhibitors may be an effective treatment for patients with HFrEF, even those without diabetes. Objective To evaluate the effects of dapagliflozin in patients with HFrEF with and without diabetes. Design, Setting, and Participants Exploratory analysis of a phase 3 randomized trial conducted at 410 sites in 20 countries. Patients with New York Heart Association classification II to IV with an ejection fraction less than or equal to 40% and elevated plasma N-terminal pro B-type natriuretic peptide were enrolled between February 15, 2017, and August 17, 2018, with final follow-up on June 6, 2019. Interventions Addition of once-daily 10 mg of dapagliflozin or placebo to recommended therapy. Main Outcomes and Measures The primary outcome was the composite of an episode of worsening heart failure or cardiovascular death. This outcome was analyzed by baseline diabetes status and, in patients without diabetes, by glycated hemoglobin level less than 5.7% vs greater than or equal to 5.7%. Results Among 4744 patients randomized (mean age, 66 years; 1109 [23%] women; 2605 [55%] without diabetes), 4742 completed the trial. Among participants without diabetes, the primary outcome occurred in 171 of 1298 (13.2%) in the dapagliflozin group and 231 of 1307 (17.7%) in the placebo group (hazard ratio, 0.73 [95% CI, 0.60-0.88]). In patients with diabetes, the primary outcome occurred in 215 of 1075 (20.0%) in the dapagliflozin group and 271 of 1064 (25.5%) in the placebo group (hazard ratio, 0.75 [95% CI, 0.63-0.90]) (P value for interaction = .80). Among patients without diabetes and a glycated hemoglobin level less than 5.7%, the primary outcome occurred in 53 of 438 patients (12.1%) in the dapagliflozin group and 71 of 419 (16.9%) in the placebo group (hazard ratio, 0.67 [95% CI, 0.47-0.96]). In patients with a glycated hemoglobin of at least 5.7%, the primary outcome occurred in 118 of 860 patients (13.7%) in the dapagliflozin group and 160 of 888 (18.0%) in the placebo group (hazard ratio, 0.74 [95% CI, 0.59-0.94]) (P value for interaction = .72). Volume depletion was reported as an adverse event in 7.3% of patients in the dapagliflozin group and 6.1% in the placebo group among patients without diabetes and in 7.8% of patients in the dapagliflozin group and 7.8% in the placebo group among patients with diabetes. A kidney adverse event was reported in 4.8% of patients in the dapagliflozin group and 6.0% in the placebo group among patients without diabetes and in 8.5% of patients in the dapagliflozin group and 8.7% in the placebo group among patients with diabetes. Conclusions and Relevance In this exploratory analysis of a randomized trial of patients with HFrEF, dapagliflozin compared with placebo, when added to recommended therapy, significantly reduced the risk of worsening heart failure or cardiovascular death independently of diabetes status.	[Petrie, Mark C.; Docherty, Kieran F.; Jhund, Pardeep S.; McMurray, John J. V.] Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland; [Verma, Subodh] Univ Toronto, St Michaels Hosp, Div Cardiac Surg, Toronto, ON, Canada; [Inzucchi, Silvio E.] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT USA; [Anand, Inder] Univ Minnesota, Dept Cardiol, Minneapolis, MN USA; [Belohlavek, Jan] Charles Univ Prague, Dept Internal Med 2, Fac Med 1, Gen Teaching Hosp,Cardiovasc Med, Prague, Czech Republic; [Boehm, Michael] Saarland Univ Hosp, Dept Med, Homburg, Germany; [Chiang, Chern-En] Taipei Vet Gen Hosp, Div Cardiol, Taipei, Taiwan; [Chiang, Chern-En] Natl Yang Ming Univ, Taipei, Taiwan; [Chopra, Vijay K.] Medanta, Dept Cardiol, Gurgaon, Haryana, India; [de Boer, Rudolf A.] Univ Groningen, Univ Med Ctr Groningen, Dept Cardiol, Groningen, Netherlands; [Desai, Akshay S.; Sabatine, Marc S.; Solomon, Scott D.] Brigham & Womens Hosp, Div Cardiovasc, 75 Francis St, Boston, MA 02115 USA; [Diez, Mirta] Inst Cardiovasc Buenos Aires, Div Cardiol, Buenos Aires, DF, Argentina; [Drozdz, Jaroslaw] Med Univ Lodz, Dept Cardiol, Lodz, Poland; [Dukat, Andre] Comenius Univ, Dept Internal Med 5, Bratislava, Slovakia; [Ge, Junbo] Fudan Univ, Zhongshan Hosp, Shanghai Inst Cardiovasc Dis, Dept Cardiol, Shanghai, Peoples R China; [Howlett, Jonathan] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst, Calgary, AB, Canada; [Katova, Tzvetana] Natl Cardiol Hosp, Clin Cardiol, Sofia, Bulgaria; [Kitakaze, Masafumi] Natl Cerebral & Cardiovasc Ctr, Cardiovasc Div Med, Osaka, Japan; [Ljungman, Charlotta E. A.] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med Cardiol, Inst Med, Gothenburg, Sweden; [Merkely, Bela] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary; [Nicolau, Jose C.] Univ Sao Paulo, Hosp Clin, Fac Med, Inst Coracao InCor, Sao Paulo, Brazil; [O'Meara, Eileen] Montreal Heart Inst, Dept Cardiol, Montreal, PQ, Canada; [Vinh, Pham Nguyen] Tan Tao Univ, Dept Internal Med, Tan Duc, Vietnam; [Schou, Morten] Gentofte Univ, Hosp Copenhagen, Dept Cardiol, Copenhagen, Denmark; [Tereshchenko, Sergey] Natl Med Res Ctr Cardiol, Dept Myocardial Dis & Heart Failure, Moscow, Russia; [Kober, Lars] Copenhagen Univ Hosp, Dept Cardiol, Copenhagen, Denmark; [Kosiborod, Mikhail N.] Univ Missouri Kansas City, St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Langkilde, Anna Maria; Sjostrand, Mikaela; Johanson, Per; Bengtsson, Olof] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Cardiovasc Renal & Metab, Gothenburg, Sweden; [Martinez, Felipe A.] Univ Nacl Cordoba, Cordoba, Argentina; [Ponikowski, Piotr] Wroclaw Med Univ, Univ Hosp, Ctr Heart Dis, Wroclaw, Poland; [Greasley, Peter J.] AstraZeneca, BioPharmaceut R&D, Early Discovery & Dev Cardiovasc Renal & Metab, Gothenburg, Sweden; [Boulton, David] AstraZeneca, BioPharmaceut R&D, Clin Pharmacol & Safety Sci, Gaithersburg, MD USA	University of Glasgow; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; Yale University; University of Minnesota System; University of Minnesota Twin Cities; Charles University Prague; General University Hospital Prague; Universitatsklinikum des Saarlandes; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; University of Groningen; Harvard University; Brigham & Women's Hospital; Instituto Cardiovascular de Buenos Aires (ICBA); Medical University Lodz; Comenius University Bratislava; Fudan University; Libin Cardiovascular Institute Of Alberta; University of Calgary; Medical University Sofia; National Cerebral & Cardiovascular Center - Japan; University of Gothenburg; Semmelweis University; Universidade de Sao Paulo; Universite de Montreal; National Medical Research Center of Cardiology; University of Copenhagen; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; AstraZeneca; National University of Cordoba; Wroclaw Medical University; AstraZeneca; AstraZeneca	McMurray, JJV (corresponding author), Univ Glasgow, Cardiovasc Res Ctr, British Heart Fdn, 126 Univ Pl, Glasgow G12 8TA, Lanark, Scotland.	john.mcmurray@glasgow.ac.uk	Ljungman, Charlotta Eva Anna/GMW-4955-2022; Kosiborod, Mikhail/HDO-1541-2022; Jhund, Pardeep/GLS-9508-2022; Chopra, Vijay/AAW-1853-2020; Drozdz, Jaroslaw/K-8951-2012; Nicolau, Jose C/E-1487-2012; Inzucchi, Silvio/ABF-4121-2021; Desai, Akshay/ABE-7250-2020; Sergey, Tereshchenko/AAA-9455-2021; de Boer, Rudolf/ABE-9879-2020; Docherty, Kieran/ABD-8183-2021	Kosiborod, Mikhail/0000-0002-3750-9789; Jhund, Pardeep/0000-0003-4306-5317; Nicolau, Jose C/0000-0002-9680-3689; Sergey, Tereshchenko/0000-0001-9234-6129; Kober, Lars/0000-0002-6635-1466; Docherty, Kieran/0000-0002-5446-9969; Howlett, Jonathan/0000-0002-0535-9771; mcmurray, john/0000-0002-6317-3975; Johanson, Per/0000-0001-9802-4147; Escobar, Carlos/0000-0001-5584-4735	AstraZeneca; British Heart Foundation Centre of Research Excellence [RE/18/6/34217]	AstraZeneca(AstraZeneca); British Heart Foundation Centre of Research Excellence(British Heart Foundation)	This study was funded by AstraZeneca. Dr McMurray was supported by a British Heart Foundation Centre of Research Excellence Grant RE/18/6/34217.	Cefalu WT, 2019, DIABETES CARE, V42, pS13, DOI 10.2337/dc19-S002; Chatterton H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4624; Devineni D, 2014, CLIN THER, V36, P698, DOI 10.1016/j.clinthera.2014.02.022; Fitchett D, 2016, EUR HEART J, V37, P1526, DOI 10.1093/eurheartj/ehv728; Garg V, 2019, PROG CARDIOVASC DIS, V62, P349, DOI 10.1016/j.pcad.2019.07.005; Green CP, 2000, J AM COLL CARDIOL, V35, P1245, DOI 10.1016/S0735-1097(00)00531-3; [Guidance for Industry Center for Drug Evaluation and Research Food and Drug Administration U. S. Department of Health and Human Services], 2008, GUID IND DIAB MELL E; Hallow KM, 2018, DIABETES OBES METAB, V20, P479, DOI 10.1111/dom.13126; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Hicks KA, 2018, J AM COLL CARDIOL, V71, P1021, DOI 10.1016/j.jacc.2017.12.048; Inzucchi SE, 2018, DIABETES CARE, V41, pE4, DOI 10.2337/dc17-1551; Kidokoro K, 2019, CIRCULATION, V140, P303, DOI 10.1161/CIRCULATIONAHA.118.037418; Kosiborod M, 2017, J DIABETES COMPLICAT, V31, P1215, DOI 10.1016/j.jdiacomp.2017.02.001; Lin DY, 2000, J ROY STAT SOC B, V62, P711, DOI 10.1111/1467-9868.00259; McMurray JJV, 2019, NEW ENGL J MED, V381, P1995, DOI 10.1056/NEJMoa1911303; McMurray J, 2016, J DIABETES COMPLICAT, V30, P3, DOI 10.1016/j.jdiacomp.2015.10.012; McMurray JJV, 2019, EUR J HEART FAIL, V21, P665, DOI 10.1002/ejhf.1432; Meng W, 2008, J MED CHEM, V51, P1145, DOI 10.1021/jm701272q; Nassif ME, 2019, CIRCULATION, V140, P1463, DOI 10.1161/CIRCULATIONAHA.119.042929; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Pfister M, 2011, CLIN PHARMACOL THER, V89, P621, DOI 10.1038/clpt.2011.16; Santos-Gallego CG, 2019, J AM COLL CARDIOL, V73, P1931, DOI 10.1016/j.jacc.2019.01.056; Thomas MC, 2018, DIABETOLOGIA, V61, P2098, DOI 10.1007/s00125-018-4669-0; US Food and Drug Administration, 2016, COLL RAC ETHN DAT CL; Verma S, 2019, CIRCULATION, V140, P1693, DOI 10.1161/CIRCULATIONAHA.119.042375; Verma S, 2018, DIABETOLOGIA, V61, P2108, DOI 10.1007/s00125-018-4670-7; Wang DL, 2016, PHARM STAT, V15, P238, DOI 10.1002/pst.1743; Wiviott SD, 2019, NEW ENGL J MED, V380, P347, DOI 10.1056/NEJMoa1812389; Wojcik C, 2019, CURR CARDIOL REP, V21, DOI 10.1007/s11886-019-1219-4; Yanai Hidekatsu, 2017, J Clin Med Res, V9, P178, DOI 10.14740/jocmr2857w; Yurista SR, 2019, EUR J HEART FAIL, V21, P862, DOI 10.1002/ejhf.1473; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	32	222	229	3	39	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 14	2020	323	14					1353	1368		10.1001/jama.2020.1906	http://dx.doi.org/10.1001/jama.2020.1906			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LH1YB	32219386	Green Published, Bronze			2022-12-28	WOS:000528583600015
J	Arakawa, M; Saiki, T; Wada, K; Ogawa, K; Kadono, T; Shirai, K; Sawada, H; Ishibashi, K; Honda, R; Sakatani, N; Iijima, Y; Okamoto, C; Yano, H; Takagi, Y; Hayakawa, M; Michel, P; Jutzi, M; Shimaki, Y; Kimura, S; Mimasu, Y; Toda, T; Imamura, H; Nakazawa, S; Hayakawa, H; Sugita, S; Morota, T; Kameda, S; Tatsumi, E; Cho, Y; Yoshioka, K; Yokota, Y; Matsuoka, M; Yamada, M; Kouyama, T; Honda, C; Tsuda, Y; Watanabe, S; Yoshikawa, M; Tanaka, S; Terui, F; Kikuchi, S; Yamaguchi, T; Ogawa, N; Ono, G; Yoshikawa, K; Takahashi, T; Takei, Y; Fujii, A; Takeuchi, H; Yamamoto, Y; Okada, T; Hirose, C; Hosoda, S; Mori, O; Shimada, T; Soldini, S; Tsukizaki, R; Iwata, T; Ozaki, M; Abe, M; Namiki, N; Kitazato, K; Tachibana, S; Ikeda, H; Hirata, N; Hirata, N; Noguchi, R; Miura, A				Arakawa, M.; Saiki, T.; Wada, K.; Ogawa, K.; Kadono, T.; Shirai, K.; Sawada, H.; Ishibashi, K.; Honda, R.; Sakatani, N.; Iijima, Y.; Okamoto, C.; Yano, H.; Takagi, Y.; Hayakawa, M.; Michel, P.; Jutzi, M.; Shimaki, Y.; Kimura, S.; Mimasu, Y.; Toda, T.; Imamura, H.; Nakazawa, S.; Hayakawa, H.; Sugita, S.; Morota, T.; Kameda, S.; Tatsumi, E.; Cho, Y.; Yoshioka, K.; Yokota, Y.; Matsuoka, M.; Yamada, M.; Kouyama, T.; Honda, C.; Tsuda, Y.; Watanabe, S.; Yoshikawa, M.; Tanaka, S.; Terui, F.; Kikuchi, S.; Yamaguchi, T.; Ogawa, N.; Ono, G.; Yoshikawa, K.; Takahashi, T.; Takei, Y.; Fujii, A.; Takeuchi, H.; Yamamoto, Y.; Okada, T.; Hirose, C.; Hosoda, S.; Mori, O.; Shimada, T.; Soldini, S.; Tsukizaki, R.; Iwata, T.; Ozaki, M.; Abe, M.; Namiki, N.; Kitazato, K.; Tachibana, S.; Ikeda, H.; Hirata, N.; Hirata, N.; Noguchi, R.; Miura, A.			An artificial impact on the asteroid (162173) Ryugu formed a crater in the gravity-dominated regime	SCIENCE			English	Article							HAYABUSA2 DCAM3-D CAMERA; DYNAMICAL EVOLUTION; EJECTA CURTAIN; DEEP IMPACT; SURFACE; SIZE; SCI	The Hayabusa2 spacecraft investigated the small asteroid Ryugu, which has a rubble-pile structure. We describe an impact experiment on Ryugu using Hayabusa2's Small Carry-on Impactor. The impact produced an artificial crater with a diameter >10 meters, which has a semicircular shape, an elevated rim, and a central pit. Images of the impact and resulting ejecta were recorded by the Deployable CAMera 3 for >8 minutes, showing the growth of an ejecta curtain (the outer edge of the ejecta) and deposition of ejecta onto the surface. The ejecta curtain was asymmetric and heterogeneous and it never fully detached from the surface. The crater formed in the gravity-dominated regime; in other words, crater growth was limited by gravity not surface strength. We discuss implications for Ryugu's surface age.	[Arakawa, M.; Ogawa, K.; Shirai, K.; Okamoto, C.; Hirata, N.] Kobe Univ, Dept Planetol, Kobe, Hyogo 6578501, Japan; [Saiki, T.; Shirai, K.; Sawada, H.; Sakatani, N.; Iijima, Y.; Yano, H.; Hayakawa, M.; Shimaki, Y.; Mimasu, Y.; Toda, T.; Imamura, H.; Nakazawa, S.; Hayakawa, H.; Yokota, Y.; Matsuoka, M.; Tsuda, Y.; Watanabe, S.; Yoshikawa, M.; Tanaka, S.; Terui, F.; Kikuchi, S.; Yamaguchi, T.; Ogawa, N.; Takahashi, T.; Takei, Y.; Fujii, A.; Takeuchi, H.; Yamamoto, Y.; Okada, T.; Hosoda, S.; Mori, O.; Shimada, T.; Tsukizaki, R.; Iwata, T.; Ozaki, M.; Abe, M.; Noguchi, R.; Miura, A.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2525210, Japan; [Wada, K.; Ishibashi, K.; Sugita, S.] Chiba Inst Technol, Planetary Explorat Res Ctr, Narashino, Chiba 2750016, Japan; [Ogawa, K.] Japan Aerosp Explorat Agcy, JAXA Space Explorat Ctr, Sagamihara, Kanagawa 2525210, Japan; [Kadono, T.] Univ Occupat & Environm Hlth, Dept Basic Sci, Kitakyushu 8078555, Japan; [Honda, R.; Yokota, Y.; Yamada, M.] Kochi Univ, Dept Informat Sci, Kochi 7808520, Japan; [Takagi, Y.] Aichi Toho Univ, Dept Reg Business, Nagoya, Aichi 4658515, Japan; [Michel, P.] Univ Cote Azur, Observ Cote Azur, CNRS, Lab Lagrange,CS34229, F-06304 Nice 4, France; [Jutzi, M.] Univ Bern, Natl Ctr Competence Res PlanetS, Phys Inst, Gesellschaftsstr 6, CH-3012 Bern, Switzerland; [Kimura, S.] Tokyo Univ Sci, Dept Elect Engn, Noda, Chiba 2788510, Japan; [Sugita, S.; Morota, T.; Tatsumi, E.; Cho, Y.; Tachibana, S.] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Kameda, S.] Rikkyo Univ, Dept Phys, Tokyo 1718501, Japan; [Tatsumi, E.] Univ La Laguna, Inst Astrofis Canarias, San Cristobal De Laguna 38205, Spain; [Yoshioka, K.] Univ Tokyo, Dept Complex Sci & Engn, Kashiwa, Chiba 2778561, Japan; [Kouyama, T.] Natl Inst Adv Ind Sci & Technol, Tokyo 1350064, Japan; [Honda, C.; Kitazato, K.; Hirata, N.] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima 9658580, Japan; [Watanabe, S.] Nagoya Univ, Dept Earth & Environm Sci, Nagoya, Aichi 4648601, Japan; [Yoshikawa, M.; Tanaka, S.; Takeuchi, H.; Yamamoto, Y.; Iwata, T.; Ozaki, M.; Abe, M.; Miura, A.] Grad Univ Adv Studies, SOKENDAI, Dept Space & Astronaut Sci, Hayama, Kanagawa 2400193, Japan; [Ono, G.; Yoshikawa, K.; Takei, Y.; Hirose, C.; Ikeda, H.] Japan Aerosp Explorat Agcy, Res & Dev Directorate, Sagamihara, Kanagawa 2525210, Japan; [Okada, T.] Univ Tokyo, Dept Chem, Tokyo 1130033, Japan; [Soldini, S.] Univ Liverpool, Dept Mech Mat & Aerosp Engn, Liverpool L3 5TQ, Merseyside, England; [Namiki, N.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Namiki, N.] Grad Univ Adv Studies, Dept Astron Sci, SOKENDAI, Hayama, Kanagawa 2400193, Japan; [Yamaguchi, T.] Mitsubishi Electr Corp, Kamakura, Kanagawa 2478520, Japan; [Takahashi, T.] NEC Corp Ltd, 1-10 Nisshin Cho, Fuchu, Tokyo 1830036, Japan	Kobe University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); Chiba Institute of Technology; Japan Aerospace Exploration Agency (JAXA); University of Occupational & Environmental Health - Japan; Kochi University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; University of Bern; Tokyo University of Science; University of Tokyo; Rikkyo University; Instituto de Astrofisica de Canarias; Universidad de la Laguna; University of Tokyo; National Institute of Advanced Industrial Science & Technology (AIST); University of Aizu; Nagoya University; Graduate University for Advanced Studies - Japan; Japan Aerospace Exploration Agency (JAXA); University of Tokyo; University of Liverpool; National Institutes of Natural Sciences (NINS) - Japan; National Astronomical Observatory of Japan (NAOJ); Graduate University for Advanced Studies - Japan; Mitsubishi Electric Corporation; NEC Corporation	Arakawa, M (corresponding author), Kobe Univ, Dept Planetol, Kobe, Hyogo 6578501, Japan.	masahiko.arakawa@penguin.kobe-u.ac.jp	Sugita, Seiji/GQI-1142-2022; Noguchi, Rina/HCH-0362-2022; Kouyama, Toru/B-1155-2017	Sugita, Seiji/0000-0001-6076-3614; Noguchi, Rina/0000-0001-8281-2448; Shimaki, Yuri/0000-0001-8966-7650; Takeuchi, Hiroshi/0000-0001-5863-4653; Takagi, Yasuhiko/0000-0003-2232-3065; Matsuoka, Moe/0000-0003-1091-3041; Soldini, Stefania/0000-0003-3121-3845; Kouyama, Toru/0000-0002-1060-3986; Wada, Koji/0000-0002-6710-1768; Tatsumi, Eri/0000-0002-6142-9842; Ishibashi, Ko/0000-0003-1805-1503; Sakatani, Naoya/0000-0003-4791-5227; Honda, Rie/0000-0001-7008-5300; Shirai, Kei/0000-0001-5661-3541; Arakawa, Masahiko/0000-0003-3670-2699; Hirata, Naru/0000-0002-2435-604X	KAKENHI from the Japanese Society for Promotion of Science (JSPS) [JP16H04041, JP17H06459, JP15K05273, JP19H01951, JP19H00719, JP16H04044, JP19K03955, JP19H00727, JP17KK0097, JP18K11610,, JP17H01175, JP19K14778]; JSPS Core-to-Core program "International Network of Planetary Sciences"; French space agency CNES; Academies of Excellence: Complex systems and Space, environment, risk, and resilience, part of the IDEX JEDI of the Universite Cote d'Azur	KAKENHI from the Japanese Society for Promotion of Science (JSPS); JSPS Core-to-Core program "International Network of Planetary Sciences"; French space agency CNES(Centre National D'etudes Spatiales); Academies of Excellence: Complex systems and Space, environment, risk, and resilience, part of the IDEX JEDI of the Universite Cote d'Azur	M.Ar., T.O., T.M., S.W., N.N., K.W., T.M., K.O., M.Ab., S.Ka., A.M., S.Su., K.Yoshio., and Y.C. were supported by KAKENHI from the Japanese Society for Promotion of Science (JSPS) (grant nos. JP16H04041, JP17H06459, JP15K05273, JP19H01951, JP19H00719, JP16H04044, JP19K03955, JP19H00727, JP17KK0097, JP18K11610, JP17H01175, and JP19K14778). This study was supported by JSPS Core-to-Core program "International Network of Planetary Sciences." P.M. acknowledges funding support from the French space agency CNES and from Academies of Excellence: Complex systems and Space, environment, risk, and resilience, part of the IDEX JEDI of the Universite Cote d'Azur.	A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; Al-Hashemi HMB, 2018, POWDER TECHNOL, V330, P397, DOI 10.1016/j.powtec.2018.02.003; Arakawa M, 2017, SPACE SCI REV, V208, P187, DOI 10.1007/s11214-016-0290-z; Barnouin OS, 2019, ICARUS, V325, P67, DOI 10.1016/j.icarus.2019.02.004; Bottke WF, 2005, ICARUS, V175, P111, DOI 10.1016/j.icarus.2004.10.026; Cintala MJ, 1999, METEORIT PLANET SCI, V34, P605, DOI 10.1111/j.1945-5100.1999.tb01367.x; Gault D.E., 1978, P 9 LUNAR PLANETARY, P3843; Guttler C, 2012, ICARUS, V220, P1040, DOI 10.1016/j.icarus.2012.06.041; Hermalyn B, 2012, ICARUS, V218, P654, DOI 10.1016/j.icarus.2011.12.025; Holsapple K., 2002, ASTEROIDS, P443; Housen KR, 2011, ICARUS, V211, P856, DOI 10.1016/j.icarus.2010.09.017; HOUSEN KR, 1983, J GEOPHYS RES, V88, P2485, DOI 10.1029/JB088iB03p02485; Ishibashi K, 2017, SPACE SCI REV, V208, P213, DOI 10.1007/s11214-016-0298-4; Jutzi M., 2015, ASTEROIDS, P679; Kiuchi M, 2019, J GEOPHYS RES-PLANET, V124, P1379, DOI 10.1029/2018JE005628; Matsue K, 2020, ICARUS, V338, DOI 10.1016/j.icarus.2019.113520; Maxwell D.E., 1977, IMPACT EXPLOSION CRA, P1003; Melosh H.J., 1989, OXFORD MONOGRAPHS GE; O'Brien DP, 2005, ICARUS, V178, P179, DOI 10.1016/j.icarus.2005.04.001; Ogawa K, 2017, SPACE SCI REV, V208, P125, DOI 10.1007/s11214-017-0347-7; Saiki T, 2017, SPACE SCI REV, V208, P165, DOI 10.1007/s11214-016-0297-5; Schultz PH, 2005, SPACE SCI REV, V117, P207, DOI 10.1007/s11214-005-3383-7; Schwanghart W, 2014, EARTH SURF DYNAM, V2, P1, DOI 10.5194/esurf-2-1-2014; Sugita S, 2019, SCIENCE, V364, P252, DOI 10.1126/science.aaw0422; Sunshine JM, 2007, ICARUS, V190, P284, DOI 10.1016/j.icarus.2007.04.024; Szeliski R., 2011, COMPUTER VISION ALGO; Tachibana S, 2014, GEOCHEM J, V48, P571, DOI 10.2343/geochemj.2.0350; Takizawa S, 2020, ICARUS, V335, DOI 10.1016/j.icarus.2019.113409; Tatsumi E, 2018, ICARUS, V300, P227, DOI 10.1016/j.icarus.2017.09.004; Tsujido S, 2015, ICARUS, V262, P79, DOI 10.1016/j.icarus.2015.08.035; Wada K, 2018, PROG EARTH PLANET SC, V5, DOI 10.1186/s40645-018-0237-y; Watanabe S, 2019, SCIENCE, V364, P268, DOI 10.1126/science.aav8032; Yasui M, 2015, ICARUS, V260, P320, DOI 10.1016/j.icarus.2015.07.032; Yue Z, 2019, ICARUS, V329, P46, DOI 10.1016/j.icarus.2019.03.032	34	101	102	8	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 3	2020	368	6486					67	+	aaz1701	10.1126/science.aaz1701	http://dx.doi.org/10.1126/science.aaz1701			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4UP	32193363	Green Submitted			2022-12-28	WOS:000523259700059
J	Jones, H				Jones, Helen			Career progression as a doctor in the Royal Navy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m938	10.1136/bmj.m938	http://dx.doi.org/10.1136/bmj.m938			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	QG5SN	32220849	Bronze			2022-12-28	WOS:000617645000001
J	Dyer, C				Dyer, Clare			Fertility clinic must release records of dead man's sperm to his brother, judge rules	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Re AB, 2020, EWHC	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1255	10.1136/bmj.m1255	http://dx.doi.org/10.1136/bmj.m1255			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217529				2022-12-28	WOS:000523764800020
J	Sayburn, A				Sayburn, Anna			Covid-19: experts question analysis suggesting half UK population has been infected	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Lourenco J, FUNDAMENTAL PRINCIPL; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1089	3	3	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m1216	10.1136/bmj.m1216	http://dx.doi.org/10.1136/bmj.m1216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213506	Bronze			2022-12-28	WOS:000523764500013
J	Slomski, A				Slomski, Anita			"Superdonor" Fecal Microbiota Transplant Effective for IBS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1124	1124		10.1001/jama.2020.2446	http://dx.doi.org/10.1001/jama.2020.2446			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207794				2022-12-28	WOS:000530807000005
J	Liu, J; Kim, YS; Richardson, CE; Tom, A; Ramakrishnan, C; Birey, F; Katsumata, T; Chen, SC; Wang, C; Wang, X; Joubert, LM; Jiang, YW; Wang, HL; Fenno, LE; Tok, JBH; Pasca, SP; Shen, K; Bao, ZA; Deisseroth, K				Liu, Jia; Kim, Yoon Seok; Richardson, Claire E.; Tom, Ariane; Ramakrishnan, Charu; Birey, Fikri; Katsumata, Toru; Chen, Shucheng; Wang, Cheng; Wang, Xiao; Joubert, Lydia-Marie; Jiang, Yuanwen; Wang, Huiliang; Fenno, Lief E.; Tok, Jeffrey B. -H.; Pasca, Sergiu P.; Shen, Kang; Bao, Zhenan; Deisseroth, Karl			Genetically targeted chemical assembly of functional materials in living cells, tissues, and animals	SCIENCE			English	Article							POLYMERIZATION; POLYANILINE; CONDUCTION; OXIDATION; HYDROGEL; DIAMETER; SURFACE	The structural and functional complexity of multicellular biological systems, such as the brain, are beyond the reach of human design or assembly capabilities. Cells in living organisms may be recruited to construct synthetic materials or structures if treated as anatomically defined compartments for specific chemistry, harnessing biology for the assembly of complex functional structures. By integrating engineered-enzyme targeting and polymer chemistry, we genetically instructed specific living neurons to guide chemical synthesis of electrically functional (conductive or insulating) polymers at the plasma membrane. Electrophysiological and behavioral analyses confirmed that rationally designed, genetically targeted assembly of functional polymers not only preserved neuronal viability but also achieved remodeling of membrane properties and modulated cell type-specific behaviors in freely moving animals. This approach may enable the creation of diverse, complex, and functional structures and materials within living systems.	[Liu, Jia; Katsumata, Toru; Chen, Shucheng; Jiang, Yuanwen; Tok, Jeffrey B. -H.; Bao, Zhenan] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Kim, Yoon Seok; Tom, Ariane; Ramakrishnan, Charu; Wang, Xiao; Wang, Huiliang; Fenno, Lief E.; Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Richardson, Claire E.; Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Birey, Fikri; Fenno, Lief E.; Pasca, Sergiu P.; Deisseroth, Karl] Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA; [Wang, Cheng] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Joubert, Lydia-Marie] Stanford Univ, Cell Sci Imaging Facil, Stanford, CA 94305 USA; [Shen, Kang; Deisseroth, Karl] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Stanford University; Howard Hughes Medical Institute; Stanford University	Bao, ZA (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Dept Psychiat, Stanford, CA 94305 USA.; Deisseroth, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA.	zbao@stanford.edu; deissero@stanford.edu	Wang, Cheng/A-9815-2014; Wang, Huiliang/ABE-2916-2020; Pasca, Sergiu/AAY-3949-2021	Wang, Huiliang/0000-0003-4063-270X; Pasca, Sergiu/0000-0002-3216-3248; Tom, Ariane/0000-0002-4708-178X; Richardson, Claire/0000-0002-7532-1808; Bao, Zhenan/0000-0002-0972-1715; Kim, Yoon Seok/0000-0003-3332-0652; Wang, Cheng/0000-0001-7192-5471; Ramakrishnan, Charu/0000-0002-3474-6332; Joubert, Lydia-Marie/0000-0002-4709-007X; Liu, Jia/0000-0003-2217-6982; Wang, Xiao/0000-0002-3090-9894	NIH; NSF [ECCS-1542152]; Stanford Bio-X; Wu-Tsai Neuroscience Institute; Kwanjeong International Fellowship; Life Sciences Research Foundation; Gordon and Betty Moore Foundation; Advanced Light Source U.S. Department of Energy (DOE) Facility [DE-AC02-05CH11231]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Stanford Bio-X; Wu-Tsai Neuroscience Institute; Kwanjeong International Fellowship; Life Sciences Research Foundation; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Advanced Light Source U.S. Department of Energy (DOE) Facility(United States Department of Energy (DOE))	K.D. was supported by NIH and NSF. J.L. was supported by Stanford Bio-X. K.D., Z.B., and S.P.P. were supported by the Wu-Tsai Neuroscience Institute. Y.S.K. was supported by the Kwanjeong International Fellowship and Stanford Bio-X. X.W. was supported by the Life Sciences Research Foundation and the Gordon and Betty Moore Foundation. We acknowledge resources of the Advanced Light Source U.S. Department of Energy (DOE) Facility (DE-AC02-05CH11231). Part of this work was performed at the Stanford Nano Shared Facilities (SNSF), supported by NSF (ECCS-1542152).	Carney RP, 2013, ACS NANO, V7, P932, DOI 10.1021/nn3036304; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; Cruz-Silva R, 2005, EUR POLYM J, V41, P1129, DOI 10.1016/j.eurpolymj.2004.11.012; Deisseroth K, 2015, NAT NEUROSCI, V18, P1213, DOI 10.1038/nn.4091; Donnelly JL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001529; Dvir T, 2011, NAT NANOTECHNOL, V6, P720, DOI [10.1038/NNANO.2011.160, 10.1038/nnano.2011.160]; GILLESPIE MJ, 1983, BRAIN RES, V259, P41, DOI 10.1016/0006-8993(83)91065-X; Gradinaru V, 2018, ANNU REV BIOPHYS, V47, P355, DOI 10.1146/annurev-biophys-070317-032905; Haraguchi S, 2009, CHEM COMMUN, P6086, DOI 10.1039/b910085g; Hartline DK, 2007, CURR BIOL, V17, pR29, DOI 10.1016/j.cub.2006.11.042; Hennig C, 1998, SYNTHETIC MET, V92, P161, DOI 10.1016/S0379-6779(98)80106-9; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Howell B., 2015, J NEURAL ENG, V12; Junker K, 2012, RSC ADV, V2, P6478, DOI 10.1039/c2ra20566a; Kato HE, 2018, NATURE, V561, P349, DOI 10.1038/s41586-018-0504-5; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Liu CY, 2015, ORG BIOMOL CHEM, V13, P8505, DOI 10.1039/c5ob00705d; LUO Y, 1995, PHYS REV A, V52, P3730, DOI 10.1103/PhysRevA.52.3730; Magnuson M, 1999, J CHEM PHYS, V111, P4756, DOI 10.1063/1.479238; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; Moulton SE, 2004, CURR APPL PHYS, V4, P402, DOI 10.1016/j.cap.2003.11.059; Mulazimoglu IE, 2010, ASIAN J CHEM, V22, P8203; Niu J, 2017, NAT CHEM, V9, P537, DOI [10.1038/NCHEM.2713, 10.1038/nchem.2713]; Ouyang LQ, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/2/026005; Pan LJ, 2012, P NATL ACAD SCI USA, V109, P9287, DOI 10.1073/pnas.1202636109; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Pavitt AS, 2017, ENVIRON SCI-PROC IMP, V19, P339, DOI 10.1039/c6em00694a; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7; Stavrinidou E, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501136; Stokes D, 2008, PRINCIPLES PRACTICE; Van Lehn RC, 2013, NANO LETT, V13, P4060, DOI 10.1021/nl401365n; WEI Y, 1990, J POLYM SCI POL LETT, V28, P81, DOI 10.1002/pol.1990.140280302	33	56	56	33	323	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1372	+		10.1126/science.aay4866	http://dx.doi.org/10.1126/science.aay4866			43	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193327	Green Submitted, Green Accepted			2022-12-28	WOS:000522167400051
J	Apte, RS				Apte, Rajendra S.			Reducing Treatment Burden in AMD	CELL			English	Editorial Material									[Apte, Rajendra S.] Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Apte, RS (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	apte@wustl.edu			NEI NIH HHS [P30 EY002687, R01 EY019287] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))			0	3	3	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 19	2020	180	6					1033	1033		10.1016/j.cell.2020.02.028	http://dx.doi.org/10.1016/j.cell.2020.02.028			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KW1IO	32200797	Green Accepted, Bronze			2022-12-28	WOS:000520925300001
J	Holmes, SM; Hansen, H; Jenks, A; Stonington, SD; Morse, M; Greene, JA; Wailoo, KA; Marmot, MG; Farmer, PE				Holmes, Seth M.; Hansen, Helena; Jenks, Angela; Stonington, Scott D.; Morse, Michelle; Greene, Jeremy A.; Wailoo, Keith A.; Marmot, Michael G.; Farmer, Paul E.			Misdiagnosis, Mistreatment, and Harm - When Medical Care Ignores Social Forces	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								The Case Studies in Social Medicine demonstrate that when physicians use only biologic or individual behavioral interventions to treat diseases that stem from or are exacerbated by social factors, we risk harming the patients we seek to serve.	[Holmes, Seth M.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Holmes, Seth M.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hansen, Helena] NYU, New York, NY USA; [Jenks, Angela] Univ Calif Irvine, Irvine, CA USA; [Stonington, Scott D.] Univ Michigan, Ann Arbor, MI 48109 USA; [Morse, Michelle; Farmer, Paul E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Morse, Michelle; Farmer, Paul E.] Harvard Med Sch, Boston, MA 02115 USA; [Greene, Jeremy A.] Johns Hopkins Univ, Baltimore, MD USA; [Wailoo, Keith A.] Princeton Univ, Princeton, NJ 08544 USA; [Marmot, Michael G.] UCL, London, England	University of California System; University of California Berkeley; University of California System; University of California San Francisco; New York University; University of California System; University of California Irvine; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Princeton University; University of London; University College London	Holmes, SM (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.; Holmes, SM (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.		Marmot, Michael/Y-3920-2019	Marmot, Michael/0000-0002-2431-6419; Stonington, Scott/0000-0002-0472-3885; Jenks, Angela/0000-0001-7057-5123				Dasgupta N, 2018, AM J PUBLIC HEALTH, V108, P182, DOI 10.2105/AJPH.2017.304187; Hansen H, STRUCTURAL COMPETENC, pSpringer; Kleinman A, 2010, LANCET, V375, P1518, DOI 10.1016/S0140-6736(10)60646-0; Sanz C, 2017, MED ANTHROPOL, V36, P187, DOI 10.1080/01459740.2016.1267172; Singer M, 2017, LANCET, V389, P941, DOI 10.1016/S0140-6736(17)30003-X	5	28	28	2	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1083	1086		10.1056/NEJMp1916269	http://dx.doi.org/10.1056/NEJMp1916269			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KW7AJ	32187466	Green Published			2022-12-28	WOS:000521333700006
J	Tanne, JH; Hayasaki, E; Zastrow, M; Pulla, P; Smith, P; Rada, AG				Tanne, Janice Hopkins; Hayasaki, Erika; Zastrow, Mark; Pulla, Priyanka; Smith, Paul; Rada, Acer Garcia			GLOBAL HEALTH Covid-19: how doctors and healthcare systems are tackling coronavirus worldwide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		[Anonymous], 2020, EP UPD MONK MULT OUT; [Anonymous], 2020, YONHAP          0302; [Anonymous], 2020, GLOBE MAIL; [Anonymous], NPR; [Anonymous], 2020, HANKYOREH; [Anonymous], 2020, FRANCE 24; [Anonymous], 2020, FRANCE; [Anonymous], 2020, GUARDIAN 1026; Bote J., 2020, USA TODAY; CNN, 2020, CNN; Day Michael, 2020, BMJ, V368, pm1086, DOI 10.1136/bmj.m1086; FAO, 2020, COR DIS 2019 COVID 1; Johns Hopkins University, 2020, CORONAVIRUS COVID 19; Kubo T., 2017, RES GATE; Mair S., 2020, WILL CORONAVIRUS CHA; Marks Simon., 2020, POLITICO; Ministerio de Sanidad, 2020, PROC ACT PRENT CAS I; Murphy B., 2020, NEWS GP; O'Rourke G., 2020, AUSDOC          0313; Papworth T., 2020, AGE; Paterlini M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1065; Picheta R, 2020, CNN; PWC, 2014, FUT IND WINN LEAP; Slobodian SR, 2020, GLOBE MAIL; Smith P., 2020, AUSDOC          0306; Wen XZ, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-019-1775-5; Worthington B., 2020, ABC	27	263	268	3	18	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m1090	10.1136/bmj.m1090	http://dx.doi.org/10.1136/bmj.m1090			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188598	Bronze			2022-12-28	WOS:000523763100011
J	Kuehn, BM				Kuehn, Bridget M.			Guided Self-help Program May Help Refugees in Distress	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1033	1033		10.1001/jama.2020.2495	http://dx.doi.org/10.1001/jama.2020.2495			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181855				2022-12-28	WOS:000521968800005
J	Li, J; Yang, XD; Liu, Y; Huang, BL; Wu, RX; Zhang, ZW; Zhao, B; Ma, HF; Dang, WQ; Wei, Z; Wang, K; Lin, ZY; Yan, XX; Sun, MZ; Li, B; Pan, XQ; Luo, J; Zhang, GY; Liu, Y; Huang, Y; Duan, XD; Duan, XF				Li, Jia; Yang, Xiangdong; Liu, Yang; Huang, Bolong; Wu, Ruixia; Zhang, Zhengwei; Zhao, Bei; Ma, Huifang; Dang, Weiqi; Wei, Zheng; Wang, Kai; Lin, Zhaoyang; Yan, Xingxu; Sun, Mingzi; Li, Bo; Pan, Xiaoqing; Luo, Jun; Zhang, Guangyu; Liu, Yuan; Huang, Yu; Duan, Xidong; Duan, Xiangfeng			General synthesis of two-dimensional van der Waals heterostructure arrays	NATURE			English	Article							EPITAXIAL-GROWTH; PHOTOCURRENT GENERATION; GRADIENT APPROXIMATION; HETEROJUNCTIONS; FERROMAGNETISM; SUPERLATTICES; TRANSISTORS; CRYSTAL	Two-dimensional van der Waals heterostructures (vdWHs) have attracted considerable interest(1-4). However, most vdWHs reported so far are created by an arduous micromechanical exfoliation and manual restacking process(5), which-although versatile for proof-of-concept demonstrations(6-16) and fundamental studies(17-30)-is clearly not scalable for practical technologies. Here we report a general synthetic strategy for two-dimensional vdWH arrays between metallic transition-metal dichalcogenides (m-TMDs) and semiconducting TMDs (s-TMDs). By selectively patterning nucleation sites on monolayer or bilayer s-TMDs, we precisely control the nucleation and growth of diverse m-TMDs with designable periodic arrangements and tunable lateral dimensions at the predesignated spatial locations, producing a series of vdWH arrays, including VSe2/WSe2, NiTe2/WSe2, CoTe2/WSe2, NbTe2/WSe2, VS2/WSe2, VSe2/MoS2 and VSe2/WS2. Systematic scanning transmission electron microscopy studies reveal nearly ideal vdW interfaces with widely tunable moire superlattices. With the atomically clean vdW interface, we further show that the m-TMDs function as highly reliable synthetic vdW contacts for the underlying WSe2 with excellent device performance and yield, delivering a high ON-current density of up to 900 microamperes per micrometre in bilayer WSe2 transistors. This general synthesis of diverse two-dimensional vdWH arrays provides a versatile material platform for exploring exotic physics and promises a scalable pathway to high-performance devices. A general strategy for the synthesis of two-dimensional van der Waals heterostructure arrays is used to produce high-performance electronic devices, showing the potential of this scalable approach for practical technologies.	[Li, Jia; Yang, Xiangdong; Wu, Ruixia; Zhang, Zhengwei; Zhao, Bei; Ma, Huifang; Dang, Weiqi; Li, Bo; Liu, Yuan; Duan, Xidong] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Hunan Key Lab Two Dimens Mat, Changsha, Peoples R China; [Liu, Yang; Lin, Zhaoyang; Duan, Xiangfeng] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Huang, Bolong; Sun, Mingzi] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Wei, Zheng; Zhang, Guangyu] Chinese Acad Sci, Inst Phys, Beijing Natl Lab Condensed Matter Phys, Beijing, Peoples R China; [Wang, Kai; Luo, Jun] Tianjin Univ Technol, Tianjin Key Lab Adv Funct Porous Mat, Ctr Electron Microscopy, Inst New Energy,Sch Mat, Tianjin, Peoples R China; [Yan, Xingxu; Pan, Xiaoqing] Univ Calif Irvine, Dept Mat Sci & Engn, Irvine, CA USA; [Li, Bo; Liu, Yuan] Hunan Univ, Sch Phys & Elect, Changsha, Peoples R China; [Pan, Xiaoqing] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA USA; [Huang, Yu] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90024 USA	Hunan University; University of California System; University of California Los Angeles; Hong Kong Polytechnic University; Chinese Academy of Sciences; Institute of Physics, CAS; Tianjin University of Technology; University of California System; University of California Irvine; Hunan University; University of California System; University of California Irvine; University of California System; University of California Los Angeles	Duan, XD (corresponding author), Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Hunan Key Lab Two Dimens Mat, Changsha, Peoples R China.; Duan, XF (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	xidongduan@hnu.edu.cn; xduan@chem.ucla.edu	Liu, Yuan/G-4834-2016; wu, ruixia/GVO-3824-2022; Luo, Jun/CAG-4333-2022; Duan, Xiangfeng/E-7522-2011; Wang, Kai/AAQ-3234-2020; Duan, Xiangfeng/AAQ-9674-2020; Huang, Yu/AAZ-9747-2020; Yan, Xingxu/A-8124-2017; Duan, Xidong/AAB-5111-2021	Liu, Yuan/0000-0002-0024-9290; Luo, Jun/0000-0001-5084-2087; Duan, Xiangfeng/0000-0002-4321-6288; Wang, Kai/0000-0001-6149-6685; Duan, Xiangfeng/0000-0002-4321-6288; Huang, Yu/0000-0003-1793-0741; Yan, Xingxu/0000-0001-7991-4849; Liu, Yang/0000-0002-6329-8647; Huang, Bolong/0000-0002-2526-2002; Yang, Xiangdong/0000-0002-0797-8293	National Natural Science Foundation of China [51991340, 51991343, 51872086]; Hunan Key Laboratory of Two-Dimensional Materials [2018TP1010]; Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-SC0014430]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Key Laboratory of Two-Dimensional Materials; Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE))	The authors at Hunan University acknowledge the support from National Natural Science Foundation of China (grant numbers 51991340, 51991343 and 51872086), and the Hunan Key Laboratory of Two-Dimensional Materials (grant number 2018TP1010). The planar TEM studies were conducted at the Center for Electron Microscopy at Tianjin University of Technology. The cross-sectional STEM experiments were conducted using the facilities in the Irvine Materials Research Institute (IMRI) at the University of California, Irvine. The work at University of California, Irvine was supported by the Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering under grant DE-SC0014430.	Ai RQ, 2017, ACS NANO, V11, P3413, DOI 10.1021/acsnano.7b01507; Alexeev EM, 2019, NATURE, V567, P81, DOI 10.1038/s41586-019-0986-9; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Cao Y, 2018, NATURE, V556, P80, DOI 10.1038/nature26154; Cao Y, 2018, NATURE, V556, P43, DOI 10.1038/nature26160; Chen JY, 2016, CHEM MATER, V28, P7194, DOI 10.1021/acs.chemmater.6b03639; Chen P, 2018, CHEM SOC REV, V47, P3129, DOI 10.1039/c7cs00887b; Cheng R, 2014, NANO LETT, V14, P5590, DOI 10.1021/nl502075n; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Cui X, 2015, NAT NANOTECHNOL, V10, P534, DOI [10.1038/nnano.2015.70, 10.1038/NNANO.2015.70]; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Duan XD, 2014, NAT NANOTECHNOL, V9, P1024, DOI [10.1038/NNANO.2014.222, 10.1038/nnano.2014.222]; Fang H, 2014, P NATL ACAD SCI USA, V111, P6198, DOI 10.1073/pnas.1405435111; Gao Y, 2017, ADV MATER, V29, DOI 10.1002/adma.201700990; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Gong C, 2017, NATURE, V546, P265, DOI 10.1038/nature22060; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/NMAT4091, 10.1038/nmat4091]; Han GH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7128; Hasnip PJ, 2006, COMPUT PHYS COMMUN, V174, P24, DOI 10.1016/j.cpc.2005.07.011; HEAD JD, 1985, CHEM PHYS LETT, V122, P264, DOI 10.1016/0009-2614(85)80574-1; Hong XP, 2014, NAT NANOTECHNOL, V9, P682, DOI [10.1038/NNANO.2014.167, 10.1038/nnano.2014.167]; Huang B, 2017, NATURE, V546, P270, DOI 10.1038/nature22391; Huang CM, 2014, NAT MATER, V13, P1096, DOI [10.1038/nmat4064, 10.1038/NMAT4064]; Jin CH, 2019, NATURE, V567, P76, DOI 10.1038/s41586-019-0976-y; Kang K, 2017, NATURE, V550, P229, DOI 10.1038/nature23905; Tran K, 2019, NATURE, V567, P71, DOI 10.1038/s41586-019-0975-z; Lee CH, 2014, NAT NANOTECHNOL, V9, P676, DOI [10.1038/NNANO.2014.150, 10.1038/nnano.2014.150]; Li MY, 2015, SCIENCE, V349, P524, DOI 10.1126/science.aab4097; Liu Y, 2019, NATURE, V567, P323, DOI 10.1038/s41586-019-1013-x; Liu Y, 2018, NATURE, V557, P696, DOI 10.1038/s41586-018-0129-8; Liu Y, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.42; Liu Y, 2015, NANO LETT, V15, P3030, DOI 10.1021/nl504957p; Mahjouri-Samani M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8749; Novoselov KS, 2016, SCIENCE, V353, DOI 10.1126/science.aac9439; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Rivera P, 2016, SCIENCE, V351, P688, DOI 10.1126/science.aac7820; Sahoo PK, 2018, NATURE, V553, P63, DOI 10.1038/nature25155; Seyler KL, 2019, NATURE, V567, P66, DOI 10.1038/s41586-019-0957-1; Song TC, 2018, SCIENCE, V360, P1214, DOI 10.1126/science.aar4851; Unuchek D, 2018, NATURE, V560, P340, DOI 10.1038/s41586-018-0357-y; Wang C, 2018, NATURE, V555, P231, DOI 10.1038/nature25774; Withers F, 2015, NAT MATER, V14, P301, DOI 10.1038/nmat4205; Wu RX, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201806611; Xie SE, 2018, SCIENCE, V359, P1131, DOI 10.1126/science.aao5360; Xu WG, 2017, NATURE, V541, P62, DOI 10.1038/nature20601; Yang TF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02093-z; Yu H, 2017, ACS NANO, V11, P12001, DOI 10.1021/acsnano.7b03819; Yu WJ, 2013, NAT NANOTECHNOL, V8, P952, DOI [10.1038/nnano.2013.219, 10.1038/NNANO.2013.219]; Yu WJ, 2013, NAT MATER, V12, P246, DOI [10.1038/NMAT3518, 10.1038/nmat3518]; Zhang CD, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1601459; Zhang Y, 2018, ADV MATER, V30, DOI 10.1002/adma.201803665; Zhang Z. W., 2020, NATL SCI REV, DOI [10.1093/nsr/nwz223/5698323, DOI 10.1093/NSR/NWZ223/5698323]; Zhang ZW, 2017, SCIENCE, V357, P788, DOI 10.1126/science.aan6814; Zhang ZP, 2019, ACS NANO, V13, P885, DOI 10.1021/acsnano.8b08677; Zhao MV, 2016, NAT NANOTECHNOL, V11, P954, DOI 10.1038/nnano.2016.115	56	258	260	133	1182	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					368	+		10.1038/s41586-020-2098-y	http://dx.doi.org/10.1038/s41586-020-2098-y		MAR 2020	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188941				2022-12-28	WOS:000519162500011
J	Won, SM; Song, EM; Reeder, JT; Rogers, JA				Won, Sang Min; Song, Enming; Reeder, Jonathan T.; Rogers, John A.			Emerging Modalities and Implantable Technologies for Neuromodulation	CELL			English	Review							DEEP BRAIN-STIMULATION; NEURAL STIMULATION; CLOSED-LOOP; SILK FIBROIN; OPTOELECTRONIC SYSTEMS; NERVE-STIMULATION; ELECTRODE ARRAY; WIRELESS; SOFT; OPTOGENETICS	yy Techniques for neuromodulation serve as effective routes to care of patients with many types of challenging conditions. Continued progress in this field of medicine will require (1) improvements in our understanding of the mechanisms of neural control over organ function and (2) advances in technologies for precisely modulating these functions in a programmable manner. This review presents recent research on devices that are relevant to both of these goals, with an emphasis on multimodal operation, miniaturized dimensions, biocompatible designs, advanced neural interface schemes, and battery-free, wireless capabilities. A future that involves recording and modulating neural activity with such systems, including those that exploit closed-loop strategies and/or bioresorbable designs, seems increasingly within reach.	[Won, Sang Min] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea; [Song, Enming] Univ Illinois, Frederick Seitz Mat Res Lab, Urbana, IL USA; [Song, Enming; Reeder, Jonathan T.; Rogers, John A.] Northwestern Univ, Ctr Biointegrated Elect, Evanston, IL 60208 USA; [Reeder, Jonathan T.; Rogers, John A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Ctr Adv Mol Imaging, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Neurol Surg, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Dept Elect & Comp Engn, Evanston, IL 60208 USA; [Rogers, John A.] Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Evanston, IL 60208 USA	Sungkyunkwan University (SKKU); University of Illinois System; University of Illinois Urbana-Champaign; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University	Rogers, JA (corresponding author), Northwestern Univ, Ctr Biointegrated Elect, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Ctr Adv Mol Imaging, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Mech Engn, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Chem, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Neurol Surg, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Dept Elect & Comp Engn, Evanston, IL 60208 USA.; Rogers, JA (corresponding author), Northwestern Univ, Simpson Querrey Inst BioNanotechnol, Evanston, IL 60208 USA.	jrogers@northwestern.edu	Rogers, John/L-2798-2016; Reeder, Jonathan/T-5358-2018	Reeder, Jonathan/0000-0002-7624-7355				Agrawal DR, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0043; Ahmad A, 2015, ASIAN SPINE J, V9, P299, DOI 10.4184/asj.2015.9.2.299; Arfin SK, 2009, J NEUROPHYSIOL, V102, P598, DOI 10.1152/jn.00017.2009; Atasoy D, 2018, PHYSIOL REV, V98, P391, DOI 10.1152/physrev.00009.2017; Bai WB, 2019, NAT BIOMED ENG, V3, P644, DOI 10.1038/s41551-019-0435-y; Bhat M.A., 2013, ADV PHY THEOR APPL, V16, P54; Bhunia S., 2015, IMPLANTABLE BIOMEDIC, DOI DOI 10.1016/C2013; Boehler C, 2015, BIOMATERIALS, V67, P346, DOI 10.1016/j.biomaterials.2015.07.036; Bonelli Raphael M, 2007, Dialogues Clin Neurosci, V9, P141; Brito R, 2014, CELLS-BASEL, V3, P517, DOI 10.3390/cells3020517; Brocker David T, 2013, Handb Clin Neurol, V116, P3, DOI 10.1016/B978-0-444-53497-2.00001-2; Byun SH, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay0418; Camporeze B, 2018, AM J CANCER RES, V8, P1900; Capogrosso M, 2016, NATURE, V539, P284, DOI 10.1038/nature20118; Cela E, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00947; Cha GD, 2019, ADV HEALTHC MATER, V8, DOI 10.1002/adhm.201801660; Chen R, 2017, NAT REV MATER, V2, DOI 10.1038/natrevmats.2016.93; Chen R, 2015, SCIENCE, V347, P1477, DOI 10.1126/science.1261821; Chen S, 2018, SCIENCE, V359, P679, DOI 10.1126/science.aaq1144; Christo SN, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/342304; Cogan SF, 2008, ANNU REV BIOMED ENG, V10, P275, DOI 10.1146/annurev.bioeng.10.061807.160518; Creed M, 2015, SCIENCE, V347, P659, DOI 10.1126/science.1260776; Dagdeviren C, 2014, P NATL ACAD SCI USA, V111, P1927, DOI 10.1073/pnas.1317233111; Dagdeviren C, 2013, SMALL, V9, P3398, DOI 10.1002/smll.201300146; Ngo DH, 2019, MOLECULES, V24, DOI 10.3390/molecules24152678; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Devinsky O, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.24; Ding H, 2018, P NATL ACAD SCI USA, V115, P6632, DOI 10.1073/pnas.1802064115; Dorey E., 2016, PHARM J, V297, P7896; Duke AR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02600; Elwassif MM, 2006, J NEURAL ENG, V3, P306, DOI 10.1088/1741-2560/3/4/008; Eom K, 2014, SMALL, V10, P3853, DOI 10.1002/smll.201400599; Erofeev A., 2016, OPERA MEDICA PHYSIOL, V2, P117, DOI [10.20388/OMP2016.002.0032, DOI 10.20388/OMP2016.002.0032]; Fard JK, 2015, ADV PHARM BULL, V5, P447, DOI 10.15171/apb.2015.061; Fenno L, 2011, ANNU REV NEUROSCI, V34, P389, DOI 10.1146/annurev-neuro-061010-113817; Ferguson JE, 2011, EXPERT REV MED DEVIC, V8, P427, DOI [10.1586/ERD.11.16, 10.1586/erd.11.16]; Fernandes J, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9020047; Fu TM, 2016, NAT METHODS, V13, P875, DOI 10.1038/nmeth.3969; Gardner J, 2013, SOC STUD SCI, V43, P707, DOI 10.1177/0306312713483678; Gerwig Ramona, 2012, Front Neuroeng, V5, P8, DOI 10.3389/fneng.2012.00008; Gilletti A, 2006, J NEURAL ENG, V3, P189, DOI 10.1088/1741-2560/3/3/001; Green RA, 2012, BIOMATERIALS, V33, P5875, DOI 10.1016/j.biomaterials.2012.05.017; Grosenick L, 2015, NEURON, V86, P106, DOI 10.1016/j.neuron.2015.03.034; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Gutruf P, 2018, NAT ELECTRON, V1, P652, DOI 10.1038/s41928-018-0175-0; Hammer N, 2016, LIVEST SCI, V187, P125, DOI 10.1016/j.livsci.2016.03.007; Hinchet R, 2019, SCIENCE, V365, P491, DOI 10.1126/science.aan3997; Phan HP, 2019, ACS NANO, V13, P11572, DOI 10.1021/acsnano.9b05168; Hong GS, 2018, SCIENCE, V360, P1447, DOI 10.1126/science.aas9160; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/NNANO.2010.125, 10.1038/nnano.2010.125]; Jakesova M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav5265; Jeong JW, 2015, CELL, V162, P662, DOI 10.1016/j.cell.2015.06.058; Jeong JW, 2015, NEURON, V86, P175, DOI 10.1016/j.neuron.2014.12.035; Jia XT, 2017, ACS ENERGY LETT, V2, P831, DOI 10.1021/acsenergylett.7b00012; Jia XT, 2016, ADV FUNCT MATER, V26, P1454, DOI 10.1002/adfm.201503498; Jiang YW, 2016, NAT MATER, V15, P1023, DOI 10.1038/NMAT4673; Johnson B, 2018, 2018 IEEE SYMPOSIUM ON PRIVACY-AWARE COMPUTING (PAC), P1, DOI 10.1109/PAC.2018.00007; Johnson RL, 2018, J INFLAMM RES, V11, P203, DOI 10.2147/JIR.S163248; Jonsson A, 2016, P NATL ACAD SCI USA, V113, P9440, DOI 10.1073/pnas.1604231113; Kang SK, 2018, ACCOUNTS CHEM RES, V51, P988, DOI 10.1021/acs.accounts.7b00548; Kang SK, 2016, NATURE, V530, P71, DOI 10.1038/nature16492; Kim DH, 2010, NAT MATER, V9, P511, DOI [10.1038/NMAT2745, 10.1038/nmat2745]; Kim TI, 2013, SCIENCE, V340, P211, DOI 10.1126/science.1232437; Kim YH, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/6/066029; Kolasinski J, 2019, J PHYSIOL-LONDON, V597, P271, DOI 10.1113/JP276626; Koo J, 2018, NAT MED, V24, P1830, DOI 10.1038/s41591-018-0196-2; Kostarelos K, 2017, ADV MATER, V29, DOI 10.1002/adma.201700909; Kozai TDY, 2016, IEEE T BIO-MED ENG, V63, P111, DOI 10.1109/TBME.2015.2445713; Kozai TDY, 2012, NAT MATER, V11, P1065, DOI [10.1038/NMAT3468, 10.1038/nmat3468]; Kringelbach ML, 2007, NAT REV NEUROSCI, V8, P623, DOI 10.1038/nrn2196; Kurs A, 2007, SCIENCE, V317, P83, DOI 10.1126/science.1143254; Lee G, 2017, ADV ENERGY MATER, V7, DOI 10.1002/aenm.201700157; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; Lee J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13198-y; Lee S, 2018, IEEE T BIOMED CIRC S, V12, P1256, DOI 10.1109/TBCAS.2018.2876069; Liang Q., 2017, INT REV PSYCHIATR, V29; Lieb A, 2019, EBIOMEDICINE, V43, P641, DOI 10.1016/j.ebiom.2019.04.059; Lieb A, 2018, NAT MED, V24, P1324, DOI 10.1038/s41591-018-0103-x; Lim LW, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.24; Liu HZ, 2015, ADV FUNCT MATER, V25, P7071, DOI 10.1002/adfm.201502752; Liu SF, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9020026; Liu YX, 2019, NAT BIOMED ENG, V3, P58, DOI 10.1038/s41551-018-0335-6; Lo MC, 2017, INT REV PSYCHIATR, V29, P191, DOI 10.1080/09540261.2017.1282438; Lothet EH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03374-9; Lotti F, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00497; Lozano AM, 2019, NAT REV NEUROL, V15, P148, DOI 10.1038/s41582-018-0128-2; Lu LY, 2018, P NATL ACAD SCI USA, V115, pE1374, DOI 10.1073/pnas.1718721115; Lu YC, 2016, SCI REP-UK, V6, DOI 10.1038/srep33526; Luan Song, 2014, Front Neuroeng, V7, P27, DOI 10.3389/fneng.2014.00027; McCall JG, 2017, CURR OPIN PHARMACOL, V36, P78, DOI 10.1016/j.coph.2017.08.010; McIntyre CC, 2004, CLIN NEUROPHYSIOL, V115, P589, DOI 10.1016/j.clinph.2003.10.033; Mickle AD, 2019, NATURE, V565, P361, DOI 10.1038/s41586-018-0823-6; Minev IR, 2015, SCIENCE, V347, P159, DOI 10.1126/science.1260318; Mitchell JW, 2012, J CENT NERV SYST DIS, V4, P105, DOI 10.4137/JCNSD.S8315; Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001; Morrell MJ, 2016, NEUROSURG CLIN N AM, V27, P111, DOI 10.1016/j.nec.2015.08.012; Musk E, 2019, J MED INTERNET RES, V21, DOI 10.2196/16194; Nelson TR, 2009, J ULTRAS MED, V28, P139, DOI 10.7863/jum.2009.28.2.139; Noh KN, 2018, SMALL, V14, DOI 10.1002/smll.201702479; Nuss P, 2015, NEUROPSYCH DIS TREAT, V11, P165, DOI 10.2147/NDT.S58841; O'Brien WD, 2007, PROG BIOPHYS MOL BIO, V93, P212, DOI 10.1016/j.pbiomolbio.2006.07.010; O'Connor DH, 2013, NAT NEUROSCI, V16, P958, DOI 10.1038/nn.3419; O'Leary G, 2018, IEEE J SOLID-ST CIRC, V53, P3150, DOI 10.1109/JSSC.2018.2869579; Opie NL, 2018, NAT BIOMED ENG, V2, P907, DOI 10.1038/s41551-018-0321-z; Owen SF, 2019, NAT NEUROSCI, V22, P1061, DOI 10.1038/s41593-019-0422-3; Parameswaran R, 2018, NAT NANOTECHNOL, V13, P260, DOI 10.1038/s41565-017-0041-7; Park S, 2010, J PHYS CHEM C, V114, P8721, DOI 10.1021/jp911256h; Park S, 2017, NAT NEUROSCI, V20, P612, DOI 10.1038/nn.4510; Park SI, 2016, P NATL ACAD SCI USA, V113, pE8169, DOI 10.1073/pnas.1611769113; Park SI, 2015, NAT BIOTECHNOL, V33, P1280, DOI 10.1038/nbt.3415; Park SI, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/5/056002; Parodi A, 2019, ELECTRONICS-SWITZ, V8, DOI 10.3390/electronics8111344; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Paz JT, 2013, NAT NEUROSCI, V16, P64, DOI 10.1038/nn.3269; Perryman L.T., 2018, AM J ANESTH CLIN RES, V4, P19; Pourbadie Hamid Gholami, 2018, Iranian Biomedical Journal, V22, P4; Proctor CM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aau1291; Qazi R, 2019, NAT BIOMED ENG, V3, P655, DOI 10.1038/s41551-019-0432-1; Quinn EJ, 2015, MOVEMENT DISORD, V30, P1750, DOI 10.1002/mds.26376; Qureshi UM, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060890; Rivnay J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11287; Robbins TW, 2019, DIALOGUES CLIN NEURO, V21, P301, DOI 10.31887/DCNS.2019.21.3/trobbins; Rogers JA, 2010, SCIENCE, V327, P1603, DOI 10.1126/science.1182383; Russo E, 2011, EPILEPSIA, V52, P1341, DOI 10.1111/j.1528-1167.2011.03112.x; Seo D, 2016, NEURON, V91, P529, DOI 10.1016/j.neuron.2016.06.034; Shin G, 2017, NEURON, V93, P509, DOI 10.1016/j.neuron.2016.12.031; Shin H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11628-5; Shin JH, 2019, NAT BIOMED ENG, V3, P37, DOI 10.1038/s41551-018-0300-4; Sim JY, 2017, LAB CHIP, V17, P1406, DOI 10.1039/c7lc00103g; Song EM, 2019, APL MATER, V7, DOI 10.1063/1.5094415; Spyropoulos GD, 2020, ADV MATER TECHNOL-US, V5, DOI 10.1002/admt.201900652; Sridharan A, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/6/066001; Stagg CJ, 2011, CURR BIOL, V21, P480, DOI 10.1016/j.cub.2011.01.069; Starr PA, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00619; Tomycz ND, 2020, SURG INFECT, V21, P378, DOI 10.1089/sur.2019.075; Turk DC, 2011, LANCET, V377, P2226, DOI 10.1016/S0140-6736(11)60402-9; Vargas MI, 2018, INSIGHTS IMAGING, V9, P549, DOI 10.1007/s13244-018-0626-1; Veiseh O, 2015, NAT MATER, V14, P643, DOI [10.1038/NMAT4290, 10.1038/nmat4290]; Venkatraman S, 2011, IEEE T NEUR SYS REH, V19, P307, DOI 10.1109/TNSRE.2011.2109399; Verrills P, 2016, J PAIN RES, V9, P481, DOI 10.2147/JPR.S108884; Vitale F, 2015, ACS NANO, V9, P4465, DOI 10.1021/acsnano.5b01060; Voroslakos M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02928-3; Wang K, 2009, IEEE T BIO-MED ENG, V56, P6, DOI 10.1109/TBME.2008.926691; Wang KZ, 2019, ADV MATER, V31, DOI 10.1002/adma.201805867; Wang LL, 2018, ADV OPT MATER, V6, DOI 10.1002/adom.201800427; Wang YC, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00069; Ware T, 2013, POLYM REV, V53, P108, DOI 10.1080/15583724.2012.751924; Wellman SM, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201701269; Wen XM, 2019, BIOSENS BIOELECTRON, V131, P37, DOI 10.1016/j.bios.2019.01.060; Weston M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1567; Wo YQ, 2016, BIOMATER SCI-UK, V4, P1161, DOI 10.1039/c6bm00271d; Won SM, 2018, ADV MATER, V30, DOI 10.1002/adma.201800534; Wu F, 2015, NEURON, V88, P1136, DOI 10.1016/j.neuron.2015.10.032; Wu X, 2019, P NATL ACAD SCI USA, V116, P26332, DOI 10.1073/pnas.1914387116; Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323; Xie ZQ, 2020, ADV MATER, V32, DOI 10.1002/adma.201902767; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Xu H, 2007, ECS T, V11, P383, DOI DOI 10.1149/1.2780952; Yan Z, 2017, P NATL ACAD SCI USA, V114, pE9455, DOI 10.1073/pnas.1713805114; Yao G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07764-z; Ye TY, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201902128; Yin L, 2014, ADV MATER, V26, P3879, DOI 10.1002/adma.201306304; Yizhar O, 2011, NATURE, V477, P171, DOI 10.1038/nature10360; Yu KJ, 2016, NAT MATER, V15, P782, DOI [10.1038/nmat4624, 10.1038/NMAT4624]; Yu XW, 2018, ADV MATER, V30, DOI 10.1002/adma.201707624; Yu XG, 2019, NATURE, V575, P473, DOI 10.1038/s41586-019-1687-0; Yuan Y., 2016, J CIRCUIT SYST COMP, V25, P2; Zhang C, 2015, MICROSYST TECHNOL, V21, P139, DOI 10.1007/s00542-013-2017-3; Zhang Y, 2019, P NATL ACAD SCI USA, V116, P21427, DOI 10.1073/pnas.1909850116; Zhang Y, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw5296; Zhang YC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1066; Zheng Q, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501478; Zhong YH, 2008, J R SOC INTERFACE, V5, P957, DOI 10.1098/rsif.2008.0071; Zhou A, 2019, NAT BIOMED ENG, V3, P15, DOI 10.1038/s41551-018-0323-x	174	75	75	29	166	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 2	2020	181	1					115	135		10.1016/j.cell.2020.02.054	http://dx.doi.org/10.1016/j.cell.2020.02.054			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	KZ5RI	32220309	Bronze			2022-12-28	WOS:000523319000017
J	Cordova, F				Cordova, France			Leadership to change a culture of sexual harassment	SCIENCE			English	Editorial Material									[Cordova, France] Natl Sci Fdn, Alexandria, VA 22314 USA	National Science Foundation (NSF)	Cordova, F (corresponding author), Natl Sci Fdn, Alexandria, VA 22314 USA.	programcomplaints@nsf.gov						NSF, 2018, FED REGISTER, V83, P47940; Wessel L., 2019, SCIENCE	2	0	0	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1430	1431		10.1126/science.abb5791	http://dx.doi.org/10.1126/science.abb5791			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217716				2022-12-28	WOS:000523251600018
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: What is the UK's testing strategy?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, COVID 19 POINT EPIDE; [Anonymous], 2020, CORONAVIRUS INFECT 1; [Anonymous], 2020, CORONAVIRUS COVID 19	3	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1222	10.1136/bmj.m1222	http://dx.doi.org/10.1136/bmj.m1222			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217754	Bronze			2022-12-28	WOS:000523764800015
J	Mahase, E				Mahase, Elisabeth			Covid-19: what treatments are being investigated?	BMJ-BRITISH MEDICAL JOURNAL			English	News Item							CHLOROQUINE											[Anonymous], SEARCH ORPH DRUG DES; Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282; Chen C, 2020, MEDRXIV, DOI [10.1101/2020.03.17.20037432, DOI 10.1101/2020.03.17.20037432]; Financial Times, 2020, FINANCIAL TIMES; Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1166; Sayburn A., 2020, BMJ-BRIT MED J, V368, pm1206, DOI [10.1136/bmj.m1206, DOI 10.1136/BMJ.M1206]; Touret F, 2020, ANTIVIR RES, V177, DOI 10.1016/j.antiviral.2020.104762; Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0	9	32	33	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1252	10.1136/bmj.m1252	http://dx.doi.org/10.1136/bmj.m1252			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217607	Bronze			2022-12-28	WOS:000523764800018
J	[Anonymous]				[Anonymous]			Seven days in medicine: 18-24 March	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2020, TIMES	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1177	10.1136/bmj.m1177	http://dx.doi.org/10.1136/bmj.m1177			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217519				2022-12-28	WOS:000523764800006
J	Nagendran, M; Chen, Y; Lovejoy, CA; Gordon, AC; Komorowski, M; Harvey, H; Topol, EJ; Ioannidis, JPA; Collins, GS; Maruthappu, M				Nagendran, Myura; Chen, Yang; Lovejoy, Christopher A.; Gordon, Anthony C.; Komorowski, Matthieu; Harvey, Hugh; Topol, Eric J.; Ioannidis, John P. A.; Collins, Gary S.; Maruthappu, Mahiben			Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PREDICTION MODEL; REDUCING WASTE; APPLICABILITY; EXPLANATION; PROBAST; RISK; BIAS; TOOL; FDA	OBJECTIVE To systematically examine the design, reporting standards, risk of bias, and claims of studies comparing the performance of diagnostic deep learning algorithms for medical imaging with that of expert clinicians. DESIGN Systematic review. DATA SOURCES Medline, Embase, Cochrane Central Register of Controlled Trials, and the World Health Organization trial registry from 2010 to June 2019. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised trial registrations and non-randomised studies comparing the performance of a deep learning algorithm in medical imaging with a contemporary group of one or more expert clinicians. Medical imaging has seen a growing interest in deep learning research. The main distinguishing feature of convolutional neural networks (CNNs) in deep learning is that when CNNs are fed with raw data, they develop their own representations needed for pattern recognition. The algorithm learns for itself the features of an image that are important for classification rather than being told by humans which features to use. The selected studies aimed to use medical imaging for predicting absolute risk of existing disease or classification into diagnostic groups (eg, disease or non-disease). For example, raw chest radiographs tagged with a label such as pneumothorax or no pneumothorax and the CNN learning which pixel patterns suggest pneumothorax. REVIEW METHODS Adherence to reporting standards was assessed by using CONSORT (consolidated standards of reporting trials) for randomised studies and TRIPOD (transparent reporting of a multivariable prediction model for individual prognosis or diagnosis) for non-randomised studies. Risk of bias was assessed by using the Cochrane risk of bias tool for randomised studies and PROBAST (prediction model risk of bias assessment tool) for non-randomised studies. RESULTS Only 10 records were found for deep learning randomised clinical trials, two of which have been published (with low risk of bias, except for lack of blinding, and high adherence to reporting standards) and eight are ongoing. Of 81 non-randomised clinical trials identified, only nine were prospective and just six were tested in a real world clinical setting. The median number of experts in the comparator group was only four (interquartile range 2-9). Full access to all datasets and code was severely limited (unavailable in 95% and 93% of studies, respectively). The overall risk of bias was high in 58 of 81 studies and adherence to reporting standards was suboptimal (<50% adherence for 12 of 29 TRIPOD items). 61 of 81 studies stated in their abstract that performance of artificial intelligence was at least comparable to (or better than) that of clinicians. Only 31 of 81 studies (38%) stated that further prospective studies or trials were required. CONCLUSIONS Few prospective deep learning studies and randomised trials exist in medical imaging. Most nonrandomised trials are not prospective, are at high risk of bias, and deviate from existing reporting standards. Data and code availability are lacking in most studies, and human comparator groups are often small. Future studies should diminish risk of bias, enhance real world clinical relevance, improve reporting and transparency, and appropriately temper conclusions. STUDY REGISTRATION PROSPERO CRD42019123605.	[Nagendran, Myura; Gordon, Anthony C.] Imperial Coll London, Dept Surg & Canc, Div Anaesthet Pain Med & Intens Care, London, England; [Chen, Yang] UCL, Inst Cardiovasc Sci, London, England; [Lovejoy, Christopher A.; Maruthappu, Mahiben] Cera Care, London, England; [Gordon, Anthony C.] Imperial Coll Healthcare NHS Trust, Ctr Perioperat & Crit Care Res, London, England; [Komorowski, Matthieu] Imperial Coll London, Dept Bioengn, London, England; [Harvey, Hugh] Hardian Hlth, London, England; [Topol, Eric J.] Scripps Res Translat Inst, La Jolla, CA USA; [Ioannidis, John P. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Hlth Res & Policy, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA; [Collins, Gary S.] Univ Oxford, Ctr Stat Med, Oxford, England; [Collins, Gary S.] Oxford Univ Hosp NHS Trust, NIHR Oxford Biomed Res Ctr, Oxford, England	Imperial College London; University of London; University College London; Imperial College London; Imperial College London; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Nagendran, M (corresponding author), Imperial Coll London, Intens Care, St Marys Campus,Praed St, London W2 1NY, England.	nagendran@imperial.ac.uk	Collins, Gary Stephen/A-2258-2014; Chen, Yang/ABF-7660-2021; Ioannidis, John P. A./G-9836-2011; Gordon, Anthony/A-3472-2012	Collins, Gary Stephen/0000-0002-2772-2316; Gordon, Anthony/0000-0002-0419-547X; Nagendran, Myura/0000-0002-4656-5096; Topol, Eric/0000-0002-1478-4729; Komorowski, Matthieu/0000-0003-0559-5747; Lovejoy, Christopher Andrew/0000-0003-0919-1264; Ioannidis, John P./0000-0003-3118-6859; Chen, Yang/0000-0001-6032-3387	National Institute for Health Research (NIHR) academic clinical fellowships; UK NIHR research professor award [RP-2015-06-018]; NIHR Imperial Biomedical Research Centre; Laura and John Arnold Foundation; NIHR Oxford Biomedical Research Centre; Cancer Research UK [C49297/A27294]	National Institute for Health Research (NIHR) academic clinical fellowships(National Institute for Health Research (NIHR)); UK NIHR research professor award; NIHR Imperial Biomedical Research Centre; Laura and John Arnold Foundation; NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK)	There is no specific funding for this study. MN and YC are supported by National Institute for Health Research (NIHR) academic clinical fellowships. ACG is funded by a UK NIHR research professor award (RP-2015-06-018). MN and ACG are both supported by the NIHR Imperial Biomedical Research Centre. The Meta-Research Innovation Center at Stanford (METRICS) has been funded by a grant from the Laura and John Arnold Foundation. GSC is supported by the NIHR Oxford Biomedical Research Centre and Cancer Research UK (grant C49297/A27294).	Allen B, 2019, J AM COLL RADIOL, V16, P208, DOI 10.1016/j.jacr.2018.09.007; Boutron I, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1330-9; Camerer CF, 2018, NAT HUM BEHAV, V2, P637, DOI 10.1038/s41562-018-0399-z; Carfagno J, 2019, 5 FDA APPROVED USES; Carson E., 2015, IBM WATSON HLTH COMP; Collins GS, 2019, LANCET, V393, P1577, DOI 10.1016/S0140-6736(19)30037-6; Collins GS, 2015, J CLIN EPIDEMIOL, V68, P112, DOI [10.1016/j.jclinepi.2014.11.010, 10.7326/M14-0697, 10.1136/bmj.g7594, 10.1186/s12916-014-0241-z, 10.1016/j.eururo.2014.11.025, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.1038/bjc.2014.639, 10.7326/M14-0698]; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Ebrahim S, 2014, JAMA-J AM MED ASSOC, V312, P1024, DOI 10.1001/jama.2014.9646; Esteva A, 2019, NAT MED, V25, P24, DOI 10.1038/s41591-018-0316-z; FDA, 2019, ART INT MACH LEARN S; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Han SS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191493; Heus P, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025611; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hwang DK, 2019, THERANOSTICS, V9, P232, DOI 10.7150/thno.28447; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Kappen Teus H, 2018, Diagn Progn Res, V2, P11, DOI 10.1186/s41512-018-0033-6; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lin HT, 2019, ECLINICALMEDICINE, V9, P52, DOI 10.1016/j.eclinm.2019.03.001; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moons KGM, 2019, ANN INTERN MED, V170, pW1, DOI 10.7326/M18-1377; Murphy M., 2019, GOOGLE SAYS ITS CAN; NCBI, 2019, PUBMED SEARCH DEEP L; Price E., 2018, AL IS BETTER DIAGNOS; Psaty BM, 2005, NEW ENGL J MED, V352, P1133, DOI 10.1056/NEJMe058042; Ratner M, 2018, NAT BIOTECHNOL, V36, P673, DOI 10.1038/nbt0818-673a; ReportLinker, 2018, ART INT HEALTHC MARK; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.4103/0976-500X.72352, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]; Section FDA, 2018, 510 K PREM NOT INT M; Sumner P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168217; Topol EJ, 2019, NAT MED, V25, P44, DOI 10.1038/s41591-018-0300-7; Van Calster B, 2019, JAMA INTERN MED, V179, P731, DOI 10.1001/jamainternmed.2019.0597; Vollmer S, 2018, MACHINE LEARNING RES; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wallace E, 2011, BMC MED INFORM DECIS, V11, DOI 10.1186/1472-6947-11-62; Wallach OD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006930; Wang P, 2019, GUT, V68, P1813, DOI 10.1136/gutjnl-2018-317500; Wolff RF, 2019, ANN INTERN MED, V170, P51, DOI 10.7326/M18-1376	40	305	310	14	63	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m689	10.1136/bmj.m689	http://dx.doi.org/10.1136/bmj.m689			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213531	hybrid, Green Published			2022-12-28	WOS:000523764500002
J	Iacobucci, G				Iacobucci, Gareth			Covid-19: doctors are given new guidelines on when to admit patients to critical care	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Iacobucci G, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1106; National Institute for Health and Care Excellence, 2020, COVID 19 RAP GUID CR; National Institute for Health and Care Excellence (NICE), 2020, COVID 19 RAP GUID DI; National Institute for Health and Care Excellence (NICE), 2020, COVID 19 RAP GUID DE	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 24	2020	368								m1189	10.1136/bmj.m1189	http://dx.doi.org/10.1136/bmj.m1189			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DU	32209558	Bronze			2022-12-28	WOS:000523764200007
J	Ni, ZY; Bao, CX; Liu, Y; Jiang, Q; Wu, WQ; Chen, SS; Dai, XZ; Chen, B; Hartweg, B; Yu, ZS; Holman, Z; Huang, JS				Ni, Zhenyi; Bao, Chunxiong; Liu, Ye; Jiang, Qi; Wu, Wu-Qiang; Chen, Shangshang; Dai, Xuezeng; Chen, Bo; Hartweg, Barry; Yu, Zhengshan; Holman, Zachary; Huang, Jinsong			Resolving spatial and energetic distributions of trap states in metal halide perovskite solar cells	SCIENCE			English	Article							SINGLE-CRYSTAL; DEFECTS	We report the profiling of spatial and energetic distributions of trap states in metal halide perovskite single-crystalline and polycrystalline solar cells. The trap densities in single crystals varied by five orders of magnitude, with a lowest value of 2 x 10(11) per cubic centimeter and most of the deep traps located at crystal surfaces. The charge trap densities of all depths of the interfaces of the polycrystalline films were one to two orders of magnitude greater than that of the film interior, and the trap density at the film interior was still two to three orders of magnitude greater than that in high-quality single crystals. Suprisingly, after surface passivation, most deep traps were detected near the interface of perovskites and hole transport layers, where a large density of nanocrystals were embedded, limiting the efficiency of solar cells.	[Ni, Zhenyi; Liu, Ye; Jiang, Qi; Wu, Wu-Qiang; Chen, Shangshang; Dai, Xuezeng; Chen, Bo; Huang, Jinsong] Univ N Carolina, Dept Appl Phys Sci, Chapel Hill, NC 27599 USA; [Bao, Chunxiong; Liu, Ye; Huang, Jinsong] Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA; [Bao, Chunxiong; Liu, Ye; Huang, Jinsong] Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA; [Hartweg, Barry; Yu, Zhengshan; Holman, Zachary] Arizona State Univ, Sch Elect Comp & Energy Engn, Tempe, AZ 85287 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Arizona State University; Arizona State University-Tempe	Huang, JS (corresponding author), Univ N Carolina, Dept Appl Phys Sci, Chapel Hill, NC 27599 USA.; Huang, JS (corresponding author), Univ Nebraska, Dept Mech & Mat Engn, Lincoln, NE 68588 USA.; Huang, JS (corresponding author), Univ Nebraska, Nebraska Ctr Mat & Nanosci, Lincoln, NE 68588 USA.	jhuang@unc.edu	Chen, Bo/ABC-4629-2020; (CHANL), Chapel Hill Analytical and Nanofabrication Laboratory/AAA-9271-2022; Bao, Chunxiong/D-7970-2015; Wu, Wuqiang/G-3380-2014; Yu, Zhengshan/C-4718-2015	Bao, Chunxiong/0000-0001-7076-7635; Liu, Ye/0000-0002-5415-1686; Wu, Wuqiang/0000-0001-5414-5668; Yu, Zhengshan/0000-0002-4305-5912; Ni, Zhenyi/0000-0002-8379-9182; Chen, Shangshang/0000-0003-4828-8608	Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center - Office of Basic Energy Sciences, Office of Science within the U.S. Department of Energy; Solar Energy Technologies Office (SETO) within the U.S. Department of Energy [DE-EE0008749]; Defense Threat Reduction Agency [HDTRA1170054]	Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center - Office of Basic Energy Sciences, Office of Science within the U.S. Department of Energy(United States Department of Energy (DOE)); Solar Energy Technologies Office (SETO) within the U.S. Department of Energy(United States Department of Energy (DOE)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Center for Hybrid Organic Inorganic Semiconductors for Energy (CHOISE), an Energy Frontier Research Center funded by the Office of Basic Energy Sciences, Office of Science within the U.S. Department of Energy. The study of the silicon device was supported by the Solar Energy Technologies Office (SETO) within the U.S. Department of Energy under award no. DE-EE0008749. Partial study of the single crystal growth was supported by Defense Threat Reduction Agency under Grant HDTRA1170054.	Ball JM, 2016, NAT ENERGY, V1, P1, DOI [10.1038/NENERGY.2016.149, 10.1038/nenergy.2016.149]; BLEICHER M, 1973, SOLID STATE ELECTRON, V16, P375, DOI 10.1016/0038-1101(73)90012-9; Burgelman M, 2000, THIN SOLID FILMS, V361, P527, DOI 10.1016/S0040-6090(99)00825-1; Chen B, 2019, CHEM SOC REV, V48, P3842, DOI 10.1039/c8cs00853a; Chen ZL, 2019, ACS ENERGY LETT, V4, P1258, DOI 10.1021/acsenergylett.9b00847; Chen ZL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02039-5; Dong QF, 2015, SCIENCE, V347, P967, DOI 10.1126/science.aaa5760; Duan HS, 2013, ADV FUNCT MATER, V23, P1466, DOI 10.1002/adfm.201201732; Eames C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8497; Gehrmann C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11087-y; Heath JT, 2004, J APPL PHYS, V95, P1000, DOI 10.1063/1.1633982; Hentz O, 2016, NANO LETT, V16, P1485, DOI 10.1021/acs.nanolett.5b05181; Herz LM, 2017, ACS ENERGY LETT, V2, P1539, DOI 10.1021/acsenergylett.7b00276; Hoke ET, 2015, CHEM SCI, V6, P613, DOI 10.1039/c4sc03141e; Hu YH, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201703057; Jiang Q, 2019, NAT PHOTONICS, V13, P460, DOI 10.1038/s41566-019-0398-2; Leijtens T, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201500963; Levine I, 2019, ACS ENERGY LETT, V4, P1150, DOI 10.1021/acsenergylett.9b00709; Matsui T, 2019, ADV MATER, V31, DOI 10.1002/adma.201806823; MICHELSON CE, 1985, APPL PHYS LETT, V47, P412, DOI 10.1063/1.96129; Musiienko A, 2019, ENERG ENVIRON SCI, V12, P1413, DOI 10.1039/c9ee00311h; Niu TQ, 2018, ENERG ENVIRON SCI, V11, P3358, DOI 10.1039/c8ee02542h; Park NG, 2015, MATER TODAY, V18, P65, DOI 10.1016/j.mattod.2014.07.007; Ran CX, 2018, CHEM SOC REV, V47, P4581, DOI 10.1039/c7cs00868f; Rao HS, 2017, CHEM COMMUN, V53, P5163, DOI 10.1039/c7cc02447a; Shao YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6784; Shi D, 2015, SCIENCE, V347, P519, DOI 10.1126/science.aaa2725; Steirer KX, 2016, ACS ENERGY LETT, V1, P360, DOI 10.1021/acsenergylett.6b00196; Sutter-Fella CM, 2017, ACS ENERGY LETT, V2, P709, DOI 10.1021/acsenergylett.6b00727; Tennyson EM, 2019, NAT REV MATER, V4, P573, DOI 10.1038/s41578-019-0125-0; Tress Wolfgang, 2015, Advanced Energy Materials, V5, DOI 10.1002/aenm.201400812; Tress W, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201400812; Walsh A, 2015, ANGEW CHEM INT EDIT, V54, P1791, DOI 10.1002/anie.201409740; Wang Q, 2014, ENERG ENVIRON SCI, V7, P2359, DOI 10.1039/c4ee00233d; Wetzelaer GJAH, 2015, ADV MATER, V27, P1837, DOI 10.1002/adma.201405372; Wu WQ, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav8925; Yang S, 2019, SCIENCE, V365, P473, DOI 10.1126/science.aax3294; Yang ZB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12513-x; Yin WJ, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4864778; Zhang SB, 1997, PHYS REV LETT, V78, P4059, DOI 10.1103/PhysRevLett.78.4059	40	384	389	87	750	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1352	+		10.1126/science.aba0893	http://dx.doi.org/10.1126/science.aba0893			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193323	Green Submitted			2022-12-28	WOS:000522167400047
J	Kar, P				Kar, Partha			Partha Kar: Covid-19-we must keep faith in our experts	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kar, Partha] Portsmouth Hosp NHS Trust, Portsmouth, Hants, England	Portsmouth Hospitals NHS Trust	Kar, P (corresponding author), Portsmouth Hosp NHS Trust, Portsmouth, Hants, England.	drparthakar@gmail.com	Kar, Partha/AAT-4839-2020						0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 19	2020	368								m1143	10.1136/bmj.m1143	http://dx.doi.org/10.1136/bmj.m1143			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DM	32193174	Bronze			2022-12-28	WOS:000523763400008
J	Madhusoodanan, J				Madhusoodanan, Jyoti			THE CELL'S SWEET SIDE EXPOSED	NATURE			English	Editorial Material																		Black AP, 2019, ANAL CHEM, V91, P8429, DOI 10.1021/acs.analchem.9b01445; De Leoz MLA, 2020, MOL CELL PROTEOMICS, V19, P11, DOI 10.1074/mcp.RA119.001677; Hong SL, 2019, ANGEW CHEM INT EDIT, V58, P14327, DOI 10.1002/anie.201907410; Kopec M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36622-7; Narimatsu Y, 2019, MOL CELL, V75, P394, DOI 10.1016/j.molcel.2019.05.017; Pilobello KT, 2005, CHEMBIOCHEM, V6, P985, DOI 10.1002/cbic.200400403; Srivastava J., 2020, PREPRINT, DOI [10.1101/2020.01.15.908491, DOI 10.1101/2020.01.15.908491]; Xu R, 2013, SCIENCE, V342, P1230, DOI 10.1126/science.1243761; Ye ZL, 2019, NAT METHODS, V16, P902, DOI 10.1038/s41592-019-0504-x	9	1	1	0	12	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 19	2020	579	7799					459	461		10.1038/d41586-020-00769-z	http://dx.doi.org/10.1038/d41586-020-00769-z			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MD2DD	32179859				2022-12-28	WOS:000543782900001
J	Dunn, A				Dunn, Andrew			In AF, DOACs were linked to lower risk for clinical fracture at 17 months compared with warfarin	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							THERAPY		[Dunn, Andrew] Icahn Mt Sinai Sch Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Dunn, A (corresponding author), Icahn Mt Sinai Sch Med, New York, NY 10029 USA.				Copenhagen University Hospital Herlev and Gentofte	Copenhagen University Hospital Herlev and Gentofte	Copenhagen University Hospital Herlev and Gentofte.	Eikelboom JW, 2013, NEW ENGL J MED, V369, P1206, DOI 10.1056/NEJMoa1300615; Fiordellisi W, 2019, J GEN INTERN MED, V34, P304, DOI 10.1007/s11606-018-4758-2; January CT, 2019, J AM COLL CARDIOL, V74, P104, DOI 10.1016/j.jacc.2019.01.011; Kearon C, 2016, CHEST, V149, P315, DOI 10.1016/j.chest.2015.11.026; Lopez-Lopez JA, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5058; Namba S, 2015, BBA CLIN, V4, P76, DOI 10.1016/j.bbacli.2015.08.002; Ordi-Ros J, 2019, ANN INTERN MED, V171, P685, DOI 10.7326/M19-0291	7	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC34	JC35		10.7326/ACPJ202003170-034	http://dx.doi.org/10.7326/ACPJ202003170-034			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176900				2022-12-28	WOS:000520170800021
J	Rimmer, A				Rimmer, Abi			Don't panic: five minutes with ... Kai Zacharowski	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1092	10.1136/bmj.m1092	http://dx.doi.org/10.1136/bmj.m1092			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184202	Bronze			2022-12-28	WOS:000523762400011
J	Vallabhajosyula, S; Ingram, C				Vallabhajosyula, Saraschandra; Ingram, Cory			In high-risk ICU patients, early palliative care consultation increased transition to DNR/DNI status	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Vallabhajosyula, Saraschandra; Ingram, Cory] Mayo Clin, Rochester, MN 55902 USA	Mayo Clinic	Vallabhajosyula, S (corresponding author), Mayo Clin, Rochester, MN 55902 USA.		Vallabhajosyula, Saraschandra/I-9707-2019	Vallabhajosyula, Saraschandra/0000-0002-1631-8238				Aslakson RA, 2014, CRIT CARE MED, V42, P2418, DOI 10.1097/CCM.0000000000000573; Kamal AH, 2017, AM J MED, V130, P113, DOI 10.1016/j.amjmed.2016.08.046; Vallabhajosyula S, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.011954	3	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					JC30	JC30		10.7326/ACPJ202003170-030	http://dx.doi.org/10.7326/ACPJ202003170-030			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176896				2022-12-28	WOS:000520170800013
J	Dong, L; Tian, JH; He, SM; Zhu, CC; Wang, J; Liu, C; Yang, J				Dong, Lan; Tian, Jinhua; He, Songming; Zhu, Chuchao; Wang, Jian; Liu, Chen; Yang, Jing			Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This case report describes birth of an infant with elevated anti-SARS-CoV-2 IgM antibodies and cytokine levels to a mother with polymerase chain reaction-confirmed coronavirus disease 2019 (COVID-19) despite no physical contact.	[Dong, Lan; Tian, Jinhua; He, Songming; Yang, Jing] Wuhan Univ, Dept Obstet & Gynecol, Renmin Hosp, 283 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China; [Zhu, Chuchao] Cent Command Theater PLA, Dept Obstet & Gynecol, Gen Hosp, Wuhan, Hubei, Peoples R China; [Wang, Jian; Liu, Chen] Army Med Univ, Dept Radiol, Affiliated Hosp 1, 30 Gao Tan Yan St, Chongqing 400038, Peoples R China	Wuhan University; Army Medical University	Yang, J (corresponding author), Wuhan Univ, Dept Obstet & Gynecol, Renmin Hosp, 283 Jiefang Rd, Wuhan 430060, Hubei, Peoples R China.; Liu, C (corresponding author), Army Med Univ, Dept Radiol, Affiliated Hosp 1, 30 Gao Tan Yan St, Chongqing 400038, Peoples R China.	liuchen@aifmri.com; 13507182023@163.com	liu, chen/AAE-4040-2020	liu, chen/0000-0001-5149-2496	Chongqing Key technology and application demonstration of medical imaging depth intelligent diagnostic platform [cstc2018jszx-cyztzxX0017]; National Key Research and Development Project [2018YFC1002804, 2016YFC1000600]; National Natural Science Foundation of China [81771618, 81801524]	Chongqing Key technology and application demonstration of medical imaging depth intelligent diagnostic platform; National Key Research and Development Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Chongqing Key technology and application demonstration of medical imaging depth intelligent diagnostic platform (cstc2018jszx-cyztzxX0017), the National Key Research and Development Project (2018YFC1002804, 2016YFC1000600), and the National Natural Science Foundation of China (No. 81771618 and No. 81801524).	Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Woo PCY, 2004, J CLIN MICROBIOL, V42, P2306, DOI 10.1128/JCM.42.5.2306-2309.2004; [徐万洲 Xu Wanzhou], 2020, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V43, P230	4	708	745	8	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1846	1848		10.1001/jama.2020.4621	http://dx.doi.org/10.1001/jama.2020.4621			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32215581	Bronze, Green Published			2022-12-28	WOS:000536221500027
J	Ranney, ML; Griffeth, V; Jha, AK				Ranney, Megan L.; Griffeth, Valerie; Jha, Ashish K.			Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								U.S. hospitals are already reporting shortages of key equipment needed to care for critically ill patients with Covid-19, including ventilators and personal protective equipment for medical staff. Adequate production and distribution of this equipment is crucial.	[Ranney, Megan L.] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA; [Griffeth, Valerie] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Jha, Ashish K.] Harvard Global Hlth Inst, Cambridge, MA USA	Brown University; Oregon Health & Science University	Ranney, ML (corresponding author), Brown Univ, Alpert Med Sch, Providence, RI 02912 USA.							Balmer C., 2020, REUTERS; Bolton J., 2020, ROOM IT HAPPENED WHI; Fink S., 2020, NEW YORK TIMES; Jacobs A, 2020, NY TIMES; Johns Hopkins Center for Health Security, 2020, VENT STOCKP AV US	5	1036	1047	13	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 30	2020	382	18							e41	10.1056/NEJMp2006141	http://dx.doi.org/10.1056/NEJMp2006141			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LL1YQ	32212516	Bronze			2022-12-28	WOS:000531351300002
J	Feero, WG; Wicklund, CA				Feero, W. Gregory; Wicklund, Catherine A.			Consumer Genomic Testing in 2020	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This Viewpoint discusses gaps between the growth of direct-to-consumer genomic testing and knowledge about how best to use the information, highlighting the absence of diversity in genetic databases, the scarcity of accompanying genetic counseling, and data security and privacy concerns.	[Feero, W. Gregory] Maine Dartmouth Family Med Residency, 4 Sheridan Dr,Ste 2, Fairfield, ME 04937 USA; [Wicklund, Catherine A.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Feero, WG (corresponding author), Maine Dartmouth Family Med Residency, 4 Sheridan Dr,Ste 2, Fairfield, ME 04937 USA.	wfeero@mainegeneral.org						Allyse MA, 2018, MAYO CLIN PROC, V93, P113, DOI 10.1016/j.mayocp.2017.11.001; Caswell-Jin JL, 2018, GENET MED, V20, P234, DOI 10.1038/gim.2017.96; Gill J, 2018, JAMA-J AM MED ASSOC, V319, P2377, DOI 10.1001/jama.2018.5330; Hendricks-Sturrup RM, 2019, JAMA-J AM MED ASSOC, V321, P1869, DOI 10.1001/jama.2019.3384; Murphy Heather, 2019, NY TIMES; National Academies of Sciences Engineering and Medicine, 2020, EXPL CURR LANDSC CON; Phillips KA, 2019, JAMA-J AM MED ASSOC, V321, P2403, DOI 10.1001/jama.2019.5670; Regalado A., 2019, MIT TECHNOL REV; US Government Accountability Office, 2010, DIR CONS GEN TESTS M	9	5	5	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 21	2020	323	15					1445	1446		10.1001/jama.2020.3525	http://dx.doi.org/10.1001/jama.2020.3525			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LJ1ZH	32191262				2022-12-28	WOS:000529969700010
J	Curtis, C				Curtis, Christina			Quantifying mutations in healthy blood	SCIENCE			English	Editorial Material							CLASSIFICATION; PROGNOSIS		[Curtis, Christina] Stanford Univ, Sch Med, Dept Med, Lorry Lokey Stem Cell Res Bldg, Stanford, CA 94305 USA; [Curtis, Christina] Stanford Univ, Sch Med, Dept Genet, Lorry Lokey Stem Cell Res Bldg, Stanford, CA 94305 USA	Stanford University; Stanford University	Curtis, C (corresponding author), Stanford Univ, Sch Med, Dept Med, Lorry Lokey Stem Cell Res Bldg, Stanford, CA 94305 USA.; Curtis, C (corresponding author), Stanford Univ, Sch Med, Dept Genet, Lorry Lokey Stem Cell Res Bldg, Stanford, CA 94305 USA.	cncurtis@stanford.edu						Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Bowman RL, 2018, CELL STEM CELL, V22, P157, DOI 10.1016/j.stem.2018.01.011; Desai P, 2018, NAT MED, V24, P1015, DOI 10.1038/s41591-018-0081-z; Grinfeld J, 2018, NEW ENGL J MED, V379, P1416, DOI 10.1056/NEJMoa1716614; Gruber M, 2019, NATURE, V570, P474, DOI 10.1038/s41586-019-1252-x; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Srivastava S, 2018, TRENDS CANCER, V4, P513, DOI 10.1016/j.trecan.2018.06.003; Steensma DP, 2020, EXP HEMATOL, V83, P48, DOI 10.1016/j.exphem.2019.12.001; Sun RP, 2017, NAT GENET, V49, P1015, DOI 10.1038/ng.3891; Tsao JL, 2000, P NATL ACAD SCI USA, V97, P1236, DOI 10.1073/pnas.97.3.1236; Watson CJ, 2020, SCIENCE, V367, P1449, DOI 10.1126/science.aay9333; Williams MJ, 2018, NAT GENET, V50, P895, DOI 10.1038/s41588-018-0128-6; Yizhak K, 2019, SCIENCE, V364, P970, DOI 10.1126/science.aaw0726	15	3	3	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1426	1427		10.1126/science.aba9891	http://dx.doi.org/10.1126/science.aba9891			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217714				2022-12-28	WOS:000523251600016
J	Watson, CJ; Papula, AL; Poon, GYP; Wong, WH; Young, AL; Druley, TE; Fisher, DS; Blundell, JR				Watson, Caroline J.; Papula, A. L.; Poon, Gladys Y. P.; Wong, Wing H.; Young, Andrew L.; Druley, Todd E.; Fisher, Daniel S.; Blundell, Jamie R.			The evolutionary dynamics and fitness landscape of clonal hematopoiesis	SCIENCE			English	Article							SOMATIC MUTATIONS; STEM-CELLS; MYELODYSPLASTIC SYNDROME; MYELOID-LEUKEMIA; SELECTION; CANCER; RISK; IDENTIFICATION; PATTERNS; DNMT3A	Somatic mutations acquired in healthy tissues as we age are major determinants of cancer risk. Whether variants confer a fitness advantage or rise to detectable frequencies by chance remains largely unknown. Blood sequencing data from similar to 50,000 individuals reveal how mutation, genetic drift, and fitness shape the genetic diversity of healthy blood (clonal hematopoiesis). We show that positive selection, not drift, is the major force shaping clonal hematopoiesis, provide bounds on the number of hematopoietic stem cells, and quantify the fitness advantages of key pathogenic variants, at single-nucleotide resolution, as well as the distribution of fitness effects (fitness landscape) within commonly mutated driver genes. These data are consistent with clonal hematopoiesis being driven by a continuing risk of mutations and clonal expansions that become increasingly detectable with age.	[Watson, Caroline J.; Poon, Gladys Y. P.; Blundell, Jamie R.] Univ Cambridge, Dept Oncol, Cambridge, England; [Watson, Caroline J.; Poon, Gladys Y. P.; Blundell, Jamie R.] Univ Cambridge, CRUK Cambridge Canc Ctr, Early Detect Programme, Cambridge, England; [Papula, A. L.; Fisher, Daniel S.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Wong, Wing H.; Young, Andrew L.; Druley, Todd E.] Washington Univ, Sch Med, Dept Pediat, Div Hematol & Oncol, St Louis, MO 63110 USA	University of Cambridge; University of Cambridge; Stanford University; Washington University (WUSTL)	Watson, CJ; Blundell, JR (corresponding author), Univ Cambridge, Dept Oncol, Cambridge, England.; Watson, CJ; Blundell, JR (corresponding author), Univ Cambridge, CRUK Cambridge Canc Ctr, Early Detect Programme, Cambridge, England.	cw672@cam.ac.uk; jrb75@cam.ac.uk		Wong, Wing Hing/0000-0003-2494-1721; Papula, Alana/0000-0002-4835-9050; Blundell, Jamie Rees/0000-0001-9747-7363; Poon, Gladys/0000-0001-6788-5163; Druley, Todd/0000-0002-3245-7561; Young, Andrew/0000-0001-7698-3267	CRUK Cambridge Centre Clinical Research Fellowship; National Science Foundation GRFP; CRUK Cambridge Centre Early Detection Programme; Bei Shan Tang Foundation; NIH/NCI [1R01CA211711]; Stand Up to Cancer Foundation; National Science Foundation [PHY-1545840]; UKRI Future Leaders Fellowship; UKRI [MR/S031782/1] Funding Source: UKRI	CRUK Cambridge Centre Clinical Research Fellowship; National Science Foundation GRFP(National Science Foundation (NSF)); CRUK Cambridge Centre Early Detection Programme; Bei Shan Tang Foundation; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stand Up to Cancer Foundation; National Science Foundation(National Science Foundation (NSF)); UKRI Future Leaders Fellowship(UK Research & Innovation (UKRI)); UKRI	C.J.W. is funded by a CRUK Cambridge Centre Clinical Research Fellowship. A.L.P. is supported by the National Science Foundation GRFP. G.Y.P.P. is funded by the CRUK Cambridge Centre Early Detection Programme and the Bei Shan Tang Foundation. W.H.W., A.L.Y., and T.E.D. are supported by NIH/NCI 1R01CA211711. D.S.F. and J.R.B. are supported by the Stand Up to Cancer Foundation and the National Science Foundation through PHY-1545840. J.R.B. is funded by the CRUK Cambridge Centre Early Detection Programme and by a UKRI Future Leaders Fellowship.	Abelson S, 2018, NATURE, V559, P400, DOI 10.1038/s41586-018-0317-6; Acuna-Hidalgo R, 2017, AM J HUM GENET, V101, P50, DOI 10.1016/j.ajhg.2017.05.013; Ashcroft P, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005803; Blokzijl F, 2016, NATURE, V538, P260, DOI 10.1038/nature19768; Blundell JR, 2019, NAT ECOL EVOL, V3, P293, DOI 10.1038/s41559-018-0758-1; Boettcher S, 2019, SCIENCE, V365, P599, DOI 10.1126/science.aax3649; Bolton K. L., 2019, BIORXIV 848739; Bolton K.L., 2019, ONCOLOGIC THERAPY SH, DOI [10.1101/848739, DOI 10.1101/848739]; Bolton KL, 2019, J CLIN ONCOL, V37, P7, DOI 10.1200/JCO.18.00331; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chan SM, 2013, INT J HEMATOL, V98, P648, DOI 10.1007/s12185-013-1407-8; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Coombs CC, 2017, CELL STEM CELL, V21, P374, DOI 10.1016/j.stem.2017.07.010; Corces-Zimmerman MR, 2014, LEUKEMIA, V28, P2276, DOI 10.1038/leu.2014.211; Desai MM, 2007, GENETICS, V176, P1759, DOI 10.1534/genetics.106.067678; Desai P, 2018, NAT MED, V24, P1015, DOI 10.1038/s41591-018-0081-z; DOANE DP, 1976, AM STAT, V30, P181, DOI 10.2307/2683757; Genovese G, 2014, NEW ENGL J MED, V371, P2477, DOI 10.1056/NEJMoa1409405; Hsu JI, 2018, CELL STEM CELL, V23, P700, DOI 10.1016/j.stem.2018.10.004; Hwang SM, 2018, LEUKEMIA RES, V71, P92, DOI 10.1016/j.leukres.2018.07.007; Jaiswal S, 2017, NEW ENGL J MED, V377, P111, DOI 10.1056/NEJMoa1701719; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Jan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004315; Jeong M, 2018, CELL REP, V23, P1, DOI 10.1016/j.celrep.2018.03.025; Jonason AS, 1996, P NATL ACAD SCI USA, V93, P14025, DOI 10.1073/pnas.93.24.14025; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Klein AM, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021910; Lee-Six H, 2019, NATURE, V574, P532, DOI 10.1038/s41586-019-1672-7; Lee-Six H, 2018, NATURE, V561, P473, DOI 10.1038/s41586-018-0497-0; Lindsley RC, 2017, NEW ENGL J MED, V376, P536, DOI 10.1056/NEJMoa1611604; Liu J, 2019, ANN ONCOL, V30, P464, DOI 10.1093/annonc/mdy513; Loh PR, 2018, NATURE, V559, P350, DOI 10.1038/s41586-018-0321-x; Luria SE, 1943, GENETICS, V28, P491; Martincorena I, 2018, SCIENCE, V362, P911, DOI 10.1126/science.aau3879; Martincorena I, 2017, CELL, V171, P1029, DOI 10.1016/j.cell.2017.09.042; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; McKerrell T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac4428; McKerrell T, 2015, CELL REP, V10, P1239, DOI 10.1016/j.celrep.2015.02.005; Meisel M, 2018, NATURE, V557, P580, DOI 10.1038/s41586-018-0125-z; Murai K, 2018, CELL STEM CELL, V23, P687, DOI 10.1016/j.stem.2018.08.017; Nielsen C, 2014, HAEMATOLOGICA, V99, P1448, DOI 10.3324/haematol.2014.107631; Osorio FG, 2018, CELL REP, V25, P2308, DOI 10.1016/j.celrep.2018.11.014; Page` s H., 2019, BIOSTRINGS EFFICIENT; Robertson NA, 2019, CURR BIOL, V29, pR786, DOI 10.1016/j.cub.2019.07.011; Rozhok AI, 2015, P NATL ACAD SCI USA, V112, P8914, DOI 10.1073/pnas.1501713112; SHLUSH LI, 2013, BLOOD, V122; Shlush LI, 2017, NATURE, V547, P104, DOI 10.1038/nature22993; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Simons BD, 2016, P NATL ACAD SCI USA, V113, P128, DOI 10.1073/pnas.1516123113; Steensma DP, 2015, BLOOD, V126, P9, DOI 10.1182/blood-2015-03-631747; Swanton C, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.12003; Takahashi K, 2017, LANCET ONCOL, V18, P100, DOI 10.1016/S1470-2045(16)30626-X; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Venkataram S, 2016, CELL, V166, P1585, DOI 10.1016/j.cell.2016.08.002; Williams MJ, 2018, NAT GENET, V50, P895, DOI 10.1038/s41588-018-0128-6; Williams MJ, 2016, NAT GENET, V48, P238, DOI 10.1038/ng.3489; Wong TN, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02858-0; Wong TN, 2015, NATURE, V518, P552, DOI 10.1038/nature13968; Xie MC, 2014, NAT MED, V20, P1472, DOI 10.1038/nm.3733; Yoda A, 2014, BLOOD, V124; Yokoyama A, 2019, NATURE, V565, P312, DOI 10.1038/s41586-018-0811-x; Yoshizato T, 2015, NEW ENGL J MED, V373, P35, DOI 10.1056/NEJMoa1414799; Young AL, 2019, HAEMATOLOGICA, V104, P2410, DOI 10.3324/haematol.2018.215269; Young AL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12484; Zink F, 2017, BLOOD, V130, P742, DOI 10.1182/blood-2017-02-769869; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	67	155	155	6	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1449	+		10.1126/science.aay9333	http://dx.doi.org/10.1126/science.aay9333			72	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ4RP	32217721				2022-12-28	WOS:000523251600030
J	Llewellyn, S				Llewellyn, Sue			MEDICINE AND THE MEDIA Covid-19: how to be careful with trust and expertise on social media	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												suellewellyn2020@gmail.com						[Anonymous], 2020, BBC NEWS; Gaynor G., 2020, IT ONLY TAKES 20 SEC	2	51	52	4	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m1160	10.1136/bmj.m1160	http://dx.doi.org/10.1136/bmj.m1160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213480	Bronze			2022-12-28	WOS:000523764500006
J	Jones, H				Jones, Helen			Life as a doctor in the Royal Navy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m749	10.1136/bmj.m749	http://dx.doi.org/10.1136/bmj.m749			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205308	Bronze			2022-12-28	WOS:000523764100002
J	Chen, C; Pfennig, KS				Chen, Catherine; Pfennig, Karin S.			Female toads engaging in adaptive hybridization prefer high-quality heterospecifics as mates	SCIENCE			English	Article							CHARACTER DISPLACEMENT; SEXUAL SELECTION; INTROGRESSION; CHOICE; ECOLOGY	Hybridization-interbreeding between species-is generally thought to occur randomly between members of two species. Contrary to expectation, female plains spadefoot toads (Spea bombifrons) can increase their evolutionary fitness by preferentially mating with high-quality males of another species, the Mexican spadefoot toad (Spea multiplicata). Aspects of Mexican spadefoot males' mating calls predict their hybrid offspring's fitness, and plains spadefoot females prefer Mexican spadefoot males on the basis of these attributes, but only in populations and ecological conditions where hybridization is adaptive. By selecting fitness-enhancing mates of another species, females increase hybridization's benefits and exert sexual selection across species. Nonrandom mating between species can thereby increase the potential for adaptive gene flow between species so that adaptive introgression is not simply happenstance.	[Chen, Catherine; Pfennig, Karin S.] Univ N Carolina, Dept Biol, Campus Box 3280,Coker Hall, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Chen, C; Pfennig, KS (corresponding author), Univ N Carolina, Dept Biol, Campus Box 3280,Coker Hall, Chapel Hill, NC 27599 USA.	catherine.chen@unc.edu; kpfennig@unc.edu		Chen, Catherine/0000-0002-8877-9359	U.S. NSF [IOS-1555520]; NSF GRFP [DGE-1650116]; Society for the Study of Evolution; Sigma Xi; Southwestern Association of Naturalists	U.S. NSF(National Science Foundation (NSF)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); Society for the Study of Evolution; Sigma Xi; Southwestern Association of Naturalists	A grant from the U.S. NSF (IOS-1555520) supported this work; C.C. was additionally supported by the NSF GRFP (DGE-1650116) and grants from the Society for the Study of Evolution, Sigma Xi, and the Southwestern Association of Naturalists.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Arnold ML, 2017, TRENDS ECOL EVOL, V32, P601, DOI 10.1016/j.tree.2017.05.007; Audacity Team, 2018, AUD R FREE AUD ED RE; Barton K., 2020, MUMIN MULTIMODEL INF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bragg AN, 1965, GNOMES NIGHT SPADEFO; BURNHAM K.P., 2002, MODEL SELECTION MULT, V2nd, DOI DOI 10.1007/B97636; Center for Conservation Bioacoustics, 2014, RAV PRO INT SOUND AN; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hamilton JA, 2016, CONSERV BIOL, V30, P33, DOI 10.1111/cobi.12574; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Jones MR, 2018, SCIENCE, V360, P1355, DOI 10.1126/science.aar5273; Kelly PW, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0179; Kovach RP, 2016, CONSERV BIOL, V30, P428, DOI 10.1111/cobi.12678; Lamichhaney S, 2018, SCIENCE, V359, P224, DOI 10.1126/science.aao4593; Lesna I, 1999, NATURE, V401, P581, DOI 10.1038/44125; OBrien R., 2018, THESIS, DOI [10.17615/ckjn-ed89, DOI 10.17615/CKJN-ED89]; Oziolor EM, 2019, SCIENCE, V364, P455, DOI 10.1126/science.aav4155; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; PFENNIG DW, 1992, EVOLUTION, V46, P1408, DOI 10.1111/j.1558-5646.1992.tb01133.x; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; Pfennig KS, 2019, SCIENCE, V364, P433, DOI 10.1126/science.aax3713; Pfennig KS, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1329; Pfennig KS, 2012, MOL ECOL RESOUR, V12, P909, DOI 10.1111/j.1755-0998.2012.03150.x; Pfennig KS, 2000, BEHAV ECOL, V11, P220, DOI 10.1093/beheco/11.2.220; Pfennig KS, 2005, EVOLUTION, V59, P2200; Pfennig KS, 2002, EVOLUTION, V56, P1840; Pierce AA, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0007; R Development Core Team, 2009, R LANG ENV STAT COMP; Rice AM, 2008, J EVOLUTION BIOL, V21, P696, DOI 10.1111/j.1420-9101.2008.01518.x; Rosenthal GG, 2013, J EVOLUTION BIOL, V26, P252, DOI 10.1111/jeb.12004; Rosenthal G.G., 2017, MATE CHOICE EVOLUTIO, DOI DOI 10.2307/J.CTT1VWMHB0; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; RYAN MJ, 1987, SCIENCE, V236, P595, DOI 10.1126/science.236.4801.595; SULLIVAN BK, 1985, SOUTHWEST NAT, V30, P349, DOI 10.2307/3671266; Taylor SA, 2019, NAT ECOL EVOL, V3, P170, DOI 10.1038/s41559-018-0777-y; Veen T, 2001, NATURE, V411, P45, DOI 10.1038/35075000; Zeng C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096637; Zuur Alain F., 2009, P1	40	13	14	2	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1377	+		10.1126/science.aaz5109	http://dx.doi.org/10.1126/science.aaz5109			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX9AK	32193328				2022-12-28	WOS:000522167400052
J	Duan, QH; Liu, MCJ; Kita, D; Jordan, SS; Yeh, FLJ; Yvon, R; Carpenter, H; Federico, AN; Garcia-Valencia, LE; Eyles, SJ; Wang, CS; Wu, HM; Cheung, AY				Duan, Qiaohong; Liu, Ming-Che James; Kita, Daniel; Jordan, Samuel S.; Yeh, Fang-Ling Jessica; Yvon, Robert; Carpenter, Hunter; Federico, Anthony N.; Garcia-Valencia, Liliana E.; Eyles, Stephen J.; Wang, Co-Shine; Wu, Hen-Ming; Cheung, Alice Y.			FERONIA controls pectin- and nitric oxide-mediated male-female interaction	NATURE			English	Article							POLLEN-TUBE GROWTH; CELL-WALL; ARABIDOPSIS-THALIANA; IDENTIFICATION; HOMEOSTASIS; GUIDANCE; FUSION	Species that propagate by sexual reproduction actively guard against the fertilization of an egg by multiple sperm (polyspermy). Flowering plants rely on pollen tubes to transport their immotile sperm to fertilize the female gametophytes inside ovules. In Arabidopsis, pollen tubes are guided by cysteine-rich chemoattractants to target the female gametophyte(1,2). The FERONIA receptor kinase has a dual role in ensuring sperm delivery and blocking polyspermy(3). It has previously been reported that FERONIA generates a female gametophyte environment that is required for sperm release(4). Here we show that FERONIA controls several functionally linked conditions to prevent the penetration of female gametophytes by multiple pollen tubes in Arabidopsis. We demonstrate that FERONIA is crucial for maintaining de-esterified pectin at the filiform apparatus, a region of the cell wall at the entrance to the female gametophyte. Pollen tube arrival at the ovule triggers the accumulation of nitric oxide at the filiform apparatus in a process that is dependent on FERONIA and mediated by de-esterified pectin. Nitric oxide nitrosates both precursor and mature forms of the chemoattractant LURE1(1), respectively blocking its secretion and interaction with its receptor, to suppress pollen tube attraction. Our results elucidate a mechanism controlled by FERONIA in which the arrival of the first pollen tube alters ovular conditions to disengage pollen tube attraction and prevent the approach and penetration of the female gametophyte by late-arriving pollen tubes, thus averting polyspermy. FERONIA prevents polyspermy in Arabidopsis by enabling pectin-stimulated nitric oxide accumulation at the filiform apparatus after the first pollen tube arrives, which disengages LURE1 chemoattraction to prevent late-arriving pollen tubes from entering the ovule.	[Duan, Qiaohong; Liu, Ming-Che James; Kita, Daniel; Jordan, Samuel S.; Yeh, Fang-Ling Jessica; Yvon, Robert; Carpenter, Hunter; Federico, Anthony N.; Garcia-Valencia, Liliana E.; Eyles, Stephen J.; Wu, Hen-Ming; Cheung, Alice Y.] Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA; [Duan, Qiaohong] Shandong Agr Univ, Coll Hort Sci & Engn, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Liu, Ming-Che James; Wang, Co-Shine] Natl Chung Hsing Univ, Grad Inst Biotechnol, Taichung, Taiwan; [Kita, Daniel; Yvon, Robert; Carpenter, Hunter; Wu, Hen-Ming; Cheung, Alice Y.] Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA; [Eyles, Stephen J.; Cheung, Alice Y.] Univ Massachusetts, Inst Appl Life Sci, Mass Spectrometry Ctr, Amherst, MA 01003 USA; [Cheung, Alice Y.] Univ Massachusetts, Plant Biol Grad Program, Amherst, MA 01003 USA; [Kita, Daniel] Alex Pharmaceut Inc, New Haven, CT USA; [Federico, Anthony N.] Boston Univ, Bioinformat Dept, Boston, MA 02215 USA	University of Massachusetts System; University of Massachusetts Amherst; Shandong Agricultural University; National Chung Hsing University; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Boston University	Wu, HM; Cheung, AY (corresponding author), Univ Massachusetts, Dept Biochem & Mol Biol, Amherst, MA 01003 USA.; Wu, HM; Cheung, AY (corresponding author), Univ Massachusetts, Mol & Cellular Biol Program, Amherst, MA 01003 USA.; Cheung, AY (corresponding author), Univ Massachusetts, Inst Appl Life Sci, Mass Spectrometry Ctr, Amherst, MA 01003 USA.; Cheung, AY (corresponding author), Univ Massachusetts, Plant Biol Grad Program, Amherst, MA 01003 USA.	hmwu@biochem.umass.edu; acheung@biochem.umass.edu	Liu, Ming-Che/AAJ-3378-2020	YEH, FANGLING/0000-0003-4433-3870; Eyles, Stephen/0000-0003-0451-2903; Garcia-Valencia, Liliana E./0000-0002-7528-7697; Duan, Qiaohong/0000-0001-9016-8904	Ministry of Science and Technology Overseas Project, 2013 Graduate Student Study Abroad Program; Estancias Posdoctorales en el Extranjero, Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional 2018; NSF [IOS-1147165, IOS-1146941, IOS-1645854, MCB-1715764]; National Institutes of Health [S10OD010645]; NIFA/USDA, the Center for Agriculture, Food and the Environment [MAS00525]; Massachusetts Life Science Center	Ministry of Science and Technology Overseas Project, 2013 Graduate Student Study Abroad Program; Estancias Posdoctorales en el Extranjero, Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional 2018; NSF(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIFA/USDA, the Center for Agriculture, Food and the Environment; Massachusetts Life Science Center	We thank G. Drews for DD2p::DD2 (AtLURE1)-GFP seeds; M. Johnson for hap2/+ seeds; B. McClure for LAT52::tdTomato transformed Arabidopsis seeds; H. Hofte for 35S:PMEI5 seeds; a large number of undergraduates who helped with plant growth and maintenance over many years, and K. McNamara and T. Lichoulas, in particular, for contributing to protein purifications; P. Huesgen and R. Tomaino for advice, and the Harvard Medical School Talpin mass spectrometry facility for service; and Y.-j. Zou for the blue-dot assay shown in Extended Data Fig. 1a. M.-C.J.L. was partially supported by the Ministry of Science and Technology Overseas Project, 2013 Graduate Student Study Abroad Program; and L.E.G.V. was partially supported by a fellowship from Estancias Posdoctorales en el Extranjero, Vinculadas a la Consolidacion de Grupos de Investigacion y Fortalecimiento del Posgrado Nacional 2018. This work was supported by grants from the NSF (IOS-1147165, -1146941, -1645854 and MCB-1715764 to A.Y.C. and H.-M.W.). Mass spectrometry data were partially obtained at the University of Massachusetts Mass Spectrometry Center, a facility supported by the National Institutes of Health (S10OD010645); the plant growth facility was partially supported by NIFA/USDA, the Center for Agriculture, Food and the Environment, under project number MAS00525. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, USDA or NIFA. Confocal microscopy was performed in the Light Microscopy Facility and Nikon Center of Excellence at the Institute for Applied Life Sciences, University of Massachusetts with support from the Massachusetts Life Science Center.	Beale KM, 2012, CURR BIOL, V22, P1090, DOI 10.1016/j.cub.2012.04.041; Besson-Bard A, 2008, ANNU REV PLANT BIOL, V59, P21, DOI 10.1146/annurev.arplant.59.032607.092830; Boavida LC, 2011, PLANT PHYSIOL, V155, P2066, DOI 10.1104/pp.110.169813; Chebli Y, 2012, PLANT PHYSIOL, V160, P1940, DOI 10.1104/pp.112.199729; CHEUNG AY, 1995, CELL, V82, P383, DOI 10.1016/0092-8674(95)90427-1; Chormova D, 2014, PLANT J, V77, P534, DOI 10.1111/tpj.12403; Clausen MH, 2003, CARBOHYD RES, V338, P1797, DOI 10.1016/S0008-6215(03)00272-6; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Domingos P, 2015, MOL PLANT, V8, P506, DOI 10.1016/j.molp.2014.12.010; Dresselhaus T, 2013, MOL PLANT, V6, P1018, DOI 10.1093/mp/sst061; Duan QH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4129; Duan QH, 2010, P NATL ACAD SCI USA, V107, P17821, DOI 10.1073/pnas.1005366107; Escobar-Restrepo JM, 2007, SCIENCE, V317, P656, DOI 10.1126/science.1143562; Feng W, 2018, CURR BIOL, V28, P666, DOI 10.1016/j.cub.2018.01.023; Guo FQ, 2003, SCIENCE, V302, P100, DOI 10.1126/science.1086770; Higashiyama T, 2017, PLANT PHYSIOL, V173, P112, DOI 10.1104/pp.16.01571; Hou WC, 1999, BOT BULL ACAD SINICA, V40, P115; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Huang YC, 2017, PLANT PHYSIOL, V174, P748, DOI 10.1104/pp.17.00335; Ischebeck T, 2008, PLANT CELL, V20, P3312, DOI 10.1105/tpc.108.059568; Kasahara RD, 2012, CURR BIOL, V22, P1084, DOI 10.1016/j.cub.2012.03.069; Khule N. R., 2012, Der Pharmacia Lettre, V4, P558; Leroux C, 2015, PLANT PHYSIOL, V167, P367, DOI 10.1104/pp.114.250928; Li C, 2016, PLANT PHYSIOL, V171, P2379, DOI 10.1104/pp.16.00667; Maruyama D, 2015, CELL, V161, P907, DOI 10.1016/j.cell.2015.03.018; Moreau M, 2008, J BIOL CHEM, V283, P32957, DOI 10.1074/jbc.M804838200; Okuda S, 2009, NATURE, V458, P357, DOI 10.1038/nature07882; Pattathil S, 2010, PLANT PHYSIOL, V153, P514, DOI 10.1104/pp.109.151985; Peaucelle A, 2008, CURR BIOL, V18, P1943, DOI 10.1016/j.cub.2008.10.065; Peaucelle A, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00121; Planchet E, 2006, J EXP BOT, V57, P3043, DOI 10.1093/jxb/erl070; Pleskot R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00054; Prado AM, 2004, DEVELOPMENT, V131, P2707, DOI 10.1242/dev.01153; Punwani JA, 2007, PLANT CELL, V19, P2557, DOI 10.1105/tpc.107.052076; Qu Z, 2014, J PROTEOME RES, V13, P3200, DOI 10.1021/pr401179v; Rasul S, 2012, PLANT CELL ENVIRON, V35, P1483, DOI 10.1111/j.1365-3040.2012.02505.x; Sanz L, 2014, PLANT PHYSIOL, V166, P1972, DOI 10.1104/pp.114.247445; Schiott M, 2004, P NATL ACAD SCI USA, V101, P9502, DOI 10.1073/pnas.0401542101; Sheng XY, 2012, BIOL TRACE ELEM RES, V146, P86, DOI 10.1007/s12011-011-9212-9; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Takeuchi H, 2016, NATURE, V531, P245, DOI 10.1038/nature17413; Takeuchi H, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001449; Terrile MC, 2012, PLANT J, V70, P492, DOI 10.1111/j.1365-313X.2011.04885.x; WILKINSON JQ, 1993, MOL GEN GENET, V239, P289, DOI 10.1007/BF00281630; Wolf S, 2012, CURR BIOL, V22, P1732, DOI 10.1016/j.cub.2012.07.036; Wu H, 2001, CELL MOL LIFE SCI, V58, P1418, DOI 10.1007/PL00000785; Zhang XX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01323-8; Zhong S, 2019, SCIENCE, V364, P851, DOI 10.1126/science.aau9564	48	69	76	23	172	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					561	+		10.1038/s41586-020-2106-2	http://dx.doi.org/10.1038/s41586-020-2106-2		MAR 2020	25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KX4BT	32214247				2022-12-28	WOS:000520406700007
J	Bush, LM; Kaye, D				Bush, Larry M.; Kaye, Donald			Blood Culture Results Before and After Antimicrobial Administration	ANNALS OF INTERNAL MEDICINE			English	Letter							SEPSIS		[Bush, Larry M.] Florida Atlantic Univ, Palm Beach County, FL 33431 USA; [Kaye, Donald] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Drexel University	Bush, LM (corresponding author), Florida Atlantic Univ, Palm Beach County, FL 33431 USA.							Cheng MP, 2019, ANN INTERN MED, V171, P547, DOI 10.7326/M19-1696; Levy MM, 2018, CRIT CARE MED, V46, P997, DOI 10.1097/CCM.0000000000003119; Peltan ID, 2019, CHEST, V155, P938, DOI 10.1016/j.chest.2019.02.008; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	4	0	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 17	2020	172	6					439	440		10.7326/L19-0795	http://dx.doi.org/10.7326/L19-0795			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KV1FY	32176904				2022-12-28	WOS:000520170800037
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK starts social distancing after new model points to 260 000 potential deaths	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ferguson N. M., 2020, REPORT 9 IMPACT NONP	1	52	54	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1089	10.1136/bmj.m1089	http://dx.doi.org/10.1136/bmj.m1089			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184205	Bronze			2022-12-28	WOS:000523762400010
J	Dorsey, ER; Topol, EJ				Dorsey, E. Ray; Topol, Eric J.			Digital medicine Telemedicine 2020 and the next decade	LANCET			English	Editorial Material									[Dorsey, E. Ray] Univ Rochester, Ctr Hlth Technol, Med Ctr, Rochester, NY 14642 USA; [Dorsey, E. Ray] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA; [Topol, Eric J.] Scripps Res Translat Inst, La Jolla, CA USA; [Topol, Eric J.] Scripps Res Inst, La Jolla, CA 92037 USA	University of Rochester; University of Rochester; Scripps Research Institute	Dorsey, ER (corresponding author), Univ Rochester, Ctr Hlth Technol, Med Ctr, Rochester, NY 14642 USA.; Dorsey, ER (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14642 USA.	ray.dorsey@chet.rochester.edu		Topol, Eric/0000-0002-1478-4729	NCATS NIH HHS [UL1 TR001114] Funding Source: Medline; NIH HHS [5P50NS108676-02] Funding Source: Medline	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)			0	100	101	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					859	859						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KU9DZ	32171399				2022-12-28	WOS:000520024900019
J	Mahase, E				Mahase, Elisabeth			Covid-19: UK holds off closing schools and restricts testing to people in hospital	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m959; Sridhar D, 2020, TWITTER	2	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m1060	10.1136/bmj.m1060	http://dx.doi.org/10.1136/bmj.m1060			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32169967	Bronze			2022-12-28	WOS:000520014600011
J	Pompeii, LA; Kraft, CS; Brownsword, EA; Lane, MA; Benavides, E; Rios, J; Radonovich, LJ				Pompeii, Lisa A.; Kraft, Colleen S.; Brownsword, Erik A.; Lane, Morgan A.; Benavides, Elisa; Rios, Janelle; Radonovich, Lewis J., Jr.			Training and Fit Testing of Health Care Personnel for Reusable Elastomeric Half-Mask Respirators Compared With Disposable N95 Respirators	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PROTECTIVE EQUIPMENT	This study examines the feasibility of rapidly training and fit testing health care workers to use elastomeric half-mask respirators (EHMRs), widely used in construction and manufacturing, as an alternative to N95 respirators during periods of shortage.	[Pompeii, Lisa A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Kraft, Colleen S.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Brownsword, Erik A.; Lane, Morgan A.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA; [Benavides, Elisa] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Rios, Janelle] Univ Texas Hlth Sci Ctr Houston, Dept Epidemiol Genet & Environm Sci, Houston, TX 77030 USA; [Radonovich, Lewis J., Jr.] Ctr Dis Control & Prevent, Natl Inst Occupat Safety & Hlth, Pittsburgh, PA USA	Baylor College of Medicine; Emory University; Emory University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH)	Pompeii, LA (corresponding author), Baylor Coll Med, Ctr Epidemiol & Populat Hlth, Dept Pediat, 1 Baylor Plaza,BCM 622, Houston, TX 77030 USA.	lisa.pompeii@bcm.edu	Rios, Janelle/GWV-5243-2022; Kraft, Colleen S/M-2347-2013	Kraft, Colleen S/0000-0003-1757-8477; Lane, Morgan/0000-0002-7744-0851	Centers for Disease Control and Prevention's National Personal Protective Technology Laboratory [75D30118C02646, 75D30118C02645]	Centers for Disease Control and Prevention's National Personal Protective Technology Laboratory(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by the Centers for Disease Control and Prevention's National Personal Protective Technology Laboratory (contract numbers 75D30118C02646 and 75D30118C02645).	Centers for Disease Control and Prevention, HEALTHC SUPPL PERS P; Hines SE, 2019, AM J INFECT CONTROL, V47, P648, DOI 10.1016/j.ajic.2018.11.021; Murray M, 2010, INFECT CONT HOSP EP, V31, P1011, DOI 10.1086/656564; Occupational Safety and Health Administration, 1910134 OCC SAF HLTH; Patel A, 2017, HEALTH SECUR, V15, P244, DOI 10.1089/hs.2016.0129; Wizner K, 2016, WORKPLACE HEALTH SAF, V64, P359, DOI 10.1177/2165079916657108	6	34	35	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1849	1852		10.1001/jama.2020.4806	http://dx.doi.org/10.1001/jama.2020.4806			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32211889	Green Published, Bronze			2022-12-28	WOS:000536221500029
J	Shen, CG; Wang, ZQ; Zhao, F; Yang, Y; Li, JX; Yuan, J; Wang, FX; Li, DL; Yang, MH; Xing, L; Wei, JL; Xiao, HX; Yang, Y; Qu, JX; Qing, L; Chen, L; Xu, ZX; Peng, L; Li, YJ; Zheng, HX; Chen, F; Huang, K; Jiang, YJ; Liu, DJ; Zhang, Z; Liu, YX; Liu, L				Shen, Chenguang; Wang, Zhaoqin; Zhao, Fang; Yang, Yang; Li, Jinxiu; Yuan, Jing; Wang, Fuxiang; Li, Delin; Yang, Minghui; Xing, Li; Wei, Jinli; Xiao, Haixia; Yang, Yan; Qu, Jiuxin; Qing, Ling; Chen, Li; Xu, Zhixiang; Peng, Ling; Li, Yanjie; Zheng, Haixia; Chen, Feng; Huang, Kun; Jiang, Yujing; Liu, Dongjing; Zhang, Zheng; Liu, Yingxia; Liu, Lei			Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EBOLA-VIRUS DISEASE	Question Could administration of convalescent plasma transfusion be beneficial in the treatment of critically ill patients with coronavirus disease 2019 (COVID-19)? Findings In this uncontrolled case series of 5 critically ill patients with COVID-19 and acute respiratory distress syndrome (ARDS), administration of convalescent plasma containing neutralizing antibody was followed by an improvement in clinical status. Meaning These preliminary findings raise the possibility that convalescent plasma transfusion may be helpful in the treatment of critically ill patients with COVID-19 and ARDS, but this approach requires evaluation in randomized clinical trials. Importance Coronavirus disease 2019 (COVID-19) is a pandemic with no specific therapeutic agents and substantial mortality. It is critical to find new treatments. Objective To determine whether convalescent plasma transfusion may be beneficial in the treatment of critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Design, Setting, and Participants Case series of 5 critically ill patients with laboratory-confirmed COVID-19 and acute respiratory distress syndrome (ARDS) who met the following criteria: severe pneumonia with rapid progression and continuously high viral load despite antiviral treatment; Pao(2)/Fio(2) <300; and mechanical ventilation. All 5 were treated with convalescent plasma transfusion. The study was conducted at the infectious disease department, Shenzhen Third People's Hospital in Shenzhen, China, from January 20, 2020, to March 25, 2020; final date of follow-up was March 25, 2020. Clinical outcomes were compared before and after convalescent plasma transfusion. Exposures Patients received transfusion with convalescent plasma with a SARS-CoV-2-specific antibody (IgG) binding titer greater than 1:1000 (end point dilution titer, by enzyme-linked immunosorbent assay [ELISA]) and a neutralization titer greater than 40 (end point dilution titer) that had been obtained from 5 patients who recovered from COVID-19. Convalescent plasma was administered between 10 and 22 days after admission. Main Outcomes and Measures Changes of body temperature, Sequential Organ Failure Assessment (SOFA) score (range 0-24, with higher scores indicating more severe illness), Pao(2)/Fio(2), viral load, serum antibody titer, routine blood biochemical index, ARDS, and ventilatory and extracorporeal membrane oxygenation (ECMO) supports before and after convalescent plasma transfusion. Results All 5 patients (age range, 36-65 years; 2 women) were receiving mechanical ventilation at the time of treatment and all had received antiviral agents and methylprednisolone. Following plasma transfusion, body temperature normalized within 3 days in 4 of 5 patients, the SOFA score decreased, and Pao(2)/Fio(2) increased within 12 days (range, 172-276 before and 284-366 after). Viral loads also decreased and became negative within 12 days after the transfusion, and SARS-CoV-2-specific ELISA and neutralizing antibody titers increased following the transfusion (range, 40-60 before and 80-320 on day 7). ARDS resolved in 4 patients at 12 days after transfusion, and 3 patients were weaned from mechanical ventilation within 2 weeks of treatment. Of the 5 patients, 3 have been discharged from the hospital (length of stay: 53, 51, and 55 days), and 2 are in stable condition at 37 days after transfusion. Conclusions and Relevance In this preliminary uncontrolled case series of 5 critically ill patients with COVID-19 and ARDS, administration of convalescent plasma containing neutralizing antibody was followed by improvement in their clinical status. The limited sample size and study design preclude a definitive statement about the potential effectiveness of this treatment, and these observations require evaluation in clinical trials. This case series describes clinical outcomes in 5 Chinese patients with laboratory-confirmed COVID-19, ARDS, and high viral loads despite antiviral treatment who were given human plasma with SARS-CoV-2 antibodies obtained from previously infected and recovered patients.	[Shen, Chenguang; Wang, Zhaoqin; Zhao, Fang; Yang, Yang; Li, Jinxiu; Yuan, Jing; Wang, Fuxiang; Li, Delin; Yang, Minghui; Xing, Li; Wei, Jinli; Xiao, Haixia; Yang, Yan; Qu, Jiuxin; Qing, Ling; Chen, Li; Xu, Zhixiang; Peng, Ling; Li, Yanjie; Zheng, Haixia; Chen, Feng; Huang, Kun; Jiang, Yujing; Liu, Dongjing; Zhang, Zheng; Liu, Yingxia; Liu, Lei] Southern Univ Sci & Technol, Shenzhen Key Lab Pathogen & Immun, Natl Clin Res Ctr Infect Dis,Shenzhen Peoples Hos, State Key Discipline Infect Dis,Hosp 2, Shenzhen, Peoples R China; [Li, Delin; Xiao, Haixia] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Lab Prot Engn & Vaccines, Tianjin, Peoples R China	Southern University of Science & Technology; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Zhang, Z; Liu, YX; Liu, L (corresponding author), Southern Univ, Shenzhen Peoples Hosp 3, Hosp 2, 29 Bulan Rd, Shenzhen 518112, Peoples R China.; Zhang, Z; Liu, YX; Liu, L (corresponding author), Southern Univ Sci & Technol, Shenzhen Key Lab Pathogen & Immun, Natl Clin Res Ctr Infect Dis,Shenzhen Peoples Hos, State Key Discipline Infect Dis,Hosp 2, Shenzhen, Peoples R China.	zhangzheng1975@aliyun.com; yingxialiu@hotmail.com; liulei3322@aliyun.com	沈, 晨光/N-6193-2018; Xiao, Haixia/AAZ-3374-2020	Xiao, Haixia/0000-0003-0032-5430; Yuan, Jing/0000-0002-8937-9568	National Science and Technology Major Project [2018ZX10711001, 2017ZX10103011, 20177X10204401]; Sanming Project of Medicine in Shenzhen [SZSM201412003, SZSM201512005]; China Postdoctoral Science Foundation [20191120147, 2018M641508]; Shenzhen Science and Technology Research and Development Project [202002073000002, 202002073000001]; National Natural Science Foundation of China [81902058]; Key Technology RAMP;D Program of Tianjin [17YFZCSY01090]	National Science and Technology Major Project; Sanming Project of Medicine in Shenzhen; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Shenzhen Science and Technology Research and Development Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technology RAMP;D Program of Tianjin	This work was supported by the National Science and Technology Major Project (2018ZX10711001, 2017ZX10103011, 20177X10204401), Sanming Project of Medicine in Shenzhen (SZSM201412003, SZSM201512005), China Postdoctoral Science Foundation (20191120147, 2018M641508), Shenzhen Science and Technology Research and Development Project (202002073000001), National Natural Science Foundation of China (81902058), Shenzhen Science and Technology Research and Development Project (202002073000002), and The Key Technology R&D Program of Tianjin (17YFZCSY01090).	Burnouf T, 2003, HAEMOPHILIA, V9, P24, DOI 10.1046/j.1365-2516.2003.00701.x; Chen L, 2020, LANCET INFECT DIS; Cheng Y, 2005, EUR J CLIN MICROBIOL, V24, P44, DOI 10.1007/s10096-004-1271-9; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Florescu DF, 2015, CLIN INFECT DIS, V61, P969, DOI 10.1093/cid/civ395; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hung IFN, 2011, CLIN INFECT DIS, V52, P447, DOI 10.1093/cid/ciq106; Kraft CS, 2015, CLIN INFECT DIS, V61, P496, DOI 10.1093/cid/civ334; Liu C, 2020, VIRAL ARCHITECTURE S, DOI [10.1101/2020.03.02.972927, DOI 10.1101/2020.03.02.972927]; Lu CL, 2016, SCIENCE, V352, P1001, DOI 10.1126/science.aaf1279; Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020; Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396; Ng KT, 2018, CLIN INFECT DIS, V67, P261, DOI 10.1093/cid/ciy063; Shen CG, 2019, THERANOSTICS, V9, P210, DOI 10.7150/thno.28434; Shen CG, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam5752; van Griensven J, 2016, NEW ENGL J MED, V374, P33, DOI 10.1056/NEJMoa1511812; Villar J, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006812; Wang Chunyan, 2020, Nat Commun, V11, P2251, DOI 10.1038/s41467-020-16256-y; World Health Organization, NOV COR COVID 19 SIT; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yang Y, 2020, INNOVATION-AMSTERDAM, V1, DOI 10.1016/j.xinn.2020.100061; Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346; Zhou BP, 2007, NEW ENGL J MED, V357, P1450, DOI 10.1056/NEJMc070359	23	1457	1531	17	194	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 28	2020	323	16					1582	1589		10.1001/jama.2020.4783	http://dx.doi.org/10.1001/jama.2020.4783			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LL2GR	32219428	Green Published, Bronze			2022-12-28	WOS:000531373700024
J	Vallurupalli, M; MacFadyen, JG; Glynn, RJ; Thuren, T; Libby, P; Berliner, N; Ridker, PM				Vallurupalli, Mounica; MacFadyen, Jean G.; Glynn, Robert J.; Thuren, Tom; Libby, Peter; Berliner, Nancy; Ridker, Paul M.			Effects of Interleukin-1 beta Inhibition on Incident Anemia Exploratory Analyses From a Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							C-REACTIVE PROTEIN; INFLAMMATION; HEPCIDIN; ROSUVASTATIN; AUTOPHAGY	Background: Inflammatory cytokines, such as interleukin (IL)1 beta, alter iron homeostasis and erythropoiesis, resulting in anemia, but whether inhibition of IL-1 beta can reverse these effects is unclear. Objective: To determine whether IL-1 beta inhibition with canakinumab reduces incident anemia and improves hemoglobin levels among those with prevalent anemia. Design: Exploratory analysis of a randomized controlled trial. (ClinicalTrials.gov: NCT01327846) Setting: Many clinical sites in 39 countries. Participants: 8683 CANTOS (Canakinumab Anti-inflammatory Thrombosis Outcomes Study) participants without anemia at trial entry and 1303 with prevalent anemia at trial entry. Intervention: Random assignment to receive placebo or canakinumab (50, 150, or 300 mg) subcutaneously once every 3 months. Measurements: Primary outcome was incident anemia (hemoglobin level <130 g/L in men or <120 g/L in women). Results: Anemia incidence increased with rising baseline levels of high-sensitivity C-reactive protein (hsCRP), and both hsCRP and IL-6 decreased among participants receiving canakinumab compared with the placebo group. During a median follow-up of 3.7 years, participants without baseline anemia who received canakinumab at any dosage had significantly less incident anemia than those who received placebo (hazard ratio, 0.84 [95% CI, 0.77 to 0.93]; P < 0.001). Compared with placebo, the greatest benefits of IL-1 beta inhibition on incident anemia were observed among participants with the most robust anti-inflammatory response, an effect corroborated in formal mediation analyses. Among those with baseline anemia, canakinumab increased mean hemoglobin levels by 11.3 g/L (P < 0.001) compared with placebo after 2 years of treatment. Canakinumab increased the risk for infection and was associated with mild cases of thrombocytopenia and neutropenia, none of which was grade 3 or higher. Limitation: CANTOS was not designed to assess the cause of anemia in individual trial participants. Conclusion: These exploratory analyses of randomized trial data provide proof of principle that inflammation inhibition, at least through the IL-1 beta/IL-6 signaling pathway, reduces the incidence of anemia and improves hemoglobin levels in patients with anemia. Primary Funding Source: Novartis Pharmaceuticals.	[Vallurupalli, Mounica; MacFadyen, Jean G.; Glynn, Robert J.; Libby, Peter; Berliner, Nancy; Ridker, Paul M.] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA 02115 USA; [Thuren, Tom] Novartis Pharmaceut, One Hlth Plaza, E Hanover, NJ 07936 USA; [Vallurupalli, Mounica; Berliner, Nancy] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Hematol, 75 Francis St, Boston, MA 02115 USA; [MacFadyen, Jean G.; Glynn, Robert J.; Ridker, Paul M.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA; [Libby, Peter] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Novartis; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Ridker, PM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 900 Commonwealth Ave, Boston, MA 02215 USA.	pridker@bwh.harvard.edu	Libby, Peter/AAY-6404-2021	Libby, Peter/0000-0002-1502-502X	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	This study was funded by Novartis Pharmaceuticals.	Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Andrews NC, 2004, J CLIN INVEST, V113, P1251, DOI 10.1172/JCI200421441; Brookhart MA, 2011, J CLIN PHARMACOL, V51, P1483, DOI 10.1177/0091270010386607; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Glynn RJ, 2009, CLIN CHEM, V55, P305, DOI 10.1373/clinchem.2008.120642; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Guralnik JM, 2004, BLOOD, V104, P2263, DOI 10.1182/blood-2004-05-1812; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nemeth E, 2014, HEMATOL ONCOL CLIN N, V28, P671, DOI 10.1016/j.hoc.2014.04.005; Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686; Penninx BWJH, 2004, J AM GERIATR SOC, V52, P719, DOI 10.1111/j.1532-5415.2004.52208.x; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; PRENTICE RL, 1978, BIOMETRICS, V34, P57, DOI 10.2307/2529588; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2019, CIRC RES, V124, P437, DOI 10.1161/CIRCRESAHA.118.313129; Ridker PM, 2018, EUR HEART J, V39, P3499, DOI 10.1093/eurheartj/ehy310; Ridker PM, 2018, LANCET, V391, P319, DOI 10.1016/S0140-6736(17)32814-3; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Solomon DH, 2018, ANN INTERN MED, V169, P535, DOI 10.7326/M18-1167; Valeri L, 2015, EPIDEMIOLOGY, V26, pE23, DOI 10.1097/EDE.0000000000000253; Weiss G, 2005, NEW ENGL J MED, V352, P1011, DOI 10.1056/NEJMra041809	26	21	21	3	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2020	172	8					523	+		10.7326/M19-2945	http://dx.doi.org/10.7326/M19-2945			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF9LH	32203978	Green Accepted			2022-12-28	WOS:000527733800013
J	Harvey, A				Harvey, Anna			Covid-19: medical students and FY1 doctors to be given early registration to help combat covid-19	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2020, COVID 19 EARL PROV R; General Medical Council, OUTC PROV REG DOCT; General Medical Council, OUTC GRAD PLUS SUPPL; Harvey A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1227	4	10	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1268	10.1136/bmj.m1268	http://dx.doi.org/10.1136/bmj.m1268			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220863	Bronze			2022-12-28	WOS:000523765200008
J	Zilhao, J; Angelucci, DE; Igreja, MA; Arnold, LJ; Badal, E; Callapez, P; Cardoso, JL; d'Errico, F; Daura, J; Demuro, M; Deschamps, M; Dupont, C; Gabriel, S; Hoffmann, DL; Legoinha, P; Matias, H; Soares, AMM; Nabais, M; Portela, P; Queffelec, A; Rodrigues, F; Souto, P				Zilhao, J.; Angelucci, D. E.; Igreja, M. Araujo; Arnold, L. J.; Badal, E.; Callapez, P.; Cardoso, J. L.; d'Errico, F.; Daura, J.; Demuro, M.; Deschamps, M.; Dupont, C.; Gabriel, S.; Hoffmann, D. L.; Legoinha, P.; Matias, H.; Soares, A. M. Monge; Nabais, M.; Portela, P.; Queffelec, A.; Rodrigues, F.; Souto, P.			Last Interglacial Iberian Neandertals as fisher-hunter-gatherers	SCIENCE			English	Article							WESTERN CAPE PROVINCE; BROAD-SPECTRUM REVOLUTION; MODERN HUMAN-BEHAVIOR; JINMIUM ROCK SHELTER; COASTAL RESOURCE USE; SEA-LEVEL CHANGES; 13B MOSSEL BAY; PINNACLE POINT; KLASIES RIVER; SOUTH-AFRICA	Marine food-reliant subsistence systems such as those in the African Middle Stone Age (MSA) were not thought to exist in Europe until the much later Mesolithic. Whether this apparent lag reflects taphonomic biases or behavioral distinctions between archaic and modern humans remains much debated. Figueira Brava cave, in the Arrabida range (Portugal), provides an exceptionally well preserved record of Neandertal coastal resource exploitation on a comparable scale to the MSA and dated to similar to 86 to 106 thousand years ago. The breadth of the subsistence base-pine nuts, marine invertebrates, fish, marine birds and mammals, tortoises, waterfowl, and hoofed game-exceeds that of regional early Holocene sites. Fisher-hunter-gatherer economies are not the preserve of anatomically modern people; by the Last Interglacial, they were in place across the Old World in the appropriate settings.	[Zilhao, J.] ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain; [Zilhao, J.; Daura, J.] Univ Barcelona, Dept Hist & Arqueol, Fac Geog & Hist, C Montalegre 6, Barcelona 08001, Spain; [Zilhao, J.; Igreja, M. Araujo; Cardoso, J. L.; Daura, J.; Deschamps, M.; Gabriel, S.; Matias, H.; Nabais, M.; Rodrigues, F.] Univ Lisbon, Ctr Arqueol Univ Lisboa UNIARQ, Fac Letras Lisboa, Alameda Univ, P-1600214 Lisbon, Portugal; [Angelucci, D. E.] Univ Trento, Dipartimento Lettere & Filosofia, Via Tommaso Gar 14, I-38122 Trento, Italy; [Igreja, M. Araujo; Gabriel, S.] Direccao Geral Patrimonio Cultural, Lab Arqueociencias LARC, Calcada Mirante Ajuda 10A, P-1300418 Lisbon, Portugal; [Igreja, M. Araujo; Gabriel, S.] Univ Porto, Environm Archaeol Grp, Res Ctr Biodivers & Genet Resources ENVARCH, CIBIO InBIO, Rua Padre Armando Quintas 7, P-4485661 Vairao, Portugal; [Arnold, L. J.; Demuro, M.] Univ Adelaide, Environm Inst, Dept Earth Sci, Sch Phys Sci, North Terrace Campus, Adelaide, SA 5005, Australia; [Arnold, L. J.; Demuro, M.] Univ Adelaide, IPAS, Dept Earth Sci, Sch Phys Sci, North Terrace Campus, Adelaide, SA 5005, Australia; [Badal, E.] Univ Valencia, Dept Prehist Arqueol & Hist Antiga, Ave Blasco Ibanez 28, Valencia 46010, Spain; [Callapez, P.] Univ Coimbra, Dept Ciencias Terra CITEUC, Fac Ciencias & Tecnol, Rua Silvio Lima, P-3030790 Coimbra, Portugal; [Cardoso, J. L.] Univ Aberta, Rua Escola Politecn 147, P-1269001 Lisbon, Portugal; [d'Errico, F.; Queffelec, A.] Univ Bordeaux, CNRS, PACEA, UMR 5199, Bat B18,Allee Geoffroy St Hilaire,CS 50023, F-33615 Pessac, France; [d'Errico, F.] Univ Bergen, SFF Ctr Early Sapiens Behav SapienCE, Sydnesplassen 12-13,4 Etage,Postboks 7805, N-5020 Bergen, Norway; [Deschamps, M.] Univ Toulouse Jean Jaures, CNRS, UMR 5608, TRACES,Maison Rech, 5 Allees Antonio Machado, F-31058 Toulouse 9, France; [Dupont, C.] Univ Rennes 1, CNRS, UMR 6566, CReAAH,Lab Archeosci, Bat 24-25,Campus Beaulieu, F-35042 Rennes, France; [Hoffmann, D. L.] Max Planck Inst Evolutionary Anthropol, Deutsch Pl 6, D-04103 Leipzig, Germany; [Hoffmann, D. L.] Univ Gottingen, Geosci Ctr, Isotope Geol Div, Goldschmidtstr 3, D-37077 Gottingen, Germany; [Legoinha, P.] Univ Nova Lisboa, Geobiotec, Dept Ciencias Terra, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Soares, A. M. Monge; Portela, P.] Univ Lisbon, C2TN, Inst Super Tecn, Estr Nacl 10, P-2695066 Bobadela, Portugal; [Nabais, M.] UCL, Inst Archaeol, 31-34 Gordon Sq, London WC1H 0PY, England; [Souto, P.] Soc Torrejana Espeleol & Arqueol, P-2350510 Quinta Da Leziria, Torres Novas, Portugal	ICREA; University of Barcelona; Universidade de Lisboa; University of Trento; Universidade do Porto; University of Adelaide; University of Adelaide; University of Valencia; Universidade de Coimbra; Universidade Aberta; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of Bergen; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Rennes; Max Planck Society; University of Gottingen; Universidade Nova de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; University of London; University College London	Zilhao, J (corresponding author), ICREA, Passeig Lluis Co 23, Barcelona 08010, Spain.; Zilhao, J (corresponding author), Univ Barcelona, Dept Hist & Arqueol, Fac Geog & Hist, C Montalegre 6, Barcelona 08001, Spain.; Zilhao, J (corresponding author), Univ Lisbon, Ctr Arqueol Univ Lisboa UNIARQ, Fac Letras Lisboa, Alameda Univ, P-1600214 Lisbon, Portugal.	joao.zilhao@ub.edu	Zilhão, João/L-5670-2014; Daura, Joan/C-9827-2016; Tonicher, Pedro Miguel Callapez/L-7089-2014; Angelucci, Diego E./K-6699-2014; Tonicher, Pedro Miguel Callapez/N-3467-2019; Nabais, Mariana/AAL-3890-2020; Legoinha, Paulo A. R. R./C-8843-2012; Demuro, Martina/AAD-9985-2019; Demuro, Martina/AAV-9757-2021; Gabriel, Sonia/M-2381-2013; Deschamps, Marianne/R-4726-2016; Arnold, Lee/J-4356-2018; Matias, Henrique/N-9189-2016; Badal Garcia, Ernestina/K-9462-2014	Zilhão, João/0000-0001-5937-3061; Daura, Joan/0000-0002-8364-3655; Tonicher, Pedro Miguel Callapez/0000-0002-6493-2208; Angelucci, Diego E./0000-0001-7411-261X; Tonicher, Pedro Miguel Callapez/0000-0002-6493-2208; Nabais, Mariana/0000-0001-5344-237X; Legoinha, Paulo A. R. R./0000-0002-7592-7949; Demuro, Martina/0000-0002-5799-4216; Demuro, Martina/0000-0002-5799-4216; Cardoso, Joao Luis/0000-0003-2234-2266; Queffelec, Alain/0000-0002-9763-7600; Gabriel, Sonia/0000-0001-9457-8695; Igreja, Marina/0000-0001-7959-6422; Deschamps, Marianne/0000-0002-4985-6382; Rodrigues, Filipa/0000-0002-1025-507X; Arnold, Lee/0000-0001-9603-3824; Matias, Henrique/0000-0003-3212-2902; Badal Garcia, Ernestina/0000-0002-8296-1870	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PTDC/HIS-ARQ/098164/2008, PTDC/HAR-ARQ/30413/2017]; Max Planck Institute for Evolutionary Anthropology (Leipzig, Germany); Ministerio de Ciencia, Innovacion y Universidades (MICINN, Spain) [CGL2011-27187]; Programme Investissements d'Avenir IdEx universite de Bordeaux, the French Agence Nationale de la Recherche [ANR-10-LABX-52]; Research Council of Norway [262618]; Australian Research Council [DE160100743, FT130100195]; ORADS program [2006/1/4]; London Arts and Humanities Partnership, an AHRC	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Max Planck Institute for Evolutionary Anthropology (Leipzig, Germany); Ministerio de Ciencia, Innovacion y Universidades (MICINN, Spain); Programme Investissements d'Avenir IdEx universite de Bordeaux, the French Agence Nationale de la Recherche(French National Research Agency (ANR)); Research Council of Norway(Research Council of Norway); Australian Research Council(Australian Research Council); ORADS program; London Arts and Humanities Partnership, an AHRC	Excavation and analysis of the finds were supported by research grants from Fundacao para a Ciencia e Tecnologia (FCT, Portugal) projects "Middle Paleolithic Archaeology of the Almonda Karstic System" (grant PTDC/HIS-ARQ/098164/2008) and "Archeology and Evolution of Early Humans in the Western Facade of Iberia" (grant PTDC/HAR-ARQ/30413/2017). U-series dating was additionally supported by the Max Planck Institute for Evolutionary Anthropology (Leipzig, Germany) and, for the Centro Nacional de Investigacion de la Evolucion Humana (CENIEH, Burgos, Spain) results, by Ministerio de Ciencia, Innovacion y Universidades (MICINN, Spain) research grant CGL2011-27187. The study of the nonfood shells was partly supported by the Programme Investissements d'Avenir IdEx universite de Bordeaux, the French Agence Nationale de la Recherche (ANR-10-LABX-52, LaScArBx Cluster of Excellence), and the Research Council of Norway (project 262618). OSL dating analyses and manuscript production were partly supported by Australian Research Council grants DE160100743 and FT130100195. The OxA radiocarbon dates numbered 19978 to 19982 were funded by the ORADS program (application 2006/1/4). The analysis of all faunal remains (except fish) was supported by a doctoral award by the London Arts and Humanities Partnership, an AHRC-funded Doctoral Training Programme, to the research project "Neanderthal subsistence in Portugal: small and large prey consumption during the Marine Isotope Stage 5 (MIS-5)."	Ainis AF, 2014, J ARCHAEOL SCI, V49, P343, DOI 10.1016/j.jas.2014.05.024; Aitken MJ, 1985, THERMOLUMINESCENCE D; Alcoforado M. J., 2014, GEOGRAFIA FISICA REG, P11; Aldeias V, 2016, GEOARCHAEOLOGY, V31, P530, DOI 10.1002/gea.21573; Angelucci DE, 2018, QUATERN INT, V485, P4, DOI 10.1016/j.quaint.2017.04.006; Angelucci DE, 2013, QUATERN INT, V315, P24, DOI 10.1016/j.quaint.2013.03.014; [Anonymous], 2012, WOOD CHARCOAL EVIDEN; [Anonymous], 1990, ANATOMIE EUROPAISCHE; Antunes M.T., 2000, ULTIMOS NEANDERTAIS; Araujo A. C., 1995, ARQUEOLOGO PORTUGUES, VIV-13/15, P87; Araujo AC, 2011, CONCHEIRO TOLEDO CON; Arnaud J. E., 1989, 3 INT S, P614; Arnold LJ, 2008, QUAT GEOCHRONOL, V3, P114, DOI 10.1016/j.quageo.2007.09.002; Arnold LJ, 2007, QUAT GEOCHRONOL, V2, P162, DOI 10.1016/j.quageo.2006.05.003; Arnold LJ, 2012, RADIAT MEAS, V47, P652, DOI 10.1016/j.radmeas.2012.02.005; Arnold LJ, 2012, RADIAT MEAS, V47, P6, DOI 10.1016/j.radmeas.2011.09.001; Arnold LJ, 2009, QUAT GEOCHRONOL, V4, P306, DOI 10.1016/j.quageo.2009.02.017; Arnold LJ, 2009, QUAT GEOCHRONOL, V4, P204, DOI 10.1016/j.quageo.2008.12.001; Arnold LJ, 2016, QUAT GEOCHRONOL, V36, P78, DOI 10.1016/j.quageo.2016.07.003; Arnold LJ, 2015, QUAT GEOCHRONOL, V30, P472, DOI 10.1016/j.quageo.2015.02.005; Arnold LJ, 2014, J HUM EVOL, V67, P85, DOI 10.1016/j.jhevol.2013.12.001; Arnold LJ, 2013, BOREAS, V42, P285, DOI 10.1111/j.1502-3885.2012.00262.x; Arnold LJ, 2011, BOREAS, V40, P417, DOI 10.1111/j.1502-3885.2010.00181.x; Aubert M, 2018, J HUM EVOL, V125, P215, DOI 10.1016/j.jhevol.2018.08.004; Aubry T, 2009, RECENT FUNCTIONAL ST; Avery G., 2008, S AFRI ARCHAEOL SOC, V10, P66, DOI [10.2307/40650020, DOI 10.2307/40650020]; Badal E., 1998, CULTURAS PLEISTOCENO, P287; Bailey RM, 2006, QUATERNARY SCI REV, V25, P2475, DOI 10.1016/j.quascirev.2005.09.012; Barton Nick, 2000, P211; Barton R.N.E., 2012, NEANDERTHALS CONTEXT, P243; Barton RNE., 2012, NEANDERTHALS CONTEXT, P151; Benjamin J, 2017, QUATERN INT, V449, P29, DOI 10.1016/j.quaint.2017.06.025; Bicho N, 2017, QUATERN INT, V446, P31, DOI 10.1016/j.quaint.2016.09.049; Bicho N, 2013, QUATERN INT, V308, P130, DOI 10.1016/j.quaint.2012.10.049; BOTTERJENSEN L, 1988, NUCL TRACKS RAD MEAS, V14, P187; Bowler JM, 2003, NATURE, V421, P837, DOI 10.1038/nature01383; Brennan BJ, 2003, RADIAT MEAS, V37, P299, DOI 10.1016/S1350-4487(03)00011-8; Brenner MJ, 2019, J ARCHAEOL SCI-REP, V26, DOI 10.1016/j.jasrep.2019.101891; Breuil H., 1945, COMUNICACOES SERVICO, VXXVII, P1; Brito P., 2009, THESIS; Brock F, 2010, RADIOCARBON, V52, P103, DOI 10.1017/S0033822200045069; Bullock P., 1985, HDB SOIL THIN SECTIO; Busschers FS, 2014, RADIOCARBON, V56, P1151, DOI 10.2458/56.16505; Cardoso J. L., 1993, CAMARA MUNICIPAL OEI, P567; Cardoso J. L., 2001, ESTUDOS ARQUEOLOGICO, V10, P39; Carrillo-Briceno JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139230; Cawthra HC, 2018, QUATERNARY SCI REV, V181, P156, DOI 10.1016/j.quascirev.2017.12.002; Chakroun A, 2017, AFR ARCHAEOL REV, V34, P493, DOI 10.1007/s10437-017-9279-6; Chauviere F.-X, 2002, REV PORTUGUESA ARQUE, V5, P5; Cheng H, 2000, CHEM GEOL, V169, P17, DOI 10.1016/S0009-2541(99)00157-6; Collcutt S. N., 2012, NEANDERTHALS CONTEXT, P37; Collins SW, 2012, NEW MIDDLE AGES, P15; Colonese AC, 2011, QUATERN INT, V239, P86, DOI 10.1016/j.quaint.2010.09.001; Cortes-Sanchez M., 2007, PALEOLITICO MEDIO SU; Cortes-Sanchez M, 2019, QUATERNARY SCI REV, V217, P284, DOI 10.1016/j.quascirev.2019.02.007; Cortes-Sanchez M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024026; Cuenca-Bescos G, 2014, INTEGR ZOOL, V9, P481, DOI 10.1111/1749-4877.12053; Cunnane SC, 2014, J HUM EVOL, V77, P88, DOI 10.1016/j.jhevol.2014.05.001; d'Errico F, 2009, P NATL ACAD SCI USA, V106, P16051, DOI 10.1073/pnas.0903532106; da Silva C. Tavares, 1986, ARQUEOLOGIA ARRABIDA; Deacon H.J., 1988, S AFR ARCHAEOL B, V43, P5, DOI [DOI 10.2307/3887608, 10.2307/3887608]; Demuro M, 2013, QUAT GEOCHRONOL, V15, P67, DOI 10.1016/j.quageo.2012.11.003; DERRICO F, 1994, ANTIQUITY, V68, P39, DOI 10.1017/S0003598X00046172; Dibble H.L., 2012, PALEOANTHROPOLOGY, V2012, P145, DOI DOI 10.4207/PA.2012.ART74; Doerschner N, 2019, QUATERN INT, V501, P289, DOI 10.1016/j.quaint.2018.02.020; Dorale JA, 2010, SCIENCE, V327, P860, DOI 10.1126/science.1181725; Douka K., 2012, P266; Douka K, 2012, J WORLD PREHIST, V25, P45, DOI 10.1007/s10963-012-9056-z; Duarte C, 2019, ARCHAEOL ANTHROP SCI, V11, P483, DOI 10.1007/s12520-017-0519-0; Duller G.A.T., 2007, ANCIENT TL, V25, P15; Duller GAT, 2003, RADIAT MEAS, V37, P161, DOI 10.1016/S1350-4487(02)00170-1; Dupont C., 2006, BRIT ARCHAEOLOGICAL, V1571; Dusseldorp GL, 2013, SOUTH AFR HUMANIT, V25, P105; Erlandson JM, 2001, AM ANTIQUITY, V66, P413, DOI 10.2307/2694242; Feathers JK, 2002, J ARCHAEOL SCI, V29, P177, DOI 10.1006/jasc.2001.0685; Figueiredo P., 2015, THESIS; Finlayson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045927; Fins JJ, 2012, BASIC BIOETH, P77; Fisher EC, 2010, QUATERNARY SCI REV, V29, P1382, DOI 10.1016/j.quascirev.2010.01.015; Fonseca AF, 2014, J MAPS, V10, P103, DOI 10.1080/17445647.2013.859637; Gabriel S., 2015, THESIS; Galbraith RF, 1999, ARCHAEOMETRY, V41, P339, DOI 10.1111/j.1475-4754.1999.tb00987.x; Galbraith RF, 2002, ANCIENT TL, V20, P49; Garcia-Escarzaga A., 2015, INVESTIGACION ARQUEO, P77; Garcia-Escarzaga A, 2017, PAP INST ARCHAEOL, V27, DOI 10.5334/pia-481; Goldberg P, 2006, EVOL ANTHROPOL, V15, P20, DOI 10.1002/evan.20094; Granadeiro J. P., 2013, DISTRIBUICAO IMPACTO; Grine FE, 2017, J HUM EVOL, V103, P53, DOI 10.1016/j.jhevol.2016.12.001; Guerin G., 2011, ANCIENT TL, V29, P5; Guiry EJ, 2015, CURR ANTHROPOL, V56, P460, DOI 10.1086/680854; Gutierrez-Zugasti I., 2009, EXPLOTACION MOLUSCOS, P539; Gutierrez-Zugasti I, 2018, QUATERN INT, V474, P44, DOI 10.1016/j.quaint.2017.06.059; Gutierrez-Zugasti I, 2013, J ANTHROPOL ARCHAEOL, V32, P242, DOI 10.1016/j.jaa.2013.03.001; Haig J. A., 2015, 51 BANG U FISH CONS; Hansen V, 2015, RADIAT MEAS, V81, P123, DOI 10.1016/j.radmeas.2015.02.017; Hardy K, 2016, J ANTHROPOL ARCHAEOL, V41, P19, DOI 10.1016/j.jaa.2015.11.001; Henshilwood C, 2004, SCIENCE, V304, P404, DOI 10.1126/science.1095905; Henshilwood CS, 2018, NATURE, V562, P115, DOI 10.1038/s41586-018-0514-3; Henshilwood CS, 2011, SCIENCE, V334, P219, DOI 10.1126/science.1211535; Henshilwood CS, 2002, SCIENCE, V295, P1278, DOI 10.1126/science.1067575; Henshilwood CS, 2001, J ARCHAEOL SCI, V28, P421, DOI 10.1006/jasc.2000.0638; Higham T. F. G., 2012, NEANDERTHALS CONTEXT, P62; Hoffmann DL, 2018, SCIENCE, V362, DOI 10.1126/science.aau1736; Hoffmann DL, 2018, SCIENCE, V359, P912, DOI 10.1126/science.aap7778; Hoffmann DL, 2007, INT J MASS SPECTROM, V264, P97, DOI 10.1016/j.ijms.2007.03.020; Hoffmann DL, 2019, J HUM EVOL, V135, DOI 10.1016/j.jhevol.2019.102644; Hoffmann DL, 2018, NAT ECOL EVOL, V2, P1044, DOI 10.1038/s41559-018-0598-z; Hoffmann DL, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5255; Hoffmann DL, 2016, QUAT GEOCHRONOL, V36, P104, DOI 10.1016/j.quageo.2016.07.004; HOLDEN NE, 1990, PURE APPL CHEM, V62, P941, DOI 10.1351/pac199062050941; Igreja M., 2009, 200 SECULOS HIST VAL, P235; Igreja M.d.A., 2007, REV PORTUGUESA ARQUE, V10, P17; Jacobs Z, 2006, RADIAT MEAS, V41, P264, DOI 10.1016/j.radmeas.2005.07.027; Jacobs Z, 2008, J ARCHAEOL SCI, V35, P1808, DOI 10.1016/j.jas.2007.11.027; Jacobs Z, 2020, QUATERNARY SCI REV, V235, DOI 10.1016/j.quascirev.2019.07.032; Jacoby D., 2014, ANGUILLA ANGUILLA IU, DOI [10.2305/IUCN.UK.2014-1.RLTS.T60344A45833138.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T58706A118983374.EN, DOI 10.2305/IUCN.UK.2014-1.RLTS.T60344A45833138.EN]; JAFFEY AH, 1971, PHYS REV C, V4, P1889, DOI 10.1103/PhysRevC.4.1889; Jankowski NR, 2016, J QUATERNARY SCI, V31, P538, DOI 10.1002/jqs.2877; Jaouen K, 2019, P NATL ACAD SCI USA, V116, P4928, DOI 10.1073/pnas.1814087116; Jerardino A, 2016, J ANTHROPOL ARCHAEOL, V41, P213, DOI 10.1016/j.jaa.2016.01.001; Jerardino A, 2010, J HUM EVOL, V59, P412, DOI 10.1016/j.jhevol.2010.07.003; Joordens JCA, 2014, J HUM EVOL, V77, P107, DOI 10.1016/j.jhevol.2014.04.004; Karkanas P, 2015, J HUM EVOL, V85, P1, DOI 10.1016/j.jhevol.2015.04.006; Karkanas P, 2010, J HUM EVOL, V59, P256, DOI 10.1016/j.jhevol.2010.07.001; KIDWELL SM, 1991, TAPHONOMY RELEASING, P211, DOI DOI 10.1016/S0031-0182(97)00028-X; Klein RG, 2016, J ANTHROPOL ARCHAEOL, V44, P198, DOI 10.1016/j.jaa.2016.07.008; Kullberg J. C., 2006, GEOLOGIA PORTUGAL CO, P369; Kyriacou K, 2015, J ARCHAEOL SCI, V57, P197, DOI 10.1016/j.jas.2015.01.018; Kyriacou K, 2014, J HUM EVOL, V77, P64, DOI 10.1016/j.jhevol.2014.02.024; Langejans GHJ, 2012, QUATERN INT, V270, P80, DOI 10.1016/j.quaint.2011.09.003; Leitao E., 2019, EXTRAIR PRODUZIR PRI, P35; Leorri E, 2012, QUATERNARY SCI REV, V42, P59, DOI 10.1016/j.quascirev.2012.03.014; Lesley C., 2009, CSIRO LAND WATER SCI, V12/09; Lisiecki LE, 2016, PALEOCEANOGRAPHY, V31, P1368, DOI 10.1002/2016PA003002; Lopez S. F., 1999, TRATADO PALEONTOLOGI, P51; LUBELL D, 1994, J ARCHAEOL SCI, V21, P201, DOI 10.1006/jasc.1994.1022; Lubell D., 1985, ACTAS REUNIAO QUATER, V2, P113; Lubell D., 2007, MEDITERRANEAN BASIN, P119; LUDWIG KR, 1994, GEOCHIM COSMOCHIM AC, V58, P5031, DOI 10.1016/0016-7037(94)90229-1; Macphail R. I., 2012, NEANDERTHALS CONTEXT, P193; Macphail R. I., 2000, NEANDERTHALS EDGE, P182; Mannino MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049802; Mannino MA, 2011, J ARCHAEOL SCI, V38, P3094, DOI 10.1016/j.jas.2011.07.009; Marean CW, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0239; Marean CW, 2014, J HUM EVOL, V77, P17, DOI 10.1016/j.jhevol.2014.02.025; Marean CW, 2010, J HUM EVOL, V59, P425, DOI 10.1016/j.jhevol.2010.07.011; Marean CW, 2010, J HUM EVOL, V59, P234, DOI 10.1016/j.jhevol.2010.07.007; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; MEIRINHO A., 2014, ATLAS AVES MARINHAS; MEJDAHL V, 1979, ARCHAEOMETRY, V21, P61, DOI 10.1111/j.1475-4754.1979.tb00241.x; Mejdahl V., 1987, ANCIENT TL, V5, P10; Mellars P, 2013, P NATL ACAD SCI USA, V110, P10699, DOI 10.1073/pnas.1306043110; Montes R., 1991, MEMORIAS ARQEOLOGIA, V2, P35; Montoya J. M., 1990, PINO PINONERO; Munoz-Fernandez E., 2007, INTERVENCIONES ARQUE, VIII, P15; Murray AS, 2000, RADIAT MEAS, V32, P57, DOI 10.1016/S1350-4487(99)00253-X; Nabais M., 2012, ACT 4 JORN JOV INV A, V1, P381; Nabais M, 2019, QUATERNARY SCI REV, V217, P225, DOI 10.1016/j.quascirev.2019.03.024; Nathan RP, 2003, RADIAT MEAS, V37, P305, DOI 10.1016/S1350-4487(03)00008-8; Nergiz C, 2004, FOOD CHEM, V86, P365, DOI 10.1016/j.foodchem.2003.09.009; Olley JM, 1999, RADIAT MEAS, V30, P207, DOI 10.1016/S1350-4487(99)00040-2; Olley JM, 2004, GEOMORPHOLOGY, V60, P337, DOI 10.1016/j.geomorph.2003.09.020; Olley JM, 1997, RADIAT MEAS, V27, P433, DOI 10.1016/S1350-4487(96)00114-X; Oppenheimer S, 2009, QUATERN INT, V202, P2, DOI 10.1016/j.quaint.2008.05.015; Pais J., 2000, ULTIMOS NEANDERTAIS, P69; Pawley SM, 2008, QUATERNARY SCI REV, V27, P1363, DOI 10.1016/j.quascirev.2008.02.013; Pearce DG, 2018, NAT ECOL EVOL, V2, P925, DOI 10.1038/s41559-018-0540-4; Peresani M, 2011, P NATL ACAD SCI USA, V108, P3888, DOI 10.1073/pnas.1016212108; Peyroteo R., 2016, OCCASIONAL PAPERS AR; Pike AWG, 2012, SCIENCE, V336, P1409, DOI 10.1126/science.1219957; Pimenta C., 2008, REV PORTUGUESA ARQUE, V11, P361; Pimentel N, 2015, MUGE 150 ANNIVERSARY, P321; Potts P.J.P., 2003, GEOPT13 INT PROFICIE; PRESCOTT JR, 1994, RADIAT MEAS, V23, P497, DOI 10.1016/1350-4487(94)90086-8; Prideaux GJ, 2010, P NATL ACAD SCI USA, V107, P22157, DOI 10.1073/pnas.1011073107; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rasmussen SO, 2014, QUATERNARY SCI REV, V106, P14, DOI 10.1016/j.quascirev.2014.09.007; Rees-Jones J, 1995, ANCIENT TL, V13, P9; ReesJones J, 1997, ARCHAEOMETRY, V39, P177, DOI 10.1111/j.1475-4754.1997.tb00797.x; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rhodes E. J., 2012, NEANDERTHALS CONTEXT, P211; RIBEIRO A, 1990, TECTONOPHYSICS, V184, P357, DOI 10.1016/0040-1951(90)90448-H; Rink W.J., 2000, P165; Roberts R, 1998, NATURE, V393, P358, DOI 10.1038/30718; ROBERTS RG, 1996, AUST ARCHAEOL, V42, P7; Rodriguez-Vidal J, 2013, GEOMORPHOLOGY, V203, P105, DOI 10.1016/j.geomorph.2013.02.015; Romagnoli F, 2016, QUATERN INT, V407, P29, DOI 10.1016/j.quaint.2015.07.034; Serjeantson D., 2009, BIRDS CAMBRIDGE MANU; Silva ACF, 2010, MAR ECOL PROG SER, V406, P197, DOI 10.3354/meps08543; Silva C. T., 1986, ARQUEOLOGIA ARRABIDA; Silva C. T., 1985, ARQUEOLOGIA, V11, P5; Slimak L, 2018, SCIENCE, V361, DOI 10.1126/science.aau1371; Smith EI, 2018, NATURE, V555, P511, DOI 10.1038/nature25967; Soares AMM, 2006, RADIOCARBON, V48, P45, DOI 10.1017/S0033822200035384; Soares R, 2021, LACANT, V1, P7; Steele Teresa E., 2019, Paleoanthropology, P24; Stiner MC, 2001, P NATL ACAD SCI USA, V98, P6993, DOI 10.1073/pnas.121176198; Stoops G., 2003, GUIDELINES ANAL DESC; Straus LG., 1992, IBERIA IBERIANS; Stringer CB, 2008, P NATL ACAD SCI USA, V105, P14319, DOI 10.1073/pnas.0805474105; TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73; Thackeray J.F., 1988, South African Archaeological Bulletin, V43, P27, DOI 10.2307/3887610; Trinkaus E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220464; VALENTE M.J, 2010, AT 7 ENC ARQ ALG XEL, V10, P16; Van Niekerk K. L., 2011, THESIS; Ward S., 2012, NEANDERTHALS CONTEXT, P89; WEDEPOHL KH, 1995, GEOCHIM COSMOCHIM AC, V59, P1217, DOI 10.1016/0016-7037(95)00038-2; Will M., 2015, SETTLEMENT DYNAMICS, VIV, P47; Will M, 2019, J WORLD PREHIST, V32, P33, DOI 10.1007/s10963-018-09127-4; Woll A.K., 2006, EDIBLE CRAB BIOL GRA; Wurz S, 2018, QUATERN INT, V495, P102, DOI 10.1016/j.quaint.2018.03.039; Yoshida H, 2000, RADIAT MEAS, V32, P439, DOI 10.1016/S1350-4487(99)00287-5; Zeder MA, 2012, J ANTHROPOL ARCHAEOL, V31, P241, DOI 10.1016/j.jaa.2012.03.003; Zilhao J, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00435; Zilhao J, 2016, QUATERNARY SCI REV, V146, P251, DOI 10.1016/j.quascirev.2016.05.038; Zilhao J, 2010, P NATL ACAD SCI USA, V107, P1023, DOI 10.1073/pnas.0914088107	216	44	44	3	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 27	2020	367	6485					1443	+	eaaz7943	10.1126/science.aaz7943	http://dx.doi.org/10.1126/science.aaz7943			186	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KZ4RP	32217702	Green Submitted			2022-12-28	WOS:000523251600028
J	Cappellini, MD; Viprakasit, V; Taher, AT; Georgiev, P; Kuo, KHM; Coates, T; Voskaridou, E; Liew, HK; Pazgal-Kobrowski, I; Forni, GL; Perrotta, S; Khelif, A; Lal, A; Kattamis, A; Vlachaki, E; Origa, R; Aydinok, Y; Bejaoui, M; Ho, PJ; Chew, LP; Bee, PC; Lim, SM; Lu, MY; Tantiworawit, A; Ganeva, P; Gercheva, L; Shah, F; Neufeld, EJ; Thompson, A; Laadem, A; Shetty, JK; Zou, J; Zhang, J; Miteva, D; Zinger, T; Linde, PG; Sherman, ML; Hermine, O; Porter, J; Piga, A				Cappellini, M. D.; Viprakasit, V.; Taher, A. T.; Georgiev, P.; Kuo, K. H. M.; Coates, T.; Voskaridou, E.; Liew, H. -K.; Pazgal-Kobrowski, I.; Forni, G. L.; Perrotta, S.; Khelif, A.; Lal, A.; Kattamis, A.; Vlachaki, E.; Origa, R.; Aydinok, Y.; Bejaoui, M.; Ho, P. J.; Chew, L. -P.; Bee, P. -C.; Lim, S. -M.; Lu, M. -Y.; Tantiworawit, A.; Ganeva, P.; Gercheva, L.; Shah, F.; Neufeld, E. J.; Thompson, A.; Laadem, A.; Shetty, J. K.; Zou, J.; Zhang, J.; Miteva, D.; Zinger, T.; Linde, P. G.; Sherman, M. L.; Hermine, O.; Porter, J.; Piga, A.		BELIEVE Investigators	A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent beta-Thalassemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							QUALITY-OF-LIFE; IRON; HEMOGLOBIN; THERAPY; COMPLICATIONS; SURVIVAL; ACE-536; DISEASE; ANEMIA	Background Patients with transfusion-dependent beta-thalassemia need regular red-cell transfusions. Luspatercept, a recombinant fusion protein that binds to select transforming growth factor beta superfamily ligands, may enhance erythroid maturation and reduce the transfusion burden (the total number of red-cell units transfused) in such patients. Methods In this randomized, double-blind, phase 3 trial, we assigned, in a 2:1 ratio, adults with transfusion-dependent beta-thalassemia to receive best supportive care plus luspatercept (at a dose of 1.00 to 1.25 mg per kilogram of body weight) or placebo for at least 48 weeks. The primary end point was the percentage of patients who had a reduction in the transfusion burden of at least 33% from baseline during weeks 13 through 24 plus a reduction of at least 2 red-cell units over this 12-week interval. Other efficacy end points included reductions in the transfusion burden during any 12-week interval and results of iron studies. Results A total of 224 patients were assigned to the luspatercept group and 112 to the placebo group. Luspatercept or placebo was administered for a median of approximately 64 weeks in both groups. The percentage of patients who had a reduction in the transfusion burden of at least 33% from baseline during weeks 13 through 24 plus a reduction of at least 2 red-cell units over this 12-week interval was significantly greater in the luspatercept group than in the placebo group (21.4% vs. 4.5%, P < 0.001). During any 12-week interval, the percentage of patients who had a reduction in transfusion burden of at least 33% was greater in the luspatercept group than in the placebo group (70.5% vs. 29.5%), as was the percentage of those who had a reduction of at least 50% (40.2% vs. 6.3%). The least-squares mean difference between the groups in serum ferritin levels at week 48 was -348 mu g per liter (95% confidence interval, -517 to -179) in favor of luspatercept. Adverse events of transient bone pain, arthralgia, dizziness, hypertension, and hyperuricemia were more common with luspatercept than placebo. Conclusions The percentage of patients with transfusion-dependent beta-thalassemia who had a reduction in transfusion burden was significantly greater in the luspatercept group than in the placebo group, and few adverse events led to the discontinuation of treatment. (Funded by Celgene and Acceleron Pharma; BELIEVE ClinicalTrials.gov number, NCT02604433; EudraCT number, 2015-003224-31.)	[Cappellini, M. D.] Univ Milan, Dept Clin Sci & Community, IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Via Francesco Sforza 35, I-20122 Milan, Italy; [Forni, G. L.] EO Osped Galliera, Ctr Microcitemia & Anemie Congenite & Dismetab Fe, Genoa, Italy; [Origa, R.] Azienda Osped G Brotzu, Osped Pediat Microcitem A Cao, Cagliari, Italy; [Perrotta, S.] Univ Campania L Vanvitelli, Ematol & Oncol Pediat, Caserta, Italy; [Piga, A.] Univ Turin, Dept Clin & Biol Sci, Turin, Italy; [Viprakasit, V.] Mahidol Univ, Siriraj Hosp, Bangkok, Thailand; [Tantiworawit, A.] Chiang Mai Univ, Dept Internal Med, Div Hematol, Chiang Mai, Thailand; [Taher, A. T.] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon; [Georgiev, P.] St George Univ Hosp Act Treatment, Plovdiv, Bulgaria; [Georgiev, P.] Med Univ Plovdiv, Plovdiv, Bulgaria; [Ganeva, P.] Univ Specialized Hosp Act Treatment Oncol, Sofia, Bulgaria; [Gercheva, L.] Univ Hosp St Marina, Varna, Bulgaria; [Kuo, K. H. M.] Univ Hlth Network, Div Med Oncol & Hematol, Dept Med, Toronto, ON, Canada; [Kuo, K. H. M.] Univ Toronto, Dept Med, Div Hematol, Toronto, ON, Canada; [Coates, T.] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, Los Angeles, CA 90027 USA; [Coates, T.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA; [Lal, A.] Univ Calif San Francisco, Benioff Childrens Hosp, Oakland, CA USA; [Voskaridou, E.] Laikon Gen Hosp, Thalassemia & Sickle Cell Ctr, Athens, Greece; [Kattamis, A.] Natl & Kapodistrian Univ Athens, Dept Pediat 1, Athens, Greece; [Vlachaki, E.] Hippokrateion Hosp, Adult Thalassemia Unit, Thessaloniki, Greece; [Liew, H. -K.] Hosp Sultanah Bahiyah, Alor Setar, Malaysia; [Chew, L. -P.] Hosp Umum, Sarawak, Kuching, Malaysia; [Bee, P. -C.] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Lim, S. -M.] Hosp Sultanah Aminah, Johor Baharu, Malaysia; [Pazgal-Kobrowski, I.] Beilinson Med Ctr, Rabin Med Ctr, Comprehens Ctr Thalassemia, Petah Tiqwa, Israel; [Khelif, A.] Farhat Hached Univ Hosp, Sousse, Tunisia; [Bejaoui, M.] Univ Tunis El Manar, Natl Bone Marrow Transplant Ctr, Tunis, Tunisia; [Bejaoui, M.] Univ Tunis El Manar, Fac Med, Tunis, Tunisia; [Aydinok, Y.] Ege Univ Hosp, Dept Pediat Hematol & Oncol, Izmir, Turkey; [Ho, P. J.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Ho, P. J.] Univ Sydney, Sydney, NSW, Australia; [Lu, M. -Y.] Natl Taiwan Univ, Taipei, Taiwan; [Shah, F.] Whittington Hlth NHS Trust, Dept Haematol, London, England; [Porter, J.] UCL, Dept Haematol, London, England; [Porter, J.] Univ Coll London Hosp NHS Fdn Trust, London, England; [Neufeld, E. J.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Thompson, A.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Laadem, A.; Zou, J.; Zhang, J.] Celgene, Summit, NJ USA; [Shetty, J. K.; Miteva, D.; Zinger, T.] Celgene, Boudry, Switzerland; [Linde, P. G.; Sherman, M. L.] Acceleron Pharma, Cambridge, MA USA; [Hermine, O.] Hop Necker Enfants Malad, AP HP, Dept Hematol, Paris, France; [Hermine, O.] Univ Paris, INSERM, U1163, Imagine Inst, Paris, France	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Ente Ospedaliero Ospedali Galliera; Universita della Campania Vanvitelli; University of Turin; Mahidol University; Chiang Mai University; American University of Beirut; Medical University Plovdiv; Medical University Varna; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Children's Hospital Los Angeles; University of Southern California; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Laiko General Hospital; National & Kapodistrian University of Athens; Universiti Malaya; Rabin Medical Center; Universite de Sousse; Hopital Farhat Hached; Universite de Tunis-El-Manar; Centre Nationale de Greffe de la Moelle Osseuse; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Ege University; University of Sydney; University of Sydney; National Taiwan University; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; St Jude Children's Research Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Bristol-Myers Squibb; Celgene Corporation; Acceleron Pharma; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Cappellini, MD (corresponding author), Univ Milan, Dept Clin Sci & Community, IRCCS Ca Granda Fdn Maggiore Policlin Hosp, Via Francesco Sforza 35, I-20122 Milan, Italy.	maria.cappellini@unimi.it	Ricchi, Paolo/J-5140-2019; Neufeld, Ellis J./F-9331-2011; kuo, kevin/GXM-4399-2022; chew, lee ping/H-4355-2011; Georgiev, Pencho/AAV-6464-2020; BEE, PING CHONG/B-5373-2010; Coates, Thomas/AAN-3556-2020; Kuo, Kevin/AAV-5580-2021	Ricchi, Paolo/0000-0001-7361-3308; Neufeld, Ellis J./0000-0001-8092-6281; Georgiev, Pencho/0000-0001-5677-6754; BEE, PING CHONG/0000-0003-4253-760X; Coates, Thomas/0000-0001-9878-6029; Voi, Vincenzo/0000-0001-7249-2735; Durst, Ronen/0000-0003-3559-1050; Hill, Quentin/0000-0002-0627-4358; Pinto, Valeria Maria/0000-0002-8375-6289	Celgene; Acceleron Pharma; EudraCT [2015--003224-31]; BELIEVE	Celgene(Bristol-Myers SquibbCelgene Corporation); Acceleron Pharma; EudraCT; BELIEVE	Funded by Celgene and Acceleron Pharma; BELIEVE ClinicalTrials.gov number, NCT02604433; EudraCT number, 2015--003224-31.	[Anonymous], 2019, ZYNT SUMM PROD CHAR; [Anonymous], 2012, KIDNEY INT, V2, ps1; Attie KM, 2014, AM J HEMATOL, V89, P766, DOI 10.1002/ajh.23732; Aydinok Y, 2015, EUR J HAEMATOL, V95, P244, DOI 10.1111/ejh.12487; Borgna-Pignatti C, 2004, HAEMATOLOGICA, V89, P1187; Brittenham GM, 2011, NEW ENGL J MED, V364, P146, DOI 10.1056/NEJMct1004810; Cappellini MD, 2018, BLOOD REV, V32, P300, DOI 10.1016/j.blre.2018.02.001; Cappellini MD, 2012, EXPERT REV HEMATOL, V5, P505, DOI [10.1586/ehm.12.42, 10.1586/EHM.12.42]; Cappellini MD., 2014, GUIDELINES MANAGEMEN, V3; Coates TD, 2014, FREE RADICAL BIO MED, V72, P23, DOI 10.1016/j.freeradbiomed.2014.03.039; Gan GG, 2016, ANN ACAD MED SINGAP, V45, P520; Guerra A, 2019, BLOOD, V134, P568, DOI 10.1182/blood.2019001057; Locatelli F, 2013, BLOOD, V122, P1072, DOI 10.1182/blood-2013-03-489112; Modell B, 2000, LANCET, V355, P2051, DOI 10.1016/S0140-6736(00)02357-6; Modell B, 2008, B WORLD HEALTH ORGAN, V86, P480, DOI 10.2471/BLT.06.036673; Musallam KM, 2013, HAEMATOLOGICA, V98, P833, DOI 10.3324/haematol.2012.066845; Piga A, 2019, BLOOD, V133, P1279, DOI 10.1182/blood-2018-10-879247; Platzbecker U, 2017, LANCET ONCOL, V18, P1338, DOI 10.1016/S1470-2045(17)30615-0; Scalone L, 2008, CURR MED RES OPIN, V24, P1905, DOI 10.1185/03007990802160834 ; Suragani RNVS, 2014, BLOOD, V123, P3864, DOI 10.1182/blood-2013-06-511238; Suragani RNVS, 2014, NAT MED, V20, P408, DOI 10.1038/nm.3512; Taher AT, 2018, LANCET, V391, P155, DOI 10.1016/S0140-6736(17)31822-6; Taher AT, 2010, BLOOD, V115, P1886, DOI 10.1182/blood-2009-09-243154; Thompson AA, 2018, NEW ENGL J MED, V378, P1479, DOI 10.1056/NEJMoa1705342; Weatherall DJ, 2010, BLOOD, V115, P4331, DOI 10.1182/blood-2010-01-251348	25	99	102	5	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 26	2020	382	13					1219	1231		10.1056/NEJMoa1910182	http://dx.doi.org/10.1056/NEJMoa1910182			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KY1UO	32212518	Bronze, Green Published			2022-12-28	WOS:000522357300009
J	Bivens, M				Bivens, Matt			The Dishonesty of Informed Consent Rituals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Out of respect for patient autonomy, we ritually inform patients of self-evident risks, even as we mock the very idea of informed consent by routinely prescribing combined medications that we must know will cost 10 times as much as the separate components.	[Bivens, Matt] Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA; [Bivens, Matt] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Bivens, M (corresponding author), Beth Israel Deaconess Med Ctr, Dept Emergency Med, Boston, MA 02215 USA.; Bivens, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Himmelstein DU, 2019, AM J PUBLIC HEALTH, V109, P431, DOI 10.2105/AJPH.2018.304901; Janitzky AA, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001852; Kliff S, 2018, VOX             1004; Rosenthal E, 2019, JAMA INTERN MED, V179, P114, DOI 10.1001/jamainternmed.2018.5007	4	1	1	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1089	1091		10.1056/NEJMp1916864	http://dx.doi.org/10.1056/NEJMp1916864			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KW7AJ	32187468				2022-12-28	WOS:000521333700008
J	Reynolds, KL; Sullivan, RJ; Fintelmann, FJ; Mansour, MK; England, J				Reynolds, Kerry L.; Sullivan, Ryan J.; Fintelmann, Florian J.; Mansour, Michael K.; England, Jonathan			Case 9-2020: A 64-Year-Old Man with Shortness of Breath, Cough, and Hypoxemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								A 64-year-old man with a history of melanoma presented to the hospital after evaluation for clumsiness of the right arm had revealed a brain mass. Metastatic melanoma was diagnosed, and treatment included combination immune checkpoint inhibitor therapy. Fevers, dyspnea, and cough developed. Treatment decisions were made.	[Reynolds, Kerry L.; Sullivan, Ryan J.; Mansour, Michael K.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fintelmann, Florian J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [England, Jonathan] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Reynolds, Kerry L.; Sullivan, Ryan J.; Mansour, Michael K.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Fintelmann, Florian J.] Harvard Med Sch, Dept Radiol, Boston, MA 02115 USA; [England, Jonathan] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Reynolds, KL (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Reynolds, KL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.			England, Jonathan/0000-0002-6330-3688				[Anonymous], 2019, NEW ENGL J MED, V381, P1268; Baddley JW, 2009, J CLIN MICROBIOL, V47, P3271, DOI 10.1128/JCM.00854-09; Brahmer JR, 2018, J ONCOL PRACT, V14, P247, DOI 10.1200/JOP.18.00005; Champiat S, 2017, CLIN CANCER RES, V23, P1920, DOI 10.1158/1078-0432.CCR-16-1741; Chen JH, 2017, AM J SURG PATHOL, V41, P643, DOI 10.1097/PAS.0000000000000829; Haanen JBAG, 2017, ANN ONCOL, V28, P119, DOI 10.1093/annonc/mdx225; Kao JC, 2017, JAMA NEUROL, V74, P1216, DOI 10.1001/jamaneurol.2017.1912; Karamchandani DM, 2018, J CLIN PATHOL, V71, P665, DOI 10.1136/jclinpath-2018-205143; Molina DK, 2012, AM J FOREN MED PATH, V33, P368, DOI 10.1097/PAF.0b013e31823d29ad; Naidoo J, 2017, J CLIN ONCOL, V35, P709, DOI 10.1200/JCO.2016.68.2005; National Comprehensive Cancer Network, 2019, NCCN IMM; Puzanov I, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0300-z; Risslegger B, 2017, CLIN MICROBIOL INFEC, V23, p776E1, DOI 10.1016/j.cmi.2017.04.012; Steinbach WJ, 2004, CLIN INFECT DIS, V39, P192, DOI 10.1086/421950; Wang DY, 2018, JAMA ONCOL, V4, P1721, DOI 10.1001/jamaoncol.2018.3923; Wolchok JD, 2017, NEW ENGL J MED, V377, P1345, DOI 10.1056/NEJMoa1709684; Zubiri L, 2020, ONCOLOGIST, V25, pE398, DOI 10.1634/theoncologist.2018-0883	17	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 19	2020	382	12					1150	1159		10.1056/NEJMcpc1909621	http://dx.doi.org/10.1056/NEJMcpc1909621			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KW7AJ	32187473				2022-12-28	WOS:000521333700015
J	Shah, R; Ahluwalia, S				Shah, Rupal; Ahluwalia, Sanjiv			Different ways of knowing	LANCET			English	Editorial Material									[Shah, Rupal; Ahluwalia, Sanjiv] Hlth Educ England, London, England; [Shah, Rupal] Bridge Lane Grp Practice, London SW11 3AD, England; [Ahluwalia, Sanjiv] Wentworth Med Practice, London, England		Shah, R (corresponding author), Hlth Educ England, London, England.; Shah, R (corresponding author), Bridge Lane Grp Practice, London SW11 3AD, England.	rupal.shah@hee.nhs.uk		Ahluwalia, Sanjiv/0000-0002-5830-0853; Shah, Rupal/0000-0001-9079-0971					0	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 14	2020	395	10227					862	863						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	QC8NO	32171401				2022-12-28	WOS:000615088500001
J	Han, Y; Reyes, AA; Malik, S; He, Y				Han, Yan; Reyes, Alexis A.; Malik, Sara; He, Yuan			Cryo-EM structure of SWI/SNF complex bound to a nucleosome	NATURE			English	Article							CHROMATIN; VISUALIZATION; TRANSCRIPTION; MECHANISMS; EXPRESSION; MICROSCOPY; PROTEINS	The chromatin-remodelling complex SWI/SNF is highly conserved and has critical roles in various cellular processes, including transcription and DNA-damage repair(1,2). It hydrolyses ATP to remodel chromatin structure by sliding and evicting histone octamers(3-8), creating DNA regions that become accessible to other essential factors. However, our mechanistic understanding of the remodelling activity is hindered by the lack of a high-resolution structure of complexes from this family. Here we report the cryo-electron microscopy structure of Saccharomyces cerevisiae SWI/SNF bound to a nucleosome, at near-atomic resolution. In the structure, the actin-related protein (Arp) module is sandwiched between the ATPase and the rest of the complex, with the Snf2 helicase-SANT associated (HSA) domain connecting all modules. The body contains an assembly scaffold composed of conserved subunits Snf12 (also known as SMARCD or BAF60), Snf5 (also known as SMARCB1, BAF47 or INI1) and an asymmetric dimer of Swi3 (also known as SMARCC, BAF155 or BAF170). Another conserved subunit, Swi1 (also known as ARID1 or BAF250), resides in the core of SWI/SNF, acting as a molecular hub. We also observed interactions between Snf5 and the histones at the acidic patch, which could serve as an anchor during active DNA translocation. Our structure enables us to map and rationalize a subset of cancer-related mutations in the human SWI/SNF complex and to propose a model for how SWI/SNF recognizes and remodels the +1 nucleosome to generate nucleosome-depleted regions during gene activation(9). The cryo-electron microscopy structure of the yeast SWI/SNF complex bound to a nucleosome substrate provides insights into the chromatin-remodelling function of this family of protein complexes and suggests mechanisms by which the mutated proteins may cause cancer.	[Han, Yan; Reyes, Alexis A.; Malik, Sara; He, Yuan] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Reyes, Alexis A.; He, Yuan] Northwestern Univ, Interdisciplinary Biol Sci Program, Evanston, IL 60208 USA; [He, Yuan] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [He, Yuan] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	He, Y (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.; He, Y (corresponding author), Northwestern Univ, Interdisciplinary Biol Sci Program, Evanston, IL 60208 USA.; He, Y (corresponding author), Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA.; He, Y (corresponding author), Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	yuanhe@northwestern.edu	Classen, Scott/AAY-8176-2020; Han, Yan/ABC-1031-2020; He, Yuan/GVT-7268-2022	Han, Yan/0000-0002-1207-7756; He, Yuan/0000-0002-1455-3963	Cornew Innovation Award from the Chemistry of Life Processes Institute at Northwestern University; Catalyst Award by the Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; American Cancer Society [IRG-15-173-21]; H Foundation Core Facility Pilot Project Award; NIGMS [R01GM135651]; NCI [P01CA092584]; NCI grant [U54CA193419]; Chicago Biomedical Consortium Postdoctoral Research Grant; Molecular Biophysics Training Program from NIGMS/NIH [5T32 GM008382]	Cornew Innovation Award from the Chemistry of Life Processes Institute at Northwestern University; Catalyst Award by the Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; American Cancer Society(American Cancer Society); H Foundation Core Facility Pilot Project Award; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chicago Biomedical Consortium Postdoctoral Research Grant; Molecular Biophysics Training Program from NIGMS/NIH	We thank J. Remis for assistance with microscope operation and data collection and J. Pattie for computer support; A. Rosenzweig, I. Radhakrishnan and S. Fishbain for helpful discussion and comments on the manuscript; the staff at the Structural Biology Facility of Northwestern University for technical support. This work was supported by a Cornew Innovation Award from the Chemistry of Life Processes Institute at Northwestern University (to Y. He), a Catalyst Award by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust (to Y. He), an Institutional Research Grant from the American Cancer Society (IRG-15-173-21 to Y. He), an H Foundation Core Facility Pilot Project Award (to Y. He). Y. He is supported by NIGMS grant R01GM135651, NCI grant P01CA092584 and a Pilot Project Award from NCI grant U54CA193419. Y. Han is a recipient of the Chicago Biomedical Consortium Postdoctoral Research Grant. A.A.R. is supported by the Molecular Biophysics Training Program from NIGMS/NIH (5T32 GM008382).	Armache JP, 2019, ELIFE, V8, DOI 10.7554/eLife.46057; Ayala R, 2018, NATURE, V556, P391, DOI 10.1038/s41586-018-0021-6; Bai XC, 2015, ELIFE, V4, DOI 10.7554/eLife.11182; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Cairns BR, 1996, GENE DEV, V10, P2131, DOI 10.1101/gad.10.17.2131; Cairns BR, 1998, TRENDS BIOCHEM SCI, V23, P20, DOI 10.1016/S0968-0004(97)01160-2; Clapier CR, 2017, NAT REV MOL CELL BIO, V18, P407, DOI 10.1038/nrm.2017.26; Dechassa ML, 2008, MOL CELL BIOL, V28, P6010, DOI 10.1128/MCB.00693-08; Dutta A, 2017, CELL REP, V18, P2124, DOI 10.1016/j.celrep.2017.01.058; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eustermann S, 2018, NATURE, V556, P386, DOI 10.1038/s41586-018-0029-y; Farnung L, 2017, NATURE, V550, P539, DOI 10.1038/nature24046; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Han Y, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0044-z; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; Henderson R, 2012, STRUCTURE, V20, P205, DOI 10.1016/j.str.2011.12.014; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Jung LA, 2017, ONCOGENE, V36, P1911, DOI 10.1038/onc.2016.354; Kidmose RT, 2019, IUCRJ, V6, P526, DOI 10.1107/S2052252519007619; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Lander GC, 2009, J STRUCT BIOL, V166, P95, DOI 10.1016/j.jsb.2009.01.002; Li MJ, 2019, NATURE, V567, P409, DOI 10.1038/s41586-019-1029-2; Liu XY, 2017, NATURE, V544, P440, DOI 10.1038/nature22036; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Mashtalir N, 2018, CELL, V175, P1272, DOI 10.1016/j.cell.2018.09.032; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Narlikar GJ, 2013, CELL, V154, P490, DOI 10.1016/j.cell.2013.07.011; Neely KE, 2002, MOL CELL BIOL, V22, P1615, DOI 10.1128/MCB.22.6.1615-1625.2002; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sandhya S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205267; Schubert HL, 2013, P NATL ACAD SCI USA, V110, P3345, DOI 10.1073/pnas.1215379110; Sen P, 2017, CELL REP, V18, P2135, DOI 10.1016/j.celrep.2017.02.017; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sunderamoothy R, 2017, ELIFE, V6, DOI 10.7554/eLife.22510; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Treich I, 1998, NUCLEIC ACIDS RES, V26, P3739, DOI 10.1093/nar/26.16.3739; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Voss NR, 2009, J STRUCT BIOL, V166, P205, DOI 10.1016/j.jsb.2009.01.004; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Willhoft O, 2018, SCIENCE, V362, P199, DOI 10.1126/science.aat7716; Yan L, 2017, J MOL BIOL, V429, P1650, DOI 10.1016/j.jmb.2017.04.008; Yang XF, 2007, NAT STRUCT MOL BIOL, V14, P540, DOI 10.1038/nsmb1238; Yen KY, 2012, CELL, V149, P1461, DOI 10.1016/j.cell.2012.04.036; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang ZH, 2018, PROTEIN CELL, V9, P1045, DOI 10.1007/s13238-018-0524-9; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou CY, 2016, ANNU REV BIOPHYS, V45, P153, DOI 10.1146/annurev-biophys-051013-022819	62	57	59	3	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					452	+		10.1038/s41586-020-2087-1	http://dx.doi.org/10.1038/s41586-020-2087-1		MAR 2020	17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188938	Green Accepted			2022-12-28	WOS:000519162500010
J	Houben, L; Weissman, H; Wolf, SG; Rybtchinski, B				Houben, Lothar; Weissman, Haim; Wolf, Sharon G.; Rybtchinski, Boris			A mechanism of ferritin crystallization revealed by cryo-STEM tomography	NATURE			English	Article							NONCLASSICAL NUCLEATION; PROTEIN; PRECURSORS; CLUSTERS; CRYSTALS; ORDER	Protein crystallization is important in structural biology, disease research and pharmaceuticals. It has recently been recognized that nonclassical crystallization involving initial formation of an amorphous precursor phase-occurs often in protein, organic and inorganic crystallization processes(1-5). A two-step nucleation theory has thus been proposed, in which initial low-density, solvated amorphous aggregates subsequently densify, leading to nucleation(4,6,7). This view differs from classical nucleation theory, which implies that crystalline nuclei forming in solution have the same density and structure as does the final crystalline state(1). A protein crystallization mechanism involving this classical pathway has recently been observed directly(8). However, a molecular mechanism of nonclassical protein crystallization(9-15) has not been established(9,11,14). To determine the nature of the amorphous precursors and whether crystallization takes place within them (and if so, how order develops at the molecular level), three-dimensional (3D) molecular-level imaging of a crystallization process is required. Here we report cryogenic scanning transmission microscopy tomography of ferritin aggregates at various stages of crystallization, followed by 3D reconstruction using simultaneous iterative reconstruction techniques to provide a 3D picture of crystallization with molecular resolution. As crystalline order gradually increased in the studied aggregates, they exhibited an increase in both order and density from their surface towards their interior. We observed no highly ordered small structures typical of a classical nucleation process, and occasionally we observed several ordered domains emerging within one amorphous aggregate, a phenomenon not predicted by either classical or two-step nucleation theories. Our molecular-level analysis hints at desolvation as the driver of the continuous order-evolution mechanism, a view that goes beyond current nucleation models, yet is consistent with a broad spectrum of protein crystallization mechanisms.	[Houben, Lothar; Wolf, Sharon G.] Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel; [Houben, Lothar; Wolf, Sharon G.] Weizmann Inst Sci, Dept Organ Chem, Rehovot, Israel; [Weissman, Haim; Rybtchinski, Boris] Weizmann Inst Sci, Dept Organ Chem, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science	Houben, L (corresponding author), Weizmann Inst Sci, Dept Chem Res Support, Rehovot, Israel.; Houben, L (corresponding author), Weizmann Inst Sci, Dept Organ Chem, Rehovot, Israel.; Rybtchinski, B (corresponding author), Weizmann Inst Sci, Dept Organ Chem, Rehovot, Israel.	lothar.houben@weizmann.ac.il; boris.rybtchinski@weizmann.ac.il	Houben, Lothar/K-3593-2013; WOLF, SHARON G/K-1768-2012	Houben, Lothar/0000-0003-0200-3611; WOLF, SHARON G/0000-0002-5337-5063	Helen and Martin Kimmel Center for Molecular Design; Irving and Cherna Moskowitz Center for Nano and BioNano Imaging (Weizmann Institute of Science); Israel Science Foundation [1285/14]	Helen and Martin Kimmel Center for Molecular Design; Irving and Cherna Moskowitz Center for Nano and BioNano Imaging (Weizmann Institute of Science); Israel Science Foundation(Israel Science Foundation)	This work was supported by the Helen and Martin Kimmel Center for Molecular Design. We thank S. Albeck, M. Peretz and J. Jacobovitch for assistance with GPC experiments, I. Biran for help acquiring cryo-STEM tomograms, and B. Palmer and R. Diskin for discussions. The electron microscopy studies were partially supported by the Irving and Cherna Moskowitz Center for Nano and BioNano Imaging (Weizmann Institute of Science). S.G.W. acknowledges support for cryo-STEM tomography studies from the Israel Science Foundation (grant number 1285/14).	Anwar J, 2011, ANGEW CHEM INT EDIT, V50, P1996, DOI 10.1002/anie.201000463; De Yoreo JJ, 2015, SCIENCE, V349, DOI 10.1126/science.aaa6760; Erdemir D, 2009, ACCOUNTS CHEM RES, V42, P621, DOI 10.1021/ar800217x; Gasser U, 2014, EUR PHYS J-SPEC TOP, V223, P455, DOI 10.1140/epjst/e2014-02102-6; Gebauer D, 2014, CHEM SOC REV, V43, P2348, DOI 10.1039/c3cs60451a; Granier T, 1997, ACTA CRYSTALLOGR D, V53, P580, DOI 10.1107/S0907444997003314; Janssens KGF, 2006, NAT MATER, V5, P124, DOI 10.1038/nmat1559; Lechner W, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2977970; Sauter A, 2015, J AM CHEM SOC, V137, P1485, DOI 10.1021/ja510533x; Sear RP, 2012, INT MATER REV, V57, P328, DOI 10.1179/1743280411Y.0000000015; Sleutel M, 2018, NANOSCALE, V10, P12256, DOI 10.1039/c8nr02867b; Sleutel M, 2014, P NATL ACAD SCI USA, V111, pE546, DOI 10.1073/pnas.1309320111; STEINHARDT PJ, 1983, PHYS REV B, V28, P784, DOI 10.1103/PhysRevB.28.784; tenWolde PR, 1997, SCIENCE, V277, P1975, DOI 10.1126/science.277.5334.1975; Van Driessche AES, 2018, NATURE, V556, P89, DOI 10.1038/nature25971; Vekilov PG, 2016, PROG CRYST GROWTH CH, V62, P136, DOI 10.1016/j.pcrysgrow.2016.04.007; Vekilov PG, 2014, ACTA CRYSTALLOGR F, V70, P271, DOI 10.1107/S2053230X14002386; Vekilov PG, 2010, CRYST GROWTH DES, V10, P5007, DOI 10.1021/cg1011633; Wolf SG, 2014, NAT METHODS, V11, P423, DOI [10.1038/NMETH.2842, 10.1038/nmeth.2842]; Yamazaki T, 2017, P NATL ACAD SCI USA, V114, P2154, DOI 10.1073/pnas.1606948114; Yau ST, 2000, NATURE, V406, P494, DOI 10.1038/35020035; Zhang FJ, 2017, J PHYS-CONDENS MAT, V29, DOI 10.1088/1361-648X/aa8253	22	36	36	4	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7800					540	+		10.1038/s41586-020-2104-4	http://dx.doi.org/10.1038/s41586-020-2104-4			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LF2ML	32214264				2022-12-28	WOS:000527257200001
J	Page, KR; Venkataramani, M; Beyrer, C; Polk, S				Page, Kathleen R.; Venkataramani, Maya; Beyrer, Chris; Polk, Sarah			Undocumented US Immigrants and Covid-19	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								Years of anti-immigrant policies and rhetoric will be difficult to reverse, but it's essential that the Trump administration address the needs of undocumented immigrants in its response to the Covid-19 pandemic.	[Page, Kathleen R.; Venkataramani, Maya; Polk, Sarah] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Page, KR (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.							[Anonymous], 2011, 2011 OP MAN ICE PERF; Cheng YLJ, 2019, JAMA-J AM MED ASSOC, V322, P2389, DOI 10.1001/jama.2019.19365; Page KR, 2017, NEW ENGL J MED, V376, DOI 10.1056/NEJMp1700829; Radford J, 2019, FACTS US IMMIGRANTS; Zallman L, 2019, JAMA PEDIATR, V173, DOI 10.1001/jamapediatrics.2019.1744	5	135	135	3	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 21	2020	382	21							e62	10.1056/NEJMp2005953	http://dx.doi.org/10.1056/NEJMp2005953			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LT1TD	32220207	Bronze			2022-12-28	WOS:000536856000003
J	van der Pluijm, RW; Tripura, R; Hoglund, RM; Phyo, AP; Lek, D; Ul Islam, A; Anvikar, AR; Satpathi, P; Satpathi, S; Behera, PK; Tripura, A; Baidya, S; Onyamboko, M; Chau, NH; Sovann, Y; Suon, S; Sreng, S; Mao, S; Oun, S; Yen, S; Amaratunga, C; Chutasmit, K; Saelow, C; Runcharern, R; Kaewmok, W; Hoa, NT; Thanh, NV; Hanboonkunupakarn, B; Callery, JJ; Mohanty, AK; Heaton, J; Thant, M; Gantait, K; Ghosh, T; Amato, R; Pearson, RD; Jacob, CG; Goncalves, S; Mukaka, M; Waithira, N; Woodrow, CJ; Grobusch, MP; van Vugt, M; Fairhurst, RM; Cheah, PY; Peto, TJ; von Seidlein, L; Dhorda, M; Maude, RJ; Winterberg, M; Thuy-Nhien, NT; Kwiatkowski, DP; Imwong, M; Jittamala, P; Lin, K; Hlaing, TM; Chotivanich, K; Huy, R; Fanello, C; Ashley, E; Mayxay, M; Newton, PN; Hien, TT; Valecha, N; Smithuis, F; Pukrittayakamee, S; Faiz, A; Miotto, O; Tarning, J; Day, NPJ; White, NJ; Dondorp, AM				van der Pluijm, Rob W.; Tripura, Rupam; Hoglund, Richard M.; Phyo, Aung Pyae; Lek, Dysoley; Ul Islam, Akhter; Anvikar, Anupkumar R.; Satpathi, Parthasarathi; Satpathi, Sanghamitra; Behera, Prativa Kumari; Tripura, Amar; Baidya, Subrata; Onyamboko, Marie; Nguyen Hoang Chau; Sovann, Yok; Suon, Seila; Sreng, Sokunthea; Mao, Sivanna; Oun, Savuth; Yen, Sovannary; Amaratunga, Chanaki; Chutasmit, Kitipumi; Saelow, Chalermpon; Runcharern, Ratchadaporn; Kaewmok, Weerayuth; Nhu Thi Hoa; Ngo Viet Thanh; Hanboonkunupakarn, Borimas; Callery, James J.; Mohanty, Akshaya Kumar; Heaton, James; Thant, Myo; Gantait, Kripasindhu; Ghosh, Tarapada; Amato, Roberto; Pearson, Richard D.; Jacob, Christopher G.; Goncalves, Sonia; Mukaka, Mavuto; Waithira, Naomi; Woodrow, Charles J.; Grobusch, Martin P.; van Vugt, Michele; Fairhurst, Rick M.; Cheah, Phaik Yeong; Peto, Thomas J.; von Seidlein, Lorenz; Dhorda, Mehul; Maude, Richard J.; Winterberg, Markus; Nguyen Thanh Thuy-Nhien; Kwiatkowski, Dominic P.; Imwong, Mallika; Jittamala, Podjanee; Lin, Khin; Hlaing, Tin Maung; Chotivanich, Kesinee; Huy, Rekol; Fanello, Caterina; Ashley, Elizabeth; Mayxay, Mayfong; Newton, Paul N.; Tran Tinh Hien; Valecha, Neena; Smithuis, Frank; Pukrittayakamee, Sasithon; Faiz, Abul; Miotto, Olivo; Tarning, Joel; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.		Tracking Resistance Artemisinin	Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial	LANCET			English	Article							MASS-SPECTROMETRIC METHOD; METABOLITE DIHYDROARTEMISININ; PIPERAQUINE RESISTANCE; CHLOROQUINE RESISTANCE; SPREAD; ARTESUNATE; ARTEMETHER; CAMBODIA; IMPACT	Background Artemisinin and partner-drug resistance in Plasmodium falciparum are major threats to malaria control and elimination. Triple artemisinin-based combination therapies (TACTs), which combine existing co-formulated ACTs with a second partner drug that is slowly eliminated, might provide effective treatment and delay emergence of antimalarial drug resistance. Methods In this multicentre, open-label, randomised trial, we recruited patients with uncomplicated P falciparum malaria at 18 hospitals and health clinics in eight countries. Eligible patients were aged 2-65 years, with acute, uncomplicated P falciparum malaria alone or mixed with non-falciparum species, and a temperature of 37.5 degrees C or higher, or a history of fever in the past 24 h. Patients were randomly assigned (1:1) to one of two treatments using block randomisation, depending on their location: in Thailand, Cambodia, Vietnam, and Myanmar patients were assigned to either dihydroartemisinin-piperaquine or dihydroartemisinin-piperaquine plus mefloquine; at three sites in Cambodia they were assigned to either artesunate-mefloquine or dihydroartemisinin-piperaquine plus mefloquine; and in Laos, Myanmar, Bangladesh, India, and the Democratic Republic of the Congo they were assigned to either artemether-lumefantrine or artemether-lumefantrine plus amodiaquine. All drugs were administered orally and doses varied by drug combination and site. Patients were followed-up weekly for 42 days. The primary endpoint was efficacy, defined by 42-day PCR-corrected adequate clinical and parasitological response. Primary analysis was by intention to treat. A detailed assessment of safety and tolerability of the study drugs was done in all patients randomly assigned to treatment. This study is registered at ClinicalTrials.gov, NCT02453308, and is complete. Findings Between Aug 7, 2015, and Feb 8, 2018, 1100 patients were given either dihydroartemisinin-piperaquine (183 [17%]), dihydroartemisinin-piperaquine plus mefloquine (269 [24%]), artesunate-mefloquine (73 [7%]), artemether-lumefantrine (289 [26%]), or artemether-lumefantrine plus amodiaquine (286 [26%]). The median age was 23 years (IQR 13 to 34) and 854 (78%) of 1100 patients were male. In Cambodia, Thailand, and Vietnam the 42-day PCR-corrected efficacy after dihydroartemisinin-piperaquine plus mefloquine was 98% (149 of 152; 95% CI 94 to 100) and after dihydroartemisinin-piperaquine was 48% (67 of 141; 95% CI 39 to 56; risk difference 51%, 95% CI 42 to 59; p<0.0001). Efficacy of dihydroartemisinin-piperaquine plus mefloquine in the three sites in Myanmar was 91% (42 of 46; 95% CI 79 to 98) versus 100% (42 of 42; 95% CI 92 to 100) after dihydroartemisinin-piperaquine (risk difference 9%, 95% CI 1 to 17; p=0.12). The 42-day PCR corrected efficacy of dihydroartemisinin-piperaquine plus mefloquine (96% [68 of 71; 95% CI 88 to 99]) was non-inferior to that of artesunate-mefloquine (95% [69 of 73; 95% CI 87 to 99]) in three sites in Cambodia (risk difference 1%; 95% CI -6 to 8; p=1.00). The overall 42-day PCR-corrected efficacy of artemether-lumefantrine plus amodiaquine (98% [281 of 286; 95% CI 97 to 99]) was similar to that of artemether-lumefantrine (97% [279 of 289; 95% CI 94 to 98]; risk difference 2%, 95% CI -1 to 4; p=0.30). Both TACTs were well tolerated, although early vomiting (within 1 h) was more frequent after dihydroartemisinin-piperaquine plus mefloquine (30 [3.8%] of 794) than after dihydroartemisinin-piperaquine (eight [1.5%] of 543; p=0.012). Vomiting after artemether-lumefantrine plus amodiaquine (22 [1.3%] of 1703) and artemetherlumefantrine (11 [0.6%] of 1721) was infrequent. Adding amodiaquine to artemether-lumefantrine extended the electrocardiogram corrected QT interval (mean increase at 52 h compared with baseline of 8.8 ms [SD 18.6] vs 0.9 ms [16.1]; p<0.01) but adding mefloquine to dihydroartemisinin-piperaquine did not (mean increase of 22.1 ms [SD 19.2] for dihydroartemisinin-piperaquine vs 20.8 ms [SD 17.8] for dihydroartemisinin-piperaquine plus mefloquine; p=0.50). Interpretation Dihydroartemisinin-piperaquine plus mefloquine and artemether-lumefantrine plus amodiaquine TACTs are efficacious, well tolerated, and safe treatments of uncomplicated P falciparum malaria, including in areas with artemisinin and ACT partner-drug resistance.	[van der Pluijm, Rob W.; Tripura, Rupam; Hoglund, Richard M.; Amaratunga, Chanaki; Hanboonkunupakarn, Borimas; Callery, James J.; Mukaka, Mavuto; Waithira, Naomi; Woodrow, Charles J.; Cheah, Phaik Yeong; Peto, Thomas J.; von Seidlein, Lorenz; Dhorda, Mehul; Maude, Richard J.; Winterberg, Markus; Imwong, Mallika; Jittamala, Podjanee; Chotivanich, Kesinee; Fanello, Caterina; Ashley, Elizabeth; Pukrittayakamee, Sasithon; Miotto, Olivo; Tarning, Joel; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand; [Hanboonkunupakarn, Borimas; Chotivanich, Kesinee; Pukrittayakamee, Sasithon] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand; [Imwong, Mallika] Mahidol Univ, Fac Trop Med, Dept Mol Trop Med & Genet, Bangkok, Thailand; [Jittamala, Podjanee] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand; [van der Pluijm, Rob W.; Tripura, Rupam; Hoglund, Richard M.; Amaratunga, Chanaki; Mukaka, Mavuto; Waithira, Naomi; Woodrow, Charles J.; Cheah, Phaik Yeong; Peto, Thomas J.; von Seidlein, Lorenz; Dhorda, Mehul; Maude, Richard J.; Winterberg, Markus; Fanello, Caterina; Ashley, Elizabeth; Newton, Paul N.; Tran Tinh Hien; Smithuis, Frank; Miotto, Olivo; Tarning, Joel; Day, Nicholas P. J.; White, Nicholas J.; Dondorp, Arjen M.] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Ghosh, Tarapada; Amato, Roberto; Kwiatkowski, Dominic P.; Miotto, Olivo] Univ Oxford, Nuffield Dept Med, Big Data Inst, Oxford, England; [Ghosh, Tarapada; Amato, Roberto; Kwiatkowski, Dominic P.; Miotto, Olivo] Univ Oxford, MRC Ctr Genom & Global Hlth, Big Data Inst, Oxford, England; [Maude, Richard J.] Open Univ, Milton Keynes, Bucks, England; [Phyo, Aung Pyae; Heaton, James; Smithuis, Frank] Myanmar Oxford Clin Res Unit, Yangon, Myanmar; [Lek, Dysoley; Suon, Seila; Sreng, Sokunthea; Huy, Rekol] Natl Ctr Parasitol, Entomol & Malaria Control, Phnom Penh, Cambodia; [Lek, Dysoley] Natl Inst Publ Hlth, Sch Publ Hlth, Phnom Penh, Cambodia; [Ul Islam, Akhter] Ramu Upazila Hlth Complex, Coxs Bazar, Bangladesh; [Anvikar, Anupkumar R.; Valecha, Neena] Indian Council Med Res, Natl Inst Malaria Res, New Delhi, India; [Satpathi, Parthasarathi; Satpathi, Sanghamitra; Gantait, Kripasindhu; Ghosh, Tarapada] Midnapore Med Coll, Midnapore, India; [Satpathi, Sanghamitra; Behera, Prativa Kumari] Ispat Gen Hosp, Rourkela, India; [Tripura, Amar; Baidya, Subrata] Agartala Med Coll, Agartala, India; [Onyamboko, Marie; Fanello, Caterina] Kinshasa Mahidol Oxford Res Unit KIMORU, Kinshasa, DEM REP CONGO; [Onyamboko, Marie] Kinshasa Sch Publ Hlth, Kinshasa, DEM REP CONGO; [Nguyen Hoang Chau; Nhu Thi Hoa; Ngo Viet Thanh; Nguyen Thanh Thuy-Nhien; Tran Tinh Hien] Oxford Univ Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Sovann, Yok] Pailin Prov Hlth Dept, Pailin, Cambodia; [Mao, Sivanna] Sampov Meas Referral Hosp, Pursat, Cambodia; [Oun, Savuth; Yen, Sovannary] Ratanakiri Referral Hosp, Ratanakiri, Cambodia; [Amaratunga, Chanaki; Chutasmit, Kitipumi] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA; [Chutasmit, Kitipumi; Saelow, Chalermpon] Phu Sing Hosp, Phu Sing, Sisaket, Thailand; [Runcharern, Ratchadaporn; Kaewmok, Weerayuth] Khun Han Hosp, Khun Han, Sisaket, Thailand; [Mohanty, Akshaya Kumar] Rourkela Res Unit ILS, Infect Dis Biol Unit, IGH, Bhubeneswar, Rourkela, India; [Thant, Myo; Hlaing, Tin Maung] Def Serv Med Res Ctr, Yangon, Myanmar; [Amato, Roberto; Pearson, Richard D.; Jacob, Christopher G.; Goncalves, Sonia; Kwiatkowski, Dominic P.; Imwong, Mallika] Wellcome Sanger Inst, Hinxton, England; [Fairhurst, Rick M.] AstraZeneca, Gaithersburg, MD USA; [Woodrow, Charles J.; Grobusch, Martin P.; van Vugt, Michele] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis, Ctr Trop Med & Travel Med, Amsterdam, Netherlands; [Dhorda, Mehul] WorldWide Antimalarial Resistance Network Asia Re, Bangkok, Thailand; [Maude, Richard J.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Lin, Khin] Dept Med Res, Pyin Oo Lwin, Myanmar; [Ashley, Elizabeth; Mayxay, Mayfong; Newton, Paul N.] Lao Oxford Mahosot Hosp, Wellcome Trust Res Unit LOMWRU, Viangchan, Laos; [Mayxay, Mayfong] Univ Hlth Sci, Inst Res & Educ Dev IRED, Minist Hlth, Viangchan, Laos; [Pukrittayakamee, Sasithon] Royal Soc Thailand, Bangkok, Thailand; [Faiz, Abul] Malaria Res Grp & Dev Care Fdn, Dhaka, Bangladesh	Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; Mahidol University; Mahidol University; Mahidol University; University of Oxford; University of Oxford; University of Oxford; Open University - UK; National Center Parasitology, Entomology & Malaria Control; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Midnapore Medical College; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Wellcome Trust Sanger Institute; AstraZeneca; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Harvard T.H. Chan School of Public Health	Dondorp, AM (corresponding author), Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10400, Thailand.	arjen@tropmedres.ac	Phyo, Aung Pyae/GYU-6181-2022; Waithira, Naomi/AAG-5575-2021; Maude, Richard James/AAV-3567-2020; Fanello, Caterina/AAT-9679-2021; Phyo, Aung Pyae/K-2413-2019; Miotto, Olivo/AAE-7124-2019; Imwong, Mallika/ABE-6493-2020	Phyo, Aung Pyae/0000-0002-0383-9624; Maude, Richard James/0000-0002-5355-0562; Fanello, Caterina/0000-0003-1932-9562; Phyo, Aung Pyae/0000-0002-0383-9624; Miotto, Olivo/0000-0001-8060-6771; Tarning, Joel/0000-0003-4566-4030; White, Nicholas/0000-0002-1897-1978; Waithira, Naomi/0000-0002-2267-9347; Cheah, Phaik Yeong/0000-0001-6327-3266; Peto, Thomas/0000-0003-3197-9891; Callery, James/0000-0002-3218-2166; smithuis, frank/0000-0002-4704-9915; Ashley, Elizabeth/0000-0002-7620-4822	UK Department for International Development; Wellcome Trust; Bill AMP; Melinda Gates Foundation; UK Medical Research Council; US National Institutes of Health; MRC [MR/M006212/1] Funding Source: UKRI	UK Department for International Development; Wellcome Trust(Wellcome TrustEuropean Commission); Bill AMP; Melinda Gates Foundation(CGIAR); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UK Department for International Development, Wellcome Trust, Bill & Melinda Gates Foundation, UK Medical Research Council, and US National Institutes of Health.	Amaratunga C, 2019, BMC MED, V17, DOI 10.1186/s12916-018-1207-3; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; Amato R, 2017, LANCET INFECT DIS, V17, P164, DOI [10.1016/S1473-3099(16)30409-1, 10.1016/s1473-3099(16)30409-1]; [Anonymous], 2007, METHODS TECHNIQUES C; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bopp S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04104-z; Chan XHS, 2018, LANCET INFECT DIS, V18, P913, DOI 10.1016/S1473-3099(18)30297-4; Das S, 2019, CLIN INFECT DIS, V69, P1144, DOI 10.1093/cid/ciy1038; Dini S, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.01068-18, 10.1128/aac.01068-18]; Division of AIDS, 2014, DIV AIDS DAIDS TABL; Eastman RT, 2011, ANTIMICROB AGENTS CH, V55, P3908, DOI 10.1128/AAC.01793-10; Flegg JA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-339; Hamilton WL, 2019, LANCET INFECT DIS, V19, P943, DOI 10.1016/S1473-3099(19)30392-5; Hanboonkunupakarn B, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00060-19; Hanpithakpong W, 2008, J CHROMATOGR B, V876, P61, DOI 10.1016/j.jchromb.2008.10.018; Hanpithakpong W, 2009, BIOANALYSIS, V1, P37, DOI 10.4155/BIO.09.6; Imwong M, 2017, LANCET INFECT DIS, V17, P491, DOI [10.1016/s1473-3099(17)30048-8, 10.1016/S1473-3099(17)30048-8]; Lindegardh N, 2008, J CHROMATOGR B, V862, P227, DOI 10.1016/j.jchromb.2007.12.011; Mai NTH, 1996, LANCET, V348, P917, DOI 10.1016/S0140-6736(96)01409-2; Miotto O, 2015, NAT GENET, V47, P226, DOI 10.1038/ng.3189; Onyamboko MA, 2014, ANTIMICROB AGENTS CH, V58, P5528, DOI 10.1128/AAC.02682-14; Phyo AP, 2016, CLIN INFECT DIS, V63, P784, DOI 10.1093/cid/ciw388; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Rossi G, 2017, LANCET INFECT DIS, V17, P1233, DOI 10.1016/S1473-3099(17)30635-7; Trape JF, 2001, AM J TROP MED HYG, V64, P12, DOI 10.4269/ajtmh.2001.64.12; Tse EG, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2724-z; van der Pluijm RW, 2019, LANCET INFECT DIS, V19, P952, DOI 10.1016/S1473-3099(19)30391-3; Veiga MI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11553; Venkatesan M, 2014, AM J TROP MED HYG, V91, P833, DOI 10.4269/ajtmh.14-0031; WHO, 2019, WORLD MALARIA REPORT; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/S1473-3099(16)30415-7, 10.1016/s1473-3099(16)30415-7]; Woodrow CJ, 2017, FEMS MICROBIOL REV, V41, P34, DOI 10.1093/femsre/fuw037; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813; World Health Organization, 2015, GUID TREATM MAL, Vthird; Worthington RJ, 2013, TRENDS BIOTECHNOL, V31, P177, DOI 10.1016/j.tibtech.2012.12.006	36	105	105	4	13	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 25	2020	395	10233					1345	1360		10.1016/S0140-6736(20)30552-3	http://dx.doi.org/10.1016/S0140-6736(20)30552-3			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MP7SQ	32171078	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000552401700027
J	Chari, ST; Sharma, A; Maitra, A				Chari, Suresh T.; Sharma, Ayush; Maitra, Anirban			Early Detection of Sporadic Pancreatic Ductal Adenocarcinoma: Problems, Promise, and Prospects	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CANCER		[Chari, Suresh T.; Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Sharma, Ayush] Mayo Clin, Rochester, MN USA; [Chari, Suresh T.] Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Unit 1466,1400 Pressler St, Houston, TX 77030 USA; [Sharma, Ayush] Mayo Clin, Div Gastroenterol & Hepatol, 200 First St SW, Rochester, MN 55905 USA; [Maitra, Anirban] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center	Chari, ST (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Gastroenterol Hepatol & Nutr, Unit 1466,1400 Pressler St, Houston, TX 77030 USA.	stchari@mdanderson.org	Sharma, Ayush/AAV-1636-2020	Chari, Suresh/0000-0002-3924-0971	Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer [NIH DK108288]; Kenner Family Research Fund; Prokopanko family; Pancreatic Cancer Action Network	Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer; Kenner Family Research Fund; Prokopanko family; Pancreatic Cancer Action Network	By the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer (grant NIH DK108288) (Drs. Chari and Maitra); the Kenner Family Research Fund (Dr. Chari); the Prokopanko family gift to the Mayo Foundation (Drs. Chari and Sharma); and the Pancreatic Cancer Action Network (Drs. Chari and Maitra).	Chari ST, 2015, PANCREAS, V44, P693, DOI 10.1097/MPA.0000000000000368; Corral JE, 2019, CLIN GASTROENTEROL H, V17, P41, DOI 10.1016/j.cgh.2018.04.065; Maitra A, 2018, PANCREAS, V47, P1244, DOI 10.1097/MPA.0000000000001169; Pannala R, 2009, LANCET ONCOL, V10, P88, DOI 10.1016/S1470-2045(08)70337-1; Sah RP, 2019, GASTROENTEROLOGY, V156, P1742, DOI 10.1053/j.gastro.2019.01.039; Sharma A, 2018, GASTROENTEROLOGY, V155, P490, DOI 10.1053/j.gastro.2018.04.025; Sharma A, 2018, GASTROENTEROLOGY, V155, P730, DOI 10.1053/j.gastro.2018.05.023; Singhi AD, 2019, GASTROENTEROLOGY, V156, P2024, DOI 10.1053/j.gastro.2019.01.259; U.S. Preventive Services Task Force, 2019, PANCR CANC SCREEN	9	4	4	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 21	2020	172	8					558	+		10.7326/M19-2336	http://dx.doi.org/10.7326/M19-2336			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LF9LH	32176886				2022-12-28	WOS:000527733800017
J	Day, M				Day, Michael			Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Corriere della Sera, 2020, COR CONT PAR DORD MA; World Health Organization, REP WHO CHIN JOINT M	2	251	257	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1165	10.1136/bmj.m1165	http://dx.doi.org/10.1136/bmj.m1165			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205334	Bronze			2022-12-28	WOS:000523764100009
J	Garrett, L				Garrett, Laurie			COVID-19: the medium is the message	LANCET			English	Editorial Material												laurie@laurieagarrett.com							0	120	125	5	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					942	943		10.1016/S0140-6736(20)30600-0	http://dx.doi.org/10.1016/S0140-6736(20)30600-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KX2XG	32171075	Green Published, Bronze			2022-12-28	WOS:000521744600017
J	Martinez, L; Cords, O; Horsburgh, CR; Andrews, JR				Martinez, Leonardo; Cords, Olivia; Horsburgh, C. Robert; Andrews, Jason R.		Pediat TB Contact Studies	The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis	LANCET			English	Review							DRUG-RESISTANT TUBERCULOSIS; INTRATHORACIC TUBERCULOSIS; PULMONARY TUBERCULOSIS; CHILDHOOD; INFECTION; DISEASE; BURDEN; HIV; HOUSEHOLDS; COUNTRIES	Background Tens of millions of children are exposed to Mycobacterium tuberculosis globally every year; however, there are no contemporary estimates of the risk of developing tuberculosis in exposed children. The effectiveness of contact investigations and preventive therapy remains poorly understood. Methods In this systematic review and meta-analysis, we investigated the development of tuberculosis in children closely exposed to a tuberculosis case and followed for incident disease. We restricted our search to cohort studies published between Jan 1, 1998, and April 6, 2018, in MEDLINE, Web of Science, BIOSIS, and Embase electronic databases. Individual-participant data and a pre-specified list of variables were requested from authors of all eligible studies. These included characteristics of the exposed child, the index case, and environmental characteristics. To be eligible for inclusion in the final analysis, a dataset needed to include: (1) individuals below 19 years of age; (2) follow-up for tuberculosis for a minimum of 6 months; (3) individuals with household or close exposure to an individual with tuberculosis; (4) information on the age and sex of the child; and (5) start and end follow-up dates. Studies assessing incident tuberculosis but without dates or time of follow-up were excluded. Our analysis had two primary aims: (1) estimating the risk of developing tuberculosis by time-period of follow-up, demographics (age, region), and clinical attributes (HIV, tuberculosis infection status, previous tuberculosis); and (2) estimating the effectiveness of preventive therapy and BCG vaccination on the risk of developing tuberculosis. We estimated the odds of prevalent tuberculosis with mixed-effects logistic models and estimated adjusted hazard ratios (HRs) for incident tuberculosis with mixed-effects Poisson regression models. The effectiveness of preventive therapy against incident tuberculosis was estimated through propensity score matching. The study protocol is registered with PROSPERO (CRD42018087022). Findings In total, study groups from 46 cohort studies in 34 countries-29 (63%) prospective studies and 17 (37%) retrospective-agreed to share their data and were included in the final analysis. 137 647 tuberculosis-exposed children were evaluated at baseline and 130 512 children were followed for 429 538 person-years, during which 1299 prevalent and 999 incident tuberculosis cases were diagnosed. Children not receiving preventive therapy with a positive result for tuberculosis infection had significantly higher 2-year cumulative tuberculosis incidence than children with a negative result for tuberculosis infection, and this incidence was greatest among children below 5 years of age (19.0% [95% CI 8.4-37.4]). The effectiveness of preventive therapy was 63% (adjusted HR 0.37 [95% CI 0.30-0.47]) among all exposed children, and 91% (adjusted HR 0.09 [0.05-0.15]) among those with a positive result for tuberculosis infection. Among all children <5 years of age who developed tuberculosis, 83% were diagnosed within 90 days of the baseline visit. Interpretation The risk of developing tuberculosis among exposed infants and young children is very high. Most cases occurred within weeks of contact investigation initiation and might not be preventable through prophylaxis. This suggests that alternative strategies for prevention are needed, such as earlier initiation of preventive therapy through rapid diagnosis of adult cases or community-wide screening approaches. Copyright (C) 2020 Elsevier Ltd. All rights reserved.	[Martinez, Leonardo; Cords, Olivia; Andrews, Jason R.] Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA; [Horsburgh, C. Robert] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Horsburgh, C. Robert] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Horsburgh, C. Robert] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Horsburgh, C. Robert] Boston Univ, Sch Publ Hlth, Dept Global Hlth, Boston, MA USA	Stanford University; Boston University; Boston University; Boston University; Boston University	Martinez, L (corresponding author), Stanford Univ, Sch Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.	leomarti@stanford.edu	Baliashvili, Davit/AAG-2984-2022; Netto, Eduardo/D-1432-2013; Verhagen, Lilly M./AAG-3044-2021; Fang, Chi-Tai/P-2908-2016; Baliashvili, Davit/AET-0396-2022; Villalba, Julian/AAK-4222-2020; Carvalho, Anna C.C./K-2662-2016; varela, elisa lopez/ABE-4092-2020; Singh, Sarman/AAR-8914-2020; Lee, Chih-Hsin/D-2697-2014; Seddon, James/HHC-2093-2022; Mashiya, Nombeko Monica/AET-3950-2022	Baliashvili, Davit/0000-0001-8390-3325; Netto, Eduardo/0000-0003-1691-6761; Verhagen, Lilly M./0000-0002-3451-9201; Fang, Chi-Tai/0000-0002-7380-1699; Baliashvili, Davit/0000-0001-8390-3325; Villalba, Julian/0000-0001-9230-8747; Carvalho, Anna C.C./0000-0002-0128-942X; varela, elisa lopez/0000-0002-6725-5687; Singh, Sarman/0000-0002-0749-9647; Triasih, Rina/0000-0002-6907-3422; Parsonnet, Julie/0000-0001-7342-5366; Fielding, Katherine/0000-0002-6524-3754; Datta, Sumona/0000-0002-3476-9753; WANG, JANN-YUAN/0000-0003-3406-366X; Lee, Chih-Hsin/0000-0003-1492-3044; Schaaf, Hendrik Simon/0000-0001-5755-4133; van Schalkwyk, Cari/0000-0001-5154-1390; Zar, Heather/0000-0002-9046-759X; Seddon, James/0000-0002-2296-2302; Otero, Larissa/0000-0002-8348-4340; Dietze, Reynaldo/0000-0002-6995-8001; Cohen, Ted/0000-0002-8091-7198; Dobler, Claudia/0000-0002-5460-0189; Andrews, Jason/0000-0002-5967-251X; Sloot, Rosa/0000-0001-7295-3247; Mashiya, Nombeko Monica/0000-0003-0124-9118; Evans, Carlton/0000-0002-6873-5447; Jaramillo Garcia, Luis Fernando/0000-0003-2909-9318; Jones Lopez, Edward/0000-0001-6323-286X; Grandjean, Louis/0000-0002-1457-8327	National Institutes of Health; MRC [MR/M007340/1, MR/K007467/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	National Institutes of Health.	Andrews JR, 2017, LANCET RESP MED, V5, P282, DOI [10.1016/S2213-2600(17)30060-7, 10.1016/s2213-2600(17)30060-7]; Ayieko J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-91; Bentley FJ, 1954, TUBERCULOSIS CHILDHO; Brailey M, 1940, AM J HYG, V31, P1; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; CURRY FJ, 1967, NEW ENGL J MED, V277, P562, DOI 10.1056/NEJM196709142771103; Dodd PJ, 2016, LANCET INFECT DIS, V16, P1193, DOI 10.1016/S1473-3099(16)30132-3; Dodd PJ, 2014, LANCET GLOB HEALTH, V2, pE453, DOI 10.1016/S2214-109X(14)70245-1; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Garcia-Basteiro AL, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.00176-2018; Graham SM, 2015, CLIN INFECT DIS, V61, pS179, DOI 10.1093/cid/civ581; Jenkins HE, 2014, LANCET, V383, P1572, DOI 10.1016/S0140-6736(14)60195-1; Lincoln EM., 1963, TUBERCULOSIS CHILDRE; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Mandalakas AM, 2015, AM J RESP CRIT CARE, V191, P820, DOI 10.1164/rccm.201406-1165OC; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P278; Marais BJ, 2004, INT J TUBERC LUNG D, V8, P392; Martinez L, 2019, LANCET RESP MED, V7, P544, DOI 10.1016/S2213-2600(19)30137-7; Martinez L, 2018, LANCET CHILD ADOLESC, V2, P46, DOI 10.1016/S2352-4642(17)30149-9; Martinez L, 2017, AM J EPIDEMIOL, V185, P1327, DOI 10.1093/aje/kwx025; Miller FJW, 1963, TUBERCULOSIS CHILDRE; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Shah NS, 2014, CLIN INFECT DIS, V58, P381, DOI 10.1093/cid/cit643; Snow KJ, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02352-2017; Stewart LA, 2015, JAMA-J AM MED ASSOC, V313, P1657, DOI 10.1001/jama.2015.3656; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; Wells G., NEWCASTLE OTTAWA SCA; Yuen CM, 2016, PUBLIC HEALTH ACTION, V6, P83, DOI 10.5588/pha.16.0022; Zar HJ, 2007, BRIT MED J, V334, P136, DOI 10.1136/bmj.39000.486400.55	29	80	83	6	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 21	2020	395	10228					973	984						12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX2XG	32199484	Green Accepted, Green Submitted, Bronze, Green Published			2022-12-28	WOS:000521744600028
J	Raman, AP				Raman, Aaswath P.			Thermal light tunnels its way into electricity	SCIENCE			English	Editorial Material									[Raman, Aaswath P.] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90049 USA	University of California System; University of California Los Angeles	Raman, AP (corresponding author), Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90049 USA.	aaswath@ucla.edu	Raman, Aaswath/H-4245-2013	Raman, Aaswath/0000-0003-0106-8341	Sloan Research Fellowship in Physics (Alfred P. Sloan Foundation)	Sloan Research Fellowship in Physics (Alfred P. Sloan Foundation)	Supported by a Sloan Research Fellowship in Physics (Alfred P. Sloan Foundation).	Carnot S., 1824, REFLEXIONS PUISSANCE; Davids PS, 2020, SCIENCE, V367, P1341, DOI 10.1126/science.aba2089; Davids PS, 2015, NAT NANOTECHNOL, V10, P1033, DOI [10.1038/nnano.2015.216, 10.1038/NNANO.2015.216]; Fiorino A, 2018, NAT NANOTECHNOL, V13, P806, DOI 10.1038/s41565-018-0172-5; Grover S, 2010, IEEE T NANOTECHNOL, V9, P716, DOI 10.1109/TNANO.2010.2051334; Lenert A, 2014, NAT NANOTECHNOL, V9, P126, DOI [10.1038/nnano.2013.286, 10.1038/NNANO.2013.286]; MCSPADDEN JO, 1992, IEEE T MICROW THEORY, V40, P2359, DOI 10.1109/22.179902; Raman AP, 2019, JOULE, V3, P2679, DOI 10.1016/j.joule.2019.08.009; Santhanam P, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.161410; Shahsafi A, 2018, PHYS REV APPL, V10, DOI 10.1103/PhysRevApplied.10.034019; Shank J, 2018, PHYS REV APPL, V9, DOI 10.1103/PhysRevApplied.9.054040; U.S. Department of Energy,Advanced Research Projects Agency, 2016, REQ INF RFI FOA DE F	12	3	3	2	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1301	1302		10.1126/science.aba8976	http://dx.doi.org/10.1126/science.aba8976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193308				2022-12-28	WOS:000522167400027
J	Gornall, J				Gornall, Jonathan			INVESTIGATION Tobacco cash behind cannabis research in Oxford	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jgornall@mac.com						Blakely R., 2018, TIMES MAGAZINE  1215; Claridge G, 2018, WORLD LIBRARY PSYCH, P29; Di Forti M, 2019, LANCET PSYCHIAT, V6, P427, DOI 10.1016/S2215-0366(19)30048-3; Gornall J, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1002	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m1044	10.1136/bmj.m1044	http://dx.doi.org/10.1136/bmj.m1044			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188591				2022-12-28	WOS:000523763100008
J	Feng, KB; Quevedo, RE; Kohrt, JT; Oderinde, MS; Reilly, U; White, MC				Feng, Kaibo; Quevedo, Raundi E.; Kohrt, Jeffrey T.; Oderinde, Martins S.; Reilly, Usa; White, M. Christina			Late-stage oxidative C(sp(3))-H methylation	NATURE			English	Article							GLYCOSYL FLUORIDES; AMINO-ACIDS; POTENT; CONVERSION; DISCOVERY; NITROGEN; FUNCTIONALIZATION; SELECTIVITY; ACTIVATION; ALKYLATION	Frequently referred to as the 'magic methyl effect', the installation of methyl groups-especially adjacent (alpha) to heteroatoms-has been shown to dramatically increase the potency of biologically active molecules(1-3). However, existing methylation methods show limited scope and have not been demonstrated in complex settings(1). Here we report a regioselective and chemoselective oxidative C(sp(3))-H methylation method that is compatible with late-stage functionalization of drug scaffolds and natural products. This combines a highly site-selective and chemoselective C-H hydroxylation with a mild, functional-group-tolerant methylation. Using a small-molecule manganese catalyst, Mn(CF3PDP), at low loading (at a substrate/catalyst ratio of 200) affords targeted C-H hydroxylation on heterocyclic cores, while preserving electron-neutral and electron-rich aryls. Fluorine- or Lewis-acid-assisted formation of reactive iminium or oxonium intermediates enables the use of a mildly nucleophilic organoaluminium methylating reagent that preserves other electrophilic functionalities on the substrate. We show this late-stage C(sp(3))-H methylation on 41 substrates housing 16 different medicinally important cores that include electron-rich aryls, heterocycles, carbonyls and amines. Eighteen pharmacologically relevant molecules with competing sites-including drugs (for example, tedizolid) and natural products-are methylated site-selectively at the most electron rich, least sterically hindered position. We demonstrate the syntheses of two magic methyl substrates-an inverse agonist for the nuclear receptor RORc and an antagonist of the sphingosine-1-phosphate receptor-1-via late-stage methylation from the drug or its advanced precursor. We also show a remote methylation of the B-ring carbocycle of an abiraterone analogue. The ability to methylate such complex molecules at late stages will reduce synthetic effort and thereby expedite broader exploration of the magic methyl effect in pursuit of new small-molecule therapeutics and chemical probes. A manganese-catalysed oxidative C(sp(3))-H methylation method allows a methyl group to be selectively installed into medicinally important heterocycles, providing a way to improve pharmaceuticals and better understand the 'magic methyl effect'.	[Feng, Kaibo; Quevedo, Raundi E.; White, M. Christina] Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA; [Kohrt, Jeffrey T.; Reilly, Usa] Pfizer Worldwide Res & Dev, Groton Labs, Groton, CT USA; [Oderinde, Martins S.] Bristol Myers Squibb Co, Res & Dev, Lawrenceville, NJ USA	University of Illinois System; University of Illinois Urbana-Champaign; Pfizer; Bristol-Myers Squibb	White, MC (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	mcwhite7@illinois.edu	Feng, Kaibo/AAH-3592-2020	Feng, Kaibo/0000-0002-8558-4396; Quevedo, Raundi/0000-0002-5939-8936	National Institute of General Medical Sciences (NIGMS) Maximizing Investigators' Research Award (MIRA) [R35 GM122525]; Pfizer; Roy J. Carver Charitable Trust, Muscatine, IA, USA	National Institute of General Medical Sciences (NIGMS) Maximizing Investigators' Research Award (MIRA); Pfizer(Pfizer); Roy J. Carver Charitable Trust, Muscatine, IA, USA	Financial support for this work was provided by the National Institute of General Medical Sciences (NIGMS) Maximizing Investigators' Research Award (MIRA; grant R35 GM122525), and from Pfizer to study the modifications of natural products and medicinal compounds. We thank L. Zhu and the University of Illinois School of Chemical Science (SCS) nuclear magnetic resonance (NMR) laboratory for assistance with NMR spectroscopy, and B. Budaitis for checking the procedure in Fig. 3, molecule 8. The Bruker 500-Mz NMR spectrometer was obtained with the financial support of the Roy J. Carver Charitable Trust, Muscatine, IA, USA.	Andrus MB, 2002, TETRAHEDRON, V58, P845, DOI 10.1016/S0040-4020(01)01172-3; Annese C, 2017, CHEM-EUR J, V23, P259, DOI 10.1002/chem.201604507; Barreiro EJ, 2011, CHEM REV, V111, P5215, DOI 10.1021/cr200060g; Beak P, 1996, ACCOUNTS CHEM RES, V29, P552, DOI 10.1021/ar950142b; BELSHAW PJ, 1995, ANGEW CHEM INT EDIT, V34, P2129, DOI 10.1002/anie.199521291; Blakemore DC, 2018, NAT CHEM, V10, P383, DOI 10.1038/s41557-018-0021-z; Campos KR, 2007, CHEM SOC REV, V36, P1069, DOI 10.1039/b607547a; Cernak T, 2016, CHEM SOC REV, V45, P546, DOI 10.1039/c5cs00628g; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Cordier CJ, 2013, J AM CHEM SOC, V135, P10946, DOI 10.1021/ja4054114; Cui L, 2009, J AM CHEM SOC, V131, P8394, DOI 10.1021/ja903531g; Fauber BP, 2015, J MED CHEM, V58, P5308, DOI 10.1021/acs.jmedchem.5b00597; Fujimoto J, 2017, J MED CHEM, V60, P8963, DOI 10.1021/acs.jmedchem.7b01210; Gormisky PE, 2013, J AM CHEM SOC, V135, P14052, DOI 10.1021/ja407388y; Hiemstra H., 1991, COMPREHENSIVE ORGANI, V2, P1047; Howell JM, 2015, J AM CHEM SOC, V137, P14590, DOI 10.1021/jacs.5b10299; Ito R, 2005, J AM CHEM SOC, V127, P834, DOI 10.1021/ja045603f; Jain P, 2017, NAT CHEM, V9, P140, DOI [10.1038/NCHEM.2619, 10.1038/nchem.2619]; Kato N, 2015, J PORPHYR PHTHALOCYA, V19, P411, DOI 10.1142/S1088424615500297; Kawamata Y, 2017, J AM CHEM SOC, V139, P7448, DOI 10.1021/jacs.7b03539; Kitamura M, 1999, TETRAHEDRON LETT, V40, P4563, DOI 10.1016/S0040-4039(99)00791-1; Le C, 2017, NATURE, V547, P79, DOI 10.1038/nature22813; Leung CS, 2012, J MED CHEM, V55, P4489, DOI 10.1021/jm3003697; Li ZP, 2006, P NATL ACAD SCI USA, V103, P8928, DOI 10.1073/pnas.0601687103; Lunn MR, 2004, CHEM BIOL, V11, P1489, DOI 10.1016/j.chembiol.2004.08.024; MARYANOFF BE, 1984, J MED CHEM, V27, P943, DOI 10.1021/jm00374a001; Mason JD, 2017, ANGEW CHEM INT EDIT, V56, P16674, DOI 10.1002/anie.201710943; Milan M, 2017, ACS CATAL, V7, P5903, DOI 10.1021/acscatal.7b02151; Milligan JA, 2019, ANGEW CHEM INT EDIT, V58, P6152, DOI 10.1002/anie.201809431; NICOLAOU KC, 1984, J CHEM SOC CHEM COMM, P1153, DOI 10.1039/c39840001153; Osberger TJ, 2016, NATURE, V537, P214, DOI 10.1038/nature18941; Paul A, 2019, J AM CHEM SOC, V141, P8778, DOI 10.1021/jacs.9b04325; POSNER GH, 1985, TETRAHEDRON LETT, V26, P1823, DOI 10.1016/S0040-4039(00)94747-6; Prendergast MA, 1998, PSYCHOPHARMACOLOGY, V136, P50, DOI 10.1007/s002130050538; Quancard J, 2012, CHEM BIOL, V19, P1142, DOI 10.1016/j.chembiol.2012.07.016; Schonherr H, 2013, ANGEW CHEM INT EDIT, V52, P12256, DOI 10.1002/anie.201303207; Shogren-Knaak MA, 2001, ANNU REV CELL DEV BI, V17, P405, DOI 10.1146/annurev.cellbio.17.1.405; STEVENS RV, 1984, ACCOUNTS CHEM RES, V17, P289, DOI 10.1021/ar00104a005; Sugi K, 2000, CHEM PHARM BULL, V48, P529; Taylor RD, 2014, J MED CHEM, V57, P5845, DOI 10.1021/jm4017625; TOMOOKA K, 1987, TETRAHEDRON LETT, V28, P6339, DOI 10.1016/S0040-4039(01)91368-1; Vitaku E, 2014, J MED CHEM, V57, P10257, DOI 10.1021/jm501100b; White MC, 2018, J AM CHEM SOC, V140, P13988, DOI 10.1021/jacs.8b05195; YOSHIFUJI S, 1985, CHEM PHARM BULL, V33, P5515; Zhao JP, 2019, NAT CHEM, V11, P213, DOI 10.1038/s41557-018-0175-8	45	75	76	21	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR	2020	580	7805					621	+		10.1038/s41586-020-2137-8	http://dx.doi.org/10.1038/s41586-020-2137-8		MAR 2020	9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LI6NQ	32179876	Green Accepted			2022-12-28	WOS:000528161700001
J	Rimmer, A				Rimmer, Abi			How do I tell a colleague they have made a mistake?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 16	2020	368								m1035	10.1136/bmj.m1035	http://dx.doi.org/10.1136/bmj.m1035			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2CT	32179518	Bronze			2022-12-28	WOS:000523761500003
J	Cowper, A				Cowper, Andy			MEDICINE AND THE MEDIA Budgeting for covid-19: changing the narrative and narrating the change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cowper, Andy] Hlth Policy Insight, London, England		Cowper, A (corresponding author), Hlth Policy Insight, London, England.	andycowper@hotmail.com						[Anonymous], 2020, BBC NEWS; Bank of England, 2020, BANK ENGL MEAS RESP; Collins A., 2020, HSJ; Cowper A, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m919; Dunhill L., 2020, HSJ; Illman J., 2020, HSJ; Institute for Fiscal Studies, 2020, SPRING BUDG 2020 IFS; Norton T., 2020, HSJ; Peston R., 2020, ITV             0312; Treasury HM, 2020, BUDGET SPEECH 2020; Whitty Chris, 2020, TWITTER	11	0	0	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 13	2020	368								m1053	10.1136/bmj.m1053	http://dx.doi.org/10.1136/bmj.m1053			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KU9AW	32169833	Bronze			2022-12-28	WOS:000520014600006
J	Bourouiba, L				Bourouiba, Lydia			Turbulent Gas Clouds and Respiratory Pathogen Emissions Potential Implications for Reducing Transmission of COVID-19	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								This JAMA Insights Clinical Update discusses the need to better understand the dynamics of respiratory disease transmission by better characterizing transmission routes, the role of patient physiology in shaping them, and best approaches for source control in the context of the COVID-19 outbreak.	[Bourouiba, Lydia] MIT, Fluid Dynam Dis Transmiss Lab, Cambridge, MA USA	Massachusetts Institute of Technology (MIT)	Bourouiba, L (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lbouro@mit.edu			Smith Family Foundation; Massachusetts Institute of Technology (MIT) Policy Lab; MIT Reed Fund; Esther and Harold E. Edgerton Career Development chair at MIT	Smith Family Foundation; Massachusetts Institute of Technology (MIT) Policy Lab; MIT Reed Fund; Esther and Harold E. Edgerton Career Development chair at MIT	Dr Bourouiba reported receiving research support from the Smith Family Foundation, the Massachusetts Institute of Technology (MIT) Policy Lab, the MIT Reed Fund, and the Esther and Harold E. Edgerton Career Development chair at MIT.	[Anonymous], 2020, MANAGEMENT ILL TRAVE; [Anonymous], 2020, TRAV COUNTR WID SUST; Bourouiba L, 2016, NEW ENGL J MED, V375, pE15, DOI 10.1056/NEJMicm1501197; Bourouiba L, 2014, J FLUID MECH, V745, P537, DOI 10.1017/jfm.2014.88; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227; Scharfman BE, 2016, EXP FLUIDS, V57, DOI 10.1007/s00348-015-2078-4; World Health Organization (WHO), 2014, GUID VOL ORG VOL PRA	8	733	753	20	74	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 12	2020	323	18					1837	1838		10.1001/jama.2020.4756	http://dx.doi.org/10.1001/jama.2020.4756			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LS2LS	32215590	Bronze			2022-12-28	WOS:000536221500023
J	Wilder-Smith, A				Wilder-Smith, Annelies			Evaluation of a tetravalent dengue vaccine by serostatus and serotype	LANCET			English	Editorial Material									[Wilder-Smith, Annelies] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Wilder-Smith, Annelies] Heidelberg Univ, Heidelberg Inst Publ Hlth, Heidelberg, Germany	University of London; London School of Hygiene & Tropical Medicine; Ruprecht Karls University Heidelberg	Wilder-Smith, A (corresponding author), London Sch Hyg & Trop Med, London WC1E 7HT, England.; Wilder-Smith, A (corresponding author), Heidelberg Univ, Heidelberg Inst Publ Hlth, Heidelberg, Germany.	annelies.wilder-smith@lshtm.ac.uk						Biswal S, 2020, LANCET, V395, P1423, DOI 10.1016/S0140-6736(20)30414-1; Chu HY, 2015, J INFECT DIS, V212, P1618, DOI 10.1093/infdis/jiv258; Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; Tricou V, 2020, LANCET, V395, P1434, DOI 10.1016/S0140-6736(20)30556-0; Vannice KS, 2018, VACCINE, V36, P3411, DOI 10.1016/j.vaccine.2018.02.062; Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1; World Health Organization, 2018, Weekly Epidemiological Record, V93, P457	8	2	2	2	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 2	2020	395	10234					1402	1404		10.1016/S0140-6736(20)30603-6	http://dx.doi.org/10.1016/S0140-6736(20)30603-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LO3LS	32197106				2022-12-28	WOS:000533530700008
J	Kraemer, MUG; Yang, CH; Gutierrez, B; Wu, CH; Klein, B; Pigott, DM; du Plessis, L; Faria, NR; Li, RR; Hanage, WP; Brownstein, JS; Layan, M; Vespignani, A; Tian, HY; Dye, C; Pybus, OG; Scarpino, SV				Kraemer, Moritz U. G.; Yang, Chia-Hung; Gutierrez, Bernardo; Wu, Chieh-Hsi; Klein, Brennan; Pigott, David M.; du Plessis, Louis; Faria, Nuno R.; Li, Ruoran; Hanage, William P.; Brownstein, John S.; Layan, Maylis; Vespignani, Alessandro; Tian, Huaiyu; Dye, Christopher; Pybus, Oliver G.; Scarpino, Samuel V.		Open COVID-19 Data Working Grp	The effect of human mobility and control measures on the COVID-19 epidemic in China	SCIENCE			English	Article							REGRESSION-MODELS; DISEASE; WUHAN; TRANSMISSION	The ongoing coronavirus disease 2019 (COVID-19) outbreak expanded rapidly Throughout China. Major behavioral, clinical, and state interventions were undertaken to mitigate the epidemic and prevent the persistence of the virus in human populations in China and worldwide. It remains unclear how these unprecedented interventions, including travel restrictions, affected COVID-19 spread in China. We used real-time mobility data from Wuhan and detailed case data including travel history to elucidate the role of case importation in transmission in cities across China and to ascertain the impact of control measures. Early on, the spatial distribution of COVID-19 cases in China was explained well by human mobility data. After the implementation of control measures, this correlation dropped and growth rates became negative in most locations, although shifts in the demographics of reported cases were still indicative of local chains of transmission outside of Wuhan. This study shows that the drastic control measures implemented in China substantially mitigated the spread of COVID-19.	[Kraemer, Moritz U. G.; Gutierrez, Bernardo; du Plessis, Louis; Faria, Nuno R.; Dye, Christopher; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England; [Kraemer, Moritz U. G.; Brownstein, John S.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA; [Kraemer, Moritz U. G.; Brownstein, John S.] Boston Childrens Hosp, Boston, MA 02115 USA; [Yang, Chia-Hung; Klein, Brennan; Vespignani, Alessandro; Scarpino, Samuel V.] Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA; [Gutierrez, Bernardo] Univ San Francisco Quito USFQ, Sch Biol & Environm Sci, Quito, Ecuador; [Wu, Chieh-Hsi] Univ Southampton, Math Sci, Southampton, Hants, England; [Pigott, David M.] Univ Washington, Dept Hlth Metr, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Li, Ruoran; Hanage, William P.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Layan, Maylis] CNRS, Inst Pasteur, UMR2000, Math Modelling Infect Dis Unit, Paris, France; [Layan, Maylis] Sorbonne Univ, Paris, France; [Vespignani, Alessandro] ISI Fdn, Turin, Italy; [Tian, Huaiyu] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Pybus, Oliver G.] Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England	University of Oxford; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Northeastern University; University of Southampton; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Beijing Normal University; University of London; University of London Royal Veterinary College	Kraemer, MUG; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Kraemer, MUG (corresponding author), Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.; Kraemer, MUG (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.; Scarpino, SV (corresponding author), Northeastern Univ, Network Sci Inst, Boston, MA 02115 USA.; Pybus, OG (corresponding author), Royal Vet Coll, Dept Pathobiol & Populat Sci, London, England.	moritz.kraemer@zoo.ox.ac.uk; oliver.pybus@zoo.ox.ac.uk; s.scarpino@northeastern.edu	Hanage, Bill/CAF-1813-2022; Faria, Nuno R/I-2975-2012; Tian, Huaiyu/G-1934-2016; Pybus, Oliver G/B-2640-2012; Wang, Lin/B-4145-2013; Gutierrez, Bernardo/AAQ-6684-2021; Dye, Christopher/AIC-4659-2022; du Plessis, Louis/K-1667-2013	Faria, Nuno R/0000-0001-8839-2798; Tian, Huaiyu/0000-0002-4466-0858; Pybus, Oliver G/0000-0002-8797-2667; Wang, Lin/0000-0002-5371-2138; Gutierrez, Bernardo/0000-0002-9220-2739; Klein, Brennan/0000-0001-8326-5044; Vespignani, Alessandro/0000-0003-3419-4205; Wu, Chieh-Hsi/0000-0001-9386-725X; Pigott, David/0000-0002-6731-4034; du Plessis, Louis/0000-0003-0352-6289	Oxford Martin School; Branco Weiss Fellowship; Universities of Academic Excellence Scholarship Program of the Secretariat for Higher Education, Science, Technology, and Innovation of the Republic of Ecuador [ARSEQ-BEC-003163-2017]; Sir Henry Dale Fellowship; National Institute of General Medical Sciences [U54GM088558]; MRC [MR/S019510/1] Funding Source: UKRI	Oxford Martin School; Branco Weiss Fellowship; Universities of Academic Excellence Scholarship Program of the Secretariat for Higher Education, Science, Technology, and Innovation of the Republic of Ecuador; Sir Henry Dale Fellowship; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	H.T., O.G.P., and M.U.G.K. acknowledge support from the Oxford Martin School. M.U.G.K. is supported by a Branco Weiss Fellowship. B.G. is supported by a Universities of Academic Excellence Scholarship Program of the Secretariat for Higher Education, Science, Technology, and Innovation of the Republic of Ecuador (grant no. ARSEQ-BEC-003163-2017). N.R.F. is supported by a Sir Henry Dale Fellowship. W.P.H. is supported by the National Institute of General Medical Sciences (grant no. U54GM088558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aurora Big Data, 2017, MOB MAP APP RES REP; Backer J.A., 2020, EUROSURVEILLANCE, V25, P20, DOI DOI 10.2807/1560-7917.ES.2020.25.5.2000062; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1001/jama.2020.2565, 10.1056/NEJMoa2001316]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9; Chen SM, 2020, LANCET, V395, P764, DOI 10.1016/S0140-6736(20)30421-9; Du ZW, 2020, EMERG INFECT DIS, V26, P1049, DOI 10.3201/eid2605.200146; Du ZQ, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4855-9; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Goldstein E, 2017, EPIDEMIOLOGY, V28, P136, DOI 10.1097/EDE.0000000000000571; Hastie TJ, 1992, STAT MODELS S; Heinzl H, 2003, COMPUT STAT DATA AN, V44, P253, DOI 10.1016/S0167-9473(03)00062-8; Jin G, 2020, IMPACT TRAFFIC ISOLA, DOI [10.1101/2020.02.04.20020438, DOI 10.1101/2020.02.04.20020438]; Keeling MJ, 2004, ECOLOGY GENETICS EVO, P415, DOI [10.1016/B978-012323448-3/50019-2, DOI 10.1016/B978-012323448-3/50019-2]; Kraemer M. U. G., 2020, ZENODO, DOI [10.5281/zenodo.3714914., DOI 10.5281/ZENODO.3714914]; Kraemer M. U. G., 2020, ZENODO, DOI [10.5281/zenodo.3714914., DOI 10.5281/ZENODO.3714914.]; Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Li R., 2020, MEDRXIV 2020 02 14 2, DOI DOI 10.1101/2020.02.14.20023127.; Li R., 2020, SCIENCE, DOI [10.1126/science.aba9757, DOI 10.1126/SCIENCE.ABA9757]; Lin, 2020, POPULATION MOVEMENT, DOI [10.1101/2020.02.04.20020339, 10.1101/2020.02.04.20020339., DOI 10.1101/2020.02.04.20020339]; McDonald J.H, 2014, HDB BIOL STAT, V3rd; McHugh ML, 2013, BIOCHEM MEDICA, V23, P143, DOI 10.11613/BM.2013.018; Ramshaw RE, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0330-0; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Ripley B, 2019, R PACKAGE VERSION, V7, P3; Tian H., 2020, MEDRXIV; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Tuite AR, 2020, ANN INTERN MED, V172, P567, DOI 10.7326/M20-0358; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; WHO, 2019, REP WHO CHIN JOINT M; WHO, 2020, ELL DIAGR; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu Z., 2019, JAMA-J AM MED ASSOC, V2020, P17; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu B, 2020, LANCET INFECT DIS, V3099, P30119, DOI DOI 10.1016/S1473-3099(20)30119-5; Xu B, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0448-0; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zhao S, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa022; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	44	1290	1340	87	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2020	368	6490					493	+		10.1126/science.abb4218	http://dx.doi.org/10.1126/science.abb4218			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LK9KT	32213647	Green Published, Green Submitted			2022-12-28	WOS:000531178400041
J	Gross, AM; Wolters, PL; Dombi, E; Baldwin, A; Whitcomb, P; Fisher, MJ; Weiss, B; Kim, AR; Bornhorst, M; Shah, AC; Martin, S; Roderick, MC; Pichard, DC; Carbonell, A; Paul, SM; Therrien, J; Kapustina, O; Heisey, K; Clapp, DW; Zhang, C; Peer, CJ; Figg, WD; Smith, M; Glod, J; Blakeley, JO; Steinberg, SM; Venzon, DJ; Doyle, LA; Widemann, BC				Gross, Andrea M.; Wolters, Pamela L.; Dombi, Eva; Baldwin, Andrea; Whitcomb, Patricia; Fisher, Michael J.; Weiss, Brian; Kim, AeRang; Bornhorst, Miriam; Shah, Amish C.; Martin, Staci; Roderick, Marie C.; Pichard, Dominique C.; Carbonell, Amanda; Paul, Scott M.; Therrien, Janet; Kapustina, Oxana; Heisey, Kara; Clapp, D. Wade; Zhang, Chi; Peer, Cody J.; Figg, William D.; Smith, Malcolm; Glod, John; Blakeley, Jaishri O.; Steinberg, Seth M.; Venzon, David J.; Doyle, L. Austin; Widemann, Brigitte C.			Selumetinib in Children with Inoperable Plexiform Neurofibromas	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICALLY IMPORTANT DIFFERENCE; QUALITY-OF-LIFE; INTERFERENCE INDEX; YOUNG-ADULTS; PAIN; TYPE-1; TRIALS; ADOLESCENTS; SCALES; MRI	Background No approved therapies exist for inoperable plexiform neurofibromas in patients with neurofibromatosis type 1. Methods We conducted an open-label, phase 2 trial of selumetinib to determine the objective response rate among patients with plexiform neurofibromas and to assess clinical benefit. Children with neurofibromatosis type 1 and symptomatic inoperable plexiform neurofibromas received oral selumetinib twice daily at a dose of 25 mg per square meter of body-surface area on a continuous dosing schedule (28-day cycles). Volumetric magnetic resonance imaging and clinical outcome assessments (pain, quality of life, disfigurement, and function) were performed at least every four cycles. Children rated tumor pain intensity on a scale from 0 (no pain) to 10 (worst pain imaginable). Results A total of 50 children (median age, 10.2 years; range, 3.5 to 17.4) were enrolled from August 2015 through August 2016. The most frequent neurofibroma-related symptoms were disfigurement (44 patients), motor dysfunction (33), and pain (26). A total of 35 patients (70%) had a confirmed partial response as of March 29, 2019, and 28 of these patients had a durable response (lasting >= 1 year). After 1 year of treatment, the mean decrease in child-reported tumor pain-intensity scores was 2 points, considered a clinically meaningful improvement. In addition, clinically meaningful improvements were seen in child-reported and parent-reported interference of pain in daily functioning (38% and 50%, respectively) and overall health-related quality of life (48% and 58%, respectively) as well as in functional outcomes of strength (56% of patients) and range of motion (38% of patients). Five patients discontinued treatment because of toxic effects possibly related to selumetinib, and 6 patients had disease progression. The most frequent toxic effects were nausea, vomiting, or diarrhea; an asymptomatic increase in the creatine phosphokinase level; acneiform rash; and paronychia. Conclusions In this phase 2 trial, most children with neurofibromatosis type 1 and inoperable plexiform neurofibromas had durable tumor shrinkage and clinical benefit from selumetinib. (Funded by the Intramural Research Program of the National Institutes of Health and others; ClinicalTrials.gov number, .) Neurofibromatosis involves activation of the RAS pathway. Inhibition of MEK, a component of the pathway, with selumetinib was performed in 50 children with inoperable disease. A total of 70% had a response, which was maintained in the majority for more than a year. Pain relief, improved function, and higher quality of life were also observed.	[Gross, Andrea M.; Wolters, Pamela L.; Dombi, Eva; Whitcomb, Patricia; Martin, Staci; Roderick, Marie C.; Pichard, Dominique C.; Carbonell, Amanda; Therrien, Janet; Kapustina, Oxana; Glod, John; Widemann, Brigitte C.] NCI, Pediat Oncol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Peer, Cody J.; Figg, William D.] NCI, Clin Pharmacol Program, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Paul, Scott M.] NIH, Ctr Clin, Dept Rehabil Med, Bethesda, MD 20892 USA; [Baldwin, Andrea; Heisey, Kara] NCI, Clin Monitoring Res Program Directorate, Frederick Natl Lab Canc Res, Frederick, MD 21701 USA; [Smith, Malcolm; Doyle, L. Austin] NCI, Canc Therapy Evaluat Program, NIH, Shady Grove, MD USA; [Steinberg, Seth M.; Venzon, David J.] NCI, Biostat & Data Management Sect, Ctr Canc Res, NIH, Shady Grove, MD USA; [Blakeley, Jaishri O.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Fisher, Michael J.; Shah, Amish C.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Weiss, Brian] Cincinnati Childrens Hosp, Cincinnati, OH USA; [Kim, AeRang; Bornhorst, Miriam] Childrens Natl Hosp, Washington, DC USA; [Clapp, D. Wade; Zhang, Chi] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Cincinnati Children's Hospital Medical Center; Children's National Health System; Indiana University System; Indiana University Bloomington	Gross, AM (corresponding author), NCI, Pediat Oncol Branch, NIH, 9000 Rockville Pike,Bldg 10,Rm 1-5742, Bethesda, MD 20892 USA.	andrea.gross@nih.gov	Zhang, Chi/AAD-3036-2021	Zhang, Chi/0000-0001-9553-0925; Pichard, Dominique/0000-0002-6492-622X; Figg, William/0000-0003-2428-5613	Intramural Research Program of the National Institutes of Health; Center for Cancer Research of the National Cancer Institute (NCI); NCI Cancer Therapy Evaluation Program (CTEP); AstraZeneca; NCI CTEP; Developmental and Hyperactive Ras Tumor (DHART) Specialized Program of Research Excellence [U54 CA196519-04]; Neurofibromatosis Therapeutic Acceleration Program (NTAP)	Intramural Research Program of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Cancer Research of the National Cancer Institute (NCI); NCI Cancer Therapy Evaluation Program (CTEP); AstraZeneca(AstraZeneca); NCI CTEP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Developmental and Hyperactive Ras Tumor (DHART) Specialized Program of Research Excellence; Neurofibromatosis Therapeutic Acceleration Program (NTAP)	Supported by the Intramural Research Program of the National Institutes of Health; the Center for Cancer Research of the National Cancer Institute (NCI); the NCI Cancer Therapy Evaluation Program (CTEP); AstraZeneca through a Cooperative Research and Development Agreement with the NCI CTEP (provision of selumetinib and funding for the pharmacokinetic analysis and clinical-trial support); a grant (U54 CA196519-04) from the Developmental and Hyperactive Ras Tumor (DHART) Specialized Program of Research Excellence (funding for the pharmacodynamic studies); and the Neurofibromatosis Therapeutic Acceleration Program (NTAP) (funding for trial conduct at the Children's Hospital of Philadelphia and Cincinnati Children's Hospital Medical Center).	Abdel-Rahman Omar, 2015, J Glob Oncol, V1, P73, DOI 10.1200/JGO.2015.000802; [Anonymous], 1988, Neurofibromatosis, V1, P172; Avery RA, 2016, J AAPOS, V20, P268, DOI 10.1016/j.jaapos.2016.01.012; Avery RA, 2012, J NEURO-ONCOL, V110, P1, DOI 10.1007/s11060-012-0944-y; Banerjee A, 2017, NEURO-ONCOLOGY, V19, P1135, DOI 10.1093/neuonc/now282; DeWalt DA, 2015, QUAL LIFE RES, V24, P2195, DOI 10.1007/s11136-015-0953-3; DeWitt EM, 2011, J CLIN EPIDEMIOL, V64, P794, DOI 10.1016/j.jclinepi.2010.10.012; Dombi E, 2007, NEUROLOGY, V68, P643, DOI 10.1212/01.wnl.0000250332.89420.e6; Dombi E, 2016, NEW ENGL J MED, V375, P2550, DOI 10.1056/NEJMoa1605943; Dombi E, 2013, NEUROLOGY, V81, pS33, DOI 10.1212/01.wnl.0000435744.57038.af; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Fangusaro J, 2019, LANCET ONCOL, V20, P1011, DOI 10.1016/S1470-2045(19)30277-3; Farrar JT, 2000, PAIN, V88, P287, DOI 10.1016/S0304-3959(00)00339-0; Gross AM, 2018, NEURO-ONCOLOGY, V20, P1643, DOI 10.1093/neuonc/noy067; Gutmann DH, 2013, EXPERT OPIN INV DRUG, V22, P443, DOI 10.1517/13543784.2013.772979; Guy W, 1976, ECDEU ASSESSMENT MAN, DOI DOI 10.1037/E591322011-001; Holmstrom L, 2015, J DEV BEHAV PEDIATR, V36, P450, DOI 10.1097/DBP.0000000000000191; Jakacki RI, 2017, NEURO-ONCOLOGY, V19, P289, DOI 10.1093/neuonc/now158; Jessen WJ, 2013, J CLIN INVEST, V123, P340, DOI 10.1172/JCI60578; Korf BR, 1999, AM J MED GENET, V89, P31, DOI 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W; Martin S, 2015, PAIN MED, V16, P367, DOI 10.1111/pme.12620; Mautner VF, 2008, NEURO-ONCOLOGY, V10, P593, DOI 10.1215/15228517-2008-011; McCowage GB, 2018, J CLIN ONCOL S, V15, P10504; Nguyen R, 2011, J PEDIAT, V159, P652; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Plotkin SR, 2016, NEUROLOGY, V87, pS13, DOI 10.1212/WNL.0000000000002933; Rai SK, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0658-6; Salaffi F, 2004, EUR J PAIN, V8, P283, DOI 10.1016/j.ejpain.2003.09.004; Vaassen P, 2019, NEUROPEDIATRICS, V50, P300, DOI 10.1055/s-0039-1691830; Varni James W, 2005, Expert Rev Pharmacoecon Outcomes Res, V5, P705, DOI 10.1586/14737167.5.6.705; Varni JW, 2001, MED CARE, V39, P800, DOI 10.1097/00005650-200108000-00006; VISKOCHIL D, 1993, ANNU REV NEUROSCI, V16, P183, DOI 10.1146/annurev.ne.16.030193.001151; Weber ML, 2016, JAMA OPHTHALMOL, V134, P855, DOI 10.1001/jamaophthalmol.2016.0090; Weiss B, 2018, NEURO-ONCOLOGY, V20, P143; Weiss B, 2015, NEURO-ONCOLOGY, V17, P596, DOI 10.1093/neuonc/nou235; Widemann BC, 2014, PEDIATR BLOOD CANCER, V61, P1598, DOI 10.1002/pbc.25041; Widemann BC, 2014, NEURO-ONCOLOGY, V16, P707, DOI 10.1093/neuonc/nou004; Williams VC, 2009, PEDIATRICS, V123, P124, DOI 10.1542/peds.2007-3204; Wright A, 2012, J MAN MANIP THER, V20, P160, DOI 10.1179/2042618612Y.0000000001	39	178	183	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 9	2020	382	15					1430	1442		10.1056/NEJMoa1912735	http://dx.doi.org/10.1056/NEJMoa1912735			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LE6DO	32187457	Bronze, Green Accepted			2022-12-28	WOS:000526813400010
J	Herten-Crabb, A; Davies, SE				Herten-Crabb, Asha; Davies, Sara E.			Why WHO needs a feminist economic agenda	LANCET			English	Editorial Material									[Herten-Crabb, Asha] London Sch Econ & Polit Sci, Dept Int Relat, London WC2A 2AB, England; [Herten-Crabb, Asha] ActionAid UK, Policy Advocacy & Programmes, London, England; [Davies, Sara E.] Griffith Univ, Sch Govt & Int Relat, Brisbane, Qld, Australia	University of London; London School Economics & Political Science; Griffith University	Herten-Crabb, A (corresponding author), London Sch Econ & Polit Sci, Dept Int Relat, London WC2A 2AB, England.; Herten-Crabb, A (corresponding author), ActionAid UK, Policy Advocacy & Programmes, London, England.	a.k.herten-crabb@lse.ac.uk						Burgisser E., 2019, IMF GEND EQUALITY; Crenshaw K., 1991, STANFORD LAW REV, V43, P1241, DOI [10.2307/1229039, DOI 10.2307/1229039]; Donnelly M, 2019, WHAT IS PUBLIC HISTORY GLOBALLY?: WORKING WITH THE PAST IN THE PRESENT, P23; Forster T, 2020, SOC SCI MED, V267, DOI 10.1016/j.socscimed.2019.112496; Fraser, 2019, FEMINISM 99 MANIFEST; G20, 2014, 2014 G20 BRISB COMM; Garcia-Moreno C, 2015, LANCET, V385, P1685, DOI 10.1016/S0140-6736(14)61830-4; Goddard M, 2015, CONVERSATION; Government of France, 2019, MAK GEND EQ MAJ GLOB; Hopkins E., 2019, WORLD BANK GENDER EQ; International Monetary Fund, 2017, 5 THINGS YOU NEED KN; Irwin RE, 2019, LANCET, V393, pE27, DOI 10.1016/S0140-6736(19)30209-0; Kickbusch I, 2016, LANCET GLOB HEALTH, V4, pE895, DOI 10.1016/S2214-109X(16)30217-0; Manzoor Mehr., 2019, DELIVERED WOMEN LED; Morgan R, 2018, HEALTH RES POLICY SY, V16, DOI 10.1186/s12961-018-0338-5; Ruckert A, 2015, PALGRAVE INTERNATIONAL HANDBOOK OF HEALTHCARE POLICY AND GOVERNANCE, P37; Steege R, 2018, SOC SCI MED, V209, P1, DOI 10.1016/j.socscimed.2018.05.002; United Nations, 1995, 4 WORLD C WOM; Wenham C, 2020, LANCET, V395, P846, DOI 10.1016/S0140-6736(20)30526-2; WHO, 2010, SOC DET HLTH SER; World Bank Group, 2015, INV URB RES; World Health Organization (WHO), 1946, WHO CONSTITUTION	22	6	6	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 28	2020	395	10229					1018	1020						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	KY5YW	32222184	Bronze, Green Published			2022-12-28	WOS:000522650100014
J	O'Dowd, A				O'Dowd, Adrian			Guidance needed for singlehanded GPs to deal with covid-19 pandemic	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		BMA, 2020, COVID 19 STEPS GP PR; General Medical Council, 2020, OUR GUID DOCT; NHS England & NHS Improvement, 2020, COMMUNICATION   0322; NHS England & NHS Improvement, 2020, LETT CAR PEOPL HIGH	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1261	10.1136/bmj.m1261	http://dx.doi.org/10.1136/bmj.m1261			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220929	Bronze			2022-12-28	WOS:000523765200005
J	Paterlini, M				Paterlini, Marta			Covid-19: Over 300 Italian doctors and scientists call for more testing	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			1	3	3	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 27	2020	368								m1274	10.1136/bmj.m1274	http://dx.doi.org/10.1136/bmj.m1274			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EE	32220862	Bronze			2022-12-28	WOS:000523765200011
J	Huang, ZX; Huang, Q				Huang, Zhenxiao; Huang, Qian			Unilateral bloodstained nasal discharge	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Huang, Zhenxiao; Huang, Qian] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China	Capital Medical University	Huang, Q (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	qian_ner@sina.com						Caplan LS, 2000, ANN EPIDEMIOL, V10, P186, DOI 10.1016/S1047-2797(99)00049-6; Kennedy DW, 2012, RHINOLOGY DIS NOSE S, DOI [10.1055/b-002-85513, DOI 10.1055/B-002-85513]; Sataloff R, 2016, SATALOFFS COMPREHENS, V2	3	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m9	10.1136/bmj.m9	http://dx.doi.org/10.1136/bmj.m9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217604				2022-12-28	WOS:000523764800001
J	Limb, M				Limb, Matthew			The BMJ Awards 2020: Primary care team	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												limb@btinternet.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1095	10.1136/bmj.m1095	http://dx.doi.org/10.1136/bmj.m1095			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217567				2022-12-28	WOS:000523764800004
J	Mahase, E				Mahase, Elisabeth			Covid-19: Gilead withdraws orphan drug designation from potential treatment after criticism	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		US Food and Drug Administration, SEARCH ORPHAN DRUG D	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1259	10.1136/bmj.m1259	http://dx.doi.org/10.1136/bmj.m1259			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217532	Bronze			2022-12-28	WOS:000523764800023
J	Extance, A				Extance, Andy			Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												andy@exeterempirical.com						[Anonymous], 2020, GUIDANCE SHIELDING P	1	36	36	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 25	2020	368								m1174	10.1136/bmj.m1174	http://dx.doi.org/10.1136/bmj.m1174			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DX	32213482	Bronze			2022-12-28	WOS:000523764500009
J	Saint-Maurice, PF; Troiano, RP; Bassett, DR; Graubard, BI; Carlson, SA; Shiroma, EJ; Fulton, JE; Matthews, CE				Saint-Maurice, Pedro F.; Troiano, Richard P.; Bassett, David R., Jr.; Graubard, Barry I.; Carlson, Susan A.; Shiroma, Eric J.; Fulton, Janet E.; Matthews, Charles E.			Association of Daily Step Count and Step Intensity With Mortality Among US Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICAL-ACTIVITY; DOSE-RESPONSE; ALL-CAUSE; HEALTH; CADENCE	IMPORTANCE It is unclear whether the number of steps per day and the intensity of stepping are associated with lower mortality. OBJECTIVE Describe the dose-response relationship between step count and intensity and mortality. DESIGN, SETTING, AND PARTICIPANTS Representative sample of US adults aged at least 40 years in the National Health and Nutrition Examination Survey who wore an accelerometer for up to 7 days ( from 2003-2006). Mortality was ascertained through December 2015. EXPOSURES Accelerometer-measured number of steps per day and 3 step intensity measures (extended bout cadence, peak 30-minute cadence, and peak 1-minute cadence [steps/min]). Accelerometer data were based on measurements obtained during a 7-day period at baseline. MAIN OUTCOMES AND MEASURES The primary outcome was all-cause mortality. Secondary outcomes were cardiovascular disease (CVD) and cancer mortality. Hazard ratios (HRs), mortality rates, and 95% CIs were estimated using cubic splines and quartile classifications adjusting for age; sex; race/ethnicity; education; diet; smoking status; body mass index; self-reported health; mobility limitations; and diagnoses of diabetes, stroke, heart disease, heart failure, cancer, chronic bronchitis, and emphysema. RESULTS A total of 4840 participants (mean age, 56.8 years; 2435 [54%] women; 1732 [36%] individuals with obesity) wore accelerometers for a mean of 5.7 days for a mean of 14.4 hours per day. The mean number of steps per day was 9124. There were 1165 deaths over a mean 10.1 years of follow-up, including 406 CVD and 283 cancer deaths. The unadjusted incidence density for all-cause mortality was 76.7 per 1000 person-years (419 deaths) for the 655 individuals who took less than 4000 steps per day; 21.4 per 1000 person-years (488 deaths) for the 1727 individuals who took 4000 to 7999 steps per day; 6.9 per 1000 person-years (176 deaths) for the 1539 individuals who took 8000 to 11 999 steps per day; and 4.8 per 1000 person-years (82 deaths) for the 919 individuals who took at least 12 000 steps per day. Compared with taking 4000 steps per day, taking 8000 steps per day was associated with significantly lower all-cause mortality (HR, 0.49 [95% CI, 0.44-0.55]), as was taking 12 000 steps per day (HR, 0.35 [95% CI, 0.28-0.45]). Unadjusted incidence density for all-cause mortality by peak 30 cadence was 32.9 per 1000 person-years (406 deaths) for the 1080 individuals who took 18.5 to 56.0 steps per minute; 12.6 per 1000 person-years (207 deaths) for the 1153 individuals who took 56.1 to 69.2 steps per minute; 6.8 per 1000 person-years (124 deaths) for the 1074 individuals who took 69.3 to 82.8 steps per minute; and 5.3 per 1000 person-years (108 deaths) for the 1037 individuals who took 82.9 to 149.5 steps per minute. Greater step intensity was not significantly associated with lower mortality after adjustment for total steps per day (eg, highest vs lowest quartile of peak 30 cadence: HR, 0.90 [95% CI, 0.65-1.27]; P value for trend =.34). CONCLUSIONS AND RELEVANCE Based on a representative sample of US adults, a greater number of daily steps was significantly associated with lower all-cause mortality. There was no significant association between step intensity and mortality after adjusting for total steps per day.	[Saint-Maurice, Pedro F.; Graubard, Barry I.; Matthews, Charles E.] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA; [Troiano, Richard P.] NCI, Div Canc Control & Populat Sci, Rockville, MD USA; [Bassett, David R., Jr.] Univ Tennessee, Dept Kinesiol Recreat & Sport Studies, Knoxville, TN USA; [Carlson, Susan A.; Fulton, Janet E.] Ctr Dis Control & Prevent, Div Nutr Phys Act & Obes, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Shiroma, Eric J.] NIA, Epidemiol & Populat Sci Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Tennessee System; University of Tennessee Knoxville; Centers for Disease Control & Prevention - USA; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Saint-Maurice, PF (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, HHS, 9609 Med Ctr Dr,Room 6E-572, Bethesda, MD 20892 USA.	pedro.saintmaurice@nih.gov	Shiroma, Eric/AAV-5487-2021; Troiano, Richard/AAK-3540-2021	Shiroma, Eric/0000-0003-4920-2642; Troiano, Richard/0000-0002-6807-989X; Saint-Maurice, Pedro F./0000-0002-8752-2340	National Institutes of Health's Intramural Research Program; extramural Division of Cancer Control and Population Sciences of the National Cancer Institute; individual fellowship grant by Fundacao para a Ciencia e Tecnologia under the Programa Operacional Potencial Humano/Fundo Social Europeu [SFRH/BI/114330/2016]	National Institutes of Health's Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); extramural Division of Cancer Control and Population Sciences of the National Cancer Institute; individual fellowship grant by Fundacao para a Ciencia e Tecnologia under the Programa Operacional Potencial Humano/Fundo Social Europeu	Drs Saint-Maurice, Matthews, Graubard, and Shiroma were supported by the National Institutes of Health's Intramural Research Program. Dr Troiano was supported by the extramural Division of Cancer Control and Population Sciences of the National Cancer Institute. Dr Saint-Maurice received additional support from an individual fellowship grant awarded by the Fundacao para a Ciencia e Tecnologia (SFRH/BI/114330/2016) under the Programa Operacional Potencial Humano/Fundo Social Europeu.	Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Bassett DR, 2017, SPORTS MED, V47, P1303, DOI 10.1007/s40279-016-0663-1; Dall PM, 2013, MED SCI SPORT EXER, V45, P1995, DOI 10.1249/MSS.0b013e3182955780; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Dwyer T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141274; Feito Y, 2012, MED SCI SPORT EXER, V44, P733, DOI 10.1249/MSS.0b013e3182351913; Graubard BI, 2007, STAT MED, V26, P2639, DOI 10.1002/sim.2734; Izawa KP, 2013, AM J CARDIOL, V111, P1767, DOI 10.1016/j.amjcard.2013.02.034; Jefferis BJ, 2019, BRIT J SPORT MED, V53, P1013, DOI 10.1136/bjsports-2017-098733; Keadle SK, 2017, AM J PREV MED, V52, P541, DOI 10.1016/j.amepre.2016.11.010; Lee IM, 2019, JAMA INTERN MED, V179, P1105, DOI 10.1001/jamainternmed.2019.0899; Liu BM, 2016, STAT MED, V35, P5170, DOI 10.1002/sim.7049; Lobelo F, 2018, CIRCULATION, V137, pE495, DOI 10.1161/CIR.0000000000000559; Matthews CE, 2016, AM J CLIN NUTR, V104, P1424, DOI 10.3945/ajcn.116.135129; National Cancer Institute Epidemiology and Genomics Research Program, HLTH EAT IND SAS COD; National Statistics Office (NSO), 2019, OH V2018 PREP DAT GL; Rosenberger ME, 2016, MED SCI SPORT EXER, V48, P457, DOI 10.1249/MSS.0000000000000778; Saint-Maurice PF, 2020, MED SCI SPORT EXER, V52, P876, DOI 10.1249/MSS.0000000000002206; SAS Institute, 2013, SAS STAT 13 1 US GUI, V62, P5172; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Toth LP, 2018, MED SCI SPORT EXER, V50, P1315, DOI 10.1249/MSS.0000000000001569; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2018, BRIT J SPORT MED, V52, P776, DOI 10.1136/bjsports-2017-097628; Tudor-Locke C, 2017, MED SCI SPORT EXER, V49, P283, DOI 10.1249/MSS.0000000000001100; U.S. Department of Health and Human Services, 2018, 2018 PHYS ACTIVITY G; Waschki B, 2011, CHEST, V140, P331, DOI 10.1378/chest.10-2521; Yates T, 2017, EUR HEART J, V38, P3232, DOI 10.1093/eurheartj/ehx449	27	175	177	20	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 24	2020	323	12					1151	1160		10.1001/jama.2020.1382	http://dx.doi.org/10.1001/jama.2020.1382			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK4BZ	32207799	Green Published, Bronze			2022-12-28	WOS:000530807000018
J	Tanne, JH				Tanne, Janice Hopkins			New York is centre of US epidemic as Trump pitches in to help	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Forgey Quint, 2020, POLITICO; Kiro 7 News Staff, 2020, KIRO 7 NEWS STA 0322; McKinley J, 2020, NEW YORK TIMES; Willin P, 2020, LA IMPOSES MORE REST	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 23	2020	368								m1179	10.1136/bmj.m1179	http://dx.doi.org/10.1136/bmj.m1179			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DT	32205318	Bronze			2022-12-28	WOS:000523764100018
J	Dyer, C				Dyer, Clare			Covid-19: 15 000 deregistered doctors are told, "Your NHS needs you"	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 20	2020	368								m1152	10.1136/bmj.m1152	http://dx.doi.org/10.1136/bmj.m1152			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DO	32198153	Bronze			2022-12-28	WOS:000523763600010
J	Zhang, T				Zhang, Tao			Taking on all of the biomass for conversion	SCIENCE			English	Editorial Material							LIGNIN; DEPOLYMERIZATION; CHEMICALS		[Zhang, Tao] Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; State Key Laboratory of Catalysis, CAS	Zhang, T (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, State Key Lab Catalysis, Dalian 116023, Peoples R China.	taozhang@dicp.ac.cn			National Natural Science Foundation of China [21690080, 21721004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support from the National Natural Science Foundation of China (21690080, 21721004) is gratefully acknowledged.	Guo HW, 2016, CHEMSUSCHEM, V9, P3220, DOI 10.1002/cssc.201600901; Li CZ, 2015, CHEM REV, V115, P11559, DOI 10.1021/acs.chemrev.5b00155; Liao YH, 2020, SCIENCE, V367, P1385, DOI 10.1126/science.aau1567; Liu YX, 2019, ACS CATAL, V9, P4441, DOI 10.1021/acscatal.9b00669; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Rinaldi R, 2016, ANGEW CHEM INT EDIT, V55, P8164, DOI 10.1002/anie.201510351; Schutyser W, 2018, CHEM SOC REV, V47, P852, DOI 10.1039/c7cs00566k; Shuai L, 2016, SCIENCE, V354, P329, DOI 10.1126/science.aaf7810; Wu XJ, 2018, NAT CATAL, V1, P772, DOI 10.1038/s41929-018-0148-8	9	22	24	28	216	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 20	2020	367	6484			SI		1305	1306		10.1126/science.abb1463	http://dx.doi.org/10.1126/science.abb1463			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	KX9AK	32193311				2022-12-28	WOS:000522167400030
J	Rimmer, A				Rimmer, Abi			Covid-19: pregnant doctors should speak to occupational health, say experts	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1089; Royal College of Obstetricians and Gynaecologists, 2020, COR COVID 19 INF PRE	2	2	3	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2020	368								m1104	10.1136/bmj.m1104	http://dx.doi.org/10.1136/bmj.m1104			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DJ	32188586	Bronze			2022-12-28	WOS:000523763100012
J	Black, S; Sisco, S; Williams, T; Brathwaite, M; Bhandarkar, K; Chokshi, DA; Katz, MH				Black, Shinelle; Sisco, Sarah; Williams, Tatiana; Brathwaite, Makeela; Bhandarkar, Kalpana; Chokshi, Dave A.; Katz, Mitchell H.			Return on Investment From Co-locating Tax Assistance for Low-Income Persons at Clinical Sites	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter								This study characterizes net dollars low-income persons received from participation in tax preparation services co-located at clinical sites in New York City intended to maximize credits and reduce poverty.	[Black, Shinelle] Univ Chicago, Metcalf Program, Chicago, IL 60637 USA; [Sisco, Sarah; Bhandarkar, Kalpana; Chokshi, Dave A.; Katz, Mitchell H.] NYC Hlth Hosp, New York, NY USA; [Williams, Tatiana] Urban Upbound, New York, NY USA; [Brathwaite, Makeela] Grow Brooklyn, New York, NY USA	University of Chicago	Chokshi, DA (corresponding author), 7 Hanover Sq,Ninth Floor, New York, NY 10004 USA.	dave.chokshi@nychhc.org		Chokshi, Dave/0000-0001-7467-4591				Harris BH, 2016, FIGHTING POVERTY NEE; Hussein T, 2016, COMMUNITY CURE HLTH; Internal Revenue Service, EITC FAST FACTS; Marcil LE, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3608; Simon D.M.M., 2018, HLTH AFFAIRS; US Bureau of Labor Statistics, OCC EMPL STAT OCC EM	6	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1093	1095		10.1001/jama.2020.0545	http://dx.doi.org/10.1001/jama.2020.0545			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181840	Green Published, Bronze			2022-12-28	WOS:000521968800025
J	Dyer, O				Dyer, Owen			Covid-19: Trump sought to buy vaccine developer exclusively for US, say German officials	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dams J., 2020, WELT AM SONNTAG; DYER O, 2020, BMJ-BRIT MED J, V368, DOI DOI 10.1136/BMJ.M941	2	8	9	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1100	10.1136/bmj.m1100	http://dx.doi.org/10.1136/bmj.m1100			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184216	Bronze			2022-12-28	WOS:000523762400016
J	Rimmer, A				Rimmer, Abi			Covid-19: trainees will not move jobs in April	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 17	2020	368								m1088	10.1136/bmj.m1088	http://dx.doi.org/10.1136/bmj.m1088			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2DC	32184209	Bronze			2022-12-28	WOS:000523762400009
J	Mergner, J; Frejno, M; List, M; Papacek, M; Chen, X; Chaudhary, A; Samaras, P; Richter, S; Shikata, H; Messerer, M; Lang, D; Altmann, S; Cyprys, P; Zolg, DP; Mathieson, T; Bantscheff, M; Hazarika, RR; Schmidt, T; Dawid, C; Dunkel, A; Hofmann, T; Sprunck, S; Falter-Braun, P; Johannes, F; Mayer, KFX; Jurgens, G; Wilhelm, M; Baumbach, J; Grill, E; Schneitz, K; Schwechheimer, C; Kuster, B				Mergner, Julia; Frejno, Martin; List, Markus; Papacek, Michael; Chen, Xia; Chaudhary, Ajeet; Samaras, Patroklos; Richter, Sandra; Shikata, Hiromasa; Messerer, Maxim; Lang, Daniel; Altmann, Stefan; Cyprys, Philipp; Zolg, Daniel P.; Mathieson, Toby; Bantscheff, Marcus; Hazarika, Rashmi R.; Schmidt, Tobias; Dawid, Corinna; Dunkel, Andreas; Hofmann, Thomas; Sprunck, Stefanie; Falter-Braun, Pascal; Johannes, Frank; Mayer, Klaus F. X.; Juergens, Gerd; Wilhelm, Mathias; Baumbach, Jan; Grill, Erwin; Schneitz, Kay; Schwechheimer, Claus; Kuster, Bernhard			Mass-spectrometry-based draft of the Arabidopsis proteome	NATURE			English	Article							COMPUTATIONAL PLATFORM; COMPREHENSIVE ANALYSIS; AGC KINASES; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; PROTEINS; DATABASE; REVEALS; NETWORK	Plants are essential for life and are extremely diverse organisms with unique molecular capabilities(1). Here we present a quantitative atlas of the transcriptomes, proteomes and phosphoproteomes of 30 tissues of the model plant Arabidopsis thaliana. Our analysis provides initial answers to how many genes exist as proteins (more than 18,000), where they are expressed, in which approximate quantities (a dynamic range of more than six orders of magnitude) and to what extent they are phosphorylated (over 43,000 sites). We present examples of how the data may be used, such as to discover proteins that are translated from short open-reading frames, to uncover sequence motifs that are involved in the regulation of protein production, and to identify tissue-specific protein complexes or phosphorylation-mediated signalling events. Interactive access to this resource for the plant community is provided by the ProteomicsDB and ATHENA databases, which include powerful bioinformatics tools to explore and characterize Arabidopsis proteins, their modifications and interactions. A quantitative atlas of the transcriptomes, proteomes and phosphoproteomes of 30 tissues of the model plant Arabidopsis thaliana provides a valuable resource for plant research.	[Mergner, Julia; Frejno, Martin; Samaras, Patroklos; Zolg, Daniel P.; Schmidt, Tobias; Wilhelm, Mathias; Kuster, Bernhard] TUM, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany; [List, Markus; Baumbach, Jan] TUM, Chair Expt Bioinformat, Freising, Turkey; [Papacek, Michael; Grill, Erwin] TUM, Chair Bot, Freising Weihenstephan, Germany; [Chen, Xia; Chaudhary, Ajeet; Schneitz, Kay] TUM, Plant Dev Biol, Freising Weihenstephan, Germany; [Richter, Sandra; Juergens, Gerd] Univ Tubingen, Ctr Plant Mol Biol, Tubingen, Germany; [Shikata, Hiromasa; Schwechheimer, Claus] TUM, Chair Plant Syst Biol, Freising Weihenstephan, Germany; [Shikata, Hiromasa] Natl Inst Basic Biol, Devis Plant Environm Responses, Okazaki, Aichi, Japan; [Messerer, Maxim; Lang, Daniel; Mayer, Klaus F. X.] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Plant Genome & Syst Biol, Munich, Germany; [Altmann, Stefan; Falter-Braun, Pascal] Helmholtz Ctr Munich, German Res Ctr Environm Hlth, Inst Network Biol INET, Munich, Germany; [Cyprys, Philipp; Sprunck, Stefanie] Univ Regensburg, Cell Biol & Plant Biochem, Regensburg, Germany; [Mathieson, Toby; Bantscheff, Marcus] Cellzome GmbH, Heidelberg, Germany; [Hazarika, Rashmi R.; Johannes, Frank] TUM, Populat Epigenet & Epigen, Freising Weihenstephan, Germany; [Hazarika, Rashmi R.; Johannes, Frank; Kuster, Bernhard] TUM, IAS, Freising Weihenstephan, Germany; [Dawid, Corinna; Dunkel, Andreas; Hofmann, Thomas] TUM, Chair Food Chem & Mol Sensory Sci, Freising Weihenstephan, Germany; [Falter-Braun, Pascal] LMU, Chair Microbe Host Interact, Munich, Germany; [Mayer, Klaus F. X.] TUM, Plant Genome Biol, Freising Weihenstephan, Germany; [Kuster, Bernhard] TUM, Bavarian Biomol Mass Spectrometry Ctr BayBioMS, Freising Weihenstephan, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Eberhard Karls University of Tubingen; Technical University of Munich; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Regensburg; GlaxoSmithKline; Cellzome GmbH; Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Technical University of Munich	Kuster, B (corresponding author), TUM, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany.; Kuster, B (corresponding author), TUM, IAS, Freising Weihenstephan, Germany.; Kuster, B (corresponding author), TUM, Bavarian Biomol Mass Spectrometry Ctr BayBioMS, Freising Weihenstephan, Germany.	kuster@tum.de	Bantscheff, Marcus/AAQ-2903-2021; Messerer, Maxim/GWU-5619-2022; Chaudhary, Ajeet/HHZ-5896-2022; Lang, Daniel/M-5597-2019; Schwechheimer, Claus/Q-7907-2016; Falter-Braun, Pascal/B-9669-2013	Bantscheff, Marcus/0000-0002-8343-8977; Messerer, Maxim/0000-0003-0554-5045; Lang, Daniel/0000-0002-2166-0716; Baumbach, Jan/0000-0002-0282-0462; Mergner, Julia/0000-0002-4332-1280; Samaras, Patroklos/0000-0001-6042-1585; Schwechheimer, Claus/0000-0003-0269-2330; Shikata, Hiromasa/0000-0002-2650-3293; Wilhelm, Mathias/0000-0002-9224-3258; Schmidt, Tobias/0000-0002-1883-6514; Chaudhary, Ajeet/0000-0002-3719-4182; Dunkel, Andreas/0000-0002-4445-6144; Falter-Braun, Pascal/0000-0003-2012-6746	German Science Foundation (DFG) [SFB924]; Japan Society for the Promotion of Sciences; Chinese Research Council	German Science Foundation (DFG)(German Research Foundation (DFG)); Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Chinese Research Council	We thank the NGS@tum core facility for RNA sequencing, R. Tofanelli for help with imaging the ovules, R. J. Schmitz for providing data access for the feature analysis and M. Reinecke, F. Bayer and S. Galinec for mass spectrometry measurements. This work was in part funded by the German Science Foundation (DFG, SFB924), a research fellowship to H.S. by the Japan Society for the Promotion of Sciences, and a research fellowship to X.C. by the Chinese Research Council.	Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Bah A, 2015, NATURE, V519, P106, DOI 10.1038/nature13999; Bai B, 2020, PLANT PHYSIOL, V182, P378, DOI 10.1104/pp.19.00644; Bar-On YM, 2019, P NATL ACAD SCI USA, V116, P4738, DOI 10.1073/pnas.1816654116; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bian YY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13973-x; Bienvenut WV, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.015131; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bowman J., 1994, ARABIDOPSIS ATLAS MO, V102, P117; Box MS, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-7; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandao MM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-454; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Camiolo S, 2015, DNA RES, V22, P461, DOI 10.1093/dnares/dsv027; Carbon S, 2017, NUCLEIC ACIDS RES, V45, pD331, DOI 10.1093/nar/gkw1108; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Celaj A, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177532; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Das S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212678; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Durek P, 2010, NUCLEIC ACIDS RES, V38, pD828, DOI 10.1093/nar/gkp810; Enugutti B, 2012, P NATL ACAD SCI USA, V109, P15060, DOI 10.1073/pnas.1205089109; Eraslan B, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188513; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Fulton L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000355; Galvan-Ampudia CS, 2007, TRENDS PLANT SCI, V12, P541, DOI 10.1016/j.tplants.2007.10.004; Gebert D, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190020; Gessulat S, 2019, NAT METHODS, V16, P509, DOI 10.1038/s41592-019-0426-7; Goel R, 2012, MOL BIOSYST, V8, P453, DOI 10.1039/c1mb05340j; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gromping U, 2006, J STAT SOFTW, V17, DOI 10.18637/jss.v017.i01; Gupta R, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00022; Hahne H, 2013, NAT METHODS, V10, P989, DOI [10.1038/nmeth.2610, 10.1038/NMETH.2610]; Hanada K, 2010, BIOINFORMATICS, V26, P399, DOI 10.1093/bioinformatics/btp688; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Hauser F, 2017, CELL, V171, P1708, DOI 10.1016/j.cell.2017.11.045; Hazarika RR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1458-y; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Heusel M, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188438; Johnson-Brousseau SA, 2004, PLANT J, V39, P761, DOI 10.1111/j.1365-313X.2004.02147.x; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawakatsu T, 2016, CELL, V166, P492, DOI 10.1016/j.cell.2016.06.044; Knecht W, 2005, DOTFAAAM0515; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Kramer U, 2015, ELIFE, V4, DOI 10.7554/eLife.06100; Kristensen AR, 2012, NAT METHODS, V9, P907, DOI 10.1038/nmeth.2131; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; List M, 2016, NUCLEIC ACIDS RES, V44, pW98, DOI 10.1093/nar/gkw373; Litt A, 2010, SEMIN CELL DEV BIOL, V21, P129, DOI 10.1016/j.semcdb.2009.11.019; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Lloyd J, 2012, PLANT PHYSIOL, V158, P1115, DOI 10.1104/pp.111.192393; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loytynoja A, 2014, METHODS MOL BIOL, V1079, P155, DOI 10.1007/978-1-62703-646-7_10; Luo J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010259; Marx H, 2013, NAT BIOTECHNOL, V31, P557, DOI 10.1038/nbt.2585; MAYER U, 1993, DEVELOPMENT, V117, P149; McBride Z, 2017, MOL CELL PROTEOMICS, V16, P1972, DOI 10.1074/mcp.RA117.000276; Mitra SK, 2015, PLANT J, V82, P1042, DOI 10.1111/tpj.12863; Moes D, 2008, PLANT J, V54, P806, DOI 10.1111/j.1365-313X.2008.03454.x; Niederhuth CE, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1059-0; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Onate-Sanchez Luis, 2008, BMC Res Notes, V1, P93, DOI 10.1186/1756-0500-1-93; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quigley F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2001-3-1-research0001; R Core Team, R LANG ENV STAT COMP; Rijpkema AS, 2010, SEMIN CELL DEV BIOL, V21, P100, DOI 10.1016/j.semcdb.2009.11.002; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Ruprecht B, 2017, METHODS MOL BIOL, V1550, P47, DOI 10.1007/978-1-4939-6747-6_5; Ruprecht B, 2017, METHODS MOL BIOL, V1550, P83, DOI 10.1007/978-1-4939-6747-6_8; Santner A, 2010, PLANT J, V61, P1029, DOI 10.1111/j.1365-313X.2010.04112.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schmidt T, 2018, NUCLEIC ACIDS RES, V46, pD1271, DOI 10.1093/nar/gkx1029; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Sharma K, 2014, CELL REP, V8, P1583, DOI 10.1016/j.celrep.2014.07.036; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sprunck S, 2012, SCIENCE, V338, P1093, DOI 10.1126/science.1223944; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tischer SV, 2017, P NATL ACAD SCI USA, V114, P10280, DOI 10.1073/pnas.1706593114; Toprak UH, 2014, MOL CELL PROTEOMICS, V13, P2056, DOI 10.1074/mcp.O113.036475; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uhlen M, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20155865; Vaddepalli P, 2014, DEVELOPMENT, V141, P4139, DOI 10.1242/dev.113878; van der Graaf A, 2015, P NATL ACAD SCI USA, V112, P6676, DOI 10.1073/pnas.1424254112; van Wijk KJ, 2014, PLANT CELL, V26, P2367, DOI 10.1105/tpc.114.125815; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wagih O, 2017, BIOINFORMATICS, V33, P3645, DOI 10.1093/bioinformatics/btx469; Wang YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-652; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Yang M, 2010, PLANT SYST EVOL, V289, P111, DOI 10.1007/s00606-010-0336-8; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang Y, 2009, PLANT J, V58, P474, DOI 10.1111/j.1365-313X.2009.03792.x; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.35; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Zolg DP, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700263; Zourelidou M, 2009, DEVELOPMENT, V136, P627, DOI 10.1242/dev.028365	122	163	164	31	184	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR	2020	579	7799					409	+		10.1038/s41586-020-2094-2	http://dx.doi.org/10.1038/s41586-020-2094-2		MAR 2020	26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KV9EG	32188942	Green Submitted			2022-12-28	WOS:000519162500007
J	Davies, R				Davies, Rachael			Liz Grant: prioritising palliative care and planetary health	LANCET			English	Biographical-Item																			0	0	0	1	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 30	2019	394	10213					1983	1983						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	JT4GR	32171416				2022-12-28	WOS:000500950200013
J	Sharfstein, JM; Olsen, Y				Sharfstein, Joshua M.; Olsen, Yngvild			How Not to Spend an Opioid Settlement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Sharfstein, Joshua M.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 NWolfe St, Baltimore, MD 21205 USA; [Olsen, Yngvild] Inst Behav Resources Inc, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, 615 NWolfe St, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2020	323	11					1031	1032		10.1001/jama.2020.1371	http://dx.doi.org/10.1001/jama.2020.1371			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KX6DC	32181838	Bronze			2022-12-28	WOS:000521968800002
J	Li, RY; Pei, S; Chen, B; Song, YM; Zhang, T; Yang, W; Shaman, J				Li, Ruiyun; Pei, Sen; Chen, Bin; Song, Yimeng; Zhang, Tao; Yang, Wan; Shaman, Jeffrey			Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)	SCIENCE			English	Article							DISEASE; TRANSMISSION; INFERENCE; WUHAN	Estimation of the prevalence and contagiousness of undocumented novel coronavirus [severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2)] infections is critical for understanding the overall prevalence and pandemic potential of this disease. Here, we use observations of reported infection within China, in conjunction with mobility data, a networked dynamic metapopulation model, and Bayesian inference, to infer critical epidemiological characteristics associated with SARS-CoV-2, including the fraction of undocumented infections and their contagiousness. We estimate that 86% of all infections were undocumented [95% credible interval (CI): 82-90%] before the 23 January 2020 travel restrictions. The transmission rate of undocumented infections per person was 55% the transmission rate of documented infections (95% CI: 46-62%), yet, because of their greater numbers, undocumented infections were the source of 79% of the documented cases. These findings explain the rapid geographic spread of SARS-CoV-2 and indicate that containment of this virus will be particularly challenging.	[Li, Ruiyun] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Global Infect Dis Anal,Fac Med, London W2 1PG, England; [Pei, Sen; Shaman, Jeffrey] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA; [Chen, Bin] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Song, Yimeng] Univ Hong Kong, Dept Urban Planning & Design, Hong Kong, Peoples R China; [Zhang, Tao] Tsinghua Univ, Dept Earth Syst Sci, Key Lab Earth Syst Modeling, Minist Educ, Beijing 10084, Peoples R China; [Yang, Wan] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA	Imperial College London; Columbia University; University of California System; University of California Davis; University of Hong Kong; Tsinghua University; Columbia University	Pei, S; Shaman, J (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA.	sp3449@cumc.columbia.edu; jls106@cumc.columbia.edu	Pei, Sen/AAN-8662-2020; Song, Yimeng/I-9990-2019; Li, Ruiyun/AAA-4708-2021; Li, Ruiyun/AAL-7902-2021; Chen, Bin/ABD-5074-2021; Yang, Wan/K-7592-2013	Pei, Sen/0000-0002-7072-2995; Song, Yimeng/0000-0001-9558-1220; Li, Ruiyun/0000-0001-8927-9965; Chen, Bin/0000-0003-3496-2876; Yang, Wan/0000-0002-7555-9728	U.S. National Institutes of Health (NIH) [GM110748, AI145883]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institutes of Health (NIH) grants GM110748 and AI145883. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences, the National Institute of Allergy and Infectious Diseases, or the NIH.	Anderson JL, 2001, MON WEATHER REV, V129, P2884, DOI 10.1175/1520-0493(2001)129<2884:AEAKFF>2.0.CO;2; [Anonymous], DIAMOND PRINCESS COV; Arulampalam MS, 2002, IEEE T SIGNAL PROCES, V50, P174, DOI 10.1109/78.978374; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; China National Health Commission, POL REG DOC; Chretien JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0094130, 10.1371/currents.outbreaks.3408774290b1a0f2dd7cae877c8b8ff6]; DeFelice NB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14592; Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Du ZW, 2020, EMERG INFECT DIS, V26, P1049, DOI 10.3201/eid2605.200146; Du ZQ, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4855-9; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151; Health Commission of Hubei Province, 8 PRESS C PREV CONTR; Health Commission of Hubei Province, 9 PRESS C PREV CONTR; Imai N., 2020, 2 IMP COLL; Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103; King AA, 2008, NATURE, V454, P877, DOI 10.1038/nature07084; Kramer M, EPIDEMIOLOGICAL DATA; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; National Health Commission of the People's Republic of China, UPD NOV COR PNEUM OU; Pei S, 2018, ELIFE, V7, DOI 10.7554/eLife.40977; Pei S, 2018, P NATL ACAD SCI USA, V115, P2752, DOI 10.1073/pnas.1708856115; Qiao X., 2018, PEOPLES DAILY; Rambaut A., 2020, 129 GENOMES; Reis J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005133; Riou J, 2020, EUROSURVEILLANCE, V25, P7, DOI 10.2807/1560-7917.ES.2020.25.4.2000058; Snyder C, 2008, MON WEATHER REV, V136, P4629, DOI 10.1175/2008MWR2529.1; Tarabella G, 2020, FLEX PRINT ELECTRON, V5, DOI 10.1088/2058-8585/ab61c4; World Health Organization, COR DIS COVID 2019 S; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9; Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044; Yang W, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003583; Zhu D, 2018, INT J GEOGR INF SCI, V32, P783, DOI 10.1080/13658816.2017.1413192	34	1788	1866	39	201	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 1	2020	368	6490					489	+		10.1126/science.abb3221	http://dx.doi.org/10.1126/science.abb3221			52	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LK9KT	32179701	Green Published			2022-12-28	WOS:000531178400040
J	Chen, T; Wu, D; Chen, HL; Yan, WM; Yang, DL; Chen, G; Ma, K; Xu, D; Yu, HJ; Wang, HW; Wang, T; Guo, W; Chen, J; Ding, C; Zhang, XP; Huang, JQ; Han, MF; Li, SS; Luo, XP; Zhao, JP; Ning, Q				Chen, Tao; Wu, Di; Chen, Huilong; Yan, Weiming; Yang, Danlei; Chen, Guang; Ma, Ke; Xu, Dong; Yu, Haijing; Wang, Hongwu; Wang, Tao; Guo, Wei; Chen, Jia; Ding, Chen; Zhang, Xiaoping; Huang, Jiaquan; Han, Meifang; Li, Shusheng; Luo, Xiaoping; Zhao, Jianping; Ning, Qin			Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PNEUMONIA	OBJECTIVE To delineate the clinical characteristics of patients with coronavirus disease 2019 (covid-19) who died. DESIGN Retrospective case series. SETTING Tongji Hospital in Wuhan, China. PARTICIPANTS Among a cohort of 799 patients, 113 who died and 161 who recovered with a diagnosis of covid-19 were analysed. Data were collected until 28 February 2020. MAIN OUTCOME MEASURES Clinical characteristics and laboratory findings were obtained from electronic medical records with data collection RESULTS The median age of deceased patients (68 years) was significantly older than recovered patients (51 years). Male sex was more predominant in deceased patients (83; 73%) than in recovered patients (88; 55%). Chronic hypertension and other cardiovascular comorbidities were more frequent among deceased patients (54 (48%) and 16 (14%)) than recovered patients (39 (24%) and 7 (4%)). Dyspnoea, chest tightness, and disorder of consciousness were more common in deceased patients (70 (62%), 55 (49%), and 25 (22%)) than in recovered patients (50 (31%), 48 (30%), and 1 (1%)). The median time from disease onset to death in deceased patients was 16 (interquartile range 12.0-20.0) days. Leukocytosis was present in 56 (50%) patients who died and 6 (4%) who recovered, and lymphopenia was present in 103 (91%) and 76 (47%) respectively. Concentrations of alanine aminotransferase, aspartate aminotransferase, creatinine, creatine kinase, lactate dehydrogenase, cardiac troponin I, N-terminal pro-brain natriuretic peptide, and D-dimer were markedly higher in deceased patients than in recovered patients. Common complications observed more frequently in deceased patients included acute respiratory distress syndrome (113; 100%), type I respiratory failure (18/35; 51%), sepsis (113; 100%), acute cardiac injury (72/94; 77%), heart failure (41/83; 49%), alkalosis (14/35; 40%), hyperkalaemia (42; 37%), acute kidney injury (28; 25%), and hypoxic encephalopathy (23; 20%). Patients with cardiovascular comorbidity were more likely to develop cardiac complications. Regardless of history of cardiovascular disease, acute cardiac injury and heart failure were more common in deceased patients. CONCLUSION Severe acute respiratory syndrome coronavirus 2 infection can cause both pulmonary and systemic inflammation, leading to multi-organ dysfunction in patients at high risk. Acute respiratory distress syndrome and respiratory failure, sepsis, acute cardiac injury, and heart failure were the most common critical complications during exacerbation of covid-19.	[Chen, Tao; Wu, Di; Chen, Huilong; Yan, Weiming; Chen, Guang; Ma, Ke; Xu, Dong; Yu, Haijing; Wang, Hongwu; Guo, Wei; Chen, Jia; Ding, Chen; Zhang, Xiaoping; Huang, Jiaquan; Han, Meifang; Ning, Qin] Huazhong Univ Sci & Technol, Tongji Hosp, Dept & Inst Infect Dis, Tongji Med Coll, Wuhan 430030, Peoples R China; [Yang, Danlei; Wang, Tao; Zhao, Jianping] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Resp Dis, Tongji Med Coll, Wuhan, Peoples R China; [Li, Shusheng] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Emergency Med, Wuhan, Peoples R China; [Luo, Xiaoping] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Paediat, Tongji Med Coll, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Ning, Q (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Dept & Inst Infect Dis, Tongji Med Coll, Wuhan 430030, Peoples R China.	qning@vip.sina.com		Han, Meifang/0000-0002-1948-8128; Zhao, Jianping/0000-0003-3057-5617	Tongji Hospital for Pilot Scheme Project; Chinese National Thirteenth Five Years Project in Science and Technology [2017ZX10202201]; National Commission of Health, People's Republic of China	Tongji Hospital for Pilot Scheme Project; Chinese National Thirteenth Five Years Project in Science and Technology; National Commission of Health, People's Republic of China	This work was funded by grants from the Tongji Hospital for Pilot Scheme Project and partly supported by the Chinese National Thirteenth Five Years Project in Science and Technology (2017ZX10202201), National Commission of Health, People's Republic of China. The research was designed, conducted, analysed, and interpreted by the authors entirely independently of the funding sources.	[Anonymous], 2020, PEDIATR MED RODZ, V16, P9, DOI 10.15557/PiMR.2020.0003; [Anonymous], 2020, NEW CORONAVIRUS PNEU; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135; Huang C, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Januzzi JL, 2006, EUR HEART J, V27, P330, DOI 10.1093/eurheartj/ehi631; Li Q., 2020, NEW ENGL J MED, V382, P1199; Lin CL, 2004, CHEST, V126, P509, DOI 10.1378/chest.126.2.509; Wang DW, 2020, J COASTAL RES, P1, DOI [10.2112/JCR-SI109-001.1, 10.1001/jama.2020.1585]; WHO, 2019, WHO; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; Xu XW, 2020, BMJ-BRIT MED J, V368, DOI [10.1136/bmj.m606, 10.1136/bmj.m792]; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	19	2294	2363	23	153	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 26	2020	368								m1091	10.1136/bmj.m1091	http://dx.doi.org/10.1136/bmj.m1091			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LA2EA	32217556	hybrid, Green Published			2022-12-28	WOS:000523764800003
